PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Blauenburg, B; Mielcarek, A; Altegoer, F; Fage, CD; Linne, U; Bange, G; Marahiel, MA				Blauenburg, Bastian; Mielcarek, Andreas; Altegoer, Florian; Fage, Christopher D.; Linne, Uwe; Bange, Gert; Marahiel, Mohamed A.			Crystal Structure of Bacillus subtilis Cysteine Desulfurase SufS and Its Dynamic Interaction with Frataxin and Scaffold Protein SufU	PLOS ONE			English	Article							FE-S CLUSTER; IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; YEAST FRATAXIN; BIOGENESIS; HOMOLOG; CYAY; GENE; BIOSYNTHESIS; SEQUENCE	The biosynthesis of iron sulfur (Fe-S) clusters in Bacillus subtilis is mediated by a SUF-type gene cluster, consisting of the cysteine desulfurase SufS, the scaffold protein SufU, and the putative chaperone complex SufB/SufC/SufD. Here, we present the high-resolution crystal structure of the SufS homodimer in its product-bound state (i.e., in complex with pyrodoxal-5'-phosphate, alanine, Cys361-persulfide). By performing hydrogen/deuterium exchange (H/DX) experiments, we characterized the interaction of SufS with SufU and demonstrate that SufU induces an opening of the active site pocket of SufS. Recent data indicate that frataxin could be involved in Fe-S cluster biosynthesis by facilitating iron incorporation. H/DX experiments show that frataxin indeed interacts with the SufS/SufU complex at the active site. Our findings deepen the current understanding of Fe-S cluster biosynthesis, a complex yet essential process, in the model organism B. subtilis.	[Blauenburg, Bastian; Mielcarek, Andreas; Fage, Christopher D.; Linne, Uwe; Bange, Gert; Marahiel, Mohamed A.] Philipps Univ Marburg, Dept Chem, Biochem, Hans Meerwein Str 4, D-35043 Marburg, Germany; [Altegoer, Florian; Bange, Gert] Philipps Univ Marburg, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Marahiel, MA (corresponding author), Philipps Univ Marburg, Dept Chem, Biochem, Hans Meerwein Str 4, D-35043 Marburg, Germany.	marahiel@staff.uni-marburg.de	Bange, Gert/AAB-3734-2021; Altegoer, Florian/AAM-1354-2020	Fage, Christopher Dane/0000-0001-5015-644X; Altegoer, Florian/0000-0002-6012-9047; Bange, Gert/0000-0002-7826-0932	Deutsche Forschungsgemeinschaft (DFG) by Sonderforschungsbereich 987 [SFB 987]; LOEWE excellence initiative of the state of Hesse, Germany; Deutsche Forschungsgemeinschaft (DFG) Scientific Instrumentation Grant [160/621-1 FUGG]; European Synchrotron Radiation Facility (ESRF), Grenoble, France	Deutsche Forschungsgemeinschaft (DFG) by Sonderforschungsbereich 987(German Research Foundation (DFG)); LOEWE excellence initiative of the state of Hesse, Germany; Deutsche Forschungsgemeinschaft (DFG) Scientific Instrumentation Grant(German Research Foundation (DFG)); European Synchrotron Radiation Facility (ESRF), Grenoble, France	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) by Sonderforschungsbereich 987 (SFB 987) Project B1 (http://www.sfb987.de) to MAM, LOEWE excellence initiative of the state of Hesse, Germany (http://www.synmikro.com/en/) to GB and MAM and the Deutsche Forschungsgemeinschaft (DFG) Scientific Instrumentation Grant 160/621-1 FUGG (http://www.dfg.de/en/research_funding/programmes/infrastructure/scientific_instrumentation/ equipment_programmes/index.html) to GB and UL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by SFB987 Project B1 (M.A.M.) and the LOEWE excellence initiative of the state of Hesse, Germany, (M.A.M. and G.B.) and the Scientific Instrumentation Grant 160/621-1 FUGG (G.B. and U.L.). We also acknowledge excellent support by the European Synchrotron Radiation Facility (ESRF), Grenoble, France.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Agar JN, 2000, BIOCHEMISTRY; Albrecht AG, 2011, CHEMBIOCHEM, V12, P2052, DOI 10.1002/cbic.201100190; Albrecht AG, 2011, FEBS LETT, V585, P465, DOI 10.1016/j.febslet.2011.01.005; Albrecht AG, 2010, J BACTERIOL, V192, P1643, DOI 10.1128/JB.01536-09; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1999, CURR OPIN CHEM BIOL, V3, P152, DOI 10.1016/S1367-5931(99)80027-1; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Black KA, 2015, J BACTERIOL, V197, P1952, DOI 10.1128/JB.02625-14; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Correia AR, 2010, BIOCHEM J, V426, P197, DOI 10.1042/BJ20091612; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint DH, 1996, J BIOL CHEM, V271, P16068; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kim S, 2013, J BIOL CHEM, V288, P27172, DOI 10.1074/jbc.M113.480277; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Li DS, 1999, FEBS LETT, V456, P13, DOI 10.1016/S0014-5793(99)00896-0; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mielcarek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122538; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Pastore C, 2006, STRUCTURE, V14, P857, DOI 10.1016/j.str.2006.02.010; Pohl Thomas, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-13; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Qi WB, 2010, CHEM COMMUN, V46, P719, DOI 10.1039/b911975b; Roche B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005134; Selbach B, 2010, BIOCHEMISTRY-US, V49, P8794, DOI 10.1021/bi101358k; Selbach BP, 2014, BIOCHEMISTRY-US, V53, P152, DOI 10.1021/bi4011978; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Silberg JJ, 2001, J BIOL CHEM, V276, P1696, DOI 10.1074/jbc.M009542200; Singh H, 2013, J BIOL CHEM, V288, P36189, DOI 10.1074/jbc.M113.525709; SUN DX, 1993, J BACTERIOL, V175, P1423, DOI 10.1128/JB.175.5.1423-1432.1993; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Yoon H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005135; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	68	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158749	10.1371/journal.pone.0158749	http://dx.doi.org/10.1371/journal.pone.0158749			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27382962	Green Submitted, gold, Green Published			2022-12-27	WOS:000379809400082
J	Campoy, EM; Laurito, SR; Branham, MT; Urrutia, G; Mathison, A; Gago, F; Orozco, J; Urrutia, R; Mayorga, LS; Roque, M				Campoy, Emanuel M.; Laurito, Sergio R.; Branham, Maria T.; Urrutia, Guillermo; Mathison, Angela; Gago, Francisco; Orozco, Javier; Urrutia, Raul; Mayorga, Luis S.; Roque, Maria			Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body	PLOS ONE			English	Article							PROMOTER HYPERMETHYLATION; METHYLATION PROFILE; LATERALITY; ASSOCIATION; SURVIVAL	During the last decades it has been established that breast cancer arises through the accumulation of genetic and epigenetic alterations in different cancer related genes. These alterations confer the tumor oncogenic abilities, which can be resumed as cancer hallmarks (CH). The purpose of this study was to establish the methylation profile of CpG sites located in cancer genes in breast tumors so as to infer their potential impact on 6 CH: i.e. sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, induction of angiogenesis, genome instability and invasion and metastasis. For 51 breast carcinomas, MS-MLPA derived-methylation profiles of 81 CpG sites were converted into 6 CH profiles. CH profiles distribution was tested by different statistical methods and correlated with clinical-pathological data. Unsupervised Hierarchical Cluster Analysis revealed that CH profiles segregate in two main groups (bootstrapping 90-100%), which correlate with breast laterality (p = 0.05). For validating these observations, gene expression data was obtained by RealTime-PCR in a different cohort of 25 tumors and converted into CH profiles. This analyses confirmed the same clustering and a tendency of association with breast laterality (p = 0.15). In silico analyses on gene expression data from TCGA Breast dataset from left and right breast tumors showed that they differed significantly when data was previously converted into CH profiles (p = 0.033). We show here for the first time, that breast carcinomas arising on different sides of the body present differential cancer traits inferred from methylation and expression profiles. Our results indicate that by converting methylation or expression profiles in terms of Cancer Hallmarks, it would allow to uncover veiled associations with clinical features. These results contribute with a new finding to the better understanding of breast tumor behavior, and can moreover serve as proof of principle for other bilateral cancers like lung, testes or kidney.	[Campoy, Emanuel M.; Laurito, Sergio R.; Branham, Maria T.; Urrutia, Guillermo; Mayorga, Luis S.; Roque, Maria] IHEM CONICET, Mendoza, Argentina; [Campoy, Emanuel M.; Gago, Francisco; Orozco, Javier; Mayorga, Luis S.] Natl Univ Cuyo, Fac Med Sci, Mendoza, Argentina; [Laurito, Sergio R.; Roque, Maria] Natl Univ Cuyo, Fac Exact Sci, Mendoza, Argentina; [Mathison, Angela; Urrutia, Raul] Mayo Clin, Epigenet & Chromatin Dynam Lab, Div Gastroenterol & Hepatol, GI Res Unit,Epigen Translat Program,Ctr Individua, Rochester, MN USA; [Gago, Francisco; Orozco, Javier] Gineco Mamario Inst, Mendoza, Argentina; [Gago, Francisco; Orozco, Javier] Italian Hosp Mendoza, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza; Mayo Clinic	Roque, M (corresponding author), IHEM CONICET, Mendoza, Argentina.; Roque, M (corresponding author), Natl Univ Cuyo, Fac Exact Sci, Mendoza, Argentina.	mroque@mendoza-conicet.gob.ar		Mayorga, Luis S/0000-0002-5995-0671; Campoy, Emanuel/0000-0003-0521-6073; Mathison, Angela/0000-0002-6763-2710	Argentine National Institute of Cancer from Argentina; Scientific and Technical Secretary (SECTyP) of the National University of Cuyo, Argentina; Argentine National Institute of Cancer (INC); American Society of Biochemist and Molecular Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	Argentine National Institute of Cancer from Argentina; Scientific and Technical Secretary (SECTyP) of the National University of Cuyo, Argentina; Argentine National Institute of Cancer (INC); American Society of Biochemist and Molecular Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been in part supported by a Grant from the Argentine National Institute of Cancer from Argentina and from the Scientific and Technical Secretary (SECTyP) of the National University of Cuyo, Argentina (MR received the funding).; This work has been in part supported by a Grant from the Argentine National Institute of Cancer (INC) and from the Scientific and Technical Secretary (SECTyP) of the National University of Cuyo, Argentina. EC obtained a fellowship from the American Society of Biochemist and Molecular Biology to perform the gene expression assays.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Borisenkov MF, 2001, SURVIVAL HUMAN BREAS, V27, P631; Branham MT, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.17; Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216; Cappello F, 2001, J ANAT, V199, P617, DOI 10.1017/S002187820100841X; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Dammann R, 2001, CANCER RES, V61, P3105; Dane S, 2008, LYMPHOLOGY, V41, P75; de Blacam C, 2011, IRISH J MED SCI, V180, P727, DOI 10.1007/s11845-011-0713-5; Delahunt B, 1994, RENAL CELL CARCINOMA, P300; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; Fatima N, 2013, ASIAN PAC J CANCER P, V14, P43, DOI 10.7314/APJCP.2013.14.1.43; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Garfinkel L, 1969, APPRAISAL LEFT RIGHT, V1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARTVEIT F, 1984, ONCOLOGY, V41, P149, DOI 10.1159/000225812; HSIEH CC, 1991, EUR J CANCER, V27, P131, DOI 10.1016/0277-5379(91)90469-T; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Marzese DM, 2012, J MOL DIAGN, V14, P613, DOI 10.1016/j.jmoldx.2012.07.001; Marzese DM, 2010, MOL CELL PROBE, V24, P271, DOI 10.1016/j.mcp.2010.05.002; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Moelans CB, 2011, J PATHOL, V225, P222, DOI 10.1002/path.2930; Onibokun O, 2015, BREAST J, V21, P213, DOI 10.1111/tbj.12385; Perkins CI, 2004, CANCER CAUSE CONTROL, V15, P637, DOI 10.1023/B:CACO.0000036171.44162.5f; Robichaux JP, 2015, ONCOGENE, V34, P2003, DOI 10.1038/onc.2014.149; Roychoudhuri R, 2006, CANCER CAUSE CONTROL, V17, P655, DOI 10.1007/s10552-005-0615-9; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sodir NM, 2011, ONCOTARGET, V2, P1307; STONE JM, 1991, BRIT J CANCER, V64, P132, DOI 10.1038/bjc.1991.256; Twelves D, 2013, BREAST CANCER RES TR, V139, P341, DOI 10.1007/s10549-013-2544-8; Veltmaat JM, 2013, J MAMMARY GLAND BIOL, V18, P179, DOI 10.1007/s10911-013-9287-3; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Waterland RA, 2009, EPIGENETICS-US, V4, P523, DOI 10.4161/epi.4.8.10155; Wilting J, 2011, CURR MED CHEM, V18, P5519, DOI 10.2174/092986711798347252	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157416	10.1371/journal.pone.0157416	http://dx.doi.org/10.1371/journal.pone.0157416			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383829	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400013
J	Groot, E; Kouyoumdjian, FG; Kiefer, L; Madadi, P; Gross, J; Prevost, B; Jhirad, R; Huyer, D; Snowdon, V; Persaud, N				Groot, Emily; Kouyoumdjian, Fiona G.; Kiefer, Lori; Madadi, Parvaz; Gross, Jeremy; Prevost, Brittany; Jhirad, Reuven; Huyer, Dirk; Snowdon, Victoria; Persaud, Navindra			Drug Toxicity Deaths after Release from Incarceration in Ontario, 2006-2013: Review of Coroner's Cases	PLOS ONE			English	Review							THERAPEUTIC-COMMUNITY TREATMENT; OPIOID SUBSTITUTION THERAPY; MORTALITY; PRISON; RISK; INMATES; OFFENDERS; OVERDOSE; SCOTLAND; IMPACT	Background There is an increased risk of death due to drug toxicity after release from incarceration. The purpose of this study was to describe the timing, rate and circumstances of drug toxicity deaths following release from incarceration. This information can be used to help design potential preventive interventions. Methods and Findings We reviewed coroner's files to identify deaths in adults in Ontario between 2006 and 2013 caused by drug toxicity (n = 6,978) and these records were matched with provincial correctional records to identify individuals who died within one year of being released from incarceration (n = 702). Twenty percent (n = 137) of the 702 deaths occurred within one week of release. The majority (77%, n = 538) of deaths after release involved one or more opioids. Of the deaths involving opioids, intervention by another person may have been possible in 318 cases. Conclusions Between 2006 and 2013 in Ontario, one in ten drug toxicity deaths in adults occurred within one year of release from provincial incarceration. These findings may help to inform the implemention and assessment of interventions aimed at reducing drug toxicity deaths following release from incarceration.	[Groot, Emily] Queens Univ, Dept Family Med, Kingston, ON, Canada; [Kouyoumdjian, Fiona G.; Persaud, Navindra] St Michaels Hosp, Toronto, ON, Canada; [Kiefer, Lori] Ontario Minist Community Safety & Correct Serv, Toronto, ON, Canada; [Kiefer, Lori] Unviers Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Madadi, Parvaz] Ctr Forens Sci, Toronto, ON, Canada; [Gross, Jeremy; Prevost, Brittany] Univ Toronto, Fac Med, Toronto, ON, Canada; [Jhirad, Reuven; Huyer, Dirk; Snowdon, Victoria; Persaud, Navindra] Off Chief Coroner Ontario, Toronto, ON, Canada; [Persaud, Navindra] Univ Toronto, Toronto, ON, Canada	Queens University - Canada; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Persaud, N (corresponding author), St Michaels Hosp, Toronto, ON, Canada.; Persaud, N (corresponding author), Off Chief Coroner Ontario, Toronto, ON, Canada.; Persaud, N (corresponding author), Univ Toronto, Toronto, ON, Canada.	nav.persaud@utoronto.ca	Cuscó, Xavier Garcia/S-7576-2019	Cuscó, Xavier Garcia/0000-0001-7199-6931				Andrews JY, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-270; [Anonymous], 2010, MICR EXC; [Anonymous], 2014, PREV OV DEATHS CRIM; Beswick T, 2002, J DRUG ISSUES, V32, P1103, DOI 10.1177/002204260203200406; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Binswanger IA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-3; Bird SM, 2015, ADDICTION, V110, P1617, DOI 10.1111/add.12969; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; Christensen PB, 2006, INT J PRISON HEALTH, V2, P13, DOI 10.1080/17449200600743644; Degenhardt L, 2014, ADDICTION, V109, P1306, DOI 10.1111/add.12536; Farrell M, 2008, ADDICTION, V103, P251, DOI 10.1111/j.1360-0443.2007.02081.x; Forsberg LG, 2011, SUBST USE MISUSE, V46, P1477, DOI 10.3109/10826084.2011.591880; Freudenberg N, 2010, J ADOLESCENT HEALTH, V47, P448, DOI 10.1016/j.jadohealth.2010.01.008; Grommon E, 2013, J OFFENDER REHABIL, V52, P287, DOI 10.1080/10509674.2013.782775; HARDINGPINK D, 1988, BRIT MED J, V297, P596, DOI 10.1136/bmj.297.6648.596; Information Services Division of the NHS National Services Scotland [Internet], 2014, NAT NAL PROGR SCOTL; Joukamaa M, 1998, FORENSIC SCI INT, V96, P11, DOI 10.1016/S0379-0738(98)00098-X; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kouyoumdjian Fiona G, 2016, CMAJ Open, V4, pE153, DOI 10.9778/cmajo.20150098; Kouyoumdjian FG, 2015, AM J PUBLIC HEALTH, V105, pE13, DOI 10.2105/AJPH.2014.302498; Kouyoumdjian FG, 2014, CAN J PUBLIC HEALTH, V105, pE198, DOI 10.17269/cjph.105.4193; Krinsky CS, 2009, AM J FOREN MED PATH, V30, P6, DOI 10.1097/PAF.0b013e3181873784; Lattimore PK, 1997, J RES CRIME DELINQ, V34, P187, DOI 10.1177/0022427897034002002; Luce J, 2011, CROSS CANADA SCAN ME; Lyons S, 2010, INT J PRISON HLTH, V35, P26; Madadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060600; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Needels K, 2005, J URBAN HEALTH, V82, P420, DOI 10.1093/jurban/jti092; Prendergast M, 2011, J EXP CRIMINOL, V7, P225, DOI 10.1007/s11292-011-9123-y; Putkonen H, 2001, FORENSIC SCI INT, V119, P221, DOI 10.1016/S0379-0738(00)00431-X; Sacks JY, 2012, J ADDICT DIS, V31, P258, DOI 10.1080/10550887.2012.694601; Statistics Canada, 2014, POP AG SEX POP EST A; Stewart LM, 2004, AUST NZ J PUBL HEAL, V28, P32, DOI 10.1111/j.1467-842X.2004.tb00629.x; Strang J, 2013, J URBAN HEALTH, V90, P983, DOI 10.1007/s11524-013-9803-1; Sullivan CJ, 2007, AM J DRUG ALCOHOL AB, V33, P823, DOI 10.1080/00952990701653800; Verger P, 2003, J FORENSIC SCI, V48, P614; WHO, 2014, COMM MAN OP OV; Zakaria D., 2010, SUMMARY EMERGING FIN; Zlotnick C, 2009, BEHAV THER, V40, P325, DOI 10.1016/j.beth.2008.09.004	40	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157512	10.1371/journal.pone.0157512	http://dx.doi.org/10.1371/journal.pone.0157512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27384044	gold, Green Published, Green Submitted			2022-12-27	WOS:000379809400014
J	Skeffington, PM; Rees, CS; Mazzucchelli, TG; Kane, RT				Skeffington, Petra M.; Rees, Clare S.; Mazzucchelli, Trevor G.; Kane, Robert T.			The Primary Prevention of PTSD in Firefighters: Preliminary Results of an RCT with 12-Month Follow-Up	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PSYCHOMETRIC PROPERTIES; SOCIAL SUPPORT; COPING STRATEGIES; POLICE OFFICERS; TRAUMA; CHECKLIST; IMPACT; INTERVENTION; APPRAISALS	Aim To develop and evaluate an evidence-based and theory driven program for the primary prevention of Post-traumatic Stress Disorder (PTSD). Design A pre-intervention / post-intervention / follow up control group design with clustered random allocation of participants to groups was used. The "control" group received "Training as Usual" (TAU). Method Participants were 45 career recruits within the recruit school at the Department of Fire and Emergency Services (DFES) in Western Australia. The intervention group received a four-hour resilience training intervention (Mental Agility and Psychological Strength training) as part of their recruit training school curriculum. Data was collected at baseline and at 6- and 12-months post intervention. Results We found no evidence that the intervention was effective in the primary prevention of mental health issues, nor did we find any significant impact of MAPS training on social support or coping strategies. A significant difference across conditions in trauma knowledge is indicative of some impact of the MAPS program. Conclusion While the key hypotheses were not supported, this study is the first randomised control trial investigating the primary prevention of PTSD. Practical barriers around the implementation of this program, including constraints within the recruit school, may inform the design and implementation of similar programs in the future.	[Skeffington, Petra M.; Rees, Clare S.; Mazzucchelli, Trevor G.; Kane, Robert T.] Curtin Univ, Fac Hlth Sci, Sch Psychol & Speech Pathol, Perth, WA, Australia	Curtin University	Skeffington, PM (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Psychol & Speech Pathol, Perth, WA, Australia.	petra.skeffington@curtin.edu.au	Mazzucchelli, Trevor G/B-6659-2013; Mazzucchelli, Trevor/AAC-5853-2019	Mazzucchelli, Trevor G/0000-0002-8306-3917; Mazzucchelli, Trevor/0000-0002-8306-3917; Skeffington, Petra/0000-0002-4830-1131				ACPMH, 2013, GUID TREATM AD AC ST; Aldao A, 2012, J ABNORM PSYCHOL, V121, P276, DOI 10.1037/a0023598; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; [Anonymous], 2011, AM J HLTH SCI, DOI DOI 10.19030/AJHS.V2I1.4365; Antonellis PJ, 2012, FIRE ENG, V16, P69; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Australian Bureau of Statistics [ABS], 2008, NAT SURV MENT HLTH W; Barrington A, 2013, J LOSS TRAUMA, V18, P429, DOI 10.1080/15325024.2012.714210; Basoglu M, 1997, PSYCHOL MED, V27, P1421, DOI 10.1017/S0033291797005679; Beaton R, 1998, J TRAUMA STRESS, V11, P821, DOI 10.1023/A:1024461920456; Berger W, 2012, SOC PSYCH PSYCH EPID, V47, P1001, DOI 10.1007/s00127-011-0408-2; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boozer RH, 1998, PSYCHOTRAUMATOLOGY F; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Britt TW, 2012, CONT OCCUPATIONAL HL, V2, P57, DOI DOI 10.1002/9781119942849.CH4; Bryant RA, 2005, PSYCHOL SCI, V16, P749, DOI 10.1111/j.1467-9280.2005.01608.x; Bryant RA, 1996, J TRAUMA STRESS, V9, P51, DOI 10.1007/BF02116833; Bryant RA, 2003, BEHAV RES THER, V41, P489, DOI 10.1016/S0005-7967(02)00179-1; Bryant RA, 2007, J CONSULT CLIN PSYCH, V75, P812, DOI 10.1037/0022-006X.75.5.812; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chamberlin MJA, 2010, J LOSS TRAUMA, V15, P548, DOI 10.1080/15325024.2010.519275; Chan AOM, 2003, J CLIN PSYCHIAT, V64, P175, DOI 10.4088/JCP.v64n0210; Charuvastra A, 2008, ANNU REV PSYCHOL, V59, P301, DOI 10.1146/annurev.psych.58.110405.085650; Choi KW, 2015, ARCH WOMEN MENT HLTH, P1; Community Development and Justice Standing Committee, 2012, THE TOLL OF TRAUMA O; Coyne JC, 1996, J PERS, V64, P959, DOI 10.1111/j.1467-6494.1996.tb00950.x; Deahl M, 2000, BRIT J MED PSYCHOL, V73, P77, DOI 10.1348/000711200160318; Devilly GJ, 2006, REV GEN PSYCHOL, V10, P318, DOI 10.1037/1089-2680.10.4.318; DURHAM TW, 1985, ANN EMERG MED, V14, P664, DOI 10.1016/S0196-0644(85)80884-2; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Eidelson R., 2012, 1 COAL ETH PSYCH; Feldner MT, 2007, BEHAV MODIF, V31, P80, DOI 10.1177/0145445506295057; Field A., 2013, DISCOVERING STAT USI; Gidron Y, 2001, J TRAUMA STRESS, V14, P773, DOI 10.1023/A:1013046322993; Hall GB, 2010, J OCCUP ORGAN PSYCH, V83, P237, DOI 10.1348/096317908X401723; Harris R., 2008, THE HAPPINESS TRAP; Harrop Emily, 2006, RESILIENCE COPING SA; Holden JE, 2008, AM J NEPHROL, V28, P792, DOI 10.1159/000131102; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Lee JS, 2014, J AFFECT DISORDERS, V162, P128, DOI 10.1016/j.jad.2014.02.031; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; MCFARLANE AC, 1989, BRIT J PSYCHIAT, V154, P221, DOI 10.1192/bjp.154.2.221; McNally Richard J, 2003, Psychol Sci Public Interest, V4, P45, DOI 10.1111/1529-1006.01421; Moore BC, 2011, J SOC WORK PRACT ADD, V11, P17, DOI 10.1080/1533256X.2011.544600; Moss A, 2013, R10895451 JHC COMM A; Norris FH, 2004, ASSESSING PSYCHOL TR, P63; Orsillo S.M., 2002, PRACTITIONERS GUIDE, P255, DOI [10.1007/0-306-47628-2_20, DOI 10.1007/0-306-47628-2_20]; Paton D., 2005, TRAUMATOLOGY, V11, P335, DOI [10.1177/153476560501100411, DOI 10.1177/153476560501100411]; Rasbash J, 2004, USERS GUIDE MLWIN; Renshaw KD, 2011, J AFFECT DISORDERS, V128, P321, DOI 10.1016/j.jad.2010.07.022; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Schnurr P P, 1999, Semin Clin Neuropsychiatry, V4, P295; Shakespeare-Finch J.E., P 2014 AUSTR NZ DIS; Shakespeare-Finch J, 2011, J PERS ASSESS, V93, P483, DOI 10.1080/00223891.2011.594124; Shochet I.M., 2011, TRAUMATOLOGY, V17, P43, DOI [10.1177/1534765611429080, DOI 10.1177/1534765611429080]; Sijaric-Voloder S, 2008, HEALTHMED, V2, P288; Skeffington PM, 2013, J TRAUMA DISSOCIATIO, V14, P404, DOI 10.1080/15299732.2012.753653; Smith AJ, 2015, ANXIETY STRESS COPIN, V28, P340, DOI 10.1080/10615806.2014.969719; Sripada RK, 2015, PSYCHIAT SERV, V66, P65, DOI 10.1176/appi.ps.201400029; Stander VA, 2013, CLIN PSYCHOL REV; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Stephens C., 1998, POLICING INT J POLIC, V21, P178, DOI DOI 10.1108/13639519810206664; Tuckey MR, 2013, ANXIETY STRESS COPIN; Voracek M, 2010, SCAND J PSYCHOL, V51, P146, DOI 10.1111/j.1467-9450.2009.00758.x; Wolmer L, 2011, J AM ACAD CHILD PSY, V50, P340, DOI 10.1016/j.jaac.2011.01.002	66	33	35	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0155873	10.1371/journal.pone.0155873	http://dx.doi.org/10.1371/journal.pone.0155873			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27382968	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400002
J	Song, YF; Nikoloff, JM; Fu, G; Chen, JQ; Li, QG; Xie, NZ; Zheng, P; Sun, JB; Zhang, DW				Song, Yafeng; Nikoloff, Jonas M.; Fu, Gang; Chen, Jingqi; Li, Qinggang; Xie, Nengzhong; Zheng, Ping; Sun, Jibin; Zhang, Dawei			Promoter Screening from Bacillus subtilis in Various Conditions Hunting for Synthetic Biology and Industrial Applications	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAIN; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; RIBOFLAVIN PRODUCTION; RNA-POLYMERASE; SYSTEMS; DESIGN; BIOSYNTHESIS; ADAPTATION; STRESS	The use of Bacillus subtilis in synthetic biology and metabolic engineering is highly desirable to take advantage of the unique metabolic pathways present in this organism. To do this, an evaluation of B. subtilis' intrinsic biological parts is required to determine the best strategies to accurately regulate metabolic circuits and expression of target proteins. The strengths of promoter candidates were evaluated by measuring relative fluorescence units of a green fluorescent protein reporter, integrated into B. subtilis' chromosome. A total of 84 predicted promoter sequences located upstream of different classes of proteins including heat shock proteins, cell-envelope proteins, and proteins resistant against toxic metals (based on similarity) and other kinds of genes were tested. The expression levels measured ranged from 0.0023 to 4.53-fold of the activity of the well-characterized strong promoter P43. No significant shifts were observed when strains, carrying different promoter candidates, were cultured at high temperature or in media with ethanol, but some strains showed increased activity when cultured under high osmotic pressure. Randomly selected promoter candidates were tested and found to activate transcription of thermostable beta-galactosidase (bgaB) at a similar level, implying the ability of these sequences to function as promoter elements in multiple genetic contexts. In addition, selected promoters elevated the final production of both cytoplasmic bgaB and secreted protein alpha-amylase to about fourfold and twofold, respectively. The generated data allows a deeper understanding of B. subtilis' metabolism and will facilitate future work to develop this organism for synthetic biology.	[Song, Yafeng; Nikoloff, Jonas M.; Fu, Gang; Chen, Jingqi; Li, Qinggang; Zheng, Ping; Sun, Jibin; Zhang, Dawei] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China; [Song, Yafeng; Fu, Gang; Chen, Jingqi; Li, Qinggang; Zheng, Ping; Sun, Jibin; Zhang, Dawei] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Xie, Nengzhong] Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass Energy & Enzyme Tec, Nanning 5300074, Peoples R China; [Xie, Nengzhong] Guangxi Acad Sci, Guangxi Biomass Ind Engn Inst, Nanning 530007, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences	Zhang, DW (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.; Zhang, DW (corresponding author), Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China.	zhang_dw@tib.cas.cn	Chen, Jingqi/AAE-6883-2022	Chen, Jingqi/0000-0003-0750-8539; Sun, Jibin/0000-0002-0208-504X	National Nature Science Foundation of China [31370089, 21506244, 31400079]; State Key Development 973 Program for Basic Research of China [2013CB733601]; Nature Science Foundation of Tianjin City (CN) [16JCYBJC23500, 15JCQNJC09500]; Guangxi Science and Technology Development Project [14125008-2-22]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development 973 Program for Basic Research of China; Nature Science Foundation of Tianjin City (CN); Guangxi Science and Technology Development Project	This work was supported by National Nature Science Foundation of China (31370089 to DZ, 21506244 to GF, 31400079 to NX; http://www.nsfc.gov.cn/), State Key Development 973 Program for Basic Research of China (2013CB733601 to DZ, http://www.most.gov.cn/), Nature Science Foundation of Tianjin City (CN) (16JCYBJC23500 to DZ, 15JCQNJC09500 to DZ; http://www.tstc.gov.cn/) and the Guangxi Science and Technology Development Project (14125008-2-22 to NX; http://www.gxsti.net.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Asai K, 2007, MICROBIOL-SGM, V153, P92, DOI 10.1099/mic.0.29239-0; Bai C, 2015, P NATL ACAD SCI US; Bernhardt J, 2003, GENOME RES, V13, P224, DOI 10.1101/gr.905003; Bienick MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109105; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Brewster RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002811; Chen JQ, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0282-9; Chen JQ, 2015, BIOTECHNOL LETT, V37, P899, DOI 10.1007/s10529-014-1755-3; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curran KA, 2013, METAB ENG, V19, P88, DOI 10.1016/j.ymben.2013.07.001; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Dempwolff F, 2012, J BACTERIOL, V194, P4652, DOI 10.1128/JB.00910-12; Duan YX, 2010, APPL MICROBIOL BIOT, V85, P1907, DOI 10.1007/s00253-009-2247-6; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Ferreira LCS, 2005, AN ACAD BRAS CIENC, V77, P113, DOI 10.1590/S0001-37652005000100009; Gerosa L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.14; Guo XR, 2005, J BIOL CHEM, V280, P39601, DOI 10.1074/jbc.M508132200; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Haynes KA, 2009, J CELL BIOL, V187, P589, DOI 10.1083/jcb.200908138; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Jervis AJ, 2007, J BACTERIOL, V189, P4534, DOI 10.1128/JB.00130-07; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Kang SY, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0268-7; Kang SY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-153; Keren L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.59; Kingston AW, 2013, MOL MICROBIOL, V90, P502, DOI 10.1111/mmi.12380; Koga K, 2006, J GEN APPL MICROBIOL, V52, P119, DOI 10.2323/jgam.52.119; Kohlstedt M, 2014, ENVIRON MICROBIOL, V16, P1898, DOI 10.1111/1462-2920.12438; Liu L, 2013, APPL MICROBIOL BIOT, V97, P6113, DOI 10.1007/s00253-013-4960-4; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Ng CY, 2015, CURR OPIN CHEM BIOL, V28, P105, DOI 10.1016/j.cbpa.2015.06.026; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Overkamp W, 2015, ENVIRON MICROBIOL, V17, P346, DOI 10.1111/1462-2920.12676; Qi H, 2015, BIOTECHNOL ADV; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rollenhagen C, 2003, J BACTERIOL, V185, P35, DOI 10.1128/JB.185.1.35-40.2003; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schumann W, 2003, CELL STRESS CHAPERON, V8, P207, DOI 10.1379/1466-1268(2003)008<0207:TBSHSS>2.0.CO;2; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; Tamehiro N, 2002, ANTIMICROB AGENTS CH, V46, P315, DOI 10.1128/AAC.46.2.315-320.2002; Tojo S, 2008, J BACTERIOL, V190, P6134, DOI 10.1128/JB.00606-08; Trang TPP, 2012, J BIOTECHNOL, V157, P167, DOI 10.1016/j.jbiotec.2011.10.006; Wang GL, 2014, WORLD J MICROB BIOT, V30, P1893, DOI [10.1007/s11274-014-1611-6, 1]; Wang JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062960; WANG PZ, 1984, J BIOL CHEM, V259, P8619; Wang ZW, 2011, BIORESOURCE TECHNOL, V102, P3934, DOI 10.1016/j.biortech.2010.11.120; Westers L, 2004, BBA-MOL CELL RES, V1694, P299, DOI 10.1016/j.bbamcr.2004.02.011; Wong Ng J., 2010, PHYS REV E, V81; Yamanishi M, 2013, ACS SYNTH BIOL, V2, P337, DOI 10.1021/sb300116y; You C, 2012, APPL ENVIRON MICROB, V78, P1593, DOI 10.1128/AEM.07105-11; YUAN G, 1995, J BACTERIOL, V177, P5427, DOI 10.1128/jb.177.19.5427-5433.1995; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang XZ, 2014, METHODS MOL BIOL, V1151, P95, DOI 10.1007/978-1-4939-0554-6_7	57	73	83	8	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158447	10.1371/journal.pone.0158447	http://dx.doi.org/10.1371/journal.pone.0158447			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380260	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700032
J	Nilsson, K				Nilsson, Kerstin			Parents' Attitudes to Risk and Injury to Children and Young People on Farms	PLOS ONE			English	Article							AGRICULTURAL INJURIES	Objectives Children and young people growing up in a farm environment run a greater risk of being injured or dying in an accident than their non-farming counterparts. This study examines farming parents' attitudes and experiences of having their children grow up on farms, one of the most dangerous work environments as their home, everyday environment and playground. Method Data were collected using two ethnological methods, a question list and interviews, with a study population of 20 parents. The data were analysed phenomenologically. Results The analysis pursued four themes: i) the most dangerous places and situations on the farm; ii) children's tasks on the farm; iii) children as a safety risk on the farm; and iv) farm risk education for children. Conclusions Most parents know the risks on their farm, but are sometimes careless when working under stress or exhaustion. Some parents wanted more information and some wanted compulsory preventative or safety measures by manufacturers, e.g. a safety belt as standard on the extra seat in tractors. Children's friends were described as one of the greatest risks for injury due to peer pressure. Some parents mentioned that people who grow up on farms are sometimes 'blind' to the dangers. Other parents seemed to overlook the risks and had their children carrying out tasks for which they were not mentally or physically equipped. Some of the tasks the children reportedly carried out on farms contravened Swedish legislation. It is thus important for farming parents to be repeatedly reminded of the risks to their children and to increase their awareness of how to prevent and eliminate risks in order to avoid accidents on the farm. The situation for farm children is highlighted in a critical discussion.	[Nilsson, Kerstin] Swedish Univ Agr Sci, Dept Work Sci Econ & Environm Psychol, Alnarp, Sweden; [Nilsson, Kerstin] Lund Univ, Div Occupat & Environm Med, Lund, Sweden	Swedish University of Agricultural Sciences; Lund University	Nilsson, K (corresponding author), Swedish Univ Agr Sci, Dept Work Sci Econ & Environm Psychol, Alnarp, Sweden.; Nilsson, K (corresponding author), Lund Univ, Div Occupat & Environm Med, Lund, Sweden.	kerstin.nilsson@slu.se		Nilsson, Kerstin/0000-0002-3193-205X	Swedish Farmers' Foundation for Agricultural Research	Swedish Farmers' Foundation for Agricultural Research	The study was funded by The Swedish Farmers' Foundation for Agricultural Research and was performed by the Swedish University of Agricultural Sciences, Institution of Work Science, Business Economics and Environmental Psychology, Alnarp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, 20123 AFS SWED WORK; [Anonymous], 1988, BRIT J PSYCHIAT, DOI DOI 10.1192/S0007125000223416; Bandura Albert, 1963, SOCIAL LEARNING PERS; Benfalk C, 2007, CHILDREN ACCIDENTS A; CIPA (Child Injury Prevention Alliance), 2012, KEEP KIDS SAF FARMS; Cullberg J., 2001, CRISIS DEV; Esser N, 2003, CREATING SAFE PLAY A; Farmsafe Australia, 1999, CHILD SAF FARMS FRAM; Gallagher SS, 2012, J AGROMEDICINE, V17, P109, DOI 10.1080/1059924X.2012.664033; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; GLANZ K, 1997, HLTH BEHAV HLTH ED T; Hagstrom C, 2005, QUESTION LIST SOURS; Hall A., 2003, STRATEGIZING CONTEXT; Hard DL, 2012, J AGROMEDICINE, V17, P225, DOI 10.1080/1059924X.2012.658341; Hartling L, 2004, PEDIATRICS, V114, pE483, DOI 10.1542/peds.2003-1038-L; Koskela H, 2000, GEOFORUM, V31, P269, DOI 10.1016/S0016-7185(99)00033-0; Kvale S., 1997, COMMUNICATION; Lee B., 2012, BLUEPRINT PROTECTING; Lehtola MM, 2008, SCAND J WORK ENV HEA, V34, P327, DOI 10.5271/sjweh.1279; Lueder R., 2008, ERGONOMICS CHILDREN; Marlenga B, 2004, J Agric Saf Health, V10, P17; McCall BP, 2007, J ADOLESCENT HEALTH, V41, P248, DOI 10.1016/j.jadohealth.2007.02.004; Miller ME, 2012, J AGROMEDICINE, V17, P163, DOI 10.1080/1059924X.2012.660434; Morrongiello BA, 2008, ACCIDENT ANAL PREV, V40, P1149, DOI 10.1016/j.aap.2007.12.007; Morrongiello BA, 2007, SOC SCI MED, V65, P1364, DOI 10.1016/j.socscimed.2007.05.013; Morrongiello BA, 2012, J AGROMEDICINE, V17, P149, DOI 10.1080/1059924X.2012.655127; Naidoo J, 2000, HLTH PROMOTION FDN P; National Agricultural Statics Service (NASS), 2004, NAT AGR STAT SERV NA; Nilsson K, 2010, J AGRIC SAF HEALTH, V16, P19, DOI 10.13031/2013.29246; Nilsson K, FORALDRARS ATTITYDER; Nilsson K, 2016, WORK J PREVENTION AS; Nordic Council of Ministers, 2011, NORD2011501 NORD COU, V2011, P501; Ostberg V, 1997, SOCIOL HEALTH ILL, V19, P415; Pinzke S, 2006, WORK ACCIDENTS FORES; Pinzke S, 2014, WORK, V49, P39, DOI 10.3233/WOR-131767; Rautiainen RH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006398.pub2; Robertson SM, 2006, J RURAL HEALTH, V22, P26, DOI 10.1111/j.1748-0361.2006.00001.x; Runyan CW, 2011, J ADOLESCENT HEALTH, V49, P84, DOI 10.1016/j.jadohealth.2010.09.024; Runyan CW, 2009, J ADOLESCENT HEALTH, V44, P349, DOI 10.1016/j.jadohealth.2008.08.009; Sakert Bondfornuft, 2013, CHILD SAF FARM; Sanderson LL, FARM APPRENTICE AGR; Schwebel DC, 2012, J AGROMEDICINE, V17, P214, DOI 10.1080/1059924X.2012.655120; Skinner B. F, 1974, BEHAVIORISM, V1st; Sorensen J, 2009, SOCIAL MARKETING INJ; Swedish Board of Agriculture, 2008, AGR STAT 2008; Swedish Ministry of Health and Social Affairs, 2002, 200268 SOU SWED MIN; Swedish Ministry of Health and Social Affairs, 2002, 200299 SOU SWED MIN; Swedish Ministry of Health and Social Affairs, 2003, 2003127 SOU SWED MIN; The Australian Centre for Agricultural Health and Safety. Child Safety on Farms, 2004, CHILD SAF FARMS, V7; The Norwegian Farmers Association for Occupational Health and Safety, 2000, SAF FARM HOLD PLANN; The Swedish Work Environment Authority, 2012, 20122 SWED WORK ENV; The Swedish Work Environment Authority, 2008, 20082 SWED WORK ENV; Thelin A, 2002, J Agric Saf Health, V8, P289; Westaby JD, 2005, J APPL PSYCHOL, V90, P1027, DOI 10.1037/0021-9010.90.5.1027; Wright S, 2013, CURR PROB PEDIATR AD, V43, P8, DOI 10.1016/j.cppeds.2012.08.002; Zerubavel E., 2006, ELEPHANT ROOM SILENC	56	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158368	10.1371/journal.pone.0158368	http://dx.doi.org/10.1371/journal.pone.0158368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362751	Green Submitted, gold, Green Published			2022-12-27	WOS:000378865200066
J	Petersen, PE; Penman, DJ; Dahle, G; Patursson, O; Taggart, JB				Petersen, Petra E.; Penman, David J.; Dahle, Geir; Patursson, Oystein; Taggart, John B.			Differential Survival among Batches of Atlantic Cod (Gadus morhua L.) from Fertilisation through to Post-Metamorphosis	PLOS ONE			English	Article							EARLY EMBRYONIC CLEAVAGE; REPRODUCTIVE SUCCESS; HATCHING SUCCESS; LARVAL QUALITY; EGG SIZE; GROWTH; VIABILITY; COMPETITION; SELECTION	Aquaculture production of cod has decreased from over 20,000 tonnes in 2009 to less than 2,000 tonnes in 2014 and the industry faces many challenges, one of which is high and unpredictably variable mortality rates in the early life stages. Hence, full-cycle farming with hatchery produced juveniles is still considered unprofitable compared to fisheries and on-growing of wild cod. In the present study, potential batch differences in progeny survival of wild-caught, hatchery-spawned Faroe Bank cod (Gadus morhua L.) were investigated at two defined periods during early life history; i) the embryo stage (60 day degrees post fertilisation) and ii) the fry stage (110 days post hatch), post metamorphosis. The fry stage experiment was conducted in three replicates (N = 300 per replicate), and a panel of three polymorphic microsatellite markers was used for parental analysis. Mean survival rate at the embryo stage was 69% (+/- 20% SD). Survival was positively associated with egg diameter (P < 0.01), explaining 90% of the variation in egg survival rates. The data were too scarce to conclude either way concerning a possible correlation between survival rates between the two periods (P < 0.10). Offspring from three batches (from a total of eight) dominated in the fry stage, contributing over 90% of the progeny, and results were consistent over all three replicate tanks. The skewed batch representation observed may be of relevance to the effective management of selective breeding programmes for cod.	[Petersen, Petra E.; Patursson, Oystein] Aquaculture Res Stn Faroes, Dept Biotechnol, Hvalvik, Faroe Islands, Denmark; [Petersen, Petra E.; Penman, David J.; Taggart, John B.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling, Scotland; [Dahle, Geir] Inst Marine Res, Bergen, Norway	University of Stirling; Institute of Marine Research - Norway	Petersen, PE (corresponding author), Aquaculture Res Stn Faroes, Dept Biotechnol, Hvalvik, Faroe Islands, Denmark.; Petersen, PE (corresponding author), Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling, Scotland.	petrapetersen79@gmail.com		Taggart, John/0000-0002-3843-9663	Faroese Research Council; Fiskaaling, the Aquaculture Research Station of the Faroes; MASTS (The Marine Alliance for Science and Technology for Scotland) - Scottish Funding Council grant [HR09001]	Faroese Research Council; Fiskaaling, the Aquaculture Research Station of the Faroes; MASTS (The Marine Alliance for Science and Technology for Scotland) - Scottish Funding Council grant	This work has received financial support from the Faroese Research Council (http://www.gransking.fo/) and Fiskaaling, the Aquaculture Research Station of the Faroes (http://www.fiskaaling.fo/) (GD and PEP). JBT and DJP are partly supported by the MASTS (The Marine Alliance for Science and Technology for Scotland; http://www.masts.ac.uk) pooling initiative which is funded by a Scottish Funding Council grant (HR09001) and contributing institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annitage D, 2007, AQUACULTURE, V272, pS242, DOI 10.1016/j.aquaculture.2007.07.026; Avery TS, 2009, AQUACULTURE, V289, P265, DOI 10.1016/j.aquaculture.2008.12.011; Bekkevold D, 2002, MOL ECOL, V11, P91, DOI 10.1046/j.0962-1083.2001.01424.x; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; Brander K., 2005, ICES COOP RES REP, V274, P1; Chambers RC, 1996, CAN J FISH AQUAT SCI, V53, P1896; *FAO, FISH STAT COLL; Gjerde B, 2004, AQUACULTURE, V236, P167, DOI 10.1016/j.aquaculture.2004.03.004; Gunnarsli KS, 2009, AQUACULTURE, V288, P344, DOI 10.1016/j.aquaculture.2008.11.039; Halldorsson JE, 2012, MAR POLICY, V36, P11, DOI 10.1016/j.marpol.2011.03.001; Hansen LA, 2004, GAD MAR DEV FUT CHAL; Hansen OJ, 2010, AQUAC RES, V41, P1791, DOI 10.1111/j.1365-2109.2010.02506.x; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Herlin M, 2008, AQUACULTURE, V274, P218, DOI 10.1016/j.aquaculture.2007.11.034; Hutchings JA, 1999, CAN J FISH AQUAT SCI, V56, P97, DOI 10.1139/cjfas-56-1-97; ICES, 2014ACOM ICES CM; Kamler E, 2005, REV FISH BIOL FISHER, V15, P399, DOI 10.1007/s11160-006-0002-y; Karlsen O, 2006, ICES J MAR SCI, V63, P355, DOI 10.1016/j.icesjms.2005.10.013; KJESBU OS, 1991, CAN J FISH AQUAT SCI, V48, P2333, DOI 10.1139/f91-274; KJESBU OS, 1989, J FISH BIOL, V34, P195, DOI 10.1111/j.1095-8649.1989.tb03302.x; Kjesbu OS, 2006, ICES J MAR SCI, V63, P187, DOI 10.1016/j.icesjms.2005.12.003; Kjesbu OS, 1996, CAN J FISH AQUAT SCI, V53, P610, DOI 10.1139/cjfas-53-3-610; Kjorsvik E, 2003, AQUACULTURE, V227, P9, DOI 10.1016/S0044-8486(03)00492-7; Kristjansson T, 2016, AQUAC RES, V47, P349, DOI 10.1111/are.12496; Marteinsdottir G, 1998, J FISH BIOL, V52, P1241, DOI 10.1111/j.1095-8649.1998.tb00969.x; Miller KM, 2000, MOL ECOL, V9, P238, DOI 10.1046/j.1365-294x.2000.00804-2.x; Nocillado JN, 2000, FISH PHYSIOL BIOCHEM, V22, P1, DOI 10.1023/A:1007881231664; Nordeide JT, 2000, FISH FISH, V1, P90, DOI 10.1046/j.1467-2979.2000.00005.x; O'Reilly PT, 2000, J FISH BIOL, V56, P1074, DOI 10.1111/j.1095-8649.2000.tb02124.x; Ottera H, 2006, ICES J MAR SCI, V63, P216, DOI 10.1016/j.icesjms.2005.11.004; Ottera H, 2005, OPPDRETT AV TORSK; Ouellet P, 2001, ICES J MAR SCI, V58, P672, DOI 10.1006/jmsc.2001.1065; PEDERSEN T, 1992, J FISH BIOL, V41, P449, DOI 10.1111/j.1095-8649.1992.tb02673.x; Pickova J, 1997, CAN J FISH AQUAT SCI, V54, P2410, DOI 10.1139/cjfas-54-10-2410; Planes S, 2004, MOL ECOL, V13, P2049, DOI 10.1111/j.1365-294X.2004.02202.x; Rakitin A, 2001, MAR BIOL, V138, P1077, DOI 10.1007/s002270100551; Rosendal GK, 2013, AQUACULTURE, V402, P97, DOI 10.1016/j.aquaculture.2013.03.026; Rosenlund G, 2006, ICES J MAR SCI, V63, P194, DOI 10.1016/j.icesjms.2005.11.012; Rowe S, 2007, CAN J FISH AQUAT SCI, V64, P219, DOI 10.1139/F06-182; Rudolfsen G, 2005, J EVOLUTION BIOL, V18, P172, DOI 10.1111/j.1420-9101.2004.00778.x; Salvesen I., 1995, Aquaculture International, V3, P155, DOI 10.1007/BF00118098; Steingrund P, 2005, SPAWNING LIFE HIST I, P50; Stottrup JG, 2002, 10702 DFU DAN I FISH; Taggart JB, 2007, MOL ECOL NOTES, V7, P412, DOI 10.1111/j.1471-8286.2006.01616.x; Teletchea F, 2014, FISH FISH, V15, P181, DOI 10.1111/faf.12006; Trippel EA, 1998, T AM FISH SOC, V127, P339, DOI 10.1577/1548-8659(1998)127&lt;0339:ESAVAS&gt;2.0.CO;2; Trippel Edward A., 2003, Journal of Northwest Atlantic Fishery Science, V33, P81, DOI 10.2960/J.v33.a6; Walpole RE., 2012, PROBABILITY STAT ENG, V9; Wesmajervi MS, 2006, AQUAC RES, V37, P1195, DOI 10.1111/j.1365-2109.2006.01549.x	49	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158091	10.1371/journal.pone.0158091	http://dx.doi.org/10.1371/journal.pone.0158091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362346	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200039
J	Vogele, AM; Zsoldos, RR; Kruger, B; Licka, T				Voegele, Anna Magdalena; Zsoldos, Rebeka R.; Krueger, Bjoern; Licka, Theresia			Novel Methods for Surface EMG Analysis and Exploration Based on Multi-Modal Gaussian Mixture Models	PLOS ONE			English	Article							LONGISSIMUS-DORSI MUSCLES; PELVIC LIMB MUSCLES; ELECTROMYOGRAPHIC ACTIVITY; WALKING; HORSES; IDENTIFICATION; GAIT; REPEATABILITY; BACK	This paper introduces a new method for data analysis of animal muscle activation during locomotion. It is based on fitting Gaussian mixture models (GMMs) to surface EMG data (sEMG). This approach enables researchers/users to isolate parts of the overall muscle activation within locomotion EMG data. Furthermore, it provides new opportunities for analysis and exploration of sEMG data by using the resulting Gaussian modes as atomic building blocks for a hierarchical clustering. In our experiments, composite peak models representing the general activation pattern per sensor location (one sensor on the long back muscle, three sensors on the gluteus muscle on each body side) were identified per individual for all 14 horses during walk and trot in the present study. Hereby we show the applicability of the method to identify composite peak models, which describe activation of different muscles throughout cycles of locomotion.	[Voegele, Anna Magdalena] Univ Bonn, Inst Comp Sci 2, Multimedia Simulat & Virtual Real Grp, Bonn, Germany; [Zsoldos, Rebeka R.] Univ Nat Resources & Life Sci Vienna, Dept Sustainable Agr Syst, Working Grp Anim Breeding, Vienna, Austria; [Krueger, Bjoern] Gokhale Method Inst, Stanford, CA USA; [Licka, Theresia] Univ Vet Med Vienna, Dept Small Anim & Horses, Movement Sci Grp, Vienna, Austria; [Licka, Theresia] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland	University of Bonn; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna; University of Edinburgh	Vogele, AM (corresponding author), Univ Bonn, Inst Comp Sci 2, Multimedia Simulat & Virtual Real Grp, Bonn, Germany.	voegele@cs.uni-bonn.de	Krüger, Björn/AAA-6944-2022; Zsoldos, Rebeka R./M-6376-2014	Zsoldos, Rebeka R./0000-0001-6690-1862; Licka, Theresia/0000-0001-7651-5180	Deutsche Forschungsgemeinschaft [KR 4309/2-1]; Austrian Science Fund as part of the GeMMQuad project [I1532-B23]; Austrian Science Fund (FWF) [I 1532] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund as part of the GeMMQuad project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft, Grant KR 4309/2-1 (http://www.dfg.de/), and Austrian Science Fund as part of the GeMMQuad project, Grant I1532-B23 (https://www.fwf.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard J, 2013, IEEE T VIS COMPUT GR, V19, P2257, DOI 10.1109/TVCG.2013.178; Bishop C. M, 2006, PATTERN RECOGNITION; Blomer J, 2013, CORR ABS 1312 5946; Boudaoud S, 2010, IEEE ENG MED BIO, P4703, DOI 10.1109/IEMBS.2010.5626378; BRUCE V, 1985, EQUINE VET J, V17, P317, DOI 10.1111/j.2042-3306.1985.tb02508.x; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; Cottriall S, 2008, COMP EXERC PHYSIOL, V5, P111, DOI 10.1017/S1478061509342346; Crook TC, 2010, J ANAT, V217, P26, DOI 10.1111/j.1469-7580.2010.01241.x; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Ding Q, TRANSACTIONS ON INDU; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; Farina D, 2013, J PHYSIOL-LONDON, V591, P2403, DOI 10.1113/jphysiol.2012.246082; FUGLEVAND AJ, 1992, BIOL CYBERN, V67, P143, DOI 10.1007/BF00201021; George LS, 2013, COMP EXERC PHYSIOL, V9, P23, DOI 10.3920/CEP12024; Gizzi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137844; Granata KP, 2005, GAIT POSTURE, V22, P346, DOI 10.1016/j.gaitpost.2004.11.014; Groesel M, 2010, EQUINE VET J, V42, P401, DOI 10.1111/j.2042-3306.2010.00282.x; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Hermens H.J., 2000, EUROPEAN RECOMMENDAT; Hill C., 2010, 101 HORSEMANSHIP EQU; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Ju ZJ, 2013, IEEE SENS J, V13, P3302, DOI 10.1109/JSEN.2013.2259051; Kampa K, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P2578, DOI 10.1109/IJCNN.2011.6033555; Kwedlo W, 2013, ADV INTELL SYST, V226, P81, DOI 10.1007/978-3-319-00969-8_8; Licka T, 2009, VET J, V180, P71, DOI 10.1016/j.tvjl.2007.11.001; Licka TF, 2004, AM J VET RES, V65, P155, DOI 10.2460/ajvr.2004.65.155; MARISCOTTI MA, 1967, NUCL INSTRUM METHODS, V50, P309, DOI 10.1016/0029-554X(67)90058-4; Martens J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144998; Mazoyer B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101165; Melnykov V, 2012, COMPUT STAT DATA AN, V56, P1381, DOI 10.1016/j.csda.2011.11.002; Merletti R, 2015, J ELECTROMYOGR, V25, pI, DOI 10.1016/S1050-6411(15)00131-5; Naim I, 2012, ICML ICML CC OMNIPRE; Negro F, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/036008; Olsen E, 2012, SENSORS-BASEL, V12, P8145, DOI 10.3390/s120608145; OLSON CF, 1995, PARALLEL COMPUT, V21, P1313, DOI 10.1016/0167-8191(95)00017-I; Peham C, 2001, AM J VET RES, V62, P1687, DOI 10.2460/ajvr.2001.62.1687; Rani S., 2012, INT J COMPUTER APPL, V52, P1, DOI DOI 10.5120/8282-1278; Rash G.S., 2003, ELECTROMYOGRAPHY FUN, V4; Robilliard JJ, 2007, J EXP BIOL, V210, P187, DOI 10.1242/jeb.02611; Rodrigues PP, 2008, IEEE T KNOWL DATA EN, V20, P615, DOI 10.1109/TKDE.2007.190727; Spainhour JCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111016; Staudenmann D, 2013, J ELECTROMYOGR KINES, V23, P892, DOI 10.1016/j.jelekin.2013.03.004; Valentin S, 2015, JOURNAL OF ELECTROMY; Vogele A, 2014, 2014 ACM SIGGRAPH EU; Wakeling J. M., 2006, Equine and Comparative Exercise Physiology, V3, P153; Wakeling J. M., 2007, Equine and Comparative Exercise Physiology, V4, P95, DOI 10.1017/S1478061507812126; Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P251, DOI 10.1016/j.jelekin.2011.11.004; Wilhelm N, 2015, PROC SPIE, V9397, DOI 10.1117/12.2080001; Williams J., 2013, The Veterinary Nurse, V4, P566; Williams JM, 2014, COMP EXERC PHYSIOL, V10, P223, DOI 10.3920/CEP143004; WU CFJ, 1983, ANN STAT, V11, P95, DOI 10.1214/aos/1176346060; Zaneb H, 2009, AM J VET RES, V70, P1129, DOI 10.2460/ajvr.70.9.1129; Zhou F, 2013, IEEE T PATTERN ANAL, V35, P582, DOI 10.1109/TPAMI.2012.137; Zsoldos R, 2015, PROGRESS IN MOTOR CO; Zsoldos R, 2015, 25 C INT SOC BIOM IS; Zwarts MJ, 2000, J ELECTROMYOGR KINES, V10, P287, DOI 10.1016/S1050-6411(00)00020-1	57	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157239	10.1371/journal.pone.0157239	http://dx.doi.org/10.1371/journal.pone.0157239			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362752	Green Submitted, gold, Green Published			2022-12-27	WOS:000378865200011
J	Wong, MH; Chan, DL; Lee, A; Li, BT; Lumba, S; Clarke, SJ; Samra, J; Pavlakis, N				Wong, Matthew H.; Chan, David L.; Lee, Adrian; Li, Bob T.; Lumba, Sumit; Clarke, Stephen J.; Samra, Jaswinder; Pavlakis, Nick			Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)	PLOS ONE			English	Article							ENETS CONSENSUS GUIDELINES; ISLET-CELL-CARCINOMA; STREPTOZOCIN PLUS FLUOROURACIL; PROGNOSTIC-FACTORS; MANAGEMENT; TEMOZOLOMIDE; DOXORUBICIN; NEOPLASMS; INTERFERON; PANCREAS	Background/Objectives In the era of somatostatin analogues and targeted therapies, the role of chemotherapy in NET remains largely undefined. This systematic review aimed to assess the effect of chemotherapy on response rates (RR), progression-free survival (PFS), overall survival (OS) and toxicity compared to other chemotherapies/systemic therapies or best supportive care in patients with advanced or metastatic NET. Methods Randomised controlled trials (RCTs) from 1946 to 2015 were identified from MEDLINE, EMBASE, other databases and conference proceedings. Review of abstracts, quality assessment and data abstraction were performed independently by two investigators. Meta-analyses were conducted using Mantel-Haenszel analysis with random-effects modelling. Results Six RCTs comparing standard streptozotocin plus 5-fluorouacil (STZ/5FU) chemotherapy to other chemotherapy regimens, and 2 comparing this to interferon (IFN) were included. Only 1 study was considered at low risk of bias. STZ/5-FU was no different to other chemotherapies in response rate [RR 0.96; 95% confidence interval (CI) 0.72-1.27], PFS (RR 0.95; CI 0.81-1.13), or OS (RR 1.03; CI 0.77-1.39). IFN may produce higher response than STZ/5FU (RR 0.20; CI 0.04-1.13), but event rates were small and survival was no different. Interferon was associated with higher overall haematological (RR 0.47; CI 0.27-0.82) and lower overall renal toxicity (RR 3.61; CI 1.24-10.51). Conclusion Strong evidence is lacking in the area of chemotherapy in neuroendocrine tumors. There is currently no evidence that one chemotherapeutic regimen is significantly better than the other, nor is interferon better than chemotherapy. There is an urgent need to design RCTs comparing modern chemotherapy to other agents in NET.	[Wong, Matthew H.] Gosford Hosp, Dept Med Oncol, Gosford, Australia; [Wong, Matthew H.; Chan, David L.; Lee, Adrian; Clarke, Stephen J.; Pavlakis, Nick] Univ Sydney, Kolling Inst Med Res, Sydney, NSW, Australia; [Chan, David L.; Lee, Adrian; Lumba, Sumit; Clarke, Stephen J.; Pavlakis, Nick] Royal N Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Lee, Adrian] Northern Canc Inst, Sydney, NSW, Australia; [Li, Bob T.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, 1275 York Ave, New York, NY 10021 USA; [Li, Bob T.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Samra, Jaswinder] Royal N Shore Hosp, Dept Gastrointestinal Surg, Sydney, NSW, Australia; [Samra, Jaswinder] Macquarie Univ Hosp, Dept Gastrointestinal Surg, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; Memorial Sloan Kettering Cancer Center; University of Sydney; Royal North Shore Hospital; University of Sydney; Macquarie University	Wong, MH (corresponding author), Gosford Hosp, Dept Med Oncol, Gosford, Australia.; Wong, MH (corresponding author), Univ Sydney, Kolling Inst Med Res, Sydney, NSW, Australia.	matt.wong@health.nsw.gov.au	Chan, David L/E-7149-2017	Chan, David/0000-0002-7773-3144; Clarke, Stephen/0000-0001-5817-1222; Lee, Adrian/0000-0001-5345-5226	Roche; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Roche(Roche Holding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DLC has received honoraria from Ipsen and travel support from Novartis. NP has received honoraria from Bayer, Roche and Sanofi; provided advice to Roche, Merck, Bayer, Sanofi and Amgen; and received a travel grant from Roche. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Barakat MT, 2004, ENDOCR-RELAT CANCER, V11, P1, DOI 10.1677/erc.0.0110001; BRODER LE, 1973, ANN INTERN MED, V79, P108, DOI 10.7326/0003-4819-79-1-108; Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI 10.1056/NEJMoa1316158; Dahan L, 2009, ENDOCR-RELAT CANCER, V16, P1351, DOI 10.1677/ERC-09-0104; Delaunoit T, 2009, ACTA GASTRO-ENT BELG, V72, P49; Dhall D, 2012, HUM PATHOL, V43, P489, DOI 10.1016/j.humpath.2011.06.011; Dixon E, 2007, CURR OPIN ONCOL, V19, P30, DOI 10.1097/CCO.0b013e328011a236; Ekeblad S, 2007, CLIN CANCER RES, V13, P2986, DOI 10.1158/1078-0432.CCR-06-2053; ENGSTROM PF, 1984, J CLIN ONCOL, V2, P1255, DOI 10.1200/JCO.1984.2.11.1255; Falconi M, 2012, NEUROENDOCRINOLOGY, V95, P120, DOI 10.1159/000335587; Gustafsson BI, 2008, CURR OPIN ONCOL, V20, P1, DOI 10.1097/CCO.0b013e3282f1c595; HEAL JM, 1979, CANCER RES, V39, P82; Higgins J, 2011, HDB SYSTEMATIC REV I; Jensen RT, 2012, NEUROENDOCRINOLOGY, V95, P98, DOI 10.1159/000335591; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Kulke MH, 2011, J CLIN ONCOL, V29, P934, DOI 10.1200/JCO.2010.33.2056; Kulke MH, 2010, PANCREAS, V39, P735, DOI 10.1097/MPA.0b013e3181ebb168; Kulke MH, 2006, J CLIN ONCOL, V24, P401, DOI 10.1200/JCO.2005.03.6046; Meyer T, 2014, EUR J CANCER, V50, P902, DOI 10.1016/j.ejca.2013.12.011; Modlin IM, 2008, EXPERT OPIN PHARMACO, V9, P2617, DOI 10.1517/14656566.9.15.2617 ; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Moertel C G, 1979, Cancer Clin Trials, V2, P327; MOERTEL CG, 1992, NEW ENGL J MED, V326, P519, DOI 10.1056/NEJM199202203260804; MOERTEL CG, 1975, CANCER, V36, P675, DOI 10.1002/1097-0142(197508)36:2+<675::AID-CNCR2820360810>3.0.CO;2-A; MOERTEL CG, 1980, NEW ENGL J MED, V303, P1189, DOI 10.1056/NEJM198011203032101; MURRAYLY.IM, 1968, LANCET, V2, P895; OBERG K, 1989, EUR J CANCER CLIN ON, V25, P1475, DOI 10.1016/0277-5379(89)90107-7; Pape UF, 2012, NEUROENDOCRINOLOGY, V95, P135, DOI 10.1159/000335629; Ramage JK, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2011-300831; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Seregni E, 2001, ANN ONCOL, V12, pS69, DOI 10.1093/annonc/12.suppl_2.S69; Sorbye H, 2013, ANN ONCOL, V24, P152, DOI 10.1093/annonc/mds276; Strosberg JR, 2011, CANCER-AM CANCER SOC, V117, P268, DOI 10.1002/cncr.25425; Sun WJ, 2005, J CLIN ONCOL, V23, P4897, DOI 10.1200/JCO.2005.03.616; Wolin E, 2015, LANCET; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290	37	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158140	10.1371/journal.pone.0158140	http://dx.doi.org/10.1371/journal.pone.0158140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362760	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200044
J	Ferreira, R; Michel, RC; Greghi, SLA; de Resende, MLR; Sant'Ana, ACP; Damante, CA; Zangrando, MSR				Ferreira, Rafael; Michel, Raphaella Coelho; Aguiar Greghi, Sebastiao Luiz; Rubo de Resende, Maria Lucia; Passanezi Sant'Ana, Adriana Campos; Damante, Carla Andreotti; Ragghianti Zangrando, Mariana Schutzer			Prevention and Periodontal Treatment in Down Syndrome Patients: A Systematic Review	PLOS ONE			English	Article							ORAL-HEALTH; SUBGINGIVAL MICROFLORA; PHAGOCYTIC FUNCTION; DENTAL-CARE; CHILDREN; ADULTS; CHLORHEXIDINE; THERAPY; INDIVIDUALS; PREVALENCE	The aim of this systematic literature review was to evaluate which type of periodontal preventive and therapeutic approaches presents superior outcomes in patients with Down syndrome (DS). Studies reporting different methods of periodontal care from DS patients were considered eligible. Included clinical studies should indicate at least two periodontal parameters in different periods of assessment. Screening of the articles, data extraction and quality assessment were conducted independently and in duplicate. Electronic search according to the PICO search, with both Key-words and MESH terms were conducted in MEDLINE, EMBASE and CENTRAL databases until March 2016. Manual search was conducted in four journals, namely Journal of Periodontology, Journal of Clinical Periodontology, Journal of Periodontal Research and Special Care in Dentistry and their electronic databases were searched. Electronic and manual search resulted in 763 papers, and of them 744 were excluded after title/abstract assessment. The full text of 19 potentially eligible publications was screened and 9 studies met inclusion criteria. The results demonstrated the importance to introduce youngest DS patients in preventive programs, as well as participation of parents, caregivers or institutional attendants in supervising/performing oral hygiene. In studies with higher frequency of attendance, all age groups presented superior preventive and therapeutic results, irrespective of the therapeutic approach used (surgical/nonsurgical/periodontal care program). The important factors for reducing periodontal parameters were the frequency of the appointments and association with chlorhexidine/plaque disclosing agents as adjuvant treatment. This systematic review demonstrated that early introduction in periodontal care, participation of parents/caregivers/institutional attendants, frequency of attendance and association with chemical adjuvants (independently of the periodontal treatment adopted) seems to improve periodontal outcomes in preventive and periodontal treatment of DS patients.	[Ferreira, Rafael; Michel, Raphaella Coelho; Aguiar Greghi, Sebastiao Luiz; Rubo de Resende, Maria Lucia; Passanezi Sant'Ana, Adriana Campos; Damante, Carla Andreotti; Ragghianti Zangrando, Mariana Schutzer] Univ Sao Paulo, Bauru Sch Dent, Dept Prosthodont, Div Periodont, Bauru, SP, Brazil	Universidade de Sao Paulo	Zangrando, MSR (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Prosthodont, Div Periodont, Bauru, SP, Brazil.	mariana@fob.usp.br	Rezende, Maria Lucia Rubo/D-7729-2012; LA Greghi, Sebastião/D-6644-2012; Damante, Carla Andreotti/B-9643-2012; Zangrando, Mariana/L-6139-2017; Sant'Ana, Adriana C P/D-2330-2012	Rezende, Maria Lucia Rubo/0000-0002-3646-1402; Damante, Carla Andreotti/0000-0002-6782-8596; Sant'Ana, Adriana C P/0000-0001-5640-9292	FAPESP (Sao Paulo Research Foundation) [2013/16607-1, 2013/05382-9]	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP (Sao Paulo Research Foundation) #2013/16607-1 and #2013/05382-9 (http://www.fapesp.br/). The foundation had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agholme WB, 1999, EUR J ORAL SCI, V107, P82; AINAMO J, 1975, INT DENT J, V25, P229; Allison PJ, 2004, COMMUNITY DENT ORAL, V32, P99, DOI 10.1111/j.0301-5661.2004.00130.x; Amano A, 2000, J PERIODONTOL, V71, P249, DOI 10.1902/jop.2000.71.2.249; Anders PL, 2010, SPEC CARE DENT, V30, P110, DOI 10.1111/j.1754-4505.2010.00136.x; [Anonymous], 2015, SYNDR FACT SHEET, P1; [Anonymous], 2015, DOWN SYNDR; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bagic I, 2003, COLLEGIUM ANTROPOL, V27, P75; BARKIN RM, 1980, J MENT DEFIC RES, V24, P243; BARKIN RM, 1980, J MENT DEFIC RES, V24, P251; Barmes D, 1994, Int Dent J, V44, P523; Bonito AJ, 2005, J PERIODONTOL, V76, P1227, DOI 10.1902/jop.2005.76.8.1227; BOREA G, 1990, Journal of Pedodontics, V14, P139; Cavalcante LB, 2012, J PERIODONTOL, V83, P926, DOI 10.1902/jop.2011.110056; Chambrone L, 2013, J DENT RES, V92, p119S, DOI 10.1177/0022034513504947; Chambrone L, 2014, CLIN ORAL IMPLAN RES, V21, P1; Chambrone L, 2014, CLIN ORAL IMPLAN RES, V25, P408, DOI 10.1111/clr.12186; Chambrone L, 2010, J CLIN PERIODONTOL, V37, P1110, DOI 10.1111/j.1600-051X.2010.01634.x; Chambrone L, 2010, J CLIN PERIODONTOL, V37, P675, DOI 10.1111/j.1600-051X.2010.01587.x; Cheng RHW, 2008, J PERIODONTOL, V79, P379, DOI [10.1902/jop.2008.070247, 10.1902/jop.2008.070247 ]; Cichon P, 1998, Ann Periodontol, V3, P370, DOI 10.1902/annals.1998.3.1.370; Cogulu D, 2006, ARCH ORAL BIOL, V51, P23, DOI 10.1016/j.archoralbio.2005.06.001; Dababneh RH, 2002, J CLIN PERIODONTOL, V29, P1107, DOI 10.1034/j.1600-051X.2002.291210.x; Davidovich E, 2010, INT J PAEDIATR DENT, V20, P235, DOI 10.1111/j.1365-263X.2010.01045.x; Freedman L, 2011, J DISABIL ORAL HLTH, V12, P59; Frydman Alon, 2012, Compend Contin Educ Dent, V33, P356; GIBBS CH, 1988, J CLIN PERIODONTOL, V15, P137, DOI 10.1111/j.1600-051X.1988.tb01008.x; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; HAMERTON JL, 1961, LANCET, V2, P788; Hanookai D, 2000, J PERIODONTOL, V71, P376, DOI 10.1902/jop.2000.71.3.376; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Jones CG, 1997, PERIODONTOL 2000, V15, P55, DOI 10.1111/j.1600-0757.1997.tb00105.x; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LOBENE R R, 1986, Clinical Preventive Dentistry, V8, P3; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Lopez-Perez Ruben, 2002, Spec Care Dentist, V22, P214, DOI 10.1111/j.1754-4505.2002.tb00274.x; MANHOLD JH, 1965, J PERIODONTOL, V36, P299, DOI 10.1902/jop.1965.36.4.299; MCKENZIE WT, 1992, J PERIODONTOL, V63, P187, DOI 10.1902/jop.1992.63.3.187; Meyle J, 2001, PERIODONTOL 2000, V26, P92, DOI 10.1034/j.1600-0757.2001.2260105.x; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Patrick DL, 2006, BMC ORAL HEALTH, V6, pS1, DOI DOI 10.1186/1472-6831-6-S1-S4; Pels Elzbieta, 2002, Ann Univ Mariae Curie Sklodowska Med, V57, P442; PRICE JH, 1978, J SCHOOL HEALTH, V48, P171, DOI 10.1111/j.1746-1561.1978.tb07116.x; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; Reuland-Bosma W, 2001, J CLIN PERIODONTOL, V28, P1004, DOI 10.1034/j.1600-051X.2001.281103.x; Rostami MN, 2012, EUR CYTOKINE NETW, V23, P64, DOI 10.1684/ecn.2012.0307; Sakellari D, 2005, J CLIN PERIODONTOL, V32, P684, DOI 10.1111/j.1600-051X.2005.00737.x; Sakellari D, 2001, ORAL MICROBIOL IMMUN, V16, P376, DOI 10.1034/j.1399-302X.2001.160610.x; Salvi GE, 2002, J CLIN PERIODONTOL, V29, P540, DOI 10.1034/j.1600-051X.2002.290611.x; Shapira J, 1996, Spec Care Dentist, V16, P33, DOI 10.1111/j.1754-4505.1996.tb01541.x; Shott SR, 2006, ARCH OTOLARYNGOL, V132, P432, DOI 10.1001/archotol.132.4.432; Shyama Maddi, 2003, Spec Care Dentist, V23, P94, DOI 10.1111/j.1754-4505.2003.tb01668.x; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; STABHOLZ A, 1991, Clinical Preventive Dentistry, V13, P9; Stiefel D J, 1995, Spec Care Dentist, V15, P159, DOI 10.1111/j.1754-4505.1995.tb00505.x; Suvan JE, 2005, PERIODONTOL 2000, V37, P48, DOI 10.1111/j.1600-0757.2004.03794.x; Teitelbaum AP, 2009, COMMUNITY DENT ORAL, V37, P463, DOI 10.1111/j.1600-0528.2009.00488.x; UDIN RD, 1984, J AM DENT ASSOC, V109, P591, DOI 10.14219/jada.archive.1984.0134; Wells G.A., 2000, VIS COMMUN Q; Yoshihara T, 2005, J CLIN PERIODONTOL, V32, P556, DOI 10.1111/j.1600-051X.2005.00712.x; Zaldivar-Chiapa RM, 2005, J PERIODONTOL, V76, P1061, DOI 10.1902/jop.2005.76.7.1061; Zampieri BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107218; Zandbergen D, 2013, J PERIODONTOL, V84, P332, DOI 10.1902/jop.2012.120040; Zigmond M, 2006, J INTELL DISABIL RES, V50, P492, DOI 10.1111/j.1365-2788.2006.00794.x	68	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158339	10.1371/journal.pone.0158339	http://dx.doi.org/10.1371/journal.pone.0158339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355338	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400051
J	Schirrmann, M; Joschko, M; Gebbers, R; Kramer, E; Zorner, M; Barkusky, D; Timmer, J				Schirrmann, Michael; Joschko, Monika; Gebbers, Robin; Kramer, Eckart; Zoerner, Mirjam; Barkusky, Dietmar; Timmer, Jens			Proximal Soil Sensing - A Contribution for Species Habitat Distribution Modelling of Earthworms in Agricultural Soils?	PLOS ONE			English	Article							ELECTRICAL-CONDUCTIVITY; REGRESSION; POPULATIONS; COMMUNITY; TILLAGE	Background Earthworms are important for maintaining soil ecosystem functioning and serve as indicators of soil fertility. However, detection of earthworms is time-consuming, which hinders the assessment of earthworm abundances with high sampling density over entire fields. Recent developments of mobile terrestrial sensor platforms for proximal soil sensing (PSS) provided new tools for collecting dense spatial information of soils using various sensing principles. Yet, the potential of PSS for assessing earthworm habitats is largely unexplored. This study investigates whether PSS data contribute to the spatial prediction of earthworm abundances in species distribution models of agricultural soils. Methodology/Principal Findings Proximal soil sensing data, e.g., soil electrical conductivity (EC), pH, and near infrared absorbance (NIR), were collected in real-time in a field with two management strategies (reduced tillage / conventional tillage) and sandy to loam soils. PSS was related to observations from a long-term (11 years) earthworm observation study conducted at 42 plots. Earthworms were sampled from 0.5 x 0.5 x 0.2 m(3) soil blocks and identified to species level. Sensor data were highly correlated with earthworm abundances observed in reduced tillage but less correlated with earthworm abundances observed in conventional tillage. This may indicate that management influences the sensor-earthworm relationship. Generalized additive models and state-space models showed that modelling based on data fusion from EC, pH, and NIR sensors produced better results than modelling without sensor data or data from just a single sensor. Regarding the individual earthworm species, particular sensor combinations were more appropriate than others due to the different habitat requirements of the earthworms. Earthworm species with soil-specific habitat preferences were spatially predicted with higher accuracy by PSS than more ubiquitous species. Conclusions/Significance Our findings suggest that PSS contributes to the spatial modelling of earthworm abundances at field scale and that it will support species distribution modelling in the attempt to understand the soil-earthworm relationships in agroecosystems.	[Schirrmann, Michael; Gebbers, Robin] Leibniz Inst Agr Engn Potsdam Bornim, Max Eyth Allee 100, D-14469 Potsdam, Germany; [Joschko, Monika] Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Eberswalder Str 84, D-15374 Muncheberg, Germany; [Kramer, Eckart] Eberswalde Univ Sustainable Dev, Schicklerstr 5, D-16225 Eberswalde, Germany; [Zoerner, Mirjam] Forschungszentrum Julich, Inst Bio & Geosci, IBG-3,Wilhelm Johnen Str, D-52428 Julich, Germany; [Barkusky, Dietmar] Leibniz Ctr Agr Landscape Res ZALF, Res Stn Muencheberg, Eberswalder Str 84, D-15374 Muncheberg, Germany; [Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany	Leibniz Institut fur Agrartechnik und Biookonomie (ATB); Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); Eberswalde University for Sustainable Development; Helmholtz Association; Research Center Julich; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Schirrmann, M (corresponding author), Leibniz Inst Agr Engn Potsdam Bornim, Max Eyth Allee 100, D-14469 Potsdam, Germany.	mschirrmann@atb-potsdam.de			Rentenbank; Monsanto; Open Access Fund of the Leibniz Association	Rentenbank; Monsanto; Open Access Fund of the Leibniz Association	Financial support for this study was received from Rentenbank (https://www.rentenbank.de/) and Monsanto (http://www.monsanto.com/global/de/). Additionally, the publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchuk VI, 2010, PROGR SOIL SCI, P15, DOI 10.1007/978-90-481-8859-8_2; Bastian O., 2002, DEV PERSPECTIVES LAN; Birkhofer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043292; Blouin M, 2013, EUR J SOIL SCI, V64, P161, DOI 10.1111/ejss.12025; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cannavacciuolo M, 1998, APPL SOIL ECOL, V9, P345, DOI 10.1016/S0929-1393(98)00087-0; Chen J, 2001, J CHEM INF COMP SCI, V41, P992, DOI 10.1021/ci0004053; Clark R.N., 1999, REMOTE SENSING EARTH, P3, DOI DOI 10.1111/J.1945-5100.2004.TB00079.X; Corwin DL, 2005, COMPUT ELECTRON AGR, V46, P11, DOI 10.1016/j.compag.2004.10.005; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Curry JP, EARTHWORM ECOLOGY, P91; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fox C, 2004, FRAMEWORK DEV INDICA; Gareth J., 2013, INTRO STAT LEARNING; Gebbers R, 2009, SENSITIVITY ANAL SOI, P513; Gebbers R, 2009, NEAR SURF GEOPHYS, V7, P179, DOI 10.3997/1873-0604.2009011; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hernandez P, 2007, PEDOBIOLOGIA, V51, P13, DOI 10.1016/j.pedobi.2006.11.002; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Joschko M, 2006, AGR ECOSYST ENVIRON, V112, P367, DOI 10.1016/j.agee.2005.08.026; Joschko M, 2012, ARCH ACKER PFLANZENB, V58, P252; Joschko M, 2010, J PLANT NUTR SOIL SC, V173, P584, DOI 10.1002/jpln.200800071; Joschko M, 2009, SOIL TILL RES, V102, P55, DOI 10.1016/j.still.2008.07.023; Jouquet P, 2006, APPL SOIL ECOL, V32, P153, DOI 10.1016/j.apsoil.2005.07.004; Kim HJ, 2009, J ENVIRON MONITOR, V11, P1810, DOI 10.1039/b906634a; Kladivko EJ, 1997, SOIL BIOL BIOCHEM, V29, P613, DOI 10.1016/S0038-0717(96)00187-3; Kruck S, 2006, J PLANT NUTR SOIL SC, V169, P651, DOI 10.1002/jpln.200521903; Lardo E, 2012, APPL SOIL ECOL, V61, P76, DOI 10.1016/j.apsoil.2012.06.003; Lee K. E., 1985, Earthworms: their ecology and relationships with soils and land use.; Liebig J., 1863, NATURAL LAWS HUSBAND; Mouazen AM, 2005, SOIL TILL RES, V80, P171, DOI 10.1016/j.still.2004.03.022; Nielsen D. R., 2003, Spatial and temporal statistics: sampling field soils and their vegetation; NIELSEN DR, 1989, PLANT SOIL, V115, P285, DOI 10.1007/BF02202595; Nuutinen V, 1998, APPL SOIL ECOL, V8, P85, DOI 10.1016/S0929-1393(97)00063-2; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pelosi C, 2016, SOIL TILL RES, V156, P25, DOI 10.1016/j.still.2015.07.016; PIEARCE TG, 1972, J ANIM ECOL, V41, P167, DOI 10.2307/3511; Press W. H., 1992, ART SCI COMPUTING; R Core Team, 2013, R LANG ENV STAT COMP; RIPLEY BD, 1987, ANALYST, V112, P377, DOI 10.1039/an9871200377; Satchell J. E., 1955, P180; Schirrmann M, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0199; Schirrmann M, 2011, SENSORS-BASEL, V11, P573, DOI 10.3390/s110100573; Schirrmann M, 2011, J PLANT NUTR SOIL SC, V174, P333, DOI 10.1002/jpln.200900367; SCHRADER S, 1994, ZOOL ANZ, V233, P211; Schroder B, 2008, J PLANT NUTR SOIL SC, V171, P325, DOI 10.1002/jpln.200700027; SHUMWAY RH, 2000, TIME SERIES ANAL ITS; Sims RW, 1985, EARTHWORMS; Stenberg B, 2010, PROGR SOIL SCI, P29, DOI 10.1007/978-90-481-8859-8_3; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Valckx J, 2011, SOIL BIOL, V24, P19, DOI 10.1007/978-3-642-14636-7_2; Valckx J, 2009, APPL SOIL ECOL, V41, P315, DOI 10.1016/j.apsoil.2008.12.005; VDLUFA, 2004, METH; Vitharana UWA, 2006, SOIL USE MANAGE, V22, P405, DOI 10.1111/j.1475-2743.2006.00052.x; Webster R., 2007, STAT PRACTICE; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374	62	4	4	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158271	10.1371/journal.pone.0158271	http://dx.doi.org/10.1371/journal.pone.0158271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355340	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400042
J	Minervini, S; Accogli, G; Pirone, A; Graic, JM; Cozzi, B; Desantis, S				Minervini, Serena; Accogli, Gianluca; Pirone, Andrea; Graic, Jean-Marie; Cozzi, Bruno; Desantis, Salvatore			Brain Mass and Encephalization Quotients in the Domestic Industrial Pig (Sus scrofa)	PLOS ONE			English	Article							ANTHROPOID PRIMATES; EVOLUTION; SIZE; MAMMALS; CEREBELLUM; ELEPHANTS; CETACEANS; SOCIALITY; COGNITION; SURVIVAL	In the present study we examined the brain of fetal, newborn, and adult pigs raised for meat production. The fresh and formalin-fixed weights of the brain have been recorded and used, together with body weight, to calculate the Encephalization Quotient (EQ). The weight of the cerebellum has been used to calculate the Cerebellar Quotient (CQ). The results have been discussed together with analogue data obtained in other terrestrial Cetartiodactyla (including the domestic bovine, sheep, goat, and camel), domesticated Carnivora, Proboscidata, and Primates. Our study, based on a relatively large experimental series, corrects former observations present in the literature based on smaller samples, and emphasizes that the domestic pig has a small brain relative to its body size (EQ = 0.38 for adults), possibly due to factors linked to the necessity of meat production and improved body weight. Comparison with other terrestrial Cetartiodactyla indicates a similar trend for all domesticated species.	[Minervini, Serena; Accogli, Gianluca; Desantis, Salvatore] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat DETO, Sect Vet Clin & Anim Prod, Valenzano, Ba, Italy; [Pirone, Andrea] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Graic, Jean-Marie; Cozzi, Bruno] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy	Universita degli Studi di Bari Aldo Moro; University of Pisa; University of Padua	Desantis, S (corresponding author), Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat DETO, Sect Vet Clin & Anim Prod, Valenzano, Ba, Italy.	salvatore.desantis@uniba.it	Cozzi, Bruno/H-9618-2019; PIRONE, ANDREA/S-7228-2019; Graïc, Jean-Marie/I-2710-2019	Cozzi, Bruno/0000-0002-7531-7040; Graïc, Jean-Marie/0000-0002-1974-8356; PIRONE, ANDREA/0000-0001-6363-392X				AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Ariens Kappers CU, 1927, P ROYAL ACAD AMSTERD, V31, P5; Arloing S, 1879, TRAITE ANATOMIE COMP, P1; Ballarin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154580; Baron G, 1996, COMP NEUROBIOLOGY CH; Boddy AM, 2012, J EVOLUTION BIOL, V25, P981, DOI 10.1111/j.1420-9101.2012.02491.x; BOICE R, 1972, BEHAVIOUR, V43, P198; Bortolami R, 2006, EDAGRICOLE, V6, P1; Camerlink I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113502; Canario L, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00410; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Cozzi B, 2009, NEUROANATOMIA UOMO, P1; Cozzi B, 2014, BRAIN BEHAV EVOLUT, V83, P9, DOI 10.1159/000356527; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Ellenberger W, 1912, HDB VERGLEICHENDEN A, P1; Finarelli JA, 2009, P NATL ACAD SCI USA, V106, P9345, DOI 10.1073/pnas.0901780106; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hartwig W, 2011, ANAT REC, V294, P2207, DOI 10.1002/ar.21515; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Jerison H J, 1977, Ann N Y Acad Sci, V299, P146, DOI 10.1111/j.1749-6632.1977.tb41903.x; JERISON HJ, 1985, PHILOS T ROY SOC B, V308, P21, DOI 10.1098/rstb.1985.0007; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kelava I, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00016; KRUSKA D, 1982, Z ZOOL SYST EVOL, V20, P1; KRUSKA D, 1973, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V11, P81; Kruska D.C.T., 2007, P143; Kruska DCT, 2005, BRAIN BEHAV EVOLUT, V65, P73, DOI 10.1159/000082979; Larsen T, 2015, RES VET SCI, V98, P19, DOI 10.1016/j.rvsc.2014.11.001; Lauer EW, 1982, COMP CORRELATIVE NEU, P501; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Manger PR, 2012, J COMP NEUROL, V520, P2430, DOI 10.1002/cne.23046; Marino L, 2000, BRAIN BEHAV EVOLUT, V56, P204, DOI 10.1159/000047205; Marino L, 1998, BRAIN BEHAV EVOLUT, V51, P230, DOI 10.1159/000006540; Martin R.D., 1984, P73; Maseko BC, 2012, ANAT REC, V295, P661, DOI 10.1002/ar.22425; Maselyne J, 2015, PHYSIOL BEHAV, V138, P37, DOI 10.1016/j.physbeh.2014.09.012; McGeady T. A., 2006, VET EMBRYOLOGY, P331; MILLER AKH, 1977, ANN HUM BIOL, V4, P253, DOI 10.1080/03014467700007142; Perez-Barberia FJ, 2005, OECOLOGIA, V145, P41, DOI 10.1007/s00442-005-0067-7; Pillay P, 2007, EUR J NEUROSCI, V25, P2705, DOI 10.1111/j.1460-9568.2007.05524.x; Ratcliffe JM, 2006, BRAIN BEHAV EVOLUT, V67, P165, DOI 10.1159/000090980; Rault JL, 2014, J ANIM SCI, V92, P5683, DOI 10.2527/jas.2014-8238; Sack WO, 1982, ESSENTIALS PIG ANATO; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Schelenska G, 1969, J HIRNFROSCH, V15, P401; Seiferle E, 1988, TRATTATO ANATOMIA AN, V4, P1; Shoshani J, 2006, BRAIN RES BULL, V70, P124, DOI 10.1016/j.brainresbull.2006.03.016; Shultz S, 2006, P ROY SOC B-BIOL SCI, V273, P207, DOI 10.1098/rspb.2005.3283; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Sisson S., 1982, ANATOMIA ANIMALI DOM, V2; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; St. Clair L. E., 1981, DIS SWINE; Taylor AB, 2007, J HUM EVOL, V52, P59, DOI 10.1016/j.jhevol.2006.07.010; Thorup F, 2009, LARGE ANIM REV, V15, P89; Weaver AH, 2005, P NATL ACAD SCI USA, V102, P3576, DOI 10.1073/pnas.0500692102; Witting A, 1913, HAMBURG VERHANDLUNGE, P200; Xie ZH, 2011, SELECTED RESEARCH ON GROSS ANATOMY AND HISTOLOGY OF CAMELS, P361; Xie ZH, 2011, SELECTED RESEARCH ON GROSS ANATOMY AND HISTOLOGY OF CAMELS, P355; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006; Zimmerl U., 1909, TRATTATO ANATOMIA VE, V3, P1	62	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157378	10.1371/journal.pone.0157378	http://dx.doi.org/10.1371/journal.pone.0157378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351807	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900009
J	Li, BT; Shi, YZ; Gong, JW; Li, JW; Liu, AY; Shang, HH; Gong, WK; Chen, TT; Ge, Q; Jia, CY; Lei, YK; Hu, YS; Yuan, YL				Li, Botao; Shi, Yuzhen; Gong, Juwu; Li, Junwen; Liu, Aiying; Shang, Haihong; Gong, Wankui; Chen, Tingting; Ge, Qun; Jia, Chaoyang; Lei, Yake; Hu, Yushu; Yuan, Youlu			Genetic Effects and Heterosis of Yield and Yield Component Traits Based on Gossypium Barbadense Chromosome Segment Substitution Lines in Two Gossypium Hirsutum Backgrounds	PLOS ONE			English	Article							AGRONOMIC TRAITS	We hybridized 10 chromosome segment substitution lines (CSSLs) each from two CSSL populations and produced 50 F-1 hybrids according to North Carolina Design II. We analyzed the genetic effects and heterosis of yield and yield components in the F-1 hybrids and parents in four environments via the additive-dominance genetic model. Yield and yield components of the CSSLs were controlled by combined additive and dominance effects, and lint percentage was mainly controlled by additive effects, but boll weight, boll number, seedcotton yield and lint yield were mainly controlled by dominance effects. We detected significant interaction effects between genetics and the environment for all yields traits. Similar interactions were detected between two CSSL populations (Pop CCRI 36 and Pop CCRI 45). Significant positive mid-parent heterosis was detected for all yield traits in both populations, and significant positive better-parent heterosis was also detected for all yield traits except lint percentage. The differences among parents were relatively small, but significant heterosis was detected for yield and yield components. Therefore, the relationship between heterosis and genetic distance for yield traits is complicated and requires further study. These CSSLs represent useful tools for improving yield and yield components in cotton.	[Li, Botao; Shi, Yuzhen; Gong, Juwu; Li, Junwen; Liu, Aiying; Shang, Haihong; Gong, Wankui; Chen, Tingting; Ge, Qun; Yuan, Youlu] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Key Lab Biol & Genet Breeding Cotton,Minist Agr, Anyang 455000, Henan, Peoples R China; [Li, Botao] Changde Agr Sci Res Inst, Changde 415000, Hunan, Peoples R China; [Jia, Chaoyang; Lei, Yake] Zhoukou Acad Agr Sci, Zhoukou 466001, Henan, Peoples R China; [Hu, Yushu] Liaoning Prov Inst Cash Crops, Liaoyang 111000, Liaoning, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs	Yuan, YL (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Key Lab Biol & Genet Breeding Cotton,Minist Agr, Anyang 455000, Henan, Peoples R China.	yylcri@126.com	Gǒng, Wànkuí/AAL-5622-2020	Gǒng, Wànkuí/0000-0002-8556-0669	National Natural Science Foundation of China [31101188]; National High Technology Research and Development Program of China [2012AA101108]; National Agricultural Science and Technology Innovation Project for CAAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Agricultural Science and Technology Innovation Project for CAAS	This work was funded by the National Natural Science Foundation of China (31101188), the National High Technology Research and Development Program of China (2012AA101108), and the National Agricultural Science and Technology Innovation Project for CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; Guo X, 2013, J INTEGR PLANT BIOL, V55, P759, DOI 10.1111/jipb.12054; Jenkins JN, 2012, EUPHYTICA, V187, P161, DOI 10.1007/s10681-011-0580-1; Li JunWen, 2010, Cotton Science, V22, P163; [刘芦苇 LIU Luwei], 2007, [棉花学报, Cotton Science], V19, P33; Liu YanGai, 2014, Cotton Science, V26, P25; Luan MingBao, 2008, Agricultural Sciences in China, V7, P1290, DOI 10.1016/S1671-2927(08)60177-7; Ma LiuJun, 2013, Cotton Science, V25, P486; Paterson AH, 2004, CROP SCI, V44, P1900, DOI 10.2135/cropsci2004.1900; Saha S, 2013, THEOR APPL GENET, V126, P109, DOI 10.1007/s00122-012-1965-9; Shi YZ, 2015, J INTEGR PLANT BIOL, V57, P450, DOI 10.1111/jipb.12288; Shi YZ, 2008, CHINESE AGR SCI B, V24, P139; Song MZ, 2015, EUPHYTICA, V204, P135, DOI 10.1007/s10681-014-1348-1; Sun J., 1994, ACTA GOSSYPII SIN, V3, P135; Tang FY, 2013, EUPHYTICA, V194, P41, DOI 10.1007/s10681-013-0958-3; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; White TG, 1967, CROP RES, P34; Wu J, 2010, PLANT BREEDING, V129, P526, DOI 10.1111/j.1439-0523.2009.01715.x; Wu YaoTing, 2002, Agricultural Sciences in China, V1, P498; Xing ChaoZhu, 2007, Scientia Agricultura Sinica, V40, P1056; Yang DaiGang, 2012, Cotton Science, V24, P191; YOUNG ND, 1989, THEOR APPL GENET, V77, P95, DOI 10.1007/BF00292322; [Yuang Youlu 袁有禄], 2002, [作物学报, Acta Agronomica Sinica], V28, P196; Zeng LH, 2012, EUPHYTICA, V187, P247, DOI 10.1007/s10681-012-0708-y; [张金凤 Zhang Jinfeng], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P773; Zhu J., 1993, J BIOMATH, V8, P32; Zhu J., 1998, ANAL METHODS GENETIC; 王鹏, 2008, [科学通报, Chinese Science Bulletin], V53, P1065	29	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157978	10.1371/journal.pone.0157978	http://dx.doi.org/10.1371/journal.pone.0157978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348815	Green Published, gold, Green Submitted			2022-12-27	WOS:000378801200027
J	Dang, YF; Xu, XY; Shen, YB; Hu, MY; Zhang, M; Li, LS; Lv, LQ; Li, JL				Dang, Yunfei; Xu, Xiaoyan; Shen, Yubang; Hu, Moyan; Zhang, Meng; Li, Lisen; Lv, Liqun; Li, Jiale			Transcriptome Analysis of the Innate Immunity-Related Complement System in Spleen Tissue of Ctenopharyngodon idella Infected with Aeromonas hydrophila	PLOS ONE			English	Article							RNA-SEQ ANALYSIS; GRASS CARP; FUNCTIONAL-CHARACTERIZATION; EXPRESSION ANALYSIS; SIGNALING PATHWAY; MOLECULAR-CLONING; TELEOST FISH; IDENTIFICATION; GENES; ANNOTATION	The grass carp (Ctenopharyngodon idella) is an important commercial farmed herbivorous fish species in China, but is susceptible to Aeromonas hydrophila infections. In the present study, we performed de novo RNA-Seq sequencing of spleen tissue from specimens of a disease-resistant family, which were given intra-peritoneal injections containing PBS with or without a dose of A. hydrophila. The fish were sampled from the control group at 0 h, and from the experimental group at 4, 8, 12, 24, 48 and 72 h. 122.18 million clean reads were obtained from the normalized cDNA libraries; these were assembled into 425,260 contigs and then 191,795 transcripts. Of those, 52,668 transcripts were annotated with the NCBI Nr database, and 41,347 of the annotated transcripts were assigned into 90 functional groups. 20,569 unigenes were classified into six main categories, including 38 secondary KEGG pathways. 2,992 unigenes were used in the analysis of differentially expressed genes (DEGs). 89 of the putative DEGs were related to the immune system and 41 of them were involved in the complement and coagulation cascades pathway. This study provides insights into the complement and complement-related pathways involved in innate immunity, through expression profile analysis of the genomic resources in C. idella. We conclude that complement and complement-related genes play important roles during defense against A. hydrophila infection. The immune response is activated at 4 h after the bacterial injections, indicating that the complement pathways are activated at the early stage of bacterial infection. The study has improved our understanding of the immune response mechanisms in C. idella to bacterial pathogens.	[Dang, Yunfei; Xu, Xiaoyan; Shen, Yubang; Hu, Moyan; Zhang, Meng; Li, Lisen; Li, Jiale] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China; [Lv, Liqun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Natl Pathogen Collect Ctr Aquat Anim, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China	Shanghai Ocean University; Shanghai Ocean University	Li, JL (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China.	jlli2009@126.com	li, jia/GVT-7587-2022		China's Agricultural Research System [CARS-46-04]; National Key Technology R&D Program of China [2012BAD26B02]	China's Agricultural Research System; National Key Technology R&D Program of China(National Key Technology R&D Program)	The work was supported by the following: the China's Agricultural Research System (CARS-46-04), Jiale Li; and the National Key Technology R&D Program of China (2012BAD26B02), Jiale Li.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boshra H, 2004, J IMMUNOL, V173, P349, DOI 10.4049/jimmunol.173.1.349; Chen J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-108; Chen XH, 2013, DEV COMP IMMUNOL, V41, P82, DOI 10.1016/j.dci.2013.04.015; Chu Q, 2015, FISH SHELLFISH IMMUN, V47, P168, DOI 10.1016/j.fsi.2015.08.032; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Du FK, 2013, FISH SHELLFISH IMMUN, V34, P1476, DOI 10.1016/j.fsi.2013.03.352; Du JL, 2014, MOL BIOSYST, V10, P2441, DOI 10.1039/c4mb00287c; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Figueras MJ, 2005, REV MED MICROBIOL, V16, P145; Gao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088804; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Thanh HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109656; Hallstrom T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147709; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; Heng JF, 2011, FISH SHELLFISH IMMUN, V30, P45, DOI 10.1016/j.fsi.2010.09.004; Hewavisenti RV, 2016, PEERJ, V4, DOI 10.7717/peerj.1569; Hirano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142062; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Hu MY, 2016, DEV COMP IMMUNOL, V54, P20, DOI 10.1016/j.dci.2015.08.010; Huang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131146; Igbinosa IH, 2012, SCI WORLD J, DOI 10.1100/2012/625023; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jiang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105122; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li FG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142801; Lintner KE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00036; Liu L, 2015, FISH SHELLFISH IMMUN, V45, P175, DOI 10.1016/j.fsi.2015.03.043; Liu QL, 2013, FISH SHELLFISH IMMUN, V35, P618, DOI 10.1016/j.fsi.2013.05.015; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lujan E, 2016, INFECT IMMUN, V84, P452, DOI 10.1128/IAI.01267-15; Mao WF, 2004, AQUACULTURE, V242, P93, DOI 10.1016/j.aquaculture.2004.07.020; Meng FX, 2012, FISH SHELLFISH IMMUN, V32, P1171, DOI 10.1016/j.fsi.2012.02.010; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Qi ZT, 2016, VET IMMUNOL IMMUNOP, V169, P85, DOI 10.1016/j.vetimm.2015.11.004; Rao YL, 2013, DEV COMP IMMUNOL, V41, P164, DOI 10.1016/j.dci.2013.06.002; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1149; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Song XH, 2014, AQUACULTURE, V434, P171, DOI 10.1016/j.aquaculture.2014.08.015; Su JG, 2012, DEV COMP IMMUNOL, V36, P450, DOI 10.1016/j.dci.2011.08.015; Su JG, 2009, FISH SHELLFISH IMMUN, V27, P33, DOI 10.1016/j.fsi.2009.02.016; Su JG, 2009, FISH SHELLFISH IMMUN, V26, P828, DOI 10.1016/j.fsi.2008.12.007; Su JG, 2009, FISH SHELLFISH IMMUN, V26, P164, DOI 10.1016/j.fsi.2008.10.002; Tong C, 2015, FISH SHELLFISH IMMUN, V46, P366, DOI 10.1016/j.fsi.2015.06.025; Tsujikura M, 2015, J IMMUNOL, V194, P262, DOI 10.4049/jimmunol.1303179; Unamba CIN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01074; Wang YD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1102; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Wu Chao, 2004, Acta Zoologica Sinica, V50, P137; Xu XY, 2013, FISH SHELLFISH IMMUN, V35, P801, DOI 10.1016/j.fsi.2013.06.009; Xu XY, 2012, FISH SHELLFISH IMMUN, V33, P251, DOI 10.1016/j.fsi.2012.05.015; Xu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112722; Yan NN, 2015, DEV COMP IMMUNOL, V48, P102, DOI 10.1016/j.dci.2014.09.009; Yu HY, 2014, DEV COMP IMMUNOL, V47, P215, DOI 10.1016/j.dci.2014.07.019; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng WD, 2012, AFR J MICROBIOL RES, V6, P4512, DOI 10.5897/AJMR11.1405	67	55	60	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157413	10.1371/journal.pone.0157413	http://dx.doi.org/10.1371/journal.pone.0157413			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383749	gold, Green Published			2022-12-27	WOS:000379809400012
J	Renauld, E; Descoteaux, M; Bernier, M; Garyfallidis, E; Whittingstall, K				Renauld, Emmanuelle; Descoteaux, Maxime; Bernier, Michael; Garyfallidis, Eleftherios; Whittingstall, Kevin			Semi-Automatic Segmentation of Optic Radiations and LGN, and Their Relationship to EEG Alpha Waves	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; MILD COGNITIVE IMPAIRMENT; TENSOR FIBER TRACTOGRAPHY; MAGNETIC-RESONANCE IMAGES; VISUAL-FIELD DEFICITS; THALAMIC NUCLEI; ARTERIOVENOUS-MALFORMATIONS; PROBABILISTIC TRACTOGRAPHY; DIFFUSION TRACTOGRAPHY; AUTOMATIC SEGMENTATION	At rest, healthy human brain activity is characterized by large electroencephalography (EEG) fluctuations in the 8-13 Hz range, commonly referred to as the alpha band. Although it is well known that EEG alpha activity varies across individuals, few studies have investigated how this may be related to underlying morphological variations in brain structure. Specifically, it is generally believed that the lateral geniculate nucleus (LGN) and its efferent fibres (optic radiation, OR) play a key role in alpha activity, yet it is unclear whether their shape or size variations contribute to its inter-subject variability. Given the widespread use of EEG alpha in basic and clinical research, addressing this is important, though difficult given the problems associated with reliably segmenting the LGN and OR. For this, we employed a multi-modal approach and combined diffusion magnetic resonance imaging (dMRI), functional magnetic resonance imaging (fMRI) and EEG in 20 healthy subjects to measure structure and function, respectively. For the former, we developed a new, semi-automated approach for segmenting the OR and LGN, from which we extracted several structural metrics such as volume, position and diffusivity. Although these measures corresponded well with known morphology based on previous post-mortem studies, we nonetheless found that their inter-subject variability was not significantly correlated to alpha power or peak frequency (p > 0.05). Our results therefore suggest that alpha variability may be mediated by an alternative structural source and our proposed methodology may in general help in better understanding the influence of anatomy on function such as measured by EEG or fMRI.	[Renauld, Emmanuelle; Bernier, Michael; Whittingstall, Kevin] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Nucl Med & Radiobiol, Sherbrooke, PQ, Canada; [Whittingstall, Kevin] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Diagnost Radiol, Sherbrooke, PQ, Canada; [Descoteaux, Maxime; Garyfallidis, Eleftherios] Univ Sherbrooke, Fac Sci, Dept Comp Sci, SCIL, Sherbrooke, PQ, Canada; [Descoteaux, Maxime; Whittingstall, Kevin] CHUS, Sherbrooke, PQ, Canada; [Descoteaux, Maxime; Whittingstall, Kevin] CHUS, Ctr Rech, CIMS, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Whittingstall, K (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Nucl Med & Radiobiol, Sherbrooke, PQ, Canada.; Whittingstall, K (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Diagnost Radiol, Sherbrooke, PQ, Canada.; Whittingstall, K (corresponding author), CHUS, Sherbrooke, PQ, Canada.; Whittingstall, K (corresponding author), CHUS, Ctr Rech, CIMS, Sherbrooke, PQ, Canada.	kevin.whittingstall@usherbrooke.ca		Renauld, Emmanuelle/0000-0003-1292-5097	Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds Quebecois de Recherche en Nature et Technologie (FQRNT); Faculty of Medicine of the University of Sherbrooke	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de Recherche en Nature et Technologie (FQRNT)(FQRNT); Faculty of Medicine of the University of Sherbrooke	This work was supported by The Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/); The Fonds Quebecois de Recherche en Nature et Technologie (FQRNT) (http://www.frqnt.gouv.qc.ca/en/bourses-et-subventions); and The Faculty of Medicine of the University of Sherbrooke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to Gabriel Girard and Maxime Chamberland for their precious listening and their valued suggestions. Thanks to the Fonds Quebecois de Recherche en Nature et Technologie (FQRNT), to the Faculty of Medecine of the University of Sherbrooke and to the The Natural Sciences and Engineering Research Council of Canada (NSERC) for their financial support.	Alvarez I, 2014, BRAIN STRUCTURE FUNC, P1; Amini L, 2004, IEEE T BIO-MED ENG, V51, P800, DOI 10.1109/TBME.2004.826654; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Avants BB., 2009, INSIGHT J, V2, P1, DOI DOI 10.54294/UVNHIN; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1113, DOI 10.1016/j.clinph.2006.01.020; Barnes GR, 2010, INVEST OPHTH VIS SCI, V51, P1432, DOI 10.1167/iovs.09-3931; Bazanova O., 2013, NEUROSCIENCE BIOBEHA; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Benjamin CFA, 2014, HUM BRAIN MAPP, V35, P683, DOI 10.1002/hbm.22204; Bernier M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00715; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Calamante F, 2015, NEUROIMAGE, V117, P284, DOI 10.1016/j.neuroimage.2015.05.070; Calamante F, 2013, HUM BRAIN MAPP, V34, P2538, DOI 10.1002/hbm.22083; Chen X, 2009, NEUROIMAGE, V45, P286, DOI 10.1016/j.neuroimage.2008.11.038; Cote MA, 2013, MED IMAGE ANAL, V17, P844, DOI 10.1016/j.media.2013.03.009; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; de Gervai PD, 2014, EPILEPSY RES, V108, P872, DOI 10.1016/j.eplepsyres.2014.03.006; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deoni SCL, 2007, NEUROIMAGE, V34, P117, DOI 10.1016/j.neuroimage.2006.09.016; Descoteaux M, 2008, LECT NOTES COMPUT SC, V5242, P122, DOI 10.1007/978-3-540-85990-1_15; Duan Y, 2007, INT J BIOMEDICAL IMA, V2007, P7; EBELING U, 1988, ACTA NEUROCHIR, V92, P29, DOI 10.1007/BF01401969; Elias WJ, 2012, NEUROIMAGE, V59, P2025, DOI 10.1016/j.neuroimage.2011.10.049; Fujita N, 2001, AM J NEURORADIOL, V22, P1719; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Haueisen J, 2002, NEUROIMAGE, V15, P159, DOI 10.1006/nimg.2001.0962; Hindriks R, 2015, NEUROIMAGE, V106, P328, DOI 10.1016/j.neuroimage.2014.10.057; Jbabdi S, 2007, NEUROIMAGE, V37, P116, DOI 10.1016/j.neuroimage.2007.04.039; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jonasson L, 2007, SIGNAL PROCESS, V87, P309, DOI 10.1016/j.sigpro.2005.12.017; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kammen A, 2016, NEUROIMAGE, V125, P767, DOI 10.1016/j.neuroimage.2015.11.005; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Keller SS, 2012, NEUROINFORMATICS, V10, P341, DOI 10.1007/s12021-012-9147-0; Kikuta K, 2006, NEUROSURGERY, V58, P331, DOI 10.1227/01.NEU.0000195017.82776.90; Leh SE, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/789539; Lilja Y, 2014, EPILEPSY RES, V108, P481, DOI 10.1016/j.eplepsyres.2014.01.017; Liu ZM, 2012, NEUROIMAGE, V63, P1060, DOI 10.1016/j.neuroimage.2012.08.025; Magnotta VA, 2000, NEUROIMAGE, V11, P341, DOI 10.1006/nimg.2000.0552; Mang SC, 2012, MAGN RESON MED, V67, P118, DOI 10.1002/mrm.22996; Martinez-Heras E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137064; Mcketton L, 2014, J COMP NEUROL, V522, P2680, DOI 10.1002/cne.23565; Moretti DV, 2012, NEUROIMAGE, V60, P489, DOI 10.1016/j.neuroimage.2011.11.086; Musall S, 2014, CEREB CORTEX, V24, P1045, DOI 10.1093/cercor/bhs389; Nunez PL, 2011, NEUROIMAGE, V57, P1293, DOI 10.1016/j.neuroimage.2010.03.087; NUNEZ PL, 1978, ELECTROEN CLIN NEURO, V44, P344, DOI 10.1016/0013-4694(78)90309-7; Nunez PL, 2014, CLIN NEUROPHYSIOLOGY; Okada T, 2007, AM J NEURORADIOL, V28, P1107, DOI 10.3174/ajnr.A0493; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Posthuma D, 2001, BEHAV GENET, V31, P567, DOI 10.1023/A:1013345411774; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Rittner L, 2010, I S BIOMED IMAGING, P1173, DOI 10.1109/ISBI.2010.5490203; Schultz T, 2011, LECT NOTES COMPUT SC, V6892, P141, DOI 10.1007/978-3-642-23629-7_18; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Smit DJA, 2012, TWIN RES HUM GENET, V15, P384, DOI 10.1017/thg.2012.6; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Steele CJ, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00289; Stieglitz LH, 2011, NEUROSURGERY, V68, P1239, DOI 10.1227/NEU.0b013e31820b52e1; Tourdias T, 2014, NEUROIMAGE, V84, P534, DOI 10.1016/j.neuroimage.2013.08.069; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Traynor C, 2010, NEUROIMAGE, V52, P69, DOI 10.1016/j.neuroimage.2010.04.024; Traynor CR, 2011, NEUROIMAGE, V56, P939, DOI 10.1016/j.neuroimage.2011.01.083; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Unrath A, 2008, NEUROSCI LETT, V434, P322, DOI 10.1016/j.neulet.2008.02.013; Valdes-Hernandez PA, 2010, NEUROIMAGE, V49, P2328, DOI 10.1016/j.neuroimage.2009.10.030; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273; Whittingstall K, 2010, MAGN RESON IMAGING, V28, P1135, DOI 10.1016/j.mri.2010.03.042; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Willats L, 2014, NEUROIMAGE, V87, P18, DOI 10.1016/j.neuroimage.2013.11.016; Winston GP, 2011, EPILEPSY RES, V97, P124, DOI 10.1016/j.eplepsyres.2011.07.019; Wu W, 2013, NEUROSURGERY, V70, P1; Yamamoto A, 2007, AM J NEURORADIOL, V28, P92; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Ziyan U, 2006, LECT NOTES COMPUT SC, V4191, P807; Ziyan U, 2008, LECT NOTES COMPUT SC, V5241, P279, DOI 10.1007/978-3-540-85988-8_34	85	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156436	10.1371/journal.pone.0156436	http://dx.doi.org/10.1371/journal.pone.0156436			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383146	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400004
J	Du, MM; Jiao, S; Bien, SA; Gala, M; Abecasis, G; Bezieau, S; Brenner, H; Butterbach, K; Caan, BJ; Carlson, CS; Casey, G; Chang-Claude, J; Conti, DV; Curtis, KR; Duggan, D; Gallinger, S; Haile, RW; Harrison, TA; Hayes, RB; Hoffmeister, M; Hopper, JL; Hudson, TJ; Jenkins, MA; Kury, S; Le Marchand, L; Leal, SM; Newcomb, PA; Nickerson, DA; Potter, JD; Schoen, RE; Schumacher, FR; Seminara, D; Slattery, ML; Hsu, L; Chan, AT; White, E; Berndt, SI; Peters, U				Du, Mengmeng; Jiao, Shuo; Bien, Stephanie A.; Gala, Manish; Abecasis, Goncalo; Bezieau, Stephane; Brenner, Hermann; Butterbach, Katja; Caan, Bette J.; Carlson, Christopher S.; Casey, Graham; Chang-Claude, Jenny; Conti, David V.; Curtis, Keith R.; Duggan, David; Gallinger, Steven; Haile, Robert W.; Harrison, Tabitha A.; Hayes, Richard B.; Hoffmeister, Michael; Hopper, John L.; Hudson, Thomas J.; Jenkins, Mark A.; Kury, Sebastien; Le Marchand, Loic; Leal, Suzanne M.; Newcomb, Polly A.; Nickerson, Deborah A.; Potter, John D.; Schoen, Robert E.; Schumacher, Fredrick R.; Seminara, Daniela; Slattery, Martha L.; Hsu, Li; Chan, Andrew T.; White, Emily; Berndt, Sonja I.; Peters, Ulrike			Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANCER SUSCEPTIBILITY LOCUS; GENOTYPE IMPUTATION; SNP RS6983267; 8Q24; SCAN; METAANALYSIS; REFINEMENT; TRANSCRIPTOME; EXPRESSION	Genome-wide association studies (GWAS) have identified many common single nucleotide polymorphisms (SNPs) associated with colorectal cancer risk. These SNPs may tag correlated variants with biological importance. Fine-mapping around GWAS loci can facilitate detection of functional candidates and additional independent risk variants. We analyzed 11,900 cases and 14,311 controls in the Genetics and Epidemiology of Colorectal Cancer Consortium and the Colon Cancer Family Registry. To fine-map genomic regions containing all known common risk variants, we imputed high-density genetic data from the 1000 Genomes Project. We tested single-variant associations with colorectal tumor risk for all variants spanning genomic regions 250-kb upstream or downstream of 31 GWAS-identified SNPs (index SNPs). We queried the University of California, Santa Cruz Genome Browser to examine evidence for biological function. Index SNPs did not show the strongest association signals with colorectal tumor risk in their respective genomic regions. Bioinformatics analysis of SNPs showing smaller P-values in each region revealed 21 functional candidates in 12 loci (5q31.1, 8q24, 11q13.4, 11q23, 12p13.32, 12q24.21, 14q22.2, 15q13, 18q21, 19q13.1, 20p12.3, and 20q13.33). We did not observe evidence of additional independent association signals in GWAS-identified regions. Our results support the utility of integrating data from comprehensive fine-mapping with expanding publicly available genomic databases to help clarify GWAS associations and identify functional candidates that warrant more onerous laboratory follow-up. Such efforts may aid the eventual discovery of disease-causing variant(s).	[Du, Mengmeng] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Du, Mengmeng; Jiao, Shuo; Bien, Stephanie A.; Carlson, Christopher S.; Curtis, Keith R.; Harrison, Tabitha A.; Newcomb, Polly A.; Hsu, Li; White, Emily; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Bien, Stephanie A.; Newcomb, Polly A.; Potter, John D.; White, Emily; Peters, Ulrike] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Gala, Manish; Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Gala, Manish; Chan, Andrew T.] Harvard Med Sch, Boston, MA USA; [Abecasis, Goncalo] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Bezieau, Stephane; Kury, Sebastien] CHU Nantes, Serv Genet Med, Nantes, France; [Brenner, Hermann; Butterbach, Katja; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Consortium DKTK, Heidelberg, Germany; [Caan, Bette J.] Kaiser Permanente Med Care Program Northern Calif, Div Res, Oakland, CA USA; [Casey, Graham; Conti, David V.; Haile, Robert W.; Schumacher, Fredrick R.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Gallinger, Steven] Mt Sinai Hosp, Dept Surg, Toronto, ON, Canada; [Hayes, Richard B.] NYU, Sch Med, Dept Populat Hlth, Div Epidemiol, New York, NY USA; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Nickerson, Deborah A.] Univ Washington, Genome Sci, Seattle, WA 98195 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA; [Seminara, Daniela] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Slattery, Martha L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA; [Chan, Andrew T.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Nantes Universite; CHU de Nantes; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Kaiser Permanente; University of Southern California; Helmholtz Association; German Cancer Research Center (DKFZ); Translational Genomics Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; New York University; University of Melbourne; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; Cancer Research Center of Hawaii; University of Hawaii System; Baylor College of Medicine; University of Washington; University of Washington Seattle; Massey University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Du, MM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.; Du, MM; Peters, U (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Peters, U (corresponding author), Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA.	dumeng@mskcc.org; upeters@fhcrc.org	Hoffmeister, Michael/T-7187-2019; Hoffmeister, Michael/AAB-2321-2022; KÜRY, Sébastien/G-5971-2015; Jenkins, Mark/P-7803-2015; Brenner, Hermann/B-4627-2017	Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; KÜRY, Sébastien/0000-0001-5497-0465; Hayes, Richard/0000-0002-0918-661X; Schumacher, Fredrick/0000-0002-3073-7463; Harrison, Tabitha/0000-0002-4173-7530; Caan, Bette/0000-0002-5803-310X; Bien, Stephanie/0000-0002-8713-4583; Jenkins, Mark/0000-0002-8964-6160; Brenner, Hermann/0000-0002-6129-1572	GECCO: National Cancer Institute; GECCO: National Institutes of Health; GECCO: U.S. Department of Health and Human Services [U01 CA137088, R01 CA059045, U01 CA164930]; National Cancer Institute [R25 CA94880, P30 CA008748]; Regional Council of Pays de la Loire; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Cancer Institute, National Institutes of Health [U01 CA122839]; National Institutes of Health: Australasian Colorectal Cancer Family Registry [U01 CA097735]; National Institutes of Health: Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; National Institutes of Health: Seattle Colorectal Cancer Family Registry [U01 CA074794]; DACHS: German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; COLO2&3: National Institutes of Health [R01 CA60987]; CCFR: National Institutes of Health (RFA) [CA-95-011]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; DALS: National Institutes of Health [R01 CA48998]; NHS; PHS: HPFS by National Institutes of Health [P01 CA 055075, UM1 CA167552, R01 137178, P50 CA 127003]; NHS by the National Institutes of Health [P50 CA 127003, R01 CA137178, P01 CA 087969]; National Institutes of Health [CA42182]; Damon Runyon Clinical investigator Award; MEC: National Institutes of Health [R37 CA54281, P01 CA033619, R01 CA63464]; OFCCR: National Institutes of Health [U01 CA074783]; GL2 grant from Ontario Research Fund; Canadian Institutes of Health Research; Cancer Risk Evaluation (CaRE) Program grant from Canadian Cancer Society Research Institute; Senior Investigator Awards from Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation; PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) [Z01 CP 010200]; NIH [U01 HG004446]; NIH GEI [U01 HG 004438]; PMH-CCFR: National Institutes of Health [R01 CA076366]; VITAL: National Institutes of Health [K05 CA154337]; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; CORECT: National Cancer Institute, National Institutes of Health under RFA [CA-09-002 (U19 CA148107)];  [K24 DK098311]; NATIONAL CANCER INSTITUTE [R25CA094880, P30CA071789, U01CA164930, P30CA008748, UM1CA167551] Funding Source: NIH RePORTER	GECCO: National Cancer Institute; GECCO: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GECCO: U.S. Department of Health and Human Services; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Regional Council of Pays de la Loire(Region Pays de la Loire); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health: Australasian Colorectal Cancer Family Registry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health: Ontario Registry for Studies of Familial Colorectal Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health: Seattle Colorectal Cancer Family Registry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DACHS: German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); COLO2&3: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFR: National Institutes of Health (RFA); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DALS: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHS; PHS: HPFS by National Institutes of Health; NHS by the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Clinical investigator Award; MEC: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USASpanish Government); OFCCR: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GL2 grant from Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Risk Evaluation (CaRE) Program grant from Canadian Cancer Society Research Institute; Senior Investigator Awards from Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH GEI; PMH-CCFR: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VITAL: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CORECT: National Cancer Institute, National Institutes of Health under RFA; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following: GECCO: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CA137088; R01 CA059045; U01 CA164930), M.D. is supported by grants R25 CA94880 and P30 CA008748 from the National Cancer Institute. ASTERISK: Hospital Clinical Research Program (PHRC) and supported by the Regional Council of Pays de la Loire, the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), the Association Anne de Bretagne Genetique and the Ligue Regionale Contre le Cancer (LRCC). COLO2&3: National Institutes of Health (R01 CA60987). CCFR: National Institutes of Health (RFA # CA-95-011) and through cooperative agreements with members of the Colon Cancer Family Registry and P.I.s. This genome wide scan was supported by the National Cancer Institute, National Institutes of Health by U01 CA122839. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the CFR. The following Colon CFR centers contributed data to this manuscript and were supported by National Institutes of Health: Australasian Colorectal Cancer Family Registry (U01 CA097735), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), and Seattle Colorectal Cancer Family Registry (U01 CA074794). DACHS: German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4 and CH 117/1-1), and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814). DALS: National Institutes of Health (R01 CA48998 to M.L.S.); HPFS, NHS, and PHS: HPFS by the National Institutes of Health (P01 CA 055075, UM1 CA167552, R01 137178, and P50 CA 127003), NHS by the National Institutes of Health (R01 CA137178, P01 CA 087969 and P50 CA 127003,) and PHS by the National Institutes of Health (CA42182). A.T.C. is also supported by a Damon Runyon Clinical investigator Award and K24 DK098311. MEC: National Institutes of Health (R37 CA54281, P01 CA033619, and R01 CA63464). OFCCR: National Institutes of Health, through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783); see CCFR section above. As subset of ARCTIC, OFCCR is supported by a GL2 grant from the Ontario Research Fund, the Canadian Institutes of Health Research, and the Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute. T.J.H. is a recipient of Senior Investigator Awards from the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation. PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. Additionally, a subset of control samples were genotyped as part of the Cancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer GWAS (Yeager, M et al. Nat Genet 2007 May;39(5):645-9), Colon CGEMS pancreatic cancer scan (PanScan) (Amundadottir, L et al. Nat Genet. 2009 Sep;41(9):986-90 and Petersen, GM et al Nat Genet. 2010 Mar;42(3):2248), and the Lung Cancer and Smoking study. The prostate and PanScan study datasets were accessed with appropriate approval through the dbGaP online resource (http://cgems.cancer.gov/data/) accession numbers phs000207v.1p1 and phs000206.v3.; p2, respectively, and the lung datasets were accessed from the dbGaP website (http://www.ncbi.nlm.nih.gov/gap) through accession number phs000093v2.p2. Funding for the Lung Cancer and Smoking study was provided by National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) Z01 CP 010200, NIH U01 HG004446, and NIH GEI U01 HG 004438. For the lung study, the GENEVA Coordinating Center provided assistance with genotype cleaning and general study coordination, and the Johns Hopkins University Center for Inherited Disease Research conducted genotyping. PMH-CCFR: National Institutes of Health (R01 CA076366 to P.A.N.). VITAL: National Institutes of Health (K05 CA154337). WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. CORECT: National Cancer Institute, National Institutes of Health under RFA #CA-09-002 (U19 CA148107). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in CORECT, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or CORECT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Biancolella M, 2014, HUM MOL GENET, V23, P2198, DOI 10.1093/hmg/ddt584; Birnbaum RY, 2012, GENOME RES, V22, P1059, DOI 10.1101/gr.133546.111; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Carvajal-Carmona LG, 2011, HUM MOL GENET, V20, P2879, DOI 10.1093/hmg/ddr190; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunlop MG, 2013, GUT, V62, P871, DOI 10.1136/gutjnl-2011-300537; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Durkin ME, 1997, FEBS LETT, V411, P296, DOI 10.1016/S0014-5793(97)00686-8; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huang L, 2009, AM J HUM GENET, V85, P692, DOI 10.1016/j.ajhg.2009.09.017; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jaeger E, 2012, NAT GENET, V44, P699, DOI 10.1038/ng.2263; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Jiao S, 2011, GENET EPIDEMIOL, V35, P597, DOI 10.1002/gepi.20608; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kocarnik JD, 2010, CANCER EPIDEM BIOMAR, V19, P3131, DOI 10.1158/1055-9965.EPI-10-0878; Kote-Jarai Z, 2013, HUM MOL GENET, V22, P2520, DOI 10.1093/hmg/ddt086; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2008, HUM MOL GENET, V17, P3720, DOI 10.1093/hmg/ddn267; Pittman AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001126; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Spain SL, 2012, HUM MOL GENET, V21, P934, DOI 10.1093/hmg/ddr523; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang HS, 2013, HUM MOL GENET, V22, P5048, DOI 10.1093/hmg/ddt337; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Whiffin N, 2014, HUM MOL GENET, V23, P4729, DOI 10.1093/hmg/ddu177; Whiffin N, 2013, HUM MOL GENET, V22, P5075, DOI 10.1093/hmg/ddt357; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552	75	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157521	10.1371/journal.pone.0157521	http://dx.doi.org/10.1371/journal.pone.0157521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379672	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700007
J	Hilligan, KL; Connor, LM; Schmidt, AJ; Ronchese, F				Hilligan, Kerry L.; Connor, Lisa M.; Schmidt, Alfonso J.; Ronchese, Franca			Activation-Induced TIM-4 Expression Identifies Differential Responsiveness of Intestinal CD103+CD11b+Dendritic Cells to a Mucosal Adjuvant	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; LAMINA-PROPRIA; APOPTOTIC CELLS; ORAL TOLERANCE; CHOLERA-TOXIN; T-CELLS; ANTIGEN; LYMPH; PHOSPHATIDYLSERINE; MACROPHAGES	Macrophage and dendritic cell (DC) populations residing in the intestinal lamina propria (LP) are highly heterogeneous and have disparate yet collaborative roles in the promotion of adaptive immune responses towards intestinal antigen. Under steady-state conditions, macrophages are efficient at acquiring antigen but are non-migratory. In comparison, intestinal DC are inefficient at antigen uptake but migrate to the mesenteric lymph nodes (mLN) where they present antigen to T cells. Whether such distinction in the roles of DC and macrophages in the uptake and transport of antigen is maintained under immunostimulatory conditions is less clear. Here we show that the scavenger and phosphatidylserine receptor T cell Immunoglobulin and Mucin (TIM)-4 is expressed by the majority of LP macrophages at steady-state, whereas DC are TIM-4 negative. Oral treatment with the mucosal adjuvant cholera toxin (CT) induces expression of TIM-4 on a proportion of CD103+ CD11b+ DC in the LP. TIM-4+ DC selectively express high levels of co-stimulatory molecules after CT treatment and are detected in the mLN a short time after appearing in the LP. Importantly, intestinal macrophages and DC expressing TIM-4 are more efficient than their TIM-4 negative counterparts at taking up apoptotic cells and soluble antigen ex vivo. Taken together, our results show that CT induces phenotypic changes to migratory intestinal DC that may impact their ability to take up local antigens and in turn promote the priming of mucosal immunity.	[Hilligan, Kerry L.; Connor, Lisa M.; Schmidt, Alfonso J.; Ronchese, Franca] Malaghan Inst Med Res, Wellington, New Zealand; [Hilligan, Kerry L.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; Victoria University Wellington	Connor, LM (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	lconnor@malaghan.org.nz	Hilligan, Kerry/AAK-8480-2021; Connor, Lisa/N-7803-2017; Ronchese, Franca/M-9618-2019	Connor, Lisa/0000-0002-3882-8765; Ronchese, Franca/0000-0001-5835-8230; Hilligan, Kerry/0000-0003-1238-1552	Health Research Council of New Zealand [14034FRA]; Masters scholarship from the Victoria University of Wellington	Health Research Council of New Zealand(Health Research Council of New Zealand); Masters scholarship from the Victoria University of Wellington	This study was funded by a grant (14034FRA) awarded to FR from the Health Research Council of New Zealand (http://www.hrc.govt.nz/). KLH was supported by a Masters scholarship from the Victoria University of Wellington (http://www.victoria.ac.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albacker LA, 2013, MUCOSAL IMMUNOL, V6, P580, DOI 10.1038/mi.2012.100; Albacker LA, 2010, J IMMUNOL, V185, P6839, DOI 10.4049/jimmunol.1001360; Anjuere F, 2004, J IMMUNOL, V173, P5103, DOI 10.4049/jimmunol.173.8.5103; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; Blazquez AB, 2008, J IMMUNOL, V180, P4441, DOI 10.4049/jimmunol.180.7.4441; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Czuczman MA, 2014, NATURE, V509, P230, DOI 10.1038/nature13168; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Feng BS, 2008, J ALLERGY CLIN IMMUN, V122, P55, DOI 10.1016/j.jaci.2008.04.036; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Gustafsson T, 2013, EUR J IMMUNOL, V43, P1779, DOI 10.1002/eji.201242867; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kawamura YI, 2003, EUR J IMMUNOL, V33, P3205, DOI 10.1002/eji.200324135; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Liu T, 2007, MOL IMMUNOL, V44, P3580, DOI 10.1016/j.molimm.2007.03.004; Mattsson J, 2015, MUCOSAL IMMUNOL, V8, P815, DOI 10.1038/mi.2014.111; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Nakano H, 2014, J IMMUNOL, V192; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nishi C, 2014, MOL CELL BIOL, V34, P1512, DOI 10.1128/MCB.01394-13; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Saeki H, 1999, J IMMUNOL, V162, P2472; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Valente M, 2014, EUR J IMMUNOL, V44, P2274, DOI 10.1002/eji.201344191; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006	50	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158775	10.1371/journal.pone.0158775	http://dx.doi.org/10.1371/journal.pone.0158775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379516	Green Submitted, gold, Green Published			2022-12-27	WOS:000379798700046
J	Chan, JCK; Mahjoubfar, A; Chen, CL; Jalali, B				Chan, Jacky C. K.; Mahjoubfar, Ata; Chen, Claire L.; Jalali, Bahram			Context-Aware Image Compression	PLOS ONE			English	Article							PHASE RETRIEVAL; TIME; CLASSIFICATION; ALGORITHMS; JPEG	We describe a physics-based data compression method inspired by the photonic time stretch wherein information-rich portions of the data are dilated in a process that emulates the effect of group velocity dispersion on temporal signals. With this coding operation, the data can be downsampled at a lower rate than without it. In contrast to previous implementation of the warped stretch compression, here the decoding can be performed without the need of phase recovery. We present rate-distortion analysis and show improvement in PSNR compared to compression via uniform downsampling.	[Chan, Jacky C. K.; Mahjoubfar, Ata; Chen, Claire L.; Jalali, Bahram] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Mahjoubfar, Ata; Chen, Claire L.; Jalali, Bahram] Calif NanoSyst Inst, Los Angeles, CA USA; [Jalali, Bahram] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chan, JCK (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA.	jckchan@ucla.edu	jalali, bahram/AFK-2299-2022		Office of Naval Research (ONR) MURI Program on Optical Computing [N00014-14-1-0505]	Office of Naval Research (ONR) MURI Program on Optical Computing	This work was supported by the Office of Naval Research (ONR) MURI Program on Optical Computing under Award Number N00014-14-1-0505. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asghari MH, 2015, EDGE DETECTION DIGIT, V2015, P1; Asghari MH, 2014, IEEE IMAGE PROC, P5571, DOI 10.1109/ICIP.2014.7026127; Asghari MH, 2014, IEEE SIGNAL PROC LET, V21, P829, DOI 10.1109/LSP.2014.2319586; Atrey PK, 2002, 2002 IEEE REGION 10 CONFERENCE ON COMPUTERS, COMMUNICATIONS, CONTROL AND POWER ENGINEERING, VOLS I-III, PROCEEDINGS, P257, DOI 10.1109/TENCON.2002.1181263; Bhushan AS, 1998, ELECTRON LETT, V34, P1081, DOI 10.1049/el:19980750; Bruyant PP, 2005, IEEE T NUCL SCI, V52, P1288, DOI 10.1109/TNS.2005.858208; Chan J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902986; Chan KY, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2536719; Chen CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21471; Chen CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125106; Fard AM, 2013, LASER PHOTONICS REV, V7, P207, DOI 10.1002/lpor.201200015; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; Rojo MG, 2006, INT J SURG PATHOL, V14, P285, DOI 10.1177/1066896906292274; Goda K, 2013, NAT PHOTONICS, V7, P102, DOI [10.1038/NPHOTON.2012.359, 10.1038/nphoton.2012.359]; Goda K, 2009, NATURE, V458, P1145, DOI 10.1038/nature07980; Han Y, 2003, J LIGHTWAVE TECHNOL, V21, P3085, DOI 10.1109/JLT.2003.821731; Jaganathan K, 2013, IEEE INT SYMP INFO, P1022, DOI 10.1109/ISIT.2013.6620381; Jalali B, 2015, P IEEE, V103, P1071, DOI 10.1109/JPROC.2015.2418538; Jalali B, 2014, OPTICA, V1, P23, DOI 10.1364/OPTICA.1.000023; Kalyanpur A, 2000, RADIOLOGY, V217, P772, DOI 10.1148/radiology.217.3.r00nv22772; LIU G, 1987, J OPT SOC AM A, V4, P159, DOI 10.1364/JOSAA.4.000159; Louys M, 1999, ASTRON ASTROPHYS SUP, V136, P579, DOI 10.1051/aas:1999235; Mahjoubfar A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17148; Mahjoubfar A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3563707; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; MARK JW, 1981, IEEE T COMMUN, V29, P24, DOI 10.1109/TCOM.1981.1094872; Myler HR., 1999, FUNDAM MACH VIS, P30; PAOLA JD, 1995, INT GEOSCI REMOTE SE, P118, DOI 10.1109/IGARSS.1995.519665; Rosenberg C.J., 1990, LOSSY IMAGE COMPRESS; Roussel E, 2015, SCI REP-UK, V5, DOI 10.1038/srep10330; Runge AFJ, 2015, OPTICA, V2, P36, DOI 10.1364/OPTICA.2.000036; Siebel N, 2001, IEEE WORK PETS 2001; Singh V, 2004, INT CO SIG PROC COMM, P37, DOI 10.1109/SPCOM.2004.1458352; Solli DR, 2007, NATURE, V450, P1054, DOI 10.1038/nature06402; Solli DR, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3271678; Sonka M, 2014, IMAGE PROCESS ANAL M, P734; Tintrup F, 1998, INT CONF ACOUST SPEE, P2565, DOI 10.1109/ICASSP.1998.678046; WHITE RL, 1994, P SOC PHOTO-OPT INS, V2199, P703, DOI 10.1117/12.176239; White RL., 1993, SP EARTH SCI DATA WO, P117; Xu YQ, 2015, OPT LETT, V40, P3595, DOI 10.1364/OL.40.003595; Zabala A, 2006, INT GEOSCI REMOTE SE, P790, DOI 10.1109/IGARSS.2006.203	42	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158201	10.1371/journal.pone.0158201	http://dx.doi.org/10.1371/journal.pone.0158201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367904	Green Submitted, gold, Green Published			2022-12-27	WOS:000378914900021
J	Lerchenmueller, MJ; Sorenson, O				Lerchenmueller, Marc J.; Sorenson, Olav			Author Disambiguation in PubMed: Evidence on the Precision and Recall of Author-ity among NIH-Funded Scientists	PLOS ONE			English	Article							NAME DISAMBIGUATION; CO-AUTHORSHIP; PUBLICATION; DATABASE	We examined the usefulness (precision) and completeness (recall) of the Authority author disambiguation for PubMed articles by associating articles with scientists funded by the National Institutes of Health (NIH). In doing so, we exploited established unique identifiers-Principal Investigator (PI) IDs-that the NIH assigns to funded scientists. Analyzing a set of 36,987 NIH scientists who received their first R01 grant between 1985 and 2009, we identified 355,921 articles appearing in PubMed that would allow us to evaluate the precision and recall of the Authority disambiguation. We found that Authority identified the NIH scientists with 99.51% precision across the articles. It had a corresponding recall of 99.64%. Precision and recall, moreover, appeared stable across common and uncommon last names, across ethnic backgrounds, and across levels of scientist productivity.	[Lerchenmueller, Marc J.; Sorenson, Olav] Yale Univ, Yale Sch Management, New Haven, CT 06520 USA	Yale University	Lerchenmueller, MJ (corresponding author), Yale Univ, Yale Sch Management, New Haven, CT 06520 USA.	marc.lerchenmueller@yale.edu	Sorenson, Olav/ABE-5373-2020; lerchenmueller, marc/AAL-6081-2020	Sorenson, Olav/0000-0002-0599-6738; 	Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation [LE 3426/1-1]; Yale University, Initiative on Leadership and Organization; German Research Foundation (DFG) [LE 3426/1-1]; Initiative on Leadership and Organization at the Yale School of Management	Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation(German Research Foundation (DFG)); Yale University, Initiative on Leadership and Organization; German Research Foundation (DFG)(German Research Foundation (DFG)); Initiative on Leadership and Organization at the Yale School of Management	This work was supported by Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation, grant number LE 3426/1-1 (recipient MJL), and Yale University, Initiative on Leadership and Organization (recipients MJL and OS) (http://som.yale.edu/faculty-research/our-centers-initiatives/initiative-leadership-and-organization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support from the German Research Foundation (DFG) under grant number LE 3426/1-1 and from the Initiative on Leadership and Organization at the Yale School of Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay P, 2011, RAND J ECON, V42, P527, DOI 10.1111/j.1756-2171.2011.00140.x; Chin WS, 2014, J MACH LEARN RES, V15, P3037; Ferreira AA, 2012, SIGMOD REC, V41, P15, DOI 10.1145/2350036.2350040; GitHub, 2015, SURN ETHN US CENS 20; Tran HN, 2014, LECT NOTES COMPUT SC, V8397, P123, DOI 10.1007/978-3-319-05476-6_13; Kang IS, 2011, INFORM PROCESS MANAG, V47, P452, DOI 10.1016/j.ipm.2010.10.001; Kang IS, 2009, INFORM PROCESS MANAG, V45, P84, DOI 10.1016/j.ipm.2008.06.006; Kawashima H, 2015, SCIENTOMETRICS, V103, P1061, DOI 10.1007/s11192-015-1580-z; Laudel G, 2003, SCIENTOMETRICS, V57, P215, DOI 10.1023/A:1024137718393; Levin M, 2012, J AM SOC INF SCI TEC, V63, P1030, DOI 10.1002/asi.22621; Li GC, 2014, RES POLICY, V43, P941, DOI 10.1016/j.respol.2014.01.012; Liu WL, 2014, J ASSOC INF SCI TECH, V65, P765, DOI 10.1002/asi.23063; NCBI, 2016, NCBI HELP MAN PUBMED; NIH, 2016, NIH ACT GLOSS 2016; NIH, 2016, NIH EXPORTER DAT DIC; NIH, 2016, NIH EXPORTER DAT 201; Python Software Foundation, PYTH LANG REF VERS 2; Reijnhoudt L, 2014, SCIENTOMETRICS, V101, P1403, DOI 10.1007/s11192-014-1256-0; Scopus, 2014, SCOP AUTH ID 2014; Shin D, 2014, SCIENTOMETRICS, V100, P15, DOI 10.1007/s11192-014-1289-4; StataCorp, 2015, STAT SOFTW REL 14; Torvik VI, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1552303.1552304; Torvik VI, AUTHORITY TOOLS IDEN; Varadharajalu A, 2011, LECT NOTES ARTIF INT, V7106, P152, DOI 10.1007/978-3-642-25832-9_16; Wu H, 2014, SCIENTOMETRICS, V101, P1955, DOI 10.1007/s11192-014-1283-x; Wu J, 2013, SCIENTOMETRICS, V96, P683, DOI 10.1007/s11192-013-0978-8; Yamashita Y, 2014, SCIENTOMETRICS, V101, P1475, DOI 10.1007/s11192-014-1384-6	27	27	28	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158731	10.1371/journal.pone.0158731	http://dx.doi.org/10.1371/journal.pone.0158731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0TX	27367860	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900050
J	Williams, ST; Ito, S; Wakamatsu, K; Goral, T; Edwards, NP; Wogelius, RA; Henkel, T; de Oliveira, LFC; Maia, LF; Strekopytov, S; Jeffries, T; Speiser, DI; Marsden, JT				Williams, S. T.; Ito, S.; Wakamatsu, K.; Goral, T.; Edwards, N. P.; Wogelius, R. A.; Henkel, T.; de Oliveira, L. F. C.; Maia, L. F.; Strekopytov, S.; Jeffries, T.; Speiser, D. I.; Marsden, J. T.			Identification of Shell Colour Pigments in Marine Snails Clanculus pharaonius and C-margaritarius (Trochoidea; Gastropoda)	PLOS ONE			English	Article							ACID-SOLUBLE PIGMENTS; RAMAN-SPECTROSCOPY; CONJUGATED POLYENES; MOLLUSCAN SHELLS; CAROTENOIDS; PORPHYRINS; PHEOMELANIN; EUMELANIN; SPECTRA; TOOL	Colour and pattern are key traits with important roles in camouflage, warning and attraction. Ideally, in order to begin to understand the evolution and ecology of colour in nature, it is important to identify and, where possible, fully characterise pigments using biochemical methods. The phylum Mollusca includes some of the most beautiful exemplars of biological pigmentation, with the vivid colours of sea shells particularly prized by collectors and scientists alike. Biochemical studies of molluscan shell colour were fairly common in the last century, but few of these studies have been confirmed using modern methods and very few shell pigments have been fully characterised. Here, we use modern chemical and multimodal spectroscopic techniques to identify two porphyrin pigments and eumelanin in the shell of marine snails Clanculus pharaonius and C margaritarius. The same porphyrins were also identified in coloured foot tissue of both species. We use high performance liquid chromatography (HPLC) to show definitively that these porphyrins are uroporphyrin I and uroporphyrin III. Evidence from confocal microscopy analyses shows that the distribution of porphyrin pigments corresponds to the striking pink-red of C. pharaonius shells, as well as pink-red dots and lines on the early whorls of C. margaritarius and yellow-brown colour of later whorls. Additional HPLC results suggest that eumelanin is likely responsible for black spots. We refer to the two differently coloured porphyrin pigments as trochopuniceus (pinkred) and trochoxouthos (yellow-brown) in order to distinguish between them. Trochopuniceus and trochoxouthos were not found in the shell of a third species of the same superfamily, Calliostoma zizyphinum, despite its superficially similar colouration, suggesting that this species has different shell pigments. These findings have important implications for the study of colour and pattern in molluscs specifically, but in other taxa more generally, since this study shows that homology of visible colour cannot be assumed without identification of pigments.	[Williams, S. T.] Nat Hist Museum, Dept Life Sci, London, England; [Ito, S.; Wakamatsu, K.] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi, Japan; [Goral, T.; Strekopytov, S.; Jeffries, T.] Nat Hist Museum, Imaging & Anal Ctr, London, England; [Edwards, N. P.; Wogelius, R. A.; Henkel, T.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [de Oliveira, L. F. C.; Maia, L. F.] Univ Fed Juiz de Fora, NEEM, Dept Quim, Inst Ciencias Exatas, Juiz De Fora, MG, Brazil; [Speiser, D. I.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Marsden, J. T.] Kings Coll Hosp London, Reference Biochem Labs, Viapath, London, England	Natural History Museum London; Fujita Health University; Natural History Museum London; University of Manchester; Universidade Federal de Juiz de Fora; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; King's College Hospital NHS Foundation Trust; King's College Hospital	Williams, ST (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.	s.williams@nhm.ac.uk	Maia, Lenize F./N-9420-2013; Williams, Suzanne T/A-9604-2008; Wakamatsu, Kazumasa/AAZ-5877-2020; Strekopytov, Stanislav/A-8863-2011; Speiser, Daniel Isaac/AGL-4870-2022; Strekopytov, Stanislav/ABI-2251-2020	Maia, Lenize F./0000-0002-7433-4156; Williams, Suzanne T/0000-0003-2995-5823; Wakamatsu, Kazumasa/0000-0003-1748-9001; Strekopytov, Stanislav/0000-0001-5129-9880; Speiser, Daniel Isaac/0000-0001-6662-3583; Ito, Shosuke/0000-0001-9182-5144; Edwards, Nicholas/0000-0002-3760-4225	Department of Life Sciences, Natural History Museum; Brazilian agency CNPq; Brazilian agency CAPES; Brazilian agency FAPEMIG; KAUST [CRG-1-2012-BER-002, 59130357]; National Science Foundation [IOS-1457148]; NERC [NE/J023426/1]; Natural Environment Research Council [NE/J023426/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/M001253/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K09794] Funding Source: KAKEN; STFC [ST/M001253/1] Funding Source: UKRI	Department of Life Sciences, Natural History Museum; Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); KAUST(King Abdullah University of Science & Technology); National Science Foundation(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	STW gratefully acknowledges financial support from the Department of Life Sciences, Natural History Museum. LFCO and LFM thank the Brazilian agencies CNPq, CAPES and FAPEMIG for financial support. STW's visit to the King Abdullah University of Science and Technology was funded by KAUST awards CRG-1-2012-BER-002 and 59130357 (to M.L. Berumen). DIS acknowledges funding from the National Science Foundation (IOS-1457148). We acknowledge the Diamond Light Source for synchrotron access granted under proposal SP9488 and NPE is funded by NERC grant NE/J023426/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining authors received no specific funding for this work.	[Anonymous], 1997, COLOURLIFE INTRO C; Aydin M, 2013, VIB SPECTROSC, V68, P141, DOI 10.1016/j.vibspec.2013.06.005; Barnard W, 2006, J RAMAN SPECTROSC, V37, P342, DOI 10.1002/jrs.1461; Bergamonti L, 2013, EUR J MINERAL, V25, P845, DOI 10.1127/0935-1221/2013/0025-2318; Bertsch PM, 2001, CHEM REV, V101, P1809, DOI 10.1021/cr990070s; Britton George, 2008, V4, P99, DOI 10.1007/978-3-7643-7499-0_6; Cai ZX, 2011, FOOD CHEM, V128, P129, DOI 10.1016/j.foodchem.2011.03.006; Caze B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126745; Church A. H., 1892, Philosophical Transactions, Vclxxxviii, P511; Church AH., 1869, PHILOS T ROYAL SOC L, V159, P627, DOI DOI 10.1098/RSTL.1869.0024; COMFORT A, 1949, BIOCHEM J, V45, P199, DOI 10.1042/bj0450199; COMFORT A, 1950, BIOCHEM J, V47, P254, DOI 10.1042/bj0470254; COMFORT A., 1950, PROC MALACOL SOC LONDON, V28, P79; COMFORT A, 1949, BIOCHEM J, V44, P111, DOI 10.1042/bj0440111; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; COMFORT A., 1951, PROC MALACOL SOC LONDON, V29, P35; COMFORT A, 1949, BIOCHEM J, V45, P204, DOI 10.1042/bj0450204; COMFORT A, 1950, SCIENCE, V112, P279, DOI 10.1126/science.112.2906.279; d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; de Oliveira LN, 2013, SPECTROCHIM ACTA A, V114, P541, DOI 10.1016/j.saa.2013.05.095; Delgado-Vargas F, 2000, CRIT REV FOOD SCI, V40, P173, DOI 10.1080/10408690091189257; DYCK J, 1992, AUK, V109, P293, DOI 10.2307/4088197; Fernandes RF, 2015, SPECTROCHIM ACTA A, V134, P434, DOI 10.1016/j.saa.2014.06.022; Ferrer P, 2013, MARTECH 2013 5TH INT; Fischer H, 1932, H-S Z PHYSIOL CHEM, V204, P101, DOI 10.1515/bchm2.1932.204.1-2.101; Fischer H, 1930, H-S Z PHYSIOL CHEM, V190, P75, DOI 10.1515/bchm2.1930.190.1-2.75; Fletcher JS, 2006, APPL SURF SCI, V252, P6513, DOI 10.1016/j.apsusc.2006.02.213; Fox DL, 1976, ANIMAL BIOCHROMES ST, V2d; Goodwin T.W., 1972, P187; Hedegaard C, 2006, J MOLLUS STUD, V72, P157, DOI 10.1093/mollus/eyi062; HENDRY GAF, 1980, J MED GENET, V17, P1, DOI 10.1136/jmg.17.1.1; Henkel T, 2014, TREATISE GEOCHEMISTR, P411, DOI DOI 10.1016/B978-0-08-095975-7.01431-5; Henkel T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2735565; Henkel T, 2009, RAPID COMMUN MASS SP, V23, P3355, DOI 10.1002/rcm.4257; Hessels J, 2004, J INHERIT METAB DIS, V27, P19, DOI 10.1023/B:BOLI.0000016613.75677.05; Ito S, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P167; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; JONES P, 1979, COMP BIOCHEM PHYS B, V63, P185, DOI 10.1016/0305-0491(79)90027-0; JORDAN PM, 1987, FEBS LETT, V225, P87, DOI 10.1016/0014-5793(87)81136-5; Karampelas S, 2007, J RAMAN SPECTROSC, V38, P217, DOI 10.1002/jrs.1626; Karampelas S, 2009, EUR J MINERAL, V21, P85, DOI 10.1127/0935-1221/2009/0021-1897; Kennedy G.Y., 1979, Advances in Marine Biology, V16, P309, DOI 10.1016/S0065-2881(08)60295-3; KENNEDY GY, 1975, ANN NY ACAD SCI, V244, P662, DOI 10.1111/j.1749-6632.1975.tb41560.x; KENNEDY GY, 1954, J MAR BIOL ASSOC UK, V33, P663, DOI 10.1017/S002531540002693X; KENNEDY GY, 1959, J MAR BIOL ASSOC UK, V38, P27, DOI 10.1017/S0025315400015551; KOBLUK D R, 1989, Palaios, V4, P63, DOI 10.2307/3514734; Konstantinidou K, 2017, STUD CONSERV, V62, P24, DOI 10.1080/00393630.2016.1150411; Kosaki T., 1947, SEIRI SEITAI, V1, P247; Lemer S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1776-x; Lindstedt C, 2010, FUNCT ECOL, V24, P759, DOI 10.1111/j.1365-2435.2010.01686.x; Macmunn C. A., 1886, Journal Physiol, Vvii, P240; Maia LF, 2013, J RAMAN SPECTROSC, V44, P560, DOI 10.1002/jrs.4226; Mann K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-249; Maoka T, 2012, J OLEO SCI, V61, P69, DOI 10.5650/jos.61.69; McGraw K.J., 2006, BIRD COLORATION, P354; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; Nakayama S, 2013, FEBS OPEN BIO, V3, P421, DOI 10.1016/j.fob.2013.10.001; NICHOLAS REH, 1949, BIOCHEM J, V45, P208, DOI 10.1042/bj0450208; NICHOLAS REH, 1951, BIOCHEM J, V50, P194, DOI 10.1042/bj0500194; Niecke M, 1999, J ORNITHOL, V140, P355, DOI 10.1007/BF01651032; OGATA T, 1979, COMP BIOCHEM PHYS B, V63, P239, DOI 10.1016/0305-0491(79)90035-X; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Ozgo M, 2012, GLOBAL CHANGE BIOL, V18, P74, DOI 10.1111/j.1365-2486.2011.02514.x; PAUL KG, 1953, J CLIN PATHOL, V6, P135, DOI 10.1136/jcp.6.2.135; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Speiser DI, 2014, J NAT HIST, V48, P2899, DOI 10.1080/00222933.2014.959572; SPIRO TG, 1990, COORDIN CHEM REV, V100, P541, DOI 10.1016/0010-8545(90)85019-O; Stemmer K, 2014, J MOLLUS STUD, V80, P365, DOI 10.1093/mollus/eyu033; Thomas DB, 2015, J EXP BIOL, V218, P2670, DOI 10.1242/jeb.124917; Thompson CM, 2014, J RAMAN SPECTROSC, V45, P349, DOI 10.1002/jrs.4470; Tixier R., 1952, Memoires Museum Histoire Nat Paris NS, V5A, P41; Tixier R., 1945, ANN I OCEANOGRAPHIQU, V22, P243; TOWNSLEY PM, 1965, CAN J ZOOLOG, V43, P167, DOI 10.1139/z65-015; UNDERWOOD AJ, 1976, J EXP MAR BIOL ECOL, V23, P229, DOI 10.1016/0022-0981(76)90022-8; URMOS J, 1991, AM MINERAL, V76, P641; Verdes A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143545; VERONELLI M, 1995, J RAMAN SPECTROSC, V26, P683, DOI 10.1002/jrs.1250260815; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; WALDENSTROM J, 1937, ACTA MED SCAND     S, V82, P1; WIJESEKERA TP, 1985, ADV EXP MED BIOL, V193, P229; Williams ST, 2017, BIOL REV, V92, P1039, DOI 10.1111/brv.12268; Williams ST, 2012, ZOOL SCR, V41, P571, DOI 10.1111/j.1463-6409.2012.00552.x; WITH TK, 1955, BIOCHEM J, V60, P703, DOI 10.1042/bj0600703; Wogelius RA, 2011, SCIENCE, V333, P1622, DOI 10.1126/science.1205748; Zheng HP, 2010, FOOD CHEM, V122, P1164, DOI 10.1016/j.foodchem.2010.03.109	88	43	45	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156664	10.1371/journal.pone.0156664	http://dx.doi.org/10.1371/journal.pone.0156664			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367426	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900006
J	Ansari, S; Fatma, T				Ansari, Sabbir; Fatma, Tasneem			Cyanobacterial Polyhydroxybutyrate (PHB): Screening, Optimization and Characterization	PLOS ONE			English	Article							POLY-BETA-HYDROXYBUTYRATE; BLUE-GREEN-ALGA; BACTERIAL POLYHYDROXYALKANOATES; BLEND FILMS; ACCUMULATION; METABOLISM; POLY(3-HYDROXYBUTYRATE); BIODEGRADATION; POLY(3-HYDROXYALKANOATES); POLY-3-HYDROXYBUTYRATE	In modern life petroleum-based plastic has become indispensable due to its frequent use as an easily available and a low cost packaging and moulding material. However, its rapidly growing use is causing aquatic and terrestrial pollution. Under these circumstances, research and development for biodegradable plastic (bioplastics) is inevitable. Polyhydroxybutyrate (PHB), a type of microbial polyester that accumulates as a carbon/energy storage material in various microorganisms can be a good alternative. In this study, 23 cyanobacterial strains (15 heterocystous and 8 non-heterocystous) were screened for PHB production. The highest PHB (6.44% w/w of dry cells) was detected in Nostoc muscorum NCCU-442 and the lowest in Spirulina platensis NCCU-S5 (0.51% w/w of dry cells), whereas no PHB was found in Cylindrospermum sp., Oscillatoria sp. and Plectonema sp. Presence of PHB granules in Nostoc muscorum NCCU-442 was confirmed microscopically with Sudan black B and Nile red A staining. Pretreatment of biomass with methanol: acetone: water: dimethylformamide [40: 40: 18: 2 (MAD-I)] with 2 h magnetic bar stirring followed by 30 h continuous chloroform soxhlet extraction acted as optimal extraction conditions. Optimized physicochemical conditions viz. 7.5 pH, 30 degrees C temperature, 10: 14 h light: dark periods with 0.4% glucose (as additional carbon source), 1.0 gl(-1) sodium chloride and phosphorus deficiency yielded 26.37% PHB on 7(th) day instead of 21(st) day. Using FTIR, H-1 NMR and GC-MS, extracted polymer was identified as PHB. Thermal properties (melting temperature, decomposition temperatures etc.) of the extracted polymer were determined by TGA and DSC. Further, the polymer showed good tensile strength and young's modulus with a low extension to break ratio comparable to petrochemical plastic. Biodegradability potential tested as weight loss percentage showed efficient degradation (24.58%) of PHB within 60 days by mixed microbial culture in comparison to petrochemical plastic.	[Ansari, Sabbir; Fatma, Tasneem] Jamia Millia Islamia, Dept Biosci, Cyanobacterial Biotechnol Lab, New Delhi, India	Jamia Millia Islamia	Fatma, T (corresponding author), Jamia Millia Islamia, Dept Biosci, Cyanobacterial Biotechnol Lab, New Delhi, India.	fatma_cbl@yahoo.com						Alves VD, 2011, CARBOHYD POLYM, V83, P1582, DOI 10.1016/j.carbpol.2010.10.010; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Arora NK, 2006, WORLD J MICROB BIOT, V22, P603, DOI 10.1007/s11274-005-9077-1; Asada Y, 1999, INT J BIOL MACROMOL, V25, P37, DOI 10.1016/S0141-8130(99)00013-6; BARHAM PJ, 1984, J MATER SCI, V19, P2781, DOI 10.1007/BF01026954; Bhati R, 2010, BIOTECHNOL J, V5, P1181, DOI 10.1002/biot.201000252; BOTTOMLEY PJ, 1976, ARCH MICROBIOL, V108, P249, DOI 10.1007/BF00454849; Bucci DZ, 2007, POLYM TEST, V26, P908, DOI 10.1016/j.polymertesting.2007.06.013; CARR NG, 1966, BIOCHIM BIOPHYS ACTA, V120, P308, DOI 10.1016/0926-6585(66)90353-0; Carraher Jr C.E, 1996, POLYM CHEM INTRO; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; Cheng GX, 2003, J MATER SCI-MATER M, V14, P1073, DOI 10.1023/B:JMSM.0000004004.37103.f4; Doi Y., 1990, MICROBIAL POLYESTERS; Furuya Ken, 1998, Journal of Oceanography, V54, P199, DOI 10.1007/BF02751695; Godbole S, 2003, BIORESOURCE TECHNOL, V86, P33, DOI 10.1016/S0960-8524(02)00110-4; GRASSIE N, 1984, POLYM DEGRAD STABIL, V6, P127, DOI 10.1016/0141-3910(84)90032-6; Gumel AM, 2014, BRAZ J MICROBIOL, V45, P427, DOI 10.1590/S1517-83822014000200009; HOARE DS, 1971, ARCH MIKROBIOL, V78, P310, DOI 10.1007/BF00412271; Jau MH, 2005, INT J BIOL MACROMOL, V36, P144, DOI 10.1016/j.ijbiomac.2005.05.002; Karbasi F., 2011, World Applied Sciences Journal, V14, P36; Kessler B, 2001, J BIOTECHNOL, V86, P97, DOI 10.1016/S0168-1656(00)00404-1; Khoja TM, 1975, EUR J PHYCOL, P139; LAW JH, 1961, J BACTERIOL, V82, P33, DOI 10.1128/JB.82.1.33-36.1961; Lee SN, 2002, J APPL POLYM SCI, V83, P2945, DOI 10.1002/app.10318; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Mallick N., 2011, NEW FRONTIERS ENV BI, P56; Nishioka M, 2001, BIOTECHNOL LETT, V23, P1095, DOI 10.1023/A:1010551614648; Oliveira FC, 2007, BIORESOURCE TECHNOL, V98, P633, DOI 10.1016/j.biortech.2006.02.022; Panda B, 2006, BIORESOURCE TECHNOL, V97, P1296, DOI 10.1016/j.biortech.2005.05.013; Parra DF, 2006, POLYM DEGRAD STABIL, V91, P1954, DOI 10.1016/j.polymdegradstab.2006.02.008; PELROY RA, 1972, ARCH MIKROBIOL, V86, P25, DOI 10.1007/BF00412397; Queiroz MI, 2011, APPL ENERG, V88, P3438, DOI 10.1016/j.apenergy.2010.12.047; RIIS V, 1988, J CHROMATOGR, V445, P285, DOI 10.1016/S0021-9673(01)84535-0; Samantaray S, 2011, APPL ENVIRON MICROB, V77, P8735, DOI 10.1128/AEM.05275-11; Sharma L, 2005, BIOTECHNOL LETT, V27, P59, DOI 10.1007/s10529-004-6586-1; Shrivastav A, 2010, INT J BIOL MACROMOL, V46, P255, DOI 10.1016/j.ijbiomac.2010.01.001; STAL LJ, 1992, FEMS MICROBIOL LETT, V103, P169, DOI 10.1111/j.1574-6968.1992.tb05835.x; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; Terada M, 1999, INT J BIOL MACROMOL, V25, P207, DOI 10.1016/S0141-8130(99)00036-7; Tokiwa Y, 2004, BIOTECHNOL LETT, V26, P1181, DOI 10.1023/B:BILE.0000036599.15302.e5; VINCENZINI M, 1990, J BACTERIOL, V172, P2791, DOI 10.1128/jb.172.5.2791-2792.1990; VINCENZINI M, 1999, CHEM MICROALGAE, P292; Wei YH, 2011, INT J MOL SCI, V12, P252, DOI 10.3390/ijms12010252; Yellore V, 1998, LETT APPL MICROBIOL, V26, P391, DOI 10.1046/j.1472-765X.1998.00362.x; Zarrouk C., 1966, THESIS; Zhang S, 1997, POLYMER, V38, P5379; Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6; [No title captured]	50	60	65	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158168	10.1371/journal.pone.0158168	http://dx.doi.org/10.1371/journal.pone.0158168			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359097	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200047
J	Hassold, S; Lowry, PP; Bauert, MR; Razafintsalama, A; Ramamonjisoa, L; Widmer, A				Hassold, Sonja; Lowry, Porter P., II; Bauert, Martin R.; Razafintsalama, Annick; Ramamonjisoa, Lolona; Widmer, Alex			DNA Barcoding of Malagasy Rosewoods: Towards a Molecular Identification of CITES-Listed Dalbergia Species	PLOS ONE			English	Article							ENDANGERED ROSEWOOD; GEOGRAPHIC ORIGIN; CAOS SOFTWARE; FOREST; IVORY; INSIGHTS; TRADE; TOOL; CONSERVATION; BIODIVERSITY	Illegal selective logging of tropical timber is of increasing concern worldwide. Madagascar is a biodiversity hotspot and home to some of the world's most sought after tropical timber species. Malagasy rosewoods belong to the genus Dalbergia (Fabaceae), which is highly diverse and has a pantropical distribution, but these timber species are among the most threatened as a consequence of intensive illegal selective logging and deforestation. Reliable identification of Dalbergia species from Madagascar is important for law enforcement but is almost impossible without fertile plant material, which is often unavailable during forest inventories or when attempting to identify logged trees of cut wood. DNA barcoding has been promoted as a promising tool for species identification in such cases. In this study we tested whether DNA barcoding with partial sequences of three plastid markers (matK, rbcL and trnL (UAA)) can distinguish between Dalbergia from Madagascar and from other areas of its distributional range, and whether Malagasy species can be distinguished from one another. Phylogenetic analyses revealed that the Malagasy Dalbergia species studied form two monophyletic groups, each containing two subgroups, only one of which corresponds to a single species. We characterized diagnostic polymorphisms in the three DNA barcoding markers that allow rapid discrimination between Dalbergia from Madagascar and from other areas of its distribution range. Species identification success based on individual barcoding markers or combinations was poor, whereas subgroup identification success was much higher (up to 98%), revealing both the value and limitations of a DNA barcoding approach for the identification of closely related Malagasy rosewoods.	[Hassold, Sonja; Widmer, Alex] ETH, Inst Integrat Biol, Zurich, Switzerland; [Lowry, Porter P., II] Missouri Bot Garden, St Louis, MO USA; [Lowry, Porter P., II] Museum Natl Hist Nat, Dept Syst & Evolut, ISYEB, UMR 7205, Paris, France; [Bauert, Martin R.] Zoo Zurich AG, Zurich, Switzerland; [Razafintsalama, Annick; Ramamonjisoa, Lolona] Silo Natl Graines Forestiers, Antananarivo, Madagascar	Swiss Federal Institutes of Technology Domain; ETH Zurich; Missouri Botanical Gardens; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Widmer, A (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	alex.widmer@env.ethz.ch	Widmer, Alex/B-6841-2009	Widmer, Alex/0000-0001-8253-5137	Mercator Foundation Switzerland through the Zuerich-Basel Plant Science Center [2009-0549]; Ruebel Foundation Switzerland	Mercator Foundation Switzerland through the Zuerich-Basel Plant Science Center; Ruebel Foundation Switzerland	This work was performed as part of the PSC-Mercator PhD Fellowship: Bridging Plant Sciences and Policy supported by the Mercator Foundation Switzerland (project code 2009-0549; http://www.stiftungmercator.ch/stiftung/projektformate/wissenschaft.html) through the Zuerich-Basel Plant Science Center (http://www.plantsciences.uzh.ch/en/research/fellowships/mercator.html) and the Ruebel Foundation Switzerland. AW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Asif MJ, 2005, PLANT MOL BIOL REP, V23, P185, DOI 10.1007/BF02772709; Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Babineau M, 2013, S AFR J BOT, V89, P94, DOI 10.1016/j.sajb.2013.06.018; Barrett MA, 2013, NATURE, V499, P29, DOI 10.1038/499029c; Barrett MA, 2010, SCIENCE, V328, P1109, DOI 10.1126/science.1187740; Leite FAB, 2014, TREE GENET GENOMES, V10, P307, DOI 10.1007/s11295-013-0685-x; Bennett EL, 2015, CONSERV BIOL, V29, P54, DOI 10.1111/cobi.12377; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bhagwat RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142965; Biggs D, 2013, SCIENCE, V339, P1038, DOI 10.1126/science.1229998; Bosser J, 2002, LEGUMINOSAE MADAGASC, P321; Bosser Jean, 2005, Adansonia (Paris), V27, P209; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Cardoso D, 2013, S AFR J BOT, V89, P58, DOI 10.1016/j.sajb.2013.05.001; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Degen B, 2013, FORENSIC SCI INT-GEN, V7, P55, DOI 10.1016/j.fsigen.2012.06.003; Degen B., 2007, P INT WORKSH FING ME, P6; Deguilloux MF, 2004, ANN FOREST SCI, V61, P97, DOI 10.1051/forest:2003089; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duminil J, 2012, MOL PHYLOGENET EVOL, V62, P275, DOI 10.1016/j.ympev.2011.09.020; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finkeldey R, 2010, APPL MICROBIOL BIOT, V85, P1251, DOI 10.1007/s00253-009-2328-6; Gagnon E, 2013, S AFR J BOT, V89, P111, DOI 10.1016/j.sajb.2013.07.027; Galal-Khallaf A, 2014, FOOD CONTROL, V46, P441, DOI 10.1016/j.foodcont.2014.06.016; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Gore ML, 2013, CONSERV LETT, V6, P430, DOI 10.1111/conl.12032; Hartvig I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138231; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holtken AM, 2012, HOLZFORSCHUNG, V66, P97, DOI 10.1515/HF.2011.142; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Innes J. L., 2010, Madagascar Conservation and Development, V5, P6; Jiao LC, 2014, HOLZFORSCHUNG, V68, P487, DOI 10.1515/hf-2013-0129; Jorger KM, 2014, SPIXIANA, V37, P21; Jolivet C, 2012, FORENSIC SCI INT-GEN, V6, P487, DOI 10.1016/j.fsigen.2011.11.002; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keong CH, 2007, INT FOREST REV, V9, P805, DOI 10.1505/ifor.9.3.805; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lamendin R, 2015, FOOD CONTROL, V47, P436, DOI 10.1016/j.foodcont.2014.07.039; Lopez P., 2009, MADAGASCAR CONSERVAT, V5, P110, DOI DOI 10.4314/MCD.V5I2.63141; Lowe A., 2007, P INT WORKSH FING ME; Lowe AJ, 2011, IAWA J, V32, P251, DOI 10.1163/22941932-90000055; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Patel E. R., 2007, MADAG CONSERV DEV, V2, P11, DOI DOI 10.4314/MCD.V2I1.44124; Phong DT, 2014, ASIAN J APPL SCI, V02, P116; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Randriamalala H., 2010, Madagascar Conservation and Development, V5, P11; Ribeiro RA, 2011, HEREDITY, V106, P46, DOI 10.1038/hdy.2010.64; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Saslis-Lagoudakis CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022275; Schuurman D., 2009, Madagascar Conservation and Development, V4, P98; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Styger E, 2007, AGR ECOSYST ENVIRON, V119, P257, DOI 10.1016/j.agee.2006.07.012; Subedi A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-64; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Turner B, 2013, MOL PHYLOGENET EVOL, V69, P740, DOI 10.1016/j.ympev.2013.07.002; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vatanparast M, 2013, S AFR J BOT, V89, P143, DOI 10.1016/j.sajb.2013.07.001; WAEBER PO, 2013, MADAG CONSERV DEV, V8, P52, DOI DOI 10.4314/mcd.v8i2.1; Wasser S, 2010, SCIENCE, V327, P1331, DOI 10.1126/science.1187811; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; Wilme L, 2009, PRECIOUS TREES PAY O; Wozney KM, 2012, FORENSIC SCI INT, V219, P106, DOI 10.1016/j.forsciint.2011.12.006; Zinner D, 2014, REG ENVIRON CHANGE, V14, P157, DOI 10.1007/s10113-013-0475-x	77	34	37	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157881	10.1371/journal.pone.0157881	http://dx.doi.org/10.1371/journal.pone.0157881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362258	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200027
J	Pignat, JM; Mauron, E; Johr, J; de Keranflec'h, CG; Van De Ville, D; Preti, MG; Meskaldji, DE; Homberg, V; Laureys, S; Draganski, B; Frackowiak, R; Diserens, K				Pignat, Jean-Michel; Mauron, Etienne; Johr, Jane; de Keranflec'h, Charlotte Gilart; Van De Ville, Dimitri; Preti, Maria Giulia; Meskaldji, Djalel E.; Hoemberg, Volker; Laureys, Steven; Draganski, Bogdan; Frackowiak, Richard; Diserens, Karin			Outcome Prediction of Consciousness Disorders in the Acute Stage Based on a Complementary Motor Behavioural Tool	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; VEGETATIVE STATE; UNRESPONSIVE WAKEFULNESS; DIAGNOSTIC-ACCURACY; FOLLOW-UP; RECOVERY; REHABILITATION; PROGNOSIS; COMA	Introduction Attaining an accurate diagnosis in the acute phase for severely brain-damaged patients presenting Disorders of Consciousness (DOC) is crucial for prognostic validity; such a diagnosis determines further medical management, in terms of therapeutic choices and end-of-life decisions. However, DOC evaluation based on validated scales, such as the Revised Coma Recovery Scale (CRS-R), can lead to an underestimation of consciousness and to frequent misdiagnoses particularly in cases of cognitive motor dissociation due to other aetiologies. The purpose of this study is to determine the clinical signs that lead to a more accurate consciousness assessment allowing more reliable outcome prediction. Methods From the Unit of Acute Neurorehabilitation (University Hospital, Lausanne, Switzerland) between 2011 and 2014, we enrolled 33 DOC patients with a DOC diagnosis according to the CRS-R that had been established within 28 days of brain damage. The first CRS-R assessment established the initial diagnosis of Unresponsive Wakefulness Syndrome (UWS) in 20 patients and a Minimally Consciousness State (MCS) in the remaining13 patients. We clinically evaluated the patients over time using the CRS-R scale and concurrently from the beginning with complementary clinical items of a new observational Motor Behaviour Tool (MBT). Primary endpoint was outcome at unit discharge distinguishing two main classes of patients (DOC patients having emerged from DOC and those remaining in DOC) and 6 subclasses detailing the outcome of UWS and MCS patients, respectively. Based on CRS-R and MBT scores assessed separately and jointly, statistical testing was performed in the acute phase using a non-parametric Mann-Whitney U test; longitudinal CRS-R data were modelled with a Generalized Linear Model. Results Fifty-five per cent of the UWS patients and 77% of the MCS patients had emerged from DOC. First, statistical prediction of the first CRS-R scores did not permit outcome differentiation between classes; longitudinal regression modelling of the CRS-R data identified distinct outcome evolution, but not earlier than 19 days. Second, the MBT yielded a significant outcome predictability in the acute phase (p<0.02, sensitivity>0.81). Third, a statistical comparison of the CRS-R subscales weighted by MBT became significantly predictive for DOC outcome (p<0.02). Discussion The association of MBT and CRS-R scoring improves significantly the evaluation of consciousness and the predictability of outcome in the acute phase. Subtle motor behaviour assessment provides accurate insight into the amount and the content of consciousness even in the case of cognitive motor dissociation.	[Pignat, Jean-Michel; Johr, Jane; de Keranflec'h, Charlotte Gilart; Diserens, Karin] Univ Lausanne Hosp, Dept Clin Neurosci, Acute Neurorehabil Unit, Lausanne, Switzerland; [Pignat, Jean-Michel; Draganski, Bogdan; Frackowiak, Richard; Diserens, Karin] Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland; [Mauron, Etienne] Univ Lausanne, Fac Med, Lausanne, Switzerland; [Laureys, Steven] Univ Liege, Coma Sci Grp, Liege, Belgium; [Van De Ville, Dimitri; Preti, Maria Giulia; Meskaldji, Djalel E.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Van De Ville, Dimitri; Preti, Maria Giulia; Meskaldji, Djalel E.] Univ Geneva, Fac Med, Geneva, Switzerland; [Hoemberg, Volker] SRH Gesundheitszentrum, Dept Neurol, Bad Wimpfen, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne; University of Liege; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Pignat, JM (corresponding author), Univ Lausanne Hosp, Dept Clin Neurosci, Acute Neurorehabil Unit, Lausanne, Switzerland.; Pignat, JM (corresponding author), Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland.	jean-michel.pignat@chuv.ch	Preti, Maria Giulia/X-9430-2019; Frackowiak, Richard/H-4383-2011; Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; Draganski, Bogdan/C-3096-2016; Jöhr, Jane/AAL-3611-2021; Van De Ville, Dimitri/A-5364-2008	Preti, Maria Giulia/0000-0002-5323-5327; Frackowiak, Richard/0000-0002-3151-822X; Laureys, Steven/0000-0002-3096-3807; Draganski, Bogdan/0000-0002-5159-5919; Van De Ville, Dimitri/0000-0002-2879-3861; Johr, Jane/0000-0003-4280-9310	German Research Foundation; National Fund for Scientific Research (NFSR); Foundation Parkinson Switzerland; Foundation Synapsis; Swiss National Science Foundation; Fondation Roger de Spoelberch; Partridge Foundation; Gianni Biaggi de Blasys Foundation; Schumacher Foundation; company Merz; company Allergan	German Research Foundation(German Research Foundation (DFG)); National Fund for Scientific Research (NFSR); Foundation Parkinson Switzerland; Foundation Synapsis; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Roger de Spoelberch; Partridge Foundation(General Electric); Gianni Biaggi de Blasys Foundation; Schumacher Foundation; company Merz; company Allergan(AbbVieAllergan)	V. Homberg received funding from the German Research Foundation. S. Laureys received funding from National Fund for Scientific Research (NFSR). B. Draganski received funding from the Foundation Parkinson Switzerland, the Foundation Synapsis, the German Research Foundation and the Swiss National Science Foundation. R. Frackowiak received funding from the Fondation Roger de Spoelberch, the Partridge Foundation and for the LREN research neuroimaging platform. K. Diserens received funding from the Gianni Biaggi de Blasys Foundation and the Schumacher Foundation. K. Diserens received also funding from the companies Merz and Allergan for research on botulinum toxin treatment. This study was financially supported by the peer reviewed Gianni Biaggi de Blasys Foundation, which had no role in study design, in data collection, analysis and interpretation, nor in writing the final report. All the aforementioned institutions and companies had no role in study design, in data collection, analysis and interpretation, nor in writing the final report.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2015, CLIN NEUROPHYSIOL, V126, P959, DOI 10.1016/j.clinph.2014.08.005; Bodart O, 2013, SEMIN NEUROL, V33, P83, DOI 10.1055/s-0033-1348965; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cavanna AE, 2011, BEHAV NEUROL, V24, P107, DOI [10.1155/2011/645159, 10.3233/BEN-2011-0322]; Chatelle C, 2012, BRAIN INJURY, V26, P1510, DOI 10.3109/02699052.2012.698362; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Di Perri C, 2014, WORLD J RADIOL, V6, P589, DOI 10.4329/wjr.v6.i8.589; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; Fernandez-Espejo D, 2015, JAMA NEUROL, P1, DOI [10.1001/jamaneurol.2015.2614, DOI 10.1001/JAMANEUROL.2015.2614]; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Formisano R, 2011, FUNCT NEUROL, V26, P15; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2006, BRAIN INJURY, V20, P1321, DOI 10.1080/02699050601081802; Holler Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080479; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lupi A, 2014, CURR RADIOPHARM, V7, P57, DOI 10.2174/1874471007666140411103819; Owen AM, 2014, NAT REV NEUROL, V10, P370, DOI 10.1038/nrneurol.2014.102; Posner JB, 2007, PLUM POSNERS DIAGNOS; Rossetti AO, 2012, NEUROLOGY, V78, P796, DOI 10.1212/WNL.0b013e318249f6bb; SAZBON L, 1991, Brain Injury, V5, P3, DOI 10.3109/02699059108998505; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2015, NEUROREHAB NEURAL RE, V29, P41, DOI 10.1177/1545968314528067; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Serrao M, 2006, J NEUROSCI, V26, P3505, DOI 10.1523/JNEUROSCI.5160-05.2006; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; 1994, NEW ENGL J MED, V330, P1572, DOI DOI 10.1056/NEJM199406023302206	45	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0156882	10.1371/journal.pone.0156882	http://dx.doi.org/10.1371/journal.pone.0156882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359335	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200004
J	Baumann, M; Tchicaya, A; Lorentz, N; Le Bihan, E				Baumann, Michele; Tchicaya, Anastase; Lorentz, Nathalie; Le Bihan, Etienne			Impact of Patients' Communication with the Medical Practitioners, on Their Adherence Declared to Preventive Behaviours, Five Years after a Coronary Angiography, in Luxembourg	PLOS ONE			English	Article							LIFE SATISFACTION; DISEASE; CARE	Background Patients of the National Institute of Cardiac Surgery and Interventional Cardiology in Luxembourg who underwent coronary angiography were surveyed for hypertension, hypercholesterolemia, diabetes and overweight/obesity between 2008/9 and 2013/4. For each cardiovascular risk factor (CVRFs), we analysed the associations between the quality of the patients' communication with the medical practitioner and their adherence declared to preventive behaviours. Methods 1,289 completed a self-administered questionnaire on communication with the medical practitioner (P'Com-5 items scale; Cronbach 0.87). 61.8% stopped smoking, 57.9% reduced or stopped their consumption of salt, 71.9% of fat, and 62.8% of sugar, and whereas 65% increased their consumption of fruit and vegetables and 19.8% increased their physical activity. Around 37% reported having made changes following their doctor's advice. 90% were followed by a cardiologist and 95.9% by an attending physician. Results No link was observed between declaration of physical activity, smoking, fats, and quality of communication. Significant associations: for increased consumption of fruit and vegetables was linked with the quality of doctor-patient communication when patients were overweight (OR = 1.081), obese (OR = 1.130), hypercholesterolemic (OR = 1.102), hypertensive (OR = 1.084) or diabetic (OR = 1.103). Reduction in salt intake was linked only to patients with hypertension (OR = 1.102), whereas reduction or cessation of sugar consumption was linked to overweight (OR = 1.093), and more so obese, (OR = 1.106), hypercholesterolemics (OR = 1.103) and diabetics (OR = 1.173). Conclusions Good doctor-patient communication was related to nutrition, particularly increased consumption of fresh fruits and vegetables. Accurate perception of CVRFs by both patients and medical practitioners is essential for CV protection. The aim of instructing patients is to encourage them to make informed decisions about how to change their lifestyle. In routinely, P'Com-5 scale can collect data to assess the improvement of the professional skills. It can be used in medical training to enhance the quality of the therapeutic communication, especially for nutritional coaching, and to evaluate its efficacy in reducing CVRFs.	[Baumann, Michele; Le Bihan, Etienne] Univ Luxembourg, Inst Hlth & Behav, Res Unit INSIDE, Esch Sur Alzette, Luxembourg; [Tchicaya, Anastase; Lorentz, Nathalie] LISER, Esch Sur Alzette, Luxembourg	University of Luxembourg	Baumann, M (corresponding author), Univ Luxembourg, Inst Hlth & Behav, Res Unit INSIDE, Esch Sur Alzette, Luxembourg.	michele.baumann@uni.lu	TCHICAYA, Anastase/AAI-4994-2020		Luxembourg National Research Fund [FNR/C12/BM/3978355]	Luxembourg National Research Fund(Luxembourg National Research Fund)	The authors thank the Institut National de Chirurgie Cardiaque et de Cardiologie Interventionnelle (INCCI) in Luxembourg, and are grateful for the financial support received from the Luxembourg National Research Fund FNR/C12/BM/3978355. The project is titled 'Monitoring and DYNamics of health status through the Risk Factors for Cardiovascular disease' (MDYNRFC).; The authors thank the Institut National de Chirurgie Cardiaque et de Cardiologie Interventionnelle (INCCI) in Luxembourg, and are grateful for the financial support received from the Luxembourg National Research Fund FNR/C12/BM/3978355. The project is titled 'Monitoring and DYNamics of health status through the Risk Factors for Cardiovascular disease' (MDYNRFC).	Alaszewski A, 2005, PLOS MED, V2, P93, DOI 10.1371/journal.pmed.0020041; Alkerwi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-468; Baumann M, 2007, CLIN EXP RHEUMATOL, V25, P404; Baumann M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2047-0; Baumann M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-244; Dalen JE, 2014, AM J MED, V127, P364, DOI 10.1016/j.amjmed.2013.12.014; Godin G, 2005, BRIT J SOC PSYCHOL, V44, P497, DOI 10.1348/014466604X17452; Godin G, 2008, AM J HEALTH PROMOT, V22, P180, DOI 10.4278/ajhp.22.3.180; Kolandaivelu K, 2014, EUR HEART J, V35, P3267, DOI 10.1093/eurheartj/ehu364; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; O'Neil A, 2014, EUR J PREV CARDIOL, V21, P30, DOI 10.1177/2047487312460515; OECD, 2013, HLTH GLANC 2013 OECD; Orbell S, 1998, BRIT J SOC PSYCHOL, V37, P151, DOI 10.1111/j.2044-8309.1998.tb01162.x; Rogers AE, 2000, BMJ-BRIT MED J, V321, P605, DOI 10.1136/bmj.321.7261.605; Ruilope LM, 2013, EUR HEART J, V34, P2931, DOI 10.1093/eurheartj/eht299; Stevenson FA, 2004, HEALTH EXPECT, V7, P235, DOI 10.1111/j.1369-7625.2004.00281.x; Wang Y, 2014, SOC INDIC RES, V116, P843, DOI 10.1007/s11205-013-0327-6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2013, WHO GLOB BRIEF HYP	21	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157321	10.1371/journal.pone.0157321	http://dx.doi.org/10.1371/journal.pone.0157321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355320	Green Published, gold			2022-12-27	WOS:000378859400011
J	Caceres, A; Esko, T; Pappa, I; Gutierrez, A; Lopez-Espinosa, MJ; Llop, S; Bustamante, M; Tiemeier, H; Metspalu, A; Joshi, PK; Wilsonx, JF; Reina-Castillon, J; Shin, J; Pausova, Z; Paus, T; Sunyer, J; Perez-Jurado, LA; Gonzalez, JR				Caceres, Alejandro; Esko, Tonu; Pappa, Irene; Gutierrez, Armand; Lopez-Espinosa, Maria-Jose; Llop, Sabrina; Bustamante, Mariona; Tiemeier, Henning; Metspalu, Andres; Joshi, Peter K.; Wilsonx, James F.; Reina-Castillon, Judith; Shin, Jean; Pausova, Zdenka; Paus, Tomas; Sunyer, Jordi; Perez-Jurado, Luis A.; Gonzalez, Juan R.			Ancient Haplotypes at the 15q24.2 Microdeletion Region Are Linked to Brain Expression of MAN2C1 and Children's Intelligence	PLOS ONE			English	Article							PROTEIN; SUSCEPTIBILITY; GLYCOSYLATION; ORIGIN	The chromosome bands 15q24.1-15q24.3 contain a complex region with numerous segmental duplications that predispose to regional microduplications and microdeletions, both of which have been linked to intellectual disability, speech delay and autistic features. The region may also harbour common inversion polymorphisms whose functional and phenotypic manifestations are unknown. Using single nucleotide polymorphism (SNP) data, we detected four large contiguous haplotype-genotypes at 15q24 with Mendelian inheritance in 2,562 trios, African origin, high population stratification and reduced recombination rates. Although the haplotype-genotypes have been most likely generated by decreased or absent recombination among them, we could not confirm that they were the product of inversion polymorphisms in the region. One of the blocks was composed of three haplotype-genotypes (N1a, N1b and N2), which significantly correlated with intelligence quotient (IQ) in 2,735 children of European ancestry from three independent population cohorts. Homozygosity for N2 was associated with lower verbal IQ (2.4-point loss, p-value = 0.01), while homozygosity for N1b was associated with 3.2-point loss in non-verbal IQ ( p-value = 0.0006). The three alleles strongly correlated with expression levels of MAN2C1 and SNUPN in blood and brain. Homozygosity for N2 correlated with over-expression of MAN2C1 over many brain areas but the occipital cortex where N1b homozygous highly under-expressed. Our population-based analyses suggest that MAN2C1 may contribute to the verbal difficulties observed in microduplications and to the intellectual disability of microdeletion syndromes, whose characteristic dosage increment and removal may affect different brain areas.	[Caceres, Alejandro; Bustamante, Mariona; Sunyer, Jordi; Gonzalez, Juan R.] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Caceres, Alejandro; Bustamante, Mariona; Sunyer, Jordi; Gonzalez, Juan R.] Univ Pompeu Fabra, Barcelona, Spain; [Caceres, Alejandro; Lopez-Espinosa, Maria-Jose; Llop, Sabrina; Bustamante, Mariona; Sunyer, Jordi; Gonzalez, Juan R.] CIBERESP, Madrid, Spain; [Esko, Tonu] Harvard Med Sch, Dept Genet, Boston, MA USA; [Esko, Tonu] Broad Inst, Cambridge, MA USA; [Esko, Tonu] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Pappa, Irene] Erasmus Univ, Sch Pedag & Educ Sci, Rotterdam, Netherlands; [Pappa, Irene] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Gutierrez, Armand; Reina-Castillon, Judith; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Gutierrez, Armand; Reina-Castillon, Judith; Perez-Jurado, Luis A.] CIBERER, Madrid, Spain; [Gutierrez, Armand; Reina-Castillon, Judith; Sunyer, Jordi; Perez-Jurado, Luis A.] Hosp Mar Res Inst IMIM, Barcelona, Spain; [Lopez-Espinosa, Maria-Jose; Llop, Sabrina] Univ Valencia, FISABIO, Epidemiol & Environm Hlth Joint Res Unit, Univ Jaume 1, Valencia, Spain; [Bustamante, Mariona] CRG, Genom & Dis Grp, Barcelona, Spain; [Tiemeier, Henning] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Joshi, Peter K.; Wilsonx, James F.] Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Wilsonx, James F.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Shin, Jean; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Gonzalez, Juan R.] Univ Autonoma Barcelona, Dept Math, Bellaterra, Barcelona, Spain	ISGlobal; Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; University of Tartu; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universitat Jaume I; University of Valencia; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; University of Tartu; University of Edinburgh; University of Edinburgh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Baycrest; Autonomous University of Barcelona	Caceres, A; Gonzalez, JR (corresponding author), ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.; Caceres, A; Gonzalez, JR (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.; Caceres, A; Gonzalez, JR (corresponding author), CIBERESP, Madrid, Spain.; Gonzalez, JR (corresponding author), Univ Autonoma Barcelona, Dept Math, Bellaterra, Barcelona, Spain.	acaceres@creal.cat; jrgonzalez@creal.cat	Tiemeier, Henning/H-6534-2019; Gonzalez, Juan R/B-7860-2018; lopez, maria jose/ABH-7031-2020; Pappa, Irene/AAD-2738-2019; Llop, Sabrina/L-2122-2015; Bustamante, Mariona/ABB-9142-2021; Caceres, Alejandro/ABF-4180-2021; Lopez, Maria/HHC-3659-2022; Sunyer, Jordi/G-6909-2014	Tiemeier, Henning/0000-0002-4395-1397; Gonzalez, Juan R/0000-0003-3267-2146; lopez, maria jose/0000-0003-1202-8740; Llop, Sabrina/0000-0002-6784-4211; Bustamante, Mariona/0000-0003-0127-2860; Sunyer, Jordi/0000-0002-2602-4110; Pappa, Irene/0000-0003-4936-5791; Caceres, Alejandro/0000-0001-8551-6695; Joshi, Peter/0000-0002-6361-5059	Spanish Ministry of Science and Innovation [MTM2011-26515, SAF2008-00357]; Statistical Genetics Network-GENOMET [MTM2010-09526-E]; Instituto de Salud Carlos III [FIS PI1002512, PI1302481CB06/02/0041, Red INMA G03/176, FIS PI041436, PI081151, PI041705, PS09/00432, FIS-FEDER PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI09/02647, PI13/1944, PI14/0891]; Instituto de Salud Carlos III [Miguel Servet-FEDER] [CP11/0178, CP15/0025]; Generalitat de Catalunya [2014SGR1468, SRG1468-2014]; European Commission [HEALTH-F4-2007-201413, FP7-ENV-2011 cod 282957, HEALTH. 2010.2.4.5-1]; Fundacio La Marato de TV3, Generalitat de Catalunya [CIRIT 1999SGR00241]; Conselleria de Sanitat, Generalitat Valenciana; Fundacion Roger Torne; Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation; Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development [ZonMw]; Netherlands Organization for Health Research and Development [2100.0074]; Estonian Government [SF0180142s08]; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics [EXCEGEN]; University of Tartu [SP1GVARENG], Estonian Research Council [IUT2-2]; European Regional Development Fund; Chief Scientist Office of the Scottish Government; Royal Society; MRC Human Genetics Unit; Arthritis Research UK; European Union framework program [LSHG-CT-2006-018947]; Spanish Ministry of Health (FEDER) [FIS-PI1302481]; ICREA-Academia program; Spanish Ministry of Economy and Competiveness "Programa de Excelencia Maria de Maeztu" [MDM-2014-0370]; Medical Research Council [1201677] Funding Source: researchfish	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Statistical Genetics Network-GENOMET; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III [Miguel Servet-FEDER]; Generalitat de Catalunya(Generalitat de Catalunya); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacio La Marato de TV3, Generalitat de Catalunya(Generalitat de Catalunya); Conselleria de Sanitat, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Fundacion Roger Torne; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development [ZonMw](Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Estonian Government; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics [EXCEGEN]; University of Tartu [SP1GVARENG], Estonian Research Council(Estonian Research Council); European Regional Development Fund(European Commission); Chief Scientist Office of the Scottish Government; Royal Society(Royal Society of London); MRC Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); European Union framework program(European Commission); Spanish Ministry of Health (FEDER); ICREA-Academia program(ICREA); Spanish Ministry of Economy and Competiveness "Programa de Excelencia Maria de Maeztu"; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Spanish Ministry of Science and Innovation [MTM2011-26515]; Statistical Genetics Network-GENOMET [MTM2010-09526-E]; Instituto de Salud Carlos III [FIS PI1002512, PI1302481CB06/02/0041, Red INMA G03/176, FIS PI041436, PI081151, PI041705, PS09/00432, FIS-FEDER PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI09/02647, PI13/1944, PI14/0891, and Miguel Servet-FEDER CP11/0178 and CP15/0025]; Generalitat de Catalunya [2014SGR1468]; Spanish Ministry of Science and Innovation [SAF2008-00357]; the European Commission [HEALTH-F4-2007-201413, FP7-ENV-2011 cod 282957, HEALTH. 2010.2.4.5-1]; Fundacio La Marato de TV3, Generalitat de Catalunya [CIRIT 1999SGR00241]; Conselleria de Sanitat, Generalitat Valenciana to MJLE; Fundacion Roger Torne to MJLE; Canadian Institutes of Health Research to TP and ZP; Heart and Stroke Foundation of Quebec to ZP; The Canadian Foundation for Innovation to ZP; Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development [ZonMw]; Netherlands Organization for Health Research and Development [2100.0074]; Estonian Government [SF0180142s08]; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics [EXCEGEN]; University of Tartu [SP1GVARENG], Estonian Research Council [IUT2-2]; European Regional Development Fund; The Chief Scientist Office of the Scottish Government; The Royal Society; The MRC Human Genetics Unit; Arthritis Research UK and The European Union framework program [LSHG-CT-2006-018947]. LAPJ is funded by the Spanish Ministry of Health (FIS-PI1302481 co-funded by FEDER), the Generalitat de Catalunya (SRG1468-2014), the ICREA-Academia program, and also acknowledges support from the Spanish Ministry of Economy and Competiveness "Programa de Excelencia Maria de Maeztu" (MDM-2014-0370).	Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Bernon C, 2011, GLYCOBIOLOGY, V21, P363, DOI 10.1093/glycob/cwq169; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Caceres A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv073; Caceres A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-28; Cusco I, 2008, GENOME RES, V18, P683, DOI 10.1101/gr.073197.107; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gonzalez JR, 2014, AM J HUM GENET, V94, P361, DOI 10.1016/j.ajhg.2014.01.015; Guxens M, 2012, INT J EPIDEMIOL, V41, P930, DOI 10.1093/ije/dyr054; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Magoulas PL, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-2; McInnes LA, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-5; Mefford HC, 2012, J MED GENET, V49, P110, DOI 10.1136/jmedgenet-2011-100499; Mkrtchyan G, 2014, NEUROSCI BEHAV PHYSL, V44, P442; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; NAGLIERI JA, 1980, PSYCHOL REP, V47, P591, DOI 10.2466/pr0.1980.47.2.591; Narayanan U, 2002, HUM MOL GENET, V11, P1785, DOI 10.1093/hmg/11.15.1785; Paterson T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-246; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; Roetzer KM, 2010, AM J MED GENET A, V152A, P3173, DOI 10.1002/ajmg.a.33750; Salm MPA, 2012, GENOME RES, V22, P1144, DOI 10.1101/gr.126037.111; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Tellegen P, 1993, LEARNING POTENTIAL A, P267; Uddin M, 2011, DIS MARKERS, V30, P111, DOI [10.1155/2011/513659, 10.3233/DMA-2011-0750]; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang L, 2013, J BIOL CHEM, V288, P11887, DOI 10.1074/jbc.M112.425702; Xiang ZG, 2010, TRANSGENIC RES, V19, P67, DOI 10.1007/s11248-009-9299-3; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157739	10.1371/journal.pone.0157739	http://dx.doi.org/10.1371/journal.pone.0157739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355585	Green Published, gold			2022-12-27	WOS:000378859400017
J	Kretschmer-Trendowicz, A; Ellis, JA; Altgassen, M				Kretschmer-Trendowicz, Anett; Ellis, Judith A.; Altgassen, Mareike			Effects of Episodic Future Thinking and Self-Projection on Children's Prospective Memory Performance	PLOS ONE			English	Article							IMPLEMENTATION INTENTIONS; EXECUTIVE FUNCTION; FALSE-BELIEF; AGE; MIND; SCHOOLCHILDREN; SIMULATION	The present study is the first to investigate the benefits of episodic future thinking (EFT) at encoding on prospective memory (PM) in preschool (age: M = 66.34 months, SD = 3.28) and primary school children (age: M = 88.36 months, SD = 3.12). A second aim was to examine if self-projection influences the possible effects of EFT instructions. PM was assessed using a standard PM paradigm in children with a picture-naming task as the ongoing activity in which the PM task was embedded. Further, two first-and two second-order ToM tasks were administered as indicator of children's self-projection abilities. Forty-one preschoolers and 39 school-aged children were recruited. Half of the participants in each age group were instructed to use EFT as a strategy to encode the PM task, while the others received standard PM instructions. Results revealed a significant age effect, with school-aged children significantly outperforming preschoolers and a significant effect of encoding condition with overall better performance when receiving EFT instructions compared to the standard encoding condition. Even though the interaction between age group and encoding condition was not significant, planned comparisons revealed first evidence that compared to the younger age group, older children's PM benefitted more from EFT instructions during intention encoding. Moreover, results showed that although self-projection had a significant impact on PM performance, it did not influence the effects of EFT instructions. Overall, results indicate that children can use EFT encoding strategies to improve their PM performance once EFT abilities are sufficiently developed. Further, they provide first evidence that in addition to executive functions, which have already been shown to influence the development of PM across childhood, self-projection seems to be another key mechanism underlying this development.	[Kretschmer-Trendowicz, Anett; Altgassen, Mareike] Tech Univ Dresden, Dept Psychol, Dresden, Germany; [Ellis, Judith A.] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Altgassen, Mareike] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Technische Universitat Dresden; University of Reading; Radboud University Nijmegen	Kretschmer-Trendowicz, A (corresponding author), Tech Univ Dresden, Dept Psychol, Dresden, Germany.	anett.kretschmer-trendowicz@tu-dresden.de	Kretschmer-Trendowicz, Anett/L-9513-2016; Altgassen, Mareike/J-3048-2012; Altgassen, Mareike/AAN-1767-2020	Altgassen, Mareike/0000-0002-2644-8298	German Research Foundation Deutsche Forschungsgemeinschaft [SFB 940/1 2012]; German Research Foundation (DFG) [SFB 940/1 2012]	German Research Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Foundation Deutsche Forschungsgemeinschaft (grant SFB 940/1 2012), http://www.sfb940.de/en/home.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the German Research Foundation (DFG grant SFB 940/1 2012). We thank Marie-Luise Krautz for her help with recruitment and data collection and all families who participated in the study.	Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Altgassen M, 2017, CHILD NEUROPSYCHOL, V23, P536, DOI 10.1080/09297049.2016.1158247; Altgassen M, 2015, Q J EXP PSYCHOL, V68, P192, DOI 10.1080/17470218.2014.956127; Altgassen M, 2014, J EXP CHILD PSYCHOL, V127, P163, DOI 10.1016/j.jecp.2014.03.009; Altgassen M, 2012, J AUTISM DEV DISORD, V42, P2141, DOI 10.1007/s10803-012-1466-3; Atance C. M., 2005, FIRST LANG, V25, P5; Atance CM, 2005, LEARN MOTIV, V36, P126, DOI 10.1016/j.lmot.2005.02.003; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Atance CM, 2009, J EXP CHILD PSYCHOL, V102, P379, DOI 10.1016/j.jecp.2009.01.001; Baron-Cohen S., 2001, PRISME, V34, P74; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Brewer GA, 2010, COGN NEUROSCI-UK, V1, P81, DOI 10.1080/17588920903373960; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; de Vito S, 2012, NEUROPSYCHOLOGIA, V50, P1494, DOI 10.1016/j.neuropsychologia.2012.03.001; Ellis J., 1996, PROSPECTIVE MEMORY T, P1; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Ford RM, 2012, J EXP CHILD PSYCHOL, V111, P468, DOI 10.1016/j.jecp.2011.10.006; Gollwitzer P.M., 1993, EUR REV SOC PSYCHOL, V4, DOI [10.1080/14792779343000059, DOI 10.1080/14792779343000059]; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gott C, 2014, CHILD NEUROPSYCHOL, V20, P625, DOI 10.1080/09297049.2013.840362; Hanson LK, 2014, J EXP CHILD PSYCHOL, V128, P120, DOI 10.1016/j.jecp.2014.07.006; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Hollebrandse B, 2014, SYNTHESE, V191, P321, DOI 10.1007/s11229-012-0169-9; Huitema B., 1980, ANALYSIS OF COVARIAN; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M, 2004, MEMORY, V12, P553, DOI 10.1080/09658210344000099; Kliegel M., 2002, PSYCHOL BEITR, V44, P303; Kliegel M, 2008, PSYCHOL AGING, V23, P203, DOI 10.1037/0882-7974.23.1.203; Kliegel M, 2007, COGNITIVE DEV, V22, P33, DOI 10.1016/j.cogdev.2006.08.003; Kliegel M, 2013, J EXP CHILD PSYCHOL, V116, P792, DOI 10.1016/j.jecp.2013.07.012; Kretschmer A, 2014, CHILD NEUROPSYCHOL, V20, P662, DOI 10.1080/09297049.2013.841881; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Leitz JR, 2009, PSYCHOPHARMACOLOGY, V205, P379, DOI 10.1007/s00213-009-1546-z; Liu LL, 2004, PSYCHOL AGING, V19, P318, DOI 10.1037/0882-7974.19.2.318; Mackinlay RJ, 2009, J EXP CHILD PSYCHOL, V102, P251, DOI 10.1016/j.jecp.2008.08.006; Mahy CEV, 2014, DEV REV, V34, P305, DOI 10.1016/j.dr.2014.08.001; Mahy CEV, 2011, COGNITIVE DEV, V26, P269, DOI 10.1016/j.cogdev.2011.06.002; Mattli F, 2014, AGING NEUROPSYCHOL C, V21, P515, DOI 10.1080/13825585.2013.837860; McDaniel M.A., 2008, PROSPECTIVE MEMORY C, P115; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McFarland C, 2012, MEM COGNITION, V40, P62, DOI 10.3758/s13421-011-0126-8; Meeks JT, 2010, PSYCHOL RES-PSYCH FO, V74, P82, DOI 10.1007/s00426-008-0223-x; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Neroni MA, 2014, CONSCIOUS COGN, V23, P53, DOI 10.1016/j.concog.2013.12.001; Nigro G, 2014, J EXP CHILD PSYCHOL, V127, P82, DOI 10.1016/j.jecp.2013.10.013; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125, DOI 10.1111/j.2044-835X.1987.tb01048.x; Petermann F., 2008, HAMBURG WECHSLER INT; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Ricken G., 2007, HANNOVER WECHSLER IN; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Sheppard DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140987; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Suddendorf T, 2013, ANN NY ACAD SCI, V1296, P135, DOI 10.1111/nyas.12189; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Voigt B, 2011, Z PSYCHOL, V219, P92, DOI 10.1027/2151-2604/a000053; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Williams D, 2013, J AUTISM DEV DISORD, V43, P1555, DOI 10.1007/s10803-012-1703-9; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zimmermann TD, 2006, Q J EXP PSYCHOL, V59, P2040, DOI 10.1080/17470210600917835	70	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158366	10.1371/journal.pone.0158366	http://dx.doi.org/10.1371/journal.pone.0158366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355645	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400056
J	Talar, B; Gajos-Michniewicz, A; Talar, M; Chouaib, S; Czyz, M				Talar, Beata; Gajos-Michniewicz, Anna; Talar, Marcin; Chouaib, Salem; Czyz, Malgorzata			Pentoxifylline Inhibits WNT Signalling in beta-Catenin(high) Patient-Derived Melanoma Cell Populations	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; NF-KAPPA-B; BETA-CATENIN; MALIGNANT-MELANOMA; TARGETED THERAPIES; EXPRESSION; MITF; IMMUNOTHERAPY; PARTHENOLIDE; APOPTOSIS	Background The heterogeneity of melanoma needs to be addressed and combination therapies seem to be necessary to overcome intrinsic and acquired resistance to newly developed immunotherapies and targeted therapies. Although the role of WNT/beta-catenin pathway in melanoma was early demonstrated, its contribution to the lack of the melanoma patient response to treatment was only recently recognized. Using patient-derived melanoma cell populations, we investigated the influence of pentoxifylline on melanoma cells with either high or low expression of beta-catenin. Findings Our results indicate that pentoxifylline inhibits the activity of the canonical WNT pathway in melanoma cell populations with high basal activity of this signalling. This is supported by lowered overall activity of transcription factors TCF/LEF and reduced nuclear localisation of active beta-catenin. Moreover, treatment of beta-catenin(high) melanoma cell populations with pentoxifylline induces downregulation of genes that are targets of the WNT/beta-catenin pathway including connective tissue growth factor (CTGF) and microphthalmia-associated transcription factor (MITF-M), a melanocyte-and melanoma cell-specific regulator. Conclusions These results suggest that pentoxifylline, a drug approved by the FDA in the treatment of peripheral arterial disease, might be tested in a subset of melanoma patients with elevated activity of beta-catenin. This pharmaceutical might be tested as an adjuvant drug in combination therapies when the response to immunotherapy is prevented by high activity of the WNT/beta-catenin pathway.	[Talar, Beata; Gajos-Michniewicz, Anna; Czyz, Malgorzata] Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland; [Talar, Marcin] Med Univ Lodz, Dept Haemostasis & Haemostat Disorders, Lodz, Poland; [Chouaib, Salem] Unite INSERM U1186, Inst Cancerol Gustave Roussy, Villejuif, France	Medical University Lodz; Medical University Lodz; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Czyz, M (corresponding author), Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland.	malgorzata.czyz@umed.lodz.pl	Chouaib, Salem/F-7939-2016; Czyz, Malgorzata/AAD-1869-2020	Czyz, Malgorzata/0000-0002-8279-4742	National Science Centre (Poland) [2012/06/M/NZ2/00109]; Equipe labellisee par la Ligue Contre le Cancer [EL2015.LNCC/SaC]	National Science Centre (Poland); Equipe labellisee par la Ligue Contre le Cancer	This work was financially supported by 2012/06/M/NZ2/00109 from National Science Centre (Poland). SC was supported by a grant "Equipe labellisee par la Ligue Contre le Cancer" (EL2015.LNCC/SaC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. M. Sztiller-Sikorska for melanoma cell isolation and their propagation and E. Lewandowska for her excellent administrative and technical support. This work was financially supported by 2012/06/M/NZ2/00109 from National Science Centre (Poland). SC was supported by a grant "Equipe labellisee par la Ligue Contre le Cancer" (EL2015.LNCC/SaC).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Anastas JN, 2014, WNT SIGNALING DEV DI; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Atkinson JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125028; Atlasi Y, 2014, CURR TOP DEV BIOL, V107, P373, DOI 10.1016/B978-0-12-416022-4.00013-5; Barbolina MV, 2009, INT J CANCER, V125, P816, DOI 10.1002/ijc.24347; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Chen A, 2008, BRIT J PHARMACOL, V153, P557, DOI 10.1038/sj.bjp.0707542; Chen YM, 2003, BRIT J PHARMACOL, V138, P950, DOI 10.1038/sj.bjp.0705088; Chien AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094748; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Czyz M, 2010, BRIT J PHARMACOL, V160, P1144, DOI 10.1111/j.1476-5381.2010.00749.x; Czyz M, 2013, CANCER BIOL THER, V14, P135, DOI 10.4161/cbt.22952; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Drake CG, 2014, NAT REV CLIN ONCOL, V11, DOI 10.1038/nrclinonc.2013.208-c2; Drake CG, 2014, NAT REV CLIN ONCOL, V11, P24, DOI 10.1038/nrclinonc.2013.208; Dua P, 2006, CANCER CHEMOTH PHARM, V58, P195, DOI 10.1007/s00280-005-0155-8; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Finger EC, 2014, ONCOGENE, V33, P1093, DOI 10.1038/onc.2013.47; Flaherty KT, 2015, CANCER BIOL THER, V16, P645, DOI 10.1080/15384047.2015.1030553; Gahlot S, 2010, BIOCHEM PHARMACOL, V80, P1650, DOI 10.1016/j.bcp.2010.08.018; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hartman ML, 2015, CELL MOL LIFE SCI, V72, P1249, DOI 10.1007/s00018-014-1791-0; Hartman ML, 2015, J INVEST DERMATOL, V135, P352, DOI 10.1038/jid.2014.319; Hartman ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095157; Hartman ML, 2016, ONCOTARGET, V10; Ho AW, 2015, J INVEST DERMATOL, V135, P1929, DOI 10.1038/jid.2015.14; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Kamran MZ, 2013, BIOMED PHARMACOTHER, V67, P399, DOI 10.1016/j.biopha.2013.03.020; Kamran MZ, 2012, BIOMED PHARMACOTHER, V66, P617, DOI 10.1016/j.biopha.2012.03.006; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Kelderman S, 2014, MOL ONCOL, V8, P1132, DOI 10.1016/j.molonc.2014.07.011; Koprowska K, 2013, ANTI-CANCER DRUG, V24, P835, DOI 10.1097/CAD.0b013e3283635a04; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Marques LJ, 1999, AM J RESP CRIT CARE, V159, P508, DOI 10.1164/ajrccm.159.2.9804085; Massey PR, 2015, CANCER BIOL THER, V16, P1014, DOI 10.1080/15384047.2015.1046650; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Roesch A, 2015, ONCOGENE, V34, P2951, DOI 10.1038/onc.2014.249; Sanlorenzo M, 2014, CANCER BIOL THER, V15, P665, DOI 10.4161/cbt.28555; Seidensticker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112731; Sharma K, 2016, BIOCHEM PHARMACOL, V103, P17, DOI 10.1016/j.bcp.2015.12.018; Shukla V, 2003, CANCER BIOTHER RADIO, V18, P559, DOI 10.1089/108497803322287637; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Syed DN, 2011, J INVEST DERMATOL, V131, P1291, DOI 10.1038/jid.2011.6; Sztiller-Sikorska M, 2015, LAB INVEST, V95, P672, DOI 10.1038/labinvest.2015.48; Sztiller-Sikorska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090783; Sztiller-Sikorska M, 2012, MELANOMA RES, V22, P215, DOI 10.1097/CMR.0b013e3283531317; Theron T, 2000, INT J RADIAT BIOL, V76, P1197, DOI 10.1080/09553000050134438; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Wyluda EJ, 2015, CANCER BIOL THER, V16, P662, DOI 10.1080/15384047.2015.1026507; Zhen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064976; Zimmerman ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069593	58	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158275	10.1371/journal.pone.0158275	http://dx.doi.org/10.1371/journal.pone.0158275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351373	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900049
J	Anderson, JL; Mota, TM; Evans, VA; Kumar, N; Rezaei, SD; Cheong, K; Solomon, A; Wightman, F; Cameron, PU; Lewin, SR				Anderson, Jenny L.; Mota, Talia M.; Evans, Vanessa A.; Kumar, Nitasha; Rezaei, Simin D.; Cheong, Karey; Solomon, Ajantha; Wightman, Fiona; Cameron, Paul U.; Lewin, Sharon R.			Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+T-Cells In Vitro	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; CHEMOKINE RECEPTOR; ACTIN CYTOSKELETON; INFECTION; TRANSCRIPTION; REPLICATION; RESTRICTION; IDENTIFICATION; LYMPHOCYTES	Developing robust in vitro models of HIV latency is needed to better understand how latency is established, maintained and reversed. In this study, we examined the effects of donor variability, HIV titre and co-receptor usage on establishing HIV latency in vitro using two models of HIV latency. Using the CCL19 model of HIV latency, we found that in up to 50% of donors, CCL19 enhanced latent infection of resting CD4+T-cells by CXCR4-tropic HIV in the presence of low dose IL-2. Increasing the infectious titre of CXCR4-tropic HIV increased both productive and latent infection of resting CD4+T-cells. In a different model where myeloid dendritic cells (mDC) were co-cultured with resting CD4+T-cells, we observed a higher frequency of latently infected cells in vitro than CCL19-treated or unstimulated CD4+T-cells in the presence of low dose IL-2. In the DC-T-cell model, latency was established with both CCR5- and CXCR4-tropic virus but higher titres of CCR5- tropic virus was required in most donors. The establishment of latency in vitro through direct infection of resting CD4+T-cells is significantly enhanced by CCL19 and mDC, but the efficiency is dependent on virus titre, co-receptor usage and there is significant donor variability.	[Anderson, Jenny L.; Mota, Talia M.; Evans, Vanessa A.; Kumar, Nitasha; Rezaei, Simin D.; Cheong, Karey; Solomon, Ajantha; Wightman, Fiona; Cameron, Paul U.; Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Cameron, Paul U.; Lewin, Sharon R.] Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia; [Cameron, Paul U.; Lewin, Sharon R.] Alfred Hosp, Melbourne, Vic, Australia	University of Melbourne; Monash University; Florey Institute of Neuroscience & Mental Health	Lewin, SR (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Lewin, SR (corresponding author), Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia.; Lewin, SR (corresponding author), Alfred Hosp, Melbourne, Vic, Australia.	sharon.lewin@unimelb.edu.au	Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241; Anderson, Jenny/0000-0003-4636-6633; Wightman, Fiona/0000-0003-1203-1325; Mota, Talia/0000-0002-8925-0158; Cameron, Paul Urquhart/0000-0002-1906-6945	National Health and Medical Research Council of Australia Program Grant [1052979]; Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE) [U19AI096109]	National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE)	This study was funded by a National Health and Medical Research Council of Australia Program Grant 1052979 (http://www.nhmrc.gov.au). SRL, PUC and JLA are supported by the Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE; U19AI096109, http://www.niaid.nih.gov). SRL is also a National Health and Medical Research Council of Australia Practitioner Fellow (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Evans VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003799; Evans VA, 2012, CYTOKINE GROWTH F R, V23, P151, DOI 10.1016/j.cytogfr.2012.05.002; Evans VA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-43; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; GOFF S, 1981, J VIROL, V38, P239, DOI 10.1128/JVI.38.1.239-248.1981; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; HO WZ, 1993, J LEUKOCYTE BIOL, V53, P208, DOI 10.1002/jlb.53.2.208; Iyer SR, 2009, J VIROL, V83, P8662, DOI 10.1128/JVI.00874-09; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kumar NA, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0204-2; Kumari S, 2014, BBA-BIOMEMBRANES, V1838, P546, DOI 10.1016/j.bbamem.2013.05.004; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; Lewin SR, 2008, JAIDS-J ACQ IMM DEF, V47, P140, DOI 10.1097/QAI.0b013e31815dbf7f; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; MCKEATING JA, 1991, J VIROL, V65, P852, DOI 10.1128/JVI.65.2.852-860.1991; Melar M, 2007, J VIROL, V81, P1773, DOI 10.1128/JVI.01316-06; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907; Saleh S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-80; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Shen AD, 2013, J VIROL, V87, P9768, DOI 10.1128/JVI.01478-13; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Soares H, 2013, IMMUNOL REV, V256, P118, DOI 10.1111/imr.12110; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Trinite B, 2013, J VIROL, V87, P12701, DOI 10.1128/JVI.01939-13; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Wightman F, 2013, AIDS, V27, P2853, DOI 10.1097/QAD.0000000000000067; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zack JA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-37	56	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158778	10.1371/journal.pone.0158778	http://dx.doi.org/10.1371/journal.pone.0158778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383184	gold, Green Published, Green Submitted			2022-12-27	WOS:000379809400084
J	Pickell, PD; Coops, NC; Gergel, SE; Andison, DW; Marshall, PL				Pickell, Paul D.; Coops, Nicholas C.; Gergel, Sarah E.; Andison, David W.; Marshall, Peter L.			Evolution of Canada's Boreal Forest Spatial Patterns as Seen from Space	PLOS ONE			English	Article							LANDSAT TIME-SERIES; NATURAL DISTURBANCES; MANAGEMENT; RECOVERY; WILDFIRE; MAP; INDEXES; ALBERTA; TRENDS	Understanding the development of landscape patterns over broad spatial and temporal scales is a major contribution to ecological sciences and is a critical area of research for forested land management. Boreal forests represent an excellent case study for such research because these forests have undergone significant changes over recent decades. We analyzed the temporal trends of four widely-used landscape pattern indices for boreal forests of Canada: forest cover, largest forest patch index, forest edge density, and core (interior) forest cover. The indices were computed over landscape extents ranging from 5,000 ha (n = 18,185) to 50,000 ha (n = 1,662) and across nine major ecozones of Canada. We used 26 years of Landsat satellite imagery to derive annualized trends of the landscape pattern indices. The largest declines in forest cover, largest forest patch index, and core forest cover were observed in the Boreal Shield, Boreal Plain, and Boreal Cordillera ecozones. Forest edge density increased at all landscape extents for all ecozones. Rapidly changing landscapes, defined as the 90th percentile of forest cover change, were among the most forested initially and were characterized by four times greater decrease in largest forest patch index, three times greater increase in forest edge density, and four times greater decrease in core forest cover compared with all 50,000 ha landscapes. Moreover, approximately 18% of all 50,000 ha landscapes did not change due to a lack of disturbance. The pattern database results provide important context for forest management agencies committed to implementing ecosystem-based management strategies.	[Pickell, Paul D.; Coops, Nicholas C.; Gergel, Sarah E.; Marshall, Peter L.] Univ British Columbia, Fac Forestry, Vancouver, BC, Canada; [Andison, David W.] Bandaloop Landscape Ecosyst Serv, N Vancouver, BC, Canada	University of British Columbia	Pickell, PD (corresponding author), Univ British Columbia, Fac Forestry, Vancouver, BC, Canada.	paul.pickell@forestry.ubc.ca	Coops, Nicholas/L-3652-2019; Coops, Nicholas C/J-1543-2012	Coops, Nicholas/0000-0002-0151-9037; Coops, Nicholas C/0000-0002-0151-9037				Andison DW, 2012, CAN J FOREST RES, V42, P1253, DOI [10.1139/X2012-074, 10.1139/x2012-074]; Banskota A, 2014, CAN J REMOTE SENS, V40, P362, DOI 10.1080/07038992.2014.987376; Bergeron Y, 2007, FOREST CHRON, V83, P326, DOI 10.5558/tfc83326-3; Bouchard M, 2011, FOREST ECOL MANAG, V261, P811, DOI 10.1016/j.foreco.2010.11.020; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Canada Forest Inventory, 2013, CAN FOR INV 2013 DEC; Cardille J, 2005, BIOSCIENCE, V55, P983, DOI 10.1641/0006-3568(2005)055[0983:MCSPAS]2.0.CO;2; Cardille JA, 2012, ENVIRON MANAGE, V49, P163, DOI 10.1007/s00267-011-9785-2; Carslaw DC, 2012, ENVIRON MODELL SOFTW, V27-28, P52, DOI 10.1016/j.envsoft.2011.09.008; Chapin FS, 2010, CAN J FOREST RES, V40, P1360, DOI 10.1139/X10-074; CRIST EP, 1985, REMOTE SENS ENVIRON, V17, P301, DOI 10.1016/0034-4257(85)90102-6; Cumming SG, 2001, CAN J FOREST RES, V31, P1297, DOI 10.1139/cjfr-31-8-1297; DeLong SC, 1996, BIODIVERS CONSERV, V5, P1191, DOI 10.1007/BF00051571; Drever CR, 2006, CAN J FOREST RES, V36, P2285, DOI 10.1139/X06-132; EBERHART KE, 1987, CAN J FOREST RES, V17, P1207, DOI 10.1139/x87-186; Ecological Stratification Working Group, 1996, NATL ECOLOGICAL FRAM; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Flannigan MD, 1998, J VEG SCI, V9, P469, DOI 10.2307/3237261; Forest Stewardship Council Canada Working Group, 2004, NAT BOR STAND; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gergel S. E., 2007, UNDERSTANDING FOREST; Gillis MD, 2005, FOREST CHRON, V81, P214, DOI 10.5558/tfc81214-2; Gustafson EJ, 1998, ECOSYSTEMS, V1, P143, DOI 10.1007/s100219900011; HainesYoung R, 1996, PROG PHYS GEOG, V20, P418, DOI 10.1177/030913339602000403; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Healey SP, 2005, REMOTE SENS ENVIRON, V97, P301, DOI 10.1016/j.rse.2005.05.009; Hermosilla T, 2015, REMOTE SENS ENVIRON, V158, P220, DOI 10.1016/j.rse.2014.11.005; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Huang CQ, 2010, REMOTE SENS ENVIRON, V114, P183, DOI 10.1016/j.rse.2009.08.017; HUNTER ML, 1993, BIOL CONSERV, V65, P115, DOI 10.1016/0006-3207(93)90440-C; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; Jin SM, 2013, REMOTE SENS ENVIRON, V132, P159, DOI 10.1016/j.rse.2013.01.012; Klenk N, 2008, CAN J FOREST RES, V38, P2159, DOI 10.1139/X08-054; Kupfer JA, 2012, PROG PHYS GEOG, V36, P400, DOI 10.1177/0309133312439594; Landres PB, 1999, ECOL APPL, V9, P1179, DOI 10.2307/2641389; Langford WT, 2006, ECOSYSTEMS, V9, P474, DOI 10.1007/s10021-005-0119-1; Lee P, 2006, J ENVIRON MANAGE, V78, P240, DOI 10.1016/j.jenvman.2005.03.016; Lee P., 2003, CANADAS LARGE INTACT; McGarigal K., FRAGSTATS V4 SPATIAL; McLeod A.I., 2011, PACKAGE KENDALL KEND; Metzger MJ, 2013, GLOBAL ECOL BIOGEOGR, V22, P630, DOI 10.1111/geb.12022; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morgan P., 1994, Journal of Sustainable Forestry, V2, P87, DOI 10.1300/J091v02n01_04; Ontario Ministry of Natural Resources (OMNR), FOR MAN GUID NAT DIS; Pasher J, 2013, CAN J REMOTE SENS, V39, P42, DOI 10.5589/m13-007; Pflugmacher D, 2014, REMOTE SENS ENVIRON, V151, P124, DOI 10.1016/j.rse.2013.05.033; Pickell PD, 2016, INT J REMOTE SENS, V37, P138, DOI 10.1080/2150704X.2015.1126375; Pickell PD, 2015, CAN J FOREST RES, V45, P732, DOI 10.1139/cjfr-2014-0546; Pickell PD, 2014, REMOTE SENS LETT, V5, P783, DOI 10.1080/2150704X.2014.967881; Pickell PD, 2013, FOREST ECOL MANAG, V304, P243, DOI 10.1016/j.foreco.2013.04.031; Pyrcz M., 2003, NEWSLETTER, V18, P3; Remmel T., 2003, J GEOGR SYST, V5, P331, DOI DOI 10.1007/S10109-003-0116-X; Scheffer M, 2012, P NATL ACAD SCI USA, V109, P21384, DOI 10.1073/pnas.1219844110; Schneider RR, 2003, CONSERV ECOL, V7; Schroeder TA, 2011, REMOTE SENS ENVIRON, V115, P1421, DOI 10.1016/j.rse.2011.01.022; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Shvidenko A., 2005, MILLENNIUM ECOSYSTEM, P585; Statistics Canada, 2011, CENS AGR; Thomas NE, 2011, REMOTE SENS ENVIRON, V115, P19, DOI 10.1016/j.rse.2010.07.009; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Venables WN., 2002, MODERN APPL STAT S 4; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; White JC, 2014, CAN J REMOTE SENS, V40, P192, DOI 10.1080/07038992.2014.945827; Wilcox RR, 1998, STAT PROBABIL LETT, V39, P43, DOI 10.1016/S0167-7152(98)00022-4; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963; Wulder MA, EOSD LAND COVER CLAS; Wulder MA, 2011, CAN GEOGR-GEOGR CAN, V55, P288, DOI 10.1111/j.1541-0064.2010.00335.x; Wulder MA, 2008, CAN J REMOTE SENS, V34, P563, DOI 10.5589/m08-081; Yue S, 2004, HYDROLOG SCI J, V49, P21, DOI 10.1623/hysj.49.1.21.53996; Zeng HQ, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045508; Zhang XY, 2004, GLOBAL CHANGE BIOL, V10, P1133, DOI 10.1111/j.1529-8817.2003.00784.x	74	16	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157736	10.1371/journal.pone.0157736	http://dx.doi.org/10.1371/journal.pone.0157736			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383055	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400023
J	Shiferaw, S; Spigt, M; Tekie, M; Abdullah, M; Fantahun, M; Dinant, GJ				Shiferaw, Solomon; Spigt, Mark; Tekie, Michael; Abdullah, Muna; Fantahun, Mesganaw; Dinant, Geert-Jan			The Effects of a Locally Developed mHealth Intervention on Delivery and Postnatal Care Utilization; A Prospective Controlled Evaluation among Health Centres in Ethiopia	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BEHAVIOR-CHANGE; MOBILE HEALTH; PHONES	Background Although there are studies showing that mobile phone solutions can improve health service delivery outcomes in the developed world, there is little empirical evidence that demonstrates the impact of mHealth interventions on key maternal health outcomes in low income settings. Methods A non-randomized controlled study was conducted in the Amhara region, Ethiopia in 10 health facilities (5 intervention, 5 control) together serving around 250,000 people. Health workers in the intervention group received an android phone (3 phones per facility) loaded with an application that sends reminders for scheduled visits during antenatal care (ANC), delivery and postnatal care (PNC), and educational messages on dangers signs and common complaints during pregnancy. The intervention was developed at Addis Ababa University in Ethiopia. Primary outcomes were the percentage of women who had at least 4 ANC visits, institutional delivery and PNC visits at the health center after 12 months of implementation of the intervention. Findings Overall 933 and 1037 women were included in the cross-sectional surveys at baseline and at follow-up respectively. In addition, the medical records of 1224 women who had at least one antenatal care visit were followed in the longitudinal study. Women who had their ANC visit in the intervention health centers were significantly more likely to deliver their baby in the same health center compared to the control group (43.1% versus 28.4%; Adjusted Odds Ratio (AOR): 1.98 (95% CI 1.53-2.55)). A significantly higher percentage of women who had ANC in the intervention group had PNC in the same health center compared to the control health centers (41.2% versus 21.1%: AOR: 2.77 (95% CI 2.12-3.61)). Conclusions Our findings demonstrated that a locally customized mHealth application during ANC can significantly improve delivery and postnatal care service utilization possibly through positively influencing the behavior of health workers and their clients.	[Shiferaw, Solomon; Fantahun, Mesganaw] Univ Addis Ababa, Dept Reprod Hlth, Addis Ababa, Ethiopia; [Shiferaw, Solomon; Fantahun, Mesganaw] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Hlth Serv Management, Addis Ababa, Ethiopia; [Spigt, Mark; Dinant, Geert-Jan] Maastricht Univ, Dept Family Med, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Spigt, Mark] Arctic Univ Norway, Dept Community Med, Gen Practice Res Unit, Tromso, Norway; [Tekie, Michael] UNFPA Liaison Off, Addis Ababa, Ethiopia; [Abdullah, Muna] UNFPA East & Southern Africa Reg Off, Johannesburg, South Africa	Addis Ababa University; Addis Ababa University; Maastricht University; UiT The Arctic University of Tromso; United Nations Population Fund	Shiferaw, S (corresponding author), Univ Addis Ababa, Dept Reprod Hlth, Addis Ababa, Ethiopia.; Shiferaw, S (corresponding author), Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Hlth Serv Management, Addis Ababa, Ethiopia.	solomonshiferaw@gmail.com						Amharic Mobiles-Made In Ethiopia, 2012, AFRICAN BUSINES 0219; [Anonymous], 2001, ETH DEM HLTH SURV 20; Beyene Waju J C, 2011, ETHIOP J HLTH SCI, P21; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bloomfield GS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-49; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Free C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001362; GSMA Intelligence, 2021, MOB EC 2021; Gurol-Urganci I, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007458.pub3; Hall CS, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25606; Health FDRoEMo, 2010, MAN PROT SEL OBST TO; Horvath T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009756; Kelly JD, 2011, AIDS, V25, P1137, DOI 10.1097/QAD.0b013e32834670d7; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lim MSC, 2008, INT J STD AIDS, V19, P287, DOI 10.1258/ijsa.2007.007264; Little A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077563; Lund S, 2012, BJOG-INT J OBSTET GY, V119, P1256, DOI 10.1111/j.1471-0528.2012.03413.x; Medhanyie AA, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/1478-4491-13-2; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Royston G, 2015, LANCET GLOB HEALTH, V3, pE356, DOI 10.1016/S2214-109X(15)00054-6; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Solomon Shiferaw YM, 2008, ASSESSMENT KNOWLEDGE; Tamrat T, 2012, MATERN CHILD HLTH J, V16, P1092, DOI 10.1007/s10995-011-0836-3; Tayelgn Azmeraw Z DT K Y, 2011, BMC PREGNANCY CHILDB, P11; Thirumurthy H, 2012, B WORLD HEALTH ORGAN, V90, P390, DOI 10.2471/BLT.11.099317; WHO U UNFPA and The World Bank, 2012, TRENDS MAT MORT 1990	29	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158600	10.1371/journal.pone.0158600	http://dx.doi.org/10.1371/journal.pone.0158600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383186	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400064
J	Akamatsu, M; Makino, N; Ikeda, Y; Matsuda, A; Ito, M; Kakizaki, Y; Saito, Y; Ishizawa, T; Kobayashi, T; Furukawa, T; Ueno, Y				Akamatsu, Manabu; Makino, Naohiko; Ikeda, Yushi; Matsuda, Akiko; Ito, Miho; Kakizaki, Yasuharu; Saito, Yoshihiko; Ishizawa, Tetsuya; Kobayashi, Toshikazu; Furukawa, Toru; Ueno, Yoshiyuki			Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis	PLOS ONE			English	Article							NEEDLE-ASPIRATION BIOPSY; DIAGNOSTIC-CRITERIA; EXPRESSION; PATHWAY; GENES; ADENOCARCINOMA; BIOMARKERS; BLOOD; IGG4	Pancreatic ductal adenocarcinoma (PDAC) is difficult to distinguish from autoimmune pancreatitis (AIP) because of their clinical and radiological similarities, and therefore simple and minimally invasive surrogate markers for differential diagnosis would be useful. In our previous studies, we identified four microRNAs (miRNAs)-miR-7, miR-34a, miR-181d, and miR-193b -as MAPK-associated microRNAs whose expression was altered significantly with upregulation of the MAPK signaling pathway. Recently it has been reported that these miRNAs could be used as biomarkers in serum samples for accurate diagnosis of pancreatic lesions. The aim of the present study was to evaluate whether these MAPK-associated miRNAs in serum could be used as biomarkers for differentiating PDAC from AIP. We enrolled 69 patients with PDAC, 26 with intraductal papillary mucinous neoplasm (IPMN) and 15 with AIP. The expression of MAPK-associated miRNAs in serum was measured by quantitative real-time PCR. The 2(-Delta CT) method was used to quantify the expression of miRNAs, and the data were normalized using spiked-in synthetic cel-miR-39. Patients with PDAC or IPMN showed significantly higher amounts of serum MAPK-associated miRNAs than those with AIP (p<0.009 for miR-7, p<0.002 for miR-34a, p<0.001 for miR-181d, p<0.002 for miR-193b). ROC curve analysis demonstrated that these miRNAs had an area under the ROC curve (AUC) of 0.723-0.882 for differentiation between PDAC or IPMN from AIP. Furthermore, serum miR-181d was significantly associated with the presence of metastasis in patients with PDA (p = 0.014). Serum MAPK-associated miRNAs could be novel noninvasive biomarkers for differentiation between PDAC or IPMN and AIP.	[Akamatsu, Manabu; Makino, Naohiko; Ikeda, Yushi; Matsuda, Akiko; Ito, Miho; Kakizaki, Yasuharu; Saito, Yoshihiko; Ishizawa, Tetsuya; Kobayashi, Toshikazu; Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata, Japan; [Furukawa, Toru] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan	Yamagata University; Tokyo Women's Medical University	Makino, N (corresponding author), Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata, Japan.	namakino@med.id.yamagata-u.ac.jp	Furukawa, Toru/AAF-5596-2021; Ueno, Yoshiyuki/R-9242-2019	Furukawa, Toru/0000-0002-1083-2324; Ueno, Yoshiyuki/0000-0001-5623-4250				ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Deshpande V, 2005, AM J SURG PATHOL, V29, P1464, DOI 10.1097/01.pas.0000173656.49557.48; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Furukawa T., 1993, ANN CANCER RES THER, V2, P121; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Holmes BJ, 2012, ACTA CYTOL, V56, P228, DOI 10.1159/000336135; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Imai K, 2011, DIGEST LIVER DIS, V43, P869, DOI 10.1016/j.dld.2011.05.021; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamisawa T, 2006, WORLD J GASTROENTERO, V12, P6225, DOI 10.3748/wjg.v12.i38.6225; Kato H, 2008, CANC STAT JAPAN; Khalid A, 2011, PANCREATOLOGY, V11, P482, DOI 10.1159/000331505; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuno N, 2009, J GASTROENTEROL, V44, P742, DOI 10.1007/s00535-009-0062-6; Nalls D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024099; Ogura T, 2012, GASTROINTEST ENDOSC, V75, P769, DOI 10.1016/j.gie.2011.11.012; Schultz NA, 2014, JAMA-J AM MED ASSOC, V311, P392, DOI 10.1001/jama.2013.284664; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Thatcher JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3119tr1; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Wang XF, 2012, J CANCER RES CLIN, V138, P573, DOI 10.1007/s00432-011-1114-x	32	21	21	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158669	10.1371/journal.pone.0158669	http://dx.doi.org/10.1371/journal.pone.0158669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380024	Green Published, gold, Green Submitted			2022-12-27	WOS:000379798700040
J	Newton, CL; Wood, MD; Strange, PG				Newton, Claire L.; Wood, Martyn D.; Strange, Philip G.			Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D-2 and D-3 Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATION; SITE CREVICE; AGONIST; D2; SENSITIVITY; DISORDERS; PLATELETS; MEMBRANE; AFFINITY	Many G protein-coupled receptors have been shown to be sensitive to the presence of sodium ions (Na+). Using radioligand competition binding assays, we have examined and compared the effects of sodium ions on the binding affinities of a number of structurally diverse ligands at human dopamine D-2 and dopamine D-3 receptor subtypes, which are important therapeutic targets for the treatment of psychotic disorders. At both receptors, the binding affinities of the antagonists/inverse agonists SB-277011-A, L, 741,626, GR 103691 and U 99194 were higher in the presence of sodium ions compared to those measured in the presence of the organic cation, N-methyl-D-glucamine, used to control for ionic strength. Conversely, the affinities of spiperone and (+)-butaclamol were unaffected by the presence of sodium ions. Interestingly, the binding of the antagonist/inverse agonist clozapine was affected by changes in ionic strength of the buffer used rather than the presence of specific cations. Similar sensitivities to sodium ions were seen at both receptors, suggesting parallel effects of sodium ion interactions on receptor conformation. However, no clear correlation between ligand characteristics, such as subtype selectivity, and sodium ion sensitivity were observed. Therefore, the properties which determine this sensitivity remain unclear. However these findings do highlight the importance of careful consideration of assay buffer composition for in vitro assays and when comparing data from different studies, and may indicate a further level of control for ligand binding in vivo.	[Newton, Claire L.; Strange, Philip G.] Univ Reading, Sch Pharm, Reading RG6 6AJ, Berks, England; [Wood, Martyn D.] GlaxoSmithKline, Psychiat CEDD, Harlow CM19 5AW, Essex, England; [Newton, Claire L.] Univ Pretoria, Fac Hlth Sci, Ctr Neuroendocrinol, POB 2034, ZA-0001 Pretoria, South Africa; [Newton, Claire L.] Univ Pretoria, Fac Hlth Sci, Dept Immunol, POB 2034, ZA-0001 Pretoria, South Africa; [Wood, Martyn D.] UCB Bioprod SA, CNS Res, Allee Rech 60, B-1070 Brussels, Belgium	University of Reading; GlaxoSmithKline; University of Pretoria; University of Pretoria; UCB Pharma SA	Newton, CL (corresponding author), Univ Reading, Sch Pharm, Reading RG6 6AJ, Berks, England.; Newton, CL (corresponding author), Univ Pretoria, Fac Hlth Sci, Ctr Neuroendocrinol, POB 2034, ZA-0001 Pretoria, South Africa.; Newton, CL (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Immunol, POB 2034, ZA-0001 Pretoria, South Africa.	claire.newton@up.ac.za	Newton, Claire L/B-7114-2011; Newton, Claire/AAC-4663-2019; Newton, Claire/R-1783-2019	Newton, Claire L/0000-0001-6050-556X; Newton, Claire/0000-0001-6050-556X	Biotechnology and Biological Sciences Research Council (BBSRC); GlaxoSmithKline (GSK); GSK	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline (GSK)(GlaxoSmithKline); GSK(GlaxoSmithKline)	Financial support for this work was provided through a CASE PhD studentship awarded jointly by the Biotechnology and Biological Sciences Research Council (BBSRC) and GlaxoSmithKline (GSK). This studentship provided support in the form of a PhD stipend for CLN (who was involved in study design, data collection/analysis and preparation of the manuscript) and project running expenses. The BBSRC did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. GSK also provided support in the form of salary for MDW (who was involved in the study design and decision to publish). GSK did not have any additional role in the study design, data collection and analysis or decision to publish, but did review the manuscript prior to submission. The specific role of all authors are articulated in the 'author contributions' section.	Akam E, 2004, BIOCHEM PHARMACOL, V67, P2039, DOI 10.1016/j.bcp.2004.02.017; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; Boundy VA, 1996, J PHARMACOL EXP THER, V276, P784; CERESA BP, 1994, J BIOL CHEM, V269, P29557; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cordeaux Y, 2001, J BIOL CHEM, V276, P28667, DOI 10.1074/jbc.M008644200; Ericksen SS, 2009, J PHARMACOL EXP THER, V328, P40, DOI 10.1124/jpet.108.141531; GOODMAN RR, 1982, MOL PHARMACOL, V21, P329; Heidbreder C, 2013, N-S ARCH PHARMACOL, V386, P167, DOI 10.1007/s00210-012-0803-6; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; Javitch JA, 1999, BIOCHEMISTRY-US, V38, P7961, DOI 10.1021/bi9905314; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; LIMBIRD LE, 1982, MOL PHARMACOL, V21, P609; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALMBERG A, 1993, MOL PHARMACOL, V43, P749; MALMBERG A, 1995, J PHARMACOL EXP THER, V274, P790; Michino M, 2015, CHEM COMMUN, V51, P8618, DOI 10.1039/c5cc02204e; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MOTULSKY HJ, 1983, J BIOL CHEM, V258, P3913; NEVE KA, 1991, MOL PHARMACOL, V39, P733; NEVE KA, 1990, J PHARMACOL EXP THER, V252, P1108; NEVE KA, 1991, MOL PHARMACOL, V39, P570; Neve KA, 2001, MOL PHARMACOL, V60, P373, DOI 10.1124/mol.60.2.373; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PERT CB, 1974, MOL PHARMACOL, V10, P868; Schetz JA, 2001, J PHARMACOL EXP THER, V296, P359; Schwartz JC, 2000, BRAIN RES REV, V31, P277, DOI 10.1016/S0165-0173(99)00043-0; Selent J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000884; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; Strange PG, 2008, TRENDS PHARMACOL SCI, V29, P314, DOI 10.1016/j.tips.2008.03.009; TEETER MM, 1994, J MED CHEM, V37, P2874, DOI 10.1021/jm00044a008; TSAI BS, 1978, MOL PHARMACOL, V14, P540; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6	34	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158808	10.1371/journal.pone.0158808	http://dx.doi.org/10.1371/journal.pone.0158808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379794	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000379798700048
J	Sadhukhan, P; Saha, S; Sinha, K; Brahmachari, G; Sil, PC				Sadhukhan, Pritam; Saha, Sukanya; Sinha, Krishnendu; Brahmachari, Goutam; Sil, Parames C.			Selective Pro-Apoptotic Activity of Novel 3,3 '-(Aryl/Alkyl-Methylene) Bis(2-Hydroxynaphthalene-1,4-Dione) Derivatives on Human Cancer Cells via the Induction Reactive Oxygen Species	PLOS ONE			English	Article							OXIDATIVE STRESS; ARJUNOLIC ACID; IN-VITRO; INDUCED CYTOTOXICITY; MEDICINAL CHEMISTRY; REDUCED GLUTATHIONE; LAWSONIA-INERMIS; PROTECTIVE ROLE; FLOW-CYTOMETRY; PATHWAYS	Selective induction of apoptosis in cancer cells barring the normal cells is considered as an effective strategy to combat cancer. In the present study, a series of twenty-two (22) synthetic 3,3'-(aryl/alkyl-methylene)bis(2-hydroxynaphthalene-1,4-dione)bis-lawsone derivatives were assayed for their pro-apoptotic activity in six different cell lines (five cancerous and one normal) using MTT assay. Out of these 22 test compounds, 1j was found to be the most effective in inducing apoptosis in human glioma cells (CCF-4) among the different cell lines used in the study. The activity of this compound, 1j, was then compared to a popular anticancer drug, cisplatin, having limited usage because of its nephrotoxic nature. In this study, 1j derivative showed much less toxicity to the normal kidney cells compared to cisplatin, thus indicating the superiority of 1j as a possible anticancer agent. This compound was observed to induce apoptosis in the glioma cells by inducing the caspase dependent apoptotic pathways via ROS and downregulating the PI3K/AKT/mTOR pathway. Estimation of different oxidative stress markers also confirms the induction of oxidative stress in 1j exposed cancer cells. The toxicity of 1j compound toward cancer cells was confirmed further by different flow cytometrical analyses to estimate the mitochondrial membrane potential and cell cycle. The sensitivity of malignant cells to apoptosis, provoked by this synthetic derivative in vitro, deserves further studies in suitable in vivo models. These studies not only identified a novel anticancer drug candidate but also help to understand the metabolism of ROS and its application in cancer treatment.	[Sadhukhan, Pritam; Saha, Sukanya; Sinha, Krishnendu; Sil, Parames C.] Bose Inst, Div Mol Med, P-1-12,CIT Scheme 7 M, Kolkata 700054, India; [Brahmachari, Goutam] Visva Bharati, Lab Nat Prod & Organ Synth, Dept Chem, Santini Ketan 731235, W Bengal, India	Department of Science & Technology (India); Bose Institute; Visva Bharati University	Sil, PC (corresponding author), Bose Inst, Div Mol Med, P-1-12,CIT Scheme 7 M, Kolkata 700054, India.	parames@jcbose.ac.in	Saha, Sukanya/AHC-8389-2022; Sadhukhan, Pritam/AAB-2655-2021; Brahmachari, Goutam/H-9416-2017; saha, sukanya/AHD-1166-2022	Saha, Sukanya/0000-0001-7592-8936; Sadhukhan, Pritam/0000-0003-4948-1012; Brahmachari, Goutam/0000-0001-9925-6281; saha, sukanya/0000-0001-7592-8936; Sinha, Krishnendu/0000-0001-9590-3875	SERB-DST, New Delhi [EMR/2014/001220]	SERB-DST, New Delhi	This work was funded by SERB-DST, New Delhi (No. EMR/2014/001220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, BIOMARKERS J; Ayhan-Kilcigil G, 2012, CHEM BIOL DRUG DES, V79, P869, DOI 10.1111/j.1747-0285.2012.01347.x; Banerjee S, 2016, BIOCH ANAL BIOCH, V5, P255, DOI [10.4172/2161-1009.1000255, DOI 10.4172/2161-1009.1000255]; Benada J, 2015, BIOMOLECULES, V5, P1912, DOI 10.3390/biom5031912; Biradar S, 2013, INDIAN J EXP BIOL, V51, P256; Brahmachari G, 2015, ACS SUSTAIN CHEM ENG, V3, P2058, DOI 10.1021/acssuschemeng.5b00325; CANMAN CE, 1995, SEMIN CANCER BIOL, V6, P17, DOI 10.1006/scbi.1995.0003; Caron S, 2007, ORG PROCESS RES DEV, V11, P1015, DOI 10.1021/op7001886; Cerqueira BB, 2015, EUROPEAN J PHARM BIO; Chai EZ, 2015, PHARMACOL THERAPEUT, V162, P86; Chakraborty S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7184; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Corbett JW, 2000, J MED CHEM, V43, P2019, DOI 10.1021/jm990580e; Cossarizza A, 2009, NAT PROTOC, V4, P1790, DOI 10.1038/nprot.2009.189; Cui Q, 2007, ACTA PHARMACOL SIN, V28, P1057, DOI 10.1111/j.1745-7254.2007.00588.x; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Das J, 2015, TOXICOL REP, V2, P600, DOI 10.1016/j.toxrep.2015.03.013; Das Joydeep, 2008, Pathophysiology, V15, P181, DOI 10.1016/j.pathophys.2008.06.002; DesMarteau D., 2010, J AM CHEM SOC, V132, P3229, DOI [10.1021/ja100496w, DOI 10.1021/JA100496W]; Dho SH, 2015, ONCOTARGET, V6, P39235, DOI 10.18632/oncotarget.5743; DIDRY N, 1994, PHARMAZIE, V49, P681; Dixit S. N., 1980, Indian Phytopathol., V31, P131; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; Fetoni AR, 2015, BRIT J CANCER, V113, P1434, DOI 10.1038/bjc.2015.359; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ghosh J, 2008, TOXICOL IN VITRO, V22, P1918, DOI 10.1016/j.tiv.2008.09.010; Ghosh J, 2011, BIOMATERIALS, V32, P4857, DOI 10.1016/j.biomaterials.2011.03.048; Gonec T, 2013, BIOORGAN MED CHEM, V21, P6531, DOI 10.1016/j.bmc.2013.08.030; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; Hattangadi DK, 2004, BIOCHEM PHARMACOL, V68, P1699, DOI 10.1016/j.bcp.2004.06.033; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Kirk KL, 2006, J FLUORINE CHEM, V127, P1013, DOI 10.1016/j.jfluchem.2006.06.007; Kirsch P., 2013, MODERN FLUOROORGANIC, P179, DOI [DOI 10.1002/9783527651351, 10.1002/9783527651351]; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li J, 2015, BIOMATERIALS, V47, P51, DOI 10.1016/j.biomaterials.2015.01.005; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu RM, 2015, REDOX BIOL, V6, P565, DOI 10.1016/j.redox.2015.09.009; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Ma JA, 2004, CHEM REV, V104, P6119, DOI 10.1021/cr030143e; Manna P, 2009, CHEM-BIOL INTERACT, V181, P297, DOI 10.1016/j.cbi.2009.08.004; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Mendez I, 2016, BIOCHIMIE, V124, P178, DOI 10.1016/j.biochi.2015.04.014; Monti D, 2000, MECH AGEING DEV, V121, P239; Ojima I, 2009, FLUORINE MED CHEM CH, DOI [10.1002/9781444312096, DOI 10.1002/9781444312096]; Pal S, 2011, TOXICOLOGY, V283, P129, DOI 10.1016/j.tox.2011.03.006; Philchenkov A, 2004, EXP ONCOL, V26, P82; Pratibha G., 1999, Journal of Medicinal and Aromatic Plant Sciences, V21, P658; RAO VR, 1993, INDIAN J CHEM B, V32, P903; Rapoport BL, 2015, LANCET ONCOL, V16, P1079, DOI 10.1016/S1470-2045(15)00035-2; Ravishankar D, 2013, INT J BIOCHEM CELL B, V45, P2821, DOI 10.1016/j.biocel.2013.10.004; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roy A, 2009, FREE RADICAL RES, V43, P995, DOI 10.1080/10715760903164998; Saadeh HA, 2009, MOLECULES, V14, P2758, DOI 10.3390/molecules14082758; Saha Sukanya, 2016, Biochem Biophys Rep, V5, P313, DOI 10.1016/j.bbrep.2016.01.011; Saha S, 2014, MINI-REV MED CHEM, V14, P920, DOI 10.2174/1389557514666141029233442; Sarkar A, 2011, TOXICOLOGY, V290, P208, DOI 10.1016/j.tox.2011.09.086; Sarkar K, 2006, TOXICOL IN VITRO, V20, P634, DOI 10.1016/j.tiv.2005.11.003; Sauriasari R, 2007, TOXICOLOGY, V235, P103, DOI 10.1016/j.tox.2007.03.019; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Sengupta D, 2014, BBA-GEN SUBJECTS, V1840, P219, DOI 10.1016/j.bbagen.2013.08.020; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sil, 2015, BIOCH ANAL BIOCH, V4; Sinha K, 2015, BBA-GEN SUBJECTS, V1850, P769, DOI 10.1016/j.bbagen.2015.01.008; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Sinha M, 2008, J MED FOOD, V11, P733, DOI 10.1089/jmf.2007.0130; Sinha M, 2007, TOXICOL IN VITRO, V21, P1419, DOI 10.1016/j.tiv.2007.05.010; Sinha M, 2007, J NAT MED-TOKYO, V61, P251, DOI 10.1007/s11418-007-0133-z; Sultana N, 2009, J ENZYM INHIB MED CH, V24, P257, DOI [10.1080/14756360802057500, 10.1080/14756360802057500 ]; Takasu A, 2016, CANCER GENE THER, V23, P107, DOI 10.1038/cgt.2016.8; Tetsu O, 2015, PHARMACOL RES, V102, P132, DOI 10.1016/j.phrs.2015.09.022; Tsukahara T, 2015, CELL MOL BIOL LETT, V20, P38, DOI 10.2478/s11658-014-0224-2; Vidak M, 2015, MOLECULES, V20, P19406, DOI 10.3390/molecules201019406; Wang HN, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/6264317; Warren GW, 2014, LANCET ONCOL, V15, pE568, DOI 10.1016/S1470-2045(14)70266-9; Yan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095609; Yogisha S, 2002, FITOTERAPIA, V73, P690, DOI 10.1016/S0367-326X(02)00214-9; Zhang Wei, 2014, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V30, P1209	82	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158694	10.1371/journal.pone.0158694	http://dx.doi.org/10.1371/journal.pone.0158694			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380262	gold, Green Published, Green Submitted			2022-12-27	WOS:000379798700042
J	Yang, CL; Mi, L; Hu, XL; Liu, JX; Wang, JK				Yang, Chunlei; Mi, Lan; Hu, Xialu; Liu, Jianxin; Wang, Jiakun			Investigation into Host Selection of the Cecal Acetogen Population in Rabbits after Weaning	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; IN-VITRO; FERMENTATION PATTERN; ORYCTOLAGUS-CUNICULUS; BOVINE RUMEN; AGE; EVOLUTION; COMMUNITY; HYDROGEN; CARBON	Homoacetogenic bacteria have received attention as a hydrogenotrophic population that offers a significant energetic advantage to the host animal. Reductive acetogenesis is likely an important hydrogen disposal mechanism in the cecum of rabbits. However, molecular ecology information about cecal acetogen candidates has rarely been reported. To better understand the effect of host selection in the rabbit cecal acetogen community with respect to growth, rabbits at four different age stages (30, 60, 120 and 180 days) with the same diet were studied. Although the abundance of potential acetogens and methanogens was high in the cecum of rabbits undergoing growth, many novel potential acetogen populations were observed in the cecum of rabbits across all age groups. Young and adult rabbits had their own distinct acetogen community although they received the same diet, which suggests that as the rabbit ages, acetogens in the cecum undergo developmental changes because of host selection that are independent of diet, and perhaps the different acetogen communities result in different hydrogenotrophic characteristics. The within-group similarity increased with age, indicating that the acetogen community converges to a more homogeneous and stable arrangement with aging.	[Yang, Chunlei; Mi, Lan; Hu, Xialu; Liu, Jianxin; Wang, Jiakun] Zhejiang Univ, Inst Dairy Sci, MoE Key Lab Mol Anim Nutr, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Wang, JK (corresponding author), Zhejiang Univ, Inst Dairy Sci, MoE Key Lab Mol Anim Nutr, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.	jiakunwang@zju.edu.cn		Wang, Jiakun/0000-0002-7213-3721	National Natural Science Foundation of China [31372337]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from the National Natural Science Foundation of China (31372337) for JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Stuart Denman at CSIRO, Australia, for his assistance in the data analysis of this manuscript. The authors acknowledge the financial support from Natural Science Foundation of China (31372337).	Abecia L, 2005, FEMS MICROBIOL LETT, V244, P111, DOI 10.1016/j.femsle.2005.01.028; Abecia L, 2013, J ANIM PHYSIOL AN N, V97, P80, DOI 10.1111/jpn.12049; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Belenguer A, 2011, WORLD RABBIT SCI, V19, P75, DOI 10.4995/wrs.2011.826; Bengelsdorf FR, 2013, ENVIRON TECHNOL, V34, P1639, DOI 10.1080/09593330.2013.827747; Bernalier A, 1996, ARCH MICROBIOL, V166, P176, DOI 10.1007/s002030050373; Blackmore TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075079; Bovera F, 2008, J ANIM PHYSIOL AN N, V92, P260, DOI 10.1111/j.1439-0396.2007.00748.x; BREZNAK JA, 1991, ARCH MICROBIOL, V156, P105, DOI 10.1007/BF00290981; BREZNAK JA, 1990, FEMS MICROBIOL LETT, V87, P309, DOI 10.1016/0378-1097(90)90471-2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Combes S, 2011, FEMS MICROBIOL ECOL, V77, P680, DOI 10.1111/j.1574-6941.2011.01148.x; CORDRUWISCH R, 1988, ARCH MICROBIOL, V149, P350, DOI 10.1007/BF00411655; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Dong H, 2006, CLIMATE CHANGE 2006; Drake H.L., 1994, ACETOGENESIS, P3; ERNSTER L, 1957, PEDIATRICS, V20, P647; Eshar D, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-62; FORSYTHE SJ, 1985, J APPL BACTERIOL, V58, P363, DOI 10.1111/j.1365-2672.1985.tb01475.x; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; Gallois M, 2008, ANIMAL, V2, P525, DOI 10.1017/S1751731108001729; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GEERLIGS G, 1987, ARCH MICROBIOL, V148, P305, DOI 10.1007/BF00456709; GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679; Godwin S, 2014, ISME J, V8, P1855, DOI 10.1038/ismej.2014.25; GOUET P, 1973, ANN BIOL ANIM BIOCH, V13, P733, DOI 10.1051/rnd:19730423; Hu WL, 2005, ANIM FEED SCI TECH, V120, P333, DOI 10.1016/j.anifeedsci.2005.02.029; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Joblin KN, 1999, AUST J AGR RES, V50, P1307, DOI 10.1071/AR99004; Kita A, 2013, J BIOSCI BIOENG, V115, P347, DOI 10.1016/j.jbiosc.2012.10.013; Kopke M, 2011, APPL ENVIRON MICROB, V77, P5467, DOI 10.1128/AEM.00355-11; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Kundiyana DK, 2011, BIORESOURCE TECHNOL, V102, P6058, DOI 10.1016/j.biortech.2011.03.020; Kusar D, 2010, FEMS MICROBIOL ECOL, V74, P623, DOI 10.1111/j.1574-6941.2010.00980.x; Leaphart AB, 2001, APPL ENVIRON MICROB, V67, P1392, DOI 10.1128/AEM.67.3.1392-1395.2001; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LOROWITZ WH, 1984, APPL ENVIRON MICROB, V47, P961, DOI 10.1128/AEM.47.5.961-964.1984; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marounek M, 1999, ARCH ANIM NUTR, V52, P195, DOI 10.1080/17450399909386162; Martinez G, 2011, ADV ANIMAL BIOSCIENC, V2, P488; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Piattoni F, 1996, REPROD NUTR DEV, V36, P253, DOI 10.1051/rnd:19960303; RieuLesme F, 1996, FEMS MICROBIOL LETT, V140, P281; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; Sakai S, 2005, J BIOSCI BIOENG, V99, P252, DOI 10.1263/jbb.99.252; Schink B, 1994, ACETOGENESIS, P197, DOI DOI 10.1007/978-1-4615-1777-1_7; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Warnes G.R., 2009, GPLOTS VARIOUS R PRO; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOOD HG, 1991, FASEB J, V5, P156, DOI 10.1096/fasebj.5.2.1900793; Xu KW, 2009, ANAEROBE, V15, P204, DOI 10.1016/j.anaerobe.2009.03.005; Yang B, 2015, J ANIM SCI, V93, P4984, DOI 10.2527/jas.2015-9266; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	66	7	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158768	10.1371/journal.pone.0158768	http://dx.doi.org/10.1371/journal.pone.0158768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379387	Green Submitted, Green Published, gold			2022-12-27	WOS:000379798700045
J	Aghajafari, F; Field, CJ; Kaplan, BJ; Rabi, DM; Maggiore, JA; O'Beirne, M; Hanley, DA; Eliasziw, M; Dewey, D; Weinberg, A; Ross, SJ				Aghajafari, Fariba; Field, Catherine J.; Kaplan, Bonnie J.; Rabi, Doreen M.; Maggiore, Jack A.; O'Beirne, Maeve; Hanley, David A.; Eliasziw, Misha; Dewey, Deborah; Weinberg, Amy; Ross, Sue J.		APrON Study Team	The Current Recommended Vitamin D Intake Guideline for Diet and Supplements During Pregnancy Is Not Adequate to Achieve Vitamin D Sufficiency for Most Pregnant Women	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; D DEFICIENCY; ADULTS; INSUFFICIENCY; HEALTH; RISK	Background The aims of this study were to determine if pregnant women consumed the recommended vitamin D through diet alone or through diet and supplements, and if they achieved the current reference range vitamin D status when their reported dietary intake met the current recommendations. Methods Data and banked blood samples collected in second trimester from a subset of 537 women in the APrON (Alberta Pregnant Outcomes and Nutrition) study cohort were examined. Frozen collected plasma were assayed using LC-MS/MS (liquid chromatography-tandem mass spectrometry) to determine 25(OH)D-2, 25(OH)D-3, 3-epi-25(OH)D-3 concentrations. Dietary data were obtained from questionnaires including a Supplement Intake Questionnaire and a 24-hour recall of the previous day's diet. Results Participants were 87% Caucasian; mean (SD) age of 31.3 (4.3); BMI 25.8 (4.7); 58% were primiparous; 90% had education beyond high school; 80% had a family income higher than CAN $ 70,000/year. 25(OH)D-2, 25(OH)D-3, and 3-epi-25(OH)D-3) were identified in all of the 537 plasma samples; 3-epi-25(OH)D-3 contributed 5% of the total vitamin D. The median (IQR) total 25(OH)D (D-2+D-3) was 92.7 (30.4) nmol/L and 20% of women had 25(OH)D concentration < 75 nmol/L. The median (IQR) reported vitamin D intake from diet and supplements was 600 (472) IU/day. There was a significant relationship between maternal reported dietary vitamin D intake (diet and supplement) and 25(OH)D and 3-epi-25(OH)D-3 concentrations in an adjusted linear regression model. Conclusions We demonstrated the current RDA (600 IU/day) may not be adequate to achieve vitamin D status > 75 nmol/L in some pregnant women who are residing in higher latitudes (Calgary, 51 degrees N) in Alberta, Canada and the current vitamin D recommendations for Canadian pregnant women need to be re-evaluated.	[Aghajafari, Fariba; Kaplan, Bonnie J.; Rabi, Doreen M.; O'Beirne, Maeve; Hanley, David A.; Dewey, Deborah] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Field, Catherine J.; Weinberg, Amy] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Maggiore, Jack A.] Doctors Data Inc, Res & Dev, St Charles, IL USA; [Eliasziw, Misha] Tufts Univ, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Ross, Sue J.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada	University of Calgary; University of Alberta; Massachusetts Department of Public Health; Tufts University; University of Alberta	Aghajafari, F (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.	fariba.aghajafari@ucalgary.ca	Dewey, Deborah/AGK-7348-2022	Aghajafari, Fariba/0000-0002-2229-2054; Dewey, Deborah/0000-0002-1323-5832; Field, Catherine/0000-0001-7285-4767	Cumming School of Medicine, University of Calgary; Janus Research Award from College of Family Physicians of Canada	Cumming School of Medicine, University of Calgary; Janus Research Award from College of Family Physicians of Canada	This work was funded by Bridge funding from the Cumming School of Medicine, University of Calgary, and Janus Research Award from College of Family Physicians of Canada. The funder provided support in the form of research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F., 2015, J NUTR; Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Bailey D, 2014, CLIN BIOCHEM, V47, P816, DOI 10.1016/j.clinbiochem.2014.01.015; Bailey D, 2013, CLIN BIOCHEM, V46, P190, DOI 10.1016/j.clinbiochem.2012.10.037; Canada Health, VIT D CALC UPD DIET; Canada Health [CD], 2004, NUTRIENT INTAKES FRO, V1; Canadian Cancer Society, 2016, BEING SAF SUN; Cashman KD, 2014, J NUTR, V144, P1050, DOI 10.3945/jn.114.192419; Food and Drug Administration, 2009, FED REGISTER, V74, P53743; Gomez MF, 2015, MATERN CHILD NUTR, V11, P497, DOI 10.1111/mcn.12038; Gozdzik A, 2010, J NUTR, V140, P2213, DOI 10.3945/jn.110.126284; Hanley DA, 2010, CAN MED ASSOC J, V182, pE610, DOI 10.1503/cmaj.080663; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Harville EW, 2004, J AM COLL NUTR, V23, P43, DOI 10.1080/07315724.2004.10719341; Haugen M, 2008, ANN NUTR METAB, V52, P272, DOI 10.1159/000146274; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Institute of Medicine, 2012, DIET REF INT CALC VI; Kaplan BJ, 2014, MATERN CHILD NUTR, V10, P44, DOI 10.1111/j.1740-8709.2012.00433.x; Kramer CK, 2016, CLIN ENDOCRINOL, V84, P680, DOI 10.1111/cen.12989; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Lucas RM, 2013, J STEROID BIOCHEM, V136, P300, DOI 10.1016/j.jsbmb.2013.01.011; Mannion CA, 2007, J AM COLL NUTR, V26, P149, DOI 10.1080/07315724.2007.10719596; Oken E, 2007, ANN EPIDEMIOL, V17, P663, DOI 10.1016/j.annepidem.2007.03.003; Ozias MK, 2014, J AM COLL NUTR, V33, P394, DOI 10.1080/07315724.2013.879843; Rifas-Shiman SL, 2006, PAEDIATR PERINAT EP, V20, P35, DOI 10.1111/j.1365-3016.2006.00691.x; Rucker D, 2002, CAN MED ASSOC J, V166, P1517; Sarafin K, 2015, AM J CLIN NUTR, V102, P1044, DOI 10.3945/ajcn.114.103689; Sham L, 2015, J PHOTOCH PHOTOBIO B, V145, P25, DOI 10.1016/j.jphotobiol.2015.02.007; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; van den Ouweland JMW, 2010, J CHROMATOGR B, V878, P1163, DOI 10.1016/j.jchromb.2010.03.035; Veugelers PJ, 2015, NUTRIENTS, V7, P10189, DOI 10.3390/nu7125527; Wagner CL, 2012, WOMENS HEALTH, V8, P323, DOI [10.2217/WHE.12.17, 10.2217/whe.12.17]; Wangyang L., 2011, CAN J PUBLIC HLTH, V102, P308; Whiting SJ, 2011, AM J CLIN NUTR, V94, P128, DOI 10.3945/ajcn.111.013268; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S	38	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157262	10.1371/journal.pone.0157262	http://dx.doi.org/10.1371/journal.pone.0157262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367800	gold, Green Published, Green Submitted			2022-12-27	WOS:000378914900009
J	Balestrieri, A; Bogliani, G; Boano, G; Ruiz-Gonzalez, A; Saino, N; Costa, S; Milanesi, P				Balestrieri, Alessandro; Bogliani, Giuseppe; Boano, Giovanni; Ruiz-Gonzalez, Aritz; Saino, Nicola; Costa, Stefano; Milanesi, Pietro			Modelling the Distribution of Forest-Dependent Species in Human-Dominated Landscapes: Patterns for the Pine Marten in Intensively Cultivated Lowlands	PLOS ONE			English	Article							HABITAT SELECTION; RANGE-EXPANSION; RIPARIAN; CARNIVORES; EVOLUTION; INVASIONS; PREDICT; SHIFTS	In recent years, the "forest-specialist" pine marten Martes martes has been reported to also occur also in largely fragmented, lowland landscapes of north-western Italy. The colonization of such an apparently unsuitable area provided the opportunity for investigating pine marten ecological requirements and predicting its potential south-and eastwards expansion. We collected available pine marten occurrence data in the flood plain of the River Po (N Italy) and relate them to 11 environmental variables by developing nine Species Distribution Models. To account for inter-model variability we used average ensemble predictions (EP). EP predicted a total of 482 suitable patches (8.31% of the total study area) for the pine marten. The main factors driving pine marten occurrence in the western River Po plain were the distance from watercourses and the distance from woods. EP suggested that the pine marten may further expand in the western lowland, whilst the negligible residual wood cover of large areas in the central and eastern plain makes the habitat unsuitable for the pine marten, except for some riparian corridors and the pine wood patches bordering the Adriatic coast. Based on our results, conservation strategies should seek to preserve remnant forest patches and enhance the functional connectivity provided by riparian corridors.	[Balestrieri, Alessandro; Saino, Nicola] Univ Milan, Dept Biosci, Milan, Italy; [Bogliani, Giuseppe; Milanesi, Pietro] Univ Pavia, Dept Earth & Environm Sci, Pavia, Italy; [Boano, Giovanni] Nat Hist Museum Carmagnola, Carmagnola, TO, Italy; [Ruiz-Gonzalez, Aritz] Univ Basque Country UPV EHU, Dept Zool & Anim Cell Biol, Vitoria, Spain; [Ruiz-Gonzalez, Aritz] Univ Basque Country, UPV EHU, Lascaray Res Ctr, Systemat Biogeog & Populat Dynam Res Grp, Vitoria, Spain; [Costa, Stefano] Via Quintino Sella 16, Cossato, BI, Italy	University of Milan; University of Pavia; University of Basque Country; University of Basque Country	Balestrieri, A (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	alebls@libero.it	GONZALEZ, ARITZ RUIZ/P-3384-2019; Milanesi, Pietro/AAW-4309-2021; Ruiz-Gonzalez, Aritz/A-1613-2013	GONZALEZ, ARITZ RUIZ/0000-0001-7409-4634; Milanesi, Pietro/0000-0002-1878-9762; Boano, Giovanni/0000-0002-2670-4351	Dept. of Biosciences of the University of Milan; Dept. of Earth and Environmental Sciences, University of Pavia; Basque Government through the Research group on 'Systematics, Biogeography and Population Dynamics' [IT317-10, GIC10/76, IT575/13]; SAIOTEK research programme [S-PE11UN028]; Dept. of Education, Universities and Research of the Basque Government [DKR-2012-64]	Dept. of Biosciences of the University of Milan; Dept. of Earth and Environmental Sciences, University of Pavia; Basque Government through the Research group on 'Systematics, Biogeography and Population Dynamics'; SAIOTEK research programme; Dept. of Education, Universities and Research of the Basque Government	A. Balestrieri was supported by a Ph.D. fellowship awarded by the Dept. of Biosciences of the University of Milan. P. Milanesi was supported by the Dept. of Earth and Environmental Sciences, University of Pavia. This study has been partially funded by the Basque Government through the Research group on 'Systematics, Biogeography and Population Dynamics' (Ref. IT317-10; GIC10/76; IT575/13), the SAIOTEK research programme (Ref: S-PE11UN028). A. Ruiz-Gonzalez (Ref. DKR-2012-64) was supported by a Ph.D. and Post-doctoral fellowships awarded by the Dept. of Education, Universities and Research of the Basque Government.	Aertsen W, 2011, ENVIRON MODELL SOFTW, V221, P1119; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Althoff DP, 1997, J WILDLIFE MANAGE, V61, P450, DOI 10.2307/3802603; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Ascensao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103544; Baldwin RA, 2008, J MAMMAL, V89, P419, DOI 10.1644/07-MAMM-A-053R1.1; Balestrieri A, 2015, ETHOL ECOL EVOL; Balestrieri A, MAMMAL RES UNPUB; Balestrieri A, 2016, MAMM BIOL, V81, P439, DOI 10.1016/j.mambio.2016.05.005; Balestrieri A, 2015, ECOL RES, V30, P153, DOI 10.1007/s11284-014-1220-8; Balestrieri A, 2011, ACTA THERIOL, V56, P199, DOI 10.1007/s13364-010-0015-8; Balestrieri A, 2010, MAMM BIOL, V75, P412, DOI 10.1016/j.mambio.2009.05.003; Barrull J, 2014, MAMM BIOL, V79, P123, DOI 10.1016/j.mambio.2013.11.004; Bon M, 1995, LAV SOC VEN SCI NA S, V21; Bon M, 2012, 8 C ASS TER IT PIAC; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Broenniman O, 2014, ECOSPAT SPATIAL ECOL; BUSKIRK SW, 1992, CONSERV BIOL, V6, P318, DOI 10.1046/j.1523-1739.1992.06030318.x; Calenge C, 2008, ECOLOGY, V89, P555, DOI 10.1890/06-1750.1; Calenge C, 2005, ECOL MODEL, V186, P143, DOI 10.1016/j.ecolmodel.2004.12.005; Camerano P, 2010, BOSCHI PLANIZIALI CO, DOI Torino; Carone TM, 2014, ECOL MODEL, V274, P21, DOI 10.1016/j.ecolmodel.2013.11.027; Caryl FM, 2012, J MAMMAL, V93, P464, DOI 10.1644/11-MAMM-A-149.1; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; COLES T F, 1989, Regulated Rivers Research and Management, V4, P179, DOI 10.1002/rrr.3450040210; Crickenberger S, 2016, HYDROBIOLOGIA, V763, P193, DOI 10.1007/s10750-015-2376-0; Cushman SA, 2011, LANDSCAPE ECOL, V26, P1137, DOI 10.1007/s10980-011-9645-8; Darimont CT, 2005, DIVERS DISTRIB, V11, P235, DOI 10.1111/j.1366-9516.2005.00135.x; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; de Rivera CE, 2011, DIVERS DISTRIB, V17, P1198, DOI 10.1111/j.1472-4642.2011.00790.x; Di Febbraro M, 2015, DIVERS DISTRIB, P1; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; DOYLE AT, 1990, J MAMMAL, V71, P14, DOI 10.2307/1381312; Ducci L, 2015, LANDSCAPE ECOL, V30, P2147, DOI 10.1007/s10980-015-0237-x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Falcucci A, 2013, BIOL CONSERV, V158, P63, DOI 10.1016/j.biocon.2012.08.029; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Fawcett T., 2004, ROC GRAPHS NOTES PRA; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gherardi M, 2009, EQA-INT J ENVIRON QU, V2, P29, DOI 10.6092/issn.2281-4485/3817; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hastie T., 1986, STAT SCI, V1, P297; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Holt RD, 1996, OIKOS, V75, P182, DOI 10.2307/3546242; Kampichler C, 2010, ECOL INFORM, V254, P390; Kinlan BP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P381; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Ko CY, 2011, ECOL MODEL, V222, P947, DOI 10.1016/j.ecolmodel.2010.12.001; La Morgia V, 2011, LANDSCAPE ECOL, V26, P969, DOI 10.1007/s10980-011-9621-3; Lapini Luca, 2009, Bollettino del Museo Civico di Storia Naturale di Venezia, V60, P169; Larroque J, 2016, LANDSCAPE ECOL, V31, P517, DOI 10.1007/s10980-015-0281-6; Larroque J, 2015, ECOGRAPHY, V38, P1129, DOI 10.1111/ecog.01133; Lassini P., 2007, EUROPES LIVING LANDS, P83; Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000; MacArthur R.H., 1972, pvii; Mantovani Sergio, 2010, Pianura, V25, P95; Marmion M, 2009, ECOL MODEL, V6; McCullagh P, 1989, GEN LINEAR MODELS; Milanesi P, 2015, BASIC APPL ECOL; Moyle PB, 1996, ECOLOGY, V77, P1666, DOI 10.2307/2265770; Olaya-Marin EJ, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013052; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; Pereboom V, 2008, CAN J ZOOL, V86, P983, DOI 10.1139/Z08-076; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prigioni C., 2001, ATLANTE MAMMIFERI LO; Remonti L, 2011, ECOL RES, V26, P487, DOI 10.1007/s11284-011-0804-9; Ripley B. D., 1996, PATTERN RECOGNITION; Salek M, 2014, EUR J WILDLIFE RES, V60, P99, DOI 10.1007/s10344-013-0755-2; Santos MJ, 2016, EUR J WILDLIFE RES, V62, P251, DOI 10.1007/s10344-016-0984-2; Savoldelli P, 2008, GRANDI PICCOLI PREDA; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Sidorovich VE, 2005, FOLIA ZOOL, V54, P39; Sindaco R, 2010, RIV PIEMONTESE STORI, V31, P397; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Stolar J, 2015, DIVERS DISTRIB, V21, P595, DOI 10.1111/ddi.12279; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tattersall FH, 2002, J APPL ECOL, V39, P643, DOI 10.1046/j.1365-2664.2002.00741.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thuiller W., 2013, R PACKAGE VERSION, V2, P560; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Uboni A, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00419.1; Veech JA, 2011, J BIOGEOGR, V38, P69, DOI 10.1111/j.1365-2699.2010.02397.x; Verdade L.M., 2011, MIDDLE SIZED CARNIVO, P1; Vergara M, 2016, LANDSCAPE ECOL, V31, P1241, DOI 10.1007/s10980-015-0307-0; Virgos E, 2012, BIOL CONSERVATION MA, P255; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wereszczuk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139852; White TA, 2012, BIOL INVASIONS, V14, P2203, DOI 10.1007/s10530-012-0225-x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Zalewski A, 2006, ECOGRAPHY, V29, P31, DOI 10.1111/j.2005.0906-7590.04313.x; Zuur Alain F., 2009, P1	101	19	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158203	10.1371/journal.pone.0158203	http://dx.doi.org/10.1371/journal.pone.0158203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27368056	Green Published, gold			2022-12-27	WOS:000378914900022
J	Muga, MA; Owili, PO; Hsu, CY; Rau, HH; Chao, JCJ				Muga, Miriam Adoyo; Owili, Patrick Opiyo; Hsu, Chien-Yeh; Rau, Hsiao-Hsien; Chao, Jane C-J			Association between Dietary Patterns and Cardiovascular Risk Factors among Middle-Aged and Elderly Adults in Taiwan: A Population-Based Study from 2003 to 2012	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; METABOLIC SYNDROME; INSULIN-RESISTANCE; ENDOTHELIAL ACTIVATION; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; WHOLE-GRAIN; INFLAMMATION; MARKERS	Background Cardiovascular disease (CVD) is one of the leading causes of mortality and loss of disability-adjusted life years in developed countries. This study derived a dietary pattern using an a priori method and additionally derived dietary patterns using a posteriori methods, and assessed the relationship with CVD risk factors in Taiwanese middle-aged and elderly adults. Methods Cross-sectional analyses of 62,965 subjects aged 40 years and above from the Mei Jau (MJ) database collected between 2003 and 2012 in Taiwan. Diet was assessed using a 22 item semi-quantitative food frequency questionnaire. Using this information, three dietary patterns were generated. The a priori diet was labeled the Taiwanese dietary pattern and was derived using hypothesized effect of 22 food groups, while two a posteriori dietary patterns, "vegi-fruits" and "meat-processed", were derived using principal component analysis. The association between dietary patterns and a range of CVD risk factors (i.e. blood lipids, blood glucose and C-reactive protein) was evaluated using linear regression. Results The results showed that high intake (Q5, quintile 5) of Taiwanese diet was negatively associated with CVD risk factors at (p < 0.001, model 3), but not with triacylglycerol. In addition, high intake of vegi-fruit dietary pattern (Q5) was negatively associated with CVD risk factors (p < 0.001), but not with high-density lipoprotein, while high consumption of meat-processed dietary pattern (Q5) was positively associated with CVD risk factors (p < 0.001), but negatively related with triacylglycerol in Q3 level and no association with C-reactive protein. Conclusion A negative association was observed between Taiwanese or vegi-fruit dietary patterns and CVD risk factors, while a positive association was found between meat-processed dietary pattern and CVD risk factors. The findings suggested that a diet rich in vegetables and fruits has a beneficial effect in the management of CVD risk factors.	[Muga, Miriam Adoyo; Chao, Jane C-J] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Owili, Patrick Opiyo] Natl Yang Ming Univ, Inst Publ Hlth, Int Hlth Program, Taipei, Taiwan; [Hsu, Chien-Yeh] Natl Taipei Univ Nursing & Hlth Sci, Dept Informat Management, Taipei, Taiwan; [Hsu, Chien-Yeh; Chao, Jane C-J] Taipei Med Univ, Coll Publ Hlth & Nutr, Master Program Global Hlth & Dev, Taipei, Taiwan; [Rau, Hsiao-Hsien] Taipei Med Univ, Coll Med Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Chao, Jane C-J] Taipei Med Univ Hosp, Nutr Res Ctr, Taipei, Taiwan	Taipei Medical University; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Chao, JCJ (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Nutr & Hlth Sci, Taipei, Taiwan.; Hsu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Informat Management, Taipei, Taiwan.; Hsu, CY; Chao, JCJ (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Master Program Global Hlth & Dev, Taipei, Taiwan.; Chao, JCJ (corresponding author), Taipei Med Univ Hosp, Nutr Res Ctr, Taipei, Taiwan.	cyhsu@ntunhs.edu.tw; chenjui@tmu.edu.tw	Owili, Patrick Opiyo/J-8948-2019	Owili, Patrick Opiyo/0000-0002-9417-8947; Muga, Miriam/0000-0002-9180-5394				Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x; Akter S, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-30; Arisawa K, 2014, J MED INVESTIG, V61, P333, DOI 10.2152/jmi.61.333; Bailey RL, 2007, J NUTR, V137, P421, DOI 10.1093/jn/137.2.421; Baxter AJ, 2006, ASIA PAC J CLIN NUTR, V15, P134; Brown J., 2009, SHIKEN JALT TESTING, V13, P19; Bruce WR, 2000, NUTR CANCER, V37, P19, DOI 10.1207/S15327914NC3701_2; Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; Calton EK, 2014, NUTR RES, V34, P559, DOI 10.1016/j.nutres.2014.06.012; Centritto F, 2009, NUTR METAB CARDIOVAS, V19, P697, DOI 10.1016/j.numecd.2008.11.009; Cho YA, 2011, NUTR METAB CARDIOVAS, V21, P893, DOI 10.1016/j.numecd.2010.02.018; De Biase SG, 2007, ARQ BRAS CARDIOL, V88, P35, DOI 10.1590/S0066-782X2007000100006; Denova-Gutierrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671; Eilat-Adar S, 2013, NUTR METAB CARDIOVAS, V23, P528, DOI 10.1016/j.numecd.2011.12.005; Field A., 2012, DISCOVERING STAT USI; Fonseca MJ, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-64; Fredrikson GN, 2004, METABOLISM, V53, P1436, DOI 10.1016/j.metabol.2004.06.010; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Ganguli D, 2011, BRIT J NUTR, V105, P1520, DOI 10.1017/S0007114510005131; Garduno-Diaz SD, 2013, J HUM NUTR DIET, V26, P145, DOI 10.1111/j.1365-277X.2012.01284.x; Gorsuch R. L., 2014, FACTOR ANAL CLASSIC; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; He Y, 2013, NUTR METAB CARDIOVAS, V23, P920, DOI 10.1016/j.numecd.2012.09.001; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; HUIJBREGTS PPCW, 1995, INT J EPIDEMIOL, V24, P313, DOI 10.1093/ije/24.2.313; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Jolliffe IT., 2013, PRINCIPAL COMPONENT; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; King DE, 2007, ARCH INTERN MED, V167, P502, DOI 10.1001/archinte.167.5.502; Lin PH, 2013, ASIA PAC J CLIN NUTR, V22, P482, DOI 10.6133/apjcn.2013.22.3.05; Lockheart MSK, 2007, BRIT J NUTR, V98, P380, DOI 10.1017/S0007114507701654; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Lovegrove JA., 2015, NUTR RES METHODOLOGI; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Lutsey PL, 2007, BRIT J NUTR, V98, P397, DOI 10.1017/S0007114507700715; Lyu LC, 2007, ASIA PAC J CLIN NUTR, V16, P766; McPherson RA, 2011, HENRYS CLIN DIAGNOSI; Meyer KA, 2013, FREE RADICAL BIO MED, V57, P201, DOI 10.1016/j.freeradbiomed.2012.08.574; Mirzaei M, 2009, HEART, V95, P740, DOI 10.1136/hrt.2008.154856; Mizoue T, 2006, J NUTR, V136, P1352, DOI 10.1093/jn/136.5.1352; MJ Group, MJ HLTH SCREEN CTR Q; Teixeira RDMD, 2007, ARQ BRAS CARDIOL, V89, P237, DOI 10.1590/S0066-782X2007001600005; Naja F, 2013, EUR J NUTR, V52, P97, DOI 10.1007/s00394-011-0291-3; Nanri A, 2008, AM J CLIN NUTR, V87, P1488, DOI 10.1093/ajcn/87.5.1488; Nettleton JA, 2008, AM J CLIN NUTR, V88, P185, DOI 10.1093/ajcn/88.1.185; Nettleton JA, 2006, AM J CLIN NUTR, V83, P1369, DOI 10.1093/ajcn/83.6.1369; Newby PK, 2004, AM J CLIN NUTR, V80, P759; Oliveira A, 2011, J AM DIET ASSOC, V111, P241, DOI 10.1016/j.jada.2010.10.042; ORourke Norm, 2013, STEP BY STEP APPROAC; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Rizzo NS, 2011, DIABETES CARE, V34, P1225, DOI 10.2337/dc10-1221; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Rowley K, 2003, MED J AUSTRALIA, V178, P495, DOI 10.5694/j.1326-5377.2003.tb05324.x; SHEKELLE RB, 1982, AM J EPIDEMIOL, V115, P506, DOI 10.1093/oxfordjournals.aje.a113332; Song SuJin, 2012, Korean Journal of Nutrition, V45, P80, DOI 10.4163/kjn.2012.45.1.80; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Sun Jing, 2013, Front Public Health, V1, P48, DOI 10.3389/fpubh.2013.00048; Tortosa A, 2007, DIABETES CARE, V30, P2957, DOI 10.2337/dc07-1231; Tourlouki E, 2009, CLIN INTERV AGING, V4, P319, DOI 10.2147/CIA.S5697; Walker J, 2010, INTERPRETING STAT FI; Weickert MO, 2008, J NUTR, V138, P439, DOI 10.1093/jn/138.3.439; WHO, 2003, DIET NUTR PREVENTION, V916; Willett WC, 2012, J INTERN MED, V272, P13, DOI 10.1111/j.1365-2796.2012.02553.x; Willett WC, 2008, ASIA PAC J CLIN NUTR, V17, P75	72	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157745	10.1371/journal.pone.0157745	http://dx.doi.org/10.1371/journal.pone.0157745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27366909	Green Submitted, gold, Green Published			2022-12-27	WOS:000378914900013
J	Saleem, A; Masood, I				Saleem, Ahsan; Masood, Imran			Pattern and Predictors of Medication Dosing Errors in Chronic Kidney Disease Patients in Pakistan: A Single Center Retrospective Analysis	PLOS ONE			English	Article							DRUG-DOSAGE ADJUSTMENTS; RENAL IMPAIRMENT; HOSPITALIZED-PATIENTS; CREATININE CLEARANCE; SERUM CREATININE; ELDERLY-PATIENTS; EPIDEMIOLOGY; PREVALENCE; GUIDELINES; COMMUNITY	Background Chronic kidney disease (CKD) alters the pharmacokinetic and pharmacodynamic response of various drugs and increases the risk of toxicity. The data regarding the pattern and predictors of medication dosing errors is scare from the developing countries. Therefore, the present study was conducted to assess the pattern and predictors of medication dosing errors in CKD patients in a tertiary care setting in Pakistan. Methods A retrospective study design was employed and medical charts of all those CKD patients who had an eGFR <= 60ml/min/1.73m(2), hospitalization >= 24 hours, and admitted in the nephrology unit during January 2013 to December 2014 were assessed. Descriptive statistics and the logistic regression analysis were done using IBM SPSS version 20. Results In total, 205 medical charts were assessed. The mean age of patients was 38.64 (+/- 16.82) years. Overall, 1534 drugs were prescribed to CKD patients, of which, nearly 34.0% drugs required dose adjustment. Among those drugs, only 41.8% were properly adjusted, and the remaining 58.2% were unadjusted. The logistic regression analysis revealed that the medication dosing errors were significantly associated with the CKD stages, i.e. stage 4 (OR 0.054; 95% CI [0.017-0.177]; p < 0.001) and stage 5 (OR 0.098; 95% CI [0.040-0.241]; p < 0.001), the number of prescribed medicines >= 5 (OR 0.306; 95% CI [0.133-0.704]; p 0.005), and the presence of a comorbidity (OR 0.455; 95% CI [0.226-0.916]; p 0.027) such as the hypertension (OR 0.453; 95% CI [0.231-0.887]; p 0.021). Conclusions It is concluded that more than half drugs prescribed to CKD patients requiring dose adjustment were unadjusted. The predictors of medication dosing errors were the severe-to-end stages of chronic kidney disease, the presence of a comorbidity such as hypertension, and a higher number of prescribed medicines. Therefore, attention should be paid to these risk factors.	[Saleem, Ahsan; Masood, Imran] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan	Islamia University of Bahawalpur	Saleem, A; Masood, I (corresponding author), Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan.	saleemahsan77@gmail.com; drimranmasoodppiub@gmail.com	Saleem, Ahsan/P-4760-2014	Saleem, Ahsan/0000-0003-1710-3578				Alahdal AM, 2012, SAUDI PHARM J, V20, P217, DOI 10.1016/j.jsps.2011.12.005; Alam Ashar, 2014, BMC Res Notes, V7, P179, DOI 10.1186/1756-0500-7-179; Bassetti M, 2016, EXPERT OPIN DRUG SAF, V15, P467, DOI 10.1517/14740338.2016.1142528; BENNETT WM, 1983, AM J KIDNEY DIS, V3, P155, DOI 10.1016/S0272-6386(83)80060-2; British Medical Association Royal Pharmaceutical Society of Great Britain, 2009, BRIT NATL FORMULARY; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Decloedt E, 2010, SAMJ S AFR MED J, V100, P304, DOI 10.7196/SAMJ.3955; Drenth-van Maanen AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128237; Erler A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-91; Getachew H, 2015, BMC NEPHROL, V15, P1; Gilani SI, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-16; Haider SI, 2014, VALUE HEALTH, V17, pA129, DOI 10.1016/j.jval.2014.03.747; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hanlon JT, 2011, J AM MED DIR ASSOC, V12, P377, DOI 10.1016/j.jamda.2010.04.008; Hartmann B, 2010, DTSCH ARZTEBL INT, V107, P647, DOI 10.3238/arztebl.2010.0647; Hu KT, 2001, AM J MED SCI, V322, P133, DOI 10.1097/00000441-200109000-00004; Hug BL, 2009, KIDNEY INT, V76, P1192, DOI 10.1038/ki.2009.353; Khanal A, 2015, DRUG AGING, V32, P391, DOI 10.1007/s40266-015-0261-1; Lassiter J, 2013, CLIN GERIATR MED, V29, P657, DOI 10.1016/j.cger.2013.05.008; Leendertse AJ, 2012, ANN PHARMACOTHER, V46, P625, DOI 10.1345/aph.1Q633; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marasinghe KM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006539; Markota NP, 2009, J NEPHROL, V22, P497; Munar MY, 2007, AM FAM PHYSICIAN, V75, P1487; Papaioannou A, 2000, J AM GERIATR SOC, V48, P1470, DOI 10.1111/j.1532-5415.2000.tb02639.x; Pillans PI, 2003, INTERN MED J, V33, P10, DOI 10.1046/j.1445-5994.2003.00330.x; Prajapati Arpit, 2013, J Pharm Bioallied Sci, V5, P136, DOI 10.4103/0975-7406.111829; Sah S K, 2014, J Nepal Health Res Counc, V12, P54; Salomon L, 2003, INT J QUAL HEALTH C, V15, P331, DOI 10.1093/intqhc/mzg046; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Soetikno V, 2009, MED J INDONES, V18, P108; Stevens LA, 2009, CLIN PHARMACOL THER, V86, P465, DOI 10.1038/clpt.2009.124; Sweileh WM, 2007, PHARMACOEPIDEM DR S, V16, P908, DOI 10.1002/pds.1412; Tamizuddin S, 2010, J PAK MED ASSOC, V60, P342; Ullah K, 2015, SAUDI J KIDNEY DIS T, V26, P1307, DOI 10.4103/1319-2442.168694; van Dijk EA, 2006, ANN PHARMACOTHER, V40, P1254, DOI 10.1345/aph.1G742; Verbeeck RK, 2009, EUR J CLIN PHARMACOL, V65, P757, DOI 10.1007/s00228-009-0678-8; WHO, PAK STAT 2013	41	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158677	10.1371/journal.pone.0158677	http://dx.doi.org/10.1371/journal.pone.0158677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367594	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900048
J	Atwell, J; Savit, R				Atwell, Jon; Savit, Robert			The Emergence of Groups and Inequality through Co-Adaptation	PLOS ONE			English	Article							SELF-ORGANIZATION; STIGMERGY; EVOLUTION; DYNAMICS; MARKETS	The emergence of groups and of inequality is often traced to pre-existing differences, exclusionary practices, or resource accumulation processes, but can the emergence of groups and their differential success simply be a feature of the behaviors of a priori equally-capable actors who have mutually adapted? Using a simple model of behavioral co-adaptation among agents whose individual actions construct a common environment, we present evidence that the formation of unequal groups is endemic to co-adaptive processes that endogenously alter the environment; agents tend to separate into two groups, one whose members stop adapting earliest (the in-group), and another comprising agents who continue to adapt (the out-group). Over a wide range of model parameters, members of the in-group are rewarded more on average than members of the out-group. The primary reason is that the in-group is able to have a more profound influence on the environment and mold it to the benefit of its members. This molding capacity proves more beneficial than the persistence of adaptivity, yet, crucially, which agents are able to form a coalition to successfully exert this control is strongly contingent on random aspects of the set of agent behaviors. In this paper, we present the model, relevant definitions, and results. We then discuss its implications for the study of complex adaptive systems generally.	[Atwell, Jon] Univ Michigan, Dept Sociol, Ann Arbor, MI 48109 USA; [Atwell, Jon; Savit, Robert] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; [Savit, Robert] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Atwell, J (corresponding author), Univ Michigan, Dept Sociol, Ann Arbor, MI 48109 USA.; Atwell, J (corresponding author), Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA.	atwell@umich.edu		Atwell, Jon/0000-0002-9706-2640				Akcay E, 2011, P ROY SOC B-BIOL SCI, V278, P2198, DOI 10.1098/rspb.2010.2105; Altman E, 2007, GLOB TELECOMM CONF, P315; ANDERSON JM, 1995, LINKING SPECIES & ECOSYSTEMS, P94; Barthes Roland., 1977, ELEMENTS SEMIOLOGY; Blumer H, 1968, ANN M SOC ED SCHOL L; CARROLL GR, 1985, AM J SOCIOL, V90, P1262, DOI 10.1086/228210; Centola D, 2015, P NATL ACAD SCI USA, V112, P1989, DOI 10.1073/pnas.1418838112; Cisco Systems, 2012, INT TECHN HDB; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Durkheim E., 2001, ELEMENTARY FORMS REL; Goldman M, 2000, ANNU REV SOCIOL, V26, P563, DOI 10.1146/annurev.soc.26.1.563; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; HENSCHEL JR, 1995, ETHOLOGY, V101, P187; Herrnstein R J, 1994, BELL CURVE; Holland O, 1999, ARTIF LIFE, V5, P173, DOI 10.1162/106454699568737; Katznelson Ira, 2005, AFFIRMATIVE ACTION W; Keane W, 2003, LANG COMMUN, V23, P409, DOI 10.1016/S0271-5309(03)00010-7; Keister LA, 2000, ANNU REV SOCIOL, V26, P63, DOI 10.1146/annurev.soc.26.1.63; Laland K, 2014, NATURE, V514, P161, DOI 10.1038/514161a; Marx K, 1978, CAPITAL, V1; Odling-Smee J., 2003, MONOGRAPHS POPULATIO, V37; Padgett JF, 2012, EMERGENCE OF ORGANIZATIONS AND MARKETS, P1; Pager D, 2008, ANNU REV SOCIOL, V34, P181, DOI 10.1146/annurev.soc.33.040406.131740; Parziale L, 2006, TCP IP TUTORIAL TECH; Peirce Charles Sanders, 1991, PEIRCE SIGNS WRITING; Pigliucci Massimo, 2010, EVOLUTION EXTENDED S, DOI DOI 10.1016/j.tree.2008.04.005; Piketty T., 2000, HDB INCOME DISTRIBUT, V1, P430; PODOLNY JM, 1993, AM J SOCIOL, V98, P829, DOI 10.1086/230091; Roughgarden J, 2009, GENIAL GENE DECONSTR; Savit R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071828; Smith RD, 2011, ADV COMPLEX SYST, V14, P905, DOI 10.1142/S0219525911003451; Theraulaz G, 1999, ARTIF LIFE, V5, P97, DOI 10.1162/106454699568700; WHITE HC, 1981, AM J SOCIOL, V87, P517, DOI 10.1086/227495; Worden L, 2007, J THEOR BIOL, V245, P411, DOI 10.1016/j.jtbi.2006.10.011	35	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158144	10.1371/journal.pone.0158144	http://dx.doi.org/10.1371/journal.pone.0158144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362837	gold, Green Published			2022-12-27	WOS:000378865200045
J	Kerepesi, C; Szalkai, B; Varga, B; Grolmusz, V				Kerepesi, Csaba; Szalkai, Balazs; Varga, Balint; Grolmusz, Vince			How to Direct the Edges of the Connectomes: Dynamics of the Consensus Connectomes and the Development of the Connections in the Human Brain	PLOS ONE			English	Article							APOPTOSIS; ELIMINATION	The human braingraph or the connectome is the object of an intensive research today. The advantage of the graph-approach to brain science is that the rich structures, algorithms and definitions of graph theory can be applied to the anatomical networks of the connections of the human brain. In these graphs, the vertices correspond to the small (1-1.5 cm(2)) areas of the gray matter, and two vertices are connected by an edge, if a diffusion-MRI based workflow finds fibers of axons, running between those small gray matter areas in the white matter of the brain. One main question of the field today is discovering the directions of the connections between the small gray matter areas. In a previous work we have reported the construction of the Budapest Reference Connectome Server http://connectome.pitgroup.org from the data recorded in the Human Connectome Project of the NIH. The server generates the consensus braingraph of 96 subjects in Version 2, and of 418 subjects in Version 3, according to selectable parameters. After the Budapest Reference Connectome Server had been published, we recognized a surprising and unforeseen property of the server. The server can generate the braingraph of connections that are present in at least k graphs out of the 418, for any value of k = 1, 2, ..., 418. When the value of k is changed from k = 418 through 1 by moving a slider at the webserver from right to left, certainly more and more edges appear in the consensus graph. The astonishing observation is that the appearance of the new edges is not random: it is similar to a growing shrub. We refer to this phenomenon as the Consensus Connectome Dynamics. We hypothesize that this movement of the slider in the webserver may copy the development of the connections in the human brain in the following sense: the connections that are present in all subjects are the oldest ones, and those that are present only in a decreasing fraction of the subjects are gradually the newer connections in the individual brain development. An animation on the phenomenon is available at https://youtu.be/yxlyudPaVUE. Based on this observation and the related hypothesis, we can assign directions to some of the edges of the connectome as follows: Let Gk+ 1 denote the consensus connectome where each edge is present in at least k + 1 graphs, and let G(k) denote the consensus connectome where each edge is present in at least k graphs. Suppose that vertex v is not connected to any other vertices in G(k+1), and becomes connected to a vertex u in G(k), where u was connected to other vertices already in G(k+1). Then we direct this (v, u) edge from v to u.	[Kerepesi, Csaba; Szalkai, Balazs; Varga, Balint; Grolmusz, Vince] Eotvos Lorand Univ, PIT Bioinformat Grp, H-1117 Budapest, Hungary; [Grolmusz, Vince] Uratim Ltd, H-1118 Budapest, Hungary; [Kerepesi, Csaba] Inst Comp Sci & Control, H-1111 Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Computer Science & Control	Grolmusz, V (corresponding author), Eotvos Lorand Univ, PIT Bioinformat Grp, H-1117 Budapest, Hungary.	grolmusz@pitgroup.org	Kerepesi, Csaba/R-1787-2017; Szalkai, Balázs/I-4315-2017; Varga, Bálint/AAC-4316-2021	Kerepesi, Csaba/0000-0001-9541-246X; Szalkai, Balázs/0000-0002-0920-5083; Varga, Bálint/0000-0001-8827-6754; Grolmusz, Vince/0000-0001-9456-8876	NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Systems Neuroscience at Washington University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Data were provided in part by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University.	Craddock RC, 2013, NEUROIMAGE, V82, P127, DOI 10.1016/j.neuroimage.2013.05.072; GORDON N, 1995, BRAIN DEV-JPN, V17, P73, DOI 10.1016/0387-7604(94)00109-B; Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Kerepesi C., 2015, ARXIV150700327; Lewis TL, 2013, J CELL BIOL, V202, P837, DOI 10.1083/jcb.201305098; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Nonomura K, 2013, DEV CELL, V27, P621, DOI 10.1016/j.devcel.2013.11.015; Roth KA, 2001, MENT RETARD DEV D R, V7, P261, DOI 10.1002/mrdd.1036; Szalkai B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130045; Szalkai B, 2015, NEUROSCI LETT, V595, P60, DOI 10.1016/j.neulet.2015.03.071	11	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158680	10.1371/journal.pone.0158680	http://dx.doi.org/10.1371/journal.pone.0158680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362431	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000378865200106
J	Nikezic, D; Beni, MS; Krstic, D; Yu, KN				Nikezic, D.; Beni, Mehrdad Shahmohammadi; Krstic, D.; Yu, K. N.			Characteristics of Protons Exiting from a Polyethylene Converter Irradiated by Neutrons with Energies between 1 keV and 10 MeV	PLOS ONE			English	Article							DOSIMETER	Monte Carlo method has been used to determine the efficiency for proton production and to study the energy and angular distributions of the generated protons. The ENDF library of cross sections is used to simulate the interactions between the neutrons and the atoms in a polyethylene (PE) layer, while the ranges of protons with different energies in PE are determined using the Stopping and Range of Ions in Matter (SRIM) computer code. The efficiency of proton production increases with the PE layer thickness. However the proton escaping from a certain polyethylene volume is highly dependent on the neutron energy and target thickness, except for a very thin PE layer. The energy and angular distributions of protons are also estimated in the present paper, showing that, for the range of energy and thickness considered, the proton flux escaping is dependent on the PE layer thickness, with the presence of an optimal thickness for a fixed primary neutron energy.	[Nikezic, D.; Beni, Mehrdad Shahmohammadi; Yu, K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China; [Nikezic, D.; Krstic, D.] Univ Kragujevac, Fac Sci, Kragujevac, Serbia	City University of Hong Kong; University of Kragujevac	Yu, KN (corresponding author), City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.	peter.yu@cityu.edu.hk	Beni, Mehrdad Shahmohammadi/ABA-8764-2020; Nikezic, Dragoslav R/B-9343-2009	Nikezic, Dragoslav/0000-0002-3236-4912; Krstic, Dragana/0000-0002-3517-9210; YU, Kwan Ngok Peter/0000-0003-1669-5348	City University of Hong Kong [7004194]	City University of Hong Kong(City University of Hong Kong)	This research was supported by a Strategic Research Grant 7004194 from the City University of Hong Kong. http://www.cityu.edu.hk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlen TT, 2014, NUCL DATA SHEETS, V120, P211, DOI 10.1016/j.nds.2014.07.049; Castillo F, 2013, RADIAT MEAS, V50, P71, DOI 10.1016/j.radmeas.2012.09.007; ElKhatib A, 1996, MATER LETT, V26, P59, DOI 10.1016/0167-577X(95)00205-7; Ferrari A, 2005, CERN200510; Love J., 2012, PASSIVE SHIELDING NE; MAKOVICKA L, 1986, RADIAT PROT DOSIM, V16, P273, DOI 10.1093/oxfordjournals.rpd.a079757; Nikezic D, 2004, MAT SCI ENG R, V46, P51, DOI 10.1016/j.mser.2004.07.003; Pszona S, 2014, RADIAT PROT DOSIM, V161, P237, DOI 10.1093/rpd/nct274; SADAKA S, 1986, RADIAT PROT DOSIM, V16, P281, DOI 10.1093/oxfordjournals.rpd.a079758; Tanimura Y, 2014, RADIAT PROT DOSIM, V161, P144, DOI 10.1093/rpd/nct345; Trompier F, 2014, RADIAT PROT DOSIM, V161, P78, DOI 10.1093/rpd/nct275; Ziegler JF, 2010, NUCL INSTRUM METH B, V268, P1818, DOI 10.1016/j.nimb.2010.02.091	12	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157627	10.1371/journal.pone.0157627	http://dx.doi.org/10.1371/journal.pone.0157627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362656	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200021
J	Sawano, M; Kohsaka, S; Okamura, T; Inohara, T; Sugiyama, D; Shiraishi, Y; Watanabe, M; Nakamura, Y; Higashiyama, A; Kadota, A; Okuda, N; Murakami, Y; Ohkubo, T; Fujiyoshi, A; Miura, K; Okayama, A; Ueshima, H				Sawano, Mitsuaki; Kohsaka, Shun; Okamura, Tomonori; Inohara, Taku; Sugiyama, Daisuke; Shiraishi, Yasuyuki; Watanabe, Makoto; Nakamura, Yasuyuki; Higashiyama, Aya; Kadota, Aya; Okuda, Nagako; Murakami, Yoshitaka; Ohkubo, Takayoshi; Fujiyoshi, Akira; Miura, Katsuyuki; Okayama, Akira; Ueshima, Hirotsugu		Nippon Data 80 90 Res Grp	Independent Prognostic Value of Single and Multiple Non-Specific 12-Lead Electrocardiographic Findings for Long-Term Cardiovascular Outcomes: A Prospective Cohort Study	PLOS ONE			English	Article							ST-T ABNORMALITIES; CORONARY-HEART-DISEASE; 24-YEAR FOLLOW-UP; RISK PROFILE; MORTALITY; STROKE; ASSOCIATION; TRENDS; JAPAN; ECG	Aims The long-term prognostic effect of non-specific 12-lead electrocardiogram findings is unknown. We aimed to evaluate the cumulative prognostic impact of axial, structural, and repolarization categorical abnormalities on cardiovascular death, independent from traditional risk scoring systems such as the Framingham risk score and the NIPPON DATA80 risk chart. Methods and Results A total of 16,816 healthy men and women from two prospective, longitudinal cohort studies were evaluated. 3,794 (22.6%) individuals died during a median follow-up of 15 years (range, 2.0-24 years). Hazard ratios for cardiovascular death, all-cause death, coronary death and stroke death were calculated for the cumulative and independent axial, structural, and repolarization categorical abnormalities adjusted for the Framingham risk score and the NIPPON DATA80 risk chart. Individuals with two or more abnormal categories had a higher risk of cardiovascular death after adjustment for Framingham risk score (men: HR 4.27, 95% CI 3.35-5.45; women: HR 4.83, 95% CI 3.76-6.22) and NIPPON DATA80 risk chart (men: HR 2.39, 95% CI 1.87-3.07; women: HR 2.04, 95% CI 1.58-2.64). Conclusion Cumulative findings of axial, structural, and repolarization abnormalities are significant predictors of long-term cardiovascular death in asymptomatic, healthy individuals independent of traditional risk stratification systems.	[Sawano, Mitsuaki; Kohsaka, Shun; Inohara, Taku; Shiraishi, Yasuyuki] Keio Univ Hosp, Dept Cardiol, Tokyo, Japan; [Okamura, Tomonori; Sugiyama, Daisuke] Keio Univ, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Watanabe, Makoto] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Shiraishi, Yasuyuki] Kyoto Womens Univ, Dept Cardiovasc Epidemiol, Kyoto, Japan; [Higashiyama, Aya] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Osaka, Japan; [Kadota, Aya; Fujiyoshi, Akira; Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Shiga, Japan; [Okuda, Nagako] Univ Human Arts & Sci, Dept Hlth & Nutr, Saitama, Japan; [Murakami, Yoshitaka] Toho Univ, Sch Med, Dept Med Stat, Tokyo, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo, Japan; [Fujiyoshi, Akira; Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga, Japan; [Okayama, Akira] Res Inst Lifestyle Related Dis Prevent, Tokyo, Japan	Keio University; Keio University; National Cerebral & Cardiovascular Center - Japan; Kyoto Womens University; National Cerebral & Cardiovascular Center - Japan; Shiga University of Medical Science; Toho University; Teikyo University; Shiga University of Medical Science	Kohsaka, S (corresponding author), Keio Univ Hosp, Dept Cardiol, Tokyo, Japan.	kohsaka@cpnet.med.keio.jp	Sugiyama, Daisuke/L-4347-2013; Okamura, Tomonori/L-1693-2013	Sugiyama, Daisuke/0000-0002-6487-8934; Okamura, Tomonori/0000-0003-0488-0351; Okuda, Nagako/0000-0002-6893-0509; Ohkubo, Takayoshi/0000-0002-3283-8196; Fujiyoshi, Akira/0000-0002-5790-7119; Kohsaka, Shun/0000-0003-3779-2972	Ministry of Health, Labor, and Welfare; Health and Labor Sciences (Comprehensive Research on Aging and Health) [H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014]; Health and Labor Sciences (Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus) [H22-Jyunkankitou-Seisyu-Sitei-017, H25-Jyunkankitou-Seisyu-Sitei-022]; Japanese Association for Cerebro-Cardiovascular Disease Control	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Health and Labor Sciences (Comprehensive Research on Aging and Health); Health and Labor Sciences (Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus); Japanese Association for Cerebro-Cardiovascular Disease Control	This study was supported by a grant-in-aid from the Ministry of Health, Labor, and Welfare under the auspices of the Japanese Association for Cerebro-Cardiovascular Disease Control, a research grant for cardiovascular diseases (7A-2) from the Ministry of Health, Labor, and Welfare, and research grants from Health and Labor Sciences (Comprehensive Research on Aging and Health H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014; Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus H22-Jyunkankitou-Seisyu-Sitei-017 and H25-Jyunkankitou-Seisyu-Sitei-022).	Al-Zaiti SS, 2014, HEART LUNG, V43, P516, DOI 10.1016/j.hrtlng.2014.05.004; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; [Anonymous], 1978, J Chronic Dis, V31, P201; Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Chou R, 2011, ANN INTERN MED, V155, P375, DOI 10.7326/0003-4819-155-6-201109200-00006; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Daviglus ML, 1999, JAMA-J AM MED ASSOC, V281, P530, DOI 10.1001/jama.281.6.530; DAVIS TP, 1993, PROG CARDIOVASC DIS, V36, P245, DOI 10.1016/0033-0620(93)90017-8; De Leo V, 2000, MATURITAS, V36, P43, DOI 10.1016/S0378-5122(00)00123-7; Di Tullio MR, 1999, STROKE, V30, P2019, DOI 10.1161/01.STR.30.10.2019; Horibe H, 2005, J EPIDEMIOL, V15, P125, DOI 10.2188/jea.15.125; Inohara T, 2014, EUR J PREV CARDIOL, V21, P1501, DOI 10.1177/2047487313500568; Inohara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080853; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; Kita Y, 1999, INT J EPIDEMIOL, V28, P1059, DOI 10.1093/ije/28.6.1059; Kohsaka S, 2005, STROKE, V36, P2481, DOI 10.1161/01.STR.0000185682.09981.26; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189; Menotti A, 1997, G Ital Cardiol, V27, P40; Nakamura Y, 2013, J ELECTROCARDIOL, V46, P360, DOI 10.1016/j.jelectrocard.2013.03.009; Nakamura Y, 2012, CIRCULATION, V125, P1226, DOI 10.1161/CIRCULATIONAHA.111.070045; Ohira T, 2003, STROKE, V34, pE250, DOI 10.1161/01.STR.0000103742.83117.FB; Okamura T, 2003, J INTERN MED, V253, P169, DOI 10.1046/j.1365-2796.2003.01080.x; Okamura T, 2004, AM HEART J, V147, P1024, DOI 10.1016/j.ahj.2003.12.020; Prineas RI, 2010, MINNESOTA CODE MANUA, pxiii; Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population, 2006, CIRCULATION J OFFICI, V70, P1249; Rumana N, 2011, AM J CARDIOL, V107, P1718, DOI 10.1016/j.amjcard.2011.02.335; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Yamamoto T, 2008, CIRC J, V72, P545	31	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157563	10.1371/journal.pone.0157563	http://dx.doi.org/10.1371/journal.pone.0157563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362562	Green Submitted, gold, Green Published			2022-12-27	WOS:000378865200020
J	Wang, YQ; Zhang, YH; Ji, W; Yu, P; Wang, B; Li, JP; Han, MK; Xu, XX; Wang, ZM				Wang, Yunqi; Zhang, Yinghua; Ji, Wei; Yu, Peng; Wang, Bin; Li, Jinpeng; Han, Meikun; Xu, Xuexin; Wang, Zhimin			Cultivar Mixture Cropping Increased Water Use Efficiency in Winter Wheat under Limited Irrigation Conditions	PLOS ONE			English	Article							NORTH CHINA PLAIN; BARLEY VARIETY MIXTURES; GRAIN-YIELD; PHYSIOLOGICAL TRAITS; GENETIC-IMPROVEMENT; PLANT-COMMUNITIES; HENAN PROVINCE; PERFORMANCE; BIODIVERSITY; GROUNDWATER	The effects of cultivar mixture cropping on yield, biomass, and water use efficiency (WUE) in winter wheat (Triticum aestivum L.) were investigated under non-irrigation (W0, no irrigation during growth stage), one time irrigation (W1, irrigation applied at stem elongation) and two times irrigation (W2, irrigation applied at stem elongation and anthesis) conditions. Nearly 90% of cultivar mixture cropping treatments experienced an increase in grain yield as compared with the mean of the pure stands under W0, those for W1 and W2 were 80% and 85%, respectively. Over 75% of cultivar mixture cropping treatments got greater biomass than the mean of the pure stands under the three irrigation conditions. Cultivar mixture cropping cost more water than pure stands under W0 and W1, whereas the water consumption under W2 decreased by 5.9%-6.8% as compared with pure stands. Approximately 90% of cultivar mixtures showed an increase of 5.4%-34.5% in WUE as compared with the mean of the pure stands, and about 75% of cultivar mixtures had 0.8%-28.5% higher WUE than the better pure stands under W0. Similarly, there were a majority of mixture cropping treatments with higher WUE than the mean and the better one of the pure stands under W1 and W2. On the whole, proper cultivar mixture cropping could increase yield and WUE, and a higher increase in WUE occurred under limited irrigation condition.	[Wang, Yunqi; Zhang, Yinghua; Ji, Wei; Yu, Peng; Wang, Bin; Li, Jinpeng; Han, Meikun; Xu, Xuexin; Wang, Zhimin] China Agr Univ, Coll Agron, Beijing 100193, Peoples R China	China Agricultural University	Zhang, YH; Wang, ZM (corresponding author), China Agr Univ, Coll Agron, Beijing 100193, Peoples R China.	zhangyh1216@126.com; zhimin206@263.net	Zhang, Yinghua/HGE-7633-2022	Zhang, Yinghua/0000-0002-1356-6084; Wang, Zhimin/0000-0003-1325-2015; Wang, Yunqi/0000-0002-3377-9466	Special Fund for Agro-scientific Research in the Public Interest in China [201303133]; Science and Technology Innovation Program for Increase in Yield and Efficiency of Food Crop; National Natural Science Foundation of China [31401297]; Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3)	Special Fund for Agro-scientific Research in the Public Interest in China; Science and Technology Innovation Program for Increase in Yield and Efficiency of Food Crop; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3)	This study was supported by the Special Fund for Agro-scientific Research in the Public Interest in China (201303133), the Science and Technology Innovation Program for Increase in Yield and Efficiency of Food Crop, the National Natural Science Foundation of China (No. 31401297), and the Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Special Fund for Agro-scientific Research in the Public Interest in China (201303133), the Science and Technology Innovation Program for Increase in Yield and Efficiency of Food Crop, the National Natural Science Foundation of China (No. 31401297), and the Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3).	[Anonymous], 2002, SAS STAT VERS 9 0 US; Baker EFI, 1979, EXP AGR, V5, P41; BAKER RJ, 1984, CROP SCI, V24, P85, DOI 10.2135/cropsci1984.0011183X002400010019x; Biabani A, 2008, INT J PLANT PROD, V2, P215; Brooker RW, 2016, FUNCT ECOL, V30, P98, DOI 10.1111/1365-2435.12496; Brooker RW, 2015, NEW PHYTOL, V206, P107, DOI 10.1111/nph.13132; Doring TF, 2015, FIELD CROP RES, V183, P235, DOI 10.1016/j.fcr.2015.08.009; Ebeling A, 2014, BASIC APPL ECOL, V15, P229, DOI 10.1016/j.baae.2014.02.003; Fang Y, 2014, FIELD CROP RES, V156, P12, DOI 10.1016/j.fcr.2013.10.013; FREY KJ, 1967, CROP SCI, V7, P532, DOI 10.2135/cropsci1967.0011183X000700050037x; Ghosh PK, 2009, EUR J AGRON, V31, P43, DOI 10.1016/j.eja.2009.03.002; Gigot C, 2013, PLANT PATHOL, V62, P1011, DOI 10.1111/ppa.12012; HOEKSTRA GJ, 1985, CAN J PLANT SCI, V65, P481, DOI 10.4141/cjps85-069; Iqbal MA, 2014, AGR WATER MANAGE, V135, P61, DOI 10.1016/j.agwat.2013.12.012; JOKINEN K, 1991, J AGR SCI FINLAND, V63, P307; Kabululu MS, 2014, INT J VEG SCI, V20, P1; Kendy E, 2004, HYDROL PROCESS, V18, P2289, DOI 10.1002/hyp.5529; Kiaer LP, 2012, EUPHYTICA, V185, P123, DOI 10.1007/s10681-012-0640-1; Kiaer LP, 2009, FIELD CROP RES, V114, P361, DOI 10.1016/j.fcr.2009.09.006; Liu CM, 2001, WATER INT, V26, P265, DOI 10.1080/02508060108686913; MANTHEY R, 1993, CROP PROT, V12, P63, DOI 10.1016/0261-2194(93)90022-B; Marquard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075599; MARSHALL DR, 1973, EUPHYTICA, V22, P405, DOI 10.1007/BF00022654; Milbau A, 2005, FUNCT ECOL, V19, P27, DOI 10.1111/j.0269-8463.2005.00939.x; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Newton AC, 2002, EUPHYTICA, V125, P325, DOI 10.1023/A:1016052121581; PATTERSON FRED L., 1963, CROP SCI, V3, P558, DOI 10.2135/cropsci1963.0011183X000300060032x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Qin XL, 2015, FIELD CROP RES, V177, P117, DOI 10.1016/j.fcr.2015.03.013; Sharma RC, 1996, FIELD CROP RES, V48, P95, DOI 10.1016/S0378-4290(96)01031-3; SHIPLEY B, 1994, OIKOS, V69, P340, DOI 10.2307/3546158; Smith RG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102920, 10.1371/journal.pone.0097351]; Sun YY, 2014, FIELD CROP RES, V167, P1, DOI 10.1016/j.fcr.2014.07.002; Tian ZW, 2011, FIELD CROP RES, V124, P417, DOI 10.1016/j.fcr.2011.07.012; WALL GW, 1990, AGR FOREST METEOROL, V49, P81, DOI 10.1016/0168-1923(90)90044-7; Wilcox JR, 1998, PLANT DIS, V82, P303, DOI 10.1094/PDIS.1998.82.3.303; Wu HY, 2005, PROG NAT SCI-MATER, V15, P477; Wu W, 2014, EUPHYTICA, V196, P155, DOI 10.1007/s10681-013-1033-9; Xiao YG, 2012, CROP SCI, V52, P44, DOI 10.2135/cropsci2011.05.0246; Zhang XY, 2006, AGRON J, V98, P1620, DOI 10.2134/agronj2005.0358; Zhang XY, 2003, IRRIGATION SCI, V21, P159, DOI 10.1007/s00271-002-0059-x; Zhang YP, 2011, FIELD CROP RES, V123, P187, DOI 10.1016/j.fcr.2011.04.014; Zhang YQ, 2004, AGR WATER MANAGE, V64, P107, DOI 10.1016/S0378-3774(03)00201-4; Zheng TC, 2011, FIELD CROP RES, V122, P225, DOI 10.1016/j.fcr.2011.03.015; Zhou BW, 2014, J INTEGR PLANT BIOL, V56, P492, DOI 10.1111/jipb.12148; Zhou Y, 2007, EUPHYTICA, V157, P465, DOI 10.1007/s10681-007-9376-8; Zhou Y, 2007, CROP SCI, V47, P245, DOI 10.2135/cropsci2006.03.0175; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zuppinger-Dingley D, 2014, NATURE, V515, P108, DOI 10.1038/nature13869	50	10	10	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158439	10.1371/journal.pone.0158439	http://dx.doi.org/10.1371/journal.pone.0158439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362563	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200075
J	Alami, S; Hervouet, L; Poiraudeau, S; Briot, K; Roux, C				Alami, Sophie; Hervouet, Lucile; Poiraudeau, Serge; Briot, Karine; Roux, Christian			Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views	PLOS ONE			English	Article							HIP FRACTURE; OLDER WOMEN; RISK; MORTALITY; DENSITY; PRESCRIPTIONS; IMPACT; CARE	Background Only a minority of patients at high risk for osteoporotic fracture receive treatment. Objective Study patients' and physicians' views regarding postmenopausal osteoporosis (PMO) to identify impediments to good care. Methods A qualitative study involving 18 physicians and 37 women (age 57-87) with PMO. Results All women interviewed considered PMO to be somewhat normal wear-and-tear associated with old age. The women identified a large number of "causes" for osteoporosis but finally viewed it as chance. They all described its progression as slow. Three representations of PMO severity were identified: some women tended to interpreted it as benign (21), others tended to dramatize it (11), and the rest were uncertain (5). These representations did not appear linked to age or fracture. Even the women who associated fracture and PMO were uncertain of the link between them. Fractures were considered to be random events, independent of osteoporosis. Women received general life-style recommendations from their physicians positively, but did not connect them specifically to osteoporosis. Indeed, these recommendations, along with the fear of side effects, the absence of tangible results of treatments, the view of PMO as a natural process, and the representations of PMO severity are factors that may deter treatments and impact compliance. As for the physicians, they identified eight risk factors, recognizing menopause as central to PMO and recognized the link between risk of fracture and PMO. However, some considered the impact of fractures to be limited in time, and viewed PMO as a "benign" disease. Seeing the progression of PMO as slow and inevitable reduced their urgency to diagnose and treat it as compared to other diseases. Some physicians acknowledged limited mastery of the existing therapeutic arsenal and unsuccessful handling of patient compliance. Conclusion Women's and physicians' perspectives on PMO converged to trivialize postmenopausal osteoporosis and thus disqualify it as a legitimate disease. A better understanding of women's and physicians' views, practices, and concerns related to PMO can improve osteoporosis management.	[Alami, Sophie] Interlis, Paris, France; [Hervouet, Lucile] CNRS, Inst Sci Polit, Ctr Sociol Org, UMR 7116, Paris, France; [Poiraudeau, Serge; Briot, Karine; Roux, Christian] INSERM, U1153, Paris, France; [Poiraudeau, Serge; Briot, Karine; Roux, Christian] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Poiraudeau, Serge] Hop Cochin, AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, Paris, France; [Briot, Karine; Roux, Christian] Hop Cochin, AP HP, Serv Rhumatol B, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Alami, S (corresponding author), Interlis, Paris, France.	alami.sophie@noos.fr; christian.roux@aphp.fr	POIRAUDEAU, SERGE/P-5301-2016; Briot, Karine/P-2116-2016	Briot, Karine/0000-0002-6238-2601; Poiraudeau, Serge/0000-0002-1988-9124; , ALAMI/0000-0002-2999-8551	Association de Recherche Clinique en Rhumatologie, (ARCR), Paris, France; Merck Sharp and Dohme Laboratory	Association de Recherche Clinique en Rhumatologie, (ARCR), Paris, France; Merck Sharp and Dohme Laboratory	The study was funded by the Association de Recherche Clinique en Rhumatologie, (ARCR), 75006 Paris, France. The Association received a grant from Merck Sharp and Dohme Laboratory. ARCR hired Interlis (SA) to provide sociological expertise and conduct the qualitative survey. The funder (ARCR) provided support in the form of honoraries for authors (SA, LH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck Sharp and Dohme Laboratory had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Interlis has no financial conflict with the materials discussed in the manuscript.	Balasubramanian Akhila, 2014, J Bone Joint Surg Am, V96, pe52, DOI 10.2106/JBJS.L.01781; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bliuc D, 2013, J BONE MINER RES, V28, P2317, DOI 10.1002/jbmr.1968; Brody J. E., 2011, NY TIMES; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Fraser LA, 2011, OSTEOPOROSIS INT, V22, P789, DOI 10.1007/s00198-010-1359-2; Giangregorio L, 2006, SEMIN ARTHRITIS RHEU, V35, P293, DOI 10.1016/j.semarthrit.2005.11.001; Giangregorio L, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-38; Glaser B.G., 1968, DISCOV GROUNDED THEO; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Haynes RB, 1996, LANCET, V348, P383; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hoang-Kim A, 2014, ARCH ORTHOP TRAUM SU, V134, P207, DOI 10.1007/s00402-013-1799-1; Jennings LA, 2010, J AM GERIATR SOC, V58, P650, DOI 10.1111/j.1532-5415.2010.02769.x; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P1623, DOI 10.1007/s00198-011-1630-1; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Lyles KW, 2007, N ENGL J MED, V357; Majumdar SR, 2014, OSTEOPOROSIS INT, V25, P2173, DOI 10.1007/s00198-014-2728-z; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Meadows LM, 2007, OSTEOPOROSIS INT, V18, P159, DOI 10.1007/s00198-006-0213-z; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Peeters G, 2010, PHARMACOEPIDEMIOL AN, V23, P1303; Rimes KA, 2002, BEHAV RES THER, V40, P359, DOI 10.1016/S0005-7967(01)00015-8; Roux C., 2009, INT J CLIN RHEUMATOL, V4, P651; Sale JEM, 2014, OSTEOPOROSIS INT, V25, P2581, DOI 10.1007/s00198-014-2804-4; Sale JEM, 2014, OSTEOPOROSIS INT, V25, P281, DOI 10.1007/s00198-013-2405-7; Sale JEM, 2012, OSTEOPOROSIS INT, V23, P2829, DOI 10.1007/s00198-012-1914-0; Sambrook PN, 2010, MED J AUSTRALIA, V193, P154, DOI 10.5694/j.1326-5377.2010.tb03835.x; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Siris ES, 2011, OSTEOPOROSIS INT, V22, P27, DOI 10.1007/s00198-010-1211-8; Solomon DH, 2014, J BONE MINER RES, V29, P1929, DOI 10.1002/jbmr.2202; tain RPS of G, 1997, COMPLIANCE CONCORDAN; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; van Geel TACM, 2009, ANN RHEUM DIS, V68, P99, DOI 10.1136/ard.2008.092775; Wysowski DK, 2013, BONE, V57, P423, DOI 10.1016/j.bone.2013.09.008	44	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158365	10.1371/journal.pone.0158365	http://dx.doi.org/10.1371/journal.pone.0158365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355576	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400055
J	Le, DJ; Chung, DWD; Frausto, RF; Kim, MJ; Aldave, AJ				Le, Derek J.; Chung, Duk-Won D.; Frausto, Ricardo F.; Kim, Michelle J.; Aldave, Anthony J.			Identification of Potentially Pathogenic Variants in the Posterior Polymorphous Corneal Dystrophy 1 Locus	PLOS ONE			English	Article							GENE; MUTATIONS; CLASSIFICATION; EXCLUSION; FRAMEWORK; LINKAGE; VSX1; RNA	Posterior polymorphous corneal dystrophy 1 (PPCD1) is a genetic disorder that affects corneal endothelial cell function and leads to loss of visual acuity. PPCD1 has been linked to a locus on chromosome 20 in multiple families; however, Sanger sequencing of protein-coding genes in the consensus region failed to identify any causative missense mutations. In this study, custom capture probes were utilized for targeted next-generation sequencing of the linked region in a previously reported family with PPCD1. Variants were detected through two bioinformatics pipelines and filtered according to multiple criteria. Additionally, a high-resolution microarray was used to detect copy number variations. No non-synonymous variants in the protein-coding region of annotated genes were identified. However, 12 single nucleotide variants in 10 genes, and 9 indels in 7 genes met the filtering criteria and were considered candidate variants for PPCD1. Eleven single nucleotide variants were confirmed by Sanger sequencing, including 2 synonymous variants and 9 non-coding variants, in 9 genes. One microdeletion was detected in an intron of OVOL2 by microarray but was subsequently not identified by PCR. Using a comprehensive next-generation sequencing approach, a total of 16 genes containing single nucleotide variants or indels that segregated with the affected phenotype in an affected family previously mapped to the PPCD1 locus were identified. Screening of these candidate genes in other families previously mapped to the PPCD1 locus will likely result in the identification of the genetic basis of PPCD1.	[Le, Derek J.; Chung, Duk-Won D.; Frausto, Ricardo F.; Kim, Michelle J.; Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Aldave, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.	aldave@jsei.ucla.edu	Frausto, Ricardo/AAE-3146-2021	Frausto, Ricardo/0000-0003-3064-6745	National Eye Institute [R01EY022082, P30EY000331]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022082, P30EY000331] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The following are the sources of funding for this work: National Eye Institute (https://nei.nih.gov/), R01EY022082 (AJA), core grant P30EY000331; Research to Prevent Blindness (https://www.rpbusa.org/rpb/), unrestricted grant (AJA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2005, CORNEA, V24, P151, DOI 10.1097/01.ico.0000141235.26096.1d; Aldave AJ, 2013, JAMA OPHTHALMOL, V131, P1583, DOI 10.1001/jamaophthalmol.2013.5036; Aldave AJ, 2009, CORNEA, V28, P801, DOI 10.1097/ICO.0b013e31819672fb; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Frausto RF, 2016, CELL TRANSPLANT, V25, P1159, DOI 10.3727/096368915X688948; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Hosseini SM, 2008, MOL VIS, V14, P71; Jia DY, 2015, ONCOTARGET, V6, P15436, DOI 10.18632/oncotarget.3623; Jonsson F, 2015, HUM MUTAT, V36, P463, DOI 10.1002/humu.22764; Krachmer J H, 1985, Trans Am Ophthalmol Soc, V83, P413; LAGANOWSKI HC, 1991, CORNEA, V10, P224, DOI 10.1097/00003226-199105000-00008; Lai IN, 2010, MOL VIS, V16, P2829; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Oliver VF, 2016, OPHTHALMOLOGY, V123, P709, DOI 10.1016/j.ophtha.2015.12.008; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Watanabe K, 2014, DEV CELL, V29, P59, DOI 10.1016/j.devcel.2014.03.006; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Yellore VS, 2007, GENET MED, V9, P228, DOI 10.1097/GIM.0b013e31803c4dc2; Yellore VS, 2005, INVEST OPHTH VIS SCI, V46, P1599, DOI 10.1167/iovs.04-1321	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158467	10.1371/journal.pone.0158467	http://dx.doi.org/10.1371/journal.pone.0158467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355326	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400071
J	Rahman, MS; Howlader, T; Masud, MS; Rahman, ML				Rahman, M. Shafiqur; Howlader, Tamanna; Masud, Mohammad Shahed; Rahman, Mohammad Lutfor			Association of Low-Birth Weight with Malnutrition in Children under Five Years in Bangladesh: Do Mother's Education, Socio-Economic Status, and Birth Interval Matter?	PLOS ONE			English	Article							RISK-FACTORS; PRESCHOOL-CHILDREN; NUTRITIONAL-STATUS; DETERMINANTS; DHAKA; PREVALENCE; INFANTS; SLUMS; CITY; AGE	Background Malnutrition in children under five years remains a significant problem in Bangladesh, despite substantial socio-economic progress and a decade of interventions aimed at improving it. Although several studies have been conducted to identify the important risk factors of malnutrition, none of them assess the role of low birth weight (LBW) despite its high prevalence (36%). This study examines the association between LBW and malnutrition using data from the Bangladesh Demographic and Health Survey (BDHS) 2011 and provides practical guidelines for improving nutritional status of children. Methods Malnutrition in children is measured in terms of their height-for-age, weight-for-height, and weight-for-age. Children whose Z-scores for either of these indices are below two standard deviations (-2SD) from median of WHO's reference population are considered as stunted, wasted or underweight, respectively. The association between malnutrition and LBW was investigated by calculating adjusted risk-ratio (RR), which controls for potential confounders such as child's age and sex, mother's education and height, length of preceding-birth-interval, access to food, area of residence, household socio-economic status. Adjusted RR was calculated using both Cochran-Mantel-Haenszel approach and multivariable logistic regression models controlling for confounder. Results The prevalence of malnutrition was markedly higher in children with LBW than those with normal birth-weights (stunting: 51% vs 39%; wasting: 25% vs 14% and underweight: 52% vs 33%). While controlling for the known risk factors, children with LBW had significantly increased risk of becoming malnourished compared to their counter part with RR 1.23 (95% CI: 1.16-1.30), 1.71 (95% CI: 1.53-1.92) and 1.47 (95% CI: 1.38-1.56) for stunting, wasting and underweight, respectively. The observed associations were not modified by factors known to reduce the prevalence of malnutrition, such as higher education of mother, better household socio-economic conditions and longer birth-interval. Conclusions Higher education of mother, better household socio-economic conditions and prolonged birth intervals alone are not sufficient in bringing about substantial reductions in prevalence of child malnutrition in Bangladesh. Targeted interventions should be designed to reduce prevalence of LBW in addition to improving mother's education and other socio-demographic conditions.	[Rahman, M. Shafiqur; Howlader, Tamanna; Masud, Mohammad Shahed; Rahman, Mohammad Lutfor] Univ Dhaka, Inst Stat Res & Training, Dhaka 1000, Bangladesh	University of Dhaka	Rahman, MS (corresponding author), Univ Dhaka, Inst Stat Res & Training, Dhaka 1000, Bangladesh.	shafiq@isrt.ac.bd		Masud, Mohammad/0000-0003-3939-1021				Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; Ahmed T, 2009, BMJ-BRIT MED J, V339, P1060; ALAM N, 1989, AM J CLIN NUTR, V49, P884, DOI 10.1093/ajcn/49.5.884; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Anand D, 2003, ARCH DIS CHILD, V88, P135, DOI 10.1136/adc.88.2.135; Arifeen SE, 2000, AM J CLIN NUTR, V72, P1010; Balci MM, 2010, INT J CARDIOL, V144, P110, DOI 10.1016/j.ijcard.2008.12.111; Bangladesh Bureau of Statistics, 2004, NAT LOW BIRTH WEIGHT; Beiersmann C, 2013, J TROP PEDIAT, V59; Correia LL, 2014, REV SAUDE PUBL, V48, P19, DOI 10.1590/S0034-8910.2014048004828; Das S, 2008, P PAK ACAD SCI, V62, P137; Dhar B, 2002, J HEALTH POPUL NUTR, V20, P36; Directorate General of Health Services, 2014, HLTH B; Ergin F, 2007, TURKISH J PEDIATR, V49, P283; GRANTHAMMCGREGOR S, 1995, J NUTR, V125, pS2233; Gulati JK, 2010, ANTHROPOLOGIST, V12, P131, DOI 10.1080/09720073.2010.11891143; Haque SMR, 2015, PUBLIC HLTH RES, V5, P184; Hossain M, 2015, FINANCIAL EXPRESS; Islam MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-11; Jesmin A, 2011, J HEALTH POPUL NUTR, P29; Jesmin A, 2011, J HEALTH POPUL NUTR, V29, P494; Kabubo-Mariara J, 2009, J AFR EC, V18; Khanal V, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-32; Khanam R, 2011, J BIOSOC SCI, V43, P437, DOI 10.1017/S0021932011000149; Khattak M, 2010, J MED SCI, V10; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Masiye F, 2010, ZAMBIA SOC SCI J, V1; Mishra K, 2014, INDIAN J PEDIATR, V81, P762, DOI 10.1007/s12098-013-1127-3; Motta Maria Eugênia Farias Almeida, 2005, J. Pediatr. (Rio J.), V81, P377, DOI 10.1590/S0021-75572005000600007; Mozumder ABMKA, 2000, J BIOSOC SCI, V32, P289, DOI 10.1017/S0021932000002893; National Institute of Population Research and Training (NIPORT) Mitra and Associates ICF International, 2011, BANGL DEM HLTH SURV; Nations United, 2015, MILL DEV GOALS REP 2; Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Rahman A, 2007, J BIOSOC SCI, V39, P161, DOI 10.1017/S0021932006001295; Rahman A, 2009, ASIA-PAC J PUBLIC HE, V21, P294, DOI 10.1177/1010539509335399; Rahman M. S., 2007, Pakistan Journal of Nutrition, V6, P286; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Rasmussen K, 2001, J NUTR, V131, P601; Rattan V, 1997, WOMEN CHILD DEV SUST; Rayhan MI, 2006, PAK J NUTR, V5, P558, DOI [DOI 10.3923/PJN.2006.558.562, 10.3923/pjn.2006.558.562]; Romero CX, 2012, J HEALTH CARE POOR U, V23, P604, DOI 10.1353/hpu.2012.0065; Smith LC, 1999, EXPLAINING CHILD MAL; Sreeramareddy CT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-403; Tin TT, 1994, J REPROD HLTH, V12, P32; UNICEF East Asia & Pacific Regional Office, 2003, STRAT RED MAT CHILD; W.H. Organization, 2009, WORLD HLTH STAT 2009; WHO, 2006, WHO CHILD GROWTH STA; Wong HJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-785	49	100	102	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157814	10.1371/journal.pone.0157814	http://dx.doi.org/10.1371/journal.pone.0157814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355682	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400019
J	Avey, MT; Griffin, G				Avey, Marc T.; Griffin, Gilly			Pedagogical Merit Review of Animal Use for Education in Canada	PLOS ONE			English	Review							DATA SATURATION	There are two components to the review of animal based protocols in Canada: review for the merit of the study itself, and review of the ethical acceptability of the work. Despite the perceived importance for the quality assurance these reviews provide; there are few studies of the peer-based merit review system for animal-based protocols for research and education. Institutional animal care committees (ACC)s generally rely on the external peer review of scientific merit for animal-based research. In contrast, peer review for animal based teaching/training is dependent on the review of pedagogical merit carried out by the ACC itself or another committee within the institution. The objective of this study was to evaluate the views of ACC members about current practices and policies as well as alternate policies for the review of animal based teaching/training. We conducted a national web-based survey of ACC members with both quantitative and qualitative response options. Responses from 167 ACC members indicated broad concerns about administrative burden despite strong support for both the current and alternate policies. Participants' comments focused mostly on the merit review process (54%) relative to the efficiency (21%), impact (13%), and other (12%) aspects of evaluation. Approximately half (49%) of the comments were classified into emergent themes that focused on some type of burden: burden from additional pedagogical merit review (16%), a limited need for the review (12%), and a lack of resources (expertise 11%; people/money 10%). Participants indicated that the current system for pedagogical merit review is effective (60%); but most also indicated that there was at least some challenge (86%) with the current peer review process. There was broad support for additional guidance on the justification, criteria, types of animal use, and objectives of pedagogical merit review. Participants also supported the ethical review and application of the Three Rs in the review process. A clear priority from participants in the survey was updating guidance to better facilitate the merit review process of animal-based protocols for education. Balancing the need for improved guidance with the reality of limited resources at local institutions will be essential to do this successfully; a familiar dilemma to both scientists and policy makers alike.	[Avey, Marc T.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Avey, Marc T.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Griffin, Gilly] Canadian Council Anim Care, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Avey, MT (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.; Avey, MT (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	mavey@ohri.ca		Avey, Marc/0000-0002-8696-3232	Canadian Institutes of Health Research; Institute of Health Services [KPD 130840]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Health Services	This work was supported by Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca/e/193.html; Directed Grant to the Canadian Council on Animal Care, http://webapps.cihr-irsc.gc.ca/funding/detail_e?pResearchId=5722651& and Institute of Health Services and Policy Research (grant number KPD 130840) to Dr. Marc T. Avey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen I.E., 2007, QUAL PROG, V40, P64, DOI DOI 10.1111/J.1365-2929.2004.02012.X; Board NS, 2014, REDUCING INVESTIGATO, P98; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; Carifio J., 2007, J SOCIAL SCI, V3, P106, DOI DOI 10.3844/JSSP.2007.106.116; CCAC, 2006, TERMS REF AN CAR COM; CCAC, 2000, CCAC POL IMP IND PEE; CCAC, 2013, MAND AND PURP; CCAC, 1989, ETH AN INV; CCAC, 2008, POL STAT SEN ADM RES; CCAC, 1997, CCAC GUID AN US PROT; CCAC, 1996, CCAC INT B; CCAC, 2010, FREQ ASK QUEST CCAC; Demicheli V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000003.pub2; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Fenwick N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022478; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Jefferson T, 2007, Cochrane Database Syst Rev, pMR000016; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Litwin M.S., 1995, MEASURE SURVEY RELIA, DOI 10.4135/9781483348957; Morgan D., 2008, SAGE ENCY QUALITATIV, P816, DOI 10.4135/9781412963909; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Pal Leslie A, 2006, POLICY ANAL PUBLIC I	23	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158002	10.1371/journal.pone.0158002	http://dx.doi.org/10.1371/journal.pone.0158002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352243	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900024
J	Brandt, C; Thronicke, A; Roehmel, JF; Krannich, A; Staab, D; Schwarz, C				Brandt, Claudia; Thronicke, Anja; Roehmel, Jobst F.; Krannich, Alexander; Staab, Doris; Schwarz, Carsten			Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FEV1 DECLINE; INFLAMMATION; ASTHMA; COPD; BRONCHODILATORS; STRATEGIES; EFFICACY; OUTCOMES; ALPHA	Background Chronic lung disease is the leading cause of death in patients with Cystic Fibrosis (CF) and is often treated with bronchodilators. It is not known whether long-term tiotropium bromide treatment may have a positive impact on lung function. Methods This retrospective cohort study estimated annual lung function decline utilizing longitudinal data for forced expiratory volume in 1 s (FEV1). Results A total of 160 adult patients with CF were analyzed. The subjects treated for 24 months with tiotropium bromide had a significantly slower decline of mean annual change of FEV1 (treated: -0.3 +/- 4.0%; control: -2.3 +/- 5.0%; p = 0.0130). In patients with FEV1 >= 70% predicted, long-term tiotropium bromide treatment was associated with greater improvements in annual lung function decline (FEV1 >= 70% predicted: treated: +0.5 +/- 4.7%; control: -4.0 +/- 6.3%; p = 0.0132; FEV1 50-69% predicted: treated: -0.5 +/- 4.4%; control: -0.8 +/- 3.8%; p = 0.7142; FEV1 <= 49% predicted: treated: -0.6 +/- 3.4%; control: -2.4 +/- 4.8%; p = 0.0898). Conclusion This study suggests that long-term tiotropium bromide treatment may be associated with reduced annual decline of FEV1 in patients with CF, particularly in adults with a mild degree of severity.	[Brandt, Claudia; Thronicke, Anja; Roehmel, Jobst F.; Staab, Doris; Schwarz, Carsten] Charite, Dept Pediat Pneumol & Immunol, Cyst Fibrosis Ctr, Augustenburger Pl 1, D-13353 Berlin, Germany; [Krannich, Alexander] Charite, Biostat Unit, Berlin Inst Hlth, Augustenburger Pl 1, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schwarz, C (corresponding author), Charite, Dept Pediat Pneumol & Immunol, Cyst Fibrosis Ctr, Augustenburger Pl 1, D-13353 Berlin, Germany.	carsten.schwarz@charite.de	Schwarz, Carsten/AAE-9576-2022; Thronicke, Anja/AAR-2482-2021; Thronicke, Anja/AAZ-3508-2020; Krannich, Alexander/AAR-1285-2021; Krannich, Alexander/N-9221-2015; Schwarz, Carsten/AFE-4586-2022	Krannich, Alexander/0000-0002-4025-6495; Krannich, Alexander/0000-0002-4025-6495; Roehmel, Jobst/0000-0002-1535-8852				Adam D, 2015, J PATHOL, V235, P408, DOI 10.1002/path.4471; Bateman Eric, 2010, Int J Chron Obstruct Pulmon Dis, V5, P197; Bhatt JM, 2013, EUR RESPIR REV, V22, P205, DOI 10.1183/09059180.00006512; Bilton D, 2011, J CYST FIBROS, V10, pS79, DOI 10.1016/S1569-1993(11)60012-X; Bradley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106195; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Chopra R, 2015, EXPERT OPIN DRUG SAF, V14, P401, DOI 10.1517/14740338.2015.994503; Colombo JL, 2003, CURR OPIN PULM MED, V9, P504, DOI 10.1097/00063198-200311000-00010; Cropp GJ, 1996, AM J MED, V100, pS19, DOI 10.1016/S0002-9343(96)80049-0; Cui Y, 2010, EUR RESPIR J, V35, P1370, DOI 10.1183/09031936.00139909; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Ferguson GT, 2015, ADV THER, V32, P523, DOI 10.1007/s12325-015-0218-0; Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73; Halfhide C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003428.pub2; Johnson C, 2003, CHEST, V123, P20, DOI 10.1378/chest.123.1.20; Kallet RH, 2013, RESP CARE, V58, P702, DOI 10.4187/respcare.02412; Kang JY, 2012, ANN ALLERG ASTHMA IM, V109, P29, DOI 10.1016/j.anai.2012.05.005; Keam Susan J, 2004, Treat Respir Med, V3, P247, DOI 10.2165/00151829-200403040-00005; Kerem E, 2014, EUR RESPIR J, V43, P125, DOI 10.1183/09031936.00166412; King SJ, 2014, CLIN NUTR, V33, P150, DOI 10.1016/j.clnu.2013.04.012; Konstan MW, 2015, J AEROSOL MED PULM D, V28, P137, DOI 10.1089/jamp.2013.1115; Konstan MW, 2012, J CYST FIBROS, V11, P405, DOI 10.1016/j.jcf.2012.03.009; Konstan MW, 2011, PEDIATR PULM, V46, P545, DOI 10.1002/ppul.21388; Konstan MW, 1999, PEDIATR PULM, V28, P248, DOI 10.1002/(SICI)1099-0496(199910)28:4<248::AID-PPUL3>3.0.CO;2-N; Liou TG, 2010, J CYST FIBROS, V9, P250, DOI 10.1016/j.jcf.2010.04.002; McCuaig S, 2013, LANCET RESP MED, V1, P137, DOI 10.1016/S2213-2600(12)70058-9; Montuschi Paolo, 2006, Int J Chron Obstruct Pulmon Dis, V1, P409, DOI 10.2147/copd.2006.1.4.409; Moser BK, 1989, COMMUNICATIONS STA A, V18; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Ratjen F, 2015, J CYSTIC FIBROSIS OF; Ratjen FA, 2009, RESP CARE, V54, P595, DOI 10.4187/aarc0427; Regamey N, 2011, THORAX, V66, P624, DOI 10.1136/thx.2009.134106; Sharma A, 2014, PULM PHARMACOL THER, V29, P217, DOI 10.1016/j.pupt.2014.08.004; Stanojevic S, 2015, EUR RESPIR J, V46, P262, DOI 10.1183/09031936.00187314; Tashkin D, 2003, CHEST, V123, P1441, DOI 10.1378/chest.123.5.1441; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158193	10.1371/journal.pone.0158193	http://dx.doi.org/10.1371/journal.pone.0158193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351829	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900042
J	Samaan, Z; Vaz, SM; Bawor, M; Potter, TH; Eskandarian, S; Loeb, M				Samaan, Zainab; Vaz, Stephanie McDermid; Bawor, Monica; Potter, Tammy Hlywka; Eskandarian, Sasha; Loeb, Mark			Neuropsychological Impact of West Nile Virus Infection: An Extensive Neuropsychiatric Assessment of 49 Cases in Canada	PLOS ONE			English	Article							VERBAL-LEARNING TEST; STRESS SCALES DASS; NORMATIVE DATA; FOLLOW-UP; NEW-YORK; MULTIPLE-SCLEROSIS; MEMORY; ENCEPHALITIS; DEPRESSION; IMPAIRMENT	Background West Nile virus emerged as an important human pathogen in North America and continues to pose a risk to public health. It can cause a highly variable range of clinical manifestations ranging from asymptomatic to severe illness. Neuroinvasive disease due to West Nile virus can lead to long-term neurological deficits and psychological impairment. However, these deficits have not been well described. The objective of this study was to characterize the neuropsychological manifestations of West Nile virus infection with a focus on neuroinvasive status and time since infection. Methods Patients from Ontario Canada with a diagnosis of neuroinvasive disease (meningitis, encephalitis, or acute flaccid paralysis) and non-neuroinvasive disease who had participated in a cohort study were enrolled. Clinical and laboratory were collected, as well as demographics and medical history. Cognitive functioning was assessed using a comprehensive battery of neuropsychological tests. Results Data from 49 individuals (32 with West Nile fever and 17 with West Nile neuroinvasive disease) were included in the present cross-sectional analysis. Patterns of neuropsychological impairment were comparable across participants with both neuroinvasive and non-neuroinvasive West Nile virus infection on all cognitive measures. Neuropsychiatric impairment was also observed more frequently at two to four years post-infection compared to earlier stages of illness. Conclusions Our data provide objective evidence for cognitive difficulties among patients who were infected with West Nile virus; these deficits appear to manifest regardless of severity of West Nile virus infection (West Nile fever vs. West Nile neuroinvasive disease), and are more prevalent with increasing illness duration (2-4 years vs. 1 month). Data from this study will help inform patients and healthcare providers about the expected course of recovery, as well as the need to implement effective treatment strategies that include neuropsychological interventions.	[Samaan, Zainab; Vaz, Stephanie McDermid] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Samaan, Zainab; Eskandarian, Sasha; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Samaan, Zainab; Bawor, Monica] McMaster Univ, Chanchlani Res Ctr, Populat Genom Program, Hamilton, ON, Canada; [Vaz, Stephanie McDermid] St Josephs Healthcare, Cleghorn Early Intervent Psychosis Program, Hamilton, ON, Canada; [Bawor, Monica] McMaster Univ, MiNDS Neurosci Grad Program, Hamilton, ON, Canada; [Potter, Tammy Hlywka; Loeb, Mark] McMaster Univ, Div Infect Dis, Hamilton, ON, Canada; [Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Loeb, M (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Div Infect Dis, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	loebm@mcmaster.ca	samaan, z/J-4289-2012					Anastasiadou A, 2013, INT J INFECT DIS, V17, pE494, DOI 10.1016/j.ijid.2012.12.006; [Anonymous], 1989, INSTR GROOV PEGB TES; [Anonymous], 2003, MMWR MORB MORTAL WKL, DOI DOI 10.15585/MMWR.MM7121-1; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Benton A.L., 1994, CONTRIBUTIONS NEUROP; Benton AL, 1976, MULTILINGUAL APHASIA; Berg Patti J, 2010, S D Med, V63, P127; Berner YN, 2002, J AM GERIATR SOC, V50, P1844, DOI 10.1046/j.1532-5415.2002.505402.x; Brandt J., 2001, HOPKINS VERBAL LEARN; Bravo G, 2002, J AM GERIATR SOC, V50, P740, DOI 10.1046/j.1532-5415.2002.50172.x; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Buchanan RW, 2005, SCHIZOPHRENIA BULL, V31, P5, DOI 10.1093/schbul/sbi020; Carey CL, 2004, CLIN NEUROPSYCHOL, V18, P234, DOI 10.1080/13854040490501448; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P37; Couderc T, 2002, J GEN VIROL, V83, P1925, DOI 10.1099/0022-1317-83-8-1925; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; de Jager CA, 2003, PSYCHOL MED, V33, P1039, DOI 10.1017/S0033291703008031; Einarsson U, 2003, CLIN REHABIL, V17, P294, DOI 10.1191/0269215503cr611oa; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Golden C. J., 2002, STROOP COLOR WORD TE; Golden CJ, 1978, STROOP COLOR WORD TE; Gottfried K, 2005, SOUTH MED J, V98, P603, DOI 10.1097/01.SMJ.0000155633.43244.AC; Grace J, 2007, PARKINSONISM RELAT D, V13, P443, DOI 10.1016/j.parkreldis.2006.09.001; Groth-Marnat G, 2000, NEUROPSYCHOLOGICAL A, P129; Haaland KY, 2006, EMERG INFECT DIS, V12, P1260, DOI 10.3201/eid1708.060097; Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248; Hayes CG, 1989, ARBOVIRUSES EPIDEMIO, VV, P59; Hughes C, 1999, J CHILD PSYCHOL PSYC, V40, P705, DOI 10.1017/S0021963099004023; IWASAKI Y, 1986, ACTA NEUROPATHOL, V70, P79, DOI 10.1007/BF00689518; Johnson Richard T, 2002, Curr Neurol Neurosci Rep, V2, P496, DOI 10.1007/s11910-002-0035-0; Kavanagh D, 1987, INT J CLIN NEUROPSYC; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; Loeb M, 2008, ANN INTERN MED, V149, P232, DOI 10.7326/0003-4819-149-4-200808190-00004; Lynch W, 2004, J HEAD TRAUMA REHAB, V19, P277, DOI 10.1097/00001199-200405000-00008; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mead LA, 2002, J INT NEUROPSYCH SOC, V8, P735, DOI 10.1017/S1355617702860015; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; MORRIS RG, 1988, J NEUROL NEUROSUR PS, V51, P757, DOI 10.1136/jnnp.51.6.757; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murray KO, 2007, EMERG INFECT DIS, V13, P479, DOI 10.3201/eid1303.060602; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Ng VWK, 2000, HUM BRAIN MAPP, V10, P80, DOI 10.1002/(SICI)1097-0193(200006)10:2<80::AID-HBM40>3.0.CO;2-2; Nolan MS, 2012, J CLIN PSYCHOL, V68, P801, DOI 10.1002/jclp.21871; Ou Alan C, 2005, J La State Med Soc, V157, P42; Patnaik JL, 2006, EMERG INFECT DIS, V12, P1129, DOI 10.3201/eid1207.051399; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; PHAC: Public Health Agency of Canada, 2007, HUM W NIL VIR CAS AS; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Ryan JJ, 2001, ARCH CLIN NEUROPSYCH, V16, P151, DOI 10.1016/S0887-6177(99)00061-X; Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918; Sampson BA, 2001, ANN NY ACAD SCI, V951, P172; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Smith A., 1982, SYMBOL DIGIT MODALIT; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Strauss E., 2006, COMPENDIUM NEUROPSYC; SUGAMATA M, 1992, J VIROL, V66, P1252, DOI 10.1128/JVI.66.2.1252-1260.1992; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010; Wechsler D., 1997, WAIS 3 ADM SCORING M; West R, 1997, NEUROPSYCHOLOGY, V11, P421, DOI 10.1037/0894-4105.11.3.421; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Zilmer E, 2004, TOWER OF LONDON DX	77	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158364	10.1371/journal.pone.0158364	http://dx.doi.org/10.1371/journal.pone.0158364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352145	gold, Green Submitted, Green Published			2022-12-27	WOS:000378858900056
J	Chen, YA; Prabhudesai, V; Castel, H; Gupta, S				Chen, Yingming Amy; Prabhudesai, Vikramaditya; Castel, Helene; Gupta, Samir			CT Scan Does Not Differentiate Patients with Hepatopulmonary Syndrome from Other Patients with Liver Disease	PLOS ONE			English	Article							INTRAPULMONARY VASCULAR DILATATIONS; AIRWAY WALL THICKNESS; HIGH-RESOLUTION CT; HYPERDYNAMIC CIRCULATION; TRANSPLANT CANDIDATES; LUNG-FUNCTION; NITRIC-OXIDE; ECHOCARDIOGRAPHY; OPTIMIZATION; CIRRHOSIS	Background Hepatopulmonary syndrome (HPS) is defined by liver dysfunction, intrapulmonary vascular dilatations, and impaired oxygenation. The gold standard for detection of intrapulmonary vascular dilatations in HPS is contrast echocardiography. However, two small studies have suggested that patients with HPS have larger segmental pulmonary arterial diameters than both normal subjects and normoxemic subjects with cirrhosis, when measured by CT. We sought to compare CT imaging-based pulmonary vasodilatation in patients with HPS, patients with liver dysfunction without HPS, and matching controls on CT imaging. Methods We performed a retrospective cohort study at two quaternary care Canadian HPS centers. We analyzed CT thorax scans in 23 patients with HPS, 29 patients with liver dysfunction without HPS, and 52 gender- and age-matched controls. We measured the artery-bronchus ratios (ABRs) in upper and lower lung zones, calculated the "delta ABR" by subtracting the upper from the lower ABR, compared these measurements between groups, and correlated them with clinically relevant parameters (partial pressure of arterial oxygen, alveolar-arterial oxygen gradient, macroaggregated albumin shunt fraction, and diffusion capacity). We repeated measurements in patients with post-transplant CTs. Results Patients had significantly larger lower zone ABRs and delta ABRs than controls (1.20 +/- 0.19 versus 0.98 +/- 0.10, p<0.01; and 0.12 +/- 0.17 versus -0.06 +/- 0.10, p<0.01, respectively). However, there were no significant differences between liver disease patients with and without HPS, nor any significant correlations between CT measurements and clinically relevant parameters. There were no significant changes in ABRs after liver transplantation (14 patients). Conclusions Basilar segmental artery-bronchus ratios are larger in patients with liver disease than in normal controls, but this vasodilatation is no more severe in patients with HPS. CT does not distinguish patients with HPS from those with uncomplicated liver disease.	[Chen, Yingming Amy; Prabhudesai, Vikramaditya] Univ Toronto, St Michaels Hosp, Dept Med Imaging, Toronto, ON, Canada; [Castel, Helene] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Gupta, Samir] Univ Toronto, St Michaels Hosp, Dept Med, Div Respirol, Toronto, ON, Canada; [Gupta, Samir] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Universite de Montreal; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Gupta, S (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Div Respirol, Toronto, ON, Canada.; Gupta, S (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	guptas@smh.ca		Chen, Yingming Amy/0000-0001-5315-8328	Department of Medicine of the University of Toronto; Li Ka Shing Research Institute of St. Michael's Hospital; Michael Locke Chair in Rare Lung Disease and Knowledge Translation Research	Department of Medicine of the University of Toronto; Li Ka Shing Research Institute of St. Michael's Hospital; Michael Locke Chair in Rare Lung Disease and Knowledge Translation Research	Dr. Gupta is supported by the Department of Medicine of the University of Toronto, The Li Ka Shing Research Institute of St. Michael's Hospital, and the Michael Locke Chair in Rare Lung Disease and Knowledge Translation Research.	ABRAMS GA, 1995, GASTROENTEROLOGY, V109, P1283, DOI 10.1016/0016-5085(95)90589-8; Awadh N, 1998, THORAX, V53, P248, DOI 10.1136/thx.53.4.248; Battaglia SE, 1997, HEPATOLOGY, V25, P1228, DOI 10.1002/hep.510250527; Castro M, 1996, CLIN CHEST MED, V17, P35, DOI 10.1016/S0272-5231(05)70297-5; Evert R, 1999, TRANSPLANT INT, V12, P222; Fallon MB, 2000, HEPATOLOGY, V32, P859, DOI 10.1053/jhep.2000.7519; Fallon MB, 2008, GASTROENTEROLOGY, V135, P1168, DOI 10.1053/j.gastro.2008.06.038; Fritz JS, 2013, AM J RESP CRIT CARE, V187, P133, DOI 10.1164/rccm.201209-1583CI; Gupta S, 2010, AM J TRANSPLANT, V10, P354, DOI 10.1111/j.1600-6143.2009.02822.x; Hughes JMB, 2005, EUR RESPIR J, V25, P211, DOI 10.1183/09031936.04.00095604; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Jaffe TA, 2006, RADIOLOGY, V238, P292, DOI 10.1148/radiol.2381050404; KIM SJ, 1995, J COMPUT ASSIST TOMO, V19, P365, DOI 10.1097/00004728-199505000-00005; Koksal D, 2006, J CLIN GASTROENTEROL, V40, P77; KROWKA MJ, 1990, CHEST, V97, P1165, DOI 10.1378/chest.97.5.1165; KROWKA MJ, 1993, CHEST, V104, P515, DOI 10.1378/chest.104.2.515; Lee KN, 1999, RADIOLOGY, V211, P549, DOI 10.1148/radiology.211.2.r99ma46549; Lima BLG, 2004, MAYO CLIN PROC, V79, P42, DOI 10.4065/79.1.42; Little SA, 2002, THORAX, V57, P247, DOI 10.1136/thorax.57.3.247; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Martinez-Palli G, 2006, WORLD J GASTROENTERO, V12, P5878, DOI 10.3748/wjg.v12.i36.5878; Matsuoka S, 2003, AM J ROENTGENOL, V180, P513, DOI 10.2214/ajr.180.2.1800513; McAdams HP, 1996, AM J ROENTGENOL, V166, P1379, DOI 10.2214/ajr.166.6.8633451; Mincewicz G, 2012, BRIT J RADIOL, V85, P1093, DOI 10.1259/bjr/74259914; Nakano Y, 2002, CHEST, V122, p271S, DOI 10.1378/chest.122.6_suppl.271S-a; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Rasaratnam B, 2004, CLIN SCI, V107, P425, DOI 10.1042/CS20040157; Rodriguez-Roisin R, 2004, EUR RESPIR J, V24, P861, DOI 10.1183/09031936.04.00010904; RODRIGUEZROISIN R, 1992, THORAX, V47, P897, DOI 10.1136/thx.47.11.897; Rolla G, 2004, DIGEST LIVER DIS, V36, P303, DOI 10.1016/j.dld.2003.12.016; Tanikella R, 2008, LIVER TRANSPLANT, V14, P1199, DOI 10.1002/lt.21482; Webb WR, 2009, HIGH RESOLUTION CT L, V4th; West JB., 2008, WESTS RESP PHYSL ESS, V9th	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158637	10.1371/journal.pone.0158637	http://dx.doi.org/10.1371/journal.pone.0158637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384058	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400071
J	Hirata, Y; Amigo, JM; Matsuzaka, Y; Yokota, R; Mushiake, H; Aihara, K				Hirata, Yoshito; Amigo, Jose M.; Matsuzaka, Yoshiya; Yokota, Ryo; Mushiake, Hajime; Aihara, Kazuyuki			Detecting Causality by Combined Use of Multiple Methods: Climate and Brain Examples	PLOS ONE			English	Article							STRUCTURAL EQUATION MODELS; PAST 800,000 YEARS; TIME-SERIES; CORTICOCORTICAL CONNECTIONS; COUPLING DIRECTIONS; GRANGER CAUSALITY; RECURRENCE PLOTS; SYSTEMS; NETWORK; PREDICTION	Identifying causal relations from time series is the first step to understanding the behavior of complex systems. Although many methods have been proposed, few papers have applied multiple methods together to detect causal relations based on time series generated from coupled nonlinear systems with some unobserved parts. Here we propose the combined use of three methods and a majority vote to infer causality under such circumstances. Two of these methods are proposed here for the first time, and all of the three methods can be applied even if the underlying dynamics is nonlinear and there are hidden common causes. We test our methods with coupled logistic maps, coupled Rossler models, and coupled Lorenz models. In addition, we show from ice core data how the causal relations among the temperature, the CH4 level, and the CO2 level in the atmosphere changed in the last 800,000 years, a conclusion also supported by irregularly sampled data analysis. Moreover, these methods show how three regions of the brain interact with each other during the visually cued, two-choice arm reaching task. Especially, we demonstrate that this is due to bottom up influences at the beginning of the task, while there exist mutual influences between the posterior medial prefrontal cortex and the presupplementary motor area. Based on our results, we conclude that identifying causality with an appropriate ensemble of multiple methods ensures the validity of the obtained results more firmly.	[Hirata, Yoshito; Yokota, Ryo; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan; [Amigo, Jose M.] Univ Miguel Hernandez, Ctr Invest Operat, Avda Univ S-N, Elche 03202, Spain; [Matsuzaka, Yoshiya; Mushiake, Hajime] Tohoku Univ, Sch Med, Dept Physiol, 2-1 Seiryo Machi Aoba Ku, Sendai, Miyagi 9808575, Japan	University of Tokyo; Universidad Miguel Hernandez de Elche; Tohoku University	Hirata, Y (corresponding author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	yoshito@sat.t.u-tokyo.ac.jp	Amigo, Jose/B-2217-2008; Hirata, Yoshito/L-9297-2018	Amigo, Jose/0000-0002-1642-1171; Hirata, Yoshito/0000-0002-9245-2543; Mushiake, Hajime/0000-0002-5130-4720	Aihara Innovative Mathematical Modelling Project of the Japanese Society for the Promotion of Science (JSPS); JSPS KAKENHI [15H05707]; CREST, JST; Spanish Ministry of Economy and Competitiveness [MTM2012-31698]; World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living Systems) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [15H05871] Funding Source: KAKEN	Aihara Innovative Mathematical Modelling Project of the Japanese Society for the Promotion of Science (JSPS); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Spanish Ministry of Economy and Competitiveness(Spanish Government); World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living Systems) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Aihara Innovative Mathematical Modelling Project of the Japanese Society for the Promotion of Science (JSPS), through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP), and by the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living Systems) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Agency for Medical Research and Development (AMED). This work was also partially supported by JSPS KAKENHI Grant Number 15H05707 and CREST, JST. J.M.A. was supported by the Spanish Ministry of Economy and Competitiveness, Project MTM2012-31698.	Arnhold J, 1999, PHYSICA D, V134, P419, DOI 10.1016/S0167-2789(99)00140-2; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Chen YH, 2004, PHYS LETT A, V324, P26, DOI 10.1016/j.physleta.2004.02.032; Chen ZT, 2013, NEURAL COMPUT, V25, P1605, DOI 10.1162/NECO_a_00444; DeGroot M.H., 2002, PROBABILITY STAT; Donges JF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48007; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Feldhoff JH, 2012, PHYS LETT A, V376, P3504, DOI 10.1016/j.physleta.2012.10.008; Furl N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00253; Gershenfeld N., 1999, NATURE MATH MODELING; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hirata Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016203; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Hoyer PO, 2008, INT J APPROX REASON, V49, P362, DOI 10.1016/j.ijar.2008.02.006; Hyvarinen A, 2013, J MACH LEARN RES, V14, P111; Hyvarinen A, 2010, J MACH LEARN RES, V11, P1709; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kang J, 2014, THEOR APPL CLIMATOL, V116, P537, DOI 10.1007/s00704-013-0960-7; Lo LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138596; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; LUPPINO G, 1990, EXP BRAIN RES, V82, P214; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; Ma HF, 2014, SCI REP-UK, V4, DOI 10.1038/srep07464; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Matsuzaka Y, 2012, P NATL ACAD SCI USA, V109, P4633, DOI 10.1073/pnas.1119971109; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MEES A, 1992, PHYS LETT A, V169, P41, DOI 10.1016/0375-9601(92)90802-S; Monetti R, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022911; Nawrath J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038701; Palus M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046211; Palus M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056211; Romano MC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036211; Rosenblum MG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.045202; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Schiff SJ, 1996, PHYS REV E, V54, P6708, DOI 10.1103/PhysRevE.54.6708; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Shimizu S, 2014, J MACH LEARN RES, V15, P2629; Stark J, 1999, J NONLINEAR SCI, V9, P255, DOI 10.1007/s003329900072; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; van Nes EH, 2015, NAT CLIM CHANGE, V5, P445, DOI [10.1038/nclimate2568, 10.1038/NCLIMATE2568]; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Winterhalder M, 2007, INT J BIFURCAT CHAOS, V17, P3735, DOI 10.1142/S0218127407019664; Zou Y, 2011, INT J BIFURCAT CHAOS, V21, P1099, DOI 10.1142/S0218127411029033	50	24	24	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158572	10.1371/journal.pone.0158572	http://dx.doi.org/10.1371/journal.pone.0158572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380515	Green Published, gold			2022-12-27	WOS:000379798700034
J	Khan, AL; Al-Harrasi, A; Al-Rawahi, A; Al-Farsi, Z; Al-Mamari, A; Waqas, M; Asaf, S; Elyassi, A; Mabood, F; Shin, JH; Lee, IJ				Khan, Abdul Latif; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed; Al-Farsi, Zainab; Al-Mamari, Aza; Waqas, Muhammad; Asaf, Sajjad; Elyassi, Ali; Mabood, Fazal; Shin, Jae-Ho; Lee, In-Jung			Endophytic Fungi from Frankincense Tree Improves Host Growth and Produces Extracellular Enzymes and Indole Acetic Acid	PLOS ONE			English	Article							STRESS TOLERANCE; PLANT-GROWTH; DIVERSITY; BIOSYNTHESIS; PHYLLOPLANE; CAPABILITY; BACTERIA; TISSUE	Boswellia sacra, an economically important frankincense-producing tree found in the desert woodlands of Oman, is least known for its endophytic fungal diversity and the potential of these fungi to produce extracellular enzymes and auxins. We isolated various fungal endophytes belonging to Eurotiales (11.8%), Chaetomiaceae (17.6%), Incertae sadis (29.5%), Aureobasidiaceae (17.6%), Nectriaceae (5.9%) and Sporomiaceae (17.6%) from the phylloplane (leaf) and caulosphere (stem) of the tree. Endophytes were identified using genomic DNA extraction, PCR amplification and sequencing the internal transcribed spacer regions, whereas a detailed phylogenetic analysis of the same gene fragment was made with homologous sequences. The endophytic colonization rate was significantly higher in the leaf (5.33%) than the stem (0.262%). The Shannon-Weiner diversity index was H' 0.8729, while Simpson index was higher in the leaf (0.583) than in the stem (0.416). Regarding the endophytic fungi's potential for extracellular enzyme production, fluorogenic 4-methylum-belliferone standards and substrates were used to determine the presence of cellulases, phosphatases and glucosidases in the pure culture. Among fungal strains, Penicillum citrinum BSL17 showed significantly higher amounts of glucosidases (62.15 +/- 1.8 mu M(-1)min(-1)mL) and cellulases (62.11 +/- 1.6 mu M(-1)min(-1)mL), whereas Preussia sp. BSL10 showed significantly higher secretion of glucosidases (69.4 +/- 0.79 mu M(-1)min(-1)mL) and phosphatases (3.46 +/- 0.31 mu M(-1)min(-1)mL) compared to other strains. Aureobasidium sp. BSS6 and Preussia sp. BSL10 showed significantly higher potential for indole acetic acid production (tryptophan-dependent and independent pathways). Preussia sp. BSL10 was applied to the host B. sacra tree saplings, which exhibited significant improvements in plant growth parameters and accumulation of photosynthetic pigments. The current study concluded that endophytic microbial resources producing extracellular enzymes and auxin could establish a unique niche for ecological adaptation during symbiosis with the host Frankincense tree.	[Khan, Abdul Latif; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed; Al-Farsi, Zainab; Al-Mamari, Aza; Elyassi, Ali; Mabood, Fazal] Univ Nizwa, UoN Chair Omans Med Plants & Marine Nat Prod, Nizwa, Oman; [Waqas, Muhammad; Asaf, Sajjad; Shin, Jae-Ho; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Waqas, Muhammad] Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan	University of Nizwa; Kyungpook National University	Al-Harrasi, A (corresponding author), Univ Nizwa, UoN Chair Omans Med Plants & Marine Nat Prod, Nizwa, Oman.; Lee, IJ (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	aharrasi@unizwa.edu.om; ijlee@knu.ac.kr	Asaf, Sajjad/ABA-3647-2021; Mabood, Fazal/L-4868-2019; Lee, In-Jung/GLS-0432-2022	Lee, In-Jung/0000-0001-7154-4820; Khan, Abdul Latif/0000-0001-9700-8903	Open Research Grant Project [ORG/EBR/15/007]; National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-Science Research Program [2014R1A1A2A10058022]; Oman Research Council	Open Research Grant Project; National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-Science Research Program(National Research Foundation of Korea); Oman Research Council(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This work was financially supported by the Oman Research Council, Open Research Grant Project (ORG/EBR/15/007) and by National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-Science Research Program (2014R1A1A2A10058022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by the Oman Research Council, Open Research Grant Project ( ORG/EBR/15/ 007) and by National Research Foundation of Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic- Science Research Program (2014R1A1A2A10058022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenal F, 2007, FUNGAL DIVERS, V25, P1; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Bacon CW, 2000, MICROBIAL ENDOPHYTES, P28; Bischoff KM, 2009, CURR MICROBIOL, V58, P499, DOI 10.1007/s00284-008-9353-z; Castillo P, 2015, HANDBOOK FOR AZOSPIRILLUM: TECHNICAL ISSUES AND PROTOCOLS, P115, DOI 10.1007/978-3-319-06542-7_7; Coppi A, 2010, GENET RESOUR CROP EV, V57, P1041, DOI 10.1007/s10722-010-9546-8; Del Prada R, 2006, MYCOL RES, V110, P511, DOI 10.1016/j.mycres.2005.08.013; El-Nagerabi S. A. F., 2014, Biodiversitas: Journal of Biological Diversity, V15, P24; Esteves AC, 2014, CAN J MICROBIOL, V60, P332, DOI 10.1139/cjm-2014-0134; Farah MH, 2008, PROQUEST; Fouda AH, 2015, ANN AGR SCI; Garcia A, 2012, BIOL RES, V45, P139, DOI 10.4067/S0716-97602012000200006; Gazis R, 2015, FUNGAL ECOL, V17, P18, DOI 10.1016/j.funeco.2015.04.001; Gebrehiwot K, 2003, INT FOREST REV, V5, P348, DOI 10.1505/IFOR.5.4.348.22661; Ghimire SR, 2011, FUNGAL DIVERS, V47, P19, DOI 10.1007/s13225-010-0085-6; Correa RCG, 2014, J IND MICROBIOL BIOT, V41, P1467, DOI 10.1007/s10295-014-1496-2; Gunatilaka AAL, 2006, J NAT PROD, V69, P509, DOI 10.1021/np058128n; Han ML, 2016, FUNGAL DIVERS, V80, P343, DOI 10.1007/s13225-016-0364-y; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hoffman MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073132; Hofstetter RW, 2005, J CHEM ECOL, V31, P539, DOI 10.1007/s10886-005-2035-4; Huang Q, 2015, RES MICROBIOL, V166, P45, DOI 10.1016/j.resmic.2014.12.004; Huang WY, 2009, FUNGAL DIVERS, V36, P69; Khan AL, 2016, ELECTRON J BIOTECHN, V21, P58, DOI 10.1016/j.ejbt.2016.02.001; Khan AL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-86; Khan AL, 2015, J HAZARD MATER, V295, P70, DOI 10.1016/j.jhazmat.2015.04.008; Khan AL, 2014, SCI HORTIC-AMSTERDAM, V175, P167, DOI 10.1016/j.scienta.2014.06.008; Khan AL, 2015, CRIT REV BIOTECHNOL, V35, P62, DOI 10.3109/07388551.2013.800018; Khan AL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-3; Khan SA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-231; Kim YB, 2009, TREE PHYSIOL, V29, P737, DOI 10.1093/treephys/tpp002; Kumar DSS, 2004, FUNGAL DIVERS, V17, P69; Kusari S, 2012, METABOLOMICS, P241; Limtong S, 2014, WORLD J MICROB BIOT, V30, P1785, DOI 10.1007/s11274-014-1602-7; Liu XL, 2007, FOOD CHEM, V105, P548, DOI 10.1016/j.foodchem.2007.04.008; Ludwig-Muller J, 2015, BIOTECHNOL LETT, V37, P1325, DOI 10.1007/s10529-015-1814-4; Lumyong S, 2002, CAN J MICROBIOL, V48, P1109, DOI 10.1139/W02-112; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Marx MC, 2001, SOIL BIOL BIOCHEM, V33, P1633, DOI 10.1016/S0038-0717(01)00079-7; Mercado-Blanco J., 2014, CURR BIOTECHNOL, V3, P60, DOI [10.2174/22115501113026660038, DOI 10.2174/22115501113026660038]; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Pandey SS, 2016, PLANTA, V243, P1097, DOI 10.1007/s00425-016-2467-9; Park YS, 2002, PLANTA MED, V68, P397, DOI 10.1055/s-2002-32090; Pedraza RO, 2009, EUR J SOIL BIOL, V45, P36, DOI 10.1016/j.ejsobi.2008.09.007; Petrini Orlando, 1992, Natural Toxins, V1, P185, DOI 10.1002/nt.2620010306; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; Ritpitakphong U, 2016, NEW PHYTOL, V210, P1033, DOI 10.1111/nph.13808; Robl D, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-94; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Sakayaroj J, 2010, FUNGAL DIVERS, V42, P27, DOI 10.1007/s13225-009-0013-9; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Soussi A, 2015, PLANT SOIL, V28, P1; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Sun PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114196; Sun Y, 2011, MYCOSPHERE, V2, P239; Sunitha V. H., 2013, World Journal of Agricultural Sciences, V9, P1; Takahashi M, 2012, CARCINOGENESIS, V33, P2441, DOI 10.1093/carcin/bgs286; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THULIN M, 1987, Kew Bulletin, V42, P487, DOI 10.2307/4110063; Tolera M, 2013, FOREST ECOL MANAG, V304, P65, DOI 10.1016/j.foreco.2013.04.036; Ueda H, 2015, APPL MICROBIOL BIOT, V99, P6405, DOI 10.1007/s00253-015-6523-3; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Yan JF, 2015, FUNGAL ECOL, V13, P53, DOI 10.1016/j.funeco.2014.07.005; Zhao S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00024	68	72	77	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158207	10.1371/journal.pone.0158207	http://dx.doi.org/10.1371/journal.pone.0158207			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359330	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200048
J	Larsen, KT; Huang, T; Ried-Larsen, M; Andersen, LB; Heidemann, M; Moller, NC				Larsen, Kristian Traberg; Huang, Tao; Ried-Larsen, Mathias; Andersen, Lars Bo; Heidemann, Malene; Moller, Niels Christian			A Multi-Component Day-Camp Weight-Loss Program Is Effective in Reducing BMI in Children after One Year: A Randomized Controlled Trial	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK; OVERWEIGHT CHILDREN; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; HEART; INTERVENTION; ADIPOSITY; REDUCTION; COHORT	The objective of the present study was to evaluate the effectiveness of a one-year multi-component immersive day-camp weight-loss intervention for children with overweight and obesity. The study design was a parallel-group randomized controlled trial. One hundred fifteen 11-13-year-old children with overweight and obesity were randomized into either: A six-week day-camp intervention arm focusing on increased physical activity, and healthy diet followed by a subsequent one-year family-based intervention, or a standard intervention arm consisting of one weekly exercise session for six weeks. Body mass index (BMI) was the primary outcome. BMI z-score, clustered cardiovascular risk z-score, and body composition were secondary outcomes. All outcomes were measured at baseline, six week-, and 52 week follow-up. After six weeks, children from the day-camp intervention arm had improved their BMI (-2.2 kg/m(2) (95% CI -2.6 to -1.7, P<0.001)) and all secondary outcomes when compared to the children from the standard intervention arm. After 52 weeks, the day-camp intervention arm had a lower BMI (-1.2 kg/m(2) (95% CI -1.8 to -0.5, P = 0.001)), and BMI z-score (-0.20 (95% CI -0.35 to -0.05, P = 0.008)), and clustered cardiovascular risk z-score (-0.23 (95% CI -0.37 to -0.08, P = 0.002)) compared to the standard intervention arm. No group differences were detected in body composition after 52 weeks. This study shows that the day-camp intervention arm is effective in reducing BMI and improving the metabolic health of children with overweight and obesity. However, the effects seem to be diminishing over time.	[Larsen, Kristian Traberg; Huang, Tao; Andersen, Lars Bo; Moller, Niels Christian] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Ctr Res Childhood Hlth RICH, Odense, Denmark; [Ried-Larsen, Mathias] Rigshosp, Danish Diabet Acad, CIM, Copenhagen, Denmark; [Ried-Larsen, Mathias] Rigshosp, Danish Diabet Acad, Ctr Phys Activ Res CFAS, Copenhagen, Denmark; [Andersen, Lars Bo] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway; [Heidemann, Malene] Hosp Lillebaelt, Dept Pediat, Kolding, Denmark; [Ried-Larsen, Mathias] Danish Diabet Acad, Odense, Denmark	University of Southern Denmark; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Norwegian School of Sport Sciences; University of Southern Denmark	Larsen, KT (corresponding author), Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Ctr Res Childhood Hlth RICH, Odense, Denmark.	ktlarsen@health.sdu.dk	Heidemann, Malene/AAE-1754-2019; Ried-Larsen, Mathias/GPX-7640-2022; Larsen, Kristian Traberg/J-3975-2015	Ried-Larsen, Mathias/0000-0002-8388-5291; Moller, Niels Christian/0000-0001-5842-5595; Larsen, Kristian Traberg/0000-0002-3918-6645	Trygfonden [7-11-0700]; municipality of Odense	Trygfonden; municipality of Odense	Co-author Lars Bo Andersen has received the funding from Trygfonden (https://www.trygfonden.dk/english), Grant number: 7-11-0700. URL: http://www.trygfonden.dk/Om-TrygFonden/In-English The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the significant support from the municipality of Odense, especially, Mette Morkenborg and Mie Hansen for making a huge effort to run the camps and support children and parents participating in the intervention program. Acknowledgments also go to Kirsten Kjaer, Dorte Mengers Flindt, and Ulrik Frandsen for assistance with blood sampling and analyses, and to Eleanor Boyle for statistical guidance. The authors acknowledge all participants in the study, as well as the many school nurses involved in the project. We also thank the members of the OOIS Steering Committee for their advice and support. Finally, the authors acknowledge the tenacious work of the test personnel.	Accurso EC, 2014, CHILD OBES, V10, P392, DOI 10.1089/chi.2014.0023; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Astrup Arne V, 2005, Ugeskr Laeger, V167, P2296; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001; Brambilla P, 2011, INT J OBESITY, V35, P16, DOI 10.1038/ijo.2010.255; Carraway ME, 2014, CHILD OBES, V10, P122, DOI 10.1089/chi.2013.0111; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 2005, EUR J CLIN NUTR, V59, P419, DOI 10.1038/sj.ejcn.1602090; Cooper Christopher, 2006, Surg Obes Relat Dis, V2, P622, DOI 10.1016/j.soard.2006.07.010; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Ford AL, 2010, ARCH DIS CHILD, V95, P256, DOI 10.1136/adc.2009.165340; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gately PJ, 2000, INT J OBESITY, V24, P1445, DOI 10.1038/sj.ijo.0801405; Gately PJ, 2005, PEDIATRICS, V116, P73, DOI 10.1542/peds.2004-0397; Huelsing J, 2010, PEDIATRICS, V125, pE884, DOI 10.1542/peds.2009-1007; I'Allemand D, 2008, OBESITY, V16, P1672, DOI 10.1038/oby.2008.259; Jensen CD, 2012, OBESITY, V20, P2250, DOI 10.1038/oby.2012.96; Juhola J, 2013, CIRCULATION, V128, P217, DOI 10.1161/CIRCULATIONAHA.113.001614; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kelly KP, 2011, OBES REV, V12, P37, DOI 10.1111/j.1467-789X.2009.00710.x; Larsen KT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-313; Magnussen CG, 2012, J AM COLL CARDIOL, V60, P1631, DOI 10.1016/j.jacc.2012.05.056; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meucci M, 2013, WORLD J PEDIATR, V9, P307, DOI 10.1007/s12519-013-0440-2; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Reinehr T, 2013, NAT REV ENDOCRINOL, V9, P607, DOI 10.1038/nrendo.2013.149; Savoye M, 2007, JAMA-J AM MED ASSOC, V297, P2697, DOI 10.1001/jama.297.24.2697; Schein EH, 1996, SYST PRACTICE, V9, P27, DOI 10.1007/BF02173417; Schwingshandl J, 1999, ARCH DIS CHILD, V81, P426, DOI 10.1136/adc.81.5.426; Shukla AP, 2015, J CARDIOPULM REHABIL, V35, P81, DOI 10.1097/HCR.0000000000000112; Skinner AC, 2016, CHILD OBES, V12, P155, DOI 10.1089/chi.2015.0222; SOUTHAM MA, 1984, ADOLESCENCE, V19, P855; Tershakovec AM, 2003, OBES RES, V11, P17, DOI 10.1038/oby.2003.4; Twisk J, 2013, J CLIN EPIDEMIOL, V66, P1022, DOI 10.1016/j.jclinepi.2013.03.017; van Hoek E, 2014, CHILD OBES, V10, P448, DOI 10.1089/chi.2013.0149; Walker LLM, 2003, INT J OBESITY, V27, P748, DOI 10.1038/sj.ijo.0802290; Williamson DA, 2006, OBESITY, V14, P1231, DOI 10.1038/oby.2006.140; ZWIAUER KFM, 1992, INT J OBESITY, V16, P11	43	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157182	10.1371/journal.pone.0157182	http://dx.doi.org/10.1371/journal.pone.0157182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362497	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200008
J	Carvalho, PS; Almeida, LR; Neto, JHA; Medina, ACQD; Menezes, ACS; Sousa, JF; Oliveira, SS; Camargo, AJ; Napolitano, HB				Carvalho, Paulo S., Jr.; Almeida, Leonardo R.; Araujo Neto, Joao H.; Medina, Ana Carolina Q. D.; Menezes, Antonio C. S.; Sousa, Jose. F.; Oliveira, Solemar S.; Camargo, Ademir J.; Napolitano, Hamilton B.			Structural and Theoretical Investigation of Anhydrous 3,4,5-Triacetoxybenzoic Acid	PLOS ONE			English	Article							GALLIC ACID; TRIMESIC ACID; CRYSTAL-STRUCTURES; PYROMELLITIC ACID; ORGANIC-SYNTHESIS; POLYMORPHISM; DENSITY; COMPLEX; SURFACE; ESTERS	A comprehensive investigation of anhydrous form of 3,4,5-Triacetoxybenzoic acid (TABA) is reported. Single crystal X-ray diffraction, Thermal analysis, Fourier Transform Infrared spectroscopy (FTIR) and DFT calculations were applied for TABA characterization. This anhydrous phase crystallizes in the triclinic P (1) over bar space group (Z' = 1) and its packing shows a supramolecular motif in a classical R-2(2)(4)ring formed by acid-acid groups association. The phase stability is accounted in terms of supramolecular architecture and its thermal behaviour. Conformation search at B3LYP/6-311++ G(2d,p) level of theory shows the existence of three stable conformers and the most stable conformation was found experimentally. The reactivity of TABA was investigated using the molecular orbital theory and molecular electrostatic potential. The calculation results were used to simulate the infrared spectrum. There is a good agreement between calculated and experimental IR spectrum, which allowed the assignment of the normal vibrational modes	[Carvalho, Paulo S., Jr.; Almeida, Leonardo R.; Medina, Ana Carolina Q. D.] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil; [Carvalho, Paulo S., Jr.; Almeida, Leonardo R.; Araujo Neto, Joao H.; Menezes, Antonio C. S.; Sousa, Jose. F.; Oliveira, Solemar S.; Camargo, Ademir J.; Napolitano, Hamilton B.] Univ Estadual Goias, Ciencias Exatas & Tecnol, BR-75132400 Anapolis, Go, Brazil; [Araujo Neto, Joao H.] Univ Fed Sao Carlos, Dept Quim, BR-13565905 Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Goias; Universidade Federal de Sao Carlos	Napolitano, HB (corresponding author), Univ Estadual Goias, Ciencias Exatas & Tecnol, BR-75132400 Anapolis, Go, Brazil.	hamilton@ueg.br	Napolitano, Hamilton Barbosa/ABC-1986-2020; Oliveira, Solemar/AAP-8936-2021; CAMARGO, ADEMIR JOÃO/B-7001-2013; Carvalho Jr, Paulo S./G-8049-2016; Menezes, Antonio Carlos Severo/AAJ-7903-2021; Honorato, João/Q-1094-2019	Oliveira, Solemar/0000-0003-2892-3109; CAMARGO, ADEMIR JOÃO/0000-0001-9016-222X; Carvalho Jr, Paulo S./0000-0002-5551-9155; Menezes, Antonio Carlos Severo/0000-0001-8484-315X; Honorato, João/0000-0002-1127-6083; Almeida, Leonardo/0000-0002-6737-0642	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [313070/2014-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (BR) [12/05616-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (BR)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 313070/2014-8 Dr. Hamilton Barbosa Napolitano and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (BR) 12/05616-7 Dr. Paulo S. Carvalho Jr.	Aakeroy CB, 2005, CRYSTENGCOMM, V7, P439, DOI 10.1039/b505883j; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; [Anonymous], 2009, GAUSSVIEW VERS; [Anonymous], HYPERCHEM PROF 7 5 1; [Anonymous], 2015, ADV MICROBIOLOGY, DOI [10.4236/aim.2015.57053, DOI 10.4236/AIM.2015.57053]; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BERNSTEIN J, 1993, J PHYS D APPL PHYS, V26, pB66, DOI 10.1088/0022-3727/26/8B/010; Bernstein J., 2020, POLYMORPHISM MOL CRY, VVolume 30; Braun DE, 2013, CRYST GROWTH DES, V13, P19, DOI 10.1021/cg301506x; Cacialli F, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00186-5; Chen J, 2011, CRYST GROWTH DES, V11, P887, DOI 10.1021/cg101556s; Clarke HD, 2011, CRYST GROWTH DES, V11, P964, DOI 10.1021/cg2001865; Desiraju GR, 2010, J CHEM SCI, V122, P667, DOI 10.1007/s12039-010-0055-2; DESIRAJU GR, 1995, ANGEW CHEM INT EDIT, V34, P2311, DOI 10.1002/anie.199523111; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Du M, 2005, CRYST GROWTH DES, V5, P1247, DOI 10.1021/cg0495680; Ermer O, 2012, HELV CHIM ACTA, V95, P872, DOI 10.1002/hlca.201200017; Frisch G. W., 2013, GAUSSIAN 09; Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w; Hilfiker R., 2006, RELEVANCE SOLID STAT, P1; Hsu FL, 2007, APPL MICROBIOL BIOT, V74, P659, DOI 10.1007/s00253-006-0692-z; Kaur R., 2014, INT J PHARM SCI REV, V28, P16; Kaur R, 2014, CRYST GROWTH DES, V14, P423, DOI 10.1021/cg4018807; Kaur R, 2012, CRYST GROWTH DES, V12, P2744, DOI 10.1021/cg300536n; KROES BH, 1992, PLANTA MED, V58, P499, DOI 10.1055/s-2006-961535; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li ZH, 2007, ACTA CRYSTALLOGR E, V63, po1167, DOI 10.1107/S1600536807004916; Locatelli C, 2013, EUR J MED CHEM, V60, P233, DOI 10.1016/j.ejmech.2012.10.056; Lu JJ, 2007, SEP PURIF TECHNOL, V55, P40, DOI 10.1016/j.seppur.2006.10.022; Lu LL, 2007, J CHEM ENG DATA, V52, P37, DOI 10.1021/je0601661; Macrae CF, 2006, J APPL CRYSTALLOGR, V39, P453, DOI [10.1107/S002188980600731X, 10.1107/S0021 88980600731X]; Mark A. S., 2013, PHYS SCR, V87, DOI 10.1088/0031-8949/87/04/048103; Martins ICB, 2016, CRYST GROWTH DES, V16, P154, DOI 10.1021/acs.cgd.5b01057; Merrick JP, 2007, J PHYS CHEM A, V111, P11683, DOI 10.1021/jp073974n; Miller SPFRAS, 2006, SCI CONSIDERATIONS P, P385; Nangia Ashwini, 2007, Journal of the Indian Institute of Science, V87, P133; NARAYSZABO G, 1995, CHEM REV, V95, P829, DOI 10.1021/cr00036a002; Rajput L, 2010, CRYST GROWTH DES, V10, P4565, DOI 10.1021/cg100862y; Reutzel-Edens SM, 2000, J CHEM SOC PERK T 2, V5, P913; Sartori G, 2004, CHEM REV, V104, P199, DOI 10.1021/cr0200769; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SJOBERG P, 1990, J PHYS CHEM-US, V94, P3959, DOI 10.1021/j100373a017; Spackman MA, 2002, CRYSTENGCOMM, V4, P378, DOI 10.1039/b203191b; Spackman MA, 2009, CRYSTENGCOMM, V11, P19, DOI 10.1039/b818330a; Vishweshwar P, 2006, CRYST GROWTH DES, V6, P2429, DOI 10.1021/cg060349j; Wolff S, 2007, CRYSTALEXPLORER 2 1	46	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158029	10.1371/journal.pone.0158029	http://dx.doi.org/10.1371/journal.pone.0158029			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355378	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400024
J	Pomper, R; Saffran, JR				Pomper, Ron; Saffran, Jenny R.			Roses Are Red, Socks Are Blue: Switching Dimensions Disrupts Young Children's Language Comprehension	PLOS ONE			English	Article							EXECUTIVE FUNCTION; COGNITIVE CONTROL; BROCAS AREA; PERSEVERATION; DISSOCIATION; FLEXIBILITY; AMBIGUITY; TASKS; AGE	Language is used to identify objects in many different ways. An apple can be identified using its name, color, and other attributes. Skilled language comprehension requires listeners to flexibly shift between different dimensions. We asked whether this shifting would be difficult for 3-year-olds, who have relatively immature executive function skills and struggle to switch between dimensions in card sorting tasks. In the current experiment, children first heard a series of sentences identifying objects using a single dimension (either names or colors). In the second half of the experiment, the labeling dimension was switched. Children were significantly less accurate in fixating the correct object following the dimensional switch. This disruption, however, was temporary; recognition accuracy recovered with increased exposure to the new labeling dimension. These findings provide the first evidence that children's difficulty in shifting between dimensions impacts their ability to comprehend speech. This limitation may affect children's ability to form rich, multi-dimensional representations when learning new words.	[Pomper, Ron; Saffran, Jenny R.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pomper, R (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	ron.pomper@wisc.edu	Pomper, Ron/AAT-2166-2021	Pomper, Ron/0000-0001-5595-4192	National Institute of Child Health and Human Development [T32HD049899, R37HD037466, P30HD03352]; National Institute on Deafness and Other Communication Disorders [T32DC005359-11]; James F. McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD037466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC005359] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); James F. McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by the following: National Institute of Child Health and Human Development (www.nichd. nih.gov) Grants funding RP (T32HD049899, PI Maryellen MacDonald), JRS (R37HD037466), and the Waisman Center (P30HD03352); National Institute on Deafness and Other Communication Disorders (www.nidcd.nih.gov) Grant funding RP (T32DC005359-11, PI Susan Ellis-Weismer); and James F. McDonnell Foundation (www.jsmf.org) Grant to JRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson RP, 1997, PSYCHOL METHODS, V2, P315, DOI 10.1037/1082-989X.2.4.315; Akshoomoff N, 2014, NEUROPSYCHOLOGY, V28, P1, DOI 10.1037/neu0000001; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barr DJ, 2008, J MEM LANG, V59, P457, DOI 10.1016/j.jml.2007.09.002; Blakey E, 2015, CHILD DEV; Borovsky A, 2014, J MEM LANG, V73, P1, DOI 10.1016/j.jml.2014.02.001; Borovsky A, 2012, J EXP CHILD PSYCHOL, V112, P417, DOI 10.1016/j.jecp.2012.01.005; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Chevalier N, 2014, DEV NEUROPSYCHOL, V39, P585, DOI 10.1080/87565641.2014.973497; Chevalier N, 2010, DEV PSYCHOL, V46, P955, DOI 10.1037/a0019674; Copland DA, 2007, BRAIN RES, V1131, P163, DOI 10.1016/j.brainres.2006.11.016; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI [10.1093/acprof:oso/9780195134971.003.0029, DOI 10.1093/ACPROF:OSO/9780195134971.003.0029, /10.1093/acprof:oso/9780195134971.003.0029]; Diamond A., 2006, LIFESPAN COGNITION M, P70, DOI [10.1093/acprof:oso/9780195169539.003.0006, DOI 10.1093/ACPROF:OSO/9780195169539.003.0006]; Dunn LM, 2007, SUMM SHUTE I, V30, P1, DOI DOI 10.1037/T15144-000; Fedorenko E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00335; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; Fernald A, 2008, DEVELOPMENTAL PSYCHOLINGUISTICS: ON-LINE METHODS IN CHILDREN'S LANGUAGE PROCESSING, P97; Grindrod CM, 2008, BRAIN RES, V1229, P167, DOI 10.1016/j.brainres.2008.07.017; Ibbotson P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145030; January D, 2009, J COGNITIVE NEUROSCI, V21, P2434, DOI 10.1162/jocn.2008.21179; Keen R, 2003, CURR DIR PSYCHOL SCI, V12, P79, DOI 10.1111/1467-8721.01234; Khanna MM, 2010, Q J EXP PSYCHOL, V63, P160, DOI 10.1080/17470210902866664; Kirkham NZ, 2003, DEVELOPMENTAL SCI, V6, P449, DOI 10.1111/1467-7687.00300; Mazuka R, 2009, LANG LINGUIST COMPAS, V3, P59, DOI 10.1111/j.1749-818x.2008.00102.x; McMillan CT, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00153; Mirman D., 2014, GROWTH CURVE ANAL VI; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morton JB, 2002, DEV PSYCHOBIOL, V40, P255, DOI 10.1002/dev.10033; Novais-Santos S, 2007, NEUROIMAGE, V37, P361, DOI 10.1016/j.neuroimage.2007.03.077; Novick JM, 2014, LANG COGN NEUROSCI, V29, P186, DOI 10.1080/01690965.2012.758297; Novick JM, 2010, LANG LINGUIST COMPAS, V4, P906, DOI 10.1111/j.1749-818x.2010.00244.x; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Perry LK, 2017, COGNITIVE SCI, V41, P1090, DOI 10.1111/cogs.12370; Rodd JM, 2005, CEREB CORTEX, V15, P1261, DOI 10.1093/cercor/bhi009; Trueswell JC, 1999, COGNITION, V73, P89, DOI 10.1016/S0010-0277(99)00032-3; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wiebe SA, 2011, J EXP CHILD PSYCHOL, V108, P436, DOI 10.1016/j.jecp.2010.08.008; Woodard K, 2016, J EXP CHILD PSYCHOL, V141, P187, DOI 10.1016/j.jecp.2015.08.005; Ye Z, 2008, BRAIN RES, V1203, P103, DOI 10.1016/j.brainres.2008.01.090; Yerys BE, 2006, CHILD DEV, V77, P1589, DOI 10.1111/j.1467-8624.2006.00961.x; Zelazo PD, 1996, COGNITIVE DEV, V11, P37, DOI 10.1016/S0885-2014(96)90027-1; Zelazo PD, 2003, MONOGR SOC RES CHILD, V68, P1, DOI 10.1111/j.0037-976X.2003.00261.x; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	45	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158459	10.1371/journal.pone.0158459	http://dx.doi.org/10.1371/journal.pone.0158459			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355690	Green Submitted, gold, Green Published			2022-12-27	WOS:000378859400068
J	Chang, HF; Lee, YS; Tang, TK; Cheng, JY				Chang, Hui-Fang; Lee, Ying-Shan; Tang, Tang K.; Cheng, Ji-Yen			Pulsed DC Electric Field-Induced Differentiation of Cortical Neural Precursor Cells	PLOS ONE			English	Article							NEURITE GROWTH; STEM-CELLS; PROGENITOR CELLS; RETINOIC ACID; CHICK-EMBRYO; SPINAL-CORD; IN-VIVO; SOX2; MIGRATION; NEURONS	We report the differentiation of neural stem and progenitor cells solely induced by direct current (DC) pulses stimulation. Neural stem and progenitor cells in the adult mammalian brain are promising candidates for the development of therapeutic neuroregeneration strategies. The differentiation of neural stem and progenitor cells depends on various in vivo environmental factors, such as nerve growth factor and endogenous EF. In this study, we demonstrated that the morphologic and phenotypic changes of mouse neural stem and progenitor cells (mNPCs) could be induced solely by exposure to square-wave DC pulses (magnitude 300 mV/mm at frequency of 100-Hz). The DC pulse stimulation was conducted for 48 h, and the morphologic changes of mNPCs were monitored continuously. The length of primary processes and the amount of branching significantly increased after stimulation by DC pulses for 48 h. After DC pulse treatment, the mNPCs differentiated into neurons, astrocytes, and oligodendrocytes simultaneously in stem cell maintenance medium. Our results suggest that simple DC pulse treatment could control the fate of NPCs. With further studies, DC pulses may be applied to manipulate NPC differentiation and may be used for the development of therapeutic strategies that employ NPCs to treat nervous system disorders.	[Chang, Hui-Fang; Cheng, Ji-Yen] Acad Sinica, Res Ctr Appl Sci, Taipei, Taiwan; [Lee, Ying-Shan; Tang, Tang K.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Cheng, Ji-Yen] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan; [Cheng, Ji-Yen] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr BMIRC, Taipei, Taiwan; [Cheng, Ji-Yen] Natl Taiwan Ocean Univ, Dept Mech & Mechantron Engn, Keelung, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan Ocean University	Cheng, JY (corresponding author), Acad Sinica, Res Ctr Appl Sci, Taipei, Taiwan.; Cheng, JY (corresponding author), Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan.; Cheng, JY (corresponding author), Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr BMIRC, Taipei, Taiwan.; Cheng, JY (corresponding author), Natl Taiwan Ocean Univ, Dept Mech & Mechantron Engn, Keelung, Taiwan.	jycheng@gate.sinica.edu.tw	Tang, Tang K./S-7012-2018; Cheng, Ji-Yen/D-7272-2011	Tang, Tang K./0000-0002-3660-0695; Cheng, Ji-Yen/0000-0001-7623-7555	Ministry of Science and Technology, Taiwan [MOST 103-2113-M-001-003-MY2, MOST 104-2811-M-001-070]; Thematic Research Program of Academia Sinica, Taiwan [AS-104-TP-B09-1]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Thematic Research Program of Academia Sinica, Taiwan(Academia Sinica - Taiwan)	The authors acknowledge financial support from Ministry of Science and Technology, Taiwan (MOST 103-2113-M-001-003-MY2 and MOST 104-2811-M-001-070) and the Thematic Research Program of Academia Sinica, Taiwan (AS-104-TP-B09-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge financial support from Ministry of Science and Technology, Taiwan (MOST 103-2113-M-001-003-MY2 and MOST 104-2811-M-001-070) and the Thematic Research Program of Academia Sinica, Taiwan (AS-104-TP-B09-1).	Ariza CA, 2010, STEM CELL REV REP, V6, P585, DOI 10.1007/s12015-010-9171-0; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chang KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018738; Cheng JY, 2008, BIOMICROFLUIDICS, V2, DOI 10.1063/1.2952290; CORK RJ, 1994, J NEUROBIOL, V25, P1509, DOI 10.1002/neu.480251204; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Feng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111809; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Hammerick KE, 2010, TISSUE ENG PT A, V16, P917, DOI [10.1089/ten.tea.2009.0267, 10.1089/ten.TEA.2009.0267]; Hilpert F, 2005, SCAND J IMMUNOL, V62, P399, DOI 10.1111/j.1365-3083.2005.01677.x; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; HOTARY KB, 1992, DEVELOPMENT, V114, P985; HOTARY KB, 1990, DEV BIOL, V140, P149, DOI 10.1016/0012-1606(90)90062-N; Hou HS, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4896296; Huang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025928; Kanakasabai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050500; Kim SY, 2010, J HISTOCHEM CYTOCHEM, V58, P567, DOI 10.1369/jhc.2010.955682; Kim YH, 2010, STEM CELLS, V28, P1816, DOI 10.1002/stem.511; Kimura K, 1998, MED BIOL ENG COMPUT, V36, P493, DOI 10.1007/BF02523221; Kindzelskii AL, 2000, BBA-MOL CELL RES, V1495, P90, DOI 10.1016/S0167-4889(99)00148-2; Laga AC, 2011, EXP DERMATOL, V20, P339, DOI 10.1111/j.1600-0625.2011.01247.x; Lee R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06319; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061195; Li SF, 2010, HEARING RES, V267, P111, DOI 10.1016/j.heares.2010.04.004; Lim JH, 2013, CELL REPROGRAM, V15, P405, DOI 10.1089/cell.2013.0001; Lu J, 2012, INTEGR BIOL-UK, V4, P1223, DOI 10.1039/c2ib20171b; Matos MA, 2010, BIOTECHNOL PROGR, V26, P664, DOI 10.1002/btpr.389; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Mostafavi FS, 2014, INT J PREVENTIVE MED, V5, P584; NOLL E, 1994, DEVELOPMENT, V120, P649; PATEL N, 1982, J NEUROSCI, V2, P483; Pereira A, 2010, PROG NEUROBIOL, V92, P405, DOI 10.1016/j.pneurobio.2010.07.001; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Rajnicek AM, 1998, DEV BIOL, V203, P412, DOI 10.1006/dbio.1998.9039; Rajnicek AM, 2006, J CELL SCI, V119, P1736, DOI 10.1242/jcs.02897; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Shapiro S, 2005, J NEUROSURG-SPINE, V2, P3, DOI 10.3171/spi.2005.2.1.0003; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Tsai CH, 2013, J ORTHOP RES, V31, P322, DOI 10.1002/jor.22215; Tsai HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073418; Woo DG, 2009, BIOMATERIALS, V30, P5631, DOI 10.1016/j.biomaterials.2009.07.026; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yao L, 2008, J CELL PHYSIOL, V216, P527, DOI 10.1002/jcp.21431; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhao M, 1999, P NATL ACAD SCI USA, V96, P4942, DOI 10.1073/pnas.96.9.4942	51	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158133	10.1371/journal.pone.0158133	http://dx.doi.org/10.1371/journal.pone.0158133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352251	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900035
J	Franz, DN; Belousova, E; Sparagana, S; Bebin, EM; Frost, MD; Kuperman, R; Witt, O; Kohrman, MH; Flamini, JR; Wu, JY; Curatolo, P; de Vries, PJ; Berkowitz, N; Niolat, J; Jozwiak, S				Franz, David N.; Belousova, Elena; Sparagana, Steven; Bebin, E. Martina; Frost, Michael D.; Kuperman, Rachel; Witt, Olaf; Kohrman, Michael H.; Flamini, J. Robert; Wu, Joyce Y.; Curatolo, Paolo; de Vries, Petrus J.; Berkowitz, Noah; Niolat, Julie; Jozwiak, Sergiusz			Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study	PLOS ONE			English	Article							GIANT-CELL ASTROCYTOMA; CONSENSUS CONFERENCE; RECOMMENDATIONS; ANGIOMYOLIPOMA; MULTICENTER; MANAGEMENT; DIAGNOSIS; EFFICACY; SAFETY; TUMORS	Background Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has demonstrated efficacy in treating subependymal giant cell astrocytomas (SEGAs) and other manifestations of tuberous sclerosis complex (TSC). However, long-term use of mTOR inhibitors might be necessary. This analysis explored long-term efficacy and safety of everolimus from the conclusion of the EXIST-1 study (NCT00789828). Methods and Findings EXIST-1 was an international, prospective, double-blind, placebo-controlled phase 3 trial examining everolimus in patients with new or growing TSC-related SEGA. After a double-blind core phase, all remaining patients could receive everolimus in a long-term, open-label extension. Everolimus was initiated at a dose (4.5 mg/m(2)/day) titrated to a target blood trough of 5-15 ng/mL. SEGA response rate (primary end point) was defined as the proportion of patients achieving confirmed >= 50% reduction in the sum volume of target SEGA lesions from baseline in the absence of worsening nontarget SEGA lesions, new target SEGA lesions, and new or worsening hydrocephalus. Of 111 patients (median age, 9.5 years) who received >= 1 dose of everolimus (median duration, 47.1 months), 57.7% (95% confidence interval [CI], 47.9-67.0) achieved SEGA response. Of 41 patients with target renal angiomyolipomas at baseline, 30 (73.2%) achieved renal angiomyolipoma response. In 105 patients with >= 1 skin lesion at baseline, skin lesion response rate was 58.1%. Incidence of adverse events (AEs) was comparable with that of previous reports, and occurrence of emergent AEs generally decreased over time. The most common AEs (>= 30% incidence) suspected to be treatment-related were stomatitis (43.2%) and mouth ulceration (32.4%). Conclusions Everolimus use led to sustained reduction in tumor volume, and new responses were observed for SEGA and renal angiomyolipoma from the blinded core phase of the study. These findings support the hypothesis that everolimus can safely reverse multisystem manifestations of TSC in a significant proportion of patients.	[Franz, David N.] Cincinnati Childrens Hosp Med Ctr, Dept Neurol, Cincinnati, OH 45229 USA; [Belousova, Elena] Pirogov Russian Natl Res Med Univ, Dept Pediat, Res & Clin Inst Pediat, Moscow, Russia; [Sparagana, Steven] Texas Scottish Rite Hosp Children, Dept Neurol, Dallas, TX 75219 USA; [Bebin, E. Martina] Univ Alabama Birmingham, Sch Med, Dept Neurol, Birmingham, AL USA; [Frost, Michael D.] Minnesota Epilepsy Grp, Dept Neurol, St Paul, MN USA; [Kuperman, Rachel] Childrens Hosp & Res Ctr, Dept Neurol, Oakland, CA USA; [Witt, Olaf] Heidelberg Univ, Med Ctr, Dept Oncol, Heidelberg, Germany; [Witt, Olaf] German Canc Res Ctr, Heidelberg, Germany; [Kohrman, Michael H.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Flamini, J. Robert] Childrens Healthcare Atlanta, Dept Neurol, Atlanta, GA USA; [Wu, Joyce Y.] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Neurol, Los Angeles, CA USA; [Curatolo, Paolo] Univ Roma Tor Vergata, Dept Neurol, Rome, Italy; [de Vries, Petrus J.] Univ Cape Town, Div Child & Adolescent Psychiat, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Berkowitz, Noah] Novartis Pharmaceut, Dept Oncol, E Hanover, NJ USA; [Niolat, Julie] Novartis Pharmaceut SAS, Dept Oncol, Rueil Malmaison, France; [Jozwiak, Sergiusz] Med Univ Warsaw, Dept Pediat Neurol, Warsaw, Poland	Cincinnati Children's Hospital Medical Center; Pirogov Russian National Research Medical University; Texas Scottish Rite Hospital for Children; University of Alabama System; University of Alabama Birmingham; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Chicago; Children's Healthcare of Atlanta (CHOA); University of California System; University of California Los Angeles; University of Rome Tor Vergata; University of Cape Town; Novartis; Novartis; Medical University of Warsaw	Franz, DN (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Neurol, Cincinnati, OH 45229 USA.	David.Franz@cchmc.org	frost, michael/AAG-4031-2021	Belousova, Elena Dmitrievna/0000-0003-3594-6974; Jozwiak, Sergiusz/0000-0003-3350-6326; Sparagana, Steven/0000-0002-8439-4312	Novartis Pharmaceuticals Corporation	Novartis Pharmaceuticals Corporation(Novartis)	Supported by Novartis Pharmaceuticals Corporation. Novartis was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.; The authors thank the study participants, the EXIST-1 investigators, and study site personnel for their important contributions to this study. Medical writing and editorial assistance was provided by Traci Stuve, MA, and Robert J. Schoen, PharmD, of ApotheCom (Yardley, PA) with funding by Novartis Pharmaceuticals Corporation.	Adriaensen MEAPM, 2009, EUR J NEUROL, V16, P691, DOI 10.1111/j.1468-1331.2009.02567.x; [Anonymous], 2015, AF PACK INS; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bissler JJ, 2016, NEPHROL DIAL TRANSPL, V31, P111, DOI 10.1093/ndt/gfv249; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Budde K, 2012, AM J KIDNEY DIS, V59, P276, DOI 10.1053/j.ajkd.2011.10.013; Casper KA, 2002, RADIOLOGY, V225, P451, DOI 10.1148/radiol.2252011584; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Curatolo P, 2015, LANCET NEUROL, V14, P733, DOI 10.1016/S1474-4422(15)00069-1; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Franz DN, 2015, ANN NEUROL, V78, P929, DOI 10.1002/ana.24523; Franz DN, 2014, LANCET ONCOL, V15, P1513, DOI 10.1016/S1470-2045(14)70489-9; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; Goh S, 2004, NEUROLOGY, V63, P1457, DOI 10.1212/01.wnl.0000142039.14522.1a; Hyman MH, 2000, ARCH NEUROL-CHICAGO, V57, P662, DOI 10.1001/archneur.57.5.662; Jozwiak S, 2013, EUR J PAEDIATR NEURO, V17, P348, DOI 10.1016/j.ejpn.2012.12.008; Kotulska K, 2014, PEDIATR NEUROL, V50, P307, DOI 10.1016/j.pediatrneurol.2013.12.004; Kranz B, 2013, PEDIATR NEPHROL, V28, P1293, DOI 10.1007/s00467-013-2459-y; Krueger DA, 2013, PEDIATR NEUROL, V49, P255, DOI 10.1016/j.pediatrneurol.2013.08.002; Krueger DA, 2013, NEUROLOGY, V80, P574, DOI 10.1212/WNL.0b013e3182815428; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Moavero R, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-57; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Pape L, 2010, AM J TRANSPLANT, V10, P2349, DOI 10.1111/j.1600-6143.2010.03266.x; Rakowski SK, 2006, KIDNEY INT, V70, P1777, DOI 10.1038/sj.ki.5001853; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Roth J, 2013, PEDIATR NEUROL, V49, P439, DOI 10.1016/j.pediatrneurol.2013.08.017; Schwartz RA, 2007, J AM ACAD DERMATOL, V57, P189, DOI 10.1016/j.jaad.2007.05.004	29	104	106	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158476	10.1371/journal.pone.0158476	http://dx.doi.org/10.1371/journal.pone.0158476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351628	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900062
J	Kansau, I; Barketi-Klai, A; Monot, M; Hoys, S; Dupuy, B; Janoir, C; Collignon, A				Kansau, Imad; Barketi-Klai, Amira; Monot, Marc; Hoys, Sandra; Dupuy, Bruno; Janoir, Claire; Collignon, Anne			Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis	PLOS ONE			English	Article							TOXIN-B; INCREASED SPORULATION; VIRULENCE; PROTEINS; COLONIZATION; GENES; PATHOGENESIS; ADHESIN; BINDING; LAYER	Clostridium difficile is responsible for a wide spectrum of infection from asymptomatic carriage to severe, relapsing colitis. Since 2003, C. difficile infections have increased with a higher morbidity and mortality due to the emergence of epidemic and hypervirulent C. difficile strains such as those of the epidemic lineage 027/BI/NAP1. To decipher the hypervirulence and epidemicity of 027 strains, we analyzed gene expression profiles of the R20291 027 strain using a monoxenic mouse model during the first 38h of infection. A total of 741 genes were differentially expressed during the course of infection. They are mainly distributed in functional categories involved in host adaptation. Several genes of PTS and ABC transporters were significantly regulated during the infection, underlying the ability of strain R20291 to adapt its metabolism according to nutrient availability in the digestive tract. In this animal model, despite the early sporulation process, sporulation efficiency seems to indicate that growth of R20291 vegetative cells versus spores were favored during infection. The bacterial mechanisms associated to adaptability and flexibility within the gut environment, in addition to the virulence factor expression and antibiotic resistance, should contribute to the epidemicity and hypervirulence of the C. difficile 027 strains.	[Kansau, Imad; Barketi-Klai, Amira; Hoys, Sandra; Janoir, Claire; Collignon, Anne] Univ Paris Saclay, Univ Paris 11, Unite Bacteries Pathogenes & Sante UBaPS, EA4043, F-92296 Chatenay Malabry, France; [Monot, Marc; Dupuy, Bruno] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, 25-28 Rue Docteur Roux, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Collignon, A (corresponding author), Univ Paris Saclay, Univ Paris 11, Unite Bacteries Pathogenes & Sante UBaPS, EA4043, F-92296 Chatenay Malabry, France.	anne.collignon@u-psud.fr	Kansau, Imad/GRX-4789-2022; Monot, Marc/F-3058-2015	Kansau, Imad/0000-0002-1893-6822; Monot, Marc/0000-0003-0738-7335	EU [Health-F3-2008-223585]; Institut Pasteur; European Union [Health-F3-2008-223585]	EU(European Commission); Institut Pasteur(European Commission); European Union(European Commission)	This work was supported by EU Health-F3-2008-223585, Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the European Union (HEALTH-F3-2008-223585) and Institut Pasteur. The funders had no role in study design, data collection ans analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Awad MM, 2014, GUT MICROBES, V5, P579, DOI 10.4161/19490976.2014.969632; Baban ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073026; Barketi-Klai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096876; Barketi-Klai A, 2011, J MED MICROBIOL, V60, P1155, DOI 10.1099/jmm.0.029553-0; Bouillaut L, 2015, RES MICROBIOL, V166, P375, DOI 10.1016/j.resmic.2014.10.002; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Chen JW, 2013, J PROTEOME RES, V12, P1151, DOI 10.1021/pr3007528; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Diaz-Gonzalez F, 2015, J PROTEOMICS, V123, P1, DOI 10.1016/j.jprot.2015.03.035; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Edwards AN, 2014, INFECT IMMUN, V82, P4276, DOI 10.1128/IAI.02323-14; Escartin F, 2008, P NATL ACAD SCI USA, V105, P9948, DOI 10.1073/pnas.0801356105; Fimlaid KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003660; Gerding DN, 2014, GUT MICROBES, V5, P15, DOI 10.4161/gmic.26854; Govind R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002727; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Janoir C, 2013, INFECT IMMUN, V81, P3757, DOI 10.1128/IAI.00515-13; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Knetsch CW, 2011, MICROBIOL-SGM, V157, P3113, DOI 10.1099/mic.0.051953-0; Kovacs-Simon A, 2014, J INFECT DIS, V210, P274, DOI 10.1093/infdis/jiu070; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper E J, 2007, Euro Surveill, V12, pE1; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Martin MJ, 2013, J BACTERIOL, V195, P3672, DOI 10.1128/JB.00473-13; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Merrigan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078404; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Pereira FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003782; Robinson CD, 2014, INFECT IMMUN, V82, P2815, DOI 10.1128/IAI.01524-14; Scaria J, 2011, J INFECT DIS, V203, P1613, DOI 10.1093/infdis/jir112; Shakeri-Garakani A, 2004, MOL GENET GENOMICS, V271, P717, DOI 10.1007/s00438-004-1022-8; Stabler RA, 2010, GUT MICROBES, V1, P269, DOI 10.4161/gmic.1.4.11870; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Tulli L, 2013, CELL MICROBIOL, V15, P1674, DOI 10.1111/cmi.12139; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	43	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158204	10.1371/journal.pone.0158204	http://dx.doi.org/10.1371/journal.pone.0158204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351947	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900043
J	Avery, CL; Holliday, KM; Chakladar, S; Engeda, JC; Hardy, ST; Reis, JP; Schreiner, PJ; Shay, CM; Daviglus, ML; Heiss, G; Lin, DY; Zeng, DL				Avery, Christy L.; Holliday, Katelyn M.; Chakladar, Sujatro; Engeda, Joseph C.; Hardy, Shakia T.; Reis, Jared P.; Schreiner, Pamela J.; Shay, Christina M.; Daviglus, Martha L.; Heiss, Gerardo; Lin, Dan Yu; Zeng, Donglin			Disparities in Early Transitions to Obesity in Contemporary Multi-Ethnic US Populations	PLOS ONE			English	Article							BODY-MASS INDEX; UNITED-STATES; CARDIOVASCULAR-DISEASE; AMERICAN-INDIANS; YOUNG ADULTHOOD; WEIGHT-GAIN; OVERWEIGHT; RISK; PREVALENCE; CHILDHOOD	Background Few studies have examined weight transitions in contemporary multi-ethnic populations spanning early childhood through adulthood despite the ability of such research to inform obesity prevention, control, and disparities reduction. Methods and Results We characterized the ages at which African American, Caucasian, and Mexican American populations transitioned to overweight and obesity using contemporary and nationally representative cross-sectional National Health and Nutrition Examination Survey data (n = 21,220; aged 2-80 years). Age-, sex-, and race/ethnic-specific one-year net transition probabilities between body mass index-classified normal weight, overweight, and obesity were estimated using calibrated and validated Markov-type models that accommodated complex sampling. At age two, the obesity prevalence ranged from 7.3% in Caucasian males to 16.1% in Mexican American males. For all populations, estimated one-year overweight to obesity net transition probabilities peaked at age two and were highest for Mexican American males and African American females, for whom a net 12.3%(95% CI: 7.6%-17.0%) and 11.9% (95% CI: 8.5%-15.3%) of the overweight populations transitioned to obesity by age three, respectively. However, extrapolation to the 2010 U.S. population demonstrated that Mexican American males were the only population for whom net increases in obesity peaked during early childhood; age-specific net increases in obesity were approximately constant through the second decade of life for African Americans and Mexican American females and peaked at age 20 for Caucasians. Conclusions African American and Mexican American populations shoulder elevated rates of many obesity-associated chronic diseases and disparities in early transitions to obesity could further increase these inequalities if left unaddressed.	[Avery, Christy L.; Holliday, Katelyn M.; Engeda, Joseph C.; Hardy, Shakia T.; Heiss, Gerardo] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Chakladar, Sujatro; Lin, Dan Yu; Zeng, Donglin] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Reis, Jared P.] NHLBI, Epidemiol Branch, Populat & Prevent Sci Program, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Schreiner, Pamela J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Shay, Christina M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Daviglus, Martha L.] Univ Illinois, Dept Med, Inst Minor Hlth Res, Chicago, IL USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Avery, CL (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA.	Christy_avery@unc.edu		Hardy, Shakia/0000-0001-9211-0474; Schreiner, Pamela/0000-0002-9920-6257; Holliday, Katelyn/0000-0002-2540-5974	National Heart, Lung, and Blood Institute (NHLBI) [AG0005]; University of Alabama at Birmingham [HHSN268201300025C, HHSN268201300026C]; Northwestern University [HHSN268201300027C]; University of Minnesota [HHSN268201300028C]; Kaiser Foundation Research Institute [HHSN268201300029C]; Johns Hopkins University School of Medicine [HHSN268200900041C]; Intramural Research Program of the National Institute on Aging (NIA); NIA [AG0005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007055, R21HL121580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007750] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham; Northwestern University; University of Minnesota(University of Minnesota System); Kaiser Foundation Research Institute; Johns Hopkins University School of Medicine(Johns Hopkins University); Intramural Research Program of the National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This publication was made possible in part by R21HL121580, R00HL098458, and T32HL007055. The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham HHSN268201300025C & HHSN268201300026C), Northwestern University (HHSN268201300027C), University of Minnesota (HHSN268201300028C), Kaiser Foundation Research Institute (HHSN268201300029C), and Johns Hopkins University School of Medicine (HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). This manuscript has been reviewed by CARDIA for scientific content.	[Anonymous], 2013, LANCET NEUROL, V12, P623, DOI 10.1016/S1474-4422(13)70137-6; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Cao Y, 2011, CANCER PREV RES, V4, P486, DOI 10.1158/1940-6207.CAPR-10-0229; Centers for Disease Control and Prevention National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Community Preventive Services Task Force, 2014, OB PREV CONTR INT CO; Cooper R, 2000, CIRCULATION, V102, P3137; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Fryar C.D., 2014, PREVALENCE OVERWEIGH; Gonzalez-Barrera A, 2013, DEMOGRAPHIC PORTRAIT; Gordon-Larsen P, 2004, AM J CLIN NUTR, V80, P569; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; McCullagh P, 1989, GEN LINEAR MODELS; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Passel JS, 2008, US POPULATION PROJEC; Rauscher GH, 2000, AM J EPIDEMIOL, V152, P506, DOI 10.1093/aje/152.6.506; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Reis JP, 2013, JAMA-J AM MED ASSOC, V310, P280, DOI 10.1001/jama.2013.7833; Reis JP, 2013, DIABETES CARE, V36, P1241, DOI 10.2337/dc12-1714; Stenholm S, 2015, EPIDEMIOLOGY, V26, P165, DOI 10.1097/EDE.0000000000000228; Tran MK, 2016, AM J EPIDEMIOL, V183, P643, DOI 10.1093/aje/kwv233; van de Kassteele J, 2012, STAT MED, V31, P533, DOI 10.1002/sim.4423; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Zamosky Lisa, 2013, Med Econ, V90, P14; Zhang Y, 2008, CIRCULATION, V118, P1577, DOI 10.1161/CIRCULATIONAHA.108.772285	38	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158025	10.1371/journal.pone.0158025	http://dx.doi.org/10.1371/journal.pone.0158025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348868	gold, Green Submitted, Green Published			2022-12-27	WOS:000378801200028
J	Khan, NU; Liu, MJ; Yang, XF; Qiu, DW				Khan, Najeeb Ullah; Liu, Mengjie; Yang, Xiufen; Qiu, Dewen			Fungal Elicitor MoHrip2 Induces Disease Resistance in Rice Leaves, Triggering Stress-Related Pathways	PLOS ONE			English	Article							ACID SIGNALING PATHWAY; PROGRAMMED CELL-DEATH; PROTEOMIC ANALYSIS; MAGNAPORTHE-ORYZAE; ABSCISIC-ACID; BLAST FUNGUS; RESPONSIVE PROTEINS; GENE-EXPRESSION; PLANTS; TOLERANCE	MoHrip2 Magnaporthe oryzae hypersensitive protein 2 is an elicitor protein of rice blast fungus M. oryzae. Rice seedlings treated with MoHrip2 have shown an induced resistance to rice blast. To elucidate the mechanism underlying this MoHrip2 elicitation in rice, we used differential-display 2-D gel electrophoresis and qRT-PCR to assess the differential expression among the total proteins extracted from rice leaves at 24 h after treatment with MoHrip2 and buffer as a control. Among similar to 1000 protein spots detected on each gel, 10 proteins were newly induced, 4 were up-regulated, and 3 were down-regulated in MoHrip2-treated samples compared with the buffer control. Seventeen differentially expressed proteins were detected using MS/MS analysis and categorized into six groups according to their putative function: defense-related transcriptional factors, signal transduction-related proteins, reactive oxygen species (ROS) production, programmed cell death (PCD), defense-related proteins, and photosynthesis and energy-related proteins. The qPCR results (relative expression level of genes) further supported the differential expression of proteins in MoHrip2-treated rice leaves identified with 2D-gel, suggesting that MoHrip2 triggers an early defense response in rice leaves via stress-related pathways, and the results provide evidence for elicitor-induced resistance at the protein level.	[Khan, Najeeb Ullah; Liu, Mengjie; Yang, Xiufen; Qiu, Dewen] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100081, Peoples R China; [Khan, Najeeb Ullah] Univ Agr Peshawar, Inst Biotechnol & Genet Engn, Peshawar, Pakistan	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Qiu, DW (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100081, Peoples R China.	qiudewen@caas.cn	Khan, Najeeb Ullah/AFW-4303-2022	Khan, Najeeb Ullah/0000-0003-2568-9484	National Natural Science Foundation of China [31371984]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 31371984).	Achuo EA, 2006, PLANT PATHOL, V55, P178, DOI 10.1111/j.1365-3059.2006.01340.x; Agrawal GK, 2006, MASS SPECTROM REV, V25, P1, DOI 10.1002/mas.20056; Baldrich Patricia, 2015, RNA Biol, V12, P847, DOI 10.1080/15476286.2015.1050577; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breen J, 2010, FUNCT INTEGR GENOMIC, V10, P463, DOI 10.1007/s10142-010-0184-1; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Chen MJ, 2014, PLANT CELL REP, V33, P1865, DOI 10.1007/s00299-014-1663-y; Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037654; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Delaunois B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00249; Ding CQ, 2011, PLANT MOL BIOL REP, V29, P618, DOI 10.1007/s11105-010-0268-z; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; Fan WH, 2011, J PLANT PHYSIOL, V168, P500, DOI 10.1016/j.jplph.2010.08.012; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gorg a, 2004, GE HEALTHCARE HDB, P27; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Grun S, 2006, J EXP BOT, V57, P507, DOI 10.1093/jxb/erj053; Hakeem KR, 2012, APPL BIOCHEM BIOTECH, V168, P834, DOI 10.1007/s12010-012-9823-4; Hou MM, 2012, PLANT CELL REP, V31, P895, DOI 10.1007/s00299-011-1210-z; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Jwa NS, 2006, PLANT PHYSIOL BIOCH, V44, P261, DOI 10.1016/j.plaphy.2006.06.010; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Kim ST, 2003, PROTEOMICS, V3, P2368, DOI 10.1002/pmic.200300577; Kim ST, 2014, PROTEOMICS, V14, P593, DOI 10.1002/pmic.201300388; Koga H, 2012, PHYSIOL MOL PLANT P, V77, P60, DOI 10.1016/j.pmpp.2011.12.001; Kuroda K, 2006, PHYSIOL MOL PLANT P, V69, P13, DOI 10.1016/j.pmpp.2006.12.003; Kuwagata T, 2012, PLANT CELL PHYSIOL, V53, P1418, DOI 10.1093/pcp/pcs087; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Li W, 2011, CELL RES, V21, P835, DOI 10.1038/cr.2011.4; Liao M, 2009, PROTEOMICS, V9, P2809, DOI 10.1002/pmic.200800192; Liu Y, 2013, THEOR APPL GENET, V126, P985, DOI 10.1007/s00122-012-2031-3; Mahmood T, 2009, BIOL PLANTARUM, V53, P285, DOI 10.1007/s10535-009-0052-9; Manavalan LP, 2012, J EXP BOT, V63, P163, DOI 10.1093/jxb/err258; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Obara N, 2002, BIOSCI BIOTECH BIOCH, V66, P2549, DOI 10.1271/bbb.66.2549; Patel Prabhudas S, 2005, Asian Pac J Cancer Prev, V6, P113; Rakwal R, 2002, BIOCHEM BIOPH RES CO, V295, P1041, DOI 10.1016/S0006-291X(02)00779-9; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Sharma N, 2007, PLANT SCI, V172, P95, DOI 10.1016/j.plantsci.2006.07.016; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wei T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059720; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Xie KB, 2014, PLANT CELL, V26, P3077, DOI 10.1105/tpc.114.126441; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zang X, 2007, PHYTOCHEMISTRY, V68, P426, DOI 10.1016/j.phytochem.2006.11.005	51	5	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158112	10.1371/journal.pone.0158112	http://dx.doi.org/10.1371/journal.pone.0158112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348754	Green Published, Green Submitted, gold			2022-12-27	WOS:000378801200037
J	Davidson, JA; Urban, T; Tong, SH; Twite, M; Woodruff, A; Wischmeyer, PE; Klawitter, J				Davidson, Jesse A.; Urban, Tracy; Tong, Suhong; Twite, Mark; Woodruff, Alan; Wischmeyer, Paul E.; Klawitter, Jelena			Alkaline Phosphatase, Soluble Extracellular Adenine Nucleotides, and Adenosine Production after Infant Cardiopulmonary Bypass	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; ACUTE KIDNEY INJURY; CONTROLLED-TRIAL; CARDIAC-SURGERY; GUT MICROBIOTA; IN-VIVO; INFLAMMATION; CHILDREN; COLITIS; SEPSIS	Rationale Decreased alkaline phosphatase activity after infant cardiac surgery is associated with increased post-operative cardiovascular support requirements. In adults undergoing coronary artery bypass grafting, alkaline phosphatase infusion may reduce inflammation. Mechanisms underlying these effects have not been explored but may include decreased conversion of extracellular adenine nucleotides to adenosine. Objectives 1) Evaluate the association between alkaline phosphatase activity and serum conversion of adenosine monophosphate to adenosine after infant cardiac surgery; 2) assess if inhibition/supplementation of serum alkaline phosphatase modulates this conversion. Methods and Research Pre/post-bypass serum samples were obtained from 75 infants <4 months of age. Serum conversion of 13C5-adenosine monophosphate to 13C5-adenosine was assessed with/without selective inhibition of alkaline phosphatase and CD73. Low and high concentration 13C5-adenosine monophosphate (simulating normal/stress concentrations) were used. Effects of alkaline phosphatase supplementation on adenosine monophosphate clearance were also assessed. Changes in serum alkaline phosphatase activity were strongly correlated with changes in 13C5-adenosine production with or without CD73 inhibition (r = 0.83; p<0.0001). Serum with low alkaline phosphatase activity (<= 80 U/L) generated significantly less 13C5-adenosine, particularly in the presence of high concentration 13C5-adenosine monophosphate (10.4 mu mol/L vs 12.9 mu mol/L; p = 0.0004). Inhibition of alkaline phosphatase led to a marked decrease in 13C5-adenosine production ( 11.9 mu mol/L vs 2.7 mu mol/L; p<0.0001). Supplementation with physiologic dose human tissue non-specific alkaline phosphatase or high dose bovine intestinal alkaline phosphatase doubled 13C5-adenosine monophosphate conversion to 13C5-adenosine (p<0.0001). Conclusions Alkaline phosphatase represents the primary serum ectonucleotidase after infant cardiac surgery and low post-operative alkaline phosphatase activity leads to impaired capacity to clear adenosine monophosphate. AP supplementation improves serum clearance of adenosine monophosphate to adenosine. These findings represent a potential therapeutic mechanism for alkaline phosphatase infusion during cardiac surgery. New and Noteworthy We identify alkaline phosphatase (AP) as the primary soluble ectonucleotidase in infants undergoing cardiopulmonary bypass and show decreased capacity to clear AMP when AP activity decreases post-bypass. Supplementation of AP ex vivo improves this capacity and may represent the beneficial therapeutic mechanism of AP infusion seen in phase 2 studies.	[Davidson, Jesse A.] Univ Colorado, Dept Pediat, Pediat Cardiol, Aurora, CO 80045 USA; [Urban, Tracy] Childrens Hosp Colorado, CCRO, Aurora, CO USA; [Tong, Suhong] Univ Colorado, Dept Biostat, Aurora, CO USA; [Twite, Mark; Wischmeyer, Paul E.; Klawitter, Jelena] Univ Colorado, Dept Anesthesiol, Aurora, CO USA; [Woodruff, Alan] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesia, Div Pediat Crit Care Med, Boston, MA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Boston Children's Hospital; Harvard Medical School	Davidson, JA (corresponding author), Univ Colorado, Dept Pediat, Pediat Cardiol, Aurora, CO 80045 USA.	jesse.davidson@childrenscolorado.org	Woodruff, MD, Alan G/AAM-3427-2021	Woodruff, MD, Alan G/0000-0003-2219-7660; Davidson, Jesse/0000-0001-9193-9803	National Institute of Health/Heart Lung and Blood Institute [1K23HL123634-01]; National Institute of Health/National Center for Advancing Translational Science Colorado Clinical and Translational Science Award [UL1 TR001082]; American Heart Association [13CRP17300016]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL123634] Funding Source: NIH RePORTER	National Institute of Health/Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Health/National Center for Advancing Translational Science Colorado Clinical and Translational Science Award; American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by National Institute of Health/Heart Lung and Blood Institute 1K23HL123634-01 (JAD), National Institute of Health/National Center for Advancing Translational Science Colorado Clinical and Translational Science Award Grant Number UL1 TR001082 (JAD), and American Heart Association 13CRP17300016 (JAD). Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascione R, 2006, ANN THORAC SURG, V81, P97, DOI 10.1016/j.athoracsur.2005.06.038; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; Blinder JJ, 2012, J THORAC CARDIOV SUR, V143, P368, DOI 10.1016/j.jtcvs.2011.06.021; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; Cremer J, 1996, ANN THORAC SURG, V61, P1714, DOI 10.1016/0003-4975(96)00055-0; Davidson J, 2012, CRIT CARE, V16, DOI 10.1186/cc11483; de Jong PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035070; Ebrahimi F, 2011, J GASTROINTEST SURG, V15, P860, DOI 10.1007/s11605-010-1405-6; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fiechter D, 2011, CARDIOL RES, V2, P236, DOI 10.4021/cr81w; Heemskerk S, 2009, CRIT CARE MED, V37, P417, DOI 10.1097/CCM.0b013e31819598af; Hoffman TM, 2003, CIRCULATION, V107, P996, DOI 10.1161/01.CIR.0000051365.81920.28; Kats S, 2009, RECENT PATENTS INFLA, V3, P214, DOI 10.2174/187221309789257388; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Lukas M, 2010, INFLAMM BOWEL DIS, V16, P1180, DOI 10.1002/ibd.21161; LUM G, 1989, CLIN CHEM, V35, P664; Malo MS, 2010, GUT, V59, P1476, DOI 10.1136/gut.2010.211706; MOSS DW, 1982, CLIN CHEM, V28, P2007; NEUTZE JM, 1974, AM HEART J, V88, P553, DOI 10.1016/0002-8703(74)90237-3; Newburger JW, 2006, CIRCULATION, V113, P183, DOI 10.1161/CIRCULATIONAHA.105.594804; Pavione MA, 2012, J THORAC CARDIOV SUR, V144, P178, DOI 10.1016/j.jtcvs.2011.12.029; Peters E, ALKALINE PHOSPHATASE; Petrovic-Djergovic D, 2012, J IMMUNOL, V188, P2387, DOI 10.4049/jimmunol.1003671; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212; Pickkers P, 2012, CRIT CARE, V16, DOI 10.1186/cc11159; Pike AF, 2013, BBA-MOL BASIS DIS, V1832, P2044, DOI 10.1016/j.bbadis.2013.07.016; Poelstra K, 1997, AM J PATHOL, V151, P1163; Poupon R, 2015, HEPATOLOGY, V61, P2080, DOI 10.1002/hep.27715; Ramasamy S, 2011, INFLAMM BOWEL DIS, V17, P532, DOI 10.1002/ibd.21377; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rossano JW, 2012, J CARD FAIL, V18, P459, DOI 10.1016/j.cardfail.2012.03.001; Tuin A, 2009, GUT, V58, P379, DOI 10.1136/gut.2007.128868; Verweij WR, 2004, SHOCK, V22, P174, DOI 10.1097/01.shk.0000132485.05049.8a; Whitehouse JS, 2010, J SURG RES, V163, P79, DOI 10.1016/j.jss.2010.04.048; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	40	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158981	10.1371/journal.pone.0158981	http://dx.doi.org/10.1371/journal.pone.0158981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384524	gold, Green Submitted, Green Published			2022-12-27	WOS:000379809400095
J	Humer, E; Khol-Parisini, A; Metzler-Zebeli, BU; Gruber, L; Zebeli, Q				Humer, Elke; Khol-Parisini, Annabella; Metzler-Zebeli, Barbara U.; Gruber, Leonhard; Zebeli, Qendrim			Alterations of the Lipid Metabolome in Dairy Cows Experiencing Excessive Lipolysis Early Postpartum	PLOS ONE			English	Article							NONESTERIFIED FATTY-ACIDS; INSULIN-RESISTANCE; EARLY LACTATION; GLUCOSE-METABOLISM; SUBCLINICAL KETOSIS; BETA-OXIDATION; BODY CONDITION; DRY PERIOD; CARNITINE; PLASMA	A decrease in insulin sensitivity enhances adipose tissue lipolysis helping early lactation cows counteracting their energy deficit. However, excessive lipolysis poses serious health risks for cows, and its underlying mechanisms are not clearly understood. The present study used targeted ESI-LC-MS/MS-based metabolomics and indirect insulin sensitivity measurements to evaluate metabolic alterations in the serum of dairy cows of various parities experiencing variable lipolysis early postpartum. Thirty (12 primiparous and 18 multiparous) cows of Holstein Friesian and Simmental breeds, fed the same diet and kept under the same management conditions, were sampled at d 21 postpartum and classified as low (n = 10), medium (n = 8), and high (n = 12) lipolysis groups, based on serum concentration of nonesterified fatty acids. Overall, excessive lipolysis in the high group came along with impaired estimated insulin sensitivity and characteristic shifts in acylcarnitine, sphingomyelin, phosphatidylcholine and lysophospholipid metabolome profiles compared to the low group. From the detected phosphatidylcholines mainly those with diacyl-residues showed differences among lipolysis groups. Furthermore, more than half of the detected sphingomyelins were increased in cows experiencing high lipomobilization. Additionally, strong differences in serum acylcarnitines were noticed among lipolysis groups. The study suggests an altered serum phospholipidome in dairy cows associated with an increase in certain long-chain sphingomyelins and the progression of disturbed insulin function. In conclusion, the present study revealed 37 key metabolites as part of alterations in the synthesis or breakdown of sphingolipids and phospholipids associated with lowered estimated insulin sensitivity and excessive lipolysis in early-lactating cows.	[Humer, Elke; Khol-Parisini, Annabella; Zebeli, Qendrim] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Metzler-Zebeli, Barbara U.] Univ Vet Med Vienna, Univ Clin Swine, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Gruber, Leonhard] Agr Res & Educ Ctr Raumberg Gumpenstein, Inst Livestock Res, Irdning, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Zebeli, Q (corresponding author), Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria.	qendrim.zebeli@vetmeduni.ac.at		Humer, Elke/0000-0001-9776-0353	collaborative project ADDA (ADvancement of Dairying in Austria) of Austrian Research Promotion Agency (FFG) [843543]	collaborative project ADDA (ADvancement of Dairying in Austria) of Austrian Research Promotion Agency (FFG)	This research was supported by collaborative project ADDA (ADvancement of Dairying in Austria) of Austrian Research Promotion Agency (FFG), (Grant No. 843543) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Adewuyi AA, 2005, VET QUART, V27, P117, DOI 10.1080/01652176.2005.9695192; Almanza-Perez JC, 2010, BIOMED PHARMACOTHER, V64, P534, DOI 10.1016/j.biopha.2009.04.047; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Bell DH, 1981, LIPID METABOLISM LIV, P363; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; Breukink H. J., 1997, Israel Journal of Veterinary Medicine, V52, P66; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chilliard Y, 2000, P NUTR SOC, V59, P127, DOI 10.1017/S002966510000015X; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Cozzi G, 2011, J DAIRY SCI, V94, P3895, DOI 10.3168/jds.2010-3687; De Koster JD, 2013, VET CLIN N AM-FOOD A, V29, P299, DOI 10.1016/j.cvfa.2013.04.002; Drackley JK., 2000, LIPID METABOLISM; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; GENUTH SM, 1979, DIABETES, V28, P1083, DOI 10.2337/diab.28.12.1083; GfE (Gesellschaft fur Ernahrungsphysiologie), 2001, REC SUPPL EN NUTR DA; Gonzalez FD, 2011, J VET SCI, V12, P251, DOI 10.4142/jvs.2011.12.3.251; Gruffat D, 1996, REPROD NUTR DEV, V36, P375, DOI 10.1051/rnd:19960404; Grum DE, 1996, J DAIRY SCI, V79, P1850, DOI 10.3168/jds.S0022-0302(96)76553-0; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2014, CELL METAB, V20, P703, DOI 10.1016/j.cmet.2014.10.017; Holtenius P, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-29; Humer E, 2016, ANIMAL; Imhasly S, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-122; Ingvartsen KL, 2000, J DAIRY SCI, V83, P1573, DOI 10.3168/jds.S0022-0302(00)75029-6; Inokuchi T, 1995, DIABETES RES CLIN PR, V30, P1, DOI 10.1016/0168-8227(95)01140-4; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lapierre H, 2012, J ANIM SCI, V90, P1708, DOI 10.2527/jas.2011-4645; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Li Y, 2014, VET QUART, V34, P152, DOI 10.1080/01652176.2014.962116; MARKUSFELD O, 1987, J DAIRY SCI, V70, P158, DOI 10.3168/jds.S0022-0302(87)79990-1; MCGARRY JD, 1975, P NATL ACAD SCI USA, V72, P4385, DOI 10.1073/pnas.72.11.4385; Meikle A, 2004, REPRODUCTION, V127, P727, DOI 10.1530/rep.1.00080; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Metzler-Zebeli BU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130553; Moore JH, 1981, LIPID METABOLISM MAM; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Oetzel GR, 2004, VET CLIN N AM-FOOD A, V20, P651, DOI 10.1016/j.cvfa.2004.06.006; Ospina PA, 2010, J DAIRY SCI, V93, P3595, DOI 10.3168/jds.2010-3074; Piepenbrink MS, 2003, J DAIRY SCI, V86, P1722, DOI 10.3168/jds.S0022-0302(03)73758-8; Pires JAA, 2007, J DAIRY SCI, V90, P2735, DOI 10.3168/jds.2006-759; PULLEN DL, 1990, J ANIM SCI, V68, P1395; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Ramsay S L, 2007, Apparatus and method for analyzing a metabolite profile, Patent No. [EP 1875401 A211, 1875401]; Rico JE, 2015, J DAIRY SCI, V98, P7757, DOI 10.3168/jds.2015-9519; Sun LW, 2014, J DAIRY SCI, V97, P1552, DOI 10.3168/jds.2013-6757; Suthar VS, 2013, J DAIRY SCI, V96, P2925, DOI 10.3168/jds.2012-6035; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; van Dorland HA, 2009, J DAIRY SCI, V92, P1924, DOI 10.3168/jds.2008-1454; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Weber C, 2013, J DAIRY SCI, V96, P165, DOI 10.3168/jds.2012-5574; WINTER SC, 1989, AM J DIS CHILD, V143, P1337, DOI 10.1001/archpedi.1989.02150230095030; Zeisel SH, 2001, CHOLINE, P513; Zhang HY, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-186; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	63	30	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158633	10.1371/journal.pone.0158633	http://dx.doi.org/10.1371/journal.pone.0158633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383746	gold, Green Published, Green Submitted			2022-12-27	WOS:000379809400069
J	Sepulveda, RD; Valdivia, N				Sepulveda, Roger D.; Valdivia, Nelson			Localised Effects of a Mega-Disturbance: Spatiotemporal Responses of Intertidal Sandy Shore Communities to the 2010 Chilean Earthquake	PLOS ONE			English	Article							ANALOGA STIMPSON 1857; BEACH ECOSYSTEMS; CRAB; MULTIVARIATE; ASSEMBLAGES; ORIENTATION; VARIABILITY; ABUNDANCE; ZONATION; BACI	Determining the effects of unpredictable disturbances on dynamic ecological systems is challenged by the paucity of appropriate temporal and spatial coverage of data. On 27 February 2010, an 8.8 Mw mega-earthquake and tsunami struck central Chile and caused coastal land-level changes, massive damage to coastal infrastructure, and widespread mortality of coastal organisms. Wave-exposed sandy beaches showed significant changes of species abundances from before to after the earthquake, but the highly dynamic biotic and abiotic conditions of these habitats make difficult to draw clear-cut conclusions from these patterns. Here, we analysed a beyond-BACI (Before-After Control-Impact) sampling design to test whether the effects of the Maule earthquake on sandy-shore species diversity, abundance, and structure were heterogeneous along the shore. Invertebrate species abundances were quantified before (i.e. February 2010) and after (i.e. March 2010, September 2010, and March 2011) the earthquake at three sandy shores randomly located within the earthquake rupture area and three sites within a "control" area located >400 km southward from epicentre. Immediately after the earthquake took place, the three sites located in the rupture area showed anomalous beach-profile uplifts that did not comply with the erosion (i.e. "negative" uplifts) that regularly occurs during late summer in the region. Species richness, abundance, and community structure significantly varied from before to after the strike, but these patterns of change varied among sites within both areas. Only the site with the strongest and persistent beach-profile uplift within the rupture area showed significant concomitant changes in species richness and community structure; after 13 months, this community showed a similar multivariate structure to the before-disturbance state. This site, in particular, was located in the section of the rupture area that received most of the impact of the after-earthquake tsunami. Therefore, our results suggest that the effects of the Maule mega-earthquake on the ecological communities were spatially heterogeneous and highly localised. We suggest that high mobility and other species' adaptations to the dynamic environmental conditions of sandy beaches might explain the comparatively high resilience of these assemblages. With this work we hope to motivate further experimental research on the role of individual- and population-level properties in the response of sandy-beach communities to interacting sources of disturbances.	[Sepulveda, Roger D.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Sepulveda, Roger D.] Univ Simon Bolivar, South Amer Res Grp Coastal Ecosyst SARCE, Ctr Invest, Caracas, Venezuela; [Valdivia, Nelson] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Valdivia, Nelson] Univ Austral Chile, Ctr Invest FONDAP Dinam Ecosistemas Marinos Altas, Valdivia, Chile	Universidad Austral de Chile; Simon Bolivar University; Universidad Austral de Chile; Universidad Austral de Chile	Sepulveda, RD (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.; Sepulveda, RD (corresponding author), Univ Simon Bolivar, South Amer Res Grp Coastal Ecosyst SARCE, Ctr Invest, Caracas, Venezuela.	rogersepulveda@uach.cl	; Valdivia, Nelson/C-3613-2009	Sepulveda, Roger D./0000-0003-0226-5662; Valdivia, Nelson/0000-0002-5394-2072	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [3100145, 1141037, DID-UACHS-2013-03]; Direccion de Investigacion y Desarrollo [DID-UACHS-2014-29]; Programa de Mejoramiento de la Calidad y Equidad de la Educacion Superior MECESUP [0805]	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion y Desarrollo; Programa de Mejoramiento de la Calidad y Equidad de la Educacion Superior MECESUP	This study was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT #3100145 and Direccion de Investigacion y Desarrollo DID-UACHS-2014-29 grants to R.D. Sepulveda, and supported by Programa de Mejoramiento de la Calidad y Equidad de la Educacion Superior MECESUP #0805, FONDECYT #1141037, and DID-UACHS-2013-03 grants to N. Valdivia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Brusca RC, 2003, INVERTEBRATES; Castilla JC, 2010, MAR ECOL PROG SER, V418, P17, DOI 10.3354/meps08830; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Defeo O, 2013, GEOMORPHOLOGY, V199, P106, DOI 10.1016/j.geomorph.2013.04.013; Donohue I, 2013, ECOL LETT, V16, P421, DOI 10.1111/ele.12086; Dugan JE, 2010, SCIENCE, V329, P1146, DOI 10.1126/science.329.5996.1146-a; Fanini L, 2009, MAR ECOL PROG SER, V392, P133, DOI 10.3354/meps08219; Farias M, 2010, SCIENCE, V329, P916, DOI 10.1126/science.1192094; Gower J., 2005, ENCY BIOSTATISTICS, DOI DOI 10.1111/icad.12045; Jaramillo E, 2003, ESTUAR COAST SHELF S, V58, P177, DOI 10.1016/S0272-7714(03)00049-0; Jaramillo E, 1996, REV CHIL HIST NAT, V69, P641; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Madariaga R, 2010, SCIENCE, V328, P181, DOI 10.1126/science.1189197; McLachlan A., 2010, ECOLOGY SANDY SHORES, DOI DOI 10.1016/B978-0-12-372569-1.X5000-9; Menge BA, 2015, ECOL MONOGR, V85, P213, DOI 10.1890/14-0113.1; Munguia P, 2007, OECOLOGIA, V153, P533, DOI 10.1007/s00442-007-0762-7; Nel R, 2014, ESTUAR COAST SHELF S, V150, P1, DOI 10.1016/j.ecss.2014.07.016; Nybakken J., 2005, MARINE BIOL ECOLOGIC; Rodriguez JG, 2001, REV CHIL HIST NAT, V74, P885; Rossano C, 2009, ESTUAR COAST SHELF S, V85, P573, DOI 10.1016/j.ecss.2009.09.029; Scapini F, 2008, MAR ECOL-EVOL PERSP, V29, P19, DOI 10.1111/j.1439-0485.2007.00196.x; Scapini F, 2013, CRUSTACEANA, V86, P932, DOI 10.1163/15685403-00003206; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Subramoniam T, 2003, ADV MAR BIOL, V46, P91, DOI 10.1016/S0065-2881(03)46003-3; Terlizzi A, 2005, MAR ECOL PROG SER, V289, P27, DOI 10.3354/meps289027; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Valdivia N, 2014, MAR ECOL PROG SER, V497, P131, DOI 10.3354/meps10593; Veas R, 2013, MAR ENVIRON RES, V89, P9, DOI 10.1016/j.marenvres.2013.04.004; Veas R, 2014, MAR BIOL, V161, P2345, DOI 10.1007/s00227-014-2510-y; Veiga P, 2014, J SEA RES, V90, P1, DOI 10.1016/j.seares.2014.02.009; Vigny C, 2011, SCIENCE, V332, P1417, DOI 10.1126/science.1204132; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612	40	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157910	10.1371/journal.pone.0157910	http://dx.doi.org/10.1371/journal.pone.0157910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383744	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400030
J	Stokesbury, MJW; Logan-Chesney, LM; McLean, MF; Buhariwalla, CF; Redden, AM; Beardsall, JW; Broome, JE; Dadswell, MJ				Stokesbury, Michael J. W.; Logan-Chesney, Laura M.; McLean, Montana F.; Buhariwalla, Colin F.; Redden, Anna M.; Beardsall, Jeffrey W.; Broome, Jeremy E.; Dadswell, Michael J.			Atlantic Sturgeon Spatial and Temporal Distribution in Minas Passage, Nova Scotia, Canada, a Region of Future Tidal Energy Extraction	PLOS ONE			English	Article							POPULATION CHARACTERISTICS; ACIPENSER-FULVESCENS; FISHWAY DESIGN; SUWANNEE RIVER; LAKE STURGEON; UNITED-STATES; HABITAT USE; INNER BAY; FUNDY; BASIN	In the Bay of Fundy, Atlantic sturgeon from endangered and threatened populations in the USA and Canada migrate through Minas Passage to enter and leave Minas Basin. A total of 132 sub-adult and adult Atlantic sturgeon were tagged in Minas Basin during the summers of 2010-2014 using pressure measuring, uniquely coded, acoustic transmitters with a four or eight year life span. The aim of this study was to examine spatial and seasonal distribution of sturgeon in Minas Passage during 2010-2014 and test the hypothesis that, when present, Atlantic sturgeon were evenly distributed from north to south across Minas Passage. This information is important as tidal energy extraction using in-stream, hydrokinetic turbines is planned for only the northern portion of Minas Passage. Electronic tracking data from a total of 740 sturgeon days over four years demonstrated that Atlantic sturgeon used the southern portion of Minas Passage significantly more than the northern portion. Sturgeon moved through Minas Passage at depths mostly between 15 and 45 m (n = 10,116; mean = 31.47 m; SD = 14.88). Sturgeon mean swimming depth was not significantly related to bottom depth and in deeper regions they swam pelagically. Sturgeon predominately migrated inward through Minas Passage during spring, and outward during late summer-autumn. Sturgeon were not observed in Minas Passage during winter 2012-2013 when monitoring receivers were present. This information will enable the estimation of encounters of Atlantic sturgeon with in-stream hydrokinetic turbines.	[Stokesbury, Michael J. W.; Logan-Chesney, Laura M.; McLean, Montana F.; Buhariwalla, Colin F.; Redden, Anna M.; Beardsall, Jeffrey W.; Broome, Jeremy E.; Dadswell, Michael J.] Acadia Univ, Dept Biol, Wolfville, NS, Canada	Acadia University	Stokesbury, MJW (corresponding author), Acadia Univ, Dept Biol, Wolfville, NS, Canada.	Michael.Stokesbury@AcadiaU.ca			National Science and Engineering Research Council of Canada; Offshore Energy and Environmental Research; Fundy Ocean Research Centre for Energy; Acadia Graduate Awards; Canada Research Chairs Program	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Offshore Energy and Environmental Research; Fundy Ocean Research Centre for Energy; Acadia Graduate Awards; Canada Research Chairs Program(Canada Research Chairs)	Research was funded by the National Science and Engineering Research Council of Canada grant to the Ocean Tracking Network Canada, Dr. Sara Iverson PI (http://www.nserc-crsng.gc.ca/). Research was funded by the National Science and Engineering Research Council of Canada Discovery Grant to MJWS (http://www.nserc-crsng.gc.ca/). Offshore Energy and Environmental Research, and Fundy Ocean Research Centre for Energy awards to AMR and MJWS (http://www.oera.ca/about-us/history-of-oeer-oetr/; http://fundyforce.ca/). Support was also provided by Acadia Graduate Awards to MFM, JWB, LMLC and CFB (http://www2.acadiau.ca/index.php). MJWS was supported by the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx).	Apostle R, 2013, J INT WILDLIFE LAW P, V16, P198; ASMFC (Atlantic States Marine Fisheries Commission), 1998, ATL STURG STOCK ASS; Beardsall JW, 2013, T AM FISH SOC, V142, P1202, DOI 10.1080/00028487.2013.806347; Benson RL, 2007, ENVIRON BIOL FISH, V79, P269, DOI 10.1007/s10641-006-9023-6; Bousf ield E. L., 1960, Bulletin National Museum of Canada, VNo. 166, P1; Bradford RG, 1992, CAN J ZOOL, V71, P56; Broome J, 2012, 107 AC CTR EST RES; Broome J. E., 2014, THESIS; Broome JE, 2015, P 3 MAR EN TECHN S M; Cheong TS, 2006, ENVIRON BIOL FISH, V77, P197, DOI 10.1007/s10641-006-9071-y; Coutant CC, 2000, T AM FISH SOC, V129, P351, DOI 10.1577/1548-8659(2000)129<0351:FBIRTP>2.0.CO;2; Dadswell M. J., 1987, AM FISHERIES SOC S, V1, P313; DADSWELL MJ, 1994, BIOL J LINN SOC, V51, P93, DOI 10.1111/j.1095-8312.1994.tb00947.x; DADSWELL MJ, 1986, FISHERIES, V11, P26, DOI 10.1577/1548-8446(1986)011<0026:PIOLTP>2.0.CO;2; DADSWELL MJ, 1979, CAN J ZOOL, V57, P2186, DOI 10.1139/z79-287; Dadswell MJ, 2006, FISHERIES, V31, P218, DOI 10.1577/1548-8446(2006)31[218:AROTSO]2.0.CO;2; Dadswell MJ., 1984, CAN TECH REP FISH AQ, V1256, P163; DFO (Department of Fisheries and Oceans Canada), 2009, 2009029 DFO CAN SCI; Erickson DL, 2011, J APPL ICHTHYOL, V27, P356, DOI 10.1111/j.1439-0426.2011.01690.x; Food and Drug Administration, 2012, FED REGISTER, V77, P2012; GORDON DC, 1983, CAN J FISH AQUAT SCI, V40, P1331, DOI 10.1139/f83-156; Greely J.R, 1963, MEM SEARS FOUND MAR, V1, P24; Hammar L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117756; Hammar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084141; Karsten RH, 2008, P I MECH ENG A-J POW, V222, P493, DOI 10.1243/09576509JPE555; Keyser FM, 2016, CAN J FISH AQUAT SCI, V73, P1777, DOI 10.1139/cjfas-2016-0002; McLean MF, 2013, J APPL ICHTHYOL, V29, P503, DOI 10.1111/jai.12175; McLean MF, 2014, MAR ECOL PROG SER, V496, P59, DOI 10.3354/meps10555; Moore T., 1998, THESIS; O'Rourke F, 2010, RENEW SUST ENERG REV, V14, P3206, DOI 10.1016/j.rser.2010.07.039; Peake S, 1997, CAN J FISH AQUAT SCI, V54, P1361, DOI 10.1139/cjfas-54-6-1361; Redden A.M., 2014, P 2 INT C ENV INT MA; Rulifson RA, 2008, T AM FISH SOC, V137, P23, DOI 10.1577/T06-174.1; Scott W.B., 1988, CANADIAN B FISHERIES, V219; Secor DH, 2002, AM FISH S S, V28, P89; Stein AB, 2004, T AM FISH SOC, V133, P527, DOI 10.1577/T02-151.1; Stokesbury KDE, 2014, REV FISH SCI AQUAC, V22, P193, DOI 10.1080/23308249.2014.913005; Sulak KJ, 1999, J APPL ICHTHYOL, V15, P116, DOI 10.1111/j.1439-0426.1999.tb00220.x; Sulak KJ, 2002, J APPL ICHTHYOL, V18, P617, DOI 10.1046/j.1439-0426.2002.00401.x; Taylor DA, PLOS ONE, V11, DOI [10.1371/journal.pone.01524702016, DOI 10.1371/JOURNAL.PONE.01524702016]; Vennell R, 2010, J FLUID MECH, V663, P253, DOI 10.1017/S0022112010003502; Viehman HA, 2015, ESTUAR COAST, V38, pS215, DOI 10.1007/s12237-014-9776-7; Viehman HA, 2015, ESTUAR COAST, V38, pS241, DOI 10.1007/s12237-014-9767-8; WEBB PW, 1986, CAN J ZOOL, V64, P2137, DOI 10.1139/z86-328; Wirgin I, 2012, T AM FISH SOC, V141, P1389, DOI 10.1080/00028487.2012.700899; YEO RK, 1979, GEOSCI CAN, V6, P115	46	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158387	10.1371/journal.pone.0158387	http://dx.doi.org/10.1371/journal.pone.0158387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383274	Green Published, gold			2022-12-27	WOS:000379809400046
J	Banares-Hidalgo, A; Perez-Gil, J; Estrada, P				Banares-Hidalgo, Angeles; Perez-Gil, Jesus; Estrada, Pilar			Conformational Stability of the NH2-Terminal Propeptide of the Precursor of Pulmonary Surfactant Protein SP-B	PLOS ONE			English	Article							ESCHERICHIA-COLI; RECOMBINANT FORM; IN-VITRO; AGGREGATION; XYLANASE; BINDING; MODEL	Assembly of pulmonary surfactant lipid-protein complexes depends on conformational changes coupled with proteolytic maturation of proSP-B, the precursor of pulmonary surfactant protein B (SP-B), along the surfactant biogenesis pathway in pneumocytes. Conformational destabilization of the N-terminal propeptide of proSP-B (SP-B-N) triggers exposure of the mature SP-B domain for insertion into surfactant lipids. We have studied the conformational stability during GdmCl- or urea-promoted unfolding of SP-B-N with trp fluorescence and circular dichroism spectroscopies. Binding of the intermediate states to bis-ANS suggests their molten globule-like character. Delta G(H2O)(0) was similar to 12.7 kJ center dot mol(-1) either with urea or GdmCl. None of the thermal transitions of SP-B-N detected by CD correspond to protein unfolding. Differential scanning calorimetry of SP-B-N evidenced two endothermic peaks involved in oligomer dissociation as confirmed with 2 M urea. Ionic strength was relevant since at 150 mM NaCl, the process originating the endotherm at the highest temperature was irreversible (T-m2 = 108.5 degrees C) with an activation energy of 703.8 kJ center dot mol(-1). At 500 mM NaCl the process became reversible (T-m2 = 114.4 degrees C) and data were fitted to the Non-two States model with two subpeaks. No free thiois in the propeptide could be titrated by DTNB with or without 5.7 M GdmCl, indicating disulfide bonds establishment.	[Banares-Hidalgo, Angeles; Perez-Gil, Jesus; Estrada, Pilar] Univ Complutense, Fac Biol, Dept Bioquim & Biol Mol 1, Ciudad Univ, E-28040 Madrid, Spain	Complutense University of Madrid	Perez-Gil, J (corresponding author), Univ Complutense, Fac Biol, Dept Bioquim & Biol Mol 1, Ciudad Univ, E-28040 Madrid, Spain.	jperezgil@bio.ucm.es	Perez-Gil, Jesus/H-3102-2019	Perez-Gil, Jesus/0000-0003-3587-7147	Spanish Ministry of Economy and Competition [BIO2012-30733, BIO2015-67930-R]; Regional Government of Madrid [P2013/MIT-2807]	Spanish Ministry of Economy and Competition(Spanish Government); Regional Government of Madrid	This research has been supported by grants from the Spanish Ministry of Economy and Competition (BIO2012-30733, BIO2015-67930-R), and the Regional Government of Madrid (P2013/MIT-2807).	Banares-Hidalgo A, 2008, J IND MICROBIOL BIOT, V35, P1367, DOI 10.1007/s10295-008-0437-3; Banares-Hidalgo A, 2014, BBA-BIOMEMBRANES, V1838, P1738, DOI 10.1016/j.bbamem.2014.03.016; Brasch F, 2004, AM J RESP CELL MOL, V30, P449, DOI 10.1165/rcmb.2003-0262OC; Burgos I, 2008, J PHYS CHEM B, V112, P14325, DOI 10.1021/jp804465c; Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200; Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200; Clarke J, 1998, CURR OPIN STRUC BIOL, V8, P112, DOI 10.1016/S0959-440X(98)80018-3; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Fan DJ, 2009, BIOCHIM BIOPHYS ACTA, V1794, P994; Faull KF, 2000, ARCH BIOCHEM BIOPHYS, V376, P266, DOI 10.1006/abbi.2000.1714; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; FREIRE E, 1978, BIOPOLYMERS, V17, P463, DOI 10.1002/bip.1978.360170212; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Gozdek A, 2008, ACTA BIOCHIM POL, V55, P57, DOI 10.18388/abp.2008_3201; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Guo SY, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1267, DOI 10.1023/B:BIRY.0000009143.92546.33; Ishimaru D, 2004, BIOPHYS J, V87, P2691, DOI 10.1529/biophysj.104.044685; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lima LMTR, 2004, EUR J BIOCHEM, V271, P3580, DOI 10.1111/j.0014-2956.2004.04295.x; Lin S, 1996, J BIOL CHEM, V271, P19689, DOI 10.1074/jbc.271.33.19689; Lopez G, 2011, J IND MICROBIOL BIOT, V38, P113, DOI 10.1007/s10295-010-0836-0; Lyubarev AE, 2000, J THERM ANAL CALORIM, V62, P51, DOI 10.1023/A:1010102525964; Menendez M, 1995, EUR J BIOCHEM, V234, P887, DOI 10.1111/j.1432-1033.1995.887_a.x; Milardi D, 1996, BIOPHYS CHEM, V62, P95, DOI 10.1016/S0301-4622(96)02191-6; Nath D, 2001, EUR J BIOCHEM, V268, P5471, DOI 10.1046/j.0014-2956.2001.02485.x; Palacios A, 2006, ENZYME MICROB TECH, V40, P85, DOI 10.1016/j.enzmictec.2005.10.042; PAPPA HS, 1993, EUR J BIOCHEM, V212, P227, DOI 10.1111/j.1432-1033.1993.tb17654.x; PATTHY L, 1991, J BIOL CHEM, V266, P6035; Pfeil W., 1998, PROTEIN STABILITY FO; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; QI XY, 1994, J BIOL CHEM, V269, P16746; Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2; REDFIELD C, 1994, NAT STRUCT BIOL, V1, P23, DOI 10.1038/nsb0194-23; Rosgen J, 1999, HDB THERMAL ANAL CAL, P65; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Schiffer CA, 1996, CURR OPIN BIOTECH, V7, P428, DOI 10.1016/S0958-1669(96)80119-4; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TANFORD C, 1964, J AM CHEM SOC, V86, P2050, DOI 10.1021/ja01064a028; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, FEBS LETT, V514, P181, DOI 10.1016/S0014-5793(02)02359-1; Uversky VN, 1997, PROTEIN PEPTIDE LETT, V4, P355; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Yang L, 2010, J IMMUNOL, V184, P975, DOI 10.4049/jimmunol.0900650; Zhai YF, 2000, BBA-REV BIOMEMBRANES, V1469, P87, DOI 10.1016/S0304-4157(00)00003-4	48	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158430	10.1371/journal.pone.0158430	http://dx.doi.org/10.1371/journal.pone.0158430			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380171	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000379798700031
J	Lipovsek, S; Novak, T; Janzekovic, F; Weiland, N; Leitinger, G				Lipovsek, Saska; Novak, Tone; Janzekovic, Franc; Weiland, Nina; Leitinger, Gerd			Malpighian Tubule Cells in Overwintering Cave Crickets Troglophilus cavicola (Kollar, 1833) and T. neglectus Krauss, 1879 (Rhaphidophoridae, Ensifera)	PLOS ONE			English	Article							FINE-STRUCTURE; FAT-BODY; AUTOPHAGY; ORTHOPTERA; STARVATION; MIDGUT; TRANSPORT	During winter, cave cricket larvae undergo dormancy in subterranean habitats; this dormancy is termed diapause in second year Troglophilus cavicola larvae because they mature during this time, and termed quiescence in T. neglectus, because they mature after dormancy. Here we used electron microscopy to analyze ultrastructural changes in the epithelial cells in the Malpighian tubules (MTs) of T. cavicola during diapause, in order to compare them with previous findings on T. neglectus. Moreover, the autophagosomes were studied with immunofluorescence microscopy in both species. Although the basic ultrastructure of the cells was similar, specific differences appeared during overwintering. During this natural starvation period, the nucleus, rER, the Golgi apparatus and mitochondria did not show structural changes, and the spherites were exploited. The abundances of autophagic structures in both species increased during overwintering. At the beginning of overwintering, in both species and sexes, the rates of cells with autophagic structures (phagophores, autophagosomes, autolysosomes and residual bodies) were low, while their rates increased gradually towards the end of overwintering. Between sexes, in T. cavicola significant differences were found in the autophagosome abundances in the middle and at the end, and in T. neglectus at the end of overwintering. Females showed higher rates of autophagic cells than males, and these were more abundant in T. cavicola. Thus, autophagic processes in the MT epithelial cells induced by starvation are mostly parallel in diapausing T. cavicola and quiescent T. neglectus, but more intensive in diapausing females.	[Lipovsek, Saska] Univ Maribor, Fac Med, Maribor, Slovenia; [Lipovsek, Saska; Novak, Tone; Janzekovic, Franc; Weiland, Nina] Univ Maribor, Fac Nat Sci & Math, Dept Biol, Maribor, Slovenia; [Lipovsek, Saska] Univ Maribor, Fac Chem & Chem Engn, Maribor, Slovenia; [Leitinger, Gerd] Med Univ Graz, Inst Cell Biol Histol & Embryol, Res Unit Electron Microscop Tech, Graz, Austria	University of Maribor; University of Maribor; University of Maribor; Medical University of Graz	Leitinger, G (corresponding author), Med Univ Graz, Inst Cell Biol Histol & Embryol, Res Unit Electron Microscop Tech, Graz, Austria.	gerd.leitinger@medunigraz.at	Janžekovič, Franc/H-9096-2015	Leitinger, Gerd/0000-0002-5281-9830				Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Alberts B, 2008, MOL BIOL CELL, P813; Alberts B, 2004, ESSENTIAL CELL BIOL, P39; Alexiou S, 2013, PARNASSIANA ARCH, V1, P51; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Bradley T.J., 1985, P421; Bradley TJ, 2008, J EXP BIOL, V211, P835, DOI 10.1242/jeb.009589; Chopard L, 1983, BIOL ORTHOPTERES, P541; CHRISTIAN, 2008, HOHLE, V59, P48; Cooper GM, 2009, CELL MOL APPROACH, P309; Delakorda SL, 2009, ARTHROPOD STRUCT DEV, V38, P315, DOI 10.1016/j.asd.2009.02.001; Di Russo C., 1998, ENCY BIOSPELEOLOGICA, VII, P989; Di Russo Claudio, 2007, Journal of Orthoptera Research, V16, P67, DOI 10.1665/1082-6467(2007)16[67:TCCONT]2.0.CO;2; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Eskelinen Eeva-Liisa, 2008, V445, P11, DOI 10.1007/978-1-59745-157-4_2; GARRETT MA, 1988, J MORPHOL, V195, P313, DOI 10.1002/jmor.1051950306; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hazelton SR, 2001, J MORPHOL, V247, P80, DOI 10.1002/1097-4687(200101)247:1<80::AID-JMOR1004>3.0.CO;2-X; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heller GH, 2004, FAUNA EUROPEA RHAPHI; Kalender Yusuf, 2002, Acta Zoologica Bulgarica, V54, P87; Karaman I, 2011, ZOOL J LINN SOC-LOND, V163, P1035, DOI 10.1111/j.1096-3642.2011.00738.x; Kaya S, 2013, BIOL J LINN SOC, V108, P335, DOI 10.1111/j.1095-8312.2012.02025.x; Ketmaier V, 2000, BELG J ZOOL, V130, P51; Khoa DB, 2012, INSECT MOL BIOL, V21, P473, DOI 10.1111/j.1365-2583.2012.01152.x; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kogler K, 1983, THESIS; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; LEROY YVELINE, 1967, ANN SPELEOL, V22, P659; Lipovsek S, 2016, PROTOPLASMA, V253, P457, DOI 10.1007/s00709-015-0824-3; Lipovsek S, 2014, ARTHROPOD STRUCT DEV, V43, P493, DOI 10.1016/j.asd.2014.06.001; Lipovsek S, 2011, ARTHROPOD STRUCT DEV, V40, P54, DOI 10.1016/j.asd.2010.09.002; Martoja R., 1984, P199; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moog O, 1982, SITZ BER OSTERR MN 1, V191, P185; Novak T., 1983, MEM BIOSPEOL, V10, P127; Novak T, 2013, ACTA CARSOLOGICA, V42, P301; Pacheco CA, 2014, ENTOMOL ORNITHOL HER, V3, P2, DOI [DOI 10.4172/2161-0983.1000122, 10.4172/2161-0983.1000122]; Pal R, 2013, TISSUE CELL, V45, P312, DOI 10.1016/j.tice.2013.04.002; PANNABECKER T, 1995, ANNU REV ENTOMOL, V40, P493, DOI 10.1146/annurev.en.40.010195.002425; Pehani Spela, 1997, Entomologist, V116, P224; Pigino G, 2005, TISSUE CELL, V37, P223, DOI 10.1016/j.tice.2005.02.001; Remy P., 1931, Annales des Sciences Naturelles (Zoologie) Paris, V(10), P263; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Sbordoni V, 2004, ENCY CAVES KARST SCI, P451; Taylan MS, 2013, ZOOKEYS, P33, DOI 10.3897/zookeys.257.4133; Taylan S, 2012, ZOOTAXA, V3597, P33; Wheeler DE, 2003, ENCY INSECTS, P991; Yea SY, 1992, B I BASIC SCI INHA U, V13, P97	51	9	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158598	10.1371/journal.pone.0158598	http://dx.doi.org/10.1371/journal.pone.0158598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379687	Green Submitted, gold, Green Published			2022-12-27	WOS:000379798700037
J	Vantangoli, MM; Madnick, SJ; Wilson, S; Boekelheide, K				Vantangoli, Marguerite M.; Madnick, Samantha J.; Wilson, Shelby; Boekelheide, Kim			Estradiol Exposure Differentially Alters Monolayer versus Microtissue MCF-7 Human Breast Carcinoma Cultures	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; E-CADHERIN; GENE-EXPRESSION; ESTROGEN; PROLIFERATION; SNAIL; SLUG	The development of three-dimensional (3D) cultures is increasing, as they are able to provide the utility of in vitro models and the strength of testing in physiologically relevant systems. When cultured in a scaffold-free agarose hydrogel system, MCF-7 human breast carcinoma cells organize and develop into microtissues that contain a luminal space, in stark contrast to the flat morphology of MCF-7 two-dimensional (2D) monolayer cultures. Following exposure to 1nM E2, expression of typical estrogen-responsive genes, including progesterone receptor (PGR), PDZ containing domain 1 (PDZK1) and amphiregulin (AREG) is increased in both 2D and 3D cultures. When examining expression of other genes, particularly those involved in cell adhesion, there were large changes in 3D MCF-7 microtissues, with little to no change observed in the MCF-7 monolayer cultures. Together, these results indicate that while the initial estrogen-regulated transcriptional targets respond similarly in 2D and 3D cultures, there are large differences in activation of other pathways related to cell-cell interactions.	[Vantangoli, Marguerite M.; Madnick, Samantha J.; Wilson, Shelby; Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, 70 Ship St, Providence, RI 02903 USA	Brown University	Boekelheide, K (corresponding author), Brown Univ, Dept Pathol & Lab Med, 70 Ship St, Providence, RI 02903 USA.	Kim_Boekelheide@brown.edu			National Institute of Environmental Health Sciences (NIEHS) Training Grant [T32 ES007272]; NIH [RO1 ES 020750]; Unilever; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007272, R01ES020750] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS) Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unilever(Unilever); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Major support for this research was provided by the National Institute of Environmental Health Sciences (NIEHS) Training Grant T32 ES007272, Unilever, and the generous gift of Donna McGraw Weiss '89 and Jason Weiss, with additional support by NIH RO1 ES 020750. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors would like to thank Dr. Edward Dere for assistance with data analysis and visualization.; Major support for this research was provided NIEHS Training Grant T32 ES007272, Unilever, and the generous gift of Donna McGraw Weiss '89 and Jason Weiss, with additional support by NIH RO1 ES 020750. The authors would like to thank Dr. Edward Dere for assistance with data analysis and visualization.	[Anonymous], 2002, NORMAL TUMOR DERIVED; [Anonymous], 2007, MORPHOLOGIES BREAST; [Anonymous], 2003, FIBROBLAST BIOL 3 DI; [Anonymous], 1973, HUMAN CELL LINE PLEU; [Anonymous], 2007, DYNAMICS SELF ASSEMB; [Anonymous], 2004, USE 3 DIMENSIONAL BA; [Anonymous], 2003, MORPHOGENESIS ONCOGE; [Anonymous], 2005, MODELLING GLANDULAR; [Anonymous], 2007, 3 DIMENSIONAL CULTUR; [Anonymous], 1991, CONTROL MAMMARY EPIT; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Chambers A, 2010, J TOXICOL ENV HEAL B, V13, P546, DOI 10.1080/10937404.2010.538657; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Ghosh MG, 2000, CANCER RES, V60, P6367; Hajra KM, 2002, CANCER RES, V62, P1613; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Kohl M, 2007, SLQPCR FUNCTIONS ANA; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; R Core Team, 2012, R LANG ENV STAT COMP; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Scherbakov AM, 2012, J CELL BIOCHEM, V113, P2147, DOI 10.1002/jcb.24087; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Vantangoli MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135426; Vendrell JA, 2004, J MOL ENDOCRINOL, V32, P397, DOI 10.1677/jme.0.0320397; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	32	7	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157997	10.1371/journal.pone.0157997	http://dx.doi.org/10.1371/journal.pone.0157997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379522	Green Submitted, Green Published, gold			2022-12-27	WOS:000379798700016
J	Horppu, R; Martimo, KP; Viikari-Juntura, E; Lallukka, T; MacEachen, E				Horppu, Ritva; Martimo, Kari-Pekka; Viikari-Juntura, Eira; Lallukka, Tea; MacEachen, Ellen			Occupational Physicians' Reasoning about Recommending Early Return to Work with Work Modifications	PLOS ONE			English	Article							LOW-BACK-PAIN; TO-WORK; SICK LEAVE; WORKPLACE INTERVENTION; EXPERIENCES; IMPLEMENTATION; PERSPECTIVES; DEPRESSION; DISORDERS; FRAMEWORK	Previous research indicates that work modifications can effectively enhance return to work (RTW) at an early stage of work disability. We aimed to examine how occupational physicians (OPs) reason about recommending early return to work (RTW) with work modifications. Pre-defined propositions regarding the use of work modifications in promoting early RTW were discussed in four focus groups with altogether 11 Finnish OPs. Discussions were audio recorded, and the transcribed data were analyzed using qualitative content analysis. Five different rationales for supporting early RTW were identified: to manage medical conditions, to enhance employee well-being, to help workplace stakeholders, to reduce costs to society, and to enhance OP's own professional fulfillment. However, OPs identified situations and conditions in which early RTW may not be suitable. In addition, there were differences between the OPs in the interpretation of the rationales, suggesting variation in clinical practice. In conclusion, encouraging early RTW with work modifications was perceived by OPs as a meaningful task and, to a large extent, beneficial for employees and several stakeholders. However, this practice was not accepted without consideration to the RTW situation and context. If early RTW and work modifications are to be promoted, OPs should be offered education that addresses their views regarding this practice.	[Horppu, Ritva; Martimo, Kari-Pekka; Viikari-Juntura, Eira; Lallukka, Tea] Finnish Inst Occupat Hlth, Prevent Work Disabil, Helsinki, Finland; [MacEachen, Ellen] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [MacEachen, Ellen] Inst Work Hlth, Ctr Res Work Disabil Policy, Toronto, ON, Canada	Finnish Institute of Occupational Health; University of Waterloo; Institute for Work & Health	Horppu, R (corresponding author), Finnish Inst Occupat Hlth, Prevent Work Disabil, Helsinki, Finland.	ritva.horppu@ttl.fi		Lallukka, Tea/0000-0003-3841-3129	Finnish Work Environment Fund [112257]; Academy of Finland [267589]	Finnish Work Environment Fund; Academy of Finland(Academy of Finland)	Funded by Finnish Work Environment Fund (grant #112257) (RH, KPM, EVJ, TL) and Academy of Finland (grant #267589) (RH, KPM, EVJ, TL). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anema JR, 2007, SPINE, V32, P291, DOI 10.1097/01.brs.0000253604.90039.ad; Barbour R., 2007, DOING FOCUS GROUPS; Barbour RS, 2005, MED EDUC, V39, P742, DOI 10.1111/j.1365-2929.2005.02200.x; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Cote P, 2001, J MANIP PHYSIOL THER, V24, P309, DOI 10.1067/mmt.2001.115267; de Vries G, 2012, J AFFECT DISORDERS, V136, P1017, DOI 10.1016/j.jad.2011.06.035; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Fassier JB, 2011, SCAND J WORK ENV HEA, V37, P99, DOI 10.5271/sjweh.3138; Foss L, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-19; Gabbay M, 2015, OCCUP ENVIRON MED, V72, P467, DOI 10.1136/oemed-2014-102307; Gardner BT, 2010, DISABIL REHABIL, V32, P72, DOI 10.3109/09638280903195278; Green J, 2014, QUALITATIVE METHODS; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Haukka E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008300; Hoefsmit N, 2014, WORK, V48, P203, DOI 10.3233/WOR-131657; Hollander JA, 2004, J CONTEMP ETHNOGR, V33, P602, DOI 10.1177/0891241604266988; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; MacEachen E, 2007, POLICY PRACT HEALTH, V5, P41, DOI 10.1080/14774003.2007.11667693; Mann K. V., 2002, INT HDB RES MED ED, P415; Martimo KP, 2010, SCAND J WORK ENV HEA, V36, P25, DOI 10.5271/sjweh.2880; Mason J., 1996, QUALITATIVE RES; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Nieuwenhuijsen K, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006237.pub3, 10.1002/14651858.CD006237.pub4]; Rebergen DS, 2010, SCAND J WORK ENV HEA, V36, P488, DOI 10.5271/sjweh.3084; Schaafsma F, 2007, SCAND J WORK ENV HEA, V33, P368, DOI 10.5271/sjweh.1156; Scheel IB, 2002, SPINE, V27, P654, DOI 10.1097/00007632-200203150-00016; Shirazi M, 2013, J EVAL CLIN PRACT, V19, P16, DOI 10.1111/j.1365-2753.2011.01761.x; Shiri R, 2011, SCAND J WORK ENV HEA, V37, P120, DOI 10.5271/sjweh.3141; Silverman D., 1993, INTERPRETING QUALITA; Smits PB, 2003, SCAND J WORK ENV HEA, V29, P280, DOI 10.5271/sjweh.732; Soklaridis S, 2010, SOC SCI MED, V71, P1557, DOI 10.1016/j.socscimed.2010.08.017; Stigmar K, 2010, DISABIL REHABIL, V32, P1780, DOI 10.3109/09638281003678309; Tiedtke C, 2012, J OCCUP REHABIL, V22, P241, DOI 10.1007/s10926-011-9342-0; van Duijn M, 2004, J OCCUP REHABIL, V14, P31, DOI 10.1023/B:JOOR.0000015009.00933.16; van Duijn M, 2010, OCCUP ENVIRON MED, V67, P744, DOI 10.1136/oem.2009.049874; van Oostrom SH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006955.pub2; van Vilsteren M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006955.pub3; Wainwright E, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613133; Wynne-Jones G, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-210	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158588	10.1371/journal.pone.0158588	http://dx.doi.org/10.1371/journal.pone.0158588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0TX	27367908	Green Submitted, gold, Green Published			2022-12-27	WOS:000378914900041
J	Kumara, PM; Srimany, A; Arunan, S; Ravikanth, G; Shaanker, RU; Pradeep, T				Kumara, Patel Mohana; Srimany, Amitava; Arunan, Suganya; Ravikanth, Gudasalamani; Shaanker, Ramanan Uma; Pradeep, Thalappil			Desorption Electrospray Ionization (DESI) Mass Spectrometric Imaging of the Distribution of Rohitukine in the Seedling of Dysoxylum binectariferum Hook. F	PLOS ONE			English	Article							III POLYKETIDE SYNTHASE; SECONDARY METABOLITES; PENTAKETIDE CHROMONE; PLANT METABOLITES; KINASE INHIBITOR; FLAVOPIRIDOL; BIOSYNTHESIS; TRANSPORT; ALKALOIDS; LEAVES	Ambient ionization mass spectrometric imaging of all parts of the seedling of Dysoxylum binectariferum Hook. f (Meliaceae) was performed to reconstruct the molecular distribution of rohitukine (Rh) and related compounds. The species accumulates Rh, a prominent chromone alkaloid, in its seeds, fruits, and stem bark. Rh possesses anti- inflammatory, anticancer, and immuno-modulatory properties. Desorption electrospray ionization mass spectrometry imaging (DESI MSI) and electrospray ionization (ESI) tandem mass spectrometry (MS/MS) analysis detected Rh as well as its glycosylated, acetylated, oxidized, and methoxylated analogues. Rh was predominantly distributed in the main roots, collar region of the stem, and young leaves. In the stem and roots, Rh was primarily restricted to the cortex region. The identities of the metabolites were assigned based on both the fragmentation patterns and exact mass analyses. We discuss these results, with specific reference to the possible pathways of Rh biosynthesis and translocation during seedling development in D. binectariferum.	[Kumara, Patel Mohana; Srimany, Amitava; Arunan, Suganya; Pradeep, Thalappil] Indian Inst Technol Madras, DST Unit Nanosci, Dept Chem, Chennai 600036, Tamil Nadu, India; [Kumara, Patel Mohana; Srimany, Amitava; Arunan, Suganya; Pradeep, Thalappil] Indian Inst Technol Madras, Themat Unit Excellence, Dept Chem, Chennai 600036, Tamil Nadu, India; [Ravikanth, Gudasalamani; Shaanker, Ramanan Uma] Univ Agr Sci, GKVK, Sch Ecol & Conservat, Dept Crop Physiol, Bengaluru 560065, India; [Ravikanth, Gudasalamani; Shaanker, Ramanan Uma] Ashoka Trust Res Ecol & Environm, Jakkur 560064, Bengaluru, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; University of Agricultural Sciences Bangalore	Pradeep, T (corresponding author), Indian Inst Technol Madras, DST Unit Nanosci, Dept Chem, Chennai 600036, Tamil Nadu, India.; Pradeep, T (corresponding author), Indian Inst Technol Madras, Themat Unit Excellence, Dept Chem, Chennai 600036, Tamil Nadu, India.	pradeep@iitm.ac.in	G, Ravikanth/AAI-5668-2020	G, Ravikanth/0000-0002-9399-8580; Dalisay, Doralyn/0000-0003-2850-7797; Pradeep, T./0000-0003-3174-534X	Department of Science and Technology (DST); SERB-DST Fast Track grant [SB/YS/LS-361/2013]; Department of Biotechnology (DBT), Government of India	Department of Science and Technology (DST)(Department of Science & Technology (India)); SERB-DST Fast Track grant; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	Department of Science and Technology (DST), SERB-DST Fast Track grant (File No. SB/YS/LS-361/2013) and Department of Biotechnology (DBT), Government of India supported to carry out this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2005, J AM CHEM SOC, V127, P1362, DOI 10.1021/ja0431206; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bjarnholt N, 2014, NAT PROD REP, V31, P818, DOI 10.1039/c3np70100j; Cabral EC, 2013, J AM SOC MASS SPECTR, V24, P956, DOI 10.1007/s13361-013-0616-y; Dalisay DS, 2015, J NAT PROD, V78, P1231, DOI 10.1021/acs.jnatprod.5b00023; Gamble J. S, 1997, FLORA PRESIDENCY MAD, VI-III; HARMON AD, 1979, TETRAHEDRON LETT, P721, DOI 10.1016/S0040-4039(01)93556-7; Hemalatha RG, 2013, J AGR FOOD CHEM, V61, P7477, DOI 10.1021/jf4011998; HERBERT RB, 1995, NAT PROD REP, V12, P445, DOI 10.1039/np9951200445; HOUGHTON PJ, 1987, PLANTA MED, P262, DOI 10.1055/s-2006-962698; Houghton PJ., 2002, J CHROMATOGRAPHY A, V967; Ifa DR, 2011, ANAL METHODS-UK, V3, P1910, DOI 10.1039/c1ay05295k; Ismail IS, 2009, J NAT PROD, V72, P1879, DOI 10.1021/np9003849; Jain SK, 2012, MINI-REV MED CHEM, V12, P632; Jain SK, 2013, TETRAHEDRON LETT, V54, P7140, DOI 10.1016/j.tetlet.2013.10.096; Khadem S, 2012, MOLECULES, V17, P191, DOI 10.3390/molecules17010191; Korte AR, 2012, ANAL METHODS-UK, V4, P474, DOI 10.1039/c2ay05618f; Kueger S, 2012, PLANT J, V70, P39, DOI 10.1111/j.1365-313X.2012.04902.x; Kumara PM, 2015, PHYTOCHEMISTRY, V116, P104, DOI 10.1016/j.phytochem.2015.02.031; Kumara PM, 2014, PHYTOMEDICINE, V21, P541, DOI 10.1016/j.phymed.2013.09.019; Kumara PM, 2012, ANTON LEEUW INT J G, V101, P323, DOI 10.1007/s10482-011-9638-2; Lee YJ, 2012, PLANT J, V70, P81, DOI 10.1111/j.1365-313X.2012.04899.x; Li B, 2013, INT J MASS SPECTROM, V348, P15, DOI 10.1016/j.ijms.2013.04.018; Li B, 2013, PLANT J, V74, P1059, DOI 10.1111/tpj.12183; Mahajan V, 2015, PHARM BIOL, V53, P446, DOI 10.3109/13880209.2014.923006; Manske R.H., 1987, ALKALOIDS CHEM PHARM, V31, P123; Marques JV, 2014, MOL BIOSYST, V10, P2838, DOI 10.1039/c4mb00403e; Marques JV, 2013, J BIOL CHEM, V288, P466, DOI 10.1074/jbc.M112.400689; Mohana Kumara P., 2012, ASSESSING THE GENETI; Mohanakumara P, 2010, FITOTERAPIA, V81, P145, DOI 10.1016/j.fitote.2009.08.010; Morita H, 2007, ACTA CRYSTALLOGR F, V63, P947, DOI 10.1107/S1744309107047069; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Morita H, 2011, P NATL ACAD SCI USA, V108, P13504, DOI 10.1073/pnas.1107782108; NAIK RG, 1988, TETRAHEDRON, V44, P2081, DOI 10.1016/S0040-4020(01)90352-7; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Petrussa E, 2013, INT J MOL SCI, V14, P14950, DOI 10.3390/ijms140714950; Sedlacek HH, 1996, INT J ONCOL, V9, P1143, DOI 10.3892/ijo.9.6.1143; Sethi P, 2012, J TROP ECOL, V28, P531, DOI 10.1017/S0266467412000648; Sirikantaramas S, 2007, PHYTOCHEMISTRY, V68, P2881, DOI 10.1016/j.phytochem.2007.08.028; Sirikantaramas Supaart, 2008, Phytochemistry Reviews, V7, P467, DOI 10.1007/s11101-007-9080-2; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Stadler WM, 2000, J CLIN ONCOL, V18, P371, DOI 10.1200/JCO.2000.18.2.371; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Varshney S, 2014, J LIPID RES, V55, P1019, DOI 10.1194/jlr.M039925; Velho N, 2009, J TROP ECOL, V25, P507, DOI 10.1017/S0266467409990083; Yang DH, 2004, J ASIAN NAT PROD RES, V6, P233, DOI 10.1080/10286020310001608930; Yazaki K, 2005, CURR OPIN PLANT BIOL, V8, P301, DOI 10.1016/j.pbi.2005.03.011; Yazaki Kazufumi, 2008, Phytochemistry Reviews, V7, P513, DOI 10.1007/s11101-007-9079-8	48	13	14	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158099	10.1371/journal.pone.0158099	http://dx.doi.org/10.1371/journal.pone.0158099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362422	Green Submitted, gold, Green Published			2022-12-27	WOS:000378865200040
J	Magalhaes, AFB; de Camargo, GMF; Fernandes, GA; Gordo, DGM; Tonussi, RL; Costa, RB; Espigolan, R; Silva, RMD; Bresolin, T; de Andrade, WBF; Takada, L; Feitosa, FLB; Baldi, F; Carvalheiro, R; Chardulo, LAL; de Albuquerque, LG				Magalhaes, Ana F. B.; de Camargo, Gregorio M. F.; Fernandes Junior, Gerardo A.; Gordo, Daniel G. M.; Tonussi, Rafael L.; Costa, Raphael B.; Espigolan, Rafael; Silva, Rafael M. de O.; Bresolin, Tiago; de Andrade, Willian B. F.; Takada, Luciana; Feitosa, Fabieli L. B.; Baldi, Fernando; Carvalheiro, Roberto; Chardulo, Luis A. L.; de Albuquerque, Lucia G.			Genome-Wide Association Study of Meat Quality Traits in Nellore Cattle	PLOS ONE			English	Article							INTRAMUSCULAR FAT DEPOSITION; LOCI AFFECTING GROWTH; BOS-TAURUS; CARCASS COMPOSITION; GENETIC EVALUATION; FULL PEDIGREE; BEEF; EXPRESSION; TENDERNESS; WEIGHT	The objective of this study was to identify genomic regions that are associated with meat quality traits in the Nellore breed. Nellore steers were finished in feedlots and slaughtered at a commercial slaughterhouse. This analysis included 1,822 phenotypic records of tenderness and 1,873 marbling records. After quality control, 1,630 animals genotyped for tenderness, 1,633 animals genotyped for marbling, and 369,722 SNPs remained. The results are reported as the proportion of variance explained by windows of 150 adjacent SNPs. Only windows with largest effects were considered. The genomic regions were located on chromosomes 5, 15, 16 and 25 for marbling and on chromosomes 5, 7, 10, 14 and 21 for tenderness. These windows explained 3,89% and 3,80% of the additive genetic variance for marbling and tenderness, respectively. The genes associated with the traits are related to growth, muscle development and lipid metabolism. The study of these genes in Nellore cattle is the first step in the identification of causal mutations that will contribute to the genetic evaluation of the breed.	[Magalhaes, Ana F. B.; de Camargo, Gregorio M. F.; Fernandes Junior, Gerardo A.; Gordo, Daniel G. M.; Tonussi, Rafael L.; Costa, Raphael B.; Espigolan, Rafael; Silva, Rafael M. de O.; Bresolin, Tiago; de Andrade, Willian B. F.; Takada, Luciana; Feitosa, Fabieli L. B.; Baldi, Fernando; Carvalheiro, Roberto; de Albuquerque, Lucia G.] Fac Ciencias Agr & Vet, Dept Zootecnia, Jaboticabal, SP, Brazil; [Carvalheiro, Roberto; Chardulo, Luis A. L.; de Albuquerque, Lucia G.] Conselho Nacl Desenvolvimento Cient & Tecnol CNPq, Brasilia, DF, Brazil; [Chardulo, Luis A. L.] Fac Med Vet & Zootecnia, Dept Melhoramento & Nutr Anim, Botucatu, SP, Brazil; [de Camargo, Gregorio M. F.] Univ Tecnol Parana, Dois Vizinhos, Parana, Brazil; [Costa, Raphael B.] Univ Fed Bahia, Dept Med Vet Prevent & Prod Anim, Salvador, BA, Brazil	Universidade Estadual Paulista; Universidade Federal da Bahia	de Albuquerque, LG (corresponding author), Fac Ciencias Agr & Vet, Dept Zootecnia, Jaboticabal, SP, Brazil.; de Albuquerque, LG (corresponding author), Conselho Nacl Desenvolvimento Cient & Tecnol CNPq, Brasilia, DF, Brazil.	lgalb@fcav.unesp.br	Carvalheiro, Roberto/AAG-2222-2020; Carvalheiro, Roberto/I-2239-2013; Albuquerque, Lucia/A-7402-2013; Camargo, Gregorio M. F./J-9511-2016; Baldi, Fernando/E-5492-2012; Espigolan, Rafael/E-6255-2017; Chardulo, Luis Artur/ABF-3928-2020; Feitosa, Fabieli L. B./D-4996-2014; Magalhães, Ana Fabrícia Braga/GLQ-5906-2022; Costa, Raphael Bermal/AAK-3528-2021	Carvalheiro, Roberto/0000-0002-4506-0555; Carvalheiro, Roberto/0000-0002-4506-0555; Albuquerque, Lucia/0000-0002-2030-7590; Baldi, Fernando/0000-0003-4094-2011; Espigolan, Rafael/0000-0003-2586-1643; Chardulo, Luis Artur/0000-0003-2656-1562; Feitosa, Fabieli L. B./0000-0003-4218-0348; de Camargo, Gregorio Miguel Ferreira/0000-0002-8736-5576	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/21969-7, 2009/16118-5]	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo < http://www.fapesp.br/>) for the first author's scholarship (No 2012/21969-7) and for funding this study (No 2009/16118-5).	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Barendse W, 2001, PLOSONE, V6; Baumeier C, 2015, BBA-MOL CELL BIOL L, V1851, P566, DOI 10.1016/j.bbalip.2015.01.013; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bressan MC, 2011, REV BRAS ZOOTECN, V40, P1250, DOI 10.1590/S1516-35982011000600013; Casas E, 2000, J ANIM SCI, V78, P560; Casas E, 1998, J ANIM SCI, V76, P468; Casas E, 2001, J ANIM SCI, V79, P854; Cesar ASM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-39; Cheng KKY, 2014, DIABETES, V63, P3748, DOI 10.2337/db14-0337; Cheong HS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-33; Davis GP, 2008, ANIM GENET, V39, P40, DOI 10.1111/j.1365-2052.2007.01677.x; de Castro LM, 2014, REV CIENC AGRON, V45, P393, DOI 10.1590/S1806-66902014000200022; De Lemos MVA, 2015, P 24 C AS LAT AM PRO; Eom GH, 2011, J BIOL CHEM, V286, P34733, DOI 10.1074/jbc.M110.203307; Everaert I, 2013, EUR J APPL PHYSIOL, V113, P1169, DOI 10.1007/s00421-012-2540-4; Fernandes Junior GA., 2015, THESIS; de Camargo GMF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1595-0; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; Fortes MRS, 2013, ANDROLOGY-US, V1, P644, DOI 10.1111/j.2047-2927.2013.00101.x; Godoy TF, 2015, ANIM GENET, V46, P158, DOI 10.1111/age.12271; Hirschhorn JN., 2005, NATURE, V6; Hoshiba H, 2013, ANIM SCI J, V84, P529, DOI 10.1111/asj.12033; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Koohmaraie M, 1996, MEAT SCI, V43, pS193, DOI 10.1016/0309-1740(96)00065-4; Lee SH, 2013, PLOS ONE, V8, P10, DOI DOI 10.1371/J0URNAL.P0NE.0074677; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Littlejohn M, 2012, ANIM GENET, V43, P591, DOI 10.1111/j.1365-2052.2011.02293.x; Loch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075716; Luo QB, 2014, GENE, V546, P200, DOI 10.1016/j.gene.2014.06.017; Maltin C, 2003, P NUTR SOC, V62, P337, DOI 10.1079/PNS2003248; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Misztal I, 2012, BLUPF90 A FLEXIBLE M; Neto LRP, 2012, ANIM GENET, V43, P785, DOI 10.1111/j.1365-2052.2012.02330.x; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; OConnor SF, 1997, J ANIM SCI, V75, P1822; Pinto LFB, 2010, GENET MOL RES, V9, P1431, DOI 10.4238/vol9-3gmr881; Primeaux SD, 2013, DIGEST DIS SCI, V58, P72, DOI 10.1007/s10620-012-2421-z; Ramayo-Caldas Y, 2014, J ANIM SCI, V92, P2832, DOI 10.2527/jas.2013-7484; Riley DG, 2013, LIVEST SCI, V155, P186, DOI 10.1016/j.livsci.2013.05.022; Russell PJ, 2007, BIOLOGY THE DYNAMIC, P400; Ryan MJ, 2008, HEPATOLOGY; SAATCHI M, 2014, BMC GENOMICS, V0015; Sharma A, 2014, ANIM GENET, V45, P863, DOI 10.1111/age.12204; Smith TPL, 2000, J ANIM SCI, V78, P2589; Terakado APN, 2015, THESIS; Thu NT D, 2006, SCIENCE TECHNOLOGY D, V9; Tizioto PC, 2013, PHYSIOL GENOMICS, V45, P1012, DOI 10.1152/physiolgenomics.00066.2013; Tonussi RL, 2015, GENET MOL RES, V14, P18713, DOI 10.4238/2015.December.28.20; United States Departament of Agriculture, 2000, U S STANDARDS FOR GR; USDA, 2014, LIV POULTR WORLD MAR; Utsunomiya YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088561; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; von der Heyde S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-381; Voz ML, 2004, ONCOGENE, V23, P179, DOI 10.1038/sj.onc.1207013; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; Wheeler T.L., 1995, STANDARDIZED WARNER; WHEELER TL, 1994, J ANIM SCI, V72, P3145, DOI 10.2527/1994.72123145x; Williams J.L., 2008, MEAT BIOTECHNOLOGY, P21, DOI DOI 10.1007/978-0-387-79382-52.CJAS2012-100; Yoshizumi S, 2007, METABOLISM, V56, P420, DOI 10.1016/j.metabol.2006.10.027; Zhang LF, 2012, INT J BIOL SCI, V8, P838, DOI 10.7150/ijbs.4403	65	52	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157845	10.1371/journal.pone.0157845	http://dx.doi.org/10.1371/journal.pone.0157845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359122	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200025
J	Nosratnejad, S; Rashidian, A; Dror, DM				Nosratnejad, Shirin; Rashidian, Arash; Dror, David Mark			Systematic Review of Willingness to Pay for Health Insurance in Low and Middle Income Countries	PLOS ONE			English	Article							COMMUNITY-BASED INSURANCE; CONTINGENT VALUATION; INFORMAL SECTOR; POOR; CARE; EXPENDITURE	Objective Access to healthcare is mostly contingent on out-of-pocket spending (OOPS) by health seekers, particularly in low-and middle-income countries (LMICs). This would require many LMICs to raise enough funds to achieve universal health insurance coverage. But, are individuals or households willing to pay for health insurance, and how much? What factors positively affect WTP for health insurance? We wanted to examine the evidence for this, through a review of the literature. Methods We systematically searched databases up to February 2016 and included studies of individual or household WTP for health insurance. Two authors appraised the identified studies. We estimated the WTP as a percentage of GDP per capita, and adjusted net national income per capita of each country. We used meta-analysis to calculate WTP means and confidence intervals, and vote-counting to identify the variables that more often affected WTP. Result 16 studies (21 articles) from ten countries met the inclusion criteria. The mean WTP of individuals was 1.18% of GDP per capita and 1.39% of adjusted net national income per capita. The corresponding figures for households were 1.82% and 2.16%, respectively. Increases in family size, education level and income were consistently correlated with higher WTP for insurance, and increases in age were correlated with reduced WTP. Conclusions The WTP for healthcare insurance among rural households in LMICs was just below 2% of the GPD per capita. The findings demonstrate that in moving towards universal health coverage in LMICs, governments should not rely on households' premiums as a major financing source and should increase their fiscal capacity for an equitable health care system using other sources.	[Nosratnejad, Shirin] Tabriz Univ Med Sci, Sch Management & Med Informat, Iranian Ctr Excellence Hlth Serv Management, Tabriz, Iran; [Nosratnejad, Shirin] Tabriz Univ Med Sci, Sch Management & Med Informat, Dept Hlth Serv Management, Tabriz Hlth Serv Management Res Ctr, Tabriz, Iran; [Rashidian, Arash] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran; [Rashidian, Arash] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Tehran, Iran; [Dror, David Mark] Micro Insurance Acad, New Delhi, India; [Dror, David Mark] Erasmus Univ, Rotterdam, Netherlands	Tabriz University of Medical Science; Tabriz University of Medical Science; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Erasmus University Rotterdam	Nosratnejad, S (corresponding author), Tabriz Univ Med Sci, Sch Management & Med Informat, Iranian Ctr Excellence Hlth Serv Management, Tabriz, Iran.; Nosratnejad, S (corresponding author), Tabriz Univ Med Sci, Sch Management & Med Informat, Dept Hlth Serv Management, Tabriz Hlth Serv Management Res Ctr, Tabriz, Iran.	Sh_nosratnejad@yahoo.com	Dror, David/I-6021-2013	Dror, David/0000-0002-8757-4239; Rashidian, Arash/0000-0002-4005-5183				Ahmed S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148211; Asenso-Okyere WK, 1997, HEALTH POLICY, V42, P223, DOI 10.1016/S0168-8510(97)00069-9; Asfaw A, 2004, HEALTH POLICY, V70, P97, DOI 10.1016/j.healthpol.2004.02.005; Asfaw Abay, 2005, Int J Health Care Finance Econ, V5, P241, DOI 10.1007/s10754-005-2333-y; Asgary Ali, 2004, Eur J Health Econ, V5, P209, DOI 10.1007/s10198-004-0233-6; Ataguba J, SSRN ELECT J; Barnighausen T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-114; Binam JN, 2004, ESTIMATING WILLINGNE; Carson RT, 2000, ENVIRON SCI TECHNOL, V34, P1413, DOI 10.1021/es990728j; Centre for Reviews and Dissemination, 2009, SYSTEMATIC REV CRDS; Ciriacy-Wantrup SV, 1947, J FARM ECON, V29, P1181, DOI 10.2307/1232747; Davenport CF, 2003, BRIT DENT J, V195, P87, DOI 10.1038/sj.bdj.4810337; Donfouet HPP, 2011, INT J HEALTH CARE FI, V11, P209, DOI 10.1007/s10754-011-9097-3; Donfouet HP, 2011, GLOBAL J HLTH SCI, V3; Dong HJ, 2004, HEALTH POLICY, V69, P45, DOI 10.1016/j.healthpol.2003.12.001; Dong HJ, 2004, HEALTH POLICY PLANN, V19, P120, DOI 10.1093/heapol/czh014; Dong HJ, 2003, HEALTH ECON, V12, P849, DOI 10.1002/hec.771; Dong HJ, 2003, HEALTH POLICY, V64, P153, DOI 10.1016/S0168-8510(02)00144-6; Dror DM, 2014, GENEVA PAP R I-ISS P, V39, P693, DOI 10.1057/gpp.2014.24; Dror DM, 2007, HEALTH POLICY, V82, P12, DOI 10.1016/j.healthpol.2006.07.011; Dror DM, 2012, ELUSIVE QUEST ESTIMA, P156; Edoh D, 2004, AFRICAN J HLTH SCI, V9, P41; Folland S, 2007, EC HLTH HLTH CARE; GETZEN TE, 1992, J GERONTOL, V47, pS98, DOI 10.1093/geronj/47.3.S98; Ghosh S, 2011, J HEALTH MANAG, V13, P419, DOI 10.1177/097206341101300404; Gumber A., 2000, Economic and Political Weekly, V35, P3607; Hanley N, 2003, HEALTH ECON, V12, P3, DOI 10.1002/hec.763; Iskedjian M, 2011, J PAIN SYMPTOM MANAG, V41, P104, DOI 10.1016/j.jpainsymman.2010.04.012; Kavosi Z, 2012, HEALTH POLICY PLANN, V27, P613, DOI 10.1093/heapol/czs001; Kumar N, 2015, INT J HEALTH PLAN M, V30, P366, DOI 10.1002/hpm.2244; Lofgren Curt, 2008, Cost Eff Resour Alloc, V6, P16, DOI 10.1186/1478-7547-6-16; Mathiyazhagan K, 1998, INT J HEALTH PLAN M, V13, P47, DOI 10.1002/(SICI)1099-1751(199801/03)13:1&lt;47::AID-HPM495&gt;3.0.CO;2-I; Nosratnejad S, 2014, GLOBAL J HLTH SCI, V6; Nosratnejad S, 2016, WORLD MED H IN PRESS; Onwujekwe O, 2010, HEALTH POLICY PLANN, V25, P155, DOI 10.1093/heapol/czp046; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; Scheil-Adlung X, 2013, INT SOC SECUR REV, V66, P25, DOI 10.1111/issr.12001; Schneider P, 2004, HEALTH POLICY PLANN, V19, P349, DOI 10.1093/heapol/czh050; Smith RD, 2003, HEALTH ECON, V12, P609, DOI 10.1002/hec.755; SOINI E, 2012, OPEN COMPLEMENTARY M, V2012, P1, DOI DOI 10.2174/1876391X01204010001; Spaan E, 2012, B WORLD HEALTH ORGAN, V90, P685, DOI 10.2471/BLT.12.102301; van der Star SM, 2011, HEALTH POLICY, V101, P300, DOI 10.1016/j.healthpol.2010.10.001; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; WHO, 2010, WOR HEALT REP, P1	44	47	47	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157470	10.1371/journal.pone.0157470	http://dx.doi.org/10.1371/journal.pone.0157470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362356	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200017
J	Shah, KH; Varia, SN; Cook, LA; Herman, PK				Shah, Khyati H.; Varia, Sapna N.; Cook, Laura A.; Herman, Paul K.			A Hybrid-Body Containing Constituents of Both P-Bodies and Stress Granules Forms in Response to Hypoosmotic Stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; CELL-FREE FORMATION; CYTOPLASMIC GRANULES; SIGNALING PATHWAY; PROCESSING BODIES; STATIONARY-PHASE; PROTEIN; YEAST; DECAY; SITES	The cytoplasm of the eukaryotic cell is a highly compartmentalized space that contains a variety of ribonucleoprotein (RNP) granules in addition to its complement of membrane-bound organelles. These RNP granules contain specific sets of proteins and mRNAs and form in response to particular environmental and developmental stimuli. Two of the better-characterized of these RNP structures are the stress granule and Processing-body (P-body) that have been conserved from yeast to humans. In this report, we examined the cues regulating stress granule assembly and the relationship between stress granule and P-body foci. These two RNP structures are generally thought to be independent entities in eukaryotic cells. However, we found here that stress granule and P-body proteins were localized to a common or merged granule specifically in response to a hypoosmotic stress. Interestingly, these hybrid-bodies were found to be transient structures that were resolved with time into separate P-body and stress granule foci. In all, these data suggest that the identity of an RNP granule is not absolute and that it can vary depending upon the nature of the induction conditions. Since the activities of a granule are likely influenced by its protein constituency, these observations are consistent with the possibility of RNP granules having distinct functions in different cellular contexts.	[Shah, Khyati H.; Varia, Sapna N.; Cook, Laura A.; Herman, Paul K.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Shah, Khyati H.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University System of Ohio; Ohio State University; Stanford University	Herman, PK (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	heman.81@osu.edu			National Institutes of Health [GM065227, GM101191]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by R01 grants from the National Institutes of Health to PKH (GM065227 and GM101191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; BAKER RT, 1992, J BIOL CHEM, V267, P23364; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Brewster JL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005458; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Chang YW, 2004, MOL CELL, V15, P107, DOI 10.1016/j.molcel.2004.05.021; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dechant R, 2008, CURR OPIN CELL BIOL, V20, P678, DOI 10.1016/j.ceb.2008.09.009; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Herman PK, 1997, EMBO J, V16, P6171, DOI 10.1093/emboj/16.20.6171; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Izawa S, 2007, BIOSCI BIOTECH BIOCH, V71, P2800, DOI 10.1271/bbb.70417; Jonas S, 2013, GENE DEV, V27, P2628, DOI 10.1101/gad.227843.113; Kaiser C., 1994, METHODS YEAST GENETI; Kato K, 2011, YEAST, V28, P339, DOI 10.1002/yea.1842; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KUO SC, 1971, J BACTERIOL, V106, P183, DOI 10.1128/JB.106.1.183-191.1971; Liu IC, 2012, MOL BIOL CELL, V23, P1231, DOI 10.1091/mbc.E11-09-0752; Lloyd RE, 2013, WIRES RNA, V4, P317, DOI 10.1002/wrna.1162; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Nostramo R, 2016, CURR GENET, V62, P503, DOI 10.1007/s00294-016-0571-9; Nostramo R, 2016, MOL CELL BIOL, V36, P173, DOI 10.1128/MCB.00609-15; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Philips J, 1997, J CELL BIOL, V138, P961, DOI 10.1083/jcb.138.5.961; Ramachandran V, 2011, MOL CELL, V43, P973, DOI 10.1016/j.molcel.2011.06.032; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Sagot I, 2006, MOL BIOL CELL, V17, P4645, DOI 10.1091/mbc.E06-04-0282; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Shah KH, 2014, GENETICS, V198, P1495, DOI 10.1534/genetics.114.172031; Shah KH, 2013, GENETICS, V193, P109, DOI 10.1534/genetics.112.146993; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wen WL, 2010, NUCLEIC ACIDS RES, V38, P6555, DOI 10.1093/nar/gkq555; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566; Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019	66	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158776	10.1371/journal.pone.0158776	http://dx.doi.org/10.1371/journal.pone.0158776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359124	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200113
J	Stanish, LF; Hull, NM; Robertson, CE; Harris, JK; Stevens, MJ; Spear, JR; Pace, NR				Stanish, Lee F.; Hull, Natalie M.; Robertson, Charles E.; Harris, J. Kirk; Stevens, Mark J.; Spear, John R.; Pace, Norman R.			Factors Influencing Bacterial Diversity and Community Composition in Municipal Drinking Waters in the Ohio River Basin, USA	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; DISTRIBUTION-SYSTEM; NONTUBERCULOUS MYCOBACTERIA; LEGIONELLA-PNEUMOPHILA; FRANCISELLA-TULARENSIS; MOLECULAR ANALYSIS; MICROBIAL ECOLOGY; BIOFILM FORMATION; GEN. NOV.; PATTERNS	The composition and metabolic activities of microbes in drinking water distribution systems can affect water quality and distribution system integrity. In order to understand regional variations in drinking water microbiology in the upper Ohio River watershed, the chemical and microbiological constituents of 17 municipal distribution systems were assessed. While sporadic variations were observed, the microbial diversity was generally dominated by fewer than 10 taxa, and was driven by the amount of disinfectant residual in the water. Overall, Mycobacterium spp. (Actinobacteria), MLE1-12 (phylum Cyanobacteria), Methylobacterium spp., and sphingomonads were the dominant taxa. Shifts in community composition from Alphaproteobacteria and Betaproteobacteria to Firmicutes and Gammaproteobacteria were associated with higher residual chlorine. Alpha-and beta-diversity were higher in systems with higher chlorine loads, which may reflect changes in the ecological processes structuring the communities under different levels of oxidative stress. These results expand the assessment of microbial diversity in municipal distribution systems and demonstrate the value of considering ecological theory to understand the processes controlling microbial makeup. Such understanding may inform the management of municipal drinking water resources.	[Stanish, Lee F.; Hull, Natalie M.; Robertson, Charles E.; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Harris, J. Kirk; Stevens, Mark J.] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA; [Spear, John R.] Colorado Sch Mines, Dept Civil & Environm Engn, Golden, CO USA; [Hull, Natalie M.] Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Mines; University of Colorado System; University of Colorado Boulder	Stanish, LF (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	lee.stanish@colorado.edu	Spear, John R./ABI-5873-2020; HULL, NATALIE/L-1166-2019	HULL, NATALIE/0000-0003-2876-6721; Harris, Jonathan/0000-0002-2378-4202; ROBERTSON, CHARLES/0000-0002-4136-4121; Spear, John/0000-0002-4664-7438	Alfred P. Sloan Foundation "Microbiology of the Built Environment" Program	Alfred P. Sloan Foundation "Microbiology of the Built Environment" Program	Alfred P. Sloan Foundation "Microbiology of the Built Environment" Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by generous funding from the Alfred P. Sloan Foundation's "Microbiology of the Built Environment" program. We are grateful to Jingrang Liu and Nick Ashbolt (US Environmental Protection Agency, Cincinnati OH) for their support of the field campaign. Dorothy Vesper (West Virginia University) and Gail Brion (University of Kentucky) provided vital logistical and analytical support during the sampling campaign. Thanks to Tricia Coakley and John May (University of Kentucky) for assistance with laboratory analyses. Finally, many thanks to Mark Hernandez for insights into pipe corrosion, and Kim Ross, Eric Holinger, and Mark Norman for guidance and support throughout the project.	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; American Water Works Association, 2012, BUR NO LONG CONFR AM, P37; Armitage DW, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00293; Beier CL, 2002, APPL ENVIRON MICROB, V68, P6043, DOI 10.1128/AEM.68.12.6043-6050.2002; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Block J.C., 1997, P63; Buse HY, 2011, LETT APPL MICROBIOL, V53, P217, DOI 10.1111/j.1472-765X.2011.03094.x; Carrico BA, 2008, J AWWA, V157; Chandy JP, 2001, WATER RES, V35, P2677, DOI 10.1016/S0043-1354(00)00572-8; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chowdhury S, 2012, ENVIRON MONIT ASSESS, V184, P6087, DOI 10.1007/s10661-011-2407-x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Douterelo I, 2014, J APPL MICROBIOL; Dubrou S, 2013, APPL ENVIRON MICROB, V79, P5498, DOI 10.1128/AEM.00900-13; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Falkinham JO, 2008, J WATER HEALTH, V6, P209, DOI [10.2166/wh.2008.232, 10.2166/wh.2008.032]; Falkinham JO, 2011, EMERG INFECT DIS, V17, P419, DOI 10.3201/eid1703.101510; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; HENKE M, 1986, ISRAEL J MED SCI, V22, P690; Hoefel D, 2005, APPL ENVIRON MICROB, V71, P6479, DOI 10.1128/AEM.71.11.6479-6488.2005; Holinger EP, 2014, WATER RES, V49, P225, DOI 10.1016/j.watres.2013.11.027; Hull NM, 2015, WATER RES, V69, P318, DOI 10.1016/j.watres.2014.11.024; Hwang C, 2012, APPL ENVIRON MICROB, V78, P7856, DOI 10.1128/AEM.01892-12; JENSEN AB, 1995, PROCESS BIOCHEM, V30, P225, DOI 10.1016/0032-9592(95)95721-T; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kapoor A, 1997, J ENVIRON ENG-ASCE, V123, P371, DOI 10.1061/(ASCE)0733-9372(1997)123:4(371); Kelly DP, 2000, INT J SYST EVOL MICR, V50, P511, DOI 10.1099/00207713-50-2-511; Kelly JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098542; Kormas KA, 2010, ENVIRON MONIT ASSESS, V165, P27, DOI 10.1007/s10661-009-0924-7; Krishna KCB, 2013, WATER RES, V47, P4666, DOI 10.1016/j.watres.2013.04.035; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lau KWK, 2007, INT J SYST EVOL MICR, V57, P2665, DOI 10.1099/ijs.0.65156-0; Lautenschlager K, 2013, WATER RES, V47, P3015, DOI 10.1016/j.watres.2013.03.002; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649, DOI 10.1128/AEM.54.3.649-654.1988; Lee HK, 2010, APPL ENVIRON MICROB, V76, P6547, DOI 10.1128/AEM.00422-10; Li D, 2010, APPL ENVIRON MICROB, V76, P7171, DOI 10.1128/AEM.00832-10; Ling AL, 2014, ENVIRON SCI TECHNOL, V48, P7357, DOI 10.1021/es500763e; Liu G, 2013, WATER RES, V47, P3523, DOI 10.1016/j.watres.2013.03.058; Lu W, 1999, WATER RES, V33, P827, DOI 10.1016/S0043-1354(98)00229-2; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; Mathieu L, 2009, WATER RES, V43, P3375, DOI 10.1016/j.watres.2009.05.005; McColloch JS, 2012, REPORT NO 36, P172; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Nicorarat D, 2008, SOIL BIOL BIOCHEM, V40, P312, DOI 10.1016/j.soilbio.2007.08.009; Oksanen J, 2005, VEGAN R FUNCTIONS FO; Onyenwoke RU, 2004, ARCH MICROBIOL, V182, P182, DOI 10.1007/s00203-004-0696-y; Piersimoni C, 2008, LANCET INFECT DIS, V8, P323, DOI 10.1016/S1473-3099(08)70100-2; Pillar VD, 2013, COMMUNITY ECOL, V14, P153, DOI 10.1556/ComEc.14.2013.2.5; Pinto AJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00054-15; Pinto AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01135-14; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Pryor M, 2004, WATER SCI TECHNOL, V50, P83, DOI 10.2166/wst.2004.0025; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2011, R A LANGUAGE AND ENV; Regan JM, 2002, APPL ENVIRON MICROB, V68, P73, DOI 10.1128/AEM.68.1.73-81.2002; RIDGWAY HF, 1982, APPL ENVIRON MICROB, V44, P972, DOI 10.1128/AEM.44.4.972-987.1982; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Roeselers G, 2015, ENVIRON MICROBIOL, V17, P2505, DOI 10.1111/1462-2920.12739; ROGERS J, 1994, APPL ENVIRON MICROB, V60, P1585, DOI 10.1128/AEM.60.5.1585-1592.1994; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; Smith RA, 2003, ENVIRON SCI TECHNOL, V37, P3039, DOI 10.1021/es020663b; Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073; Srinivasan S, 2008, WATER RES, V42, P3393, DOI 10.1016/j.watres.2008.04.025; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TEMPLE KL, 1953, APPL MICROBIOL, V1, P255, DOI 10.1128/AEM.1.5.255-258.1953; Thomas V, 2008, ENVIRON MICROBIOL, V10, P2728, DOI 10.1111/j.1462-2920.2008.01693.x; US EPA O, 2009, REPORT NO EPA 816 R, P80; VANDERWENDE E, 1989, WATER RES, V23, P1313, DOI 10.1016/0043-1354(89)90193-0; VONREYN CF, 1994, LANCET, V343, P1137, DOI 10.1016/S0140-6736(94)90239-9; Wang H, 2014, ENVIRON SCI TECHNOL, V48, P1426, DOI 10.1021/es402636u; Warton DI, 2004, ECOLOGY, V85, P858, DOI 10.1890/02-0419; Williams MM, 2004, J APPL MICROBIOL, V96, P954, DOI 10.1111/j.1365-2672.2004.02229.x; Woolschlagar J, 2001, WATER SCIENCE & TECHNOLOGY: WATER SUPPLY, VOL 1, NO 4, P103, DOI 10.2166/ws.2001.0073; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813; Zhang P, 2009, ENVIRON SCI TECHNOL, V43, P3169, DOI 10.1021/es802990e; Zhang Y, 2009, CRIT REV ENV SCI TEC, V39, P153, DOI 10.1080/10643380701631739; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	84	46	47	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157966	10.1371/journal.pone.0157966	http://dx.doi.org/10.1371/journal.pone.0157966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362708	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200033
J	Kudova, J; Prochazkova, J; Vasicek, O; Perecko, T; Sedlackova, M; Pesl, M; Pachernik, J; Kubala, L				Kudova, Jana; Prochazkova, Jirina; Vasicek, Ondrej; Perecko, Tomas; Sedlackova, Miroslava; Pesl, Martin; Pachernik, Jiri; Kubala, Lukas			HIF-1alpha Deficiency Attenuates the Cardiomyogenesis of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							CARDIAC DIFFERENTIATION; HIF-1-ALPHA; EXPRESSION; HEART; CARDIOMYOCYTES; MORPHOGENESIS; ENDODERM; HOMEOSTASIS; APOPTOSIS; DELETION	Cardiac cell formation, cardiomyogenesis, is critically dependent on oxygen availability. It is known that hypoxia, a reduced oxygen level, modulates the in vitro differentiation of pluripotent cells into cardiomyocytes via hypoxia inducible factor-1alpha (HIF-1 alpha)-dependent mechanisms. However, the direct impact of HIF-1 alpha deficiency on the formation and maturation of cardiac-like cells derived from mouse embryonic stem cells (mESC) in vitro remains to be elucidated. In the present study, we demonstrated that HIF-1 alpha deficiency significantly altered the quality and quantity of mESC-derived cardiomyocytes. It was accompanied with lower mRNA and protein levels of cardiac cell specific markers (myosin heavy chains 6 and 7) and with a decreasing percentage of myosin heavy chain alpha and beta, and cardiac troponin T-positive cells. As to structural aspects of the differentiated cardiomyocytes, the localization of contractile proteins (cardiac troponin T, myosin heavy chain alpha and beta) and the organization of myofibrils were also different. Simultaneously, HIF-1 alpha deficiency was associated with a lower percentage of beating embryoid bodies. Interestingly, an observed alteration in the in vitro differentiation scheme of HIF-1 alpha deficient cells was accompanied with significantly lower expression of the endodermal marker (hepatic nuclear factor 4 alpha). These findings thus suggest that HIF-1 alpha deficiency attenuates spontaneous cardiomyogenesis through the negative regulation of endoderm development in mESC differentiating in vitro.	[Kudova, Jana; Vasicek, Ondrej; Perecko, Tomas; Kubala, Lukas] Acad Sci Czech Republ, Inst Biophys, Brno, Czech Republic; [Kudova, Jana; Pachernik, Jiri] Masaryk Univ, Fac Sci, Inst Expt Biol, Brno, Czech Republic; [Kudova, Jana; Vasicek, Ondrej; Perecko, Tomas; Pachernik, Jiri; Kubala, Lukas] St Annes Univ Hosp, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic; [Prochazkova, Jirina; Sedlackova, Miroslava] Masaryk Univ, Dept Histol & Embryol, Fac Med, Brno, Czech Republic; [Pesl, Martin] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Pesl, Martin] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Kubala, L (corresponding author), Acad Sci Czech Republ, Inst Biophys, Brno, Czech Republic.; Kubala, L (corresponding author), St Annes Univ Hosp, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic.	kubalal@ibp.cz	Perecko, Tomas/H-1901-2014; Vasicek, Ondrej/C-4395-2015; Prochazkova, Jirina/D-4403-2015; Pesl, Martin/D-5952-2013; Kubala, Lukas/H-6329-2014	Perecko, Tomas/0000-0003-4278-4088; Vasicek, Ondrej/0000-0001-5892-0457; Prochazkova, Jirina/0000-0003-2738-8546; Pesl, Martin/0000-0001-8704-1005; Kubala, Lukas/0000-0002-7729-7338; Pesl, Martin/0000-0002-9234-2432; Pereckova, Jana/0000-0002-7565-993X	Czech Science Foundation [GJ15-13443Y, GA13-29358S]; Ministry of Education, Youth and Sports, Czech Republic project of the European Regional Development Fund FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Ministry of Education, Youth and Sports, Czech Republic project of the HistoPARK [CZ.1.07/2.3.00/20.0185]; NICHD	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports, Czech Republic project of the European Regional Development Fund FNUSA-ICRC; Ministry of Education, Youth and Sports, Czech Republic project of the HistoPARK; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Czech Science Foundation No. GJ15-13443Y and GA13-29358S (https://gacr.cz/), and Ministry of Education, Youth and Sports, Czech Republic projects of the European Regional Development Fund FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and HistoPARK CZ.1.07/2.3.00/20.0185) (www.msmt.cz/).; We wish to thank Dr. Petra Ovesna for her assistance with the statistical evaluation of data, and Lenka Vystrcilova for her expert technical assistance. We would like to thank prof. Peter F. Carmeliet from the Vesalius Research Center, VIB, University of Leuven, Belgium for providing us with the HIF-1 alpha<SUP>-/</SUP>-mESC line. Further, we would like to thank Donald A. Fishman for the development of the MF20 cell line and Paul H. Patterson for the development of the FORSE-1 cell line which was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Ateghang B, 2006, J CELL SCI, V119, P1043, DOI 10.1242/jcs.02798; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bianco C, 2009, AM J PATHOL, V175, P2146, DOI 10.2353/ajpath.2009.090218; Braunwald E, 2000, CIRCULATION, V102, P14; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen K, 2010, J CELL BIOCHEM, V111, P29, DOI 10.1002/jcb.22680; Choi WY, 2012, CURR TOP DEV BIOL, V100, P319, DOI 10.1016/B978-0-12-387786-4.00010-5; Dabiri GA, 1997, P NATL ACAD SCI USA, V94, P9493, DOI 10.1073/pnas.94.17.9493; Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fukushima A, 2015, CURR PHARM DESIGN, V21, P3654, DOI 10.2174/1381612821666150710150445; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Krishnan J, 2008, CIRC RES, V103, P1139, DOI 10.1161/01.RES.0000338613.89841.c1; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Liang S, 2014, DEV GROWTH DIFFER, V56, P276, DOI 10.1111/dgd.12129; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Madabhushi M, 2011, DEV CELL, V21, P907, DOI 10.1016/j.devcel.2011.08.027; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Medley TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080280; Ng KM, 2010, J MOL CELL CARDIOL, V48, P1129, DOI 10.1016/j.yjmcc.2010.01.015; Pesl M, 2014, HEART VESSELS, V29, P834, DOI 10.1007/s00380-013-0436-9; Qi YM, 2012, J CELL BIOL, V198, P103, DOI 10.1083/jcb.201111063; Radaszkiewicz KA, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4941776; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Gonzalez IR, 2011, VITAM HORM, V87, P367, DOI 10.1016/B978-0-12-386015-6.00036-6; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Sun XT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0447-7; Van Vliet P, 2012, CARDIOVASC RES, V96, P352, DOI 10.1093/cvr/cvs270; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Youngblood BA, 2014, STEM CELL RES, V13, P413, DOI 10.1016/j.scr.2014.09.005	40	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158358	10.1371/journal.pone.0158358	http://dx.doi.org/10.1371/journal.pone.0158358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355368	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400053
J	Li, LL; Han, Y; Chen, WY; Lv, CM; Sun, DW				Li, Lingling; Han, Ye; Chen, Wenyuan; Lv, Congmin; Sun, Dongwang			An Improved Wavelet Packet-Chaos Model for Life Prediction of Space Relays Based on Volterra Series	PLOS ONE			English	Article							TRANSFORM	In this paper, an improved algorithm of wavelet packet-chaos model for life prediction of space relays based on volterra series is proposed. In the proposed method, the high and low frequency time sequence components of performance parameters are obtained by employing the improved wavelet packet transform to decompose the performance parameters of the relay into multiple scales. Then the optimization algorithm of parameters in volterra series is improved, and is used to construct a chaotic forecasting model for the high and low frequency time sequence components gained by the wavelet packet transform. At last, the chaotic forecasting results of the high and low frequency components are combined by taking the wavelet packet reconstruction approach, so as to predict the lifetime of the studied space relay. The algorithm can predict the life curve of the relay accurately and reflect the characteristics of the relay performance with sufficient accuracy. The proposed method is validated via a case study of a space relay.	[Li, Lingling; Han, Ye; Lv, Congmin; Sun, Dongwang] Hebei Univ Technol, Dept Elect Engn, Tianjin, Peoples R China; [Li, Lingling; Chen, Wenyuan] Natl Chin Yi Univ Technol, Dept Elect Engn, Taichung, Taiwan; [Sun, Dongwang] Jiangxi Elect Power Design Inst, Pingxiang, Jiangxi, Peoples R China	Hebei University of Technology; National Chin-Yi University of Technology	Li, LL (corresponding author), Hebei Univ Technol, Dept Elect Engn, Tianjin, Peoples R China.; Li, LL; Chen, WY (corresponding author), Natl Chin Yi Univ Technol, Dept Elect Engn, Taichung, Taiwan.	lilingling@hebut.edu.cn; cwy@ncut.edu.tw			National Natural Science Foundation of China [51475136]; Natural Science Foundation of Tianjin [12JCYBJC12400]; Natural Science Foundation of Hebei Province of China [E2014202230]; University Innovation Team Leader Program of Hebei Province [LJRC003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); University Innovation Team Leader Program of Hebei Province	This work was supported by the National Natural Science Foundation of China, Program No. 51475136 (http://www.nsfc.gov.cn/), Natural Science Foundation of Tianjin, Program No. 12JCYBJC12400 (http://www.tstc.gov.cn/), Natural Science Foundation of Hebei Province of China, Program No. E2014202230 and University Innovation Team Leader Program of Hebei Province (Program No. LJRC003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baragona R, 2004, COMPUT STAT DATA AN, V47, P277, DOI 10.1016/j.csda.2003.11.003; BARAKA A, 2014, GRANULAR COMPUTING, P13; Bianco A, 2010, J NONPARAMETR STAT, V22, P797, DOI 10.1080/10485250903469744; Chen DY, 2010, ACTA PHYS SINICA, V61, P7623; Cherif LH, 2010, EXPERT SYST APPL, V37, P913, DOI 10.1016/j.eswa.2009.09.036; COIFMAN RR, 1992, IEEE T INFORM THEORY, V38, P713, DOI 10.1109/18.119732; Evagorou D, 2010, IET SCI MEAS TECHNOL, V4, P177, DOI 10.1049/iet-smt.2009.0023; Fehri B, 2014, IEEE T MICROW THEORY, V62, P2594, DOI 10.1109/TMTT.2014.2360387; Gruber JK, 2015, INT J ROBUST NONLIN, V25, P3546, DOI 10.1002/rnc.3279; Hamidia M, 2016, DIGIT SIGNAL PROCESS, V49, P44, DOI 10.1016/j.dsp.2015.10.015; Hemmati F, 2016, APPL ACOUST, V104, P101, DOI 10.1016/j.apacoust.2015.11.003; Hu HC, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/956907; Jouini T, 2015, J STAT COMPUT SIM, V85, P2214, DOI 10.1080/00949655.2014.925898; Kaur L, 2007, DIGIT SIGNAL PROCESS, V17, P189, DOI 10.1016/j.dsp.2006.05.008; Li Jiao-jun, 2011, 2011 Proceedings of IEEE International Conference on Computer Science and Automation Engineering (CSAE), P666, DOI 10.1109/CSAE.2011.5953306; Li LL, 2015, IEEE T COMP PACK MAN, V5, P1582, DOI 10.1109/TCPMT.2015.2480229; [李玲玲 Li Lingling], 2014, [电工技术学报, Transactions of China Electrotechnical Society], V29, P187; [李志刚 Li Zhigang], 2015, [电工技术学报, Transactions of China Electrotechnical Society], V30, P233; Liu Y, 2015, IEEE T RELIAB, V64, P1287, DOI 10.1109/TR.2015.2418294; [陆俭国 Lu Jianguo], 2009, [电工技术学报, Transactions of China Electrotechnical Society], V24, P54; Lu Zhen-bo, 2007, Journal of System Simulation, V19, P2527; Ma CY, 2012, J VIB CONTROL, V18, P2176, DOI 10.1177/1077546311429587; Mohammad D, 1999, MAXIMUM ENTROPY BAYE, P71; Pence BL, 2014, IEEE T CONTR SYST T, V22, P224, DOI 10.1109/TCST.2013.2252349; Przystalka P, 2015, ENG APPL ARTIF INTEL, V41, P25, DOI 10.1016/j.engappai.2015.01.016; Shi L, 2016, ELECTRON LETT, V52, P519, DOI 10.1049/el.2015.3882; Wang ZB, 2014, ELECTR CONTACT, P43; Ye XR, 2010, 2010 11TH INTERNATIONAL CONFERENCE ON ELECTRONIC PACKAGING TECHNOLOGY & HIGH DENSITY PACKAGING (ICEPT-HDP), P1269, DOI 10.1109/ICEPT.2010.5582785; Zhang WL, 2009, SOLID STATE SCI, V11, P2008, DOI 10.1016/j.solidstatesciences.2009.06.034; Zhang YM, 2008, 2008 3RD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM AND KNOWLEDGE ENGINEERING, VOLS 1 AND 2, P609, DOI 10.1109/ISKE.2008.4731003; Zhou R, 2010, DIGIT SIGNAL PROCESS, V20, P276, DOI 10.1016/j.dsp.2009.04.005	31	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158435	10.1371/journal.pone.0158435	http://dx.doi.org/10.1371/journal.pone.0158435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355578	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400066
J	Ostergaard, SD; Larsen, JT; Dalsgaard, S; Wilens, TE; Mortensen, PB; Agerbo, E; Mors, O; Petersen, L				Ostergaard, Soren D.; Larsen, Janne T.; Dalsgaard, Soren; Wilens, Timothy E.; Mortensen, Preben B.; Agerbo, Esben; Mors, Ole; Petersen, Liselotte			Predicting ADHD by Assessment of Rutter's Indicators of Adversity in Infancy	PLOS ONE			English	Article							2 GEOGRAPHICAL AREAS; DEFICIT HYPERACTIVITY DISORDER; RISK-FACTORS; INSTITUTIONAL DEPRIVATION; MENTAL-DISORDERS; SYMPTOMS; PREVALENCE; ATTAINMENT; ADJUSTMENT; CHILDREN	Background Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder with early onset. ADHD is associated with significant morbidity and mortality, partly due to delayed diagnosis. Identification of children at high risk for developing ADHD could lead to earlier diagnosis and potentially change the negative trajectory of the illness for the better. Since early psychosocial adversity is considered to be a likely etiological risk factor for ADHD, markers of this construct may be useful for early identification of children at high risk. Therefore, we sought to investigate whether Rutter's indicators of adversity (low social class, severe marital discord, large family size, paternal criminality, maternal mental disorder, and placement in out-of-home care) assessed in infancy could serve as early predictors for the development of ADHD. Methods and Findings Using data from the Danish nationwide population-based registers, we established a cohort consisting of all 994,407 children born in Denmark between January 1st 1993 and December 31st 2011 and extracted dichotomous values for the six Rutter's indicators of adversity at age 0-12 months (infancy) for each cohort member. The cohort members were followed from their second birthday and the association between the sum of Rutter's indicators of adversity (RIA-score) in infancy and subsequent development of ADHD was estimated by means of Cox regression. Also, the number needed to screen (NNS) to detect one case of ADHD based on the RIA-scores in infancy was calculated. During follow-up (9.6 million person-years), 15,857 males and 5,663 females from the cohort developed ADHD. For both males and females, there was a marked dose-response relationship between RIA-scores assessed in infancy and the risk for developing ADHD. The hazard ratios for ADHD were 11.0 (95% CI: 8.2-14.7) and 11.4 (95% CI: 7.1-18.3) respectively, for males and females with RIA-scores of 5-6, compared to males and females with RIA-scores of 0. Among males with RIA-scores of 5-6, 37.6% (95% CI: 27.0-50.7) had been diagnosed with ADHD prior to the age of 20, corresponding to a NNS of 3.0 (95% CI: 2.2-4.0). Conclusions Rutter's indicators of adversity assessed in infancy strongly predicted ADHD. This knowledge may be important for early identification of ADHD.	[Ostergaard, Soren D.] Aarhus Univ Hosp, Dept Clin Med, iPSYCH, Aarhus, Denmark; [Ostergaard, Soren D.; Mors, Ole] Aarhus Univ Hosp, Psychosis Res Unit, iPSYCH, Risskov, Denmark; [Ostergaard, Soren D.; Larsen, Janne T.; Dalsgaard, Soren; Mortensen, Preben B.; Agerbo, Esben; Mors, Ole; Petersen, Liselotte] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Larsen, Janne T.; Dalsgaard, Soren; Mortensen, Preben B.; Agerbo, Esben; Petersen, Liselotte] Aarhus Univ, Natl Ctr Register Based Res, iPSYCH, Aarhus, Denmark; [Wilens, Timothy E.] Harvard Med Sch, Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychopharmacol, Boston, MA USA; [Wilens, Timothy E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Mortensen, Preben B.; Agerbo, Esben] Ctr Integrated Register Based Res Aarhus Univ CIR, iPSYCH, Aarhus, Denmark	Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Ostergaard, SD (corresponding author), Aarhus Univ Hosp, Dept Clin Med, iPSYCH, Aarhus, Denmark.; Ostergaard, SD (corresponding author), Aarhus Univ Hosp, Psychosis Res Unit, iPSYCH, Risskov, Denmark.; Ostergaard, SD (corresponding author), Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark.	soeoes@rm.dk	Mortensen, Preben B/D-2358-2015; Dalsgaard, Søren/AAA-4475-2020; Agerbo, Esben/A-2645-2012; Dalsgaard, Søren/I-4595-2013	Mortensen, Preben B/0000-0002-5230-9865; Dalsgaard, Søren/0000-0003-4659-0969; Agerbo, Esben/0000-0002-2849-524X; Dalsgaard, Søren/0000-0003-4659-0969; Larsen, Janne Tidselbak/0000-0002-0385-1017; Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Ostergaard, Soren Dinesen/0000-0002-8032-6208; Mors, Ole/0000-0002-5660-0393	Lundbeck Foundation; Lundbeck Foundation [R155-2014-1724, R165-2013-15320] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	The study was supported by grants from the Lundbeck Foundation (http://www.lundbeckfonden.com/). The funders of the study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Antshel KM, 2013, EXPERT REV NEUROTHER, V13, P1117, DOI 10.1586/14737175.2013.840417; Antshel KM, 2016, EXPERT REV NEUROTHER; Arnett AB, 2013, J CHILD PSYCHOL PSYC, V54, P1284, DOI 10.1111/jcpp.12104; BERGER M, 1975, BRIT J PSYCHIAT, V126, P510, DOI 10.1192/bjp.126.6.510; Bergh A, 2014, EUR J POLIT ECON, V35, P183, DOI 10.1016/j.ejpoleco.2014.06.002; BIEDERMAN J, 1995, ARCH GEN PSYCHIAT, V52, P464; Biederman J, 2002, AM J PSYCHIAT, V159, P1556, DOI 10.1176/appi.ajp.159.9.1556; Biederman J, 2011, J PSYCHIATR RES, V45, P150, DOI 10.1016/j.jpsychires.2010.06.009; Dalsgaard S, 2001, EUR CHILD ADOLES PSY, V10, P230, DOI 10.1007/s007870170012; Dalsgaard S, 2015, LANCET; Danish National Board of Health. Classification of Diseases, 1971, CLASS DIS EXT DAN LA; Faraone SV, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0497-1; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faraone SV, 2015, LANCET; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Johnson MH, 2015, J CHILD PSYCHOL PSYC, V56, P228, DOI 10.1111/jcpp.12328; Johnson P, 2014, INT J METH PSYCH RES, V23, P9, DOI 10.1002/mpr.1436; Kumsta R, 2010, J CHILD PSYCHOL PSYC, V51, P755, DOI 10.1111/j.1469-7610.2010.02249.x; Kyvsgaard B., 1998, CRIMINAL CAREER THE; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P1673, DOI 10.4088/JCP.v68n1106; Linnet KM, 2009, ACTA PAEDIATR, V98, P173, DOI 10.1111/j.1651-2227.2008.00980.x; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Munk-Jorgensen P, 2011, SCAND J PUBLIC HEALT, V39, P170, DOI 10.1177/1403494810390728; Nigg J, 2010, J AM ACAD CHILD PSY, V49, P863, DOI 10.1016/j.jaac.2010.01.025; Ostergaard SD, 2013, J AFFECT DISORDERS, V147, P232, DOI 10.1016/j.jad.2012.11.009; Pedersen CB, 2014, JAMA PSYCHIAT, V71, P573, DOI 10.1001/jamapsychiatry.2014.16; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersson F, 2011, SCAND J PUBLIC HEALT, V39, P95, DOI 10.1177/1403494811408483; Pheula GF, 2011, EUR CHILD ADOLES PSY, V20, P137, DOI 10.1007/s00787-011-0158-4; Pinto Carmen, 2006, J Atten Disord, V10, P83, DOI 10.1177/1087054705286058; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Ronald A, 2014, J ABNORM PSYCHOL, V123, P440, DOI 10.1037/a0036088; Rutter M, 2004, DEV PSYCHOL, V40, P81, DOI 10.1037/0012-1649.40.1.81; RUTTER M, 1975, BRIT J PSYCHIAT, V126, P493, DOI 10.1192/bjp.126.6.493; RUTTER M, 1975, BRIT J PSYCHIAT, V126, P520, DOI 10.1192/bjp.126.6.520; Statistics Denmark, 2015, FAFA DAT C FAM; Statistics Denmark, FAIN DAT HOUS FAM; Stevens SE, 2008, J ABNORM CHILD PSYCH, V36, P385, DOI 10.1007/s10802-007-9185-5; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Thapar A, 2012, ARCH DIS CHILD, V97, P260, DOI 10.1136/archdischild-2011-300482; Ubbesen MB, 2012, CHILD YOUTH SERV REV, V34, P2147, DOI 10.1016/j.childyouth.2012.07.014; Vukojevic M, 2012, COLLEGIUM ANTROPOL, V36, P1183; WHO, 2012, ICD 10 CLASS MENT BE; Wiik KL, 2011, J CHILD PSYCHOL PSYC, V52, P56, DOI 10.1111/j.1469-7610.2010.02294.x	46	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157352	10.1371/journal.pone.0157352	http://dx.doi.org/10.1371/journal.pone.0157352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355346	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400012
J	Zhang, ZT; Telesford, QK; Giusti, C; Lim, KO; Bassett, DS				Zhang, Zitong; Telesford, Qawi K.; Giusti, Chad; Lim, Kelvin O.; Bassett, Danielle S.			Choosing Wavelet Methods, Filters, and Lengths for Functional Brain Network Construction	PLOS ONE			English	Article							RESTING-STATE; SMALL-WORLD; LOW-FREQUENCY; MOTOR CORTEX; CONNECTIVITY; CLASSIFICATION; SIGNAL; SCHIZOPHRENIA; ORGANIZATION; FLUCTUATIONS	Wavelet methods are widely used to decompose fMRI, EEG, or MEG signals into time series representing neurophysiological activity in fixed frequency bands. Using these time series, one can estimate frequency-band specific functional connectivity between sensors or regions of interest, and thereby construct functional brain networks that can be examined from a graph theoretic perspective. Despite their common use, however, practical guidelines for the choice of wavelet method, filter, and length have remained largely undelineated. Here, we explicitly explore the effects of wavelet method (MODWT vs. DWT), wavelet filter (Daubechies Extremal Phase, Daubechies Least Asymmetric, and Coiflet families), and wavelet length (2 to 24)-each essential parameters in wavelet-based methods-on the estimated values of graph metrics and in their sensitivity to alterations in psychiatric disease. We observe that the MODWT method produces less variable estimates than the DWT method. We also observe that the length of the wavelet filter chosen has a greater impact on the estimated values of graph metrics than the type of wavelet chosen. Furthermore, wavelet length impacts the sensitivity of the method to detect differences between health and disease and tunes classification accuracy. Collectively, our results suggest that the choice of wavelet method and length significantly alters the reliability and sensitivity of these methods in estimating values of metrics drawn from graph theory. They furthermore demonstrate the importance of reporting the choices utilized in neuroimaging studies and support the utility of exploring wavelet parameters to maximize classification accuracy in the development of biomarkers of psychiatric disease and neurological disorders.	[Zhang, Zitong] Tsinghua Univ, Dept Biomed Engn, Beijing 100084, Peoples R China; [Zhang, Zitong; Telesford, Qawi K.; Giusti, Chad; Bassett, Danielle S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Giusti, Chad] Univ Penn, Warren Ctr Network & Data Sci, Philadelphia, PA 19104 USA; [Lim, Kelvin O.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Bassett, Danielle S.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	Tsinghua University; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania	Bassett, DS (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Bassett, DS (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	dsb@seas.upenn.edu	Lim, Kelvin/AAF-6833-2020	Giusti, Chad/0000-0003-2412-3622; Lim, Kelvin/0000-0002-2390-7268	John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation; Army Research Laboratory; Army Research Office [W911NF-10-2-0022, W911NF-14-1-0679]; National Institute of Mental Health [2-R01-DC-009209-11]; National Institute of Child Health and Human Development [1R01HD086888-01]; Office of Naval Research; National Science Foundation [BCS-1441502, BCS-1430087, PHY-1554488]; US-China Summer Research Program of the University of Pennsylvania; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009209] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); US-China Summer Research Program of the University of Pennsylvania; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the Army Research Laboratory and the Army Research Office through contract numbers W911NF-10-2-0022 and W911NF-14-1-0679, the National Institute of Mental Health (2-R01-DC-009209-11), the National Institute of Child Health and Human Development (1R01HD086888-01), the Office of Naval Research, and the National Science Foundation (BCS-1441502 and BCS-1430087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ZZ acknowledges support from the US-China Summer Research Program of the University of Pennsylvania. This work was supported by the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the Army Research Laboratory and the Army Research Office through contract numbers W911NF-10-2-0022 and W911NF-14-1-0679, the National Institute of Mental Health (2-R01-DC-009209-11), the National Institute of Child Health and Human Development (1R01HD086888-01), the Office of Naval Research, and the National Science Foundation (BCS-1441502, BCS-1430087, and PHY-1554488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Sarah Feldt Muldoon for helpful comments on an early version of the manuscript.	Abu-Rezq AN, 1999, COMPUT BIOMED RES, V32, P449, DOI 10.1006/cbmr.1999.1523; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Addison P. S., 2002, ILLUSTRATED WAVELET; Akansu AN, 1992, MULTIRESOLUTION SIGN; Azpiroz-Leehan J, 2000, MED ENG PHYS, V22, P335, DOI 10.1016/S1350-4533(00)00042-4; Bassett DS, 2014, CHAOS, V24, DOI 10.1063/1.4858457; Bassett DS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003171; Bassett DS, 2013, CHAOS, V23, DOI 10.1063/1.4790830; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2015, 14036034 ARXIV; Beran J., 1994, STAT LONG MEMORY PRO; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Boersma M, 2013, BRAIN CONNECT, V3, P41, DOI 10.1089/brain.2012.0127; Breakspear M, 2004, HUM BRAIN MAPP, V23, P1, DOI 10.1002/hbm.20045; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2004, NEUROIMAGE, V23, pS234, DOI 10.1016/j.neuroimage.2004.07.012; Butterworth S., 1930, EXP WIRELESS WIRELES, V7, P536; Calderbank AR, 1997, P IEEE C IM PROC; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; DAUBECHIES I, 1988, COMMUN PUR APPL MATH, V41, P909, DOI 10.1002/cpa.3160410705; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fadili MJ, 2004, NEUROIMAGE, V23, P1112, DOI 10.1016/j.neuroimage.2004.07.034; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Geerligs L, 2014, HUM BRAIN MAPP, V35, P319, DOI 10.1002/hbm.22175; Gencay R., 2001, INTRO WAVELETS OTHER; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Gu S, 2015, P NATL ACAD SCI USA, V112, P13681, DOI 10.1073/pnas.1502829112; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hermundstad AM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003591; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Jakab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060982; Khullar S, 2011, NEUROIMAGE, V54, P2867, DOI 10.1016/j.neuroimage.2010.10.063; Laine AF, 2000, ANNU REV BIOMED ENG, V2, P511, DOI 10.1146/annurev.bioeng.2.1.511; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liang XY, 2015, BRAIN CONNECT, V5, P543, DOI 10.1089/brain.2014.0290; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lohse C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003712; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mallat S. G., 1999, WAVELET TOUR SIGNAL; Mantzaris AV, 2013, J COMPLEX NETW, V1, P83, DOI 10.1093/comnet/cnt001; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ortiz-Rosario A, 2015, J NEUROSCI METH, V246, P106, DOI 10.1016/j.jneumeth.2015.03.014; Palit M, 2010, IEEE T INSTRUM MEAS, V59, P2230, DOI 10.1109/TIM.2009.2032883; Patel AX, 2014, NEUROIMAGE, V95, P287, DOI 10.1016/j.neuroimage.2014.03.012; Peters JM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-54; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Pritchard WS, 2014, BRAIN CONNECT, V4, P454, DOI 10.1089/brain.2013.0217; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan JR, 1993, MORGAN KAUFMANN SERI, DOI 10.1016/C2009-0-27846-9; Sarty GE, 2004, COMPUTING BRAIN ACTI; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Semler L, 2005, COMP MED SY, P265, DOI 10.1109/CBMS.2005.105; Siebenhuhner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072351; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Sporns O, 2002, BEHAV BRAIN RES, V135, P69, DOI 10.1016/S0166-4328(02)00157-2; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Srikanth R, 2006, INT J NEURAL SYST, V16, P125, DOI 10.1142/S012906570600055X; Stausberg S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041914; Strela V, 1999, IEEE T IMAGE PROCESS, V8, P548, DOI 10.1109/83.753742; Subasi A, 2007, EXPERT SYST APPL, V32, P1084, DOI 10.1016/j.eswa.2006.02.005; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Turkheimer FE, 2008, J NUCL MED, V49, P657, DOI 10.2967/jnumed.107.041871; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitcher B, 2000, J GEOPHYS RES-ATMOS, V105, P14941, DOI 10.1029/2000JD900110; Wiltschko AB, 2008, J NEUROSCI METH, V173, P34, DOI 10.1016/j.jneumeth.2008.05.016; Wink AM, 2006, NEUROBIOL AGING, V27, P1395, DOI 10.1016/j.neurobiolaging.2005.08.011; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001	95	79	82	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157243	10.1371/journal.pone.0157243	http://dx.doi.org/10.1371/journal.pone.0157243			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355202	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400010
J	Grasman, J; Grasman, RPPP; van der Maas, HLJ				Grasman, Johan; Grasman, Raoul P. P. P.; van der Maas, Han L. J.			The Dynamics of Addiction: Craving versus Self-Control	PLOS ONE			English	Article							EGO DEPLETION; ALCOHOL-USE; SENSITIVITY; PSYCHOLOGY; MECHANISMS; RELAPSE; COCAINE; SYSTEM; MODEL; CUES	This study deals with addictive acts that exhibit a stable pattern not intervening with the normal routine of daily life. Nevertheless, in the long term such behaviour may result in health damage. Alcohol consumption is an example of such addictive habit. The aim is to describe the process of addiction as a dynamical system in the way this is done in the natural and technological sciences. The dynamics of the addictive behaviour is described by a mathematical model consisting of two coupled difference equations. They determine the change in time of two state variables, craving and self-control. The model equations contain terms that represent external forces such as societal rules, peer influences and cues. The latter are formulated as events that are Poisson distributed in time. With the model it is shown how a person can get addicted when changing lifestyle. Although craving is the dominant variable in the process of addiction, the moment of getting dependent is clearly marked by a switch in a variable that fits the definition of addiction vulnerability in the literature. Furthermore, the way chance affects a therapeutic addiction intervention is analysed by carrying out a Monte Carlo simulation. Essential in the dynamical model is a nonlinear component which determines the configuration of the two stable states of the system: being dependent or not dependent. Under identical external conditions both may be stable (hysteresis). With the dynamical systems approach possible switches between the two states are explored (repeated relapses).	[Grasman, Johan] Wageningen Univ & Res Ctr, Biometris, Wageningen, Netherlands; [Grasman, Raoul P. P. P.; van der Maas, Han L. J.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	Wageningen University & Research; University of Amsterdam	Grasman, J (corresponding author), Wageningen Univ & Res Ctr, Biometris, Wageningen, Netherlands.	johan.grasman@wur.nl		van der Maas, Han L. J./0000-0001-8278-319X				Baschnagel JS, 2013, ADDICT BEHAV, V38, P2837, DOI 10.1016/j.addbeh.2013.08.005; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Caselles A, 2010, BRIT J MATH STAT PSY, V63, P449, DOI 10.1348/000711009X470768; Caselli G, 2015, ADDICT BEHAV, V44, P71, DOI 10.1016/j.addbeh.2014.07.021; Cooney NL, 1997, J ABNORM PSYCHOL, V106, P243, DOI 10.1037/0021-843X.106.2.243; Edelstein-Keshet L., 1988, MATH MODELS BIOL; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Franken IHA, 2002, PERS INDIV DIFFER, V32, P349, DOI 10.1016/S0191-8869(01)00030-7; Gelfand LA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00382; Grasman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047139; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hill AJ, 2007, P NUTR SOC, V66, P277, DOI 10.1017/S0029665107005502; Hufford MR, 2003, J ABNORM PSYCHOL, V112, P219, DOI 10.1037/0021-843X.112.2.219; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; Johan G., 1999, ASYMPTOTIC METHODS F; Jones A, 2013, FRONT PSYCHIATRY, V4; Moeller FG, 2012, AM J PSYCHIAT, V169, P351, DOI 10.1176/appi.ajp.2012.12010041; Muraven M, 2002, PSYCHOL ADDICT BEHAV, V16, P113, DOI 10.1037//0893-164X.16.2.113; NICOLAYSEN LC, 1988, PHARMACOL BIOCHEM BE, V31, P327, DOI 10.1016/0091-3057(88)90354-1; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ramirez J, 2014, PSYCHOPHARMACOLOGY, V231, P1841, DOI 10.1007/s00213-013-3372-6; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Snelleman M, 2014, ADDICT BEHAV, V39, P1884, DOI 10.1016/j.addbeh.2014.07.024; Stewart MJ, 2014, J GAMBL STUD, V30, P653, DOI 10.1007/s10899-013-9383-8; Warren K, 2003, ADDICT BEHAV, V28, P369, DOI 10.1016/S0306-4603(01)00234-9; Witkiewitz K, 2007, J ABNORM PSYCHOL, V116, P378, DOI 10.1037/0021-843X.116.2.378	27	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158323	10.1371/journal.pone.0158323	http://dx.doi.org/10.1371/journal.pone.0158323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352037	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900055
J	Obamiro, KO; Chalmers, L; Bereznicki, LRE				Obamiro, Kehinde O.; Chalmers, Leanne; Bereznicki, Luke R. E.			Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT)	PLOS ONE			English	Article							CONTENT VALIDITY; INTERRATER RELIABILITY; PATIENT KNOWLEDGE; WARFARIN THERAPY; AGREEMENT; INDEX	Background Assessing and improving patients' anticoagulation knowledge can lead to better treatment outcomes. While validated knowledge instruments exist for use in people taking warfarin, these tools are not necessarily applicable to patients taking direct-acting oral anticoagulants. Objective To develop and validate an oral anticoagulation knowledge instrument that is applicable to all oral anticoagulant medications. Methods Ten anticoagulation experts participated in the development of the Anticoagulation Knowledge Tool to ensure content validity. The knowledge instrument was administered to three groups of participants comprising of 44 pharmacists, 50 patients and 50 members of the general public. A subgroup of participants in the patient and pharmacist group were retested approximately 2-3 months after the initial testing. Statistical tests were conducted to determine the validity and reliability of the scale, and item analysis was used to determine the performance of individual questions. Results The 28-item instrument developed had a scale content validity index of 0.92, supporting content validity. The pharmacist group's mean score was significantly higher than that of the patient group, and the patient group scored significantly higher than the general public group (94% vs 62% vs 20%, respectively; p<0.001), supporting construct validity. Internal consistency reliability was acceptable with a Cronbach's a value of > 0.7 across the three groups, and the test retest reliability was confirmed with a Pearson's correlation coefficient of 0.72 and 0.78 for the pharmacist and patient groups, respectively. Conclusion The Anticoagulation Knowledge Tool is a valid and reliable instrument that can be used in routine clinical practice to assess patients' anticoagulation knowledge.	[Obamiro, Kehinde O.; Chalmers, Leanne; Bereznicki, Luke R. E.] Univ Tasmania, Sch Med, Pharm, Hobart, Tas, Australia	University of Tasmania	Obamiro, KO (corresponding author), Univ Tasmania, Sch Med, Pharm, Hobart, Tas, Australia.	Kehinde.Obamiro@utas.edu.au		Obamiro, Kehinde/0000-0002-0265-1953; Bereznicki, Luke/0000-0003-3974-3437; Chalmers, Leanne/0000-0002-2477-2190				Baker JW, 2011, J MANAGE CARE PHARM, V17, P133; Briggs Amber L, 2005, Res Social Adm Pharm, V1, P40, DOI 10.1016/j.sapharm.2004.12.002; Davis NJ, 2005, ANN PHARMACOTHER, V39, P632, DOI 10.1345/aph.1E464; Dentali F, 2012, CIRCULATION; Hawkins RJ, 2014, J PERIANESTH NURS, V29, P28, DOI 10.1016/j.jopan.2013.05.011; Hu A, 2006, J CARDIOVASC NURS, V21, P169, DOI 10.1097/00005082-200605000-00003; JAMES LR, 1984, J APPL PSYCHOL, V69, P85, DOI 10.1037/0021-9010.69.1.85; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Kagansky N, 2004, ARCH INTERN MED, V164, P2044, DOI 10.1001/archinte.164.18.2044; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Lindell MK, 1999, APPL PSYCH MEAS, V23, P127, DOI 10.1177/01466219922031257; LYNN MR, 1986, NURS RES, V35, P382; Mekaj YH, 2015, THER CLIN RISK MANAG, V11, DOI [10.2147/TCRM.S92222, 10.2147/TCRM.S84210]; Paiva CE, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-8; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Tang EOYL, 2003, ANN PHARMACOTHER, V37, P34, DOI 10.1345/aph.1A198; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Taylor F C, 1994, Qual Health Care, V3, P79, DOI 10.1136/qshc.3.2.79; Thayn KS, 2010, EVALUATION MULTIPLE; TINSLEY HEA, 1975, J COUNS PSYCHOL, V22, P358, DOI 10.1037/h0076640; Westen D, 2003, J PERS SOC PSYCHOL, V84, P608, DOI 10.1037/0022-3514.84.3.608; Winans ARM, 2010, ANN PHARMACOTHER, V44, P1152, DOI 10.1345/aph.1P092; Yahaya AHM, 2009, J CLIN DIAGN RES, V3, P1663; Zeolla MM, 2006, ANN PHARMACOTHER, V40, P633, DOI 10.1345/aph.1G562	25	23	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158071	10.1371/journal.pone.0158071	http://dx.doi.org/10.1371/journal.pone.0158071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27351746	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900030
J	Park, SM; Jeong, IS; Jun, SS				Park, Soon Mi; Jeong, Ihn Sook; Jun, Seong Sook			Identification of Risk Factors for Intravenous Infiltration among Hospitalized Children: A Retrospective Study	PLOS ONE			English	Article							EXTRAVASATION	This retrospective study was aimed to identify risk factors of intravenous (IV) infiltration for hospitalized children. The participants were 1,174 children admitted to a general hospital, who received peripheral intravenous injection therapy at least once, and had complete records. Data were analyzed with frequency and percentage or mean and standard deviation were calculated, and odds ratio (OR) from univariate and multiple logistic regressions. The number and % of infiltrations were 92 and 7.8%, respectively. IV infiltration risk factors were lower limb (OR = 1.72), phenytoin (OR = 11.03), 10% dextrose (OR = 6.55), steroids (OR = 6.21), vancomycin (OR = 4.10), high-concentration electrolytes (OR = 3.49), and ampicillin/sulbactam combination (OR = 3.37). Nurses working at children's hospitals should consider the risk of IV infiltration for children receiving IV infusion therapy and make a preventive effort to identify IV infiltration in high-risk children at an early stage.	[Park, Soon Mi] Pusan Natl Univ, Yangsan Hosp, Dept Nursing, Yangsan, South Korea; [Jeong, Ihn Sook; Jun, Seong Sook] Pusan Natl Univ, Coll Nursing, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University	Jeong, IS; Jun, SS (corresponding author), Pusan Natl Univ, Coll Nursing, Yangsan, South Korea.	jeongis@pusan.ac.kr; jss@pusan.ac.kr						Ahn H. S., 2012, PEDIATRICS; Amjad I, 2011, J INFUS MURS, V34, P242, DOI 10.1097/NAN.0b013e31821da1b3; Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; Clark E, 2013, J INFUS MURS, V36, P37, DOI 10.1097/NAN.0b013e3182798844; Clifton-Koeppel R, 2006, NEWBORN INFANT NURS, V6, P202, DOI 10.1053/j.nainr.2006.10.001; Jacinto AKD, 2011, J INFUS MURS, V34, P391, DOI 10.1097/NAN.0b013e3182306491; Doellman D, 2009, J INFUS MURS, V32, P203, DOI 10.1097/NAN.0b013e3181aac042; Dougherty Lisa, 2008, Br J Nurs, V17, pS3; Earhart A, 2011, J INFUS MURS, V34, P97, DOI 10.1097/NAN.0b013e31820b4a11; Fang L, 2011, J INFUS MURS, V34, P366, DOI 10.1097/NAN.0b013e31823061c1; Flemmer L, 1993, Pediatr Nurs, V19, P355; Glueck CJ, 2014, CLIN APPL THROMB-HEM, V20, P244, DOI 10.1177/1076029613499819; Goolsby TV, 2006, SEMIN ONCOL, V33, P139, DOI 10.1053/j.seminoncol.2005.11.007; Hadaway L, 2007, AM J NURS, V107, P64, DOI 10.1097/01.NAJ.0000282299.03441.c7; Hetzler R, 2011, J PEDIATR NURS, V26, P143, DOI 10.1016/j.pedn.2010.12.008; Infusion Nurses Society, 2006, J Infus Nurs, V29, pS1; Ji-Soo Kim，, 2012, Child Health Nursing Research, V18, P135, DOI 10.4094/jkachn.2012.18.3.135; 성세희, 2007, [Journal of Korean Clinical Nursing Research, 임상간호연구], V13, P61; Kumar RJ, 2001, ANZ J SURG, V71, P285, DOI 10.1046/j.1440-1622.2001.02104.x; Le A, 2014, ANN PHARMACOTHER, V48, P870, DOI 10.1177/1060028014527820; McCullen KL, 2006, J WOUND OSTOMY CONT, V33, P133, DOI 10.1097/00152192-200603000-00006; McDonnell PJ, 2004, PENNSYLVANIA PATIENT, V3, P1; Montgomery L A, 1999, Pediatr Nurs, V25, P167; Patient Safety Advisory, 2004, PENNSYLVANIA PATIENT, V1, P1; Payne AS, 2013, EXTRAVASATION INJURY; Sarovath A., 2006, THAI J SURG, V27, P19; Sauerland C, 2006, ONCOL NURS FORUM, V33, P1134, DOI 10.1188/06.ONF.1134-1141; Talbot SG, 2011, ANN PLAS SURG, V67, P531, DOI 10.1097/SAP.0b013e3182085915; Wilson J., 2006, INFECT CONTROL CLIN; Woody G, 2013, J INFUS MURS, V36, P413, DOI 10.1097/NAN.0000000000000013; YOSOWITZ P, 1975, ANN SURG, V182, P553, DOI 10.1097/00000658-197511000-00003	31	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158045	10.1371/journal.pone.0158045	http://dx.doi.org/10.1371/journal.pone.0158045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351488	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900028
J	Xu, SH; Soroka, CJ; Sun, AQ; Backos, DS; Mennone, A; Suchy, FJ; Boyer, JL				Xu, Shuhua; Soroka, Carol J.; Sun, An-Qiang; Backos, Donald S.; Mennone, Albert; Suchy, Frederick J.; Boyer, James L.			A Novel Di-Leucine Motif at the N-Terminus of Human Organic Solute Transporter Beta Is Essential for Protein Association and Membrane Localization	PLOS ONE			English	Article							ALPHA-OST-BETA; STEROID TRANSPORTER; CRYSTAL-STRUCTURE; TRAFFICKING; HETERODIMERIZATION; SYNTHETASE	The heteromeric membrane protein Organic Solute Transporter alpha/beta is the major bile acid efflux transporter in the intestine. Physical association of its alpha and beta subunits is essential for their polarized basolateral membrane localization and function in the transport of bile acids and other organic solutes. We identified a highly conserved acidic dileucine motif (-EL20L21EE) at the extracellular amino-tail of organic solute transporter beta from multiple species. To characterize the role of this protein interacting domain in the association of the human beta and alpha subunits and in membrane localization of the transporter, Leu20 and Leu21 on the amino-tail of human organic solute transporter beta were replaced with alanines by site-directed mutagenesis. Co-immunoprecipitation study in HEK293 cells demonstrated that substitution of the leucine residues with alanines prevented the interaction of the human beta mutant with the alpha subunit. Membrane biotinylation demonstrated that the LL/AA mutant eliminated membrane expression of both subunits. Computational-based modelling of human organic solute transporter beta suggested that the LL/AA mutation substantially alters both the structure and lipophilicity of the surface, thereby not only affecting the interaction with the alpha subunit but also possibly impacting the capacity of the beta subunit to traffick through the cell and interact with the membrane. In summary, our findings indicate that the dileucine motif in the extracellular N-terminal region of human organic solute transporter beta subunit plays a critical role in the association with the alpha subunit and in its polarized plasma membrane localization.	[Xu, Shuhua; Soroka, Carol J.; Mennone, Albert; Boyer, James L.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Xu, Shuhua; Soroka, Carol J.; Mennone, Albert; Boyer, James L.] Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT 06510 USA; [Sun, An-Qiang; Suchy, Frederick J.] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA; [Backos, Donald S.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA	Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Boyer, JL (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Boyer, JL (corresponding author), Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT 06510 USA.	james.boyer@yale.edu	Backos, Donald/Q-4791-2018; Backos, Donald/N-5265-2019	Backos, Donald/0000-0001-6735-6210; Backos, Donald/0000-0001-6735-6210	National Institute of Diabetes and Digestive and Kidney Diseases [DK 02563, DK P30-343989, DK84434]; NIH/NCATS [UL1 TR001082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025636, P30DK034989] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020142] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institute of Diabetes and Digestive and Kidney Diseases grants DK 02563 (JLB), DK P30-343989 (JLB), and DK84434 (FS). Molecular modeling studies were conducted at the University of Colorado Computational Chemistry and Biology Core Facility, which is funded in part by NIH/NCATS UL1 TR001082. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatori N, 2005, EXP BIOL MED, V230, P689, DOI 10.1177/153537020523001001; Ballatori N, 2013, MOL ASPECTS MED, V34, P683, DOI 10.1016/j.mam.2012.11.005; Ballatori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2829, DOI 10.2741/3416; Christian WV, 2012, J BIOL CHEM, V287, P21233, DOI 10.1074/jbc.M112.352245; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Dawson PA, 2010, BBA-MOL CELL BIOL L, V1801, P994, DOI 10.1016/j.bbalip.2010.06.002; Diao FQ, 2010, MOL CELL NEUROSCI, V45, P75, DOI 10.1016/j.mcn.2010.06.001; Diaz-Bello B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064096; Doly S, 2015, TRENDS PHARMACOL SCI, V36, P636, DOI 10.1016/j.tips.2015.06.007; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Kasai K, 2008, CELL MOL BIOL LETT, V13, P144, DOI 10.2478/s11658-007-0043-9; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lam P, 2012, HEPATOLOGY, V55, P1901, DOI 10.1002/hep.25523; Li N, 2007, BIOCHEM J, V407, P363, DOI 10.1042/BJ20070716; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Poirier S, 2013, TRAFFIC, V14, P458, DOI 10.1111/tra.12046; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Seward DJ, 2003, J BIOL CHEM, V278, P27473, DOI 10.1074/jbc.M301106200; Soroka CJ, 2010, SEMIN LIVER DIS, V30, P178, DOI 10.1055/s-0030-1253226; Soroka CJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-57; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Spassov VZ, 2002, J PHYS CHEM B, V106, P8726, DOI 10.1021/jp020674r; Sun AQ, 2007, AM J PHYSIOL-GASTR L, V292, pG1586, DOI 10.1152/ajpgi.00457.2006; Sun An-Qiang, 2012, Int J Biochem Mol Biol, V3, P290; Takei T, 2006, J BIOCHEM, V139, P271, DOI 10.1093/jb/mvj031; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Yi L, 2015, HUM MOL GENET, V24, P2411, DOI 10.1093/hmg/ddv002	30	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158269	10.1371/journal.pone.0158269	http://dx.doi.org/10.1371/journal.pone.0158269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351185	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900048
J	Bowman, LR; Tejeda, GS; Coelho, GE; Sulaiman, LH; Gill, BS; McCall, PJ; Olliaro, PL; Ranzinger, SR; Quang, LC; Ramm, RS; Kroeger, A; Petzold, MG				Bowman, Leigh R.; Tejeda, Gustavo S.; Coelho, Giovanini E.; Sulaiman, Lokman H.; Gill, Balvinder S.; McCall, Philip J.; Olliaro, Piero L.; Ranzinger, Silvia R.; Quang, Luong C.; Ramm, Ronald S.; Kroeger, Axel; Petzold, Max G.			Alarm Variables for Dengue Outbreaks: A Multi-Centre Study in Asia and Latin America	PLOS ONE			English	Article							VECTOR-BORNE DISEASES; AEDES-AEGYPTI; TRANSMISSION DYNAMICS; HUMAN MOVEMENT; QUERY DATA; VIRUS; SURVEILLANCE; CLIMATE; TEMPERATURE; MODEL	Background Worldwide, dengue is an unrelenting economic and health burden. Dengue outbreaks have become increasingly common, which place great strain on health infrastructure and services. Early warning models could allow health systems and vector control programmes to respond more cost-effectively and efficiently. Methodology/Principal Findings The Shewhart method and Endemic Channel were used to identify alarm variables that may predict dengue outbreaks. Five country datasets were compiled by epidemiological week over the years 2007-2013. These data were split between the years 2007-2011 (historic period) and 2012-2013 (evaluation period). Associations between alarm/outbreak variables were analysed using logistic regression during the historic period while alarm and outbreak signals were captured during the evaluation period. These signals were combined to form alarm/outbreak periods, where 2 signals were equal to 1 period. Alarm periods were quantified and used to predict subsequent outbreak periods. Across Mexico and Dominican Republic, an increase in probable cases predicted outbreaks of hospitalised cases with sensitivities and positive predictive values (PPV) of 93%/83% and 97%/86% respectively, at a lag of 1-12 weeks. An increase in mean temperature ably predicted outbreaks of hospitalised cases in Mexico and Brazil, with sensitivities and PPVs of 79%/73% and 81%/46% respectively, also at a lag of 1-12 weeks. Mean age was predictive of hospitalised cases at sensitivities and PPVs of 72%/74% and 96%/45% in Mexico and Malaysia respectively, at a lag of 4-16 weeks. Conclusions/Significance An increase in probable cases was predictive of outbreaks, while meteorological variables, particularly mean temperature, demonstrated predictive potential in some countries, but not all. While it is difficult to define uniform variables applicable in every country context, the use of probable cases and meteorological variables in tailored early warning systems could be used to highlight the occurrence of dengue outbreaks or indicate increased risk of dengue transmission.	[Bowman, Leigh R.; McCall, Philip J.; Kroeger, Axel] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Tejeda, Gustavo S.] Minist Hlth, Mexico City, DF, Mexico; [Coelho, Giovanini E.] Minist Hlth, Brasilia, DF, Brazil; [Sulaiman, Lokman H.; Gill, Balvinder S.] Minist Hlth, Kuala Lumpur, Malaysia; [Bowman, Leigh R.; Olliaro, Piero L.; Ranzinger, Silvia R.; Kroeger, Axel; Petzold, Max G.] UNICEF UNDP World Bank WHO Special Programme Res, Geneva, Switzerland; [Ranzinger, Silvia R.] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Quang, Luong C.] Inst Pasteur, Ho Chi Minh City, Vietnam; [Ramm, Ronald S.] Minist Hlth, Santo Domingo, Dominican Rep; [Petzold, Max G.] Univ Gothenburg, Gothenburg, Sweden	Liverpool School of Tropical Medicine; University of Liverpool; Kementerian Kesihatan Malaysia; The World Bank; World Health Organization; Ruprecht Karls University Heidelberg; University of Gothenburg	Bowman, LR (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England.; Bowman, LR (corresponding author), UNICEF UNDP World Bank WHO Special Programme Res, Geneva, Switzerland.	leigh.bowman@gmail.com	Bowman, Leigh/H-6880-2019; Sulaiman, Lokman Hakim/GYD-6287-2022	Bowman, Leigh/0000-0003-0657-7911; Sulaiman, Lokman Hakim/0000-0002-5840-8450; McCall, Philip J/0000-0002-0007-3985	European Commission within 7th Framework Programme [m281803]; Special Programme for Research and Training in Tropical Diseases (TDR-WHO)	European Commission within 7th Framework Programme; Special Programme for Research and Training in Tropical Diseases (TDR-WHO)(World Health Organization)	The project was financially supported by a grant from the European Commission (grant number m281803) to the IDAMS network (www.idams.eu) within the 7th Framework Programme and by the Special Programme for Research and Training in Tropical Diseases (TDR-WHO). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258; Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015; [Anonymous], 2005, ASIA PAC; Badurdeen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-607; Barbazan P, 2002, MICROBES INFECT, V4, P699, DOI 10.1016/S1286-4579(02)01589-7; Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; Betts RA, 2004, THEOR APPL CLIMATOL, V78, P157, DOI 10.1007/s00704-004-0050-y; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002; Campbell KM, 2013, AM J TROP MED HYG, V89, P1066, DOI 10.4269/ajtmh.13-0321; Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043; Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012; Christiansen-Jucht CL, 2014, TEMPERATURE DURING L, V7, P1, DOI [10.1186/s13071-014-0489-3, DOI 10.1186/S13071-014-0489-3]; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; CULLEN JR, 1984, B WORLD HEALTH ORGAN, V62, P107; De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003; Phung D, 2015, ACTA TROP, V141, P88, DOI 10.1016/j.actatropica.2014.10.005; Ellis AM, 2011, AM J TROP MED HYG, V85, P257, DOI 10.4269/ajtmh.2011.10-0516; Hernandez-Avila JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070231; Farrington C, 2003, MONITORING HLTH POPU, V2003, P203; Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713; Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halide H, 2008, INT J ENVIRON HEAL R, V18, P253, DOI 10.1080/09603120801966043; Harrington J, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/756832; Hii YL, 2009, GLOBAL HEALTH ACTION, V2, P124, DOI 10.3402/gha.v2i0.2036; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001848; Hugo LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002669; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447; Kroeger A, 2014, WHO TDR MEETING; Kuhn K, 2005, USING CLIMATE TO PRE; Lee KS, 2010, DENGUE VIRUS SURVEIL; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50; Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9; Madoff LC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001215; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Meza-Ballesta Angye, 2014, Rev. salud pública, V16, P293, DOI 10.15446/rsap.v16n2.38146; Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556; Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167; Ninphanomchai S, 2014, INT J ENV RES PUB HE, V11, P10694, DOI 10.3390/ijerph111010694; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Pham HV, 2011, STOCH ENV RES RISK A, V25, P485, DOI DOI 10.1007/S00477-010-0417-9; Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002581; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; Reid RD, 2004, OPERATIONS MANAGEMEN; Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111; Rigau-Perez JG, 1999, AM J PUBLIC HEALTH, V89, P374, DOI 10.2105/AJPH.89.3.374; Rodrigues HS, 2012, INT J COMPUT MATH, V89, P334, DOI 10.1080/00207160.2011.554540; Rosenbaum L, 2015, NEW ENGL J MED, V372, P7, DOI 10.1056/NEJMp1413816; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333; Runge-Ranzinger S, 2008, TROP MED INT HEALTH, V13, P1022, DOI 10.1111/j.1365-3156.2008.02112.x; Scott TW, 2010, CURR TOP MICROBIOL, V338, P115, DOI 10.1007/978-3-642-02215-9_9; Semenza JC, 2015, INT J ENV RES PUB HE, V12, P6333, DOI 10.3390/ijerph120606333; Shewhart WA, 1930, BELL SYST TECH J, V9, P364, DOI 10.1002/j.1538-7305.1930.tb00373.x; Shi Y, 2016, ENVIRON HEALTH PERSP, V124, P1369, DOI 10.1289/ehp.1509981; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; StataCorp, 2013, STATA STATISTICAL SO; Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; STROUP DF, 1989, STAT MED, V8, P323, DOI 10.1002/sim.4780080312; Thai KTD, 2011, EXP BIOL MED, V236, P944, DOI 10.1258/ebm.2011.010402; Tran HP, 2010, INT HEALTH, V2, P136, DOI 10.1016/j.inhe.2009.12.007; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 2012, WORLD HEAL ORGAN, P1; Xu HY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002805; Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322; Yi Bintang, 2003, Wei Sheng Yan Jiu, V32, P152; Zhang Y, 2008, ASIA-PAC J PUBLIC HE, V20, P64, DOI 10.1177/1010539507308385	82	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157971	10.1371/journal.pone.0157971	http://dx.doi.org/10.1371/journal.pone.0157971			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348752	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000378801200026
J	Abdulhamid, SM; Abd Latiff, MS; Abdul-Salaam, G; Madni, SHH				Abdulhamid, Shafi'i Muhammad; Abd Latiff, Muhammad Shafie; Abdul-Salaam, Gaddafi; Madni, Syed Hamid Hussain			Secure Scientific Applications Scheduling Technique for Cloud Computing Environment Using Global League Championship Algorithm	PLOS ONE			English	Article							INFRASTRUCTURE; SEARCH	Cloud computing system is a huge cluster of interconnected servers residing in a datacenter and dynamically provisioned to clients on-demand via a front-end interface. Scientific applications scheduling in the cloud computing environment is identified as NP-hard problem due to the dynamic nature of heterogeneous resources. Recently, a number of metaheuristics optimization schemes have been applied to address the challenges of applications scheduling in the cloud system, without much emphasis on the issue of secure global scheduling. In this paper, scientific applications scheduling techniques using the Global League Championship Algorithm (GBLCA) optimization technique is first presented for global task scheduling in the cloud environment. The experiment is carried out using Cloud-Sim simulator. The experimental results show that, the proposed GBLCA technique produced remarkable performance improvement rate on the makespan that ranges between 14.44% to 46.41%. It also shows significant reduction in the time taken to securely schedule applications as parametrically measured in terms of the response time. In view of the experimental results, the proposed technique provides better-quality scheduling solution that is suitable for scientific applications task execution in the Cloud Computing environment than the MinMin, MaxMin, Genetic Algorithm (GA) and Ant Colony Optimization (ACO) scheduling techniques.	[Abdulhamid, Shafi'i Muhammad; Abd Latiff, Muhammad Shafie; Madni, Syed Hamid Hussain] Univ Teknol Malaysia, Fac Comp, Johor Baharu, Malaysia; [Abdulhamid, Shafi'i Muhammad] Fed Univ Technol, Dept Cyber Secur Sci, Minna, Nigeria; [Abdul-Salaam, Gaddafi] Kwame Nkuruma Univ Sci & Technol, Kumasi, Ghana	Universiti Teknologi Malaysia	Abdulhamid, SM (corresponding author), Univ Teknol Malaysia, Fac Comp, Johor Baharu, Malaysia.; Abdulhamid, SM (corresponding author), Fed Univ Technol, Dept Cyber Secur Sci, Minna, Nigeria.	shafii.abdulhamid@futminna.edu.ng	Abdulhamid, Shafi'i Muhammad/J-4288-2016; Abd Latiff, Muhammad Shafie/P-1648-2015; Madni, Hamid/AIC-1780-2022; Madni, Syed Hamid Hussain/AAF-6434-2019	Abdulhamid, Shafi'i Muhammad/0000-0001-9196-9447; Abd Latiff, Muhammad Shafie/0000-0002-0741-2257; Madni, Hamid/0000-0002-3816-1382; Madni, Syed Hamid Hussain/0000-0002-3816-1382				Abdulhamid S.I.M., 2014, ARPN J ENG APPL SCI, V9, P2528; Abdulhamid Shafi'I Muhammad, 2014, Journal of Theoretical and Applied Information Technology, V63, P10; Abdulhamid Shafii Muhammad, 2015, INDIAN J SCI TECHNOL, V8, P1; Abdulhamid SM, 2014, LEAGUE CHAMPIONSHIP, P381; Abdullahi M, 2016, FUTURE GENER COMP SY, V56, P640, DOI 10.1016/j.future.2015.08.006; Abrishami S, 2013, FUTURE GENER COMP SY, V29, P158, DOI 10.1016/j.future.2012.05.004; Aceto G, 2013, CLOUD MONITORING SUR; Achary R, 2015, ADV INTELL SYST, V321, P71, DOI 10.1007/978-3-319-11227-5_7; Alkhanak E. N., 2015, FUTURE GENERATION CO; Bala A, 2015, CONCURRENT ENG; Beegom ASA, 2015, LECT NOTES COMPUT SC, V8956, P356, DOI 10.1007/978-3-319-14977-6_38; Chen Zong-Gan, 2015, EV COMP CEC 2015 IEE; Cheng MY, 2014, COMPUT STRUCT, V139, P98, DOI 10.1016/j.compstruc.2014.03.007; Dutta D, 2011, GENETIC ALGORITHM AP, P422; Frincu ME, 2011, THESIS; Gasior Jakub, 2013, Algorithms and Architectures for Parallel Processing. 13th International Conference, ICA3PP 2013. Proceedings: LNCS 8285, P247, DOI 10.1007/978-3-319-03859-9_21; Geng J, 2015, NEUROCOMPUTING, V151, P1362, DOI 10.1016/j.neucom.2014.10.055; Guo-ning G, 2010, GENETIC SIMULATED AN, P60; Hao Yuan, 2014, Journal of Software, V9, P705, DOI 10.4304/jsw.9.3.705-708; Hazlewood V, 2015, PARALLEL WORKLOAD AR; Hu X, 2014, J COMPUTATIONAL INFO, V10, P8723; Jin G, 2015, J INFORM COMPUTATION, V12, P1045, DOI DOI 10.12733/jics20105450; Kashan HA, 2009, LEAGUE CHAMPIONSHIP, P43; Keshk Arabi E., 2014, International Journal of Intelligent Systems and Applications, V6, P25, DOI 10.5815/ijisa.2014.05.02; Kolodziej J, 2011, GENETIC ALGORITHMS E, P17; Kun Li, 2011, 2011 Sixth ChinaGrid Annual Conference (ChinaGrid), P3, DOI 10.1109/ChinaGrid.2011.17; Li H-H, 2015, P COMP PUBL 2015 GEN; Li JY, 2012, J PARALLEL DISTR COM, V72, P666, DOI 10.1016/j.jpdc.2012.02.002; Liu X.-F., 2014, P 2014 C GEN EV COMP; Madni S.H.H., 2016, INDIAN J SCI TECHNOL, V9; Madni SHH, J NETWORK COMPUTER A; Madni SHH, 2016, J NETW COMPUT APPL, V68, P173, DOI 10.1016/j.jnca.2016.04.016; MATHEW T, 2014, STUDY ANAL VARIOUS T, P658; Moharana S.S., 2013, INT J COMPUT SCI ENG, V2, P101; Moschakis IA, 2013, CONCURRENCY COMPUTAT; PAN Y, 2015, PLOS ONE, V10; Pandey S, 2010, INT CON ADV INFO NET, P400, DOI 10.1109/AINA.2010.31; Ramezani F, 2014, INT J PARALLEL PROG, V42, P739, DOI 10.1007/s10766-013-0275-4; Rodriguez MA, 2014, IEEE T CLOUD COMPUT, V2, P222, DOI 10.1109/TCC.2014.2314655; Shanahan HP, 2014, BIOINFORMATICS CLOUD; Sidhu J, 2015, INT J APPL ENG RES, V10; Smanchat S, 2015, FUTURE GENER COMP SY, V52, P1, DOI 10.1016/j.future.2015.04.019; SRIKANTH GU, 2015, INDIAN J SCI TECHN S, V8, P33; Tawfeek M, 2015, CLOUD TASK SCHEDULIN, P64; Tsai CW, 2014, IEEE T CLOUD COMPUT, V2, P236, DOI 10.1109/TCC.2014.2315797; Verma A, 2014, BICRITERIA PRIORITY, P1; Wu K., 2014, TUNABLE WORKFLOW SCH; Yang W, 2014, INT J GRID DISTRIBUT, V7; Yazar S, 2014, BENCHMARKING UNDEDIC; Yousif A, 2012, OPTIMIZING JOB SCHED, P97; Zhan ZH, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2788397; Zhang W, 2014, MATHEMATICAL PROBLEM, V2014; Zhong SB, 2010, KEY ENG MATER, V439-440, P1487, DOI 10.4028/www.scientific.net/KEM.439-440.1487	53	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158102	10.1371/journal.pone.0158102	http://dx.doi.org/10.1371/journal.pone.0158102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384239	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400034
J	Hontelez, JAC; Tanser, FC; Naidu, KK; Pillay, D; Barnighausen, T				Hontelez, Jan A. C.; Tanser, Frank C.; Naidu, Kevindra K.; Pillay, Deenan; Barnighausen, Till			The Effect of Antiretroviral Treatment on Health Care Utilization in Rural South Africa: A Population-Based Cohort Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV TREATMENT; SERVICES; THERAPY; ACCESS; PREVENTION; COVERAGE; DELIVERY; LESSONS; PROGRAM	Background The effect of the rapid scale-up of vertical antiretroviral treatment (ART) programs for HIV in sub-Saharan Africa on the overall health system is under intense debate. Some have argued that these programs have reduced access for people suffering from diseases unrelated to HIV because ART programs have drained human and physical resources from other parts of the health system; others have claimed that the investments through ART programs have strengthened the general health system and the population health impacts of ART have freed up health care capacity for the treatment of diseases that are not related to HIV. To establish the population-level impact of ART programs on health care utilization in the public-sector health system, we compared trends in health care utilization among HIV-infected people receiving and not receiving ART with HIV-uninfected people during a period of rapid ART scale-up. Methods and Findings We used data from the Wellcome Trust Africa Centre for Population Health, which annually elicited information on health care utilization from all surveillance participants over the period 2009-2012 (N = 32,319). We determined trends in hospitalization, and public-sector and private-sector primary health care (PHC) clinic visits for HIV-infected and -uninfected people over a time period of rapid ART scale-up (2009-2012) in this community. We regressed health care utilization on HIV status and ART status in different calendar years, controlling for sex, age, and area of residence. The proportion of people who reported to have visited a public-sector primary health care (PHC) clinic in the last 6 months increased significantly over the period 2009-2012, for both HIV-infected people (from 59% to 67%; p<0.001), and HIV-uninfected people (from 41% to 47%; p<0.001). In contrast, the proportion of HIV-infected people visiting a private-sector PHC clinic declined from 22% to 12% p<0.001) and hospitalization rates declined from 128 to 82 per 1000 PY (p<0.001). For HIV-uninfected people, the proportion visiting a private-sector PHC clinic declined from 16% to 9%, and hospitalization rates declined from 78 to 44 per 1000 PY (p<0.001). After controlling for potential confounding factors, all trends remained of similar magnitude and significance. Conclusions Our results indicate that the ART scale-up in this high HIV prevalence community has shifted health care utilization from hospitals and private-sector primary care to public-sector primary care. Remarkably, this shift is observed for both HIV-infected and -uninfected populations, supporting and extending hypotheses of 'therapeutic citizenship' whereby HIV-infected patients receiving ART facilitate primary care access for family and community members. One explanation of our findings is that ART has improved the capacity or quality of primary care in this community and, as a consequence, increasingly met overall health care needs at the primary care level rather than at the secondary level. Future research needs to confirm this causal interpretation of our findings using qualitative work to understand causal mechanisms or quasi-experimental quantitative studies to increase the strength of causal inference.	[Hontelez, Jan A. C.; Tanser, Frank C.; Naidu, Kevindra K.; Pillay, Deenan; Barnighausen, Till] Univ KwaZulu Natal, Wellcome Trust Africa Ctr Populat Hlth, Mtubatuba, South Africa; [Hontelez, Jan A. C.; Barnighausen, Till] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Hontelez, Jan A. C.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Tanser, Frank C.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Pillay, Deenan] UCL, Div Infect & Immun, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; University of Kwazulu Natal; University of London; University College London	Hontelez, JAC (corresponding author), Univ KwaZulu Natal, Wellcome Trust Africa Ctr Populat Hlth, Mtubatuba, South Africa.; Hontelez, JAC (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.; Hontelez, JAC (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	j.hontelez@erasmusmc.nl	Bärnighausen, Till/Y-2388-2019; Tanser, Frank/ABE-8326-2021	Tanser, Frank/0000-0001-9797-0000	Bill and Melinda Gates foundation from the HIV Modelling Consortium; Talent Scheme Veni research programme - Netherlands Organisation for Scientific Research (NWO); US National Institutes of Health, National Institute of Child Health and Human Development [R01 HD058482]; Wellcome Trust; American people through the United States Agency for International Development (USAID); President's Emergency Plan (PEPFAR) [674-A-00-08-0001-00]; Academy of Medical Sciences (AMS) [AMS-NAF2-Tanser] Funding Source: researchfish	Bill and Melinda Gates foundation from the HIV Modelling Consortium; Talent Scheme Veni research programme - Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); US National Institutes of Health, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); President's Emergency Plan (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	This study received funding from the Bill and Melinda Gates foundation through grants from the HIV Modelling Consortium. Jan Hontelez is supported by the Talent Scheme Veni research programme, which is financed by the Netherlands Organisation for Scientific Research (NWO). Till Barnighausen and Frank Tanser were supported by grant R01 HD058482 from the US National Institutes of Health, National Institute of Child Health and Human Development. The Africa Centre for Health and Population Studies received funding from the Wellcome Trust. The funding organizations had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review or approval of the manuscript. In addition, this study is made possible by the generous support of the American people through the United States Agency for International Development (USAID) and the President's Emergency Plan (PEPFAR) under the terms of Award No. 674-A-00-08-0001-00 for the Hlabisa Treatment and Care Programme. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID or the United States Government.	Aday LA, 2006, DESIGNING CONDUCTING; Anekwe TD, 2015, VACCINE, V33, P5020, DOI 10.1016/j.vaccine.2015.04.072; Atun RA, 2008, DO VERTICAL STAND AL; Baernighausen T, 2011, NEW ENGL J MED, V364, P2181, DOI 10.1056/NEJMp1014255; Baltussen Rob, 2013, Cost Eff Resour Alloc, V11, P26, DOI 10.1186/1478-7547-11-26; Barnighausen T, 2013, LANCET; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bor J, 2012, HEALTH AFFAIR, V31, P1459, DOI 10.1377/hlthaff.2012.0407; Chimbindi N, 2013, 6 SA AIDS C 18 21 JU; Cooke GS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-585; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; England R, 2009, LANCET, V374, P1674, DOI 10.1016/S0140-6736(09)61984-X; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Hontelez JAC, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-39; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Hontelez JAC, 2011, AIDS, V25, P1665, DOI 10.1097/QAD.0b013e32834982ea; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Levine R, 2009, JAIDS-J ACQ IMM DEF, V52, pS3, DOI 10.1097/QAI.0b013e3181bbc807; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Matoso MP, 2013, S AFR MED J, V103, P156; Matsubayashi T, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S9; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McCoy D, 2005, AM J PUBLIC HEALTH, V95, P18, DOI 10.2105/AJPH.2004.040121; Meyer-Rath G, 2013, JAIDS-J ACQ IMM DEF, V62, P322, DOI 10.1097/QAI.0b013e31827e8785; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Naidoo S, 2012, J PUBLIC HEALTH-UK, V34, P149, DOI 10.1093/pubmed/fds008; Ndirangu J, 2009, TROP MED INT HEALTH, V14, P1383, DOI 10.1111/j.1365-3156.2009.02382.x; Nguyen VK, 2007, AIDS, V21, pS31, DOI 10.1097/01.aids.0000298100.48990.58; Nguyen VK, ANTIRETROVIRAL GLOBA, P124; Ooms G, 2007, PLOS MED, V4, P605, DOI 10.1371/journal.pmed.0040128; Piot P, 2009, LANCET, V374, P260, DOI 10.1016/S0140-6736(09)60321-4; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starrs AM, 2009, LANCET, V374, P1674, DOI 10.1016/S0140-6736(09)61985-1; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; UNAIDS, 2014, REP GLOB AIDS EP 201; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2013, CONGUID UANT DRU; Wouters E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-210; Yu DB, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-8; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158015	10.1371/journal.pone.0158015	http://dx.doi.org/10.1371/journal.pone.0158015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27384178	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400033
J	Negm, OH; Hamed, MR; Schoen, RE; Whelan, RL; Steele, RJ; Scholefield, J; Dilnot, EM; Kumara, HMCS; Robertson, JFR; Sewell, HF				Negm, Ola H.; Hamed, Mohamed R.; Schoen, Robert E.; Whelan, Richard L.; Steele, Robert J.; Scholefield, John; Dilnot, Elizabeth M.; Kumara, H. M. C. Shantha; Robertson, John F. R.; Sewell, Herbert F.			Human Blood Autoantibodies in the Detection of Colorectal Cancer	PLOS ONE			English	Article							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; LUNG-CANCER; FOLLOW-UP; POPULATION; PROGRAM; SIGMOIDOSCOPY; VALIDATION; MORTALITY; DIAGNOSIS	Colorectal cancer (CRC) is the second most common malignancy in the western world. Early detection and diagnosis of all cancer types is vital to improved prognosis by enabling early treatment when tumours should be both resectable and curable. Sera from 3 different cohorts; 42 sera (21 CRC and 21 matched controls) from New York, USA, 200 sera from Pittsburgh, USA (100 CRC and 100 controls) and 20 sera from Dundee, UK (10 CRC and 10 controls) were tested against a panel of multiple tumour-associated antigens (TAAs) using an optimised multiplex microarray system. TAA specific IgG responses were interpolated against the internal IgG standard curve for each sample. Individual TAA specific responses were examined in each cohort to determine cutoffs for a robust initial scoring method to establish sensitivity and specificity. Sensitivity and specificity of combinations of TAAs provided good discrimination between cancer-positive and normal serum. The overall sensitivity and specificity of the sample sets tested against a panel of 32 TAAs were 61.1% and 80.9% respectively for 6 antigens; p53, AFP, K RAS, Annexin, RAF1 and NY-CO16. Furthermore, the observed sensitivity in Pittsburgh sample set in different clinical stages of CRC; stage I (n = 19), stage II (n = 40), stage III (n = 34) and stage IV (n = 6) was similar (73.6%, 75.0%, 73.5% and 83.3%, respectively), with similar levels of sensitivity for right and left sided CRC. We identified an antigen panel of sufficient sensitivity and specificity for early detection of CRC, based upon serum profiling of autoantibody response using a robust multiplex antigen microarray technology. This opens the possibility of a blood test for screening and detection of early colorectal cancer. However this panel will require further validation studies before they can be proposed for clinical practice.	[Negm, Ola H.; Dilnot, Elizabeth M.; Sewell, Herbert F.] Univ Nottingham, Sch Life Sci, Immunol, Nottingham, England; [Negm, Ola H.; Hamed, Mohamed R.] Mansoura Univ, Fac Med, Med Microbiol & Immunol Dept, Mansoura, Egypt; [Hamed, Mohamed R.; Robertson, John F. R.] Univ Nottingham, Sch Med, Derby, England; [Schoen, Robert E.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Whelan, Richard L.; Kumara, H. M. C. Shantha] Mt Sinai Roosevelt, Div Colon & Rectal Surg, Dept Surg, New York, NY USA; [Steele, Robert J.] Ninewells Hosp & Med Sch, Med Res Inst, Dundee, Scotland; [Scholefield, John] Univ Nottingham Hosp, Nottingham Digest Dis Ctr, Nottingham, England	University of Nottingham; Egyptian Knowledge Bank (EKB); Mansoura University; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mount Sinai West; University of Dundee; University of Nottingham	Robertson, JFR (corresponding author), Univ Nottingham, Sch Med, Derby, England.	john.robertson@nottingham.ac.uk	Negm, Ola H/P-8241-2017	Negm, Ola H/0000-0002-5999-6012; Steele, Robert JC/0000-0003-4248-6785	UK Medical Research Council's Confidence in Concept (CiC) grant [CiC12003]; Early Detection Research Network [U01CA152753];  [P30CA047904]; MRC [MR/N006577/1, MC_PC_12019] Funding Source: UKRI; Medical Research Council [MR/N006577/1, MC_PC_12019] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA152753, P30CA047904] Funding Source: NIH RePORTER	UK Medical Research Council's Confidence in Concept (CiC) grant; Early Detection Research Network; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by a UK Medical Research Council's Confidence in Concept (CiC) grant (Reference no: CiC12003). RES was supported in part by award P30CA047904. Research reported in this publication was supported by the Early Detection Research Network under award number U01CA152753.; This study was funded by a UK Medical Research Council's Confidence in Concept (CiC) grant (Reference no: CiC12003). RES was supported in part by award P30CA047904. We acknowledge the support and valuable comments provided by Professor Olivera J Finn (Pittsburgh, USA) and Dr Sharon Crouch (Nottingham, UK) during the development of this project. Research reported in this publication was supported by the Early Detection Research Network under award number U01CA152753.	Adler A, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-183; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Chapman CJ, 2012, TUMOR BIOL, V33, P1319, DOI 10.1007/s13277-012-0379-2; Chen HD, 2014, CANCER LETT, V346, P178, DOI 10.1016/j.canlet.2014.01.007; Doubeni CA, 2015, ANN INTERN MED, V163, P390, DOI 10.7326/M15-1677; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; Group UCCSP, 2004, BMJ-BRIT MED J, V329, P133; Healey GF, 2013, J THORAC DIS, V5, P618, DOI 10.3978/j.issn.2072-1439.2013.08.65; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Jett JR, 2014, LUNG CANCER, V83, P51, DOI 10.1016/j.lungcan.2013.10.008; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lam S, 2011, CANCER PREV RES, V4, P1126, DOI 10.1158/1940-6207.CAPR-10-0328; Lee CS, 2012, EXPERT REV GASTROENT, V6, P301, DOI [10.1586/EGH.12.12, 10.1586/egh.12.12]; Liles EG, 2012, AM J MANAG CARE, V18, P588; Macdonald IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051002; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Middleton CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103867; Murray A, 2010, ANN ONCOL, V21, P1687, DOI 10.1093/annonc/mdp606; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Provenzale Dawn, 2002, Gastrointest Endosc Clin N Am, V12, P93, DOI 10.1016/S1052-5157(03)00061-8; Robb K, 2010, J MED SCREEN, V17, P75, DOI 10.1258/jms.2010.010055; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Scholefield JH, 2012, GUT, V61, P1036, DOI 10.1136/gutjnl-2011-300774; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Steele RJC, 2012, GUT, V61, P576, DOI 10.1136/gutjnl-2011-300535; Sullivan F., 2015, PROGR RCT DET AUT TU; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Wang SY, 2015, INT J CANCER, V136, P152, DOI 10.1002/ijc.28136; Yabroff KR, 2008, HEALTH ECON, V17, P947, DOI 10.1002/hec.1307; Yao YB, 2012, BIOCHEM BIOPH RES CO, V423, P613, DOI 10.1016/j.bbrc.2012.06.050; Zhang JY, 2004, CANCER DETECT PREV, V28, P114, DOI 10.1016/j.cdp.2003.12.006	37	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156971	10.1371/journal.pone.0156971	http://dx.doi.org/10.1371/journal.pone.0156971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383396	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400009
J	Samson, S; Basri, M; Masoumi, HRF; Malek, EA; Karjiban, RA				Samson, Shazwani; Basri, Mahiran; Masoumi, Hamid Reza Fard; Malek, Emilia Abdul; Karjiban, Roghayeh Abedi			An Artificial Neural Network Based Analysis of Factors Controlling Particle Size in a Virgin Coconut Oil-Based Nanoemulsion System Containing Copper Peptide	PLOS ONE			English	Article							ZNO NANOPARTICLES; NANO-EMULSIONS; OPTIMIZATION; FORMULATION; DELIVERY; EXTRACT; DESIGN; ACID	A predictive model of a virgin coconut oil (VCO) nanoemulsion system for the topical delivery of copper peptide (an anti-aging compound) was developed using an artificial neural network (ANN) to investigate the factors that influence particle size. Four independent variables including the amount of VCO, Tween 80:Pluronic F68 (T80:PF68), xanthan gum and water were the inputs whereas particle size was taken as the response for the trained network. Genetic algorithms (GA) were used to model the data which were divided into training sets, testing sets and validation sets. The model obtained indicated the high quality performance of the neural network and its capability to identify the critical composition factors for the VCO nanoemulsion. The main factor controlling the particle size was found out to be xanthan gum (28.56%) followed by T80:PF68 (26.9%), VCO (22.8%) and water (21.74%). The formulation containing copper peptide was then successfully prepared using optimum conditions and particle sizes of 120.7 nm were obtained. The final formulation exhibited a zeta potential lower than -25 mV and showed good physical stability towards centrifugation test, freeze-thaw cycle test and storage at temperature 25 degrees C and 45 degrees C.	[Samson, Shazwani; Basri, Mahiran; Masoumi, Hamid Reza Fard; Malek, Emilia Abdul; Karjiban, Roghayeh Abedi] Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia	Samson, S; Basri, M (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia.	dorawanie_89@yahoo.com; mahiran@science.upm.edu.my						Abdollahi Y, 2015, J IND ENG CHEM, V25, P168, DOI 10.1016/j.jiec.2014.10.029; Aghaeinejad-Meybodi A, 2015, J TAIWAN INST CHEM E, V48, P40, DOI 10.1016/j.jtice.2014.10.022; Arenillo SA, 2008, J HIGHER ED RES, V5, P190; Ba-Abbad MM, 2013, J IND ENG CHEM, V19, P99, DOI 10.1016/j.jiec.2012.07.010; Badhani B, 2015, RSC ADV, V5, P27540, DOI 10.1039/c5ra01911g; Catalogna M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044587; Chen SM, 2013, J EARTH SYST SCI, V122, P399, DOI 10.1007/s12040-013-0289-8; Choudhury AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077071; Ribeiro RCD, 2015, MOLECULES, V20, P2492, DOI 10.3390/molecules20022492; de Carvalho SM, 2013, IND CROP PROD, V49, P278, DOI 10.1016/j.indcrop.2013.04.054; Fadare DA, 2007, AFR J BIOTECHNOL, V6, P2184; Gibbs MS, 2003, MODSIM 2003: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, VOLS 1-4, P789; Hadzir NM, 2013, AAPS PHARMSCITECH, V14, P456, DOI 10.1208/s12249-013-9929-1; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; Kamariah L, 2008, J TROP AGR FOOD SCI, V36, P1; Kamble Meghana S., 2013, J BIOMED PHARM RES, V2, P100; Kiransan M, 2015, SPECTROCHIM ACTA A, V140, P465, DOI 10.1016/j.saa.2014.12.100; Kumar SN, 2015, EUR J PHARM SCI, V67, P97, DOI 10.1016/j.ejps.2014.10.014; Kumar P, 2014, TRANSPORT RES C-EMER, V40, P111, DOI 10.1016/j.trc.2014.01.006; Leelapornpisid P., 2014, INT J PHARM PHARM SC, V6, P313; Loong NC, 2014, IND CROP PROD, V59, P309, DOI 10.1016/j.indcrop.2014.05.042; Lupo MP, 2005, DERMATOL SURG, V31, P832; Mahdi ES, 2011, INT J NANOMED, V6, P2499, DOI 10.2147/IJN.S22337; Mansor T. S. T., 2012, International Food Research Journal, V19, P837; Marina AM, 2009, TRENDS FOOD SCI TECH, V20, P481, DOI 10.1016/j.tifs.2009.06.003; Marinkovski M, 2014, J SUPERCRIT FLUID, V92, P242; Masoumi HRF, 2013, SCI WORLD J, DOI 10.1155/2013/962083; Moghaddam MG, 2010, J BIOTECHNOL, V13, DOI [10.2225/vol13-issue3-fulltext-9, DOI 10.2225/VOL13-ISSUE3-FULLTEXT-9]; Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003; Musharavati F., 2010, J ADV MAT MANUFACT E, V41, P140; Ngan CL, 2014, SCI WORLD J, DOI 10.1155/2014/219035; Pickart L, 2010, SOFW-J, V136, P10; Pickart L., 2012, J AGING RES CLIN PRA, V1, P13; Rebolleda S, 2015, FOOD CHEM, V167, P16, DOI 10.1016/j.foodchem.2014.06.097; Rezaee M, 2014, IND CROP PROD, V52, P506, DOI 10.1016/j.indcrop.2013.10.046; Sarkar A, 2015, AQUAT PR, V4, P1070, DOI 10.1016/j.aqpro.2015.02.135; Setya S, 2014, WORLD J, V3, P2214; Shilin M, 2013, INT J NANOMED, V8, P4045, DOI [10.2147/IJN.S47956, DOI 10.2147/IJN.S47956]; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023; Tsai MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102850	40	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157737	10.1371/journal.pone.0157737	http://dx.doi.org/10.1371/journal.pone.0157737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383135	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400024
J	Teymoori, A; Jetten, J; Bastian, B; Ariyanto, A; Autin, F; Ayub, N; Badea, C; Besta, T; Butera, F; Costa-Lopes, R; Cui, LJ; Fantini, C; Finchilescu, G; Gaertner, L; Gollwitzer, M; Gomez, A; Gonzalez, R; Hong, YY; Jensen, DH; Karasawa, M; Kessler, T; Klein, O; Lima, M; Mahonen, TA; Megevand, L; Morton, T; Paladino, P; Polya, T; Ruza, A; Shahrazad, W; Sharma, S; Torres, AR; van der Bles, AM; Wohl, M				Teymoori, Ali; Jetten, Jolanda; Bastian, Brock; Ariyanto, Amarina; Autin, Frederique; Ayub, Nadia; Badea, Constantina; Besta, Tomasz; Butera, Fabrizio; Costa-Lopes, Rui; Cui, Lijuan; Fantini, Carole; Finchilescu, Gillian; Gaertner, Lowell; Gollwitzer, Mario; Gomez, Angel; Gonzalez, Roberto; Hong, Ying Yi; Jensen, Dorthe Hoj; Karasawa, Minoru; Kessler, Thomas; Klein, Olivier; Lima, Marcus; Mahonen, Tuuli Anna; Megevand, Laura; Morton, Thomas; Paladino, Paola; Polya, Tibor; Ruza, Aleksejs; Shahrazad, Wan; Sharma, Sushama; Torres, Ana Raquel; van der Bles, Anne Marthe; Wohl, Michael			Revisiting the Measurement of Anomie	PLOS ONE			English	Article							SOCIAL IDENTITY; SYSTEM-JUSTIFICATION; COLLECTIVE EFFICACY; NATIONAL IDENTITY; BIG-5 PERSONALITY; BBC PRISON; WEAK TIES; MODEL; MULTILEVEL; TRUST	Sociologists coined the term "anomie" to describe societies that are characterized by disintegration and deregulation. Extending beyond conceptualizations of anomie that conflate the measurements of anomie as 'a state of society' and as a 'state of mind', we disentangle these conceptualizations and develop an analysis and measure of this phenomenon focusing on anomie as a perception of the 'state of society'. We propose that anomie encompasses two dimensions: a perceived breakdown in social fabric (i.e., disintegration as lack of trust and erosion of moral standards) and a perceived breakdown in leadership (i.e., deregulation as lack of legitimacy and effectiveness of leadership). Across six studies we present evidence for the validity of the new measure, the Perception of Anomie Scale (PAS). Studies 1a and 1b provide evidence for the proposed factor structure and internal consistency of PAS. Studies 2a-c provide evidence of convergent and discriminant validity. Finally, assessing PAS in 28 countries, we show that PAS correlates with national indicators of societal functioning and that PAS predicts national identification and well-being (Studies 3a & 3b). The broader implications of the anomie construct for the study of group processes are discussed.	[Teymoori, Ali; Jetten, Jolanda] Univ Queensland, Brisbane, Qld, Australia; [Bastian, Brock] Univ Melbourne, Melbourne, Vic, Australia; [Ariyanto, Amarina] Univ Indonesia, Jakarta, Indonesia; [Autin, Frederique; Butera, Fabrizio] Univ Lausanne, Lausanne, Switzerland; [Ayub, Nadia] Inst Business Management, Karachi, Pakistan; [Badea, Constantina] Univ Paris Ouest Nanterre La Def, Paris, France; [Besta, Tomasz] Univ Gdansk, Gdansk, Poland; [Costa-Lopes, Rui] Univ Lisbon, Lisbon, Portugal; [Cui, Lijuan] East China Normal Univ, Shanghai, Peoples R China; [Fantini, Carole; Klein, Olivier] Univ Libre Bruxelles, Brussels, Belgium; [Finchilescu, Gillian] Univ Witwatersrand, Johannesburg, South Africa; [Gaertner, Lowell] Univ Tennessee, Knoxville, TN USA; [Gollwitzer, Mario] Univ Marburg, Marburg, Germany; [Gomez, Angel] UNED, Madrid, Spain; [Gonzalez, Roberto] Pontificia Univ Catolica Chile, Santiago, Chile; [Hong, Ying Yi] Nanyang Technol Univ, Singapore, Singapore; [Jensen, Dorthe Hoj] Aarhus Univ, Aarhus, Denmark; [Karasawa, Minoru] Nagoya Univ, Nagoya, Aichi, Japan; [Kessler, Thomas] Univ Jena, Jena, Thuringia, Germany; [Lima, Marcus] Univ Fed Sergipe, Sergipe, Brazil; [Mahonen, Tuuli Anna] Univ Helsinki, Helsinki, Finland; [Megevand, Laura] ISCTE Univ Inst Lisbon, Lisbon, Portugal; [Morton, Thomas] Univ Exeter, Exeter, Devon, England; [Paladino, Paola] Univ Trento, Trento, Italy; [Polya, Tibor] Hungarian Acad Sci, Budapest, Hungary; [Ruza, Aleksejs] Daugavpils Univ, Daugavpils, Latvia; [Shahrazad, Wan] Natl Univ Malaysia, Bangi, Malaysia; [Sharma, Sushama] Kurukshetra Univ, Kurukshetra, Haryana, India; [Torres, Ana Raquel] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil; [van der Bles, Anne Marthe] Univ Groningen, Groningen, Netherlands; [Wohl, Michael] Carleton Univ, Ottawa, ON, Canada	University of Queensland; University of Melbourne; University of Indonesia; University of Lausanne; Universite Paris Nanterre; Fahrenheit Universities; University of Gdansk; Universidade de Lisboa; East China Normal University; Universite Libre de Bruxelles; University of Witwatersrand; University of Tennessee System; University of Tennessee Knoxville; Philipps University Marburg; Universidad Nacional de Educacion a Distancia (UNED); Pontificia Universidad Catolica de Chile; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Aarhus University; Nagoya University; Friedrich Schiller University of Jena; Universidade Federal de Sergipe; University of Helsinki; Instituto Universitario de Lisboa; University of Exeter; University of Trento; Hungarian Academy of Sciences; University of Daugavpils; Universiti Kebangsaan Malaysia; Kurukshetra University; Universidade Federal da Paraiba; University of Groningen; Carleton University	Teymoori, A (corresponding author), Univ Queensland, Brisbane, Qld, Australia.	a.teymoori@uq.edu.au	Wohl, Michael/AAS-5819-2021; Ruža, Aleksejs/GPG-3406-2022; Gollwitzer, Mario/ABA-7217-2021; Besta, Tomasz/AAA-8549-2020; Gómez, Ángel/C-6108-2011; Hong, Ying-yi/GQR-0227-2022; Gollwitzer, Mario/AAE-6042-2020; Costa-Lopes, Rui/M-6050-2013; Ruza, Aleksejs/ABB-7859-2021; Ayub, Nadia/M-2011-2016; Klein, Olivier/F-1954-2011	Wohl, Michael/0000-0001-6945-5562; Besta, Tomasz/0000-0001-6209-3677; Gómez, Ángel/0000-0002-4287-4916; Hong, Ying-yi/0000-0003-3172-9243; Gollwitzer, Mario/0000-0003-4310-4793; Costa-Lopes, Rui/0000-0002-1509-6397; Ruza, Aleksejs/0000-0003-3156-9331; Ayub, Nadia/0000-0003-4308-3777; Wan Sulaiman, Wan Shahrazad/0000-0001-7432-7637; Paladino, Maria Paola/0000-0002-1664-9475; /0000-0002-7577-7047; Butera, Fabrizio/0000-0002-8856-4374; Autin, Frederique/0000-0002-5341-7470; fantini-hauwel, carole/0000-0002-1520-5178; Polya, Tibor/0000-0002-3801-9992; Bastian, Brock/0000-0003-4619-3322; Teymoori, Ali/0000-0003-2227-7361; Klein, Olivier/0000-0003-2737-8049	Australian Research Council [DP120100053]; Center for Social Conflict and Cohesion Studies [FONDAP 15130009]; Anillos CONICYT [SOC1103]	Australian Research Council(Australian Research Council); Center for Social Conflict and Cohesion Studies; Anillos CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS)	This research was supported by a Discovery grant from the Australian Research Council's Discovery Project funding scheme (DP120100053) to Jolanda Jetten and funding from the Center for Social Conflict and Cohesion Studies (FONDAP 15130009) and Anillos CONICYT (SOC1103) to Roberto Gonzalez.	Adnanes M, 2007, YOUNG, V15, P49, DOI [10.1177/1103308807072684, DOI 10.1177/1103308807072684]; AGNEW RS, 1980, SOCIOL QUART, V21, P53, DOI 10.1111/j.1533-8525.1980.tb02198.x; Alexander JC, 2004, CULTURAL TRAUMA AND COLLECTIVE IDENTITY, P1, DOI 10.1525/california/9780520235946.003.0001; Ambrose ML, 2005, HANDBOOK OF ORGANIZATIONAL JUSTICE, P59; [Anonymous], 2014, FRAGILITY WORLD 2014; [Anonymous], SOCIAL JUSTICE, V27, P16; [Anonymous], 1979, INTEGRATIVE THEORY I; Arendt, 2004, ORIGINS TOTALITARIAN; Axelrod R., 2006, EVOLUTION COOPERATIO; BASS BM, 1990, ORGAN DYN, V18, P19, DOI 10.1016/0090-2616(90)90061-S; Baumer EP, 2007, THEOR CRIMINOL, V11, P63, DOI 10.1177/1362480607072736; Bjarnason T, 1998, J SCI STUD RELIG, V37, P742, DOI 10.2307/1388154; Bjarnason T, 2009, SOCIOL FORUM, V24, P135, DOI 10.1111/j.1573-7861.2008.01089.x; Blanco A, 2007, PSYCHOL SPAIN, V11, P61; Blank T, 2003, POLIT PSYCHOL, V24, P259, DOI 10.1111/0162-895X.00328; Brockmann H, 2009, J HAPPINESS STUD, V10, P387, DOI 10.1007/s10902-008-9095-4; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burke, 2006, CONT SOCIAL PSYCHOL, P353; Chang EC, 1997, PERS INDIV DIFFER, V23, P433, DOI 10.1016/S0191-8869(97)80009-8; Chiu CY, 2010, PERSPECT PSYCHOL SCI, V5, P482, DOI 10.1177/1745691610375562; Das TK, 1998, ACAD MANAGE REV, V23, P491, DOI 10.5465/AMR.1998.926623; David O, 2009, PERS SOC PSYCHOL REV, V13, P354, DOI 10.1177/1088868309344412; DAVOL SH, 1959, J INDIV PSYCHOL, V15, P215; de Winter JCF, 2012, J APPL STAT, V39, P695, DOI 10.1080/02664763.2011.610445; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dirks KT, 1999, J APPL PSYCHOL, V84, P445, DOI 10.1037/0021-9010.84.3.445; Duckitt J, 2002, J PERS SOC PSYCHOL, V83, P75, DOI 10.1037//0022-3514.83.1.75; Durkheim E, 1897, SUICIDE; Elgar FJ, 2011, HEALTH PLACE, V17, P1044, DOI 10.1016/j.healthplace.2011.06.010; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; FISCHER CS, 1973, AM SOCIOL REV, V38, P311, DOI 10.2307/2094355; FORM WH, 1975, AM J SOCIOL, V80, P1165, DOI 10.1086/225949; Fritsche I, 2011, SOC ISS POLICY REV, V5, P101, DOI 10.1111/j.1751-2409.2011.01027.x; FROST RO, 1990, COGNITIVE THER RES, V14, P449, DOI 10.1007/BF01172967; Furnham A, 2003, PERS INDIV DIFFER, V34, P795, DOI 10.1016/S0191-8869(02)00072-7; Genov N, 1998, SOC INDIC RES, V43, P197, DOI 10.1023/A:1006895413626; Glatzer W, 1998, SOC INDIC RES, V43, P171, DOI 10.1023/A:1006874710181; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Granovetter M., 1983, SOCIOL THEOR, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hardin C.D., 1996, HDB MOTIVATION COGNI, V3, P28; Haslam SA, 2011, NEW PSYCHOLOGY OF LEADERSHIP: IDENTITY, INFLUENCE, AND POWER, P1; Haslam SA, 2007, SOC PSYCHOL QUART, V70, P125, DOI 10.1177/019027250707000204; Heydari A, 2014, SOC SCI INFORM, V53, P240, DOI 10.1177/0539018413517521; Heydari A, 2013, OMEGA-J DEATH DYING, V68, P63, DOI 10.2190/OM.68.1.d; Hilbert R, 1986, SOCIOLOGICAL THEORY, V4, P1, DOI DOI 10.2307/202102; Hornsey MJ, 2000, PERS SOC PSYCHOL REV, V4, P143, DOI 10.1207/S15327957PSPR0402_03; Huschka D, 2006, SOC INDIC RES, V76, P467, DOI 10.1007/s11205-005-2903-x; Jamieson Ruth, 1998, NEW EUROPEAN CRIMINO, P480; Jetten J, 1996, J PERS SOC PSYCHOL, V71, P1222, DOI 10.1037/0022-3514.71.6.1222; JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; KAPSIS RE, 1978, AM J SOCIOL, V83, P1132, DOI 10.1086/226677; Konty M, 2005, CRIMINOLOGY, V43, P107, DOI 10.1111/j.0011-1348.2005.00004.x; Lachman ME, 1998, J PERS SOC PSYCHOL, V74, P763, DOI 10.1037/0022-3514.74.3.763; LEGER RG, 1980, ADOLESCENCE, V15, P283; Levin DZ, 2004, MANAGE SCI, V50, P1477, DOI 10.1287/mnsc.1030.0136; LIPKUS I, 1991, PERS INDIV DIFFER, V12, P1171, DOI 10.1016/0191-8869(91)90081-L; Lopes CA, 2012, J CONSUM POLICY, V35, P477, DOI 10.1007/s10603-012-9212-y; Martin R., 2000, J CONTEMP CRIM JUST, V16, P75, DOI [10.1177/1043986200016001005, DOI 10.1177/1043986200016001005]; Mazerolle L, 2010, J RES CRIME DELINQ, V47, P3, DOI 10.1177/0022427809348898; MCCLOSKY H, 1965, AM SOCIOL REV, V30, P14, DOI 10.2307/2091771; Merton R. K., 1957, SOCIAL THEORY SOCIAL; Merton RK, 1938, AM SOCIOL REV, V3, P672, DOI 10.2307/2084686; Messner S.F., 2001, CRIME AM DREAM; Messner SF, 1980, COMP SOCIAL RES, V3, P185; MESTROVIC SG, 1987, BRIT J SOCIOL, V38, P567, DOI 10.2307/590917; Mestrovic SG, 2008, J CLASS SOCIOL, V8, P179, DOI 10.1177/1468795X08088871; MIZRUCHI EH, 1960, AM SOCIOL REV, V25, P645, DOI 10.2307/2090138; MOORE AB, 1980, ADULT ED, V30, P82, DOI 10.1177/074171368003000202; Moscovici S, 2000, SOCIAL REPRESENTATIO, P18; Muftic LR, 2006, INT J OFFENDER THER, V50, P630, DOI 10.1177/0306624X06287284; Oesterreich D, 2005, POLIT PSYCHOL, V26, P275, DOI 10.1111/j.1467-9221.2005.00418.x; Oishi S, 2009, PERS SOC PSYCHOL REV, V13, P334, DOI 10.1177/1088868309347835; ORRU M, 1983, BRIT J SOCIOL, V34, P499, DOI 10.2307/590936; Pallant J., 2011, SPSS PRIRUCNIK PREZI, V3rd ed.; Passas N., 1995, ADV CRIMINOLOGICAL T, P91; Putnam RD., 2000, BOWLING ALONE COLLAP; Reicher S, 2006, BRIT J SOC PSYCHOL, V45, P1, DOI 10.1348/014466605X48998; Reicher S, 2005, LEADERSHIP QUART, V16, P547, DOI 10.1016/j.leaqua.2005.06.007; Rothstein B, 2000, J THEOR POLIT, V12, P477, DOI 10.1177/0951692800012004007; Rothstein B, 2009, RATION SOC, V21, P81, DOI 10.1177/1043463108099349; RUSHING WA, 1971, AM J SOCIOL, V76, P857, DOI 10.1086/225002; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sani F, 2005, PERS SOC PSYCHOL B, V31, P1074, DOI 10.1177/0146167204274092; Sani F., 2008, SELF CONTINUITY INDI; Savolainen J, 2000, CRIMINOLOGY, V38, P1021, DOI 10.1111/j.1745-9125.2000.tb01413.x; Scheepers P., 1992, POLITICS INDIVIDUAL, V2, P43; Schmitt MT, 2003, BRIT J SOC PSYCHOL, V42, P161, DOI 10.1348/014466603322127166; Sibley CG, 2009, J SOC PSYCHOL, V149, P545, DOI 10.1080/00224540903232308; Sidanius J., 2001, SOCIAL DOMINANCE INT; SROLE L, 1956, AM SOCIOL REV, V21, P709, DOI 10.2307/2088422; Steenvoorden EH, 2015, SOC INDIC RES, V124, P85, DOI 10.1007/s11205-014-0786-4; Stoeber J, 2006, PERS SOC PSYCHOL REV, V10, P295, DOI 10.1207/s15327957pspr1004_2; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tajfel, 1981, SOCIAL IDENTITY INTE; TEEVAN JJ, 1975, PAC SOCIOL REV, V18, P159; Teymoori A, 2016, PSYCHOL ANAL A UNPUB; Thompson K., 1998, MORAL PANICS; Thorlindsson T, 2004, EUR SOCIOL REV, V20, P271, DOI 10.1093/esr/jch025; TRAVIS R, 1993, SOC INDIC RES, V28, P71, DOI 10.1007/BF01086717; Tyler TR, 2006, ANNU REV PSYCHOL, V57, P375, DOI 10.1146/annurev.psych.57.102904.190038; Tyler TR, 2001, PSYCHOLOGY OF LEGITIMACY, P416; Tyler TR, 2003, PERS SOC PSYCHOL REV, V7, P349, DOI 10.1207/S15327957PSPR0704_07; Tyler TR, 2000, INT J PSYCHOL, V35, P117, DOI 10.1080/002075900399411; United Nations Development Programme, 2014, HUM DEV REP 2014 SUS; Uslaner E., 2002, MORAL FDN TRUST; Van der Doef M, 1999, WORK STRESS, V13, P87, DOI 10.1080/026783799296084; VANSNIPPENBURG LB, 1991, POLIT PSYCHOL, V12, P41; WINSLOW RW, 1968, BRIT J SOCIOL, V19, P143, DOI 10.2307/588691; Wohl MJA, 2010, PERS SOC PSYCHOL B, V36, P898, DOI 10.1177/0146167210372505; Wohl MJA, 2009, POLIT PSYCHOL, V30, P193, DOI 10.1111/j.1467-9221.2008.00688.x; World Bank, 2022, WORLDWIDE GOVERNANCE; Zhao LS, 2008, INT CRIM JUSTICE REV, V18, P137, DOI 10.1177/1057567708318485; Zhao RH, 2010, SOC FORCES, V88, P1209	115	48	50	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158370	10.1371/journal.pone.0158370	http://dx.doi.org/10.1371/journal.pone.0158370			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383133	Green Published, gold, Green Accepted			2022-12-27	WOS:000379809400044
J	Li, AN; Zhang, YR; Zhao, ZD; Wang, MM; Zan, LS				Li, Anning; Zhang, Yaran; Zhao, Zhidong; Wang, Mingming; Zan, Linsen			Molecular Characterization and Transcriptional Regulation Analysis of the Bovine PDHB Gene	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; INTRAMUSCULAR FAT-CONTENT; LONGISSIMUS MUSCLE; E1-BETA SUBUNIT; EXPRESSION; BINDING; PROTEIN; DEFICIENCY; PIGS; METABOLISM	The pyruvate dehydrogenase beta subunit (PDHB) is a subunit of pyruvate dehydrogenase (E1), which catalyzes pyruvate into acetyl-CoA and provides a linkage between the tricarboxylic acid cycle (TCA) and the glycolysis pathway. Previous studies demonstrated PDHB to be positively related to the intramuscular fat (IMF) content. However, the transcriptional regulation of PDHB remains unclear. In our present study, the cDNA of bovine PDHB was cloned and the genomic structure was analyzed. The phylogenetic tree showed bovine PDHB to be closely related to goat and sheep, and least related to chicken. Spatial expression pattern analysis revealed the products of bovine PDHB to be widely expressed with the highest level in the fat of testis. To understand the transcriptional regulation of bovine PDHB, 1899 base pairs (bp) of the 5'-regulatory region was cloned. Sequence analysis neither found consensus TATA-box nor CCAAT-box in the 5'-flanking region of bovine PDHB. However, a CpG island was predicted from nucleotides -284 to + 117. Serial deletion constructs of the 5'-flanking region, evaluated in dual-luciferase reporter assay, revealed the core promoter to be located 490bp upstream from the transcription initiation site (+ 1). Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation assay (ChIP) in combination with asite-directed mutation experiment indicated both myogenin (MYOG) and the CCAAT/enhancer-binding protein beta (C/EBP beta) to be important transcription factors for bovine PDHB in skeletal muscle cells and adipocytes. Our results provide an important basis for further investigation of the bovine PDHB function and regulation in cattle.	[Li, Anning; Zhang, Yaran; Zhao, Zhidong; Wang, Mingming; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Zan, Linsen] Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.; Zan, LS (corresponding author), Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China.	zanlinsen@163.com		Li, Anning/0000-0001-7695-161X	National Natural Science Foundation of China [31402042]; National 863 Program of China [2013AA102505]; Northwest A & F University Special Funds of Central Colleges Basic Scientific Research Operating Expenses [2014YB009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); Northwest A & F University Special Funds of Central Colleges Basic Scientific Research Operating Expenses	This research was funded by the National Natural Science Foundation of China (Grant No. 31402042), National 863 Program of China (Grant No. 2013AA102505) and the Northwest A & F University Special Funds of Central Colleges Basic Scientific Research Operating Expenses (Grant No. 2014YB009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the National Natural Science Foundation of China (Grant No. 31402042), National 863 Program of China (Grant No. 2013AA102505) and the Northwest A&F University Special Funds of Central Colleges Basic Scientific Research Operating Expenses (Grant No. 2014YB009).	Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; Cai Z, 2010, MOL CELL PROTEOMICS, V9, P2617, DOI 10.1074/mcp.M110.000661; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chow G, 2005, J BIOL CHEM, V280, P26904, DOI 10.1074/jbc.M413845200; Gerbens F, 2001, J ANIM SCI, V79, P347; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Han Z, 2008, J BIOL CHEM, V283, P237, DOI 10.1074/jbc.M704748200; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Imbard A, 2011, MOL GENET METAB, V104, P507, DOI 10.1016/j.ymgme.2011.08.008; Kanda A, 2015, J BIOL CHEM; Kikuchi D, 2014, BIOCHEM BIOPH RES CO, V451, P288, DOI 10.1016/j.bbrc.2014.07.114; KOIKE K, 1990, P NATL ACAD SCI USA, V87, P5594, DOI 10.1073/pnas.87.15.5594; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Li A, 2015, J ANIM SCI, V93, P5144, DOI 10.2527/jas.2015-9378; Li AN, 2013, MAMM GENOME, V24, P72, DOI 10.1007/s00335-012-9440-0; Li AN, 2010, MOL GENET GENOMICS, V284, P185, DOI 10.1007/s00438-010-0558-z; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Mercimek-Mahmutoglu S, 2015, EPILEPSIA; Okajima K, 2008, MOL GENET METAB, V93, P371, DOI 10.1016/j.ymgme.2007.10.135; Park SY, 2014, BIOCHEM BIOPH RES CO, V450, P1631, DOI 10.1016/j.bbrc.2014.07.061; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Platter WJ, 2005, J ANIM SCI, V83, P890; Prasad C, 2011, BRAIN DEV-JPN, V33, P856, DOI 10.1016/j.braindev.2011.08.003; Quintana E, 2009, J INHERIT METAB DIS; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Sasaki Y, 2006, ANIM GENET, V37, P40, DOI 10.1111/j.1365-2052.2005.01380.x; Serao NVL, 2011, J ANIM BREED GENET, V128, P28, DOI 10.1111/j.1439-0388.2010.00887.x; Sun WQ, 2015, LIFE SCI, V121, P97, DOI 10.1016/j.lfs.2014.11.030; TAYLOR SI, 1975, J BIOL CHEM, V250, P2028; Wang H, 2014, MOL BIOL REP, V41, P251, DOI 10.1007/s11033-013-2858-y; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zheng AJ, 2014, J PROTEOMICS, V98, P271, DOI 10.1016/j.jprot.2013.12.021	36	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157445	10.1371/journal.pone.0157445	http://dx.doi.org/10.1371/journal.pone.0157445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379520	gold, Green Published, Green Submitted			2022-12-27	WOS:000379798700006
J	Alehagen, U; Alexander, J; Aaseth, J				Alehagen, Urban; Alexander, Jan; Aaseth, Jan			Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial	PLOS ONE			English	Article							VENTRICULAR EJECTION FRACTION; NUTRITION EXAMINATION SURVEY; PLACEBO-CONTROLLED TRIAL; SERUM SELENIUM; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; NATIONAL-HEALTH; FOLLOW-UP; POPULATION; SPECIATION	Background Selenium is needed by all living cells in order to ensure the optimal function of several enzyme systems. However, the selenium content in the soil in Europe is generally low. Previous reports indicate that a dietary supplement of selenium could reduce cardiovascular disease but mainly in populations in low selenium areas. The objective of this secondary analysis of a previous randomised double-blind placebo-controlled trial from our group was to determine whether the effects on cardiovascular mortality of supplementation with a fixed dose of selenium and coenzyme Q10 combined during a four-year intervention were dependent on the basal level of selenium. Methods In 668 healthy elderly individuals from a municipality in Sweden, serum selenium concentration was measured. Of these, 219 individuals received daily supplementation with selenium (200 mu g Se as selenized yeast) and coenzyme Q10 (200 mg) combined for four years. The remaining participants (n = 449) received either placebo (n = 222) or no treatment (n = 227). All cardiovascular mortality was registered. No participant was lost during a median follow-up of 5.2 years. Based on death certificates and autopsy results, all mortality was registered. Findings The mean serum selenium concentration among participants at baseline was low, 67.1 mu g/L. Based on the distribution of selenium concentration at baseline, the supplemented group was divided into three groups; <65 mu g/L, 65-85 mu g/L, and >85 mu g/L (45 and 90 percentiles) and the remaining participants were distributed accordingly. Among the non-treated participants, lower cardiovascular mortality was found in the high selenium group as compared with the low selenium group (13.0% vs. 24.1%; P = 0.04). In the group with the lowest selenium basal concentration, those receiving placebo or no supplementation had a mortality of 24.1%, while mortality was 12.1% in the group receiving the active substance, which was an absolute risk reduction of 12%. In the middle selenium concentration group a mortality of 14.0% in the non-treated group, and 6.0% in the actively treated group could be demonstrated; thus, there was an absolute risk reduction of 8.0%. In the group with a serum concentration of >85 mu g/L, a cardiovascular mortality of 17.5% in the non-treated group, and 13.0% in the actively treated group was observed. No significant risk reduction by supplementation could thus be found in this group. Conclusions In this evaluation of healthy elderly Swedish municipality members, two important results could be reported. Firstly, a low mean serum selenium concentration, 67 mu g/L, was found among the participants, and the cardiovascular mortality was higher in the subgroup with the lower selenium concentrations < 65 mu g/L in comparison with those having a selenium concentration > 85 mu g/L. Secondly, supplementation was cardio-protective in those with a low selenium concentration, <= 85 at inclusion. In those with serum selenium> 85 mu g/L and no apparent deficiency, there was no effect of supplementation. This is a small study, but it presents interesting data, and more research on the impact of lower selenium intake than recommended is therefore warranted.	[Alehagen, Urban] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Alexander, Jan] Norwegian Inst Publ Hlth, Oslo, Norway; [Alexander, Jan] Norwegian Univ Life Sci NMBU, As, Norway; [Aaseth, Jan] Innlandet Hosp Trust, Res Dept, Elverum, Norway; [Aaseth, Jan] Hedmark Univ Coll, Elverum, Norway	Linkoping University; Norwegian Institute of Public Health (NIPH); Norwegian University of Life Sciences; Innlandet Hospital Trust; Inland Norway University of Applied Sciences	Alehagen, U (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden.	Urban.Alehagen@liu.se	Aaseth, Jan/J-6764-2017	Aaseth, Jan/0000-0002-7518-5703	Pharma Nord Aps, Denmark; County Council of Ostergotland; Linkoping University	Pharma Nord Aps, Denmark; County Council of Ostergotland; Linkoping University	The costs of the analysis were partially supported by grants from Pharma Nord Aps, Denmark, the County Council of Ostergotland, and Linkoping University. The funding organizations had no role in the design, management, analysis, interpretation of the data, preparation, review or approval of the manuscript. No economic compensation was distributed.	Akbaraly NT, 2005, CLIN CHEM, V51, P2117, DOI 10.1373/clinchem.2005.055301; Alehagen U, 2016, EUR J CLIN NUTR, V70, P91, DOI 10.1038/ejcn.2015.92; Alehagen U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141641; Alehagen U, 2013, INT J CARDIOL, V167, P1860, DOI 10.1016/j.ijcard.2012.04.156; Alfthan G, 2015, J TRACE ELEM MED BIO, V31, P142, DOI 10.1016/j.jtemb.2014.04.009; BEAGLEHOLE R, 1990, INT J EPIDEMIOL, V19, P918, DOI 10.1093/ije/19.4.918; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bleys J, 2009, AM J EPIDEMIOL, V169, P996, DOI 10.1093/aje/kwn414; Bugel S., 2008, FOOD NUTR RES, V52, DOI [10.3402/fnr.v52i0.1642, DOI 10.3402/FNR.V52I0.1642]; Burri J, 2008, J TRACE ELEM MED BIO, V22, P112, DOI 10.1016/j.jtemb.2007.11.002; Dumont E, 2006, ANAL BIOANAL CHEM, V385, P1304, DOI 10.1007/s00216-006-0529-8; Eaton CB, 2010, ATHEROSCLEROSIS, V212, P689, DOI 10.1016/j.atherosclerosis.2010.07.008; Ellingsen DG, 2009, J TRACE ELEM MED BIO, V23, P107, DOI 10.1016/j.jtemb.2009.01.004; FOLKERS K, 1994, MOL ASPECTS MED, V15, P281; Galan-Chilet I, 2014, FREE RADICAL BIO MED, V74, P229, DOI 10.1016/j.freeradbiomed.2014.07.005; Gao H, 2014, DIABETIC MED, V31, P787, DOI 10.1111/dme.12429; Hatfield DL, 2009, MOL INTERV, V9, P18, DOI 10.1124/mi.9.1.6; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hurst R, 2013, CRIT REV FOOD SCI, V53, P1077, DOI 10.1080/10408398.2012.742861; Hurst R, 2010, AM J CLIN NUTR, V91, P923, DOI 10.3945/ajcn.2009.28169; Jensen-Urstad K, 1998, AM J CARDIOL, V81, P538, DOI 10.1016/S0002-9149(97)00964-8; Kafai MR, 2003, J TRACE ELEM MED BIO, V17, P13, DOI 10.1016/S0946-672X(03)80040-8; KOIVISTOINEN P, 1986, ANN CLIN RES, V18, P13; Larsen EH, 2004, J AOAC INT, V87, P225; Larsen EH, 2003, J ANAL ATOM SPECTROM, V18, P310, DOI 10.1039/b209586f; Letsiou S, 2009, BIOL TRACE ELEM RES, V128, P8, DOI 10.1007/s12011-008-8252-2; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; SALONEN JT, 1982, LANCET, V2, P175; Spina A, 2013, FREE RADICAL BIO MED, V65, P1315, DOI 10.1016/j.freeradbiomed.2013.09.025; Suadicani P, 2012, EUR RESPIR J, V39, P1443, DOI 10.1183/09031936.00102711; Tanguy S, 2011, MOL NUTR FOOD RES, V55, P522, DOI 10.1002/mnfr.201000393; Van Cauwenbergh R, 2004, J TRACE ELEM MED BIO, V18, P99, DOI 10.1016/j.jtemb.2004.04.004; vanRoyen N, 1996, AM J CARDIOL, V77, P843, DOI 10.1016/S0002-9149(97)89179-5; WEIS M, 1994, MOL ASPECTS MED, V15, P273, DOI 10.1016/0098-2997(94)90038-8; Xia L, 2003, J BIOL CHEM, V278, P2141, DOI 10.1074/jbc.M210456200	37	52	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157541	10.1371/journal.pone.0157541	http://dx.doi.org/10.1371/journal.pone.0157541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367855	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000378914900010
J	Hunsperger, HM; Ford, CJ; Miller, JS; Cattolico, RA				Hunsperger, Heather M.; Ford, Christopher J.; Miller, James S.; Cattolico, Rose Ann			Differential Regulation of Duplicate Light-Dependent Protochlorophyllide Oxidoreductases in the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							CHLOROPHYLL BIOSYNTHESIS; NADPH; IDENTIFICATION; PHOTOSYNTHESIS; MUTAGENESIS; EXPRESSION; PROTEINS; GENES; SITE; PHOTOACCLIMATION	Background Diatoms (Bacilliariophyceae) encode two light-dependent protochlorophyllide oxidoreductases (POR1 and POR2) that catalyze the penultimate step of chlorophyll biosynthesis in the light. Algae live in dynamic environments whose changing light levels induce photoacclimative metabolic shifts, including altered cellular chlorophyll levels. We hypothesized that the two POR proteins may be differentially adaptive under varying light conditions. Using the diatom Phaeodactylum tricornutum as a test system, differences in POR protein abundance and por gene expression were examined when this organism was grown on an alternating light: dark cycles at different irradiances; exposed to continuous light; and challenged by a significant decrease in light availability. Results For cultures maintained on a 12h light: 12h dark photoperiod at 200 mu Em(-2) s(-1) (200L/D), both por genes were up-regulated during the light and down-regulated in the dark, though por1 transcript abundance rose and fell earlier than that of por2. Little concordance occurred between por1 mRNA and POR1 protein abundance. In contrast, por2 mRNA and POR2 protein abundances followed similar diurnal patterns. When 200L/D P. tricornutum cultures were transferred to continuous light (200L/L), the diurnal regulatory pattern of por1 mRNA abundance but not of por2 was disrupted, and POR1 but not POR2 protein abundance dropped steeply. Under 1200 mu Em(-2) s(-1) (1200L/D), both por1 mRNA and POR1 protein abundance displayed diurnal oscillations. A compromised diel por2 mRNA response under 1200L/D did not impact the oscillation in POR2 abundance. When cells grown at 1200L/D were then shifted to 50 mu Em(-2) s(-1) (50L/D), por1 and por2 mRNA levels decreased swiftly but briefly upon light reduction. Thereafter, POR1 but not POR2 protein levels rose significantly in response to this light stepdown. Conclusion Given the sensitivity of diatom por1/POR1 to real-time light cues and adherence of por2/POR2 regulation to the diurnal cycle, we suggest that POR1 supports photoacclimation, whereas POR2 is the workhorse for daily chlorophyll synthesis.	[Hunsperger, Heather M.; Ford, Christopher J.; Miller, James S.; Cattolico, Rose Ann] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hunsperger, HM; Cattolico, RA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	hheather@uw.edu; racat@uw.edu			National Science Foundation Graduate Research Fellowship Program [DGE-0718124, DGE-1256082]; University of Washington Department of Biology Plant Biology Fellowship; Melinda Denton Writing Fellowship; US Department of Energy as part of the National Alliance for Advanced Biofuels and Bioproducts [DE-EE0003046]; NOAA Sea Grant [NA070AR4170007]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); University of Washington Department of Biology Plant Biology Fellowship; Melinda Denton Writing Fellowship; US Department of Energy as part of the National Alliance for Advanced Biofuels and Bioproducts; NOAA Sea Grant(National Oceanic Atmospheric Admin (NOAA) - USA)	HMH was supported by the National Science Foundation Graduate Research Fellowship Program (DGE-0718124; DGE-1256082; http://www.nsfgrfp.org) as well as a University of Washington Department of Biology Plant Biology Fellowship and a Melinda Denton Writing Fellowship (http://www.biology.washington.edu). This research was funded by the US Department of Energy under a contract awarded to RAC as part of the National Alliance for Advanced Biofuels and Bioproducts (DE-EE0003046; http://www.energy.gov), and by a NOAA Sea Grant to RAC (NA070AR4170007; http://seagrant.noaa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anning T, 2000, LIMNOL OCEANOGR, V45, P1807, DOI 10.4319/lo.2000.45.8.1807; ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Birve SJ, 1996, BIOCHEM J, V317, P549, DOI 10.1042/bj3170549; Costa BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074451; Daboussi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4831; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Deblois CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057139; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Fujita Y., 2003, PORPHYRIN HDB CHLORO, P109, DOI DOI 10.1016/B978-0-08-092387-1.50010-2; GIBBS SP, 1979, J CELL SCI, V35, P253; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Heyes DJ, 2002, BIOCHEM SOC T, V30, P601, DOI 10.1042/bst0300601; HOLTORF H, 1995, P NATL ACAD SCI USA, V92, P3254, DOI 10.1073/pnas.92.8.3254; Hovde BT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005469; Hunsperger HM, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0286-4; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Lebedev N, 2001, BIOCHEMISTRY-US, V40, P12562, DOI 10.1021/bi0105025; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Liu H, 2010, MOL BIOL EVOL, V27, P161, DOI 10.1093/molbev/msp222; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; Maheswari U, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r85; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Martin GEM, 1997, BIOCHEM J, V325, P139, DOI 10.1042/bj3250139; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Masuda T, 2002, PHOTOSYNTH RES, V74, P165, DOI 10.1023/A:1020951409135; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Murchie EH, 1997, PLANT CELL ENVIRON, V20, P438, DOI 10.1046/j.1365-3040.1997.d01-95.x; Nymark M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058722; Ohno S., 1970, EVOLUTION GENE DUPLI; Oliveri P, 2014, MAR GENOM, V14, P23, DOI 10.1016/j.margen.2014.02.001; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PUTT M, 1988, J PHYCOL, V24, P315, DOI 10.1111/j.1529-8817.1988.tb04472.x; Ragni M, 2007, J PLANKTON RES, V29, P141, DOI 10.1093/plankt/fbm002; REINBOTHE C, 1995, MOL CELL BIOL, V15, P6206; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Skinner JS, 1999, PLANT MOL BIOL, V39, P577, DOI 10.1023/A:1006144630071; SPANO AJ, 1992, PLANT MOL BIOL, V18, P967, DOI 10.1007/BF00019210; Su QX, 2001, PLANT MOL BIOL, V47, P805, DOI 10.1023/A:1013699721301; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valle KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114211; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang P, 2015, PHOTOSYNTH RES, V126, P189, DOI 10.1007/s11120-015-0154-5; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilhelm C, 2014, MAR GENOM, V16, P5, DOI 10.1016/j.margen.2013.12.003; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Yuan M, 2012, J PLANT PHYSIOL, V169, P1311, DOI 10.1016/j.jplph.2012.05.010; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	68	3	3	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158614	10.1371/journal.pone.0158614	http://dx.doi.org/10.1371/journal.pone.0158614			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367227	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900045
J	Nilsson, AR; Soneji, S; Adolfsson, S; Bryder, D; Pronk, CJ				Nilsson, Alexandra Rundberg; Soneji, Shamit; Adolfsson, Sofia; Bryder, David; Pronk, Cornelis Jan			Human and Murine Hematopoietic Stem Cell Aging Is Associated with Functional Impairments and Intrinsic Megakaryocytic/Erythroid Bias	PLOS ONE			English	Article							AGE-RELATED-CHANGES; BONE-MARROW; STEM/PROGENITOR CELLS; UNRELATED DONORS; PROGENITOR CELLS; SELF-RENEWAL; TRANSPLANTATION; HIERARCHY; EXPANSION; DECLINE	Aging within the human hematopoietic system associates with various deficiencies and disease states, including anemia, myeloid neoplasms and reduced adaptive immune responses. Similar phenotypes are observed in mice and have been linked to alterations arising at the hematopoietic stem cell (HSC) level. Such an association is, however, less established in human hematopoiesis and prompted us here to detail characteristics of the most primitive human hematopoietic compartments throughout ontogeny. In addition, we also attempted to interrogate similarities between aging human and murine hematopoiesis. Coupled to the transition from human cord blood (CB) to young and aged bone marrow (BM), we observed a gradual increase in frequency of candidate HSCs. This was accompanied by functional impairments, including decreased lymphoid output and reduced proliferative potential. Downstream of human HSCs, we observed decreasing levels of common lymphoid progenitors (CLPs), and increasing frequencies of megakaryocyte/erythrocyte progenitors (MEPs) with age, which could be linked to changes in lineage-affiliated gene expression patterns in aged human HSCs. These findings were paralleled in mice. Therefore, our data support the notion that age-related changes also in human hematopoiesis involve the HSC pool, with a prominent skewing towards the megakaryocytic/erythroid lineages, and suggests conserved mechanisms underlying aging of the blood cell system.	[Nilsson, Alexandra Rundberg; Soneji, Shamit; Adolfsson, Sofia; Bryder, David; Pronk, Cornelis Jan] Lund Univ, Inst Lab Med, Fac Med, Div Mol Hematol, Lund, Sweden; [Nilsson, Alexandra Rundberg; Soneji, Shamit; Adolfsson, Sofia; Bryder, David; Pronk, Cornelis Jan] Lund Univ, Fac Med, Lund Stem Cell Ctr, Lund, Sweden; [Pronk, Cornelis Jan] Skane Univ Hosp, Dept Pediat Oncol Hematol, Lund, Sweden	Lund University; Lund University; Lund University; Skane University Hospital	Pronk, CJ (corresponding author), Lund Univ, Inst Lab Med, Fac Med, Div Mol Hematol, Lund, Sweden.; Pronk, CJ (corresponding author), Lund Univ, Fac Med, Lund Stem Cell Ctr, Lund, Sweden.; Pronk, CJ (corresponding author), Skane Univ Hosp, Dept Pediat Oncol Hematol, Lund, Sweden.	kees-jan.pronk@med.lu.se	Bryder, David/Q-6292-2019	Bryder, David/0000-0002-8761-4237	Swedish Research Council; Swedish Cancer Society; Swedish Children Cancer Foundation; StemTherapy (Lund); ALF (Avtal om Lakarutbildning och Forskning)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Children Cancer Foundation; StemTherapy (Lund); ALF (Avtal om Lakarutbildning och Forskning)	This work was supported by grants to D.B. from the Swedish Research Council and Swedish Cancer Society, and to C.J.P. by grants from the Swedish Research Council, Swedish Children Cancer Foundation, StemTherapy (Lund), and ALF (Avtal om Lakarutbildning och Forskning).	Balduini CL, 2014, HAEMATOLOGICA, V99, P953, DOI 10.3324/haematol.2014.106260; Banerjee ER, 2008, EXP HEMATOL, V36, P1004, DOI 10.1016/j.exphem.2008.03.008; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Berliner Nancy, 2013, Trans Am Clin Climatol Assoc, V124, P230; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Boraschi D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005624; Burch JB, 2014, J GERONTOL A-BIOL, V69, pS1, DOI 10.1093/gerona/glu041; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Edvardsson L, 2006, EXP HEMATOL, V34, P599, DOI 10.1016/j.exphem.2006.01.017; Ferrucci L, 2008, SEMIN HEMATOL, V45, P242, DOI 10.1053/j.seminhematol.2008.06.001; Finke J, 2012, BIOL BLOOD MARROW TR, V18, P1716, DOI 10.1016/j.bbmt.2012.06.001; Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x; Grover A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11075; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Heining C, 2007, BONE MARROW TRANSPL, V39, P613, DOI 10.1038/sj.bmt.1705648; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Kuranda K, 2011, AGING CELL, V10, P542, DOI 10.1111/j.1474-9726.2011.00675.x; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; Lichtman MA, 2004, SEMIN ONCOL, V31, P185, DOI 10.1053/j.seminoncol.2003.12.029; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Marley SB, 1999, BRIT J HAEMATOL, V106, P162; Mori Y, 2015, P NATL ACAD SCI USA, V112, P9638, DOI 10.1073/pnas.1512076112; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Muller-Sieburg C, 2008, CELL CYCLE, V7, P3798, DOI 10.4161/cc.7.24.7214; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Norddahl GL, 2012, AGING CELL, V11, P1128, DOI 10.1111/j.1474-9726.2012.00863.x; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Price EA, 2008, BLOOD CELL MOL DIS, V41, P158, DOI 10.1016/j.bcmd.2008.04.005; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Pronk CJH, 2011, METHODS MOL BIOL, V699, P275, DOI 10.1007/978-1-61737-950-5_13; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Spinelli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2012-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Taraldsrud E, 2009, SCAND J CLIN LAB INV, V69, P79, DOI 10.1080/00365510802419447; Umemoto T, 2008, BIOCHEM BIOPH RES CO, V365, P176, DOI 10.1016/j.bbrc.2007.10.168; van Galen P, 2014, CELL STEM CELL, V14, P94, DOI 10.1016/j.stem.2013.11.021; Vas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042080; Verovskaya E, 2013, BLOOD, V122, P523, DOI 10.1182/blood-2013-01-481135; Wahlestedt M, 2015, STEM CELL TRANSL MED, V4, P186, DOI 10.5966/sctm.2014-0132; Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Woolthuis CM, 2014, BIOL BLOOD MARROW TR, V20, P865, DOI 10.1016/j.bbmt.2014.03.001; Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	63	57	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158369	10.1371/journal.pone.0158369	http://dx.doi.org/10.1371/journal.pone.0158369			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27368054	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900032
J	Vegvari, C; Hadjichrysanthou, C; Cauet, E; Lawrence, E; Cori, A; de Wolf, F; Anderson, RM				Vegvari, Carolin; Hadjichrysanthou, Christoforos; Cauet, Emilie; Lawrence, Emma; Cori, Anne; de Wolf, Frank; Anderson, Roy M.			How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?	PLOS ONE			English	Article							INFLUENZA-VIRUS; TISSUE-CULTURE; OSELTAMIVIR; INHIBITION	Acute viral infections pose many practical challenges for the accurate assessment of the impact of novel therapies on viral growth and decay. Using the example of influenza A, we illustrate how the measurement of infection-related quantities that determine the dynamics of viral load within the human host, can inform investigators on the course and severity of infection and the efficacy of a novel treatment. We estimated the values of key infection-related quantities that determine the course of natural infection from viral load data, using Markov Chain Monte Carlo methods. The data were placebo group viral load measurements collected during volunteer challenge studies, conducted by Roche, as part of the oseltamivir trials. We calculated the values of the quantities for each patient and the correlations between the quantities, symptom severity and body temperature. The greatest variation among individuals occurred in the viral load peak and area under the viral load curve. Total symptom severity correlated positively with the basic reproductive number. The most sensitive endpoint for therapeutic trials with the goal to cure patients is the duration of infection. We suggest laboratory experiments to obtain more precise estimates of virological quantities that can supplement clinical endpoint measurements.	[Vegvari, Carolin; Hadjichrysanthou, Christoforos; Cauet, Emilie; Lawrence, Emma; Cori, Anne; Anderson, Roy M.] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England; [de Wolf, Frank] Janssen Prevent Ctr, Leiden, Netherlands	Imperial College London	Vegvari, C (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.	c.vegvari@imperial.ac.uk	Cori, Anne/AFL-1641-2022; Cauët, Emilie L. M./H-5849-2012	Cori, Anne/0000-0002-8443-9162; Cauët, Emilie L. M./0000-0002-2923-245X; Anderson, Roy/0000-0002-9528-3175	Janssen Prevention Center; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Janssen Prevention Center; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Janssen Prevention Center. The funder provided support in the form of salaries for authors CV, EC, CH, EL, FdW, RA, but did not have any additional role in the study design, data collection and analysis. FdW approved the final manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.; We would like to thank Hoffman La Roche for providing access to their data for this analysis and the Janssen Prevention Center for funding this research.	Atmar RL, 1996, J CLIN MICROBIOL, V34, P2604, DOI 10.1128/JCM.34.10.2604-2606.1996; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cleeland CS, 2013, CANCER-AM CANCER SOC, V119, P411, DOI 10.1002/cncr.27744; Clinch B, 2015, CLIN MICROBIOL INFEC, V21, P226, DOI 10.1016/j.cmi.2015.01.014; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; FRANK AL, 1979, J CLIN MICROBIOL, V10, P32, DOI 10.1128/JCM.10.1.32-36.1979; Hadjichrysanthou C, J R SOC INT IN PRESS; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Ison MG, 2010, J INFECT DIS, V201, P1654, DOI 10.1086/652498; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Kamal MA, 2015, ANTIMICROB AGENTS CH, V59, P5388, DOI 10.1128/AAC.00069-15; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; Price GE, 1997, J GEN VIROL, V78, P2821, DOI 10.1099/0022-1317-78-11-2821; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; TCSDD TCftSoDD, 2014, COST DEV WIN MARK AP; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10; Virlogeux V, 2015, EPIDEMIOLOGY; Wathen MW, 2013, INFLUENZA OTHER RESP, V7, P76, DOI 10.1111/irv.12049	27	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158237	10.1371/journal.pone.0158237	http://dx.doi.org/10.1371/journal.pone.0158237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367230	gold, Green Published, Green Submitted			2022-12-27	WOS:000378914900025
J	Bailleul, D; Ollier, S; Lecomte, J				Bailleul, Diane; Ollier, Sebastien; Lecomte, Jane			Genetic Diversity of Oilseed Rape Fields and Feral Populations in the Context of Coexistence with GM Crops	PLOS ONE			English	Article							CANOLA BRASSICA-NAPUS; HERBICIDE RESISTANCE; VOLUNTEER CANOLA; POLLEN-DISPERSAL; SEED; PERSISTENCE; PLANT; FLOW; DORMANCY; HARVEST	Despite growing concern about transgenes escaping from fields, few studies have analysed the genetic diversity of crops in an agroecosystem over several years. Accurate information about the dynamics and relationship of the genetic diversity of crops in an agroecosystem is essential for risk assessment and policies concerning the containment of genetically modified crops and their coexistence with crops grown by conventional practices. Here, we analysed the genetic diversity of oilseed rape plants from fields and feral populations over 4 years in an agricultural landscape of 41 km(2). We used exact compatibility and maximum likelihood assignment methods to assign these plants to cultivars. Even pure lines and hybrid cultivar seed lots contained several genotypes. The cultivar diversity in fields reflected the conventional view of agroecosystems quite well: that is, there was a succession of cultivars, some grown for longer than others because of their good performance, some used for one year and then abandoned, and others gradually adopted. Three types of field emerged: fields sown with a single cultivar, fields sown with two cultivars, and unassigned fields (too many cultivars or unassigned plants to reliably assign the field). Field plant diversity was higher than expected, indicating the persistence of cultivars that were grown for only one year. The cultivar composition of feral populations was similar to that of field plants, with an increasing number of cultivars each year. By using genetic tools, we found a link between the cultivars of field plants in a particular year and the cultivars of feral population plants in the following year. Feral populations on road verges were more diverse than those on path verges. All of these findings are discussed in terms of their consequences in the context of coexistence with genetically modified crops.	[Bailleul, Diane] IFREMER, UMR MARBEC, Stn Sete, Ave Jean Monnet,CS 30171, F-34203 Sete, Sete, France; [Bailleul, Diane; Ollier, Sebastien; Lecomte, Jane] Univ Paris 11, CNRS, AgroParisTech, Univ Paris Saclay,Ecol Systemat Evolut, F-91406 Orsay, France	Ifremer; Universite de Montpellier; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bailleul, D (corresponding author), IFREMER, UMR MARBEC, Stn Sete, Ave Jean Monnet,CS 30171, F-34203 Sete, Sete, France.; Bailleul, D; Lecomte, J (corresponding author), Univ Paris 11, CNRS, AgroParisTech, Univ Paris Saclay,Ecol Systemat Evolut, F-91406 Orsay, France.	diane.bailleul@gmail.com; jane.lecomte@u-psud.fr			Programme National de Recherche sur les OGM; GMBIOIMPACT project [ANR-06-POGM-0004]	Programme National de Recherche sur les OGM; GMBIOIMPACT project	This study was supported by the Programme National de Recherche sur les OGM (2006), GMBIOIMPACT project, ANR-06-POGM-0004, http://www.agence-nationale-recherche.fr/?Projet=ANR-06-POGM-0004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NS, 2010, EUR J AGRON, V32, P121, DOI 10.1016/j.eja.2009.09.001; Aono Mitsuko, 2006, Environmental Biosafety Research, V5, P77, DOI 10.1051/ebr:2006017; Bailleul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032752; Beckie HJ, 2003, ECOL APPL, V13, P1276, DOI 10.1890/02-5231; Bond JM, 2004, EUPHYTICA, V139, P173, DOI 10.1007/s10681-004-2781-3; Ceddia MG, 2008, DESCRIPTIVE ANAL CON, P1; Chifflet R, 2011, J APPL ECOL, V48, P689, DOI 10.1111/j.1365-2664.2010.01904.x; CHUNG MG, 1994, J PLANT RES, V107, P377, DOI 10.1007/BF02344060; CRAWLEY MJ, 1995, P ROY SOC B-BIOL SCI, V259, P49, DOI 10.1098/rspb.1995.0008; Cuthbert JL, 2001, CAN J PLANT SCI, V81, P657, DOI 10.4141/P01-070; D'Hertefeldt T, 2008, BIOL LETTERS, V4, P314, DOI 10.1098/rsbl.2008.0123; Devaux C, 2005, MOL ECOL, V14, P2269, DOI 10.1111/j.1365-294X.2005.02554.x; Devaux C, 2006, THESIS; Downey R, 2002, ISOLATION EFFECTIVEN, P1; Elling B, 2009, BASIC APPL ECOL, V10, P544, DOI 10.1016/j.baae.2009.01.005; Friesen LF, 2003, AGRON J, V95, P1342, DOI 10.2134/agronj2003.1342; Garnier A, 2008, BASIC APPL ECOL, V9, P533, DOI 10.1016/j.baae.2007.08.014; Gomez-Campo C, 1999, DEV PL GEN, V4, P33; Gruber S, 2004, J AGR SCI-CAMBRIDGE, V142, P29, DOI 10.1017/S0021859604003892; Gulden RH, 2003, WEED SCI, V51, P904, DOI 10.1614/P2002-170; Gulden RH, 2003, WEED SCI, V51, P83, DOI 10.1614/0043-1745(2003)051[0083:HLOCBN]2.0.CO;2; Hall L, 2000, WEED SCI, V48, P688, DOI 10.1614/0043-1745(2000)048[0688:PFBHRB]2.0.CO;2; Hecht M, 2014, ENVIRON SCI POLLUT R, V21, P1455, DOI 10.1007/s11356-013-1881-9; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; Jorgensen RB, 2007, ADV BOT RES, V45, P451, DOI 10.1016/S0065-2296(07)45016-9; Jorgensen T, 2007, SEED SCI RES, V17, P115, DOI 10.1017/S0960258507708103; Knispel AL, 2008, WEED SCI, V56, P72, DOI 10.1614/WS-07-097.1; Knispel AL, 2010, ENVIRON SCI POLLUT R, V17, P13, DOI 10.1007/s11356-009-0219-0; Lavigne C, 1998, THEOR APPL GENET, V96, P886, DOI 10.1007/s001220050816; Mallory-Smith CA, 2011, J AGR FOOD CHEM, V59, P5813, DOI 10.1021/jf103389v; Meffin R, 2015, AGR ECOSYST ENVIRON, V203, P119, DOI 10.1016/j.agee.2015.01.024; Messean A, 2007, EUR J AGRON, V27, P115, DOI 10.1016/j.eja.2007.02.009; MIDDENDORF LR, 1992, ELECTROPHORESIS, V13, P487, DOI 10.1002/elps.11501301103; Munier DJ, 2012, ENVIRON SCI POLLUT R, V19, P2281, DOI 10.1007/s11356-011-0733-8; Ostrowski MF, 2010, HEREDITY, V105, P358, DOI 10.1038/hdy.2009.156; Pascher K, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-63; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pekrun C, 1997, EUR J AGRON, V6, P245, DOI 10.1016/S1161-0301(96)02051-5; Pessel FD, 2001, THEOR APPL GENET, V102, P841, DOI 10.1007/s001220100583; Pivard S, 2008, J APPL ECOL, V45, P476, DOI 10.1111/j.1365-2664.2007.01358.x; Rieger MA, 2002, SCIENCE, V296, P2386, DOI 10.1126/science.1071682; Saji Hikaru, 2005, Environmental Biosafety Research, V4, P217, DOI 10.1051/ebr:2006003; Saseendran SA, 2010, AGRON J, V102, P1606, DOI 10.2134/agronj2010.0277; Sausse C, 2013, LAND USE POLICY, V30, P719, DOI 10.1016/j.landusepol.2012.05.018; Schafer MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025736; Schoenenberger Nicola, 2012, Environmental Sciences Europe, V24, P23, DOI 10.1186/2190-4715-24-23; Schulze H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087159; Simard MJ, 2002, WEED TECHNOL, V16, P433, DOI 10.1614/0890-037X(2002)016[0433:TFAPOV]2.0.CO;2; Squire GR, 2011, ENVIRON SCI POLLUT R, V18, P111, DOI 10.1007/s11356-010-0376-1; Terres Inovia, I TECHN PROC OL PROT; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; von der Lippe M, 2007, ECOGRAPHY, V30, P483, DOI 10.1111/j.2007.0906-7590.05072.x; Yoshimura Yasuyuki, 2006, Environmental Biosafety Research, V5, P67, DOI 10.1051/ebr:2006019	53	7	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158403	10.1371/journal.pone.0158403	http://dx.doi.org/10.1371/journal.pone.0158403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359342	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200070
J	Graupera, I; Sola, E; Fabrellas, N; Moreira, R; Sole, C; Huelin, P; de la Prada, G; Pose, E; Ariza, X; Risso, A; Albertos, S; Morales-Ruiz, M; Jimenez, W; Gines, P				Graupera, Isabel; Sola, Elsa; Fabrellas, Nuria; Moreira, Rebeca; Sole, Cristina; Huelin, Patricia; de la Prada, Gloria; Pose, Elisa; Ariza, Xavier; Risso, Alessandro; Albertos, Sonia; Morales-Ruiz, Manuel; Jimenez, Wladimiro; Gines, Pere			Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; SYSTEMIC INFLAMMATORY RESPONSE; ACUTE KIDNEY INJURY; CHRONIC LIVER-FAILURE; PHARMACOLOGICAL INHIBITION; MACROPHAGE INFILTRATION; CHEMOTACTIC PROTEIN-1; HEPATORENAL-SYNDROME; IMMUNE DYSFUNCTION; RENAL-FAILURE	MCP-1 (monocyte chemoattractant protein-1) is a proinflammatory cytokine involved in chemotaxis of monocytes. In several diseases, such as acute coronary syndromes and heart failure, elevated MCP-1 levels have been associated with poor outcomes. Little is known about MCP-1 in cirrhosis. AIM: To investigate the relationship between MCP-1 and outcome in decompensated cirrhosis. METHODS: Prospective study of 218 patients discharged from hospital after an admission for complications of cirrhosis. Urine and plasma levels of MCP-1 and other urine proinflammatroy biomarkers: osteopontin(OPN), trefoil-factor3 and liver-fatty-acid-binding protein were measured at admission. Urine non-inflammatory mediators cystatin-C, beta 2microglobulin and albumin were measured as control biomarkers. The relationship between these biomarkers and the 3-month hospital readmission, complications of cirrhosis, and mortality were assessed. RESULTS: 69 patients(32%) had at least one readmission during the 3-month period of follow-up and 30 patients died(14%). Urine MCP-1 and OPN levels, were associated with 3-month probability of readmission (0.85 (0.27-2.1) and 2003 (705-4586) ug/g creat vs 0.47 (0.2-1.1) and 1188 (512-2958) ug/g creat, in patients with and without readmission, respectively; p<0.05; median (IQR)). Furthermore, urine levels of MCP-1 were significantly associated with mortality (1.01 (1-3.6) vs 0.5 (0.2-1.1) mu g/g creat, in dead and alive patients at 3 months; p<0.05). Patients with higher levels of urine MCP-1 (above percentile 75th) had higher probability of development of hepatic encephalopathy, bacterial infections or AKI. Urine MCP-1 was an independent predictive factor of hospital readmission and combined end-point of readmission or dead at 3 months. Plasma levels of MCP-1 did not correlated with outcomes. CONCLUSION: Urine, but not plasma, MCP-1 levels are associated with hospital readmission, development of complications of cirrhosis, and mortality. These results suggest that in cirrhosis there is an inflammatory response that is associated with poor outcomes.	[Graupera, Isabel; Sola, Elsa; Moreira, Rebeca; Sole, Cristina; Huelin, Patricia; de la Prada, Gloria; Pose, Elisa; Ariza, Xavier; Gines, Pere] Univ Barcelona, Hosp Clin, Liver Unit, Barcelona, Spain; [Graupera, Isabel; Sola, Elsa; Fabrellas, Nuria; Moreira, Rebeca; Sole, Cristina; Huelin, Patricia; Pose, Elisa; Ariza, Xavier; Risso, Alessandro; Albertos, Sonia; Morales-Ruiz, Manuel; Jimenez, Wladimiro; Gines, Pere] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Graupera, Isabel; Sola, Elsa; Moreira, Rebeca; Sole, Cristina; Huelin, Patricia; Pose, Elisa; Ariza, Xavier; Morales-Ruiz, Manuel; Jimenez, Wladimiro; Gines, Pere] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Fabrellas, Nuria] Univ Barcelona, Sch Nursing, Barcelona, Spain; [Morales-Ruiz, Manuel; Jimenez, Wladimiro] Univ Barcelona, Hosp Clin, Biochem & Mol Genet Dept, Barcelona, Spain; [Morales-Ruiz, Manuel; Jimenez, Wladimiro] Univ Barcelona, Dept Physiol Sci, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Gines, P (corresponding author), Univ Barcelona, Hosp Clin, Liver Unit, Barcelona, Spain.; Gines, P (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.; Gines, P (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	pgines@clinic.cat	Morales-Ruiz, Manuel/L-1031-2014; Pose, Elisa/AAE-1743-2022; Morales-Ruiz, Manuel/Z-2332-2019; Morales-Ruiz, Manuel/AAM-1487-2020; Gines, Pere/B-6646-2009	Morales-Ruiz, Manuel/0000-0002-9074-2272; Morales-Ruiz, Manuel/0000-0002-9074-2272; Gines, Pere/0000-0003-4657-4504; POSE MENDEZ, ELISA/0000-0002-0224-7686; huelin alvarez, patricia/0000-0003-2340-4772; Sole, Cristina/0000-0002-6104-8345; Jimenez, Wladimiro/0000-0002-9376-0214; Graupera, Isabel/0000-0001-9170-9784; Fabrellas, Nuria/0000-0001-6720-0291; SOLA, ELSA/0000-0001-6897-2760	Fondos de Investigacion de Salud Carlos III integrated in the Plan Nacional I+D+I [FIS PI12/00330]; ICREA Academia Award; Plan Estatal I+D+I and Instituto Carlos III (Rio-Hortega fellowship) [CM14/00122]; Instituto de Salud Carlos III [FI14/00227]; University of Barcelona [APIF2015]; Instituto de Salud Carlos III; Ferring Pharmaceuticals; Sequana Medical; ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund FEDER; Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) [2014/SGR 708]; Grifols S.A	Fondos de Investigacion de Salud Carlos III integrated in the Plan Nacional I+D+I; ICREA Academia Award(ICREA); Plan Estatal I+D+I and Instituto Carlos III (Rio-Hortega fellowship); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); University of Barcelona; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ferring Pharmaceuticals(Ferring Pharmaceuticals); Sequana Medical; ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund FEDER(European Commission); Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Grifols S.A	Some of the work mentioned has been supported by a grant awarded to Pere Gines (PG) (FIS PI12/00330), from Fondos de Investigacion de Salud Carlos III integrated in the Plan Nacional I+D+I and co-funded by ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund FEDER and from Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) 2014/SGR 708. PG is a recipient of an ICREA Academia Award. Isabel Graupera was supported by a grant from the Plan Estatal I+D+I and Instituto Carlos III (Rio-Hortega fellowship: CM14/00122). Cristina Sole was supported by a grant from the Instituto de Salud Carlos III (FI14/00227). Patricia Huelin was supported by a grant from the University of Barcelona (APIF2015). PG is recipient of an ICREA Academia Award. CIBEREHD is funded by the Instituto de Salud Carlos III. PG has previously received funding from Ferring Pharmaceuticals, Grifols S.A, and Sequana Medical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Aldridge DR, 2015, J CLIN EXP HEPATOL, V5, pS7, DOI 10.1016/j.jceh.2014.06.004; Angeli P, 2015, J HEPATOL, V62, P968, DOI 10.1016/j.jhep.2014.12.029; Ariza X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128145; Arroyo V, 2015, J HEPATOL, V62, pS131, DOI 10.1016/j.jhep.2014.11.045; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Barreto R, 2014, J HEPATOL, V61, P35, DOI 10.1016/j.jhep.2014.02.023; Barreto R, 2014, HEPATOLOGY, V59, P1505, DOI 10.1002/hep.26687; Bernardi M, 2015, J HEPATOL, V63, P1272, DOI 10.1016/j.jhep.2015.07.004; Carl DE, 2014, LIVER INT, V34, P1001, DOI 10.1111/liv.12450; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Coltart I, 2013, ARCH BIOCHEM BIOPHYS, V536, P189, DOI 10.1016/j.abb.2013.03.016; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; Degre D, 2012, CLIN EXP IMMUNOL, V169, P302, DOI 10.1111/j.1365-2249.2012.04609.x; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dirchwolf M, 2016, CYTOKINE, V77, P14, DOI 10.1016/j.cyto.2015.10.006; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Giunti S, 2006, KIDNEY INT, V69, P856, DOI 10.1038/sj.ki.5000197; Haller H, 2016, CURR OPIN NEPHROL HY, V25, P42, DOI 10.1097/MNH.0000000000000186; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Kim JK, 2007, J INTERF CYTOK RES, V27, P227, DOI 10.1089/jir.2006.0055; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maiwall R, 2016, DIGEST DIS SCI, V61, P920, DOI 10.1007/s10620-015-3921-4; Marra F, 1998, AM J PATHOL, V152, P423; Michelena J, 2015, HEPATOLOGY, V62, P762, DOI 10.1002/hep.27779; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Mortensen C, 2012, EUR J GASTROEN HEPAT, V24, P619, DOI 10.1097/MEG.0b013e328351db6e; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Shah N, 2013, LIVER INT, V33, P398, DOI 10.1111/liv.12047; Shah N, 2012, J HEPATOL, V56, P1047, DOI 10.1016/j.jhep.2011.11.024; Terra C, 2005, GASTROENTEROLOGY, V129, P1944, DOI 10.1053/j.gastro.2005.09.024; Thabut D, 2007, HEPATOLOGY, V46, P1872, DOI 10.1002/hep.21920; Yao Y, 2014, CELL MOL LIFE SCI, V71, P683, DOI 10.1007/s00018-013-1459-1	38	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157371	10.1371/journal.pone.0157371	http://dx.doi.org/10.1371/journal.pone.0157371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359339	Green Published, gold			2022-12-27	WOS:000378865200015
J	Hartmann, SB; Mohanty, S; Skovgaard, K; Brogaard, L; Flagstad, FB; Emneus, J; Wolff, A; Summerfield, A; Jungersen, G				Hartmann, Sofie Bruun; Mohanty, Soumyaranjan; Skovgaard, Kerstin; Brogaard, Louise; Flagstad, Frederikke Bjergvang; Emneus, Jenny; Wolff, Anders; Summerfield, Artur; Jungersen, Gregers			Investigating the Role of Surface Materials and Three Dimensional Architecture on In Vitro Differentiation of Porcine Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							BLOOD; CULTURE; CANCER; SYSTEMS; TISSUE; IDENTIFICATION; FABRICATION; TECHNOLOGY; SCAFFOLDS; MODEL	In vitro generation of dendritic-like cells through differentiation of peripheral blood monocytes is typically done using two-dimensional polystyrene culture plates. In the process of optimising cell culture techniques, engineers have developed fluidic micro-devises usually manufactured in materials other than polystyrene and applying three-dimensional structures more similar to the in vivo environment. Polydimethylsiloxane (PDMS) is an often used polymer for lab-on-a-chip devices but not much is known about the effect of changing the culture surface material from polystyrene to PDMS. In the present study the differentiation of porcine monocytes to monocyte-derived dendritic cells (moDCs) was investigated using CD172apos pig blood monocytes stimulated with GM-CSF and IL-4. Monocytes were cultured on surfaces made of two-and three-dimensional polystyrene as well as two-and three-dimensional PDMS and carbonised three-dimensional PDMS. Cells cultured conventionally (on two-dimensional polystyrene) differentiated into moDCs as expected. Interestingly, gene expression of a wide range of cytokines, chemokines, and pattern recognition receptors was influenced by culture surface material and architecture. Distinct clustering of cells, based on similar expression patterns of 46 genes of interest, was seen for cells isolated from two-and three-dimensional polystyrene as well as two-and three-dimensional PDMS. Changing the material from polystyrene to PDMS resulted in cells with expression patterns usually associated with macrophage expression (upregulation of CD163 and downregulation of CD1a, FLT3, LAMP3 and BATF3). However, this was purely based on gene expression level, and no functional assays were included in this study which would be necessary in order to classify the cells as being macrophages. When changing to three-dimensional culture the cells became increasingly activated in terms of IL6, IL8, IL10 and CCR5 gene expression. Further stimulation with LPS resulted in a slight increase in the expression of maturation markers (SLA-DRB1, CD86 and CD40) as well as cytokines (IL6, IL8, IL10 and IL23A) but the influence of the surfaces was unchanged. These findings highlights future challenges of combining and comparing data generated from microfluidic cell culture-devices made using alternative materials to data generated using conventional polystyrene plates used by most laboratories today.	[Hartmann, Sofie Bruun; Skovgaard, Kerstin; Brogaard, Louise; Flagstad, Frederikke Bjergvang; Jungersen, Gregers] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark; [Mohanty, Soumyaranjan; Emneus, Jenny; Wolff, Anders] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark; [Summerfield, Artur] IVI, Mittelhausern, Switzerland; [Mohanty, Soumyaranjan] Thermo Fisher Sci, Roskilde, Denmark	Technical University of Denmark; Technical University of Denmark; Thermo Fisher Scientific	Jungersen, G (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark.	grju@vet.dtu.dk	Summerfield, Artur/H-6025-2019; Jungersen, Gregers/P-9767-2019; Wolff, Anders/B-7601-2011; Jungersen, Gregers/C-3940-2011; Summerfield, Artur/K-2105-2016; Emneus, Jenny/A-5763-2012	Summerfield, Artur/0000-0001-8292-4634; Jungersen, Gregers/0000-0003-3147-6960; Wolff, Anders/0000-0001-9596-1215; Jungersen, Gregers/0000-0003-3147-6960; Summerfield, Artur/0000-0001-8292-4634; Brogaard, Louise/0000-0003-4571-6822; skovgaard, kerstin/0000-0001-5663-4879; Emneus, Jenny/0000-0002-8061-201X				Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barbetta A, 2005, LANGMUIR, V21, P12333, DOI 10.1021/la0520233; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Buonerba C, 2011, EXPERT REV ANTICANC, V11, P25, DOI [10.1586/era.10.180, 10.1586/ERA.10.180]; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Castiello L, 2011, CANCER IMMUNOL IMMUN, V60, P457, DOI 10.1007/s00262-010-0954-6; Cha KJ, 2011, BIOMED MICRODEVICES, V13, P877, DOI 10.1007/s10544-011-9557-z; Chamorro S, 2004, IMMUNOBIOLOGY, V209, P57, DOI 10.1016/j.imbio.2004.02.002; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Facci MR, 2010, IMMUNOLOGY, V129, P396, DOI 10.1111/j.1365-2567.2009.03192.x; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; Guzylack-Piriou L, 2010, DEV COMP IMMUNOL, V34, P455, DOI 10.1016/j.dci.2009.12.006; INABA K, 1992, J EXP MED, V175, P1157, DOI 10.1084/jem.175.5.1157; Jamin A, 2006, VET IMMUNOL IMMUNOP, V114, P224, DOI 10.1016/j.vetimm.2006.08.009; Johansson E, 2003, VET IMMUNOL IMMUNOP, V91, P183, DOI 10.1016/S0165-2427(02)00310-0; Kartalov EP, 2006, J NANOSCI NANOTECHNO, V6, P2265, DOI 10.1166/jnn.2006.504; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Kyrova K, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0244-1; Lopacinska JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053107; Maltman DJ, 2010, BIOCHEM SOC T, V38, P1072, DOI 10.1042/BST0381072; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Mohanty S, 2012, P 39 INT C MICR; Mohanty S, 2016, MAT SCI ENG C-MATER, V61, P180, DOI 10.1016/j.msec.2015.12.032; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; Sanchez C, 1999, J IMMUNOL, V162, P5230; Skovgaard K, 2009, VET RES, V40, DOI 10.1051/vetres/2009006; Summerfield A, 2003, IMMUNOLOGY, V110, P440, DOI 10.1111/j.1365-2567.2003.01755.x; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; Summerfield A, 2015, ANNU REV ANIM BIOSCI, V3, P533, DOI 10.1146/annurev-animal-022114-111009; Tehranirokh M, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4826935; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yang L, 2004, ADV CANCER RES, V92, P13, DOI 10.1016/S0065-230X(04)92002-7; Zhang WJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02332	37	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158503	10.1371/journal.pone.0158503	http://dx.doi.org/10.1371/journal.pone.0158503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362493	Green Published, gold			2022-12-27	WOS:000378865200085
J	Ikeda, MLR; Barcellos, NT; Alencastro, PR; Wolff, FH; Moreira, LB; Gus, M; Brandao, ABM; Fuchs, FD; Fuchs, SC				Ikeda, Maria Leticia R.; Barcellos, Nemora T.; Alencastro, Paulo R.; Wolff, Fernando H.; Moreira, Leila B.; Gus, Miguel; Brandao, Ajacio B. M.; Fuchs, Flavio D.; Fuchs, Sandra C.			Alcohol Drinking Pattern: A Comparison between HIV-Infected Patients and Individuals from the General Population	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HEAVY DRINKING; UNITED-STATES; USE DISORDERS; SUBSTANCE USE; CONSUMPTION; RISK; PREVALENCE; ABUSE	Background Alcohol consumption is highly prevalent in the general population and among HIV-infected population. This study aimed to compare the pattern of alcohol consumption and to describe characteristics associated with heavy alcohol consumption in individuals from the general population with patients infected with HIV. Methods Participants for this analysis came from a population-based cross-sectional study and from a consecutive sampling of patients infected with HIV. Participants aged 18 years or older were interviewed using similar questionnaires with questions pertaining to socio-demographic characteristics, alcohol consumption, smoking, physical activity, and HIV-related characteristics, among others. Blood pressure and anthropometric measures were measured using standardized procedures. Results Weekly alcohol consumption was more prevalent among individuals from the general population than HIV-infected patients: 57.0 vs. 31.1%, P<0.001. The prevalence of heavy episodic drinking was higher in the population sample as well: 46.1 vs. 17.0%, P<0.001. In the general population, heavy alcohol consumption was more prevalent in men. Cigarette smoking was independently associated with heavy alcohol consumption among HIV infected (Prevalence Ratio; PR = 5.9; 95% CI 2.6-13.9; P<0,001) and general population (PR = 2.6; 95% CI 1.9-3.0; P<0.001). Years at school were inversely associated with heavy alcohol consumption among HIV-infected patients and directly associated among participants from the general population, even after controlling for sex, age, skin color, and smoking. Conclusions Heavy alcohol consumption is more prevalent in the general population than among HIV-infected patients. Individuals aware about their disease may reduce the amount of alcoholic beverages consumption comparatively to healthy individuals from the general population.	[Ikeda, Maria Leticia R.; Moreira, Leila B.; Gus, Miguel; Fuchs, Flavio D.; Fuchs, Sandra C.] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Cardiol, R Ramiro Barcelos 2600,2 Andar, Porto Alegre, RS, Brazil; [Ikeda, Maria Leticia R.; Barcellos, Nemora T.; Alencastro, Paulo R.] Hosp Sanat Partenon, State Dept Hlth, Rio Grande Sul Av Bento Goncalves 3722, BR-90650001 Porto Alegre, RS, Brazil; [Wolff, Fernando H.] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Program Sci Gastroenterol & Hepatol, R Ramiro Barcelos 2600, BR-90035003 Porto Alegre, RS, Brazil; [Brandao, Ajacio B. M.] Univ Fed Ciencias Saude Porto Alegre, Postgrad Program Med Hepatol, Porto Alegre, RS, Brazil; [Fuchs, Flavio D.] Hosp Clin Porto Alegre, Div Cardiol, Ctr Pesquisa Clin, R Ramiro Barcelos 2350, BR-90035003 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre	Fuchs, SC (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Cardiol, R Ramiro Barcelos 2600,2 Andar, Porto Alegre, RS, Brazil.	scfuchs@terra.com.br	Fuchs, Sandra C/T-2670-2019; Fuchs, Flávio D/L-5078-2016; MOREIRA, LEILA LEILA B/AAC-2240-2019	MOREIRA, LEILA LEILA B/0000-0002-4730-7988; Brandao, Ajacio/0000-0001-8411-5654; fuchs, flavio/0000-0002-1191-0523	CNPq (National Council for Scientific and Technological Development); Ministry of Health/Secretariat of Health Surveillance/National STD and AIDS Programme (MOH/SHS/NAP); FIPE-HCPA (Fundo de Apoio a Pesquisa, Hospital de Clinicas de Porto Alegre) [GPPG: 06-243]	CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health/Secretariat of Health Surveillance/National STD and AIDS Programme (MOH/SHS/NAP); FIPE-HCPA (Fundo de Apoio a Pesquisa, Hospital de Clinicas de Porto Alegre)	This work was partially supported by the CNPq (National Council for Scientific and Technological Development), Ministry of Health/Secretariat of Health Surveillance/National STD and AIDS Programme (MOH/SHS/NAP), and FIPE-HCPA (GPPG: 06-243; Fundo de Apoio a Pesquisa, Hospital de Clinicas de Porto Alegre). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencastro PR, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-29; Alencastro PR, 2011, AIDS PATIENT CARE ST, V25, P627, DOI 10.1089/apc.2010.0360; Almeida-Filho N, 2004, REV SAUDE PUBL, V38, P45, DOI 10.1590/S0034-89102004000100007; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Assanangkornchai S, 2010, ALCOHOL ALCOHOLISM, V45, P278, DOI 10.1093/alcalc/agq018; Atwoli L, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-34; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Bonacini M, 2011, ANN HEPATOL, V10, P502, DOI 10.1016/S1665-2681(19)31519-4; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Conigliaro J, 2003, JAIDS-J ACQ IMM DEF, V33, P521, DOI 10.1097/00126334-200308010-00014; De Boni RB, 2016, DRUG ALCOHOL DEPEN, V159, P174, DOI 10.1016/j.drugalcdep.2015.12.013; De Leon J, 2007, ALCOHOL ALCOHOLISM, V42, P252, DOI 10.1093/alcalc/agm029; Deiss RG, 2016, ALCOHOL CLIN EXP RES, V40, P529, DOI 10.1111/acer.12975; Di Castelnuovo A, 2010, INTERN EMERG MED, V5, P291, DOI 10.1007/s11739-010-0346-0; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Eigenbrodt ML, 2006, J EPIDEMIOL COMMUN H, V60, P345, DOI 10.1136/jech.2005.039735; Foulds J, 2012, ACTA PSYCHIAT SCAND, V126, P434, DOI 10.1111/j.1600-0447.2012.01871.x; Freiberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P247, DOI 10.1097/QAI.0b013e3181c6c4b7; Fuchs FD, 2007, ALCOHOL, V41, P399, DOI 10.1016/j.alcohol.2007.05.004; Fuchs SC, 2008, CAD SAUDE PUBLICA, V24, pS285, DOI 10.1590/S0102-311X2008001400013; Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179; Ghosh S, 2012, J HEALTH POPUL NUTR, V30, P73; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grittner U, 2012, ALCOHOL ALCOHOLISM, V47, P597, DOI 10.1093/alcalc/ags040; Hahn Judith A, 2010, Curr HIV/AIDS Rep, V7, P226, DOI 10.1007/s11904-010-0060-6; Helakorpi S, 2010, ALCOHOL ALCOHOLISM, V45, P286, DOI 10.1093/alcalc/agq007; Huerta MC, 2010, SOC SCI MED, V71, P143, DOI 10.1016/j.socscimed.2010.03.022; Ikeda Maria Leticia R, 2013, ScientificWorldJournal, V2013, P169825, DOI 10.1155/2013/169825; Kahler CW, 2015, AIDS BEHAV, V19, P422, DOI 10.1007/s10461-014-0896-7; Keyes KM, 2008, ADDICTION, V103, P1120, DOI 10.1111/j.1360-0443.2008.02218.x; Kloner RA, 2007, CIRCULATION, V116, P1306, DOI 10.1161/CIRCULATIONAHA.106.678375; Laranjeira R, 2010, REV BRAS PSIQUIATR, V32, P231, DOI 10.1590/S1516-44462009005000012; Latvala A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-73; Li TK, 2008, J GASTROEN HEPATOL, V23, pS2, DOI 10.1111/j.1440-1746.2007.05298.x; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Moreira LB, 1996, J STUD ALCOHOL, V57, P253, DOI 10.15288/jsa.1996.57.253; Nguyen NPT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118185; O'Connor PG, 2001, J GEN INTERN MED, V16, P70; Pandrea I, 2010, ALCOHOL RES HEALTH, V33, P16; Peregoy J.A., 2012, SUMMARY HLTH STAT US; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Samet JH, 2004, AIDS RES HUM RETROV, V20, P151, DOI 10.1089/088922204773004860; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Steffens AA, 2006, J HYPERTENS, V24, P1489, DOI 10.1097/01.hjh.0000239282.27938.0f; Subramaniam M, 2012, ADDICTION, V107, P1443, DOI 10.1111/j.1360-0443.2012.03830.x; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Trevisol DJ, 2012, J HUM HYPERTENS, V26, P374, DOI 10.1038/jhh.2011.48; Vagenas P, 2015, CURR HIV-AIDS REP, V12, P421, DOI 10.1007/s11904-015-0285-5; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392	52	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158535	10.1371/journal.pone.0158535	http://dx.doi.org/10.1371/journal.pone.0158535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362541	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200086
J	Lundgren, GP; Wickstrom, A; Hasselblad, T; Dahllof, G				Lundgren, Gunilla Pousette; Wickstrom, Anette; Hasselblad, Tove; Dahllof, Goran			Amelogenesis Imperfecta and Early Restorative Crown Therapy: An Interview Study with Adolescents and Young Adults on Their Experiences	PLOS ONE			English	Article							QUALITY-OF-LIFE; ORAL-HEALTH; APPEARANCE; IMPACT; CHILD; DISABILITIES; PEOPLE	Patients with Amelogenesis imperfecta (AI) can present with rapid tooth loss or fractures of enamel as well as alterations in enamel thickness, color, and shape; factors that may compromise aesthetic appearance and masticatory function. The aim was to explore the experiences and perceptions of adolescents and young adults living with AI and receiving early prosthetic therapy. Seven patients with severe AI aged 16 to 23 years who underwent porcelain crown therapy participated in one-to-one individual interviews. The interviews followed a topic guide consisting of open-ended questions related to experiences of having AI. Transcripts from the interviews were analyzed using thematic analysis. The analysis process identified three main themes: Disturbances in daily life, Managing disturbances, and Normalization of daily life. These themes explain the experiences of patients living with enamel disturbances caused by AI and receiving early crown therapy. Experiences include severe pain and sensitivity problems, feelings of embarrassment, and dealing with dental staff that lack knowledge and understanding of their condition. The patients described ways to manage their disturbances and to reduce pain when eating or drinking, and strategies for meeting other people. After definitive treatment with porcelain crown therapy, they described feeling like a normal patient. In conclusion the results showed that adolescents and young adults describe a profound effect of AI on several aspects of their daily life.	[Lundgren, Gunilla Pousette; Hasselblad, Tove; Dahllof, Goran] Karolinska Inst, Dept Dent Med, Div Pediat Dent, Stockholm, Sweden; [Lundgren, Gunilla Pousette; Hasselblad, Tove; Dahllof, Goran] Ctr Pediat Oral Hlth Res, Stockholm, Sweden; [Lundgren, Gunilla Pousette] Publ Dent Hlth Serv, Dept Pediat Dent, Falun, Dalarna County, Sweden; [Wickstrom, Anette] Linkoping Univ, Dept Themat Studies, Child Studies, Linkoping, Sweden; [Lundgren, Gunilla Pousette] Karolinska Inst, Dept Dent Med, Div Pediat Dent, POB 4064, SE-14104 Huddinge, Sweden	Karolinska Institutet; Linkoping University; Karolinska Institutet	Lundgren, GP (corresponding author), Karolinska Inst, Dept Dent Med, Div Pediat Dent, Stockholm, Sweden.; Lundgren, GP (corresponding author), Ctr Pediat Oral Hlth Res, Stockholm, Sweden.; Lundgren, GP (corresponding author), Publ Dent Hlth Serv, Dept Pediat Dent, Falun, Dalarna County, Sweden.; Lundgren, GP (corresponding author), Karolinska Inst, Dept Dent Med, Div Pediat Dent, POB 4064, SE-14104 Huddinge, Sweden.	gunilla.pousette-lundgren@ki.se		Dahllof, Goran/0000-0001-8536-5292				Aldred M J, 1995, Oral Dis, V1, P2; BACKMAN B, 1986, COMMUNITY DENT ORAL, V14, P43, DOI 10.1111/j.1600-0528.1986.tb01493.x; Boyce C., 2006, MONITORING EVALUATIO; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Broder HL, 2014, AM J PUBLIC HEALTH, V104, P865, DOI 10.2105/AJPH.2013.301686; Brown JD, 2002, J ADOLESCENT HEALTH, V31, P153, DOI 10.1016/S1054-139X(02)00507-4; Chamlin SL, 2006, DERMATOL THER, V19, P104, DOI 10.1111/j.1529-8019.2006.00060.x; Chen CF, 2013, PEDIATR DENT, V35, P337; Coffield KD, 2005, J AM DENT ASSOC, V136, P620, DOI 10.14219/jada.archive.2005.0233; Crawford PJM, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-17; Griffiths C, 2012, J HEALTH PSYCHOL, V17, P1053, DOI 10.1177/1359105311433909; Hallberg U, 2004, ACTA ODONTOL SCAND, V62, P319, DOI 10.1080/00016350410001810; Hashem A, 2013, J DENT, V41, P689, DOI 10.1016/j.jdent.2013.06.004; Jasim H, 2014, J ORAL REHABIL, V41, P122, DOI 10.1111/joor.12118; Klingberg G, 2012, EUR J ORAL SCI, V120, P232, DOI 10.1111/j.1600-0722.2012.00961.x; Kvist T, 2014, EUR J ORAL SCI, V122, P332, DOI 10.1111/eos.12143; Lovegrove E, 2005, CLEFT PALATE-CRAN J, V42, P33, DOI 10.1597/03-097.5.1; Lundgren GP, 2015, J DENT RES, V94, P1041, DOI 10.1177/0022034515584385; Lundgren GP, 2014, J DENT, V42, P1382, DOI 10.1016/j.jdent.2014.07.017; Lundgren GP, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0393-3; Malik K, 2012, BRIT DENT J, V212, P537, DOI 10.1038/sj.bdj.2012.469; Marshman Z, 2007, INT J PAEDIATR DENT, V17, P320, DOI 10.1111/j.1365-263X.2007.00845.x; McDonald S, 2012, BRIT DENT J, V212, P425, DOI 10.1038/sj.bdj.2012.366; Parekh S, 2014, INT J PAEDIATR DENT, V24, P326, DOI 10.1111/ipd.12080; Rumsey N, 2004, J ADV NURS, V48, P443, DOI 10.1111/j.1365-2648.2004.03227.x; Seehra J, 2011, BRIT DENT J, V210, P411, DOI 10.1038/sj.bdj.2011.339; Sneller J, 2014, INT J PAEDIATR DENT, V24, P409, DOI 10.1111/ipd.12086; Trulsson U, 2003, EUR J ORAL SCI, V111, P19, DOI 10.1034/j.1600-0722.2003.00001.x; Wickstrom A., 2015, MED ANTHR Q; WITKOP CJ, 1988, J ORAL PATHOL MED, V17, P547, DOI 10.1111/j.1600-0714.1988.tb01332.x; Yang SE, 2015, J ORAL REHABIL	31	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0156879	10.1371/journal.pone.0156879	http://dx.doi.org/10.1371/journal.pone.0156879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27359125	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200003
J	de Jong, M; Ouyang, JQ; van Grunsven, RHA; Visser, ME; Spoelstra, K				de Jong, Maaike; Ouyang, Jenny Q.; van Grunsven, Roy H. A.; Visser, Marcel E.; Spoelstra, Kamiel			Do Wild Great Tits Avoid Exposure to Light at Night?	PLOS ONE			English	Article								Studies of wild populations have provided important insights into the effects of artificial light at night on organisms, populations and ecosystems. However, in most studies the exact amount of light at night individuals are exposed to remains unknown. Individuals can potentially control their nighttime light exposure by seeking dark spots within illuminated areas. This uncertainty makes it difficult to attribute effects to a direct effect of light at night, or to indirect effects, e.g., via an effect of light at night on food availability. In this study, we aim to quantify the nocturnal light exposure of wild birds in a previously dark forest-edge habitat, experimentally illuminated with three different colors of street lighting, in comparison to a dark control. During two consecutive breeding seasons, we deployed male great tits (Parus major) with a light logger measuring light intensity every five minutes over a 24h period. We found that three males from pairs breeding in brightly illuminated nest boxes close to green and red lamp posts, were not exposed to more artificial light at night than males from pairs breeding further away. This suggests, based on our limited sample size, that these males could have been avoiding light at night by choosing a roosting place with a reduced light intensity. Therefore, effects of light at night previously reported for this species in our experimental set-up might be indirect. In contrast to urban areas where light is omnipresent, bird species in non-urban areas may evade exposure to nocturnal artificial light, thereby avoiding direct consequences of light at night.	[de Jong, Maaike; Ouyang, Jenny Q.; Visser, Marcel E.; Spoelstra, Kamiel] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Ouyang, Jenny Q.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [van Grunsven, Roy H. A.] Wageningen Univ, Plant Ecol & Nat Conservat Grp, Wageningen, Netherlands; [van Grunsven, Roy H. A.] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Nevada System of Higher Education (NSHE); University of Nevada Reno; Wageningen University & Research; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	de Jong, M (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	m.dejong@nioo.knaw.nl	Visser, Marcel E/A-9151-2009; Spoelstra, Kamiel/B-4222-2015; KNAW, NIOO-KNAW/A-4320-2012; van Grunsven, Roy/G-7029-2011	Visser, Marcel E/0000-0002-1456-1939; Spoelstra, Kamiel/0000-0001-8614-4387; KNAW, NIOO-KNAW/0000-0002-3835-159X; van Grunsven, Roy/0000-0001-8873-1024	Dutch Technology Foundation STW; Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs; Philips; Nederlandse Aardolie Maatschappij (NAM); NSF postdoctoral research fellowship in biology [DBI-1306025]	Dutch Technology Foundation STW(Technologiestichting STW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs; Philips; Nederlandse Aardolie Maatschappij (NAM); NSF postdoctoral research fellowship in biology(National Science Foundation (NSF))	This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs. The project is supported by Philips and the Nederlandse Aardolie Maatschappij (NAM). JQO was supported by an NSF postdoctoral research fellowship in biology (DBI-1306025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Natuurmonumenten for allowing us to perform our experiment on effects of artificial lighting on their terrain. We thank Raymond Klaassen for instructions on deployment of loggers, Koosje Lamers, Helen Schepp, Sofia Scheltinga, Annemieke Kolvoort and Ilse Scholten for participating in the fieldwork and Peter Grey (Sigma Delta Technologies) for technological assistance. This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. The project is supported by Philips and the Nederlandse Aardolie Maatschappij (NAM). J.Q.O. was supported by an NSF postdoctoral research fellowship in biology (DBI-1306025).	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Bennie J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0131; Calvo B., 1992, Ringing and Migration, V13, P129; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; de Jong M, 2016, PHYSIOL BEHAV, V155, P172, DOI 10.1016/j.physbeh.2015.12.012; de Jong M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0128; Dominoni D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3017; Dominoni DM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0118; Dominoni DM, 2014, J ANIM ECOL, V83, P681, DOI 10.1111/1365-2656.12150; Dominoni DM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-60; Holker F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0130; Murray DL, 2000, METH C CONS, P15; Ouyang JQ, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0517; Raap T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13557; Rich C., 2006, ECOLOGICAL CONSEQUEN; Robert KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1745; Spoelstra K, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0129; Wakefield A, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150291	19	21	21	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157357	10.1371/journal.pone.0157357	http://dx.doi.org/10.1371/journal.pone.0157357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355354	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400013
J	Tokutake, T; Baba, H; Shimada, Y; Takeda, W; Sato, K; Hiroshima, Y; Kirihara, T; Shimizu, I; Nakazawa, H; Kobayashi, H; Ishida, F				Tokutake, Takayoshi; Baba, Hisami; Shimada, Yuji; Takeda, Wataru; Sato, Keijiro; Hiroshima, Yuki; Kirihara, Takehiko; Shimizu, Ikuo; Nakazawa, Hideyuki; Kobayashi, Hikaru; Ishida, Fumihiro			Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients	PLOS ONE			English	Article							FACTOR-IX; REAGENTS; BINDING; PROTEIN; CALCIUM; IONS	The activated partial thromboplastin time (APTT) assay is a basic hemostatic assay based on the time it takes for clots to form in plasma samples after the addition of calcium chloride. It is used to screen for various coagulation disorders. Several previous reports have suggested that magnesium (Mg) might contribute to coagulation reactions by binding to specific coagulation proteins. We investigated the effects of Mg on the APTT. In healthy controls, the APTT was significantly prolonged in proportion to the increase in the concentration of magnesium chloride in the range from 2.1 to 16.7 mmol/L. Among eight samples from patients with various disorders that exhibited prolonged APTT, two samples demonstrated shorter APTT when Mg was added, both of which were from patients that were positive for lupus anticoagulant. When we examined 206 clinical APTT samples, we found that Mg shortened the APTT of two samples. These two samples were also from lupus anticoagulant-positive patients (p-value: < 0.003). Our findings regarding the unique effects of exogenous Mg on the APTT of lupus anticoagulant-positive patients might shed light on the role of Mg in APTT assays and lead to the development of a novel screening method for lupus anticoagulant.	[Tokutake, Takayoshi; Baba, Hisami; Shimada, Yuji; Kobayashi, Hikaru] Nagano Red Cross Hosp, Dept Clin Lab, Nagano, Japan; [Takeda, Wataru; Sato, Keijiro; Hiroshima, Yuki; Kirihara, Takehiko; Shimizu, Ikuo; Kobayashi, Hikaru] Nagano Red Cross Hosp, Dept Hematol, Nagano, Japan; [Shimizu, Ikuo] Shinshu Univ, Sch Med, Ctr Med Educ, Matsumoto, Nagano, Japan; [Nakazawa, Hideyuki; Ishida, Fumihiro] Shinshu Univ, Sch Med, Dept Hematol, Matsumoto, Nagano, Japan; [Ishida, Fumihiro] Shinshu Univ, Sch Med, Sch Hlth Sci, Dept Biomed Lab Sci, Matsumoto, Nagano, Japan	Nagano Red Cross Hospital; Nagano Red Cross Hospital; Shinshu University; Shinshu University; Shinshu University	Ishida, F (corresponding author), Shinshu Univ, Sch Med, Dept Hematol, Matsumoto, Nagano, Japan.; Ishida, F (corresponding author), Shinshu Univ, Sch Med, Sch Hlth Sci, Dept Biomed Lab Sci, Matsumoto, Nagano, Japan.	fumishi@shinshu-u.ac.jp	Nakazawa, Hideyuki/Z-1259-2019	Nakazawa, Hideyuki/0000-0002-6457-5052; Shimizu, Ikuo/0000-0002-6731-7104				Agah S, 2009, J THROMB HAEMOST, V7, P1426, DOI 10.1111/j.1538-7836.2009.03506.x; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; DENISMAGDELAINE A, 1995, HAEMOSTASIS, V25, P98; Kottke-Marchant K, 2012, LAB HEMATOLOGY PRACT, P420; Krilis SA, 2014, HEMATOL-AM SOC HEMAT, P321, DOI 10.1182/asheducation-2014.1.321; Pengo V, 2009, J THROMB HAEMOST, V7, P1737, DOI 10.1111/j.1538-7836.2009.03555.x; Sekiya F, 1996, J BIOL CHEM, V271, P8541, DOI 10.1074/jbc.271.15.8541; Shikamoto Y, 2003, J BIOL CHEM, V278, P24090, DOI 10.1074/jbc.M300650200; Vadivel K, 2013, J MOL BIOL, V425, P1961, DOI 10.1016/j.jmb.2013.02.017; van den Besselaar AMHP, 2002, BLOOD COAGUL FIBRIN, V13, P19, DOI 10.1097/00001721-200201000-00003; van den Besselaar AMHP, 2003, THROMB HAEMOSTASIS, V89, P43	11	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157835	10.1371/journal.pone.0157835	http://dx.doi.org/10.1371/journal.pone.0157835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355205	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400020
J	Pavlova, MA; Mayer, A; Hosl, F; Sokolov, AN				Pavlova, Marina A.; Mayer, Annika; Hosl, Franziska; Sokolov, Alexander N.			Faces on Her and His Mind: Female and Likable	PLOS ONE			English	Article							SEX-DIFFERENCES; AESTHETIC APPRECIATION; BRAIN ACTIVITY; GENDER; RECOGNITION; EMOTION; MEN; METAANALYSIS; PERCEPTION; BIAS	Faces are a valuable source of non-verbal information for daily life social interaction. Mounting evidence points to gender specificity in face perception. Here we search for the factors that can potentially trigger gender differences in tuning to faces. By using a set of Face-n-Food images slightly bordering on the Giuseppe Arcimboldo style, we examine: (i) whether face resemblance is linked to gender specific face impression, and, if so, whether this association is perceiver gender specific; and (ii) whether images most resembling a face are also most likable for female and male perceivers. First, in a spontaneous recognition task, participants were shown a set of Face-n-Food images in a predetermined order from the least to most resembling a face. Then in a two-alternative forced-choice (2AFC) task, participants judged whether each face appeared for them (i) either female or male (Exp. 1); or (ii) either likable or unlikable (Exp. 2). Remarkably, face resemblance is closely connected to gender specific impressions: images more resembling a face elicit also more female-face responses. This link is not perceiver gender specific as it occurs for both females and males. Moreover, face resemblance is positively linked to face likability, but this holds true only for female perceivers. The findings shed light on gender specificity in tuning to faces, and help to clarify abnormalities of the social brain in neurodevelopmental, psychiatric and psychosomatic disorders.	[Pavlova, Marina A.; Mayer, Annika; Hosl, Franziska] Univ Tubingen, Sch Med, Dept Biomed Magnet Resonance, Tubingen, Germany; [Sokolov, Alexander N.] Univ Tubingen, Univ Hosp, Womens Hlth Res Inst, Dept Womens Hlth, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Pavlova, MA (corresponding author), Univ Tubingen, Sch Med, Dept Biomed Magnet Resonance, Tubingen, Germany.	marina.pavlova@uni-tuebingen.de		Pavlova, Marina/0000-0001-8239-3589	Else Kroner-Fresenius Foundation [P2013_127]; Deutsche Forschungsgemeinschaft (DFG); Eberhard Karls University of Tubingen	Else Kroner-Fresenius Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Eberhard Karls University of Tubingen	This work was supported by the Else Kroner-Fresenius Foundation (Grant P2013_127 to MAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the students of the University of Tubingen for participation and assistance with testing. The authors acknowledge support toward open access publishing by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publishing Fund of Eberhard Karls University of Tubingen.	Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Armann R, 2012, VISION RES, V63, P69, DOI 10.1016/j.visres.2012.05.005; Arrais KC, 2010, J PSYCHIATR RES, V44, P535, DOI 10.1016/j.jpsychires.2009.11.003; Barraclough NE, 2011, PHILOS T R SOC B, V366, P1739, DOI 10.1098/rstb.2010.0352; Batres C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100966; Boccia M, 2015, BEHAV BRAIN RES, V278, P147, DOI 10.1016/j.bbr.2014.09.041; Boccia M, 2014, ATTEN PERCEPT PSYCHO, V76, P1516, DOI 10.3758/s13414-014-0739-7; Briceno EM, 2015, AM J GERIAT PSYCHIAT, V23, P304, DOI 10.1016/j.jagp.2014.05.007; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; BRUCE AJ, 1993, J GEN PSYCHOL, V120, P451, DOI 10.1080/00221309.1993.9711159; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; Buchala S, 2005, PROC IEEE ICMI, V7; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P4057, DOI 10.1016/j.neuropsychologia.2010.09.017; Bzdok D, 2011, BRAIN STRUCT FUNCT, V215, P209, DOI 10.1007/s00429-010-0287-4; Caharel S, 2013, INT J PSYCHOPHYSIOL, V90, P157, DOI 10.1016/j.ijpsycho.2013.06.024; CHRONICLE EP, 1995, PERCEPTION, V24, P969, DOI 10.1068/p240969; Dalrymple KA, 2007, NEUROPSYCHOLOGIA, V45, P871, DOI 10.1016/j.neuropsychologia.2006.07.013; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Fazzi E, 2009, DEV MED CHILD NEUROL, V51, P974, DOI 10.1111/j.1469-8749.2009.03272.x; Feuerriegel D, 2015, CLIN NEUROPHYSIOL, V126, P1141, DOI 10.1016/j.clinph.2014.09.015; Gilboa-Schechtman E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00904; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; Hahn AC, 2014, NEUROSCI BIOBEHAV R, V46, P591, DOI 10.1016/j.neubiorev.2014.08.015; Herlitz A, 2013, VIS COGN, V21, P1306, DOI 10.1080/13506285.2013.823140; Ino T, 2010, BRAIN IMAGING BEHAV, V4, P55, DOI 10.1007/s11682-009-9085-0; Jaensch M, 2014, J EXP PSYCHOL HUMAN, V40, P2101, DOI 10.1037/a0038078; Jakesch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074084; Jakesch M, 2009, Q J EXP PSYCHOL, V62, P2105, DOI 10.1080/17470210903038974; Jones Lynne, 2008, Eat Behav, V9, P389, DOI 10.1016/j.eatbeh.2008.03.001; Kaul C, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00238; Kobayashi M, 2012, J EXP CHILD PSYCHOL, V111, P22, DOI 10.1016/j.jecp.2011.07.008; Koelkebeck K, 2015, PSYCHIAT RES, V228, P39, DOI 10.1016/j.psychres.2015.04.005; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kret ME, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00711; Kret ME, 2015, NEUROSCI BIOBEHAV R, V52, P153, DOI 10.1016/j.neubiorev.2015.02.011; Kret ME, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00003; Kruger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081716; Lazar SM, 2014, BEHAV BRAIN RES, V263, P1, DOI 10.1016/j.bbr.2014.01.010; Legenbauer T, 2008, J CLIN PSYCHOL, V64, P687, DOI 10.1002/jclp.20483; Lewin C, 2002, BRAIN COGNITION, V50, P121, DOI 10.1016/S0278-2626(02)00016-7; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Loven J, 2014, SOC COGN AFFECT NEUR, V9, P1000, DOI 10.1093/scan/nst073; Loven J, 2011, EXP PSYCHOL, V58, P333, DOI 10.1027/1618-3169/a000100; Marzi T, 2010, BIOL PSYCHOL, V84, P192, DOI 10.1016/j.biopsycho.2010.01.013; McBain R, 2009, ACTA PSYCHOL, V130, P168, DOI 10.1016/j.actpsy.2008.12.005; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Mende-Siedlecki P, 2013, SOC COGN AFFECT NEUR, V8, P285, DOI 10.1093/scan/nsr090; Milne Elizabeth, 2009, Adv Cogn Psychol, V5, P1, DOI 10.2478/v10053-008-0062-8; Okazaki Y, 2010, BRAIN TOPOGR, V23, P14, DOI 10.1007/s10548-009-0112-7; Pavlova MA, 2015, CEREB CORTEX, V25, P3468, DOI 10.1093/cercor/bhu175; Pavlova MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130363; Pavlova MA, 2013, BRAIN, V136, P998, DOI 10.1093/brain/aws334; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pelphrey KA, 2014, CURR TOP BEHAV NEURO, V16, P215, DOI 10.1007/7854_2013_253; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pollatos O, 2008, PSYCHOSOM MED, V70, P701, DOI 10.1097/PSY.0b013e31817e41e6; Proverbio AM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00169; Rehnman J, 2007, ACTA PSYCHOL, V124, P344, DOI 10.1016/j.actpsy.2006.04.004; Rhodes G, 2013, NEUROPSYCHOLOGIA, V51, P2702, DOI 10.1016/j.neuropsychologia.2013.08.016; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; Sokolov AA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00016; Sommer W, 2013, ACTA PSYCHOL, V142, P62, DOI 10.1016/j.actpsy.2012.11.001; Stephen ID, 2012, EVOL PSYCHOL-US, V10, P562; van Hooff JC, 2011, SOC COGN AFFECT NEUR, V6, P477, DOI 10.1093/scan/nsq066; Wincenciak J, 2013, VISION RES, V87, P30, DOI 10.1016/j.visres.2013.05.007; Witkin HA, 1981, PSYCHOL ISSUES MONOG, V51	70	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157636	10.1371/journal.pone.0157636	http://dx.doi.org/10.1371/journal.pone.0157636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352016	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900011
J	Costa, JB; Dufeu-Duchesne, T; Leroy, V; Bertucci, I; Bouvier-Alias, M; Pouget, N; Brevot-Lutton, O; Bourliere, M; Zoulim, F; Plumas, J; Aspord, C				Costa, Juliana Bruder; Dufeu-Duchesne, Tania; Leroy, Vincent; Bertucci, Inga; Bouvier-Alias, Magali; Pouget, Noelle; Brevot-Lutton, Ophelie; Bourliere, Marc; Zoulim, Fabien; Plumas, Joel; Aspord, Caroline		ANRS HB06 PEGAN Study Grp	Pegylated Interferon alpha-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATITIS-B-VIRUS; PLASMACYTOID DENDRITIC CELLS; PEGINTERFERON ALPHA-2A; PERIPHERAL-BLOOD; I INTERFERONS; COMBINATION; THERAPY; LAMIVUDINE; RIBAVIRIN	Pegylated interferon alpha-2a (Peg-IFN-alpha) represents a therapeutic alternative to the prolonged use of nucleos(t)ide analog (NA) in chronic hepatitis B (CHB) infection. The mechanisms leading to a positive clinical outcome remain unclear. As immune responses are critical for virus control, we investigated the effects of Peg-IFN-alpha on both innate and adaptive immunity, and related it to the clinical evolution. The phenotypic and functional features of the dendritic cells (DCs), natural killer (NK) cells and HBV-specific CD4/CD8 T cells were analyzed in HBeAg-negative CHB patients treated for 48-weeks with NA alone or together with Peg-IFN-alpha, before, during and up to 2-years after therapy. Peg-IFN-alpha induced an early activation of DCs, a potent expansion of the CD56(bright) NK subset, and enhanced the activation and functionality of the CD56(dim) NK subset. Peg-IFN-alpha triggered an increase in the frequencies of Th1- and Th17-oriented HBV-specific CD4/CD8 T cells. Peg-IFN-alpha reversed the unresponsiveness of patients to a specific stimulation. Most of the parameters returned to baseline after the stop of Peg-IFN-alpha therapy. Peg-IFN-alpha impacts both innate and adaptive immunity, overcoming dysfunctional immune responses in CHB patients. These modulations were not associated with seroconversion, which questioned the benefit of the add-on Peg-IFN-alpha treatment.	[Costa, Juliana Bruder; Dufeu-Duchesne, Tania; Leroy, Vincent; Plumas, Joel; Aspord, Caroline] Univ Grenoble Alpes, F-38041 Grenoble, France; [Costa, Juliana Bruder; Plumas, Joel; Aspord, Caroline] INSERM, U1209, Immunobiol & Immunotherapy Chron Deseases, F-38706 La Tronche, France; [Costa, Juliana Bruder; Dufeu-Duchesne, Tania; Leroy, Vincent] CHU Grenoble, Michallon Hosp, Hepatogastroenterol Unit, F-38043 Grenoble, France; [Dufeu-Duchesne, Tania; Leroy, Vincent] INSERM, U1209, Analyt Immunol Chron Pathol, F-38706 La Tronche, France; [Bertucci, Inga] ANRS France REch Nord & Sud Sida Hiv Hepatites FR, Paris, France; [Bouvier-Alias, Magali] Univ Paris Est, Henri Mondor Hosp, Dept Virol, Creteil, France; [Bouvier-Alias, Magali] INSERM, U955, Creteil, France; [Pouget, Noelle; Brevot-Lutton, Ophelie] Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,UMRS 113, F-75012 Paris, France; [Bourliere, Marc] St Joseph Hosp, Hepatogastroenterol Dept, F-13008 Marseille, France; [Zoulim, Fabien] Canc Res Ctr Lyon, INSERM U1052, CNRS 5286, Lyon, France; [Zoulim, Fabien] Hosp Civils Lyon, Hepatol Dept, Lyon, France; [Zoulim, Fabien] Univ Lyon, Lyon, France; [Plumas, Joel; Aspord, Caroline] EFS Rhone Alpes, R&D Lab, F-38701 La Tronche, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; CHU Lyon	Plumas, J; Aspord, C (corresponding author), Univ Grenoble Alpes, F-38041 Grenoble, France.; Plumas, J; Aspord, C (corresponding author), INSERM, U1209, Immunobiol & Immunotherapy Chron Deseases, F-38706 La Tronche, France.; Plumas, J; Aspord, C (corresponding author), EFS Rhone Alpes, R&D Lab, F-38701 La Tronche, France.	joel.plumas@efs.sante.fr; carolineaspord@yahoo.com	Bouvier-Alias, Magali/S-5631-2018; Zoulim, Fabien/ABD-5594-2021; ASPORD, Caroline/AAU-1805-2020; ASPORD, CAROLINE/N-3179-2013	Bouvier-Alias, Magali/0000-0003-1590-5980; Zoulim, Fabien/0000-0002-2245-0083; Ganne-Carrie, Nathalie/0000-0002-7351-5027; rosa, isabelle/0000-0001-6879-3148; Cales, Paul/0000-0003-4866-5274; ASPORD, CAROLINE/0000-0002-4979-7044; Ratziu, Vlad/0000-0002-6865-3791	French Blood Service (EFS); ANRS (France REcherche Nord AMP; sud Sida-hiv Hepatites)	French Blood Service (EFS); ANRS (France REcherche Nord AMP; sud Sida-hiv Hepatites)	This work was supported by the French Blood Service (EFS) and the study was sponsored and funded by ANRS (France REcherche Nord & sud Sida-hiv Hepatites).	Boltjes A, 2013, MOL IMMUNOL, V53, P72, DOI 10.1016/j.molimm.2012.06.016; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Lampertico P, 2013, GUT, V62, P290, DOI 10.1136/gutjnl-2011-301430; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liang XS, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-43; Liu YZ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-274; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Martinet J, 2012, GASTROENTEROLOGY, V143, P1586, DOI 10.1053/j.gastro.2012.08.046; Martinet J, 2012, HEPATOLOGY, V56, P1706, DOI 10.1002/hep.25879; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Mondelli MU, 2010, EUR J CLIN INVEST, V40, P851, DOI 10.1111/j.1365-2362.2010.02332.x; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Penna A, 2012, J HEPATOL, V56, P1239, DOI 10.1016/j.jhep.2011.12.032; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Rehermann B, 1996, J CLIN INVEST, V97, P1655, DOI 10.1172/JCI118592; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rijckborst V, 2010, AM J GASTROENTEROL, V105, P1762, DOI 10.1038/ajg.2010.186; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Schepis D, 2009, IMMUNOLOGY, V126, P140, DOI 10.1111/j.1365-2567.2008.02887.x; Schiavoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00483; Sprinzl MF, 2014, J VIRAL HEPATITIS, V21, P633, DOI 10.1111/jvh.12189; Stelma F, 2015, J INFECT DIS, V212, P1042, DOI 10.1093/infdis/jiv180; Swiecki M, 2011, CURR OPIN VIROL, V1, P463, DOI 10.1016/j.coviro.2011.10.026; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Tan AT, 2014, J HEPATOL, V60, P54, DOI 10.1016/j.jhep.2013.08.020; Thimme R, 2013, J HEPATOL, V58, P205, DOI 10.1016/j.jhep.2012.11.007; Tujios SR, 2013, CURR OPIN GASTROEN, V29, P250, DOI 10.1097/MOG.0b013e32835ff1e9; Woltman AM, 2010, GUT, V59, P115, DOI 10.1136/gut.2009.181040; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273	38	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158297	10.1371/journal.pone.0158297	http://dx.doi.org/10.1371/journal.pone.0158297			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348813	Green Published, Green Submitted, gold			2022-12-27	WOS:000378801200060
J	Cucchi, T; Dai, LL; Balasse, M; Zhao, CQ; Gao, JT; Hu, YW; Yuan, J; Vigne, JD				Cucchi, Thomas; Dai, Lingling; Balasse, Marie; Zhao, Chunqing; Gao, Jiangtao; Hu, Yaowu; Yuan, Jing; Vigne, Jean-Denis			Social Complexification and Pig (Sus scrofa) Husbandry in Ancient China: A Combined Geometric Morphometric and Isotopic Approach	PLOS ONE			English	Article							COMPLEX SOCIETIES; BONE-COLLAGEN; GENE FLOW; DOMESTICATION; CARBON; LONG; TRANSITION; EVOLUTION; RESPONSES; NITROGEN	Pigs have played a major role in the economic, social and symbolic systems of China since the Early Neolithic more than 8,000 years ago. However, the interaction between the history of pig domestication and transformations in Chinese society since then, have not been fully explored. In this paper, we investigated the co-evolution from the earliest farming communities through to the new political and economic models of state-like societies, up to the Chinese Empire, using 5,000 years of archaeological records from the Xiawanggang (XWG) and Xinzhai (XZ) sites (Henan Province). To trace the changes of pig populations against husbandry practices, we combined the geometric morphometric analysis of dental traits with a study of the stable carbon and nitrogen isotope ratios from bone collagen. The domestication process intensified during the Neolithic Yangshao, prompted by greater selective pressure and/or better herd control against wild introgression. After that, pig farming, in XWG, relied on local livestock and a gradual change of husbandry practices overtime. This was characterized by a gentle increase in millet foddering and animal protein intake, until a complete change over to household management during the Han dynasty. The only rupture in this steady trend of husbandry occurred during the Longshan period, with the appearance of small sized and idiosyncratic pigs with specific feeding practices (relying on millet and household scraps). From three exploratory hypothesis, we explored the possibility of anti-elite pig production in XWG during the Longshan period, as a means to resist incorporation into a new economic model promoting intensified domestic production. This exploratory hypothesis is the most suitable to our dataset; however, numerous areas need to be explored further in order to adequately document the role of pigs in the rise of China's complex societies.	[Cucchi, Thomas; Balasse, Marie; Vigne, Jean-Denis] Univ Paris 04, CNRS, Museum Natl Hist Nat, UMR Archeozool Archeobot Soc Prat & Environm 7209, Paris, France; [Cucchi, Thomas] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Dai, Lingling; Hu, Yaowu] Anhui Univ, Hist Fac, Hefei, Peoples R China; [Dai, Lingling] Chinese Acad Sci, Inst Vertebrate Palaeontol & Palaeoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Zhao, Chunqing; Gao, Jiangtao; Yuan, Jing] Chinese Acad Sci, Inst Archaeol, Beijing, Peoples R China	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Aberdeen; Anhui University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences	Cucchi, T (corresponding author), Univ Paris 04, CNRS, Museum Natl Hist Nat, UMR Archeozool Archeobot Soc Prat & Environm 7209, Paris, France.; Cucchi, T (corresponding author), Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland.	cucchi@mnhn.fr	Cucchi, Thomas/Q-4014-2018	Cucchi, Thomas/0000-0001-6021-5001; Balasse, Marie/0000-0003-1925-5110	CNRS-CASS program; ERAnet Co- Reach project (European-Chinese Bioarchaeological Collaboration, Euch-Bioarch) [137]	CNRS-CASS program; ERAnet Co- Reach project (European-Chinese Bioarchaeological Collaboration, Euch-Bioarch)	This work was supported by the CNRS-CASS program for the training of Chinese PhD students.; We are most grateful to Curator Kang Le, Institute of Zoology, CAS; Curator Zhou Zhonghe, Institute of vertebrate paleontology and paleoanthropology, CAS for allowing us access to modern sample samples of domestic pigs and wild boars. The ERAnet (https://ec.europa.eu) Co- Reach project no137 (European-Chinese Bioarchaeological Collaboration, Euch-Bioarch).	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; An CB, 2015, J ARCHAEOL SCI, V53, P316, DOI 10.1016/j.jas.2014.11.001; [Anonymous], 2007, ARCHAEOLOGY; Arbuckle BS, 2012, J ANTHROPOL ARCHAEOL, V31, P302, DOI 10.1016/j.jaa.2012.01.008; Balasse M, 2017, QUATERN INT, V436, P29, DOI 10.1016/j.quaint.2015.07.030; Balasse M, 2016, J ANTHROPOL ARCHAEOL, V42, P27, DOI 10.1016/j.jaa.2016.02.002; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Baylac M., 2007, RMORPH R GEOMETRIC M; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Bookstein F L, 1997, Med Image Anal, V1, P225; Chang K. -C, 1986, ARCHAEOLOGY ANCIENT; Chen XL, 2016, INT J OSTEOARCHAEOL, V26, P42, DOI 10.1002/oa.2393; Childe V. G., 1929, DANUBE PREHISTORY; Colominas L, 2014, ARCHAEOL ANTHROP SCI, V6, P1, DOI 10.1007/s12520-013-0116-9; Cucchi T, 2011, J ARCHAEOL SCI, V38, P11, DOI 10.1016/j.jas.2010.07.024; Dai L, 2015, INT J OSTEOARCHAEOL, DOI 10.1002/oa.2503; deFrance SD, 2009, J ARCHAEOL RES, V17, P105, DOI 10.1007/s10814-008-9027-1; Deng ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139885; DIENER P, 1978, CURR ANTHROPOL, V19, P493, DOI 10.1086/202138; Duval C, 2015, J ARCHAEOL SCI, V57, P345, DOI 10.1016/j.jas.2015.03.004; Everitt B.S., 2001, APPL MULTUVARIATE DA, P248; Evin A, 2015, PHILOS T R SOC B, V370, P138, DOI [10.1098/rstb.2015.0018, 10.1098/rstb.2013.0616]; Evin A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-014-0269-x; Evin A, 2014, J ARCHAEOL SCI, V43, P1, DOI 10.1016/j.jas.2013.11.033; Evin A, 2013, J ARCHAEOL SCI, V40, P735, DOI 10.1016/j.jas.2012.08.005; FALCONER SE, 1995, J FIELD ARCHAEOL, V22, P399, DOI 10.1179/009346995791974107; Fogel ML, 1989, CARNEGIE I WASHINGTO, P88; Fowler C.W., 1987, Current Mammalogy, V1, P401; Fraley C, 2012, 597 U WASH; Frantz LAF, 2015, NAT GENET, V47, P1141, DOI 10.1038/ng.3394; FREYER HD, 1983, J GEOPHYS RES-OCEANS, V88, P6844, DOI 10.1029/JC088iC11p06844; Fu QM, 2010, CHINESE SCI BULL, V55, P614, DOI 10.1007/s11434-009-0621-5; Grant A., 1976, EXCAVATIONS PORTCHES, P437; Grigson C., 1982, BRIT ARCHAEOLOGICAL; Groves C., 2007, PIGS HUMANS 10000 YE, P15; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Guo Y, 2015, INT J OSTEOARCHAEOL, DOI 10.1002/oa.2465; Haselgrove C, 2007, LATE IRON AGE BRITAI, P393; Hirth Kenneth G., 1996, J ARCHAEOL RES, V4, P203, DOI DOI 10.1007/BF02228881; Hu YW, 2006, J ARCHAEOL SCI, V33, P1319, DOI 10.1016/j.jas.2006.01.007; Jing Y, 2002, ANTIQUITY, V76, P724, DOI 10.1017/S0003598X00091171; KIM SO, 1994, CURR ANTHROPOL, V35, P119, DOI 10.1086/204251; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Larson G, 2011, GENETICS OF THE PIG, 2ND EDITION, P14, DOI 10.1079/9781845937560.0014; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Liu FG, 2012, HOLOCENE, V22, P1181, DOI 10.1177/0959683612441839; Liu L., 2005, CHINESE NEOLITHIC TR; Liu L, 2009, ANNU REV ANTHROPOL, V38, P217, DOI 10.1146/annurev-anthro-091908-164513; Liu Li, 2004, CHINESE NEOLITHIC TR; Locker A., 2000, ENVIRON ARCHAEOL, V5, P35, DOI DOI 10.1179/ENV.2000.5.1.35; Luo Y, 2008, JIANGHAN ARCHAEOLOGY, V1; Luo Y., 2012, DOMESTICATION RAISIN; Ma X, 2006, BRIT ARCHAEOLOGICAL; MacKinnon M, 2010, WORLD ARCHAEOL, V42, P55, DOI 10.1080/00438240903429730; Matsui Akira, 2005, P148; Mattioli S, 2014, J MOUNTAIN ECOLOGY, V3; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Nemeth D., 1998, ANCESTORS PIGS PIGS; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Payne S., 1988, ARCHAEOZOOLOGIA, V2, P27; Pechenkina EA, 2005, J ARCHAEOL SCI, V32, P1176, DOI 10.1016/j.jas.2005.02.015; Peterson CE, 2012, J ANTHROPOL ARCHAEOL, V31, P265, DOI 10.1016/j.jaa.2012.01.007; Price E. O., 2002, Animal domestication and behavior, DOI 10.1079/9780851995977.0000; Redding RW, 2015, J ARCHAEOL RES, V23, P325, DOI 10.1007/s10814-015-9083-2; Ripley B. D., 1996, PATTERN RECOGNITION; Rohlf F., 2010, TPSDIG 2 THIN PLATE; Rohlf FJ, 2005, TPSRELW 1 41 THIN PL; Rowley-Conwy P., 1993, HUNTING ANIMAL EXPLO, P179; Schneider M, 2014, CHINAS PORK MIRACLE, P34; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Shelach G, 2000, J WORLD PREHIST, V14, P363, DOI 10.1023/A:1011124209079; Shelach G, 2014, J ARCHAEOL RES, V22, P327, DOI 10.1007/s10814-014-9074-8; TONGE CH, 1965, BRIT J NUTR, V19, P361, DOI 10.1079/BJN19650034; Underhill AP, 2008, J ANTHROPOL ARCHAEOL, V27, P1, DOI 10.1016/j.jaa.2006.11.002; Vigne JD, 2015, ANTHROPOZOOLOGICA, V50, P123, DOI 10.5252/az2015n2a5; Wang X, 2003, AGR HIST CHINA, V3, P4; Weisskopf A, 2015, ARCHAEOL RES ASIA, V4, P36, DOI 10.1016/j.ara.2015.10.002; Wu X, 2007, KEJI KAOGU, V2, P42; Xu SZ., 2004, CULTURAL RELICS CENT, V4, P46; Yuan J., 2006, ORIGIN ANCIENT SUS D; Zeng Z., 2013, YANGTZE RIVER CIVILI, V1; Zhao CQ., 2004, CULTURAL RELICS CENT, V3, P12	83	32	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158523	10.1371/journal.pone.0158523	http://dx.doi.org/10.1371/journal.pone.0158523			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27384523	Green Submitted, gold, Green Published			2022-12-27	WOS:000379809400056
J	Huang, YH; Yang, HY; Huang, SW; Ou, G; Hsu, YF; Hsu, MJ				Huang, Yu-Han; Yang, Hung-Yu; Huang, Shiu-Wen; Ou, George; Hsu, Ya-Fen; Hsu, Ming-Jen			Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR LYMPHANGIOGENESIS; VEGF-C; METASTASIS; ANGIOGENESIS; PHOSPHORYLATION; PROGRESSION; INHIBITION; CARCINOMA; PATHWAY	Elevated serum interleukin-6 (IL-6) levels correlates with tumor grade and poor prognosis in cancer patients. IL-6 has been shown to promote tumor lymphangiogenesis through vascular endothelial growth factor-C (VEGF-C) induction in tumor cells. We recently showed that IL-6 also induced VEGF-C expression in lymphatic endothelial cells (LECs). However, the signaling mechanisms involved in IL-6-induces VEGF-C induction in LECs remain incompletely understood. In this study, we explored the causal role of focal adhesion kinase (FAK) in inducing VEGF-C expression in IL-6-stimulated murine LECs (SV-LECs). FAK signaling blockade by NSC 667249 (a FAK inhibitor) attenuated IL-6-induced VEGF-C expression and VEGF-C promoter-luciferase activities. IL-6's enhancing effects of increasing FAK, ERK1/2, p38MAPK, C/EBP beta, p65 and STAT3 phosphorylation as well as C/EBP beta-, kappa B- and STAT3-luciferase activities were reduced in the presence of NSC 667249. STAT3 knockdown by STAT3 siRNA abrogated IL-6's actions in elevating VEGF-C mRNA and protein levels. Moreover, Src-FAK signaling blockade reduced IL-6's enhancing effects of increasing STAT3 binding to the VEGF-C promoter region, cell migration and endothelial tube formation of SV-LECs. Together these results suggest that IL-6 increases VEGF-C induction and lymphangiogenesis may involve, at least in part, Src-FAK-STAT3 cascade in LECs.	[Huang, Yu-Han; Hsu, Ming-Jen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Yang, Hung-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Cardiovasc Med, Taipei, Taiwan; [Yang, Hung-Yu] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Yang, Hung-Yu] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Huang, Shiu-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Pharmacol, Taipei, Taiwan; [Ou, George] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Hsu, Ya-Fen] Landseed Hosp, Dept Surg, Div Gen Surg, Taoyuan, Taiwan; [Hsu, Ming-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Pharmacol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; University of British Columbia; Taipei Medical University	Hsu, MJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Hsu, YF (corresponding author), Landseed Hosp, Dept Surg, Div Gen Surg, Taoyuan, Taiwan.; Hsu, MJ (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pharmacol, Taipei, Taiwan.	yafen0505@gmail.com; aspirin@tmu.edu.tw		Hsu, Ming-Jen/0000-0001-9688-8494	Ministry of Science and Technology of Taiwan [MOST 102-2314-B-706-001, 103-2314-B-706-001]; Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan [102TMU-WFH-02-4]; Landseed Hospital, Taoyuan, Taiwan [LSH-2013-01]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan; Landseed Hospital, Taoyuan, Taiwan	This work was supported by grants (MOST 102-2314-B-706-001, 103-2314-B-706-001) from the Ministry of Science and Technology of Taiwan (https://www.most.gov.tw/), Y.F.H; grant (102TMU-WFH-02-4) from the Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan (http://wfh.tmu.edu.tw/), M.J.H; and grant (LSH-2013-01) from the Landseed Hospital, Taoyuan, Taiwan (http://www.landseedhospital.com.tw), Y.F.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; Andreozzi F, 2007, MOL CELL BIOL, V27, P2372, DOI 10.1128/MCB.01340-06; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Barbier D, 2012, AM J RESP CELL MOL, V47, P149, DOI 10.1165/rcmb.2011-0405OC; Belluco C, 2000, ANN SURG ONCOL, V7, P133, DOI 10.1007/s10434-000-0133-7; Besser D, 1999, MOL CELL BIOL, V19, P1401; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chang HL, 2013, BBA-GEN SUBJECTS, V1830, P4053, DOI 10.1016/j.bbagen.2013.04.011; Chang YF, 2015, ONCOTARGET, V6, P85, DOI 10.18632/oncotarget.2765; Che KF, 2012, MOL MED, V18, P1169, DOI 10.2119/molmed.2012.00103; Chelsky ZL, 2015, MOL PHARMACOL, V88, P524, DOI 10.1124/mol.115.099093; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hu J, 2014, EUR J CANCER, V50, P2336, DOI 10.1016/j.ejca.2014.06.005; Huang YH, 2014, ANGIOGENESIS, V17, P407, DOI 10.1007/s10456-013-9386-1; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Ji H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5944; Karpanen T, 2001, CANCER RES, V61, P1786; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Lee H, 2011, CANCER RES, V71, P3772, DOI 10.1158/0008-5472.CAN-10-3304; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liao WC, 2008, CLIN CANCER RES, V14, P428, DOI 10.1158/1078-0432.CCR-07-1032; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Luo Y, 2011, ONCOGENE, V30, P2098, DOI 10.1038/onc.2010.590; Maeng YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20739; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Miyazaki T, 2015, CIRC RES, V116, P1170, DOI 10.1161/CIRCRESAHA.116.305363; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; Ou JJ, 2015, CANCER LETT, V358, P200, DOI 10.1016/j.canlet.2014.12.046; Qu ZX, 2015, CANCER RES, V75, P3209, DOI 10.1158/0008-5472.CAN-14-3042; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schoppmann SF, 2010, ANN ONCOL, V21, P955, DOI 10.1093/annonc/mdp532; Semenza GL, 2013, ONCOGENE, V32, P4057, DOI 10.1038/onc.2012.578; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Shinriki S, 2011, J PATHOL, V225, P142, DOI 10.1002/path.2935; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Snyder M, 2014, J BIOL CHEM, V289, P30082, DOI 10.1074/jbc.M114.591719; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang Q, 2008, J BIOL CHEM, V283, P13491, DOI 10.1074/jbc.M708055200	59	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158839	10.1371/journal.pone.0158839	http://dx.doi.org/10.1371/journal.pone.0158839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383632	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400088
J	Robins, MT; Lu, J; van Rijn, RM				Robins, Meridith T.; Lu, Julie; van Rijn, Richard M.			Unique Behavioral and Neurochemical Effects Induced by Repeated Adolescent Consumption of Caffeine-Mixed Alcohol in C57BL/6 Mice	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; ENERGY DRINK CONSUMPTION; NUCLEUS-ACCUMBENS; DELTA-FOSB; HIGH-RISK; LOCOMOTOR-ACTIVITY; RECEPTOR AGONIST; SEX-DIFFERENCES; DOPAMINE; COCAINE	The number of highly caffeinated products has increased dramatically in the past few years. Among these products, highly caffeinated energy drinks are the most heavily advertised and purchased, which has resulted in increased incidences of co-consumption of energy drinks with alcohol. Despite the growing number of adolescents and young adults reporting caffeine-mixed alcohol use, knowledge of the potential consequences associated with co-consumption has been limited to survey-based results and in-laboratory human behavioral testing. Here, we investigate the effect of repeated adolescent (post-natal days P35-61) exposure to caffeine-mixed alcohol in C57BL/6 mice on common drug-related behaviors such as locomotor sensitivity, drug reward and cross-sensitivity, and natural reward. To determine changes in neurological activity resulting from adolescent exposure, we monitored changes in expression of the transcription factor Delta FosB in the dopaminergic reward pathway as a sign of long-term increases in neuronal activity. Repeated adolescent exposure to caffeine-mixed alcohol exposure induced significant locomotor sensitization, desensitized cocaine conditioned place preference, decreased cocaine locomotor cross-sensitivity, and increased natural reward consumption. We also observed increased accumulation of Delta FosB in the nucleus accumbens following repeated adolescent caffeine-mixed alcohol exposure compared to alcohol or caffeine alone. Using our exposure model, we found that repeated exposure to caffeine-mixed alcohol during adolescence causes unique behavioral and neurochemical effects not observed in mice exposed to caffeine or alcohol alone. Based on similar findings for different substances of abuse, it is possible that repeated exposure to caffeine-mixed alcohol during adolescence could potentially alter or escalate future substance abuse as means to compensate for these behavioral and neurochemical alterations.	[Robins, Meridith T.; van Rijn, Richard M.] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Lu, Julie] Univ Calif San Francisco, Dept Neurosci, San Francisco, CA 94158 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Francisco	van Rijn, RM (corresponding author), Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	rvanrijn@purdue.edu	van Rijn, Richard M./I-8790-2019	van Rijn, Richard M./0000-0002-9957-1633; Robins, Meridith/0000-0003-0582-7907	Pathway to Independence grant [R00AA20539]; Alcoholic Beverage Medical Research Foundation/Foundation for Alcohol Research; Ralph W. and Grace M. Showalter Research Trust [207566]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA020539] Funding Source: NIH RePORTER	Pathway to Independence grant; Alcoholic Beverage Medical Research Foundation/Foundation for Alcohol Research; Ralph W. and Grace M. Showalter Research Trust; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Richard M. van Rijn is supported by a Pathway to Independence grant for the National Institute on Alcohol Abuse and Alcoholism (R00AA20539), a grant from the Alcoholic Beverage Medical Research Foundation/Foundation for Alcohol Research (http://www.abmrf.org/) and a grant from the Ralph W. and Grace M. Showalter Research Trust (#207566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Richard M. van Rijn is supported by a Pathway to Independence grant for the National Institute on Alcohol Abuse and Alcoholism (R00AA20539) a grant from the Alcoholic Beverage Medical Research Foundation/Foundation for Alcohol Research and a grant from the Ralph W. and Grace M. Showalter Research Trust (#207566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Adriani W, 2004, NEUROPSYCHOPHARMACOL, V29, P869, DOI 10.1038/sj.npp.1300366; [Anonymous], 2013, ENERGY DRINKS SHOTS; Arria AM, 2011, JAMA-J AM MED ASSOC, V305, P600, DOI 10.1001/jama.2011.109; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Avci S, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2013.06.031; Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Berger AC, 2011, EMBO MOL MED, V3, P385, DOI 10.1002/emmm.201100144; Bobzean SAM, 2014, EXP NEUROL, V259, P64, DOI 10.1016/j.expneurol.2014.01.022; Bonar EE, 2015, ADDICT BEHAV, V43, P11, DOI 10.1016/j.addbeh.2014.11.023; Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003; CHEN JF, 1993, NEUROSCIENCE, V54, P669, DOI 10.1016/0306-4522(93)90238-B; Crawford CA, 2011, PSYCHOPHARMACOLOGY, V213, P43, DOI 10.1007/s00213-010-2011-8; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; De Vries TJ, 1998, NEUROREPORT, V9, P1763, DOI 10.1097/00001756-199806010-00017; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Do J, 2013, LEARN MEMORY, V20, P21, DOI 10.1101/lm.025015.111; Engle SE, 2013, MOL PHARMACOL, V84, P393, DOI 10.1124/mol.113.087346; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; Ferre Sergi, 2011, J Caffeine Res, V1, P153; Flaisher-Grinberg S, 2009, J NEUROSCI METH, V177, P44, DOI 10.1016/j.jneumeth.2008.09.018; Freet CS, 2015, PHYSIOL BEHAV, V149, P174, DOI 10.1016/j.physbeh.2015.06.009; Fritz BM, 2014, ALCOHOL CLIN EXP RES, V38, P2269, DOI 10.1111/acer.12472; Fuxe K, 2007, PHYSIOL BEHAV, V92, P210, DOI 10.1016/j.physbeh.2007.05.034; Garrett BE, 1997, PHARMACOL BIOCHEM BE, V57, P533, DOI 10.1016/S0091-3057(96)00435-2; Gladwin TE, 2011, DEV COGN NEUROS-NETH, V1, P364, DOI 10.1016/j.dcn.2011.06.008; Hansen ST, 2013, PHARMACOL BIOCHEM BE, V103, P582, DOI 10.1016/j.pbb.2012.10.010; Hilbert MLT, 2013, PHARMACOL BIOCHEM BE, V110, P168, DOI 10.1016/j.pbb.2013.07.008; Hnasko TS, 2007, J NEUROSCI, V27, P12484, DOI 10.1523/JNEUROSCI.3133-07.2007; HOOKS MS, 1993, PSYCHOPHARMACOLOGY, V111, P109, DOI 10.1007/BF02257416; Ikemoto S, 2002, NEUROSCIENCE, V113, P939, DOI 10.1016/S0306-4522(02)00247-6; Itzhak Y, 1999, BRAIN RES, V818, P204, DOI 10.1016/S0006-8993(98)01260-8; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Kovacs KM, 2005, ALCOHOL CLIN EXP RES, V29, P730, DOI 10.1097/01.ALC.0000164361.62346.D6; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Marczinski CA, 2014, ALCOHOL CLIN EXP RES, V38, P1822, DOI 10.1111/acer.12493; Martz ME, 2015, J ADOLESCENT HEALTH, V56, P557, DOI 10.1016/j.jadohealth.2015.01.019; May CE, 2015, ALCOHOL CLIN EXP RES, V39, P1443, DOI 10.1111/acer.12794; McLellan TM, 2012, NUTR REV, V70, P730, DOI 10.1111/j.1753-4887.2012.00525.x; Merritt KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078258; Miyake ER, 2015, ADDICT BEHAV, V43, P60, DOI 10.1016/j.addbeh.2014.12.009; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nestler EJ., 2013, J DRUG ALCOHOL RES, V2, P1; Novier A, 2015, PHARMACOL BIOCHEM BE, V133, P65, DOI 10.1016/j.pbb.2015.03.015; O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x; O'Neill CE, 2015, NEUROPSYCHOPHARMACOL, V40, P813, DOI 10.1038/npp.2014.278; Oteri A, 2007, ALCOHOL CLIN EXP RES, V31, P1677, DOI 10.1111/j.1530-0277.2007.00464.x; Peacock A, 2015, ALCOHOL CLIN EXP RES, V39, P733, DOI 10.1111/acer.12680; Peacock A, 2014, ADDICTION, V109, P1612, DOI 10.1111/add.12622; Peacock A, 2014, APPETITE, V76, P60, DOI 10.1016/j.appet.2014.01.003; Peacock A, 2013, APPETITE, V64, P1, DOI 10.1016/j.appet.2012.12.021; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Thiele TE, 2014, ALCOHOL, V48, P235, DOI 10.1016/j.alcohol.2013.08.005; Thompson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011038; van Rijn RM, 2012, DRUG ALCOHOL DEPEN, V122, P156, DOI 10.1016/j.drugalcdep.2011.09.024; Van Swearingen AED, 2013, PSYCHOPHARMACOLOGY, V225, P707, DOI 10.1007/s00213-012-2860-4; Volkow ND, 2010, BIOESSAYS, V32, P748, DOI 10.1002/bies.201000042; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636	65	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158189	10.1371/journal.pone.0158189	http://dx.doi.org/10.1371/journal.pone.0158189			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380261	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700022
J	Grinstead, KM; Rowe, L; Ensor, CM; Joel, S; Daftarian, P; Dikici, E; Zingg, JM; Daunert, S				Grinstead, Kristen M.; Rowe, Laura; Ensor, Charles M.; Joel, Smita; Daftarian, Pirouz; Dikici, Emre; Zingg, Jean-Marc; Daunert, Sylvia			Red-Shifted Aequorin Variants Incorporating Non-Canonical Amino Acids: Applications in In Vivo Imaging	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; REPORTER GENE-EXPRESSION; BIOLUMINESCENCE IMMUNOASSAY; PHOTOPROTEIN AEQUORIN; RENILLA LUCIFERASE; LIVING SUBJECTS; MUTANTS; MUTAGENESIS; SWITCH; CELLS	The increased importance of in vivo diagnostics has posed new demands for imaging technologies. In that regard, there is a need for imaging molecules capable of expanding the applications of current state-of-the-art imaging in vivo diagnostics. To that end, there is a desire for new reporter molecules capable of providing strong signals, are non-toxic, and can be tailored to diagnose or monitor the progression of a number of diseases. Aequorin is a non-toxic photoprotein that can be used as a sensitive marker for bioluminescence in vivo imaging. The sensitivity of aequorin is due to the fact that bioluminescence is a rare phenomenon in nature and, therefore, it does not suffer from autofluorescence, which contributes to background emission. Emission of bioluminescence in the blue-region of the spectrum by aequorin only occurs when calcium, and its luciferin coelenterazine, are bound to the protein and trigger a biochemical reaction that results in light generation. It is this reaction that endows aequorin with unique characteristics, making it ideally suited for a number of applications in bioanalysis and imaging. Herein we report the site-specific incorporation of non-canonical or non-natural amino acids and several coelenterazine analogues, resulting in a catalog of 72 cysteine-free, aequorin variants which expand the potential applications of these photoproteins by providing several red-shifted mutants better suited to use in vivo. In vivo studies in mouse models using the transparent tissue of the eye confirmed the activity of the aequorin variants incorporating L-4-iodophehylalanine and L-4-methoxyphenylalanine after injection into the eye and topical addition of coelenterazine. The signal also remained localized within the eye. This is the first time that aequorin variants incorporating non-canonical amino acids have shown to be active in vivo and useful as reporters in bioluminescence imaging.	[Grinstead, Kristen M.; Joel, Smita; Daftarian, Pirouz; Dikici, Emre; Zingg, Jean-Marc; Daunert, Sylvia] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, R Bunn Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA; [Rowe, Laura] Valparaiso Univ, Dept Chem, 1610 Campus Dr East, Valparaiso, IN 46385 USA; [Ensor, Charles M.] Univ Kentucky, Dept Pharmaceut Sci, Coll Pharm, Lexington, KY 40536 USA	University of Miami; Valparaiso University; University of Kentucky	Daunert, S (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, R Bunn Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA.	SDaunert@med.miami.edu	Zingg, Jean-Marc/H-6960-2019	Ensor, Mark/0000-0003-3065-688X; Rowe, Laura/0000-0003-4657-1194	National Institutes of Health [7R01GM047915]; Lucille P. Markey Chair; Lucille P. Markey Chair from the Miller School of Medicine of the University of Miami	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucille P. Markey Chair; Lucille P. Markey Chair from the Miller School of Medicine of the University of Miami	This study was funded by the National Institutes of Health, grant number 7R01GM047915, and by the Lucille P. Markey Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S.D. is grateful for the financial support by the Lucille P. Markey Chair from the Miller School of Medicine of the University of Miami. The authors are grateful to Dr. Peter Schultz of the Scripps Research Institute, La Jolla, CA for generously donating the pDULE plasmid.	Bakayan A, 2015, PFLUG ARCH EUR J PHY, V467, P2031, DOI 10.1007/s00424-014-1639-3; Bakayan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019520; Bhaumik S, 2004, J BIOMED OPT, V9, P578, DOI 10.1117/1.1647546; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Cai WB, 2007, SMALL, V3, P1840, DOI 10.1002/smll.200700351; Chatterjee A, 2012, P NATL ACAD SCI USA, V109, P14841, DOI 10.1073/pnas.1212454109; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; Curie T, 2007, MOL IMAGING, V6, P30, DOI 10.2310/7290.2006.00033; Daunert S, 2006, PHOTOPROTEINS BIOANA; De A, 2005, FASEB J, V19, P2017, DOI 10.1096/fj.05-4628fje; De A, 2007, CANCER RES, V67, P7175, DOI 10.1158/0008-5472.CAN-06-4623; Deo SK, 2001, ANAL CHEM, V73, P1903, DOI 10.1021/ac001100q; Deo SK, 2001, BIOCONJUGATE CHEM, V12, P378, DOI 10.1021/bc0001140; Desai UA, 2001, ANAL BIOCHEM, V294, P132, DOI 10.1006/abio.2001.5145; Dikici E, 2009, PROTEIN ENG DES SEL, V22, P243, DOI 10.1093/protein/gzn083; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Dragulescu-Andrasi A, 2011, P NATL ACAD SCI USA, V108, P12060, DOI 10.1073/pnas.1100923108; Eremeeva EV, 2009, FEBS LETT, V583, P1939, DOI 10.1016/j.febslet.2009.04.043; Grinstead KM, 2015, AEQUORIN MUTANTS WIT; Hamorsky KT, 2008, ANGEW CHEM INT EDIT, V47, P3718, DOI 10.1002/anie.200704440; Hamorsky KT, 2012, ANAL CHEM, V84, P7648, DOI 10.1021/ac301872u; Hamorsky KT, 2012, ANAL BIOCHEM, V421, P172, DOI 10.1016/j.ab.2011.10.023; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; INOUYE S, 1985, P NATL ACAD SCI USA, V82, P3154, DOI 10.1073/pnas.82.10.3154; JOHNSON FH, 1972, NATURE-NEW BIOL, V237, P287, DOI 10.1038/newbio237287a0; Lark AR, 2016, JOVE-J VIS EXP, DOI 10.3791/53705; Leppanen O, 2006, ATHEROSCLEROSIS, V188, P323, DOI 10.1016/j.atherosclerosis.2005.11.017; Lewis JC, 2001, ANAL CHEM, V73, P3227, DOI 10.1021/ac0101914; Lewis JC, 2000, BIOCONJUGATE CHEM, V11, P65, DOI 10.1021/bc9900800; Lewis JC, 2000, FRESEN J ANAL CHEM, V366, P760, DOI 10.1007/s002160051570; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; Maniatis T., 1982, MOL CLONING; Markova O, 2012, SEMIN CELL DEV BIOL, V23, P298, DOI 10.1016/j.semcdb.2012.03.006; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; Mirasoli M, 2002, ANAL BIOCHEM, V306, P204, DOI 10.1006/abio.2002.5695; Negrin RS, 2006, NAT REV IMMUNOL, V6, P484, DOI 10.1038/nri1879; Nijegorodov N, 2001, SPECTROCHIM ACTA A, V57, P1449, DOI 10.1016/S1386-1425(00)00488-1; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Ordenes VR, 2012, CELL CALCIUM, V52, P397, DOI 10.1016/j.ceca.2012.06.008; Pantaleo MA, 2008, CANCER TREAT REV, V34, P103, DOI 10.1016/j.ctrv.2007.10.001; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Qu XG, 2007, ANAL BIOCHEM, V371, P154, DOI 10.1016/j.ab.2007.08.038; Qu XG, 2014, ANAL BIOANAL CHEM, V406, P5639, DOI 10.1007/s00216-014-8039-6; Razgulin A, 2011, CHEM SOC REV, V40, P4186, DOI 10.1039/c1cs15035a; Rowe L, 2008, PROTEIN ENG DES SEL, V21, P73, DOI 10.1093/protein/gzm073; Rowe L, 2008, ANAL CHEM, V80, P8470, DOI 10.1021/ac801209x; Rowe L, 2007, BIOCONJUGATE CHEM, V18, P1772, DOI 10.1021/bc070039u; Rowe L, 2010, ACS CHEM BIOL, V5, P455, DOI 10.1021/cb9002909; Rowe L, 2009, ANAL CHEM, V81, P8662, DOI 10.1021/ac9007286; Scott D, 2011, ANNU REV ANAL CHEM, V4, P297, DOI 10.1146/annurev-anchem-061010-113855; Scott D, 2011, BIOCONJUGATE CHEM, V22, P475, DOI 10.1021/bc100486b; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; SHIMOMURA O, 1988, BIOCHEM J, V251, P405, DOI 10.1042/bj2510405; Shinde R, 2006, BIOCHEMISTRY-US, V45, P11103, DOI 10.1021/bi060475o; Shrestha S, 2002, BIOCONJUGATE CHEM, V13, P269, DOI 10.1021/bc010044c; Tricoire L, 2006, CPNAS, V103, P5; Tsuzuki K, 2005, J BIOL CHEM, V280, P34324, DOI 10.1074/jbc.M505303200; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; ZENNO SH, 1990, BIOCHEM BIOPH RES CO, V171, P169, DOI 10.1016/0006-291X(90)91372-Y; Zinn KR, 2008, ILAR J, V49, P103, DOI 10.1093/ilar.49.1.103	63	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158579	10.1371/journal.pone.0158579	http://dx.doi.org/10.1371/journal.pone.0158579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367859	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900040
J	Shi, HB; Zhang, GD; Wang, J; Wang, ZZ; Liu, XX; Cheng, L; Li, WM				Shi, Hongbo; Zhang, Guangde; Wang, Jing; Wang, Zhenzhen; Liu, Xiaoxia; Cheng, Liang; Li, Weimin			Studying Dynamic Features in Myocardial Infarction Progression by Integrating miRNA-Transcription Factor Co-Regulatory Networks and Time-Series RNA Expression Data from Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; MICRORNA EXPRESSION; FEEDFORWARD LOOPS; GENE-EXPRESSION; RESOURCE; MODEL	Myocardial infarction (MI) is a serious heart disease and a leading cause of mortality and morbidity worldwide. Although somemolecules (genes, miRNAs and transcription factors (TFs)) associated with MI have been studied in a specific pathological context, their dynamic characteristics in gene expressions, biological functions and regulatory interactions in MI progression have not been fully elucidated to date. In the current study, we analyzed time-series RNA expression data from peripheral blood mononuclear cells. We observed that significantly differentially expressed genes were sharply up- or down-regulated in the acute phase of MI, and then changed slowly until the chronic phase. Biological functions involved at each stage of MI were identified. Additionally, dynamic miRNA-TF co-regulatory networks were constructed based on the significantly differentially expressed genes and miRNA-TF co-regulatory motifs, and the dynamic interplay of miRNAs, TFs and target genes were investigated. Finally, a new panel of candidate diagnostic biomarkers (STAT3 and ICAM1) was identified to have discriminatory capability for patients with or without MI, especially the patients with or without recurrent events. The results of the present study not only shed new light on the understanding underlying regulatory mechanisms involved in MI progression, but also contribute to the discovery of true diagnostic biomarkers for MI.	[Shi, Hongbo; Wang, Jing; Wang, Zhenzhen; Cheng, Liang] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China; [Zhang, Guangde; Liu, Xiaoxia] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 4, Harbin 150001, Heilongjiang, Peoples R China; [Li, Weimin] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, WM (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin 150001, Heilongjiang, Peoples R China.	liweimin_2009@163.com	Cheng, Liang/ABY-7421-2022	Cheng, Liang/0000-0002-6665-6710	National Natural Science Foundation of China [31500675, 81270252]; Natural Science Foundation of Heilongjiang Province, China [QC2013C019]; Postdoctoral Foundation of Heilongjiang Province [LBH-Z15162]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province); Postdoctoral Foundation of Heilongjiang Province	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 31500675,81270252), the Natural Science Foundation of Heilongjiang Province, China (Grant No. QC2013C019) and the Postdoctoral Foundation of Heilongjiang Province (Grant No. LBH-Z15162).	Arora S, 2013, MOL GENET GENOMICS, V288, P77, DOI 10.1007/s00438-013-0734-z; Azuaje FJ, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-59; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dymacek J, 2015, TOXICOL SCI, V144, P51, DOI 10.1093/toxsci/kfu262; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gallogly MM, 2010, ANTIOXID REDOX SIGN, V12, P1339, DOI 10.1089/ars.2009.2791; Hsu PC, 2011, KAOHSIUNG J MED SCI, V27, P195, DOI 10.1016/j.kjms.2010.08.003; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hu JF, 2010, BIOINFORMATICS, V26, P2289, DOI 10.1093/bioinformatics/btq408; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Karangelis DE, 2010, CURR MED CHEM, V17, P4018; Kiliszek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050054; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li X, 2012, BRIEF BIOINFORM, V13, P175, DOI 10.1093/bib/bbr043; Li YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09283; Li YX, 2010, TRENDS CARDIOVAS MED, V20, P228, DOI 10.1016/j.tcm.2011.11.006; Lin Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09653; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Lu Y, 2014, J CARDIOVASC PHARM, V63, P412, DOI 10.1097/FJC.0000000000000062; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mozaffarian D., 2014, CIRCULATION; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Peng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078197; Port JD, 2011, PHYSIOL GENOMICS, V43, P1087, DOI 10.1152/physiolgenomics.00074.2011; Qin S, 2015, BIOINFORMATICS, V31, P76, DOI 10.1093/bioinformatics/btu597; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Soong TT, 2008, BIOINFORMATICS, V24, P2608, DOI 10.1093/bioinformatics/btn498; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Tian W, 2016, ONCOL REP, V35, P2171, DOI 10.3892/or.2016.4561; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Turner M, 2011, ADV EXP MED BIOL, V780, P1, DOI 10.1007/978-1-4419-5632-3_1; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; von Lueder TG, 2011, CLIN LAB, V57, P615; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang ZF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0318-9; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yamauchi T, 1998, Kansenshogaku Zasshi, V72, P286; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Ye HS, 2012, NUCLEIC ACIDS RES, V40, P5201, DOI 10.1093/nar/gks175; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135339; Zhang HM, 2015, BRIEF BIOINFORM, V16, P45, DOI 10.1093/bib/bbt085; Zhang T, 2014, GENE, V543, P259, DOI 10.1016/j.gene.2014.04.002	53	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158638	10.1371/journal.pone.0158638	http://dx.doi.org/10.1371/journal.pone.0158638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367417	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900046
J	Civade, R; Dejean, T; Valentini, A; Roset, N; Raymond, JC; Bonin, A; Taberlet, P; Pont, D				Civade, Raphael; Dejean, Tony; Valentini, Alice; Roset, Nicolas; Raymond, Jean-Claude; Bonin, Aurelie; Taberlet, Pierre; Pont, Didier			Spatial Representativeness of Environmental DNA Metabarcoding Signal for Fish Biodiversity Assessment in a Natural Freshwater System	PLOS ONE			English	Article							SURVEY TOOL; EDNA; CONSERVATION; PERSISTENCE; ECOLOGY; PCR	In the last few years, the study of environmental DNA (eDNA) has drawn attention for many reasons, including its advantages for monitoring and conservation purposes. So far, in aquatic environments, most of eDNA research has focused on the detection of single species using species-specific markers. Recently, species inventories based on the analysis of a single generalist marker targeting a larger taxonomic group (eDNA metabarcoding) have proven useful for bony fish and amphibian biodiversity surveys. This approach involves in situ filtering of large volumes of water followed by amplification and sequencing of a short discriminative fragment from the 12S rDNA mitochondrial gene. In this study, we went one step further by investigating the spatial representativeness (i.e. ecological reliability and signal variability in space) of eDNA metabarcoding for large-scale fish biodiversity assessment in a freshwater system including lentic and lotic environments. We tested the ability of this approach to characterize large-scale organization of fish communities along a longitudinal gradient, from a lake to the outflowing river. First, our results confirm that eDNA metabarcoding is more efficient than a single traditional sampling campaign to detect species presence, especially in rivers. Second, the species list obtained using this approach is comparable to the one obtained when cumulating all traditional sampling sessions since 1995 and 1988 for the lake and the river, respectively. In conclusion, eDNA metabarcoding gives a faithful description of local fish biodiversity in the study system, more specifically within a range of a few kilometers along the river in our study conditions, i.e. longer than a traditional fish sampling site.	[Civade, Raphael; Pont, Didier] IRSTEA, Hydrosyst & Bioproc Res Unit, Antony, France; [Dejean, Tony; Valentini, Alice] SPYGEN, Le Bourget Du Lac, France; [Roset, Nicolas; Raymond, Jean-Claude] ONEMA, Rhone Alpes Reg Direct, Bron, France; [Bonin, Aurelie; Taberlet, Pierre] CNRS, Lab Ecol Alpine LECA, Grenoble, France; [Bonin, Aurelie; Taberlet, Pierre] Univ Grenoble Alpes, Lab Ecol Alpine LECA, Grenoble, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Civade, R (corresponding author), IRSTEA, Hydrosyst & Bioproc Res Unit, Antony, France.	civade_raphael@hotmail.fr	valentini, alice/S-2040-2019; Valentini, Alice/AFS-1389-2022	Valentini, Alice/0000-0001-5829-5479; Bonin, Aurelie/0000-0001-7800-8609; pont, Didier/0000-0001-5187-0135	EDF (Electricity of France); ONEMA (French National Agency for Water and Aquatic Environments); SPYGEN	EDF (Electricity of France); ONEMA (French National Agency for Water and Aquatic Environments); SPYGEN	In addition to their participation to field work, data collection and preparation of the manuscript, ONEMA (French National Agency for Water and Aquatic Environments) and SPYGEN financially supported this work (Contract IRSTEA-SPYGENONEMA, 2012-2015). EDF (Electricity of France) also supported financially this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Boyer F., 2015, MOL ECOLOGY RESOURCE; COWX IG, 1983, FISH MANAGE, V14, P67; CSP-DR-Lyon, 1996, ET ICHT AIG; CSP-DR-Lyon, 2007, LAC AIG EV PEUPL PIS; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deiner K., 2015, BIORXIV; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; European Committee for Standardization, 2005, 14757 EUR COMM STAND; European Committee for Standardization, 2003, 14011 EUR COMM STAND; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Ficetola G. F., 2010, BMC GENOMICS, V11; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Irz P, 2006, AQUAT SCI, V68, P109, DOI 10.1007/s00027-005-0812-3; Keith P., 2001, ATLAS POISSONS EAU D; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Merkes CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113346; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Raymond J-C, 2009, COMPOSITION ABONDANC; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Roussel JM, 2015, J APPL ECOL, V52, P823, DOI 10.1111/1365-2664.12428; Schnell IB, 2015, MOL ECOL RESOUR, V15, P1289, DOI 10.1111/1755-0998.12402; Sutherland WJ, 2013, TRENDS ECOL EVOL, V28, P16, DOI 10.1016/j.tree.2012.10.022; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A., 2014, J APPL ECOLOGY; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wanzenbock J, 2000, J FISH BIOL, V56, P1553, DOI 10.1111/j.1095-8649.2000.tb02165.x; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	44	78	91	6	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157366	10.1371/journal.pone.0157366	http://dx.doi.org/10.1371/journal.pone.0157366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359116	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200014
J	Grandl, S; Sztrokay-Gaul, A; Mittone, A; Gasilov, S; Brun, E; Bravin, A; Mayr, D; Auweter, SD; Hellerhoff, K; Reiser, M; Coan, P				Grandl, Susanne; Sztrokay-Gaul, Aniko; Mittone, Alberto; Gasilov, Sergey; Brun, Emmanuel; Bravin, Alberto; Mayr, Doris; Auweter, Sigrid D.; Hellerhoff, Karin; Reiser, Maximilian; Coan, Paola			Detection of Post-Therapeutic Effects in Breast Carcinoma Using Hard X-Ray Index of Refraction Computed Tomography - A Feasibility Study	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; INDUCTION CHEMOTHERAPY; SPECIMEN SHRINKAGE; HIGH-RESOLUTION; CANCER; CT; MAMMOGRAPHY; THERAPY	Objectives Neoadjuvant chemotherapy is the state-of-the-art treatment in advanced breast cancer. A correct visualization of the post-therapeutic tumor size is of high prognostic relevance. Xray phase-contrast computed tomography (PC-CT) has been shown to provide improved soft-tissue contrast at a resolution formerly restricted to histopathology, at low doses. This study aimed at assessing ex-vivo the potential use of PC-CT for visualizing the effects of neoadjuvant chemotherapy on breast carcinoma. Materials and Methods The analysis was performed on two ex-vivo formalin-fixed mastectomy samples containing an invasive carcinoma removed from two patients treated with neoadjuvant chemotherapy. Images were matched with corresponding histological slices. The visibility of typical post-therapeutic tissue changes was assessed and compared to results obtained with conventional clinical imaging modalities. Results PC-CT depicted the different tissue types with an excellent correlation to histopathology. Post-therapeutic tissue changes were correctly visualized and the residual tumor mass could be detected. PC-CT outperformed clinical imaging modalities in the detection of chemotherapy-induced tissue alterations including post-therapeutic tumor size. Conclusions PC-CT might become a unique diagnostic tool in the prediction of tumor response to neoadjuvant chemotherapy. PC-CT might be used to assist during histopathological diagnosis, offering a high-resolution and high-contrast virtual histological tool for the accurate delineation of tumor boundaries.	[Grandl, Susanne; Sztrokay-Gaul, Aniko; Mittone, Alberto; Auweter, Sigrid D.; Hellerhoff, Karin; Reiser, Maximilian; Coan, Paola] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany; [Mittone, Alberto; Gasilov, Sergey; Brun, Emmanuel; Coan, Paola] Univ Munich, Dept Phys, Garching, Germany; [Gasilov, Sergey] Karlsruhe Inst Technol, ANKA Synchrotron Radiat Facil, Eggenstein, Germany; [Brun, Emmanuel; Bravin, Alberto] European Synchrotron Radiat Facil, Grenoble, France; [Mayr, Doris] Ludwig Maximilians Univ Hosp Munich, Inst Pathol, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Karlsruhe Institute of Technology; European Synchrotron Radiation Facility (ESRF); University of Munich	Sztrokay-Gaul, A (corresponding author), Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany.	aniko.sztrokay@med.uni-muenchen.de	brun, emmanuel/U-8780-2019; Bravin, Alberto/AAN-6114-2020; Coan, Paola/GPC-5718-2022; Mittone, Alberto/C-8653-2018; Bravin, Alberto/R-8633-2016; Brun, emmanuel/J-7942-2018; Coan, Paola/L-8804-2013	brun, emmanuel/0000-0002-0332-4903; Bravin, Alberto/0000-0001-6868-2755; Coan, Paola/0000-0003-1399-2398; Mittone, Alberto/0000-0002-2018-5714; Bravin, Alberto/0000-0001-6868-2755; Brun, emmanuel/0000-0002-0332-4903; Coan, Paola/0000-0003-1399-2398	Deutsche Forschungsgemeinschaft-Cluster of Excellence Munich-Centre for Advanced Photonics EXC158	Deutsche Forschungsgemeinschaft-Cluster of Excellence Munich-Centre for Advanced Photonics EXC158	The authors acknowledge the European Synchrotron Radiation Facility (ESRF) for provision of beamtime and laboratory facilities. The authors would like to acknowledge, T. Brochard, Dr. C. Nemoz and Dr. H. Requardt for the technical support and electronic, computing and software assistance. The study was supported by the Deutsche Forschungsgemeinschaft-Cluster of Excellence Munich-Centre for Advanced Photonics EXC158.	Akazawa K, 2006, BREAST J, V12, P130, DOI 10.1111/j.1075-122X.2006.00220.x; Arlinghaus LR, 2010, J ONCOL, V2010, DOI 10.1155/2010/919620; Balu-Maestro C, 2002, BREAST CANCER RES TR, V72, P145, DOI 10.1023/A:1014856713942; Bhattacharyya M, 2008, BRIT J CANCER, V98, P289, DOI 10.1038/sj.bjc.6604171; Brain E, 1997, BRIT J CANCER, V75, P1360, DOI 10.1038/bjc.1997.230; Bravin A, 2007, PHYS MED BIOL, V52, P2197, DOI 10.1088/0031-9155/52/8/011; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; CHEVALLIER B, 1993, AM J CLIN ONCOL-CANC, V16, P223, DOI 10.1097/00000421-199306000-00006; Chollet P, 2002, BRIT J CANCER, V86, P1041, DOI 10.1038/sj/bjc/6600210; Coan P, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/49/494007; Dialani V, 2015, ANN SURG ONCOL, V22, P1416, DOI 10.1245/s10434-015-4403-9; El-Didi MH, 2000, SURG TODAY, V30, P249, DOI 10.1007/s005950050054; FARIS GW, 1988, APPL OPTICS, V27, P5202, DOI 10.1364/AO.27.005202; Fiedler S, 2004, PHYS MED BIOL, V49, P175, DOI 10.1088/0031-9155/49/2/001; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher ER, 2002, CANCER-AM CANCER SOC, V95, P681, DOI 10.1002/cncr.10741; Gasilov S, 2014, OPT EXPRESS, V22, P5216, DOI 10.1364/OE.22.005216; Gunderman RB, 2006, ESSENTIAL RADIOLOGY, P10; Krekel NMA, 2012, J CLIN PATHOL, V65, P224, DOI 10.1136/jclinpath-2011-200392; Langer F, 2004, PATHOLOGE, V25, P455, DOI 10.1007/s00292-004-0713-6; Londero V, 2004, EUR RADIOL, V14, P1371, DOI 10.1007/s00330-004-2246-z; Maksimenko A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721378; Mittone A, 2015, PHYS MED BIOL, V60, P3433, DOI 10.1088/0031-9155/60/9/3433; Mittone A, 2014, PHYS MED BIOL, V59, P2199, DOI 10.1088/0031-9155/59/9/2199; Moreno A, 2002, BREAST CANCER RES TR, V75, P119, DOI 10.1023/A:1019607924403; O'Flynn EAM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2815; SINN HP, 1994, GEBURTSH FRAUENHEILK, V54, P552, DOI 10.1055/s-2007-1022338; Sztrokay A, 2012, PHYS MED BIOL, V57, P2931, DOI 10.1088/0031-9155/57/10/2931; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; Wasser K, 2007, RADIOLOGE, V47, P421, DOI 10.1007/s00117-005-1303-1; Yeap BH, 2007, ASIAN J SURG, V30, P183, DOI 10.1016/S1015-9584(08)60020-2; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	32	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158306	10.1371/journal.pone.0158306	http://dx.doi.org/10.1371/journal.pone.0158306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362638	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200054
J	Homs, M; Rodriguez-Frias, F; Gregori, J; Ruiz, A; Reimundo, P; Casillas, R; Tabernero, D; Godoy, C; Barakat, S; Quer, J; Riveiro-Barciela, M; Roggendorf, M; Esteban, R; Buti, M				Homs, Maria; Rodriguez-Frias, Francisco; Gregori, Josep; Ruiz, Alicia; Reimundo, Pilar; Casillas, Rosario; Tabernero, David; Godoy, Cristina; Barakat, Salma; Quer, Josep; Riveiro-Barciela, Mar; Roggendorf, Michael; Esteban, Rafael; Buti, Maria			Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection	PLOS ONE			English	Article							RNA; REPLICATION; MUTATIONS; SEQUENCE; ANTIGEN; HETEROGENEITY; DIVERSITY; GENOME	Chronic HDV infection can cause a severe form of viral hepatitis for which there is no specific treatment. Characterization of the hepatitis B or C viral quasispecies has provided insight into treatment failure and disease recurrence following liver transplantation, has proven useful to understand hepatitis B e antigen seroconversion, and has helped to predict whether hepatitis C infection will resolve or become chronic. It is likely that characterization of the hepatitis delta virus (HDV) quasispecies will ultimately have similar value for the management of this infection. This study sought to determine the RNA evolution rates in serum of chronic hepatitis delta (CHD) treatment-naive patients, using next-generation sequencing methods. The region selected for study encompassed nucleotide positions 910 to 1270 of the genome and included the amber/W codon. Amber/W is a substrate of the editing process by the ADAR1 host enzyme and is essential for encoding the 2 delta antigens (HDAg). The amber codon encodes the small (unedited) HDAg form and theWcodon the large (edited) HDAg form. The evolution rate was analyzed taking into account the time elapsed between samples, the percentage of unedited and edited genomes, and the complexity of the viral population. The longitudinal studies included 29 sequential samples from CHD patients followed up for a mean of 11.5 years. In total, 121,116 sequences were analyzed. The HDV evolution rate ranged from 9.5x10(-3) to 1.2x10(-3) substitutions/site/year and showed a negative correlation with the time elapsed between samples (p<0.05). An accumulation of transition-type changes was found to be responsible for higher evolution rates. The percentages of unedited and edited genomes and the quasispecies complexity showed no relationships with the evolution rate, but the fluctuations in the percentages of genomes and in complexity suggest continuous adaptation of HDV to the host conditions.	[Homs, Maria; Rodriguez-Frias, Francisco; Gregori, Josep; Tabernero, David; Godoy, Cristina; Quer, Josep; Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Homs, Maria; Rodriguez-Frias, Francisco; Ruiz, Alicia; Reimundo, Pilar; Casillas, Rosario; Tabernero, David; Godoy, Cristina] Univ Autonoma Barcelona, Dept Biochem, Liver Pathol Unit, Barcelona, Spain; [Homs, Maria; Rodriguez-Frias, Francisco; Ruiz, Alicia; Reimundo, Pilar; Casillas, Rosario; Tabernero, David; Godoy, Cristina] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Microbiol, Barcelona, Spain; [Gregori, Josep; Casillas, Rosario; Quer, Josep] Vall dHebron Res Inst, Liver Dis Unit, Barcelona, Spain; [Gregori, Josep] Roche Diagnost SL, Sant Cugat Del Valles, Spain; [Barakat, Salma] Natl Ctr Gastrointestinal & Liver Dis, Dept Gastroenterol, Khartoum, Sudan; [Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Liver Unit, Barcelona, Spain; [Roggendorf, Michael] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Roche Holding; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Rodriguez-Frias, F (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	frarodri@vhebron.net	Gregori, Josep/J-2586-2015; Quer, Josep/A-6741-2012; Tabernero, David/AAB-3848-2019; Rodriguez-Frias, Francisco/AAC-3507-2020	Gregori, Josep/0000-0002-4253-8015; Quer, Josep/0000-0003-0014-084X; Tabernero, David/0000-0002-1146-4084; Homs, Maria/0000-0002-8370-8375; esteban, rafael/0000-0001-5280-392X; Godoy, Cristina/0000-0001-5037-1916; Buti Ferret, Maria/0000-0002-0732-3078; rodriguez-frias, francisco/0000-0002-9128-7013; Casillas, Rosario/0000-0002-6758-6734	Instituto de Salud Carlos III [PI14/01416]; European Regional Development Fund (ERDF); Roche Diagnostics	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); Roche Diagnostics	This study was funded by Instituto de Salud Carlos III (grant PI14/01416), cofinanced by the European Regional Development Fund (ERDF). Roche Diagnostics provided support in the form of a salary for JG, but did not have any role in the study design or execution, data collection or analysis, decision to publish, or preparation of the manuscript.	Beeharry Y, 2014, VIROLOGY, V450, P165, DOI 10.1016/j.virol.2013.12.017; Casey JL, 2012, CURR TOP MICROBIOL, V353, P123, DOI 10.1007/82_2011_146; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; CHEN PJ, 1986, P NATL ACAD SCI USA, V83, P8774, DOI 10.1073/pnas.83.22.8774; Cheng Y, 2013, GUT, V62, P1347, DOI 10.1136/gutjnl-2012-302408; Cheng Y, 2013, J HEPATOL, V58, P217, DOI 10.1016/j.jhep.2012.09.017; Cramer P, 2004, ADV PROTEIN CHEM, V67, P1; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Duchene S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0732; Ebrahimi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087679; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; Flores R, 2012, SEMIN LIVER DIS, V32, P201, DOI 10.1055/s-0032-1323624; Giersch K, 2015, J HEPATOL, V63, P346, DOI 10.1016/j.jhep.2015.03.011; Gregori J, 2016, VIROLOGY, V493, P227, DOI 10.1016/j.virol.2016.03.017; Gregori J, 2014, BIOINFORMATICS, V30, P1104, DOI 10.1093/bioinformatics/btt768; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Homs M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112306; Homs M, 2014, J CLIN MICROBIOL, V52, P3334, DOI 10.1128/JCM.00940-14; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Koh C, 2015, LANCET INFECT DIS, V15, P1167, DOI 10.1016/S1473-3099(15)00074-2; LEE CM, 1992, VIROLOGY, V188, P265, DOI 10.1016/0042-6822(92)90756-F; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liu F, 2011, GUT, V60, P1269, DOI 10.1136/gut.2010.226225; Lyra AC, 2002, GASTROENTEROLOGY, V123, P1485, DOI 10.1053/gast.2002.36546; Macnaughton TB, 2003, J VIROL, V77, P12048, DOI 10.1128/JVI.77.22.12048-12056.2003; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Perez-del-Pulgar S, 2015, J GEN VIROL, V96, P3493, DOI 10.1099/jgv.0.000289; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Rodriguez-Frias F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037874; Sherman KE, 2010, J INFECT DIS, V201, P712, DOI 10.1086/650490; SOBRINO F, 1986, GENE, V50, P149, DOI 10.1016/0378-1119(86)90320-3; Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013; Team RC, 2016, R LANG ENV STAT COMP, V3.3.2; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; WANG KS, 1986, NATURE, V323, P508, DOI 10.1038/323508a0; Yin L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-108	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158557	10.1371/journal.pone.0158557	http://dx.doi.org/10.1371/journal.pone.0158557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362848	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200090
J	Li, X; Tse, VC; Lau, WCY; Cheung, BMY; Lip, GYH; Wong, ICK; Chan, EW				Li, Xue; Tse, Vicki C.; Lau, Wallis C. Y.; Cheung, Bernard M. Y.; Lip, Gregory Y. H.; Wong, Ian C. K.; Chan, Esther W.			Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses	PLOS ONE			English	Article							STROKE PREVENTION; ORAL ANTICOAGULANTS; INTRACRANIAL HEMORRHAGE; ASIAN PATIENTS; ASPIRIN; QUALITY; THERAPY; DABIGATRAN; EFFICACY; OUTCOMES	Objectives Many of the cost-effectiveness analyses of apixaban against warfarin focused on Western populations but Asian evidence remains less clear. The present study aims to evaluate the cost-effectiveness of apixaban against warfarin in Chinese patients with non-valvular atrial fibrillation (NVAF) from a public institutional perspective in Hong Kong. Methods We used a Markov model incorporating 12 health state transitions, and simulated the disease progression of NVAF in 1,000 hypothetical patients treated with apixaban/warfarin. Risks of clinical events were based on the ARISTOTLE trial and were adjusted with local International Normalized Ratio control, defined as the time in therapeutic range. Real-life input for the model, including patients' demographics and clinical profiles, post-event treatment patterns, and healthcare costs, were determined by a retrospective cohort of 40,569 incident patients retrieved from a Hong Kong-wide electronic medical database. Main outcome measurements included numbers of thromboembolic and bleeding events, life years, quality-adjusted life years (QALYs) and direct healthcare cost. When comparing apixaban and warfarin, treatment with incremental cost-effectiveness ratio (ICER) less than one local GDP per capita (USD 33,534 in 2014) was defined to be cost-effective. Results In the lifetime simulation, fewer numbers of events were estimated for the apixaban group, resulting in reduced event-related direct medical costs. The estimated ICER of apixaban was USD 7,057 per QALY at base-case analysis and ranged from USD 1,061 to 14,867 per QALY under the 116 tested scenarios in deterministic sensitivity analysis. While in probabilistic sensitivity analysis, the probability of apixaban being the cost-effective alternative to warfarin was 96% and 98% at a willingness to pay threshold of USD 33,534 and 100,602 per QALY, respectively. Conclusions Apixaban is likely to be a cost-effective alternative to warfarin for stroke prophylaxis in Chinese patients with NVAF in Hong Kong.	[Li, Xue; Tse, Vicki C.; Lau, Wallis C. Y.; Wong, Ian C. K.; Chan, Esther W.] Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Hong Kong, Peoples R China; [Cheung, Bernard M. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Wong, Ian C. K.] UCL, Sch Pharm, Res Dept Practice & Policy, London, England	University of Hong Kong; University of Hong Kong; University of Birmingham; University of London; University College London; University of London School of Pharmacy	Chan, EW (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Hong Kong, Peoples R China.	ewchan@hku.hk	/E-9829-2010; Lau, Wallis/J-3800-2018; Chan, Esther Wai Yin/B-3522-2012	/0000-0001-9106-7363; Lau, Wallis/0000-0003-2320-0470; Chan, Esther Wai Yin/0000-0002-7602-9470; Wong, Ian Chi Kei/0000-0001-8242-0014	Bristol Myers Squibb; Pfizer [260007295]; Janssen, a division of Johnson and Johnson; Eisai; Pharmaceutical Society of Hong Kong; University of Hong Kong; Early Career Scheme, Research Grants Council, Hong Kong; General Research Fund, Research Grants Council, Hong Kong	Bristol Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Janssen, a division of Johnson and Johnson; Eisai(Eisai Co Ltd); Pharmaceutical Society of Hong Kong; University of Hong Kong(University of Hong Kong); Early Career Scheme, Research Grants Council, Hong Kong; General Research Fund, Research Grants Council, Hong Kong	This study was supported by a grant from Bristol Myers Squibb and Pfizer (reference number: 260007295). EWC received financial support from Janssen, a division of Johnson and Johnson, Bristol Myers Squibb, Pfizer and Eisai; The Pharmaceutical Society of Hong Kong; The University of Hong Kong; Early Career Scheme and the General Research Fund, Research Grants Council, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademi Z, 2015, EUR J PREV CARDIOL, V22, P344, DOI 10.1177/2047487313514019; Albertsen IE, 2013, STROKE, V44, P1329, DOI 10.1161/STROKEAHA.113.000883; Boccuzzi SJ, 2009, CURR MED RES OPIN, V25, P2853, DOI 10.1185/03007990903196422; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chan EW, 2016, HEART RHYTHM, V13, P1581, DOI 10.1016/j.hrthm.2016.03.049; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Claassen DO, 2008, ARCH NEUROL-CHICAGO, V65, P1313, DOI 10.1001/archneur.65.10.1313; Clancy CM, 2005, HEALTH AFFAIR, V24, P151, DOI 10.1377/hlthaff.24.1.151; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443; Dorian P, 2014, EUR HEART J, V35, P1897, DOI 10.1093/eurheartj/ehu006; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Goto S, 2014, AM HEART J, V168, P303, DOI 10.1016/j.ahj.2014.06.005; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Ho CW, 2015, STROKE, V46, P23, DOI 10.1161/STROKEAHA.114.006476; Ho JCS, 2012, CLIN CARDIOL, V35, pE40, DOI 10.1002/clc.22069; Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Hong Kong Government Gazette, PROVISON FOR PUBLIC; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Lanitis T, 2014, THROMB RES, V134, P278, DOI 10.1016/j.thromres.2014.05.027; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047473; Lip GYH, 2014, CLIN THER, V36, P192, DOI 10.1016/j.clinthera.2013.12.011; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; National Institute for Health and Care Excellence, 2013, GUIDE TO THE METHODS; Reynolds MW, 2004, CHEST, V126, P1938, DOI 10.1378/chest.126.6.1938; Sabir I, 2014, NAT REV CARDIOL, V11, P290, DOI 10.1038/nrcardio.2014.22; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Stevanovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103974; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; Suzman R, GLOBAL HEALTH AND AG; The Commission on Macroeconomics and Health of the World Health Organization, MACROECONOMICS AND H; The Government of Hong Kong Special Administrative Region, HONG KONG THE FACTS; The World Bank, HONG KONG GDP PER CA; Tse HF, 2013, HEART RHYTHM, V10, P1082, DOI 10.1016/j.hrthm.2013.03.017; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185; Wang CJ, 2014, J STROKE CEREBROVASC, V23, P1157, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.006; Warren J, 2015, ATRIAL FIBRILLATION; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239; Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261; Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157129	10.1371/journal.pone.0157129	http://dx.doi.org/10.1371/journal.pone.0157129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362421	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200007
J	Santibanez, M; Garrastazu, R; Ruiz-Nunez, M; Helguera, JM; Arenal, S; Bonnardeux, C; Leon, C; Garcia-Rivero, JL				Santibanez, Miguel; Garrastazu, Roberto; Ruiz-Nunez, Mario; Manuel Helguera, Jose; Arenal, Sandra; Bonnardeux, Cristina; Leon, Carlos; Luis Garcia-Rivero, Juan			Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							RISK-FACTORS; COPD EXACERBATIONS; ADMISSION; DEATH	Background and Aim Exacerbations of chronic obstructive pulmonary disease (COPD) carry significant consequences for patients and are responsible for considerable health-care costs-particularly if hospitalization is required. Despite the importance of hospitalized exacerbations, relatively little is known about their determinants. This study aimed to analyze predictors of hospitalized exacerbations and mortality in COPD patients. Methods This was a retrospective population-based cohort study. We selected 900 patients with confirmed COPD aged >= 35 years by simple random sampling among all COPD patients in Cantabria (northern Spain) on December 31, 2011. We defined moderate exacerbations as events that led a care provider to prescribe antibiotics or corticosteroids and severe exacerbations as exacerbations requiring hospital admission. We observed exacerbation frequency over the previous year (2011) and following year (2012). We categorized patients according to COPD severity based on forced expiratory volume in 1 second (Global Initiative for Chronic Obstructive Lung Disease [GOLD] grades 1-4). We estimated the odds ratios (ORs) by logistic regression, adjusting for age, sex, smoking status, COPD severity, and frequent exacerbator phenotype the previous year. Results Of the patients, 16.4% had >= 1 severe exacerbations, varying from 9.3% in mild GOLD grade 1 to 44% in very severe COPD patients. A history of at least two prior severe exacerbations was positively associated with new severe exacerbations (adjusted OR, 6.73; 95% confidence interval [CI], 3.53-12.83) and mortality (adjusted OR, 7.63; 95% CI, 3.41-17.05). Older age and several comorbidities, such as heart failure and diabetes, were similarly associated. Conclusions Hospitalized exacerbations occurred with all grades of airflow limitation. A history of severe exacerbations was associated with new hospitalized exacerbations and mortality.	[Santibanez, Miguel] Univ Cantabria, IDIVAL, Prevent Med & Publ Hlth Area, Santander, Cantabria, Spain; [Garrastazu, Roberto] Ctr Salud Gama, Serv Cantabro Salud, Barcena De Cicero, Cantabria, Spain; [Ruiz-Nunez, Mario] Ctr Salud Lierganes, Serv Cantabro Salud, Miera, Cantabria, Spain; [Manuel Helguera, Jose] Ctr Salud Bajo Ason, Serv Cantabro Salud, Cantabria, Ampuero, Spain; [Arenal, Sandra] Ctr Salud Suances, Serv Cantabro Salud, Suances, Cantabria, Spain; [Bonnardeux, Cristina] Ctr Salud Campoo Los Valles, Serv Cantabro Salud, Mataporquera, Cantabria, Spain; [Leon, Carlos] Ctr Salud Suances, Serv Cantabro Salud, Suances, Cantabria, Spain; [Luis Garcia-Rivero, Juan] Hosp Laredo, Serv Cantabro Salud, Dept Pneumol, Laredo, Cantabria, Spain	Universidad de Cantabria	Santibanez, M (corresponding author), Univ Cantabria, IDIVAL, Prevent Med & Publ Hlth Area, Santander, Cantabria, Spain.	santibanezm@unican.es	Santibanez, Miguel/L-3323-2017	Santibanez, Miguel/0000-0003-2634-615X; GARCIA RIVERO, JUAN LUIS/0000-0002-6407-5832	Almirall; Boehringer-Ingelheim; Pfizer; Astra Zeneca; Chiesi; GlaxoSmithKline; Menarini; Takeda; Teva; Ferrer; Novartis; Mundipharma; AstraZeneca	Almirall(Almirall); Boehringer-Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); Astra Zeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); GlaxoSmithKline(GlaxoSmithKline); Menarini(Menarini Group); Takeda(Takeda Pharmaceutical Company Ltd); Teva(Teva Pharmaceutical Industries); Ferrer; Novartis(Novartis); Mundipharma; AstraZeneca(AstraZeneca)	Dr. Garcia Rivero reports receiving consulting and/or speaking fees from Almirall, Boehringer-Ingelheim, Pfizer, Astra Zeneca, Chiesi, GlaxoSmithKline, Menarini, Takeda, Teva, Ferrer and Novartis; Dr. Helguera, receives speaking fees from GlaxoSmithKline, Boehringer-Ingelheim, Novartis, Mundipharma, and AstraZeneca; Dr. Bonnardeaux, receives speaking fees from GlaxoSmithKline, Boehringer-Ingelheim, Ferrer, AstraZeneca, Teva, and Chiesi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; ANTHONISEN NR, 1986, AM REV RESPIR DIS, V133, P14, DOI 10.1164/arrd.1986.133.1.14; Bahadori Katayoon, 2007, Int J Chron Obstruct Pulmon Dis, V2, P241; Blasi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101228; Burge S, 2003, EUR RESPIR J, V41, p46s, DOI DOI 10.1183/09031936.03.00078002; Celli BR, 2015, EUR RESPIR REV, V24, P159, DOI 10.1183/16000617.00000315; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Garcia-Aymerich J, 2011, THORAX, V66, P585, DOI 10.1136/thx.2010.152876; Glasgow RE, 2005, MED CARE, V43, P551, DOI 10.1097/01.mlr.0000163645.41407.09; Gudmundsson G, 2005, EUR RESPIR J, V26, P414, DOI 10.1183/09031936.05.00078504; HofmansOkkes IM, 1996, FAM PRACT, V13, P294, DOI 10.1093/fampra/13.3.294; Holcomb WL, 2001, OBSTET GYNECOL, V98, P685, DOI 10.1016/S0029-7844(01)01488-0; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Soler-Cataluna JJ, 2009, RESP MED, V103, P692, DOI 10.1016/j.rmed.2008.12.005; Julian DG, 1997, INTERPRETING TRIAL R; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lusuardi M, 2008, Monaldi Arch Chest Dis, V69, P164; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Miravitlles M, 2000, RESPIRATION, V67, P495, DOI 10.1159/000067462; Miravitlles M, 2004, THORAX, V59, P387, DOI 10.1136/thx.2003.008730; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P155, DOI 10.1016/j.arbres.2013.09.001; Moreno A, 2009, ARCH BRONCONEUMOL, V45, P181, DOI 10.1016/j.arbres.2008.09.004; Muellerova H, 2015, CHEST, V147, P999, DOI 10.1378/chest.14-0655; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Pandya Dhruti, 2014, Open Respir Med J, V8, P59, DOI 10.2174/1874306401408010059; Persaud N, 2006, J EVAL CLIN PRACT, V12, P450, DOI 10.1111/j.1365-2753.2006.00730.x; Quintana JM, 2014, RESPIRATION, V88, P298, DOI 10.1159/000365996; Rowe BH, 2009, ACAD EMERG MED, V16, P316, DOI 10.1111/j.1553-2712.2009.00366.x; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; Solanes I, 2007, ARCH BRONCONEUMOL, V43, P445, DOI 10.1016/S1579-2129(07)60101-3; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Steer J, 2010, QJM-INT J MED, V103, P817, DOI 10.1093/qjmed/hcq126; Sullivan SD, 2000, CHEST, V117, P5; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Tsoumakidou M, 2004, RESP MED, V98, P178, DOI 10.1016/j.rmed.2003.09.011; Vestbo J, 2015, GLOBAL STRATEGY DIAG; Vestbo J, 2014, AM J RESP CRIT CARE, V189, P1022, DOI 10.1164/rccm.201311-2006PP; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181; Yang H, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-18; Zhou Y, 2009, EUR RESPIR J, V33, P509, DOI 10.1183/09031936.00084408	47	41	43	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158727	10.1371/journal.pone.0158727	http://dx.doi.org/10.1371/journal.pone.0158727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362765	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200110
J	Schabrun, SM; Lamont, RM; Brauer, SG				Schabrun, Siobhan M.; Lamont, Robyn M.; Brauer, Sandra G.			Transcranial Direct Current Stimulation to Enhance Dual-Task Gait Training in Parkinson's Disease: A Pilot RCT	PLOS ONE			English	Article							MAGNETIC STIMULATION; MOTOR-PERFORMANCE; IMPROVE GAIT; PEOPLE; WALKING; MECHANISMS; ATTENTION; MOVEMENT; VALIDITY; SINGLE	Objective To investigate the feasibility and safety of a combined anodal transcranial direct current stimulation (tDCS) and dual task gait training intervention in people with Parkinson's Disease (PD) and to provide data to support a sample size calculation for a fully powered trial should trends of effectiveness be present. Design A pilot, randomized, double-blind, sham-controlled parallel group trial with 12 week follow-up. Setting A university physiotherapy department. Interventions Sixteen participants diagnosed with PD received nine dual task gait training sessions over 3 weeks. Participants were randomized to receive either active or sham tDCS applied for the first 20 minutes of each session. Main Measures The primary outcome was gait speed while undertaking concurrent cognitive tasks (word lists, counting, conversation). Secondary measures included step length, cadence, Timed Up and Go, bradykinesia and motor speed. Results Gait speed, step length and cadence improved in both groups, under all dual task conditions. This effect was maintained at follow-up. There was no difference between the active and sham tDCS groups. Time taken to perform the TUG(words) also improved, with no difference between groups. The active tDCS group did however increase their correct cognitive response rate during the TUG(words) and TUG(count). Bradykinesia improved after training in both groups. Conclusion Three weeks of dual task gait training resulted in improved gait under dual task conditions, and bradykinesia, immediately following training and at 12 weeks follow-up. The only parameter enhanced by tDCS was the number of correct responses while performing the dual task TUG. tDCS applied to M1 may not be an effective adjunct to dual task gait training in PD.	[Schabrun, Siobhan M.] Univ Western Sydney, Sch Sci & Hlth, Brain Rehabil & Neuroplast Unit, Penrith, NSW, Australia; [Lamont, Robyn M.; Brauer, Sandra G.] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	Western Sydney University; University of Queensland	Schabrun, SM (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Brain Rehabil & Neuroplast Unit, Penrith, NSW, Australia.	s.schabrun@westernsydney.edu.au	Brauer, Sandra G/D-4519-2011	Brauer, Sandra G/0000-0001-9961-4739; Schabrun, Siobhan/0000-0002-9083-3107	Parkinson's Queensland Inc., Australia; Career Development Fellowship from The National Health and Medical Research Council of Australia [1105040]	Parkinson's Queensland Inc., Australia; Career Development Fellowship from The National Health and Medical Research Council of Australia	This study was supported by a seeding grant from Parkinson's Queensland Inc., Australia. SM Schabrun is supported by a Career Development Fellowship from The National Health and Medical Research Council of Australia (1105040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker K, 2007, ARCH PHYS MED REHAB, V88, P1593, DOI 10.1016/j.apmr.2007.07.026; Benninger DH, 2010, J NEUROL NEUROSUR PS, V81, P1105, DOI 10.1136/jnnp.2009.202556; Benninger DH, 2009, CLIN NEUROPHYSIOL, V120, P809, DOI 10.1016/j.clinph.2009.01.012; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Bond JM, 2000, ARCH PHYS MED REHAB, V81, P110, DOI 10.1016/S0003-9993(00)90230-2; Brauer SG, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-90; Brauer SG, 2010, GAIT POSTURE, V31, P229, DOI 10.1016/j.gaitpost.2009.10.011; Broeder S, 2015, NEUROSCI BIOBEHAV R, V57, P105, DOI 10.1016/j.neubiorev.2015.08.010; Canning CG, 2005, PARKINSONISM RELAT D, V11, P95, DOI 10.1016/j.parkreldis.2004.09.006; Canning CG, 2008, CLIN REHABIL, V22, P226, DOI 10.1177/0269215507082341; Domellof ME, 2011, MOVEMENT DISORD, V26, P2183, DOI 10.1002/mds.23814; Doruk D, 2014, NEUROSCI LETT, V582, P27, DOI 10.1016/j.neulet.2014.08.043; Fernandes A, 2015, SOMATOSENS MOT RES, V32, P122, DOI 10.3109/08990220.2014.1002605; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Galletly R, 2005, AUST J PHYSIOTHER, V51, P175, DOI 10.1016/S0004-9514(05)70024-6; Ghabra MB, 1999, NEUROLOGY, V52, P768, DOI 10.1212/WNL.52.4.768; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Kaski D, 2014, CLIN REHABIL, V28, P1115, DOI 10.1177/0269215514534277; Khedr EM, 2006, MOVEMENT DISORD, V21, P2201, DOI 10.1002/mds.21089; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Lefaucheur JP, 2004, CLIN NEUROPHYSIOL, V115, P2530, DOI 10.1016/j.clinph.2004.05.025; Mak MKY, 2013, J PHYSIOTHER, V59, P128, DOI 10.1016/S1836-9553(13)70167-X; Manenti R, 2014, NEUROSCI LETT, V580, P74, DOI 10.1016/j.neulet.2014.07.052; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Muslimovic D, 2007, BRAIN, V130, P2887, DOI 10.1093/brain/awm211; Nelson AJ, 2002, NEUROREHABILITATION, V17, P255; Rochester L, 2011, MOVEMENT DISORD, V26, P430, DOI 10.1002/mds.23450; Rothkegel H, 2009, NEUROREHAB NEURAL RE, V23, P373, DOI 10.1177/1545968308322842; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Siebner HR, 1999, NEUROREPORT, V10, P589, DOI 10.1097/00001756-199902250-00027; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Vervoort G, 2016, NEUROSCIENCE, V317, P36, DOI 10.1016/j.neuroscience.2015.12.056; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3; Yogev-Seligmann G, 2012, ARCH PHYS MED REHAB, V93, P176, DOI 10.1016/j.apmr.2011.06.005; Zhou JH, 2014, EUR J NEUROSCI, V39, P1343, DOI 10.1111/ejn.12492	40	35	42	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158497	10.1371/journal.pone.0158497	http://dx.doi.org/10.1371/journal.pone.0158497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359338	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200081
J	Wang, YY; Schroeder, HA; Nunn, KL; Woods, K; Anderson, DJ; Lai, SK; Cone, RA				Wang, Ying-Ying; Schroeder, Holly A.; Nunn, Kenetta L.; Woods, Karen; Anderson, Deborah J.; Lai, Samuel K.; Cone, Richard A.			Diffusion of Immunoglobulin G in Shed Vaginal Epithelial Cells and in Cell-Free Regions of Human Cervicovaginal Mucus	PLOS ONE			English	Article							HUMAN CERVICAL-MUCUS; MENSTRUAL-CYCLE; FLUID; MUCINS	Human cervicovaginal mucus (CVM) is a viscoelastic gel containing a complex mixture of mucins, shed epithelial cells, microbes and macromolecules, such as antibodies, that together serve as the first line of defense against invading pathogens. Here, to investigate the affinity between IgG and different mucus constituents, we used Fluorescence Recovery After Photobleaching (FRAP) to measure the diffusion of IgG in fresh, minimally modified CVM. We found that CVM exhibits substantial spatial variations that necessitate careful selection of the regions in which to perform FRAP. In portions of CVM devoid of cells, FRAP measurements using different IgG antibodies and labeling methods consistently demonstrate that both exogenous and endogenous IgG undergo rapid diffusion, almost as fast as in saline, in good agreement with the rapid diffusion of IgG in mid-cycle endocervical mucus that is largely devoid of cells. This rapid diffusion indicates the interactions between secreted mucins and IgG must be very weak and transient. IgG also accumulated in cellular debris and shed epithelial cells that had become permeable to IgG, which may allow shed epithelial cells to serve as reservoirs of secreted IgG. Interestingly, in contrast to cell-free regions of CVM, the diffusion of cell-associated IgG was markedly slowed, suggesting greater affinity between IgG and cellular constituents. Our findings contribute to an improved understanding of the role of IgG in mucosal protection against infectious diseases, and may also provide a framework for using FRAP to study molecular interactions in mucus and other complex biological environments.	[Wang, Ying-Ying; Woods, Karen; Cone, Richard A.] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Schroeder, Holly A.; Lai, Samuel K.] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Nunn, Kenetta L.; Lai, Samuel K.] Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Chapel Hill, NC USA; [Lai, Samuel K.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Anderson, Deborah J.] Boston Univ, Sch Med, Dept Obstet Gynecol, Boston, MA 02118 USA; [Anderson, Deborah J.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Anderson, Deborah J.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Boston University; Boston University; Boston University	Cone, RA (corresponding author), Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA.; Lai, SK (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA.; Lai, SK (corresponding author), Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Chapel Hill, NC USA.; Lai, SK (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.	lai@unc.edu; cone@jhu.edu	wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022	Lai, Samuel/0000-0003-4721-528X	National Institutes of Health [R21AI093242, U19AI096398, 1F32AI102535]; National Science Foundation CAREER Award [DMR-1151477]; Packard Foundation; Eshelman Institute of Innovation; startup funds from Eshelman School of Pharmacy at University of North Carolina-Chapel Hill;  [AI096398 S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM089569] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1151477] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Award(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Eshelman Institute of Innovation; startup funds from Eshelman School of Pharmacy at University of North Carolina-Chapel Hill; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Institutes of Health (http://www.nih.gov/) grants R21AI093242 (SKL), U19AI096398 (SKL, DJA and RAC), 1F32AI102535 (YYW), and Diversity Supplement AI096398 S1 (KLN); National Science Foundation (http://www.nsf.gov/) CAREER Award DMR-1151477 (SKL); Packard Foundation (https://www.packard.org/; SKL); Eshelman Institute of Innovation (http://unceii.org/; SKL), and startup funds from the Eshelman School of Pharmacy at the University of North Carolina-Chapel Hill (https://pharmacy.unc.edu/; SKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Chen A, 2014, BIOPHYS J, V106, P2028, DOI 10.1016/j.bpj.2014.02.038; CHIPPERFIELD EJ, 1975, INFECT IMMUN, V11, P215, DOI 10.1128/IAI.11.2.215-221.1975; Cone R., 1999, MUCOSAL IMMUNOLOGY, P43; Fahrbach KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076176; Georgiades P, 2014, BIOPOLYMERS, V101, P366, DOI 10.1002/bip.22372; Gipson IK, 1997, BIOL REPROD, V56, P999, DOI 10.1095/biolreprod56.4.999; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Gipson IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100393; Gunn B. M., 2016, MUCOSAL IMMUNOL; HILL JA, 1992, AM J OBSTET GYNECOL, V166, P720, DOI 10.1016/0002-9378(92)91703-D; KREMER J, 1992, HUM REPROD, V7, P781, DOI 10.1093/oxfordjournals.humrep.a137737; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nunn KL, 2015, MBIO, V6, DOI 10.1128/mBio.01084-15; ODEBLAD E, 1965, ACTA OBSTET GYN SCAN, V43, P360, DOI 10.3109/00016346409162686; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Rehan N, 1975, Fertil Steril, V26, P492; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011; Santos RS, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.46; SCHUMACHER GFB, 1988, HUM REPROD, V3, P289, DOI 10.1093/oxfordjournals.humrep.a136698; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; STONE A, 1959, AM J OBSTET GYNECOL, V78, P279, DOI 10.1016/0002-9378(59)90173-5; USALA SJ, 1989, J REPROD MED, V34, P292; WAGNER G, 1980, J REPROD FERTIL, V60, P17; Wang YY, 2014, MUCOSAL IMMUNOL, V7, P1036, DOI 10.1038/mi.2013.120; Wessler T, 2015, ACS INFECT IN PRESS	33	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158338	10.1371/journal.pone.0158338	http://dx.doi.org/10.1371/journal.pone.0158338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362256	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200060
J	Bloch, A; Tamir, D; Vakil, E; Zeilig, G				Bloch, Ayala; Tamir, Dror; Vakil, Eli; Zeilig, Gabi			Specific Deficit in Implicit Motor Sequence Learning following Spinal Cord Injury	PLOS ONE			English	Article							CLOSED HEAD-INJURY; REACTION-TIME-TASK; BASAL GANGLIA; SUPPORTED EMPLOYMENT; DEPRESSION; BRAIN; ANXIETY; MULTISITE; VETERANS; AMNESIA	Background Physical and psychosocial rehabilitation following spinal cord injury (SCI) leans heavily on learning and practicing new skills. However, despite research relating motor sequence learning to spinal cord activity and clinical observations of impeded skill-learning after SCI, implicit procedural learning following spinal cord damage has not been examined. Objective To test the hypothesis that spinal cord injury (SCI) in the absence of concomitant brain injury is associated with a specific implicit motor sequence learning deficit that cannot be explained by depression or impairments in other cognitive measures. Methods Ten participants with SCI in T1-T11, unharmed upper limb motor and sensory functioning, and no concomitant brain injury were compared to ten matched control participants on measures derived from the serial reaction time (SRT) task, which was used to assess implicit motor sequence learning. Explicit generation of the SRT sequence, depression, and additional measures of learning, memory, and intelligence were included to explore the source and specificity of potential learning deficits. Results There was no between-group difference in baseline reaction time, indicating that potential differences between the learning curves of the two groups could not be attributed to an overall reduction in response speed in the SCI group. Unlike controls, the SCI group showed no decline in reaction time over the first six blocks of the SRT task and no advantage for the initially presented sequence over the novel interference sequence. Meanwhile, no group differences were found in explicit learning, depression, or any additional cognitive measures. Conclusions The dissociation between impaired implicit learning and intact declarative memory represents novel empirical evidence of a specific implicit procedural learning deficit following SCI, with broad implications for rehabilitation and adjustment.	[Bloch, Ayala] Natl Inst Rehabil Brain Injured, Tel Aviv, Israel; [Tamir, Dror] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Vakil, Eli] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Vakil, Eli] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Zeilig, Gabi] Chaim Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Israel; [Zeilig, Gabi] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Hebrew University of Jerusalem; Bar Ilan University; Bar Ilan University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Bloch, A (corresponding author), Natl Inst Rehabil Brain Injured, Tel Aviv, Israel.	ayalabl@shikumil.org.il		Bloch, Ayala/0000-0002-1964-7053				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baddeley A. D., 1992, NEUROPSYCHOLOGY MEMO, P309; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CRAIG AR, 1994, BRIT J CLIN PSYCHOL, V33, P221, DOI 10.1111/j.2044-8260.1994.tb01116.x; Craig A, 2015, BRIT J HEALTH PSYCH, V20, P807, DOI 10.1111/bjhp.12143; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Golden CJ, 2008, NEUROPSYCHOLOGY INPA, P79; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; KNOPMAN D, 1991, NEUROPSYCHOLOGIA, V29, P245, DOI 10.1016/0028-3932(91)90085-M; Lum JAG, 2014, CORTEX, V51, P1, DOI 10.1016/j.cortex.2013.10.011; Lungu O, 2010, J NEUROPHYSIOL, V103, P2675, DOI 10.1152/jn.00006.2010; Macartney-Filgate M S, 1988, Arch Clin Neuropsychol, V3, P121, DOI 10.1016/0887-6177(88)90057-1; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Osterrieth PA., 1944, ARCH PSYCHOL-GENEVE, V30, P286; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Ottomanelli L, 2009, J REHABIL RES DEV, V46, P919, DOI 10.1682/JRRD.2008.10.0145; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rush AJ, 2005, NEUROPSYCHOPHARMACOL, V30, P405, DOI 10.1038/sj.npp.1300614; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Schueneman AL, 1982, SCI DIG, V4, P64; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; Siegert RJ, 2006, NEUROPSYCHOLOGY, V20, P490, DOI 10.1037/0894-4105.20.4.490; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Taylor L, 1991, COMPENDIUM NEUROPSYC; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Trieschmann RB, 1988, SPINAL CORD INJURIES; Vahdat S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002186; Vakil E, 1998, CHILD NEUROPSYCHOL, V4, P161, DOI 10.1076/chin.4.3.161.3173; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wilkinson L, 2004, J EXP PSYCHOL LEARN, V30, P354, DOI 10.1037/0278-7393.30.2.354; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042993	51	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158396	10.1371/journal.pone.0158396	http://dx.doi.org/10.1371/journal.pone.0158396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355834	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400058
J	Chen, C; Wang, JH; Cai, RP; Yuan, YM; Guo, ZY; Grewer, C; Zhang, Z				Chen, Chen; Wang, Jiahong; Cai, Ruiping; Yuan, Yanmeng; Guo, Zhanyun; Grewer, Christof; Zhang, Zhou			Identification of a Disulfide Bridge in Sodium-Coupled Neutral Amino Acid Transporter 2(SNAT2) by Chemical Modification	PLOS ONE			English	Article							TISSUE EXPRESSION PATTERN; SYSTEM-A; GLUTAMINE TRANSPORTER; FUNCTIONAL-CHARACTERISTICS; CYSTEINE RESIDUES; SKELETAL-MUSCLE; FAMILIES SLC32; SNAT2; CELL; SUBTYPE	Sodium-coupled neutral amino acid transporter 2 (SNAT2) belongs to solute carrier 38 (SLC38) family of transporters, which is ubiquitously expressed in mammalian tissues and mediates transport of small, neutral amino acids, exemplified by alanine(Ala, A). Yet structural data on SNAT2, including the relevance of intrinsic cysteine residues on structure and function, is scarce, in spite of its essential roles in many tissues. To better define the potential of intrinsic cysteines to form disulfide bonds in SNAT2, mutagenesis experiments and thiol-specific chemical modifications by N-ethylmaleimide (NEM) and methoxy-polyethylene glycol maleimide (mPEG-Mal, MW 5000) were performed, with or without the reducing regent dithiothreitol (DTT) treatment. Seven single mutant transporters with various cysteine (Cys, C) to alanine (Ala, A) substitutions, and a C245,279A double mutant were introduced to SNAT2 with a hemagglutinin (HA) tag at the C-terminus. The results showed that the cells expressing C245A or C279A were labeled by one equivalent of mPEG-Mal in the presence of DTT, while wild-type or all the other single Cys to Ala mutants were modified by two equivalents of mPEG-Mal. Furthermore, the molecular weight of C245,279A was not changed in the presence or absence of DTT treatment. The results suggest a disulfide bond between Cys245 and Cys279 in SNAT2 which has no effect on cell surface trafficking, as well as transporter function. The proposed disulfide bond may be important to delineate proximity in the extracellular domain of SNAT2 and related proteins.	[Chen, Chen; Wang, Jiahong; Cai, Ruiping; Yuan, Yanmeng; Zhang, Zhou] Shenyang Pharmaceut Univ, Coll Life Sci & Biopharm, Shenyang 110015, Peoples R China; [Guo, Zhanyun] Tongji Univ, Inst Prot Res, Coll Life Sci & Technol, Shanghai 200092, Peoples R China; [Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Grewer, Christof] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA	Shenyang Pharmaceutical University; Tongji University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Zhang, Z (corresponding author), Shenyang Pharmaceut Univ, Coll Life Sci & Biopharm, Shenyang 110015, Peoples R China.	zzhouzhang@163.com			Innovation Program of Shanghai Municipal Education Commission [13ZZ103]; National Natural Science Foundation of China [31270883]; National Science Foundation [1515028]	Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	This research was funded by the Innovation Program of Shanghai Municipal Education Commission (Grant No. 13ZZ103) and the National Natural Science Foundation of China (Grant No. 31270883) to Zhou Zhang and National Science Foundation award #1515028 to Christof Grewer.	Baird FE, 2006, BIOCHEM J, V397, P369, DOI 10.1042/BJ20060026; BARKER GA, 1990, EXP PHYSIOL, V75, P3, DOI 10.1113/expphysiol.1990.sp003382; Bevilacqua E, 2005, FEBS LETT, V579, P3376, DOI 10.1016/j.febslet.2005.05.002; Blot A, 2009, NEUROSCIENCE, V164, P998, DOI 10.1016/j.neuroscience.2009.09.015; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Bror S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y; Calderon-Rivera A, 2012, CELL CALCIUM, V51, P22, DOI 10.1016/j.ceca.2011.10.002; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; Cook JV, ENDOCRINOLOGY, V138, P2800; Dorn M, 2009, J BIOL CHEM, V284, P22123, DOI 10.1074/jbc.M109.023713; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Evans K, 2008, J AM SOC NEPHROL, V19, P2119, DOI 10.1681/ASN.2007101108; Evans K, 2007, J AM SOC NEPHROL, V18, P1426, DOI 10.1681/ASN.2006091014; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Franchi-Gazzola R, 2004, BBA-BIOMEMBRANES, V1667, P157, DOI 10.1016/j.bbamem.2004.09.012; Frandberg PA, 2001, BIOCHEM BIOPH RES CO, V281, P851, DOI 10.1006/bbrc.2001.4429; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Gagnon DG, 2006, J GEN PHYSIOL, V127, P145, DOI 10.1085/jgp.200509439; Gammelsaeter R, 2009, BIOCHEM BIOPH RES CO, V381, P378, DOI 10.1016/j.bbrc.2009.02.062; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Guo ZY, 2005, BIOCHEMISTRY-US, V44, P6537, DOI 10.1021/bi047409b; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Hatanaka T, 2000, BBA-BIOMEMBRANES, V1467, P1, DOI 10.1016/S0005-2736(00)00252-2; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Jenstad M, 2009, CEREB CORTEX, V19, P1092, DOI 10.1093/cercor/bhn151; JOHNSON LW, 1988, AM J PHYSIOL, V254, pC773, DOI 10.1152/ajpcell.1988.254.6.C773; KILBERG MS, 1980, J BIOL CHEM, V255, P4011; Lambert G, 2000, J MEMBRANE BIOL, V176, P143, DOI 10.1007/s002320001083; Lee IP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109803; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; Messens J, 2013, ANTIOXID REDOX SIGN, V18, P1594, DOI 10.1089/ars.2012.5156; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Nakanishi T, 2001, AM J PHYSIOL-CELL PH, V281, pC1757, DOI 10.1152/ajpcell.2001.281.6.C1757; Okudaira H, 2011, J NUCL MED, V52, P822, DOI 10.2967/jnumed.110.086074; Ortiz V, 2011, AM J PHYSIOL-ENDOC M, V300, pE1092, DOI 10.1152/ajpendo.00459.2010; OXENDER DL, 1963, J BIOL CHEM, V238, P3686; PADMANABHAN R, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0056792; Padmanabhan Rugmani, 2012, Int J Biochem Mol Biol, V3, P374; Palmada Monica, 1998, Frontiers in Bioscience, V3, pD701; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Varoqui H, 2002, BIOCHEM BIOPH RES CO, V290, P903, DOI 10.1006/bbrc.2001.6281; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang Z, 2008, J BIOL CHEM, V283, P12284, DOI 10.1074/jbc.M706774200; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776; Zhang Z, 2011, BIOCHEM J, V434, P287, DOI 10.1042/BJ20100507; Zhang Z, 2009, J BIOL CHEM, V284, P25314, DOI 10.1074/jbc.M109.038422	65	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158319	10.1371/journal.pone.0158319	http://dx.doi.org/10.1371/journal.pone.0158319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355203	gold, Green Submitted, Green Published			2022-12-27	WOS:000378859400050
J	Lee, JY; Linge, HM; Ochani, K; Lin, K; Miller, EJ				Lee, Ji Young; Linge, Helena M.; Ochani, Kanta; Lin, Ke; Miller, Edmund J.			N-Ethylmaleimide Sensitive Factor (NSF) Inhibition Prevents Vascular Instability following Gram-Positive Pulmonary Challenge	PLOS ONE			English	Article							WEIBEL-PALADE BODIES; ENDOTHELIAL-CELLS; SEPTIC SHOCK; EXOCYTOSIS; SEPSIS; ANGIOPOIETIN-2; MORTALITY; INJURY; CARE	Background The Acute Respiratory Distress Syndrome (ARDS), remains a significant source of morbidity and mortality in critically ill patients. Pneumonia and sepsis are leading causes of ARDS, the pathophysiology of which includes increased pulmonary microvascular permeability and hemodynamic instability resulting in organ dysfunction. We hypothesized that N-ethylmaleimide sensitive factor (NSF) regulates exocytosis of inflammatory mediators, such as Angiopoietin-2 (Ang-2), and cytoskeletal stability by modulating myosin light chain (MLC) phosphorylation. Therefore, we challenged pulmonary cells, in vivo and in vitro, with Gram Positive bacterial cell wall components, lipoteichoic acid (LTA), and peptidoglycan (PGN) and examined the effects of NSF inhibition. Methods Mice were pre-treated with an inhibitor of NSF, TAT-NSF700 (to prevent Ang-2 release). After 30min, LTA and PGN (or saline alone) were instilled intratracheally. Pulse oximetry was assessed in awake mice prior to, and 6 hour post instillation. Post mortem, tissues were collected for studies of inflammation and Ang-2. In vitro, pulmonary endothelial cells were assessed for their responses to LTA and PGN. Results Pulmonary challenge induced signs of airspace and systemic inflammation such as changes in neutrophil counts and protein concentration in bronchoalveolar lavage fluid and tissue Ang-2 concentration, and decreased physiological parameters including oxygen saturation and pulse distention. TAT-NSF700 pre-treatment reduced LTA-PGN induced changes in lung tissue Ang-2, oxygen saturation and pulse distention. In vitro, LTA-PGN induced a rapid (<2 min) release of Ang-2, which was significantly attenuated by TAT-NSF700 or anti TLR2 antibody. Furthermore, TAT-NSF700 reduced LTA-PGN-induced MLC phosphorylation at low concentrations of 1-10 nM. Conclusions TAT-NSF700 decreased Ang-2 release, improved oxygen saturation and pulse distention following pulmonary challenge by inhibiting MLC phosphorylation, an important component of endothelial cell retraction. The data suggest that inhibition of NSF in pneumonia and sepsis may be beneficial to prevent the pulmonary microvascular and hemodynamic instability associated with ARDS.	[Lee, Ji Young; Miller, Edmund J.] Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA; [Linge, Helena M.; Ochani, Kanta; Lin, Ke; Miller, Edmund J.] Feinstein Inst Med Res, Ctr Heart & Lung Res, Manhasset, NY USA; [Miller, Edmund J.] Hofstra North Shore LIJ Med Sch, Hempstead, NY USA; [Lee, Ji Young] Univ S Alabama, Dept Pulm & Crit Care Med, Mobile, AL 36688 USA	Northwell Health; Northwell Health; Hofstra University; University of South Alabama	Lee, JY (corresponding author), Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA.; Lee, JY (corresponding author), Univ S Alabama, Dept Pulm & Crit Care Med, Mobile, AL 36688 USA.	jiyounglee98@gmail.com		Linge, Helena/0000-0002-8919-0300; Lee, Ji Young/0000-0002-8005-2446	Elmezzi Graduate School of Molecular Medicine; Feinstein Institute for Medical Research	Elmezzi Graduate School of Molecular Medicine; Feinstein Institute for Medical Research	This study was supported by funds from The Elmezzi Graduate School of Molecular Medicine and The Feinstein Institute for Medical Research.	Aikawa N, 1996, Nihon Geka Gakkai Zasshi, V97, P771; Aird WC, ROLE ENDOTHELIUM SEV, P3765; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Calvert JW, 2007, CIRC RES, V101, P1247, DOI 10.1161/CIRCRESAHA.107.162610; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Friedman G, 1998, INTENS CARE MED, V24, P118, DOI 10.1007/s001340050531; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Goel A, 2010, CIRC RES, V107, P242, DOI 10.1161/CIRCRESAHA.109.210229; Linge HM, 2015, EXP LUNG RES, V41, P216, DOI 10.3109/01902148.2014.999174; Linge HM, 2010, CRITICAL CARE S2, V14, pP8; Matsushita K, 2005, MOL PHARMACOL, V67, P1137, DOI 10.1124/mol.104.004275; Morrell CN, 2005, J PHARMACOL EXP THER, V314, P155, DOI 10.1124/jpet.104.082529; National Institutes of Health. National Heart LaBI, 2007, NAT HEART LABI AC RE; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Pittoni GM, 2009, CURR OPIN ANESTHESIO, V22, P232, DOI 10.1097/ACO.0b013e328323f9a8; Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Sheldon R, 1993, ROLE MYOSIN LIGHT CH, pL606; Shen Q, 2010, MYOSIN LIGHT CHAIN K, P272; Siner JM, 2009, SHOCK, V31, P348, DOI 10.1097/SHK.0b013e318188bd06; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tran Q. -K., 2006, V176, P145; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; Valentijn KM, 2010, MULTIGRANULAR EXOCYT; Vincent JL, 1998, J ANTIMICROB CHEMOTH, V41, P9, DOI 10.1093/jac/41.suppl_1.9; Wu SW, 2014, PULM CIRC, V4, P110, DOI 10.1086/674879; Yamakuchi Munekazu, 2008, V440, P203, DOI 10.1007/978-1-59745-178-9_15; Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549; Zupancic G, 2002, J PHYSIOL-LONDON, V544, P741, DOI 10.1113/jphysiol.2002.027490	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157837	10.1371/journal.pone.0157837	http://dx.doi.org/10.1371/journal.pone.0157837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355324	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400021
J	Pallister, T; Jennings, A; Mohney, RP; Yarand, D; Mangino, M; Cassidy, A; MacGregor, A; Spector, TD; Menni, C				Pallister, Tess; Jennings, Amy; Mohney, Robert P.; Yarand, Darioush; Mangino, Massimo; Cassidy, Aedin; MacGregor, Alexander; Spector, Tim D.; Menni, Cristina			Characterizing Blood Metabolomics Profiles Associated with Self-Reported Food Intakes in Female Twins	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; CHAIN AMINO-ACIDS; ATHEROSCLEROSIS RISK; AFRICAN-AMERICANS; METABOLITE LEVELS; HUMAN-POPULATIONS; OXIDATIVE DAMAGE; GUT PERMEABILITY; DIETARY-INTAKE	Using dietary biomarkers in nutritional epidemiological studies may better capture exposure and improve the level at which diet-disease associations can be established and explored. Here, we aimed to identify and evaluate reproducibility of novel biomarkers of reported habitual food intake using targeted and non-targeted metabolomic blood profiling in a large twin cohort. Reported intakes of 71 food groups, determined by FFQ, were assessed against 601 fasting blood metabolites in over 3500 adult female twins from the TwinsUK cohort. For each metabolite, linear regression analysis was undertaken in the discovery group (excluding MZ twin pairs discordant [>= 1 SD apart] for food group intake) with each food group as a predictor adjusting for age, batch effects, BMI, family relatedness and multiple testing (1.17x10(-6) = 0.05/[71 food groups x 601 detected metabolites]). Significant results were then replicated (non-targeted: P<0.05; targeted: same direction) in the MZ discordant twin group and results from both analyses meta-analyzed. We identified and replicated 180 significant associations with 39 food groups (P<1.17x10(-6)), overall consisting of 106 different metabolites (74 known and 32 unknown), including 73 novel associations. In particular we identified trans-4-hydroxyproline as a potential marker of red meat intake (0.075[0.009]; P = 1.08x10(-17)), ergothioneine as a marker of mushroom consumption (0.181[0.019]; P = 5.93x10(-22)), and three potential markers of fruit consumption (top association: apple and pears): including metabolites derived from gut bacterial transformation of phenolic compounds, 3-phenylpropionate (0.024[0.004]; P = 1.24x10(-8)) and indolepropionate (0.026[0.004]; P = 2.39x10(-9)), and threitol (0.033[0.003]; P = 1.69x10(-21)). With the largest nutritional metabolomics dataset to date, we have identified 73 novel candidate biomarkers of food intake for potential use in nutritional epidemiological studies. We compiled our findings into the DietMetab database (http://www.twinsuk.ac.uk/dietmetab-data/), an online tool to investigate our top associations.	[Pallister, Tess; Yarand, Darioush; Mangino, Massimo; Spector, Tim D.; Menni, Cristina] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Jennings, Amy; Cassidy, Aedin; MacGregor, Alexander] Univ E Anglia, Norwich Med Sch, Dept Nutr, Norwich, Norfolk, England; [Mohney, Robert P.] Metabolon Inc, Durham, NC USA	University of London; King's College London; University of East Anglia; Metabolon	Pallister, T (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.	tess.pallister@kcl.ac.uk	Mangino, Massimo/F-5134-2011	Mangino, Massimo/0000-0002-2167-7470; MacGregor, Alex/0000-0003-2163-2325; Menni, Cristina/0000-0001-9790-0571	Wellcome Trust; European Community; National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; Pfizer; Royal Society Wolfson Research Merit Award; Metabolon, Inc.; King's College London; MRC [MR/M004422/1] Funding Source: UKRI; Medical Research Council [MR/M004422/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; Pfizer(Pfizer); Royal Society Wolfson Research Merit Award(Royal Society of London); Metabolon, Inc.; King's College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	TwinsUK was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. Metabolomic analysis was funded by Pfizer. Aedin Cassidy is a Royal Society Wolfson Research Merit Award Holder. Metabolon, Inc. provided support in the form of salary for author Robert P. Mohney, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Abdullah MMH, 2015, BRIT J NUTR, V113, P435, DOI 10.1017/S0007114514003894; Alexander D, 2011, EUR J CLIN INVEST, V41, P527, DOI 10.1111/j.1365-2362.2010.02441.x; Altmaier E, 2011, EUR J EPIDEMIOL, V26, P145, DOI 10.1007/s10654-010-9524-7; Anson NM, 2009, J AGR FOOD CHEM, V57, P6148, DOI 10.1021/jf900492h; Ballatori N, 2008, AM J PHYSIOL-GASTR L, V295, pG179, DOI 10.1152/ajpgi.90319.2008; Barawkar DA, 2012, BIOORG MED CHEM LETT, V22, P4341, DOI 10.1016/j.bmcl.2012.05.020; Bene J, 2005, WORLD J GASTROENTERO, V11, P6671, DOI 10.3748/wjg.v11.i42.6671; Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102; Bondia-Pons I, 2013, MOL NUTR FOOD RES, V57, P412, DOI 10.1002/mnfr.201200571; BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003; Charlton KE, 2012, BRIT J NUTR, V107, P1037, DOI 10.1017/S0007114511003850; Deiana M, 2004, CLIN NUTR, V23, P183, DOI 10.1016/S0261-5614(03)00108-0; DELANGHE J, 1989, CLIN CHEM, V35, P1802; Ey J, 2007, J AGR FOOD CHEM, V55, P6466, DOI 10.1021/jf071328f; Floegel A, 2013, EUR J CLIN NUTR, V67, P1100, DOI 10.1038/ejcn.2013.147; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Franceschini N, 2014, CLIN J AM SOC NEPHRO, V9, P150, DOI 10.2215/CJN.02300213; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Goncalves I, 2012, ARTERIOSCL THROM VAS, V32, P1505, DOI 10.1161/ATVBAHA.112.249854; Guertin KA, 2014, AM J CLIN NUTR, V100, P208, DOI 10.3945/ajcn.113.078758; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jensen BM, 2015, EUR J NUTR; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Jin M, 2015, NEUROBIOL DIS, V82, P152, DOI 10.1016/j.nbd.2015.05.020; JOHNSON IT, 1986, J NUTR, V116, P2270, DOI 10.1093/jn/116.11.2270; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Karbownik M, 2001, J CELL BIOCHEM, V81, P507, DOI 10.1002/1097-4644(20010601)81:3<507::AID-JCB1064>3.0.CO;2-M; Kasuya F, 1996, BIOCHEM PHARMACOL, V51, P805, DOI 10.1016/0006-2952(95)02399-2; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kiyohara C, 2014, ARTHRIT CARE RES, V66, P1048, DOI 10.1002/acr.22282; Knudsen D, 2008, BRIT J NUTR, V100, P120, DOI 10.1017/S0007114507886338; Lee YH, 2012, HUM IMMUNOL, V73, P805, DOI 10.1016/j.humimm.2012.05.004; Li RWS, 2014, J PHARMACOL EXP THER, V350, P691, DOI 10.1124/jpet.114.214049; Lindner I, 2006, MOL NUTR FOOD RES, V50, P270, DOI 10.1002/mnfr.200500241; Lindtner C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005123; Ling Y, 2014, DIABETIC MED, V31, P1350, DOI 10.1111/dme.12528; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Lustgarten MS, 2014, J GERONTOL A-BIOL, V69, P717, DOI 10.1093/gerona/glt152; Maiti S, 2015, ARCH PHYSIOL BIOCHEM, V121, P68, DOI 10.3109/13813455.2014.992440; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094; Menni C, 2013, METABOLOMICS, V9, P506, DOI 10.1007/s11306-012-0469-6; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Nakayama A, 2013, HUM CELL, V26, P133, DOI 10.1007/s13577-013-0073-8; O'Sullivan A, 2011, AM J CLIN NUTR, V93, P314, DOI 10.3945/ajcn.110.000950; Ohara H, 2007, J AGR FOOD CHEM, V55, P1532, DOI 10.1021/jf062834s; Ou KQ, 2014, MOL NUTR FOOD RES, V58, P2196, DOI 10.1002/mnfr.201400243; Qi QB, 2015, J LIPID RES, V56, P713, DOI 10.1194/jlr.P055715; Rodriguez A, 2015, CLIN BIOCH; Rodriguez-Suarez Eva, 2012, Methods Mol Biol, V909, P241, DOI 10.1007/978-1-61779-959-4_16; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Safranow K, 2005, J CHROMATOGR B, V819, P229, DOI 10.1016/j.jchromb.2004.11.013; Sampson JN, 2013, CANCER EPIDEM BIOMAR, V22, P631, DOI 10.1158/1055-9965.EPI-12-1109; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Smith CE, 2015, MOL NUTR FOOD RES, V59, P1373, DOI 10.1002/mnfr.201400734; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Sun H, 2015, GENE THER, V22, P341, DOI 10.1038/gt.2014.114; SUZUKI T, 1975, BIOCHEM J, V146, P87, DOI 10.1042/bj1460087; Teucher B, 2007, TWIN RES HUM GENET, V10, P734, DOI 10.1375/twin.10.5.734; Trysberg E, 2004, ARTHRITIS RES THER, V6, pR129, DOI 10.1186/ar1040; van Dorsten FA, 2012, J AGR FOOD CHEM, V60, P11331, DOI 10.1021/jf303165w; Westerterp KR, 2002, CURR OPIN CLIN NUTR, V5, P489, DOI 10.1097/00075197-200209000-00006; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wittenbecher C, 2015, AM J CLIN NUTR, V101, P1241, DOI 10.3945/ajcn.114.099150; Wolever TMS, 2010, AM J CLIN NUTR, V92, P723, DOI 10.3945/ajcn.2010.29174; Xu M, 2015, J NUTR, V145, P1289, DOI 10.3945/jn.115.212514; Yamagishi K, 2008, AM HEART J, V156, P965, DOI 10.1016/j.ahj.2008.06.017; Yang Q, 2015, INT J CLIN EXP PATHO, V8, P7318; Yousri NA, 2014, METABOLOMICS, V10, P1005, DOI 10.1007/s11306-014-0629-y; Zheng Y, 2014, AM J EPIDEMIOL, V179, P1424, DOI 10.1093/aje/kwu073; Zheng Y, 2014, AM J CLIN NUTR, V99, P1470, DOI 10.3945/ajcn.113.074070	74	67	67	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158568	10.1371/journal.pone.0158568	http://dx.doi.org/10.1371/journal.pone.0158568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355821	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000378859400079
J	Dumonteil, E; Herrera, C; Martini, L; Grijalva, MJ; Guevara, AG; Costales, JA; Aguilar, HM; Breniere, SF; Waleckx, E				Dumonteil, Eric; Herrera, Claudia; Martini, Luiggi; Grijalva, Mario J.; Guevara, Angel G.; Costales, Jaime A.; Marcelo Aguilar, H.; Frederique Breniere, S.; Waleckx, Etienne			Chagas Disease Has Not Been Controlled in Ecuador	PLOS ONE			English	Editorial Material							TRYPANOSOMA-CRUZI INFECTION; VECTOR CONTROL; AMAZON REGION; RISK-FACTORS; SEROPREVALENCE; SEROPOSITIVITY; TRIATOMINE; ACCESS		[Dumonteil, Eric; Waleckx, Etienne] Univ Autonoma Yucatan, Ctr Invest Reg Hideyo Noguchi, Lab Parasitol, Merida, Yucatan, Mexico; [Dumonteil, Eric; Herrera, Claudia] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, Vector Borne Infect Dis Res Ctr, New Orleans, LA USA; [Martini, Luiggi] Lab Parasitol L Martini & Colaboradores, Guayaquil, Ecuador; [Grijalva, Mario J.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Trop Dis Inst, Athens, OH 45701 USA; [Grijalva, Mario J.; Costales, Jaime A.; Frederique Breniere, S.] Pontifical Catholic Univ Ecuador, Sch Biol Sci, Ctr Infect & Chron Dis Res, Quito, Ecuador; [Guevara, Angel G.] Univ Cent Ecuador, Ctr Biomed, Carrera Med, Quito, Ecuador; [Marcelo Aguilar, H.] Univ Cent Ecuador, Fac Ciencias Med, Inst Super Invest & Posgrad, Unidad Salud Publ, Quito, Ecuador; [Frederique Breniere, S.] IRD, UMR INTERTRYP, IRD CIRAD, Interact Hosts Vectors Parasites Environm Trop Ne, TA A-17-G,Campus Int Baillarguet, Montpellier, France	Universidad Autonoma de Yucatan; Tulane University; Ohio University; Pontificia Universidad Catolica del Ecuador; Universidad Central del Ecuador; Universidad Central del Ecuador; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Dumonteil, E (corresponding author), Univ Autonoma Yucatan, Ctr Invest Reg Hideyo Noguchi, Lab Parasitol, Merida, Yucatan, Mexico.; Dumonteil, E (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, Vector Borne Infect Dis Res Ctr, New Orleans, LA USA.	oliver@correo.uady.mx	Grijalva, Mario J/U-8356-2018; Waleckx, Etienne/GOG-9370-2022; Waleckx, Etienne/G-2439-2017; Breniere, Simone Frederique/J-9214-2016	Grijalva, Mario J/0000-0003-1964-1425; Waleckx, Etienne/0000-0002-3270-6476; Costales, Jaime/0000-0001-9418-6640; Breniere, Simone Frederique/0000-0003-4385-3989; Dumonteil, Eric/0000-0001-9376-0209				Abad-Franch F, 2003, CONTROL ENFERMEDAD C; Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; Amunarriz M, 2010, REV PANAM SALUD PUBL, V28, P25, DOI 10.1590/S1020-49892010000700004; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Black CL, 2007, J PARASITOL, V93, P12, DOI 10.1645/GE-899R.1; Black CL, 2009, AM J TROP MED HYG, V81, P1035, DOI 10.4269/ajtmh.2009.08-0594; Gestal MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138311; Costales JA, 2015, AM J TROP MED HYG, V92, P807, DOI 10.4269/ajtmh.14-0562; Forsyth C, 2015, SOC SCI MED, V145, P7, DOI 10.1016/j.socscimed.2015.09.022; Grijalva MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004142; Grijalva MJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-20; Grijalva MJ, 2003, AM J TROP MED HYG, V69, P380, DOI 10.4269/ajtmh.2003.69.380; Grijalva MJ, 1997, AM J TROP MED HYG, V57, P740, DOI 10.4269/ajtmh.1997.57.740; Guevara A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-358; Guevara Angel G, 2013, Trop Med Health, V41, P21, DOI 10.2149/tmh.2012-31; Manne JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002488; Ministerio de Salud Publica, 2013, MAN PROC SUBS AL ACC, P220; Nieto-Sanchez C, 2015, MEM I O CRUZ, V0; Quinde-Calderon L, 2016, TROP MED INT HEALTH, V21, P84, DOI 10.1111/tmi.12620; Buitrago NLR, 2013, INFECT GENET EVOL, V19, P141, DOI 10.1016/j.meegid.2013.07.002; Tarleton RL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003219; Vargas CC, 2015, AM J TROP MED HYG, V93, P774, DOI 10.4269/ajtmh.14-0807; Villa L, 2007, MEM I OSWALDO CRUZ, V102, P87, DOI 10.1590/S0074-02762007005000081; Villacis AG, 2015, AM J TROP MED HYG, V92, P187, DOI 10.4269/ajtmh.14-0250; Waleckx E, 2015, MEM I OSWALDO CRUZ, V110, P324, DOI 10.1590/0074-02760140409	25	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158145	10.1371/journal.pone.0158145	http://dx.doi.org/10.1371/journal.pone.0158145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351178	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900037
J	Johnson, GJ; Slater, BCS; Leis, LA; Rector, TS; Bach, RR				Johnson, Gerhard J.; Slater, Billie C. S.; Leis, Linda A.; Rector, Thomas S.; Bach, Ronald R.			Blood Biomarkers of Chronic Inflammation in Gulf War Illness	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CHRONIC MULTISYMPTOM ILLNESS; CORONARY-HEART-DISEASE; ACID-BINDING PROTEIN; NEUROTROPHIC FACTOR; DIFFERENTIAL EXPRESSION; MYOCARDIAL-INFARCTION; CYTOKINE EXPRESSION; LYMPHOCYTE RATIO; SERUM-LEVELS	Background More than twenty years following the end of the 1990-1991 Gulf War it is estimated that approximately 300,000 veterans of this conflict suffer from an unexplained chronic, multi system disorder known as Gulf War Illness (GWI). The etiology of GWI may be exposure to chemical toxins, but it remains only partially defined, and its case definition is based only on symptoms. Objective criteria for the diagnosis of GWI are urgently needed for diagnosis and therapeutic research. Objective This study was designed to determine if blood biomarkers could provide objective criteria to assist diagnosis of GWI. Design A surveillance study of 85 Gulf War Veteran volunteers identified from the Department of Veterans Affairs Minnesota Gulf War registry was performed. All subjects were deployed to the Gulf War. Fifty seven subjects had GWI defined by CDC criteria, and 28 did not have symptomatic criteria for a diagnosis of GWI. Statistical analyses were performed on peripheral blood counts and assays of 61 plasma proteins using the Mann-Whitney rank sum test to compare biomarker distributions and stepwise logistic regression to formulate a diagnostic model. Results Lymphocyte, monocyte, neutrophil, and platelet counts were higher in GWI subjects. Six serum proteins associated with inflammation were significantly different in GWI subjects. A diagnostic model of three biomarkers lymphocytes, monocytes, and C reactive protein had a predicted probability of 90% (CI 76-90%) for diagnosing GWI when the probability of having GWI was above 70%. Significance The results of the current study indicate that inflammation is a component of the pathobiology of GWI. Analysis of the data resulted in a model utilizing three readily measurable biomarkers that appears to significantly augment the symptom-based case definition of GWI. These new observations are highly relevant to the diagnosis of GWI, and to therapeutic trials.	[Johnson, Gerhard J.; Slater, Billie C. S.; Leis, Linda A.; Rector, Thomas S.; Bach, Ronald R.] Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; [Johnson, Gerhard J.; Rector, Thomas S.; Bach, Ronald R.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Johnson, GJ (corresponding author), Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA.; Johnson, GJ (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	gerhard.johnson@va.gov		Slater, Billie C.S./0000-0003-0738-5639	Department of Defense Congressionally Directed Medical Research Programs/Gulf War Illness Research Program [W81XWH-09-2-0047]	Department of Defense Congressionally Directed Medical Research Programs/Gulf War Illness Research Program	This work was supported by Department of Defense Congressionally Directed Medical Research Programs/Gulf War Illness Research Program Grant Number W81XWH-09-2-0047.	Aguilar-Valles A, 2015, NEUROPHARMACOLOGY, V96, P124, DOI 10.1016/j.neuropharm.2014.12.023; Akpek M, 2012, AM J CARDIOL, V110, P621, DOI 10.1016/j.amjcard.2012.04.041; Balta S, 2015, CLIN APPL THROMBOSIS; Benites-Zapata VA, 2015, AM J CARDIOL, V115, P57, DOI 10.1016/j.amjcard.2014.10.008; Blanchard MS, 2006, AM J EPIDEMIOL, V163, P66, DOI 10.1093/aje/kwj008; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Broderick Gordon, 2012, Methods Mol Biol, V934, P145, DOI 10.1007/978-1-62703-071-7_8; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Chen ZY, 2015, BRIT J CANCER, V112, P1088, DOI 10.1038/bjc.2015.61; Claycombe K, 2008, P NATL ACAD SCI USA, V105, P2017, DOI 10.1073/pnas.0712053105; Coughlin Steven S, 2011, Open Epidemiol J, V4, P140; Craddock TJA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132774; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Dias CC, 2013, PEPTIDES, V50, P24, DOI 10.1016/j.peptides.2013.09.012; Dias CC, 2015, J CELLULAR BIOCH; Dursa EK, 2016, J OCCUP ENVIRON MED, V58, P41, DOI 10.1097/JOM.0000000000000627; Faria MC, 2014, J PSYCHIATR RES, V53, P166, DOI 10.1016/j.jpsychires.2014.01.019; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gajewska E, 2014, EUR REV MED PHARMACO, V18, P3246; Gosselink JV, 2010, AM J RESP CRIT CARE, V181, P1329, DOI 10.1164/rccm.200812-1902OC; Haas L, 2010, NEUROCHEM RES, V35, P830, DOI 10.1007/s11064-010-0129-z; Hirose H, 1998, CLIN SCI, V94, P633, DOI 10.1042/cs0940633; Hopps E, 2015, EUR REV MED PHARMACO, V19, P2583; Huang CJ, 2014, PHYSIOL BEHAV, V123, P76, DOI 10.1016/j.physbeh.2013.10.004; Institute of Medicine, 2014, CHRON MULT ILLN GULF; Institute of Medicine of the National academies Committee on Gulf War and Health, 2013, GULF WAR HLTH TREATM; Johnson GJ, 2013, BLOOD COAGUL FIBRIN, V24, P736, DOI 10.1097/MBC.0b013e328362627f; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kelsall HL, 2009, AM J EPIDEMIOL, V170, P1048, DOI 10.1093/aje/kwp238; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Khaiboullina SF, 2015, CYTOKINE, V72, P1, DOI 10.1016/j.cyto.2014.11.019; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Leal G., 2014, BRAIN RES; Luchting B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104883; Maloney CDRSR, 2013, MED HYPOTHESES, V80, P220, DOI 10.1016/j.mehy.2012.11.024; Memon RA, 1998, AM J PHYSIOL-ENDOC M, V274, pE210, DOI 10.1152/ajpendo.1998.274.2.E210; Munkholm K, 2014, PSYCHONEUROENDOCRINO, V47, P199, DOI 10.1016/j.psyneuen.2014.05.011; National Resource Council, 2010, GULF WAR AND HLTH, V8; Nilsson L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108183; Parkitny L, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0122-z; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Procaccini C, 2015, METABOLISM, V64, P92, DOI 10.1016/j.metabol.2014.10.014; R.A.C. on Gulf War Veterans' Illnesses, 2014, GULF WAR ILLNESS HLT; Rabkin SW, 2014, VASA, V43, P433, DOI 10.1024/0301-1526/a000390; *RES ADV COMM GULF, 2008, GULF WAR ILLN HLTH G; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Shukla V, 2013, ARCH VIROL, V158, P2561, DOI 10.1007/s00705-013-1783-7; Singh D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00019; Singh UP, 2014, INT REV IMMUNOL, V33, P23, DOI 10.3109/08830185.2013.809071; Skowera A, 2004, J CLIN IMMUNOL, V24, P66, DOI 10.1023/B:JOCI.0000018065.64685.82; Smylie AL, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-29; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Thibault K, 2014, J NEUROSCI, V34, P14739, DOI 10.1523/JNEUROSCI.0860-14.2014; Thiele JR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/372432; Thrailkill KM, 2005, CLIN CHEM LAB MED, V43, P1392, DOI 10.1515/CCLM.2005.238; Trottier MD, 2012, P NATL ACAD SCI USA, V109, P7622, DOI 10.1073/pnas.1205129109; Vianello E, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-2; Vojdani A, 2004, ENVIRON HEALTH PERSP, V112, P840, DOI 10.1289/ehp.6881; Wang KF, 2013, CORONARY ARTERY DIS, V24, P23, DOI 10.1097/MCA.0b013e32835aab4a; Wedge R, 2016, GULF WAR AND HLTH, V10; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Yan GT, 2009, EUR J PHARMACOL, V616, P244, DOI 10.1016/j.ejphar.2009.06.039; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Zeng RP, 2013, MOL VIS, V19, P729; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999	68	56	57	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157855	10.1371/journal.pone.0157855	http://dx.doi.org/10.1371/journal.pone.0157855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352030	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900022
J	Stepanov, VG; Tirumalai, MR; Montazari, S; Checinska, A; Venkateswaran, K; Fox, GE				Stepanov, Victor G.; Tirumalai, Madhan R.; Montazari, Saied; Checinska, Aleksandra; Venkateswaran, Kasthuri; Fox, George E.			Bacillus pumilus SAFR-032 Genome Revisited: Sequence Update and Re-Annotation	PLOS ONE			English	Article							SPACECRAFT ASSEMBLY FACILITY; HYDROGEN-PEROXIDE; BACTERIAL-SPORES; RESISTANCE; STERILIZATION; ALIGNMENT; SURVIVAL; DIOXIDE; WATER	Bacillus pumilus strain SAFR-032 is a non-pathogenic spore-forming bacterium exhibiting an anomalously high persistence in bactericidal environments. In its dormant state, it is capable of withstanding doses of ultraviolet (UV) radiation or hydrogen peroxide, which are lethal for the vast majority of microorganisms. This unusual resistance profile has made SAFR-032 a reference strain for studies of bacterial spore resistance. The complete genome sequence of B. pumilus SAFR-032 was published in 2007 early in the genomics era. Since then, the SAFR-032 strain has frequently been used as a source of genetic/genomic information that was regarded as representative of the entire B. pumilus species group. Recently, our ongoing studies of conservation of gene distribution patterns in the complete genomes of various B. pumilus strains revealed indications of misassembly in the B. pumilus SAFR-032 genome. Synteny-driven local genome resequencing confirmed that the original SAFR-032 sequence contained assembly errors associated with long sequence repeats. The genome sequence was corrected according to the new findings. In addition, a significantly improved annotation is now available. Gene orders were compared and portions of the genome arrangement were found to be similar in a wide spectrum of Bacillus strains.	[Stepanov, Victor G.; Tirumalai, Madhan R.; Montazari, Saied; Fox, George E.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Checinska, Aleksandra; Venkateswaran, Kasthuri] CALTECH, Biotechnol & Planetary Protect Grp, Jet Prop Lab, Pasadena, CA 91125 USA	University of Houston System; University of Houston; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Fox, GE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	fox@uh.edu	Tirumalai, Madhan R/J-4988-2017; Willson, richard/AAD-4832-2019	Tirumalai, Madhan R/0000-0002-5999-333X; Stepanov, Victor/0000-0001-5540-7914; Fox, George/0000-0001-7767-8387				Alcaraz LD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-332; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Arias RS, 1999, J BASIC MICROB, V39, P283, DOI 10.1002/(SICI)1521-4028(199912)39:5/6<283::AID-JOBM283>3.0.CO;2-G; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Borodina TA, 2003, ANAL BIOCHEM, V321, P135, DOI 10.1016/S0003-2697(03)00403-2; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Checinska A, 2015, ANNU REV FOOD SCI T, V6, P351, DOI 10.1146/annurev-food-030713-092332; Checinska A, 2011, J MICROBIOL METH, V87, P70, DOI 10.1016/j.mimet.2011.07.008; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Friedline A, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0109-4; Friedline AW, 2015, J PHYS CHEM B, V119, P14033, DOI 10.1021/acs.jpcb.5b07437; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guan ZB, 2015, J BIOTECHNOL, V207, P8, DOI 10.1016/j.jbiotec.2015.04.019; Hall T., 2011, GERF B BIOSCI, V2, P60; Handtke S, 2014, J BIOTECHNOL, V192, P204, DOI 10.1016/j.jbiotec.2014.08.028; Horneck G, 2012, ASTROBIOLOGY, V12, P445, DOI 10.1089/ast.2011.0737; Kang Y, 2015, GENOME ANNOUNC, V3; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Kwan K, 2011, APPL ENVIRON MICROB, V77, P2943, DOI 10.1128/AEM.02978-10; Link L, 2004, MICROB ECOL, V47, P159, DOI 10.1007/s00248-003-1029-4; MIRONOV VN, 1994, MOL GEN GENET, V242, P201, DOI 10.1007/BF00391014; Misirli G, 2014, J INTEGR BIOINFORMAT, V11, DOI 10.2390/biecoll-jib-2014-244; Niazi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104651; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Ruckert C, 2011, J BIOTECHNOL, V155, P78, DOI 10.1016/j.jbiotec.2011.01.006; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmidt TR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-430; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tirumalai MR, 2013, EXTREMOPHILES, V17, P767, DOI 10.1007/s00792-013-0559-z; Tirumalai MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066012; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaishampayan PA, 2012, ASTROBIOLOGY, V12, P487, DOI 10.1089/ast.2011.0738; Villanueva J, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00327-14; Wu XH, 2014, J PROTEOME RES, V13, P2724, DOI 10.1021/pr500369b; Yuan YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10259; Zeigler DR, 2011, MICROBIOL-SGM, V157, P2033, DOI 10.1099/mic.0.048520-0	39	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157331	10.1371/journal.pone.0157331	http://dx.doi.org/10.1371/journal.pone.0157331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351589	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900007
J	Salinero-Fort, MA; Burgos-Lunar, C; Lahoz, C; Mostaza, JM; Abanades-Herranz, JC; Laguna-Cuesta, F; Estirado-de Cabo, E; Garcia-Iglesias, F; Gonzalez-Alegre, T; Fernandez-Puntero, B; Montesano-Sanchez, L; Vicent-Lopez, D; Cornejo-del Rio, V; Fernandez-Garcia, PJ; Sanchez-Arroyo, V; Sabin-Rodriguez, C; Lopez-Lopez, S; Patron-Barandio, P; Gomez-Campelo, P				Salinero-Fort, M. A.; Burgos-Lunar, C.; Lahoz, C.; Mostaza, J. M.; Abanades-Herranz, J. C.; Laguna-Cuesta, F.; Estirado-de Cabo, E.; Garcia-Iglesias, F.; Gonzalez-Alegre, T.; Fernandez-Puntero, B.; Montesano-Sanchez, L.; Vicent-Lopez, D.; Cornejo-del Rio, V.; Fernandez-Garcia, P. J.; Sanchez-Arroyo, V.; Sabin-Rodriguez, C.; Lopez-Lopez, S.; Patron-Barandio, P.; Gomez-Campelo, P.		SPREDIA-2 Grp	Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; GLYCATED HEMOGLOBIN; POPULATION; FINDRISC; PREVALENCE; VALIDATION; PREVENTION; PREDICTION; DIAGNOSIS	Aim To evaluate the performance of the Finnish Diabetes Risk Score (FINDRISC) and a simplified FINDRISC score (MADRISC) in screening for undiagnosed type 2 diabetes mellitus (UT2DM) and dysglycaemia. Methods A population-based, cross-sectional, descriptive study was carried out with participants with UT2DM, ranged between 45-74 years and lived in two districts in the north of metropolitan Madrid (Spain). The FINDRISC and MADRISC scores were evaluated using the area under the receiver operating characteristic curve method (ROC-AUC). Four different gold standards were used for UT2DM and any dysglycaemia, as follows: fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), HbA1c, and OGTT or HbA1c. Dysglycaemia and UT2DM were defined according to American Diabetes Association criteria. Results The study population comprised 1,426 participants (832 females and 594 males) with a mean age of 62 years (SD = 6.1). When HbA1c or OGTT criteria were used, the prevalence of UT2DM was 7.4% (10.4% in men and 5.2% in women; p<0.01) and the FINDRISC ROC-AUC for UT2DM was 0.72 (95% CI, 0.69-0.74). The optimal cut-off point was >= 13 (sensitivity = 63.8%, specificity = 65.1%). The ROC-AUC of MADRISC was 0.76 (95% CI, 0.72-0.81) with >= 13 as the optimal cut-off point (sensitivity = 84.8%, specificity = 54.6%). FINDRISC score >= 12 for detecting any dysglycaemia offered the best cut-off point when HbA1c alone or OGTT and HbA1c were the criteria used. Conclusions FINDRISC proved to be a useful instrument in screening for dysglycaemia and UT2DM. In the screening of UT2DM, the simplified MADRISC performed as well as FINDRISC.	[Salinero-Fort, M. A.] Consejeria Sanidad Madrid, Subdirecc Gen Invest Sanitaria, Madrid, Spain; [Salinero-Fort, M. A.; Burgos-Lunar, C.; Abanades-Herranz, J. C.; Gomez-Campelo, P.] MADIABET Res Grp, Madrid, Spain; [Salinero-Fort, M. A.; Burgos-Lunar, C.; Abanades-Herranz, J. C.; Gomez-Campelo, P.] IdiPAZ, Aging & Fragil Elderly Grp, Madrid, Spain; [Salinero-Fort, M. A.; Burgos-Lunar, C.] Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain; [Burgos-Lunar, C.] Consejeria Sanidad, Direcc Gen Salud Publ, Subdirecc Promoc Prevenc & Educ Salud, Madrid, Spain; [Lahoz, C.; Mostaza, J. M.; Laguna-Cuesta, F.; Estirado-de Cabo, E.; Garcia-Iglesias, F.; Gonzalez-Alegre, T.] Hosp Carlos III, Med Interna Serv, Madrid, Spain; [Abanades-Herranz, J. C.] Ctr Salud Monovar, Serv Madrileno Salud, Madrid, Spain; [Fernandez-Puntero, B.; Vicent-Lopez, D.; Cornejo-del Rio, V.; Fernandez-Garcia, P. J.; Sanchez-Arroyo, V.; Sabin-Rodriguez, C.; Lopez-Lopez, S.; Patron-Barandio, P.] Hosp Carlos III, Madrid, Spain; [Montesano-Sanchez, L.] Hosp Fuenlabrada, Madrid, Spain; [Gomez-Campelo, P.] Hosp La Paz, Inst Hlth Res IdiPAZ, Plataforma Apoyo Investigador Novel PAIN Platform, Madrid, Spain	Hospital Carlos III; Hospital Carlos III; Hospital Universitario Fuenlabrada; Hospital Universitario La Paz	Salinero-Fort, MA (corresponding author), Consejeria Sanidad Madrid, Subdirecc Gen Invest Sanitaria, Madrid, Spain.; Salinero-Fort, MA (corresponding author), MADIABET Res Grp, Madrid, Spain.; Salinero-Fort, MA (corresponding author), IdiPAZ, Aging & Fragil Elderly Grp, Madrid, Spain.; Salinero-Fort, MA (corresponding author), Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain.	miguel.salinero@salud.madrid.org	Vicent, David/O-2255-2014; SALINERO-FORT, MIGUEL A./GOP-2536-2022; Michalski, Fernanda/J-4691-2012	Vicent, David/0000-0002-6663-0350; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Michalski, Fernanda/0000-0002-8074-9964; Lahoz, Carlos/0000-0001-5690-7558; Gomez Campelo, Paloma/0000-0003-2299-1741	Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) Grant [RS_AP10/6]; FIS (Instituto de Salud Carlos III, Secretary of State of R+D+I and FEDER/FSE [12/01806, 15/00259]	Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) Grant; FIS (Instituto de Salud Carlos III, Secretary of State of R+D+I and FEDER/FSE	This work was funded by the Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) Grant 'RS_AP10/6' and by FIS grants 12/01806 and 15/00259 (Instituto de Salud Carlos III, Secretary of State of R+D+I and FEDER/FSE. The funders had no role in the study design, data	Salinero-Fort MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007195; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Boronat M, 2010, DIABETES CARE, V33, P2671, DOI 10.2337/dc10-0529; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Costa B, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-45; Eborall H, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X630106; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gong W, 2009, DIABETES METAB, V35, P458, DOI 10.1016/j.diabet.2009.05.005; Gyberg V, 2012, PRIM CARE DIABETES, V6, P103, DOI 10.1016/j.pcd.2011.12.003; InterAct Project, 2011, DIABETES CARE, V34, P1913, DOI 10.2337/dc11-0891; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ku GMV, 2013, PRIM CARE DIABETES, V7, P249, DOI 10.1016/j.pcd.2013.07.004; Lee CMY, 2013, DIABETES RES CLIN PR, V100, P285, DOI 10.1016/j.diabres.2013.01.024; Li J, 2009, HORM METAB RES, V41, P98, DOI 10.1055/s-0028-1087191; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Lopez JBC, 1997, REV ESP CARDIOL, V50, P507; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; Ros JM, 2011, ATEN PRIM, V43, P516, DOI 10.1016/j.aprim.2010.09.021; Mosca A, 2007, CLIN CHEM LAB MED, V45, P1077, DOI 10.1515/CCLM.2007.246; Mostaza JM, 2015, ATHEROSCLEROSIS, V242, P377, DOI 10.1016/j.atherosclerosis.2015.07.028; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Rathmann W, 2005, ARCH INTERN MED, V165, P436, DOI 10.1001/archinte.165.4.436; Ruiz-Ramos Miguel, 2006, Gac Sanit, V20 Suppl 1, P15, DOI 10.1157/13086022; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Tankova T, 2011, DIABETES RES CLIN PR, V92, P46, DOI 10.1016/j.diabres.2010.12.020; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Waugh NR, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17350; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Witte DR, 2010, DIABETIC MED, V27, P46, DOI 10.1111/j.1464-5491.2009.02891.x; World Health Organization Consultation, 1999, 992 WHO; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865	38	18	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2016	11	7							e0158489	10.1371/journal.pone.0158489	http://dx.doi.org/10.1371/journal.pone.0158489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5CG	27352247	Green Submitted, Green Published, gold			2022-12-27	WOS:000380797500014
J	Rohner, F; Leyvraz, M; Konan, AG; Esso, LJCE; Wirth, JP; Norte, A; Adiko, AF; Bonfoh, B; Aaron, GJ				Rohner, Fabian; Leyvraz, Magali; Konan, Amoin G.; Esso, Lasme J. C. E.; Wirth, James P.; Norte, Augusto; Adiko, Adiko F.; Bonfoh, Bassirou; Aaron, Grant J.			The Potential of Food Fortification to Add Micronutrients in Young Children and Women of Reproductive Age - Findings from a Cross-Sectional Survey in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; VITAMIN-A; QUANTIFICATION; VALIDATION; TOOL	Poor micronutrient intakes are a major contributing factor to the high burden of micronutrient deficiencies in Cote d'Ivoire. Large-scale food fortification is considered a cost-effective approach to deliver micronutrients, and fortification of salt (iodine), wheat flour (iron and folic acid), and vegetable oil (vitamin A) is mandatory in Cote d'Ivoire. A cross-sectional survey on households with at least one child 6-23 months was conducted to update coverage figures with adequately fortified food vehicles in Abidjan, the capital of and largest urban community in Cote d'Ivoire, and to evaluate whether additional iron and vitamin A intake is sufficient to bear the potential to reduce micronutrient malnutrition. Information on demographics and food consumption was collected, along with samples of salt and oil. Wheat flour was sampled from bakeries and retailers residing in the selected clusters. In Abidjan, 86% and 97% of salt and vegetable oil samples, respectively, were adequately fortified, while only 32% of wheat flour samples were adequately fortified, but all samples contained some added iron. There were no major differences in additional vitamin A and iron intake between poor and non-poor households. For vitamin A in oil, the additional percentage of the recommended nutrient intake was 27% and 40% for children 6-23 months and women of reproductive age, respectively, while for iron from wheat flour, only 13% and 19% could be covered. Compared to previous estimates, coverage has remained stable for salt and wheat flour, but improved for vegetable oil. Fortification of vegetable oil clearly provides a meaningful additional amount of vitamin A. This is not currently the case for iron, due to the low fortification levels. Iron levels in wheat flour should be increased and monitored, and additional vehicles should be explored to add iron to the Ivorian diet.	[Rohner, Fabian; Wirth, James P.; Norte, Augusto] GroundWork, Flaesch, Switzerland; [Leyvraz, Magali; Aaron, Grant J.] Global Alliance Improved Nutr, Geneva, Switzerland; [Konan, Amoin G.; Esso, Lasme J. C. E.; Adiko, Adiko F.; Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Konan, Amoin G.; Esso, Lasme J. C. E.; Adiko, Adiko F.] Univ Felix Houphouet Boigny, Abidjan, Cote Ivoire; [Bonfoh, Bassirou] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute	Rohner, F (corresponding author), GroundWork, Flaesch, Switzerland.	fabian@groundworkhealth.org	Rohner, Fabian/I-5088-2019	Rohner, Fabian/0000-0003-0579-6952; Wirth, James P/0000-0002-4733-0379; Rios-Leyvraz, Magali/0000-0003-0455-197X	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Participating respondents are kindly thanked for their time committed to complete the interviews. The field teams are acknowledged for their efforts in conducting the high-quality data collection. Bradley Woodruff provided some greatly appreciated statistical advice. Valentin B. Kone helped prepare survey supplies and coordinate training logistics. This survey was funded by the Bill & Melinda Gates Foundation.	Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; [Anonymous], 2011, CIRCULAR AUTORISATIO; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Copenhagen consensus, 2012, 3 COP CONS OUTC DOC; Dimova R, 2012, RIGHT PRICE RICE COT; Dubresson A, 1989, EC RURALE, V190, P3; FAO and WHO, 2004, JOINT FAO WHO EXP CO; Food and Agriculture Organization of the United Nations (FAO), 2005, FOOD NUTR BULL, V26, P166; Gaber S, 2013, GLOB PUBLIC HEALTH, V8, P698, DOI 10.1080/17441692.2013.791334; Helen Keller International Institut National de la Sante Publique Global Allliance for Improved Nutrition, 2010, UNPUB; Hess SY, 2013, FOOD NUTR BULL, V34, P21, DOI 10.1177/156482651303400104; INS, 2014, REC GEN POP HAB 2014; Institut National de la Statistique (INS) et ICF International, 2012, ENQ DEM SANT IND MUL; International HK, 2006, ET CONS FAR BLE TREN; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Laillou A, 2013, FOOD NUTR BULL, V34, pS124, DOI 10.1177/15648265130342S114; Renaud C, 2013, INT J VITAM NUTR RES, V83, P122, DOI 10.1024/0300-9831/a000154; Rivera JA, 2008, CHALLENGE HUNGER MAL; Rohner F., 2013, PUBLIC HEALTH NUTR, V15, P1; Rohner F, 2012, FOOD NUTR BULL, V33, pS330, DOI 10.1177/15648265120334S309; Rohner F, 2011, INT J VITAM NUTR RES, V81, P335, DOI 10.1024/0300-9831/a000081; West CE, 1997, FOOD CONSUMPTION NUT; World Health Organization, 2007, WHOIVB0807	24	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158552	10.1371/journal.pone.0158552	http://dx.doi.org/10.1371/journal.pone.0158552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384762	Green Published, gold, Green Accepted			2022-12-27	WOS:000379809400058
J	Sundstrom, C; Gajecki, M; Johansson, M; Blankers, M; Sinadinovic, K; Stenlund-Gens, E; Berman, AH				Sundstrom, Christopher; Gajecki, Mikael; Johansson, Magnus; Blankers, Matthijs; Sinadinovic, Kristina; Stenlund-Gens, Erik; Berman, Anne H.			Guided and Unguided Internet-Based Treatment for Problematic Alcohol Use - A Randomized Controlled Pilot Trial	PLOS ONE			English	Article							COGNITIVE-BEHAVIOR THERAPY; IDENTIFICATION TEST DUDIT; USE DISORDERS; SELF-HELP; PSYCHOMETRIC PROPERTIES; HOSPITAL ANXIETY; DRUG-USE; PSYCHOLOGICAL TREATMENTS; DEPRESSION SCALE; INTERVENTION	Background The Internet has increasingly been studied as mode of delivery for interventions targeting problematic alcohol use. Most interventions have been fully automated, but some research suggests that adding counselor guidance may improve alcohol consumption outcomes. Methods An eight-module Internet-based self-help program based on cognitive behavioral therapy (CBT) was tested among Internet help-seekers. Eighty participants with problematic alcohol use according to the Alcohol Use Disorders Identification Test (AUDIT; scores of >= 6 for women and >= 8 for men) were recruited online from an open access website and randomized into three different groups. All groups were offered the same self-help program, but participants in two of the three groups received Internet-based counselor guidance in addition to the self-help program. One of the guidance groups was given a choice between guidance via asynchronous text messages or synchronous text-based chat, while the other guidance group received counselor guidance via asynchronous text messages only. Results In the choice group, 65% (13 of 20 participants) chose guidance via asynchronous text messages. At the 10-week post-treatment follow-up, an intention-to-treat (ITT) analysis showed that participants in the two guidance groups (choice and messages) reported significantly lower past week alcohol consumption compared to the group without guidance; 10.8 (SD = 12.1) versus 22.6 (SD = 18.4); p = 0.001; Cohen's d = 0.77. Participants in both guidance groups reported significantly lower scores on the AUDIT at follow-up compared to the group without guidance, with a mean score of 14.4 (SD = 5.2) versus 18.2 (SD = 5.9); p = 0.003; Cohen's d = 0.68. A higher proportion of participants in the guidance groups said that they would recommend the program compared to the group without guidance (81% for choice; 93% for messages versus 47% for self-help). Conclusion Self-help programs for problematic alcohol use can be more effective in reducing alcohol consumption over a 10-week period when counselor guidance is added.	[Sundstrom, Christopher; Gajecki, Mikael; Johansson, Magnus; Sinadinovic, Kristina; Berman, Anne H.] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Johansson, Magnus] Karolinska Inst, Dept Publ Hlth, Stockholm, Sweden; [Johansson, Magnus; Sinadinovic, Kristina; Berman, Anne H.] Stockholm Ctr Dependency Disorders, Stockholm, Sweden; [Blankers, Matthijs] Arkin Mental Hlth Care, Amsterdam, Netherlands; [Blankers, Matthijs] Netherlands Inst Mental Hlth & Addict, Trimbos, Amsterdam, Netherlands; [Blankers, Matthijs] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Stenlund-Gens, Erik] Stockholm Univ, Dept Psychol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Trimbos Institute; University of Amsterdam; Academic Medical Center Amsterdam; Stockholm University	Sundstrom, C (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden.	christopher.sundstrom@ki.se	Berman, Anne H/C-4636-2011; Sundström, Christopher/ABH-5379-2020	Berman, Anne H/0000-0002-7709-0230; Sundström, Christopher/0000-0003-4237-7159; Johansson, Magnus/0000-0001-8583-2620	Swedish Research Council [K2012-61X-22132-01-6]; AFA Insurance grant [110248]; Swedish FORTE research council [2013-1793]; Stockholm Center for Dependency Disorders for technical development; Karolinska Institutet/Center for Psychiatry Research doctoral grant	Swedish Research Council(Swedish Research CouncilEuropean Commission); AFA Insurance grant; Swedish FORTE research council; Stockholm Center for Dependency Disorders for technical development; Karolinska Institutet/Center for Psychiatry Research doctoral grant	This study was supported by the Swedish Research Council grant no. K2012-61X-22132-01-6; AFA Insurance grant no. 110248; Swedish FORTE research council, grant no. 2013-1793; the Stockholm Center for Dependency Disorders for technical development; Karolinska Institutet/Center for Psychiatry Research doctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1111/j.1530-0277.1997.tb03811.x; Andersson G, 2003, J PSYCHOSOM RES, V55, P259, DOI 10.1016/S0022-3999(02)00575-5; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Babor TF., 2001, AUDIT ALCOHOL USE DI; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Bergman H, 2002, ALCOHOL ALCOHOLISM, V37, P245, DOI 10.1093/alcalc/37.3.245; Bergman H, 2003, LAKARTIDNINGEN, V100, P1027; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Berman AH, 2015, PSYCHOL ADDICT BEHAV, V29, P97, DOI 10.1037/a0038420; Bertholet N, 2009, ADDICT BEHAV, V34, P636, DOI 10.1016/j.addbeh.2009.03.034; Bewick BM, 2013, J MED INTERNET RES, V15, P106, DOI 10.2196/jmir.2581; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blankers M, 2011, J CONSULT CLIN PSYCH, V79, P330, DOI 10.1037/a0023498; Blankers M, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1448; Crutzen R, 2015, PSYCHOL HEALTH, V30, P122, DOI 10.1080/08870446.2014.953526; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Cunningham JA, 2004, ADDICT BEHAV, V29, P221, DOI 10.1016/S0306-4603(03)00077-7; Cunningham JA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-21; Cunningham JA, 2009, ADDICTION, V104, P2023, DOI 10.1111/j.1360-0443.2009.02726.x; Dedert EA, 2015, ANN INTERN MED, V163, P205, DOI 10.7326/M15-0285; Donoghue K, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3193; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Folkhalsoinstitutet [Swedish Public Health Agency], 2010, ALK KUNSK FOLKH RAPP; Forsberg L, 2003, ALCOHOL ALCOHOLISM, V38, P276, DOI 10.1093/alcalc/agg067; Gainsbury S, 2011, CLIN PSYCHOL REV, V31, P490, DOI 10.1016/j.cpr.2010.11.007; Hawthorne G, 2006, SOC INDIC RES, V77, P37, DOI 10.1007/s11205-005-5552-1; Hedman E, 2014, J AFFECT DISORDERS, V155, P49, DOI 10.1016/j.jad.2013.10.023; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Honaker J, 2011, J STAT SOFTW, V45, P1; Horton NJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-9; Newman MG, 2011, CLIN PSYCHOL REV, V31, P178, DOI 10.1016/j.cpr.2010.10.002; Postel MG, 2010, J MED INTERNET RES, V12, P11, DOI 10.2196/jmir.1642; Richards D, 2012, CLIN PSYCHOL REV, V32, P329, DOI 10.1016/j.cpr.2012.02.004; Riper H, 2008, ADDICTION, V103, P218, DOI 10.1111/j.1360-0443.2007.02063.x; Riper H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099912; Riper H, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1691; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SAUNDERS JB, 1993, ADDICTION, V88, P349, DOI 10.1111/j.1360-0443.1993.tb00822.x; Shawver Z, 2016, COMPUT HUM BEHAV, V55, P446, DOI 10.1016/j.chb.2015.09.030; Sinadinovic K, 2014, EUR ADDICT RES, V20, P305, DOI 10.1159/000362406; Sinadinovic K, 2011, DRUG ALCOHOL DEPEN, V114, P55, DOI 10.1016/j.drugalcdep.2010.09.004; Sinadinovic K, 2010, ADDICT BEHAV, V35, P464, DOI 10.1016/j.addbeh.2009.12.021; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Sobell L. C, 1992, MEASURING ALCOHOL CO; Sobell LC, 1996, DRUG ALCOHOL DEPEN, V42, P49, DOI 10.1016/0376-8716(96)01263-X; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Thomas BA, 2008, DRUG ALCOHOL DEPEN, V96, P121, DOI 10.1016/j.drugalcdep.2008.02.010; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Vitesnikova J, 2014, INJURY, V45, P1440, DOI 10.1016/j.injury.2014.01.004; Voluse AC, 2012, ADDICT BEHAV, V37, P36, DOI 10.1016/j.addbeh.2011.07.030; Wallace P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014740; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157817	10.1371/journal.pone.0157817	http://dx.doi.org/10.1371/journal.pone.0157817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383389	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400027
J	Metwally, AM; El-Din, EMS; Shehata, MA; Shaalan, A; El Etreby, LA; Kandeel, WA; Shaaban, SY; Rabah, TM				Metwally, Ammal M.; El-Din, Ebtissam M. Salah; Shehata, Manal A.; Shaalan, Ashraf; El Etreby, Lobna A.; Kandeel, Wafaa A.; Shaaban, Sanaa Y.; Rabah, Thanaa M.			Early Life Predictors of Socio-Emotional Development in a Sample of Egyptian Infants	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; BEHAVIOR; BRAIN; CHILDREN; ZINC; OUTCOMES; CONTEXT; SERUM; RISK	Introduction Emotional problems are amongst the most critical concerns to be intentionally handled to enhance the wellbeing and development of children. Objective To determine the predictors of socio-emotional development of Egyptian infants related to infant feeding practices, aspects of infant and maternal health and socioeconomic status. Subjects and Methods A cross-sectional comparative study included 322 breast fed, 240 bottle fed and 93 mixed fed infants, from 6-24 months of age, who were enrolled in the Well-Baby Clinic of the National Research Centre and from pediatric outpatient facilities in urban Cairo. Assessment of socio-emotional development was performed using Bayley Scales of Infant and Toddler Development (Bayley III). Detailed maternal and infant history was recorded. Levels of serum zinc, copper, iron, vitamin B12 and complete blood count (CBC) were assessed in a subsample of 193 infants. Results The risk of having below average socio-emotional composite score was nearly two and half times among formula-fed infants than among breast-fed infants. By binary logistical regression analysis, predictors of below average socio-emotional score were a lower serum zinc value, being formula fed during the first half-year and introduction of complementary food before the age of six months (p< 0.05). Conclusion Exclusive breastfeeding and to a lesser extent mixed feeding during the first half year is correlated with above average socio-emotional development. Maternal education and zinc status were also determinants of better infant mental health. Our endeavors ought to be directed towards integrated interventions addressing multiple risks to children's development.	[Metwally, Ammal M.; El Etreby, Lobna A.; Rabah, Thanaa M.] Natl Res Ctr, Div Med, Dept Community Med Res, Giza, Egypt; [El-Din, Ebtissam M. Salah; Shehata, Manal A.] Natl Res Ctr, Dept Child Hlth, Div Med, Giza, Egypt; [Shaalan, Ashraf; Kandeel, Wafaa A.] Natl Res Ctr, Dept Biol Anthropol, Div Med, Giza, Egypt; [Shaaban, Sanaa Y.] Ain Shams Univ, Dept Pediat, Fac Med, Cairo, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Ain Shams University	Shehata, MA (corresponding author), Natl Res Ctr, Dept Child Hlth, Div Med, Giza, Egypt.	dr_manalabdelkader@hotmail.com	Metwally, Ammal M/A-1531-2016; Salah El-Din, Ebtissam/ABH-2327-2021; Al-Tohamy, Muhammad/B-4273-2016; Shehata, Manal/P-4319-2015	Metwally, Ammal M/0000-0003-0575-5202; Salah El-Din, Ebtissam/0000-0002-3331-8977; Rabah, Thanaa/0000-0002-4383-9450; Al-Tohamy, Muhammad/0000-0001-9368-2570; Shehata, Manal/0000-0001-8749-7010				Allen MC, 2005, AVERYS DIS NEWBORN, P1026; [Anonymous], 2005, CHILD DEV, V76, P795; [Anonymous], 2004, TECHN CONS ASS IR ST; Aylward GP, 2002, MENT RETARD DEV D R, V8, P234, DOI 10.1002/mrdd.10043; Bayley N, 1993, BAYLEY SCALES INFANT; Behrman RE, 2007, PRETERM BIRTH CAUSES; BELL JG, 1987, AM J DIS CHILD, V141, P1128, DOI 10.1001/archpedi.1987.04460100106041; BENDERSKY M, 1994, DEV PSYCHOL, V30, P484, DOI 10.1037/0012-1649.30.4.484; Bornstein MH, 2003, MON PARENT, P29; Bryan J, 2004, NUTR REV, V62, P295, DOI 10.1301/nr.2004.aug.295-306; Bystrova K, 2009, BIRTH-ISS PERINAT C, V36, P97, DOI 10.1111/j.1523-536X.2009.00307.x; Center on the Developing Child at Harvard University, 2010, FDN LIF HLTH AR BUIL; Chilton M, 2007, INDIAN J MED RES, V126, P262; Chou PP, 1987, METHODS CLIN CHEM, P596; CIOMS/WHO, 1993, INT ETH GUID BIOM RE; Damon W., 2006, HDB CHILD PSYCHOL, V3, P226; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x; Easterbrooks MA, 2012, HDB PSYCHOL; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Emde R. N., 2005, ZERO 3 DIAGNOSTIC CL; Fergusson DM, 1999, PAEDIATR PERINAT EP, V13, P144; Folio RM., 2000, PEABODY DEV MOTOR SC, V2; Forns J, 2012, GAC SANIT, V26, P397, DOI 10.1016/j.gaceta.2011.10.011; Gardner JMM, 2005, AM J CLIN NUTR, V82, P399, DOI 10.1093/ajcn/82.2.399; Ghosh M, 2008, INDIAN J PEDIATR, V75, P685, DOI 10.1007/s12098-008-0129-z; Goodman E, 2005, J ADOLESCENT HEALTH, V37, P484, DOI 10.1016/j.jadohealth.2004.11.126; Gross J.J., 2014, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Hinshaw-Fuselier S, 2009, HDB INFANT MENTAL HL; Jain A, 2002, PEDIATRICS, V109, P1044, DOI 10.1542/peds.109.6.1044; Jansen J, 2008, DEV REV, V28, P503, DOI 10.1016/j.dr.2008.07.001; Kelsey JL., 1996, METHODS OBSERVATIONA; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Lozoff B, 1998, CHILD DEV, V69, P24, DOI 10.1111/j.1467-8624.1998.tb06130.x; Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7; Lucas-Thompson RG, 2010, PSYCHOL BULL, V136, P915, DOI 10.1037/a0020875; LUKEMAN D, 1993, J CHILD PSYCHOL PSYC, V34, P837, DOI 10.1111/j.1469-7610.1993.tb01093.x; Marquis GS, 2005, ENCY EARLY CHILDHOOD, P1; McCrory C, 2013, MATERN CHILD HLTH J, V17, P1680, DOI 10.1007/s10995-012-1182-9; McNeilly AS, 1985, MATERNAL NUTRITION L, P1; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Murray R. K., 2011, HARPERS ILLUSTRATED; Narvaez D, 2013, EARLY CHILD RES Q, V28, P759, DOI 10.1016/j.ecresq.2013.07.003; OSKI FA, 1980, AM J DIS CHILD, V134, P459, DOI 10.1001/archpedi.1980.02130170009004; PAHO, 2003, GUID PRINC COMPL FEE; Parlakian R., 2003, ABCS PROMOTING SCH R; Perry BD, 1995, INFANT MENT HEALTH J, V16, P271, DOI 10.1002/1097-0355(199524)16:4<271::AID-IMHJ2280160404>3.0.CO;2-B; Posada G, 2002, DEV PSYCHOL, V38, P67, DOI 10.1037//0012-1649.38.1.67; Prado EL, 2012, ALIVE THRIVE TECHNIC; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Quinn KP, 1998, J EMOT BEHAV DISORD, V7, P54; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Raver CC, 2004, CHILD DEV, V75, P346, DOI 10.1111/j.1467-8624.2004.00676.x; Reynolds A, 2001, PEDIATR CLIN N AM, V48, P159, DOI 10.1016/S0031-3955(05)70291-1; Richter Linda, 2004, IMPORTANCE CAREGIVER; Roy A, 2009, ENVIRON HEALTH PERSP, V117, P1607, DOI 10.1289/ehp.0900625; Saarni C., 1998, P237; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; Shonkoff J.P., 2000, NEURONS NEIGHBORHOOD; Swain JE, 2007, J CHILD PSYCHOL PSYC, V48, P262, DOI 10.1111/j.1469-7610.2007.01731.x; TAYLOR A, 1981, CLIN CHIM ACTA, V110, P83, DOI 10.1016/0009-8981(81)90304-1; The World Health Organization, 2008, FOOD NUTR B, V29; Thompson R.A., 2008, HDB ATTACHMENT THEOR, V2nd ed., P348; Thompson RA, 2010, MORAL PERSONALITY ID; Tomasello M, 2007, DEVELOPMENTAL SCI, V10, P121, DOI 10.1111/j.1467-7687.2007.00573.x; von der Lippe AL, 1999, INT J BEHAV DEV, V23, P703, DOI 10.1080/016502599383766; Wachs TD, 2009, CHILD HLTH ED, V1, P107; Wachs Theodore D., 2005, Food and Nutrition Bulletin, V26, pS159; Walker SP, INEQUALITY EARLY CHI; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WALTER T, 1989, PEDIATRICS, V84, P7; WHO, 2011, WHO TECH REP SER, V959, P1; WHO/UNICEF, 1998, WHONUT981 UNICEF; WHO-AIMS, 2006, REP MENT HLTH SYST E; Williams KR, 2003, J INTELL DISABIL RES, V47, P291, DOI 10.1046/j.1365-2788.2003.00491.x; World Health Organization,, 2012, RISKS MENT HLTH OV V; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization (WHO), 2001, 542 WHO WHA, V54.2; ZEITLIN MF, 1995, EARLY HUM DEV, V41, P97, DOI 10.1016/0378-3782(94)01612-S; Zimmerman I.L., 2002, PRESCHOOL LANGUAGE S	82	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158086	10.1371/journal.pone.0158086	http://dx.doi.org/10.1371/journal.pone.0158086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379907	Green Published, gold, Green Submitted			2022-12-27	WOS:000379798700019
J	Palanisamy, A; Friese, MB; Cotran, E; Moller, L; Boyd, JD; Crosby, G; Culley, DJ				Palanisamy, Arvind; Friese, Matthew B.; Cotran, Emily; Moller, Ludde; Boyd, Justin D.; Crosby, Gregory; Culley, Deborah J.			Prolonged Treatment with Propofol Transiently Impairs Proliferation but Not Survival of Rat Neural Progenitor Cells In Vitro	PLOS ONE			English	Article							TERM COGNITIVE IMPAIRMENT; CARE-UNIT PATIENTS; ADULT NEUROGENESIS; DENTATE GYRUS; STEM-CELLS; CRITICAL ILLNESS; AGED RATS; HIPPOCAMPAL-NEURONS; SPATIAL MEMORY; A RECEPTOR	Neurocognitive dysfunction is common in survivors of intensive care. Prolonged sedation has been implicated but the mechanisms are unclear. Neurogenesis continues into adulthood and is implicated in learning. The neural progenitor cells (NPC) that drive neurogenesis have receptors for the major classes of sedatives used clinically, suggesting that interruption of neurogenesis may partly contribute to cognitive decline in ICU survivors. Using an in vitro system, we tested the hypothesis that prolonged exposure to propofol concentration- and duration-dependently kills or markedly decreases the proliferation of NPCs. NPCs isolated from embryonic day 14 Sprague-Dawley rat pups were exposed to 0, 2.5, or 5.0 mu g/ mL of propofol, concentrations consistent with deep clinical anesthesia, for either 4 or 24 hours. Cells were assayed for cell death and proliferation either immediately following propofol exposure or 24 hours later. NPC death and apoptosis were measured by propidium iodine staining and cleaved caspase-3 immunocytochemistry, respectively, while proliferation was measured by EdU incorporation. Staurosporine (1 mu M for 6h) was used as a positive control for cell death. Cells were analyzed with unbiased high-throughput immunocytochemistry. There was no cell death at either concentration of propofol or duration of exposure. Neither concentration of propofol impaired NPC proliferation when exposure lasted 4 h, but when exposure lasted 24 h, propofol had an anti-proliferative effect at both concentrations (P < 0.0001, propofol vs. control). However, this effect was transient; proliferation returned to baseline 24 h after discontinuation of propofol (P = 0.37, propofol vs. control). The transient but reversible suppression of NPC proliferation, absence of cytotoxicity, and negligible effect on the neural stem cell pool pool suggest that propofol, even in concentrations used for clinical anesthesia, has limited impact on neural progenitor cell biology.	[Palanisamy, Arvind; Friese, Matthew B.; Cotran, Emily; Crosby, Gregory; Culley, Deborah J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Moller, Ludde] Uppsala Univ, Fac Pharm, Dept Pharmaceut Biosci, Uppsala, Sweden; [Boyd, Justin D.] Harvard Med Sch, LDDN, Harvard NeuroDiscovery Ctr, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Uppsala University; Harvard University	Palanisamy, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA.	apalanisamy@bwh.harvard.edu	Crosby, Gregory/N-6578-2019	Friese, Matthew/0000-0001-7410-285X; Boyd, Justin/0000-0002-5197-4724	NIH [GM088817]; NIH T32 training grant [5T32GM007592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088817, T32GM007592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH GM088817 to GC, and NIH grant to DC. MBF was supported by a NIH T32 training grant (5T32GM007592) to the Harvard Medical School Department of Anesthesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Marcie A. Glicksman, PhD, Director, Leads Discovery, Laboratory for Drug Discovery in Neurodegeneration (LDDN), Harvard NeuroDiscovery Center, Harvard Medical School, Brigham & Women's Hospital, Cambridge, MA for her helpful comments and advice on high-content screening. The work was supported by NIH GM088817 to GC. MBF was supported by a NIH T32 training grant (5T32GM007592) to the Harvard Medical School Department of Anesthesia	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Barr J, 2001, ANESTHESIOLOGY, V95, P324, DOI 10.1097/00000542-200108000-00011; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Brann JH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00182; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Casati A, 1999, ANESTH ANALG, V88, P917, DOI 10.1097/00000539-199904000-00043; Cattano D, 2008, ANESTH ANALG, V106, P1712, DOI 10.1213/ane.0b013e318172ba0a; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; Culley DJ, 2013, BRIT J ANAESTH, V110, P19, DOI 10.1093/bja/aet169; Culley DJ, 2011, ANESTHESIOLOGY, V115, P754, DOI 10.1097/ALN.0b013e318223b78b; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Djaiani G, 2016, ANESTHESIOLOGY, V124, P362, DOI 10.1097/ALN.0000000000000951; Dong CX, 2012, CRIT CARE MED, V40, P2407, DOI 10.1097/CCM.0b013e318253563c; Drew LJ, 2013, LEARN MEMORY, V20, P710, DOI 10.1101/lm.026542.112; Encinas JM, 2012, BEHAV BRAIN RES, V227, P433, DOI 10.1016/j.bbr.2011.10.010; Erasso DM, 2013, BRAIN RES, V1530, P1, DOI 10.1016/j.brainres.2013.07.035; Erasso DM, 2012, BRAIN RES, V1441, P38, DOI 10.1016/j.brainres.2011.11.025; Feliciano DM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018846; Fiset P, 1999, J NEUROSCI, V19, P5506; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Gunther ML, 2007, CRIT CARE CLIN, V23, P491, DOI 10.1016/j.ccc.2007.07.001; Hopkins RO, 2012, AM J RESP CRIT CARE, V186, P1220, DOI 10.1164/rccm.201206-1022CP; Hughes CG, 2011, ANESTH ANALG, V112, P1212, DOI 10.1213/ANE.0b013e318215366d; Iwakiri H, 2005, ANESTH ANALG, V100, P107, DOI 10.1213/01.ANE.0000139358.15909.EA; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018929; Kim WR, 2012, BEHAV BRAIN RES, V227, P470, DOI 10.1016/j.bbr.2011.07.012; Krzisch M, 2013, ANESTHESIOLOGY, V118, P602, DOI 10.1097/ALN.0b013e3182815948; Lee IH, 2008, ANESTH ANALG, V107, P1211, DOI 10.1213/ane.0b013e31817ee879; Li Y, 2012, P NATL ACAD SCI USA, V109, P4290, DOI 10.1073/pnas.1120754109; Liu F, 2014, NEUROTOXICOLOGY, V42, P49, DOI 10.1016/j.neuro.2014.03.011; Lonardo NW, 2014, AM J RESP CRIT CARE, V189, P1383, DOI 10.1164/rccm.201312-2291OC; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; Masica Andrew L, 2007, Am J Geriatr Pharmacother, V5, P218, DOI 10.1016/j.amjopharm.2007.10.005; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Pallotto M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00166; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Patel SB, 2012, AM J RESP CRIT CARE, V185, P486, DOI 10.1164/rccm.201102-0273CI; Pearn ML, 2012, ANESTHESIOLOGY, V116, P352, DOI 10.1097/ALN.0b013e318242a48c; Rigouzzo A, 2008, ANESTH ANALG, V106, P1109, DOI 10.1213/ane.0b013e318164f388; Sakamoto M, 2014, J NEUROSCI, V34, P5788, DOI 10.1523/JNEUROSCI.0674-14.2014; Sall JW, 2012, ANESTHESIOLOGY, V117, P1080, DOI 10.1097/ALN.0b013e31826f8d86; Sall JW, 2009, ANESTHESIOLOGY, V110, P826, DOI 10.1097/ALN.0b013e31819b62e2; Shyr MH, 1997, ANESTH ANALG, V84, P1344, DOI 10.1097/00000539-199706000-00031; SHYR MH, 1995, NEUROSCI LETT, V184, P212, DOI 10.1016/0304-3940(94)11209-2; Spahr-Schopfer I, 2000, ANESTHESIOLOGY, V92, P1408, DOI 10.1097/00000542-200005000-00032; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tao T, 2013, J NEUROSURG ANESTH, V25, P299, DOI 10.1097/ANA.0b013e31828baa93; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; Twaroski DM, 2015, ANESTHESIOLOGY, V123, P1067, DOI 10.1097/ALN.0000000000000857; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wang JW, 2015, GENET MOL RES, V14, P14920, DOI 10.4238/2015.November.18.57; Woon FL, 2012, AM J RESP CRIT CARE, V186, P333, DOI 10.1164/rccm.201112-2261OC; Wunsch H, 2009, CRIT CARE MED, V37, P3031, DOI 10.1097/CCM.0b013e3181b02eff; Zhong YL, 2014, CELL BIOCHEM FUNCT, V32, P720, DOI 10.1002/cbf.3077; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274; Zou WW, 2013, MOL MED REP, V7, P1123, DOI 10.3892/mmr.2013.1298	64	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158058	10.1371/journal.pone.0158058	http://dx.doi.org/10.1371/journal.pone.0158058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379684	gold, Green Published, Green Submitted			2022-12-27	WOS:000379798700017
J	Chang, JH; Luo, Y; Wang, YY; Pathak, R; Sridharan, V; Jones, T; Mao, XW; Nelson, G; Boerma, M; Hauer-Jensen, M; Zhou, DH; Shao, LJ				Chang, Jianhui; Luo, Yi; Wang, Yingying; Pathak, Rupak; Sridharan, Vijayalakshmi; Jones, Tamako; Mao, Xiao Wen; Nelson, Gregory; Boerma, Marjan; Hauer-Jensen, Martin; Zhou, Daohong; Shao, Lijian			Low Doses of Oxygen Ion Irradiation Cause Acute Damage to Hematopoietic Cells in Mice	PLOS ONE			English	Article							BODY PROTON IRRADIATION; STEM-CELLS; RADIATION-SYNDROME; GAMMA-IRRADIATION; PROGENITOR CELLS; MOUSE; SENESCENCE; INDUCTION; DELETION; INJURY	One of the major health risks to astronauts is radiation on long-duration space missions. Space radiation from sun and galactic cosmic rays consists primarily of 85% protons, 14% helium nuclei and 1% high-energy high-charge (HZE) particles, such as oxygen (O-16), carbon, silicon, and iron ions. HZE particles exhibit dense linear tracks of ionization associated with clustered DNA damage and often high relative biological effectiveness (RBE). Therefore, new knowledge of risks from HZE particle exposures must be obtained. In the present study, we investigated the acute effects of low doses of O-16 irradiation on the hematopoietic system. Specifically, we exposed C57BL/6J mice to 0.1, 0.25 and 1.0 Gy whole body O-16 (600 MeV/n) irradiation and examined the effects on peripheral blood (PB) cells, and bone marrow (BM) hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) at two weeks after the exposure. The results showed that the numbers of white blood cells, lymphocytes, monocytes, neutrophils and platelets were significantly decreased in PB after exposure to 1.0 Gy, but not to 0.1 or 0.25 Gy. However, both the frequency and number of HPCs and HSCs were reduced in a radiation dose-dependent manner in comparison to unirradiated controls. Furthermore, HPCs and HSCs from irradiated mice exhibited a significant reduction in clonogenic function determined by the colony-forming and cobblestone area-forming cell assays. These acute adverse effects of O-16 irradiation on HSCs coincided with an increased production of reactive oxygen species (ROS), enhanced cell cycle entry of quiescent HSCs, and increased DNA damage. However, none of the O-16 exposures induced apoptosis in HSCs. These data suggest that exposure to low doses of O-16 irradiation induces acute BM injury in a dose-dependent manner primarily via increasing ROS production, cell cycling, and DNA damage in HSCs. This finding may aid in developing novel strategies in the protection of the hematopoietic system from space radiation.	[Chang, Jianhui; Luo, Yi; Wang, Yingying; Pathak, Rupak; Sridharan, Vijayalakshmi; Boerma, Marjan; Hauer-Jensen, Martin; Zhou, Daohong; Shao, Lijian] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Jones, Tamako; Mao, Xiao Wen; Nelson, Gregory] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Radiat Res, Loma Linda, CA USA	University of Arkansas System; University of Arkansas Medical Sciences; Loma Linda University	Shao, LJ (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.	lshao@uams.edu	Shao, Lijian/AAA-1074-2020; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022	mao, xiao/0000-0002-4508-8689	National Space Biomedical Research Institute [NCC 9-58]; Centers of Biomedical Research Excellence [P20, GM109005]; Arkansas Research Alliance Scholarship; Rockefeller Leukemia and Lymphoma Research Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109005] Funding Source: NIH RePORTER	National Space Biomedical Research Institute; Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Arkansas Research Alliance Scholarship; Rockefeller Leukemia and Lymphoma Research Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by the National Space Biomedical Research Institute through NCC 9-58, Centers of Biomedical Research Excellence (P20, GM109005), Arkansas Research Alliance Scholarship, and Rockefeller Leukemia and Lymphoma Research Endowment.	Becker D, 2009, INT J RADIAT BIOL, V85, P1051, DOI 10.3109/09553000903232850; Chang JH, 2015, RADIAT RES, V183, P240, DOI 10.1667/RR13887.1; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cucinotta Francis A, 2003, Gravit Space Biol Bull, V16, P11; Gridley DS, 2008, IN VIVO, V22, P159; Habermehl D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113591; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hei TK, 2016, HEALTH PHYS, V110, P281, DOI 10.1097/HP.0000000000000452; Kajioka EH, 2000, RADIAT RES, V153, P587, DOI 10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2; Li HL, 2011, FREE RADICAL BIO MED, V51, P30, DOI 10.1016/j.freeradbiomed.2011.04.016; Miousse IR, 2014, RADIAT RES, V182, P92, DOI 10.1667/RR13580.1; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moroni M, 2011, RADIAT RES, V176, P89, DOI 10.1667/RR2481.1; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036209; Nitta E, 2011, BLOOD, V117, P4169, DOI 10.1182/blood-2010-08-297390; Otsuka K, 2006, RADIAT RES, V166, P474, DOI 10.1667/RR0561.1; Pathak R, 2007, MUTAT RES-GEN TOX EN, V632, P58, DOI 10.1016/j.mrgentox.2007.04.007; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Sanzari JK, 2013, RADIAT RES, V180, P7, DOI 10.1667/RR3027.1; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Shao LJ, 2010, BLOOD, V115, P4707, DOI 10.1182/blood-2009-10-248872; Stewart FM, 1998, BLOOD, V91, P3681; Stewart FM, 2001, BLOOD, V98, P1246, DOI 10.1182/blood.V98.4.1246; Tamme J, 2013, RADIAT RES, V179, P422, DOI [10.1667/RR3161.2, DOI 10.1667/RR3161.2]; Walker SA, 2013, ADV SPACE RES, V51, P1792, DOI 10.1016/j.asr.2012.12.011; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278	31	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158097	10.1371/journal.pone.0158097	http://dx.doi.org/10.1371/journal.pone.0158097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367604	Green Submitted, Green Published, gold			2022-12-27	WOS:000378914900018
J	Mujtaba, G; Khurshid, A; Sharif, S; Alam, MM; Aamir, UB; Shaukat, S; Angez, M; Rana, MS; Umair, M; Shah, AA; Zaidi, SSZ				Mujtaba, Ghulam; Khurshid, Adnan; Sharif, Salmaan; Alam, Muhammad Masroor; Aamir, Uzma Bashir; Shaukat, Shahzad; Angez, Mehar; Rana, Muhammad Suleman; Umair, Massab; Shah, Aamer Ali; Zaidi, Syed Sohail Zahoor			Distribution of Cytomegalovirus Genotypes among Neonates Born to Infected Mothers in Islamabad, Pakistan	PLOS ONE			English	Article							PREGNANT-WOMEN; HEARING-LOSS; VERTICAL TRANSMISSION; TOXOPLASMA-GONDII; GENOMIC VARIANTS; MIXED INFECTION; GLYCOPROTEIN-H; DISEASE; RUBELLA; SEROPREVALENCE	Background Congenital cytomegalovirus (cCMV) infection contributes to considerable long-term sequelae in neonates and children all over the world. The association between viral genotypes and severity of clinical cytomegalovirus (CMV) infection is yet to be defined. The objective of this study was to find the impact of active CMV infection during pregnancy and the clinical significance of genotypes in neonates with congenital cytomegalovirus infections in Pakistan. Methods A total of 409 blood samples from pregnant women seeking health care services at the two antenatal hospitals of Islamabad during January to December 2012 were tested by ELISA and nested-PCR. Pregnant women with active infection (detected as IgM positive, PCR positive or positive on both assays) were followed until delivery, to detect the outcome of overt cCMV infection in neonates. Genetic characterization of CMV strains was performed by sequence analysis of envelope glycoproteins: gB, gN and gH to detect the contributing CMV genotypes. Results The seroprevalence of anti-CMV IgG and IgM was 97.5% (399 out of 409) and 12.7%(52 out of 409), respectively, while 20% (82/409) pregnant women were found positive for CMV DNA by PCR. Logistic regression analysis showed a significant association of active infection with parity [OR = 2.56, 95% CI = 1.82-2.62, p = 0.04], febrile illness [OR = 1.84, 95% CI = 1.76-3.65, p = 0.01] and jaundice [OR = 22.5, 95% CI = 4.53-85.02, p = 0.002]. We were able to isolate virus in 41 out of 70 neonates; 36.6% (15 out of 41) of them were symptomatic at birth while 63.4%(26 out of 41) were asymptomatic. The most prominent clinical feature observed in symptomatic neonates was hepatosplenomegaly (26.6%; 4 out of 15). All three genotypes gB, gN and gH were found with the highest frequency of gB1 genotype, found in 75% infants with hepatic damage. Phylogenetic analysis of Pakistani strains showed 96%-100% homology to their prototype strains. Conclusions Active CMV infection during pregnancy is a major cause of congenital CMV infection with comparable distribution of all three genotypes: gB, gN and gH in symptomatic and asymptomatic neonates. Our findings emphasize to conduct a comprehensive large scale survey and introduction of country wide routine screening at maternity clinics for early diagnosis of CMV to reduce its associated devastating outcomes.	[Mujtaba, Ghulam; Shah, Aamer Ali] Quaid I Azam Univ, Dept Microbiol, Islamabad, Pakistan; [Khurshid, Adnan; Sharif, Salmaan; Alam, Muhammad Masroor; Aamir, Uzma Bashir; Shaukat, Shahzad; Angez, Mehar; Rana, Muhammad Suleman; Umair, Massab; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan	Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	sohailz@live.com	Shaukat, Shahzad/HHZ-1088-2022; Rana, Dr. Muhammad Suleman/HCH-1540-2022	Shah, Aamer/0000-0001-7454-4105	indigenous scholarship	indigenous scholarship	The study was supported by the indigenous scholarship award to Ghulam Mujtaba for his Ph. D research work.	Abu-Madi MA, 2010, AM J TROP MED HYG, V82, P626, DOI 10.4269/ajtmh.2010.09-0530; Adler SP, 2007, SEMIN PERINATOL, V31, P10, DOI 10.1053/j.semperi.2007.01.002; Ali S, 2014, J INFECT DEV COUNTR, V8, P389, DOI 10.3855/jidc.3854; Almeida LNB, 2001, REV SAUDE PUBL, V35, P124, DOI 10.1590/S0034-89102001000200004; Arav-Boger R, 2002, J INFECT DIS, V186, P1057, DOI 10.1086/344238; Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; Barbi M, 2001, J CLIN VIROL, V21, P75, DOI 10.1016/S1386-6532(00)00188-8; BERENBERG W, 1970, PEDIATRICS, V46, P403; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; CHOU SW, 1991, J INFECT DIS, V163, P1229, DOI 10.1093/infdis/163.6.1229; CHOU SW, 1992, J INFECT DIS, V166, P604, DOI 10.1093/infdis/166.3.604; Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496; Daiminger A, 2005, BJOG-INT J OBSTET GY, V112, P166, DOI 10.1111/j.1471-0528.2004.00328.x; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Dowd JB, 2008, AM J EPIDEMIOL, V167, P112, DOI 10.1093/aje/kwm247; ElNawawy A, 1996, J TROP PEDIATRICS, V42, P154, DOI 10.1093/tropej/42.3.154; Enan KA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-222; Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8; FRIES BC, 1994, J INFECT DIS, V169, P769, DOI 10.1093/infdis/169.4.769; Halwachs-Baumann G, 2001, J CLIN VIROL, V20, P49, DOI 10.1016/S1386-6532(00)00155-4; Hannachi N, 2011, Bull Soc Pathol Exot, V104, P62, DOI 10.1007/s13149-010-0119-z; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kusne S, 1999, Transpl Infect Dis, V1, P187, DOI 10.1034/j.1399-3062.1999.010307.x; Lisboa LF, 2012, TRANSPL INFECT DIS, V14, P132, DOI 10.1111/j.1399-3062.2011.00685.x; Ludwig A, 2009, EUROSURVEILLANCE, V14, P26; Lukacsi A, 2001, J MED VIROL, V65, P537, DOI 10.1002/jmv.2070; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Ocak S, 2007, SCAND J INFECT DIS, V39, P231, DOI 10.1080/00365540600978880; Omer AR, 2011, SAUDI MED J, V32, P55; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Paradowska E, 2014, J MED VIROL, V86, P1421, DOI 10.1002/jmv.23906; Paradowska E, 2013, J CLIN VIROL, V58, P271, DOI 10.1016/j.jcv.2013.05.024; Pati SK, 2013, PEDIATR INFECT DIS J, V32, P1050, DOI 10.1097/INF.0b013e31829bb0b9; Pignatelli S, 2003, J GEN VIROL, V84, P647, DOI 10.1099/vir.0.18704-0; Pignatelli S, 2001, J GEN VIROL, V82, P2777, DOI 10.1099/0022-1317-82-11-2777; Pignatelli S, 2010, CLIN INFECT DIS, V51, P33, DOI 10.1086/653423; Rasmussen L, 1997, J INFECT DIS, V175, P179, DOI 10.1093/infdis/175.1.179; Ross SA, 2014, J INFECT DIS, V210, P1415, DOI 10.1093/infdis/jiu263; Ross SA, 2011, J INFECT DIS, V204, P1003, DOI 10.1093/infdis/jir457; Tabatabaee M, 2009, J MATERN-FETAL NEO M, V22, P517, DOI 10.1080/14767050902801678; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarrago D, 2003, J CLIN MICROBIOL, V41, P2872, DOI 10.1128/JCM.41.7.2872-2877.2003; Uyar Y, 2008, NEW MICROBIOL, V31, P451; Yu ZS, 2006, INTERVIROLOGY, V49, P281, DOI 10.1159/000093458; Zhang XW, 2007, J CLIN VIROL, V40, P180, DOI 10.1016/j.jcv.2007.08.018	47	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156049	10.1371/journal.pone.0156049	http://dx.doi.org/10.1371/journal.pone.0156049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367049	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900004
J	Noutsi, P; Gratton, E; Chaieb, S				Noutsi, Pakiza; Gratton, Enrico; Chaieb, Sahraoui			Assessment of Membrane Fluidity Fluctuations during Cellular Development Reveals Time and Cell Type Specificity	PLOS ONE			English	Article							GENERALIZED POLARIZATION; LIPID-COMPOSITION; PHOSPHOLIPID-VESICLES; MYOBLAST FUSION; MESSENGER-RNA; LAURDAN; FLUORESCENCE; DEFORMABILITY; BILAYERS; PHASES	Cell membrane is made up of a complex structure of lipids and proteins that diffuse laterally giving rise to what we call membrane fluidity. During cellular development, such as differentiation cell membranes undergo dramatic fluidity changes induced by proteins such as ARC and Cofilin among others. In this study we used the generalized polarization (GP) property of fluorescent probe Laurdan using two-photon microscopy to determine membrane fluidity as a function of time and for various cell lines. A low GP value corresponds to a higher fluidity and a higher GP value is associated with a more rigid membrane. Four different cell lines were monitored such as hN2, NIH3T3, HEK293 and L6 cells. Membrane fluidity was measured at 12h, 72h and 92 h. Our results show significant changes in membrane fluidity among all cell types at different time points. GP values tend to increase significantly within 92 h in hN2 cells and 72 h in NIH3T3 cells and only at 92 h in HEK293 cells. L6 showed a marked decrease in membrane fluidity at 72 h and starts to increase at 92 h. As expected, NIH3T3 cells have more rigid membrane at earlier time points. On the other hand, neurons tend to have the highest membrane fluidity at early time points emphasizing its correlation with plasticity and the need for this malleability during differentiation. This study sheds light on the involvement of membrane fluidity during neuronal differentiation and development of other cell lines.	[Noutsi, Pakiza; Chaieb, Sahraoui] King Abdullah Univ Sci & Engn, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA USA; [Chaieb, Sahraoui] Lawrence Berkeley Natl Lab, 1 Cyclotron Rd,Mailstop 6R-2100, Berkeley, CA 94720 USA	King Abdullah University of Science & Technology; University of California System; University of California Irvine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Chaieb, S (corresponding author), King Abdullah Univ Sci & Engn, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia.; Chaieb, S (corresponding author), Lawrence Berkeley Natl Lab, 1 Cyclotron Rd,Mailstop 6R-2100, Berkeley, CA 94720 USA.	sahraoui.chaieb@kaust.edu.sa		Noutsi, Bakiza/0000-0001-5692-303X; Gratton, Enrico/0000-0002-6450-7391	National Institutes of Health [P41-GM103540, P50-GM076516]; King Abdullah University for Science and Technology (KAUST)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Abdullah University for Science and Technology (KAUST)(King Abdullah University of Science & Technology)	EG is supported by the National Institutes of Health grant P41-GM103540 and P50-GM076516. SC and PN were funded by KAUST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank King Abdullah University for Science and Technology (KAUST) for financial support. We also thank Hongtao Chen for the training on Olympus FV1000 inverted microscope, Per Niklas Hedde for helpful discussions and Milka Stakic for providing HEK293, NIH3T3 and L6 cells.	Andrisani OM, 1999, CRIT REV EUKAR GENE, V9, P19, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.20; Bieberich E, 2011, J LIPIDS, V2011, DOI 10.1155/2011/610306; Bonaventura G, 2014, CELL BIOCHEM BIOPHYS, V70, P785, DOI 10.1007/s12013-014-9982-8; Chaieb S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.078101; Cooper GM, 2009, CELL MOL APPROACH, P529; Traian MMD, 2012, J LIPID RES, V53, P609, DOI 10.1194/jlr.D021311; Duan R, 2009, DEV BIOL, V325, P374, DOI 10.1016/j.ydbio.2008.10.035; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; GHOSH C, 1993, NEUROCHEM INT, V23, P479, DOI 10.1016/0197-0186(93)90133-P; Golfetto O, 2013, BIOPHYS J, V104, P1238, DOI 10.1016/j.bpj.2012.12.057; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Higuchi Y, 2005, FEBS LETT, V579, P3009, DOI 10.1016/j.febslet.2005.04.054; HITZEMANN RJ, 1983, NEUROCHEM RES, V8, P121, DOI 10.1007/BF00963913; Hofstetter S, 2012, J MICROBIOL METH, V91, P93, DOI 10.1016/j.mimet.2012.07.023; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Kaiser HJ, 2011, J BIOL CHEM, V286, P40631, DOI 10.1074/jbc.M111.276444; Labeed FH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025458; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; LEVI M, 1993, PHOTOCHEM PHOTOBIOL, V57, P420, DOI 10.1111/j.1751-1097.1993.tb02312.x; Lin C.-B., 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/967182; LIU Y, 1994, APPL PHYS LETT, V65, P919, DOI 10.1063/1.112981; Los DA, 2013, PHOTOSYNTH RES, V116, P489, DOI 10.1007/s11120-013-9823-4; M'Baye G, 2008, BIOPHYS J, V95, P1217, DOI 10.1529/biophysj.107.127480; Maloney JM, 2013, BIOPHYS J, V105, P1767, DOI 10.1016/j.bpj.2013.08.040; METSIKKO K, 1993, INT J DEV BIOL, V37, P305; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagle JF, 2000, CURR OPIN STRUC BIOL, V10, P474, DOI 10.1016/S0959-440X(00)00117-2; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; NOZAWA Y, 1980, BIOCHIM BIOPHYS ACTA, V599, P232, DOI 10.1016/0005-2736(80)90070-X; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Paoletti R, 2012, P ADV STUDY I, P319; PARASASSI T, 1994, BIOPHYS J, V66, P763, DOI 10.1016/S0006-3495(94)80852-5; PARASASSI T, 1986, CELL MOL BIOL, V32, P103; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1995, BIOPHYS J, V68, P1895, DOI 10.1016/S0006-3495(95)80367-X; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Petrache HI, 2000, J MOL BIOL, V302, P727, DOI 10.1006/jmbi.2000.4072; Preira P, 2013, LAB CHIP, V13, P161, DOI [10.1039/c2lc40847c, 10.1039/c2lc40847]; QUINN PJ, 1989, PROG BIOPHYS MOL BIO, V53, P71, DOI 10.1016/0079-6107(89)90015-1; Sajbidor J, 1997, CRIT REV BIOTECHNOL, V17, P87, DOI 10.3109/07388559709146608; Sanchez SA, 2012, P NATL ACAD SCI USA, V109, P7314, DOI 10.1073/pnas.1118288109; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; SHERBET GV, 1989, EXP CELL BIOL, V57, P198; Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; TARABOLETTI G, 1989, INT J CANCER, V44, P707, DOI 10.1002/ijc.2910440426; WAKELAM MJO, 1984, CIBA F SYMP, V103, P100; WAKELAM MJO, 1985, BIOCHEM J, V228, P1; WAKELAM MJO, 1983, BIOCHEM J, V214, P77, DOI 10.1042/bj2140077; Weijers RNM, 2012, CURR DIABETES REV, V8, P390, DOI 10.2174/157339912802083531; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P18707, DOI 10.1073/pnas.1209893109	61	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158313	10.1371/journal.pone.0158313	http://dx.doi.org/10.1371/journal.pone.0158313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362860	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200057
J	Reich, M; Dacheva, I; Nobl, M; Siwy, J; Schanstra, JP; Mullen, W; Koch, FHJ; Kopitz, J; Kretz, FTA; Auffarth, GU; Koss, MJ				Reich, Michael; Dacheva, Ivanka; Nobl, Matthias; Siwy, Justyna; Schanstra, Joost P.; Mullen, William; Koch, Frank H. J.; Kopitz, Juergen; Kretz, Florian T. A.; Auffarth, Gerd U.; Koss, Michael J.			Proteomic Analysis of Vitreous Humor in Retinal Vein Occlusion	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; BIOMARKER DISCOVERY; MASS-SPECTROMETRY; MACULAR EDEMA; PROTEINS; DISEASE; EYE; IDENTIFICATION; PATHOGENESIS; CLUSTERIN	Purpose To analyze the protein profile of human vitreous of untreated patients with retinal vein occlusion (RVO). Methods Sixty-eight vitreous humor (VH) samples (44 from patients with treatment naive RVO, 24 controls with idiopathic floaters) were analyzed in this clinical-experimental study using capillary electrophoresis coupled to mass spectrometer and tandem mass spectrometry. To define potential candidate protein markers of RVO, proteomic analysis was performed on RVO patients (n = 30) and compared with controls (n = 16). To determine validity of potential biomarker candidates in RVO, receiver operating characteristic (ROC) was performed by using proteome data of independent RVO (n = 14) and control samples (n = 8). Results Ninety-four different proteins (736 tryptic peptides) could be identified. Sixteen proteins were found to be significant when comparing RVO and control samples (P = 1.43E-05 to 4.48E-02). Five proteins (Clusterin, Complement C3, Ig lambda-like polypeptide 5 (IGLL5), Opticin and Vitronectin), remained significant after using correction for multiple testing. These five proteins were also detected significant when comparing subgroups of RVO (central RVO, hemi-central RVO, branch RVO) to controls. Using independent samples ROC-Area under the curve was determined proving the validity of the results: Clusterin 0.884, Complement C3 0.955, IGLL5 1.000, Opticin 0.741, Vitronectin 0.786. In addition, validation through ELISA measurements was performed. Conclusion The results of the study reveal that the proteomic composition of VH differed significantly between the patients with RVO and the controls. The proteins identified may serve as potential biomarkers for pathogenesis induced by RVO.	[Reich, Michael] Univ Freiburg, Eye Ctr, Freiburg, Germany; [Dacheva, Ivanka; Nobl, Matthias; Kretz, Florian T. A.; Auffarth, Gerd U.; Koss, Michael J.] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Siwy, Justyna] Mosa Diagnost GmbH, Hannover, Germany; [Schanstra, Joost P.] INSERM, U1048, Inst Cardiovasc & Metab Dis, Toulouse, France; [Schanstra, Joost P.] Univ Toulouse 3, Toulouse, France; [Mullen, William] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Koch, Frank H. J.] Goethe Univ Frankfurt, Dept Ophthalmol, Frankfurt, Germany; [Kopitz, Juergen] Heidelberg Univ, Dept Pathol, Heidelberg, Germany; [Koss, Michael J.] Univ So Calif, Dept Ophthalmol, Los Angeles, CA USA	University of Freiburg; Ruprecht Karls University Heidelberg; Modular Open Systems Approach (MOSA) Solutions; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Glasgow; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; University of Southern California	Koss, MJ (corresponding author), Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany.; Koss, MJ (corresponding author), Univ So Calif, Dept Ophthalmol, Los Angeles, CA USA.	Michael.koss@med.uni-heidelberg.de	Mullen, William/GWC-8078-2022; Schanstra, Joost P/X-7724-2018; Auffarth, Gerd/AAE-6805-2021	Schanstra, Joost P/0000-0002-7471-372X; Mullen, William/0000-0002-5685-1563; Auffarth, Gerd/0000-0002-6927-5251; Siwy, Justyna/0000-0003-1407-2534; Reich, Michael/0000-0002-9813-8483; Nobl, Matthias/0000-0001-8772-3583	Adolf Messer Stiftung, Konigstein, Hessen, Germany; Bayer Vital GmbH, Leverkusen, Germany; Studienstiftung des deutschen Volkes; Dr. Gabriele Lederle-Stiftung; PRO RETINAStiftung zur Verhutung von Blindheit; Mosaiques diagnostics GmbH	Adolf Messer Stiftung, Konigstein, Hessen, Germany; Bayer Vital GmbH, Leverkusen, Germany(Bayer AG); Studienstiftung des deutschen Volkes; Dr. Gabriele Lederle-Stiftung; PRO RETINAStiftung zur Verhutung von Blindheit; Mosaiques diagnostics GmbH	The research group was supported by the Adolf Messer Stiftung, Konigstein, Hessen, Germany. Parts of this research were supported by a research grant from Bayer Vital GmbH, Leverkusen, Germany. Michael Reich is a recipient of scholarships from the Studienstiftung des deutschen Volkes and the Dr. Gabriele Lederle-Stiftung. He wants to thank these organizations for their support. Matthias Nobl is a recipient of scholarships from the PRO RETINAStiftung zur Verhutung von Blindheit and the Dr. Gabriele Lederle-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mosaiques diagnostics GmbH provided support in the form of salaries for authors [JS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The research group was supported by the Adolf Messer Stiftung, Konigstein, Hessen, Germany. A research grant from Bayer Vital GmbH, Leverkusen, Germany, was obtained to cover parts of the experimental costs which did not influence study design, data collection and analysis, decision to publish, or preparation of the manuscript. Michael Reich is a recipient of scholarships from the Studienstiftung des deutschen Volkes and the Dr. Gabriele Lederle-Stiftung. He wants to thank these organizations for their support. Matthias Nobl is a recipient of scholarships from the PRO RETINA-Stiftung zur Verhutung von Blindheit and the Dr. Gabriele Lederle-Stiftung. The funding organizations had no role in the design or conduct of the research.	ANGI M, 2012, MEDIAT INFLAMM, V2012, DOI DOI 10.1155/2012/148039; Aretz S, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-22; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browning DJ., 2012, RETINAL VEIN OCCLUSI; Cryan LM, 2008, PROTEOM CLIN APPL, V2, P762, DOI 10.1002/prca.200780094; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Koss MJ, 2012, ACTA OPHTHALMOL, V90, pe98, DOI 10.1111/j.1755-3768.2011.02292.x; Koss MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096895; Latosinska A., 2013, PROTEOMICS CLIN APPL; Mansor R, 2013, J PROTEOMICS, V85, P89, DOI 10.1016/j.jprot.2013.04.027; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Margolis Ron, 2006, Compr Ophthalmol Update, V7, P265; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Mischak H, 2007, PROTEOM CLIN APPL, V1, P792, DOI 10.1002/prca.200700043; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Neuhaus J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067514; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Park S, 2014, REV ENDOCR METAB DIS, V15, P45, DOI 10.1007/s11154-013-9275-3; Pfister M, 2013, CLIN OPHTHALMOL, V7, P1061, DOI 10.2147/OPTH.S42786; Ramesh S, 2004, BRIT J OPHTHALMOL, V88, P697, DOI 10.1136/bjo.2003.031989; Reardon AJ, 2000, J BIOL CHEM, V275, P2123, DOI 10.1074/jbc.275.3.2123; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Shen YF, 2005, PROTEOMICS, V5, P4034, DOI 10.1002/pmic.200401246; Siwy J, 2011, PROTEOM CLIN APPL, V5, P367, DOI 10.1002/prca.201000155; Stalmach A, 2015, METHODS MOL BIOL, V1243, P187, DOI 10.1007/978-1-4939-1872-0_11; Stefansson E, 2009, GRAEF ARCH CLIN EXP, V247, P147, DOI 10.1007/s00417-008-0980-7; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Tsujikawa A, 2010, AM J OPHTHALMOL, V149, P291, DOI 10.1016/j.ajo.2009.09.007; Weissinger EM, 2014, LEUKEMIA, V28, P842, DOI 10.1038/leu.2013.210; Yamaike N, 2008, OPHTHALMOLOGY, V115, P355, DOI 10.1016/j.ophtha.2007.04.052; Yao JQ, 2013, INT J MOL MED, V32, P1421, DOI 10.3892/ijmm.2013.1509; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	42	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158001	10.1371/journal.pone.0158001	http://dx.doi.org/10.1371/journal.pone.0158001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362861	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200035
J	Hihara, K; Iyoda, M; Tachibana, S; Iseri, K; Saito, T; Yamamoto, Y; Suzuki, T; Wada, Y; Matsumoto, K; Shibata, T				Hihara, Kei; Iyoda, Masayuki; Tachibana, Shohei; Iseri, Ken; Saito, Tomohiro; Yamamoto, Yasutaka; Suzuki, Taihei; Wada, Yukihiro; Matsumoto, Kei; Shibata, Takanori			Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy	PLOS ONE			English	Article							ANTI-PLA2R ANTIBODIES; RENAL BIOPSIES; AUTOANTIBODIES; GLOMERULONEPHRITIS; DIAGNOSIS; SUBCLASS; TITER	The phospholipase A2 receptor (PLA2R) is the major target antigen (Ag) in idiopathic membranous nephropathy (IMN). Recently, several types of immunoassay systems for anti-PLA2R antibody (Ab) have been developed. However, the correlation of serum anti-PLA2R Abs and glomerular expression of PLA2R Ag, and their association with clinicopathological characteristics have yet to be proven in Japanese patients. We examined serum anti-PLA2R Abs by both ELISA and cell-based indirect immunofluorescence assay (CIIFA), and glomerular PLA2R expression by immunofluorescence (IF) in 59 biopsy-proven MN patients including IMN (n = 38) and secondary MN (SMN) (n = 21). In this study, anti-PLA2R Abs were present in 50% of IMN patients, but was absent in SMN patients. The concordance rate between ELISA and CIIFA was 100%. Serum IgG levels were significantly lower in anti-PLA2R Ab-positive patients. Serum albumin levels correlated inversely with serum anti-PLA2R Ab titers. The prevalence and intensity of glomerular staining for IgG4 by IF were significantly higher in anti-PLA2R Ab-positive patients than in-negative patients. Glomerular PLA2 Ag expression evaluated by IF was positive in 52.6% of IMN patients, but was absent in SMN patients. The concordance rate between the prevalence of glomerular PLA2R Ag expression and anti-PLA2R Ab was 84.2%. The prevalence of anti-PLA2R Abs measured by ELISA/CIIFA was equivalent to previous Japanese studies evaluated using Western blotting. These analyses showed an excellent specificity for the diagnosis of IMN, and anti-PLA2R positivity was associated with some clinicopathological features, especially glomerular IgG4-dominant deposition.	[Hihara, Kei; Iyoda, Masayuki; Tachibana, Shohei; Iseri, Ken; Saito, Tomohiro; Yamamoto, Yasutaka; Suzuki, Taihei; Wada, Yukihiro; Matsumoto, Kei; Shibata, Takanori] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan	Showa University	Iyoda, M (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan.	iyoda@med.showa-u.ac.jp	Iseri, Ken/K-6376-2019; Saito, Tomohiro/AAD-6724-2021	Iseri, Ken/0000-0002-6610-2451; 				Akiyama S, 2015, CLIN EXP NEPHROL, V19, P653, DOI 10.1007/s10157-014-1054-2; Bech AP, 2014, CLIN J AM SOC NEPHRO, V9, P1386, DOI 10.2215/CJN.10471013; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Behnert A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/143274; Bruschi M, 2011, J PROTEOMICS, V74, P2008, DOI 10.1016/j.jprot.2011.05.021; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Hayashi N, 2015, CLIN EXP NEPHROL, V19, P797, DOI 10.1007/s10157-014-1064-0; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2015, NEPHROL DIAL TRANSPL, V30, P1862, DOI 10.1093/ndt/gfv228; Hoxha E, 2014, CLIN J AM SOC NEPHRO, V9, P1883, DOI 10.2215/CJN.03850414; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Huang CC, 2013, MODERN PATHOL, V26, P799, DOI 10.1038/modpathol.2012.237; Iwakura T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138841; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; Kattah A, 2015, AM J TRANSPLANT, V15, P1349, DOI 10.1111/ajt.13133; Kuroki A, 2002, INTERNAL MED, V41, P936, DOI 10.2169/internalmedicine.41.936; Larsen CP, 2013, MODERN PATHOL, V26, P709, DOI 10.1038/modpathol.2012.207; Lv JC, 2013, J AM SOC NEPHROL, V24, P1323, DOI 10.1681/ASN.2012080771; Murtas C, 2012, CLIN J AM SOC NEPHRO, V7, P1394, DOI 10.2215/CJN.02170312; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Ruggenenti P, 2015, J AM SOC NEPHROL, V26, P2545, DOI 10.1681/ASN.2014070640; Schlumberger W, 2014, AUTOIMMUN REV, V13, P108, DOI 10.1016/j.autrev.2013.09.005; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; Wakui H, 1999, CLIN EXP IMMUNOL, V118, P445	33	41	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158154	10.1371/journal.pone.0158154	http://dx.doi.org/10.1371/journal.pone.0158154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355365	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400033
J	Hiraoka, K; Sumiyoshi, A; Nonaka, H; Kikkawa, T; Kawashima, R; Osumi, N				Hiraoka, Kotaro; Sumiyoshi, Akira; Nonaka, Hiroi; Kikkawa, Takako; Kawashima, Ryuta; Osumi, Noriko			Regional Volume Decreases in the Brain of Pax6 Heterozygous Mutant Rats: MRI Deformation-Based Morphometry	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; AUDITORY INTERHEMISPHERIC-TRANSFER; TRANSCRIPTION FACTOR PAX6; CONGENITAL ANIRIDIA; MENTAL-RETARDATION; CORTICAL VOLUME; OLFACTORY-BULB; VISUAL-CORTEX; ADULT BRAIN; MUTATION	Pax6 is a transcription factor that pleiotropically regulates various developmental processes in the central nervous system. In a previous study, we revealed that Pax6 heterozygous mutant (rSey(2)/+) adult rats exhibit abnormalities in social interaction. However, the brain malformations underlying the behavioral abnormality are unknown. To elucidate the brain malformations in rSey(2)/+ rats, we morphometrically analyzed brains of rSey(2)/+ and wild type rats using small-animal magnetic resonance imaging (MRI). Sixty 10-week-old rats underwent brain MRI (29 rSey(2)/+ rats and 31 wild type rats). SPM8 software was used for image preprocessing and statistical image analysis. Normalized maps of the Jacobian determinant, a parameter for the expansion and/or contraction of brain regions, were obtained for each rat. rSey(2)/+ rats showed significant volume decreases in various brain regions including the neocortex, corpus callosum, olfactory structures, hippocampal formation, diencephalon, and midbrain compared to wild type rats. Among brain regions, the anterior commissure showed significant interaction between genotype and sex, indicating the effect of genotype difference on the anterior commissure volume was more robust in females than in males. The rSey(2)/+ rats exhibited decreased volume in various gray and white matter regions of the brain, which may contribute to manifestation of abnormal social behaviors.	[Hiraoka, Kotaro] Tohoku Univ, Div Cyclotron Nucl Med, Ctr Cyclotron & Radioisotope, Sendai, Miyagi, Japan; [Sumiyoshi, Akira; Nonaka, Hiroi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi, Japan; [Kikkawa, Takako; Osumi, Noriko] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Dept Dev Neurosci, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Hiraoka, K (corresponding author), Tohoku Univ, Div Cyclotron Nucl Med, Ctr Cyclotron & Radioisotope, Sendai, Miyagi, Japan.	khiraoka@cyric.tohoku.ac.jp	Osumi, Noriko/T-2823-2019; Sumiyoshi, Akira/AGR-1704-2022	Osumi, Noriko/0000-0003-0548-6452; Kikkawa, Takako/0000-0002-6643-8289; Sumiyoshi, Akira/0000-0001-9522-8064	Japan Society for the Promotion of Science (KAKENHI) [25861059, 26291046]; Grants-in-Aid for Scientific Research [16K20902, 15K08127] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by grants from Japan Society for the Promotion of Science (KAKENHI, 25861059 to Kotaro Hiraoka and 26291046 to Noriko Osumi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid H, 2009, MOL VIS, V15, P2074; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bamiou DE, 2004, ANN NEUROL, V56, P503, DOI 10.1002/ana.20227; Bamiou DE, 2007, ARCH PEDIAT ADOL MED, V161, P463, DOI 10.1001/archpedi.161.5.463; Bamiou DE, 2007, INT J AUDIOL, V46, P196, DOI 10.1080/14992020601175952; Biedermann S, 2012, NEUROIMAGE, V61, P1206, DOI 10.1016/j.neuroimage.2012.04.010; Bishop KM, 2002, J NEUROSCI, V22, P7627; Boretius S, 2009, CEREB CORTEX, V19, P2838, DOI 10.1093/cercor/bhp057; Calabrese E, 2013, NEUROIMAGE, V67, P375, DOI 10.1016/j.neuroimage.2012.11.037; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Duan DY, 2013, BRAIN STRUCT FUNCT, V218, P353, DOI 10.1007/s00429-012-0397-2; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Ellison-Wright Z, 2004, EUR J NEUROSCI, V19, P1505, DOI 10.1111/j.1460-9568.2004.03236.x; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Free SL, 2003, NEUROIMAGE, V20, P2281, DOI 10.1016/j.neuroimage.2003.07.001; FUJIWARA M, 1994, DIFFERENTIATION, V57, P31, DOI 10.1046/j.1432-0436.1994.5710031.x; Gaser C, 2012, NEUROIMAGE, V63, P47, DOI 10.1016/j.neuroimage.2012.06.066; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Gozzi A, 2013, NEUROIMAGE, V69, P112, DOI 10.1016/j.neuroimage.2012.12.015; Haba H, 2009, NEUROSCI RES, V65, P116, DOI 10.1016/j.neures.2009.05.011; Hanson IM, 2003, PEDIATR RES, V54, P791, DOI 10.1203/01.PDR.0000096455.00657.98; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; Heyman I, 1999, PSYCHIATR GENET, V9, P85, DOI 10.1097/00041444-199906000-00006; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Kageyama R, 2013, CORTICAL DEV NEURAL, P43, DOI DOI 10.1007/978-4-431-54496-8_3; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Kawano H, 1999, J COMP NEUROL, V408, P147, DOI 10.1002/(SICI)1096-9861(19990531)408:2<147::AID-CNE1>3.0.CO;2-L; Kielar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032636; Kikkawa T, 2013, GENES CELLS, V18, P636, DOI 10.1111/gtc.12061; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Lauritsen MB, 2013, EUR CHILD ADOLES PSY, V22, pS37, DOI 10.1007/s00787-012-0359-5; Lentz MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105752; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Malandrini A, 2001, CLIN GENET, V60, P151, DOI 10.1034/j.1399-0004.2001.600210.x; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Mendola JD, 2005, HUM BRAIN MAPP, V25, P222, DOI 10.1002/hbm.20109; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Moldrich RX, 2010, NEUROIMAGE, V51, P1027, DOI 10.1016/j.neuroimage.2010.03.035; Numayama-Tsuruta K A Y, 2007, RAT SMALL EYE HOMOZY, P151; Osumi N, 2001, TOHOKU J EXP MED, V193, P163, DOI 10.1620/tjem.193.163; Osumi N, 1997, DEVELOPMENT, V124, P2961; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petiet A, 2012, NEUROBIOL AGING, V33, P1533, DOI 10.1016/j.neurobiolaging.2011.03.009; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Scholz J, 2015, NEUROIMAGE, V107, P182, DOI 10.1016/j.neuroimage.2014.12.003; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Stanco A, 2014, NEURON, V84, P940, DOI 10.1016/j.neuron.2014.10.040; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Sumiyoshi A, 2012, NEUROIMAGE, V60, P738, DOI 10.1016/j.neuroimage.2011.12.082; Swanson DJ, 2011, DEV BIOL, V351, P1, DOI 10.1016/j.ydbio.2010.11.018; Takahashi M, 2011, MECH DEVELOP, V128, P289, DOI 10.1016/j.mod.2011.04.001; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Umeda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015500; Valdes-Hernandez Pedro Antonio, 2011, Front Neuroinform, V5, P26, DOI 10.3389/fninf.2011.00026; van de Ven RCG, 2007, MAGN RESON MED, V58, P390, DOI 10.1002/mrm.21313; Vernon AC, 2014, BIOL PSYCHIAT, V75, P982, DOI 10.1016/j.biopsych.2013.09.012; Vitalis T, 2000, J NEUROSCI, V20, P6501, DOI 10.1523/JNEUROSCI.20-17-06501.2000; Wu H, 2016, NEUROSCIENCE, V322, P221, DOI 10.1016/j.neuroscience.2016.02.043; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Yizhar O, 2012, BIOL PSYCHIAT, V71, P1075, DOI 10.1016/j.biopsych.2011.12.029	68	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158153	10.1371/journal.pone.0158153	http://dx.doi.org/10.1371/journal.pone.0158153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355350	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400032
J	Lockhart, SN; Baker, SL; Okamura, N; Furukawa, K; Ishiki, A; Furumoto, S; Tashiro, M; Yanai, K; Arai, H; Kudo, Y; Harada, R; Tomita, N; Hiraoka, K; Watanuki, S; Jagust, WJ				Lockhart, Samuel N.; Baker, Suzanne L.; Okamura, Nobuyuki; Furukawa, Katsutoshi; Ishiki, Aiko; Furumoto, Shozo; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka; Harada, Ryuichi; Tomita, Naoki; Hiraoka, Kotaro; Watanuki, Shoichi; Jagust, William J.			Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351	PLOS ONE			English	Article							PITTSBURGH COMPOUND-B; NEUROFIBRILLARY PATHOLOGY; MODEL; BIOMARKERS; RECEPTOR; BRAIN	Background [F-18]THK5351, a recently-developed positron emission tomography (PET) tracer for measuring tau neurofibrillary tangle accumulation, may help researchers examine aging, disease, and tau pathology in living human brains. We examined THK5351 tracer pharmacokinetics to define an optimal acquisition time for static late images. Methods Primary measurements were calculation of regional values of distribution volume ratios (DVR) and standardized uptake value ratios (SUVR) in 6 healthy older control and 10 Alzheimer's disease (AD) participants. We examined associations between DVR and SUVR, searching for a 20 min SUVR time window that was stable and comparable to DVR. We additionally examined diagnostic group differences in this 20 min SUVR. Results In healthy controls, [F-18]THK5351 uptake was low, with increased temporal relative to frontal binding. In AD, regional uptake was substantially higher than in healthy controls, with temporal exceeding frontal binding. Retention in cerebellar gray matter, which was used as the reference region, was low compared to other regions. Both DVR and SUVR values showed minimal change over time after 40 min. SUVR 20-40, 30-50, and 40-60 min were most consistently correlated with DVR; SUVR 40-60 min, the most stable time window, was used in further analyses. Significant (AD > healthy control) group differences existed in temporoparietal regions, with marginal medial temporal differences. We found high basal ganglia SUVR 40-60 min signal, with no group differences. Conclusions We examined THK5351, a new PET tracer for measuring tau accumulation, and compared multiple analysis methods for quantifying regional tracer uptake. SUVR 40-60 min performed optimally when examining 20 min SUVR windows, and appears to be a practical method for quantifying relative regional tracer retention. The results of this study offer clinical potential, given the usefulness of THK5351-PET as a biomarker of tau pathology in aging and disease.	[Lockhart, Samuel N.; Baker, Suzanne L.; Jagust, William J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Baker, Suzanne L.; Jagust, William J.] Lawrence Berkeley Natl Lab, Ctr Funct Imaging, Berkeley, CA USA; [Okamura, Nobuyuki; Yanai, Kazuhiko] Tohoku Univ, Sch Med, Dept Pharmacol, Sendai, Miyagi, Japan; [Furukawa, Katsutoshi; Ishiki, Aiko; Arai, Hiroyuki; Kudo, Yukitsuka; Harada, Ryuichi; Tomita, Naoki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Furumoto, Shozo; Tashiro, Manabu; Yanai, Kazuhiko; Hiraoka, Kotaro; Watanuki, Shoichi] Tohoku Univ, Ctr Cyclotron & Radioisotope, Sendai, Miyagi, Japan	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Tohoku University; Tohoku University; Tohoku University	Lockhart, SN (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	snl@berkeley.edu	Tashiro, Manabu/T-2859-2019; Jagust, William/ABE-6426-2020; Yanai, Kazuhiko/X-3911-2019; Okamura, Nobuyuki/C-3541-2017; Lockhart, Samuel Neal/AET-0265-2022	Yanai, Kazuhiko/0000-0001-9068-7907; Okamura, Nobuyuki/0000-0002-5991-7812; Lockhart, Samuel Neal/0000-0002-0893-5420; Furumoto, Shozo/0000-0002-9296-3079	GE Healthcare; SEI (Sumitomo Electric Industries,Ltd.) Group CSR Foundation; Industrial Technology Research Grant Program of the NEDO in Japan [09E51025a]; Ministry of Health, Labor, and Welfare of Japan; National Institute on Aging training fellowship [F32AG050389]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [15H04900, 26117003, 15K19767]; NATIONAL INSTITUTE ON AGING [F32AG050389] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K08127] Funding Source: KAKEN	GE Healthcare(General ElectricGE Healthcare); SEI (Sumitomo Electric Industries,Ltd.) Group CSR Foundation; Industrial Technology Research Grant Program of the NEDO in Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute on Aging training fellowship; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from GE Healthcare (www.gehealthcare.com), the SEI (Sumitomo Electric Industries,Ltd.) Group CSR Foundation (http://global-sei.com/csr/), the Industrial Technology Research Grant Program of the NEDO in Japan (http://www.nedo.go.jp/english/index.html, 09E51025a), Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare (http://www.mhlw.go.jp/english/) of Japan, Grant-in-Aid for Scientific Research (B) (15H04900), Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) (26117003), Grant-in-Aid for Young Scientists (B) (15K19767), and Grant-in-Aid for JSPS Fellows and "Japan Advanced Molecular Imaging Program (J-AMP)" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT; http://www.mext.go.jp/english/), Japan. Drs. Okamura and Kudo own stock in Clino Ltd. Dr. Jagust has served as a consultant to BioClinica, Banner Alzheimer Institute, Genentech, and Novartis. Dr. Lockhart is supported by a National Institute on Aging training fellowship (https://www.nia.nih.gov/, F32AG050389). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CARSON RE, 1993, J CEREBR BLOOD F MET, V13, P24, DOI 10.1038/jcbfm.1993.6; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Harada R, 2016, J NUCL MED, V57, P208, DOI 10.2967/jnumed.115.164848; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; McNamee RL, 2009, J NUCL MED, V50, P348, DOI 10.2967/jnumed.108.057612; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Okamura N, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0500-6; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Stankoff B, 2011, ANN NEUROL, V69, P673, DOI 10.1002/ana.22320; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Villemagne VL, 2015, LANCET NEUROL, V14, P114, DOI 10.1016/S1474-4422(14)70252-2	23	62	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158460	10.1371/journal.pone.0158460	http://dx.doi.org/10.1371/journal.pone.0158460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355840	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400069
J	Petrella, E; Piciucchi, S; Feletti, F; Barone, D; Piraccini, A; Minghetti, C; Gruppioni, G; Poletti, V; Bertocco, M; Traversari, M				Petrella, Enrico; Piciucchi, Sara; Feletti, Francesco; Barone, Domenico; Piraccini, Antonella; Minghetti, Caterina; Gruppioni, Giorgio; Poletti, Venerino; Bertocco, Mauro; Traversari, Mirko			CT Scan of Thirteen Natural Mummies Dating Back to the XVI-XVIII Centuries: An Emerging Tool to Investigate Living Conditions and Diseases in History	PLOS ONE			English	Article							PALEORADIOLOGY; DEATH; AGE	Objectives To correlate the radiologic findings detected with computed tomography scan with anthropological data in 13 naturally mummified bodies discovered during works of recovery of an ancient church in a crypt in Roccapelago, in the Italian Apennines. Methods From a group of about sixty not-intentionally mummified bodies, thirteen were selected to be investigated with volumetric computed tomography (CT). Once CT scan was performed, axial images were processed to gather MPR and Volume Rendering reconstructions. Elaborations of these images provided anthropometric measurements and a non-invasive analysis of the residual anatomical structures. For each body the grade of preservation and the eventual pathological changes were recorded. Furthermore, in order to identify nutritional and occupational markers, radiologic signs of bone tropism and degenerative changes were analysed and graded. Results Mummies included seven females and six males, with an estimated age ranging from 20 to 60 years. The first relevant finding identified was a general low grade of preservation, due to the lack of anatomic tissues different from bones, tendons and dehydrated skin. The low grade of preservation was related to the natural process of mummification. Analysing bone degenerative changes on CT scan, the majority of the bodies had significant occupational markers consisting of arthritis in the spine, lower limbs and shoulders even in young age. Few were the pathological findings identified. Among these, the most relevant included a severe bilateral congenital hip dysplasia and a wide osteolytic lesion involving left orbit and petrous bone that was likely the cause of death. Conclusions Although the low grade of preservation of these mummies, the multidisciplinary approach of anthropologists and radiologists allowed several important advances in knowledge for the epidemiology of Roccapelago. First of all, a profile of living conditions was delineated. It included occupational and nutritional conditions. Moreover, identification of some causes of death and, most importantly the definition of general living conditions.	[Petrella, Enrico; Piciucchi, Sara; Bertocco, Mauro] Azienda USL Romagna, Osped GB Morgagni, Dept Radiol, Forli, FC, Italy; [Feletti, Francesco; Piraccini, Antonella] Santa Maria Croci Hosp, Dept Radiol, Ravenna, RA, Italy; [Barone, Domenico] IRCCS Ist Sci Romagnolo Studio & Cura Tumori IRST, Radiol Unit, Meldola, FC, Italy; [Minghetti, Caterina; Gruppioni, Giorgio; Traversari, Mirko] Univ Bologna, Dept Hist & Methods Conservat Cultural Heritage, I-40126 Bologna, BO, Italy; [Poletti, Venerino] Azienda USL Romagna, Osped GB Morgagni, Dept Dis Thorax, Forli, FC, Italy; [Poletti, Venerino] Aarhus Univ Hosp, Dept Resp Dis & Allergol, Aarhus, Denmark	IRCCS Meldola (IRST); University of Bologna; Aarhus University	Piciucchi, S (corresponding author), Azienda USL Romagna, Osped GB Morgagni, Dept Radiol, Forli, FC, Italy.	piciucchi.sara@gmail.com	Feletti, Francesco/N-4031-2019; Poletti, Venerino/K-8821-2016; Traversari, Mirko/Q-2627-2019	Feletti, Francesco/0000-0002-3621-3871; Poletti, Venerino/0000-0002-8634-2284; Traversari, Mirko/0000-0002-6376-7626				Baggieri G, 2003, ASS SCI CULTURALE AR; Bass MW, 1995, HUMAN OSTEOLOGY LAB; Cesarani F, 2003, AM J ROENTGENOL, V180, P597, DOI 10.2214/ajr.180.3.1800597; Chhem R.K., 2008, PALEORADIOLOGY IMAGI, DOI [10.1007/978-3-540-48833-0, DOI 10.1007/978-3-540-48833-0]; Chhem RK, 2004, CAN ASSOC RADIOL J, V55, P198; Deoeking A, 1896, BRIT J PHOTOGRAPHY, V43, P131; Disaro' M, 2014, FORENSIC SCI MED PAT, V10, P139, DOI 10.1007/s12024-013-9508-5; Friedman SN, 2012, J COMPUT ASSIST TOMO, V36, P616, DOI 10.1097/RCT.0b013e31826739f5; Gruppioni G, ALLINSEGNA GIGLIO, P219; Iscan M. Y., 1989, RECONSTRUCTION LIFE; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kimmerle EH, 2008, J FORENSIC SCI, V53, P558, DOI 10.1111/j.1556-4029.2008.00711.x; Lim DS, 2008, J ANAT, V213, P482, DOI 10.1111/j.1469-7580.2008.00955.x; Lorenzini L, 2012, VESTI SEMPRE CLOTHIN; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lynnerup N, 2010, GERONTOLOGY, V56, P441, DOI 10.1159/000266031; MURAIL P, 2005, B MEM SOC ANTHRO PAR, V17, P167, DOI DOI 10.4000/BMSAP.1157; Murphy WA, 2003, RADIOLOGY, V226, P614, DOI 10.1148/radiol.2263020338; Ohrstrom LM, 2013, RADIOGRAPHICS, V33, P291, DOI 10.1148/rg.331125711; Panzer S, 2015, PLOS ONE, V5, P1; Previgliano CH, 2003, AM J ROENTGENOL, V181, P1473, DOI 10.2214/ajr.181.6.1811473; Ruhli FJ, 2004, CAN ASSOC RADIOL J, V55, P218; Schmitt Aurore, 2005, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V17, P89; Sikora M, 2014, PLOS GENET, V5, P2; Suchey JM, 1990, HUMAN EVOLUTION, V5, P227; Traversari M., 2016, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V28, P202, DOI 10.1007/s13219-015-0140-7; Traversari M, 2014, 20 C AAI VAR UM TRA, P147; Usui A, 2012, JPN J RADIOL, V30, P458, DOI 10.1007/s11604-012-0068-5	28	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0154349	10.1371/journal.pone.0154349	http://dx.doi.org/10.1371/journal.pone.0154349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355351	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400002
J	O'Beirne, SL; Salit, J; Rodriguez-Flores, JL; Staudt, MR; Khalil, CA; Fakhro, KA; Robay, A; Ramstetter, MD; Al-Azwani, IK; Malek, JA; Zirie, M; Jayyousi, A; Badii, R; Al-Marri, AA; Chiuchiolo, MJ; Al-Shakaki, A; Chidiac, O; Gharbiah, M; Bener, A; Stadler, D; Hackett, NR; Mezey, JG; Crystal, RG				O'Beirne, Sarah L.; Salit, Jacqueline; Rodriguez-Flores, Juan L.; Staudt, Michelle R.; Khalil, Charbel Abi; Fakhro, Khalid A.; Robay, Amal; Ramstetter, Monica D.; Al-Azwani, Iman K.; Malek, Joel A.; Zirie, Mahmoud; Jayyousi, Amin; Badii, Ramin; Al-Marri, Ajayeb Al-Nabet; Chiuchiolo, Maria J.; Al-Shakaki, Alya; Chidiac, Omar; Gharbiah, Maey; Bener, Abdulbari; Stadler, Dora; Hackett, Neil R.; Mezey, Jason G.; Crystal, Ronald G.			Type 2 Diabetes Risk Allele Loci in the Qatari Population	PLOS ONE			English	Article							GENETIC ARCHITECTURE; VARIANTS; SUSCEPTIBILITY; ASSOCIATION; LINKAGE; OBESITY; DISEASE; TCF7L2; COMMON	Background The prevalence of type 2 diabetes (T2D) is increasing in the Middle East. However, the genetic risk factors for T2D in the Middle Eastern populations are not known, as the majority of studies of genetic risk for T2D are in Europeans and Asians. Methods All subjects were >= 3 generation Qataris. Cases with T2D (n = 1,124) and controls (n = 590) were randomly recruited and assigned to the 3 known Qatari genetic subpopulations [Bedouin (Q1), Persian/South Asian (Q2) and African (Q3)]. Subjects underwent genotyping for 37 single nucleotide polymorphisms (SNPs) in 29 genes known to be associated with T2D in Europeans and/or Asian populations, and an additional 27 tag SNPs related to these susceptibility loci. Pre-study power analysis suggested that with the known incidence of T2D in adult Qataris (22%), the study population size would be sufficient to detect significant differences if the SNPs were risk factors among Qataris, assuming that the odds ratio (OR) for T2D SNPs in Qatari's is greater than or equal to the SNP with highest known OR in other populations. Results Haplotype analysis demonstrated that Qatari haplotypes in the region of known T2D risk alleles in Q1 and Q2 genetic subpopulations were similar to European haplotypes. After Benjamini-Hochberg adjustment for multiple testing, only two SNPs (rs7903146 and rs4506565), both associated with transcription factor 7-like 2 (TCF7L2), achieved statistical significance in the whole study population. When T2D subjects and control subjects were assigned to the known 3 Qatari subpopulations, and analyzed individually and with the Q1 and Q2 genetic subpopulations combined, one of these SNPs (rs4506565) was also significant in the admixed group. No other SNPs associated with T2D in all Qataris or individual genetic subpopulations. Conclusions With the caveats of the power analysis, the European/Asian T2D SNPs do not contribute significantly to the high prevalence of T2D in the Qatari population, suggesting that the genetic risks for T2D are likely different in Qataris compared to Europeans and Asians.	[O'Beirne, Sarah L.; Salit, Jacqueline; Rodriguez-Flores, Juan L.; Staudt, Michelle R.; Ramstetter, Monica D.; Chiuchiolo, Maria J.; Hackett, Neil R.; Mezey, Jason G.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [O'Beirne, Sarah L.; Crystal, Ronald G.] Weill Cornell Med Coll, Div Pulm & Crit Care Med, Dept Med, New York, NY USA; [Khalil, Charbel Abi; Fakhro, Khalid A.; Robay, Amal; Al-Azwani, Iman K.; Malek, Joel A.; Al-Shakaki, Alya; Chidiac, Omar; Gharbiah, Maey] Weill Cornell Med Coll Qatar, Dept Med Genet, Doha, Qatar; [Fakhro, Khalid A.] Sidra Med Res Ctr, Div Translat Med, Doha, Qatar; [Ramstetter, Monica D.; Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Zirie, Mahmoud; Jayyousi, Amin] Hamad Med Corp, Dept Med, Doha, Qatar; [Badii, Ramin; Al-Marri, Ajayeb Al-Nabet] Hamad Med Corp, Lab Med & Pathol, Doha, Qatar; [Bener, Abdulbari] Hamad Med Corp, Dept Med Stat & Epidemiol, Doha, Qatar; [Stadler, Dora] Weill Cornell Med Coll Qatar, Dept Med, Doha, Qatar	Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Sidra Medical & Research Center; Cornell University; Hamad Medical Corporation; Hamad Medical Corporation; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Khalil, CA (corresponding author), Weill Cornell Med Coll Qatar, Dept Med Genet, Doha, Qatar.	geneticmedicine@med.cornell.edu	BENER, ABDULBARİ/AAC-4436-2020; O'Beirne, Sarah/K-1214-2016; Rodriguez-Flores, Juan L/AAJ-7565-2020; Abi Khalil, Charbel/J-6813-2012	O'Beirne, Sarah/0000-0003-2876-0258; Rodriguez-Flores, Juan L/0000-0002-0394-8062; Abi Khalil, Charbel/0000-0002-1428-6324; Staudt, Michelle/0000-0002-3364-0894	Qatar Foundation; Weill Cornell Medical College in Qatar; Qatar National Research Foundation [NPRP 09-741-3-193, 09-740-3-192, NPRP 5-436-3-116]	Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Qatar National Research Foundation(National Research Foundation of Korea)	These studies were supported, in part, by The Qatar Foundation and the Weill Cornell Medical College in Qatar and Qatar National Research Foundation NPRP 09-741-3-193, 09-740-3-192 and NPRP 5-436-3-116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank N. Mohamed for editorial assistance. These studies were supported, in part, by The Qatar Foundation and the Weill Cornell Medical College in Qatar and Qatar National Research Foundation NPRP 09-741-3-193, 09-740-3-192 and NPRP 5-436-3-116.	Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Al-Daghri NM, 2014, CLIN ENDOCRINOL, V80, P532, DOI 10.1111/cen.12187; Almawi WY, 2013, DIABETES RES CLIN PR, V102, P117, DOI 10.1016/j.diabres.2013.09.001; Alsmadi O, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-72; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bener A, 2005, CROAT MED J, V46, P302; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Cauchi S, 2012, DIABETES METAB, V38, P316, DOI 10.1016/j.diabet.2012.02.003; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ezzidi I, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-33; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Grarup N, 2014, DIABETOLOGIA, V57, P1528, DOI 10.1007/s00125-014-3270-4; Gu S, 2007, EUR J HUM GENET, V15, P302, DOI 10.1038/sj.ejhg.5201751; Haiman CA, 2012, DIABETES, V61, P1642, DOI 10.2337/db11-1296; Hara K, 2014, BIOCHEM BIOPH RES CO, V452, P213, DOI 10.1016/j.bbrc.2014.08.012; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Omberg L, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-49; Popkin BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0631-4; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez-Flores JL, 2016, GENOME RES, V26, P151, DOI 10.1101/gr.191478.115; Rodriguez-Flores JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047614; Shao WJ, 2013, DIABETES, V62, P789, DOI 10.2337/db12-0365; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tomei S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0459-3; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Xu J, 2012, GENET MOL RES, V11, P1592, DOI 10.4238/2012.May.24.1; Zhou YD, 2014, HUM MOL GENET, V23, P6419, DOI 10.1093/hmg/ddu359	42	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156834	10.1371/journal.pone.0156834	http://dx.doi.org/10.1371/journal.pone.0156834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383215	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400007
J	Souza, ALA; Faria, RX; Calabrese, KS; Hardoim, DJ; Taniwaki, N; Alves, LA; De Simone, SG				Souza, Andre L. A.; Faria, Robson X.; Calabrese, Katia S.; Hardoim, Daiane J.; Taniwaki, Noemi; Alves, Luiz A.; De Simone, Salvatore G.			Temporizin and Temporizin-1 Peptides as Novel Candidates for Eliminating Trypanosoma cruzi	PLOS ONE			English	Article							FORMS ION CHANNELS; HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; CHAGAS-DISEASE; MEMBRANE-PERMEABILIZATION; PLASMA-MEMBRANE; LIPID BILAYER; IN-VITRO; GRAMICIDIN; ANTIBACTERIAL	Tropical diseases caused by parasitic infections continue to cause socioeconomic distress worldwide. Among these, Chagas disease has become a great concern because of globalization. Caused by Trypanosoma cruzi, there is an increasing need to discover new, more effective methods to manage infections that minimize disease onset. Antimicrobial peptides represent a possible solution to this challenge. As effector molecules of the innate immune response against pathogens, they are the first line of defense found in all multi-cellular organisms. In amphibians, temporins are a large family of antimicrobial peptides found in skin secretions. Their functional roles and modes of action present unique properties that indicate possible candidates for therapeutic applications. Here, we investigated the trypanocide activity of temporizin and temporizin-1. Temporizin is an artificial, hybrid peptide containing the N-terminal region of temporin A, the pore-forming region of gramicidin and a C-terminus consisting of alternating leucine and lysine. Temporizin-1 is a modification of temporizin with a reduction in the region responsible for insertion into membranes. Their activities were evaluated in a cell permeabilization assay by flow cytometry, an LDH release assay, electron microscopy, an MTT assay and patch clamp experiments. Both temporizin and temporizin-1 demonstrated toxicity against T. cruzi with temporizin displaying slightly more potency. At concentrations up to 100 mu g/ml, both peptides exhibited low toxicity in J774 cells, a macrophage lineage cell line, and no toxicity was observed in mouse primary peritoneal macrophages. In contrast, the peptides showed some toxicity in rat adenoma GH3 cells and Jurkat human lymphoma cells with temporizin-1 displaying lower toxicity. In summary, a shortened form of the hybrid temporizin peptide, temporizin-1, was efficient at killing T. cruzi and it has low toxicity in wild-type mammalian cells. These data suggest that temporizin-1 might be a candidate for Chagas disease therapy.	[Souza, Andre L. A.; De Simone, Salvatore G.] Fiocruz MS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil; [Souza, Andre L. A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Expt & Computat Biochem Pharmaceut, Rio De Janeiro, RJ, Brazil; [Faria, Robson X.] Fiocruz MS, Inst Oswaldo Cruz, Lab Toxoplasmosis & Other Protozoosis, Rio De Janeiro, RJ, Brazil; [Calabrese, Katia S.; Hardoim, Daiane J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunomodulat & Protozool, Rio De Janeiro, RJ, Brazil; [Taniwaki, Noemi] Fiocruz MS, Adolfo Lutz Inst, Elect Microscopy Sect, Sao Paulo, SP, Brazil; [Alves, Luiz A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Cellular Commun, Rio De Janeiro, RJ, Brazil; [De Simone, Salvatore G.] Univ Fed Fluminense, Inst Biol, Dept Cellular & Mol Biol, Niteroi, RJ, Brazil	Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Instituto Adolfo Lutz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Faria, RX (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Toxoplasmosis & Other Protozoosis, Rio De Janeiro, RJ, Brazil.	robson.xavier@gmail.com	De-Simone, Salvatore/I-2989-2013; Calabrese, Katia S/V-2631-2018	De-Simone, Salvatore/0000-0002-2172-656X; Hardoim, Daiana de Jesus/0000-0002-2272-2472	CNPq; FAPERJ; CAPES V/Fiocruz CNPq; PAPES VI/CNPq; Oswaldo Cruz Institute	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES V/Fiocruz CNPq; PAPES VI/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Institute	This work was supported by grants from CNPq, FAPERJ, CAPES V/Fiocruz CNPq, PAPES VI/CNPq and Oswaldo Cruz Institute.	Adade CM, 2013, TOXICON, V69, P227, DOI 10.1016/j.toxicon.2013.03.011; AGAWA Y, 1991, J BIOL CHEM, V266, P20218; Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; ANDREU D, 1992, FEBS LETT, V296, P190, DOI 10.1016/0014-5793(92)80377-S; Angelique L, 2015, MOLECULES, V20, P15392, DOI 10.3390/molecules200815392; Aquila M, 2012, PATCH CLAMP TECHNIQU; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bartel LC, 2007, HUM EXP TOXICOL, V26, P781, DOI 10.1177/0960327107084540; Bern C, 2008, CURR OPIN INFECT DIS, V21, P476, DOI 10.1097/QCO.0b013e32830ef5b6; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bezzerri V, 2014, J PEPT SCI, V20, P822, DOI 10.1002/psc.2674; Bhunia A, 2011, J BIOL CHEM, V286, P24394, DOI 10.1074/jbc.M110.189662; BRADBURY AF, 1991, TRENDS BIOCHEM SCI, V16, P112, DOI 10.1016/0968-0004(91)90044-V; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Capone R, 2010, BIOPHYS J, V98, P2644, DOI 10.1016/j.bpj.2010.02.024; Cerecetto Hugo, 2002, Current Topics in Medicinal Chemistry, V2, P1187, DOI 10.2174/1568026023393066; CLARK DP, 1994, J BIOL CHEM, V269, P10849; Conlon JM, 2009, BBA-BIOMEMBRANES, V1788, P1556, DOI 10.1016/j.bbamem.2008.09.018; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P549, DOI 10.1590/S0074-02762009000400002; Croft A M, 2006, J R Army Med Corps, V152, P156; CRUCIANI RA, 1992, EUR J PHARM-MOLEC PH, V226, P287, DOI 10.1016/0922-4106(92)90045-W; D'Elia C, 2005, REV SOC BRAS MED TRO, V38, P7, DOI 10.1590/S0037-86822005000100002; Da Silveira JF, 1991, BIOCHIM BIOPHYS ACTA, V644, P341; David JM, 2015, J KIDNEY CANCER VHL, V2, P15, DOI 10.15586/jkcvhl.2015.21; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; Deane L. M., 1964, Revista Brasileira de Malariologia, V16, P27; Delespaux V, 2007, DRUG RESIST UPDATE, V10, P30, DOI 10.1016/j.drup.2007.02.004; Dias J. C. P., 1984, Memorias do Instituto Oswaldo Cruz, V79, P85, DOI 10.1590/S0074-02761984000500017; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Dixit R, 2008, ACTA TROP, V106, P75, DOI 10.1016/j.actatropica.2008.01.001; Eggimann GA, 2015, MOLECULES, V20, P2775, DOI 10.3390/molecules20022775; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; ELLIS JA, 1993, VET PARASITOL, V50, P143, DOI 10.1016/0304-4017(93)90015-F; Fabbro DL, 2007, REV SOC BRAS MED TRO, V40, P1, DOI 10.1590/S0037-86822007000100001; Faria RX, 2009, AM J PHYSIOL-CELL PH, V297, pC28, DOI 10.1152/ajpcell.00476.2008; Faria RX, 2005, AM J PHYSIOL-CELL PH, V288, pC260, DOI 10.1152/ajpcell.00215.2004; Fieck A, 2010, EXP PARASITOL, V125, P342, DOI 10.1016/j.exppara.2010.02.016; Garcia S, 2005, ANTIMICROB AGENTS CH, V4; Grieco P, 2013, BBA-BIOMEMBRANES, V1828, P652, DOI 10.1016/j.bbamem.2012.08.027; Grieco P, 2011, J PEPT SCI, V17, P358, DOI 10.1002/psc.1350; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; KETCHEM RR, 1993, SCIENCE, V261, P1457, DOI 10.1126/science.7690158; Kim H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1111/CHS0.12019; KOEPPE RE, 1995, BIOCHEMISTRY-US, V34, P9299, DOI 10.1021/bi00029a004; KREIL G, 1994, CIBA F SYMP, V186, P77; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Leuschner C, 2003, BREAST CANCER RES TR, V78, P17, DOI 10.1023/A:1022169525521; Lombana A, 2014, J PEPT SCI, V20, P563, DOI 10.1002/psc.2654; Madison AN, 2007, INFECT IMMUN, V75, P4780, DOI 10.1128/IAI.00557-07; Mahalka AK, 2009, BBA-BIOMEMBRANES, V1788, P1600, DOI 10.1016/j.bbamem.2009.04.012; Mangoni ML, 2016, CURR TOP MED CHEM, V16, P54, DOI 10.2174/1568026615666150703121403; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Paulmann M, 2012, J BIOL CHEM, V287, P8434, DOI 10.1074/jbc.M111.332270; Pinto EG, 2013, EXP PARASITOL, V135, P655, DOI 10.1016/j.exppara.2013.09.016; Quigley EP, 2000, J MEMBRANE BIOL, V174, P207, DOI 10.1007/s002320001045; Rinaldi AC, 2002, BIOCHEM J, V368, P91, DOI 10.1042/BJ20020806; Rodrigues CO, 2001, J EUKARYOT MICROBIOL, V48, P588, DOI 10.1111/j.1550-7408.2001.tb00195.x; Saint N, 2002, BBA-BIOMEMBRANES, V1564, P359, DOI 10.1016/S0005-2736(02)00470-4; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Simmaco M, 1998, SCAND J IMMUNOL, V48, P357; Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x; Song C, 2013, P NATL ACAD SCI USA, V110, P4586, DOI 10.1073/pnas.1214739110; SPECTOR AA, 1985, J LIPID RES, V26, P1015; STANKOVIC CJ, 1990, ANAL BIOCHEM, V184, P100, DOI 10.1016/0003-2697(90)90019-6; Tempone AG, 2007, LETT DRUG DES DISCOV, V4, P67; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; WARNOCK DE, 1993, J BIOL CHEM, V268, P10145; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; YAMADA K, 1994, BIOCHEM J, V298, P623, DOI 10.1042/bj2980623; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 2009, CURR OPIN INVEST DR, V10, P164	74	14	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157673	10.1371/journal.pone.0157673	http://dx.doi.org/10.1371/journal.pone.0157673			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384541	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400019
J	Kong, ZW; Fan, XT; Sun, SY; Song, LL; Shi, QD; Nie, J				Kong, Zhaowei; Fan, Xitao; Sun, Shengyan; Song, Lili; Shi, Qingde; Nie, Jinlei			Comparison of High-Intensity Interval Training and Moderate-to-Vigorous Continuous Training for Cardiometabolic Health and Exercise Enjoyment in Obese Young Women: A Randomized Controlled Trial	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SPRINT INTERVAL; FAT OXIDATION; MUSCLE; FITNESS; MEN; ADAPTATIONS; SEDENTARY; CAPACITY; HORMONES	Objective The aim of this study was to compare the effects of 5-week high-intensity interval training (HIIT) and moderate-to-vigorous intensity continuous training (MVCT) on cardiometabolic health outcomes and enjoyment of exercise in obese young women. Methods A randomized controlled experiment was conducted that involved thirty-one obese females (age range of 18-30) randomly assigned to either HIIT or MVCT five-week training programs. Participants in HIIT condition performed 20 min of repeated 8 s cycling interspersed with 12 s rest intervals, and those in MVCT condition cycled continuously for 40 min at 60-80% of peak oxygen consumption ((V)over dotO(2peak)), both for four days in a week. Outcomes such as (V)over dotO(2peak), body composition estimated by bioimpedance analysis, blood lipids, and serum sexual hormones were measured at pre-and post-training. The scores of Physical Activity Enjoyment Scale (PAES) were collected during the intervention. Results After training, (V)over dotO(2peak) increased significantly for both training programs (9.1% in HIIT and 10.3% in MVCT) (p = 0.010, eta(2) = 0.41). Although MVCT group had a significant reduction in total body weight (TBW, -1.8%, p = 0.034), fat mass (FM, -4.7%, p = 0.002) and percentage body fat (PBF, -2.9%, p = 0.016), there were no significant between-group differences in the change of the pre- and post-measures of these variables. The HIIT group had a higher score on PAES than the MVCT group during the intervention. For both conditions, exercise training led to a decline in resting testosterone and estradiol levels, but had no significant effect on blood lipids. Conclusion Both HIIT and MVCT are effective in improving cardiorespiratory fitness and in reducing sexual hormones in obese young women; however, HIIT is a more enjoyable and time-efficient strategy. The mild-HIIT protocol seems to be useful for at least maintaining the body weight among sedentary individuals.	[Kong, Zhaowei; Fan, Xitao; Song, Lili] Univ Macau, Fac Educ, Macau, Peoples R China; [Sun, Shengyan] Huzhou Univ, Inst Phys Educ, Huzhou, Zhejiang, Peoples R China; [Shi, Qingde; Nie, Jinlei] Macao Polytech Inst, Sch Phys Educ & Sports, Macau, Peoples R China	University of Macau; Huzhou University; Macao Polytechnic University	Nie, J (corresponding author), Macao Polytech Inst, Sch Phys Educ & Sports, Macau, Peoples R China.	jnie@ipm.edu.mo	Kong, Zhaowei/O-1095-2013; Sun, Shengyan/AFT-1931-2022; Nie, Jinlei/B-6616-2011	Kong, Zhaowei/0000-0002-9999-1312; Nie, Jinlei/0000-0003-2326-3615	University of Macau [MYRG027(Y1-L1)-FED11-KZW]	University of Macau	ZK received a research grant funded by University of Macau (MYRG027(Y1-L1)-FED11-KZW). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almenning I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138793; Astorino TA, 2011, EUR J APPL PHYSIOL, V111, P1279, DOI 10.1007/s00421-010-1741-y; Bailey SJ, 2009, J APPL PHYSIOL, V106, P1875, DOI 10.1152/japplphysiol.00144.2009; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Biddle SJH, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0254-9; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Blouin K, 2008, J STEROID BIOCHEM, V108, P272, DOI 10.1016/j.jsbmb.2007.09.001; Boutcher SH, 2011, J OBES, V2011, DOI 10.1155/2011/868305; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Campbell SE, 2001, AM J PHYSIOL-ENDOC M, V281, pE803, DOI 10.1152/ajpendo.2001.281.4.E803; Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Esfarjani F, 2007, J SCI MED SPORT, V10, P27, DOI 10.1016/j.jsams.2006.05.014; Fisher G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138853; Foster C, 2015, J SPORT SCI MED, V14, P747; Franklin BA, 2000, ACSMS GUIDELINES EXE; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gist NH, 2014, SPORTS MED, V44, P269, DOI 10.1007/s40279-013-0115-0; Gormley SE, 2008, MED SCI SPORT EXER, V40, P1336, DOI 10.1249/MSS.0b013e31816c4839; Hardcastle SJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01505; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Heydari M, 2012, J OBES, V2012, DOI 10.1155/2012/480467; Iaia FM, 2009, J APPL PHYSIOL, V106, P73, DOI 10.1152/japplphysiol.90676.2008; Jung ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114541; Keating SE, 2014, J OBES, V2014, DOI 10.1155/2014/834865; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Kessler HS, 2012, SPORTS MED, V42, P489, DOI 10.2165/11630910-000000000-00000; Kirk RE, 1996, EDUC PSYCHOL MEAS, V56, P746, DOI 10.1177/0013164496056005002; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kulie T, 2011, J AM BOARD FAM MED, V24, P75, DOI 10.3122/jabfm.2011.01.100076; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Lunt H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083256, 10.1371/journal.pone.0105360]; Martinez N, 2015, J SPORT EXERCISE PSY, V37, P138, DOI 10.1123/jsep.2014-0212; McArdle WD., 2014, EXERCISE PHYSL ENERG; Moghadasi M, 2013, EUR J APPL PHYSIOL, V113, P25, DOI 10.1007/s00421-012-2410-0; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Parfitt G, 2009, J EXERC SCI FIT, V7, pS34, DOI 10.1016/S1728-869X(09)60021-6; Perri MG, 2002, HEALTH PSYCHOL, V21, P452, DOI 10.1037//0278-6133.21.5.452; Perry CGR, 2008, APPL PHYSIOL NUTR ME, V33, P1112, DOI 10.1139/H08-097; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Smith AJ, 2011, CANCER EPIDEM BIOMAR, V20, P1098, DOI 10.1158/1055-9965.EPI-10-1219; Smith-Ryan AE, 2015, PHYSICIAN SPORTSMED, V43, P107, DOI 10.1080/00913847.2015.1037231; Talanian JL, 2007, J APPL PHYSIOL, V102, P1439, DOI 10.1152/japplphysiol.01098.2006; Tchernof A, 2000, HORM METAB RES, V32, P526, DOI 10.1055/s-2007-978681; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z; Williams NI, 2010, HUM REPROD, V25, P2328, DOI 10.1093/humrep/deq172; World Health Organization, OB OV	52	64	65	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158589	10.1371/journal.pone.0158589	http://dx.doi.org/10.1371/journal.pone.0158589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27368057	gold, Green Submitted, Green Published			2022-12-27	WOS:000378914900042
J	Nordvang, RT; Nyffenegger, C; Holck, J; Jers, C; Zeuner, B; Sundekilde, UK; Meyer, AS; Mikkelsen, JD				Nordvang, Rune T.; Nyffenegger, Christian; Holck, Jesper; Jers, Carsten; Zeuner, Birgitte; Sundekilde, Ulrik K.; Meyer, Anne S.; Mikkelsen, Jorn D.			It All Starts with a Sandwich: Identification of Sialidases with Trans-Glycosylation Activity	PLOS ONE			English	Article							DIRECTED EVOLUTION; SIALYLTRANSFERASE ACTIVITY; BIOCATALYTIC PRODUCTION; TRYPANOSOMA-RANGELI; 3'-SIALYLLACTOSE; ENZYME; TRANSGLYCOSYLATION; OLIGOSACCHARIDES; NEURAMINIDASE; METHODOLOGY	Sialidases (3.2.1.18) may exhibit trans-sialidase activity to catalyze sialylation of lactose if the active site topology is congruent with that of the Trypanosoma cruzi trans-sialidase (EC 2.4.1.-). The present work was undertaken to test the hypothesis that a particular aromatic sandwich structure of two amino acids proximal to the active site of the T. cruzi trans-sialidase infers trans-sialidase activity. On this basis, four enzymes with putative trans-sialidase activity were identified through an iterative alignment from 2909 native sialidases available in GenBank, which were cloned and expressed in Escherichia coli. Of these, one enzyme, SialH, derived from Haemophilus parasuis had an aromatic sandwich structure on the protein surface facing the end of the catalytic site (Phe168; Trp366), and was indeed found to exhibit trans-sialidase activity. SialH catalyzed production of the human milk oligosaccharide 3'-sialyllactose as well as the novel trans-sialylation product 3-sialyllactose using casein glycomacropeptide as sialyl donor and lactose as acceptor. The findings corroborated that Tyr119 and Trp312 in the T. cruzi trans-sialidase are part of an aromatic sandwich structure that confers trans-sialylation activity for lactose sialylation. The in silico identification of trans-glycosidase activity by rational active site topology alignment thus proved to be a quick tool for selecting putative trans-sialidases amongst a large group of glycosyl hydrolases. The approach moreover provided data that help understand structure-function relations of trans-sialidases.	[Nordvang, Rune T.; Nyffenegger, Christian; Holck, Jesper; Jers, Carsten; Zeuner, Birgitte; Meyer, Anne S.; Mikkelsen, Jorn D.] Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, Lyngby, Denmark; [Sundekilde, Ulrik K.] Aarhus Univ, Dept Food Sci, Arslev, Denmark	Technical University of Denmark; Aarhus University	Zeuner, B (corresponding author), Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, Lyngby, Denmark.	biz@kt.dtu.dk	Zeuner, Birgitte/P-9512-2016; Sundekilde, Ulrik/J-6100-2019; Holck, Jesper/Q-4399-2016; Meyer, Anne S/AAN-2157-2020	Zeuner, Birgitte/0000-0002-8593-6742; Sundekilde, Ulrik/0000-0003-4849-0996; Holck, Jesper/0000-0002-8072-1101; Meyer, Anne S/0000-0001-8910-9931	Danish Dairy Research Foundation (Mejeribrugets Forskningsfond)	Danish Dairy Research Foundation (Mejeribrugets Forskningsfond)	This work was supported by the funding from Danish Dairy Research Foundation (Mejeribrugets Forskningsfond; www.ddrf.dk) (grant to RTN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Ammar Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003710; Bissaro B, 2015, BIOCHEM J, V467, P17, DOI 10.1042/BJ20141412; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Demir O, 2009, BIOCHEMISTRY-US, V48, P3398, DOI 10.1021/bi802230y; Desmet T, 2012, CHEM-EUR J, V18, P10786, DOI 10.1002/chem.201103069; Feng HY, 2005, J BIOL CHEM, V280, P37088, DOI 10.1074/jbc.M502873200; Holck J, 2014, NEW BIOTECHNOL, V31, P156, DOI 10.1016/j.nbt.2013.11.006; Jers C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083902; Kone FMT, 2009, PROTEIN ENG DES SEL, V22, P37, DOI 10.1093/protein/gzn065; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo JQ, 2014, BIORESOURCE TECHNOL, V166, P9, DOI 10.1016/j.biortech.2014.05.003; Michalak M, 2014, PROCESS BIOCHEM, V49, P265, DOI 10.1016/j.procbio.2013.10.023; Mitchell FL, 2010, BIOPHYS J, V98, pL38, DOI 10.1016/j.bpj.2010.01.006; Montagna G, 2002, EUR J BIOCHEM, V269, P2941, DOI 10.1046/j.1432-1033.2002.02968.x; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Nordvang RT, 2014, SEP PURIF TECHNOL, V138, P77, DOI 10.1016/j.seppur.2014.10.012; Osanjo G, 2007, BIOCHEMISTRY-US, V46, P1022, DOI 10.1021/bi061444w; Paris G, 2005, J MOL BIOL, V345, P923, DOI 10.1016/j.jmb.2004.09.031; Schmidt D, 2000, J ORG CHEM, V65, P8518, DOI 10.1021/jo000871r; Smith LE, 1997, GLYCOBIOLOGY, V7, P445, DOI 10.1093/glycob/7.3.445; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tiralongo E, 2003, BIOL CHEM, V384, P1203, DOI 10.1515/BC.2003.133; Villumsen NS, 2015, INT DAIRY J, V49, P8, DOI 10.1016/j.idairyj.2015.05.003; Watson JN, 2004, FEBS LETT, V577, P265, DOI 10.1016/j.febslet.2004.10.016; Zeuner B, 2014, J AGR FOOD CHEM, V62, P9615, DOI 10.1021/jf502619p; Zeuner B, 2014, ENZYME MICROB TECH, V55, P85, DOI 10.1016/j.enzmictec.2013.12.009	32	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158434	10.1371/journal.pone.0158434	http://dx.doi.org/10.1371/journal.pone.0158434			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367145	gold, Green Published			2022-12-27	WOS:000378914900034
J	Dettrick, Z; Gouda, HN; Hodge, A; Jimenez-Soto, E				Dettrick, Zoe; Gouda, Hebe N.; Hodge, Andrew; Jimenez-Soto, Eliana			Measuring Quality of Maternal and Newborn Care in Developing Countries Using Demographic and Health Surveys	PLOS ONE			English	Article							DETERMINANTS; CONTINUITY; SERVICES; IMPACT	Background One of the greatest obstacles facing efforts to address quality of care in low and middle income countries is the absence of relevant and reliable data. This article proposes a methodology for creating a single "Quality Index" (QI) representing quality of maternal and neonatal health care based upon data collected as part of the Demographic and Health Survey (DHS) program. Methods Using the 2012 Indonesian Demographic and Health Survey dataset, indicators of quality of care were identified based on the recommended guidelines outlined in the WHO Integrated Management of Pregnancy and Childbirth. Two sets of indicators were created; one set only including indicators available in the standard DHS questionnaire and the other including all indicators identified in the Indonesian dataset. For each indicator set composite indices were created using Principal Components Analysis and a modified form of Equal Weighting. These indices were tested for internal coherence and robustness, as well as their comparability with each other. Finally a single QI was chosen to explore the variation in index scores across a number of known equity markers in Indonesia including wealth, urban rural status and geographical region. Results The process of creating quality indexes from standard DHS data was proven to be feasible, and initial results from Indonesia indicate particular disparities in the quality of care received by the poor as well as those living in outlying regions. Conclusions The QI represents an important step forward in efforts to understand, measure and improve quality of MNCH care in developing countries.	[Dettrick, Zoe; Gouda, Hebe N.; Hodge, Andrew; Jimenez-Soto, Eliana] Univ Queensland, Sch Publ Hlth, Public Hlth Bldg,Herston Rd, Brisbane, Qld 4006, Australia	University of Queensland	Gouda, HN (corresponding author), Univ Queensland, Sch Publ Hlth, Public Hlth Bldg,Herston Rd, Brisbane, Qld 4006, Australia.	h.gouda@uq.edu.au	Dettrick, Zoe A/I-1479-2017; Dettrick, Zoe/AAP-2862-2021	Dettrick, Zoe A/0000-0003-1091-1820; Dettrick, Zoe/0000-0003-1091-1820; Gouda, Hebe/0000-0002-5709-4509	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	This work was funded by an Australian Postgraduate Award scholarship administered through the University of Queensland, Australia.	[Anonymous], 2013, IND DEM HLTH SURV 20; Barber SL, 2008, HEALTH POLICY, V88, P339, DOI 10.1016/j.healthpol.2008.04.003; Basu S, 2012, PLOS MED, V9, P19, DOI DOI 10.1371/J0URNAL.PMED.1001244; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Bryce J, 2013, PLOS MED, V10; Chaturvedi S, 2014, PLOS ONE, V9; Das J, 2014, ANNU REV ECON, V6, P525, DOI 10.1146/annurev-economics-080213-041350; Das J, 2012, J DEV ECON, V98, P76, DOI 10.1016/j.jdeveco.2011.07.001; Dettrick Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083070; Donabedian A, 1986, QRB Qual Rev Bull, V12, P99; Fan VS, 2005, J GEN INTERN MED, V20, P226, DOI 10.1111/j.1525-1497.2005.40135.x; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Foa R, 2012, METHODOLOGY SOCIAL D; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Harimurti P., 2013, NUTS BOLTS JAMKESMAS, P8; Hodge A, 2014, PLOS ONE, V9; Hussein J, 2004, REPROD HEALTH MATTER, V12, P160, DOI 10.1016/S0968-8080(04)24136-2; ICF International, 2014, DHS PROGR QUAL INF P; James CD, 2011, INT J QUAL HEALTH C, V23, P445, DOI 10.1093/intqhc/mzr029; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kozhimannil KB, 2014, J RURAL HLTH; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Lassi ZS, 2010, COCHRANE DB SYST REV, V11, P11; Lassi ZS, 2014, REPROD HLTH, P11; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060762; Marchant T, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0112-1; Mbuagbaw LCE, 2011, MATERN CHILD HLTH J, V15, P1427, DOI 10.1007/s10995-010-0707-3; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Moran AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001415; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Philippine Statistics Authority (PSA) [Philippines], 2014, INT I PHIL NAT DEM H; Pileggi-Castro C, 2014, BJOG-INT J OBSTET GY, V121, P110, DOI 10.1111/1471-0528.12637; Raven JH, 2012, MIDWIFERY, V28, pE676, DOI 10.1016/j.midw.2011.09.003; Rutstein S. O., 2004, DHS WEALTH INDEX; Salam RA, 2014, REPROD HLTH, P11; Schroders J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123629; Stanton CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060694; Steiner D, 2008, HLTH MEASUREMENT SCA; Tabachnick B. G., 2013, USING MULTIVARIATE S; Titaley CR, 2014, ASIA PAC J CLIN NUTR, V23, P91, DOI 10.6133/apjcn.2014.23.1.18; Uzochukwu B S C, 2004, East Afr Med J, V81, P293; van Duong D, 2004, INT J QUAL HEALTH C, V16, P447, DOI 10.1093/intqhc/mzh073; Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2015, TRACK UN HLTH COV 1; World Health Organization, 2006, PREGN CHILDB POSTP N	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157110	10.1371/journal.pone.0157110	http://dx.doi.org/10.1371/journal.pone.0157110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362354	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200006
J	Khade, NV; Sugiyama, T				Khade, Nilesh V.; Sugiyama, Tomohiko			Roles of C-Terminal Region of Yeast and Human Rad52 in Rad51-Nucleoprotein Filament Formation and ssDNA Annealing	PLOS ONE			English	Article							REPLICATION PROTEIN-A; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE RAD52; RECOMBINATION MEDIATOR FUNCTION; HOMOLOGOUS RECOMBINATION; DNA-REPAIR; RAD51-MEDIATED RECOMBINATION; CANCER SUSCEPTIBILITY; COMPLEX-FORMATION; BRC MOTIFS	Yeast Rad52 (yRad52) has two important functions at homologous DNA recombination (HR); annealing complementary single-strand DNA (ssDNA) molecules and recruiting Rad51 recombinase onto ssDNA (recombination mediator activity). Its human homolog (hRAD52) has a lesser role in HR, and apparently lacks mediator activity. Here we show that yRad52 can load human Rad51 (hRAD51) onto ssDNA complexed with yeast RPA in vitro. This is biochemically equivalent to mediator activity because it depends on the C-terminal Rad51-binding region of yRad52 and on functional Rad52-RPA interaction. It has been reported that the N-terminal two thirds of both yRad52 and hRAD52 is essential for binding to and annealing ssDNA. Although a second DNA binding region has been found in the C-terminal region of yRad52, its role in ssDNA annealing is not clear. In this paper, we also show that the C-terminal region of yRad52, but not of hRAD52, is involved in ssDNA annealing. This suggests that the second DNA binding site is required for the efficient ssDNA annealing by yRad52. We propose an updated model of Rad52-mediated ssDNA annealing.	[Khade, Nilesh V.; Sugiyama, Tomohiko] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Sugiyama, T (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	sugiyama@ohio.edu		Sugiyama, Tomohiko/0000-0003-2942-3667	Ohio University Student Enhancement Award [SEA 12-07]	Ohio University Student Enhancement Award	This work was supported by Ohio University Student Enhancement Award (SEA 12-07; https://www.ohio.edu/research/Funding.cfm) to NVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUNDYMILLS KL, 1993, GENETICS, V133, P39; Carreira A, 2011, P NATL ACAD SCI USA, V108, P10448, DOI 10.1073/pnas.1106971108; DONOVAN JW, 1994, GENE DEV, V8, P2552, DOI 10.1101/gad.8.21.2552; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Grimme JM, 2010, NUCLEIC ACIDS RES, V38, P2917, DOI 10.1093/nar/gkp1249; Haber JE, 2004, PHILOS T ROY SOC B, V359, P79, DOI 10.1098/rstb.2003.1367; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Ivanov EL, 1996, GENETICS, V142, P693; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; Kagawa W, 2014, NUCLEIC ACIDS RES, V42, P941, DOI 10.1093/nar/gkt986; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Li J, 2006, ONCOGENE, V25, P1186, DOI 10.1038/sj.onc.1209153; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURIS DFR, 1994, MUTAT RES-DNA REPAIR, V315, P295, DOI 10.1016/0921-8777(94)90040-X; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Phillips ER, 2007, ONCOGENE, V26, P7799, DOI 10.1038/sj.onc.1210877; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	48	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158436	10.1371/journal.pone.0158436	http://dx.doi.org/10.1371/journal.pone.0158436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362509	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200074
J	Osterberg, J; Wingstrand, A; Jensen, AN; Kerouanton, A; Cibin, V; Barco, L; Denis, M; Aabo, S; Bengtsson, B				Osterberg, Julia; Wingstrand, Anne; Jensen, Annette Nygaard; Kerouanton, Annaelle; Cibin, Veronica; Barco, Lisa; Denis, Martine; Aabo, Soren; Bengtsson, Bjorn			Antibiotic Resistance in Escherichia coli from Pigs in Organic and Conventional Farming in Four European Countries	PLOS ONE			English	Article							FOOD-PRODUCING ANIMALS; ANTIMICROBIAL RESISTANCE; SUSCEPTIBILITY; BACTERIA; SWINE; TRANSMISSION; HERDS; BEEF	Organic pig production differs in many ways from conventional production of pigs, e.g., in antibiotic use, herd structure, feeding regimes, access to outdoor areas and space allowance per pig. This study investigated if these differences result in a lower occurrence of antibiotic resistance in organic slaughter pigs in Denmark, France, Italy and Sweden. Samples were taken from the colon content and/or faeces and minimum inhibitory concentrations (MIC) of ten antibiotics were determined in isolates of Escherichia coli. In addition, the proportion of tetracycline (TET) resistant E. coli in colon content and/or faeces from individual pigs was determined. In all four countries the percentage resistance to ampicillin, streptomycin, sulphonamides or trimethoprim was significantly lower in E. coli from organic pigs. In France and Italy, the percentage of isolates resistant to chloramphenicol, ciprofloxacin, nalidixic acid or gentamicin was also significantly lower in the E. coli from organic pigs. Resistance to cefotaxime, was not found in any country. The percentage of E. coli isolates resistant to TET as well as the proportion of TET-resistant E. coli was significantly lower in organic than in conventional pigs, except in Sweden where TET-resistance was equally low in both production types. There were also differences between countries within production type in the percentage resistance to individual antibiotics as well as the proportion of TET-resistant E. coli with lower median proportions in Sweden and Denmark compared to France and Italy. The study shows that in each of the four countries resistance in intestinal E. coli was less common in organic than in conventional pigs, but that there were also large differences in resistance between countries within each production type, indicating that both country-and production-specific factors influence the occurrence of resistance.	[Osterberg, Julia; Bengtsson, Bjorn] Natl Vet Inst SVA, Uppsala, Sweden; [Wingstrand, Anne; Jensen, Annette Nygaard; Aabo, Soren] Tech Univ Denmark DTU, Natl Food Inst, Copenhagen, Denmark; [Kerouanton, Annaelle; Denis, Martine] French Agcy Food Environm & Occupat Hlth Safety A, Ploufragan, France; [Cibin, Veronica; Barco, Lisa] Ist Zooprofilatt Sperimentale Venezie IZSVe, Legnaro, Italy	National Veterinary Institute SVA; Technical University of Denmark; IZS delle Venezie	Osterberg, J (corresponding author), Natl Vet Inst SVA, Uppsala, Sweden.	Julia.Osterberg@sva.se	; Barco, Lisa/K-2284-2016	Jensen, Annette Nygaard/0000-0001-9681-7258; Barco, Lisa/0000-0002-6247-248X; Aabo, Soren/0000-0003-1430-1480	CORE Organic II Funding Bodies; FP7 ERA-Net project; CORE Organic II (Coordination of European Transnational Research in Organic Food and Farming systems) [249667]	CORE Organic II Funding Bodies; FP7 ERA-Net project; CORE Organic II (Coordination of European Transnational Research in Organic Food and Farming systems)	The authors gratefully acknowledge the financial support of the CORE Organic II Funding Bodies, partners of the FP7 ERA-Net project, CORE Organic II (Coordination of European Transnational Research in Organic Food and Farming systems, project no. 249667). For further information see: (www.coreorganic2.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the financial support of the CORE Organic II Funding Bodies, partners of the FP7 ERA-Net project, CORE Organic II (Coordination of European Transnational Research in Organic Food and Farming systems, project no. 249667). For further information, see: www.coreorganic2.org.	Alvarez-Ordonez A, 2013, INT J ENV RES PUB HE, V10, P1927, DOI 10.3390/ijerph10051927; Baquero F, 2011, J ANTIMICROB CHEMOTH, V66, P1659, DOI 10.1093/jac/dkr214; Bondt N, 2013, PREV VET MED, V108, P10, DOI 10.1016/j.prevetmed.2012.07.009; Call Douglas R., 2008, Animal Health Research Reviews, V9, P159, DOI 10.1017/S1466252308001515; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Clinical and Laboratory Standards Institute (CLSI), 2020, VET01S2 CLSI; Cuny C, 2012, APPL ENVIRON MICROB, V78, P1296, DOI 10.1128/AEM.07260-11; DANMAP 2009, 2009, US ANT AG OCC ANT RE; EFSA, 2010, EFSA J, V8, P1309, DOI [10.2903/j.efsa.2010.1309, DOI 10.2903/J.EFSA.2010.1309]; European Ctr Dis Prevention Contro, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4006, 10.2903/j.efsa.20Y15.4204]; European Food Safety Author, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3196; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; European Medicines Agency (EMA), 2014, EUR SURV VET ANT CON; Garcia-Migura L, 2014, VET MICROBIOL, V170, P1, DOI 10.1016/j.vetmic.2014.01.013; Gerzova L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132892; Guarddon M, 2011, INT J FOOD MICROBIOL, V146, P284, DOI 10.1016/j.ijfoodmicro.2011.02.026; Jacob ME, 2008, FOODBORNE PATHOG DIS, V5, P721, DOI 10.1089/fpd.2008.0095; Laanen M, 2013, VET J, V198, P508, DOI 10.1016/j.tvjl.2013.08.029; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Maynard C, 2003, ANTIMICROB AGENTS CH, V47, P3214, DOI 10.1128/AAC.47.10.3214-3221.2003; Miranda JM, 2009, MEAT SCI, V82, P284, DOI 10.1016/j.meatsci.2009.01.020; Nulsen MF, 2008, NEW ZEAL VET J, V56, P29, DOI 10.1080/00480169.2008.36801; Rosengren LB, 2007, MICROB DRUG RESIST, V13, P261, DOI 10.1089/mdr.2007.781; Sato K, 2004, J FOOD PROTECT, V67, P1104, DOI 10.4315/0362-028X-67.6.1104; Sato K, 2005, JAVMA-J AM VET MED A, V226, P589, DOI 10.2460/javma.2005.226.589; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; Tobias TJ, 2014, PREV VET MED, V117, P207, DOI 10.1016/j.prevetmed.2014.07.017; van de Vijver LPL, 2014, ZOONOSES PUBLIC HLTH, V61, P338, DOI 10.1111/zph.12076; Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; World Health Organization, 2014, ANT RES GLOB REP SUR; Wu SY, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-38; Young I, 2009, EPIDEMIOL INFECT, V137, P1217, DOI 10.1017/S0950268809002635	34	56	56	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157049	10.1371/journal.pone.0157049	http://dx.doi.org/10.1371/journal.pone.0157049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362262	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200005
J	Bacci, G; Paganin, P; Lopez, L; Vanni, C; Dalmastri, C; Cantale, C; Daddiego, L; Perrotta, G; Dolce, D; Morelli, P; Tuccio, V; De Alessandri, A; Fiscarelli, EV; Taccetti, G; Lucidi, V; Bevivino, A; Mengoni, A				Bacci, Giovanni; Paganin, Patrizia; Lopez, Loredana; Vanni, Chiara; Dalmastri, Claudia; Cantale, Cristina; Daddiego, Loretta; Perrotta, Gaetano; Dolce, Daniela; Morelli, Patrizia; Tuccio, Vanessa; De Alessandri, Alessandra; Fiscarelli, Ersilia Vita; Taccetti, Giovanni; Lucidi, Vincenzina; Bevivino, Annamaria; Mengoni, Alessio			Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline	PLOS ONE			English	Article							NETWORK ANALYSIS; PATHOGENS; PERSPECTIVE; GUIDELINES; IMPACT	Chronic airway infection is a hallmark feature of cystic fibrosis (CF) disease. In the present study, sputum samples from CF patients were collected and characterized by 16S rRNA gene-targeted approach, to assess how lung microbiota composition changes following a severe decline in lung function. In particular, we compared the airway microbiota of two groups of patients with CF, i.e. patients with a substantial decline in their lung function (SD) and patients with a stable lung function (S). The two groups showed a different bacterial composition, with SD patients reporting a more heterogeneous community than the S ones. Pseudomonas was the dominant genus in both S and SD patients followed by Staphylococcus and Prevotella. Other than the classical CF pathogens and the most commonly identified non-classical genera in CF, we found the presence of the unusual anaerobic genus Sneathia. Moreover, the oligotyping analysis revealed the presence of other minor genera described in CF, highlighting the polymicrobial nature of CF infection. Finally, the analysis of correlation and anti-correlation networks showed the presence of antagonism and ecological independence between members of Pseudomonas genus and the rest of CF airways microbiota, with S patients showing a more interconnected community in S patients than in SD ones. This population structure suggests a higher resilience of S microbiota with respect to SD, which in turn may hinder the potential adverse impact of aggressive pathogens (e.g. Pseudomonas). In conclusion, our findings shed a new light on CF airway microbiota ecology, improving current knowledge about its composition and polymicrobial interactions in patients with CF.	[Bacci, Giovanni; Vanni, Chiara; Bevivino, Annamaria; Mengoni, Alessio] Univ Florence, Dept Biol, Florence, Italy; [Paganin, Patrizia; Dalmastri, Claudia; Cantale, Cristina] ENEA Casaccia Res Ctr, Dept Sustainabil Prod & Terr Syst, Biotechnol & Agroind Div, Rome, Italy; [Lopez, Loredana; Daddiego, Loretta; Perrotta, Gaetano] ENEA Trisaia Res Ctr, Bioenergy Biorefinery & Green Chem Div, Dept Energy Technol, Rotondella, MT, Italy; [Dolce, Daniela; Taccetti, Giovanni] Meyer Hosp, Cyst Fibrosis Ctr, Dept Pediat, Florence, Italy; [Morelli, Patrizia; De Alessandri, Alessandra] G Gaslini Inst Children, Dept Pediat, Cyst Fibrosis Ctr, Genoa, Italy; [Tuccio, Vanessa; Fiscarelli, Ersilia Vita; Lucidi, Vincenzina] Childrens Hosp & Res Inst Bambino Gesu, Cyst Fibrosis Microbiol & Cyst Fibrosis Ctr, Rome, Italy	University of Florence; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Bambino Gesu	Bevivino, A (corresponding author), Univ Florence, Dept Biol, Florence, Italy.	annamaria.bevivino@enea.it	Dalmastri, Claudia/AAD-1627-2021; Fiscarelli, Ersilia Vita/K-3035-2016; Paganin, Patrizia/AAB-9735-2022; Mengoni, Alessio/G-5336-2013; Bevivino, Annamaria/F-4060-2015; Taccetti, Giovanni/K-9519-2016	Fiscarelli, Ersilia Vita/0000-0003-4156-1835; Paganin, Patrizia/0000-0002-8993-6651; Mengoni, Alessio/0000-0002-1265-8251; Lucidi, Vincenzina/0000-0003-3661-607X; Taccetti, Giovanni/0000-0002-9448-5381; Perrotta, Gaetano/0000-0003-2037-1063; Bevivino, Annamaria/0000-0003-4277-7048; Bacci, Giovanni/0000-0003-4406-7816; Dolce, Daniela/0000-0002-8317-9928	Italian Cystic Fibrosis Research Foundation (FCC) [8/2012, 10/2014]	Italian Cystic Fibrosis Research Foundation (FCC)	This research was supported by grants from the Italian Cystic Fibrosis Research Foundation (FCC) (http://www.fibrosicisticaricerca.it/) to A. B. [Project FFC # 8/2012 (with the contribution of "Delegazione FFC di Latina", "Delegazione FFC di Imola", "Delegazione FFC di Cecina", "Associazione Trentina FC onlus in ricordo di Vanessa Weber", and "Associazione Davide e Guido-Insieme Fibrosi Cistica Trust Onlus in ricordo di Katia Zattoni") and Project FFC # 10/2014 (with the contribution of "Delegazione FFC di Villa D'Alme, Bergamo", "Gruppo di Sostegno FFC di Reggello, Firenze", "Gruppo di Sostegno FFC di Lainate", and "Delegazione FFC di Verbania e V.C.O")]. G.B., P.P., L.L. were supported by grants awarded by the Italian Cystic Fibrosis Research Foundation. The funders had no role in study design, data collection, analysis and interpretation of the data, decision to publish, or preparation of the manuscript.; We thank the Italian Cystic Fibrosis Research Foundation (FCC) for its support and administrative tasks, and Gabriella Ricciotti and Silvia Campana for technical assistance.	Bacci G, 2014, MOL ECOL RESOUR, V14, P426, DOI 10.1111/1755-0998.12187; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Bittinger K, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0487-y; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Coenye T, 2005, INT J SYST EVOL MICR, V55, P251, DOI 10.1099/ijs.0.63267-0; Conrad D, 2013, AM J RESP CELL MOL, V48, P150, DOI 10.1165/rcmb.2012-0059PS; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dai TH, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00120, 10.3389/fmicb.2012.00417]; Delmont TO, 2011, ISME J, V5, P1837, DOI 10.1038/ismej.2011.61; Duran-Pinedo AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028438; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eren AM, 2014, P NATL ACAD SCI USA, V111, pE2875, DOI 10.1073/pnas.1409644111; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Filkins LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005258; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Huang YJ, 2016, CLIN CHEST MED, V37, P59, DOI 10.1016/j.ccm.2015.10.003; Jakobsen TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068484; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Ma ZS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08275; Magalhaes AP, 2016, APPL MICROBIOL BIOT, V100, P1163, DOI 10.1007/s00253-015-7177-x; Mahenthiralingam E, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2014.04.006; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paganin P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124348; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Rogers GB, 2015, THORAX, V70, P74, DOI 10.1136/thoraxjnl-2014-205826; Rogers GB, 2013, ISME J, V7, P697, DOI 10.1038/ismej.2012.145; Rogers GB, 2010, GUT MICROBES, V1, P85, DOI 10.4161/gmic.1.2.11350; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Rosenberg E, 2014, PROKARYOTES, DOI [10.1007/978-3-642-30197-1, DOI 10.1007/978-3-642-30197-1]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Sibley CD, 2009, CURR OPIN INVEST DR, V10, P787; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Smith DJ, 2014, EUR RESPIR J, V44, P922, DOI 10.1183/09031936.00203013; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Surette Michael G, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS61, DOI 10.1513/AnnalsATS.201306-159MG; VanDevanter DR, 2012, FUTURE MICROBIOL, V7, P801, DOI [10.2217/fmb.12.55, 10.2217/FMB.12.55]; Wang Y, 2016, ICES J MAR SCI, V73, P865, DOI 10.1093/icesjms/fsv187; Williams RJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00358; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zhao JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04345; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	55	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0156807	10.1371/journal.pone.0156807	http://dx.doi.org/10.1371/journal.pone.0156807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355625	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400007
J	Polosa, A; Bessaklia, H; Lachapelle, P				Polosa, Anna; Bessaklia, Hyba; Lachapelle, Pierre			Strain Differences in Light-Induced Retinopathy	PLOS ONE			English	Article							INDUCED RETINAL DEGENERATION; OXYGEN-INDUCED RETINOPATHY; ALBINO-RATS; PIGMENT EPITHELIUM; VISUAL CYCLE; DAMAGE; RPE65; SUSCEPTIBILITY; RHODOPSIN; PHOTORECEPTORS	The purpose of this study was to better understand the role of ocular pigmentation and genetics in light-induced retinal damage. Adult pigmented [Long Evans (LE) and Brown Norway (BN)] and albino [Sprague Dawley (SD) and Lewis (LW)] rats were exposed to a bright cyclic light for 6 consecutive days and where compared with juvenile animals exposed to the same bright light environment from postnatal age 14 to 28. Flash ERGs and retinal histology were performed at predetermined days (D) post-light exposure. At D1, ERGs were similar in all adult groups with no recordable a-waves and residual b-waves. A transient recovery was noticed at D30 in the LW and LE only [b-wave: 18% and 25% of their original amplitude respectively]. Histology revealed that BN retina was the most damaged, while LE retina was best preserved. SD and LW rats were almost as damaged as BN rats. In contrast, the retina of juvenile BN was almost as resistant to the bright light exposure as that of juvenile LE rats. Our results strongly suggest that, although ocular pigmentation and genetic background are important factors in regulating the severity of light-induced retinal damage, the age of the animal at the onset of light exposure appears to be the most important determining factor.	[Polosa, Anna; Lachapelle, Pierre] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Polosa, Anna; Bessaklia, Hyba; Lachapelle, Pierre] McGill Univ, Ctr Hlth, Res Inst, Dept Ophthalmol, Montreal, PQ, Canada	McGill University; McGill University	Lachapelle, P (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.; Lachapelle, P (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Dept Ophthalmol, Montreal, PQ, Canada.	pierre.lachapelle@mcgill.ca		Lachapelle, Pierre/0000-0002-7792-1102	Natural Sciences and Engineering Research Council (NSERC) of Canada [Rgpin 138448-09]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by a research grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Grant # Rgpin 138448-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a research grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Grant # Rgpin 138448-09).	BORGES JM, 1990, CURR EYE RES, V9, P799, DOI 10.3109/02713689008999576; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Cachafeiro M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.303; CICERONE CM, 1976, SCIENCE, V194, P1183, DOI 10.1126/science.996550; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Dembinska O, 2002, INVEST OPHTH VIS SCI, V43, P2481; Floyd BNI, 2005, MOL VIS, V11, P524; Gao GQ, 2002, DIABETES, V51, P1218, DOI 10.2337/diabetes.51.4.1218; Garcia-Ayuso D, 2011, MOL VIS, V17, P1716; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; HALL MO, 1969, J MOL BIOL, V45, P397, DOI 10.1016/0022-2836(69)90114-4; Hebert M, 1995, DOC OPHTHALMOL, V91, P333, DOI 10.1007/BF01214651; HUMPEL C, 1992, J NEUROSCI RES, V32, P605, DOI 10.1002/jnr.490320416; Iseli HP, 2002, EXP EYE RES, V75, P407, DOI 10.1006/exer.2002.2032; Ito S, 2013, PIGM CELL MELANOMA R, V26, P357, DOI 10.1111/pcmr.12078; Jamison JA, 2011, INVEST OPHTHALMOL VI, V52; Joly S, 2006, INVEST OPHTH VIS SCI, V47, P3202, DOI 10.1167/iovs.05-1515; KUWABARA T, 1976, ARCH OPHTHALMOL-CHIC, V94, P1369; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; LAVAIL MM, 1980, EFFECTS CONSTANT LIG, P357; MALIK S, 1986, INVEST OPHTH VIS SCI, V27, P164; MATSUBARA T, 1968, VISION RES, V8, P1139, DOI 10.1016/0042-6989(68)90023-0; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Noell W K, 1966, Invest Ophthalmol, V5, P450; OSTEEN WK, 1974, INVEST OPHTH VISUAL, V13, P334; PENN JS, 1987, EXP EYE RES, V44, P767, DOI 10.1016/S0014-4835(87)80040-4; Polosa A, 2016, PLOS ONE, V11, P1; Prota G, 1995, Fortschr Chem Org Naturst, V64, P93; RAPP LM, 1980, VISION RES, V20, P1127, DOI 10.1016/0042-6989(80)90050-4; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Reme C, 2005, INVEST OPHTH VIS SCI, V46, P2672, DOI 10.1167/iovs.04-1095; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; Tremblay F, 2013, J NUTR BIOCHEM, V24, P647, DOI 10.1016/j.jnutbio.2012.03.011; Wasowicz M, 2002, INVEST OPHTH VIS SCI, V43, P813; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Wielgus AR, 2005, PIGM CELL RES, V18, P454, DOI 10.1111/j.1600-0749.2005.00268.x; WILLIAMS RA, 1985, CURR EYE RES, V4, P97, DOI 10.3109/02713688508999974; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9	38	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158082	10.1371/journal.pone.0158082	http://dx.doi.org/10.1371/journal.pone.0158082			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355622	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400027
J	Sevastou, I; Pryce, G; Baker, D; Selwood, DL				Sevastou, Ioanna; Pryce, Gareth; Baker, David; Selwood, David L.			Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA Sequencing	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; INHIBIT INFLAMMATORY RESPONSES; MULTIPLE-SCLEROSIS PATIENTS; ACTIVATED-RECEPTOR-ALPHA; REPEAT PROTEIN 1A; LIVER X RECEPTORS; LIPID-METABOLISM; MATRIX METALLOPROTEINASE-12; ALZHEIMERS-DISEASE	Multiple sclerosis (MS) is a debilitating immune-mediated neurological disorder affecting young adults. MS is primarily relapsing-remitting, but neurodegeneration and disability accumulate from disease onset. The most commonly used mouse MS models exhibit a monophasic immune response with fast accumulation of neurological damage that does not allow the study of progressive neurodegeneration. The chronic relapsing and secondary progressive EAE (pEAE) Biozzi ABH mouse model of MS exhibits a reproducible relapsing-remitting disease course that slowly accumulates permanent neurological deficit and develops a post-relapsing progressive disease that permits the study of demyelination and neurodegeneration. RNA sequencing (RNAseq) was used to explore global gene expression in the pEAE Biozzi ABH mouse. Spinal cord tissue RNA from pEAE Biozzi ABH mice and healthy age-matched controls was sequenced. 2,072 genes were differentially expressed (q<0.05) from which 1,397 were significantly upregulated and 675 were significantly down-regulated. This hypothesis-free investigation characterised the genomic changes that describe the pEAE mouse model. The differentially expressed genes revealed a persistent immunoreactant phenotype, combined with downregulation of the cholesterol biosynthesis superpathway and the LXR/RXR activation pathway. Genes differentially expressed include the myelination genes Slc17a7, Ugt8A and Opalin, the neuroprotective genes Sprr1A, Osm and Wisp2, as well as genes identified as MS risk factors, including RGs14 and Scap2. Novel genes with unestablished roles in EAE or MS were also identified. The identification of differentially expressed novel genes and genes involved in MS pathology, opens the door to their functional study in the pEAE mouse model which recapitulates some of the important clinical features of progressive MS.	[Sevastou, Ioanna; Selwood, David L.] UCL Wolfson Inst Biomed Sci, Dept Med Chem, London WC1E 6BT, England; [Pryce, Gareth; Baker, David] Queen Mary Univ London, Barts & London Sch Med & Dent, Neuroimmmunol Unit, Blizard Inst, London E1 2AT, England; [Sevastou, Ioanna] UCL Sch Life & Med Sci, Translat Res Off, London W1T 7DN, England	University of London; University College London; University of London; Queen Mary University London; University of London; University College London	Selwood, DL (corresponding author), UCL Wolfson Inst Biomed Sci, Dept Med Chem, London WC1E 6BT, England.	d.selwood@ucl.ac.uk		Selwood, David/0000-0002-6817-5064	Canbex Therapeutics; Technology Strategy Board UK/Innovate UK [25036-166159]; MRC [MC_PC_13037] Funding Source: UKRI; Medical Research Council [MC_PC_13037] Funding Source: researchfish	Canbex Therapeutics; Technology Strategy Board UK/Innovate UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by a Canbex Therapeutics grant awarded to DLS and the Technology Strategy Board UK/Innovate UK grant no. 25036-166159 awarded to DLS and DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the support of Canbex Therapeutics and the Technology Strategy Board UK/Innovate UK grant no. 25036-166159.	Abel AM, 2015, MOL IMMUNOL, V65, P336, DOI 10.1016/j.molimm.2015.02.012; Al-Izki S, 2009, MULT SCLER, V15, P795, DOI 10.1177/1352458509104594; Al-Izki S, 2012, MULT SCLER RELAT DIS, V1, P29, DOI 10.1016/j.msard.2011.09.001; Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; Alatab S, 2011, MINERVA MED, V102, P461; Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Alikhani P, 2014, MULTIPLE SCLEROSIS R, V3, P747, DOI [10.1016/j.msard.2014.09.172, DOI 10.1016/J.MSARD.2014.09.172]; Amin B, 2014, CURR MED CHEM, V21, P1544, DOI 10.2174/09298673113206660311; BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Baker D, 2007, ADV CLIN NEUROSCI RE, V6, P10; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; BROWN AM, 1981, LAB INVEST, V45, P278; Calza L, 2010, J MOL ENDOCRINOL, V44, P13, DOI 10.1677/JME-09-0067; Chalmin F, 2015, J AUTOIMMUN, V56, P45, DOI 10.1016/j.jaut.2014.10.001; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Chen GQ, 2015, MOL MED REP, V12, P2465, DOI 10.3892/mmr.2015.3670; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dell'Acqua ML, 2012, NEUROPATH APPL NEURO, V38, P454, DOI 10.1111/j.1365-2990.2011.01228.x; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Diab A, 2004, J NEUROIMMUNOL, V148, P116, DOI 10.1016/j.jneuroim.2003.11.010; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; DUHAMELCLERIN E, 1994, GLIA, V11, P35, DOI 10.1002/glia.440110106; Evans PR, 2015, PROG MOL BIOL TRANSL, V133, P169, DOI 10.1016/bs.pmbts.2015.03.006; Feng GJ, 2003, J BIOL CHEM, V278, P33400, DOI 10.1074/jbc.M305866200; Frischer JM, 2015, ANN NEUROL, V78, P710, DOI 10.1002/ana.24497; Giorelli M, 2007, EXP NEUROL, V204, P759, DOI 10.1016/j.expneurol.2007.01.013; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guerrini MM, 2015, IMMUNITY, V43, P1174, DOI 10.1016/j.immuni.2015.10.017; Hampton DW, 2008, J NEUROIMMUNOL, V201, P200, DOI 10.1016/j.jneuroim.2008.05.034; Hampton DW, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-84; Hansmann F, 2012, ACTA NEUROPATHOL, V124, P127, DOI 10.1007/s00401-012-0942-3; He MA, 2011, J CLIN INVEST, V121, P976, DOI 10.1172/JCI42650; Heck MV, 2014, NEUROGENETICS, V15, P135, DOI 10.1007/s10048-014-0397-x; Heremans H, 1996, EUR J IMMUNOL, V26, P2393, DOI 10.1002/eji.1830261019; Hikiji H, 2014, FASEB J, V28, P871, DOI 10.1096/fj.13-233106; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Honorat JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071329; Hoppmann N, 2015, BRAIN, V138, P902, DOI 10.1093/brain/awu408; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Inglis HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048555; Jackson SJ, 2009, J NEUROPATH EXP NEUR, V68, P616, DOI 10.1097/NEN.0b013e3181a41d23; Janssens K, 2015, GLIA, V63, P1729, DOI 10.1002/glia.22840; Karlstetter M, 2010, J IMMUNOL, V185, P3379, DOI 10.4049/jimmunol.0903300; Kuerten S, 2011, APMIS, V119, P336, DOI 10.1111/j.1600-0463.2011.02744.x; Kurban S, 2008, MULT SCLER, V14, P431, DOI 10.1177/1352458507084028; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Malik B, 2012, NEUROCHEM INT, V61, P321, DOI 10.1016/j.neuint.2012.05.006; Marchesi S, 2014, DEV CELL, V31, P420, DOI 10.1016/j.devcel.2014.09.009; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Mathews ES, 2014, J NEUROSCI, V34, P3402, DOI 10.1523/JNEUROSCI.4587-13.2014; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nelissen K, 2012, J NEUROSCI RES, V90, P60, DOI 10.1002/jnr.22743; Noben-Trauth K, 2011, ADV EXP MED BIOL, V704, P229, DOI 10.1007/978-94-007-0265-3_13; Ohkawa Y, 2011, BIOCHEM BIOPH RES CO, V411, P483, DOI 10.1016/j.bbrc.2011.06.118; Papassotiropoulos A, 2005, NEURODEGENER DIS, V2, P233, DOI 10.1159/000090362; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pryce G, 2005, J NEUROIMMUNOL, V165, P41, DOI 10.1016/j.jneuroim.2005.04.009; Raddatz BBR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086643; Sahel A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00077; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sena A, 2003, J NEUROL, V250, P754, DOI 10.1007/s00415-003-1070-8; Shen Y, 2012, J NEUROSCI RES, V90, P105, DOI 10.1002/jnr.22722; Shete S, 2011, CANCER RES, V71, P7568, DOI 10.1158/0008-5472.CAN-11-0013; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Stevenson VL, 2015, MULT SCLER J, V21, P1583, DOI 10.1177/1352458514566416; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; Tanabe Y, 2014, NEUROSCI LETT, V576, P1, DOI 10.1016/j.neulet.2014.05.013; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Thompson AJ, 2008, LANCET NEUROL, V7, P1078, DOI 10.1016/S1474-4422(08)70246-1; Totsuka T, 2009, J IMMUNOL, V182, P6079, DOI 10.4049/jimmunol.0711823; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsai LJ, 2008, TISSUE ANTIGENS, V71, P114, DOI 10.1111/j.1399-0039.2007.00975.x; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Vos CMP, 2003, J NEUROIMMUNOL, V138, P106, DOI 10.1016/S0165-5728(03)00036-5; WEINSHENKER BG, 1995, NEUROL CLIN, V13, P119, DOI 10.1016/S0733-8619(18)30064-1; Xiang ZM, 2011, J NEUROSCI, V31, P9544, DOI 10.1523/JNEUROSCI.1291-11.2011; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Xu JH, 2006, J NEUROIMMUNOL, V176, P95, DOI 10.1016/j.jneuroim.2006.04.019; Yoshikawa F, 2008, J BIOL CHEM, V283, P20830, DOI 10.1074/jbc.M801314200; Zhang-Gandhi CX, 2007, J NEUROIMMUNOL, V183, P50, DOI 10.1016/j.jneuroim.2006.11.007; Zhou J, 2013, J BIOL CHEM, V288, P30064, DOI 10.1074/jbc.M113.478750; Zipp F, 2007, TRENDS PHARMACOL SCI, V28, P342, DOI 10.1016/j.tips.2007.05.001	97	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157754	10.1371/journal.pone.0157754	http://dx.doi.org/10.1371/journal.pone.0157754			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355629	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400018
J	Li, M; Sareh, S; Xu, GH; Ridzuan, MB; Luo, S; Xie, J; Wurdemann, H; Althoefer, K				Li, Min; Sareh, Sina; Xu, Guanghua; Ridzuan, Maisarah Binti; Luo, Shan; Xie, Jun; Wurdemann, Helge; Althoefer, Kaspar			Evaluation of Pseudo-Haptic Interactions with Soft Objects in Virtual Environments	PLOS ONE			English	Article							FEEDBACK; SIMULATION	This paper proposes a pseudo-haptic feedback method conveying simulated soft surface stiffness information through a visual interface. The method exploits a combination of two feedback techniques, namely visual feedback of soft surface deformation and control of the indenter avatar speed, to convey stiffness information of a simulated surface of a soft object in virtual environments. The proposed method was effective in distinguishing different sizes of virtual hard nodules integrated into the simulated soft bodies. To further improve the interactive experience, the approach was extended creating a multi-point pseudo-haptic feedback system. A comparison with regards to (a) nodule detection sensitivity and (b) elapsed time as performance indicators in hard nodule detection experiments to a tablet computer incorporating vibration feedback was conducted. The multi-point pseudo-haptic interaction is shown to be more time-efficient than the single-point pseudo-haptic interaction. It is noted that multi-point pseudo-haptic feedback performs similarly well when compared to a vibration-based feedback method based on both performance measures elapsed time and nodule detection sensitivity. This proves that the proposed method can be used to convey detailed haptic information for virtual environmental tasks, even subtle ones, using either a computer mouse or a pressure sensitive device as an input device. This pseudo-haptic feedback method provides an opportunity for low-cost simulation of objects with soft surfaces and hard inclusions, as, for example, occurring in ever more realistic video games with increasing emphasis on interaction with the physical environment and minimally invasive surgery in the form of soft tissue organs with embedded cancer nodules. Hence, the method can be used in many low-budget applications where haptic sensation is required, such as surgeon training or video games, either using desktop computers or portable devices, showing reasonably high fidelity in conveying stiffness perception to the user.	[Li, Min; Xu, Guanghua; Xie, Jun] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China; [Li, Min; Xu, Guanghua; Xie, Jun] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China; [Sareh, Sina] Univ London Imperial Coll Sci Technol & Med, Dept Aeronaut, London, England; [Ridzuan, Maisarah Binti; Luo, Shan; Wurdemann, Helge; Althoefer, Kaspar] Kings Coll London, Ctr Robot Res, Dept Informat, London, England	Xi'an Jiaotong University; Xi'an Jiaotong University; Imperial College London; University of London; King's College London	Li, M; Xu, GH (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China.; Li, M; Xu, GH (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China.	min.li@mail.xjtu.edu.cn; ghxu@mail.xjtu.edu.cn	Li, Min/W-2652-2017; Althoefer, Kaspar/AAA-5984-2022	Li, Min/0000-0002-2959-9147; Wurdemann, Helge/0000-0003-3082-146X; Luo, Shan/0000-0003-4760-0372	National Natural Science Foundation of China [51475360]; China Postdoctoral Science Foundation Grant [2015M570821]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Grant(China Postdoctoral Science Foundation)	The research leading to these results has received funding from the National Natural Science Foundation of China (Received by GX, Approval No. 51475360, http://www.nsfc.gov.cn/) and the China Postdoctoral Science Foundation Grant (Received by ML, Grant No. 2015M570821, http://res.chinapostdoctor.org.cn/BshWeb/index.shtml).	Alhalabi MO, 2005, World Haptics Conference: First Joint Eurohaptics Conference and Symposium on Haptic Interfaces for Virutual Environment and Teleoperator Systems, Proceedings, P623; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Argelaguet F, 2013, ACM T APPL PERCEPT, V10, DOI 10.1145/2501599; Coles TR, 2011, IEEE T HAPTICS, V4, P51, DOI 10.1109/ToH.2010.19; Culbertson H, 2014, IEEE T HAPTICS, V7, P381, DOI 10.1109/TOH.2014.2316797; Dominjon L, 2005, P IEEE VIRT REAL ANN, P19; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Hachisu T., 2011, P 24 ANN ACM S ADJ U, P73, DOI DOI 10.1145/2046396.2046429; Howell JN, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-14; Kawasaki H, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P2707; Khan S., 2012, DESIGN OPTIMIZATION; Kimura Takashi, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P202, DOI 10.1007/978-3-642-31404-9_36; Kokubun A, 2013, ACM SIGGRAPH 2013 PO, P38; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Langrana N A, 1994, Artif Intell Med, V6, P321, DOI 10.1016/0933-3657(94)90036-1; Lecuyer A., 2000, Proceedings IEEE Virtual Reality 2000 (Cat. No.00CB37048), P83, DOI 10.1109/VR.2000.840369; Lecuyer A, 2008, ACM T APPL PERCEPT, V5, DOI 10.1145/1402236.1402238; Lecuyer A, 2009, PRESENCE-TELEOP VIRT, V18, P39, DOI 10.1162/pres.18.1.39; Li M, 2015, MED BIOL ENG COMPUT, V53, P1177, DOI 10.1007/s11517-015-1309-4; Li M, 2014, MECHATRONICS, V24, P1092, DOI 10.1016/j.mechatronics.2014.07.004; Li M, 2014, SENSOR ACTUAT A-PHYS, V218, P132, DOI 10.1016/j.sna.2014.08.003; Li M, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/9/095007; Li M, 2012, IEEE INT CONF ROBOT, P5359, DOI 10.1109/ICRA.2012.6225143; Liu HB, 2011, IEEE T ROBOT, V27, P450, DOI 10.1109/TRO.2011.2127210; Liu HB, 2010, IEEE T BIO-MED ENG, V57, P404, DOI 10.1109/TBME.2009.2032164; Maeno T, 2006, ULTRASON, P62, DOI 10.1109/ULTSYM.2006.29; Ridzuan Maisarah Binti, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P432, DOI 10.1007/978-3-642-31401-8_39; Sangpradit K, 2009, IEEE INT CONF ROBOT, P2933; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shima Takuya, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P481, DOI 10.1007/978-3-642-31401-8_43; Shiota G., 2013, 2013 12 INT C INF TE, P1; Tashiro K, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P1, DOI 10.1109/WHC.2009.4810877; Weiss Malte, 2011, P 24 ANN ACM S US IN, P615, DOI DOI 10.1145/2047196.2047277; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	35	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157681	10.1371/journal.pone.0157681	http://dx.doi.org/10.1371/journal.pone.0157681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352234	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000378858900013
J	Singh, T; Roy, P; Jamir, L; Gupta, S; Kaur, N; Jain, DK; Kumar, R				Singh, Tarundeep; Roy, Pritam; Jamir, Limalemla; Gupta, Saurav; Kaur, Navpreet; Jain, D. K.; Kumar, Rajesh			Assessment of Universal Healthcare Coverage in a District of North India: A Rapid Cross-Sectional Survey Using Tablet Computers	PLOS ONE			English	Article							OUT-OF-POCKET; EXPENDITURES; SECTOR	Objective A rapid survey was carried out in Shaheed Bhagat Singh Nagar District of Punjab state in India to ascertain health seeking behavior and out-of-pocket health expenditures. Methods Using multistage cluster sampling design, 1,008 households (28 clusters x 36 households in each cluster) were selected proportionately from urban and rural areas. Households were selected through a house-to-house survey during April and May 2014 whose members had (a) experienced illness in the past 30 days, (b) had illness lasting longer than 30 days, (c) were hospitalized in the past 365 days, or (d) had women who were currently pregnant or experienced childbirth in the past two years. In these selected households, trained investigators, using a tablet computer-based structured questionnaire, enquired about the socio-demographics, nature of illness, source of healthcare, and healthcare and household expenditure. The data was transmitted daily to a central server using wireless communication network. Mean healthcare expenditures were computed for various health conditions. Catastrophic healthcare expenditure was defined as more than 10% of the total annual household expenditure on healthcare. Chi square test for trend was used to compare catastrophic expenditures on hospitalization between households classified into expenditure quartiles. Results The mean monthly household expenditure was 15,029 Indian Rupees (USD 188.2). Nearly 14.2% of the household expenditure was on healthcare. Fever, respiratory tract diseases, gastrointestinal diseases were the common acute illnesses, while heart disease, diabetes mellitus, and respiratory diseases were the more common chronic diseases. Hospitalizations were mainly due to cardiovascular diseases, gastrointestinal problems, and accidents. Only 17%, 18%, 20% and 31% of the healthcare for acute illnesses, chronic illnesses, hospitalizations and childbirth was sought in the government health facilities. Average expenditure in government health facilities was 16.6% less for acute care, 15% less for hospitalization and 50% less for childbirth than in the private healthcare facilities. Out-of-pocket expenditure was mostly on medicines followed by diagnostic and laboratory tests. Among households experiencing hospitalization, 56.5% had incurred catastrophic expenditures, which was significantly higher in the poorest compared to richest household expenditure quartile (p < 0.002). Conclusions Expenditure on healthcare remains high in Punjab state of India. Efforts to increase utilization of the public sector could decrease out-of-pocket healthcare expenditure.	[Singh, Tarundeep; Roy, Pritam; Jamir, Limalemla; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Dept Community Med, Chandigarh 160012, India; [Singh, Tarundeep; Roy, Pritam; Jamir, Limalemla; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; [Gupta, Saurav; Kaur, Navpreet; Jain, D. K.] Ctr Dev Adv Comp, Mohali, Punjab, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Centre for Development of Advanced Computing (C-DAC)	Kumar, R (corresponding author), Post Grad Inst Med Educ & Res, Dept Community Med, Chandigarh 160012, India.; Kumar, R (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India.	dr.rajeshkumar@gmail.com	Roy, Pritam/L-1496-2019	Singh, Tarundeep/0000-0002-3674-8227	National Rural Health Mission, Punjab	National Rural Health Mission, Punjab	The study was funded by the National Rural Health Mission, Punjab. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We are grateful to National Rural Health Mission Punjab for providing financial support for conducting this survey, and National Health System Resource Center, New Delhi for allowing us to use their questionnaires in this survey.	Archana R, 2014, J Nat Sci Biol Med, V5, P135, DOI 10.4103/0976-9668.127312; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Bhatia J, 2004, HEALTH POLICY PLANN, V19, P402, DOI 10.1093/heapol/czh055; Binnendijk E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-23; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Census of India, 2011, CENS IND 2011; Chandan Kumar, 2011, Consilience: The Journal of Sustainable Development, P25; Chandra R, 2013, INT J PUBLIC HLTH RE, V3, P257; Chaudhuri A, 2012, INDIAN J MED RES, V136, P368; Dey DK, 2014, INDAN J COMMUNITY HE, V26, P356; Duggal R, 2004, FINANCING HEALTHCARE; Ghosh S., 2011, EC POLIT WKLY, V47, P63; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; IIPS, 2015, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS), 2013, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS) and Macro International, 2008, NAT FAM HLTH SURV NF; Khumukcham T, 2015, INDAN J COMMUNITY HE, V27, P86; Leisher, 2014, SOC SCI, V3, P167, DOI [DOI 10.3390/SOCSCI3020264, 10.3390/socsci3020264]; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Mondal S, 2010, FUTURE HLTH SYSTEMS; National Sample Survey Organisation, 2006, LEV PATT CONS EXP 61; Paudel D, 2013, GLOB HEALTH-SCI PRAC, V1, P277, DOI 10.9745/GHSP-D-12-00056; Peters D.H., 2002, BETTER HLTH SYSTEMS; Prinja S, 2012, INDIAN J MED RES, V136, P421; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Ray TK, 2002, NATL MED J INDIA, V15, P257; SEN A, 1993, PHILOS PUBLIC AFF, V22, P126; Xu K, 2003, HLTH SYSTEMS PERFORM	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157831	10.1371/journal.pone.0157831	http://dx.doi.org/10.1371/journal.pone.0157831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27351743	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900019
J	Ambrosis, N; Boyd, CD; O'Toole, GA; Fernandez, J; Sisti, F				Ambrosis, Nicolas; Boyd, Chelsea D.; O'Toole, George A.; Fernandez, Julieta; Sisti, Federico			Homologs of the LapD-LapG c-di-GMP Effector System Control Biofilm Formation by Bordetella bronchiseptica	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS PF0-1; ADENYLATE-CYCLASE TOXIN; RESPIRATORY-TRACT; MECHANISM; INFECTION; VIRULENCE; PERTUSSIS; MOTILITY; PROTEASE	Biofilm formation is important for infection by many pathogens. Bordetella bronchiseptica causes respiratory tract infections in mammals and forms biofilm structures in nasal epithelium of infected mice. We previously demonstrated that cyclic di-GMP is involved in biofilm formation in B. bronchiseptica. In the present work, based on their previously reported function in Pseudomonas fluorescens, we identified three genes in the B. bronchiseptica genome likely involved in c-di-GMP-dependent biofilm formation: brtA, lapD and lapG. Genetic analysis confirmed a role for BrtA, LapD and LapG in biofilm formation using microtiter plate assays, as well as scanning electron and fluorescent microscopy to analyze the phenotypes of mutants lacking these proteins. In vitro and in vivo studies showed that the protease LapG of B. bronchiseptica cleaves the N-terminal domain of BrtA, as well as the LapA protein of P. fluorescens, indicating functional conservation between these species. Furthermore, while BrtA and LapG appear to have little or no impact on colonization in a mouse model of infection, a B. bronchiseptica strain lacking the LapG protease has a significantly higher rate of inducing a severe disease outcome compared to the wild type. These findings support a role for c-di-GMP acting through BrtA/LapD/LapG to modulate biofilm formation, as well as impact pathogenesis, by B. bronchiseptica	[Ambrosis, Nicolas; Fernandez, Julieta; Sisti, Federico] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, IBBM,CCT,CONICET La Plata, La Plata, Buenos Aires, Argentina; [Boyd, Chelsea D.; O'Toole, George A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH USA; [Boyd, Chelsea D.] NIAID, Div Extramural Act, Sci Review Program, Rockville, MD USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fernandez, J; Sisti, F (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, IBBM,CCT,CONICET La Plata, La Plata, Buenos Aires, Argentina.	julietafernandez3@gmail.com; federico.sisti@gmail.com	Sisti, Federico/GOV-3334-2022	Sisti, Federico/0000-0001-7548-0422; Fernandez, Julieta/0000-0001-7803-5885; Ambrosis, Nicolas/0000-0002-5299-3425	NIH [R01-AI097307]; NSF [MCB-9984521]; CONICET; PICT [2013-0092]; PIP [0092, 0486]; CONICET doctoral fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); PICT(ANPCyT); PIP; CONICET doctoral fellowship	This work was supported by NIH grant R01-AI097307 and NSF grant MCB-9984521 to GAO, and International Cooperation grants (2012 and 2013) from CONICET to FS and JF, PICT 2013-0092, PIP No 0092 and PIP No 0486 to FS and JF. NA was supported by CONICET doctoral fellowship.	AKERLEY BJ, 1992, J BACTERIOL, V174, P980, DOI 10.1128/jb.174.3.980-990.1992; Bakas L, 1998, BBA-BIOMEMBRANES, V1368, P225, DOI 10.1016/S0005-2736(97)00181-8; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boyd CD, 2012, J BACTERIOL, V194, P4406, DOI 10.1128/JB.00642-12; Chatterjee D, 2012, J BACTERIOL, V194, P4415, DOI 10.1128/JB.00640-12; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Inatsuka CS, 2005, P NATL ACAD SCI USA, V102, P18578, DOI 10.1073/pnas.0507910102; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Nicholson TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049166; Nishikawa S, 2016, MICROBIOL IMMUNOL, V60, P93, DOI 10.1111/1348-0421.12356; Ryan RP, 2013, MICROBIOL-SGM, V159, P1286, DOI 10.1099/mic.0.068189-0; Serra DO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028811; Sisti F, 2002, INFECT IMMUN, V70, P1791, DOI 10.1128/IAI.70.4.1791-1798.2002; Sisti F, 2013, MICROBIOL-SGM, V159, P869, DOI 10.1099/mic.0.064345-0; Skinner JA, 2004, J IMMUNOL, V173, P1934, DOI 10.4049/jimmunol.173.3.1934; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; Whiteley CG, 2015, BIOTECHNOL ADV, V33, P124, DOI 10.1016/j.biotechadv.2014.11.010	26	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158752	10.1371/journal.pone.0158752	http://dx.doi.org/10.1371/journal.pone.0158752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380521	Green Published, gold			2022-12-27	WOS:000379798700044
J	Samol, A; Gones, M; Zumhagen, S; Bruns, HJ; Paul, M; Vahlhaus, C; Waltenberger, J; Schulze-Bahr, E; Eckardt, L; Monnig, G				Samol, Alexander; Goenes, Mehmet; Zumhagen, Sven; Bruns, Hans-Juergen; Paul, Matthias; Vahlhaus, Christian; Waltenberger, Johannes; Schulze-Bahr, Eric; Eckardt, Lars; Moennig, Gerold			Improved Clinical Risk Stratification in Patients with Long QT Syndrome? Novel Insights from Multi-Channel ECGs	PLOS ONE			English	Article							REPOLARIZATION; DISPERSION; PHENOTYPE; GENOTYPE; INDEX; DEATH	Background We investigated whether multichannel ECG-recordings are useful to risk-stratify patients with congenital long-QT syndrome (LQTS) for risk of sudden cardiac death under optimized medical treatment. Methods In 34 LQTS-patients ( 11 male; age 31 +/- 13 years, QTc 478 +/- 51ms; LQT1 n = 8, LQT2 n = 15) we performed a standard 12-channel ECG and a 120-channel body surface potential mapping. The occurrence of clinical events (CE; syncope, torsade de pointes (TdP), sudden cardiac arrest (SCA)) was documented and correlated with different ECG-parameters in all lead positions. Results Seven patients developed TdP, four survived SCA and 12 experienced syncope. 12/34 had at least one CE. CE was associated with a longer QTc-interval (519 +/- 43ms vs. 458 +/- 42ms; p = 0.001), a lower T-wave integral (TWI) on the left upper chest (-1.2 +/- 74.4mV*ms vs. 63.0 +/- 29.7mV*ms; p = 0.001), a lower range of T-wave amplitude (TWA) in the region of chest lead V8 (0.10 +/- 0.08mV vs. 0.18 +/- 0.07mV; p = 0.008) and a longer T-peak-T-end time (TpTe) in lead V1 (98 +/- 23ms vs. 78 +/- 26ms; p = 0.04). Receiver-operating-characteristic (ROC) analyses revealed a sensitivity of 96% and a specificity of 75% ( area under curve (AUC) 0.89 +/- 0.06, p = 0.001) at a cut-off value of 26.8mV*ms for prediction of CE by TWI, a sensitivity of 86% and a specificity of 83% at a cut-off value of 0.11mV (AUC 0.83 +/- 0.09, p = 0.002) for prediction of CE by TWA and a sensitivity of 83% and a specificity of 73% at a cut-off value of 87ms ( AUC 0.80 +/- 0.07, p = 0.005) for prediction of CE by TpTe. Conclusions Occurrence of CE in LQTS-patients seems to be associated with a prolonged, low-amplitude T-wave.	[Samol, Alexander; Bruns, Hans-Juergen; Paul, Matthias; Vahlhaus, Christian; Waltenberger, Johannes] Univ Hosp Munster, Div Cardiol, Dept Cardiovasc Med, Munster, Germany; [Goenes, Mehmet; Zumhagen, Sven; Eckardt, Lars; Moennig, Gerold] Univ Hosp Munster, Div Electrophysiol, Dept Cardiovasc Med, Munster, Germany; [Zumhagen, Sven; Paul, Matthias; Schulze-Bahr, Eric] Univ Hosp Munster, Inst Genet Heart Dis IfGH, Dept Cardiovasc Med, Munster, Germany; [Samol, Alexander] Johannes Wesling Hosp Minden, Dept Cardiol & Crit Care Med, Minden, Germany; [Vahlhaus, Christian] Klinikum Leer, Dept Cardiol & Angiol, Leer, Germany	University of Munster; University of Munster; University of Munster; Ruhr University Bochum	Samol, A (corresponding author), Univ Hosp Munster, Div Cardiol, Dept Cardiovasc Med, Munster, Germany.; Samol, A (corresponding author), Johannes Wesling Hosp Minden, Dept Cardiol & Crit Care Med, Minden, Germany.	Alexander.Samol@muehlenkreiskliniken.de	Paul, Matthias/AAI-3187-2021; Samol, Alexander/AAB-9187-2020					DEAMBROGGI L, 1986, CIRCULATION, V74, P1334, DOI 10.1161/01.CIR.74.6.1334; Goldenberg I, 2011, J AM COLL CARDIOL, V57, P51, DOI 10.1016/j.jacc.2010.07.038; Goldenberg I, 2010, J CARDIOVASC ELECTR, V21, P893, DOI 10.1111/j.1540-8167.2010.01737.x; Gupta P, 2008, J ELECTROCARDIOL, V41, P567, DOI 10.1016/j.jelectrocard.2008.07.016; Hobbs JB, 2006, JAMA-J AM MED ASSOC, V296, P1249, DOI 10.1001/jama.296.10.1249; Kaufman ES, 2008, HEART RHYTHM, V5, P831, DOI 10.1016/j.hrthm.2008.02.029; Kies P, 2011, EUR J NUCL MED MOL I, V38, P1899, DOI 10.1007/s00259-011-1852-7; Lubinski A, 1998, PACE, V21, P172, DOI 10.1111/j.1540-8159.1998.tb01083.x; MITCHELL LB, 1992, CIRCULATION, V86, P383, DOI 10.1161/01.CIR.86.2.383; Monnig G, 2006, EUR HEART J, V27, P2074, DOI 10.1093/eurheartj/ehl159; Moss Arthur J, 2002, Card Electrophysiol Rev, V6, P311, DOI 10.1023/A:1016301730302; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Samol A, 2013, EUROPACE, V15, P582, DOI 10.1093/europace/eus311; Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144; Schwartz PJ, 2006, J INTERN MED, V259, P39, DOI 10.1111/j.1365-2796.2005.01583.x; Schwartz PJ, 2005, NAT CLIN PRACT CARD, V2, P346, DOI 10.1038/ncpcardio0239; SCHWARTZ PJ, 1985, EUR HEART J, V6, P103, DOI 10.1093/eurheartj/6.suppl_D.103; SCHWARTZ PJ, 1985, AM HEART J, V109, P399, DOI 10.1016/0002-8703(85)90626-X; Takenaka K, 2003, CIRCULATION, V107, P838, DOI 10.1161/01.CIR.0000048142.85076.A2; Vijayakumar R, 2014, CIRCULATION, V130, P1936, DOI 10.1161/CIRCULATIONAHA.114.011359; Yamaguchi M, 2003, CLIN SCI, V105, P671, DOI 10.1042/CS20030010; Zhang L, 2000, CIRCULATION, V102, P2849; Zumhagen Sven, 2012, Herzschrittmacherther Elektrophysiol, V23, P211, DOI 10.1007/s00399-012-0232-8	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158085	10.1371/journal.pone.0158085	http://dx.doi.org/10.1371/journal.pone.0158085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379800	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700018
J	Han, S; Jin, SM; Ko, JS; Kim, YR; Gwak, MS; Son, HJ; Joh, JW; Kim, GS				Han, Sangbin; Jin, Sang-Man; Ko, Justin Sangwook; Kim, Young Ri; Gwak, Mi Sook; Son, Hee Jeong; Joh, Jae-Won; Kim, Gaab Soo			Association between Serum Bilirubin and Acute Intraoperative Hyperglycemia Induced by Prolonged Intermittent Hepatic Inflow Occlusion in Living Liver Donors	PLOS ONE			English	Article							SURGICAL SITE INFECTION; HEME OXYGENASE SYSTEM; CLINICAL-IMPLICATIONS; INSULIN SENSITIVITY; GLUCOSE-METABOLISM; TRANSPLANTATION; MICROSTEATOSIS; MACROSTEATOSIS; RESISTANCE; TOLERANCE	Background Intermittent hepatic inflow occlusion (IHIO) is associated with acute hyperglycemia during living donor hepatectomy when the ischemia is prolonged. Bilirubin is a potent antioxidant to play an important role for maintaining insulin sensitivity and preventing hyperglycemia. Thus, we aimed to test whether serum bilirubin level is associated with prolonged IHIO-induced intraoperative hyperglycemia. Methods Seventy-five living liver donors who underwent a prolonged IHIO with a > 30 minute cumulative ischemia were included. The association between preoperative serum bilirubin concentrations and the risk of intraoperative hyperglycemia (blood glucose concentration > 180 mg/dl) was analyzed using binary logistic regression with adjusting for potential confounders including age and steatosis. Results The number of donors who underwent 3, 4, 5, and 6 rounds of IHIO was 41, 22, 7, and 5, respectively. Twenty-nine (35%) donors developed intraoperative hyperglycemia. Total bilirubin concentration was inversely associated with hyperglycemia risk (odds ratio [OR] 0.033, 95% confidence interval [CI] 0.004-0.313, P = 0.003). There was an interaction between age and total bilirubin concentration: the effect of lower serum total bilirubin (<= 0.7 mg/dl) on the development of hyperglycemia was greater in older donors (>40 years) than in younger donors (P = 0.0.028 versus P = 0.212). Both conjugated bilirubin (OR 0.001 95% CI 0.001-0.684) and unconjugated bilirubin (OR 0.011 95% CI 0.001-0.246) showed an independent association with hyperglycemia risk. Conclusions Lower preoperative serum bilirubin was associated with greater risk of prolonged IHIO-induced hyperglycemia during living donor hepatectomy particularly in older donors. Thus, more meticulous glycemic management is recommended when prolonged IHIO is necessary for surgical purposes in old living donors with lower serum bilirubin levels.	[Han, Sangbin; Ko, Justin Sangwook; Kim, Young Ri; Gwak, Mi Sook; Kim, Gaab Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Han, Sangbin; Son, Hee Jeong] Kangwon Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Chunchon, South Korea; [Jin, Sang-Man] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea; [Joh, Jae-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kangwon National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, GS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	gskim@skku.edu	Jin, Sang-Man/AFO-5933-2022					Akhtar S, 2010, ANESTH ANALG, V110, P478, DOI 10.1213/ANE.0b013e3181c6be63; Ammori JB, 2007, J SURG RES, V140, P227, DOI 10.1016/j.jss.2007.02.019; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Behrends M, 2010, J GASTROINTEST SURG, V14, P528, DOI 10.1007/s11605-009-1112-3; Bell RA, 2000, DIABETES CARE, V23, P1630, DOI 10.2337/diacare.23.11.1630; Biondi-Zoccai G, 2011, CONTEMP CLIN TRIALS, V32, P731, DOI 10.1016/j.cct.2011.05.006; Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806; Deyi VYM, 2002, CLIN CHEM LAB MED, V40, P1052, DOI 10.1515/CCLM.2002.184; Giugliano D, 1997, CIRCULATION, V95, P1783; Greenhill Claire, 2014, Nat Rev Gastroenterol Hepatol, V11, P270, DOI 10.1038/nrgastro.2014.59; Han SB, 2013, TRANSPL INT, V26, P623, DOI 10.1111/tri.12092; Han S, 2015, LIVER TRANSPLANT, V21, P644, DOI 10.1002/lt.24097; Han S, 2015, J HEPATOL, V62, P556, DOI 10.1016/j.jhep.2014.10.027; Han SB, 2015, LIVER TRANSPLANT, V21, P180, DOI 10.1002/lt.24029; Han SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109120; Han S, 2014, LIVER TRANSPLANT, V20, P775, DOI 10.1002/lt.23878; Han SB, 2014, LIVER TRANSPLANT, V20, P473, DOI 10.1002/lt.23824; Hiraoka A, 2015, J GASTROENTEROL, V50, P1206, DOI 10.1007/s00535-015-1068-x; Imamura H, 2002, LANCET, V360, P2049, DOI 10.1016/S0140-6736(02)11995-7; Kersten JR, 1998, AM J PHYSIOL-HEART C, V275, pH721, DOI 10.1152/ajpheart.1998.275.2.H721; Ko JS, 2009, LIVER TRANSPLANT, V15, P381, DOI 10.1002/lt.21625; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Ndisang JF, 2010, ENDOCRINOLOGY, V151, P549, DOI 10.1210/en.2009-0471; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Ohnaka K, 2010, DIABETES RES CLIN PR, V88, P103, DOI 10.1016/j.diabres.2009.12.022; Okabayashi T, 2011, WORLD J SURG, V35, P2773, DOI 10.1007/s00268-011-1299-9; Paolisso G, 1996, DIABETOLOGIA, V39, P357, DOI 10.1007/BF00418354; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Shangraw R E, 1996, Liver Transpl Surg, V2, P443, DOI 10.1002/lt.500020607; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Trotter JF, 2006, LIVER TRANSPLANT, V12, P1485, DOI 10.1002/lt.20875; Wu TW, 1996, BIOCHEM PHARMACOL, V51, P859, DOI 10.1016/0006-2952(95)02395-X; Yu K, 2011, KOREAN J FAM MED, V32, P327, DOI 10.4082/kjfm.2011.32.6.327	36	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156957	10.1371/journal.pone.0156957	http://dx.doi.org/10.1371/journal.pone.0156957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367602	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900008
J	Gregory, S; Fusca, M; Rees, G; Schwarzkopf, DS; Barnes, G				Gregory, Sarah; Fusca, Marco; Rees, Geraint; Schwarzkopf, D. Samuel; Barnes, Gareth			Gamma Frequency and the Spatial Tuning of Primary Visual Cortex	PLOS ONE			English	Article							CORTICAL MAGNIFICATION; GABA CONCENTRATION; RESTING GABA; OSCILLATIONS; SIZE; VARIABILITY; V1; SEGMENTATION; PERFORMANCE; RECORDINGS	Visual stimulation produces oscillatory gamma responses in human primary visual cortex (V1) that also relate to visual perception. We have shown previously that peak gamma frequency positively correlates with central V1 cortical surface area. We hypothesized that people with larger V1 would have smaller receptive fields and that receptive field size, not V1 area, might explain this relationship. Here we set out to test this hypothesis directly by investigating the relationship between fMRI estimated population receptive field (pRF) size and gamma frequency in V1. We stimulated both the near-center and periphery of the visual field using both large and small stimuli in each location and replicated our previous finding of a positive correlation between V1 surface area and peak gamma frequency. Counter to our expectation, we found that between participants V1 size (and not PRF size) accounted for most of the variability in gamma frequency. Within-participants we found that gamma frequency increased, rather than decreased, with stimulus eccentricity directly contradicting our initial hypothesis.	[Gregory, Sarah; Rees, Geraint; Barnes, Gareth] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Gregory, Sarah; Rees, Geraint; Schwarzkopf, D. Samuel] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Fusca, Marco] Univ Trento, Ctr Mind Brain Sci, Mattarello, Italy; [Schwarzkopf, D. Samuel] UCL, Expt Psychol, London WC1H 0AP, England	University of London; University College London; University of London; University College London; University of Trento; University of London; University College London	Gregory, S (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England.; Gregory, S (corresponding author), UCL, Inst Cognit Neurosci, London WC1N 3AR, England.	s.gregory@ucl.ac.uk	Barnes, Gareth/ABB-7650-2020; Rees, Geraint/C-1493-2008	Barnes, Gareth/0000-0002-5396-7712; Rees, Geraint/0000-0002-9623-7007; Gregory, Sarah/0000-0003-4620-6963; Fusca, Marco/0000-0001-5900-9913	Wellcome Trust [091593/Z/10/Z, 100227]; European Research Council Starting Grant [310829]; Medical Research Council UK MEG Partnership Grant [MR/K005464/1]; MRC [MR/K005464/1] Funding Source: UKRI; Medical Research Council [MR/K005464/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council Starting Grant(European Research Council (ERC)); Medical Research Council UK MEG Partnership Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z (SG, MF, GB). This work was also supported by European Research Council Starting Grant (310829) (DSS), the Wellcome Trust (100227) (GR), and a Medical Research Council UK MEG Partnership Grant, MR/K005464/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann J, 2016, CEREB CORTEX, V26, P3838, DOI 10.1093/cercor/bhv186; Bergmann J, 2016, NEUROIMAGE, V124, P654, DOI 10.1016/j.neuroimage.2015.09.036; Bergmann J, 2016, CEREB CORTEX, V26, P43, DOI 10.1093/cercor/bhu168; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cousijn H, 2014, P NATL ACAD SCI USA, V111, P9301, DOI 10.1073/pnas.1321072111; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Haas B, 2014, CURR BIOL, V24, pR66, DOI 10.1016/j.cub.2013.11.061; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Friedman-Hill S, 2000, CEREB CORTEX, V10, P1105, DOI 10.1093/cercor/10.11.1105; Frien A, 2000, EUR J NEUROSCI, V12, P1453, DOI 10.1046/j.1460-9568.2000.00025.x; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Harvey BM, 2011, J NEUROSCI, V31, P13604, DOI 10.1523/JNEUROSCI.2572-11.2011; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; Herrmann K, 2010, NAT NEUROSCI, V13, P1554, DOI 10.1038/nn.2669; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hubener M, 1997, J NEUROSCI, V17, P9270; Kujala J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16347; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Muthukumaraswamy SD, 2013, NEUROIMAGE, V69, P223, DOI 10.1016/j.neuroimage.2012.12.038; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Perry G, 2013, NEUROIMAGE, V68, P83, DOI 10.1016/j.neuroimage.2012.11.043; Pinotsis DA, 2013, NEUROIMAGE, V66, P563, DOI 10.1016/j.neuroimage.2012.10.078; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Robson SE, 2015, J ANAT, V227, P409, DOI 10.1111/joa.12339; Schira MM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000651; Schwarzkopf DS, 2014, J NEUROSCI, V34, P2713, DOI 10.1523/JNEUROSCI.4416-13.2014; Schwarzkopf DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060550; Schwarzkopf DS, 2012, J NEUROSCI, V32, P1507, DOI 10.1523/JNEUROSCI.4771-11.2012; Schwarzkopf DS, 2011, NAT NEUROSCI, V14, P28, DOI 10.1038/nn.2706; Song C, 2015, NEURON, V85, P641, DOI 10.1016/j.neuron.2014.12.041; Song C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3201; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; van Pelt S, 2013, NEUROIMAGE, V78, P439, DOI 10.1016/j.neuroimage.2013.04.040; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Zuiderbaan W, 2012, J VISION, V12, DOI 10.1167/12.3.10	43	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157374	10.1371/journal.pone.0157374	http://dx.doi.org/10.1371/journal.pone.0157374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362265	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200016
J	Kinnaird, T; Butt, M; Abdul, F; Yazji, K; Hailan, A; Gallagher, S; Ossei-Gerning, N; Chase, A; Choudhury, A; Smith, D; Anderson, R				Kinnaird, Tim; Butt, Mehmood; Abdul, Fairoz; Yazji, Khaled; Hailan, Ahmed; Gallagher, Sean; Ossei-Gerning, Nicholas; Chase, Alexander; Choudhury, Anirban; Smith, David; Anderson, Richard			Early Clinical Experience with a Polymer-Free Biolimus A9 Drug-Coated Stent in DES-Type Patients Who Are Poor Candidates for Prolonged Dual Anti-Platelet Therapy	PLOS ONE			English	Article								Introduction Prolonged dual anti-platelet therapy (DAPT) may cause excess bleeding in certain patients. The biolimus-A9 drug-coated stent (BA9-DCS) has a rapid drug-elution profile allowing shortened DAPT. Data were gathered on the early experience implanting this stent in drugeluting stent eligible patients deemed to be at high risk of bleeding. Background and Methods The demographics, procedural data and clinical outcomes were gathered prospectively for 249 patients treated with a BA9-DCS stent at 2 UK centres, and compared to a cohort of patients treated in the same period with drug-eluting stents (PCI-DES). Results Operator-defined BA9-DCS indications included warfarin therapy, age, and anaemia. Patients receiving a BA9-DCS were older (71.6 +/- 11.8 vs. 64.8 +/- 11.6yrs, p<0.001), more often female (38.2 vs. 26.8%, P<0.001), and more likely to have comorbidity including chronic kidney disease or poor LV function than PCI-DES patients. The baseline Mehran bleed risk score was also significantly higher in the BA9-DCS group (19.4 +/- 8.7 vs. 13.1 +/- 5.8, p< 0.001). Of the BA9-DCS cohort, 95.5% of patients demonstrated disease fitting NICE criteria for DES placement. The number of lesions treated (1.81 +/- 1.1 vs. 1.58 +/- 0.92, p = 0.003), total lesion length (32.1 +/- 21.7 vs. 26.1 +/- 17.6mm, p< 0.001), number of stents used (1.93 +/- 1.11 vs. 1.65 +/- 1.4, p = 0.007) and total stent length (37.5 +/- 20.8 vs. 32.4 +/- 20.3, p<0.01) were greater for BA9-DCS patients. DAPT was prescribed for 3.3 +/- 3.9 months for BA9-DCS patients and 11.3 +/- 2.4 months for PCI-DES patients (p< 0.001). At follow up of 392 +/- 124 days despite the abbreviated DAPT course stent related event were infrequent with ischemia-driven restenosis PCI (2.8 vs. 3.4%, p = 0.838), and stent thrombosis (1.6 vs. 2.1%, p = 0.265) rates similar between the BA9-DCS ad PCI-DES groups. After propensity scoring all clinical end-points were similar between both cohorts. Conclusions This early experience using polymer-free BA9 drug-coated stents in drug-eluting stent type patients at risk of bleeding are encouraging. Further studies are warranted.	[Kinnaird, Tim; Butt, Mehmood; Hailan, Ahmed; Gallagher, Sean; Ossei-Gerning, Nicholas; Choudhury, Anirban; Anderson, Richard] Univ Wales Hosp, Dept Cardiol, Cardiff, S Glam, Wales; [Abdul, Fairoz; Yazji, Khaled; Chase, Alexander; Smith, David] Morriston Cardiac Ctr, Dept Cardiol, Swansea, W Glam, Wales	Cardiff University	Kinnaird, T (corresponding author), Univ Wales Hosp, Dept Cardiol, Cardiff, S Glam, Wales.	tim.Kinnaird2@wales.nhs.uk	Anderson, Richard/S-2020-2019					Abu-Assi E, 2012, EUR HEART J-ACUTE CA, V1, P222, DOI 10.1177/2048872612453924; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Becker RC, 2011, EUR HEART J, V32, P2933, DOI 10.1093/eurheartj/ehr422; Costa RA, 2016, JACC-CARDIOVASC INTE, V9, P51, DOI 10.1016/j.jcin.2015.09.008; de Boer SPM, 2011, EUR HEART J, V32, P2161, DOI 10.1093/eurheartj/ehr126; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Giustino G, 2015, J AM COLL CARDIOL; Gott K, 2014, AM J CARDIOL, V114, P70, DOI 10.1016/j.amjcard.2014.03.060; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hordijk-Trion M, 2006, EUR HEART J, V27, P671, DOI 10.1093/eurheartj/ehi731; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Kinnaird T, 2009, HEART, V95, P15, DOI 10.1136/hrt.2007.131284; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Ludman PF, 2011, HEART, V97, P1293, DOI 10.1136/heartjnl-2011-300299; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Morice MC, 2013, J AM COLL CARDIOL, V61, P1122, DOI 10.1016/j.jacc.2012.11.049; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Silber S, 2014, EUR HEART J, V35, P1949, DOI 10.1093/eurheartj/ehu026; Sudhir Krishnankutty, 2013, ISRN Cardiol, V2013, P748736, DOI 10.1155/2013/748736; Tada N, 2010, CIRC-CARDIOVASC INTE, V3, P174, DOI 10.1161/CIRCINTERVENTIONS.109.877522; Urban P, 2015, NEW ENGL J MED, V373, P2038, DOI 10.1056/NEJMoa1503943; Valgimigli M, 2015, J AM COLL CARDIOL, V65, P805, DOI 10.1016/j.jacc.2014.11.053; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Waksman R, 2012, CATHETER CARDIO INTE, V80, P429, DOI 10.1002/ccd.23407; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157812	10.1371/journal.pone.0157812	http://dx.doi.org/10.1371/journal.pone.0157812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362841	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200023
J	Lin, TY; Chen, YG; Lin, CL; Kao, CH				Lin, Te-Yu; Chen, Yu-Guang; Lin, Cheng-Li; Kao, Chia-Hung			Increased Risk of Acute Kidney Injury following Pneumococcal Pneumonia: A Nationwide Cohort Study	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ACUTE-RENAL-FAILURE; STREPTOCOCCUS-PNEUMONIAE; SEPSIS; MORTALITY; EPIDEMIOLOGY; MULTICENTER; DYSFUNCTION; INFECTION; DISEASE	Purpose Pneumococcal disease leads to renal complications ranging from persistent proteinuria to end-stage renal disease. Studies on the association between pneumococcal pneumonia (PP) and acute kidney injury (AKI) are scant. This study assessed the relationship between PP and risk of AKI. Methods This nationwide population-based cohort study examined data from the Taiwan National Health Insurance Research Database for the period 2000-2011. We identified inpatients with newly diagnosed PP according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. In addition, we selected a comparison cohort from inpatient claims without the diagnosis of PP that was randomly frequency-matched with the PP cohort according to age, sex, index year and comorbidities. We analyzed the risks of AKI by using Cox proportional hazards regression models, adjusted for sex, age, and comorbidities. Results A total of 10,069 patients with PP and 10,069 controls were enrolled in this study. After adjustments for age, sex, and comorbidities, patients with PP had a 1.11-fold risk of developing AKI compared with the comparison cohort. Conclusion This study indicates that AKI risks are higher in patients with PP compared with the comparison cohort. Careful follow-up observation and aggressive treatment are necessary for patients with PP to reduce the risk of AKI.	[Lin, Te-Yu] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chen, Yu-Guang] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Grad Inst Clin Med Sci, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bani-Hani AH, 2008, J UROLOGY, V180, P461, DOI 10.1016/j.juro.2008.04.001; Chen LF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051452, 10.1371/journal.pone.0051512]; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Constantinescu AR, 2004, AM J KIDNEY DIS, V43, P976, DOI 10.1053/j.ajkd.2004.02.010; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Emlet DR, 2015, SEMIN NEPHROL, V35, P85, DOI 10.1016/j.semnephrol.2015.01.009; Ficek R, 2006, KIDNEY BLOOD PRESS R, V29, P203, DOI 10.1159/000095734; Himmelfarb J, 2009, SEMIN NEPHROL, V29, P658, DOI 10.1016/j.semnephrol.2009.07.008; Huang ST, 2014, KIDNEY INT, V86, P1023, DOI 10.1038/ki.2014.79; Langenberg C, 2005, CRIT CARE, V9, pR363, DOI 10.1186/cc3540; Langenberg C, 2008, CRIT CARE, V12, DOI [10.1186/cc6823, 10.1186/cc6863]; Lee CS, 2012, NEPHROLOGY, V17, P48, DOI 10.1111/j.1440-1797.2011.01500.x; Lin TY, 2014, LUNG, V192, P159, DOI 10.1007/s00408-013-9523-z; Mongardon N, 2012, CRIT CARE, V16, DOI 10.1186/cc11471; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Naucler P, 2013, THORAX, V68, P571, DOI 10.1136/thoraxjnl-2012-203106; Ortqvist A, 2005, SEMIN RESP CRIT CARE, V26, P563, DOI 10.1055/s-2005-925523; Panichi V, 2002, NEPHRON, V91, P594, DOI 10.1159/000065018; Prowle JR, 2015, SEMIN NEPHROL, V35, P64, DOI 10.1016/j.semnephrol.2015.01.007; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Verma SK, 2015, SEMIN NEPHROL, V35, P96, DOI 10.1016/j.semnephrol.2015.01.010; Wittenhagen P, 2004, CLIN MICROBIOL INFEC, V10, P409, DOI 10.1111/j.1469-0691.2004.00850.x	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158501	10.1371/journal.pone.0158501	http://dx.doi.org/10.1371/journal.pone.0158501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362355	Green Submitted, gold, Green Published			2022-12-27	WOS:000378865200083
J	Raj, RR; Subramani, S				Raj, Renu R.; Subramani, Sathya			Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances	PLOS ONE			English	Article							MECHANISMS	Phenylephrine (PE) causes vasoconstriction through alpha adrenergic receptors. PE-induced vasodilatation has also been reported earlier in pre-constricted vessels. Here we demonstrate in spiral strips of goat arteries that addition of PE can decrease tone even from base-line levels (i.e. not pre-constricted) and show that this process requires nitric oxide (NO) and alpha adrenergic stimulation, but is cGMP-independent. Under control conditions, PE caused vasoconstriction, but under conditions where NO levels are higher, as with L-Arginine or sodium nitroprusside, PE decreased vessel tension. L-Arginine/PE combination was not able to decrease tension when alpha adrenoceptors were blocked with Phentolamine or endothelial nitric oxide synthase (eNOS) was blocked with N omega-Nitro-L-arginine (L-NNA). Propranolol, a beta blocker, was unable to prevent the reduction in tension by the L-Arginine/PE combination. Adrenaline and noradrenaline (and not isoproterenol) also reduced vessel tension in the presence of L-Arginine. Even when NO levels were not enhanced, relieving NO from having to stimulate the enzyme soluble guanylyl cyclase (sGC) (either by using sGC blockers, namely ODQ or methylene blue, or by enhancing cGMP levels (with sildenafil) which by negative feedback probably inhibits sGC) led to PE-induced reduction of vascular tension. PMA-phorbol myristate acetate-an agonist which stimulates Protein Kinase C was able to prevent the ability of PE to reduce vascular tension in a high NO environment. Our conclusion is that PE reduces vascular tension through alpha adrenoceptors if there is excess NO availability to activate a putative pathway. Though the reduction of vessel tone by PE is dependent on NO, it is independent of cGMP. Prior treatment with PMA or PE itself can prevent further PE-induced reduction of tension in a high NO environment. The results here suggest, counter-intuitively, that alpha blockers may be of help in the treatment of septic shock where nitric oxide levels are high.	[Raj, Renu R.; Subramani, Sathya] Christian Med Coll & Hosp, Dept Physiol, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Subramani, S (corresponding author), Christian Med Coll & Hosp, Dept Physiol, Vellore, Tamil Nadu, India.	sathya@cmcvellore.ac.in	RAJ, RENU/AAH-7456-2021	Subramani, Sathya/0000-0002-4415-6774	Department of Physiology at Christian Medical College, Vellore	Department of Physiology at Christian Medical College, Vellore	Funds were provided by the Department of Physiology at Christian Medical College, Vellore.	BENNETT MA, 1992, BRIT J PHARMACOL, V107, P616, DOI 10.1111/j.1476-5381.1992.tb12792.x; BOND RF, 1985, CIRC SHOCK, V16, P155; BOND RF, 1984, CIRC SHOCK, V12, P9; Filippi S, 2001, J PHARMACOL EXP THER, V296, P869; Goud C, 1999, GEN PHARMACOL, V32, P51, DOI 10.1016/S0306-3623(98)00059-7; Graham RM, 1996, CIRC RES, V78, P737, DOI 10.1161/01.RES.78.5.737; HOLLENBERG SM, 1993, AM J PHYSIOL, V264, pH660, DOI 10.1152/ajpheart.1993.264.2.H660; Joyner MJ, 2003, ACTA PHYSIOL SCAND, V177, P329, DOI 10.1046/j.1365-201X.2003.01090.x; OLIVER LE, 1980, MED J AUSTRALIA, V2, P42, DOI 10.5694/j.1326-5377.1980.tb125819.x; Povoa PR, 2009, CRIT CARE MED, V37, P410, DOI 10.1097/CCM.0b013e3181958b1c; RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555; Thorin E, 1998, CIRC RES, V82, P1323, DOI 10.1161/01.RES.82.12.1323; Torp KD, 2001, J APPL PHYSIOL, V90, P1855, DOI 10.1152/jappl.2001.90.5.1855; Van Hove CE, 2009, BRIT J PHARMACOL, V158, P920, DOI 10.1111/j.1476-5381.2009.00396.x; Zschauer AOA, 1997, J APPL PHYSIOL, V82, P1918, DOI 10.1152/jappl.1997.82.6.1918	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158551	10.1371/journal.pone.0158551	http://dx.doi.org/10.1371/journal.pone.0158551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362703	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200088
J	Yoo, SH; Kim, JG; Kim, BS; Lee, J; Pi, SH; Lim, HD; Shin, HI; Cho, ES; You, HK				Yoo, Su-Hyang; Kim, Jae Goo; Kim, Beom-Su; Lee, Jun; Pi, Sung-Hee; Lim, Hyun-Dae; Shin, Hong-In; Cho, Eui-Sic; You, Hyung-Keun			BST2 Mediates Osteoblast Differentiation via the BMP2 Signaling Pathway in Human Alveolar-Derived Bone Marrow Stromal Cells	PLOS ONE			English	Article							MOLECULAR-CLONING; ANTIGEN-2; RUNX2; GENE; PHOSPHORYLATION; TRANSCRIPTION; SMAD1	The molecular mechanisms controlling the differentiation of bone marrow stromal stem cells into osteoblasts remain largely unknown. In this study, we investigated whether bone marrow stromal antigen 2 (BST2) influences differentiation toward the osteoblasts lineage. BST2 mRNA expression in human alveolar-derived bone marrow stromal cells (hAD-BMSCs) increased during differentiation into osteoblasts. hAD-BMSCs differentiation into osteoblasts and the mRNA expression of the bone-specific markers alkaline phosphatase, collagen type a 1, bone sialoprotein, osteocalcin, and osterix were reduced by BST2 knockdown using siRNA. Furthermore, BST2 knockdown in hAD-BMSCs resulted in decreased RUNX2 mRNA and protein expression. We hypothesized that BST2 is involved in differentiation of into osteoblasts via the BMP2 signaling pathway. Accordingly, we evaluated the mRNA expression levels of BMP2, BMP receptors (BMPR1 and 2), and the downstream signaling molecules SMAD1, SMAD4, and p-SMAD1/5/8 in BST2 knockdown cells. BMP2 expression following the induction of differentiation was significantly lower in BST2 knockdown cells than in cells treated with a non-targeting control siRNA. Similar results were found for the knockdown of the BMP2 receptor-BMPR1A. We also identified significantly lower expression of SMAD1, SMAD4, and p-SMAD1/5/8 in the BST2 knockdown cells than control cells. Our data provide the first evidence that BST2 is involved in the osteogenic differentiation of bone marrow stromal cells via the regulation of the BMP2 signaling pathway.	[Yoo, Su-Hyang; Pi, Sung-Hee; You, Hyung-Keun] Wonkwang Univ, Sch Dent, Dept Periodontol, Iksan, South Korea; [Yoo, Su-Hyang; Kim, Jae Goo] Chonbuk Natl Univ, Fac Biol Sci, Coll Nat Sci, Jeonju, South Korea; [Yoo, Su-Hyang; Kim, Jae Goo] Chonbuk Natl Univ, Coll Nat Sci, Inst Biodivers Res, Jeonju, South Korea; [Kim, Beom-Su] Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Daejeon, South Korea; [Kim, Beom-Su] Bone Cell Biotech Inc, Daejeon, South Korea; [Lee, Jun] Wonkwang Univ, Daejeon Dent Hosp, Dept Oral & Maxillofacial Surg, Daejeon, South Korea; [Lim, Hyun-Dae] Wonkwang Univ, Sch Dent, Dept Oral Med, Iksan, South Korea; [Shin, Hong-In] Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol, IHBR, Daegu, South Korea; [Cho, Eui-Sic] Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci, Cluster Craniofacial Dev & Regenerat Res, Jeonju, South Korea	Wonkwang University; Jeonbuk National University; Jeonbuk National University; Wonkwang University; Wonkwang University; Wonkwang University; Kyungpook National University; Jeonbuk National University	You, HK (corresponding author), Wonkwang Univ, Sch Dent, Dept Periodontol, Iksan, South Korea.	hkperio@wku.ac.kr		Lim, Hyun-Dae/0000-0001-9474-3267; Kim, Beom Su/0000-0001-6562-4373; You, Hyung-Keun/0000-0002-4585-0477	National Research Foundation (NRF) of Korea - Korean Government (MSIP) [2013M3A9B2076481]; Bone Cell Biotech	National Research Foundation (NRF) of Korea - Korean Government (MSIP); Bone Cell Biotech	This work was supported by the National Research Foundation (NRF) of Korea Grant, which was funded by the Korean Government (MSIP) (NO.2013M3A9B2076481) to HKY. Bone Cell Biotech provided support in the form of salary for BSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation (NRF) of Korea Grant, which was funded by the Korean Government (MSIP) (NO.2013M3A9B2076481). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Duque G, 2009, STEM CELLS, V27, P550, DOI 10.1634/stemcells.2008-0886; Ebisawa T, 1999, J CELL SCI, V112, P3519; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; GOTO T, 1994, BLOOD, V84, P1922; Ishibashi O, 2010, J CELL PHYSIOL, V222, P465, DOI 10.1002/jcp.21968; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Jones PH, 2013, VIROLOGY, V444, P124, DOI 10.1016/j.virol.2013.05.042; Jones PH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-10; Kagami H, 2014, TISSUE ENG PART B-RE, V20, P229, DOI [10.1089/ten.teb.2013.0578, 10.1089/ten.TEB.2013.0578]; Kim BS, 2012, BONE, V51, P506, DOI 10.1016/j.bone.2012.05.012; Mahauad-Fernandez WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123931; Mahauad-Fernandez WD, 2014, J GEN VIROL, V95, P2450, DOI 10.1099/vir.0.068643-0; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Matsubara T, 2005, J BONE MINER RES, V20, P399, DOI 10.1359/JBMR.041117; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ren DP, 2015, J CELL PHYSIOL, V230, P2426, DOI 10.1002/jcp.24972; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Swiecki M, 2012, J IMMUNOL, V188, P2488, DOI 10.4049/jimmunol.1103145; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Tavano B, 2013, J IMMUNOL, V190, P2622, DOI 10.4049/jimmunol.1202391; Vidal-Laliena M, 2005, CELL IMMUNOL, V236, P6, DOI 10.1016/j.cellimm.2005.08.002; Wysokinski D, 2015, DNA CELL BIOL, V34, P305, DOI 10.1089/dna.2014.2688; Yamada Y, 2013, CLIN ORAL IMPLAN RES, V24, P468, DOI 10.1111/j.1600-0501.2011.02353.x	33	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158481	10.1371/journal.pone.0158481	http://dx.doi.org/10.1371/journal.pone.0158481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359105	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200080
J	Zhu, HC; Cai, LJ; Liu, HY; Huang, W				Zhu, Hongchun; Cai, Lijie; Liu, Haiying; Huang, Wei			Information Extraction of High Resolution Remote Sensing Images Based on the Calculation of Optimal Segmentation Parameters	PLOS ONE			English	Article								Multi-scale image segmentation and the selection of optimal segmentation parameters are the key processes in the object-oriented information extraction of high-resolution remote sensing images. The accuracy of remote sensing special subject information depends on this extraction. On the basis of WorldView-2 high-resolution data, the optimal segmentation parameters method of object-oriented image segmentation and high-resolution image information extraction, the following processes were conducted in this study. Firstly, the best combination of the bands and weights was determined for the information extraction of high-resolution remote sensing image. An improved weighted mean-variance method was proposed andused to calculatethe optimal segmentation scale. Thereafter, the best shape factor parameter and compact factor parameters were computed with the use of the control variables and the combination of the heterogeneity and homogeneity indexes. Different types of image segmentation parameters were obtained according to the surface features. The high-resolution remote sensing images were multi-scale segmented with the optimal segmentation parameters. Ahierarchical network structure was established by setting the information extraction rules to achieve object-oriented information extraction. This study presents an effective and practical method that can explain expert input judgment by reproducible quantitative measurements. Furthermore the results of this procedure may be incorporated into a classification scheme.	[Zhu, Hongchun; Cai, Lijie; Huang, Wei] Shandong Univ Sci & Technol, Geomat Coll, Qianwan Port Rd 579, Qingdao 266590, Shandong, Peoples R China; [Zhu, Hongchun] Shandong Univ Sci & Technol, Key Lab Geomat & Digital Technol, Qianwan Port Rd 579, Qingdao 266590, Shandong, Peoples R China; [Liu, Haiying] Shandong Univ Sci & Technol, Coll Informat Sci & Engn, Qianwan Port Rd 579, Qingdao 266590, Shandong, Peoples R China	Shandong University of Science & Technology; Shandong University of Science & Technology; Shandong University of Science & Technology	Zhu, HC (corresponding author), Shandong Univ Sci & Technol, Geomat Coll, Qianwan Port Rd 579, Qingdao 266590, Shandong, Peoples R China.; Zhu, HC (corresponding author), Shandong Univ Sci & Technol, Key Lab Geomat & Digital Technol, Qianwan Port Rd 579, Qingdao 266590, Shandong, Peoples R China.	sdny_xa@163.com			National Natural Science Foundation of China [41471331, 41376108, 41301422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (NO. 41471331, 41376108,41301422), and this work is part of the research project which above mentioned. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baatz M, 2011, ECOGNITION USER GUID; Baatz M, 2007, J PHOTOGRAMMETRY REM, P3; Balaguer A, 2010, COMPUT GEOSCI-UK, V36, P231, DOI 10.1016/j.cageo.2009.05.003; Guan YX, 2008, GUIDE HIGH RESOLUTIO; [胡文亮 Hu Wenliang], 2010, [地理与地理信息科学, Geography and Geo-information Science], V26, P15; Huang H., 2003, SCALE ISSUES OBJECT; Lu C, 2012, RES INFORM EXTRACTIO; Mahmoudi FT, 2013, COMPUT GEOSCI-UK, V54, P219, DOI 10.1016/j.cageo.2012.12.007; Myint SW, 2011, REMOTE SENS ENVIRON, V115, P1145, DOI 10.1016/j.rse.2010.12.017; Ren DW, 2001, GSA GEOL SOC AM ANN, V5-833, P289; Sheffigara VK., 1992, PHOTOGRAMMETRIC ENG, V58, P561; [谭衢霖 Tan Qulin], 2010, [测绘学报, Acta Geodetica et Cartographica Sinica], V39, P618; [陶超 TAO Chao], 2010, [测绘学报, Acta Geodetica et Cartographica Sinica], V39, P39; Tian J, 2007, INT J REMOTE SENS, V28, P4625, DOI 10.1080/01431160701241746; Tian XG., 2007, OBJECT ORIENTED INFO; Wang H., 2013, J REMOTE SENS, V17, P822, DOI [10.11834/jrs.20132257, DOI 10.11834/JRS.20132257]; Yan Li, 2012, Geomatics and Information Science of Wuhan University, V37, P636; [于欢 YU Huan], 2010, [中国图象图形学报, Journal of Image and Graphics], V15, P352; Zhao YS, 2009, PRINCIPLE METHOD ANA	19	8	8	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158585	10.1371/journal.pone.0158585	http://dx.doi.org/10.1371/journal.pone.0158585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362762	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200099
J	Eshwar, AK; Tall, B; Gangiredla, J; Gopinath, GR; Patel, IR; Neuhauss, SCF; Stephan, R; Lehner, A				Eshwar, Athmanya K.; Tall, Ben D.; Gangiredla, Jayanthi; Gopinath, Gopal R.; Patel, Isha R.; Neuhauss, Stephan C. F.; Stephan, Roger; Lehner, Angelika			Linking Genomo- and Pathotype: Exploiting the Zebrafish Embryo Model to Investigate the Divergent Virulence Potential among Cronobacter spp.	PLOS ONE			English	Article							ENTEROBACTER-SAKAZAKII; CAENORHABDITIS-ELEGANS; NEONATAL MENINGITIS; HUMAN MACROPHAGES; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; COMB. NOV.; GEN. NOV; TURICENSIS; FOOD	Bacteria belonging to the genus Cronobacter have been recognized as causative agents of life-threatening systemic infections primarily in premature, low-birth weight and immune compromised neonates. Apparently not all Cronobacter species are linked to infantile infections and it has been proposed that virulence varies among strains. Whole genome comparisons and in silico analysis have proven to be powerful tools in elucidating potential virulence determinants, the presence/absence of which may explain the differential virulence behaviour of strains. However, validation of these factors has in the past been hampered by the availability of a suitable neonatal animal model. In the present study we have used zebrafish embryos to model Cronobacter infections in vivo using wild type and genetically engineered strains. Our experiments confirmed the role of the RepF1B-like plasmids as "virulence plasmids" in Cronobacter and underpinned the importantce of two putative virulence factors-cpa and zpx-in in vivo pathogenesis. We propose that by using this model in vivo infection studies are now possible on a large scale level which will boost the understanding on the virulence strategies employed by these pathogens.	[Eshwar, Athmanya K.; Stephan, Roger; Lehner, Angelika] Univ Zurich, Inst Food Safety & Hyg, Zurich, Switzerland; [Tall, Ben D.; Gangiredla, Jayanthi; Gopinath, Gopal R.; Patel, Isha R.] US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Neuhauss, Stephan C. F.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; US Food & Drug Administration (FDA); University of Zurich	Lehner, A (corresponding author), Univ Zurich, Inst Food Safety & Hyg, Zurich, Switzerland.	lehnera@fsafety.uzh.ch	Lehner, Angelika/B-2363-2018; Stephan, Roger/AAP-8501-2020	Lehner, Angelika/0000-0003-1863-5090; 	Swiss National Science Foundation [310030_138533/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation 310030_138533/1 to AE, AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsonosi A, 2015, EUR J CLIN MICROBIOL, V34, P1979, DOI 10.1007/s10096-015-2440-8; Bowen AB, 2006, EMERG INFECT DIS, V12, P1185, DOI 10.3201/eid1708.051509; Brady C, 2013, SYST APPL MICROBIOL, V36, P309, DOI 10.1016/j.syapm.2013.03.005; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P297; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Eshwar AK, 2015, RES MICROBIOL, V166, P186, DOI 10.1016/j.resmic.2015.02.005; Fehr A, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.29; Forsythe SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1121; Franco AA, 2011, APPL ENVIRON MICROB, V77, P3255, DOI 10.1128/AEM.03023-10; Franco AA, 2011, INFECT IMMUN, V79, P1578, DOI 10.1128/IAI.01165-10; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Grim CJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-366; Hariri S, 2013, EMERG INFECT DIS, V19, P175, DOI 10.3201/eid1901.120649; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; Jaradat ZW, 2012, FRONT MICROBIOL, V3, P397; Johnson JR, 2005, ANTIMICROB AGENTS CH, V49, P4739, DOI 10.1128/AAC.49.11.4739-4744.2005; Joseph S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00397; Joseph S, 2012, INT J SYST EVOL MICR, V62, P1277, DOI 10.1099/ijs.0.032292-0; Joseph S, 2011, EMERG INFECT DIS, V17, P1713, DOI 10.3201/eid1709.110260; Kothary MH, 2007, APPL ENVIRON MICROB, V73, P4142, DOI 10.1128/AEM.02729-06; Kucerova E, 2010, PLOS ONE, V5, pA51, DOI 10.1371/journal.pone.0009556; Lee Hyun-A, 2011, Lab Anim Res, V27, P59, DOI 10.5625/lar.2011.27.1.59; Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000; Mittal R, 2009, LAB INVEST, V89, P263, DOI 10.1038/labinvest.2008.164; Mullane NR, 2007, MINERVA PEDIATR, V59; Ogrodzki P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1960-z; Pagotto FJ, 2009, INT J FOOD MICROBIOL, V136, P238, DOI 10.1016/j.ijfoodmicro.2009.05.010; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Schwizer S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-38; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh N, 2015, VIRULENCE, V6, P433, DOI 10.1080/21505594.2015.1036217; Sivamaruthi BS, 2015, ARCH MICROBIOL, V197, P327, DOI 10.1007/s00203-014-1064-1; Sivamaruthi BS, 2011, J BASIC MICROB, V51, P540, DOI 10.1002/jobm.201000377; Stephan R, 2014, INT J SYST EVOL MICR, V64, P3402, DOI 10.1099/ijs.0.059832-0; Stephan R, 2011, J BACTERIOL, V193, P309, DOI 10.1128/JB.01162-10; Townsend SM, 2007, MICROBIOL-SGM, V153, P3538, DOI 10.1099/mic.0.2007/009316-0; Yan QQ, 2012, J APPL MICROBIOL, V113, P1, DOI 10.1111/j.1365-2672.2012.05281.x	37	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158428	10.1371/journal.pone.0158428	http://dx.doi.org/10.1371/journal.pone.0158428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355472	Green Accepted, Green Published, gold			2022-12-27	WOS:000378859400065
J	Son, HF; Kim, KJ				Son, Hyeoncheol Francis; Kim, Kyung-Jin			Structural Insights into a Novel Class of Aspartate Aminotransferase from Corynebacterium glutamicum	PLOS ONE			English	Article							THERMUS-THERMOPHILUS HB8; AMINO-ACIDS; CRYSTAL-STRUCTURE; REFINEMENT; MECHANISM; GENOME; HOMOLOGY; COMPLEX	Aspartate aminotransferase from Corynebacterium glutamicum (CgAspAT) is a PLP-dependent enzyme that catalyzes the production of L-aspartate and alpha-ketoglutarate from L-glutamate and oxaloacetate in L-lysine biosynthesis. In order to understand the molecular mechanism of CgAspAT and compare it with those of other aspartate aminotransferases (AspATs) from the aminotransferase class I, we determined the crystal structure of CgAspAT. CgAspAT functions as a dimer, and the CgAspAT monomer consists of two domains, the core domain and the auxiliary domain. The PLP cofactor is found to be bound to CgAspAT and stabilized through unique residues. In our current structure, a citrate molecule is bound at the active site of one molecule and mimics binding of the glutamate substrate. The residues involved in binding of the PLP cofactor and the glutamate substrate were confirmed by site-directed mutagenesis. Interestingly, compared with other AspATs from aminotransferase subgroup Ia and Ib, CgAspAT exhibited unique binding sites for both cofactor and substrate; moreover, it was found to have unusual structural features in the auxiliary domain. Based on these structural differences, we propose that CgAspAT does not belong to either subgroup Ia or Ib, and can be categorized into a subgroup Ic. The phylogenetic tree and RMSD analysis also indicates that CgAspAT is located in an independent AspAT subgroup.	[Son, Hyeoncheol Francis; Kim, Kyung-Jin] Kyungpook Natl Univ, Sch Life Sci, Creat BioRes Grp, Daehak Ro 80, Daegu 702701, South Korea	Kyungpook National University	Son, HF (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Creat BioRes Grp, Daehak Ro 80, Daegu 702701, South Korea.	kkim@knu.ac.kr			National Research Foundation of Korea (NRF) grant - Korean Government (MSIP) [2014R1A2A2A01005752, 2014M1A2A2033626]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from Ministry of Trade, Industry & Energy, Republic of Korea [20153030091360]; NRF-Global PhD Fellowship Program of the Korean Government [2015H1A2A1034233]	National Research Foundation of Korea (NRF) grant - Korean Government (MSIP); New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from Ministry of Trade, Industry & Energy, Republic of Korea; NRF-Global PhD Fellowship Program of the Korean Government	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (2014R1A2A2A01005752 and 2014M1A2A2033626), and was also supported by the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (No. 20153030091360). H-F Son was supported by the NRF-2015-Global PhD Fellowship Program of the Korean Government (2015H1A2A1034233).	Abendroth J, 2015, ACTA CRYSTALLOGR F, V71, P566, DOI 10.1107/S2053230X15001831; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUBELLIS MV, 1989, EUR J BIOCHEM, V186, P375, DOI 10.1111/j.1432-1033.1989.tb15219.x; Eggeling L, 2015, APPL MICROBIOL BIOT, V99, P3387, DOI 10.1007/s00253-015-6508-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Jeffery CJ, 1998, PROTEIN SCI, V7, P1380, DOI 10.1002/pro.5560070614; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kinoshita S, 2004, J GEN APPL MICROBIOL, V50, P331; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; KOCHHAR S, 1992, EUR J BIOCHEM, V203, P563, DOI 10.1111/j.1432-1033.1992.tb16584.x; MALASHKEVICH VN, 1982, DOKL AKAD NAUK SSSR+, V267, P1257; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McHardy AC, 2003, J BIOTECHNOL, V104, P229, DOI 10.1016/S0168-1656(03)00161-5; MCPHALEN CA, 1992, J MOL BIOL, V225, P495, DOI 10.1016/0022-2836(92)90935-D; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Okamoto A, 1996, J BIOCHEM-TOKYO, V119, P135; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OUZOUNIS C, 1993, FEBS LETT, V322, P159, DOI 10.1016/0014-5793(93)81559-I; Rhee S, 1997, J BIOL CHEM, V272, P17293, DOI 10.1074/jbc.272.28.17293; Schwarzenbacher R, 2004, PROTEINS, V55, P759, DOI 10.1002/prot.10646; Ura H, 2001, J BIOCHEM, V130, P89, DOI 10.1093/oxfordjournals.jbchem.a002966; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wendisch VF, 2014, CURR OPIN BIOTECH, V30, P51, DOI 10.1016/j.copbio.2014.05.004; Wrenger C, 2011, J MOL BIOL, V405, P956, DOI 10.1016/j.jmb.2010.11.018	27	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158402	10.1371/journal.pone.0158402	http://dx.doi.org/10.1371/journal.pone.0158402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355211	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400060
J	Wu, CL; Tsai, CC; Kor, CT; Tarng, DC; Lian, IB; Yang, TH; Chiu, PF; Chang, CC				Wu, Chia-Lin; Tsai, Chun-Chieh; Kor, Chew-Teng; Tarng, Der-Cherng; Lian, Ie-Bin; Yang, Tao-Hsiang; Chiu, Ping-Fang; Chang, Chia-Chu			Stroke and Risks of Development and Progression of Kidney Diseases and End-Stage Renal Disease: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							CHRONIC PHASE; EPIDEMIOLOGY; INFLAMMATION; VALIDATION; REDUCTION; HEALTH; SALT	Background There is little information about the association between stroke and kidney diseases. We aimed to investigate the impact of stroke on long-term renal outcomes. Methods In this large population-based retrospective cohort study, we identified 100,353 subjects registered in the National Health Insurance Research Database of Taiwan from January 1, 2000, through December 31, 2012, including 33,451 stroke patients and 66,902 age-, sexand Charlson's comorbidity index score-matched controls. Results The incidence rate of chronic kidney disease (CKD) was higher in the stroke than in the control cohort (17.5 vs. 9.06 per 1000 person-years). After multivariate adjustment, the risk of developing CKD was significantly higher in patients with stroke (adjusted hazard ratio [aHR] 1.43, 95% confidence interval [CI] 1.36-1.50, P<0.001). Subgroup analysis showed that stroke patients <50 years (aHR 1.61, P<0.001) and those with concomitant diabetes mellitus (aHR 2.12, P<0.001), hyperlipidemia (aHR 1.53, P<0.001) or gout (aHR 1.84, P<0.001) were at higher risk of incident CKD. Additionally, the risks of progression to advanced CKD and end-stage renal disease (ESRD) were significantly higher for stroke patients (aHRs, 1.22 and 1.30; P = 0.04 and P = 0.008, respectively), independent of age, sex, comorbidities and long-term medications. Conclusions Stroke is associated with higher risks for incident CKD, decline in renal function and ESRD. Younger stroke patients, as well as those with concomitant diabetes mellitus, hyperlipidemia or gout are at greater risk for kidney diseases.	[Wu, Chia-Lin; Tsai, Chun-Chieh; Chiu, Ping-Fang; Chang, Chia-Chu] Changhua Christian Hosp, Dept Internal Med, Div Nephrol, Changhua, Taiwan; [Wu, Chia-Lin; Tsai, Chun-Chieh; Chiu, Ping-Fang; Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Chia-Lin; Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Wu, Chia-Lin; Kor, Chew-Teng; Chiu, Ping-Fang; Chang, Chia-Chu] Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan; [Lian, Ie-Bin] Natl Changhua Univ Educ, Grad Inst Stat & Informat Sci, Changhua, Taiwan; [Yang, Tao-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Environm & Precis Med Lab, Changhua, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Changhua University of Education; Changhua Christian Hospital	Chiu, PF (corresponding author), Changhua Christian Hosp, Dept Internal Med, Div Nephrol, Changhua, Taiwan.; Chiu, PF (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chiu, PF (corresponding author), Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan.	27509@cch.org.tw; 68505@cch.org.tw	Wu, Chia-Lin/V-8888-2017; Lian, Ie-Bin/AAE-3368-2021	Wu, Chia-Lin/0000-0001-6045-6956; Lian, Ie-bin/0000-0003-3992-6049	Changhua Christian Hospital Research Foundation [103-CCH-IRP-10, 104-CCH-IRP-012]	Changhua Christian Hospital Research Foundation	This study was funded by grants 103-CCH-IRP-10 and 104-CCH-IRP-012 from the Changhua Christian Hospital Research Foundation. The funder had no role in study design; in data collection, analysis, and interpretation; or in preparation of the manuscript and decision to publish.; This study was funded by grants 103-CCH-IRP-10 and 104-CCH-IRP-012 from the Changhua Christian Hospital Research Foundation. The funder had no role in study design; in data collection, analysis, and interpretation; or in preparation of the manuscript and decision to publish.	Air EL, 2007, DIABETES CARE, V30, P3131, DOI 10.2337/dc06-1537; Alexandrova ML, 2005, FREE RADICAL BIO MED, V39, P297, DOI 10.1016/j.freeradbiomed.2005.04.017; Bao YS, 2013, EUR J CLIN INVEST, V43, P829, DOI 10.1111/eci.12113; Cao W, 2015, J AM SOC NEPHROL, V26, P1619, DOI 10.1681/ASN.2014050518; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Flex A, 2004, STROKE, V35, P2270, DOI 10.1161/01.STR.0000140740.19421.fe; Folino AF, 2007, PROG CARDIOVASC DIS, V50, P49, DOI 10.1016/j.pcad.2007.01.001; Grau AJ, 2001, EUR J CLIN INVEST, V31, P999, DOI 10.1046/j.1365-2362.2001.00923.x; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Haapaniemi E, 2004, ACTA NEUROL SCAND, V110, P242, DOI 10.1111/j.1600-0404.2004.00304.x; Hsieh FI, 2014, J STROKE, V16, P59, DOI 10.5853/jos.2014.16.2.59; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Huang ST, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000429; Hung PH, 2014, NEPHROL DIAL TRANSPL, V29, P873, DOI 10.1093/ndt/gft534; Kernan WN, 2005, ARCH INTERN MED, V165, P227, DOI 10.1001/archinte.165.2.227; Kobayashi M, 2010, AM J KIDNEY DIS, V56, P468, DOI 10.1053/j.ajkd.2010.03.018; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/306189; Ninomiya T, 2013, CONTRIB NEPHROL, V179, P58, DOI 10.1159/000346724; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Ou SM, 2013, KIDNEY INT, V84, P198, DOI 10.1038/ki.2013.79; Ovbiagele B, 2014, J STROKE CEREBROVASC, V23, P2265, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.016; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; The department of information services Executive Yuan R.O.C. (Taiwan), 2014, THE REPUBLIC OF CHIN; Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; van Exel E, 2002, STROKE, V33, P1135, DOI 10.1161/01.STR.0000014206.05597.9E; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Walberer M, 2014, BRAIN RES, V1581, P80, DOI 10.1016/j.brainres.2014.05.030; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Yu TM, 2014, NEUROLOGY, V83, P686, DOI 10.1212/WNL.0000000000000711; Yu YB, 2012, THROMB HAEMOSTASIS, V108, P225, DOI 10.1160/TH12-01-0010	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158533	10.1371/journal.pone.0158533	http://dx.doi.org/10.1371/journal.pone.0158533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355475	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400075
J	Ziegler, YS; Moresco, JJ; Yates, JR; Nardulli, AM				Ziegler, Yvonne S.; Moresco, James J.; Yates, John R., III; Nardulli, Ann M.			Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; 3 BINDING-PROTEIN; GROWTH-FACTOR; TUMOR-SUPPRESSOR; GENE-EXPRESSION; INCIDENCE RATES; LUNG-CANCER; CATHEPSIN-D; CELL-LINES; IN-VIVO	Cancer cells secrete factors that influence adjacent cell behavior and can lead to enhanced proliferation and metastasis. To better understand the role of these factors in oncogenesis and disease progression, estrogen and progesterone receptor positive MCF-7 cells, triple negative breast cancer MDA-MB-231, DT22, and DT28 cells, and MCF-10A non-transformed mammary epithelial cells were grown in 3D cultures. A special emphasis was placed on triple negative breast cancer since these tumors are highly aggressive and no targeted treatments are currently available. The breast cancer cells secreted factors of variable potency that stimulated proliferation of the relatively quiescent MCF-10A cells. The conditioned medium from each cell line was subjected to mass spectrometry analysis and a variety of secreted proteins were identified including glycolytic enzymes, proteases, protease inhibitors, extracellular matrix proteins, and insulin-like growth factor binding proteins. An investigation of the secretome from each cell line yielded clues about strategies used for breast cancer proliferation and metastasis. Some of the proteins we identified may be useful in the development of a serum-based test for breast cancer detection, diagnosis, prognosis, and monitoring.	[Ziegler, Yvonne S.; Nardulli, Ann M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute	Nardulli, AM (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.	anardull@life.illinois.edu		Moresco, James/0000-0003-1178-1642	National Institutes of Health: The National Institute of Diabetes and Digestive and Kidney Diseases [NIH R01 DK053884]; National Institute of General Medical Sciences [NIH P41 GM103533]	National Institutes of Health: The National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health: The National Institute of Diabetes and Digestive and Kidney Diseases NIH R01 DK053884, www.niddk.nih.gov, to AMN, and National Institute of General Medical Sciences NIH P41 GM103533, www.nigms.nih.gov, to JRY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiprik M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2116; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; Amon LM, 2012, CANCER RES, V72, P1935, DOI 10.1158/0008-5472.CAN-11-3266; Arteaga C L, 1991, Cancer Treat Res, V53, P289; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Buache E, 2011, ONCOGENE, V30, P3261, DOI 10.1038/onc.2011.41; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chan HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030397; Chang LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099254; Chang YF, 2011, ANAL CHEM, V83, P5324, DOI 10.1021/ac200754x; Chen D, 2011, CLIN CANCER RES, V17, P6693, DOI 10.1158/1078-0432.CCR-10-2774; Chignard N, 2006, GASTROENTEROLOGY, V130, P2010, DOI 10.1053/j.gastro.2006.02.058; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Curtis CD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-9; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Drews-Elger K, 2014, BREAST CANCER RES TR, V144, P503, DOI 10.1007/s10549-014-2887-9; Dunn BK, 2010, BREAST CANCER RES TR, V121, P281, DOI 10.1007/s10549-010-0827-x; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Fleming JM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-27; Garcia M, 1996, STEM CELLS, V14, P642, DOI 10.1002/stem.140642; Gaul DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16351; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gromov P, 2010, MOL ONCOL, V4, P65, DOI 10.1016/j.molonc.2009.11.003; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Henshall SM, 2006, J NATL CANCER I, V98, P1420, DOI 10.1093/jnci/djj378; Huang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069155; Huang SF, 2016, TUMOUR BIOL; Jin YX, 2016, BRIT J CANCER, V114, P532, DOI 10.1038/bjc.2015.348; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kim YJ, 2015, PROTEOMICS, V15, P3116, DOI 10.1002/pmic.201400382; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kraus TS, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-63; Laubli H, 2014, J BIOL CHEM, V289, P33481, DOI 10.1074/jbc.M114.593129; Lee EJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-7; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li BY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-239; Li LY, 2011, J CANCER, V2, P458, DOI 10.7150/jca.2.458; Li XQ, 2007, CANCER SCI, V98, P1592, DOI 10.1111/j.1349-7006.2007.00565.x; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Mosig RA, 2012, J OVARIAN RES, V5; MURPHY LC, 1987, CANCER RES, V47, P4160; Murthy SRK, 2010, CELL MOL NEUROBIOL, V30, P1377, DOI 10.1007/s10571-010-9592-y; Naderi A, 2015, ADV EXP MED BIOL, V846, P189, DOI 10.1007/978-3-319-12114-7_8; Nie S, 2014, J PROTEOME RES, V13, P1873, DOI 10.1021/pr400967x; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Olson OC, 2015, NAT REV CANCER, V15, P712, DOI 10.1038/nrc4027; Pandey V, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0429-3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parris TZ, 2014, INT J CANCER, V134, P1617, DOI 10.1002/ijc.28497; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Perez-Silva JG, 2016, NUCLEIC ACIDS RES, V44, pD351, DOI 10.1093/nar/gkv1201; Piccolo E, 2013, J MOL MED, V91, P83, DOI 10.1007/s00109-012-0936-6; Poon RT, 2004, CLIN CANCER RES, V10, P4150, DOI 10.1158/1078-0432.CCR-03-0435; Pranjol MZI, 2015, BIOMOLECULES, V5, P3260, DOI 10.3390/biom5043260; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Rehman I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030885; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Sartori DA, 2014, CURR OPIN ONCOL, V26, P259, DOI 10.1097/CCO.0000000000000065; Sato Y, 2015, J CLIN PATHOL, V68, P795, DOI 10.1136/jclinpath-2015-202987; Schneider D, 2002, BBA-MOL BASIS DIS, V1588, P1, DOI 10.1016/S0925-4439(02)00052-2; Sevenich L, 2014, GENE DEV, V28, P2331, DOI 10.1101/gad.250647.114; Shen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013133; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Stark A, 2010, CANCER-AM CANCER SOC, V116, P4926, DOI 10.1002/cncr.25276; Syed Rakashanda, 2012, Biotechnology and Molecular Biology Reviews, V7, P90; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang HY, 2012, J PROTEOME RES, V11, P678, DOI 10.1021/pr200603h; Tastekin D, 2014, TUMOR BIOL, V35, P6619, DOI 10.1007/s13277-014-1875-3; Tickner JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00127; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Tumminello FM, 2008, BIOMED PHARMACOTHER, V62, P130, DOI 10.1016/j.biopha.2007.07.001; Ueno K, 2011, INT J CANCER, V129, P2360, DOI 10.1002/ijc.25899; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024967; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Whelan SA, 2012, J PROTEOME RES, V11, P5034, DOI 10.1021/pr300606e; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu QW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-47; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59; Yip PY, 2011, PROSTATE, V71, P1638, DOI 10.1002/pros.21381; Yu H, 1998, CLIN CANCER RES, V4, P1489; Zhou ZQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-291; Zhu L, 2013, PROSTATE, V73, P219, DOI 10.1002/pros.22560; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Ziegler YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102341; Zong M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0619-0	110	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158296	10.1371/journal.pone.0158296	http://dx.doi.org/10.1371/journal.pone.0158296			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355404	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400046
J	Kritmetapak, K; Peerapornratana, S; Srisawat, N; Somlaw, N; Lakananurak, N; Dissayabutra, T; Phonork, C; Leelahavanichkul, A; Tiranathanagul, K; Susantithapong, P; Loaveeravat, P; Suwachittanont, N; Wirotwan, TO; Praditpornsilpa, K; Tungsanga, K; Eiam-Ong, S; Kittiskulnam, P				Kritmetapak, Kittrawee; Peerapornratana, Sadudee; Srisawat, Nattachai; Somlaw, Nicha; Lakananurak, Narisorn; Dissayabutra, Thasinas; Phonork, Chayanat; Leelahavanichkul, Asada; Tiranathanagul, Khajohn; Susantithapong, Paweena; Loaveeravat, Passisd; Suwachittanont, Nattachai; Wirotwan, Thaksa-on; Praditpornsilpa, Kearkiat; Tungsanga, Kriang; Eiam-Ong, Somchai; Kittiskulnam, Piyawan			The Impact of Macro-and Micronutrients on Predicting Outcomes of Critically Ill Patients Requiring Continuous Renal Replacement Therapy	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CONTINUOUS VENOVENOUS HEMODIAFILTRATION; LONG-TERM OUTCOMES; PROTEIN-INTAKE; IN-VITRO; ASSOCIATION; CLEARANCE; FAILURE; SUPPORT; BALANCE	Critically ill patients with acute kidney injury (AKI) who receive renal replacement therapy (RRT) have very high mortality rate. During RRT, there are markedly loss of macro- and micronutrients which may cause malnutrition and result in impaired renal recovery and patient survival. We aimed to examine the predictive role of macro- and micronutrients on survival and renal outcomes in critically ill patients undergoing continuous RRT (CRRT). This prospective observational study enrolled critically ill patients requiring CRRT at Intensive Care Unit of King Chulalongkorn Memorial Hospital from November 2012 until November 2013. The serum, urine, and effluent fluid were serially collected on the first three days to calculate protein metabolism including dietary protein intake (DPI), nitrogen balance, and normalized protein catabolic rate (nPCR). Serum zinc, selenium, and copper were measured for micronutrients analysis on the first three days of CRRT. Survivor was defined as being alive on day 28 after initiation of CRRT. Dialysis status on day 28 was also determined. Of the 70 critically ill patients requiring CRRT, 27 patients (37.5%) survived on day 28. The DPI and serum albumin of survivors were significantly higher than non-survivors (0.8 +/- 0.2 vs 0.5 +/- 0.3g/kg/day, p = 0.001, and 3.2 +/- 0.5 vs 2.9 +/- 0.5 g/dL, p = 0.03, respectively) while other markers were comparable. The DPI alone predicted patient survival with area under the curve (AUC) of 0.69. A combined clinical model predicted survival with AUC of 0.78. When adjusted for differences in albumin level, clinical severity score (APACHEII and SOFA score), and serum creatinine at initiation of CRRT, DPI still independently predicted survival (odds ratio 4.62, p = 0.009). The serum levels of micronutrients in both groups were comparable and unaltered following CRRT. Regarding renal outcome, patients in the dialysis independent group had higher serum albumin levels than the dialysis dependent group, p = 0.01. In conclusion, in critically ill patients requiring CRRT, DPI is a good predictor of patient survival while serum albumin is a good prognosticator of renal outcome.	[Kritmetapak, Kittrawee; Phonork, Chayanat] Konkaen Univ, Dept Med, Div Nephrol, Konkaen, Thailand; [Peerapornratana, Sadudee; Srisawat, Nattachai; Tiranathanagul, Khajohn; Susantithapong, Paweena; Loaveeravat, Passisd; Suwachittanont, Nattachai; Wirotwan, Thaksa-on; Praditpornsilpa, Kearkiat; Tungsanga, Kriang; Eiam-Ong, Somchai; Kittiskulnam, Piyawan] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Med, Div Nephrol, Bangkok, Thailand; [Somlaw, Nicha; Lakananurak, Narisorn] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Med, Div Clin Nutr, Bangkok, Thailand; [Dissayabutra, Thasinas] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Biochem, Bangkok, Thailand; [Leelahavanichkul, Asada] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Srisawat, N (corresponding author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Med, Div Nephrol, Bangkok, Thailand.	drnattachai@yahoo.com	Srisawat, Nattachai/I-3122-2019; Lakananurak, Narisorn/AAU-8566-2020; Praditpronsilpa, Kearkiat/AFT-5058-2022	Lakananurak, Narisorn/0000-0003-3166-0856; Srisawat, Nattachai/0000-0002-8544-8132	Ratchadapisek Sompoch Research Grant, Chulalongkorn University [RA57/037]; Ratchadapisek Sompoch Research Grant, Chulalongkorn University	Ratchadapisek Sompoch Research Grant, Chulalongkorn University; Ratchadapisek Sompoch Research Grant, Chulalongkorn University	This research was supported by the funding from the Ratchadapisek Sompoch Research Grant, Chulalongkorn University, grant number RA57/037.; We thank all the physicians, nurses, scientists and technicians participating in our study. This research was supported by the funding from the Ratchadapisek Sompoch Research Grant, Chulalongkorn University.	[Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Bach-Ngohou K, 2004, ANN BIOL CLIN-PARIS, V62, P395; Bellomo R, 1997, RENAL FAILURE, V19, P111, DOI 10.3109/08860229709026265; BELLOMO R, 1991, INTENS CARE MED, V17, P399, DOI 10.1007/BF01720677; Bellomo R, 2014, BLOOD PURIFICAT, V37, P325, DOI 10.1159/000363175; Berger MM, 2004, AM J CLIN NUTR, V80, P410, DOI 10.1093/ajcn/80.2.410; Biolo G, 2013, WORLD REV NUTR DIET, V105, P12, DOI 10.1159/000341545; CHIMA CS, 1993, J AM SOC NEPHROL, V3, P1516; Churchwell MD, 2007, NEPHROL DIAL TRANSPL, V22, P2970, DOI 10.1093/ndt/gfm352; DAVIES SP, 1991, CRIT CARE MED, V19, P1510, DOI 10.1097/00003246-199112000-00012; Fiaccadori E, 2008, J NEPHROL, V21, P645; FRANKENFIELD DC, 1993, JPEN-PARENTER ENTER, V17, P551, DOI 10.1177/0148607193017006551; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Leblanc M, 1998, AM J KIDNEY DIS, V32, P444, DOI 10.1053/ajkd.1998.v32.pm9740161; Li Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005426.pub2; Macias William L., 1996, Journal of Parenteral and Enteral Nutrition, V20, P56, DOI 10.1177/014860719602000156; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; Mokrzycki MH, 1996, J AM SOC NEPHROL, V7, P2259; Nakamura AT, 2004, J RENAL NUTR, V14, P214, DOI 10.1053/j.jrn.2004.07.001; Negi Shigeo, 2013, Nihon Jinzo Gakkai Shi, V55, P529; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pannu N, 2013, CLIN J AM SOC NEPHRO, V8, P194, DOI 10.2215/CJN.06480612; Pasko DA, 2009, PEDIATR NEPHROL, V24, P807, DOI 10.1007/s00467-008-1083-8; Plank LD, 2003, P NUTR SOC, V62, P545, DOI 10.1079/PNS2003259; Rech M, 2014, NUTR CLIN PRACT, V29, P78, DOI 10.1177/0884533613515724; Singer P, 2007, WIEN KLIN WOCHENSCHR, V119, P218, DOI 10.1007/s00508-007-0794-3; Wald R, 2014, CRIT CARE MED, V42, P868, DOI 10.1097/CCM.0000000000000042; Wooley Jennifer A, 2005, Nutr Clin Pract, V20, P176, DOI 10.1177/0115426505020002176	28	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0156634	10.1371/journal.pone.0156634	http://dx.doi.org/10.1371/journal.pone.0156634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352307	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900003
J	Lee, S; Yeo, IY; Sadeghi, AM; McCarty, GW; Hively, WD; Lang, MW				Lee, Sangchul; Yeo, In-Young; Sadeghi, Ali M.; McCarty, Gregory W.; Hively, W. Dean; Lang, Megan W.			Impacts of Watershed Characteristics and Crop Rotations on Winter Cover Crop Nitrate-Nitrogen Uptake Capacity within Agricultural Watersheds in the Chesapeake Bay Region	PLOS ONE			English	Article							NUTRIENT-UPTAKE EFFICIENCY; MODEL CALIBRATION; UNITED-STATES; SWAT MODEL; QUALITY; SIMULATION; SOIL; MINERALIZATION; RESIDUES; CORN	The adoption rate of winter cover crops (WCCs) as an effective conservation management practice to help reduce agricultural nutrient loads in the Chesapeake Bay (CB) is increasing. However, the WCC potential for water quality improvement has not been fully realized at the watershed scale. This study was conducted to evaluate the long-term impact of WCCs on hydrology and NO3-N loads in two adjacent watersheds and to identify key management factors that affect the effectiveness of WCCs using the Soil and Water Assessment Tool (SWAT) and statistical methods. Simulation results indicated that WCCs are effective for reducing NO3-N loads and their performance varied based on planting date, species, soil characteristics, and crop rotations. Early-planted WCCs outperformed late-planted WCCs on the reduction of NO3-N loads and early-planted rye (RE) reduced NO3-N loads by similar to 49.3% compared to the baseline (no WCC). The WCCs were more effective in a watershed dominated by well-drained soils with increased reductions in NO3-N fluxes of similar to 2.5 kg N.ha(-1) delivered to streams and similar to 10.1 kg N.ha(-1) leached into groundwater compared to poorly-drained soils. Well-drained agricultural lands had higher transport of NO3-N in the soil profile and groundwater due to increased N leaching. Poorly-drained agricultural lands had lower NO3-N due to extensive drainage ditches and anaerobic soil conditions promoting denitrification. The performance of WCCs varied by crop rotations (i.e., continuous corn and corn-soybean), with increased N uptake following soybean crops due to the increased soil mineral N availability by mineralization of soybean residue compared to corn residue. The WCCs can reduce N leaching where baseline NO3-N loads are high in well-drained soils and/or when residual and mineralized N availability is high due to the cropping practices. The findings suggested that WCC implementation plans should be established in watersheds according to local edaphic and agronomic characteristics for reducing N leaching.	[Lee, Sangchul; Yeo, In-Young; Lang, Megan W.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Yeo, In-Young] Univ Newcastle, Sch Engn, Callaghan, NSW, Australia; [Sadeghi, Ali M.] USDA ARS, Hydrol & Remote Sensing Lab, Beltsville, MD USA; [McCarty, Gregory W.; Hively, W. Dean] USGS, Eastern Geog Sci Ctr, Reston, VA USA	University System of Maryland; University of Maryland College Park; University of Newcastle; United States Department of Agriculture (USDA); United States Department of the Interior; United States Geological Survey	Yeo, IY (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.; Yeo, IY (corresponding author), Univ Newcastle, Sch Engn, Callaghan, NSW, Australia.	In-Young.Yeo@newcastle.edu.au	sadeghi, ali/AAV-8756-2020; Hively, Dean/AAK-3895-2020	Hively, Dean/0000-0002-5383-8064; Yeo, In-Young/0000-0001-5991-733X; Lang, Megan/0000-0002-2702-899X	National Aeronautics and Space Administration Land Cover and Land Use Change Program; United States Department of Agriculture Conservation Effects Assessment Project; U.S. Geological Survey Land Change Science Program; UMD Libraries Open Access Publishing Fund	National Aeronautics and Space Administration Land Cover and Land Use Change Program; United States Department of Agriculture Conservation Effects Assessment Project; U.S. Geological Survey Land Change Science Program; UMD Libraries Open Access Publishing Fund	This research was supported by National Aeronautics and Space Administration Land Cover and Land Use Change Program (http://lcluc.umd.edu/), United States Department of Agriculture Conservation Effects Assessment Project (http://www.nrcs.usda.gov/wps/portal/nrcs/main/national/technical/nra/ceap/), U.S. Geological Survey Land Change Science Program (http://www.usgs.gov/climate_landuse/lcs/), and the UMD Libraries Open Access Publishing Fund (http://www.lib.umd.edu/oa/openaccessfund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, CYCLES SOILS CARBON; Ator S.W., 2015, 1406 US GEOL SURV; Ator SW, 2012, J AM WATER RESOUR AS, V48, P1075, DOI 10.1111/j.1752-1688.2012.00672.x; Beeson PC, 2014, J ENVIRON QUAL, V43, P26, DOI 10.2134/jeq2012.0148; Boithias L, 2014, J ENVIRON QUAL, V43, P46, DOI 10.2134/jeq2011.0367; BRINSFIELD RB, 1991, COVER CROPS FOR CLEAN WATER, P79; Chesapeake Bay Program (CBP), ADD NEW COV CROP SPE; CHIANG S. L., 1971, Journal of Hydrology, V13, P54, DOI 10.1016/0022-1694(71)90200-9; Clark A., 2007, MANAGING COVER CROPS, V3rd ed.; Cohn T.A., 2004, TECHNIQUES METHODS; Dabney SM, 2001, COMMUN SOIL SCI PLAN, V32, P1221, DOI 10.1081/CSS-100104110; Denver J. M., 2004, WATER QUALITY DELMAR; Denver JM, 2010, J ENVIRON QUAL, V39, P154, DOI 10.2134/jeq2009.0107; Feyereisen GW, 2006, AGRON J, V98, P1416, DOI 10.2134/agronj2005.0134; Fisher T., 2010, CHOPTANK BASIN TRANS; Gentry LE, 2001, PLANT SOIL, V236, P175, DOI 10.1023/A:1012707617126; Gitau MW, 2010, WATER-SUI, V2, P849, DOI 10.3390/w2040849; Hively WD, 2009, J SOIL WATER CONSERV, V64, P303, DOI 10.2489/jswc.64.5.303; Jha MK, 2007, T ASABE, V50, P479, DOI 10.13031/2013.22660; Kaboneka S, 1997, COMMUN SOIL SCI PLAN, V28, P1359, DOI 10.1080/00103629709369880; Klocke NL, 1999, T ASAE, V42, P1621, DOI 10.13031/2013.13328; Larose M, 2007, J ENVIRON QUAL, V36, P521, DOI 10.2134/jeq2006.0154; Lee KY, 2000, BIOGEOCHEMISTRY, V49, P143, DOI 10.1023/A:1006375530844; Maryland Department of Agriculture (MDA), MAR 2014 2015 COV CR; McCarty GW, 2008, J SOIL WATER CONSERV, V63, P461, DOI 10.2489/jswc.63.6.461; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Neitsch S.L., 2011, SOIL WATER ASSESSMEN, DOI [10.1016/j.scitotenv.2015.11.063, DOI 10.1016/J.SCITOTENV.2015.11.063]; NRC, 2011, ACH NUTR SED RED GOA; Prabhakara K, 2015, INT J APPL EARTH OBS, V39, P88, DOI 10.1016/j.jag.2015.03.002; Qiu LJ, 2012, INT J SEDIMENT RES, V27, P226, DOI 10.1016/S1001-6279(12)60030-4; Sadeghi A., 2007, P 2007 ASABE ANN INT; Seo M, 2014, J ENVIRON QUAL, V43, P869, DOI 10.2134/jeq2013.11.0450; Singer J, COVER CROPS MIDWEST; Singh A, 2014, HYDROLOG SCI J, V59, P351, DOI 10.1080/02626667.2013.872787; SMITH SJ, 1990, AGRON J, V82, P112, DOI 10.2134/agronj1990.00021962008200010025x; STAVER K, 1989, 2 PAN ICID REG C DEN, P163; Ullrich A, 2010, ENVIRON MONIT ASSESS, V171, P513, DOI 10.1007/s10661-009-1296-8; Van Liew MW, 2007, J HYDROL ENG, V12, P173, DOI 10.1061/(ASCE)1084-0699(2007)12:2(173); Weed DAJ, 1996, J ENVIRON QUAL, V25, P709, DOI 10.2134/jeq1996.00472425002500040010x; Yeo IY, 2014, HYDROL EARTH SYST SC, V18, P5239, DOI 10.5194/hess-18-5239-2014	40	25	25	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157637	10.1371/journal.pone.0157637	http://dx.doi.org/10.1371/journal.pone.0157637			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352119	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900012
J	Cai, JH; Okamoto, M; Atieno, J; Sutton, T; Li, YL; Miklavcic, SJ				Cai, Jinhai; Okamoto, Mamoru; Atieno, Judith; Sutton, Tim; Li, Yongle; Miklavcic, Stanley J.			Quantifying the Onset and Progression of Plant Senescence by Color Image Analysis for High Throughput Applications	PLOS ONE			English	Article							LEAF SENESCENCE; SINGLE IMAGE; LEAVES; BARLEY; ROOTS; WHEAT; YIELD; NDVI	Leaf senescence, an indicator of plant age and ill health, is an important phenotypic trait for the assessment of a plant's response to stress. Manual inspection of senescence, however, is time consuming, inaccurate and subjective. In this paper we propose an objective evaluation of plant senescence by color image analysis for use in a high throughput plant phenotyping pipeline. As high throughput phenotyping platforms are designed to capture whole-of-plant features, camera lenses and camera settings are inappropriate for the capture of fine detail. Specifically, plant colors in images may not represent true plant colors, leading to errors in senescence estimation. Our algorithm features a color distortion correction and image restoration step prior to a senescence analysis. We apply our algorithm to two time series of images of wheat and chickpea plants to quantify the onset and progression of senescence. We compare our results with senescence scores resulting from manual inspection. We demonstrate that our procedure is able to process images in an automated way for an accurate estimation of plant senescence even from color distorted and blurred images obtained under high throughput conditions.	[Cai, Jinhai; Miklavcic, Stanley J.] Univ S Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5095, Australia; [Okamoto, Mamoru; Atieno, Judith; Li, Yongle] Univ Adelaide, Australian Ctr Plant Funct Genom, Urrbrae, SA 5064, Australia; [Sutton, Tim] South Australian Res & Dev Inst, 2b Hartley Grove, Urrbrae, SA 5064, Australia	University of South Australia; University of Adelaide; South Australian Research & Development Institute (SARDI)	Miklavcic, SJ (corresponding author), Univ S Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5095, Australia.	Stan.Miklavcic@unisa.edu.au	Sutton, Tim/ABC-8454-2020; Okamoto, Mamoru/AAF-4265-2019; Li, Yongle/G-3227-2017	Okamoto, Mamoru/0000-0002-2989-607X; Li, Yongle/0000-0003-3966-8596; Sutton, Timothy/0000-0002-9059-0774; Miklavcic, Stanley/0000-0002-2361-246X	Australian Research Council; Australian Grains Research and Development Corporation; South Australian Government; South Australian Government Department of Further Education, Employment, Science and Technology; Australia-India Strategic Research Fund; Australian Research Council Linkage Grant [LP140100347]; Department of Industry and Science, Australian Federal Government	Australian Research Council(Australian Research Council); Australian Grains Research and Development Corporation(Grains R&D Corp); South Australian Government; South Australian Government Department of Further Education, Employment, Science and Technology; Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council Linkage Grant(Australian Research Council); Department of Industry and Science, Australian Federal Government	The authors express their gratitude for partial funding provided by the Australian Research Council, the Australian Grains Research and Development Corporation, the South Australian Government, and the South Australian Government Department of Further Education, Employment, Science and Technology (http://www.sa.gov.au/) for partial support of JC, MO, YL and JA; and the Australia-India Strategic Research Fund, Department of Industry and Science, Australian Federal Government. Australian Research Council Linkage Grant # LP140100347 was received by SM and JC (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Drs Hamid Laga and Jason Connor from the University of South Australia, Associate Professor Qiongyan Li from Bejing Forest University and Dr. Bettina Berger from The Plant Accelerator at Adelaide University for many insightful discussions. Finally, we express our gratitude for partial funding provided by the Australian Research Council, the Australian Grains Research and Development Corporation, the South Australian Government, and the Australia-India Strategic Research Fund, Department of Industry and Science, Australian Federal Government.	Bergstrasser S, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0043-0; Cai JH, 2015, J EXP BOT, V66, P6551, DOI 10.1093/jxb/erv359; Campisi P., 2007, BLIND IMAGE DECONVOL; Can S, 1997, PLANT PHYSIOL, V113, P313; Di Bellat CM, 2004, INT J REMOTE SENS, V25, P5415, DOI 10.1080/01431160412331269724; Distelfeld A, 2014, J EXP BOT, V65, P3783, DOI 10.1093/jxb/ert477; Fergus R, 2006, ACM T GRAPHIC, V25, P787, DOI 10.1145/1141911.1141956; Furbank R. T., 2009, FUNCT PLANT BIOL, V36, P5; Gaju O, 2014, FIELD CROP RES, V155, P213, DOI 10.1016/j.fcr.2013.09.003; Gerlai R, 2002, TRENDS NEUROSCI, V25, P506, DOI 10.1016/S0166-2236(02)02250-6; Gregersen PL, 2014, BIOTECH AGR FOREST, V69, P113, DOI 10.1007/978-3-662-44406-1_7; Harris BN, 2010, PLANT SOIL, V336, P377, DOI 10.1007/s11104-010-0489-9; Kant S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116349; Kumar P, 2014, PLANT SOIL, V380, P193, DOI 10.1007/s11104-014-2071-3; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Maliro MFA, 2008, GENET RESOUR CROP EV, V55, P53, DOI 10.1007/s10722-007-9214-9; NICHOLSON SE, 1994, REMOTE SENS ENVIRON, V50, P107, DOI 10.1016/0034-4257(94)90038-8; Niklas KJ, 2002, AM NAT, V159, P482, DOI 10.1086/339459; Nishiyama M, 2011, IEEE T PATTERN ANAL, V33, P838, DOI 10.1109/TPAMI.2010.203; Romer C, 2012, FUNCT PLANT BIOL, V39, P878, DOI 10.1071/FP12060; Shan Q, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360672; Tai YW, 2009, IEEE IMAGE PROC, P1797, DOI 10.1109/ICIP.2009.5414620; Whyte O, 2012, INT J COMPUT VISION, V98, P168, DOI 10.1007/s11263-011-0502-7; Zhang L, 2006, ACM T GRAPHIC, V25, P907, DOI 10.1145/1141911.1141974; Zhu X, 2013, IEEE T IMAGE PROCESS, V22, P4879, DOI 10.1109/TIP.2013.2279316	25	22	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157102	10.1371/journal.pone.0157102	http://dx.doi.org/10.1371/journal.pone.0157102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348807	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000378801200005
J	Chen, WH; Niu, SX; Ma, X; Zhang, P; Gao, Y; Fan, Y; Pang, HG; Gong, HJ; Shen, DL; Gu, LY; Zhang, Y; Zhang, X				Chen, Weihao; Niu, Shaoxi; Ma, Xin; Zhang, Peng; Gao, Yu; Fan, Yang; Pang, Haigang; Gong, Huijie; Shen, Donglai; Gu, Liangyou; Zhang, Yu; Zhang, Xu			RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FARNESYLTRANSFERASE INHIBITORS; PROTEIN EXPRESSION; UP-REGULATION; LUNG-CANCER; RAS; INVASION; TRANSFORMATION; APOPTOSIS; SURVIVAL	This study aims to investigate the biological role of RhoB in clear cell renal cell carcinoma (ccRCC). The expression of RhoB was examined in specimens of patients and cell lines by Western blot and Immunohistochemistry. The correlation between RhoB expression and clinicopathologic variables was also analyzed. The effects of RhoB on cell proliferation, cell cycle, cell apoptosis, and invasion/migration were detected by over-expression and knockdown of RhoB level in ccRCC cells via plasmids and RNAi. The results showed that RhoB was low-expressed in ccRCC surgical specimens and cell lines compared with adjacent normal renal tissues and normal human renal proximal tubular epithelial cell lines (HKC), and its protein expression level was significantly associated with the tumor pathologic parameter embracing tumor size(P = 0.0157), pT stage(P = 0.0035), TNM stage(P = 0.0024) and Fuhrman tumor grade(P = 0.0008). Further, over-expression of RhoB remarkably inhibited the cancer cell proliferation, colony formation and promoted cancer cell apoptosis, and aslo reduced the invasion and migration ability of ccRCC cells. Interestingly, up-regulation of RhoB could induce cell cycle arrest in G2/M phase and led to cell cycle regulators(CyclineB1, CDK1) and pro-apoptotic protein(casp3, casp9) aberrant expression. Moreover, knockdown of RhoB in HKC cells promoted cell proliferation and migration. Taken together, our study indicates that RhoB expression is decreased in ccRCC carcinogenesis and progression. Up-regulation of RhoB significantly inhibits ccRCC cell malignant phenotype. These findings show that RhoB may play a tumor suppressive role in ccRCC cells, raising its potential value in futural therapeutic target for the patients of ccRCC.	[Chen, Weihao; Niu, Shaoxi; Ma, Xin; Zhang, Peng; Gao, Yu; Fan, Yang; Pang, Haigang; Gong, Huijie; Shen, Donglai; Gu, Liangyou; Zhang, Yu; Zhang, Xu] Chinese Peoples Liberat Army, Gen Hosp, Mil Postgrad Med Coll, State Key Lab Kidney Dis,Dept Urol, Beijing, Peoples R China; [Chen, Weihao] Gen Hosp Navy, Dept Urol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Sixth Medical Center of Chinese PLA General Hospital	Zhang, X (corresponding author), Chinese Peoples Liberat Army, Gen Hosp, Mil Postgrad Med Coll, State Key Lab Kidney Dis,Dept Urol, Beijing, Peoples R China.	xzhang@tjh.tjmu.edu.cn			National High Technology Research and Development Program of China [2014AA020607]; NGH Innovation Fostering Fund [CXPY201423]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NGH Innovation Fostering Fund	This work was supported by the National High Technology Research and Development Program of China (2014AA020607) to XM and NGH Innovation Fostering Fund (CXPY201423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnane J, 2002, CLIN CANCER RES, V8, P2225; Bastien L, 2009, BJU INT, V103, P1334, DOI 10.1111/j.1464-410X.2009.08454.x; Bellizzi A, 2008, INT J MOL MED, V22, P25; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Boone B, 2009, J CUTAN PATHOL, V36, P629, DOI 10.1111/j.1600-0560.2008.01117.x; Bousquet E, 2009, CANCER RES, V69, P6092, DOI 10.1158/0008-5472.CAN-08-4147; Calvayrac O, 2014, CLIN CANCER RES, V20, P6541, DOI 10.1158/1078-0432.CCR-14-0506; Campbell D, 2007, CLIN J AM SOC NEPHRO, V2, P211, DOI 10.2215/CJN.00300107; Chen YX, 2006, J STEROID BIOCHEM, V101, P179, DOI 10.1016/j.jsbmb.2006.06.030; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Hu TH, 2013, ONCOL REP, V30, P1707, DOI 10.3892/or.2013.2608; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Kamasani U, 2004, CANCER RES, V64, P8389, DOI 10.1158/0008-5472.CAN-04-2437; Kamasani U, 2003, CANCER BIOL THER, V2, P273; Karakiewicz PI, 2007, J CLIN ONCOL, V25, P1316, DOI 10.1200/JCO.2006.06.1218; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Kim BK, 2011, CARCINOGENESIS, V32, P254, DOI 10.1093/carcin/bgq244; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078417; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Marlow LA, 2009, CANCER RES, V69, P1536, DOI 10.1158/0008-5472.CAN-08-3718; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Prendergast GC, 2001, HISTOL HISTOPATHOL, V16, P269, DOI 10.14670/HH-16.269; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sato N, 2007, INT J CANCER, V120, P543, DOI 10.1002/ijc.22328; Vishnu P, 2012, GYNECOL ONCOL, V124, P589, DOI 10.1016/j.ygyno.2011.11.019; Wang DA, 2005, J BIOL CHEM, V280, P19243, DOI 10.1074/jbc.M411472200; ZALCMAN G, 1995, ONCOGENE, V10, P1935; Zhou JT, 2011, INT J CANCER, V128, P1057, DOI 10.1002/ijc.25445	40	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157599	10.1371/journal.pone.0157599	http://dx.doi.org/10.1371/journal.pone.0157599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384222	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400016
J	Clayton, KK; Swaminathan, J; Yazdanbakhsh, A; Zuk, J; Patel, AD; Kidd, G				Clayton, Kameron K.; Swaminathan, Jayaganesh; Yazdanbakhsh, Arash; Zuk, Jennifer; Patel, Aniruddh D.; Kidd, Gerald, Jr.			Executive Function, Visual Attention and the Cocktail Party Problem in Musicians and Non-Musicians	PLOS ONE			English	Article							MULTIPLE-OBJECT TRACKING; CONCURRENT SOUND SEGREGATION; VIDEO GAME PLAYERS; SHORT-TERM-MEMORY; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; INFORMATIONAL MASKING; SPEECH RECOGNITION; MUSICAL EXPERTISE; TARGET TRACKING	The goal of this study was to investigate how cognitive factors influence performance in a multi-talker, "cocktail-party" like environment in musicians and non-musicians. This was achieved by relating performance in a spatial hearing task to cognitive processing abilities assessed using measures of executive function (EF) and visual attention in musicians and non-musicians. For the spatial hearing task, a speech target was presented simultaneously with two intelligible speech maskers that were either colocated with the target (0 degrees azimuth) or were symmetrically separated from the target in azimuth (at +/- 15 degrees). EF assessment included measures of cognitive flexibility, inhibition control and auditory working memory. Selective attention was assessed in the visual domain using a multiple object tracking task (MOT). For the MOT task, the observers were required to track target dots (n = 1,2,3,4,5) in the presence of interfering distractor dots. Musicians performed significantly better than non-musicians in the spatial hearing task. For the EF measures, musicians showed better performance on measures of auditory working memory compared to non-musicians. Furthermore, across all individuals, a significant correlation was observed between performance on the spatial hearing task and measures of auditory working memory. This result suggests that individual differences in performance in a cocktail party-like environment may depend in part on cognitive factors such as auditory working memory. Performance in the MOT task did not differ between groups. However, across all individuals, a significant correlation was found between performance in the MOT and spatial hearing tasks. A stepwise multiple regression analysis revealed that musicianship and performance on the MOT task significantly predicted performance on the spatial hearing task. Overall, these findings confirm the relationship between musicianship and cognitive factors including domain-general selective attention and working memory in solving the "cocktail party problem".	[Clayton, Kameron K.; Swaminathan, Jayaganesh; Kidd, Gerald, Jr.] Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA; [Yazdanbakhsh, Arash] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Yazdanbakhsh, Arash] Boston Univ, Ctr Computat Neurosci & Neural Technol CompNet, Boston, MA 02215 USA; [Zuk, Jennifer] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Patel, Aniruddh D.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Boston University; Boston University; Boston University; Harvard University; Harvard Medical School; Tufts University	Swaminathan, J (corresponding author), Boston Univ, Dept Speech Language & Hearing Sci, Boston, MA 02215 USA.	jswamy@bu.edu		Zuk, Jennifer/0000-0001-9113-3973	National Institutes of Health [R01-DC004545, P30-DC004663]; Air Force Office of Scientific Research [FA9550-12-1-0171]; Office of naval Research [ONR N00014-11-1-0535]; Center of Excellence for Learning in Education, Science and Technology; Boston University; NIH-NIDCD [R01-DC04545, P30-DC04663]; AFOSR grant [FA9550-12-1-0171]; CELEST (NSF) [SBE-0354378]; Undergraduate Program in Neuroscience; NSF [SBE-0354378]; Undergraduate Research Opportunities Program (UROP); Funded Research Opportunity Grant (FROG); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004663, R01DC004545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of naval Research(Office of Naval Research); Center of Excellence for Learning in Education, Science and Technology; Boston University; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); AFOSR grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); CELEST (NSF); Undergraduate Program in Neuroscience; NSF(National Science Foundation (NSF)); Undergraduate Research Opportunities Program (UROP); Funded Research Opportunity Grant (FROG); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by National Institutes of Health, grants R01-DC004545, P30-DC004663 (http://www.nih.gov/), Air Force Office of Scientific Research, grant FA9550-12-1-0171 (http://www.wpafb.af.mil/afrl/afosr/), Office of naval Research, grant ONR N00014-11-1-0535 (http://www.onr.navy.mil/), Center of Excellence for Learning in Education, Science and Technology, grant NSF SBE-0354378 (http://celest.bu.edu/), and Boston University, Undergraduate Research Opportunities Program (UROP), Funded Research Opportunity Grant (FROG) (http://www.bu.edu/urop/apply/funding/).; Research supported by NIH-NIDCD grants R01-DC04545, P30-DC04663, AFOSR grant FA9550-12-1-0171, Office of Naval Research (ONR N00014-11-1-0535), CELEST (NSF SBE-0354378), Boston University UROP FROG supplies grant, and from the Undergraduate Program in Neuroscience for the summer of 2014. Part of this work was submitted as undergraduate thesis for honors in neuroscience at Boston University by the first author. We thank Jeremy Wolfe and Todd Horowitz for providing the MATLAB scripts for the Multiple Object Tracking task. We that Alexander Queen for help with statistical analysis. We thank Christine Mason, Virginia Best, Elin Roverud and Timothy Streeter for helpful comments and discussions. We thank David Somers for discussion about the visual attention experiment in our study.	Allen R, 2006, Q J EXP PSYCHOL, V59, P1101, DOI 10.1080/02724980543000097; Allen R, 2004, APPL COGNITIVE PSYCH, V18, P337, DOI 10.1002/acp.975; Amer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071630; Baskent D, 2016, J ACOUST SOC AM, V139, pEL51, DOI 10.1121/1.4942628; BERZ WL, 1995, MUSIC PERCEPT, V12, P353; Besser J, 2013, TRENDS AMPLIF, V17, P75, DOI 10.1177/1084713813495459; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Bidelman GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060676; Boebinger D, 2015, J ACOUST SOC AM, V137, P378, DOI 10.1121/1.4904537; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brochard R, 2004, BRAIN COGNITION, V54, P103, DOI 10.1016/S0278-2626(03)00264-1; Brungart DS, 2001, J ACOUST SOC AM, V109, P1101, DOI 10.1121/1.1345696; Bugos JA, 2007, AGING MENT HEALTH, V11, P464, DOI 10.1080/13607860601086504; Carlile S, 2015, CURR BIOL, V25, pR757, DOI 10.1016/j.cub.2015.07.064; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Dege F, 2011, MUSIC PERCEPT, V29, P195, DOI 10.1525/MP.2011.29.2.195; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Dobrowolski P, 2015, COMPUT HUM BEHAV, V44, P59, DOI 10.1016/j.chb.2014.11.051; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Freyman RL, 1999, J ACOUST SOC AM, V106, P3578, DOI 10.1121/1.428211; Fuller CD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00179; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; George EM, 2011, NEUROPSYCHOLOGIA, V49, P1083, DOI 10.1016/j.neuropsychologia.2011.02.001; Gerton BK, 2004, NEUROPSYCHOLOGIA, V42, P1781, DOI 10.1016/j.neuropsychologia.2004.04.023; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Hyde KL, 2009, ANN NY ACAD SCI, V1169, P182, DOI 10.1111/j.1749-6632.2009.04852.x; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Kidd Gerald Jr., 2008, V29, P143; Kidd G, 2010, J ACOUST SOC AM, V128, P1965, DOI 10.1121/1.3478781; Marrone N, 2008, J ACOUST SOC AM, V124, P1146, DOI 10.1121/1.2945710; Martens S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118294; Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Moreno S, 2014, HEARING RES, V308, P84, DOI 10.1016/j.heares.2013.09.012; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oxenham AJ, 2003, J ACOUST SOC AM, V114, P1543, DOI 10.1121/1.1598197; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Patel AD, 2014, HEARING RES, V308, P98, DOI 10.1016/j.heares.2013.08.011; Pietsch S, 2012, LEARN INDIVID DIFFER, V22, P159, DOI 10.1016/j.lindif.2011.11.012; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rodrigues AC, 2013, BRAIN COGNITION, V82, P229, DOI 10.1016/j.bandc.2013.04.009; Ruggles DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086980; Schellenberg EG, 2008, TRENDS COGN SCI, V12, P45, DOI 10.1016/j.tics.2007.11.005; Schellenberg EG, 2011, BRIT J PSYCHOL, V102, P283, DOI 10.1111/j.2044-8295.2010.02000.x; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; Schlaug G, 2015, PROG BRAIN RES, V217, P37, DOI 10.1016/bs.pbr.2014.11.020; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Sorqvist P, 2012, J SPEECH LANG HEAR R, V55, P210, DOI 10.1044/1092-4388(2011/10-0353); Souza PE, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00526; St Clair-Thompson HL, 2013, MEM COGNITION, V41, P519, DOI 10.3758/s13421-012-0277-2; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Swaminathan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11628; Trick LM, 2012, ATTEN PERCEPT PSYCHO, V74, P300, DOI 10.3758/s13414-011-0235-2; Wechsler D, 2011, PSYCHOL C WASI 2 WEC; Wechsler D., 2012, WAIS 4 KASIKIRJA; Weiss AH, 2014, J VISION, V14, DOI 10.1167/14.9.18; Wild CJ, 2012, J NEUROSCI, V32, P14010, DOI 10.1523/JNEUROSCI.1528-12.2012; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Zekveld AA, 2014, PSYCHOPHYSIOLOGY, V51, P277, DOI 10.1111/psyp.12151; Zendel BR, 2013, J COGNITIVE NEUROSCI, V25, P503, DOI 10.1162/jocn_a_00329; Zendel BR, 2009, J COGNITIVE NEUROSCI, V21, P1488, DOI 10.1162/jocn.2009.21140; Zuk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099868	70	49	49	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157638	10.1371/journal.pone.0157638	http://dx.doi.org/10.1371/journal.pone.0157638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27384330	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400017
J	Lin, PC; Yang, YF; Tyan, YC; Hsiao, ESL; Chu, PC; Lee, CT; Lee, JC; Chen, YMA; Liao, PC				Lin, Peng-Chan; Yang, Yi-Fang; Tyan, Yu-Chang; Hsiao, Eric S. L.; Chu, Po-Chen; Lee, Chung-Ta; Lee, Jenq-Chang; Chen, Yi-Ming Arthur; Liao, Pao-Chi			Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses	PLOS ONE			English	Article							CELL-CYCLE; MASS-SPECTROMETRY; PHOSPHOPEPTIDE ENRICHMENT; CARCINOEMBRYONIC ANTIGEN; MEMBRANE-PROTEINS; WEE1 KINASE; IN-VIVO; PROGNOSIS; PHOSPHOPROTEOMICS; CHROMATOGRAPHY	Colorectal cancer is the most common form of cancer in the world, and the five-year survival rate is estimated to be almost 90% in the early stages. Therefore, the identification of potential biomarkers to assess the prognosis of early stage colorectal cancer patients is critical for further clinical treatment. Dysregulated tyrosine phosphorylation has been found in several diseases that play a significant regulator of signaling in cellular pathways. In this study, this strategy was used to characterize the tyrosine phosphoproteome of colorectal cell lines with different progression abilities (SW480 and SW620). We identified a total of 280 phosphotyrosine (pTyr) peptides comprising 287 pTyr sites from 261 proteins. Label-free quantitative analysis revealed the differential level of a total of 103 pTyr peptides between SW480 and SW620 cells. We showed that cyclin-dependent kinase I (CDK1) pTyr15 level in SW480 cells was 3.3-fold greater than in SW620 cells, and these data corresponded with the label-free mass spectrometry-based proteomic quantification analysis. High level CDK1 pTyr15 was associated with prolonged disease-free survival for stage II colorectal cancer patients (n = 79). Taken together, our results suggest that the CDK1 pTyr15 protein is a potential indicator of the progression of colorectal cancer.	[Lin, Peng-Chan] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Yang, Yi-Fang; Hsiao, Eric S. L.; Liao, Pao-Chi] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Tyan, Yu-Chang; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Tyan, Yu-Chang; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chu, Po-Chen] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Lee, Chung-Ta] Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan, Taiwan; [Lee, Jenq-Chang] Natl Cheng Kung Univ, Coll Med, Dept Surg, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Liao, PC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan.	liaopc@mail.ncku.edu.tw			National Cheng Kung University, Taiwan [NCKUH-10105014]; Ministry of Science and Technology, Taiwan (MOST) [103-2811-M-006-021, 103-2113-M-006-003-MY3, 100-2113-M-006-002-MY3, 102-2352-B-006-003]; National Science Council, Taiwan (NSC) [99-2923-M-006-001]; Kaohsiung Medical University; Aim for the Top 500 Universities grant; Aim for the Top Universities Grant [KMU-TP104E12]	National Cheng Kung University, Taiwan; Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; Aim for the Top 500 Universities grant; Aim for the Top Universities Grant	This study was supported by grants from the National Cheng Kung University, Taiwan (NCKUH-10105014); the Ministry of Science and Technology, Taiwan (MOST 103-2811-M-006-021, 103-2113-M-006-003-MY3, 100-2113-M-006-002-MY3, 102-2352-B-006-003); the National Science Council, Taiwan (NSC 99-2923-M-006-001); and Kaohsiung Medical University, Aim for the Top 500 Universities grant and Aim for the Top Universities Grant, No. KMU-TP104E12.; The authors thank the Tissue Bank of National Cheng Kung University Hospital for providing tissue samples. This study was supported by grants from the National Cheng Kung University, Taiwan (NCKUH-10105014), the Ministry of Science and Technology, Taiwan(MOST103-2811-M-006-021, 103-2113-M-006-003-MY3, 100-2113-M-006-002-MY3, 102-2352-B-006-003), the National Science Council, Taiwan (NSC 99-2923-M-006-001), Kaohsiung Medical University, Aim for the Top 500 Universities grant and Aim for the Top Universities Grant, No. KMU-TP104E12.	Aggarwal C, 2013, ANN ONCOL, V24, P420, DOI 10.1093/annonc/mds336; Barascu A, 2006, INT J BIOCHEM CELL B, V38, P196, DOI 10.1016/j.biocel.2005.08.015; Bellew M, 2006, BIOINFORMATICS, V22, P1902, DOI 10.1093/bioinformatics/btl276; Bianco C, 2006, CLIN CANCER RES, V12, P5158, DOI 10.1158/1078-0432.CCR-06-0274; Blacken GR, 2007, ANAL CHEM, V79, P5449, DOI 10.1021/ac070790w; Boersema PJ, 2010, MOL CELL PROTEOMICS, V9, P84, DOI 10.1074/mcp.M900291-MCP200; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Chiu KH, 2011, J PROTEOME RES, V10, P1110, DOI 10.1021/pr1008724; COHEN AM, 1991, CANCER, V67, P1859, DOI 10.1002/1097-0142(19910401)67:7<1859::AID-CNCR2820670707>3.0.CO;2-A; Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538; Duffy MJ, 2001, CLIN CHEM, V47, P624; Fauzee NJS, 2012, PATHOL ONCOL RES, V18, P191, DOI 10.1007/s12253-011-9428-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GIBBS JB, 1994, CELL, V79, P193, DOI 10.1016/0092-8674(94)90189-9; Gilmore JM, 2012, ANAL BIOANAL CHEM, V402, P711, DOI 10.1007/s00216-011-5466-5; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Hashimoto O, 2003, MOL CARCINOGEN, V36, P171, DOI 10.1002/mc.10111; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Henriksson ML, 2011, AM J PATHOL, V178, P1387, DOI 10.1016/j.ajpath.2010.12.008; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Imanishi SY, 2007, MOL CELL PROTEOMICS, V6, P1380, DOI 10.1074/mcp.M600480-MCP200; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Kettenbach AN, 2011, ANAL CHEM, V83, P7635, DOI 10.1021/ac201894j; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li J, 2002, RADIAT RES, V157, P322, DOI 10.1667/0033-7587(2002)157[0322:WTTIGP]2.0.CO;2; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Marcantonio M, 2008, MOL CELL PROTEOMICS, V7, P645, DOI 10.1074/mcp.M700383-MCP200; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; McKinley ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080207; McLeod HL, 1999, BRIT J CANCER, V79, P191, DOI 10.1038/sj.bjc.6690033; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; MOERTEL CG, 1986, CANCER, V58, P603, DOI 10.1002/1097-0142(19860801)58:3<603::AID-CNCR2820580302>3.0.CO;2-K; Montoya A, 2011, METHODS, V54, P370, DOI 10.1016/j.ymeth.2011.02.004; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Nita-Lazar A, 2008, PROTEOMICS, V8, P4433, DOI 10.1002/pmic.200800231; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Potapova TA, 2009, MOL BIOL CELL, V20, P1737, DOI 10.1091/mbc.E08-07-0771; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; Sugimoto K, 2013, DIGEST SURG, V30, P368, DOI 10.1159/000355444; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Sung WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-951; Suzuki O, 2006, J AM COLL SURGEONS, V202, P732, DOI 10.1016/j.jamcollsurg.2006.02.007; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Wang MC, 2015, ANAL BIOANAL CHEM, V407, P1343, DOI 10.1007/s00216-014-8352-0; Wang YL, 2001, CANCER RES, V61, P8211; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Welburn JPI, 2007, J BIOL CHEM, V282, P3173, DOI 10.1074/jbc.M609151200; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Wu HY, 2007, J PROTEOME RES, V6, P1812, DOI 10.1021/pr060631d; Wu HY, 2010, J PROTEOME RES, V9, P4102, DOI 10.1021/pr1006153; Wu HY, 2009, ANAL CHEM, V81, P7778, DOI 10.1021/ac9013435; Yang TH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S10; Zeestraten ECM, 2012, BRIT J CANCER, V106, P133, DOI 10.1038/bjc.2011.504	65	5	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158844	10.1371/journal.pone.0158844	http://dx.doi.org/10.1371/journal.pone.0158844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383761	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400089
J	Martino, S; Jamme, M; Deligny, C; Busson, M; Loiseau, P; Azoulay, E; Galicier, L; Pene, F; Provot, F; Dossier, A; Saheb, S; Veyradier, A; Coppo, P				Martino, Suella; Jamme, Mathieu; Deligny, Christophe; Busson, Marc; Loiseau, Pascale; Azoulay, Elie; Galicier, Lionel; Pene, Frederic; Provot, Francois; Dossier, Antoine; Saheb, Samir; Veyradier, Agnes; Coppo, Paul		French Reference Ctr Thrombotic Mi	Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; SEVERE ADAMTS13 DEFICIENCY; MICROANGIOPATHIES REFERENCE CENTER; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISPARITIES; EXPERIENCE; ASSOCIATION; INVOLVEMENT; RITUXIMAB; DIAGNOSIS	Black people are at increased risk of thrombotic thrombocytopenic purpura (TTP). Whether clinical presentation of TTP in Black patients has specific features is unknown. We assessed here differences in TTP presentation and outcome between Black and White patients. Clinical presentation was comparable between both ethnic groups. However, prognosis differed with a lower death rate in Black patients than in White patients (2.7% versus 11.6%, respectively, P = .04). Ethnicity, increasing age and neurologic involvement were retained as risk factors for death in a multivariable model (P < .05 all). Sixty-day overall survival estimated by the Kaplan-Meier curves and compared with the Log-Rank test confirmed that Black patients had a better survival than White patients (P = .03). Salvage therapies were similarly performed between both groups, suggesting that disease severity was comparable. The comparison of HLA-DRB1*11, -DRB1*04 and -DQB1*03 allele frequencies between Black patients and healthy Black individuals revealed no significant difference. However, the protective allele against TTP, HLA-DRB1*04, was dramatically decreased in Black individuals in comparison with White individuals. Black people with TTP may have a better survival than White patients despite a comparable disease severity. A low natural frequency of HLA-DRB1*04 in Black ethnicity may account for the greater risk of TTP in this population.	[Martino, Suella; Coppo, Paul] Hop St Antoine, AP HP, Serv Hematol, Paris, France; [Martino, Suella; Jamme, Mathieu; Azoulay, Elie; Galicier, Lionel; Pene, Frederic; Provot, Francois; Dossier, Antoine; Saheb, Samir; Veyradier, Agnes; Coppo, Paul] Hop St Antoine, AP HP, Ctr Reference Microangiopathies Thrombot, Paris, France; [Martino, Suella; Jamme, Mathieu; Azoulay, Elie; Galicier, Lionel; Pene, Frederic; Provot, Francois; Dossier, Antoine; Saheb, Samir; Veyradier, Agnes; Coppo, Paul] Univ Paris 06, Paris, France; [Deligny, Christophe] CHU Ft de France, Serv Med Interne, Fort De France, Martinique, France; [Busson, Marc; Loiseau, Pascale] Hop St Louis, Sorbonne Paris Cite, Lab Jean Dausset Immunol & Histocompatibilite, AP HP, Paris, France; [Busson, Marc; Loiseau, Pascale] Hop St Louis, Sorbonne Paris Cite, INSERM, UMRS 1160, Paris, France; [Azoulay, Elie; Galicier, Lionel; Veyradier, Agnes] Univ Paris Diderot, Paris, France; [Azoulay, Elie] Hop St Louis, AP HP, Serv Reanimat Med, Paris, France; [Galicier, Lionel] Hop St Louis, AP HP, Serv Immunol Clin, Paris, France; [Pene, Frederic] Hop Cochin, AP HP, Serv Reanimat Med, Paris, France; [Pene, Frederic] Univ Paris 05, Paris, France; [Provot, Francois] Hop Albert Calmette, Serv Nephrol, Lille, France; [Dossier, Antoine] Hop Bichat Claude Bernard, AP HP, Serv Med Interne, Paris, France; [Saheb, Samir] Hop La Pitie Salpetriere, Serv Med Interne 1, Paris, France; [Veyradier, Agnes] Hop Lariboisiere, AP HP, Serv Hematol Biol, Paris, France; [Coppo, Paul] Univ Paris 06, Sorbonne Univ, Paris, France; [Coppo, Paul] Inst Gustave Roussy, INSERM, U1009, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; CHU Martinique; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Coppo, P (corresponding author), Hop St Antoine, AP HP, Serv Hematol, Paris, France.; Coppo, P (corresponding author), Hop St Antoine, AP HP, Ctr Reference Microangiopathies Thrombot, Paris, France.; Coppo, P (corresponding author), Univ Paris 06, Paris, France.; Coppo, P (corresponding author), Univ Paris 06, Sorbonne Univ, Paris, France.; Coppo, P (corresponding author), Inst Gustave Roussy, INSERM, U1009, Villejuif, France.	paul.coppo@aphp.fr	Dossier, Antoine/AGG-9850-2022; Herbrecht, Raoul/AAT-1763-2021	Herbrecht, Raoul/0000-0002-9381-4876; Stepanian, Alain/0000-0002-2942-0901; Saheb, Samir/0000-0002-7764-6016; Pene, Frederic/0000-0003-3639-3849				Benhamou Y, 2015, J THROMB HAEMOST, V13, P293, DOI 10.1111/jth.12790; Benhamou Y, 2012, HAEMATOL-HEMATOL J, V97, P1181, DOI 10.3324/haematol.2011.049676; Cataland SR, 2009, EUR J HAEMATOL, V83, P559, DOI 10.1111/j.1600-0609.2009.01331.x; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Coppo P, 2010, J THROMB HAEMOST, V8, P856, DOI 10.1111/j.1538-7836.2010.03772.x; Coppo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010208; Ferrari S, 2007, BLOOD, V109, P2815, DOI 10.1182/blood-2006-02-006064; Franchini M, 2008, BLOOD TRANSFUS-ITALY, V6, P127, DOI 10.2450/2008.0055-07; Froissart A, 2012, CRIT CARE MED, V40, P104, DOI 10.1097/CCM.0b013e31822e9d66; Greenberg AJ, 2012, LEUKEMIA, V26, P609, DOI 10.1038/leu.2011.368; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; Hughes C, 2009, J THROMB HAEMOST, V7, P529, DOI 10.1111/j.1538-7836.2009.03285.x; John ML, 2012, ANN HEMATOL, V91, P507, DOI 10.1007/s00277-011-1384-z; JOSEPH G, 1994, AM J HEMATOL, V47, P189, DOI 10.1002/ajh.2830470308; Klaus C, 2004, BLOOD, V103, P4514, DOI 10.1182/blood-2003-12-4165; Miller CH, 2003, J THROMB HAEMOST, V1, P2191, DOI 10.1046/j.1538-7836.2003.00367.x; Molokhia M, 2003, HUM GENET, V112, P310, DOI 10.1007/s00439-002-0883-3; Molokhia M, 2001, LANCET, V357, P1414, DOI 10.1016/S0140-6736(00)04580-3; Rhew EY, 2009, TRANSL RES, V153, P51, DOI 10.1016/j.trsl.2008.11.006; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Scully M, 2010, J THROMB HAEMOST, V8, P257, DOI 10.1111/j.1538-7836.2009.03692.x; Scully M, 2008, BRIT J HAEMATOL, V142, P819, DOI 10.1111/j.1365-2141.2008.07276.x; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x; Scully M, 2011, BLOOD, V118, P1746, DOI 10.1182/blood-2011-03-341131; Terrell DR, 2010, AM J HEMATOL, V85, P844, DOI 10.1002/ajh.21833; Tersteeg C, 2014, CIRCULATION, V129, P1320, DOI 10.1161/CIRCULATIONAHA.113.006727; van den Born BJH, 2006, J HYPERTENS, V24, P2299, DOI 10.1097/01.hjh.0000249710.21146.38; Wohner N, 2012, THROMB RES, V129, pE41, DOI 10.1016/j.thromres.2011.11.021	28	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156679	10.1371/journal.pone.0156679	http://dx.doi.org/10.1371/journal.pone.0156679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383202	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400006
J	Fratini, S; Ragionieri, L; Cannicci, S				Fratini, Sara; Ragionieri, Lapo; Cannicci, Stefano			Demographic History and Reproductive Output Correlates with Intraspecific Genetic Variation in Seven Species of Indo-Pacific Mangrove Crabs	PLOS ONE			English	Article							PERISESARMA-GUTTATUM BRACHYURA; SCYLLA-SERRATA CRUSTACEA; POPULATION-STRUCTURE; INHACA ISLAND; ADAPTIVE SIGNIFICANCE; DECAPOD CRUSTACEANS; SEQUENCE DIVERSITY; LAND CRAB; SAR-UANLE; MITOCHONDRIAL	The spatial distribution and the amount of intraspecific genetic variation of marine organisms are strongly influenced by many biotic and abiotic factors. Comparing biological and genetic data characterizing species living in the same habitat can help to elucidate the processes driving these variation patterns. Here, we present a comparative multispecies population genetic study on seven mangrove crabs co-occurring in the West Indian Ocean characterized by planktotrophic larvae with similar pelagic larval duration. Our main aim was to investigate whether a suite of biological, behavioural and ecological traits could affect genetic diversities of the study species in combination with historical demographic parameters. As possible current explanatory factors, we used the intertidal micro-habitat colonised by adult populations, various parameters of individual and population fecundity, and the timing of larval release. As the genetic marker, we used partial sequences of cytochrome oxidase subunit I gene. Genetic and ecological data were collected by the authors and/or gathered from primary literature. Permutational multiple regression models and ANOVA tests showed that species density and their reproductive output in combination with historical demographic parameters could explain the intraspecific genetic variation indexes across the seven species. In particular, species producing consistently less eggs per spawning event showed higher values of haplotype diversity. Moreover, Tajima's D parameters well explained the recorded values for haplotype diversity and average gamma st. We concluded that current intraspecific gene diversities in crabs inhabiting mangrove forests were affected by population fecundity as well as past demographic history. The results were also discussed in terms of management and conservation of fauna in the Western Indian Ocean mangroves.	[Fratini, Sara; Cannicci, Stefano] Univ Florence, Dept Biol, Florence, Italy; [Ragionieri, Lapo] Univ Cologne, Inst Zool, Funct Peptid, Cologne, Germany; [Cannicci, Stefano] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China; [Cannicci, Stefano] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	University of Florence; University of Cologne; University of Hong Kong; University of Hong Kong	Fratini, S (corresponding author), Univ Florence, Dept Biol, Florence, Italy.	sarafratini@unifi.it	Cannicci, Stefano/N-8512-2019	Cannicci, Stefano/0000-0002-6544-0213; Fratini, Sara/0000-0002-5754-8830; Ragionieri, Lapo/0000-0003-0099-2719	FIRB project (Italian MIUR) [RBAU01H5C3_001]; PUMPSEA project; Cannicci ex 60% project (Italian MIUR); 6th Framework Program of the EC [INCO-CT2004-510863]	FIRB project (Italian MIUR)(Ministry of Education, Universities and Research (MIUR)); PUMPSEA project; Cannicci ex 60% project (Italian MIUR)(Ministry of Education, Universities and Research (MIUR)); 6th Framework Program of the EC(European Commission)	Support was provided by FIRB project (Italian MIUR), no RBAU01H5C3_001, PUMPSEA project, 6th Framework Program of the EC, INCO-CT2004-510863, and Cannicci ex 60% project (Italian MIUR).	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arndt A, 1998, MOL ECOL, V7, P1053, DOI 10.1046/j.1365-294x.1998.00429.x; Avise J, 2004, MOL MARKERS NATURAL; Avise JC, 2000, PHYLOGEOGRAPHY HIST; Barber PH, 2006, EVOLUTION, V60, P1825; Bartolini F, 2011, MAR ENVIRON RES, V71, P53, DOI 10.1016/j.marenvres.2010.10.002; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; BRICK RW, 1974, AQUACULTURE, V3, P231, DOI 10.1016/0044-8486(74)90074-X; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Cannicci S, 2008, AQUAT BOT, V89, P186, DOI 10.1016/j.aquabot.2008.01.009; Cannicci S, 2011, MAR ECOL PROG SER, V430, P121, DOI 10.3354/meps08954; Cannicci S, 2009, ESTUAR COAST SHELF S, V84, P305, DOI 10.1016/j.ecss.2009.04.021; Carvalho GR, 1998, ITAL J ZOOL, V65, P21, DOI 10.1080/11250009809386791; Chen T., 2012, THESIS; Christy JH, 2011, INTEGR COMP BIOL, V51, P62, DOI 10.1093/icb/icr013; Clarke KR, 2006, PRIMER V 6 USER MANU; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; Collin R, 2001, MOL ECOL, V10, P2249, DOI 10.1046/j.1365-294X.2001.01372.x; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; Crisp D.J., 1978, NATO Conference Series IV Marine Sciences, V2, P257; Dahdouh-Guebas F, 1999, B MAR SCI, V64, P291; Dahdouh-Guebas F., 2002, Wetlands Ecology and Management, V10, P179, DOI 10.1023/A:1020133110407; Davis JA, 2004, J WORLD AQUACULT SOC, V35, P121, DOI 10.1111/j.1749-7345.2004.tb01068.x; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Emmerson WD, 2001, HYDROBIOLOGIA, V449, P221, DOI 10.1023/A:1017506917996; EMMERSON WD, 1994, J CRUSTACEAN BIOL, V14, P568, DOI 10.2307/1549002; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELDER DL, 1994, J CRUSTACEAN BIOL, V14, P191, DOI 10.2307/1548900; Flores AAV, 2002, J CRUSTACEAN BIOL, V22, P143, DOI 10.1651/0278-0372(2002)022[0143:SMRCAJ]2.0.CO;2; Flowers JM, 2002, EVOLUTION, V56, P1445, DOI 10.1111/j.0014-3820.2002.tb01456.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FORWARD RB, 1987, B MAR SCI, V41, P165; Fratini S, 2002, J EXP MAR BIOL ECOL, V272, P103, DOI 10.1016/S0022-0981(02)00052-7; Fratini S, 2011, J ETHOL, V29, P481, DOI 10.1007/s10164-011-0282-0; Fratini S, 2010, ESTUAR COAST SHELF S, V86, P51, DOI 10.1016/j.ecss.2009.10.009; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GIFFORD CA, 1962, BIOL BULL, V123, P207, DOI 10.2307/1539516; Gopurenko D, 1999, MAR BIOL, V134, P227, DOI 10.1007/s002270050541; Gourlan AT, 2008, EARTH PLANET SC LETT, V267, P353, DOI 10.1016/j.epsl.2007.11.054; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guzman BE, 2011, ITAL J ZOOL, V78, P444, DOI 10.1080/11250003.2011.576403; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hartnoll RG, 2010, CRUSTACEANA MONOGR, V11, P153; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; HEDGECOCK D, 1986, B MAR SCI, V39, P550; HILL BJ, 1979, MAR BIOL, V55, P209, DOI 10.1007/BF00396820; HILL BJ, 1994, MAR BIOL, V120, P379, DOI 10.1007/BF00680211; HILL BJ, 1982, MAR BIOL, V69, P117, DOI 10.1007/BF00396967; HILL BJ, 1975, MAR BIOL, V32, P119, DOI 10.1007/BF00388505; HILL BJ, 1976, MAR BIOL, V34, P109, DOI 10.1007/BF00390752; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2000, GENETICS, V155, P2011; Garcia-Merchan VH, 2012, MOL PHYLOGENET EVOL, V62, P664, DOI 10.1016/j.ympev.2011.11.009; KANNUPANDI T, 1980, INDIAN J MAR SCI, V9, P271; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Kawane M, 2008, MAR BIOL, V156, P193, DOI 10.1007/s00227-008-1076-y; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; KIMURA M, 1964, GENETICS, V49, P561; Kristensen E, 2006, LIMNOL OCEANOGR, V51, P1557, DOI 10.4319/lo.2006.51.4.1557; LAGO RP, 1993, J CRUSTACEAN BIOL, V13, P745, DOI 10.2307/1549105; LAGO RP, 1989, S AFR J ZOOL, V24, P199; Lee HJE, 2009, MOL ECOL, V18, P2165, DOI 10.1111/j.1365-294X.2009.04169.x; LI WH, 1977, GENETICS, V85, P331; MICHELI F, 1991, MAR BIOL, V111, P247, DOI 10.1007/BF01319706; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; MITTON JB, 1989, EVOLUTION, V43, P1712, DOI 10.1111/j.1558-5646.1989.tb02621.x; MORGAN SG, 1987, J EXP MAR BIOL ECOL, V113, P71, DOI 10.1016/0022-0981(87)90083-9; Naderloo R, 2016, ZOOL ANZ, V262, P10, DOI 10.1016/j.jcz.2016.03.010; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Nei M, 1987, MOL EVOLUTIONARY BIO; Ong KS, 1964, IPFC P, P135; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Papadopoulos Isabelle, 2002, Wetlands Ecology and Management, V10, P249, DOI 10.1023/A:1020183931789; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Paula J, 2004, J PLANKTON RES, V26, P1163, DOI 10.1093/plankt/fbh106; Paula J, 2003, ESTUAR COAST SHELF S, V56, P325, DOI 10.1016/S0272-7714(02)00165-8; Paula J, 2001, MAR ECOL PROG SER, V215, P251, DOI 10.3354/meps215251; Penha-Lopes G, 2009, J EXP MAR BIOL ECOL, V381, P25, DOI 10.1016/j.jembe.2009.08.009; POUPIN J., 2010, BIODIVERSITE INDO PA; Ragionieri L, 2015, HYDROBIOLOGIA, V749, P183, DOI 10.1007/s10750-014-2165-1; Ragionieri L, 2010, ESTUAR COAST SHELF S, V86, P179, DOI 10.1016/j.ecss.2009.11.002; Ragionieri L, 2009, MOL PHYLOGENET EVOL, V52, P825, DOI 10.1016/j.ympev.2009.04.008; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schneider S, 1999, GENETICS, V152, P1079; Schubart CD, 2006, B FR PECHE PISCIC, P1019, DOI 10.1051/kmae:2006008; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2008, BIOL BULL, V216, P373; Silva IC, 2010, MAR BIOL, V157, P1113, DOI 10.1007/s00227-010-1393-9; Silva IC, 2010, BIOL J LINN SOC, V99, P28, DOI 10.1111/j.1095-8312.2009.01338.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simoni R, 2013, MAR BIOL, V160, P2483, DOI 10.1007/s00227-013-2243-3; Skov MW, 2005, ECOLOGY, V86, P1164, DOI 10.1890/04-0917; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; VANNINI M, 1981, MONIT ZOOL ITAL, V14, P57, DOI 10.1080/03749444.1981.10736614; VANNINI M, 1981, MONIT ZOOL ITAL, V14, P199, DOI 10.1080/03749444.1981.10736622; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; Wolcott T.G., 1988, P55, DOI 10.1017/CBO9780511753428.004; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yuhara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084720; ZAYKIN DV, 1993, J HERED, V84, P152, DOI 10.1093/oxfordjournals.jhered.a111304	117	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158582	10.1371/journal.pone.0158582	http://dx.doi.org/10.1371/journal.pone.0158582			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379532	Green Published, gold			2022-12-27	WOS:000379798700036
J	Yeh, CH; Chen, PC; Chen, CH; Hsu, CF; Huang, RL; Ding, DC; Chu, TY				Yeh, Ching-Hua; Chen, Pao-Chu; Chen, Chiu-Hua; Hsu, Che-Fang; Huang, Rui-Len; Ding, Dah-Ching; Chu, Tang-Yuan			Platelet-Derived Growth Factor in the Ovarian Follicle Attracts the Stromal Cells of the Fallopian Tube Fimbriae	PLOS ONE			English	Article							SEROUS CARCINOMA; CANCER; MIGRATION; CARCINOGENESIS; CYTOKINES; GUIDANCE; FLUID	During human ovulation, the fallopian tube fimbriae must move to the ovulation site to catch the oocyte. As the tissue-of-origin of the majority of ovarian high-grade serous carcinoma (HGSC), the fallopian tube fimbriae carrying a precursor cancer lesion may also approach the ovulatory site for metastasis. We hypothesize that platelet-derived growth factor (PDGF) in mature follicle fluid (FF) attracts the migration of PDGFR-expressing fimbriae toward the ovulating follicle. We observed that more PDGFR-beta was expressed in the distal part than in the proximal parts of the fallopian tube, particularly in stromal cells in the lamina propria. The stromal cells, but not the epithelial cells, from normal fimbriae and fallopian tube HGSC were highly chemotactic to mature FF. The chemotactic activities were positively correlated with PDGF-BB and estradiol levels in FF and were abolished by a blocking antibody of PDGFR-beta and by tyrosine kinase inhibitor imatinib. When PDGF-BB/AB was depleted from the FF, more than 80% of chemotaxis activities were diminished. This study suggests an ovarian follicle-directed and PDGF-dependent attraction of fallopian tube fimbriae before ovulation. The same mechanism may also be crucial for the ovarian homing of HGSC, which largely originates in the fimbriae.	[Yeh, Ching-Hua; Chen, Chiu-Hua; Hsu, Che-Fang; Ding, Dah-Ching; Chu, Tang-Yuan] Tzu Chi Gen Hosp, Cerv Canc Prevent Ctr, Hualien 970, Taiwan; [Chen, Pao-Chu; Chu, Tang-Yuan] Tzu Chi Gen Hosp, Dept Obstet & Gynecol, Hualien 970, Taiwan; [Huang, Rui-Len] Taipei Med Univ, Dept Obstet & Gynecol, Shuang Ho Hosp, New Taipei, Taiwan; [Chen, Pao-Chu; Chu, Tang-Yuan] Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Taipei Medical University; Shuang Ho Hospital; Tzu Chi University	Chu, TY (corresponding author), Tzu Chi Gen Hosp, Cerv Canc Prevent Ctr, Hualien 970, Taiwan.; Chu, TY (corresponding author), Tzu Chi Gen Hosp, Dept Obstet & Gynecol, Hualien 970, Taiwan.; Chu, TY (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan.	hidrchu@gmail.com	DING, DAH-CHING/Y-3592-2019	Huang, Rui Lan/0000-0001-6458-4672; Hsu, Che-Fang/0000-0002-8024-9150; Chu, Tang-Yuan/0000-0003-2717-2681	National Science Council of Taiwan, R.O.C. [NSC 99-2628-B303-001]; Buddhist Tzu Chi General Hospital, Hualien, Taiwan [TCRD-I102-01-01]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Buddhist Tzu Chi General Hospital, Hualien, Taiwan	Funded by a grant from the National Science Council of Taiwan, R.O.C. (NSC 99-2628-B303-001) and an intramural grant from Buddhist Tzu Chi General Hospital, Hualien, Taiwan (TCRD-I102-01-01).; This study was supported by a grant of the National Science Council of Taiwan, ROC (NSC 99-2628-B-303-001) and an intramural grant of Tzu Chi General Hospital, Hualien, Taiwan TCRD-I102-01-01). The authors are grateful to the in vitro fertilization-ET team of Tzu Chi General Hospital for providing FF for this study, and to Miss Rui-Len Huang of Taipei Medical University Shuang Ho Hospital for technique assistance.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Das A, 2011, J ASSIST REPROD GEN, V28, P677, DOI 10.1007/s10815-011-9580-2; Dubeau L, 2013, ANN ONCOL, V24, P28, DOI 10.1093/annonc/mdt308; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; EDWARDS RG, 1975, J REPROD FERTIL, P121; Gordon J D, 1995, Obstet Gynecol Surv, V50, P688, DOI 10.1097/00006254-199509000-00024; Gordts Stephan, 2002, Reprod Biomed Online, V4 Suppl 3, P10; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Hasegawa A, 2009, J REPROD IMMUNOL, V83, P40, DOI 10.1016/j.jri.2009.09.002; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Huang HS, 2015, CARCINOGENESIS, V36, P1419, DOI 10.1093/carcin/bgv132; Karst Alison M, 2011, F1000 Med Rep, V3, P22, DOI 10.3410/M3-22; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Ledee N, 2008, HUM REPROD, V23, P2001, DOI 10.1093/humrep/den192; Lousse JC, 2008, FERTIL STERIL, V90, P833, DOI 10.1016/j.fertnstert.2007.12.049; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Nagel M, 2004, DEVELOPMENT, V131, P2727, DOI 10.1242/dev.01141; Nik NN, 2014, ANNU REV PATHOL-MECH, V9, P27, DOI 10.1146/annurev-pathol-020712-163949; Overton C, 1996, HUM REPROD, V11, P380, DOI 10.1093/HUMREP/11.2.380; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Pinkas H, 2008, MOL HUM REPROD, V14, P199, DOI 10.1093/molehr/gan011; Seidman JD, 2011, GYNECOL ONCOL, V120, P470, DOI 10.1016/j.ygyno.2010.11.020; Tangkijvanich P, 2002, EXP CELL RES, V281, P140, DOI 10.1006/excr.2002.5657; Wan ACA, 2016, TRENDS BIOTECHNOL, V34, P711, DOI 10.1016/j.tibtech.2016.02.015	26	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158266	10.1371/journal.pone.0158266	http://dx.doi.org/10.1371/journal.pone.0158266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379403	Green Submitted, gold, Green Published			2022-12-27	WOS:000379798700025
J	Bassani, B; Bartolini, D; Pagani, A; Principi, E; Zollo, M; Noonan, DM; Albini, A; Bruno, A				Bassani, Barbara; Bartolini, Desiree; Pagani, Arianna; Principi, Elisa; Zollo, Massimo; Noonan, Douglas M.; Albini, Adriana; Bruno, Antonino			Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3 alpha/beta-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids	PLOS ONE			English	Article							CANCER STEM-CELLS; TUMOR-INITIATING CELLS; BREAST-CANCER; IN-VITRO; INDUCED APOPTOSIS; N-(4-HYDROXYPHENYL) RETINAMIDE; STEM/PROGENITOR CELLS; MOLECULAR PATHOLOGY; MALIGNANT GLIOMAS; PHASE-II	Medulloblastoma (MB), a neuroectodermal tumor arising in the cerebellum, represents the most frequent childhood brain malignancy. Current treatments for MB combine radiation and chemotherapy and are often associated with relevant side effects; novel therapeutic strategies are urgently needed. N-(4-Hydroxyphenyl) retinamide (4-HPR, fenretinide), a synthetic analogue of all-trans retinoic acid, has emerged as a promising and well-tolerated cancer chemopreventive and chemotherapeutic agent for various neoplasms, from breast cancer to neuroblastoma. Here we investigated the effects of 4-HPR on MB cell lines and identified the mechanism of action for a potential use in therapy of MB. Flow cytometry analysis was performed to evaluate 4-HPR induction of apoptosis and oxygen reactive species (ROS) production, as well as cell cycle effects. Functional analysis to determine 4-HPR ability to interfere with MB cell migration and invasion were performed. Western Blot analysis were used to investigate the crucial molecules involved in selected signaling pathways associated with apoptosis (caspase-9 and PARP-1), cell survival (ERK 1/2) and tumor progression (Wnt3a and beta-catenin). We show that 4-HPR induces caspase 9-dependent cell death in DAOY and ONS-76 cells, associated with increased ROS generation, suggesting that free radical intermediates might be directly involved. We observed 4-HPR induction of cell cycle arrest in G1/S phase, inactivated beta-catenin, and inhibition of MB cell migration and invasion. We also evaluated the ability of 4-HPR to target MB cancer-stem/cancer-initiating cells, using an MB spheroids model, followed by flow cytometry and quantitative real-time PCR. 4-HPR treatment reduced DAOY and ONS-76 spheroid formation, in term of number and size. Decreased expression of the surface markers CD133(+) and ABCG2(+) as well as Oct-4 and Sox-2 gene expression were observed on BTICs treated with 4-HPR further reducing BITIC invasive activities. Finally, we analyzed 4-HPR ability to inhibit MB tumor cell growth in vivo in nude mice. Taken together, our data suggest that 4-HPR targets both parental and MB tumor stem/initiating cell-like populations. Since 4-HPR exerts low toxicity, it could represent a valid compound in the treatment of human MB.	[Bassani, Barbara; Bartolini, Desiree; Pagani, Arianna; Principi, Elisa; Noonan, Douglas M.; Albini, Adriana; Bruno, Antonino] IRCCS MultiMed, Sci & Technol Pole, Milan, Italy; [Zollo, Massimo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Zollo, Massimo] Ceinge Biotecnol Avanzate, Naples, Italy; [Noonan, Douglas M.] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy	IRCCS Multimedica; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Insubria	Albini, A (corresponding author), IRCCS MultiMed, Sci & Technol Pole, Milan, Italy.	adriana.albini@multimedica.it	bassani, barbara/AAB-5832-2019; Bartolini, Desirée/K-5319-2016; Bruno, Antonino/J-7066-2016; Principi, Elisa/O-2424-2015	Bartolini, Desirée/0000-0003-3849-757X; Bruno, Antonino/0000-0002-4790-0861; Albini, Adriana/0000-0002-9624-5103; Bassani, Barbara/0000-0002-8002-1607; Principi, Elisa/0000-0003-3747-1167	AIRC (Associazione Italaiana per la Ricerca sul Cancro); FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellowship; AIRC	AIRC (Associazione Italaiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellowship(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro)	These studies were funded by AIRC (Associazione Italaiana per la Ricerca sul Cancro). AB is a FUV (Fondazione Umberto Veronesi) fellow. AB and EP were previously funded by a FIRC (Fondazione Italiana per la Ricerca sul Cancro) fellowship. AP was awarded the "Caterina Forni" Fellowship from the AIRC. BB is a PhD student enrolled in the PhD program of Biotechnology, Biosciences and Surgical Technologies, at University of Insubria, Varese (Italy). Adriana Albini is the Scientific Director of Fondazione MultiMedica Onlus.	Albini A, 2011, CURR PHARM BIOTECHNO, V12, P171, DOI 10.2174/138920111794295756; Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Albini A, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv213; Albini A, 2010, CURR OPIN CELL BIOL, V22, P677, DOI 10.1016/j.ceb.2010.08.017; Antoniou A, 2013, CELL CYCLE, V12, P3743, DOI 10.4161/cc.27305; Benelli R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-142; Bonanni B, 2007, EXPERT REV ANTICANC, V7, P423, DOI 10.1586/14737140.7.4.423; Bose D, 2011, BRIT J CANCER, V105, P1759, DOI 10.1038/bjc.2011.449; Brandes Alba A, 2014, Am Soc Clin Oncol Educ Book, pe82, DOI 10.14694/EdBook_AM.2014.34.e82; Brown CC, 2015, EUR J IMMUNOL, V45, P1287, DOI 10.1002/eji.201344398; Cazzaniga M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/172897; Cevatemre B, 2013, ANTI-CANCER DRUG, V24, P577, DOI 10.1097/CAD.0b013e328360a921; Cuperus R, 2008, INT J ONCOL, V32, P1011; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; DeSouza RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00176; Di Paolo D, 2013, J CONTROL RELEASE, V170, P445, DOI 10.1016/j.jconrel.2013.06.015; Du YZ, 2014, ANTIOXID REDOX SIGN, V20, P1866, DOI 10.1089/ars.2012.4935; Duester G, 2013, SEMIN CELL DEV BIOL, V24, P694, DOI 10.1016/j.semcdb.2013.08.001; Durante S, 2014, ONCOTARGET, V5, P4811, DOI 10.18632/oncotarget.2038; Ellison D, 2002, NEUROPATH APPL NEURO, V28, P257, DOI 10.1046/j.1365-2990.2002.00419.x; Ferrari N, 2005, CLIN CANCER RES, V11, P4610, DOI 10.1158/1078-0432.CCR-04-2210; Fossati P, 2009, CANCER TREAT REV, V35, P79, DOI 10.1016/j.ctrv.2008.09.002; Gajjar A, 2004, J CLIN ONCOL, V22, P984, DOI 10.1200/JCO.2004.06.032; Gerber NU, 2014, CANCER TREAT REV, V40, P356, DOI 10.1016/j.ctrv.2013.11.010; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Gouaze-Andersson V, 2011, PROSTATE, V71, P1064, DOI 10.1002/pros.21321; Gupta T, 2015, CURR PEDIATR REV, V11, P106, DOI 10.2174/1573396311666150702104030; Hadjipanayis CG, 2009, J MOL MED, V87, P363, DOI 10.1007/s00109-009-0440-9; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Hail N, 2010, FREE RADICAL BIO MED, V49, P109, DOI 10.1016/j.freeradbiomed.2010.04.006; Hail N, 2009, APOPTOSIS, V14, P849, DOI 10.1007/s10495-009-0356-4; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Irollo E, 2013, AM J TRANSL RES, V5, P563; Kalemkerian GP, 1999, CANCER CHEMOTH PHARM, V43, P145, DOI 10.1007/s002800050875; Kang H, 2012, J CELL BIOCHEM, V113, P2845, DOI 10.1002/jcb.24159; Kim HJ, 2006, ONCOGENE, V25, P2785, DOI 10.1038/sj.onc.1209303; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Koch A, 2001, INT J CANCER, V93, P445, DOI 10.1002/ijc.1342; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lovat PE, 2000, EXP CELL RES, V260, P50, DOI 10.1006/excr.2000.4988; Lovat PE, 2004, ANN NY ACAD SCI, V1028, P81, DOI 10.1196/annals.1322.009; Maenhaut C, 2010, CARCINOGENESIS, V31, P149, DOI 10.1093/carcin/bgp259; Manoranjan B, 2012, PEDIATR RES, V71, P516, DOI 10.1038/pr.2011.62; Maurer BJ, 2013, PEDIATR BLOOD CANCER, V60, P1801, DOI 10.1002/pbc.24643; Messner MC, 2011, CANCER CHEMOTH PHARM, V68, P477, DOI 10.1007/s00280-010-1504-9; Mimeault M, 2014, CANCER EPIDEM BIOMAR, V23, P234, DOI 10.1158/1055-9965.EPI-13-0785; Mittal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110410; Montaldo PG, 1999, INT J CANCER, V81, P262, DOI 10.1002/(SICI)1097-0215(19990412)81:2<262::AID-IJC16>3.3.CO;2-1; Moore MM, 2010, CANCER CHEMOTH PHARM, V66, P845, DOI 10.1007/s00280-009-1228-x; Northcott PA, 2015, LANCET ONCOL, V16, pE293, DOI 10.1016/S1470-2045(14)71206-9; Northcott PA, 2011, ACTA NEUROPATHOL, V122, P231, DOI 10.1007/s00401-011-0846-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Puduvalli VK, 2004, J CLIN ONCOL, V22, P4282, DOI 10.1200/JCO.2004.09.096; Puduvalli VK, 1999, CLIN CANCER RES, V5, P2230; Read TA, 2012, CANCER CELL, V21, P1, DOI 10.1016/j.ccr.2011.12.011; Reddy CD, 2006, CANCER LETT, V231, P262, DOI 10.1016/j.canlet.2005.02.013; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Scatena R, 2011, PROTEOM CLIN APPL, V5, P590, DOI 10.1002/prca.201000142; Scatena R, 2011, EXPERT OPIN BIOL TH, V11, P875, DOI 10.1517/14712598.2011.573780; Schmidt C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv353; Schneider BJ, 2009, INVEST NEW DRUG, V27, P571, DOI 10.1007/s10637-009-9228-6; Sega-Pondel Dorota, 2007, Med Wieku Rozwoj, V11, P343; Simeone AM, 2005, CARCINOGENESIS, V26, P1000, DOI 10.1093/carcin/bgi038; Singh M, 2014, INT J MOL SCI, V15, P9117, DOI 10.3390/ijms15059117; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SMITH MA, 1992, J CLIN ONCOL, V10, P839, DOI 10.1200/JCO.1992.10.5.839; Sogna I, 2009, RECENT RESULTS CANC, V181, P71; Sogno I, 2010, CRIT REV ONCOL HEMAT, V75, P2, DOI 10.1016/j.critrevonc.2009.10.007; Stoll EA, 2013, AGING CELL, V12, P733, DOI 10.1111/acel.12104; Sun L, 2013, J RADIAT RES, V54, P61, DOI 10.1093/jrr/rrs078; Thompson EM, 2016, LANCET ONCOL, V17, P484, DOI 10.1016/S1470-2045(15)00581-1; Ulukaya E, 2014, BIOMED PHARMACOTHER, V68, P477, DOI 10.1016/j.biopha.2014.03.013; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Villablanca JG, 2011, CLIN CANCER RES, V17, P6858, DOI 10.1158/1078-0432.CCR-11-0995; WANG H, 2013, BIOMED RES INT, V2013; Wang X, 2012, ONCOGENE, V31, P187, DOI 10.1038/onc.2011.232; Yoshida GJ, 2016, CANCER SCI, V107, P5, DOI 10.1111/cas.12817; Zanini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063748; Zhang H, 2013, P NATL ACAD SCI USA, V110, P5606, DOI 10.1073/pnas.1302352110; Zhao JH, 2016, PHARMACOL THERAPEUT, V160, P145, DOI 10.1016/j.pharmthera.2016.02.008	81	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0154111	10.1371/journal.pone.0154111	http://dx.doi.org/10.1371/journal.pone.0154111			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367907	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900001
J	Carniglia, L; Ramirez, D; Durand, D; Saba, J; Caruso, C; Lasaga, M				Carniglia, Lila; Ramirez, Delia; Durand, Daniela; Saba, Julieta; Caruso, Carla; Lasaga, Mercedes			[Nle(4), D-Phe(7)]-alpha-MSH Inhibits Toll-Like Receptor (TLR)2-and TLR4-Induced Microglial Activation and Promotes a M2-Like Phenotype	PLOS ONE			English	Article							NF-KAPPA-B; MELANOCYTE-STIMULATING-HORMONE; ADAPTIVE IMMUNE-RESPONSES; MELANOCORTIN 4 RECEPTOR; CENTRAL-NERVOUS-SYSTEM; C-REL; AUTOIMMUNE INFLAMMATION; HUMAN MONOCYTES; NEURONAL DEATH; NITRIC-OXIDE	alpha-melanocyte stimulating hormone (alpha-MSH) is an anti-inflammatory peptide, proved to be beneficial in many neuroinflammatory disorders acting through melanocortin receptor 4 (MC4R). We previously determined that rat microglial cells express MC4R and that NDPMSH, an analog of alpha-MSH, induces PPAR-gamma expression and IL-10 release in these cells. Given the great importance of modulation of glial activation in neuroinflammatory disorders, we tested the ability of NDP-MSH to shape microglial phenotype and to modulate Toll-like receptor (TLR)-mediated inflammatory responses. Primary rat cultured microglia were stimulated with NDP-MSH followed by the TLR2 agonist Pam(3)CSK(4) or the TLR4 agonist LPS. NDP-MSH alone induced expression of the M2a/M2c marker Ag1 and reduced expression of the M2b marker Il-4ra and of the LPS receptor Tlr4. Nuclear translocation of NF-kappa B subunits p65 and c-Rel was induced by LPS and these effects were partially prevented by NDP-MSH. NDP-MSH reduced LPS- and Pam(3)CSK(4)-induced TNF-alpha release but did not affect TLR-induced IL-10 release. Also, NDP-MSH inhibited TLR2-induced HMGB1 translocation from nucleus to cytoplasm and TLR2-induced phagocytic activity. Our data show that NDP-MSH inhibits TLR2- and TLR4-mediated proinflammatory mechanisms and promotes microglial M2-like polarization, supporting melanocortins as useful tools for shaping microglial activation towards an alternative immunomodulatory phenotype.	[Carniglia, Lila; Ramirez, Delia; Durand, Daniela; Saba, Julieta; Caruso, Carla; Lasaga, Mercedes] Univ Buenos Aires, Sch Med, Inst Biomed Res INBIOMED UBA CONICET, RA-1121 Buenos Aires, DF, Argentina	University of Buenos Aires	Lasaga, M (corresponding author), Univ Buenos Aires, Sch Med, Inst Biomed Res INBIOMED UBA CONICET, RA-1121 Buenos Aires, DF, Argentina.	mlasaga@fmed.uba.ar	Caruso, Carla/AAR-5914-2020	Caruso, Carla/0000-0002-0889-0293; Ramirez, Delia/0000-0003-2253-1710; Carniglia, Lila/0000-0002-9354-8037; Lasaga, Mercedes/0000-0001-9916-3712	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnica) [PICT 0894]; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP 630]; University of Buenos Aires [20020130100120BA]	ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnica)(ANPCyT); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires)	This research was supported by grants from ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnica) PICT 0894, CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) PIP 630 and University of Buenos Aires 20020130100120BA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Campana L, 2008, CURR OPIN IMMUNOL, V20, P518, DOI 10.1016/j.coi.2008.04.012; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Carniglia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057313; Caruso C, 2004, NEUROENDOCRINOLOGY, V79, P278, DOI 10.1159/000079321; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Clarke CJP, 1998, EUR J IMMUNOL, V28, P1719, DOI 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Delgado R, 1998, J LEUKOCYTE BIOL, V63, P740, DOI 10.1002/jlb.63.6.740; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Funderburg NT, 2011, IMMUNOLOGY, V134, P151, DOI 10.1111/j.1365-2567.2011.03475.x; Giuliani D, 2007, EUR J PHARMACOL, V570, P57, DOI 10.1016/j.ejphar.2007.05.025; Giuliani D, 2006, EUR J PHARMACOL, V538, P48, DOI 10.1016/j.ejphar.2006.03.038; Giuliani D, 2014, NEUROBIOL AGING, V35, P537, DOI 10.1016/j.neurobiolaging.2013.08.030; Gonzalez P, 2013, BRAIN BEHAV IMMUN, V34, P141, DOI 10.1016/j.bbi.2013.08.007; Gurley C, 2008, PPAR RES, V2008, DOI 10.1155/2008/453120; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heyen JRR, 2000, MOL BRAIN RES, V77, P138, DOI 10.1016/S0169-328X(00)00042-5; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawanaka N, 2011, J NEUROIMMUNOL, V232, P17, DOI 10.1016/j.jneuroim.2010.09.025; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lasaga M, 2008, PEPTIDES, V29, P1825, DOI 10.1016/j.peptides.2008.06.009; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado I, 2015, BRAIN BEHAV IMMUN, V46, P137, DOI 10.1016/j.bbi.2015.01.012; MALEFYT RD, 1991, J EXP MED, V174, P1209; Manna SK, 1998, J IMMUNOL, V161, P2873; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Matsui T, 2012, INTENS CARE MED, V38, P1392, DOI 10.1007/s00134-012-2591-3; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Sarkar A, 2003, FEBS LETT, V553, P286, DOI 10.1016/S0014-5793(03)01029-9; SUZUMURA A, 1994, J NEUROIMMUNOL, V53, P209, DOI 10.1016/0165-5728(94)90031-0; Taylor AW, 2008, BRAIN BEHAV IMMUN, V22, P639, DOI 10.1016/j.bbi.2007.11.001; Tian SJ, 2015, AM J PHYSIOL-RENAL, V308, pF69, DOI 10.1152/ajprenal.00484.2014; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Gonzalez PV, 2009, BRAIN BEHAV IMMUN, V23, P817, DOI 10.1016/j.bbi.2009.03.001; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103	60	17	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158564	10.1371/journal.pone.0158564	http://dx.doi.org/10.1371/journal.pone.0158564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359332	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200092
J	Campos, PHA; Alves, TJM; Dias, MT; Assuncao, CM; Munk, M; Mattos, MS; Kraemer, LR; Almeida, BG; Russo, RC; Barcelos, L; Camargo, LSA; Viana, JHM				Henrique Almeida Campos-Junior, Paulo; Melo Alves, Thalys Jair; Dias, Marco Tulio; Assuncao, Carolina Marinho; Munk, Michele; Mattos, Matheus Silverio; Kraemer, Lucas Rocha; Almeida, Brigida Gomes; Russo, Remo Castro; Barcelos, Luciola; Almeida Camargo, Luiz Sergio; Moreira Viana, Joao Henrique			Ovarian Grafts 10 Days after Xenotransplantation: Folliculogenesis and Recovery of Viable Oocytes	PLOS ONE			English	Article							FOLLICULAR DEVELOPMENT; TISSUE; ANGIOGENESIS; EXPRESSION; FOLLICLES; GROWTH; CRYOPRESERVATION; TRANSPLANTATION; GONADOTROPINS; STIMULATION	Ovarian xenotransplantation is a promising alternative to preserve fertility of oncologic patients. However, several functional aspects of this procedure remained to be addressed. The aim of this study was evaluate the feasibility of xenotransplantation as a strategy to maintain bovine ovarian grafts and produce oocytes. Adult ovarian cortical pieces were xenotransplanted to the dorsal subcutaneous of female NOD-SCID mice (n = 62). Grafts were recovered ten days after xenotransplantation. Host and graft weights; folliculogenesis progression; blood perfusion, relative gene expression and number of macrophage and neutrophil of xenografts; in vitro developmental competence of graft-derived oocytes were evaluated. Folliculogenesis was supported in the grafts, as indicated by the presence of primordial, primary, secondary, antral, and atretic follicles. The xenografts showed a greater volumetric density of atretic follicles and higher hyperemia and number of host-derived macrophage and neutrophil (P<0.05), when compared to non-grafted fragments. There was a higher blood perfusion under the back skin in the transplantation sites of host animals than in control and non-grafted (P<0.01). BAX and PRDX1 genes were up-regulated, while BCL2, FSHR, IGF1R and IGF2R were down-regulated, when compared to the control (P<0.01). Twenty seven oocytes were successfully harvested from grafts, and some of these oocytes were able to give rise to blastocysts after in vitro fertilization. However, cleavage and blastocyst rates of xenograft derived oocytes were lower than in control (P<0.01). Despite showing some functional modifications, the ovarian xenografts were able to support folliculogenesis and produce functional oocytes.	[Henrique Almeida Campos-Junior, Paulo; Melo Alves, Thalys Jair; Dias, Marco Tulio] Univ Fed Sao Joao del Rei, Dept Nat Sci, Fertil Preservat Res Grp, BR-36301160 Sao Joao Del Rei, MG, Brazil; [Assuncao, Carolina Marinho; Munk, Michele] Univ Fed Juiz de Fora, Dept Biol, Lab Genet & Biotechnol, BR-36036900 Juiz De Fora, MG, Brazil; [Mattos, Matheus Silverio; Kraemer, Lucas Rocha; Almeida, Brigida Gomes; Russo, Remo Castro; Barcelos, Luciola] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, BR-31270901 Belo Horizonte, MG, Brazil; [Almeida Camargo, Luiz Sergio] EMBRAPA, BR-36038330 Juiz De Fora, MG, Brazil; [Moreira Viana, Joao Henrique] EMBRAPA, BR-70770917 Brasilia, DF, Brazil	Universidade Federal de Sao Joao del-Rei; Universidade Federal de Juiz de Fora; Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Campos, PHA (corresponding author), Univ Fed Sao Joao del Rei, Dept Nat Sci, Fertil Preservat Res Grp, BR-36301160 Sao Joao Del Rei, MG, Brazil.	paulohenrique@ufsj.edu.br	Barcelos, Lucíola S/A-1109-2013; Munk, Michele/T-3422-2019; Pereira, Michele Munk/D-4068-2013; da Silva Barcelos, Lucíola/AAP-5595-2021; Russo, Remo Castro/O-8980-2019; Munk, Michele/R-5882-2019; Mattos, Matheus/AAW-6644-2020; Russo, Remo Castro/F-9048-2010; Viana, Joao Henrique Moreira/O-1635-2016; Campos-Junior, Paulo HA/H-5751-2015	Barcelos, Lucíola S/0000-0001-9133-4011; Pereira, Michele Munk/0000-0001-8927-6190; da Silva Barcelos, Lucíola/0000-0001-9133-4011; Russo, Remo Castro/0000-0002-1715-3834; Munk, Michele/0000-0001-8927-6190; Mattos, Matheus/0000-0002-9163-6279; Russo, Remo Castro/0000-0002-1715-3834; Viana, Joao Henrique Moreira/0000-0002-3742-2368; Campos-Junior, Paulo HA/0000-0003-2400-2548	National Council for Scientific and Technological Development (CNPq, Brazil); Minas Gerais State Research Foundation (FAPEMIG, Brazil); CNPq; FAPEMIG	National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Research Foundation (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was supported by the National Council for Scientific and Technological Development (CNPq, Brazil) and Minas Gerais State Research Foundation (FAPEMIG, Brazil). Thalys Jair Melo Alves and Marco Tulio Dias received grants from CNPq and FAPEMIG, respectively.	Alm H, 2005, THERIOGENOLOGY, V63, P2194, DOI 10.1016/j.theriogenology.2004.09.050; Campos PHA, 2014, REPRODUCTION, V147, P291, DOI 10.1530/REP-13-0581; Campos PHA, 2012, REPROD BIOL, V12, P41, DOI 10.1016/S1642-431X(12)60076-X; Amorim CA, 2012, FERTIL STERIL, V98, P1291, DOI 10.1016/j.fertnstert.2012.07.1109; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; Barcelos LS, 2005, J LEUKOCYTE BIOL, V78, P352, DOI 10.1189/jlb.1104682; Cai CY, 2015, EJSO-EUR J SURG ONC, V41, P228, DOI 10.1016/j.ejso.2014.11.037; Campos PHA, 2011, LAB ANIM-UK, V45, P254, DOI 10.1258/la.2011.011031; Campos PHA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095430; Dittrich R, 2010, Minerva Ginecol, V62, P63; Donnez J, 2013, NAT REV ENDOCRINOL, V9, P735, DOI 10.1038/nrendo.2013.205; Hernandez-Fonseca H, 2004, FERTIL STERIL, V81, P888, DOI 10.1016/j.fertnstert.2003.10.017; Hernandez-Fonseca HJ, 2005, FERTIL STERIL, V83, P1180, DOI 10.1016/j.fertnstert.2004.07.985; Kim SS, 2002, FERTIL STERIL, V78, P77, DOI 10.1016/S0015-0282(02)03144-8; Lee Yu-Il, 2011, Clin Exp Reprod Med, V38, P18, DOI 10.5653/cerm.2011.38.1.18; Lotz L, 2016, REPROD BIOMED ONLINE, V32, P394, DOI 10.1016/j.rbmo.2015.12.012; Lotz L, 2014, FERTIL STERIL, V101, P1477, DOI 10.1016/j.fertnstert.2014.01.038; Lotz L, 2011, FERTIL STERIL, V95, P2612, DOI 10.1016/j.fertnstert.2011.05.003; Maltaris T, 2007, FERTIL STERIL, V87, P195, DOI 10.1016/j.fertnstert.2006.05.058; Mazerbourg S, 2003, REPROD DOMEST ANIM, V38, P247, DOI 10.1046/j.1439-0531.2003.00440.x; Messinis IE, 2010, ANN NY ACAD SCI, V1205, P5, DOI 10.1111/j.1749-6632.2010.05660.x; Onions VJ, 2013, MOL HUM REPROD, V19, P205, DOI 10.1093/molehr/gas053; Pfaffl MW, 2012, NUCLEIC ACIDS RES, V30, pe36; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Russo RC, 2011, AM J RESP CELL MOL, V45, P72, DOI 10.1165/rcmb.2009-0406OC; Senbon S, 2005, ZYGOTE, V13, P309, DOI 10.1017/S0967199405003400; Snow M, 2002, SCIENCE, V297, P2227, DOI 10.1126/science.1073693; Batista RITP, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-33; Van Eyck AS, 2010, FERTIL STERIL, V93, P1676, DOI 10.1016/j.fertnstert.2009.04.048; Varricchi G, 2015, J AM ACAD DERMATOL, V73, P144, DOI 10.1016/j.jaad.2015.03.041; Viana JHM, 2004, ANIM REPROD SCI, V84, P1, DOI 10.1016/j.anireprosci.2003.12.002; von Schonfeldt V, 2011, FERTIL STERIL, V95, P1428, DOI 10.1016/j.fertnstert.2010.11.003; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086	33	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158109	10.1371/journal.pone.0158109	http://dx.doi.org/10.1371/journal.pone.0158109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362486	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200041
J	Hung, MS; Chen, IC; Lung, JH; Lin, PY; Li, YC; Tsai, YH				Hung, Ming-Szu; Chen, I-Chuan; Lung, Jr-Hau; Lin, Paul-Yann; Li, Ya-Chin; Tsai, Ying-Huang			Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CADHERIN; METASTATIC BREAST-CANCER; EGFR KINASE DOMAIN; 1ST-LINE TREATMENT; VE-CADHERIN; VASCULOGENIC MIMICRY; OPEN-LABEL; CHEMOTHERAPY; GEFITINIB; ADENOCARCINOMA	Epidermal growth factor receptor (EGFR) activation has been shown to play a critical role in tumor angiogenesis. In this study, we investigate the correlation between EGFR mutations and cadherin-5 (CDH5), which is an angiogenic factor, in lung cancer cells. Increased expression CDH5 is observed in lung cancer cells with EGFR mutations. Stable lung cancer cell lines expressing mutant (exon 19 deletion E746-A750, and exon 21 missense mutation L858R) and wild type EGFR genes are established. A significantly higher expression of CDH5 is observed in exon 19 deletion stable lung cancer cells and mouse xenografts. Further studies show that expression of CDH5 is decreased after the inhibition of EGFR and downstream Akt pathways in lung cancer cells with EGFR mutation. In addition, mutant EGFR genes potentiates angiogenesis in lung cancer cells, which is inhibited by CDH5 siRNA, and potentiates migration and invasion in lung cancer cells. Our study shows that mutant EGFR genes are associated with overexpression of CDH5 through increased phosphorylation of EGFR and downstream Akt pathways. Our result may provide an insight into the association of mutant EGFR and CDH5 expression in lung cancer and aid further development of target therapy for NSCLC in the future.	[Hung, Ming-Szu; Li, Ya-Chin; Tsai, Ying-Huang] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Thorac Oncol, Chiayi, Taiwan; [Hung, Ming-Szu] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Hung, Ming-Szu] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan; [Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Chiayi, Taiwan; [Lung, Jr-Hau] Chang Gung Mem Hosp, Dept Med Res, Chiayi, Taiwan; [Lin, Paul-Yann] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Anat Pathol, Chiayi, Taiwan; [Tsai, Ying-Huang] Chang Gung Univ, Coll Med, Dept Resp Care, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Chang Gung University	Hung, MS (corresponding author), Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Thorac Oncol, Chiayi, Taiwan.; Hung, MS (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan.; Hung, MS (corresponding author), Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan.	m12049@adm.cgmh.org.tw			Chang Gung Memorial Hospital, Chiayi, Taiwan (R.O.C.) [CMRPG6B0231, CMRPG6B0232, CMRPG6E0081]	Chang Gung Memorial Hospital, Chiayi, Taiwan (R.O.C.)	This study is supported by grants CMRPG6B0231, CMRPG6B0232 and CMRPG6E0081 (to MSH) in Chang Gung Memorial Hospital, Chiayi, Taiwan (R.O.C.).	Arteaga CL, 2002, ONCOLOGIST, V7, P31; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; Bruns CJ, 2000, CANCER RES, V60, P2926; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Fry SA, 2016, BRIT J CANCER, V114, P1019, DOI 10.1038/bjc.2016.66; Fry SA, 2013, CANCER LETT, V328, P335, DOI 10.1016/j.canlet.2012.10.011; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Hsieh RK, 2005, CHEST, V128, P317, DOI 10.1378/chest.128.1.317; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Labelle M, 2008, CANCER RES, V68, P1388, DOI 10.1158/0008-5472.CAN-07-2706; Lagendijk AK, 2015, CURR TOP DEV BIOL, V112, P325, DOI 10.1016/bs.ctdb.2014.11.024; Li B, 2015, J NEURO-ONCOL, V124, P79, DOI 10.1007/s11060-015-1776-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mao XG, 2013, NEURO-ONCOLOGY, V15, P865, DOI 10.1093/neuonc/not029; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Okabe T, 2007, CANCER RES, V67, P2046, DOI 10.1158/0008-5472.CAN-06-3339; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pomme G, 2015, VIRCHOWS ARCH, V467, P55, DOI 10.1007/s00428-015-1767-y; Reinmuth N, 2008, LUNG CANCER, V62, P193, DOI 10.1016/j.lungcan.2008.03.011; Rezaei M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3367; Rosell R, 2005, LUNG CANCER-J IASLC, V50, P25, DOI 10.1016/j.lungcan.2005.05.017; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Tseng JC, 2014, J CANCER RES CLIN, V140, P61, DOI 10.1007/s00432-013-1544-8; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Zhou C, 2015, ANN ONCOL, V26, P1877, DOI 10.1093/annonc/mdv276; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	36	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158395	10.1371/journal.pone.0158395	http://dx.doi.org/10.1371/journal.pone.0158395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362942	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200068
J	Kamiya, K; Narita, N; Iwaki, S				Kamiya, Kazunobu; Narita, Noriyuki; Iwaki, Sunao			Improved Prefrontal Activity and Chewing Performance as Function of Wearing Denture in Partially Edentulous Elderly Individuals: Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SPATIAL WORKING-MEMORY; CEREBRAL-BLOOD-FLOW; TOOTH LOSS; ORAL-HEALTH; COGNITIVE IMPAIRMENT; MASTICATORY PERFORMANCE; ALZHEIMERS-DISEASE; OCCLUSAL FORCE; NATURAL TEETH	The purpose of this study was to elucidate the effects of wearing a denture on prefrontal activity during chewing performance. We specifically examined that activity in 12 elderly edentulous subjects [63.1 +/- 6.1 years old (mean +/- SD)] and 12 young healthy controls (22.1 +/- 2.3 years old) using functional near-infrared spectroscopy (fNIRS) in order to evaluate the quality of prefrontal functionality during chewing performance under the conditions of wearing a denture and tooth loss, and then compared the findings with those of young healthy controls. fNIRS and electromyography were used simultaneously to detect prefrontal and masticatory muscle activities during chewing, while occlusal force and masticatory score were also examined by use of a food intake questionnaire. A significant increase in prefrontal activity was observed during chewing while wearing a denture, which was accompanied by increased masticatory muscle activity, occlusal force, and masticatory score, as compared with the tooth loss condition. Prefrontal activation during chewing while wearing a denture in the elderly subjects was not much different from that in the young controls. In contrast, tooth loss in the elderly group resulted in marked prefrontal deactivation, accompanied by decreased masticatory muscle activity, occlusal force, and masticatory score, as compared with the young controls. We concluded that intrinsic prefrontal activation during chewing with a denture may prevent prefrontal depression induced by tooth loss in elderly edentulous patients.	[Kamiya, Kazunobu; Narita, Noriyuki] Nihon Univ, Sch Dent, Dept Removable Prosthodont, Matsudo, Chiba, Japan; [Iwaki, Sunao] Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 6, Automot Human Factors Res Ctr, Ibaraki, Japan	Nihon University; National Institute of Advanced Industrial Science & Technology (AIST)	Narita, N (corresponding author), Nihon Univ, Sch Dent, Dept Removable Prosthodont, Matsudo, Chiba, Japan.	narita.noriyuki@nihon-u.ac.jp	Iwaki, Sunao/B-1079-2011	Iwaki, Sunao/0000-0002-7123-7203	JSPS KAKENHI Grant [16591969]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 16591969, https://kaken.nii.ac.jp/d/p/16591969.ja.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinet CT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00272; Araki T, 2014, INT J GERIATR PSYCH, V29, P881, DOI 10.1002/gps.4074; Aras K, 2009, INT J PROSTHODONT, V22, P204; Avlund Kirsten, 2004, Gerodontology, V21, P17, DOI 10.1046/j.1741-2358.2003.00003.x; Banu F, 2016, CLIN IMPLANT DENT R, V18, P580, DOI 10.1111/cid.12336; Batista MJ, 2014, BRAZ ORAL RES, V28, P260, DOI 10.1590/1807-3107BOR-2014.vol28.0040; Bortoluzzi MC, 2012, CONTEMP CLIN DENT, V3, P393, DOI 10.4103/0976-237X.107424; Brambilla M, 2015, BEHAV BRAIN RES, V293, P125, DOI 10.1016/j.bbr.2015.07.037; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Chen Yan, 2009, Zhonghua Kou Qiang Yi Xue Za Zhi, V44, P193; Chiang TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106943; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dable RA, 2013, J CLIN DIAGN RES, V7, P2063, DOI 10.7860/JCDR/2013/6377.3406; Derosiere G, 2014, NEUROIMAGE, V85, P471, DOI 10.1016/j.neuroimage.2013.02.006; Eichner K, 1955, DEUT ZAHNAERZTL Z, V10, P1831; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fleming SM, 2014, BRAIN, V137, P2811, DOI 10.1093/brain/awu221; Fried PJ, 2014, EUR J NEUROSCI, V39, P1973, DOI 10.1111/ejn.12584; Furuta M, 2013, COMMUNITY DENT ORAL, V41, P173, DOI 10.1111/cdoe.12000; Garrett NR, 1996, J PROSTHET DENT, V76, P403, DOI 10.1016/S0022-3913(96)90546-6; Hansson P, 2013, EUR J ORAL SCI, V121, P333, DOI 10.1111/eos.12060; Harty S, 2014, J NEUROSCI, V34, P3646, DOI 10.1523/JNEUROSCI.5308-13.2014; Hasegawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066313; Hatipoglu MG, 2011, GERODONTOLOGY, V28, P302, DOI 10.1111/j.1741-2358.2010.00401.x; Hayasaka K, 2013, J AM GERIATR SOC, V61, P815, DOI 10.1111/jgs.12225; Herrmann MJ, 2008, AM J GERIAT PSYCHIAT, V16, P125, DOI 10.1097/JGP.0b013e3180cc1fbc; Hiraba H, 2005, SOMATOSENS MOT RES, V22, P307, DOI 10.1080/08990220500420525; Hirai T, 1994, Int J Prosthodont, V7, P454; Hirano Y, 2008, NEUROSCI LETT, V436, P189, DOI 10.1016/j.neulet.2008.03.033; Hirano Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/367026; Hirotomi T, 2015, COMMUNITY DENT ORAL, V43, P226, DOI 10.1111/cdoe.12146; Holtzer R, 2011, J GERONTOL A-BIOL, V66, P879, DOI 10.1093/gerona/glr068; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Ichikawa N, 2001, MEDIX, V34, P47; Ikebe K, 2006, INT J PROSTHODONT, V19, P475; Ikebe K, 2012, J DENT, V40, P71, DOI 10.1016/j.jdent.2011.10.007; Jou YT, 2012, J PROSTHO IMPLANTOL, V1, P6; Karton I, 2014, BEHAV BRAIN RES, V271, P89, DOI 10.1016/j.bbr.2014.05.059; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Kim JK, 2013, J DENT SCI, V8, P115, DOI 10.1016/j.jds.2012.12.011; Kimoto K, 2011, J PROSTHODONT RES, V55, P89, DOI 10.1016/j.jpor.2010.09.006; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lexomboon D, 2012, J AM GERIATR SOC, V60, P1951, DOI 10.1111/j.1532-5415.2012.04154.x; Li ZH, 2015, J NEUROSCI METH, V241, P101, DOI 10.1016/j.jneumeth.2014.12.020; Liao X, 2015, J ALZHEIMERS DIS, V48, P463, DOI 10.3233/JAD-150346; Lin JD, 2015, RES DEV DISABIL, V36, P532, DOI 10.1016/j.ridd.2014.10.051; Listl S, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-70; Lund JP, 2006, J COMMUN DISORD, V39, P381, DOI 10.1016/j.jcomdis.2006.06.014; Luo JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120986; Marumo K, 2014, NEUROIMAGE, V85, P518, DOI 10.1016/j.neuroimage.2013.04.050; Minn YK, 2013, J KOREAN MED SCI, V28, P929, DOI 10.3346/jkms.2013.28.6.929; Miura H, 1998, J ORAL REHABIL, V25, P190; Nakajima S, 2015, SCHIZOPHR RES, V164, P164, DOI 10.1016/j.schres.2015.01.043; Narita N, 2009, J PROSTHODONT RES, V53, P126, DOI 10.1016/j.jpor.2009.02.005; Niesten D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-839; Noble JM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0384-x; Nordstrom MA, 2007, ARCH ORAL BIOL, V52, P338, DOI 10.1016/j.archoralbio.2006.09.013; Obayashi S, 2013, NEUROPSYCHOLOGIA, V51, P418, DOI 10.1016/j.neuropsychologia.2012.11.023; Ohsugi H, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-10; Ohtani T, 2015, J AFFECT DISORDERS, V176, P78, DOI 10.1016/j.jad.2015.01.042; Okada E, 2010, ADV EXP MED BIOL, V662, P231, DOI 10.1007/978-1-4419-1241-1_33; Okada N, 2016, ADDICT BIOL, V21, P489, DOI 10.1111/adb.12224; Okamoto M, 2005, NEUROIMAGE, V26, P18, DOI 10.1016/j.neuroimage.2005.01.018; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Okamoto N, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-77; Ono Y, 2015, PSYCHIAT RES-NEUROIM, V233, P1, DOI 10.1016/j.pscychresns.2015.04.003; OSTERBERG T, 1990, COMMUNITY DENT ORAL, V18, P313, DOI 10.1111/j.1600-0528.1990.tb00087.x; Otsuka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/373769; Pu SH, 2015, J AFFECT DISORDERS, V181, P9, DOI 10.1016/j.jad.2015.04.010; Richter MM, 2007, WORLD J BIOL PSYCHIA, V8, P23, DOI 10.1080/15622970600960132; Savikko N, 2013, J AM GERIATR SOC, V61, P849, DOI 10.1111/jgs.12233; Sawa M, 2012, EUR ARCH PSY CLIN N, V262, P493, DOI 10.1007/s00406-012-0296-9; Shoi K, 2014, J ORAL REHABIL, V41, P486, DOI 10.1111/joor.12169; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Singhrao SK, 2014, J ALZHEIMERS DIS, V42, P723, DOI 10.3233/JAD-140387; Spiegel MA, 2013, J EXP PSYCHOL HUMAN, V39, P1326, DOI 10.1037/a0031398; Spraker MB, 2009, CEREB CORTEX, V19, P2640, DOI 10.1093/cercor/bhp015; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Syrjala AMH, 2007, ACTA ODONTOL SCAND, V65, P103, DOI 10.1080/00016350601083521; Takeuchi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141737; TALLGREN A, 1991, J ORAL REHABIL, V18, P285, DOI 10.1111/j.1365-2842.1991.tb00060.x; Tamura M, 1997, PHILOS T ROY SOC B, V352, P737, DOI 10.1098/rstb.1997.0056; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Teixeira FB, 2014, INT J MED SCI, V11, P209, DOI 10.7150/ijms.6801; Tian FH, 2014, NEUROIMAGE, V85, P166, DOI 10.1016/j.neuroimage.2013.07.016; Tomiok H, 2009, NEUROSCI LETT, V451, P252, DOI 10.1016/j.neulet.2008.12.059; Tsakos G, 2015, J AM GERIATR SOC, V63, P91, DOI 10.1111/jgs.13190; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vermeij A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00303; Vermeij A, 2014, NEUROIMAGE, V85, P608, DOI 10.1016/j.neuroimage.2013.04.107; Vermeij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046210; Yan C, 2008, EUR J ORAL SCI, V116, P387, DOI 10.1111/j.1600-0722.2008.00557.x	94	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158070	10.1371/journal.pone.0158070	http://dx.doi.org/10.1371/journal.pone.0158070			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362255	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200038
J	Warris, LT; van den Akker, ELT; Bierings, MB; van den Bos, C; Zwaan, CM; Sassen, SDT; Tissing, WJE; Veening, MA; Pieters, R; van den Heuvel-Eibrink, MM				Warris, Lidewij T.; van den Akker, Erica L. T.; Bierings, Marc B.; van den Bos, Cor; Zwaan, Christian M.; Sassen, Sebastiaan D. T.; Tissing, Wim J. E.; Veening, Margreet A.; Pieters, Rob; van den Heuvel-Eibrink, Marry M.			Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; INSULIN-RESISTANCE; OBESE CHILDREN; INDUCTION CHEMOTHERAPY; HYPERGLYCEMIA; SURVIVORS; RISK; ADOLESCENTS; GLUCOSE; AGE	Although dexamethasone is highly effective in the treatment of pediatric acute lymphoblastic leukemia (ALL), it can cause serious metabolic side effects. Because studies regarding the effects of dexamethasone are limited by their small scale, we prospectively studied the direct effects of treating pediatric ALL with dexamethasone administration with respect to activation of components of metabolic syndrome (MetS); in addition, we investigated whether these side effects were correlated with the level of dexamethasone. Fifty pediatric patients (3-16 years of age) with ALL were studied during a 5-day dexamethasone course during the maintenance phase of the Dutch Childhood Oncology Group ALL-10 and ALL-11 protocols. Fasting insulin, glucose, total cholesterol, HDL, LDL, and triglycerides levels were measured at baseline (before the start of dexamethasone; T1) and on the fifth day of treatment (T2). Dexamethasone trough levels were measured at T2. We found that dexamethasone treatment significantly increased the following fasting serum levels (P<0.05): HDL, LDL, total cholesterol, triglycerides, glucose, and insulin. In addition, dexamethasone increased insulin resistance (HOMA-IR>3.4) from 8% to 85%(P<0.01). Dexamethasone treatment also significantly increased the diastolic and systolic blood pressure. Lastly, dexamethasone trough levels (N = 24) were directly correlated with high glucose levels at T2, but not with other parameters. These results indicate that dexamethasone treatment acutely induces three components of the MetS. Together with the weight gain typically associated with dexamethasone treatment, these factors may contribute to the higher prevalence of MetS and cardiovascular risk among survivors of childhood leukemia who received dexamethasone treatment.	[Warris, Lidewij T.; Zwaan, Christian M.; Sassen, Sebastiaan D. T.; van den Heuvel-Eibrink, Marry M.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol, Rotterdam, Netherlands; [Warris, Lidewij T.; van den Akker, Erica L. T.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Endocrinol, Rotterdam, Netherlands; [van den Bos, Cor] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands; [Veening, Margreet A.] Vrije Univ Amsterdam Med Ctr, Dept Pediat Hematol & Oncol, Amsterdam, Netherlands; [Bierings, Marc B.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Hematol & Oncol, Utrecht, Netherlands; [Tissing, Wim J. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Hematol & Oncol, Groningen, Netherlands; [Warris, Lidewij T.; Bierings, Marc B.; Pieters, Rob; van den Heuvel-Eibrink, Marry M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Groningen	Warris, LT (corresponding author), Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol, Rotterdam, Netherlands.; Warris, LT (corresponding author), Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Endocrinol, Rotterdam, Netherlands.; Warris, LT (corresponding author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.	l.warris@erasmusmc.nl	Sassen, Sebastiaan/AAX-6687-2021		Stichting Kinderen Kankervrij (KiKa) [99]	Stichting Kinderen Kankervrij (KiKa)	This study was funded by Stichting Kinderen Kankervrij (KiKa): Grant 99. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ouf NM, 2015, OBES RES CLIN PRACT, V9, P114, DOI 10.1016/j.orcp.2014.06.004; Ahmed SF, 2002, CLIN ENDOCRINOL, V57, P185, DOI 10.1046/j.1365-2265.2002.01580.x; Allard P, 2003, CLIN CHEM, V49, P644, DOI 10.1373/49.4.644; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; [Anonymous], 2011, GLOB IDF ISPAG GUID; Belgaumi AF, 2003, CANCER, V97, P2898, DOI 10.1002/cncr.11390; Brar PC, 2014, CLIN PEDIATR, V53, P771, DOI 10.1177/0009922814528571; Centraal Bureau voor de Statistiek, 2015, AD OB DUTCH CHILDR; Chow EJ, 2013, PEDIATR BLOOD CANCER, V60, P621, DOI 10.1002/pbc.24364; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; d'Annunzio G, 2009, DIABETOLOGIA, V52, pS464; Esbenshade AJ, 2013, PEDIATR BLOOD CANCER, V60, P1287, DOI 10.1002/pbc.24489; Faienza MF, 2015, ENDOCRINE, V49, P353, DOI 10.1007/s12020-014-0395-7; Fredriks AM, 2005, EUR J PEDIATR, V164, P216, DOI 10.1007/s00431-004-1586-7; Howard SC, 2002, BLOOD REV, V16, P225, DOI 10.1016/S0268-960X(02)00042-5; Jung HS, 2012, DIABETES RES CLIN PR, V95, P275, DOI 10.1016/j.diabres.2011.08.029; Kamdem LK, 2008, PHARMACOGENET GENOM, V18, P507, DOI 10.1097/FPC.0b013e3282fc5801; Karakurt H, 2012, PEDIATR HEMAT ONCOL, V29, P551, DOI 10.3109/08880018.2012.708892; Kawedia JD, 2011, BLOOD, V117, P2340, DOI 10.1182/blood-2010-10-311969; Kero AE, 2016, CANCER EPIDEMIOL, V41, P42, DOI 10.1016/j.canep.2016.01.009; Keskin M, 2005, PEDIATRICS, V115, pE500, DOI 10.1542/peds.2004-1921; Kufe D.W., 2003, CANC MED 6; Lowas SR, 2009, PEDIATR BLOOD CANCER, V52, P814, DOI 10.1002/pbc.21980; Mattano LA, 2012, LANCET ONCOL, V13, P906, DOI 10.1016/S1470-2045(12)70274-7; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGrath P, 2010, COMPR CHILD ADOLES N, V33, P5, DOI 10.3109/01460860903486572; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Navarro-Millan I, 2013, ARTHRITIS RHEUM-US, V65, P1430, DOI 10.1002/art.37916; Nottage KA, 2014, BRIT J HAEMATOL, V165, P364, DOI 10.1111/bjh.12754; Reilly JJ, 2001, J CLIN ENDOCR METAB, V86, P3742, DOI 10.1210/jc.86.8.3742; ROSNER B, 1993, J PEDIATR-US, V123, P871, DOI 10.1016/S0022-3476(05)80382-8; Russell NDF, 2015, DIABETOLOGIA, V58, P1708, DOI 10.1007/s00125-015-3600-1; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stegenga ME, 2008, BLOOD, V112, P82, DOI 10.1182/blood-2007-11-121723; TEMPEL DL, 1994, J NEUROENDOCRINOL, V6, P479, DOI 10.1111/j.1365-2826.1994.tb00611.x; Turina M, 2005, CRIT CARE MED, V33, P1624, DOI 10.1097/01.CCM.0000170106.61978.D8; Vaccaro O, 2005, DIABETES CARE, V28, P1786, DOI 10.2337/diacare.28.7.1786; van der Aa MP, 2014, CLIN PEDIATR, V53, P337, DOI 10.1177/0009922813509480; Veerman AJ, 2009, LANCET ONCOL, V10, P957, DOI 10.1016/S1470-2045(09)70228-1; Wallace AM, 2003, CLIN ENDOCRINOL, V58, P770, DOI 10.1046/j.1365-2265.2003.01790.x; Warris LT, 2016, J CLIN ONCOL, V34, P2287, DOI 10.1200/JCO.2015.66.0761; Warris LT, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.2495.2495; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404; Zalachoras I, 2013, P NATL ACAD SCI USA, V110, P7910, DOI 10.1073/pnas.1219411110	44	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158225	10.1371/journal.pone.0158225	http://dx.doi.org/10.1371/journal.pone.0158225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362350	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200050
J	Zou, Y; Li, QL; Jiang, LZ; Guo, CX; Li, YB; Yu, Y; Li, Y; Duan, JC; Sun, ZW				Zou, Yang; Li, Qiuling; Jiang, Lizhen; Guo, Caixia; Li, Yanbo; Yu, Yang; Li, Yang; Duan, Junchao; Sun, Zhiwei			DNA Hypermethylation of CREB3L1 and Bcl-2 Associated with the Mitochondrial-Mediated Apoptosis via PI3K/Akt Pathway in Human BEAS-2B Cells Exposure to Silica Nanoparticles	PLOS ONE			English	Article							BREAST-CANCER CELLS; CONSUMER PRODUCTS; METHYLATION; TOXICITY; NANOTECHNOLOGY; NANOMATERIALS; MECHANISMS; GENOTOXICITY	The toxic effects of silica nanoparticles (SiNPs) are raising concerns due to its widely applications in biomedicine. However, current information about the epigenetic toxicity of SiNPs is insufficient. In this study, the epigenetic regulation of low-dose exposure to SiNPs was evaluated in human bronchial epithelial BEAS-2B cells over 30 passages. Cell viability was decreased in a dose- and passage-dependent manner. The apoptotic rate, the expression of caspase-9 and caspase-3, were significantly increased induced by SiNPs. HumanMethylation450 BeadChip analysis identified that the PI3K/Akt as the primary apoptosis-related pathway among the 25 significant altered processes. The differentially methylated sites of PI3K/Akt pathway involved 32 differential genes promoters, in which the CREB3L1 and Bcl-2 were significant hypermethylated. The methyltransferase inhibitor, 5-aza, further verified that the DNA hypermethylation status of CREB3L1 and Bcl-2 were associated with downregulation of their mRNA levels. In addition, mitochondrial-mediated apoptosis was triggered by SiNPs via the downregulation of PI3K/Akt/CREB/Bcl-2 signaling pathway. Our findings suggest that long-term low-dose exposure to SiNPs could lead to epigenetic alterations.	[Zou, Yang; Li, Qiuling; Jiang, Lizhen; Guo, Caixia; Li, Yanbo; Yu, Yang; Li, Yang; Duan, Junchao; Sun, Zhiwei] Capital Med Univ, Sch Publ Hlth, Dept Toxicol & Sanit Chem, Beijing 100069, Peoples R China; [Zou, Yang; Li, Qiuling; Jiang, Lizhen; Guo, Caixia; Li, Yanbo; Yu, Yang; Li, Yang; Duan, Junchao; Sun, Zhiwei] Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing 100069, Peoples R China	Capital Medical University; Capital Medical University	Duan, JC; Sun, ZW (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Toxicol & Sanit Chem, Beijing 100069, Peoples R China.; Duan, JC; Sun, ZW (corresponding author), Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing 100069, Peoples R China.	jcduan@ccmu.edu.cn; zwsun@ccmu.edu.cn			National Natural Science Foundation of China [81571130090, 81230065, 81502830]; Special Project of Beijing Municipal Science & Technology Commission [KZ201410025022]; Training Programme Foundation for the Talents by the Beijing Ministry of Education [2014000020124G152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Project of Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Training Programme Foundation for the Talents by the Beijing Ministry of Education	This work was supported by National Natural Science Foundation of China (No. 81571130090, 81230065, 81502830), Special Project of Beijing Municipal Science & Technology Commission (KZ201410025022), and Training Programme Foundation for the Talents by the Beijing Ministry of Education (2014000020124G152).	Al-Kaabi A, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/260549; Badr G, 2014, CELL PHYSIOL BIOCHEM, V34, P1640, DOI 10.1159/000366366; Bai WL, 2015, INT J NANOMED, V10, P5561, DOI 10.2147/IJN.S88059; Balansky R, 2013, MUTAT RES-FUND MOL M, V751, P42, DOI 10.1016/j.mrfmmm.2013.08.006; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen QQ, 2013, INT J NANOMED, V8, P1129, DOI 10.2147/IJN.S42242; Cho Y, 2012, EXP BIOL MED, V237, P1387, DOI 10.1258/ebm.2012.012244; Choi AO, 2008, J MOL MED-JMM, V86, P291, DOI 10.1007/s00109-007-0274-2; Coccini T, 2013, HISTOL HISTOPATHOL, V28, P195, DOI 10.14670/HH-28.195; Creson TK, 2009, J MOL NEUROSCI, V37, P123, DOI 10.1007/s12031-008-9122-2; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Duan JC, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0050-8; Duan JC, 2013, BIOMATERIALS, V34, P5853, DOI 10.1016/j.biomaterials.2013.04.032; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eom HJ, 2014, TOXICOL LETT, V229, P311, DOI 10.1016/j.toxlet.2014.05.019; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fard JK, 2015, ADV PHARM BULL, V5, P447, DOI 10.15171/apb.2015.061; Geng WJ, 2016, J NANOPART RES, V18, DOI 10.1007/s11051-015-3305-x; Golbamaki N, 2015, NANOSCALE, V7, P2154, DOI 10.1039/c4nr06670g; Gong CM, 2010, BIOCHEM BIOPH RES CO, V397, P397, DOI 10.1016/j.bbrc.2010.05.076; Guo CX, 2015, INT J NANOMED, V10, P1463, DOI 10.2147/IJN.S76114; Hansen SF, 2008, ECOTOXICOLOGY, V17, P438, DOI 10.1007/s10646-008-0210-4; Iavicoli I, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-78; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Malla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013731; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Napierska D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-39; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Perreault F, 2012, SCI TOTAL ENVIRON, V441, P117, DOI 10.1016/j.scitotenv.2012.09.065; Piao MJ, 2011, TOXICOL LETT, V201, P92, DOI 10.1016/j.toxlet.2010.12.010; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6; Shridhar K, 2016, ORAL ONCOL, V53, P1, DOI 10.1016/j.oraloncology.2015.11.012; Shyamasundar S, 2015, EPIGENOMICS-UK, V7, P395, DOI 10.2217/epi.15.3; Siddiqui MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069534; Sui XB, 2015, CANCER LETT, V360, P106, DOI 10.1016/j.canlet.2015.02.009; Tucci P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.76; Vance ME, 2015, BEILSTEIN J NANOTECH, V6, P1769, DOI 10.3762/bjnano.6.181; Vecchio G, 2014, SMALL, V10, P2721, DOI 10.1002/smll.201303359; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101572; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061346	44	27	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158475	10.1371/journal.pone.0158475	http://dx.doi.org/10.1371/journal.pone.0158475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362941	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200079
J	Castley, A; Williams, L; James, I; Guelfi, G; Berry, C; Nolan, D				Castley, Alison; Williams, Leah; James, Ian; Guelfi, George; Berry, Cassandra; Nolan, David			Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; IMMUNE ACTIVATION; MONOCYTE ACTIVATION; SOLUBLE CD14; T-CELL; VASCULAR INFLAMMATION; OXIDIZED LDL; THERAPY; RALTEGRAVIR; INDIVIDUALS	We investigate the associations of three established plasma biomarkers in the context of HIV and treatment-related variables including a comprehensive cardiovascular disease risk assessment, within a large ambulatory HIV cohort. Patients were recruited in 2010 to form the Royal Perth Hospital HIV/CVD risk cohort. Plasma sCD14, sCD163 and CXCL10 levels were measured in 475 consecutive patients with documented CVD risk (age, ethnicity, gender, smoking, blood pressure, BMI, fasting metabolic profile) and HIV treatment history including immunological/virological outcomes. The biomarkers assessed showed distinct associations with virological response: CXCL10 strongly correlated with HIV-1 RNA (p<0.001), sCD163 was significantly reduced among 'aviraemic' patients only (p = 0.02), while sCD14 was unaffected by virological status under 10,000 copies/mL (p>0.2). Associations between higher sCD163 and protease inhibitor therapy (p = 0.05) and lower sCD14 with integrase inhibitor therapy (p = 0.02) were observed. Levels of sCD163 were also associated with CVD risk factors (age, ethnicity, HDL, BMI), with a favourable influence of Framingham score <10% (p = 0.04). Soluble CD14 levels were higher among smokers (p = 0.002), with no effect of other CVD risk factors, except age (p = 0.045). Our findings confirm CXCL10, sCD163 and sCD14 have distinct associations with different aspects of HIV infection and treatment. Levels of CXCL10 correlated with routinely monitored variables, sCD163 levels reflect a deeper level of virological suppression and influence of CVD risk factors, while sCD14 levels were not associated with routinely monitored variables, with evidence of specific effects of smoking and integrase inhibitor therapy warranting further investigation.	[Castley, Alison; Williams, Leah; Guelfi, George; Nolan, David] Royal Perth Hosp, Dept Clin Immunol, PathWest Lab Med, Perth, WA, Australia; [Castley, Alison; Berry, Cassandra] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [James, Ian; Nolan, David] Murdoch Univ, IIID, Perth, WA, Australia	Royal Perth Hospital; Murdoch University; Murdoch University	Nolan, D (corresponding author), Royal Perth Hosp, Dept Clin Immunol, PathWest Lab Med, Perth, WA, Australia.; Nolan, D (corresponding author), Murdoch Univ, IIID, Perth, WA, Australia.	David.Nolan@health.wa.gov.au	Berry, Cassandra/AAX-7145-2020	Berry, Cassandra/0000-0003-0768-0857	Practitioner Research Fellowship by Royal Perth Hospital Medical Research Foundation	Practitioner Research Fellowship by Royal Perth Hospital Medical Research Foundation	This investigation was funded with support from a Practitioner Research Fellowship awarded to Dr. David Nolan provided by the Royal Perth Hospital Medical Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; Angelovich TA, 2015, JAIDS-J ACQ IMM DEF, V69, P11, DOI 10.1097/QAI.0000000000000559; Anzinger JJ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/569819; Arenaccio C, 2014, J VIROL, V88, P11529, DOI 10.1128/JVI.01712-14; Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Buechler Christa, 2013, Inflammation & Allergy Drug Targets, V12, P391; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Byakwaga H, 2011, J INFECT DIS, V204, P1532, DOI 10.1093/infdis/jir559; Castley A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115226; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Cioe PA, 2015, JAIDS-J ACQ IMM DEF, V70, P400, DOI 10.1097/QAI.0000000000000759; Duong M, 2006, HIV CLIN TRIALS, V7, P41, DOI 10.1310/7381-M1YD-RTV5-4RYT; Etzerodt A, 2014, J BIOL CHEM, V289, P778, DOI 10.1074/jbc.M113.520213; Fitch KV, 2013, J INFECT DIS, V208, P1737, DOI 10.1093/infdis/jit508; Fjeldborg K, 2014, J MOL ENDOCRINOL, V53, P227, DOI 10.1530/JME-14-0089; Fjeldborg K, 2013, OBESITY, V21, P2437, DOI 10.1002/oby.20376; Funderburg NT, 2015, JAIDS-J ACQ IMM DEF, V68, P396, DOI 10.1097/QAI.0000000000000478; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Hileman CO, 2015, J INFECT DIS, V212, P345, DOI 10.1093/infdis/jiv004; Ilter A, 2015, INT J CLIN EXP MED, V8, P9394; Kahle EM, 2015, J INFECT DIS, V211, P1451, DOI 10.1093/infdis/jiu621; Kelesidis T, 2015, CLIN INFECT DIS, V61, P651, DOI 10.1093/cid/civ327; Lake JE, 2014, HIV MED, V15, P431, DOI 10.1111/hiv.12128; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; McKibben RA, 2015, J INFECT DIS, V211, P1219, DOI 10.1093/infdis/jiu594; McKinnon E, 2015, HIV ME IN PRESS 1104; Mendez-Lagares G, 2013, J INFECT DIS, V207, P1221, DOI 10.1093/infdis/jit025; Moreno JA, 2012, EUR HEART J, V33, P252, DOI 10.1093/eurheartj/ehr123; Noel N, 2014, AIDS, V28, P467, DOI 10.1097/QAD.0000000000000174; Ostrowski SR, 2008, SCAND J IMMUNOL, V68, P652, DOI 10.1111/j.1365-3083.2008.02184.x; Petoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x; Ramirez LA, 2014, J LEUKOCYTE BIOL, V96, P1055, DOI 10.1189/jlb.3A0414-232RR; Reiner AP, 2013, ARTERIOSCL THROM VAS, V33, P158, DOI 10.1161/ATVBAHA.112.300421; Reus S, 2013, JAIDS-J ACQ IMM DEF, V62, P129, DOI 10.1097/QAI.0b013e3182745ab0; Ruggiero A, 2015, EBIOMEDICINE, V2, P1153, DOI 10.1016/j.ebiom.2015.07.025; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sax PE, 2013, CLIN INFECT DIS, V56, P1344, DOI 10.1093/cid/cit008; Simmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bc; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Wada NI, 2015, AIDS, V29, P463, DOI 10.1097/QAD.0000000000000545; Younas M, 2015, HIV ME IN PRESS 1010; Zidar DA, 2015, JAIDS-J ACQ IMM DEF, V69, P154, DOI 10.1097/QAI.0000000000000566	48	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158169	10.1371/journal.pone.0158169	http://dx.doi.org/10.1371/journal.pone.0158169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355513	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400035
J	Doyle, JS; Grebely, J; Spelman, T; Alavi, M; Matthews, GV; Thompson, AJ; Dore, GJ; Hellard, ME				Doyle, Joseph S.; Grebely, Jason; Spelman, Tim; Alavi, Maryam; Matthews, Gail V.; Thompson, Alexander J.; Dore, Gregory J.; Hellard, Margaret E.		ATAHC Study Grp	Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort	PLOS ONE			English	Article							INJECTION-DRUG USERS; VIRUS-INFECTION; PEGYLATED INTERFERON-ALPHA-2B; SPONTANEOUS CLEARANCE; HCV INFECTION; IQOLA PROJECT; HEALTH SURVEY; MANAGEMENT; THERAPY; VALIDATION	Aim Despite effective treatment for recent hepatitis C (HCV) infection, side-effects and adherence concerns limit its use among people who inject drugs (PWID). This study evaluated health-related quality of life (HRQoL) and social functioning following infection and during recent HCV treatment. Methods The Australian Trial of Acute Hepatitis C studied the natural history and treatment of recent HCV infection. HRQoL (SF-12v2) and social functioning (Opiate Treatment Index score) were measured over 48 weeks and their impact on treatment uptake, adherence and virological response were assessed. Results Of 163 participants, 111 received treatment (HCV n = 74, SVR 55%; HCV/HIV n = 37, SVR 74%). 116 (71%) were male, 124 (76%) ever injected drugs, with 55 (36%) injecting recently and 28/55 (51%) reported needle/syringe sharing. At baseline, median physical and mental HRQoL was 54 units (IQR 46-58) and 46 (35-54) (reference median: 50), respectively, and median social functioning score was 11 units (7-17). Higher social function (< 10 vs >= 15) predicted increased treatment uptake (AOR 3.43, 95% CI 1.01-11.6, p = 0.048) and higher SVR (AOR 5.11, 95% CI 1.30-20.15, p = 0.020). After adjustment, treated participants had lower physical (-4.90 units, 95% CI -6.33 to -3.48, p<0.001) and mental HRQoL (-3.7 units, 95% CI -5.55 to -1.86, p<0.001) at on-treatment visits, but HRQoL returned to baseline levels during follow-up. Conclusions Social functioning can predict recent HCV treatment uptake and SVR. Efforts to maximise social stability may improve treatment response. Pegylated-interferon treatment is associated with reduced HRQoL on-treatment in an already vulnerable population of PWID that would be better served by interferon-free regimens particularly in treated target at PWID to prevent transmission.	[Doyle, Joseph S.; Spelman, Tim; Hellard, Margaret E.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Doyle, Joseph S.; Hellard, Margaret E.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Doyle, Joseph S.; Hellard, Margaret E.] Monash Univ, Sch Populat Hlth & Prevent Med, Melbourne, Vic, Australia; [Grebely, Jason; Alavi, Maryam; Matthews, Gail V.; Dore, Gregory J.] UNSW Australia, Kirby Inst, Viral Hepatitis Clin Res Program, Sydney, NSW, Australia; [Matthews, Gail V.; Dore, Gregory J.] St Vincents Hosp, Infect Dis Unit, Sydney, NSW, Australia; [Thompson, Alexander J.] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Thompson, Alexander J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Burnet Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; St Vincent's Hospital Melbourne; University of Melbourne	Doyle, JS (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.; Doyle, JS (corresponding author), Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia.; Doyle, JS (corresponding author), Monash Univ, Sch Populat Hlth & Prevent Med, Melbourne, Vic, Australia.	j.doyle@burnet.edu.au	Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/AAF-6071-2022; matthews, gail/AAG-8626-2022; matthews, gail/AFL-8501-2022; dolan, kate a/G-7859-2017; Dore, Gregory John/ABD-5665-2021; White, Peter/C-6573-2012	Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; dolan, kate a/0000-0002-9848-807X; Dore, Gregory John/0000-0002-4741-2622; Matthews, Gail/0000-0002-1048-6396; Doyle, Joseph S/0000-0001-7198-0833; White, Peter/0000-0002-6046-9631	National Institutes of Health [RO1 DA 15999-01]; Roche Pharmaceuticals; National Health and Medical Research Council; Australian Government Department of Health and Ageing	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche Pharmaceuticals(Roche Holding); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The ATAHC Study was funded by the National Institutes of Health (grant RO1 DA 15999-01). Roche Pharmaceuticals supplied financial support for pegylated-IFN alfa-2a/ribavirin use in the ATAHC Study. JD, JG, GM, AT, GD, and MH acknowledge fellowship support from the National Health and Medical Research Council. JD, TS and MH acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program (Department of Health, Victoria, Australia) to the Burnet Institute. The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. None of the funding sources had any involvement in the conduct, analysis or reporting of the study. Roche Pharmaceuticals had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi M, 2012, J GASTROEN HEPATOL, V27, P957, DOI 10.1111/j.1440-1746.2011.07035.x; Bjornsson E, 2009, SCAND J GASTROENTERO, V44, P878, DOI 10.1080/00365520902898135; Bonkovsky HL, 2007, J HEPATOL, V46, P420, DOI 10.1016/j.jhep.2006.10.009; Butt AA, 2007, GUT, V56, P385, DOI 10.1136/gut.2006.099150; Dalgard O, 2005, CLIN INFECT DIS, V40, pS336, DOI 10.1086/427449; DARKE S, 1992, BRIT J ADDICT, V87, P733; De Rosa FG, 2006, J ANTIMICROB CHEMOTH, V57, P360, DOI 10.1093/jac/dki458; Deterding K, 2013, LANCET INFECT DIS, V13, P497, DOI 10.1016/S1473-3099(13)70059-8; Dietze P, 2010, ADDICTION, V105, P2141, DOI 10.1111/j.1360-0443.2010.03090.x; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Doyle J. S., 2012, Current Hepatitis Reports, V11, P221, DOI 10.1007/s11901-012-0143-5; Foster GR, 2009, J VIRAL HEPATITIS, V16, P605, DOI 10.1111/j.1365-2893.2009.01154.x; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gidding HF, 2011, MED J AUSTRALIA, V194, P398, DOI 10.5694/j.1326-5377.2011.tb03029.x; Grebely J, 2010, DRUG ALCOHOL DEPEN, V107, P244, DOI 10.1016/j.drugalcdep.2009.09.015; Grebely J, 2011, NAT REV GASTRO HEPAT, V8, P265, DOI 10.1038/nrgastro.2011.32; Grebely J, 2011, J HEPATOL, V55, P76, DOI 10.1016/j.jhep.2010.10.033; Hellard M, 2014, HEPATOLOGY, V59, P366, DOI 10.1002/hep.26623; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; John-Baptiste AA, 2009, AM J GASTROENTEROL, V104, P2439, DOI 10.1038/ajg.2009.346; Karaivazoglou K, 2010, ANN HEPATOL, V9, P419, DOI 10.1016/S1665-2681(19)31618-7; Matthews GV, 2009, CLIN INFECT DIS, V48, P650, DOI 10.1086/596770; Papastergiou V, 2011, EUROPEAN J INTERNAL, V22, pS46, DOI http://dx.doi.org/10.1016/S0953-6205%2811%2960190-8; Reddy KR, 2009, J HEPATOL, V50, P402, DOI 10.1016/j.jhep.2008.11.006; Rodrigue JR, 2011, HEPATOLOGY, V53, P1468, DOI 10.1002/hep.24248; Santantonio T, 2005, J HEPATOL, V42, P329, DOI 10.1016/j.jhep.2004.11.021; Schulte B, 2010, DRUG ALCOHOL DEPEN, V109, P248, DOI 10.1016/j.drugalcdep.2010.01.009; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Snow KK, 2010, ALIMENT PHARM THER, V31, P719, DOI 10.1111/j.1365-2036.2010.04235.x; Spiegel BMR, 2005, HEPATOLOGY, V41, P790, DOI 10.1002/hep.20659; Sulkowski MS, 2011, NAT REV GASTRO HEPAT, V8, P212, DOI 10.1038/nrgastro.2011.21; Teuber G, 2008, J HEPATOL, V49, P923, DOI 10.1016/j.jhep.2008.07.025; Thein HH, 2006, J URBAN HEALTH, V83, P275, DOI 10.1007/s11524-005-9015-4; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wiegand J, 2006, HEPATOLOGY, V43, P250, DOI 10.1002/hep.21043; Younossi Z, 2007, HEPATOLOGY, V45, P806, DOI 10.1002/hep.21565	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0150655	10.1371/journal.pone.0150655	http://dx.doi.org/10.1371/journal.pone.0150655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355323	Green Published, gold			2022-12-27	WOS:000378859400001
J	Hemminki, K; Liu, XD; Ji, JG; Forsti, A				Hemminki, Kari; Xiangdong Liu; Jianguang Ji; Foersti, Asta			Origin of B-Cell Neoplasms in Autoimmune Disease	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; METAANALYSIS; DIAGNOSIS; SUBTYPE	Autoimmune diseases (ADs) are associated with a number of B-cell neoplasms but the associations are selective in regard to the type of neoplasm and the conferred risks are variable. So far no mechanistic bases for these differential associations have been demonstrated. We speculate that developmental origin of B-cells might propose a mechanistic rationale for their carcinogenic response to autoimmune stimuli and tested the hypothesis on our previous studies on the risks of B-cell neoplasms after any of 33 ADs. We found that predominantly germinal center (GC)-derived B-cells showed multiple associations with ADs: diffuse large B cell lymphoma associated with 15 ADs, follicular lymphoma with 7 ADs and Hodgkin lymphoma with 11 ADs. Notably, these neoplasms shared significant associations with 5 ADs (immune thrombocytopenic purpura, polymyositis/dermatomyositis, rheumatoid arthritis, Sjogren syndrome and systemic lupus erythematosis). By contrast, primarily non-GC neoplasms, acute lymphocytic leukemia, chronic lymphocytic leukemia and myeloma associated with 2 ADs only and mantle cell lymphoma with 1 AD. None of the neoplasms shared associated ADs. These data may suggest that autoimmune stimulation critically interferes with the rapid cell division, somatic hypermutation, class switch recombination and immunological selection of maturing B-cell in the GC and delivers damage contributing to transformation.	[Hemminki, Kari; Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Neuenheimer Feld 580, D-69120 Heidelberg, Germany; [Hemminki, Kari; Xiangdong Liu; Jianguang Ji; Foersti, Asta] Lund Univ, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden; [Xiangdong Liu] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Dept Measles, Beijing, Peoples R China	Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Hemminki, K (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.; Hemminki, K (corresponding author), Lund Univ, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden.	k.hemminki@dkfz.de	Ji, Jianguang/E-9579-2011	Ji, Jianguang/0000-0003-0324-9496	Multiple Myeloma Research Foundation; German Ministry of Education and Science [01ZX1309B]; Deutsche Krebshilfe	Multiple Myeloma Research Foundation; German Ministry of Education and Science; Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Multiple Myeloma Research Foundation, the German Ministry of Education and Science (01ZX1309B) and Deutsche Krebshilfe.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Fallah M, 2014, ANN ONCOL, V25, P2025, DOI 10.1093/annonc/mdu365; Fallah M, 2014, ANN ONCOL, V25, P1397, DOI 10.1093/annonc/mdu144; Forabosco P, 2009, EUR J HUM GENET, V17, P236, DOI 10.1038/ejhg.2008.163; Goldin LR, 2009, INT J CANCER, V124, P1497, DOI 10.1002/ijc.24141; Hemminki K, 2013, BRIT J HAEMATOL, V161, P677, DOI 10.1111/bjh.12330; Hemminki K, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-59; Kruszka P, 2009, AM FAM PHYSICIAN, V79, P465; Li YR, 2015, NAT MED, V21, P1018, DOI 10.1038/nm.3933; Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P130, DOI 10.1093/jncimonographs/lgu013; Seifert Marc, 2013, Methods Mol Biol, V971, P1, DOI 10.1007/978-1-62703-269-8_1; Smedby KE, 2006, JNCI-J NATL CANCER I, V98, P51, DOI 10.1093/jnci/djj004; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	15	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158360	10.1371/journal.pone.0158360	http://dx.doi.org/10.1371/journal.pone.0158360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355450	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400054
J	Lin, HR; Shen, L; Zhang, XJ; Xie, JH; Hao, HX; Zhang, YX; Chen, ZH; Yamamoto, H; Liao, WJ; Bin, JP; Cao, SP; Huang, XB; Liao, YL				Lin, Hairuo; Shen, Liang; Zhang, Xiajun; Xie, Jiahe; Hao, Huixin; Zhang, Yingxue; Chen, Zhenhuan; Yamamoto, Hiroshi; Liao, Wangjun; Bin, Jianping; Cao, Shiping; Huang, Xiaobo; Liao, Yulin			HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-Overload	PLOS ONE			English	Article							STIMULATES MACROPHAGES; MYOCARDIAL APOPTOSIS; HEART-FAILURE; HYPERTROPHY; RECEPTOR; EXPRESSION; RELEASE; PROTEIN; INFLAMMATION; PROMOTES	High-mobility group box1 (HMGB1) exerts effects on inflammation by binding to receptor for advanced glycation end products (RAGE) or Toll-like receptor 4. Considering that inflammation is involved in pressure overload-induced cardiac hypertrophy, we herein attempted to investigate whether HMGB1 plays a role in myocardial hypertrophy in RAGE knockout mice as well as in the growth and apoptosis of cardiomyocytes. The myocardial expression of RAGE was not significantly changed while TLR4 mRNA was upregulated in response to transverse aortic constriction (TAC) for 1 week. The myocardial expression of HMGB1 protein was markedly increased in TAC group when compared to the sham group. Heart weight to body weight ratio (HW/BW) and lung weight to body weight ratio (LW/BW) were evaluated in RAGE knockout (KO) and wild-type (WT) mice 1 week after TAC. Significant larger HW/BW and LW/BW ratios were found in TAC groups than the corresponding sham groups, but no significant difference was found between KO and WT TAC mice. Similar results were also found when TAC duration was extended to 4 weeks. Cultured neonatal rat cardiomyocytes were treated with different concentrations of recombinant HMGB1, then cell viability was determined using MTT and CCK8 assays and cell apoptosis was determined by Hoechst staining and TUNEL assay. The results came out that HMGB1 exerted no influence on viability or apoptosis of cardiomyocytes. Besides, the protein expression levels of Bax and Bcl2 in response to different concentrations of HMGB1 were similar. These findings indicate that HMGB1 neither exerts influence on cardiac remodeling by binding to RAGE nor induces apoptosis of cardiomyocytes under physiological condition.	[Lin, Hairuo; Shen, Liang; Zhang, Xiajun; Xie, Jiahe; Hao, Huixin; Zhang, Yingxue; Chen, Zhenhuan; Bin, Jianping; Cao, Shiping; Huang, Xiaobo; Liao, Yulin] Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China; [Shen, Liang] Jiaxing Univ, Affiliated Hosp 1, Dept Cardiol, Jiaxing, Zhejiang, Peoples R China; [Liao, Wangjun] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou 510515, Guangdong, Peoples R China; [Yamamoto, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan	Southern Medical University - China; Jiaxing University; Southern Medical University - China; Kanazawa University	Liao, YL (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China.	liao18@msn.com	Liao, Yulin/AAP-6315-2021					Bangert A, 2016, P NATL ACAD SCI USA, V113, pE155, DOI 10.1073/pnas.1522288113; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen HM, 2014, AM J CHINESE MED, V42, P785, DOI 10.1142/S0192415X14500505; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Ding HS, 2013, GENE, V527, P389, DOI 10.1016/j.gene.2013.05.041; Ehrentraut H, 2011, EUR J HEART FAIL, V13, P602, DOI 10.1093/eurjhf/hfr035; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Funayama A, 2013, CARDIOVASC RES, V99, P657, DOI 10.1093/cvr/cvt128; Glezeva N, 2014, HEART FAIL REV, V19, P681, DOI 10.1007/s10741-013-9405-8; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Herzog C, 2014, CARDIOVASC RES, V101, P400, DOI 10.1093/cvr/cvt275; Jhun J, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0663-1; Jia Z, 2014, HMGB1 IS INVOLVED PR, V2014; Jiang DS, 2014, HYPERTENSION, V63, P96, DOI 10.1161/HYPERTENSIONAHA.113.01506; Kamo N, 2013, HEPATOLOGY, V58, P351, DOI 10.1002/hep.26320; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Li XX, 2015, ONCOTARGET, V6, P18829, DOI 10.18632/oncotarget.4774; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Luo T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0342-4; Melis MHM, 2013, CELL DEATH DIFFER, V20, P765, DOI 10.1038/cdd.2013.8; Meng QB, 2014, TUMOR BIOL, V35, P12265, DOI 10.1007/s13277-014-2535-3; MOSEVITSKY MI, 1989, EUR J BIOCHEM, V185, P303, DOI 10.1111/j.1432-1033.1989.tb15116.x; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Nakamura Y, 2015, J ATHEROSCLER THROMB, V22, P570, DOI 10.5551/jat.27235; Narayanan KB, 2015, APOPTOSIS, V20, P196, DOI 10.1007/s10495-014-1073-1; Narumi T, 2015, J MOL CELL CARDIOL, V82, P1, DOI 10.1016/j.yjmcc.2015.02.018; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Su FF, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/805149; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Wang WK, 2014, J CELL MOL MED, V18, P2311, DOI 10.1111/jcmm.12399; Wei X, 2015, CIRCULATION, V131, P1506, DOI 10.1161/CIRCULATIONAHA.114.013789; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Xu X, 2014, SCAND J IMMUNOL, V79, P386, DOI 10.1111/sji.12174; Xuan WL, 2011, CARDIOVASC RES, V92, P385, DOI 10.1093/cvr/cvr221; Yan L, 2014, ARTERIOSCL THROM VAS, V34, P1399, DOI 10.1161/ATVBAHA.114.303508; Yoshida T, 2014, J MOL CELL CARDIOL, V75, P141, DOI 10.1016/j.yjmcc.2014.07.007; Zeng Z, 2014, CLIN SCI, V127, P435, DOI 10.1042/CS20130716; Zhang L, 2015, J CELL MOL MED; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015	41	8	8	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158514	10.1371/journal.pone.0158514	http://dx.doi.org/10.1371/journal.pone.0158514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355349	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400072
J	Ranjith, AP; Quicke, DLJ; Saleem, UKA; Butcher, BA; Zaldivar-Riveron, A; Nasser, M				Ranjith, A. P.; Quicke, Donald L. J.; Saleem, U. K. A.; Butcher, Buntika A.; Zaldivar-Riveron, Alejandro; Nasser, M.			Entomophytophagy ('Sequential Predatory, then Phytophagous Behaviour') in an Indian Braconid 'Parasitoid' Wasp (Hymenoptera): Specialized Larval Morphology, Biology and Description of a New Species	PLOS ONE			English	Article							MESOSTOINAE; STRATEGIES; GENUS	The vast majority of braconid wasps are parasitoids of other insects. Although a few cases of pure phytophagy (primary gall production and seed predation) are known, no previous entomophytophagous species (i.e. ones that display entomophagy and phytophagy sequentially), has been discovered among braconids. We describe the detailed biology and specialized larval morphology for the first confirmed entomophytophagous braconid species. Leaf galls on Garuga pinnata Roxb. (Burseraceae) in India, induced by the psyllid, Phacopteron lentiginosum Buckton (Hemiptera: Psylloidea, Phacopteronidae) were sampled throughout a period of several months and found to suffer a high level of attack by a new species Bracon garugaphagae Ranjith & Quicke which is here described and illustrated. The wasps oviposit singly into the galls without paralysing the psyllids. The larvae first attack psyllid nymphs which they seek out within the gall, kill them with a single bite and consume them. Unique dorsal abdominal tubercles, with eversible tips present on the abdominal segments of the larvae that are used to help maintain larval position while feeding, are illustrated. After consuming all available prey, the larvae continue feeding on gall tissue until mature enough to spin cocoons and pupate. The new species illustrates, for the first time, a possible intermediate stage in the evolution of pure phytophagy within the Braconidae. Interestingly, the two unrelated seed predator Bracon species are also associated with Burseraceae, perhaps indicating that this plant family is particularly suited as a food for braconine wasps.	[Ranjith, A. P.; Saleem, U. K. A.; Nasser, M.] Univ Calicut, Dept Zool, Insect Ecol & Ethol Lab, Calicut 673635, Kerala, India; [Ranjith, A. P.] Malabar Christian Coll, Dept Zool, Calicut 673001, Kerala, India; [Quicke, Donald L. J.; Butcher, Buntika A.] Chulalongkorn Univ, Dept Biol, Fac Sci, Phayathai Rd, Pathumwan 10330, Bkk, Thailand; [Zaldivar-Riveron, Alejandro] Univ Nacl Autonoma Mexico, Inst Biol, Colecc Nacl Insectos, 3er Circuito Exterior S-N Cd Univ,AP 70-233, Coyoacan 04510, DF, Mexico; [Saleem, U. K. A.] Govt Coll Madappally, Dept Zool, Calicut 686546, Kerala, India	University of Calicut; Chulalongkorn University; Universidad Nacional Autonoma de Mexico	Nasser, M (corresponding author), Univ Calicut, Dept Zool, Insect Ecol & Ethol Lab, Calicut 673635, Kerala, India.	drnasher@gmail.com	Ranjith, Avunjikkattu Parambil/N-4483-2019		SAP and UGC	SAP and UGC	APR is grateful to Kiran Kishore and Sruthy Vasudevan for contributing much effort to the lengthy gall dissections. APR and MN are grateful to the University of Calicut for facilities provided and MN is grateful to SAP and UGC for their support. Chris Raper kindly stacked the light microscopy larval head capsule images for us.	Austin AD, 1998, AUST J BOT, V46, P559; Belshaw R, 2001, BIOL J LINN SOC, V73, P411, DOI 10.1111/j.1095-8312.2001.tb01370.x; CAPEK M, 1970, Canadian Entomologist, V102, P846; Carleton M., 1939, Journal of the Linnean Society London Zoology, V40, P575; CHADWICK C E, 1976, Journal of the Entomological Society of Australia (N. S. W.), V9, P28; DEMACEDO MV, 1989, J NEW YORK ENTOMOL S, V97, P358; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; EADY RD, 1968, PROC R ENTOMOL SOC A, V43, P66, DOI 10.1111/j.1365-3032.1968.tb01029.x; Flores S, 2005, J NAT HIST, V39, P3663, DOI 10.1080/00222930500392659; Gauld ID, 2002, ZOOL J LINN SOC-LOND, V136, P421, DOI 10.1046/j.1096-3642.2002.00031.x; GLOVER P. M., 1936, PROC INDIAN ACAD SCI SECT B, V3, P195; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Goolsby J.A., 2001, Journal of Hymenoptera Research, V10, P163; Harris R.A., 1979, California Department of Food and Agriculture Laboratory Services-Entomology Occasional Papers, P1; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; HENNEICKE K, 1992, J NAT HIST, V26, P1047, DOI 10.1080/00222939200770621; Jervis M. A., 1996, P375; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; Li F., 2000, Zoologische Mededelingen (Leiden), V74, P359; Marsh Paul M., 2002, Memoirs of the American Entomological Institute (Gainesville), V70, P1; MARSH PM, 1991, P ENTOMOL SOC WASH, V93, P92; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Perioto Nelson Wanderley, 2011, Zootaxa, V3000, P59; QUICKE DLJ, 1987, J NAT HIST, V21, P43, DOI 10.1080/00222938700770031; QUICKE DLJ, 1989, J NAT HIST, V23, P1309, DOI 10.1080/00222938900770691; Quicke DLJ, 2015, BRACONID ICHNEUMOID; Quicke Donald L. J., 2005, Journal of Hymenoptera Research, V14, P182; R Development Core Team, R LANG ENV STAT COMP; Salt G., 1931, Bulletin of Entomological Research London, V22, P479, DOI 10.1017/S0007485300035355; Shaw M.R., 1991, Handbooks for the Identification of British Insects, V7, P1; SLOBODCHIKOFF CN, 1967, PAN-PAC ENTOMOL, V43, P161; van Achterberg C., 1979, Tijdschrift voor Entomologie, V122, P241; van Achterberg C., 2000, Zoologische Mededelingen (Leiden), V74, P51; van Achterberg C, 1988, ZOOL VERH, V249, P1; Wei P, 2013, ZOOTAXA, V3640, P465, DOI 10.11646/zootaxa.3640.3.8; WHARTON RA, 1993, ANNU REV ENTOMOL, V38, P121, DOI 10.1146/annurev.en.38.010193.001005; Wharton Robert A., 2005, P495; Yu Douglas W., 1997, Journal of Hymenoptera Research, V6, P419; Zaldivar-Riveron A, 2006, MOL PHYLOGENET EVOL, V38, P130, DOI 10.1016/j.ympev.2005.08.006; Zaldivar-Riveron A, 2013, INVERTEBR SYST, V27, P673, DOI 10.1071/IS13021; Zaldivar-Riveron A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-329	41	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0156997	10.1371/journal.pone.0156997	http://dx.doi.org/10.1371/journal.pone.0156997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355679	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400008
J	Chien, E; Phiri, K; Schooley, A; Chivwala, M; Hamilton, J; Hoffman, RM				Chien, Emily; Phiri, Khumbo; Schooley, Alan; Chivwala, Mackenzie; Hamilton, John; Hoffman, Risa M.			Successes and Challenges of HIV Mentoring in Malawi: The Mentee Perspective	PLOS ONE			English	Article							QUALITATIVE CONTENT-ANALYSIS; TREATMENT PROGRAM; AFRICA; HEALTH; KENYA; CARE	HIV clinical mentoring has been utilized for capacity building in Africa, but few formal program evaluations have explored mentee perspectives on these programs. EQUIP is a PEP-FAR-USAID funded program in Malawi that has been providing HIV mentoring on clinical and health systems since 2010. We sought to understand the successes and challenges of EQUIP's mentorship program. From June-September 2014 we performed semi-structured, in-depth interviews with EQUIP mentees who had received mentoring for >= 1 year. Interview questions focused on program successes and challenges and were performed in English, audio recorded, coded, and analyzed using inductive content analysis with ATLAS. ti v7. Fifty-two mentees from 32 health centers were interviewed. The majority of mentees were 18-40 years old (79%, N = 41), 69% (N = 36) were male, 50% (N = 26) were nurses, 29% (N = 15) medical assistants, and 21% (N = 11) clinical officers. All mentees felt that EQUIP mentorship was successful (100%, N = 52). The most common benefit reported was an increase in clinical knowledge allowing for initiation of antiretroviral therapy (33%, N = 17). One-third of mentees (N = 17) reported increased clinic efficiency and improved systems for patient care due to EQUIP's systems mentoring including documentation, supply chain and support for minor construction at clinics. The most common challenge (52%, N = 27) was understaffing at facilities, with mentees having multiple responsibilities during mentorship visits resulting in impaired ability to focus on learning. Mentees also reported that medication stock-outs (42%, N = 22) created challenges for the mentoring process. EQUIP's systems-based mentorship and infrastructure improvements allowed for an optimized environment for clinical training. Shortages of health workers at sites pose a challenge for mentoring programs because mentees are pulled from learning experiences to perform non-HIV-related clinic duties. Evaluations of existing mentoring models are needed to continue to improve mentoring strategies that result in sustainable benefits for mentees, facilities, and patients.	[Chien, Emily] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Phiri, Khumbo; Schooley, Alan; Chivwala, Mackenzie; Hamilton, John] EQUIP Malawi, Hope Med Ctr, Lilongwe, Malawi; [Schooley, Alan; Hamilton, John; Hoffman, Risa M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Schooley, Alan; Hamilton, John; Hoffman, Risa M.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hoffman, RM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.; Hoffman, RM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA.	RHoffman@mednet.ucla.edu			President's Emergency Plan for AIDS Relief (PEPFAR) through USAID-Malawi [674-A-00-10-00035-00]	President's Emergency Plan for AIDS Relief (PEPFAR) through USAID-Malawi(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through USAID-Malawi under the terms of Grant No. 674-A-00-10-00035-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidspan, 2014, MAL FAC SHORT HEALTH; Anatole M, 2013, NURS OUTLOOK, V61, P137, DOI 10.1016/j.outlook.2012.10.003; Chankova S, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-58; Clevenbergh P, 2006, HIV CLIN TRIALS, V7, P255, DOI 10.1310/hct0705-255; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Gerein N, 2006, REPROD HEALTH MATTER, V14, P40, DOI 10.1016/S0968-8080(06)27225-2; Green A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098389; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huchko MJ, 2011, INT J GYNECOL OBSTET, V114, P106, DOI 10.1016/j.ijgo.2011.02.009; Kabue MM, 2008, MALAWI MED J, V20, P19; Manzi A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-275; Moon Troy D, 2010, Retrovirology (Auckl), V3, P1; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Stevens WS, 2010, J INFECT DIS, V201, pS78, DOI 10.1086/650383; UNAIDS, 2014, HIV AIDS EST; UNAIDS, 2015, COR EP SLID JUL 2015; WHO, 2014, WHO GLOB HLTH WORKF; WHO, 2006, WHO REC CLIN MENT SU; Wolak E, 2009, CLIN NURSE SPEC, V23, P61, DOI 10.1097/NUR.0b013e31819971eb; Workneh G, 2013, AIDS CARE, V25, P11, DOI 10.1080/09540121.2012.674096	22	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158258	10.1371/journal.pone.0158258	http://dx.doi.org/10.1371/journal.pone.0158258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352297	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900047
J	Cohen, TJ; Constance, BH; Hwang, AW; James, M; Yuan, CX				Cohen, Todd J.; Constance, Brian H.; Hwang, Andrew W.; James, Michael; Yuan, Chao-Xing			Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; TERMINALLY CLEAVED TAU; ALZHEIMERS-DISEASE; ACETYLTRANSFERASE ACTIVITY; IN-VITRO; HISTONE ACETYLTRANSFERASE; TRANSGENIC MICE; POSTTRANSLATIONAL MODIFICATIONS; LYSINE PROPIONYLATION; PROTEIN ACETYLATION	Tau proteins are abnormally aggregated in a range of neurodegenerative tauopathies including Alzheimer's disease (AD). Recently, tau has emerged as an extensively post-translationally modified protein, among which lysine acetylation is critical for normal tau function and its pathological aggregation. Here, we demonstrate that tau isoforms have different propensities to undergo lysine acetylation, with auto-acetylation occurring more prominently within the lysine-rich microtubule-binding repeats. Unexpectedly, we identified a unique intrinsic property of tau in which auto-acetylation induces proteolytic tau cleavage, thereby generating distinct N- and C-terminal tau fragments. Supporting a catalytic reaction-based mechanism, mapping and mutagenesis studies showed that tau cysteines, which are required for acetyl group transfer, are also essential for auto-proteolytic tau processing. Further mass spectrometry analysis identified the C-terminal 2nd and 4th microtubule binding repeats as potential sites of auto-cleavage. The identification of acetylationmediated auto-proteolysis provides a new biochemical mechanism for tau self-regulation and warrants further investigation into whether auto-catalytic functions of tau are implicated in AD and other tauopathies.	[Cohen, Todd J.; Constance, Brian H.] Univ N Carolina, Neurosci Ctr, Dept Neurol, Chapel Hill, NC 27599 USA; [Cohen, Todd J.; Constance, Brian H.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hwang, Andrew W.; James, Michael] Univ Penn, Sch Med, Inst Aging, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hwang, Andrew W.; James, Michael] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Yuan, Chao-Xing] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Cohen, TJ (corresponding author), Univ N Carolina, Neurosci Ctr, Dept Neurol, Chapel Hill, NC 27599 USA.; Cohen, TJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	toddcohen@neurology.unc.edu			Alzheimer's Association [NIRG-14-321219]; National Institutes of Health [UL1TR001111]; University of Pennsylvania Alzheimer's Disease Core Center (ADCC) [P30-AG010124-25]; National Center for Advancing Translational Sciences (NCATS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Alzheimer's Disease Core Center (ADCC); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Alzheimer's Association grant NIRG-14-321219 (TJC) (http://www.alz.org); the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number UL1TR001111 (TJC) (https://ncats.nih.gov); and the University of Pennsylvania Alzheimer's Disease Core Center (ADCC) grant P30-AG010124-25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Arai T, 2004, ANN NEUROL, V55, P72, DOI 10.1002/ana.10793; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Cohen TJ, 2013, NAT STRUCT MOL BIOL, V20, P756, DOI 10.1038/nsmb.2555; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Crowe A, 2013, J BIOL CHEM, V288, P11024, DOI 10.1074/jbc.M112.436006; Dormeyer W, 2005, MOL CELL PROTEOMICS, V4, P1226, DOI 10.1074/mcp.M500047-MCP200; Dormeyer W, 2003, ANAL BIOANAL CHEM, V376, P994, DOI 10.1007/s00216-003-2058-z; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Ghanta S, 2013, CRIT REV BIOCHEM MOL, V48, P561, DOI 10.3109/10409238.2013.838204; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hochgrafe K, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0204-4; Hosokawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052389; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Kamah A, 2014, BIOCHEMISTRY-US, V53, P3020, DOI 10.1021/bi500006v; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Lewis JD, 2011, MOL PLANT PATHOL, V12, P928, DOI [10.1111/J.1364-3703.2011.00719.X, 10.1111/j.1364-3703.2011.00719.x]; Lu L, 2011, CELL RES, V21, P1182, DOI 10.1038/cr.2011.71; Luo Y, 2014, J PHYS CHEM LETT, V5, P3026, DOI 10.1021/jz501457f; Matsumoto SE, 2015, HUM MOL GENET, V24, P6403, DOI 10.1093/hmg/ddv351; Meredith JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076523; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mittal R, 2010, J BIOL CHEM, V285, P19927, DOI 10.1074/jbc.M110.126581; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Payton M, 2001, MICROBIOL-SGM, V147, P1137, DOI 10.1099/00221287-147-5-1137; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Soeda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10216; Sokolow S, 2015, J NEUROCHEM, V133, P368, DOI 10.1111/jnc.12991; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Ustun S, 2015, PLANT PHYSIOL, V168, P107, DOI 10.1104/pp.15.00132; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wagshal D, 2015, J NEUROL NEUROSUR PS, V86, P244, DOI 10.1136/jnnp-2014-308004; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Watanabe A, 2004, J NEUROCHEM, V90, P1302, DOI 10.1111/j.1471-4159.2004.02611.x; Wischik CM, 2015, J ALZHEIMERS DIS, V44, P705, DOI 10.3233/JAD-142874; Wray S, 2008, J NEUROCHEM, V105, P2343, DOI 10.1111/j.1471-4159.2008.05321.x; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155	56	23	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158470	10.1371/journal.pone.0158470	http://dx.doi.org/10.1371/journal.pone.0158470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383765	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400050
J	Atef, ME; Anand-Srivastava, MB				Atef, Mohammed Emehdi; Anand-Srivastava, Madhu B.			Role of PKC delta in Enhanced Expression of Gq alpha/PLC beta 1 Proteins and VSMC Hypertrophy in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KINASE-C-DELTA; GROWTH-FACTOR RECEPTOR; ANGIOTENSIN-II; OXIDATIVE STRESS; NADPH OXIDASE; SHR ROLE; INCREASED PROLIFERATION; ACTIVATION MECHANISMS; VASCULAR HYPERTROPHY	Gq alpha signaling has been implicated in cardiac hypertrophy. In addition, angiotensin II (Ang II) was also shown to induce its hypertrophic effect through Gqa and PKC delta activation. We recently showed the role of enhanced expression of Gq alpha/PLC beta 1 proteins in vascular smooth muscle cell (VSMC) hypertrophy, however, the role of PKCd in VSMC hypertrophy in animal model is still lacking. The present study was therefore undertaken to examine the role of PKCd and the associated signaling mechanisms in VSMC hypertrophy using 16-week-old spontaneously hypertensive rats (SHR). VSMC from 16-week-old SHR exhibited enhanced phosphorylation of PKC delta-Tyr(311) and increased protein synthesis, marker of hypertrophy, as compared to WKY rats which was attenuated by rottlerin, an inhibitor of PKCd. In addition, knocking down of PKCd by PKC delta-siRNA also attenuated enhanced protein synthesis in VSMC from SHR. Furthermore, rottlerin attenuated the increased production of superoxide anion, NAD(P) H oxidase activity, increased expression of Gqa, phospholipase C(PLC)beta 1, insulin like growth factor-1 receptor (IGF-1R) and epidermal growth factor receptor ( EGFR) proteins in VSMC from SHR. In addition, the enhanced phosphorylation of c-Src, PKC delta-Tyr(311), IGF-1R, EGFR and ERK1/2 exhibited by VSMC from SHR was also attenuated by rottlerin. These results suggest that VSMC from SHR exhibit enhanced activity of PKCd and that PKCd is the upstream molecule of reactive oxygen species (ROS) and contributes to the enhanced expression of Gqa and PLC beta 1 proteins and resultant VSMC hypertrophy involving c-Src, growth factor receptor transactivation and MAP kinase signaling.	[Atef, Mohammed Emehdi; Anand-Srivastava, Madhu B.] Univ Montreal, Dept Mol & Integrat Physiol, Fac Med, Montreal, PQ, Canada	Universite de Montreal	Anand-Srivastava, MB (corresponding author), Univ Montreal, Dept Mol & Integrat Physiol, Fac Med, Montreal, PQ, Canada.	Madhu.anand-srivastava@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP-53074]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	MBAS was funded by a grant from the Canadian Institutes of Health Research (CIHR) (MOP-53074).	ANANDSRIVASTAVA MB, 1982, BIOCHEM BIOPH RES CO, V108, P213, DOI 10.1016/0006-291X(82)91853-8; ANDREA JE, 1992, HYPERTENSION, V20, P585, DOI 10.1161/01.HYP.20.5.585; Atef ME, 2011, FASEB J, V25, P1009; Atef ME, 2016, AM J PHYSIOL-HEART C, V310, pH608, DOI 10.1152/ajpheart.00659.2015; Atef ME, 2014, AM J PHYSIOL-CELL PH, V307, pC97, DOI 10.1152/ajpcell.00337.2013; Bankers-Fulbright JL, 2001, J CELL PHYSIOL, V189, P306, DOI 10.1002/jcp.10022; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Braun MU, 2004, MOL CELL BIOCHEM, V262, P135, DOI 10.1023/B:MCBI.0000038229.23132.9f; Chen CH, 2001, J MOL CELL CARDIOL, V33, P581, DOI 10.1006/jmcc.2000.1330; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; CLERK A, 1994, J BIOL CHEM, V269, P32848; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dreux AC, 2006, ATHEROSCLEROSIS, V186, P38, DOI 10.1016/j.atherosclerosis.2005.06.038; Fan CY, 2005, BIOCHEM J, V390, P761, DOI 10.1042/BJ20050287; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Frank GD, 2002, MOL ENDOCRINOL, V16, P367, DOI 10.1210/me.16.2.367; Fukuda N, 1999, ARTERIOSCL THROM VAS, V19, P1210, DOI 10.1161/01.ATV.19.5.1210; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Greene MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085848; Ha H, 2001, AM J KIDNEY DIS, V38, pS204, DOI 10.1053/ajkd.2001.27446; Hall KJ, 2007, BIOCHEM J, V406, P501, DOI 10.1042/BJ20070244; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Hsieh HL, 2009, ARTERIOSCL THROM VAS, V29, P1594, DOI 10.1161/ATVBAHA.109.185801; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Koide Y, 2003, HYPERTENS RES, V26, P421, DOI 10.1291/hypres.26.421; KORSGAARD N, 1993, HYPERTENSION, V22, P523, DOI 10.1161/01.HYP.22.4.523; Larroque-Cardoso P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.47; Lee IT, 2013, BIOCHEM PHARMACOL, V85, P954, DOI 10.1016/j.bcp.2012.12.016; Leszczynski D, 1996, LIFE SCI, V58, P599, DOI 10.1016/0024-3205(95)02329-1; Li CH, 2003, FASEB J, V17, P2106, DOI 10.1096/fj.03-0150fje; Li WQ, 1998, MOL CELL BIOL, V18, P5888, DOI 10.1128/MCB.18.10.5888; Li Y, 2006, CARDIOVASC RES, V72, P464, DOI 10.1016/j.cardiores.2006.08.012; Li YA, 2010, AM J PHYSIOL-HEART C, V299, pH1959, DOI 10.1152/ajpheart.00526.2010; Liebmann C, 2001, CELL SIGNAL, V13, P777, DOI 10.1016/S0898-6568(01)00192-9; Lu MH, 2003, CLIN EXP HYPERTENS, V25, P413, DOI 10.1081/CEH-120024985; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Lv P, 2012, CIRC RES, V111, P697, DOI 10.1161/CIRCRESAHA.112.272013; Maioli E, 2012, SCI WORLD J, DOI 10.1100/2012/350826; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Nakashima H, 2008, HYPERTENSION, V51, P232, DOI 10.1161/HYPERTENSIONAHA.107.101253; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ohanian V, 1996, CIRC RES, V78, P806, DOI 10.1161/01.RES.78.5.806; Reeves EP, 1999, BIOCHEM J, V344, P859, DOI 10.1042/0264-6021:3440859; Ringshausen I, 2006, LEUKEMIA, V20, P514, DOI 10.1038/sj.leu.2404113; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Saha S, 2008, CAN J PHYSIOL PHARM, V86, P190, DOI 10.1139/Y08-012; Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005; SASAGURI T, 1993, EXP CELL RES, V208, P311, DOI 10.1006/excr.1993.1251; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004; Uchiyama K, 2009, EUR J PHARM SCI, V38, P504, DOI 10.1016/j.ejps.2009.09.016; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669; Zhang MJ, 2016, HISTOCHEM CELL BIOL, V145, P119, DOI 10.1007/s00418-015-1386-3; Zhu BH, 2001, ENDOCRINOLOGY, V142, P3598, DOI 10.1210/en.142.8.3598	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157955	10.1371/journal.pone.0157955	http://dx.doi.org/10.1371/journal.pone.0157955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379421	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700015
J	Daryadel, A; Haubitz, M; Figueiredo, M; Steubl, D; Roos, M; Mader, A; Hettwer, S; Wagner, CA				Daryadel, Arezoo; Haubitz, Monika; Figueiredo, Marta; Steubl, Dominik; Roos, Marcel; Maeder, Armin; Hettwer, Stefan; Wagner, Carsten A.			The C-Terminal Fragment of Agrin (CAF), a Novel Marker of Renal Function, Is Filtered by the Kidney and Reabsorbed by the Proximal Tubule	PLOS ONE			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; NEUROMUSCULAR-JUNCTION; HEPARAN-SULFATE; NEUROTRYPSIN; EXPRESSION; CLEAVAGE; BIOMARKER; CELLS	Agrin, a multidomain proteoglycan and neurotrypsin, a neuronal serine protease, are important for forming (neuromuscular) synapses. Proteolytical activity of neurotrypsin produces a C-terminal fragment of agrin, termed CAF, of approximately 22 kDA molecular size which also circulates in blood. The presence of CAF in urine suggests either glomerular filtration or secretion into urine. Blood levels of CAF have been identified as a potential novel marker of kidney function. Here we describe that several nephron segments in the mouse kidney express agrin and neutrotrypsin in addition to the localization of both protein in the glomerulum. Agrin mRNA and protein was detected in almost all nephron segments and mRNA abundance was highest in the inner medullary collecting duct. Neurotrypsin mRNA was mostly detected in the thick ascending limb of the loop of Henle, the distal convoluted tubule, and the inner medullary collecting duct. Moreover, we show that the proximal tubule absorbs injected recombinant CAF by a process shared with receptor-mediated and fluid phase endocytosis. Co-injection of CAF with recombinant human transferrin, a substrate of the receptor-mediated endocytic pathway as well as with FITC-labelled dextran (10 kDa), a marker of fluid phase endocytosis, showed partial colocalization of CAF with both markers. Further colocalization of CAF with the lysosomal marker cathepsin B suggested degradation of CAF by the lysosome in the proximal tubule. Thus, the murine kidney expresses agrin and neurotrypsin in nephron segments beyond the glomerulum. CAF is filtered by the glomerulum and is reabsorbed by endocytosis by the proximal tubule. Thus, impaired kidney function could impair glomerular clearance of CAF and thereby increase circulating CAF levels.	[Daryadel, Arezoo; Figueiredo, Marta; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Daryadel, Arezoo; Figueiredo, Marta; Wagner, Carsten A.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Haubitz, Monika; Maeder, Armin; Hettwer, Stefan] Neurotune AG, Schlieren, Switzerland; [Steubl, Dominik; Roos, Marcel] Klinikum Rechts Der Isar, Dept Nephrol, Munich, Germany	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Technical University of Munich	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Wagner, CA (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.	Wagnerca@access.uzh.ch		Wagner, Carsten/0000-0002-9874-8898; Haubitz, Monika/0000-0001-7660-401X	EU FP7 EUROSTAR grant ("Early Diagnosis and Monitoring of Renal Diseases") [E! 6038]; Swiss Commission for Technology and Innovation [15622.1 PFLS-LS]	EU FP7 EUROSTAR grant ("Early Diagnosis and Monitoring of Renal Diseases"); Swiss Commission for Technology and Innovation	This study has been supported by an EU FP7 EUROSTAR grant ("Early Diagnosis and Monitoring of Renal Diseases, E! 6038 KIDNEY") to D. Steubl, M. Roos, A. Mader, S. Hettwer, and C.A. Wagner, and a grant from the Swiss Commission for Technology and Innovation ("CTI no. 15622.1 PFLS-LS") to A. Mader, S. Hettwer, and C.A. Wagner.	[Anonymous], 2015, DIAGN PROD INF; Bacic D, 2006, KIDNEY INT, V69, P495, DOI 10.1038/sj.ki.5000148; Barik A, 2014, DEV NEUROBIOL, V74, P828, DOI 10.1002/dneu.22190; Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; Christensen EI, 2012, COMPR PHYSIOL, V2, P805, DOI 10.1002/cphy.c100073; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Devetzis V, 2015, PLOS ONE IN PRESS; Drey M, 2015, CLIN LAB, V61, P69, DOI 10.7754/Clin.Lab.2014.140724; Eusebio A, 2003, NEUROMUSCULAR DISORD, V13, P408, DOI 10.1016/S0960-8966(03)00036-1; Frischknecht R, 2014, PROG BRAIN RES, V214, P81, DOI 10.1016/B978-0-444-63486-3.00004-9; Goldberg S, 2009, NEPHROL DIAL TRANSPL, V24, P2044, DOI 10.1093/ndt/gfn758; Groffen AJ, 1998, J HISTOCHEM CYTOCHEM, V46, P19, DOI 10.1177/002215549804600104; Groffen AJA, 1998, EUR J BIOCHEM, V254, P123, DOI 10.1046/j.1432-1327.1998.2540123.x; Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116; HATAE T, 1986, CELL TISSUE RES, V246, P271, DOI 10.1007/BF00215889; Hettwer S, 2013, EXP GERONTOL, V48, P69, DOI 10.1016/j.exger.2012.03.002; Matsumoto-Miyai K, 2009, CELL, V136, P1161, DOI 10.1016/j.cell.2009.02.034; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mohebbi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055286; Nielsen R, 2007, P NATL ACAD SCI USA, V104, P5407, DOI 10.1073/pnas.0700330104; Raats CJI, 1998, J BIOL CHEM, V273, P17832, DOI 10.1074/jbc.273.28.17832; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; Steubl D, 2015, CLIN CHEM LAB MED; Steubl D, 2015, INT UROL NEPHROL, V47, P391, DOI 10.1007/s11255-014-0852-5; Steubl D, 2014, TRANSL RES, V164, P392, DOI 10.1016/j.trsl.2014.05.005; Steubl D, 2013, AM J NEPHROL, V38, P501, DOI 10.1159/000356969; Suh JH, 2013, NAT REV NEPHROL, V9, P470, DOI 10.1038/nrneph.2013.109; Wijnhoven TJM, 2007, J AM SOC NEPHROL, V18, P823, DOI 10.1681/ASN.2006070692	31	10	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157905	10.1371/journal.pone.0157905	http://dx.doi.org/10.1371/journal.pone.0157905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380275	Green Published, gold, Green Accepted			2022-12-27	WOS:000379798700012
J	Duan, J; Wang, X; Xu, SZ; Liu, YN; Xu, C; Zhao, GF				Duan, Jie; Wang, Xiong; Xu, Shizhong; Liu, Yuanni; Xu, Chuan; Zhao, Guofeng			Cache Scheme Based on Pre-Fetch Operation in ICN	PLOS ONE			English	Article								Many recent researches focus on ICN (Information-Centric Network), in which named content becomes the first citizen instead of end-host. In ICN, Named content can be further divided into many small sized chunks, and chunk-based communication has merits over content-based communication. The universal in-network cache is one of the fundamental infrastructures for ICN. In this work, a chunk-level cache mechanism based on pre-fetch operation is proposed. The main idea is that, routers with cache store should pre-fetch and cache the next chunks which may be accessed in the near future according to received requests and cache policy for reducing the users' perceived latency. Two pre-fetch driven modes are present to answer when and how to pre-fetch. The LRU (Least Recently Used) is employed for the cache replacement. Simulation results show that the average user perceived latency and hops can be decreased by employed this cache mechanism based on pre-fetch operation. Furthermore, we also demonstrate that the results are influenced by many factors, such as the cache capacity, Zipf parameters and pre-fetch window size.	[Duan, Jie; Liu, Yuanni; Xu, Chuan; Zhao, Guofeng] Chongqing Univ Posts & Telecommun CQUPT, Commun & Informat Engn, Chongqing, Peoples R China; [Wang, Xiong; Xu, Shizhong] Univ Elect Sci & Technol China UESTC, Commun & Informat Engn, Chengdu, Peoples R China	Chongqing University of Posts & Telecommunications; University of Electronic Science & Technology of China	Duan, J (corresponding author), Chongqing Univ Posts & Telecommun CQUPT, Commun & Informat Engn, Chongqing, Peoples R China.	duanjie@cqupt.edu.cn			973 Program [2013CB329103]; NSFC Fund [61271165, 61301153, 61501075]; Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in University; 111 Project [B14039]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1400419]	973 Program(National Basic Research Program of China); NSFC Fund(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project); Scientific and Technological Research Program of Chongqing Municipal Education Commission	This work is partially supported by 973 Program (2013CB329103), NSFC Fund (61271165, 61301153, 61501075), Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in University and the 111 Project B14039, Scientific and Technological Research Program of Chongqing Municipal Education Commission, KJ1400419.	Ahlgren B., 2010, 4WARDEUFP7; [Anonymous], 2011, D2 3 ARCHITECTURE DE; Cao P., 1995, Performance Evaluation Review, V23, P188, DOI 10.1145/223586.223608; Cho K, 2012, IEEE CONF COMPUT, P316, DOI 10.1109/INFCOMW.2012.6193512; Choi J, 2011, IEEE COMMUN MAG, V49, P121, DOI 10.1109/MCOM.2011.5723809; Choo K. K. R., 2014, P 10 INT C SEC PRIV, P267; Detti A., 2011, P ACM SIGCOMM WORKSH, P50; Fengchao Zhang, 2015, 2015 IEEE 33rd VLSI Test Symposium (VTS). Proceedings, P1, DOI 10.1109/VTS.2015.7116294; Ghodsi A., 2011, HOTNETS, P1, DOI [10.1145/2070562.2070563, DOI 10.1145/2070562.2070563]; Jacobson Van, 2009, PROC 5 INT C EMERG N, P1, DOI DOI 10.1145/1658939.1658941; Koponen T, 2007, ACM SIGCOMM COMP COM, V37, P181, DOI 10.1145/1282427.1282402; Li WJ, 2015, IEEE ICC, P5747, DOI 10.1109/ICC.2015.7249238; Ming Z., 2012, P INT C MICR MILL WA, P1, DOI DOI 10.1109/INFCOMW.2014.6193504; Osanaiye O, 2016, J NETW COMPUT APPL, V67, P147, DOI 10.1016/j.jnca.2016.01.001; Padmanabhan V. N., 1996, Computer Communication Review, V26, P22, DOI 10.1145/235160.235164; Prokhorenko V, 2016, IEEE T INF FOREN SEC, V99, P1; Prokhorenko V, 2016, APPL MATH COMPUT, V285, P59, DOI 10.1016/j.amc.2016.03.026; Prokhorenko V, 2016, J NETW COMPUT APPL, V60, P95, DOI 10.1016/j.jnca.2015.11.017; Psaras I., 2012, P 2 ED ICN WORKSH IN, P55, DOI DOI 10.1145/2342488.2342501; Quevedo J, 2014, IEEE CONF COMPUT, P482, DOI 10.1109/INFCOMW.2014.6849279; Raychaudhuri D, 2012, MOB COMPUT COMMUN RE, V16, P2, DOI 10.1145/2412096.2412098; Salsano S., 2012, P 2 ED ICN WORKSH IN, P19, DOI DOI 10.1145/2342488.2342493; Seo W. J., 2015, P 11 INT C SEC PRIV, P649, DOI DOI 10.1007/978-3-319-28865-9_43; Suksomboon K, 2014, IEEE GLOB COMM CONF, P1867, DOI 10.1109/GLOCOM.2014.7037080; Wang JM, 2012, IEEE GLOB COMM CONF, P2727, DOI 10.1109/GLOCOM.2012.6503529; Wang W, 2014, P IEEE ICC 2014 SYDN, P3197; Xu AF, 2015, IEEE ICC, P5535, DOI 10.1109/ICC.2015.7249204; Yu YT, 2015, CONSUM COMM NETWORK, P588, DOI 10.1109/CCNC.2015.7158039; Zhang HF, 2001, THESIS	29	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158260	10.1371/journal.pone.0158260	http://dx.doi.org/10.1371/journal.pone.0158260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362478	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200052
J	Tavernier, E; Trinquart, L; Giraudeau, B				Tavernier, Elsa; Trinquart, Ludovic; Giraudeau, Bruno			Finding Alternatives to the Dogma of Power Based Sample Size Calculation: Is a Fixed Sample Size Prospective Meta-Experiment a Potential Alternative?	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; CLINICAL-TRIALS; RANDOMIZED-TRIALS; RELEVANT EVIDENCE; BEGIN; END	Sample sizes for randomized controlled trials are typically based on power calculations. They require us to specify values for parameters such as the treatment effect, which is often difficult because we lack sufficient prior information. The objective of this paper is to provide an alternative design which circumvents the need for sample size calculation. In a simulation study, we compared a meta-experiment approach to the classical approach to assess treatment efficacy. The meta-experiment approach involves use of meta-analyzed results from 3 randomized trials of fixed sample size, 100 subjects. The classical approach involves a single randomized trial with the sample size calculated on the basis of an a priori-formulated hypothesis. For the sample size calculation in the classical approach, we used observed articles to characterize errors made on the formulated hypothesis. A prospective meta-analysis of data from trials of fixed sample size provided the same precision, power and type I error rate, on average, as the classical approach. The meta-experiment approach may provide an alternative design which does not require a sample size calculation and addresses the essential need for study replication; results may have greater external validity.	[Tavernier, Elsa; Trinquart, Ludovic; Giraudeau, Bruno] INSERM, U1153, Paris, France; [Tavernier, Elsa; Giraudeau, Bruno] CHRU, Tours, France; [Tavernier, Elsa; Giraudeau, Bruno] INSERM, CIC 1415, Tours, France; [Trinquart, Ludovic] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Giraudeau, Bruno] Univ Tours, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Columbia University; Universite de Tours	Tavernier, E (corresponding author), INSERM, U1153, Paris, France.; Tavernier, E (corresponding author), CHRU, Tours, France.; Tavernier, E (corresponding author), INSERM, CIC 1415, Tours, France.	elsa.tavernier@univ-tours.fr	Trinquart, Ludovic/H-4961-2019; Giraudeau, Bruno/L-9003-2015	Trinquart, Ludovic/0000-0002-3028-4900; Giraudeau, Bruno/0000-0003-3031-8258; Tavernier, Elsa/0000-0003-0798-1182				[Anonymous], 1999, STAT MED, V18, P1905; Bacchetti P, 2008, BIOMETRICS, V64, P577, DOI [10.1111/j.1541-0420.2008.01004.x, 10.1111/j.1541-0420.2008.01004_1.x]; Borm GF, 2009, J CLIN EPIDEMIOL, V62, P47, DOI 10.1016/j.jclinepi.2008.02.017; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Clark T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1135; Clarke M, 2004, PLOS MED, V1, P100, DOI 10.1371/journal.pmed.0010035; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Clarke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102670; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Cooper NJ, 2005, CLIN TRIALS, V2, P260, DOI 10.1191/1740774505cn090oa; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Herbison P, 2011, J CLIN EPIDEMIOL, V64, P145, DOI 10.1016/j.jclinepi.2010.02.017; Higgins JPT, 2011, STAT MED, V30, P903, DOI 10.1002/sim.4088; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; McMahon AD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000131; Neal B, 2000, LANCET, V356, P1955; Norman G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5278; OECD Global Science Forum, POGSF FAC INT COOP N; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Tavernier E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132578; Turnbull F, 2003, LANCET, V362, P1527; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; Vickers AJ, 2003, J CLIN EPIDEMIOL, V56, P717, DOI 10.1016/S0895-4356(03)00141-0	29	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158604	10.1371/journal.pone.0158604	http://dx.doi.org/10.1371/journal.pone.0158604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362939	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200101
J	Carther-Krone, TA; Shomstein, S; Marotta, JJ				Carther-Krone, Tiffany A.; Shomstein, Sarah; Marotta, Jonathan J.			Looking without Perceiving: Impaired Preattentive Perceptual Grouping in Autism Spectrum Disorder	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; EMBEDDED FIGURES TASK; VISUAL-SEARCH; COGNITIVE-STYLE; WEAK COHERENCE; ATTENTION; INDIVIDUALS; PERFORMANCE; CHILDREN; ADULTS	Before becoming aware of a visual scene, our perceptual system has organized and selected elements in our environment to which attention should be allocated. Part of this process involves grouping perceptual features into a global whole. Individuals with autism spectrum disorders (ASD) rely on a more local processing strategy, which may be driven by difficulties perceptually grouping stimuli. We tested this notion using a line discrimination task in which two horizontal lines were superimposed on a background of black and white dots organized so that, on occasion, the dots induced the Ponzo illusion if perceptually grouped together. Results showed that even though neither group was aware of the illusion, the ASD group was significantly less likely than typically developing group to make perceptual judgments influenced by the illusion, revealing difficulties in preattentive grouping of visual stimuli. This may explain why individuals with ASD rely on local processing strategies, and offers new insight into the mechanism driving perceptual grouping in the typically developing human brain.	[Carther-Krone, Tiffany A.; Marotta, Jonathan J.] Univ Manitoba, Dept Psychol, Percept & Act Lab, Winnipeg, MB R3T 2N2, Canada; [Shomstein, Sarah] George Washington Univ, Dept Psychol, Washington, DC 20052 USA	University of Manitoba; George Washington University	Carther-Krone, TA (corresponding author), Univ Manitoba, Dept Psychol, Percept & Act Lab, Winnipeg, MB R3T 2N2, Canada.	lazart@myumanitoba.ca	Shomstein, Sarah/F-2371-2011	Shomstein, Sarah/0000-0001-8278-6630; Marotta, Jonathan/0000-0001-6635-4694	Natural Sciences and Engineering Research Council of Canada [311586-2011]; National Institutes of Health [R21-EY021644]; National Science Foundation [BCS-1059523]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant to JJM from the Natural Sciences and Engineering Research Council of Canada (311586-2011; http://www.nserc-crsng.gc.ca) and a grant to SS from the National Institutes of Health (R21-EY021644; http://www.nih.gov/) and National Science Foundation (BCS-1059523; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, DSM 4 DIAGN STAT MAN, V4th; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; Bolte S, 2007, J AUTISM DEV DISORD, V37, P1493, DOI 10.1007/s10803-006-0231-x; Brosnan MJ, 2004, J CHILD PSYCHOL PSYC, V45, P459, DOI 10.1111/j.1469-7610.2004.00237.x; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damarla SR, 2010, AUTISM RES, V3, P273, DOI 10.1002/aur.153; Dunn L.M., 1981, PEABODY PICTURE VOCA; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; HAPPE FGE, 1994, J CHILD PSYCHOL PSYC, V35, P1461, DOI 10.1111/j.1469-7610.1994.tb01287.x; Happe FGE, 1996, J CHILD PSYCHOL PSYC, V37, P873, DOI 10.1111/j.1469-7610.1996.tb01483.x; Happe FGE, 2008, Q J EXP PSYCHOL, V61, P50, DOI 10.1080/17470210701508731; Huberle E, 2006, NEUROPSYCHOLOGIA, V44, P905, DOI 10.1016/j.neuropsychologia.2005.08.013; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Karnath HO, 2000, NEUROCASE, V6, P295, DOI 10.1080/13554790008402778; Kretschmer A, 2014, RES DEV DISABIL, V35, P3108, DOI 10.1016/j.ridd.2014.07.052; Lartseva A, 2014, J AUTISM DEV DISORD, V44, P2882, DOI 10.1007/s10803-014-2149-z; Liu YN, 2011, NEUROPSYCHOLOGIA, V49, P2105, DOI 10.1016/j.neuropsychologia.2011.04.005; Manjaly ZM, 2007, NEUROIMAGE, V35, P283, DOI 10.1016/j.neuroimage.2006.11.036; Mayer J. L., 2014, J AUTISM DEV DISORD, P1; Mayer JL, 2014, AUTISM RES, V7, P40, DOI 10.1002/aur.1333; Mitchell P, 2010, AUTISM RES, V3, P113, DOI 10.1002/aur.130; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2003, J CHILD PSYCHOL PSYC, V44, P904, DOI 10.1111/1469-7610.00174; MOTTRON L, 1993, BRAIN COGNITION, V23, P279, DOI 10.1006/brcg.1993.1060; Mottron L, 1999, J CHILD PSYCHOL PSYC, V40, P743, DOI 10.1111/1469-7610.00490; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P765, DOI 10.1111/1469-7610.00375; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raven J, 2000, STANDARD PROGR MATRI; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; Ronconi L, 2013, CORTEX, V49, P1025, DOI 10.1016/j.cortex.2012.03.005; Ronconi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049019; Ropar D, 1999, J CHILD PSYCHOL PSYC, V40, P1283, DOI 10.1017/S0021963099004667; Ropar D, 2001, J CHILD PSYCHOL PSYC, V42, P539, DOI 10.1017/S002196300100717X; Scherf KS, 2008, AUTISM RES, V1, P114, DOI 10.1002/aur.17; Schneider W., 2002, E PRIME USERS GUIDE; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; TYMCHUK AJ, 1977, J MENT DEFIC RES, V21, P133; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640	47	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158566	10.1371/journal.pone.0158566	http://dx.doi.org/10.1371/journal.pone.0158566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355678	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400078
J	Lopes, MS; Bertucci, TCP; Rapagna, L; Tubino, RD; Monteiro-Neto, C; Tomas, ARG; Tenorio, MC; Lima, T; Souza, R; Carrillo-Briceno, JD; Haimovici, M; Macario, K; Carvalho, C; Socorro, OA				Lopes, Mariana Samor; Pereira Bertucci, Thayse Cristina; Rapagna, Luciano; Tubino, Rafael de Almeida; Monteiro-Neto, Cassiano; Gomes Tomas, Acacio Ribeiro; Tenorio, Maria Cristina; Lima, Tania; Souza, Rosa; Carrillo-Briceno, Jorge Domingo; Haimovici, Manuel; Macario, Kita; Carvalho, Carla; Socorro, Orangel Aguilera			The Path towards Endangered Species: Prehistoric Fisheries in Southeastern Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; BASE-LINE; GALEOCERDO-CUVIER; NURSERY AREA; TIGER SHARKS; HABITAT USE; FOOD-WEB; COAST; EXOSTOSES; DYNAMICS	Brazilian shellmounds are archaeological sites with a high concentration of marine faunal remains. There are more than 2000 sites along the coast of Brazil that range in age from 8,720 to 985 cal BP. Here, we studied the ichthyoarchaeological remains (i.e., cranial/postcranial bones, otoliths, and teeth, among others) at 13 shellmounds on the southern coast of the state of Rio de Janeiro, which are located in coastal landscapes, including a sandy plain with coastal lagoons, rocky islands, islets and rocky bays. We identified patterns of similarity between shellmounds based on fish diversity, the ages of the assemblages, littoral geomorphology and prehistoric fisheries. Our new radiocarbon dating, based on otolith samples, was used for fishery characterization over time. A taxonomical study of the ichthyoarchaeological remains includes a diversity of 97 marine species, representing 37% of all modern species (i.e., 265 spp.) that have been documented along the coast of Rio de Janeiro state. This high fish diversity recovered from the shellmounds is clear evidence of well-developed prehistoric fishery activity that targeted sharks, rays and finfishes in a productive area influenced by coastal marine upwelling. The presence of adult and neonate shark, especially oceanic species, is here interpreted as evidence of prehistoric fisheries capacity for exploitation and possibly overexploitation in nursery areas. Various tools and strategies were used to capture finfish in seasonal fisheries, over rocky reef bottoms and in sandy littoral environments. Massive catches of whitemouth croaker, main target dermersal species of South Atlantic coast, show evidence of a reduction in body size of approximately 28% compared with modern fisheries. Fishery activity involving vulnerable species, especially in nursery areas, could mark the beginning of fish depletion along the southeastern Brazilian coast and the collapse of natural fish populations.	[Lopes, Mariana Samor; Pereira Bertucci, Thayse Cristina; Rapagna, Luciano; Tubino, Rafael de Almeida; Monteiro-Neto, Cassiano; Souza, Rosa; Socorro, Orangel Aguilera] Univ Fed Fluminense, Inst Biol, Campus Valonguinho,Outeiro Sao Joao Batista S-N, BR-24020141 Niteroi, RJ, Brazil; [Gomes Tomas, Acacio Ribeiro] Inst Pesca, Ctr APTA Pescado Marinho, Av Bartolomeu de Gusmao 192, BR-11030906 Sao Paulo, Brazil; [Tenorio, Maria Cristina; Lima, Tania] Univ Fed Rio de Janeiro, Dept Anthropol, Museu Nacl, BR-20940040 Rio De Janeiro, Brazil; [Carrillo-Briceno, Jorge Domingo] Univ Zurich, Palaeontol Inst & Museum, Karl Schmid Str 4, CH-8006 Zurich, Switzerland; [Haimovici, Manuel] Univ Fed Rio Grande, Inst Oceanog, Campus Carreiros,Av Italia, BR-96201900 Rio Grande, RS, Brazil; [Macario, Kita; Carvalho, Carla] Univ Fed Fluminense, Inst Fis, Campus Praia Vermelha, BR-24210310 Niteroi, RJ, Brazil	Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; University of Zurich; Universidade Federal do Rio Grande; Universidade Federal Fluminense	Bertucci, TCP (corresponding author), Univ Fed Fluminense, Inst Biol, Campus Valonguinho,Outeiro Sao Joao Batista S-N, BR-24020141 Niteroi, RJ, Brazil.	thathab@gmail.com	Macario, Kita/B-6859-2014; Macario, Kita/ADE-6381-2022	Macario, Kita/0000-0002-0581-9854; Tomas, Acacio/0000-0002-5794-1819; Carrillo Briceno, Jorge Domingo/0000-0002-8652-7692; SOUZA, ROSA/0000-0002-3534-3770; Haimovici, Manuel/0000-0003-1741-8182	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, APQ1 [E-26/111.278/2014]; Pro-Reitoria de Pesquisa, Pos-Graduacao e Inovacao da Universidade Federal Fluminense [46094044157201298]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [306053/2013-6, 305037/2012-9]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, APQ1; Pro-Reitoria de Pesquisa, Pos-Graduacao e Inovacao da Universidade Federal Fluminense; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, APQ1, Process E-26/111.278/2014 to OA, http://www.faperj.br/; Pro-Reitoria de Pesquisa, Pos-Graduacao e Inovacao da Universidade Federal Fluminense, Process 46094044157201298 to OA, http://www.proppi.uff.br/posgraduacao/; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fellowship, Process 306053/2013-6 to CMN; Process 305037/2012-9 to MCT, http://lattes.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Perera A, 2006, MAR ECOL PROG SER, V327, P289, DOI 10.3354/meps327289; Aguilera OA, 2015, QUAT INT; Allen BR, 2002, S AFR J MARINE SCI, V24, P1, DOI 10.2989/025776102784528484; Alves E, 2015, QUAT GEOCHRONOL, V29, P30, DOI 10.1016/j.quageo.2015.05.006; Alves E, 2015, RADIOCARBON, V57, P517, DOI 10.2458/azu_rc.57.18404; Andrade Lima Tania, 1991, THESIS; Andreata José V., 2002, Rev. Bras. Zool., V19, P1139, DOI 10.1590/S0101-81752002000400019; [Anonymous], 2007, 59 GULF CAR FISH INS; [Anonymous], 2010, REV MUS ARQUEOL ETNO; [Anonymous], 2008, REV MUSEU ARQUEOLOGI, DOI DOI 10.11606/ISSN; Baisre JA, 2010, J ISL COAST ARCHAEOL, V5, P120, DOI 10.1080/15564891003663943; Barbosa-Guimaraes MS, 2006, BRMN A, V64, P271; Belem AL, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50297; Beltrao M, 2001, PREHISTORIA ESTADO R; Bender MG, 2014, PLOS ONE, V9, P110; Bornatowski H, 2008, BRAZ J OCEANOGR, V56, P317, DOI 10.1590/S1679-87592008000400008; Burgess GH., CARCHARHINUS BREVIPI; Calippo FR, 2011, REV MUS ARQUEOL ETNO, V21, P31; Carneiro MH., 2005, SERIE DOCUMENTOS REV, P94; Carvalho C, 2015, RADIOCARBON, V57, P459, DOI 10.2458/azu_rc.57.18365; Castilho Pedro Volkmer de, 2001, Revista Brasileira de Zoologia, V18, P719; Castro MA, 2015, THESIS; Chapman DD, 2015, ANNU REV MAR SCI, V7, P547, DOI 10.1146/annurev-marine-010814-015730; Cione AL, 2003, INT J OSTEOARCHAEOL, V13, P222, DOI 10.1002/oa.678; Coelho-Souza SA, 2012, BRAZ J OCEANOGR, V60, P353, DOI 10.1590/S1679-87592012000300008; Cordeiro LGM, 2014, PALAEOGEOGR PALAEOCL; Cramer KL, 2013, B MAR SCI, V89, P955, DOI 10.5343/bms.2012.1028; Cunha A.M., 2012, ANU INST GEOCIENC, V35, P236, DOI DOI 10.11137/2012_1_236_241; de Castilho PV, 2008, QUATERN INT, V180, P107, DOI 10.1016/j.quaint.2007.09.015; Denham J, SPHYRNA MOKARRAN IUC; Desmarest AG, 1983, MEM SOC LINN PARIS, V2, P163; Dias GTM, 2009, LECT NOTES EARTH SCI, V107, P225; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Drew J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059855; Eirado LG, 2006, REV BRASILEIRA GEOCI, V36, P426, DOI DOI 10.25249/0375-7536.2006363426436; Erlandson JM, 2008, J ARCHAEOL SCI, V35, P2144, DOI 10.1016/j.jas.2008.01.014; Erlandson JM, 2011, SCIENCE, V331, P1181, DOI 10.1126/science.1201477; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Fagundes Netto E.B., 1991, Neritica, V6, P139; Dubois CMF, 2012, QUATERN INT, V256, P62, DOI 10.1016/j.quaint.2011.07.041; Fergusson I, CARCHARODON CARCHARI; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Figueiredo J.L., 2003, CAT LOGO ESP CIES PE, P9; Fitzpatrick SM, 2010, J ISL COAST ARCHAEOL, V5, P173, DOI 10.1080/15564891003656624; Fossile T., 2013, THESIS; FRAYER DW, 1988, CURR ANTHROPOL, V29, P346, DOI 10.1086/203645; Gadig OBF, 1998, GREAT WHITE SHARKS B; Gaspar M. D., 1996, B MUS PARANA E GOELD, P81; Goldman KJ, 2006, ENVIRON BIOL FISH, V77, P241, DOI 10.1007/s10641-006-9128-y; Gonzalez Manoel M. B., 2005, Neotrop. ichthyol., V3, P421, DOI 10.1590/S1679-62252005000300010; GONZALEZ Milagros, 2005, THESIS; GONZALEZ MMB, 2014, CAD CEON CULT MAT, V24, P99; Gottschalk S, 2012, HYDROBIOLOGIA, V694, P41, DOI 10.1007/s10750-012-1128-7; Guimaraes M.B.C, 2007, THESIS; Guimaraes MB, 2013, AN ACAD BRAS CIENC, V85, P415, DOI 10.1590/S0001-37652013005000005; Haimovici M., 2005, USP SERIE DOCUMENTOS, P101; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hilbert L.M., 2011, THESIS; Holmes BJ, 2014, MAR BIOL, V161, P2645, DOI 10.1007/s00227-014-2536-1; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Hughes RM, 2015, ECOL INDIC, V57, P546, DOI 10.1016/j.ecolind.2015.04.044; Hurst W, 2004, J LARYNGOL OTOL, V118, P348, DOI 10.1258/002221504323086525; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jones S, 2010, J ISL COAST ARCHAEOL, V5, P159, DOI 10.1080/15564891003655998; Jorgensen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047819; Kneip LM, 2001, SER ARQUEOL MUS NAC, P5; Kneip LM., 1991, B IAB, V5, P1; Kneip LM, 1981, PESQUISAS ARQUEOLOGI; Kneip LM, 1995, RIO DE JANEIRO SER A, V3, P39; Kotas JE, 2011, BRAZ J BIOL, V71, P755, DOI 10.1590/S1519-69842011000400022; Lima TA, 2004, NUCL INSTRUM METH B, V223, P691, DOI 10.1016/j.nimb.2004.04.128; Lima TA, 2003, BRAZ J PHYS, V33, P276, DOI 10.1590/S0103-97332003000200020; Lima TA., 1999, REV U SAO PAULO, V44, P270; Litu MLA, 2012, BANGLADESH J OTORHIN, V18, P91, DOI 10.3329/bjo.v18i1.10428; Macario KD, 2015, J ENVIRON RADIOACTIV, V143, P14, DOI 10.1016/j.jenvrad.2015.02.002; Macario KD, 2014, RADIOCARBON, V56, P489, DOI 10.2458/56.16954; Macario KD, 2013, RADIOCARBON, V55, P325, DOI 10.1017/S003382220005743X; Magalhaes RMM, 2001, DOCUMENTOS TRABALHO, V5, P55; Mazzoleni R.C., 1999, NOTAS TEC FACIMAR, V3, P111; McClenachan L, 2008, P ROY SOC B-BIOL SCI, V275, P1351, DOI 10.1098/rspb.2007.1757; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; McClenachan L, 2010, J ISL COAST ARCHAEOL, V5, P165, DOI 10.1080/15564891003656178; Monteiro C, 2008, IHERINGIA SER ZOOL, V98, P50, DOI 10.1590/S0073-47212008000100007; Morris AV, 2000, BIODIVERS CONSERV, V9, P919, DOI 10.1023/A:1008996002822; Motoki A, 2008, UNESP GEOCIENCIAS, V27, P207; Mulato IP, 2015, BOL INST PESCA, V41, P1; Musick JA, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:CTDERI>2.0.CO;2; NATANSON LJ, 2002, COL VOL SCI PAP ICCA, V54, P1280; O'Connor S, 2011, SCIENCE, V334, P1117, DOI 10.1126/science.1207703; Okumura M, 2013, REV TEMP ACAD ARQ PR, V11, P38; OKUMURA MMM, 2005, REV MUS ARQUEOL ETNO, V15, P181; Oliveira Maria Dulce Barcellos Gaspar de, 2013, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V8, P517; Plew MG, 1998, EXPLORATIONS AM ARCH; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Pollard D, CARCHARIAS TAURUS IU; Pons M, 2010, COLL VOL SCI PAP ICC, V65, P2098; PROUS A., 1992, ARQUEOLOGIA BRASILEI; R Core Team, 2012, R LANG ENV STAT COMP; Rabago-Quiroz CH, 2012, MAR BIOL RES, V8, P865, DOI 10.1080/17451000.2012.692161; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reitz EJ, 2004, AM ANTIQUITY, V69, P63, DOI 10.2307/4128348; Rick TC, 2013, ANTHROPOCENE; Sadovy Y., 1999, NOAA TECHNICAL REPOR, V146, P1; Salemme M., 2009, ARQUEOLOGIA PATAGONI, P845; SALLS R A, 1989, Journal of Ethnobiology, V9, P173; Santos C.M.C., 1995, DOCUMENTO TRABALHO S, V3, P65; Savi DC, 2005, ABEQUA, V10, P29; Scartascini FL, 2013, J ARCHAEOL SCI, V40, P1059, DOI 10.1016/j.jas.2012.08.032; Scartascini FL, 2014, QUAT INT; Silva P. R., 2004, THESIS; Soares de Sousa G., 1851, TIPOGRAFIA UNIVERSAL, V1, P518; Souto DD, 2011, PALAEOGEOGR PALAEOCL, V299, P49, DOI 10.1016/j.palaeo.2010.10.032; Starr RM, 2007, MAR ECOL PROG SER, V343, P239, DOI 10.3354/meps06897; Tenorio M.C., 2010, REV MUSEU ARQUEOLOGI, V20, P127; Tenorio Maria Cristina, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P311; Tenorio MC, 2005, 13 C SAB CAMP GRAND; Tubino RD, 2007, BRAZ J OCEANOGR, V55, P187, DOI 10.1590/S1679-87592007000300003; Turcq B., 1999, ENV GEOCHEMISTRY COA, P25; Vaudo JJ, 2014, ECOL EVOL, V4, P1768, DOI 10.1002/ece3.1053; Villagran XS, 2011, J ISL COAST ARCHAEOL, V6, P211, DOI 10.1080/15564894.2011.586087; Wagner GP, 2014, ARCHAEOL DISC, DOI [10.4236/ad.2014.21001, DOI 10.4236/AD.2014.21001]; Wagner G, 2011, QUATERN INT, V239, P51, DOI 10.1016/j.quaint.2011.03.009; WALKER KJ, 2000, SE ARCHAEOL, V19, P24; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Wing SR, 2001, CORAL REEFS, V20, P1; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034; Yokota L, 2006, ENVIRON BIOL FISH, V75, P349, DOI 10.1007/s10641-006-0038-9	130	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0154476	10.1371/journal.pone.0154476	http://dx.doi.org/10.1371/journal.pone.0154476			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355355	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400003
J	Medina-Aguilar, R; Perez-Plasencia, C; Marchat, LA; Gariglio, P; Mena, JG; Cuevas, SR; Ruiz-Garcia, E; Astudillo-de la Vega, H; Juarez, JH; Flores-Perez, A; Lopez-Camarillo, C				Medina-Aguilar, Rubiceli; Perez-Plasencia, Carlos; Marchat, Laurence A.; Gariglio, Patricio; Garcia Mena, Jaime; Rodriguez Cuevas, Sergio; Ruiz-Garcia, Erika; Astudillo-de la Vega, Horacio; Hernandez Juarez, Jennifer; Flores-Perez, Ali; Lopez-Camarillo, Cesar			Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol	PLOS ONE			English	Article							PTEN/AKT PATHWAY; GENE-EXPRESSION; DNA METHYLATION; TUMOR-CELLS; CYCLIN B1; PREVENTION; HEXOKINASE; CARCINOMA; APOPTOSIS	Aberrant DNA methylation is a frequent epigenetic alteration in cancer cells that has emerged as a pivotal mechanism for tumorigenesis. Accordingly, novel therapies targeting the epigenome are being explored with the aim to restore normal DNA methylation patterns on oncogenes and tumor suppressor genes. A limited number of studies indicate that dietary compound resveratrol modulates DNA methylation of several cancer-related genes; however a complete view of changes in methylome by resveratrol has not been reported yet. In this study we performed a genome-wide survey of DNA methylation signatures in triple negative breast cancer cells exposed to resveratrol. Our data showed that resveratrol treatment for 24 h and 48 h decreased gene promoter hypermethylation and increased DNA hypomethylation. Of 2476 hypermethylated genes in control cells, 1,459 and 1,547 were differentially hypomethylated after 24 h and 48 h, respectively. Remarkably, resveratrol did not induce widespread non-specific DNA hyper- or hypomethylation as changes in methylation were found in only 12.5% of 27,728 CpG loci. Moreover, resveratrol restores the hypomethylated and hypermethylated status of key tumor suppressor genes and oncogenes, respectively. Importantly, the integrative analysis of methylome and transcriptome profiles in response to resveratrol showed that methylation alterations were concordant with changes in mRNA expression. Our findings reveal for the first time the impact of resveratrol on the methylome of breast cancer cells and identify novel potential targets for epigenetic therapy. We propose that resveratrol may be considered as a dietary epidrug as it may exert its anti-tumor activities by modifying the methylation status of cancer-related genes which deserves further in vivo characterization.	[Medina-Aguilar, Rubiceli; Gariglio, Patricio; Garcia Mena, Jaime; Hernandez Juarez, Jennifer] CINVESTAV IPN, Dept Genet & Biol Mol, Mexico City, DF, Mexico; [Perez-Plasencia, Carlos] FES Iztacala UNAM, Unidad Biomed, Lab Genom Func, Tlalnepantla, Estado De Mexic, Mexico; [Marchat, Laurence A.] Inst Politecn Nacl, Escuela Nacl Med & Homeopatia, Programa Biomed Mol & Red Biotecnol, Mexico City, DF, Mexico; [Rodriguez Cuevas, Sergio] FUCAM, Inst Enfermedades Mama, Mexico City, DF, Mexico; [Ruiz-Garcia, Erika] Inst Nacl Cancerol, Lab Med Translac, Mexico City, DF, Mexico; [Astudillo-de la Vega, Horacio] Hosp Oncol, Ctr Med Siglo 21, Lab Invest Canc & Terapia Celular, Mexico City, DF, Mexico; [Flores-Perez, Ali; Lopez-Camarillo, Cesar] Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Cancerologia (INCAN)	Lopez-Camarillo, C (corresponding author), Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, Mexico City, DF, Mexico.	genomicas@yahoo.com.mx	Marchat, Laurence A./S-8418-2018; Lopez-Camarillo, Cesar/I-1946-2019; Perez-Plasencia, Carlos/P-2372-2019; García-Mena, Jaime/B-1625-2008	Marchat, Laurence A./0000-0003-1615-8614; Lopez-Camarillo, Cesar/0000-0002-9417-2609; Perez-Plasencia, Carlos/0000-0002-8593-8211; García-Mena, Jaime/0000-0002-0595-3711; Ali, Flores-Perez/0000-0001-9141-9234; Ruiz-Garcia, Erika/0000-0002-0446-123X	CONACYT SALUD [233370, 222335]; CONACYT fellowship; Universidad Autonoma de la Ciudad de Mexico (UACM)	CONACYT SALUD(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Autonoma de la Ciudad de Mexico (UACM)	The authors acknowledge CONACYT SALUD for support of this work (233370 and 222335 grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rubiceli Medina was supported by a CONACYT fellowship. The authors also thank Universidad Autonoma de la Ciudad de Mexico (UACM) for support.; We thanks to Universidad Autonoma de la Ciudad de Mexico (UACM) for support. Rubiceli Medina was supported by CONACYT fellowship.	Adriaens ME, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-42; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; Chae SW, 2011, YONSEI MED J, V52, P445, DOI 10.3349/ymj.2011.52.3.445; Chimonidou M, 2011, CLIN CHEM, V57, P1169, DOI 10.1373/clinchem.2011.165902; Colin D, 2011, CANCER PREV RES, V4, P1095, DOI 10.1158/1940-6207.CAPR-10-0274; Dai WQ, 2015, ONCOTARGET, V6, P13703, DOI 10.18632/oncotarget.3800; Dhar S, 2015, BBA-MOL CELL RES, V1853, P265, DOI 10.1016/j.bbamcr.2014.11.004; Dickinson RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027792; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fanale D, 2013, BREAST CANCER RES TR, V140, P505, DOI 10.1007/s10549-013-2649-0; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fu DY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000637; Gao Z, 2011, BIOCHEM BIOPH RES CO, V407, P271, DOI 10.1016/j.bbrc.2011.02.008; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Li D, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-26; Lin CY, 2013, J FUNCT FOODS, V5, P790, DOI 10.1016/j.jff.2013.01.025; Link A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057709; Medina A, 2016, ONCOLOGY REPORTS; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Ong TP, 2011, J NUTRIGENET NUTRIGE, V4, P275, DOI 10.1159/000334585; Ou YW, 2013, CANCER BIOL THER, V14, P45, DOI 10.4161/cbt.22627; Paluszczak J, 2010, TOXICOL LETT, V192, P119, DOI 10.1016/j.toxlet.2009.10.010; Papoutsis AJ, 2010, J NUTR, V140, P1607, DOI 10.3945/jn.110.123422; Pfister S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm094; Phuah NH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/804510; Ross SA, 2008, NUTR REV, V66, pS1, DOI 10.1111/j.1753-4887.2008.00055.x; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Thakur VS, 2014, AAPS J, V16, P151, DOI 10.1208/s12248-013-9548-5; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Udali S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0077-1; Whitlock NC, 2012, NUTR CANCER, V64, P493, DOI 10.1080/01635581.2012.667862; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xiang TX, 2013, CHIN J CANCER, V32, P12, DOI 10.5732/cjc.011.10344; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326	38	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157866	10.1371/journal.pone.0157866	http://dx.doi.org/10.1371/journal.pone.0157866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355345	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400022
J	Stickland, MK; Fuhr, DP; Edgell, H; Byers, BW; Bhutani, M; Wong, EYL; Steinback, CD				Stickland, Michael K.; Fuhr, Desi P.; Edgell, Heather; Byers, Brad W.; Bhutani, Mohit; Wong, Eric Y. L.; Steinback, Craig D.			Chemosensitivity, Cardiovascular Risk, and the Ventilatory Response to Exercise in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CAROTID CHEMORECEPTOR MODULATION; SYMPATHETIC-NERVE ACTIVITY; ARTERIAL STIFFNESS; BLOOD-FLOW; CHEMOREFLEX FUNCTION; AT(1) RECEPTOR; HEART-FAILURE; VITAMIN-C; HYPOXIA	COPD is associated with elevated cardiovascular risk and a potentiated ventilatory response to exercise. Enhanced carotid chemoreceptor (CC) activity/sensitivity is present in other clinical conditions, has been shown to contribute to sympathetic vasoconstrictor outflow, and is predictive of mortality. CC activity/sensitivity, and the resulting functional significance, has not been well examined in COPD. We hypothesized that CC activity/sensitivity would be elevated in COPD, and related to increased pulse wave velocity (a marker of CV risk) and the ventilatory response to exercise. Methods: 30 COPD patients and 10 healthy age-matched controls were examined. Participants performed baseline cardiopulmonary exercise and pulmonary function testing. CC activity was later evaluated by the drop in ventilation with breathing 100% O-2, and CC sensitivity was then assessed by the ventilatory response to hypoxia (Delta VE/Delta SpO(2)). Peripheral arterial stiffness was subsequently evaluated by measurement of pulse wave velocity (PWV) using applanation tonometry while the subjects were breathing room air, and then following chemoreceptor inhibition by breathing 100% O-2 for 2 minutes. Results: CC activity, CC sensitivity, PWV and the ventilatory response to exercise were all increased in COPD relative to controls. CC sensitivity was related to PWV; however, neither CC activity nor CC sensitivity was related to the ventilatory response to exercise in COPD. CC inhibition by breathing 100% O-2 normalized PWV in COPD, while no effect was observed in controls. Conclusion: CC activity and sensitivity are elevated in COPD, and appear related to cardiovascular risk; however, CC activity/sensitivity does not contribute to the potentiated ventilatory response to exercise.	[Stickland, Michael K.; Fuhr, Desi P.; Edgell, Heather; Byers, Brad W.; Bhutani, Mohit; Wong, Eric Y. L.] Univ Alberta, Dept Med, Div Pulm, Edmonton, AB, Canada; [Stickland, Michael K.] Covenant Hlth, GF MacDonald Ctr Lung Hlth, Edmonton, AB, Canada; [Steinback, Craig D.] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada	University of Alberta; University of Alberta	Stickland, MK (corresponding author), Univ Alberta, Dept Med, Div Pulm, Edmonton, AB, Canada.; Stickland, MK (corresponding author), Covenant Hlth, GF MacDonald Ctr Lung Hlth, Edmonton, AB, Canada.	michael.stickland@ualberta.ca	Edgell, Heather/ABE-3182-2020	Edgell, Heather/0000-0001-8865-1921; Byers, Bradley/0000-0003-1109-9897	Canadian Institutes of Health Research [310994]; Heart and Stroke Foundation of Canada New Investigator Salary Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada New Investigator Salary Award	This research was supported by a grant from the Canadian Institutes of Health Research (grant # 310994; http://www.cihr-irsc.gc.ca/e/193.html). MS is supported by a Heart and Stroke Foundation of Canada New Investigator Salary Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 1998, J PHYSIOL-LONDON, V510, P773, DOI 10.1111/j.1469-7793.1998.773bj.x; Andreas S, 2014, LUNG, V192, P235, DOI 10.1007/s00408-013-9544-7; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; BALKOWIEC A, 1993, RESP PHYSIOL, V92, P91; Bartels MN, 2004, RESP MED, V98, P84, DOI 10.1016/j.rmed.2002.09.001; Bartels MN, 2000, CHEST, V118, P691, DOI 10.1378/chest.118.3.691; Beloka S, 2008, MED SCI SPORT EXER, V40, P1932, DOI 10.1249/MSS.0b013e31817fbe11; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; BRADLEY CA, 1979, AM REV RESPIR DIS, V120, P21; Bratel T, 2000, RESP MED, V94, P1221, DOI 10.1053/rmed.2000.0953; Curran AK, 2000, J APPL PHYSIOL, V88, P1840, DOI 10.1152/jappl.2000.88.5.1840; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; DEJOURS P, 1962, PHYSIOL REV, V42, P335, DOI 10.1152/physrev.1962.42.3.335; DEJOURS P, 1963, ANN NY ACAD SCI, V109, P682, DOI 10.1111/j.1749-6632.1963.tb13497.x; Dinenno FA, 2000, AM J PHYSIOL-HEART C, V278, pH1205, DOI 10.1152/ajpheart.2000.278.4.H1205; Edgell H, 2015, J APPL PHYSIOL, V118, P839, DOI 10.1152/japplphysiol.00898.2014; ERBLAND ML, 1990, CHEST, V97, P1289, DOI 10.1378/chest.97.6.1289; Giannoni A, 2009, J AM COLL CARDIOL, V53, P1975, DOI 10.1016/j.jacc.2009.02.030; Guyenet PG, 2000, RESP PHYSIOL, V121, P147, DOI 10.1016/S0034-5687(00)00125-0; Heindl S, 2001, AM J RESP CRIT CARE, V164, P597, DOI 10.1164/ajrccm.164.4.2007085; Holm SM, 2014, RESP PHYSIOL NEUROBI, V192, P30, DOI 10.1016/j.resp.2013.11.009; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leung PS, 2000, J ENDOCRINOL, V167, P517, DOI 10.1677/joe.0.1670517; Mak S, 2002, AM J PHYSIOL-HEART C, V282, pH2414, DOI 10.1152/ajpheart.00947.2001; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; McKelvie RS, 2013, CAN J CARDIOL, V29, P168, DOI 10.1016/j.cjca.2012.10.007; McNulty PH, 2007, J APPL PHYSIOL, V102, P2040, DOI 10.1152/japplphysiol.00595.2006; MIYAMOTO K, 1992, AM REV RESPIR DIS, V145, P1384, DOI 10.1164/ajrccm/145.6.1384; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; O'Donnell DE, 2007, CAN RESPIR J, V14, p5B, DOI 10.1155/2007/830570; Parati G, 2014, BLOOD PRESSURE ARTER; Ponikowski P, 2001, CIRCULATION, V104, P544, DOI 10.1161/hc3101.093699; Porzionato A, 2013, RESP PHYSIOL NEUROBI, V187, P31, DOI 10.1016/j.resp.2013.02.017; Raupach T, 2008, EUR RESPIR J, V32, P387, DOI 10.1183/09031936.00109607; Sabit R, 2007, AM J RESP CRIT CARE, V175, P1259, DOI 10.1164/rccm.200701-067OC; Scalvini S, 1999, EUR RESPIR J, V13, P119, DOI 10.1183/09031936.99.13111999; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Solomon IC, 2000, RESP PHYSIOL, V121, P101, DOI 10.1016/S0034-5687(00)00122-5; SOMERS VK, 1988, HYPERTENSION, V11, P608, DOI 10.1161/01.HYP.11.6.608; Stickland MK, 2008, J PHYSIOL-LONDON, V586, P1743, DOI 10.1113/jphysiol.2007.147421; Stickland MK, 2007, CIRC RES, V100, P1371, DOI 10.1161/01.RES.0000266974.84590.d2; Stickland MK, 2013, RESP PHYSIOL NEUROBI, V189, P188, DOI 10.1016/j.resp.2013.08.001; Stickland MK, 2011, J PHYSIOL-LONDON, V589, P6219, DOI 10.1113/jphysiol.2011.218099; SUN MK, 1994, PROG NEUROBIOL, V44, P197, DOI 10.1016/0301-0082(94)90038-8; Sun SY, 1999, J APPL PHYSIOL, V86, P1264, DOI 10.1152/jappl.1999.86.4.1264; Swierblewska E, 2010, J HYPERTENS, V28, P979, DOI 10.1097/HJH.0b013e328336ed9a; Timmers HJLM, 2003, J HYPERTENS, V21, P591, DOI 10.1097/00004872-200303000-00026; van de Borne P, 1998, CIRCULATION, V98, P126, DOI 10.1161/01.CIR.98.2.126; van Helvoort HAC, 2005, RESP MED, V99, P1555, DOI 10.1016/j.rmed.2005.03.028; Vedam H, 2009, EUR J APPL PHYSIOL, V105, P19, DOI 10.1007/s00421-008-0868-6; WARD SA, 1989, J PHYSIOL-LONDON, V411, P27, DOI 10.1113/jphysiol.1989.sp017557; WHIPP BJ, 1980, FED PROC, V39, P2668; Wolk R, 2005, J CARD FAIL, V11, P333, DOI 10.1016/j.cardfail.2004.11.008; Wouters EFM, 2002, THORAX, V57, P1067, DOI 10.1136/thorax.57.12.1067	59	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158341	10.1371/journal.pone.0158341	http://dx.doi.org/10.1371/journal.pone.0158341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355356	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400052
J	Fantoni, C; Rigutti, S; Piccoli, V; Sommacal, E; Carnaghi, A				Fantoni, Carlo; Rigutti, Sara; Piccoli, Valentina; Sommacal, Elena; Carnaghi, Andrea			Faster but Less Careful Prehension in Presence of High, Rather than Low, Social Status Attendees	PLOS ONE			English	Article							MERE PRESENCE; UNIVERSAL DIMENSIONS; BINOCULAR VISION; GENDER HIERARCHY; MIRROR NEURONS; ONLINE CONTROL; MOTOR CONTROL; FACILITATION; COORDINATION; HAND	Ample evidence attests that social intention, elicited through gestures explicitly signaling a request of communicative intention, affects the patterning of hand movement kinematics. The current study goes beyond the effect of social intention and addresses whether the same action of reaching to grasp an object for placing it in an end target position within or without a monitoring attendee's peripersonal space, can be moulded by pure social factors in general, and by social facilitation in particular. A motion tracking system (Optotrak Certus) was used to record motor acts. We carefully avoided the usage of communicative intention by keeping constant both the visual information and the positional uncertainty of the end target position, while we systematically varied the social status of the attendee (a high, or a low social status) in separated blocks. Only thirty acts performed in the presence of a different social status attendee, revealed a significant change of kinematic parameterization of hand movement, independently of the attendee's distance. The amplitude of peak velocity reached by the hand during the reach-to-grasp and the lift-to-place phase of the movement was larger in the high rather than in the low social status condition. By contrast, the deceleration time of the reach-to-grasp phase and the maximum grasp aperture was smaller in the high rather than in the low social status condition. These results indicated that the hand movement was faster but less carefully shaped in presence of a high, but not of a low social status attendee. This kinematic patterning suggests that being monitored by a high rather than a low social status attendee might lead participants to experience evaluation apprehension that informs the control of motor execution. Motor execution would rely more on feedforward motor control in the presence of a high social status human attendee, vs. feedback motor control, in the presence of a low social status attendee.	[Fantoni, Carlo; Rigutti, Sara; Piccoli, Valentina; Sommacal, Elena; Carnaghi, Andrea] Univ Trieste, Psychol Unit Gaetano Kanizsa, Dept Life Sci, Via Weiss 21, I-34128 Trieste, Italy	University of Trieste	Fantoni, C (corresponding author), Univ Trieste, Psychol Unit Gaetano Kanizsa, Dept Life Sci, Via Weiss 21, I-34128 Trieste, Italy.	cfantoni@units.it		Fantoni, Carlo/0000-0002-7749-1771	University of Trieste [FRA-2013]	University of Trieste	This work was supported by the University of Trieste with a grant to CF (FRA-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2014, FRONT PSYCHOL, V5; Arbib M. A., 2011, HDB PHYSL NERVOUS SY, P1449, DOI [DOI 10.1016/J.JPHYSPARIS.2008.03.001, 10.1002/cphy.cp010233]; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; BANAJI MR, 1995, J PERS SOC PSYCHOL, V68, P181, DOI 10.1037/0022-3514.68.2.181; Banaji MR, 1996, PSYCHOL SCI, V7, P136, DOI 10.1111/j.1467-9280.1996.tb00346.x; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Bates D., 2015, LINEAR MIXED EFFECTS; Bates D.M., 2010, LME4 MIXED EFFECTS M; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; BIGUER B, 1982, EXP BRAIN RES, V46, P301; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Blair IV, 1996, J PERS SOC PSYCHOL, V70, P1142, DOI 10.1037/0022-3514.70.6.1142; Blascovich J, 1999, J PERS SOC PSYCHOL, V77, P68, DOI 10.1037/0022-3514.77.1.68; Bohns VK, 2012, J EXP SOC PSYCHOL, V48, P341, DOI 10.1016/j.jesp.2011.05.022; BOND CF, 1983, PSYCHOL BULL, V94, P265, DOI 10.1037/0033-2909.94.2.265; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Bowman M, 2009, EXP BRAIN RES, V195, P273, DOI 10.1007/s00221-009-1781-x; Bozzacchi C, 2014, J NEUROPHYSIOL, V112, P3189, DOI 10.1152/jn.00439.2014; Bradshaw MF, 2004, SPATIAL VISION, V17, P95, DOI 10.1163/156856804322778288; Bradshaw MF, 2003, SPATIAL VISION, V16, P295, DOI 10.1163/156856803322467545; Brambilla M, 2011, SOC PSYCHOL-GERMANY, V42, P101, DOI 10.1027/1864-9335/a000054; Braun D, 2011, EXP BRAIN RES, V211, P631, DOI 10.1007/s00221-011-2642-y; BUSS DM, 1988, J PERS SOC PSYCHOL, V54, P616, DOI 10.1037/0022-3514.54.4.616; Buunk A.P., 2009, J EVOLUTIONARY PSYCH, V7, P37, DOI [DOI 10.1556/JEP.7.2009.1.5, 10.1556/JEP.7.2009.1.5]; Candidi M, 2014, CEREB CORTEX, V24, P435, DOI 10.1093/cercor/bhs325; Carnaghi A, 2014, J SOC PSYCHOL, V154, P105, DOI 10.1080/00224545.2013.863174; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Coello Y., 2015, SOCIOAFFECTIVE NEURO, V2015, P5; Commission European, 2015, GEND EQ SPEC EUROBAR, P428; Costantini M, 2011, PLOS ONE, V6; Costantini M, 2011, PSYCHON B REV, V18, P302, DOI 10.3758/s13423-011-0054-4; Cottrell N. B., 1972, EXPT SOCIAL PSYCHOL, V185, P236; COTTRELL NB, 1968, J PERS SOC PSYCHOL, V9, P245, DOI 10.1037/h0025902; Craighero L, 2011, COGNITION, V120, P26, DOI 10.1016/j.cognition.2011.02.011; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Dalmaso M, 2011, BIOL LETT, P11; Dalmaso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093139; de la Rosa S, 2014, PLOS ONE, V9; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desy MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000971; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; Ferri F, 2011, PLOS ONE, V6; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flatters IJ, 2012, PLOS ONE, V7; Foster R, 2011, ACTA PSYCHOL, V136, P300, DOI 10.1016/j.actpsy.2010.12.003; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Freeman JB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00059; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2001, J CONSCIOUSNESS STUD, V8, P33; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Gerbino W, 2014, P HUM FACT ERG SOC E, P403; Gianelli C, 2013, PSYCHOL RES-PSYCH FO, V77, P40, DOI 10.1007/s00426-011-0401-0; Gielen CCAM, 2009, CORTEX, V45, P340, DOI 10.1016/j.cortex.2008.02.009; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Glover S, 2004, BEHAV BRAIN SCI, V27, P57; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Goodale MA, 1996, ADV MOTOR LEARNING C, P87; Goodwin S. A, 2000, GROUP PROCESS INTERG, V3, P227, DOI [10.1177/1368430200003003001, DOI 10.1177/1368430200003003001]; GUERIN B, 1982, BRIT J SOC PSYCHOL, V21, P7, DOI 10.1111/j.2044-8309.1982.tb00506.x; Halekoh U, 2014, J STAT SOFTW, V59, P1; HENCHY T, 1968, J PERS SOC PSYCHOL, V10, P446, DOI 10.1037/h0026814; Holt RJ, 2013, PLOS ONE, P8; Iachini T, 2016, J ENVIRON PSYCHOL, V45, P154, DOI 10.1016/j.jenvp.2016.01.004; Innocenti A, 2012, PLOS ONE, P7; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Jallais C, 2010, BEHAV RES METHODS, V42, P318, DOI 10.3758/BRM.42.1.318; JEANNEROD M, 1986, BEHAV BRAIN RES, V19, P99, DOI 10.1016/0166-4328(86)90008-2; Jeannerod M, 1999, HUM MOVEMENT SCI, V18, P201, DOI 10.1016/S0167-9457(99)00008-1; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; Kliegl R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00238; Kucera D, 2012, PROCD SOC BEHV, V69, P31, DOI 10.1016/j.sbspro.2012.11.380; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025117; Loftus A, 2004, EXP BRAIN RES, V158, P317, DOI 10.1007/s00221-004-1905-2; Losin EAR, 2012, NEUROIMAGE, V59, P3594, DOI 10.1016/j.neuroimage.2011.10.074; LOVELAND K A, 1991, Ecological Psychology, V3, P99, DOI 10.1207/s15326969eco0302_3; Maner JK, 2013, EVOL HUM BEHAV, V34, P412, DOI 10.1016/j.evolhumbehav.2013.07.005; MARKUS H, 1978, J EXP SOC PSYCHOL, V14, P389, DOI 10.1016/0022-1031(78)90034-3; MARQUES JM, 1988, EUR J SOC PSYCHOL, V18, P1, DOI 10.1002/ejsp.2420180102; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Mon-Williams M, 2011, EXP BRAIN RES, V211, P145, DOI 10.1007/s00221-011-2659-2; Nicolini C, 2014, PROC SPIE, V9014, DOI 10.1117/12.2045459; PAULUS PB, 1971, J EXP SOC PSYCHOL, V7, P280, DOI 10.1016/0022-1031(71)90028-X; Pavan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025608; Pezzulo G, 2011, EXP BRAIN RES, V211, P613, DOI 10.1007/s00221-011-2712-1; PRATT J, 1994, PSYCHOL AGING, V9, P325, DOI 10.1037/0882-7974.9.2.325; PROTEAU L, 1992, Q J EXP PSYCHOL-A, V44, P557, DOI 10.1080/14640749208401298; Quesque F, 2013, FRONT NEUROROBOTICS, V7; Quesque F, 2016, Q J EXP PSYCHOL, V69, P1451, DOI 10.1080/17470218.2015.1083596; Rigutti S, 2015, WEB PARTY EFFECT COC, V3; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roney JR, 2003, PERS SOC PSYCHOL B, V29, P393, DOI 10.1177/0146167202250221; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; Rosenbaum DA, 1999, EXP BRAIN RES, V128, P92, DOI 10.1007/s002210050823; Rudman LA, 1999, J PERS SOC PSYCHOL, V77, P1004, DOI 10.1037/0022-3514.77.5.1004; Rudman LA, 2000, PERS SOC PSYCHOL B, V26, P1315, DOI 10.1177/0146167200263001; Rudman LA, 1998, J PERS SOC PSYCHOL, V74, P629, DOI 10.1037/0022-3514.74.3.629; Rudman LA, 2012, J EXP SOC PSYCHOL, V48, P165, DOI 10.1016/j.jesp.2011.10.008; Saad G, 2009, ORGAN BEHAV HUM DEC, V110, P80, DOI 10.1016/j.obhdp.2009.06.001; Sacheli LM, 2015, FRONT PSYCHOL, V6; Sacheli LM, 2013, EXP BRAIN RES, V226, P473, DOI 10.1007/s00221-013-3459-7; Sartori L, 2011, COGNITION, V119, P242, DOI 10.1016/j.cognition.2011.01.014; Sartori L, 2009, CONSCIOUS COGN, V18, P766, DOI 10.1016/j.concog.2009.06.004; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schultz W, 2013, FRONT NEUROSCI, V7; Scorolli C, 2014, NEUROPSYCHOLOGIA, V57, P196, DOI 10.1016/j.neuropsychologia.2014.03.006; Seidler RD, 2004, NEUROIMAGE, V22, P1775, DOI 10.1016/j.neuroimage.2004.05.003; Serino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004930; SERVOS P, 1994, EXP BRAIN RES, V98, P119; SERVOS P, 1992, VISION RES, V32, P1513, DOI 10.1016/0042-6989(92)90207-Y; Servos P, 2000, EXP BRAIN RES, V130, P35, DOI 10.1007/s002210050004; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Straulino E, 2015, CORTEX, V70, P179, DOI 10.1016/j.cortex.2015.02.012; Strauss B, 2002, PSYCHOL SPORT EXERC, V3, P237, DOI 10.1016/S1469-0292(01)00019-X; Sun G, 2010, HEREDITY, V105, P333, DOI 10.1038/hdy.2010.11; Triplett N., 1898, AM J PSYCHOL, V9, P507, DOI [10.2307/1412188, DOI 10.2307/1412188]; Turner JC, 1981, CAHIERS PSYCHOL COGN, V1, P93; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Uziel L, 2007, J RES PERS, V41, P579, DOI 10.1016/j.jrp.2006.06.008; Volcic R, 2013, J NEUROSCI, V 33, P17081, DOI 10.1523/JNEUROSCI.2936-13.2013; Watt SJ, 2000, NEUROPSYCHOLOGIA, V38, P1473, DOI 10.1016/S0028-3932(00)00065-8; Wolpert DM, 2012, CURR OPIN NEUROBIOL, V22, P996, DOI 10.1016/j.conb.2012.05.003; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Yap AJ, 2013, PSYCHOL SCI, V24, P2281, DOI 10.1177/0956797613492425; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269	140	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158095	10.1371/journal.pone.0158095	http://dx.doi.org/10.1371/journal.pone.0158095			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27351978	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900032
J	Lins, BR; Pushie, JM; Jones, M; Howard, DL; Howland, JG; Hackett, MJ				Lins, Brittney R.; Pushie, Jake M.; Jones, Michael; Howard, Daryl L.; Howland, John G.; Hackett, Mark J.			Mapping Alterations to the Endogenous Elemental Distribution within the Lateral Ventricles and Choroid Plexus in Brain Disorders Using X-Ray Fluorescence Imaging	PLOS ONE			English	Article							PRENATAL IMMUNE ACTIVATION; CEREBROSPINAL-FLUID SYSTEM; HIPPOCAMPAL-FORMATION; ANIMAL-MODELS; SCHIZOPHRENIA; SEROTONIN; CALCIFICATION; INFECTION; CHLORIDE; LEADS	The choroid plexus and cerebral ventricles are critical structures for the production of cerebral spinal fluid (CSF) and play an important role in regulating ion and metal transport in the brain, however many aspects of its roles in normal physiology and disease states, such as psychiatric illness, remain unknown. The choroid plexus is difficult to examine in vivo, and in situ ex vivo, and as such has typically been examined indirectly with radiolabeled tracers or ex vivo stains, making measurements of the endogenous K+, Cl-, and Ca+ distributions unreliable. In the present study, we directly examined the distribution of endogenous ions and biologically relevant transition metals in the choroid plexus and regions surrounding the ventricles (ventricle wall, cortex, corpus callosum, striatum) using X-ray fluorescence imaging (XFI). We find that the choroid plexus was rich in Cl- and Fe while K+ levels increase further from the ventricle as Cl- levels decrease, consistent with the known role of ion transporters in the choroid plexus CSF production. A polyI:C offspring displayed enlarged ventricles, elevated Cl- surrounding the ventricles, and intraventricular calcifications. These observations fit with clinical findings in patients with schizophrenia and suggest maternal treatment with polyI: C may lead to dysfunctional ion regulation in offspring. This study demonstrates the power of XFI for examining the endogenous elemental distributions of the ventricular system in healthy brain tissue as well as disease models.	[Lins, Brittney R.; Howland, John G.] Univ Saskatchewan, Dept Physiol, Saskatoon, SK, Canada; [Pushie, Jake M.] Univ Saskatchewan, Coll Med, Saskatoon, SK S7N 0W0, Canada; [Jones, Michael; Howard, Daryl L.] Australian Synchrotron, Clayton, Vic, Australia; [Jones, Michael] La Trobe Univ, La Trobe Inst Mol Sci, ARC Ctr Excellence Adv Mol Imaging, Bundoora, Vic 3086, Australia; [Hackett, Mark J.] Curtin Univ, Dept Chem, Perth, WA 6845, Australia	University of Saskatchewan; University of Saskatchewan; La Trobe University; Curtin University	Howland, JG (corresponding author), Univ Saskatchewan, Dept Physiol, Saskatoon, SK, Canada.; Hackett, MJ (corresponding author), Curtin Univ, Dept Chem, Perth, WA 6845, Australia.	john.howland@usask.ca; mark.j.hackett@curtin.edu.au	Jones, Michael/M-6895-2013; Lins, Brittney/GWU-4974-2022; Jones, Michael/AAA-3860-2021; Howard, Daryl/E-9107-2013	Jones, Michael/0000-0002-0720-8715; Lins, Brittney/0000-0002-7960-7782; Jones, Michael/0000-0002-0720-8715; Howard, Daryl/0000-0001-6071-2382; Pushie, M. Jake/0000-0001-7494-5427; hackett, mark/0000-0002-3296-7270	Canadian Institutes for Health Research (CIHR) [125984]; CIHR; Saskatchewan Health Research Foundation Postdoctoral Fellowship; joint Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant [CIF 99472]; University of Saskatchewan; DOE Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation Postdoctoral Fellowship; joint Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by a Canadian Institutes for Health Research (CIHR) Operating Grant to JGH (#125984). JGH is a CIHR New Investigator. MJH received salary support from a CIHR Postdoctoral Fellowship and a Saskatchewan Health Research Foundation Postdoctoral Fellowship. During this research MJH was a member of the CIHR-Training grant in Health Research Using Synchrotron Techniques (CIHR-THRUST) program and a postdoctoral fellow funded by the joint Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant #CIF 99472. BRL received salary support from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Quentin Greba for his help administering maternal treatments and flash freezing brain tissue. Part of this research was undertaken on the XFM beamline of the Australian Synchrotron, Victoria, Australia. We would like to thank the members of the Australian Synchrotron XFM beamline, Martin de Jonge, David Paterson, and Simon James for their assistance in experiments performed at the Australian Synchrotron. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (P41RR001209). We would like to thank Sam Webb and Courtney Roach for their assistance in experiments performed at the Stanford Synchrotron Radiation Lightsource.	Abi-Dargham A, 1997, J NEUROPSYCH CLIN N, V9, P1; Bersani G, 1999, NEUROSCI LETT, V259, P169, DOI 10.1016/S0304-3940(98)00935-5; Boksa P, 2004, BRAIN RES REV, V45, P1, DOI 10.1016/j.brainresrev.2004.01.001; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004; Brown PD, 2004, NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Chwiej J, 2012, ANAL BIOANAL CHEM, V404, P3071, DOI 10.1007/s00216-012-6425-5; Chwiej J, 2012, J BIOL INORG CHEM, V17, P731, DOI 10.1007/s00775-012-0892-1; Chwiej J, 2011, J BIOL INORG CHEM, V16, P275, DOI 10.1007/s00775-010-0724-0; Chwiej J, 2008, J BIOL INORG CHEM, V13, P1267, DOI 10.1007/s00775-008-0411-6; COPPEN AJ, 1988, J CLIN PSYCHIAT, V49, P4; Cornford EM, 1997, EXP BRAIN RES, V116, P399, DOI 10.1007/PL00005768; Davies KM, 2013, METALLOMICS, V5, P43, DOI 10.1039/c2mt20151h; DELISI LE, 1986, ARCH GEN PSYCHIAT, V43, P148; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; FISONE G, 1995, J BIOL CHEM, V270, P2427, DOI 10.1074/jbc.270.6.2427; Grubman A, 2014, CHEM SCI, V5, P2503, DOI 10.1039/c4sc00316k; Hackett MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500911; Hackett MJ, 2015, ACS CHEM NEUROSCI, V6, P226, DOI 10.1021/cn500157j; Hackett MJ, 2012, ACS CHEM NEUROSCI, V3, P178, DOI 10.1021/cn200097s; Hackett MJ, 2011, ANALYST, V136, P2941, DOI 10.1039/c0an00269k; Hare DJ, 2016, METALLOMICS, V8, P156, DOI [10.1039/c5mt00288e, 10.1039/C5MT00288E]; Hoek HW, 1998, SOC PSYCH PSYCH EPID, V33, P373, DOI 10.1007/s001270050068; JOHANSON CE, 1990, AM J PHYSIOL, V258, pC211, DOI 10.1152/ajpcell.1990.258.2.C211; JOHNSON DC, 1987, J APPL PHYSIOL, V63, P1591, DOI 10.1152/jappl.1987.63.4.1591; JOHNSTONE EC, 1976, LANCET, V2, P924; Jones PB, 1998, AM J PSYCHIAT, V155, P355, DOI 10.1176/ajp.155.3.355; Marinescu I, 2013, ROM J MORPHOL EMBRYO, V54, P365; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Meyer U, 2012, NEUROPHARMACOLOGY, V62, P1308, DOI 10.1016/j.neuropharm.2011.01.009; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Paterson D, 2011, AIP CONF PROC, V1365, P219, DOI 10.1063/1.3625343; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Piontkewitz Y, 2012, NEUROPHARMACOLOGY, V62, P1273, DOI 10.1016/j.neuropharm.2011.04.019; Piontkewitz Y, 2011, BIOL PSYCHIAT, V70, P842, DOI 10.1016/j.biopsych.2011.06.007; Pushie MJ, 2014, CHEM REV, V114, P8499, DOI 10.1021/cr4007297; Pushie MJ, 2011, METALLOMICS, V3, P206, DOI 10.1039/c0mt00037j; Pushkar Y, 2013, AGING CELL, V12, P823, DOI 10.1111/acel.12112; Redzic ZB, 2004, ADV DRUG DELIVER REV, V56, P1695, DOI 10.1016/j.addr.2004.07.005; Robison G, 2012, PLOS ONE; Ryan CG, 2014, J PHYS CONF SER, V499, DOI 10.1088/1742-6596/499/1/012002; Ryan CG, 2000, INT J IMAG SYST TECH, V11, P219, DOI 10.1002/ima.1007; SANDYK R, 1990, SCHIZOPHR RES, V3, P361, DOI 10.1016/0920-9964(90)90024-2; SANDYK R, 1993, INT J NEUROSCI, V71, P87, DOI 10.3109/00207459309000595; Skipor J, 2008, ACTA NEUROBIOL EXP, V68, P414; SMITH QR, 1981, J NEUROCHEM, V37, P107, DOI 10.1111/j.1471-4159.1981.tb05297.x; SMITH QR, 1986, J NEUROCHEM, V46, P1732; Spector R, 2015, EXP NEUROL, V267, P78, DOI 10.1016/j.expneurol.2015.02.032; Szczerbowska-Boruchowska M, 2012, X-RAY SPECTROM, V41, P328, DOI 10.1002/xrs.2407; Tauscher J, 2001, AM J PSYCHIAT, V158, P1326, DOI 10.1176/appi.ajp.158.8.1326; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Wang XQ, 2008, TOXICOL APPL PHARM, V230, P167, DOI 10.1016/j.taap.2008.02.024; Wang ZY, 2004, NEUROREPORT, V15, P1801, DOI 10.1097/01.wnr.0000132918.05366.81; WEINBERGER DR, 1979, ARCH GEN PSYCHIAT, V36, P735; WEINBERGER DR, 1980, ARCH GEN PSYCHIAT, V37, P11; Winter C, 2008, EUR NEUROPSYCHOPHARM, V18, P712, DOI 10.1016/j.euroneuro.2008.06.001; Winter C, 2009, INT J NEUROPSYCHOPH, V12, P513, DOI 10.1017/S1461145708009206; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	60	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158152	10.1371/journal.pone.0158152	http://dx.doi.org/10.1371/journal.pone.0158152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351594	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900040
J	Carey, JR; Liedo, P; Xu, C; Wang, JL; Muller, HG; Su, YR; Vaupel, JW				Carey, James R.; Liedo, Pablo; Xu, Cong; Wang, Jane-Ling; Mueller, Hans-Georg; Su, Yu-Ru; Vaupel, James W.			Diet Shapes Mortality Response to Trauma in Old Tephritid Fruit Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; STRESS RESISTANCE; REPRODUCTION; INJURY	Despite the importance of trauma in healthspan and lifespan in humans as well as in non-human species, with one important exception the literature in both gerontology and ecology contains virtually no experimental demographic studies concerned with trauma in any species. We used dietary manipulation [full diet (F) versus sugar-only (S)] to produce four levels of frailty in 55-day old tephritid fruit flies (Anastrepha ludens) that were then subject to the trauma of cage transfer stress (n = 900/sex in each of the 4 treatments). The key results included the following: (1) there is a trauma effect caused by the transfer that depends on previous diet before transfer, new diet after transfer and gender of the fly; (2) males are more vulnerable than females; (3) if initial diet was F, flies are relatively immune against the trauma, and the subsequent diet (F or S) does not matter; (4) however if initial diet was S, then the effect of the trauma depends largely on the diet after the transfer; (5) flies transferred from S to F diets do very well in terms of remaining longevity (i.e. greatest remaining longevity), while flies transferred from S to S diet do poorly (i.e. shortest remaining longevity). We discuss both the strengths and weaknesses of this study and implications of the results.	[Carey, James R.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Carey, James R.] Univ Calif Berkeley, Ctr Econ & Demog Aging, Berkeley, CA 94720 USA; [Liedo, Pablo] El Colegio Frontera Sur ECOSUR, Tapachula, Chiapas, Mexico; [Xu, Cong] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA USA; [Wang, Jane-Ling; Mueller, Hans-Georg] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Su, Yu-Ru] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Vaupel, James W.] Max Planck Inst Demog Res, Konrad Zuse Str 1, Rostock, Germany	University of California System; University of California Davis; University of California System; University of California Berkeley; El Colegio de la Frontera Sur (ECOSUR); Stanford University; University of California System; University of California Davis; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Max Planck Society	Carey, JR (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.; Carey, JR (corresponding author), Univ Calif Berkeley, Ctr Econ & Demog Aging, Berkeley, CA 94720 USA.	jrcarey@ucdavis.edu	Liedo, Pablo/E-9313-2010	Liedo, Pablo/0000-0002-0004-1721; Xu, Cong/0000-0002-8047-0488; Vaupel, James/0000-0003-0783-3905	Max Planck Institute for Demographic Research; NIA/NIH [P01 AG 022500-01]; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023313] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [1512975] Funding Source: National Science Foundation	Max Planck Institute for Demographic Research; NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work received research support from the Max Planck Institute for Demographic Research and NIA/NIH grant P01 AG 022500-01.	[Anonymous], 2014, HORMESIS HLTH DIS; Carey JR, 2007, EXP GERONTOL, V42, P166, DOI 10.1016/j.exger.2006.10.002; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Criddle LM, 2009, ADV EMERG NURS J, V31, P323, DOI 10.1097/TME.0b013e3181bd2a67; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; Roach DA, 2014, ANNU REV ECOL EVOL S, V45, P421, DOI 10.1146/annurev-ecolsys-120213-091730; Semenchenko GV, 2004, BIOGERONTOLOGY, V5, P17, DOI 10.1023/B:BGEN.0000017681.46326.9e; Sepulveda S, 2008, EXP GERONTOL, V43, P136, DOI 10.1016/j.exger.2007.10.006; Tatar M, 2009, J GERONTOL A-BIOL, V64, P161, DOI 10.1093/gerona/gln067	12	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158468	10.1371/journal.pone.0158468	http://dx.doi.org/10.1371/journal.pone.0158468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383645	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400049
J	Liu, GZ; Zhao, YS; Gowda, M; Longin, CFH; Reif, JC; Mette, MF				Liu, Guozheng; Zhao, Yusheng; Gowda, Manje; Longin, C. Friedrich H.; Reif, Jochen C.; Mette, Michael F.			Predicting Hybrid Performances for Quality Traits through Genomic-Assisted Approaches in Central European Wheat	PLOS ONE			English	Article							SEPTORIA-TRITICI BLOTCH; BREAD-MAKING QUALITY; HARD WINTER-WHEAT; 1 PSY1 GENES; COMMON WHEAT; FUNCTIONAL MARKERS; GRAIN HARDNESS; SELECTION ACCURACY; BAKING QUALITY; HEADING TIME	Bread-making quality traits are central targets for wheat breeding. The objectives of our study were to (1) examine the presence of major effect QTLs for quality traits in a Central European elite wheat population, (2) explore the optimal strategy for predicting the hybrid performance for wheat quality traits, and (3) investigate the effects of marker density and the composition and size of the training population on the accuracy of prediction of hybrid performance. In total 135 inbred lines of Central European bread wheat (Triticum aestivum L.) and 1,604 hybrids derived from them were evaluated for seven quality traits in up to six environments. The 135 parental lines were genotyped using a 90k single-nucleotide polymorphism array. Genome-wide association mapping initially suggested presence of several quantitative trait loci (QTLs), but cross-validation rather indicated the absence of major effect QTLs for all quality traits except of 1000-kernel weight. Genomic selection substantially outperformed marker-assisted selection in predicting hybrid performance. A resampling study revealed that increasing the effective population size in the estimation set of hybrids is relevant to boost the accuracy of prediction for an unrelated test population.	[Liu, Guozheng; Zhao, Yusheng; Reif, Jochen C.; Mette, Michael F.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Breeding Res, Stadt Seeland, Germany; [Gowda, Manje; Longin, C. Friedrich H.] Univ Hohenheim, State Plant Breeding Inst, Stuttgart, Germany; [Gowda, Manje] Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya; [Mette, Michael F.] King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal, Saudi Arabia	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University Hohenheim; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); King Abdullah University of Science & Technology	Reif, JC (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Breeding Res, Stadt Seeland, Germany.	reif@ipk-gatersleben.de	Gowda, Manje/AAG-2251-2019; Zhao, Yusheng/U-1883-2019; Gowda, Manje/AAH-4207-2019	Gowda, Manje/0000-0003-4434-6364; Zhao, Yusheng/0000-0001-6783-5182; Reif, Jochen/0000-0002-6742-265X	Bundesministerium fur Bildung und Forschung [FKZ0315945D]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The wheat data set for this research was generated within the HYWHEAT project funded by Bundesministerium fur Bildung und Forschung (Grant ID: FKZ0315945D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSCOMBE FJ, 1963, TECHNOMETRICS, V5, P141, DOI 10.2307/1266059; Bentley AR, 2014, THEOR APPL GENET, V127, P2619, DOI 10.1007/s00122-014-2403-y; BERNARDO R, 1994, CROP SCI, V34, P20, DOI 10.2135/cropsci1994.0011183X003400010003x; Bordes J, 2014, MOL BREEDING, V33, P755, DOI 10.1007/s11032-013-0004-0; Bundessortenamt, 2000, RICHTL DURCHF LANDW; Butler DG, 2018, ASREML R REFERENCE M; Carter AH, 2012, THEOR APPL GENET, V124, P1079, DOI 10.1007/s00122-011-1770-x; Chen F, 2012, MOL BREEDING, V29, P371, DOI 10.1007/s11032-011-9553-2; El-Feki WM, 2013, CROP SCI, V53, P1953, DOI 10.2135/cropsci2012.12.0674; Falconer D. S., 1996, INTRO QUANTITATIVE G; Freund W, 2006, FUTURE FLOUR COMPEND, P101; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; Gowda M, 2014, HEREDITY, V112, P552, DOI 10.1038/hdy.2013.139; Groos C, 2004, J CEREAL SCI, V40, P93, DOI 10.1016/j.jcs.2004.08.006; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; He XY, 2008, THEOR APPL GENET, V116, P213, DOI 10.1007/s00122-007-0660-8; He XY, 2007, THEOR APPL GENET, V115, P47, DOI 10.1007/s00122-007-0539-8; He XY, 2009, MOL BREEDING, V23, P553, DOI 10.1007/s11032-009-9255-1; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Heffner EL, 2011, CROP SCI, V51, P2597, DOI 10.2135/cropsci2011.05.0253; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Henderson C. R, 1984, APPL LINEAR MODELS A; Heslot N, 2015, CROP SCI, V55, P1, DOI 10.2135/cropsci2014.03.0249; HOLM S, 1979, SCAND J STAT, V6, P65; Ishikawa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111337; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; LANDE R, 1990, GENETICS, V124, P743; Liang D, 2010, EUPHYTICA, V172, P235, DOI 10.1007/s10681-009-0054-x; Liu YN, 2012, THEOR APPL GENET, V125, P1, DOI 10.1007/s00122-012-1829-3; Longin CFH, 2015, THEOR APPL GENET, V128, P1297, DOI 10.1007/s00122-015-2505-1; Longin CFH, 2013, THEOR APPL GENET, V126, P2791, DOI 10.1007/s00122-013-2172-z; Longin CFH, 2012, THEOR APPL GENET, V125, P1087, DOI 10.1007/s00122-012-1967-7; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Miedaner T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-858; Mirdita V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1628-8; Moreau L, 2004, EUPHYTICA, V137, P111, DOI 10.1023/B:EUPH.0000040508.01402.21; Muhleisen J, 2014, THEOR APPL GENET, V127, P309, DOI 10.1007/s00122-013-2219-1; Ortiz R, 2008, AGR ECOSYST ENVIRON, V126, P46, DOI 10.1016/j.agee.2008.01.019; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Peterson CJ, 1998, EUPHYTICA, V100, P157, DOI 10.1023/A:1018361502435; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Reif JC, 2011, THEOR APPL GENET, V123, P283, DOI 10.1007/s00122-011-1583-y; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Schrag TA, 2009, MAYDICA, V54, P353; Schrag TA, 2010, THEOR APPL GENET, V120, P451, DOI 10.1007/s00122-009-1208-x; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; SINGH NK, 1985, THEOR APPL GENET, V71, P79, DOI 10.1007/BF00278258; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Sun DJ, 2005, MOL BREEDING, V16, P209, DOI 10.1007/s11032-005-6618-0; Technow F, 2012, THEOR APPL GENET, V125, P1181, DOI 10.1007/s00122-012-1905-8; ter Braak CJF, 2005, GENETICS, V170, P1435, DOI 10.1534/genetics.105.040469; Utz HF, 2000, GENETICS, V154, P1839; Wang JW, 2009, HEREDITAS, V146, P208, DOI 10.1111/j.1601-5223.2009.02132.x; Wang LH, 2009, THEOR APPL GENET, V118, P525, DOI 10.1007/s00122-008-0918-9; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wheat Marketing Center, 2008, WHEAT FLOUR TEST MET; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Xu SZ, 2003, GENETICS, V163, P789; Xu YB, 2005, PLANT MOL BIOL, V59, P7, DOI 10.1007/s11103-004-4681-2; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yang FP, 2009, EUPHYTICA, V165, P445, DOI 10.1007/s10681-008-9745-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; Zhang YL, 2009, CROP PASTURE SCI, V60, P587, DOI 10.1071/CP08392; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1; Zhao Y, 2015, GENOME BASED ESTABLI; Zhao YS, 2015, P NATL ACAD SCI USA, V112, P15624, DOI 10.1073/pnas.1514547112; Zhao YS, 2015, PLANT BREEDING, V134, P1, DOI 10.1111/pbr.12231; Zhao YS, 2013, J EXP BOT, V64, P4453, DOI 10.1093/jxb/ert259; Zhao YS, 2013, CROP SCI, V53, P802, DOI 10.2135/cropsci2012.08.0463; Zheng SS, 2010, EUPHYTICA, V176, P357, DOI 10.1007/s10681-010-0215-y; Zhong SB, 2006, PHYTOPATHOLOGY, V96, P993, DOI 10.1094/PHYTO-96-0993; [No title captured]	76	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158635	10.1371/journal.pone.0158635	http://dx.doi.org/10.1371/journal.pone.0158635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383841	gold, Green Published, Green Submitted			2022-12-27	WOS:000379809400070
J	Luis, AR; Couchinho, MN; dos Santos, ME				Luis, Ana Rita; Couchinho, Miguel N.; dos Santos, Manuel E.			A Quantitative Analysis of Pulsed Signals Emitted by Wild Bottlenose Dolphins	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; ECHOLOCATION CLICKS; ACOUSTIC REPERTOIRE; BEHAVIOR; CALLS; CAPTURE; SPINNER; WHALES; RANGE; PREY	Common bottlenose dolphins (Tursiops truncatus), produce a wide variety of vocal emissions for communication and echolocation, of which the pulsed repertoire has been the most difficult to categorize. Packets of high repetition, broadband pulses are still largely reported under a general designation of burst-pulses, and traditional attempts to classify these emissions rely mainly in their aural characteristics and in graphical aspects of spectrograms. Here, we present a quantitative analysis of pulsed signals emitted by wild bottlenose dolphins, in the Sado estuary, Portugal (2011-2014), and test the reliability of a traditional classification approach. Acoustic parameters (minimum frequency, maximum frequency, peak frequency, duration, repetition rate and inter-click-interval) were extracted from 930 pulsed signals, previously categorized using a traditional approach. Discriminant function analysis revealed a high reliability of the traditional classification approach (93.5% of pulsed signals were consistently assigned to their aurally based categories). According to the discriminant function analysis (Wilk's A = 0.11, F-3,F-2.41 = 282.75, P < 0.001), repetition rate is the feature that best enables the discrimination of different pulsed signals (structure coefficient = 0.98). Classification using hierarchical cluster analysis led to a similar categorization pattern: two main signal types with distinct magnitudes of repetition rate were clustered into five groups. The pulsed signals, here described, present significant differences in their time-frequency features, especially repetition rate (P < 0.001), inter-click-interval (P < 0.001) and duration (P < 0.001). We document the occurrence of a distinct signal type-short burst-pulses, and highlight the existence of a diverse repertoire of pulsed vocalizations emitted in graded sequences. The use of quantitative analysis of pulsed signals is essential to improve classifications and to better assess the contexts of emission, geographic variation and the functional significance of pulsed signals.	[Luis, Ana Rita; Couchinho, Miguel N.; dos Santos, Manuel E.] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Luis, Ana Rita; Couchinho, Miguel N.; dos Santos, Manuel E.] Ctr Portugues Estudo Mamiferos Marinhos, Projecto Delfim, Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA)	Luis, AR (corresponding author), ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.; Luis, AR (corresponding author), Ctr Portugues Estudo Mamiferos Marinhos, Projecto Delfim, Lisbon, Portugal.	aluis@ispa.pt	Luís, Ana Rita/AAJ-9395-2020	Luís, Ana Rita/0000-0002-2075-1974; dos Santos, Manuel/0000-0001-8225-9398	Fundacao para a Ciencia e Tecnologia (FCT) [UID/MAR/04292/2013]; Troia-Natura S.A. [24052/4141/2010/RNES];  [SFRH / BD / 90037 / 2012]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Troia-Natura S.A.; 	This study had the support of Fundacao para a Ciencia e Tecnologia (FCT), through the strategic project UID/MAR/04292/2013 granted to MARE, and the grant awarded to ARL (SFRH / BD / 90037 / 2012). Troia-Natura S.A. funded the data collection in 2011, through the project 24052/4141/2010/RNES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizpurua O, 2014, J EXP BIOL, V217, P3318, DOI 10.1242/jeb.104992; Akamatsu T, 1998, J ACOUST SOC AM, V104, P2511, DOI 10.1121/1.423757; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Anonymous, 2008, P401, DOI 10.1007/978-0-387-78365-9_10; Au W. W., 1993, SONAR DOLPHINS; Au WWL, 2004, ACOUST PHYS+, V50, P454, DOI 10.1134/1.1776224; Baumann-Pickering S, 2010, J ACOUST SOC AM, V128, P2212, DOI 10.1121/1.3479549; Bidelman GM, 2014, NEUROSCI LETT, V572, P53, DOI 10.1016/j.neulet.2014.04.037; Blomquist C., 2004, ECHOLOCATION BATS DO, P425; Buscaino G, 2015, MAR MAMMAL SCI, V31, P891, DOI 10.1111/mms.12194; Caldwell M.C., 1990, P199; Caldwell M. C., 1967, Quarterly Los Angeles County Museum, V5, P12; CALDWELL MC, 1965, NATURE, V207, P434, DOI 10.1038/207434a0; Connor RC, 1996, BEHAVIOUR, V133, P643, DOI 10.1163/156853996X00404; Deaux EC, 2013, BEHAVIOUR, V150, P75, DOI 10.1163/1568539X-00003038; Diaz Lopez B., 2009, DOLPHINS ANATOMY BEH, P1; dos Santos Manuel E., 1995, P325; dos Santos ME., 2004, ECHOLOCATION BATS DO, P386; DOSSANTOS ME, 1990, NATO ADV SCI I A-LIF, V196, P585; Finneran JJ, 2013, J ACOUST SOC AM, V133, P1796, DOI 10.1121/1.4788997; Gage N, 2006, BRAIN RES, V1069, P166, DOI 10.1016/j.brainres.2005.11.023; Green S., 1979, SOCIAL BEHAV COMMUNI, P73, DOI DOI 10.1007/978-1-4615-9116-0_3; Gridley T, 2015, BIOACOUSTICS, V24, P153, DOI 10.1080/09524622.2015.1014851; Griffiths SR, 2013, BEHAV PROCESS, V98, P58, DOI 10.1016/j.beproc.2013.05.007; Hauser MD., 1996, COMMUNICATION; Herman LM, 2002, COGNITIVE ANIMAL, P275; Herzing Denise L., 1996, Aquatic Mammals, V22, P61; Herzing DL, 2015, DOLPHIN COMMUNICATION AND COGNITION: PAST, PRESENT, AND FUTURE, P1; Herzing DL, 2000, SPR HDB AUD, V12, P225; Herzing DL., 2015, ANIM BEHAV COGNIT, V2, P14, DOI [10.12966/abc.02.02.2015, DOI 10.12966/ABC.02.02.2015]; Janik VM, 2013, J COMP PHYSIOL A, V199, P479, DOI 10.1007/s00359-013-0817-7; Janik VM, 2000, J COMP PHYSIOL A, V186, P673, DOI 10.1007/s003590000120; Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355; Janik VM, 2000, P ROY SOC B-BIOL SCI, V267, P923, DOI 10.1098/rspb.2000.1091; Keenan S, 2013, ANIM BEHAV, V85, P109, DOI 10.1016/j.anbehav.2012.10.014; King SL, 2015, ANIM COGN, V18, P969, DOI 10.1007/s10071-015-0851-7; Lammers MO, 2015, DOLPHIN COMMUNICATION AND COGNITION: PAST, PRESENT, AND FUTURE, P107; Lammers MO, 2003, J ACOUST SOC AM, V114, P1629, DOI 10.1121/1.1596173; LILLY JC, 1961, SCIENCE, V133, P1689, DOI 10.1126/science.133.3465.1689; Madsen PT, 2007, AQUAT BIOL, V1, P141, DOI 10.3354/ab00014; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Murray SO, 1998, J ACOUST SOC AM, V104, P1679, DOI 10.1121/1.424380; Overstrom N.A., 1983, Zoo Biology, V2, P93, DOI 10.1002/zoo.1430020203; Quick NJ, 2008, J COMP PSYCHOL, V122, P305, DOI 10.1037/0735-7036.122.3.305; Ridgway SH, 2014, J EXP BIOL, V217, P2910, DOI 10.1242/jeb.100511; Ridgway S. H., 1991, J ACOUST SOC AM, V90, P2335, DOI [10.1121/1.402199, DOI 10.1121/1.402199]; Sayigh LS, 2007, ANIM BEHAV, V74, P1631, DOI 10.1016/j.anbehav.2007.02.018; Simard Peter, 2008, Aquatic Mammals, V34, P464, DOI 10.1578/AM.34.4.2008.464; Supin AY, 1995, HEARING RES, V92, P38, DOI 10.1016/0378-5955(95)00194-8; Tinsley H.E., 2000, HDB MULTIVARIATE STA, DOI DOI 10.1016/B978-012691360-6/50016-1; Van Parijs SM, 2000, J ACOUST SOC AM, V108, P1938, DOI 10.1121/1.1289667; Wahlberg M, 2011, J ACOUST SOC AM, V130, P2263, DOI 10.1121/1.3624822; Watkins W. A., 1968, MARINE BIOACOUSTICS, V2, P15, DOI DOI 10.1575/1912/2726; Wilson E.O., 1975, P1	54	16	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157781	10.1371/journal.pone.0157781	http://dx.doi.org/10.1371/journal.pone.0157781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383211	Green Published, gold			2022-12-27	WOS:000379809400025
J	Chen, JY; Liu, JH; Wu, HDI; Lin, KH; Chang, KC; Liou, YM				Chen, Jan-Yow; Liu, Jiung-Hsiun; Wu, Hong-Dar Isaac; Lin, Kuo-Hung; Chang, Kuan-Cheng; Liou, Ying-Ming			Transforming Growth Factor-beta 1 T869C Gene Polymorphism Is Associated with Acquired Sick Sinus Syndrome via Linking a Higher Serum Protein Level	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; NODE DYSFUNCTION; SCN5A MUTATION; HUMAN GENOME; CHANNEL; OVEREXPRESSION; BRADYCARDIA; MECHANISMS; ARRHYTHMIA; DISEASE	Background Familial sick sinus syndrome is associated with gene mutations and dysfunction of ion channels. In contrast, degenerative fibrosis of the sinus node tissue plays an important role in the pathogenesis of acquired sick sinus syndrome. There is a close relationship between transforming growth factor-beta 1 mediated cardiac fibrosis and acquired arrhythmia. It is of interest to examine whether transforming growth factor-beta 1 is involved in the pathogenesis of acquired sick sinus syndrome. Methods Overall, 110 patients with acquired SSS and 137 age/gender-matched controls were screened for transforming growth factor-beta 1 and cardiac sodium channel gene polymorphisms using gene sequencing or restriction fragment length polymorphism methods. An enzyme-linked immunosorbent assay was used to determine the serum level of transforming growth factor-beta 1. Results Two transforming growth factor-beta 1 gene polymorphisms (C-509T and T+869C) and one cardiac sodium channel gene polymorphism (H588R) have been identified. The C-dominant CC/CT genotype frequency of T869C was significantly higher in acquired sick sinus syndrome patients than in controls (OR 2.09, 95% CI 1.16-3.75, P = 0.01). Consistently, the level of serum transforming growth factor-beta 1 was also significantly greater in acquired sick sinus syndrome group than in controls (5.3 +/- 3.4 ng/ml vs. 3.7 +/- 2.4 ng/ml, P = 0.01). In addition, the CC/CT genotypes showed a higher transforming growth factor-beta 1 serum level than the TT genotype (4.25 +/- 2.50 ng/ml vs. 2.71 +/- 1.76 ng/ml, P = 0.028) in controls. Conclusion Transforming growth factor-beta 1 T869C polymorphism, correlated with high serum transforming growth factor-beta 1 levels, is associated with susceptibility to acquired sick sinus syndrome.	[Chen, Jan-Yow; Lin, Kuo-Hung; Chang, Kuan-Cheng] China Med Univ Hosp, Dept Med, Div Cardiol, Taichung, Taiwan; [Chen, Jan-Yow; Liou, Ying-Ming] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Chen, Jan-Yow; Liu, Jiung-Hsiun; Lin, Kuo-Hung; Chang, Kuan-Cheng] China Med Univ, Sch Med, Taichung, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Dept Appl Math, Taichung, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Inst Stat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; China Medical University Taiwan; National Chung Hsing University; National Chung Hsing University	Liou, YM (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan.	ymlion@dragon.nchu.edu.tw		Liou, Ying-Ming/0000-0002-8190-7629	Taiwan National Science Council (NSC) (Ministry of Science and Technology) [NSC 101-2314-B-039-042]	Taiwan National Science Council (NSC) (Ministry of Science and Technology)	This study was supported by funding (NSC 101-2314-B-039-042) from Taiwan National Science Council (Ministry of Science and Technology) (https://www.most.gov.tw/en/public). JYC received the funding.	Adan V, 2003, AM FAM PHYSICIAN, V67, P1725; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Chen JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029951; Chen LY, 2007, CLIN PHARMACOL THER, V81, P35, DOI 10.1038/sj.clpt.6100016; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; DUFF JL, 1995, CARDIOVASC RES, V30, P511, DOI 10.1016/0008-6363(95)00088-7; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gramley F, 2010, INT J CARDIOL, V143, P405, DOI 10.1016/j.ijcard.2009.03.110; Gregoratos G, 2003, CIRCULATION, V108, pE143, DOI 10.1161/01.CIR.0000102938.55119.EC; Hao XJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P397, DOI 10.1161/CIRCEP.110.960807; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Herrmann S, 2011, CARDIOVASC RES, V92, P179, DOI 10.1093/cvr/cvr205; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Jones SA, 2007, CIRCULATION, V115, P1183, DOI 10.1161/CIRCULATIONAHA.106.663070; Kasi VS, 2007, AM J PHYSIOL-HEART C, V293, pH182, DOI 10.1152/ajpheart.00684.2006; Lamas GA, 2000, AM HEART J, V140, P541, DOI 10.1067/mhj.2000.109652; Lau DH, 2011, CURR OPIN CARDIOL, V26, P55, DOI 10.1097/HCO.0b013e32834138f4; Li X, 2008, J CLIN LAB ANAL, V22, P164, DOI 10.1002/jcla.20236; Makita N, 2005, HEART RHYTHM, V2, P1128, DOI 10.1016/j.hrthm.2005.06.032; Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Nielsen JC, 2011, EUR HEART J, V32, P686, DOI 10.1093/eurheartj/ehr022; Peng LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067738; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; RUBENSTEIN JJ, 1972, CIRCULATION, V46, P5, DOI 10.1161/01.CIR.46.1.5; Shah R, 2006, HUM GENET, V119, P61, DOI 10.1007/s00439-005-0112-y; Stieber J, 2004, TRENDS CARDIOVAS MED, V14, P23, DOI 10.1016/j.tcm.2003.09.006; Susianti H, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-514; Tellez JO DH, 2006, J MOL CELL CARDIOL, V40, P1; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Wu CH, 2013, HEART RHYTHM, V10, P10, DOI 10.1016/j.hrthm.2012.09.016; Yamada Y, 2000, ARTHRITIS RHEUM, V43, P452, DOI 10.1002/1529-0131(200002)43:2<452::AID-ANR28>3.0.CO;2-C; Zhang H, 2007, AM J PHYSIOL-HEART C, V292, pH165, DOI 10.1152/ajpheart.01101.2005	36	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158676	10.1371/journal.pone.0158676	http://dx.doi.org/10.1371/journal.pone.0158676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380173	Green Published, gold, Green Submitted			2022-12-27	WOS:000379798700041
J	Hostetler, CM; Phillips, TJ; Ryabinin, AE				Hostetler, Caroline M.; Phillips, Tamara J.; Ryabinin, Andrey E.			Methamphetamine Consumption Inhibits Pair Bonding and Hypothalamic Oxytocin in Prairie Voles	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; MICROTUS-OCHROGASTER; PARTNER PREFERENCE; MONOGAMOUS RODENT; SEX-DIFFERENCES; MOUSE-BRAIN; DRUG; AMPHETAMINE; VASOPRESSIN; BEHAVIOR	Methamphetamine (MA) abuse has been linked to violence, risk-taking behaviors, decreased sexual inhibition, and criminal activity. It is important to understand mechanisms underlying these drug effects for prevention and treatment of MA-associated social problems. Previous studies have demonstrated that experimenter-administered amphetamine inhibits pair bonding and increases aggression in monogamous prairie voles. It is not currently known whether similar effects on social behaviors would be obtained under conditions during which the drug is voluntarily (actively) administered. The current study investigated whether MA drinking affects pair bonding and what neurocircuits are engaged. In Experiment 1, we exposed male and female voles to 4 days each of 20 and 40 mg/L MA under a continuous 2-bottle choice (2BC) procedure. Animals were housed either singly or in mesh-divided cages with a social partner. Voles consumed MA in a drinking solution, but MA drinking was not affected by either sex or housing condition. In Experiment 2, we investigated whether MA drinking disrupts social bonding by measuring aggression and partner preference formation following three consecutive days of 18-hour/day access to 100 mg/L MA in a 2BC procedure. Although aggression toward a novel opposite-sex animal was not affected by MA exposure, partner preference was inhibited in MA drinking animals. Experiment 3 examined whether alterations in hypothalamic neuropeptides provide a potential explanation for the inhibition of partner preference observed in Experiment 2. MA drinking led to significant decreases in oxytocin, but not vasopressin, in the paraventricular nucleus of the hypothalamus. These experiments are the first investigation into how voluntary pre-exposure to MA affects the development of social attachment in a socially monogamous species and identify potential neural circuits involved in these effects.	[Hostetler, Caroline M.; Phillips, Tamara J.; Ryabinin, Andrey E.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Hostetler, Caroline M.; Phillips, Tamara J.] Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA; [Phillips, Tamara J.; Ryabinin, Andrey E.] Oregon Hlth & Sci Univ, Methamphetamine Abuse Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University	Hostetler, CM (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.; Hostetler, CM (corresponding author), Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA.	Caroline.Hostetler@gmail.com		Ryabinin, Andrey/0000-0003-4662-3775	National Institutes of Health [RO1 AA019793, P50DA018165]; Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019793] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	Funding was provided by National Institutes of Health RO1 AA019793 (to AER), Department of Veterans Affairs (to TJP), and National Institutes of Health P50DA018165 (to TJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker AMJ, 2014, P NATL ACAD SCI USA, V111, P6052, DOI 10.1073/pnas.1320879111; Anacker AMJ, 2011, ADDICT BIOL, V16, P92, DOI 10.1111/j.1369-1600.2010.00234.x; Anderson Peter D, 2012, J Pharm Pract, V25, P41, DOI 10.1177/0897190011431150; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Aragona BJ, 2007, NEUROSCI LETT, V418, P190, DOI 10.1016/j.neulet.2007.03.019; Bales KL, 2013, BIOL PSYCHIAT, V74, P180, DOI 10.1016/j.biopsych.2012.08.025; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; CUNNINGHAM CL, 1992, ANN NY ACAD SCI, V654, P431, DOI 10.1111/j.1749-6632.1992.tb25989.x; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Deng XL, 2007, BIOL PSYCHIAT, V61, P1235, DOI 10.1016/j.biopsych.2006.09.010; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; DeVries AC, 1997, CAN J ZOOL, V75, P295, DOI 10.1139/z97-037; Eastwood EC, 2014, ADDICT BIOL, V19, P370, DOI 10.1111/adb.12003; Fattore L, 2008, WOMENS HEALTH, V4, P51, DOI 10.2217/17455057.4.1.51; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Gobrogge KL, 2009, P NATL ACAD SCI USA, V106, P19144, DOI 10.1073/pnas.0908620106; Grilly DM, 2001, PSYCHOPHARMACOLOGY, V153, P155, DOI 10.1007/s002130000580; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hammock EAD, 2002, EUR J NEUROSCI, V16, P399, DOI 10.1046/j.1460-9568.2002.02083.x; Harkness JH, 2015, NEUROPSYCHOPHARMACOL, V40, P2175, DOI 10.1038/npp.2015.61; Hemby SE, 1997, PSYCHOPHARMACOLOGY, V133, P7, DOI 10.1007/s002130050365; Hostetler CM, 2012, PSYCHOPHARMACOLOGY, V224, P121, DOI 10.1007/s00213-012-2836-4; Hostetler CM, 2012, NEUROSCIENCE; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Liu Y, 2011, J NEUROSCI, V31, P7960, DOI 10.1523/JNEUROSCI.1006-11.2011; Liu Y, 2010, P NATL ACAD SCI USA, V107, P1217, DOI 10.1073/pnas.0911998107; Lynch WJ, 2006, EXP CLIN PSYCHOPHARM, V14, P34, DOI 10.1037/1064-1297.14.1.34; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; McFarland K, 2003, J NEUROSCI, V23, P3531; McKetin R, 2014, ADDICTION, V109, P798, DOI 10.1111/add.12474; Phillips TJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00327; Quality CfBHSa, 2015, NSDUH SER H, VH-50; Ryabinin AE, 2000, ACTA NEUROBIOL EXP, V60, P547; Semple SJ, 2002, J SUBST ABUSE TREAT, V22, P149, DOI 10.1016/S0740-5472(02)00223-4; Shabani S, 2011, GENES BRAIN BEHAV, V10, P625, DOI 10.1111/j.1601-183X.2011.00700.x; Shabani S, 2012, NEUROPHARMACOLOGY, V62, P2169, DOI 10.1016/j.neuropharm.2012.01.002; Shi X, PLOS ONE; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wheeler JM, 2009, GENES BRAIN BEHAV, V8, P758, DOI 10.1111/j.1601-183X.2009.00522.x; WILLIAMS JR, 1994, J NEUROENDOCRINOL, V6, P247, DOI 10.1111/j.1365-2826.1994.tb00579.x; Young KA, 2014, J NEUROSCI, V34, P8499, DOI 10.1523/JNEUROSCI.4275-13.2014; Young KA, 2011, BRAIN RES, V1367, P213, DOI 10.1016/j.brainres.2010.09.109; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zanos P, 2014, PHARMACOL BIOCHEM BE, V119, P72, DOI 10.1016/j.pbb.2013.05.009; Zhu JPQ, 2006, NEUROTOXICOLOGY, V27, P131, DOI 10.1016/j.neuro.2005.05.014	48	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158178	10.1371/journal.pone.0158178	http://dx.doi.org/10.1371/journal.pone.0158178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380172	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700021
J	Amari, Y; Morimoto, S; Nakajima, F; Ando, T; Ichihara, A				Amari, Yoshifumi; Morimoto, Satoshi; Nakajima, Fumitaka; Ando, Takashi; Ichihara, Atsuhiro			Serum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis Patients	PLOS ONE			English	Article							PRO RENIN RECEPTOR; RENIN/PRORENIN RECEPTOR; BLOOD-PRESSURE; ANGIOTENSIN; PHYSIOLOGY; EXPRESSION; CLEARANCE; PRORENIN	The (pro)renin receptor [(P)RR] is cleaved by furin to generate soluble (P)RR [s(P)RR], which reflects the status of the tissue renin-angiotensin system. Hemodialysis patients have advanced atherosclerosis. The aim of this study was to investigate the relationships between serum s(P)RR levels and background factors, including indices of atherosclerosis, in hemodialysis patients. Serum s(P)RR levels were measured in hemodialysis patients and clearance of s(P)RR through the membrane of the dialyzer was examined. Furthermore, relationships between serum s(P)RR levels and background factors were assessed. Serum s(P)RR levels were significantly higher in hemodialysis patients (30.4 +/- 6.1 ng/ml, n = 258) than those in subjects with normal renal function (21.4 +/- 6.2 ng/ml, n = 39, P < 0.0001). Clearance of s(P) RR and creatinine were 56.9 +/- 33.5 and 147.6 +/- 9.50 ml/min, respectively. Serum s(P) RR levels were significantly higher in those with ankle-brachial index (ABI) of < 0.9, an indicator of severe atherosclerosis, than those with ABI of >= 0.9 (32.2 +/- 5.9 and 30.1 +/- 6.2 ng/ml, respectively, P < 0.05). An association between low ABI and high serum s(P)RR levels was observed even after correction for age, history of smoking, HbA1c, and LDL-C. Serum s(P)RR levels were significantly higher in hemodialysis patients when compared with subjects with normal renal function, although s(P)RR is dialyzed to some extent, but to a lesser extent than creatinine. High serum s(P)RR levels may be associated with atherosclerosis independent of other risk factors, suggesting that serum s(P)RR could be used as a marker for atherosclerotic conditions in hemodialysis patients.	[Amari, Yoshifumi; Morimoto, Satoshi; Ando, Takashi; Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Tokyo, Japan; [Amari, Yoshifumi; Nakajima, Fumitaka] Moriguchi Keijinkai Hosp, Dept Nephrol, Osaka, Japan	Tokyo Women's Medical University	Morimoto, S (corresponding author), Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Tokyo, Japan.	smorimoto@endm.twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25461258, 16K09657]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25461258 and 16K09657 to S. M.)	Achard V, 2011, J ENDOCRINOL INVEST, V34, P840, DOI 10.3275/7627; Achard V, 2007, AM J PHYSIOL-REG I, V292, pR274, DOI 10.1152/ajpregu.00439.2005; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Burckle CA, 2006, HYPERTENSION, V47, P552, DOI 10.1161/01.HYP.0000199912.47657.04; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; Fu WC, 2006, NEPHROLOGY, V11, P9, DOI 10.1111/j.1440-1797.2006.00534.x; Hamada K, 2013, CLIN EXPT NEPHROLOGY; Hirose T, 2010, REGUL PEPTIDES, V159, P93, DOI 10.1016/j.regpep.2009.11.006; Hirose T, 2009, PEPTIDES, V30, P2316, DOI 10.1016/j.peptides.2009.09.015; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Ichihara A, 2010, HYPERTENS RES, V33, P177, DOI 10.1038/hr.2009.214; Iseki K, 2011, CLIN EXP NEPHROL; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Lindsay RM, 2001, AM J KIDNEY DIS, V38, P565, DOI 10.1053/ajkd.2001.26874; Lowrie EG, 2004, KIDNEY INT, V66, P2077, DOI 10.1111/j.1523-1755.2004.00987.x; Maruyama Nobuhiro, 2013, Front Biosci (Elite Ed), V5, P583; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morimoto S, 2014, HYPERTENSION RES OFF; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2008, CURR OPIN PHARMACOL, V8, P127, DOI 10.1016/j.coph.2007.12.009; Nguyen G, 2014, HYPERTENSION, V63, P297, DOI 10.1161/HYPERTENSIONAHA.113.02217; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Siragy HM, 2008, EXP PHYSIOL, V93, P709, DOI 10.1113/expphysiol.2007.040550; Tsuchida K, 2011, CONTRIB NEPHROL, V173, P76, DOI 10.1159/000328957; van Eps CL, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-51; Watanabe N, 2013, J CLIN ENDOCR METAB, V98, P2528, DOI 10.1210/jc.2012-4139; Watanabe N, 2012, HYPERTENSION, V60, P1250, DOI 10.1161/HYPERTENSIONAHA.112.197418; Weir MR, 1999, AM J HYPERTENS, V12, p205S; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253; Yurugi T, 2012, CLIN EXP NEPHROL, V16, P156, DOI 10.1007/s10157-011-0544-8	36	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158068	10.1371/journal.pone.0158068	http://dx.doi.org/10.1371/journal.pone.0158068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367528	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900017
J	Huang, M; Zhang, RC; Jiang, P; Xie, XB; Zhou, XF; Cao, FB; Zou, YB				Huang, Min; Zhang, Ruichun; Jiang, Peng; Xie, Xiaobing; Zhou, Xuefeng; Cao, Fangbo; Zou, Yingbin			Temperature-Related Yield Constraints of Early-Rice in South China: A Cross-Location Analysis	PLOS ONE			English	Article							CHLOROPHYLL METER; NIGHT TEMPERATURE; IRRIGATED RICE; USE EFFICIENCY; SUPER HYBRID; GRAIN-YIELD; DRY-MATTER; NITROGEN; MANAGEMENT; IMPACT	Warm temperature during post-heading is generally hypothesized to be the critical factor limiting grain yield of early-rice in South China. However, there is no direct evidence to confirm this hypothesis in the field. This study was conducted to determine the temperature-related yield constraints of early-rice in South China. Field experiments were carried out in Huaiji (a location in South China) and Changsha (a location in the Yangtze River basin) in 2011-2013. In each year, two rice cultivars were grown in early-rice growing season in Huaiji and in single-rice growing season in Changsha. Huaiji had higher average daily maximum temperature during post-heading than Changsha. The higher temperature during post-heading induced early plant senescence (slower crop growth rate and shorter grain filling duration), but grain weight did not reduce because it was compensated for by increased translocation of pre-heading biomass. The higher temperature during post-heading also did not cause a reduction in grain filling percentage. Huaiji had lower temperature during pre-heading than Changsha, which to some extent resulted in slower crop growth rate and consequently lower biomass production and smaller sink size in Huaiji than in Changsha. As a result, grain yield was about 30% lower in Huaiji than in Changsha. Our results indicate that grain yield of early-rice in South China is limited not by warm temperature during post-heading but partially by cool temperature during pre-heading, and suggest that enhancing sink size and meanwhile maintaining good translocation of pre-heading biomass may be an effective way to achieve high yield for early-rice in South China.	[Huang, Min; Zhang, Ruichun; Jiang, Peng; Xie, Xiaobing; Zhou, Xuefeng; Cao, Fangbo; Zou, Yingbin] Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China; [Zhang, Ruichun] Hengyang Inst Agr Sci, Henyang, Peoples R China; [Jiang, Peng] Sichuan Acad Agr Sci, Rice & Sorghum Res Inst, Deyang, Peoples R China; [Jiang, Peng] Minist Agr, Key Lab Southwest Rice Biol & Genet Breeding, Deyang, Peoples R China	Hunan Agricultural University; Sichuan Academy of Agricultural Sciences (SAAS); Ministry of Agriculture & Rural Affairs	Huang, M (corresponding author), Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China.	jxhuangmin@163.com		Huang, Min/0000-0002-6944-8538	Earmarked Fund for China Agriculture Research System [CARS-01]	Earmarked Fund for China Agriculture Research System	The work was supported by the Earmarked Fund for China Agriculture Research System (CARS-01).	[Anonymous], 1999, SOIL TAX BAS SYST SO; [Anonymous], 1994, BREAKING YIELD BARRI; Horie T, 1997, FIELD CROP RES, V52, P55, DOI 10.1016/S0378-4290(96)03458-2; Huang JL, 2008, FIELD CROP RES, V105, P70, DOI 10.1016/j.fcr.2007.07.006; Huang M, 2013, FIELD CROP RES, V146, P10, DOI 10.1016/j.fcr.2013.03.007; Huang Min, 2013, Australian Journal of Crop Science, V7, P600; Huang M, 2011, AGR SCI CHINA, V10, P1537, DOI 10.1016/S1671-2927(11)60149-1; Katsura K, 2008, FIELD CROP RES, V107, P1, DOI 10.1016/j.fcr.2007.12.007; Liu QH, 2013, CHIL J AGR RES, V73, P85, DOI 10.4067/S0718-58392013000200001; Liu ZH, 2013, J GEOGR SCI, V23, P1005, DOI 10.1007/s11442-013-1059-x; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; Mohammed AR, 2009, AGR FOREST METEOROL, V149, P999, DOI 10.1016/j.agrformet.2008.12.003; Morita S, 2011, CROP SCI, V51, P818, DOI 10.2135/cropsci2010.06.0373; Peng ChangLian, 2005, Rice Science, V12, P179; Peng S, 1996, FIELD CROP RES, V47, P243, DOI 10.1016/0378-4290(96)00018-4; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Shi WJ, 2013, NEW PHYTOL, V197, P825, DOI 10.1111/nph.12088; Shimoda Seiji, 2011, Journal of Agricultural Meteorology, V67, P259, DOI 10.2480/agrmet.67.4.2; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Tang L, 2009, NJAS-WAGEN J LIFE SC, V57, P83, DOI 10.1016/j.njas.2009.12.003; TASHIRO T, 1989, ANN BOT-LONDON, V64, P59, DOI 10.1093/oxfordjournals.aob.a087808; TASHIRO T, 1991, AUST J PLANT PHYSIOL, V18, P259, DOI 10.1071/PP9910259; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112; Yin XH, 2012, RES CROP, V13, P809; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Zhang YB, 2009, FIELD CROP RES, V114, P91, DOI 10.1016/j.fcr.2009.07.008	27	11	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158601	10.1371/journal.pone.0158601	http://dx.doi.org/10.1371/journal.pone.0158601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27366908	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900043
J	Munhoz, AC; Riva, P; Simoes, D; Curi, R; Carpinelli, AR				Munhoz, Ana Claudia; Riva, Patricia; Simoes, Daniel; Curi, Rui; Carpinelli, Angelo Rafael			Control of Insulin Secretion by Production of Reactive Oxygen Species: Study Performed in Pancreatic Islets from Fed and 48-Hour Fasted Wistar Rats	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; NADPH OXIDASE ACTIVITY; BETA-CELL FUNCTION; SUPEROXIDE-PRODUCTION; OXIDATIVE STRESS; GLUCOSE-METABOLISM; GLUCAGON-SECRETION; MOUSE ISLETS; EXPRESSION; INHIBITION	Mitochondria and NADPH oxidase are important sources of reactive oxygen species in particular the superoxide radical (ROS) in pancreatic islets. These molecules derived from molecular oxygen are involved in pancreatic beta-cells signaling and control of insulin secretion. We examined the involvement of ROS produced through NADPH oxidase in the leucine-and/or glucose-induced insulin secretion by pancreatic islets from fed or 48-hour fasted rats. Glucose-stimulated insulin secretion (GSIS) in isolated islets was evaluated at low (2.8 mM) or high (16.7 mM) glucose concentrations in the presence or absence of leucine (20 mM) and/or NADPH oxidase inhibitors (VAS2870-20 mu M or diphenylene iodonium -DPI-5 mu M). ROS production was determined in islets treated with dihydroethidium (DHE) or MitoSOX Red reagent for 20 min and dispersed for fluorescence measurement by flow cytometry. NADPH content variation was examined in INS-1E cells (an insulin secreting cell line) after incubation in the presence of glucose (2.8 or 16.7 mM) and leucine (20 mM). At 2.8 mM glucose, VAS2870 and DPI reduced net ROS production (by 30%) and increased GSIS (by 70%) in a negative correlation manner (r = -0.93). At 16.7 mM glucose or 20 mM leucine, both NADPH oxidase inhibitors did not alter insulin secretion neither net ROS production. Pentose phosphate pathway inhibition by treatment with DHEA (75 mu M) at low glucose led to an increase in net ROS production in pancreatic islets from fed rats (by 40%) and induced a marked increase (by 144%) in islets from 48-hour fasted rats. The NADPH/NADP(+) ratio was increased when INS-1E cells were exposed to high glucose (by 4.3-fold) or leucine (by 3-fold). In conclusion, increased ROS production through NADPH oxidase prevents the occurrence of hypoglycemia in fasting conditions, however, in the presence of high glucose or high leucine levels, the increased production of NADPH and the consequent enhancement of the activity of the antioxidant defenses mitigate the excess of ROS production and allow the secretory process of insulin to take place.	[Munhoz, Ana Claudia; Riva, Patricia; Simoes, Daniel; Curi, Rui; Carpinelli, Angelo Rafael] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade de Sao Paulo	Munhoz, AC (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	anamunoz@icb.usp.br	Carpinelli, Angelo R/G-8566-2011; Curi, Rui/AAT-7970-2021	Carpinelli, Angelo R/0000-0002-0781-4934; Curi, Rui/0000-0001-5095-9154; Munhoz, Ana Claudia/0000-0002-7484-0518; de Jesus, Daniel/0000-0002-0828-0305	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (ARC, RC), http://www.capes.gov.br/; Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP) (DS), http://www.fapesp.br/; Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq) (ACM, RC, ARC), http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Baillet A, 2011, FASEB J, V25, P2333, DOI 10.1096/fj.10-173807; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BOSBOOM RS, 1973, DIABETOLOGIA, V9, P243, DOI 10.1007/BF01221849; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; CARPINELLI AR, 1986, CELL BIOCHEM FUNCT, V4, P123, DOI 10.1002/cbf.290040208; CHENG HM, 1976, INVEST OPHTH VISUAL, V15, P279; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Costal F, 2013, DIABETES-METAB RES, V29, P296, DOI 10.1002/dmrr.2390; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Frederiks WM, 2007, J HISTOCHEM CYTOCHEM, V55, P975, DOI 10.1369/jhc.7A7222.2007; Fu JQ, 2013, PHARM RES-DORDR, V30, P2248, DOI 10.1007/s11095-013-1013-8; GIDDINGS SJ, 1993, AM J PHYSIOL, V265, pE259, DOI 10.1152/ajpendo.1993.265.2.E259; Graciano MF, 2013, ISLETS, V5, P139, DOI 10.4161/isl.25459; Hatanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058626; HEDESKOV CJ, 1974, BIOCHEMISTRY-US, V140, P423, DOI 10.1042/bj1400423; Hegde KR, 2010, MOL CELL BIOCHEM, V343, P101, DOI 10.1007/s11010-010-0503-9; Jin HM, 2013, ENDOCRINOLOGY, V154, P4068, DOI 10.1210/en.2013-1115; KORANYI L, 1992, DIABETOLOGIA, V35, P1125, DOI 10.1007/BF00401365; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Laurindo FRM, 2008, METHOD ENZYMOL, V441, P237, DOI 10.1016/S0076-6879(08)01213-5; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lucena CF, 2015, PANCREAS, V44, P287, DOI 10.1097/MPA.0000000000000249; MALAISSE WJ, 1967, AM J PHYSIOL, V213, P843, DOI 10.1152/ajplegacy.1967.213.4.843; Michalska M, 2010, BIOSCIENCE REP, V30, P445, DOI 10.1042/BSR20090138; Michalski R, 2014, FREE RADICAL BIO MED, V67, P278, DOI 10.1016/j.freeradbiomed.2013.10.816; Zanquetta MM, 2006, METABOLISM, V55, P1538, DOI 10.1016/j.metabol.2006.06.026; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Oliveira HR, 1999, AM J PHYSIOL-CELL PH, V276, pC507, DOI 10.1152/ajpcell.1999.276.2.C507; OLIVER JR, 1977, P SOC EXP BIOL MED, V154, P210, DOI 10.3181/00379727-154-39639; PERMUTT MA, 1975, FED PROC, V34, P1549; PINILLA M, 1981, ACTA BIOL MED GER, V40, P707; PRIETO JC, 1978, REV ESP FISIOL, V34, P291; Puleston Daniel, 2015, Cold Spring Harb Protoc, V2015, DOI 10.1101/pdb.prot086298; RABINOVITCH A, 1976, J CLIN INVEST, V58, P1209, DOI 10.1172/JCI108574; RAPOPORT I, 1979, ACTA BIOL MED GER, V38, P901; Rebelato E, 2012, LIFE SCI, V91, P244, DOI 10.1016/j.lfs.2012.07.004; Rebelato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024507; Rebelato E, 2010, METABOLISM, V59, P409, DOI 10.1016/j.metabol.2009.08.010; Valle MMR, 2011, PANCREAS, V40, P390, DOI 10.1097/MPA.0b013e31820569d0; Roelofs BA, 2015, FREE RADICAL BIO MED, V86, P250, DOI 10.1016/j.freeradbiomed.2015.05.032; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Sarre A, 2012, FREE RADICAL BIO MED, V52, P142, DOI 10.1016/j.freeradbiomed.2011.10.437; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; SVENNINGSEN A, 1984, METABOLISM, V33, P612, DOI 10.1016/0026-0495(84)90058-1; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; TRENT DF, 1984, HORM RES, V19, P70, DOI 10.1159/000179869; Uchizono Y, 2006, LIFE SCI, V80, P133, DOI 10.1016/j.lfs.2006.08.031; Veras K, 2014, FEBS OPEN BIO, V4, P141, DOI 10.1016/j.fob.2014.01.005; Wang LY, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/217670; Weaver JR, 2015, DIABETOLOGIA, V58, P113, DOI 10.1007/s00125-014-3398-2; Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3; Zhang JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep12846; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zraika S, 2006, DIABETOLOGIA, V49, P1254, DOI 10.1007/s00125-006-0212-9	59	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158166	10.1371/journal.pone.0158166	http://dx.doi.org/10.1371/journal.pone.0158166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362938	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200046
J	Surova, Y; Lampinen, B; Nilsson, M; Latt, J; Hall, S; Widner, H; van Westen, D; Hansson, O				Surova, Yulia; Lampinen, Bjorn; Nilsson, Markus; Latt, Jimmy; Hall, Sara; Widner, Hakan; van Westen, Danielle; Hansson, Oskar		Swedish BioFINDER Study	Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; MULTIPLE-SYSTEM ATROPHY; IN-VIVO; MEAN DIFFUSIVITY; HUMAN BRAIN; DIAGNOSIS; MRI; VARIANT; MICROSTRUCTURE; DEGENERATION	In Parkinson's disease (PD), pathological microstructural changes occur and such changes might be detected using diffusion magnetic resonance imaging (dMRI). However, it is unclear whether dMRI improves PD diagnosis or helps differentiating between phenotypes, such as postural instability gait difficulty (PIGD) and tremor dominant (TD) PD. We included 105 patients with PD and 44 healthy controls (HC), all of whom underwent dMRI as part of the prospective Swedish BioFINDER study. Diffusion kurtosis imaging (DKI) and neurite density imaging (NDI) analyses were performed using regions of interest in the basal ganglia, the thalamus, the pons and the midbrain as well as tractography of selected white matter tracts. In the putamen, the PD group showed increased mean diffusivity (MD) (p =.003), decreased fractional anisotropy (FA) (p =.001) and decreased mean kurtosis (MK), compared to HC (p =.024). High MD and a low MK in the putamen were associated with more severe motor and cognitive symptomatology (p <.05). Also, patients with PIGD exhibited increased MD in the putamen compared to the TD patients (p =.009). In the thalamus, MD was increased (p =.001) and FA was decreased (p =.032) in PD compared to HC. Increased MD and decreased FA correlated negatively with motor speed and balance (p <.05). In the superior longitudinal fasciculus (SLF), MD (p =.019) and fiso were increased in PD compared to HC (p =.03). These changes correlated negatively with motor speed (p <.002) and balance (p <.037). However, most of the observed changes in PD were also present in cases with either multiple system atrophy (n = 11) or progressive supranuclear palsy (n = 10). In conclusion, PD patients exhibit microstructural changes in the putamen, the thalamus, and the SLF, which are associated with worse disease severity. However, the dMRI changes are not sufficiently specific to improve the diagnostic work-up of PD. Longitudinal studies should evaluate whether dMRI measures can be used to track disease progression.	[Surova, Yulia; Hall, Sara; Widner, Hakan; van Westen, Danielle] Lund Univ, Dept Clin Sci, Lund, Sweden; [Surova, Yulia; Hall, Sara; Widner, Hakan] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Lampinen, Bjorn] Lund Univ, Dept Med Radiat Phys, Lund, Sweden; [Nilsson, Markus; van Westen, Danielle] Lund Univ, Bioimaging Ctr, Lund, Sweden; [Latt, Jimmy] Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden; [Hansson, Oskar] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Surova, Y (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.; Surova, Y (corresponding author), Skane Univ Hosp, Dept Neurol, Lund, Sweden.	yulia.surova@med.lu.se	Hansson, Oskar/A-7134-2013; Nilsson, Markus/C-6920-2012	Hansson, Oskar/0000-0001-8467-7286; van Westen, Danielle/0000-0001-8649-9874; Nilsson, Markus/0000-0002-3140-8223	European Research Council; Swedish Research Council; Parkinson Foundation of Sweden; Swedish Brain Foundation; Swedish Cancer Society [CAN 2009/1076]; Swedish Foundation for Strategic Research [AM13-0090]; Swedish Federal Government under the ALF Agreement	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinson Foundation of Sweden; Swedish Brain Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Federal Government under the ALF Agreement	The study was supported by the European Research Council, the Swedish Research Council, The Parkinson Foundation of Sweden, the Swedish Brain Foundation, the Swedish Cancer Society (grant no. CAN 2009/1076), the Swedish Foundation for Strategic Research (AM13-0090), and the Swedish Federal Government under the ALF Agreement. The funding sources had no role in the design and conduct of the study; in the collection, analysis, interpretation of the data; or in the preparation, review, or approval of the manuscript.	Andersson JLR, 2007, REPORT NO FMRIB TECH; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Brooks DJ, 2008, NAT CLIN PRACT NEURO, V4, P267, DOI 10.1038/ncpneuro0773; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Cochrane CJ, 2013, NEUROLOGY, V80, P857, DOI 10.1212/WNL.0b013e318284070c; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Eden M, 2002, CONCEPTS MAGNETIC A, V18, P24; Erbetta A, 2009, AM J NEURORADIOL, V30, P1482, DOI 10.3174/ajnr.A1615; Eriksson S, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4913502; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Farina E, 2000, EUR J NEUROL, V7, P259, DOI 10.1046/j.1468-1331.2000.00066.x; Fregly AR., 1974, HDB SENSORY PHYSL, P321; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hall S, 2015, NEUROLOGY, V84, P57, DOI 10.1212/WNL.0000000000001098; Hess CP, 2014, AM J NEURORADIOL, V35, P897, DOI 10.3174/ajnr.A3832; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jelescu IO, 2016, NMR BIOMED, V29, P33, DOI 10.1002/nbm.3450; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jespersen SN, 2013, NMR BIOMED, V26, P1647, DOI 10.1002/nbm.2999; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kamagata K, 2016, EUR RADIOL, V26, P2567, DOI 10.1007/s00330-015-4066-8; Kamagata K, 2014, NEURORADIOLOGY, V56, P251, DOI 10.1007/s00234-014-1327-1; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kim HJ, 2013, NEUROSCI LETT, V550, P64, DOI 10.1016/j.neulet.2013.06.050; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Lampinen B, 2015, P ISMRM, P2772; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Latt J, 2013, J MAGN RESON IMAGING, V37, P610, DOI 10.1002/jmri.23857; Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4; Levin J, 2014, ACTA NEUROPATHOL, V127, P779, DOI 10.1007/s00401-014-1265-3; Lim LIIK, 2005, PARKINSONISM RELAT D, V11, P19, DOI 10.1016/j.parkreldis.2004.06.003; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meijer FJA, 2015, NEURORADIOLOGY, V57, P655, DOI 10.1007/s00234-015-1515-7; Nicoletti G, 2006, BRAIN, V129, P2679, DOI 10.1093/brain/awl166; Nielsen NP, 2004, PERCEPT MOTOR SKILL, V99, P1201, DOI 10.2466/PMS.99.7.1201-1204; Nilsson M, 2014, P ISMRM, P2569; Oba H, 2005, NEUROLOGY, V64, P2050, DOI 10.1212/01.WNL.0000165960.04422.D0; Paviour DC, 2007, MOVEMENT DISORD, V22, P68, DOI 10.1002/mds.21204; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Perrone D, 2015, NEUROIMAGE, V120, P441, DOI 10.1016/j.neuroimage.2015.06.068; Piattella MC, 2015, J NEUROL, V262, P1850, DOI 10.1007/s00415-015-7779-3; Planetta PJ, 2013, AM J NEURORADIOL, V34, P74, DOI 10.3174/ajnr.A3178; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Rizzo G, 2008, BRAIN, V131, P2690, DOI 10.1093/brain/awn195; Saini J, 2012, NEURORADIOLOGY, V54, P771, DOI 10.1007/s00234-011-0983-7; Schocke MFH, 2004, NEUROIMAGE, V21, P1443, DOI 10.1016/j.neuroimage.2003.12.005; Schwab R.S., 1969, 3 S PARK DIS, P152; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Stebbins GT, 2004, NEUROLOGY, V63, P1409; Surova Y, 2015, NEURORADIOLOGY, V57, P1079, DOI 10.1007/s00234-015-1563-z; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Talairach J., 1988, COPLANAR STEREOTAXIC; TAYLOR AE, 1986, BRAIN, V109, P845, DOI 10.1093/brain/109.5.845; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Veraart J, 2016, MAGN RESON MED, V76, P301, DOI 10.1002/mrm.25866; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Weingarten CP, 2015, NEUROSCI BIOBEHAV R, V59, P16, DOI 10.1016/j.neubiorev.2015.09.007; Youn J, 2015, PARKINSONISM RELAT D, V21, P12, DOI 10.1016/j.parkreldis.2014.10.003; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zheng Z, 2014, HUM BRAIN MAPP, V35, P1325, DOI 10.1002/hbm.22256	72	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157755	10.1371/journal.pone.0157755	http://dx.doi.org/10.1371/journal.pone.0157755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362763	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200022
J	Swider, K; Babel, P				Swider, Karolina; Babel, Przemyslaw			The Effect of the Type and Colour of Placebo Stimuli on Placebo Effects Induced by Observational Learning	PLOS ONE			English	Article							NOCEBO HYPERALGESIA; PAIN; EXPERIENCE; ANALGESIA; ANXIETY; FEAR; SEX	Research shows that placebo analgesia and nocebo hyperalgesia can be induced through observational learning. Our aim was to replicate and extend these results by studying the influence of the type and colour of stimuli used as placebos on the placebo effects induced by observational learning. Three experimental and two control groups were tested. All participants received pain stimuli of the same intensity preceded by colour lights (green and red) or geometric shapes (circles and squares). Before receiving pain stimuli, participants in the experimental groups, but not in the control groups, observed a model who rated pain stimuli that were preceded by either green lights (green placebo group), red lights (red placebo group), or circles (circle placebo group) as being less painful than those preceded by either red lights (green placebo group), green lights (red placebo group), or squares (circle placebo group). As a result participants in the experimental groups rated pain stimuli preceded by either green lights (green placebo group), red lights (red placebo group), or circles (circle placebo group) as being less painful than the participants in the control groups did, indicating that placebo effect was induced. No statistically significant differences were found in the magnitudes of the placebo effects between the three experimental groups (green placebo, red placebo, and circle placebo groups), indicating that neither the type nor the colour of placebo stimuli affected the placebo effects induced by observational learning. The placebo effects induced by observational learning were found to be unrelated to the individual differences in pain anxiety, fear of pain, and empathy.	[Swider, Karolina; Babel, Przemyslaw] Jagiellonian Univ, Inst Psychol, Krakow, Poland	Jagiellonian University	Babel, P (corresponding author), Jagiellonian Univ, Inst Psychol, Krakow, Poland.	przemyslaw.babel@uj.edu.pl			National Science Centre in Poland [2013/09/N/HS6/02947]	National Science Centre in Poland(National Science Centre, Poland)	This work is the result of research project no. 2013/09/N/HS6/02947, funded by the National Science Centre in Poland.	Babel P, 2008, STUD PSYCHOL, V46, P13; Bandura Albert, 1977, SOCIAL LEARNING THEO; Benedetti F, 1997, PAIN, V71, P135, DOI 10.1016/S0304-3959(97)03346-0; Benedetti F., 2020, PLACEBO EFFECTS, DOI [10.1093/oso/9780198843177.001.0001, DOI 10.1093/OSO/9780198843177.001.0001]; Bootzin RR, 2002, SCI PLACEBO INTERDIS, P108; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2010, PAIN, V151, P430, DOI 10.1016/j.pain.2010.08.007; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; deCraen AJM, 1996, BRIT MED J, V313, P1624, DOI 10.1136/bmj.313.7072.1624; deJong PJ, 1996, INT J BEHAV MED, V3, P14, DOI 10.1207/s15327558ijbm0301_2; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; EVANS FJ, 1974, INT S PAIN, P289; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Hunter T, 2014, EUR J PAIN, V18, P914, DOI 10.1002/j.1532-2149.2013.00436.x; KIRSCH I, 1985, AM PSYCHOL, V40, P1189, DOI 10.1037/0003-066X.40.11.1189; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Morton DL, 2009, PAIN, V146, P194, DOI 10.1016/j.pain.2009.07.026; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Staats PS, 2001, PAIN MED, V2, P267, DOI 10.1046/j.1526-4637.2001.01046.x; Swider K, 2013, PAIN, V154, P1312, DOI 10.1016/j.pain.2013.04.001; Vase L, 2005, PAIN, V115, P338, DOI 10.1016/j.pain.2005.03.014; Vogtle E, 2013, PAIN, V154, P1427, DOI 10.1016/j.pain.2013.04.041	26	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158363	10.1371/journal.pone.0158363	http://dx.doi.org/10.1371/journal.pone.0158363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362552	Green Published, gold			2022-12-27	WOS:000378865200064
J	Scazufca, M; Couto, MCPD; Huang, H; Kester, R; Braga, PE; Peluso, ETP; Blay, SL; Menezes, PR; Ribeiro, EE				Scazufca, Marcia; de Paula Couto, Maria Clara P.; Huang, Hsiang; Kester, Rachel; Braga, Patricia Emilia; Peluso, Erica T. P.; Blay, Sergio L.; Menezes, Paulo R.; Ribeiro, Euler E.			Public Stigma towards Older Adults with Depression: Findings from the Sao Paulo-Manaus Elderly in Primary Care Study	PLOS ONE			English	Article							MENTAL-DISORDERS; SOCIAL DISTANCE; PEOPLE; HEALTH; ATTITUDES; SCHIZOPHRENIA; DISABILITY; AUSTRALIA; VIOLENCE; ILLNESS	This study investigates three domains of public stigma (perceived negative reactions, perceived discrimination, and dangerousness) against older adults with depression. The sample comprised of older adults registered with primary care clinics (n = 1,291) and primary health care professionals (n = 469) from Sao Paulo and Manaus, Brazil. Participants read a vignette describing a 70-year-old individual (Mary or John) with a depressive disorder and answered questions measuring stigma. The prevalence of the three stigma domains was between 30.2 and 37.6% among older participants from Sao Paulo and between 27.6 and 35.4% among older participants from Manaus. Older adults from both cities reported similar prevalence of perceived stigma. Key factors associated with stigmatizing beliefs among older participants were reporting depressive symptoms, having physical limitations, and identifying the case of the vignette as a case of mental disorder. Among health professionals, the prevalence of the three stigma domains was between 19.8 and 34.8% in Sao Paulo and 30.2 and 44.6% in Manaus. The key factor associated with stigma among primary health care professionals was city, with consistently higher risk in Manaus than in Sao Paulo. Findings confirm that public stigma against older adults in Brazil is common. It is important to educate the public and primary health care providers in Brazil on stigma related to mental illness in order to reduce barriers to adequate mental health treatment.	[Scazufca, Marcia; de Paula Couto, Maria Clara P.; Huang, Hsiang] Univ Sao Paulo, Inst Psychiat, Lab Psychopathol & Psychiat Therapeut LIM 23, Sao Paulo, Brazil; [Huang, Hsiang; Kester, Rachel] Cambridge Hlth Alliance, Dept Psychiat, Cambridge, MA USA; [Braga, Patricia Emilia; Menezes, Paulo R.] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; [Peluso, Erica T. P.] Anhanguera Univ Sao Paulo UNIAN, Sao Paulo, Brazil; [Blay, Sergio L.] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Ribeiro, Euler E.] Amazonas State Univ, Open Univ Third Age, Manaus, Amazonas, Brazil	Universidade de Sao Paulo; Harvard University; Cambridge Health Alliance; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade do Estado do Amazonas	Scazufca, M (corresponding author), Univ Sao Paulo, Inst Psychiat, Lab Psychopathol & Psychiat Therapeut LIM 23, Sao Paulo, Brazil.	scazufca@gmail.com	Menezes, Paulo R/C-9985-2010; Peluso, Erica/G-2184-2012; Menezes, Paulo/AAM-3529-2021; Braga, Patricia/B-7806-2018; Scazufca, Marcia/K-7418-2012	Menezes, Paulo R/0000-0001-6330-3314; Peluso, Erica/0000-0001-5255-7669; Menezes, Paulo/0000-0001-6330-3314; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [472902/2011-3, 308954/2015-7, 305274/2014-7]; National Institutes of Health [MH20021-14]; Fundacao de Apoio a Pesquisa do Estado de Sao Paulo [2015/00648-6]; Programa Nacional de Pos-Doutorado do Nucleo de Apoio a Pesquisa da Universidade de Sao Paulo; Fulbright-Brazil Scientific Mobility Program	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Apoio a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa Nacional de Pos-Doutorado do Nucleo de Apoio a Pesquisa da Universidade de Sao Paulo; Fulbright-Brazil Scientific Mobility Program	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br): MS (472902/2011-3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HH was supported by the Fulbright-Brazil Scientific Mobility Program and the National Institutes of Health (MH20021-14). MS (grant number: 308954/2015-7), PRM and SLB (grant number: 305274/2014-7) were partially supported by a Productivity Research Grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. MCPPC was funded by Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (grant number: 2015/00648-6). PEB was funded by Programa Nacional de Pos-Doutorado do Nucleo de Apoio a Pesquisa da Universidade de Sao Paulo. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2003, CAN J PSYCHIAT, V48, P663, DOI 10.1177/070674370304801004; Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566; Aurelio Pinto H, 2012, POL NAC AT BAS; Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x; Cook TM, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-29; Coppens E, 2013, J AFFECT DISORDERS, V150, P320, DOI 10.1016/j.jad.2013.04.013; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Corrigan Patrick W, 2002, World Psychiatry, V1, P16; Coutinho LMS, 2008, REV SAUDE PUBL, V42; Couto M.C.P.P., 2012, INT PERSPECTIVEPSY, V1, P52, DOI [DOI 10.1037/A0027118, 10.1037/a0027118]; da Silva SA, 2013, EUR ARCH PSY CLIN N, V263, P153, DOI 10.1007/s00406-012-0345-4; Desai MM, 2002, J NERV MENT DIS, V190, P51, DOI 10.1097/00005053-200201000-00014; Druss BG, 1998, AM J PSYCHIAT, V155, P1775, DOI 10.1176/ajp.155.12.1775; Gragnolati M, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8802-0; Grausgruber A, 2007, ACTA PSYCHIAT SCAND, V115, P310, DOI 10.1111/j.1600-0447.2006.00882.x; Griffiths KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-25; Griffiths KM, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-21; Henderson C, 2014, LANCET PSYCHIAT, V1, P467, DOI 10.1016/S2215-0366(14)00023-6; Huang H, 2014, GEN HOSP PSYCHIAT, V36, P199, DOI 10.1016/j.genhosppsych.2013.11.003; Huang H, 2012, PSYCHOSOMATICS, V53, P21, DOI 10.1016/j.psym.2011.07.001; Instituto Brasileiro de Geografia e Estatistica, 2011, SIN CENS DEM 2011; Jackson D, 2006, J COMMUNITY PSYCHOL, V34, P563, DOI 10.1002/jcop.20115; Jorm AF, 1997, MED J AUSTRALIA, V166, P182, DOI 10.5694/j.1326-5377.1997.tb140071.x; Jorm AF, 1999, AUST NZ J PSYCHIAT, V33, P77, DOI 10.1046/j.1440-1614.1999.00513.x; Katon WJ, 2003, ARCH GEN PSYCHIAT, V60, P897, DOI 10.1001/archpsyc.60.9.897; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lauber C, 2004, COMMUNITY MENT HLT J, V40, P265, DOI 10.1023/B:COMH.0000026999.87728.2d; Li J, 2014, BMC PSYCHIAT, V14; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Martin JK, 2000, J HEALTH SOC BEHAV, V41, P208, DOI 10.2307/2676306; Monahan J., 2001, RISK ASSESSMENT MACA; Nordt C, 2006, SCHIZOPHRENIA BULL, V32, P709, DOI 10.1093/schbul/sbj065; Peluso EDP, 2009, J AFFECT DISORDERS, V115, P201, DOI 10.1016/j.jad.2008.08.013; Peluso ETP, 2011, REV BRAS PSIQUIATR, V33, P130, DOI [10.1590/S1516-44462010005000004, 10.1590/S1516-44462011000200007]; Rusch N, 2005, EUR PSYCHIAT, V20, P529, DOI 10.1016/j.eurpsy.2005.04.004; Santos IS, 2013, CAD SAUDE PUBLICA, V29, P1533, DOI [10.1590/S0102-311X2013001200006, 10.1590/0102-311X00144612]; Sirey JA, 2001, AM J PSYCHIAT, V158, P479, DOI 10.1176/appi.ajp.158.3.479; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Thomas K, 2006, AUST PSYCHOL, V41, P186, DOI 10.1080/00050060600726312; Unutzer J, 1999, MILBANK Q, V77, P225, DOI 10.1111/1468-0009.00132; Veloz M.C.T., 1999, PSICOLOGIA REFLEXAO, V12, P479, DOI [DOI 10.1590/S0102-79721999000200015, 10.1590/S0102-79721999000200015]; Von Korff M, 2008, J CLIN EPIDEMIOL, V61, P1132, DOI 10.1016/j.jclinepi.2007.12.009; Wachelke João Fernando Rech, 2008, Estud. psicol. (Natal), V13, P107, DOI 10.1590/S1413-294X2008000200002; WHO, 2001, WHO INT CLASS FUNCT; World Health Assembly, 2013, COMPREHENSIVE MENTAL; World Health Organization, 2008, GLOB BURD DIS 2004 U	47	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157719	10.1371/journal.pone.0157719	http://dx.doi.org/10.1371/journal.pone.0157719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352293	gold, Green Submitted, Green Published			2022-12-27	WOS:000378858900014
J	Su, ZH; Zhang, ML				Su, Zhi-Hao; Zhang, Ming-Li			Evolutionary History of a Desert Shrub Ephedra przewalskii (Ephedraceae): Allopatric Divergence and Range Shifts in Northwestern China	PLOS ONE			English	Article							NORTH-WESTERN CHINA; GLACIAL REFUGIA; TARIM BASIN; GENETIC CONSEQUENCES; POPULATION-GROWTH; DNA POLYMORPHISM; CHLOROPLAST DNA; SEQUENCE DATA; PHYLOGEOGRAPHY; QUATERNARY	Based on two chloroplast DNA sequences, psbA-trnH and trnT-trnF, phylogeographical patterns of a desert shrub, Ephedra przewalskii, were examined across most of its geographic range in northwestern China. A total of sixteen haplotypes were detected. There was a common haplotype in each basin, that was haplotype A in Tarim Basin, haplotype G in Junggar Basin, and haplotype M in Qaidam Basin. Genetic variance mainly occurred among populations, geographic regions, and eleven geographic groups subdivided by SAMOVA analysis. E. przewalskii likely had a smaller and more fragmented geographic range during the Last Glacial Maximum, which was determined based on ecological niche modelling. Three groups of E. przewalskii populations were detected to have experience range expansion, and this was based on significant values of Fu's F-S, Tajima's D, and unimodel mismatch distributions. The cold and dry climate during the glacial period of the Quaternary is postulated to have been a driver for significant genetic isolation and divergence among populations or groups in E. przewalskii, whereas the warmer and wetter climate during the interglacial period is speculated to have provided favourable conditions for range expansion of the species.	[Su, Zhi-Hao; Zhang, Ming-Li] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, ML (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China.; Zhang, ML (corresponding author), Chinese Acad Sci, Inst Bot, Beijing 100093, Peoples R China.	zhangml@ibcas.ac.cn			China National Key Basic Research Program [2014CB954201]; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	China National Key Basic Research Program(National Basic Research Program of China); Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by China National Key Basic Research Program (2014CB954201) to MLZ, and Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences to MLZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2009, GLOBAL ECOL BIOGEOGR, V18, P223, DOI 10.1111/j.1466-8238.2008.00439.x; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Chiang TY, 1999, MOL ECOL, V8, P1037, DOI 10.1046/j.1365-294x.1999.00668.x; Clegg MT, 1992, MOL SYSTEMATICS PLAN, P2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; [党荣理 Dang Rongli], 2002, [广西植物, Guihaia], V22, P121; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fu LG, 1999, FLORA CHINA, V4, P98; Fu YX, 1997, GENETICS, V147, P915; Guo Z.T., 1999, QUAT SCI, V19, P556; Guu YP, 2010, J SYST EVOL, V48, P153, DOI 10.1111/j.1759-6831.2010.00073.x; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; Jaeger JR, 2005, MOL ECOL, V14, P3033, DOI 10.1111/j.1365-294X.2005.02645.x; Jia DR, 2012, NEW PHYTOL, V194, P1123, DOI 10.1111/j.1469-8137.2012.04115.x; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Li WY, 1998, CHINESE QUATERNARY V; Li ZH, 2012, J SYST EVOL, V50, P351, DOI 10.1111/j.1759-6831.2012.00201.x; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Ma SM, 2012, AUST J BOT, V60, P20, DOI 10.1071/BT11055; Marske KA, 2011, MOL PHYLOGENET EVOL, V59, P89, DOI 10.1016/j.ympev.2011.01.005; Mellick R, 2012, J BIOGEOGR, V39, P2292, DOI 10.1111/j.1365-2699.2012.02747.x; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qin AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056243; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Shi YF, 2005, QUATERNARY GLACIATIO, P99; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SLATKIN M, 1991, GENETICS, V129, P555; Smith CI, 2005, MOL ECOL, V14, P1025, DOI 10.1111/j.1365-294X.2005.02472.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Su ZH, 2016, CONSERV GENET, V17, P485, DOI 10.1007/s10592-015-0798-x; Su ZH, 2013, BIOL J LINN SOC, V109, P757, DOI 10.1111/bij.12088; Su ZH, 2012, PLANT SYST EVOL, V298, P1767, DOI 10.1007/s00606-012-0677-6; Sun JM, 2008, QUATERNARY SCI REV, V27, P1012, DOI 10.1016/j.quascirev.2008.01.011; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Williams MA, 1993, QUATERNARY ENV; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu .Z.Y., 2010, FLORISTICS SEED PLAN; Xu XK, 2010, BOREAS, V39, P215, DOI 10.1111/j.1502-3885.2009.00118.x; Zhang HX, 2012, J SYST EVOL, V50, P295, DOI 10.1111/j.1759-6831.2012.00198.x; Zheng HB, 2003, TECTONOPHYSICS, V375, P49, DOI 10.1016/S0040-1951(03)00333-0; 方小敏, 1997, 科学通报, V42, P2521; 奚晓霞, 1998, 沉积学报, V16, P155	73	6	6	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158284	10.1371/journal.pone.0158284	http://dx.doi.org/10.1371/journal.pone.0158284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351630	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900051
J	Suenami, S; Paul, RK; Takeuchi, H; Okude, G; Fujiyuki, T; Shirai, K; Kubo, T				Suenami, Shota; Paul, Rajib Kumar; Takeuchi, Hideaki; Okude, Genta; Fujiyuki, Tomoko; Shirai, Kenichi; Kubo, Takeo			Analysis of the Differentiation of Kenyon Cell Subtypes Using Three Mushroom Body-Preferential Genes during Metamorphosis in the Honeybee (Apis mellifera L.)	PLOS ONE			English	Article							PUTATIVE TRANSCRIPTION FACTOR; PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; OLFACTORY MEMORY; PHOSPHOLIPASE-C; MESSENGER-RNA; EXPRESSION; BRAIN; BODIES; BEE	The adult honeybee (Apis mellifera L.) mushroom bodies (MBs, a higher center in the insect brain) comprise four subtypes of intrinsic neurons: the class-I large-, middle-, and small-type Kenyon cells (lKCs, mKCs, and sKCs, respectively), and class-II KCs. Analysis of the differentiation of KC subtypes during metamorphosis is important for the better understanding of the roles of KC subtypes related to the honeybee behaviors. In the present study, aiming at identifying marker genes for KC subtypes, we used a cDNA microarray to comprehensively search for genes expressed in an MB-preferential manner in the honeybee brain. Among the 18 genes identified, we further analyzed three genes whose expression was enriched in the MBs: phospholipase C epsilon (PLCe), synaptotagmin 14 (Syt14), and discs large homolog 5 (dlg5). Quantitative reverse transcription-polymerase chain reaction analysis revealed that expression of PLCe, Syt14, and dlg5 was more enriched in the MBs than in the other brain regions by approximately 31-, 6.8-, and 5.6-fold, respectively. In situ hybridization revealed that expression of both Syt14 and dlg5 was enriched in the lKCs but not in the mKCs and sKCs, whereas expression of PLCe was similar in all KC subtypes (the entire MBs) in the honeybee brain, suggesting that Syt14 and dlg5, and PLCe are available as marker genes for the lKCs, and all KC subtypes, respectively. In situ hybridization revealed that expression of PLCe is already detectable in the class-II KCs at the larval fifth instar feeding stage, indicating that PLCe expression is a characteristic common to the larval and adult MBs. In contrast, expression of both Syt14 and dlg5 became detectable at the day three pupa, indicating that Syt14 and dlg5 expressions are characteristic to the late pupal and adult MBs and the lKC specific molecular characteristics are established during the late pupal stages.	[Suenami, Shota; Paul, Rajib Kumar; Takeuchi, Hideaki; Okude, Genta; Fujiyuki, Tomoko; Shirai, Kenichi; Kubo, Takeo] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan.	stkubo@bs.s.u-tokyo.ac.jp	Fujiyuki, Tomoko Kaito/GYD-6398-2022; KUBO, TAKEO/G-4951-2014; Takeuchi, Hideaki/W-6739-2018	Fujiyuki, Tomoko Kaito/0000-0001-5533-4129; Takeuchi, Hideaki/0000-0001-6610-3895	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26291068]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for Scientific Research [(B) 26291068] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Akiko Wakamoto (DNA Chip Research Inc) for her support to prepare the cDNA microarray. We also thank Mr. Hiroki Kohno and Dr. Takayuki Ueno for their gifting us primers and standard samples in quantification of gapdh and Mblk-1, respectively. This work was supported by the Grant-in-Aid for Scientific Research [(B) 26291068] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya GH, 2015, CHEM SENSES, V40, P233, DOI 10.1093/chemse/bjv001; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Blenau W, 1998, J NEUROCHEM, V70, P15; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DESMEDT F, 1994, FEBS LETT, V347, P69, DOI 10.1016/0014-5793(94)00509-5; Doi H, 2011, AM J HUM GENET, V89, P320, DOI 10.1016/j.ajhg.2011.07.012; Eisenhardt D, 2001, INSECT MOL BIOL, V10, P173, DOI 10.1046/j.1365-2583.2001.00252.x; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Farris SM, 1999, J COMP NEUROL, V414, P97, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;97::AID-CNE8&gt;3.0.CO;2-Q; Farris SM, 2004, J COMP NEUROL, V474, P325, DOI 10.1002/cne.20146; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Fukuda M, 2003, J BIOCHEM, V133, P641, DOI 10.1093/jb/mvg082; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; Gehring KB, 2016, J COMP NEUROL, V524, P1165, DOI 10.1002/cne.23894; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; Kaneko K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071732; Kaneko K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009213; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kobayashi M, 2006, P NATL ACAD SCI USA, V103, P14417, DOI 10.1073/pnas.0606571103; Kurshan PT, 2003, J COMP NEUROL, V466, P91, DOI 10.1002/cne.10864; Leboulle G, 2013, INSECT BIOCHEM MOLEC, V43, P959, DOI 10.1016/j.ibmb.2013.07.006; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Locatelli F, 2005, J NEUROSCI, V25, P11614, DOI 10.1523/JNEUROSCI.3180-05.2005; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Mobbs P.G., 1985, P299; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Moda LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064815; Mustard JA, 2005, J COMP NEUROL, V483, P66, DOI 10.1002/cne.20420; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Park JM, 2003, J BIOL CHEM, V278, P18689, DOI 10.1074/jbc.M300486200; Park JM, 2002, BIOCHEM BIOPH RES CO, V291, P23, DOI 10.1006/bbrc.2002.6397; Paul RK, 2005, INSECT MOL BIOL, V14, P9, DOI 10.1111/j.1365-2583.2004.00524.x; Quintero-Rivera F, 2007, AM J MED GENET A, V143A, P558, DOI 10.1002/ajmg.a.31618; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; Roat TC, 2010, J BIOSCIENCES, V35, P415, DOI 10.1007/s12038-010-0047-x; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; Rybak J, 1998, LEARN MEMORY, V5, P133; Seeley T., 1995, WISDOM HIVE SOCIAL P; Sen Sarma M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006408; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Takeuchi H, 2004, CELL TISSUE RES, V316, P281, DOI 10.1007/s00441-004-0865-y; Takeuchi H, 2002, FEBS LETT, V513, P230, DOI 10.1016/S0014-5793(02)02319-0; Takeuchi H, 2001, INSECT MOL BIOL, V10, P487, DOI 10.1046/j.0962-1075.2001.00288.x; Takeuchi H, 2007, ZOOL SCI, V24, P596, DOI 10.2108/zsj.24.596; Ugajin A, 2013, FEBS LETT, V587, P3224, DOI 10.1016/j.febslet.2013.08.014; Uno Y, 2013, INSECT MOL BIOL, V22, P52, DOI 10.1111/imb.12002; Uno Y, 2007, FEBS LETT, V581, P97, DOI 10.1016/j.febslet.2006.12.004; Velarde RA, 2009, J INSECT PHYSIOL, V55, P59, DOI 10.1016/j.jinsphys.2008.10.006; VONFRISCH K, 1967, SCIENCE, V158, P1072; Wang SHJ, 2014, J NEUROSCI, V34, P12745, DOI 10.1523/JNEUROSCI.1280-14.2014; WEIS K, 1994, J BIOL CHEM, V269, P19142; Winston M. L, 1986, BIOL HONEYBEE; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016	64	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157841	10.1371/journal.pone.0157841	http://dx.doi.org/10.1371/journal.pone.0157841			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351839	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900020
J	Woo, YJ; Wang, T; Guadalupe, T; Nebel, RA; Vino, A; Del Bene, VA; Molholm, S; Ross, LA; Zwiers, MP; Fisher, SE; Foxe, JJ; Abrahams, BS				Woo, Young Jae; Wang, Tao; Guadalupe, Tulio; Nebel, Rebecca A.; Vino, Arianna; Del Bene, Victor A.; Molholm, Sophie; Ross, Lars A.; Zwiers, Marcel P.; Fisher, Simon E.; Foxe, John J.; Abrahams, Brett S.			A Common CYFIP1 Variant at the 15q11.2 Disease Locus Is Associated with Structural Variation at the Language-Related Left Supramarginal Gyrus	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; COPY NUMBER VARIANTS; RECURRENT MICRODELETIONS; CEREBRAL-CORTEX; SEVERE SPEECH; SCHIZOPHRENIA; BRAIN; GENE; PROTEIN; RISK	Copy number variants (CNVs) at the Breakpoint 1 to Breakpoint 2 region at 15q11.2 (BP1-2) are associated with language-related difficulties and increased risk for developmental disorders in which language is compromised. Towards underlying mechanisms, we investigated relationships between single nucleotide polymorphisms (SNPs) across the region and quantitative measures of human brain structure obtained by magnetic resonance imaging of healthy subjects. We report an association between rs4778298, a common variant at CYFIP1, and inter-individual variation in surface area across the left supramarginal gyrus (Ih.SMG), a cortical structure implicated in speech and language in independent discovery (n = 100) and validation cohorts (n = 2621). In silico analyses determined that this same variant, and others nearby, is also associated with differences in levels of CYFIP1 mRNA in human brain. One of these nearby polymorphisms is predicted to disrupt a consensus binding site for FOXP2, a transcription factor implicated in speech and language. Consistent with a model where FOXP2 regulates CYFIP1 levels and in turn influences Ih.SMG surface area, analysis of publically available expression data identified a relationship between expression of FOXP2 and CYFIP1 mRNA in human brain. We propose that altered CYFIP1 dosage, through aberrant patterning of the Ih.SMG, may contribute to language-related difficulties associated with BP1-2 CNVs. More generally, this approach may be useful in clarifying the contribution of individual genes at CNV risk loci.	[Woo, Young Jae; Nebel, Rebecca A.; Abrahams, Brett S.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Wang, Tao] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA; [Guadalupe, Tulio; Vino, Arianna; Zwiers, Marcel P.; Fisher, Simon E.] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Del Bene, Victor A.; Molholm, Sophie; Ross, Lars A.; Foxe, John J.] Albert Einstein Coll Med, CERC, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, Bronx, NY USA; [Del Bene, Victor A.; Molholm, Sophie; Ross, Lars A.; Foxe, John J.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA; [Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Foxe, John J.] Nathan S Kline Inst Psychiat Res, Cognit Neurophysiol Lab, Orangeburg, NY USA; [Del Bene, Victor A.; Molholm, Sophie; Ross, Lars A.; Foxe, John J.; Abrahams, Brett S.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Max Planck Society; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Radboud University Nijmegen; Nathan Kline Institute for Psychiatric Research; Yeshiva University; Albert Einstein College of Medicine	Abrahams, BS (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.; Abrahams, BS (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	brett.abrahams@einstein.yu.edu	Zwiers, Marcel P/D-2968-2009; Del Bene, Victor/AAD-8017-2021; Fisher, Simon E./E-9130-2012	Zwiers, Marcel P/0000-0001-5483-2935; Fisher, Simon E./0000-0002-3132-1996; Molholm, Sophie/0000-0002-0094-4015; Woo, Young/0000-0002-9233-5099	Einstein New Investigator Award; IDDRC pilot [P30HD071593]; Autism Center of Excellence [9R01 MH100027]; Training Program in Cellular and Molecular Biology and Genetics [T32GM007491]; Biobanking and Biomolecular Resources Research Infrastructure Netherlands; Hersenstichting Nederland; Netherlands Organisation for Scientific Research; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	Einstein New Investigator Award; IDDRC pilot; Autism Center of Excellence; Training Program in Cellular and Molecular Biology and Genetics; Biobanking and Biomolecular Resources Research Infrastructure Netherlands; Hersenstichting Nederland; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Max Planck Society(Max Planck Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by an Einstein New Investigator Award (www.einstein.yu.edu), an IDDRC pilot (P30HD071593, www.nichd.nih.gov), and a subcontract from an Autism Center of Excellence (9R01 MH100027, www.nimh.nih.gov) to BSA. Support for RAN was provided through the Training Program in Cellular and Molecular Biology and Genetics (T32GM007491, www.nigms.nih.gov). The Cognomics Initiative (www.cognomics.nl/) is supported by participating groups in Nijmegen and funds from the Biobanking and Biomolecular Resources Research Infrastructure Netherlands (www.bbmri.eu), the Hersenstichting Nederland (www.hersenstichting.nl), and the Netherlands Organisation for Scientific Research (www.nwo.nl/en). TG, AV and SEF are supported by the Max Planck Society (www.mpi.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnone D, 2008, SCHIZOPHR RES, V101, P124, DOI 10.1016/j.schres.2008.01.005; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bittel DC, 2006, PEDIATRICS, V118, pE1276, DOI 10.1542/peds.2006-0424; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Bozdagi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042422; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; Chaste P, 2014, AUTISM RES, V7, P355, DOI 10.1002/aur.1378; Chung L, 2015, BRAIN RES, V1629, P340, DOI 10.1016/j.brainres.2015.10.015; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dufor O, 2007, NEUROIMAGE, V34, P1692, DOI 10.1016/j.neuroimage.2006.10.034; Ecker C, 2014, NAT REV NEUROL, V10, P82, DOI 10.1038/nrneurol.2013.276; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Franke B, 2010, BIOL PSYCHIAT, V68, P586, DOI 10.1016/j.biopsych.2010.05.037; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Graham SA, 2013, CURR OPIN NEUROBIOL, V23, P43, DOI 10.1016/j.conb.2012.11.006; Guadalupe T, 2015, CORTEX, V62, P41, DOI 10.1016/j.cortex.2014.07.015; Guadalupe T, 2014, HUM BRAIN MAPP, V35, P3277, DOI 10.1002/hbm.22401; Guadalupe T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00261; Guo WB, 2015, SCHIZOPHRENIA BULL, V41, P57, DOI 10.1093/schbul/sbu126; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Izumi N, 2008, J BIOL CHEM, V283, P12981, DOI 10.1074/jbc.M710282200; Jahn JA, 2014, EPILEPSY RES, V108, P109, DOI 10.1016/j.eplepsyres.2013.10.001; Jiang YW, 2012, HUM GENET, V131, P1217, DOI 10.1007/s00439-012-1149-3; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Liegeois Frederique, 2014, Curr Dev Disord Rep, V1, P215; Linkersdorfer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043122; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mullen SA, 2013, NEUROLOGY, V81, P1507, DOI 10.1212/WNL.0b013e3182a95829; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Nonaka-Kinoshita M, 2013, EMBO J, V32, P1817, DOI 10.1038/emboj.2013.96; Oguro-Ando A, 2015, MOL PSYCHIATR, V20, P1069, DOI 10.1038/mp.2014.124; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Core Team, R LANG ENV STAT COMP; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Raschle NM, 2011, NEUROIMAGE, V57, P742, DOI 10.1016/j.neuroimage.2010.09.055; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Ruff S, 2002, NEUROREPORT, V13, P1285, DOI 10.1097/00001756-200207190-00014; Sandelin Albin, 2003, Functional & Integrative Genomics, V3, P125, DOI 10.1007/s10142-003-0086-6; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Sliwinska MW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00161; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Temple E, 2002, CURR OPIN NEUROBIOL, V12, P178, DOI 10.1016/S0959-4388(02)00303-3; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; van der Zwaag B, 2010, AM J MED GENET B, V153B, P960, DOI 10.1002/ajmg.b.31055; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Waltes R, 2014, HUM GENET, V133, P781, DOI 10.1007/s00439-013-1416-y; Wang J, 2015, ANN HUM GENET, V79, P329, DOI 10.1111/ahg.12121; Xie H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109749; Xiong Y, 2009, J CELL SCI, V122, P4218, DOI 10.1242/jcs.059196; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Zhao Q, 2013, SCHIZOPHRENIA BULL, V39, P712, DOI 10.1093/schbul/sbr197	71	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158036	10.1371/journal.pone.0158036	http://dx.doi.org/10.1371/journal.pone.0158036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351196	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900026
J	Mills, KE; Robbins, J; von Keyserlingk, MAG				Mills, Katelyn E.; Robbins, Jesse; von Keyserlingk, Marina A. G.			Tail Docking and Ear Cropping Dogs: Public Awareness and Perceptions	PLOS ONE			English	Article							WARMTH; PERSONALITY; STEREOTYPE; BEHAVIOR; PETS	Tail docking and ear cropping are two surgical procedures commonly performed on many dog breeds. These procedures are classified as medically unnecessary surgeries whose purpose is primarily cosmetic. Available attitude research surrounding these controversial practices has been limited to surveys of veterinarians and dog breeders familiar with both practices. The aim of this project was to: 1) assess public awareness of tail docking and ear cropping, 2) determine whether physical alteration of a dog affects how the dog, and 3) owner are perceived. In Experiment 1 awareness was measured using a combination of both explicit and implicit measures. We found that 42% of participants (n = 810) were unable to correctly explain the reason why tail docked and ear cropped dogs had short ears and tails. Similarly, an implicit measure of awareness ('nature vs nurture task'), found that the majority of participants believed short tails and erect ears were a consequence of genetics rather than something the owner or breeder had done. The results obtained in Experiment 2 (n = 392) provide evidence that ear cropped and tail docked dogs are perceived differently than an identical dog in its 'natural' state. Modified dogs were perceived as being more aggressive, more dominant, less playful and less attractive than natural dogs. Experiment 3 (n = 410) is the first evidence that owners of modified dogs are perceived as being more aggressive, more narcissistic, less playful, less talkative and less warm compared to owners of natural dogs. Taken together, these results suggest that although a significant proportion of subjects appear unaware of the practices of tail docking and ear cropping in dogs, these procedures have significant impacts on how modified dogs and their owners are perceived by others.	[Mills, Katelyn E.; Robbins, Jesse; von Keyserlingk, Marina A. G.] Univ British Columbia, Anim Welf Program, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	von Keyserlingk, MAG (corresponding author), Univ British Columbia, Anim Welf Program, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada.	nina@mail.ubc.ca	von Keyserlingk, Marina/AAB-6353-2019; Mills, Katelyn/AAH-3137-2019	von Keyserlingk, Marina/0000-0002-1427-3152; Mills, Katelyn/0000-0001-7296-9214	UBC Animal Welfare Program	UBC Animal Welfare Program	This work was funded through generous donations to the UBC Animal Welfare Program.	American Kennel Club, 2013, MOST POP DOG BREEDS, V1, P22; American Society of the Prevention of Cruelty to Animals, 2015, PET STAT, V8, P13; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Ashton-James CE, 2014, PAIN, V155, P2656, DOI 10.1016/j.pain.2014.09.031; Australian Veterinary Association, SURG ALT NAT STAT AN; Belk R., 1982, ADV CONSUM RES, V9, P523; Bennett PC, 2003, AUST VET J, V81, P208, DOI 10.1111/j.1751-0813.2003.tb11473.x; Bollen KS, 2008, APPL ANIM BEHAV SCI, V112, P120, DOI 10.1016/j.applanim.2007.07.007; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Council of Europe, 1987, EUR CONV PROT PET AN; Cuddy AJC, 2004, J SOC ISSUES, V60, P701, DOI 10.1111/j.0022-4537.2004.00381.x; Diesel G, 2010, VET REC, V166, P812, DOI 10.1136/vr.b4880; EMMONS RA, 1987, J PERS SOC PSYCHOL, V52, P11, DOI 10.1037/0022-3514.52.1.11; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fox M, 2010, LAW CULT HUMANIT, V6, P37, DOI 10.1177/1743872109348990; Fratkin JL, 2013, ANTHROZOOS, V26, P125, DOI 10.2752/175303713X13534238631632; Ghirlanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074770; Ramirez MTG, 2014, ANTHROZOOS, V27, P351, DOI 10.2752/175303714X13903827487926; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Henderson R, 2003, TXB SMALL ANIMAL SUR, V1, P1737; Herzog H., 2001, STATE ANIMALS, P55; Herzog HA, 2007, ANTHROZOOS, V20, P7, DOI 10.2752/089279307780216687; Hill C., 2012, FORBES MAGAZINE; Jones A. C, 2009, THESIS; Konrath S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103469; Ley J, 2008, J VET BEHAV, V3, P182, DOI DOI 10.1016/J.JVEB.2007.12.004; Mills KE, 2016, JAVMA-J AM VET MED A, V248, P162, DOI 10.2460/javma.248.2.162; Momement KM, 2010, J APPL ANIM WELF SCI, V13, P1661; Nakajima S, 2009, ANTHROZOOS, V22, P173, DOI 10.2752/175303709X434194; Naumann LP, 2009, PERS SOC PSYCHOL B, V35, P1661, DOI 10.1177/0146167209346309; Noonan GJ, 1996, AUST VET J, V73, P86, DOI 10.1111/j.1751-0813.1996.tb09982.x; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Park S, 2014, J PERS, P279; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pedersen N, 2013, J ANIM BREED GENET, V130, P236, DOI 10.1111/jbg.12017; Roy MM, 2004, PSYCHOL SCI, V15, P361, DOI 10.1111/j.0956-7976.2004.00684.x; Stephen J, 2007, APPL ANIM BEHAV SCI, V107, P88, DOI 10.1016/j.applanim.2006.09.012; Svartberg K, 2006, APPL ANIM BEHAV SCI, V96, P293, DOI 10.1016/j.applanim.2005.06.014; Swabe J, 2000, COMPANION ANIMALS AND US, P292; TERWOGT MM, 1993, BRIT J PSYCHOL, V84, P499, DOI 10.1111/j.2044-8295.1993.tb02497.x; Wayne RK, 2012, MAMM GENOME, V23, P3, DOI 10.1007/s00335-011-9386-7; Weiss Emily, 2012, Animals (Basel), V2, P144, DOI 10.3390/ani2020144; Wells M, 2001, ANTHROZOOS, V14, P161, DOI 10.2752/089279301786999472; Whiteley P, 2005, PERSPECT POLIT, P680; Wright JC, 2007, J APPL ANIM WELF SCI, V10, P255, DOI 10.1080/10888700701353956; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2	48	3	3	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158131	10.1371/journal.pone.0158131	http://dx.doi.org/10.1371/journal.pone.0158131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP9FD	27348817	gold, Green Published, Green Submitted			2022-12-27	WOS:000378801200038
J	Fulgione, A; Nocerino, N; Iannaccone, M; Roperto, S; Capuano, F; Roveri, N; Lelli, M; Crasto, A; Calogero, A; Pilloni, AP; Capparelli, R				Fulgione, Andrea; Nocerino, Nunzia; Iannaccone, Marco; Roperto, Sante; Capuano, Federico; Roveri, Norberto; Lelli, Marco; Crasto, Antonio; Calogero, Armando; Pilloni, Argenia Paola; Capparelli, Rosanna			Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection	PLOS ONE			English	Article							ADSORPTION; ERADICATION; ANTIBODIES; INCREASES	Background The resistance of Helicobacter pylori to the antibiotic therapy poses the problem to discover new therapeutic approaches. Recently it has been stated that antibacterial, immunomodulatory, and antioxidant properties of lactoferrin are increased when this protein is surface-linked to biomimetic hydroxyapatite nanocrystals. Objective Based on these knowledge, the aim of the study was to investigate the efficacy of lactoferrin delivered by biomimetic hydroxyapatite nanoparticles with cell free supernatant from probiotic Lactobacillus paracasei as an alternative therapy against Helicobacter pylori infection. Methods Antibacterial and antinflammatory properties, humoral antibody induction, histopathological analysis and absence of side effects were evaluated in both in vitro and in vivo studies. Results The tests carried out have been demonstrated better performance of lactoferrin delivered by biomimetic hydroxyapatite nanoparticles combined with cell free supernatant from probiotic Lactobacillus paracasei compared to both lactoferrin and probiotic alone or pooled. Conclusion These findings indicate the effectiveness and safety of our proposed therapy as alternative treatment for Helicobacter pylori infection.	[Fulgione, Andrea; Nocerino, Nunzia; Iannaccone, Marco; Crasto, Antonio; Capparelli, Rosanna] Univ Naples Federico II, Dept Agr, Naples, Italy; [Roperto, Sante] Univ Naples Federico II, Dept Vet Med & Anim Prod, Div Infect Dis, Naples, Italy; [Capuano, Federico] Ist Zooprofilatt Sperimentale Mezzogiorno, Dept Food Inspect, Naples, Italy; [Roveri, Norberto; Lelli, Marco] Univ Bologna, Dept Chem G Ciamician, Alma Mater Studiorum, LEBSC, Bologna, Italy; [Calogero, Armando] Univ Naples Federico II, Adv Biomed Sci Dept, Naples, Italy; [Pilloni, Argenia Paola] Univ Naples 2, Dept Expt Med, Div Clin Bacteriol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; IZS del Mezzogiorno; University of Bologna; University of Naples Federico II; Universita della Campania Vanvitelli	Capparelli, R (corresponding author), Univ Naples Federico II, Dept Agr, Naples, Italy.; Roperto, S (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Div Infect Dis, Naples, Italy.	sante.roperto@unina.it; capparel@unina.it	Capparelli, Rosanna/Q-3144-2017; Iannaccone, Marco/K-7559-2016; Fulgione, Andrea/AAK-9332-2021	Capparelli, Rosanna/0000-0001-8614-6251; Iannaccone, Marco/0000-0002-2283-6613; Fulgione, Andrea/0000-0002-8646-5073; roperto, sante/0000-0001-6210-5519; CALOGERO, Armando/0000-0003-2315-0610	RINAME Project [RBAP114AMK]; Interuniversity Consortium for Research on Chemistry of Metals in Biological Systems; Qualifu project; Chemical Center Srl; P.O.R. Campania F.S.E. (Percorsi universitari finalizzati alla incentivazione della ricerca scientifica, dell'innovazione e del trasferimento tecnologico - Tipologia progettuale: "Dottorati in Azienda" CUP) [E65E12000150006]; "Fondazione con il Sud" ("Biosensori piezoelettrici a risposta in tempo reale per applicazioni ambientali e agro-alimentari") [2011-PDR-18]	RINAME Project; Interuniversity Consortium for Research on Chemistry of Metals in Biological Systems; Qualifu project; Chemical Center Srl; P.O.R. Campania F.S.E. (Percorsi universitari finalizzati alla incentivazione della ricerca scientifica, dell'innovazione e del trasferimento tecnologico - Tipologia progettuale: "Dottorati in Azienda" CUP); "Fondazione con il Sud" ("Biosensori piezoelettrici a risposta in tempo reale per applicazioni ambientali e agro-alimentari")	Funded by RBAP114AMK, RINAME Project (funds for selected research topics), the Interuniversity Consortium for Research on Chemistry of Metals in Biological Systems, Qualifu project, Chemical Center Srl and P.O.R. Campania F.S.E. 2007/2013 (Percorsi universitari finalizzati alla incentivazione della ricerca scientifica, dell'innovazione e del trasferimento tecnologico - Tipologia progettuale: "Dottorati in Azienda" CUP E65E12000150006) for financial support. Dr. Marco Iannaccone was supported by research funding from "Fondazione con il Sud" (Project no. 2011-PDR-18, "Biosensori piezoelettrici a risposta in tempo reale per applicazioni ambientali e agro-alimentari").; The authors wish to thank Filomena Di Ruocco for technical assistance. In addition, they thank the RBAP114AMK, RINAME Project (funds for selected research topics), the Interuniversity Consortium for Research on Chemistry of Metals in Biological Systems, Qualifu project, Chemical Center Srl and P.O.R. Campania F.S.E. 2007/2013 (Percorsi universitari finalizzati alla incentivazione della ricerca scientifica, dell'innovazione e del trasferimento tecnologico-Tipologia progettuale: "Dottorati in Azienda" CUP E65E12000150006) for financial support. Dr. Marco Iannaccone was supported by research funding from "Fondazione con il Sud" (Project no. 2011-PDR-18, "Biosensori piezoelettrici a risposta in tempo reale per applicazioni ambientali e agro-alimentari")	Adlerova L, 2008, VET MED-CZECH, V53, P457, DOI 10.17221/1978-VETMED; Behnsen J, 2013, COLD SPRING HARB PER, P3; Berlutti F, 2006, BIOCHEM CELL BIOL, V84, P351, DOI 10.1139/O06-039; Bermudez-Brito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043197; Brown JC, 2011, J APPL MICROBIOL, V110, P139, DOI 10.1111/j.1365-2672.2010.04870.x; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Capparelli R, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-61; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; Delgado S, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00766; Drago L, 2011, RIV IMMUNOLOGIA ALLE, V3, P25; Drago-Serrano ME, 2010, IMMUNOL LETT, V134, P35, DOI 10.1016/j.imlet.2010.08.007; Huang XL, 2010, POSTGRAD MED J, V86, P272, DOI 10.1136/pgmj.2009.089987; Iafisco M, 2011, DALTON T, V40, P820, DOI 10.1039/c0dt00714e; Iafisco M, 2012, NANOSCALE, V4, P206, DOI 10.1039/c1nr11147g; Isolauri E, 2008, J CLIN GASTROENTEROL, V42, pS91, DOI 10.1097/MCG.0b013e3181639a98; Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110; Kikuchi Shogo, 2002, Gastric Cancer, V5, P6, DOI 10.1007/s101200200001; Mikula M, 2003, J MICROBIOL METH, V55, P351, DOI 10.1016/S0167-7012(03)00166-0; Neng L, 2011, J BASIC MICROB, V53, P147; Nocerino N, 2014, INT J NANOMED, V9, P1175, DOI 10.2147/IJN.S55060; Olokoba A B, 2013, Niger Med J, V54, P1, DOI 10.4103/0300-1652.108884; Palazzo B, 2007, ADV FUNCT MATER, V17, P2180, DOI 10.1002/adfm.200600361; Palazzo B, 2009, ACTA BIOMATER, V5, P1241, DOI 10.1016/j.actbio.2008.10.024; Pan F, 2008, BIOINTERPHASES, V3, pFB36, DOI 10.1116/1.2965135; Papastergiou Vasilios, 2014, World J Gastrointest Pathophysiol, V5, P392, DOI 10.4291/wjgp.v5.i4.392; Pepe Giacomo, 2013, J Amino Acids, V2013, P939804, DOI 10.1155/2013/939804; Rocco A, 2006, ANN ONCOL, V17, pVII103, DOI 10.1093/annonc/mdl961; ROZALSKA B, 1993, FEMS IMMUNOL MED MIC, V7, P145; Ruggiero Paolo, 2014, World J Gastrointest Pathophysiol, V5, P384, DOI 10.4291/wjgp.v5.i4.384; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Servin AL, 2003, BEST PRACT RES CL GA, V17, P741, DOI 10.1016/S1521-6918(03)00052-0; Sherman BC, 2004, United States patent, Patent No. [US 6713495, 6713495]; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Zhang MH, 2013, WORLD J MICROB BIOT, V29, P499, DOI 10.1007/s11274-012-1203-2; Zheng X, 2013, REV ESP ENFERM DIG, V105, P445, DOI 10.4321/s1130-01082013000800002	37	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158646	10.1371/journal.pone.0158646	http://dx.doi.org/10.1371/journal.pone.0158646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384186	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400072
J	Gonzalez, E; Salvo, A; Defago, MT; Valladares, G				Gonzalez, Ezequiel; Salvo, Adriana; Teresa Defago, Maria; Valladares, Graciela			A Moveable Feast: Insects Moving at the Forest-Crop Interface Are Affected by Crop Phenology and the Amount of Forest in the Landscape	PLOS ONE			English	Article							NATURAL ENEMIES; BIOLOGICAL-CONTROL; AGRICULTURAL LANDSCAPES; ECOSYSTEM SERVICES; DIVERSITY; PEST; FRAGMENTATION; CONSERVATION; BIODIVERSITY; PARASITISM	Edges have become prevailing habitats, mainly as a result of habitat fragmentation and agricultural expansion. The interchange of functionally relevant organisms like insects occurs through these edges and can influence ecosystem functioning in both crop and non-crop habitats. However, very few studies have focused on the directionality of insect movement through edges, and the role of crop and non-crop amount has been ignored. Using bidirectional flight interception traps we investigated interchange of herbivore, natural enemy, pollinator and detritivore insects between native forest fragments and soybean crops, simultaneously considering movement direction, forest cover in the landscape and crop phenology. In total, 52,173 specimens and 877 morphospecies were collected. We found that, within most functional and taxonomic groups, movement intensity was similar (richness and/or abundance) between directions, whereas a predominantly forest-to-crop movement characterized natural enemies. Insect movement was extensively affected by crop phenology, decreasing during crop senescence, and was enhanced by forest cover particularly at senescence. Mainly the same herbivore species moved to and from the forest, but different natural enemy species predominated in each direction. Finally, our analyses revealed greater forest contribution to natural enemy than to herbivore communities in the crop, fading with distance to the forest in both groups. By showing that larger amounts of forest lead to richer insect interchange, in both directions and in four functional groups, our study suggests that allocation to natural and cultivated habitats at landscape level could influence functioning of both systems. Moreover, natural enemies seemed to benefit more than pests from natural vegetation, with natural enemy spillover from forests likely contributing to pest control in soybean fields. Thus consequences of insect interchange seem to be mostly positive for the agroecosystem, although consequences for the natural system deserve further study.	[Gonzalez, Ezequiel; Salvo, Adriana; Teresa Defago, Maria; Valladares, Graciela] Ctr Invest Entomol Cordoba, Inst Multidisplinario Biol Vegetal CONICET UNC, Cordoba, Argentina		Gonzalez, E (corresponding author), Ctr Invest Entomol Cordoba, Inst Multidisplinario Biol Vegetal CONICET UNC, Cordoba, Argentina.	ezenofx@gmail.com	Gonzalez, Ezequiel/ABA-5941-2021; González, Ezequiel/ABH-7378-2020	González, Ezequiel/0000-0003-0411-1771	Consejo Nacional de Ciencia y Tecnica-Argentina [PIP 112 201201 00662]; Secretaria de Ciencia y Tecnica de la Provincia de Cordoba-Argentina	Consejo Nacional de Ciencia y Tecnica-Argentina; Secretaria de Ciencia y Tecnica de la Provincia de Cordoba-Argentina	Consejo Nacional de Ciencia y Tecnica-Argentina (Grant number: PIP 112 201201 00662). Website: http://www.conicet.gob.ar/.GV and AS received the funding. Secretaria de Ciencia y Tecnica de la Provincia de Cordoba-Argentina. Website: http://www.unc.edu.ar/investigacion. AS and GV received the funding.	Aizen Marcelo A, 2009, Ecol. austral, V19, P45; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D. M., 2007, LME4 LINEAR MIXED EF; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Boiteau G, 2000, J ECON ENTOMOL, V93, P630, DOI 10.1603/0022-0493-93.3.630; BOLDT PE, 1975, J ECON ENTOMOL, V68, P480, DOI 10.1093/jee/68.4.480; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Clough Y, 2005, J BIOGEOGR, V32, P2007, DOI 10.1111/j.1365-2699.2005.01367.x; Collinge SK, 2002, LANDSCAPE ECOL, V17, P647, DOI 10.1023/A:1021536302195; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Diaz A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8101; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Duelli P, 2003, BASIC APPL ECOL, V4, P129, DOI 10.1078/1439-1791-00140; DUELLI P, 1990, BIOL CONSERV, V54, P193, DOI 10.1016/0006-3207(90)90051-P; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fischer J, 2014, CONSERV LETT, V7, P149, DOI 10.1111/conl.12084; Frost CM, 2015, ECOLOGY, V96, P193, DOI 10.1890/14-0696.1; Gonzalez E, 2015, INSECT CONSERV DIVER, V8, P359, DOI 10.1111/icad.12117; Gustafson EJ, 1996, ECOLOGY, V77, P94, DOI 10.2307/2265659; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; HERRERA CM, 1990, OIKOS, V58, P277, DOI 10.2307/3545218; HOUSE GJ, 1985, SOIL TILL RES, V5, P351, DOI 10.1016/S0167-1987(85)80003-9; Lee JC, 2001, J APPL ECOL, V38, P472, DOI 10.1046/j.1365-2664.2001.00602.x; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; LEWIS T, 1969, J APPL ECOL, V6, P443, DOI 10.2307/2401510; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Luti R., 1979, GEOGRAFIA FISICA PRO, P297; Macfadyen S, 2015, AGR ECOSYST ENVIRON, V200, P110, DOI 10.1016/j.agee.2014.11.012; Macfadyen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059659; Marasas ME, 2001, APPL SOIL ECOL, V18, P61, DOI 10.1016/S0929-1393(01)00148-2; MAY RM, 1973, ECOLOGY, V54, P315, DOI 10.2307/1934339; McKone M, 2001, CONSERV BIOL, V15, P1315, DOI 10.1046/j.1523-1739.2001.99399.x; Milfont MD, 2013, ENVIRON CHEM LETT, V11, P335, DOI 10.1007/s10311-013-0412-8; Missa O, 2009, J INSECT CONSERV, V13, P103, DOI 10.1007/s10841-007-9130-5; MOERICKE V., 1951, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V3, P23; Moreno ML, 2014, ACTA OECOL, V60, P26, DOI 10.1016/j.actao.2014.07.002; Nams VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021886; Norris RF, 2000, WEED SCI, V48, P94, DOI 10.1614/0043-1745(2000)048[0094:IBWAPA]2.0.CO;2; Obrist MK, 2010, BIODIVERS CONSERV, V19, P2201, DOI 10.1007/s10531-010-9832-y; Perovic DJ, 2010, BIOL CONTROL, V52, P263, DOI 10.1016/j.biocontrol.2009.09.014; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Core Team, 2018, R LANG ENV STAT COMP; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Rossetti MR, 2013, J INSECT CONSERV, V17, P1137, DOI 10.1007/s10841-013-9594-4; Roubik D., 1995, POLLINATION CULTIVAT; Samways MJ, 2007, ANNU REV ENTOMOL, V52, P465, DOI 10.1146/annurev.ento.52.110405.091317; Schellhorn NA, 2014, ANNU REV ENTOMOL, V59, P559, DOI 10.1146/annurev-ento-011613-161952; Schmidt MH, 2008, J BIOGEOGR, V35, P157, DOI 10.1111/j.1365-2699.2007.01774.x; Fenoglio MS, 2012, ECOLOGY, V93, P2407, DOI 10.1890/11-2043.1; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Southwood TRE, 2000, ECOLOGICAL METHODS; Squires SE, 2009, BIOL CONSERV, V142, P203, DOI 10.1016/j.biocon.2008.10.015; Steffan-Dewenter I, 2001, P ROY SOC B-BIOL SCI, V268, P1685, DOI 10.1098/rspb.2001.1737; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; Thorbek P, 2004, J APPL ECOL, V41, P526, DOI 10.1111/j.0021-8901.2004.00913.x; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 1998, J APPL ECOL, V35, P708, DOI 10.1046/j.1365-2664.1998.355343.x; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Valladares G, 2006, CONSERV BIOL, V20, P212, DOI 10.1111/j.1523-1739.2006.00337.x; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Van EMDEN H. F., 1965, JAPPLECOL, V2, P171, DOI 10.2307/2401703; Wissinger SA, 1997, BIOL CONTROL, V10, P4, DOI 10.1006/bcon.1997.0543; Zak MR, 2008, ENVIRON MANAGE, V42, P181, DOI 10.1007/s00267-008-9101-y; Zak MR, 2004, BIOL CONSERV, V120, P589, DOI 10.1016/j.biocon.2004.03.034; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024; Zuur Alain F., 2009, P1	78	32	32	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158836	10.1371/journal.pone.0158836	http://dx.doi.org/10.1371/journal.pone.0158836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383505	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400087
J	Shih, SC; Ho, TC; Chen, SL; Tsao, YP				Shih, Shou-Chuan; Ho, Tsung-Chuan; Chen, Show-Li; Tsao, Yeou-Ping			Pigment Epithelium Derived Factor Peptide Protects Murine Hepatocytes from Carbon Tetrachloride-Induced Injury	PLOS ONE			English	Article							ACUTE LIVER-INJURY; CELL-DEATH; APOPTOSIS; IDENTIFICATION; RECEPTOR; BINDING; DAMAGE; MICE; NECROSIS; SURVIVAL	Fibrogenesis is induced by repeated injury to the liver and reactive regeneration and leads eventually to liver cirrhosis. Pigment epithelium derived factor (PEDF) has been shown to prevent liver fibrosis induced by carbon tetrachloride (CCl4). A 44 amino acid domain of PEDF (44-mer) was found to have a protective effect against various insults to several cell types. In this study, we investigated the capability of synthetic 44-mer to protect against liver injury in mice and in primary cultured hepatocytes. Acute liver injury, induced by CCl4, was evident from histological changes, such as cell necrosis, inflammation and apoptosis, and a concomitant reduction of glutathione (GSH) and GSH redox enzyme activities in the liver. Intraperitoneal injection of the 44-mer into CCl4-treated mice abolished the induction of AST and ALT and markedly reduced histological signs of liver injury. The 44-mer treatment can reduce hepatic oxidative stress as evident from lower levels of lipid hydroperoxide, and higher levels of GSH. CCl4 caused a reduction of Bcl-xL, PEDF and PPAR gamma, which was markedly restored by the 44-mer treatment. Consequently, the 44-mer suppressed liver fibrosis induced by repeated CCl4 injury. Furthermore, our observations in primary culture of rat hepatocytes showed that PEDF and the 44-mer protected primary rat hepatocytes against apoptosis induced by serum deprivation and TGF-beta 1. PEDF/44-mer induced cell protective STAT3 phosphorylation. Pharmacological STAT3 inhibition prevented the antiapoptotic action of PEDF/44-mer. Among several PEDF receptor candidates that may be responsible for hepatocyte protection, we demonstrated that PNPLA2 was essential for PEDF/44-mer-mediated STAT3 phosphorylation and antiapoptotic activity by using siRNA to selectively knockdown PNPLA2. In conclusion, the PEDF 44-mer protects hepatocytes from single and repeated CCl4 injury. This protective effect may stem from strengthening the counter oxidative stress capacity and induction of hepatoprotective factors.	[Shih, Shou-Chuan] Mackay Med Coll, New Taipei, Taiwan; [Shih, Shou-Chuan] Mackay Mem Hosp, Dept Internal Med, Taipei, Taiwan; [Ho, Tsung-Chuan; Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Show-Li] Natl Taiwan Univ, Sch Med, Dept Microbiol, Taipei, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taiwan University	Shih, SC (corresponding author), Mackay Med Coll, New Taipei, Taiwan.; Shih, SC (corresponding author), Mackay Mem Hosp, Dept Internal Med, Taipei, Taiwan.; Tsao, YP (corresponding author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.; Tsao, YP (corresponding author), Mackay Mem Hosp, Dept Ophthalmol, Taipei, Taiwan.	shihshou@gmail.com; yptsao@yahoo.com			Ministry of Science and Technology, Taiwan [MOST 104-2314-B-195-006-MY3]; Mackay Memorial Hospital [MMH-E-105-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This work was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-195-006-MY3) and Mackay Memorial Hospital (MMH-E-105-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral J, 2010, INVEST OPHTH VIS SCI, V51, P1318, DOI 10.1167/iovs.09-4455; Bansal MB, 2005, J HEPATOL, V42, P548, DOI 10.1016/j.jhep.2004.11.043; Banumathi E, 2010, EXP EYE RES, V90, P89, DOI 10.1016/j.exer.2009.09.014; Barbato DL, 2014, CELL DEATH DIFFER, V21, P113, DOI 10.1038/cdd.2013.137; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Bilak MM, 2002, J NEUROSCI, V22, P9378; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Cao W, 1999, J NEUROSCI RES, V57, P789, DOI 10.1002/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.3.CO;2-D; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Chung CH, 2009, GASTROENTEROLOGY, V136, P331, DOI 10.1053/j.gastro.2008.09.065; CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3; Filleur S, 2005, CANCER RES; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Gao X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05637; He SQ, 2006, LIVER TRANSPLANT, V12, P1869, DOI 10.1002/lt.21001; Ho TC, 2015, AM J PHYSIOL-CELL PH, V309, pC159, DOI 10.1152/ajpcell.00344.2014; Ho TC, 2013, STEM CELLS, V31, P1775, DOI 10.1002/stem.1393; Ho TC, 2010, AM J PATHOL, V177, P1798, DOI 10.2353/ajpath.2010.091085; Horiguchi N, 2010, HEPATOLOGY, V51, P1724, DOI 10.1002/hep.23532; Huang GJ, 2013, FOOD CHEM, V141, P3020, DOI 10.1016/j.foodchem.2013.03.061; Kawaguchi T, 2010, AM J PATHOL, V176, P168, DOI 10.2353/ajpath.2010.090242; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; KORNBRUST DJ, 1984, TOXICOL APPL PHARM, V72, P388, DOI 10.1016/0041-008X(84)90115-7; Lee JY, 2004, ARCH PHARM RES, V27, P340, DOI 10.1007/BF02980070; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Martin H, 2003, J NUTR, V133, P2505, DOI 10.1093/jn/133.8.2505; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Moriya K, 2012, HEPATOLOGY, V56, P311, DOI 10.1002/hep.25624; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Ogata N, 2001, CURR EYE RES, V22, P245, DOI 10.1076/ceyr.22.4.245.5506; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; Sabir SM, 2008, J ETHNOPHARMACOL, V120, P226, DOI 10.1016/j.jep.2008.08.017; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Schattenberg JM, 2012, AM J PHYSIOL-GASTR L, V303, pG498, DOI 10.1152/ajpgi.00525.2011; Shi JL, 1996, HEPATOLOGY, V24, P1256; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Subramanian P, 2013, J BIOL CHEM, V288, P23928, DOI 10.1074/jbc.M113.487884; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Tsai TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095443; Unterlauft JD, 2014, EXP EYE RES, V127, P206, DOI 10.1016/j.exer.2014.08.004; Wang K, 2010, LAB INVEST, V90, P257, DOI 10.1038/labinvest.2009.129; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Yang BY, 2015, MOLECULES, V20, P12250, DOI 10.3390/molecules200712250; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008	48	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157647	10.1371/journal.pone.0157647	http://dx.doi.org/10.1371/journal.pone.0157647			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384427	gold, Green Submitted, Green Published			2022-12-27	WOS:000379809400018
J	Kshatriya, GK; Acharya, SK				Kshatriya, Gautam K.; Acharya, Subhendu K.			Gender Disparities in the Prevalence of Undernutrition and the Higher Risk among the Young Women of Indian Tribes	PLOS ONE			English	Article							CHILDREN; ASSOCIATION; OUTCOMES	Background High undernutrition is a grave concern in India. Marginalized populations like Indian tribes have been under the serious stress of such nutritional extreme. Women, in particular, are the worst sufferers. Gender-related comprehensive studies regarding the prevalence and risks of undernutrition among the tribes have not been properly pursued in India; the vulnerability of the young females has least been examined. Methods and Findings We conducted a cross-sectional study during January 2011 to December 2013 among 1066 males and 1090 females (n = 2156) in the 20-60 years age group belonging to the nine major tribes; Santals, Oraons and Koras (West Bengal): Santals, Bhumijs and Bathudis (Odisha): Dhodias, Kuknas and Chaudharis (Gujarat). The undernutrition burden was estimated and such risks were analyzed for the women in comparison to the men. The overall undernutrition among the females was found to be 47.4% (95% CI 44.4-50.4) against 32.1% (95% CI 29.3-34.9) among males, indicating about a half of the female population undernourished. The odds of risks for underweight status among females were observed to be high in comparison to males with an odds of 1.9 (95% CI, 1.6-2.2; p <= 0.001) for the overall undernutrition category, 1.7 (95% CI, 1.3-2.3; p <= 0.001) for the mild undernutrition category, 1.3 (95% CI, 1.1-1.6; p <= 0.01) for combined moderate and mild undernutrition category and 3.3 (95% CI at 2.3-4.6; p <= 0.001) for severe undernutrition category. The young females were observed with a high prevalence of undernutrition along with increased risk. The 30-year mean BMI trend of the Indian population in comparison to the males, females, and overall tribal population places the tribal females at the highest risk. Conclusion Indian tribes are suffering from the higher prevalence of undernutrition by further highlighting a high gender bias. The health and empowerment of adolescent and young tribal girls needs additional focus. Overall, no remarkable control on undernutrition has been achieved among Indian tribes despite various efforts.	[Kshatriya, Gautam K.; Acharya, Subhendu K.] Univ Delhi, Dept Anthropol, Delhi, India	University of Delhi	Kshatriya, GK (corresponding author), Univ Delhi, Dept Anthropol, Delhi, India.	g26_51@yahoo.co.in			Indian Council of Medical Research [5/4/8-2/2010 NCD-II]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The project was funded to GKK by Indian Council of Medical Research bearing project reference number 5/4/8-2/2010 NCD-II. The funder's website is http://www.icmr.nic.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2013, J COMMUNITY NUTR HLT, V2, P3; [Anonymous], 2012, PUBL DISTR SYST; [Anonymous], DRAFT RAP SURV CHILD; [Anonymous], PROP CONF INT PROP; [Anonymous], 1995, PHYS STAT US INT ANT; [Anonymous], 2010, CENS OF IND 2011; ARAS R, 1989, Indian Pediatrics, V26, P823; Arnold F, 2009, NUTR INDIA NATL FAMI; Association of Voluntary Agencies for Rural Development (AVARD), 2012, HUNG MALN IND STAT C; Bhattacharya J, 2004, J HEALTH ECON, V23, P839, DOI 10.1016/j.jhealeco.2003.12.008; Bhattacharya R, 2015, WORKING PAPER; Bhutta ZA, 2004, BMJ, V328; Brown JL, 1986, SCI AM, P38; Central Bureau of Health Intelligence. Directorate General of Health Services Ministry of Health and Family Welfare Government of India, 2011, NAT HLTH PROF 2011; Christian P, 2010, JAMA-J AM MED ASSOC, V303, P1539, DOI 10.1001/jama.2010.469; Collins S, 2000, ASSESSMENT NUTR STAT; Dharmalingam A, 2010, MATERN CHILD HLTH J, V14, P290, DOI 10.1007/s10995-009-0451-8; FAO IFAD and WFP, 2015, M 2015 INT HUNG TARG; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; Fledderjohann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107172; Food and Agriculture Organization, 2000, STAT FOOD INS WORLD; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Gates B, 2015, TIMES INDIA; Ghosh-Jerath Suparna, 2013, Indian J Public Health, V57, P260, DOI 10.4103/0019-557X.123268; Glennie J., 2013, GUARDIAN; Gragnolati M, 2006, INDIAS UNDERNOURISHE; Hulley S., 2007, DESIGNING CLIN RES E; International Food Policy Research Institute, 2015, GLOB NUTR REP 2015 A; International Institute of Population Sciences and Macro International National Family Health Survey, 2007, NAT FAM HLTH SURV NF, VI; Kar GC, 2007, STUDY FOOD RELATED N; Kshatriya GK, 2008, ANTHROPOL ANZ, V66, P355, DOI 10.1127/aa/66/2008/355; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mahapatra R, 2015, GOVERNANCE BLOG; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Meshram II, 2012, ASIA PAC J CLIN NUTR, V21, P568; Ministry of Tribal Affairs Government of India, SCHED TRIB INTR; Mohapatra G, 2012, TRANSCIENCE J GLOBAL, V3, P51; Moore AM, 2009, SNAPSHOT ADOLESCENT; MORGANE PJ, 1993, NEUROSCI BIOBEHAV R, V17, P91, DOI 10.1016/S0149-7634(05)80234-9; National Nutrition Monitoring Bureau, 2009, 25 NNMB NAT I NUTR I; Nube M., 1998, EUROPEAN J CLIN NUTR, V77, P1186; Padhi S, 2011, 51 CRPC IIPA; Patel RC, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001223, DOI 10.1371/J0URNAL.PMED.1001223]; Pons N, 2011, FOOD PRICE CONSUMPTI; Ransom E, 2003, NUTR WOMEN ADOLESCEN; Rao K. Mallikharjuna, 2010, Journal of Human Ecology, V29, P165; Rayker N, 2015, INDIA HLTH REPORT NU; Save the Children, WINGS 2014 WORLD IND; Sawaya AL, 2005, MATERN CHILD NUTR, V1, P155, DOI 10.1111/j.1740-8709.2005.00033.x; Social Statistics Division Central Statistics Office Ministry of statistics and Programme Implementation-Government of India, 2012, CHILDR IND 2012 STAT; STRUPP BJ, 1995, J NUTR, V125, pS2221, DOI 10.1093/jn/125.suppl_8.2221S; Sumner A, 2011, GUARDIAN; UNICEF, 2013, STATE WORLDS CHILDRE; UNICEF, 2009, REP TRACJK PROGR CHI; UNICEF, 2014, NOUR IND TRIB CHILDR; Welthungerhilfe IFPRI Concern Worldwide, 2014, GLOB HUNG IND CHALL; Welthungerhilfe IFPRI Concern Worldwide, 2015, IND PROP UND POP; World Health Organization, GLOB HLTH OBS GHO DA	58	28	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158308	10.1371/journal.pone.0158308	http://dx.doi.org/10.1371/journal.pone.0158308			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379521	Green Submitted, Green Published, gold			2022-12-27	WOS:000379798700026
J	Xia, H; Huang, WX; Xiong, J; Tao, T; Zheng, XG; Wei, HB; Yue, YX; Chen, L; Luo, LJ				Xia, Hui; Huang, Weixia; Xiong, Jie; Tao, Tao; Zheng, Xiaoguo; Wei, Haibin; Yue, Yunxia; Chen, Liang; Luo, Lijun			Adaptive Epigenetic Differentiation between Upland and Lowland Rice Ecotypes Revealed by Methylation-Sensitive Amplified Polymorphism	PLOS ONE			English	Article							ORYZA-SATIVA L.; DNA METHYLATION; COLD STRESS; ADAPTATION; RESPONSES; PLANTS; POPULATIONS; INHERITANCE; ARABIDOPSIS; DIVERGENCE	The stress-induced epimutations could be inherited over generations and play important roles in plant adaption to stressful environments. Upland rice has been domesticated in water-limited environments for thousands of years and accumulated drought-induced epimutations of DNA methylation, making it epigenetically differentiated from lowland rice. To study the epigenetic differentiation between upland and lowland rice ecotypes on their drought-resistances, the epigenetic variation was investigated in 180 rice landraces under both normal and osmotic conditions via methylation-sensitive amplified polymorphism (MSAP) technique. Great alterations (52.9 similar to 54.3% of total individual-locus combinations) of DNA methylation are recorded when rice encountering the osmotic stress. Although the general level of epigenetic differentiation was very low, considerable level of FST (0.134 similar to 0.187) was detected on the highly divergent epiloci (HDE). The HDE detected in normal condition tended to stay at low levels in upland rice, particularly the ones de-methylated in responses to osmotic stress. Three out of four selected HDE genes differentially expressed between upland and lowland rice under normal or stressed conditions. Moreover, once a gene at HDE was up-/down-regulated in responses to the osmotic stress, its expression under the normal condition was higher/lower in upland rice. This result suggested expressions of genes at the HDE in upland rice might be more adaptive to the osmotic stress. The epigenetic divergence and its influence on the gene expression should contribute to the higher drought-resistance in upland rice as it is domesticated in the water-limited environment.	[Xia, Hui; Huang, Weixia; Xiong, Jie; Tao, Tao; Zheng, Xiaoguo; Wei, Haibin; Yue, Yunxia; Chen, Liang; Luo, Lijun] Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China; [Huang, Weixia; Xiong, Jie; Tao, Tao; Zheng, Xiaoguo; Yue, Yunxia; Luo, Lijun] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University	Luo, LJ (corresponding author), Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China.; Luo, LJ (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	lijun@sagc.org.cn	Xia, Hui/L-7129-2019	Xia, Hui/0000-0003-2446-5171	Natural Science Foundation of China [31200279]; Project of Shanghai Talent Youth of Agriculture [2121555]; Project of Subject Construction, Shanghai Academy of Agricultural Sciences [SAAS-2015 (07)]; National High-Tech Research and Development Program of China (863 Plan) [2014AA10A603, 2014AA10A604]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Shanghai Talent Youth of Agriculture; Project of Subject Construction, Shanghai Academy of Agricultural Sciences; National High-Tech Research and Development Program of China (863 Plan)(National High Technology Research and Development Program of China)	This research was supported by Natural Science Foundation of China (Grant No. 31200279) by HX, Project of Shanghai Talent Youth of Agriculture, 2015 (Grant No. 2121555) by HX, Project of Subject Construction, Shanghai Academy of Agricultural Sciences, 2015 (Grant No. SAAS-2015 (07)) by LJL, and the National High-Tech Research and Development Program of China (863 Plan)(Grant No. 2014AA10A603, 2014AA10A604) by LJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto K, 2007, ANN BOT-LONDON, V100, P205, DOI 10.1093/aob/mcm110; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Becker C, 2011, NATURE, V12, P480; Becker C, 2012, CURR OPIN PLANT BIOL, V15, P562, DOI 10.1016/j.pbi.2012.08.004; Bernier J, 2008, J SCI FOOD AGR, V88, P927, DOI 10.1002/jsfa.3153; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Colaneri AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059878; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1732; Fan HH, 2013, ACTA PHYSIOL PLANT, V35, P2445, DOI 10.1007/s11738-013-1278-x; Feng QiZhi, 2012, Australian Journal of Crop Science, V6, P877; Gao GZ, 2014, BREEDING SCI, V64, P125, DOI 10.1270/jsbbs.64.125; Gao LX, 2010, PLANT CELL ENVIRON, V33, P1820, DOI 10.1111/j.1365-3040.2010.02186.x; Gayacharan, 2013, PHYSIOL MOL BIOL PLA, V19, P379, DOI 10.1007/s12298-013-0176-4; Herrera CM, 2014, MOL ECOL, V23, P1085, DOI 10.1111/mec.12679; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kinoshita T, 2014, PLANT CELL PHYSIOL, V55, P1859, DOI 10.1093/pcp/pcu125; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Li X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-300; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Liu HZ, 2008, GENE, V420, P57, DOI 10.1016/j.gene.2008.05.006; Lyu J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-160; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Ou XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041143; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Rico L, 2014, PLANT BIOLOGY, V16, P419, DOI 10.1111/plb.12049; Rois AS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-205; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Sahu PP, 2013, PLANT CELL REP, V32, P1151, DOI 10.1007/s00299-013-1462-x; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schulz B, 2014, MOL ECOL, V23, P3523, DOI 10.1111/mec.12835; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; Shan XH, 2013, J PLANT BIOL, V56, P32, DOI 10.1007/s12374-012-0251-3; Shea N, 2011, J EVOLUTION BIOL, V24, P1178, DOI 10.1111/j.1420-9101.2011.02235.x; Steimer A, 2004, CURR OPIN PLANT BIOL, V7, P11, DOI 10.1016/j.pbi.2003.11.008; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wenzel MA, 2014, MOL ECOL, V23, P4256, DOI 10.1111/mec.12833; Xia H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106352; Yu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055772; Zhang XJ, 2013, PLANT PHYSIOL BIOCH, V67, P189, DOI 10.1016/j.plaphy.2013.03.013; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010; Zhao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112869; Zheng XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080253	49	20	21	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157810	10.1371/journal.pone.0157810	http://dx.doi.org/10.1371/journal.pone.0157810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380174	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700011
J	Yang, XW; Gao, JM; Zhou, ZL; Yan, J; Lai, S; Xu, YJ; Chen, G				Yang, Xiaowei; Gao, Jianmin; Zhou, Zhongliang; Yan, Jue; Lai, Sha; Xu, Yongjian; Chen, Gang			Assessing the Effects of the New Cooperative Medical Scheme on Alleviating the Health Payment-Induced Poverty in Shaanxi Province, China	PLOS ONE			English	Article							CARE	Background Disease has become one of the key causes of falling into poverty in rural China. The poor households are even more likely to suffer. The New Cooperative Medical Scheme (NCMS) has been implemented to provide rural residents financial protection against health risks. This study aims to assess the effect of the NCMS on alleviating health payment-induced poverty in the Shaanxi Province of China. Methods The data was drawn from the 5th National Health Service Survey of Shaanxi Province, conducted in 2013. In total, 41,037 individuals covered by NCMS were selected. Poverty headcount ratio (HCR), poverty gap and mean positive poverty gap were used for measuring the incidence, depth and intensity of poverty, respectively. The differences on poverty measures pre-and post-insurance reimbursement indicate the effectiveness of alleviating health payment-induced poverty under NCMS. Results For the general insured, 5.81% of households fell below the national poverty line owing to the health payment; this HCR dropped to 4.84% after insurance reimbursement. The poverty HCRs for the insured that had hospitalization in the past year dropped from 7.50% to 2.09% after reimbursement. With the NCMS compensation, the poverty gap declined from 42.90 Yuan to 34.49 Yuan (19.60% decreased) for the general insured and from 57.48 Yuan to 10.01 Yuan (82.59% decreased) for the hospital admission insured. The mean positive poverty gap declined 3.56% and 37.40% for two samples, respectively. Conclusion The NCMS could alleviate the health payment-induced poverty. The effectiveness of alleviating health payment-induced poverty is greater for hospital admission insured than for general insured, mainly because NCMS compensates for serious diseases. Our study suggests that a more comprehensive insurance benefit package design could further improve the effectiveness of poverty alleviation.	[Yang, Xiaowei; Yan, Jue; Xu, Yongjian] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian, Shaanxi, Peoples R China; [Yang, Xiaowei; Gao, Jianmin; Zhou, Zhongliang; Yan, Jue; Lai, Sha] Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China; [Chen, Gang] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia	Xi'an Jiaotong University; Xi'an Jiaotong University; Flinders University South Australia	Gao, JM (corresponding author), Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China.	gaojm@mail.xjtu.edu.cn		Chen, Gang/0000-0002-8385-5965	Shaanxi Social Science Foundation [2014P16]	Shaanxi Social Science Foundation	This study is supported by Shaanxi Social Science Foundation. Serial number is 2014P16. Xiaowei Yang recieved this funding [http://www.sxxc.gov.cn/content/2014-08/29/content_11551980.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT RUR HLTH MISS MI; [Anonymous], 2008, CHINA NEWS; Center for Health Statistics and Information National Health and Family Planning Commission, 2009, AN REP NAT HLTH SERV; Chen YC, 2005, CHINESE HLTH EC, V24, P26; Cirto C., 1995, MEASURING POVERTY NE; Deaton A., 2000, DESIGNING HOUSEHOLD, P91; Deaton A.S., 2002, 135 LSMS WORLD BANK; Finance Bureau and Health Bureau of Shaanxi Province, 2012, ANN IMPR FIN STAND N; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Gao JM, 2007, CHINA HLTH EC, V26, P30; Golovchenko B.., 2014, GILEA SCI B, V82, P46; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; National Bureau of Statistics of China, 2014, CHIN STAT YB 2014; O'Donnell O, 2007, ANAL HLTH EQUITY USI, DOI [10.1596/978-0-8213-6933-3, DOI 10.1596/978-0-8213-6933-3]; Ravallion M., 1998, POVERTY LINES THEORY, V133; Shaanxi Health and Family Planning Commission, 2014, STAT B SHAANX HLTH F; Sun XY, 2010, HEALTH POLICY PLANN, V25, P419, DOI 10.1093/heapol/czq010; The State Council The People's Republic of China, 2014, PROGR CHIN HUM RIGHT; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wan Q, 2013, ZHONG GUO WEI SHENG, V34, P5; WHO, 2005, STRAT HLTH CAR COUNT; World Bank, 2000, WORLD DEV REP 2000 2; Yan JE, 2009, CHINESE HLTH EC, V28, P59; Yan JE, 2012, CHINA HLTH EC, V31, P37; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066	26	6	6	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157918	10.1371/journal.pone.0157918	http://dx.doi.org/10.1371/journal.pone.0157918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27380417	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700013
J	Niu, LY; Feng, SW; Ding, WH; Li, G				Niu, Liyuan; Feng, Suwei; Ding, Weihua; Li, Gan			Influence of Speed and Rainfall on Large-Scale Wheat Lodging from 2007 to 2014 in China	PLOS ONE			English	Article							WINTER-WHEAT; RESISTANCE; CULTIVARS; YIELD	Strong wind and heavy rain remain the two most important causes of large acreage wheat (Triticum aestivum L.) lodging in China. For research the influence of wind speed and rainfall-separately as well as together-on the extent and degree of lodging, five levels of the severity of lodging were defined based on a combination of the lodging area and the degree of tilting. Detailed meteorological information was studied on 52 instances of large-scale lodging that occurred from 2007 to 2014. The results showed that strong wind's lodging accounted for 8% of the instances studied, continuous rainfall's lodging accounted for 19% and strong winds-heavy rainfall's accounted for 73%. The minimum instantaneous wind speed that could cause large-scale lodging was closely related to rainfall. Without rainfall, the wind speed that resulted in lodging ranging in severity from slight to severe (Level 2 to Level 5) was 14.9 m/s, 19.3 m/s, 21.5 m/s, and 26.5 m/s, respectively; when accompanied by rainfall, the wind speed that resulted in lodging of the same severity decreased linearly with the increase of rainfall. These results will be particularly useful in preventing and alleviating wheat lodging as well screening wheat varieties with good lodging resistance.	[Niu, Liyuan] Henan Inst Sci & Technol, Coll Life Sci & Technol, Xinxiang, Henan, Peoples R China; [Feng, Suwei; Ding, Weihua; Li, Gan] Henan Inst Sci & Technol, Wheat Breeding Inst, Xinxiang, Henan, Peoples R China	Henan Institute of Science & Technology; Henan Institute of Science & Technology	Niu, LY (corresponding author), Henan Inst Sci & Technol, Coll Life Sci & Technol, Xinxiang, Henan, Peoples R China.	nly1962@163.com			National Natural Science Foundation of China [31371525]; High-Level Personnel Research Project of Henan Institute of Science and Technology [2011002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-Level Personnel Research Project of Henan Institute of Science and Technology	This work was supported by the National Natural Science Foundation of China (No. 31371525) (http://www.nsfc.gov.cn/) and the High-Level Personnel Research Project of Henan Institute of Science and Technology (No. 2011002) (http://www.hist.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricultural bureau of Jingzhou district, 2012, LARG SCAL WHEAT LODG; Ai D, 2012, STRONG CONVECTIVE WE; [Anonymous], 2008, SHANDONG NEWS; Bai HB, 2011, STORM CAUSED 2 200 H; Baker CJ, 1998, J THEOR BIOL, V194, P587, DOI 10.1006/jtbi.1998.0778; Berry PM, 2003, AGR FOREST METEOROL, V119, P167, DOI 10.1016/S0168-1923(03)00139-4; Berry PM, 2003, FIELD CROP RES, V80, P111, DOI 10.1016/S0378-4290(02)00174-0; Che JJ, 2013, HEAVY RAIN LED WHEAT; Chen YD, 2009, ZHAO YAZHONG 63 REGI; China weather channel, 2013, HEAV RAIN HIT HEB LA; CROOK MJ, 1994, J AGR SCI, V123, P167, DOI 10.1017/S0021859600068428; EASSON DL, 1993, J AGR SCI, V121, P145, DOI 10.1017/S0021859600077005; Feng WY, 2013, HEAVY RAIN CAUSED 20; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Gao Z, 2013, TECHNICIANS WUQIAO C; Geng YF, 2013, STRONG WIND FROST OT; Guang JJ, 2012, HEAVY RAIN RUSHED AW; Gui SY, 2013, STORM CAUSED WHEAT L; Han JW, 2012, HEAVY RAIN 50 YEARS; Han K, 2013, HEAVY RAIN WIND ATTA; He T, 2009, TAKES MEASURES DEAL; He W, 2008, WEISHI COUNTY NEARLY; He XF, 2011, DISASTER WEATHER HIT; Hei P, 2011, DRAGON BOAT FESTIVAL; Hou YX, 2013, QUFU RAINSTORM EMERG; Hu B, 2013, WIND RAIN LED WHEAT; Hu B, 2012, HAIL CAUSE FLAKY WHE; Hua X, 2013, STORMS HIT PARTS CHI; Huang ZH, 2013, AGR EXPERTS WENT PAV; Lang Xi BBS, 2012, WHEAT RAPE LODGING S; Langya news, 2013, LANGYA NEWS; Li FM, 2013, SEVERE CONVECTIVE WE; Li HC, 2013, HEAVY RAINS CAUSED J; Liu HP, 2009, STORM HAIL HIT LUYI; LIU HP, 2012, SHANDONG AGR SCI, V44, P55; Liu W, 2012, HAIL SUCH JUJUBE CAU; Liu Y, 2010, GALE HEAVY RAIN DISA; Lu TC, 2013, STORMY RAIDED WHEAT; Mei Y, 2013, RAINSTORM WINTER WHE; Mei Y, 2013, HEAVY RAIN LED SUQIA; Meteorological bureau of Lingbi county, 2012, STRONG CONV WEATH HI; Mobile Xinxiang, 2013, HEAV RAIN WHEAT LODG; News Hebei, 2013, GAL HAIL HIT DAM COU; Niu LY, 2012, FIELD CROP RES, V139, P1, DOI 10.1016/j.fcr.2012.10.014; Pang LL, 2013, WIND RAIN HIT SHANDO; Qi K, 2013, CONTINUOUS RAINFALL; Qi S, 2010, HEAVY RAIN CAUSED WH; Qilu P, 2013, ONE 3 WHEAT LODGING; Qin QX, 2013, HEAVY RAIN CAUSED SE; Shen Y, 2013, CHINA DAILY PRECIPIT; Tao XQ, 2013, CONVECTIVE WEATHER C; Tie J, 2013, DEZHOU CITY WHEAT LO; Wang JC, 2013, DAYS RAIN BINZHOU CI; Wang Q, 2013, HEAVY RAINS LED SOME; Wang SD, 2013, RAIN STOPS TOMORROW; Wang YN, 2013, BAD WEATHER HIT LIAO; Wei Q, 2013, SHIJIAZHUANG CITY BR; Wen M, 2013, WHEAT LODGING; Wu M, 2011, AGR MACHINERY DEP AC; Wu M, 2012, SEIZE TIME REDUCE LO; Wu M, 2013, 5 FARM SUFFERED WIND; Wu W, 2013, LARGE SCALE WHEAT LO; Wu YG, 2012, STORM CAUSED JIYANG; Xinhua news agency, 2010, THUND STRONG WIND HA; Xiong JW, 2013, STORM CAUSED HEZENEA; Xuzhou bureau of meteorology, 2013, INFL HEAV RAIN MAY 2; Yang ZH, 2013, 1 SUMMER THUNDERSTOR; Yi Y, 2013, STORM RAID RESULTED; Youku video, 2012, STORM LED SOM VILL W; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhai T, 2013, EXPERTS SUGGESTED PR; Zhang HL, 2007, CONTINUOUS RAINFALL; Zhang HL, 2013, HAIL DONGE COUNTYS 6; Zhang JB, 2007, HEAVY WIND HAIL CAUS; Zhao PP, 2013, WIND RAIN LED 6600 H; Zhu XinKai, 2006, Journal of Triticeae Crops, V26, P87; Zou FL, 2013, CHINA LAND CLIMATE D	77	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157677	10.1371/journal.pone.0157677	http://dx.doi.org/10.1371/journal.pone.0157677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367926	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900011
J	Choi, SW; Kweon, SS; Lee, YH; Ryu, SY; Choi, JS; Rhee, JA; Nam, HS; Jeong, SK; Park, KS; Kim, HN; Shin, MH				Choi, Seong-Woo; Kweon, Sun-Seog; Lee, Young-Hoon; Ryu, So-Yeon; Choi, Jin-Su; Rhee, Jung-Ae; Nam, Hae-Sung; Jeong, Seul-Ki; Park, Kyeong-Soo; Kim, Hee Nam; Shin, Min-Ho			25-Hydroxyvitamin D and Parathyroid Hormone Levels Are Independently Associated with the Hemoglobin A(1c) Level of Korean Type 2 Diabetic Patients: The Dong-Gu Study	PLOS ONE			English	Article							VITAMIN-D STATUS; 1,25-DIHYDROXYVITAMIN D-3; CARDIOVASCULAR-DISEASE; CALCIUM HOMEOSTASIS; INSULIN SENSITIVITY; NATIONAL-HEALTH; SERUM-CALCIUM; GLUCOSE; PLASMA; POPULATION	In type 2 diabetic patients, the relationships between 25-hydroxyvitamin D and parathyroid hormone levels, and glycemic control, remain unclear. We evaluated associations between 25-hydroxyvitamin D, parathyroid hormone, and hemoglobin A(1c) levels after adjusting for other covariates, including log transformed 25-hydroxyvitamin D levels and log transformed parathyroid hormone levels, in Korean patients with type 2 diabetes. In total, 1,175 patients with type 2 diabetes were selected from 8,857 individuals who completed the baseline survey of the Dong-gu study, conducted in Korea from 2007 to 2010. After adjusting for other covariates, we found that the mean hemoglobin A(1c) level was inversely associated with the 25-hydroxyvitamin D level (Q1: 7.47% [7.30-7.63], Q2: 7.25% [7.09-7.40], Q3: 7.17% [7.02-7.32], Q4: 7.19% [7.02-7.35]; p for trend = 0.021, p for between groups = 0.050) and the parathyroid hormone level (Q1: 7.35%[7.19-7.51], Q2: 7.34%[7.19-7.50], Q3: 7.28% [7.13-7.43], Q4: 7.09% [6.94-7.24]; p for trend = 0.022, p for between groups = 0.048). However, the mean fasting glucose level was not associated with either the 25-hydroxyvitamin D or parathyroid hormone level. In conclusion, inverse associations were evident between hemoglobin A(1c), 25-hydroxyvitamin D and parathyroid hormone levels in Korean patients with type 2 diabetes. The associations remained significant after adjusting for other covariates, including the log transformed 25-hydroxyvitamin D levels and log transformed parathyroid hormone levels.	[Choi, Seong-Woo; Ryu, So-Yeon] Chosun Univ, Sch Med, Dept Prevent Med, 309 Pilmun Daero, Kwangju 501759, South Korea; [Kweon, Sun-Seog; Choi, Jin-Su; Rhee, Jung-Ae; Shin, Min-Ho] Chonnam Natl Univ, Sch Med, Dept Prevent Med, 160 Baekseo Ro, Kwangju 501746, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Hwasun Hosp, Jeonnam Reg Canc Ctr, 322 Seoyang Ro, Hwasun 519809, Jeollanamdo, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Sch Med, Dept Prevent Med, 344-2 Shinyong Dong, Iksan 570711, Jeollabukdo, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Sch Med, Inst Wonkwang Med Sci, 344-2 Shinyong Dong, Iksan 570711, Jeollabukdo, South Korea; [Nam, Hae-Sung] Chungnam Natl Univ, Sch Med, Dept Prevent Med, Munhwa 1 Il Dong, Daejeon 301747, South Korea; [Jeong, Seul-Ki] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Inst Biomed, Dept Neurol, San 2-20, Jeonju 561180, Jeollabukdo, South Korea; [Jeong, Seul-Ki] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Inst Biomed, Res Inst Clin Med, San 2-20, Jeonju 561180, Jeollabukdo, South Korea; [Park, Kyeong-Soo] Seonam Univ, Coll Med, Dept Prevent Med, 439 Chunhyang Ro, Namwon 590711, Jeollabukdo, South Korea; [Kim, Hee Nam; Shin, Min-Ho] Chonnam Natl Univ, Ctr Creat Biomed Scientists, 77 Yongbong Ro, Kwangju 500757, South Korea	Chosun University; Chonnam National University; Chonnam National University; Wonkwang University; Wonkwang University; Chungnam National University; Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital; Seonam University; Chonnam National University	Shin, MH (corresponding author), Chonnam Natl Univ, Sch Med, Dept Prevent Med, 160 Baekseo Ro, Kwangju 501746, South Korea.; Shin, MH (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Scientists, 77 Yongbong Ro, Kwangju 500757, South Korea.	mhshinx@paran.com	Kweon, Sun-Seog/AAZ-4732-2021	Kweon, Sun-Seog/0000-0003-2378-8550; Lee, Young-Hoon/0000-0003-1367-025X; Choi, Seong-Woo/0000-0002-6150-3934; Nam, Hae-Sung/0000-0003-0911-4576; Jeong, Seul-Ki/0000-0002-9868-621X				Alemzadeh R, 2012, METAB SYNDR RELAT D, V10, P422, DOI 10.1089/met.2012.0056; Chagas CEA, 2012, NUTRIENTS, V4, P52, DOI 10.3390/nu4010052; Bischof MG, 2006, HORM RES, V66, P211, DOI 10.1159/000094932; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; Boland ARD, 1990, ENDOCRINOLOGY, V127; Brandstedt J, 2016, CANCER CAUSE CONTROL, V27, P69, DOI 10.1007/s10552-015-0684-3; Chiu KC, 2000, METABOLISM, V49, P1501, DOI 10.1053/meta.2000.17708; Christodoulou S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/396541; Dalgard C, 2011, DIABETES CARE, V34, P1284, DOI 10.2337/dc10-2084; DEMDEN MC, 1989, BIOCHEM BIOPH RES CO, V164, P413, DOI 10.1016/0006-291X(89)91735-X; El Lithy A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-362; Farrell CJL, 2012, CLIN CHEM, V58, P531, DOI 10.1373/clinchem.2011.172155; Fraser A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013882; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hagstrom E, 2007, DIABETOLOGIA, V50, P317, DOI 10.1007/s00125-006-0532-9; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick Michael F., 1999, P1; Inouye K, 2001, Biotechnol Annu Rev, V7, P179, DOI 10.1016/S1387-2656(01)07037-5; Joergensen C, 2010, DIABETES CARE, V33, P2238, DOI 10.2337/dc10-0582; JOHNSON JA, 1994, AM J PHYSIOL, V267, pE356, DOI 10.1152/ajpendo.1994.267.3.E356; Kositsawat J, 2010, DIABETES CARE, V33, P1236, DOI 10.2337/dc09-2150; Kweon SS, 2014, INT J EPIDEMIOL, V43, P558, DOI 10.1093/ije/dys244; Lim S, 2013, AM J CLIN NUTR, V97, P524, DOI 10.3945/ajcn.112.048496; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Mezquita-Raya P, 2001, J BONE MINER RES, V16, P1408, DOI 10.1359/jbmr.2001.16.8.1408; Minambres I, 2015, ENDOCR RES, V40, P160, DOI 10.3109/07435800.2014.982326; Oh YJ, 2012, NEPHROL DIAL TRANSPL, V27, P2396, DOI 10.1093/ndt/gfr763; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Sahota O, 2004, BONE, V35, P312, DOI 10.1016/j.bone.2004.02.003; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Souberbielle JC, 2001, J CLIN ENDOCR METAB, V86, P3086, DOI 10.1210/jc.86.7.3086; Sun XM, 2015, J ATHEROSCLER THROMB, V22, P355, DOI 10.5551/jat.26070; van Dam RM, 2007, AM J CLIN NUTR, V85, P755, DOI 10.1093/ajcn/85.3.755; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Wareham NJ, 1997, METABOLISM, V46, P1171, DOI 10.1016/S0026-0495(97)90212-2; WHO, 2016, GLOB REP PSOR; Woerle HJ, 2004, ARCH INTERN MED, V164, P1627, DOI 10.1001/archinte.164.15.1627; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62; Zhang MC, 2014, MED SCI MONITOR, V20, P1274, DOI 10.12659/MSM.890930	46	6	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158764	10.1371/journal.pone.0158764	http://dx.doi.org/10.1371/journal.pone.0158764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362844	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200111
J	De Cock, E; Kritikou, P; Sandoval, M; Tao, SN; Wiesner, C; Carella, AM; Ngoh, C; Waterboer, T				De Cock, Erwin; Kritikou, Persefoni; Sandoval, Mariana; Tao, Sunning; Wiesner, Christof; Carella, Angelo Michele; Ngoh, Charles; Waterboer, Tim			Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries	PLOS ONE			English	Article							LYMPHOMA; TRASTUZUMAB	Background Rituximab is a standard treatment for non-Hodgkin lymphoma. The SABRINA trial (NCT01200758) showed that a subcutaneous (SC) rituximab formulation did not compromise efficacy or safety compared with intravenous (IV) infusion. We aimed to quantify active healthcare professional (HCP) time and patient chair time for rituximab SC and IV, including potential time savings. Methods This non-interventional time and motion study was run in eight countries and 30 day oncology units. Rituximab SC data were collected alongside the MabCute trial (NCT01461928); IV data were collected per routine real-world practice. Trained observers recorded active HCP time for pre-specified tasks (stopwatch) and chair time (time of day). A random intercept model was used to analyze active HCP time (by task and for all tasks combined) in the treatment room and drug preparation area, drug administration duration, chair time and patient treatment room time by country and/or across countries. Active HCP and chair time were extrapolated to a patient's first year of treatment (11 rituximab sessions). Results Mean active HCP time was 35.0 and 23.7 minutes for IV and SC process, respectively (-32%, p < 0.0001). By country, relative reduction in time was 27-58%. Absolute reduction in extrapolated active HCP time (first year of treatment) was 1.1-5.2 hours. Mean chair time was 262.1 minutes for IV, including 180.9 minutes infusion duration, vs. 67.3 minutes for SC, including 8.3 minutes SC injection administration (-74%, p < 0.0001). By country, relative reduction was 53-91%. Absolute reduction in extrapolated chair time for the first year of treatment was 3.1-5.5 eight-hour days. Conclusions Compared with rituximab IV, rituximab SC was associated with reduced chair time and active HCP time. The latter could be invested in other activities, whereas the former may lead to more available appointments, reducing waiting lists and increasing the efficiency of day oncology units.	[De Cock, Erwin] United Biosource Corp, Barcelona, Spain; [Kritikou, Persefoni] United Biosource Corp, London, England; [Sandoval, Mariana; Tao, Sunning] United Biosource Corp, Montreal, PQ, Canada; [Wiesner, Christof] Genentech Inc, San Francisco, CA USA; [Carella, Angelo Michele] IRCSS AOU, San Martino Buon Albergo, Italy; [Ngoh, Charles; Waterboer, Tim] F Hoffmann La Roche Ltd, Basel, Switzerland; [Waterboer, Tim] German Canc Res Ctr, Heidelberg, Germany	United Biosource Corporation; United Biosource Corporation; United Biosource Corporation; Roche Holding; Genentech; Roche Holding; Helmholtz Association; German Cancer Research Center (DKFZ)	De Cock, E (corresponding author), United Biosource Corp, Barcelona, Spain.	erwin.decock@ubc.com	Waterboer, Tim/G-1252-2010		F. Hoffmann-La Roche Ltd.	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	This work was funded by F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. provided support in the form of salaries for authors CW, CN and TW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was funded by F. Hoffmann-La Roche Ltd. Support for third-party writing assistance for this manuscript provided by Lucy Carrier and Cheryl Wright of Gardiner-Caldwell Communications was funded by F. Hoffmann-La Roche Ltd.	[Anonymous], DAT ON FIL F; Bittner B, DRUG RES ST IN PRESS; Burcombe R, 2013, ADV BREAST CANC RES, V02, P133, DOI [10.4236/abcr.2013.24022, DOI 10.4236/ABCR.2013.24022]; Davies A, 2014, LANCET ONCOL, V15, P343, DOI 10.1016/S1470-2045(14)70005-1; De Cock E, 2016, CANCER MED-US, V5, P389, DOI 10.1002/cam4.573; European Medicines Agency, 2009, MABTHERA; Fanale MA, 2007, DRUGS, V67, P333, DOI 10.2165/00003495-200767030-00002; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Marcus R, 2007, EUR J HAEMATOL, V78, P5, DOI 10.1111/j.1600-0609.2006.00789.x; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Pivot X, 2013, LANCET ONCOL, V14, P962, DOI 10.1016/S1470-2045(13)70383-8; Rule Simon, 2014, J Med Econ, V17, P459, DOI 10.3111/13696998.2014.914033; Rule S, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.3052.3052; Rummel M, 2014, HAEMATOLOGICA, V99, P152; Salar A, 2014, J CLIN ONCOL, V32, P1782, DOI 10.1200/JCO.2013.52.2631; Salar A, 2010, BLOOD, V116, P1177; Scott SD, 1998, CANCER PRACT, V6, P195, DOI 10.1046/j.1523-5394.1998.006003195.x; SEER (Surveillance Epidemiology and End Results Program), 2015, STAT FACT SHEETS NON; Sonet A, 2009, EXPERT REV ANTICANC, V9, P719, DOI [10.1586/era.09.30, 10.1586/ERA.09.30]; Tobinai K, 2014, LANCET ONCOL, V15, P254, DOI 10.1016/S1470-2045(14)70009-9	20	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157957	10.1371/journal.pone.0157957	http://dx.doi.org/10.1371/journal.pone.0157957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362533	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200031
J	Engelmann, R; Biemelt, A; Cordshagen, A; Johl, A; Kuthning, D; Muller-Hilke, B				Engelmann, Robby; Biemelt, Andra; Cordshagen, Antje; Johl, Anja; Kuthning, Daniela; Mueller-Hilke, Brigitte			The Prerequisites for Central Tolerance Induction against Citrullinated Proteins in the Mouse	PLOS ONE			English	Article							THYMIC EPITHELIAL-CELLS; PROMISCUOUS GENE-EXPRESSION; REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; SELECTION; ANTIBODY; DISEASE; ENZYMES; MICE; SELF	Objectives To assess the prerequisites for negative selection of peptidylcitrulline-specific T cells in the thymus. In detail, we here analyzed murine medullary thymic epithelial cells for the expression of peptidylarginine deiminases (PAD) and subsequent citrullination. Methods Medullary thymic epithelial cells were sorted, their mRNA was isolated and the expression of Pad genes was analyzed by quantitative PCR. Citrullination was detected by Western Blot in lysates of sorted medullary thymic epithelial cells and histologically by immunofluorescence of thymic thin sections. Results Pad2 and Pad4 are the main Pad isoforms expressed in mature medullary thymic epithelial cells of the mouse and their levels of expression are comparable to that of insulin (Ins2), another highly and promiscuously expressed protein in the thymus. Citrullination was detected in medullary thymic epithelial cells as shown by Western Blot and immunofluorescence. Conclusions Even though we here show that the murine thymus harbors the prerequisites for central tolerance to PAD and citrullinated peptides, it remains an open question whether the emergence of peptidylcitrulline-specific T cells and of autoantibodies recognizing citrullinated epitopes is caused by a failure of central or peripheral tolerance mechanisms.	[Engelmann, Robby; Biemelt, Andra; Cordshagen, Antje; Johl, Anja; Kuthning, Daniela; Mueller-Hilke, Brigitte] Univ Rostock, Med Ctr, Inst Immunol, Schillingallee 70, D-18057 Rostock, Germany	University of Rostock	Engelmann, R (corresponding author), Univ Rostock, Med Ctr, Inst Immunol, Schillingallee 70, D-18057 Rostock, Germany.	robby.engelmann@med.uni-rostock.de		Engelmann, Robby/0000-0002-1048-3638	Fritz Thyssen foundation;  [10.12.2.146];  [FORUN 889018-2013]	Fritz Thyssen foundation; ; 	The work was supported by a grant of the Fritz Thyssen foundation (http://www.fritz-thyssen-stiftung.de/foerderung/gefoerderte-vorhaben/projekt/pl/pad-gene-und-citrullinierung/p/647/?no_cache). The grant 10.12.2.146 was passed to RE. Furthermore, the project was supported by an intramural grant (FORUN 889018-2013; https://www.med.uni-rostock.de/forschung-lehre/forschung/interne-foerderung/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Bos WH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4511; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Darrah E, 2012, ANN RHEUM DIS, V71, P92, DOI 10.1136/ard.2011.151712; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Garcia-Lozano JR, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4141; Kidd BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2523; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Martinez RJ, 2012, J IMMUNOL, V188, P170, DOI 10.4049/jimmunol.1101311; Thiele GM, 2012, INT IMMUNOPHARMACOL, V13, P424, DOI 10.1016/j.intimp.2012.05.007; van Beers JJBC, 2013, BIOCHIMIE, V95, P299, DOI 10.1016/j.biochi.2012.09.029; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211	22	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158773	10.1371/journal.pone.0158773	http://dx.doi.org/10.1371/journal.pone.0158773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362943	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200112
J	Hasan, NH; Ebrahimie, E; Ignjatovic, J; Tarigan, S; Peaston, A; Hemmatzadeh, F				Hasan, Noor Haliza; Ebrahimie, Esmaeil; Ignjatovic, Jagoda; Tarigan, Simson; Peaston, Anne; Hemmatzadeh, Farhid			Epitope Mapping of Avian Influenza M2e Protein: Different Species Recognise Various Epitopes	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; INTEGRAL MEMBRANE-PROTEIN; A-VIRUS; MATRIX PROTEIN-2; ANTIGENIC DETERMINANTS; MONOCLONAL-ANTIBODY; EXTRACELLULAR DOMAIN; COMPETITIVE ELISA; ECTODOMAIN; VACCINE	A common approach for developing diagnostic tests for influenza virus detection is the use of mouse or rabbit monoclonal and/or polyclonal antibodies against a target antigen of the virus. However, comparative mapping of the target antigen using antibodies from different animal sources has not been evaluated before. This is important because identification of antigenic determinants of the target antigen in different species plays a central role to ensure the efficiency of a diagnostic test, such as competitive ELISA or immunohistochemistry- based tests. Interest in the matrix 2 ectodomain (M2e) protein of avian influenza virus (AIV) as a candidate for a universal vaccine and also as a marker for detection of virus infection in vaccinated animals (DIVA) is the rationale for the selection of this protein for comparative mapping evaluation. This study aimed to map the epitopes of the M2e protein of avian influenza virus H5N1 using chicken, mouse and rabbit monoclonal or monospecific antibodies. Our findings revealed that rabbit antibodies (rAbs) recognized epitope (EVETPTRN13)-E-6 of the M2e, located at the N-terminal of the protein, while mouse (mAb) and chicken antibodies (cAbs) recognized epitope (PTRNEWECK18)-P-10, located at the centre region of the protein. The findings highlighted the difference between the M2e antigenic determinants recognized by different species that emphasized the importance of comparative mapping of antibody reactivity from different animals to the same antigen, especially in the case of multi-host infectious agents such as influenza. The findings are of importance for antigenic mapping, as well as diagnostic test and vaccine development.	[Hasan, Noor Haliza; Ebrahimie, Esmaeil; Peaston, Anne; Hemmatzadeh, Farhid] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA 5005, Australia; [Hasan, Noor Haliza] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Sabah, Malaysia; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Adelaide, SA 5005, Australia; [Ebrahimie, Esmaeil] Univ S Australia, Div Informat Technol Engn & Environm, Sch Informat Technol & Math Sci, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA 5001, Australia; [Ignjatovic, Jagoda] Univ Melbourne, Sch Vet & Agr Sci, Melbourne, Vic 3010, Australia; [Tarigan, Simson] Indonesian Res Ctr Vet Sci, Bogor, Indonesia	University of Adelaide; Universiti Malaysia Sabah; University of Adelaide; University of South Australia; Flinders University South Australia; University of Melbourne	Hasan, NH; Ebrahimie, E; Hemmatzadeh, F (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA 5005, Australia.; Hasan, NH (corresponding author), Univ Malaysia Sabah, Inst Trop Biol & Conservat, Sabah, Malaysia.; Ebrahimie, E (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Adelaide, SA 5005, Australia.; Ebrahimie, E (corresponding author), Univ S Australia, Div Informat Technol Engn & Environm, Sch Informat Technol & Math Sci, Adelaide, SA, Australia.; Ebrahimie, E (corresponding author), Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA 5001, Australia.	noorhaliza.hasan@adelaide.edu.au; esmaeil.ebrahimie@flinders.edu.au; farhid.hemmatzadeh@adelaide.edu.au	Peaston, Anne E/H-7158-2013; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Hemmatzadeh, Farhid/0000-0002-4572-8869; Peaston, Anne/0000-0002-7501-2415; Hasan, Noor Haliza/0000-0003-0319-9417	Australian Centre for International Agricultural Research ACIAR [AH/2006/050, AH/2010/039]; Ministry of Education Malaysia	Australian Centre for International Agricultural Research ACIAR(Australian Ctr Intl Agr Res); Ministry of Education Malaysia	This research is funded by Australian Centre for International Agricultural Research ACIAR (http://aciar.gov.au/) grant numbers AH/2006/050 and AH/2010/039. NHH was funded by the Ministry of Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MIN 17 STAT SOFTW; BLACK RA, 1993, J GEN VIROL, V74, P143, DOI 10.1099/0022-1317-74-1-143; Cho KJ, 2015, J VIROL, V89, P3700, DOI 10.1128/JVI.02576-14; DARNULE TV, 1980, EXPERIENTIA, V36, P606, DOI 10.1007/BF01965829; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2011, J GEN VIROL, V92, P301, DOI 10.1099/vir.0.027086-0; Ebrahimi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096984; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Finlay WJJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00342; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; Gerhard W, 2006, EMERG INFECT DIS, V12, P569, DOI 10.3201/eid1204.051020; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Hadifar F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108420; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hemmatzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056801; Hjelm B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045817; Hjelm B, 2010, NEW BIOTECHNOL, V27, P129, DOI 10.1016/j.nbt.2009.11.001; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kim MC, 2010, CLIN VACCINE IMMUNOL, V17, P1977, DOI 10.1128/CVI.00191-10; LAMB RA, 1981, P NATL ACAD SCI-BIOL, V78, P4170, DOI 10.1073/pnas.78.7.4170; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; LAMB RA, 1981, VIROLOGY, V112, P729, DOI 10.1016/0042-6822(81)90317-2; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Lambrecht B, 2007, AVIAN DIS, V51, P221, DOI 10.1637/7589-040206R.1; Leung HC, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.22; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Liu WL, 2003, FEMS IMMUNOL MED MIC, V35, P141, DOI 10.1016/S0928-8244(03)00009-9; McCown MF, 2005, J VIROL, V79, P3595, DOI 10.1128/JVI.79.6.3595-3605.2005; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Park EK, 1998, J VIROL, V72, P2449, DOI 10.1128/JVI.72.3.2449-2455.1998; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Raghunathan G, 2012, J MOL RECOGNIT, V25, P103, DOI 10.1002/jmr.2158; ROTTER V, 1983, J IMMUNOL, V131, P329; Shafer AL, 1998, AVIAN DIS, V42, P28, DOI 10.2307/1592573; Starick E, 2006, J VET MED B, V53, P370, DOI 10.1111/j.1439-0450.2006.01007.x; SUGRUE RJ, 1990, EMBO J, V9, P3469, DOI 10.1002/j.1460-2075.1990.tb07555.x; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Sun J, 2011, IMMUNOME RES, V7, P11; Tarigan S, 2015, AVIAN PATHOL, V27, P1, DOI DOI 10.1080/03079457.2015; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; Wang YJ, 2009, BIOCHEM BIOPH RES CO, V385, P118, DOI 10.1016/j.bbrc.2009.04.129; Whittaker GR, 1998, VIROLOGY, V246, P1, DOI 10.1006/viro.1998.9165; ZEBEDEE SL, 1985, J VIROL, V56, P502, DOI 10.1128/JVI.56.2.502-511.1985; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhang MX, 2006, MOL IMMUNOL, V43, P2195, DOI 10.1016/j.molimm.2005.12.015; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Zhou C, 2012, VACCINE, V30, P3463, DOI 10.1016/j.vaccine.2012.03.021; Zhou EM, 1998, AVIAN DIS, V42, P517, DOI 10.2307/1592678; Zou P, 2005, INT IMMUNOPHARMACOL, V5, P631, DOI 10.1016/j.intimp.2004.12.005	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0156418	10.1371/journal.pone.0156418	http://dx.doi.org/10.1371/journal.pone.0156418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362795	Green Published, gold, Green Accepted			2022-12-27	WOS:000378865200001
J	Lafuerza, LF; Dyson, L; Edmonds, B; McKane, AJ				Lafuerza, Luis F.; Dyson, Louise; Edmonds, Bruce; McKane, Alan J.			Staged Models for Interdisciplinary Research	PLOS ONE			English	Article							SIMULATION; SIMPLIFICATION; REDUCTION	Modellers of complex biological or social systems are often faced with an invidious choice: to use simple models with few mechanisms that can be fully analysed, or to construct complicated models that include all the features which are thought relevant. The former ensures rigour, the latter relevance. We discuss a method that combines these two approaches, beginning with a complex model and then modelling the complicated model with simpler models. The resulting "chain" of models ensures some rigour and relevance. We illustrate this process on a complex model of voting intentions, constructing a reduced model which agrees well with the predictions of the full model. Experiments with variations of the simpler model yield additional insights which are hidden by the complexity of the full model. This approach facilitated collaboration between social scientists and physicists-the complex model was specified based on the social science literature, and the simpler model constrained to agree (in core aspects) with the complicated model.	[Lafuerza, Luis F.; Dyson, Louise; McKane, Alan J.] Univ Manchester, Sch Phys & Astron, Theoret Phys, Manchester M13 9PL, Lancs, England; [Edmonds, Bruce] Manchester Metropolitan Univ, Ctr Policy Modelling, Manchester M15 6BH, Lancs, England; [Dyson, Louise] Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England	University of Manchester; Manchester Metropolitan University; University of Warwick	Edmonds, B (corresponding author), Manchester Metropolitan Univ, Ctr Policy Modelling, Manchester M15 6BH, Lancs, England.	bruce.edmonds@gmail.com	Edmonds, Bruce/A-6030-2012; Toral, Raul/K-4653-2012	Edmonds, Bruce/0000-0002-3903-2507; Toral, Raul/0000-0003-2046-7620; Dyson, Louise/0000-0001-9788-4858	EPSRC [392 EP/H02171X]; EPSRC [EP/H02171X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H02171X/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EPSRC under grant number 392 EP/H02171X.	[Anonymous], 2014, ACM SIGKDD EXPLOR NE, DOI [DOI 10.1145/2594473.2594475, 10.1145/2594473.2594475]; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Bernardes AT, 2002, EUR PHYS J B, V25, P123, DOI 10.1140/e10051-002-0013-y; Borghesi C, 2010, EUR PHYS J B, V75, P395, DOI 10.1140/epjb/e2010-00151-1; Borghesi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036289; Bouchaud JP, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/03/P03010; Brooks RJ, 2000, INT J PROD RES, V38, P1009, DOI 10.1080/002075400188997; Burrell J, 2015, MACHINE THINKS UNDER; Centola D, 2007, J CONFLICT RESOLUT, V51, P905, DOI 10.1177/0022002707307632; Chwif L, 2006, SIMUL MODEL PRACT TH, V14, P930, DOI 10.1016/j.simpat.2006.05.001; Cutland N.J., 1980, COMPUTABILITY INTRO; Danos V, 2010, IEEE S LOG, P362, DOI 10.1109/LICS.2010.44; Edmonds B, 2014, COMPLEX MODEL VOTER; Edmonds B., 2004, P 3 INT JOINT C AUT, P938; Edmonds B, 2013, FOUND SCI, V18, P745, DOI 10.1007/s10699-012-9303-x; Fernandez-Gracia J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.158701; Feyerabend P., 1993, METHOD; Fowler J.H., 2005, SOCIAL LOGIC POLITIC, P296; Galan JM, 2009, JASSS-J ARTIF SOC S, V12; Gonzalez MC, 2004, INT J MOD PHYS C, V15, P45, DOI 10.1142/S0129183104005577; Hempei CG, 1965, ASPECTS SCI EXPLANAT; Ibrahim Y, 2004, P 2 INT C EUR SOC SC; Ibrahim YM., 2005, AUTOMATED ABSTRACTIO; INNIS G, 1983, SIMULATION, V41, P7, DOI 10.1177/003754978304100101; Loughran T, 2015, VOTER MODEL LONG DES; Rolfe M, 2012, VOTER TURNOUT: A SOCIAL THEORY OF POLITICAL PARTICIPATION, P1, DOI 10.1017/CBO9781139058513; Thomas P, 2008, UKSIM INT CONF COMP, P679, DOI 10.1109/UKSIM.2008.73; Watts D.J., 1999, SMALL WORLDS DYNAMIC	28	10	11	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157261	10.1371/journal.pone.0157261	http://dx.doi.org/10.1371/journal.pone.0157261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362836	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000378865200012
J	Petrezselyova, S; Lopez-Malo, M; Canadell, D; Roque, A; Serra-Cardona, A; Marques, MC; Vilaprinyo, E; Alves, R; Yenush, L; Arino, J				Petrezselyova, Silvia; Lopez-Malo, Maria; Canadell, David; Roque, Alicia; Serra-Cardona, Albert; Carmen Marques, M.; Vilaprinyo, Ester; Alves, Rui; Yenush, Lynne; Arino, Joaquin			Regulation of the Na+/K+-ATPase Ena1 Expression by Calcineurin/Crz1 under High pH Stress: A Quantitative Study	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; PHOSPHATE TRANSPORTER; NUCLEAR-LOCALIZATION; PROTEIN PHOSPHATASE; ALKALINE STRESS; YEAST; SODIUM; PATHWAY	Regulated expression of the Ena1 Na+-ATPase is a crucial event for adaptation to high salt and/or alkaline pH stress in the budding yeast Saccharomyces cerevisiae. ENA1 expression is under the control of diverse signaling pathways, including that mediated by the calcium-regulatable protein phosphatase calcineurin and its downstream transcription factor Crz1. We present here a quantitative study of the expression of Ena1 in response to alkalinization of the environment and we analyze the contribution of Crz1 to this response. Experimental data and mathematical models substantiate the existence of two stress-responsive Crz1-binding sites in the ENA1 promoter and estimate that the contribution of Crz1 to the early response of the ENA1 promoter is about 60%. The models suggest the existence of a second input with similar kinetics, which would be likely mediated by high pH-induced activation of the Snf1 kinase.	[Petrezselyova, Silvia; Lopez-Malo, Maria; Canadell, David; Serra-Cardona, Albert; Arino, Joaquin] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Petrezselyova, Silvia; Lopez-Malo, Maria; Canadell, David; Roque, Alicia; Serra-Cardona, Albert; Arino, Joaquin] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona 08193, Spain; [Carmen Marques, M.; Yenush, Lynne] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, E-46022 Valencia, Spain; [Vilaprinyo, Ester; Alves, Rui] Univ Lleida, IRB Lleida, Lleida 25198, Spain; [Vilaprinyo, Ester; Alves, Rui] Univ Lleida, Lleida 25198, Spain; [Petrezselyova, Silvia] ASCR, Inst Mol Genet, Vvi, Transgen Models Dis & Transgen Unit,BIOCEV, Prumyslova 595, CZ-25242 Vestec, Czech Republic; [Canadell, David] Univ Pompeu Fabra, Cell Signaling Unit, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universitat de Lleida; Universitat de Lleida; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Pompeu Fabra University	Arino, J (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.; Arino, J (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona 08193, Spain.	Joaquin.Arino@uab.es	Petrezselyova, Silvia/AAI-4044-2020; Petrezselyova, Silvia/G-6324-2014; Vilaprinyo, Ester/A-6702-2010; Alves, Rui/C-5920-2009; Yenush, Lynne/J-8815-2014; Marqués, Maricarmen/AAC-8432-2019; Canadell, David/ABE-9698-2021; Córdova, Alicia Roque/W-5229-2019; López Malo, Maria/C-2789-2017; Arino, Joaquin/D-3756-2011	Petrezselyova, Silvia/0000-0003-3054-540X; Vilaprinyo, Ester/0000-0002-5787-5890; Alves, Rui/0000-0002-8112-5184; Yenush, Lynne/0000-0001-8589-7002; Marqués, Maricarmen/0000-0001-8392-453X; Canadell, David/0000-0003-0682-2980; Córdova, Alicia Roque/0000-0002-6206-6481; López Malo, Maria/0000-0002-8612-2118; Arino, Joaquin/0000-0002-6774-2987; Serra-Cardona, Albert/0000-0003-0282-7311; Arino Carmona, Joaquin/0000-0002-0390-4270	Fondo Europeo de Desarrollo Regional [FEDER]; Ajut SGR-4 award (Generalitat de Catalunya); Spanish Ministry of Education; SysMo2 [EUI2009-04147]; Ministry of Industry and Competitivity, Spain;  [BFU2011-30197-C3-01];  [BFU2014-54591-C2-1-P]	Fondo Europeo de Desarrollo Regional [FEDER](European Commission); Ajut SGR-4 award (Generalitat de Catalunya)(Generalitat de Catalunya); Spanish Ministry of Education(Spanish Government); SysMo2; Ministry of Industry and Competitivity, Spain; ; 	This work was supported by grants BFU2011-30197-C3-01, BFU2014-54591-C2-1-P and EUI2009-04147 (SysMo2) to JA. (Ministry of Industry and Competitivity, Spain, and Fondo Europeo de Desarrollo Regional [FEDER]). JA is the recipient of an Ajut 2014SGR-4 award (Generalitat de Catalunya). DC was recipient of a predoctoral fellowship from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; Alves R, 2008, BIOTECHNOL GENET ENG, P251; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Berkey CD, 2004, EUKARYOT CELL, V3, P311, DOI 10.1128/EC.3.2.311-317.2004; Bodvard K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053404; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Brachmann CB, 1998, YEAST, V14, P115; Bush A, 2012, USING CELL ID 1 4 R; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Canadell D, 2015, BBA-GENE REGUL MECH, V1849, P653, DOI 10.1016/j.bbagrm.2015.04.001; Marques MC, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov017; Comas J, 2016, PLANT J IN PRESS; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Deneke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055442; Farre G, 2013, PLANT J, V75, P441, DOI 10.1111/tpj.12214; Finn EM, 2013, BBA-MOL CELL RES, V1833, P1096, DOI 10.1016/j.bbamcr.2012.12.020; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; GARCIADEBLAS B, 1993, MOL GEN GENET, V236, P363, DOI 10.1007/BF00277134; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Lee Y, 2011, MATH BIOSCI, V231, P49, DOI 10.1016/j.mbs.2011.03.001; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marquez JA, 1996, FEBS LETT, V382, P89, DOI 10.1016/0014-5793(96)00157-3; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; Mendizabal I, 2001, MOL GENET GENOMICS, V265, P801, DOI 10.1007/s004380100474; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Palumbo MC, 2015, WIRES RNA, V6, P327, DOI 10.1002/wrna.1277; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Polizotto RS, 2001, J CELL BIOL, V154, P951, DOI 10.1083/jcb.200104078; Ramos J, 2011, FEMS MICROBIOL LETT, V317, P1, DOI 10.1111/j.1574-6968.2011.02214.x; Reynolds A., 1997, CURRENT PROTOCOLS MO; Ruiz A, 2003, EUKARYOT CELL, V2, P937, DOI 10.1128/EC.2.5.937-948.2003; Ruiz A, 2008, J BIOL CHEM, V283, P13923, DOI 10.1074/jbc.M708683200; Ruiz A, 2007, EUKARYOT CELL, V6, P2175, DOI 10.1128/EC.00337-07; Rybakova KN, 2015, NUCLEIC ACIDS RES, V43, P153, DOI 10.1093/nar/gku1272; Salvado B, 2011, MATH BIOSCI, V231, P3, DOI 10.1016/j.mbs.2011.02.005; Savageau M., 2010, BIOCH SYSTEMS ANAL S; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serra-Cardona A, 2015, MICROB CELL, V2, P182, DOI 10.15698/mic2015.06.205; Serra-Cardona A, 2014, MOL CELL BIOL, V34, P4420, DOI 10.1128/MCB.01089-14; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Vilaprinyo E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-184; Vilaprinyo E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000674; Voit E. O., 2000, COMPUTATIONAL ANAL B; Voit EO, 2012, 1 COURSE SYSTEMS BIO, DOI DOI 10.4324/9780203702260; Vyas VK, 2005, EUKARYOT CELL, V4, P1882, DOI 10.1128/EC.4.11.1882-1891.2005; Wadskog I, 2006, MOL BIOL CELL, V17, P4988, DOI 10.1091/mbc.E05-08-0798; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244; Wang MC, 2015, PROTEOMICS, V15, P3163, DOI 10.1002/pmic.201400441; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WIELAND J, 1995, EMBO J, V14, P3870, DOI 10.1002/j.1460-2075.1995.tb00059.x; Xie ZR, 2007, BIOCHEM BIOPH RES CO, V358, P722, DOI 10.1016/j.bbrc.2007.04.207; Ye T, 2008, MICROBIOL-SGM, V154, P2814, DOI 10.1099/mic.0.2008/020149-0; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zvyagilskaya RA, 2008, FEMS YEAST RES, V8, P685, DOI 10.1111/j.1567-1364.2008.00408.x	67	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158424	10.1371/journal.pone.0158424	http://dx.doi.org/10.1371/journal.pone.0158424			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362362	Green Published, gold			2022-12-27	WOS:000378865200072
J	Robinson, DP; Jaidah, MY; Bach, S; Lee, K; Jabado, RW; Rohner, CA; March, A; Caprodossi, S; Henderson, AC; Mair, JM; Ormond, R; Pierce, SJ				Robinson, David P.; Jaidah, Mohammed Y.; Bach, Steffen; Lee, Katie; Jabado, Rima W.; Rohner, Christoph A.; March, Abi; Caprodossi, Simone; Henderson, Aaron C.; Mair, James M.; Ormond, Rupert; Pierce, Simon J.			Population Structure, Abundance and Movement of Whale Sharks in the Arabian Gulf and the Gulf of Oman	PLOS ONE			English	Article							RHINCODON-TYPUS; NINGALOO REEF; OF-CALIFORNIA; SIZE; IDENTIFICATION; CONSERVATION; AGGREGATIONS; RESIDENCY; FISHERIES; BIOLOGY	Data on the occurrence of whale sharks, Rhincodon typus, in the Arabian Gulf and Gulf of Oman were collected by dedicated boat surveys and via a public-sightings scheme during the period from 2011 to 2014. A total of 422 individual whale sharks were photo-identified from the Arabian Gulf and the northern Gulf of Oman during that period. The majority of sharks (81%, n = 341) were encountered at the Al Shaheen area of Qatar, 90 km off the coast, with the Musandam region of Oman a secondary area of interest. At Al Shaheen, there were significantly more male sharks (n = 171) than females (n = 78; X2 = 17.52, P < 0.05). Mean estimated total length (TL) for sharks was 6.90 m +/- 1.24 (median = 7 m; n = 296). Males (7.25 m +/- 1.34; median = 8 m, n = 171) were larger than females (6.44 m +/- 1.09; median = 7 m, n = 78; Mann-Whitney U test, p < 0.01). Of the male sharks assessed for maturity 63% were mature (n = 81), with 50% attaining maturity by 7.29 m and 100% by 9.00 m. Two female sharks of > 9 m individuals were visually assessed as pregnant. Connectivity among sharks sighted in Qatari, Omani and UAE waters was confirmed by individual spot pattern matches. A total of 13 identified sharks were re-sighted at locations other than that at which they were first sighted, including movements into and out of the Arabian Gulf through the Strait of Hormuz. Maximum likelihood techniques were used to model an estimated combined population for the Arabian Gulf and Gulf of Oman of 2837 sharks +/- 1243.91 S.E. (95% C. I. 1720-6295). The Al Shaheen aggregation is thus the first site described as being dominated by mature males while the free-swimming pregnant females are the first reported from the Indian Ocean.	[Robinson, David P.; Mair, James M.; Ormond, Rupert] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Jaidah, Mohammed Y.] Qatar Minist Environm, Doha, Qatar; [Bach, Steffen] Maersk Oil Res & Technol Ctr, Doha, Qatar; [Lee, Katie; March, Abi] Univ York, Dept Environm, York, N Yorkshire, England; [Jabado, Rima W.] Gulf Elasmo Project, Dubai, U Arab Emirates; [Rohner, Christoph A.; Pierce, Simon J.] Marine Megafauna Fdn, Truckee, CA USA; [Robinson, David P.; Caprodossi, Simone] Sharkwatch Arabia, Dubai, U Arab Emirates; [Henderson, Aaron C.] Sch Field Studies, Santiago, Chile; [Ormond, Rupert] Marine Conservat Int, Edinburgh, Midlothian, Scotland	Heriot Watt University; University of York - UK	Robinson, DP (corresponding author), Heriot Watt Univ, Edinburgh, Midlothian, Scotland.; Robinson, DP (corresponding author), Sharkwatch Arabia, Dubai, U Arab Emirates.	sharkwatcharabia@gmail.com	Pierce, Simon J./A-7621-2010	Pierce, Simon J./0000-0002-9375-5175; Jabado, Rima/0000-0001-6239-6723; Rohner, Christoph/0000-0001-8760-8972; Henderson, Aaron/0000-0001-8873-0785	MORTC; Save Our Seas Foundation; Shark Foundation	MORTC; Save Our Seas Foundation; Shark Foundation	Logistics for this project were provided by the Qatar Ministry of Environment (QMOE) and Maersk Oil Research and Technology Centre (MORTC). SB acted as an independent researcher throughout this study with financial support in the form of a salary from the MORTC. The MORTC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DPR's work on this manuscript was supported by two small grants from the Save Our Seas Foundation. SJP's work on this manuscript was supported by the Shark Foundation and private donors. The journal publication fees for this manuscript were provided by the MORTC. All other funders, apart from collaborators from the QMOE, had no role in the preparation or decision to publish the manuscript.	Acuna-Marrero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115946; Afonso P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102060; Alava MN, 1997, 13 AM EL SOC AES ANN, V26; Alava MNR, 2002, ELASMOBRANCH BIODIVE, P132; Anderson R.C., 1993, SHARK FISHERIES MALD; Araujo G, 2014, PEERJ, V2, DOI 10.7717/peerj.543; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Beech MJ, 2005, EMIRATES NATURAL HIS; Berumen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103536; BISHOP JM, 1993, J FISH BIOL, V43, P939, DOI 10.1006/jfbi.1993.1197; Blegvad H, 1944, DANISH SCI INVESTI 3; Brooks Katie, 2010, Western Indian Ocean Journal of Marine Science, V9, P185; Brown B., 1992, Tribulus, V2, P22; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Compagno V LJ, 2001, SHARKS WORLD ANNOTAT, V2, P186; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Duffy CAJ, 2002, NEW ZEAL J MAR FRESH, V36, P565, DOI 10.1080/00288330.2002.9517112; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Fox S, 2013, J FISH BIOL, V83, P574, DOI 10.1111/jfb.12195; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Hanfee F, 2001, GENTLE GIANTS SEA IN; Hearn A.R., 2013, ANIM BIOTELEMETRY, V1, P1, DOI [10.1186/2050-3385-1-11, DOI 10.1186/2050-3385-1-11]; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Holmberg Jason, 2009, Endangered Species Research, V7, P39, DOI 10.3354/esr00186; Hsu HH, 2012, J FISH BIOL, V80, P1595, DOI 10.1111/j.1095-8649.2012.03234.x; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Li W, 2012, J FISH BIOL, V80, P1608, DOI 10.1111/j.1095-8649.2012.03250.x; MacLeod C., 2013, INTRO USING GIS MARI; Mahdi N, 1971, ADDITIONS MARINE FIS, V28; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Norman B, 2005, IUCN 2012 IUCN RED L; Norman BM, 2004, 2127 DEP ENV HER COA; Norman BM, 2007, FISH RES, V84, P81, DOI 10.1016/j.fishres.2006.11.015; Pierce SJ, 2010, AQUAT CONSERV, V20, P782, DOI 10.1002/aqc.1149; RAMACHANDRAN A, 1990, Fishery Technology, V27, P138; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Ramirez-Macias D, 2007, FISH RES, V84, P87, DOI 10.1016/j.fishres.2006.11.038; Ramirez-Macias Deni, 2012, Endangered Species Research, V18, P115, DOI 10.3354/esr00437; Reynolds RM, 1993, MARINE POLLUTION B, V27, P1; Riley MJ, 2010, AQUAT BIOL, V8, P145, DOI 10.3354/ab00215; Robinson DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058255; Rohner C, 2013, MARINE ECOLOGY PROGR, V493, P1; Rohner CA, 2011, J FISH BIOL, V78, P378, DOI 10.1111/j.1095-8649.2010.02861.x; Rohner CA, 2015, PEERJ, V3, DOI 10.7717/peerj.886; Rohner CA, 2015, J PLANKTON RES, V37, P352, DOI 10.1093/plankt/fbv010; Rowat D, 2008, ENVIRON BIOL FISH, V82, P215, DOI 10.1007/s10641-007-9280-z; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2007, ENVIRON BIOL FISH, V80, P465, DOI 10.1007/s10641-006-9148-7; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; ROWAT D, 1997, PHELSUMA NATURE PROT, V5, P77; Rowat D, 2011, MAR FRESHWATER RES, V62, P621, DOI 10.1071/MF10135; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; TAYLOR G, 1989, Western Australian Naturalist, V18, P7; Taylor JG, 2007, FISH RES, V84, P65, DOI 10.1016/j.fishres.2006.11.014; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Trono R., 1996, IUCN NEWSLETTER SHAR, V7, P13; Tyminski JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142156; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Vignaud TM, 2014, MOL ECOL, V23, P2590, DOI 10.1111/mec.12754; White A.W., 1971, COMMON SEA FISHES AR; White AE, 1971, SURVEY TRUCIAL STATE, V1; Whitehead H, 2001, ECOLOGY, V82, P1417, DOI 10.1890/0012-9658(2001)082[1417:AOAMUO]2.0.CO;2; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wilson S., 2002, STATUS CORAL REEFS W, P53; Wimmer T, 2004, CAN J ZOOL, V82, P1782, DOI 10.1139/Z04-168	68	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158593	10.1371/journal.pone.0158593	http://dx.doi.org/10.1371/journal.pone.0158593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362839	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200100
J	Oh, BL; Lee, EJ; Kim, H; Girard, MJA; Mari, JM; Kim, TW				Oh, Baek-Lok; Lee, Eun Ji; Kim, Hyunjoong; Girard, Michael J. A.; Mari, Jean Martial; Kim, Tae-Woo			Anterior Lamina Cribrosa Surface Depth in Open-Angle Glaucoma: Relationship with the Position of the Central Retinal Vessel Trunk	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE ELEVATION; AGE-RELATED-CHANGES; NERVE HEAD; EXTRACELLULAR-MATRIX; DISPLACEMENT; DEFORMATION; ENHANCEMENT; COMPONENTS; LOCATION	Purpose To determine the factors influencing the anterior lamina cribrosa (LC) surface depth (LCD) in patients with open-angle glaucoma (OAG), focusing on the association between LCD and the position of the central retinal vessel trunk (CRVT) at the anterior LC surface. Methods Optic nerve heads of 205 OAG eyes were scanned using swept-source optical coherence tomography (SS-OCT). After processing the images using adaptive compensation, the LCD was determined from 11 horizontal B-scan images that divided the optic disc vertically into 12 equal parts. Eyes were divided into two groups (central or peripheral) according to where the CRVT exits from the anterior LC surface. The influence of CRVT position on LCD was evaluated, taking into account age, gender, untreated intraocular pressure (IOP), IOP at optic-disc scanning, retinal nerve fiber layer (RNFL) thickness, visual-field mean deviation, central corneal thickness, and axial length. Results Patients in the peripheral CRVT group were younger and more myopic, and had a larger mean LCD and thinner global RNFL than those in the central CRVT group (all P <= 0.023). On multivariate analysis, the peripheral CRVT location was significantly associated with a larger LCD (P = 0.002), together with the significant association of younger age (P < 0.001), higher untreated IOP (P = 0.010), and thinner RNFL (P = 0.003) on the larger LCD. Conclusion In OAG, CRVT location was an independent factor influencing the LCD, together with age, untreated IOP, and global RNFL thickness. The data indicate that the CRVT may contribute to the resistance of the LC against deformation. A longitudinal prospective observation is required to clarify this relationship.	[Oh, Baek-Lok; Lee, Eun Ji; Kim, Tae-Woo] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Kim, Hyunjoong] Yonsei Univ, Dept Appl Stat, Seoul, South Korea; [Girard, Michael J. A.] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Girard, Michael J. A.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Mari, Jean Martial] Univ Polynesie Francaise, GePaSud, Faaa, France	Seoul National University (SNU); Yonsei University; National University of Singapore; National University of Singapore; Singapore National Eye Center	Lee, EJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.	opticdisc@gmail.com	Girard, Michael/F-9323-2015	Girard, Michael/0000-0003-4408-5918; Kim, Tae-Woo/0000-0002-5180-0978	National Research Foundation of Korea Grant - Korean Government [2013R1A1A1A05004781]; Seoul National University Bundang Hospital Research Fund [02-2013-036]; Basic Science Research program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2012R1A1A2042177]	National Research Foundation of Korea Grant - Korean Government; Seoul National University Bundang Hospital Research Fund; Basic Science Research program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by National Research Foundation of Korea Grant funded by Korean Government (2013R1A1A1A05004781), the Seoul National University Bundang Hospital Research Fund (02-2013-036), and by Basic Science Research program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2012R1A1A2042177). The funding organizations had no role in the design or conduct of this research.	Albon J, 2000, BRIT J OPHTHALMOL, V84, P311, DOI 10.1136/bjo.84.3.311; Albon J, 2000, BRIT J OPHTHALMOL, V84, P318, DOI 10.1136/bjo.84.3.318; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; EMERY JM, 1974, T AM ACAD OPHTHALMOL, V78, pO290; GAASTERLAND D, 1978, INVEST OPHTH VIS SCI, V17, P838; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; HERNANDEZ MR, 1989, AM J OPHTHALMOL, V107, P476, DOI 10.1016/0002-9394(89)90491-1; Huang HL, 2013, BRIT J OPHTHALMOL, V97, P96, DOI 10.1136/bjophthalmol-2012-302068; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P99, DOI 10.1136/bjo.78.2.99; Jonas JB, 2001, OPHTHALMOLOGY, V108, P1059, DOI 10.1016/S0161-6420(01)00571-1; Kim TW, 2013, CURR EYE RES, V38, P903, DOI 10.3109/02713683.2013.800888; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; LEVY NS, 1984, ARCH OPHTHALMOL-CHIC, V102, P782; Loh WY, 2002, STAT SINICA, V12, P361; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Miki A, 2013, CLIN OPHTHALMOL, V7, P1995, DOI 10.2147/OPTH.S50120; MORRISON JC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1220, DOI 10.1001/archopht.1989.01070020286040; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2159; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Rho CR, 2012, CLIN EXP OPHTHALMOL, V40, pE183, DOI 10.1111/j.1442-9071.2011.02669.x; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Takayama K, 2013, INVEST OPHTH VIS SCI, V54, P4798, DOI 10.1167/iovs.13-11677; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; WILCZEK M, 1947, BRIT J OPHTHALMOL, V31, P551, DOI 10.1136/bjo.31.9.551; YAN DB, 1994, BRIT J OPHTHALMOL, V78, P643, DOI 10.1136/bjo.78.8.643; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yoshikawa M, 2014, INVEST OPHTH VIS SCI, V55, P477, DOI 10.1167/iovs.13-11897	37	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158443	10.1371/journal.pone.0158443	http://dx.doi.org/10.1371/journal.pone.0158443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355646	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400067
J	Renoux, C; Romana, M; Joly, P; Ferdinand, S; Faes, C; Lemonne, N; Skinner, S; Garnier, N; Etienne-Julan, M; Bertrand, Y; Petras, M; Cannas, G; Divialle-Doumdo, L; Nader, E; Cuzzubbo, D; Lamarre, Y; Gauthier, A; Waltz, X; Kebaili, K; Martin, C; Hot, A; Hardy-Dessources, MD; Pialoux, V; Connes, P				Renoux, Celine; Romana, Marc; Joly, Philippe; Ferdinand, Severine; Faes, Camille; Lemonne, Nathalie; Skinner, Sarah; Garnier, Nathalie; Etienne-Julan, Maryse; Bertrand, Yves; Petras, Marie; Cannas, Giovanna; Divialle-Doumdo, Lydia; Nader, Elie; Cuzzubbo, Daniela; Lamarre, Yann; Gauthier, Alexandra; Waltz, Xavier; Kebaili, Kamila; Martin, Cyril; Hot, Arnaud; Hardy-Dessources, Marie-Dominique; Pialoux, Vincent; Connes, Philippe			Effect of Age on Blood Rheology in Sickle Cell Anaemia and Sickle Cell Haemoglobin C Disease: A Cross-Sectional Study	PLOS ONE			English	Article							OXIDATIVE STRESS; VISCOSITY; CHILDREN; HYDROXYUREA; FREQUENCY; CRISES; AGGREGATION; THALASSEMIA; ADHESION; BALANCE	Objectives Blood rheology plays a key role in the pathophysiology of sickle cell anaemia (SS) and sickle cell haemoglobin C disease (SC), but its evolution over the lifespan is unknown. Materials and Methods Blood viscosity, red blood cell (RBC) deformability and aggregation, foetal haemoglobin (HbF) and haematocrit were measured in 114 healthy individuals (AA), 267 SS (161 children + 106 adults) and 138 SC (74 children + 64 adults) patients. Results Our results showed that 1) RBC deformability is at its maximal value during the early years of life in SS and SC populations, mainly because HbF level is also at its peak, 2) during childhood and adulthood, hydroxycarbamide treatment, HbF level and gender modulated RBC deformability in SS patients, independently of age, 3) blood viscosity is higher in older SS and SC patients compared to younger ones and 4) haematocrit decreases as SS patients age. Conclusion The hemorheological changes detected in older patients could play a role in the progressive development of several chronic disorders in sickle cell disease, whose prevalence increases with age. Retarding these age-related haemorheological impairments, by using suitable drugs, may minimize the risks of vaso-occlusive events and chronic disorders.	[Renoux, Celine; Joly, Philippe] Hosp Civils Lyon, Unite Pathol Mol Globule Rouge, Lab Biochim & Biol Mol, Hop Edouard Herriot, Lyon, France; [Renoux, Celine; Joly, Philippe; Faes, Camille; Skinner, Sarah; Nader, Elie; Martin, Cyril; Pialoux, Vincent; Connes, Philippe] Univ Lyon 1, Lab Interuniv Biol Motricite, Equipe Vasc Biol & Red Blood Cell, Lyon, France; [Romana, Marc; Ferdinand, Severine; Lamarre, Yann; Waltz, Xavier; Hardy-Dessources, Marie-Dominique; Connes, Philippe] Univ Antilles Guyane, Hop Pointe A Pitre, UMR Inserm U1134, Hop Ricou, Pointe A Pitre 97159, Guadeloupe, France; [Lemonne, Nathalie; Etienne-Julan, Maryse; Petras, Marie; Divialle-Doumdo, Lydia] Hop Ricou, Hop Pointe A Pitre, Unite Transversale Drepanocytose, Pointe A Pitre 97159, Guadeloupe, France; [Garnier, Nathalie; Bertrand, Yves; Cuzzubbo, Daniela; Gauthier, Alexandra; Kebaili, Kamila] Hosp Civils Lyon, Inst Hematol & Oncol Pediat, Lyon, France; [Cannas, Giovanna; Hot, Arnaud] Hosp Civils Lyon, Hop Edouard Herriot, Serv Med Interne, Lyon, France; [Renoux, Celine; Romana, Marc; Joly, Philippe; Ferdinand, Severine; Faes, Camille; Skinner, Sarah; Nader, Elie; Lamarre, Yann; Waltz, Xavier; Martin, Cyril; Hardy-Dessources, Marie-Dominique; Pialoux, Vincent; Connes, Philippe] PRES Sorbonne, Lab Excellence Globule Rouge LABEX GR Ex, Paris, France; [Connes, Philippe] Inst Univ France, Paris, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; CHU Guadeloupe; CHU Lyon; CHU Lyon; Institut Universitaire de France	Connes, P (corresponding author), Univ Lyon 1, Lab Interuniv Biol Motricite, Equipe Vasc Biol & Red Blood Cell, Lyon, France.; Connes, P (corresponding author), Univ Antilles Guyane, Hop Pointe A Pitre, UMR Inserm U1134, Hop Ricou, Pointe A Pitre 97159, Guadeloupe, France.; Connes, P (corresponding author), PRES Sorbonne, Lab Excellence Globule Rouge LABEX GR Ex, Paris, France.; Connes, P (corresponding author), Inst Univ France, Paris, France.	philippe.connes@univ-lyon1.fr	Nader, Elie/AAL-3767-2020; , Hardy-dessources/K-9189-2017; Romana, Marc/K-6442-2017; WALTZ, Xavier/M-3606-2016; MARTIN, Cyril/HGB-8079-2022; Connes, Philippe/J-7835-2019; Lamarre, Yann/ABC-2074-2020; RENOUX, Céline/AAL-3556-2020	, Hardy-dessources/0000-0003-0861-3648; Romana, Marc/0000-0002-8715-9836; WALTZ, Xavier/0000-0002-0838-290X; Connes, Philippe/0000-0002-9232-0268; Nader, Elie/0000-0002-6054-2456; ETIENNE-JULAN, Maryse/0000-0003-1339-6545; FERDINAND, Severine/0000-0001-8258-5089; RENOUX, Celine/0000-0002-7263-805X; MARTIN, Cyril/0000-0003-3378-5249				Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt O, 2008, MICROCIRCULATION, V15, P585, DOI 10.1080/10739680802107447; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charlot K, 2016, BLOOD CELL MOL DIS, V56, P41, DOI 10.1016/j.bcmd.2015.10.005; Chirico EN, 2012, IUBMB LIFE, V64, P72, DOI 10.1002/iub.584; Cita KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154866; Colin Y, 2014, CURR OPIN HEMATOL, V21, P186, DOI 10.1097/MOH.0000000000000036; Connes P, 2015, BLOOD REV; Connes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079680; Ferrone FA, 2015, AM J HEMATOL, V90, P438, DOI 10.1002/ajh.23958; Gurses D, 2014, IRAN J PEDIATR, V24, P166; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Lamarre Y, 2014, CLIN HEMORHEOL MICRO, V57, P63, DOI 10.3233/CH-131772; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; Lemonne N, 2015, HAEMATOLOGICA, V100, pE383, DOI 10.3324/haematol.2015.130435; Lemonne N, 2014, HAEMATOLOGICA, V99, pE74, DOI 10.3324/haematol.2014.104745; MACKINTOSH TF, 1973, ARCH DIS CHILD, V48, P547, DOI 10.1136/adc.48.7.547; MORRIS J, 1991, BRIT J HAEMATOL, V77, P382, DOI 10.1111/j.1365-2141.1991.tb08588.x; Nebor D, 2011, HAEMATOL-HEMATOL J, V96, P1589, DOI 10.3324/haematol.2011.047365; Noubouossie D, 2015, BLOOD REV; Renoux C, 2015, CLIN HEMORHEOL MICRO; Serjeant G R, 1995, Curr Opin Hematol, V2, P103; SERJEANT GR, 1981, BRIT J HAEMATOL, V48, P533, DOI 10.1111/j.1365-2141.1981.tb02750.x; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Simmonds MJ, 2014, BIORHEOLOGY, V51, P121, DOI 10.3233/BIR-140653; STEINBERG MH, 1995, AM J HEMATOL, V48, P175, DOI 10.1002/ajh.2830480307; STEVENS MCG, 1985, BRIT J HAEMATOL, V60, P279, DOI 10.1111/j.1365-2141.1985.tb07414.x; Tancer-Elci H, 2015, CLIN HEMORHEOL MICRO, V60, P273, DOI 10.3233/CH-131740; Tarer V, 2006, EUR J HAEMATOL, V76, P193, DOI 10.1111/j.1600-0609.2005.00590.x; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852	33	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158182	10.1371/journal.pone.0158182	http://dx.doi.org/10.1371/journal.pone.0158182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355589	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400036
J	Spicer, OS; Wong, TT; Zmora, N; Zohar, Y				Spicer, Olivia Smith; Wong, Ten-Tsao; Zmora, Nilli; Zohar, Yonathan			Targeted Mutagenesis of the Hypophysiotropic Gnrh3 in Zebrafish (Danio rerio) Reveals No Effects on Reproductive Performance	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; FOLLICLE-STIMULATING-HORMONE; MORONE-SAXATILIS; GENE DISRUPTION; STRIPED BASS; 3 FORMS; EXPRESSION; ONTOGENY; LH; COMPENSATION	Gnrh is the major neuropeptide regulator of vertebrate reproduction, triggering a cascade of events in the pituitary-gonadal axis that result in reproductive competence. Previous research in mice and humans has demonstrated that Gnrh/GNRH null mutations result in hypogonadotropic hypogonadism and infertility. The goal of this study was to eliminate gnrh3 (the hypophysiotropic Gnrh form) function in zebrafish (Danio rerio) to determine how ontogeny and reproductive performance are affected, as well as factors downstream of Gnrh3 along the reproductive axis. Using the TALEN technology, we developed a gnrh3(-/-) zebrafish line that harbors a 62 bp deletion in the gnrh3 gene. Our gnrh3(-/-) zebrafish line represents the first targeted and heritable mutation of a Gnrh isoform in any organism. Using immunohistochemistry, we verified that gnrh3(-/-) fish do not possess Gnrh3 peptide in any regions of the brain. However, other than changes in mRNA levels of pituitary gonadotropin genes (fshb, lhb, and cga) during early development, which are corrected by adulthood, there were no changes in ontogeny and reproduction in gnrh3(-/-) fish. The gnrh3(-/-) zebrafish are fertile, displaying normal gametogenesis and reproductive performance in males and females. Together with our previous results that Gnrh3 cell ablation causes infertility, these results indicate that a compensatory mechanism is being activated, which is probably primed early on upon Gnrh3 neuron differentiation and possibly confined to Gnrh3 neurons. Potential compensation factors and sensitive windows of time for compensation during development and puberty should be explored.	[Zohar, Yonathan] Univ Maryland Baltimore Cty, Dept Marine Biotechnol, Baltimore, MD 21228 USA; Univ Maryland Baltimore Cty, Inst Marine & Environm Technol, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University of Maryland Baltimore County	Zohar, Y (corresponding author), Univ Maryland Baltimore Cty, Dept Marine Biotechnol, Baltimore, MD 21228 USA.	zohar@umbc.edu	Wong, Ten-Tsao/J-7524-2017	Wong, Ten-Tsao/0000-0001-5573-9767	Homer and Martha Gudelsky Family Foundation, Inc.; Homer and Martha Gudelsky Family Foundation, Inc.	Homer and Martha Gudelsky Family Foundation, Inc.; Homer and Martha Gudelsky Family Foundation, Inc.	This work was supported by the Homer and Martha Gudelsky Family Foundation, Inc.	Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Abraham E, 2010, ENDOCRINOLOGY, V151, P332, DOI 10.1210/en.2009-0548; Aizen J, 2007, GEN COMP ENDOCR, V153, P323, DOI 10.1016/j.ygcen.2007.04.004; Aizen J, 2012, GEN COMP ENDOCR, V178, P28, DOI 10.1016/j.ygcen.2012.04.002; Alok D, 2000, MOL CELL ENDOCRINOL, V168, P65, DOI 10.1016/S0303-7207(00)00317-8; AMOSS M, 1971, BIOCHEM BIOPH RES CO, V44, P205, DOI 10.1016/S0006-291X(71)80179-1; Biran J, 2012, P NATL ACAD SCI USA, V109, P10269, DOI 10.1073/pnas.1119165109; Brent R, 1997, CURRENT PROTOCOLS MO, P11; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106; Cheng Z, 2013, NAT BIOTECHNOL, V31, P934, DOI 10.1038/nbt.2674; Chu LH, 2014, MOL ENDOCRINOL, V28, P1785, DOI 10.1210/me.2014-1061; COE IR, 1995, MOL CELL ENDOCRINOL, V115, P113, DOI 10.1016/0303-7207(95)03675-W; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Dungan HM, 2007, J NEUROSCI, V27, P12088, DOI 10.1523/JNEUROSCI.2748-07.2007; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gehlert DR, 2008, NEUROPEPTIDES, V42, P367, DOI 10.1016/j.npep.2007.10.005; Golan M, 2015, ENDOCRINOLOGY, V156, P4163, DOI 10.1210/en.2015-1150; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Guzman JM, 2009, COMP BIOCHEM PHYS A, V154, P37, DOI 10.1016/j.cbpa.2009.04.623; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hassin S, 2000, BIOL REPROD, V63, P1691, DOI 10.1095/biolreprod63.6.1691; Hassin S, 1999, BIOL REPROD, V61, P1608, DOI 10.1095/biolreprod61.6.1608; Hoskins LJ, 2008, HORM BEHAV, V54, P379, DOI 10.1016/j.yhbeh.2008.04.011; Katsuyama T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt638; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Liu Y, 2014, METHODS, V69, P58, DOI 10.1016/j.ymeth.2014.02.011; Marshall JC, 1990, RECENT PROG HORM RES, V47, P155; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; Mayer C, 2011, NAT NEUROSCI, V14, P704, DOI 10.1038/nn.2818; Mengen E, 2016, HORM RES PAEDIAT, V85, P107, DOI 10.1159/000441977; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mylonas CC, 2001, REV FISH BIOL FISHER, V10, P463; Nishiguchi R, 2012, FRONT ENDOCRINOL, P3; NOZAKI M, 1990, GEN COMP ENDOCR, V77, P358, DOI 10.1016/0016-6480(90)90225-B; Okubo K, 2001, GEN COMP ENDOCR, V124, P125, DOI 10.1006/gcen.2001.7698; Ottinger MA, 2002, SEMIN AVIAN EXOT PET, V11, P71, DOI 10.1053/saep.2002.122896; Palevitch O, 2007, CELL TISSUE RES, V327, P313, DOI 10.1007/s00441-006-0279-0; POWELL JFF, 1994, P NATL ACAD SCI USA, V91, P12081, DOI 10.1073/pnas.91.25.12081; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Soussi-Yanicostas N, 1998, J CELL SCI, V111, P2953; Steven C, 2003, GEN COMP ENDOCR, V133, P27, DOI 10.1016/S0016-6480(03)00144-8; Takahashi A, 2015, ENDOCR REV, V36, pFRI; Tang HP, 2015, ENDOCRINOLOGY, V156, P589, DOI 10.1210/en.2014-1204; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; WEISS IM, 1995, MOL CELL BIOL, V15, P2457; Wong TT, 2004, BIOL REPROD, V71, P1026, DOI 10.1095/biolreprod.104.028019; Xia W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03676; Yang JJ, 2012, ENDOCRINOLOGY, V153, P1498, DOI 10.1210/en.2011-1949; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600; Zhang ZW, 2015, ENDOCRINOLOGY, V156, P3747, DOI 10.1210/en.2015-1039; Zhang ZW, 2015, MOL ENDOCRINOL, V29, P76, DOI 10.1210/me.2014-1256; Zmora N, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097667; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	60	54	55	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158141	10.1371/journal.pone.0158141	http://dx.doi.org/10.1371/journal.pone.0158141			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355207	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400030
J	Wildeman, P; Bruggemann, H; Scholz, CFP; Leimbach, A; Soderquist, B				Wildeman, Peter; Brueggemann, Holger; Scholz, Christian F. P.; Leimbach, Andreas; Soderquist, Bo			Propionibacterium avidum as an Etiological Agent of Prosthetic Hip Joint Infection	PLOS ONE			English	Article							SURGICAL APPROACH; DIRECT ANTERIOR; MUSCLE DAMAGE; ARTHROPLASTY; ACNES; COMPLICATION; ANTIBIOTICS; INCISION; REVISION; ABSCESS	Propionibacterium acnes is well-established as a possible etiologic agent of prosthetic joint infections (PJIs). Other Propionibacterium spp. have occasionally been described as a cause of PJIs, but this has not previously been the case for P. avidum despite its capacity to form biofilm. We describe two patients with prosthetic hip joint infections caused by P. avidum. Both patients were primarily operated with an anteriorly curved skin incision close to the skin crease of the groin, and both were obese. Initial treatment was performed according to the DAIR procedure (debridement, antibiotics, and implant retention). In case 1, the outcome was successful, but in case 2, a loosening of the cup was present 18 months post debridement. The P. avidum isolate from case 1 and two isolates from case 2 (obtained 18 months apart) were selected for whole genome sequencing. The genome of P. avidum obtained from case 1 was approximately 60 kb larger than the genomes of the two isolates of case 2. These latter isolates were clonal with the exception of SNPs in the genome. All three strains possessed the gene cluster encoding exopolysaccharide synthesis. P. avidum has a pathogenic potential and the ability to cause clinically relevant infections, including abscess formation, in the presence of foreign bodies such as prosthetic joint components. Skin incision in close proximity to the groin or deep skin crease, such as the anteriorly curved skin incision approach, might pose a risk of PJIs by P. avidum, especially in obese patients.	[Wildeman, Peter] Univ Orebro, Fac Med & Hlth, Dept Orthoped, Orebro, Sweden; [Brueggemann, Holger; Scholz, Christian F. P.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Leimbach, Andreas] Univ Munster, Inst Hyg, Munster, Germany; [Soderquist, Bo] Univ Orebro, Fac Med & Hlth, Sch Med Sci, Orebro, Sweden	Orebro University; Aarhus University; University of Munster; Orebro University	Wildeman, P (corresponding author), Univ Orebro, Fac Med & Hlth, Dept Orthoped, Orebro, Sweden.	peter.wildeman@regionorebrolan.se	Scholz, Christian/F-4499-2012; Scholz, Christian Brink/H-4463-2019	Scholz, Christian/0000-0002-8894-1782; Scholz, Christian Brink/0000-0002-8894-1782; Wildeman, Peter/0000-0001-7840-8979; Leimbach, Andreas/0000-0001-9077-1041; Bruggemann, Holger/0000-0001-7433-0190; Soderquist, Bo/0000-0001-5939-2932	Foundation for Medical Research at Orebro University Hospital (Nyckelfonden); Region Orebro County [199021]; Research committee of Orebro University	Foundation for Medical Research at Orebro University Hospital (Nyckelfonden); Region Orebro County; Research committee of Orebro University	This work was supported by grants from the Foundation for Medical Research at Orebro University Hospital (Nyckelfonden) and the Research committee of Orebro University, Region Orebro County (Ref.199021). The funders had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	Alecci V, 2011, J ORTHOP TRAUMATOL, V12, P123, DOI 10.1007/s10195-011-0144-0; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bayston R, 2007, J ANTIMICROB CHEMOTH, V60, P1298, DOI 10.1093/jac/dkm408; Bergin PF, 2011, J BONE JOINT SURG AM, V93A, P1392, DOI 10.2106/JBJS.J.00557; Bertin KC, 2004, CLIN ORTHOP RELAT R, P248, DOI 10.1097/01.blo.0000150294.81825.8c; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chechik O, 2013, ARCH ORTHOP TRAUM SU, V133, P1595, DOI 10.1007/s00402-013-1828-0; Connolly KP, 2016, WORLD J ORTHOP, V7, P94, DOI 10.5312/wjo.v7.i2.94; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Janvier F, 2013, PATHOL BIOL, V61, P223, DOI 10.1016/j.patbio.2013.01.008; Khassebaf J, 2015, ANAEROBE, V32, P57, DOI 10.1016/j.anaerobe.2014.12.006; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Leunig M, 2013, CLIN ORTHOP RELAT R, V471, P2245, DOI 10.1007/s11999-013-2806-0; Lindgren V, 2012, ACTA ORTHOP, V83, P559, DOI 10.3109/17453674.2012.742394; Lutz MF, 2005, EUR J CLIN MICROBIOL, V24, P739, DOI 10.1007/s10096-005-0040-8; Mak TN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-640; Masonis JL, 2002, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000038476.05771.6c; MCGINLEY KJ, 1978, APPL ENVIRON MICROB, V35, P62, DOI 10.1128/AEM.35.1.62-66.1978; Million M, 2008, JOINT BONE SPINE, V75, P356, DOI 10.1016/j.jbspin.2007.06.012; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Muller M, 2011, ARCH ORTHOP TRAUM SU, V131, P179, DOI 10.1007/s00402-010-1117-0; Nystrom Lukas M, 2013, J Arthroplasty, V28, DOI 10.1016/j.arth.2012.03.004; Ordogh L, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00337-13; Panagea Stavroula, 2005, J Infect, V51, pe253, DOI 10.1016/j.jinf.2005.04.005; Paprosky W G, 1994, J Arthroplasty, V9, P33, DOI 10.1016/0883-5403(94)90135-X; Parvizi Javad, 2010, Orthopedics, V33, P659, DOI 10.3928/01477447-20100722-42; Perry AL, 2006, LETT APPL MICROBIOL, V42, P185, DOI 10.1111/j.1472-765X.2006.01866.x; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Petis S, 2015, CAN J SURG, V58, P128, DOI 10.1503/cjs.007214; Piper KE, 2009, J CLIN MICROBIOL, V47, P1878, DOI 10.1128/JCM.01686-08; Sendi P, 2012, CLIN MICROBIOL INFEC, V18, P1176, DOI 10.1111/1469-0691.12003; Stefansdottir A, 2009, ACTA ORTHOP, V80, P633, DOI 10.3109/17453670903316868; Tafin UF, 2012, ANTIMICROB AGENTS CH, V56, P1885, DOI 10.1128/AAC.05552-11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13; Tsukada Sachiyuki, 2015, Open Orthop J, V9, P157, DOI 10.2174/1874325001509010157; Vohra A, 1998, CLIN INFECT DIS, V26, P770, DOI 10.1086/517127; Wang B, 2013, DIAGN MICR INFEC DIS, V75, P37, DOI 10.1016/j.diagmicrobio.2012.09.014; WANG WLL, 1977, ANTIMICROB AGENTS CH, V11, P171, DOI 10.1128/AAC.11.1.171; WOO RYG, 1982, J BONE JOINT SURG AM, V64, P1295, DOI 10.2106/00004623-198264090-00004; Xu CB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068214, 10.1371/journal.pone.0068837]; Zeller V, 2007, J INFECTION, V55, P119, DOI 10.1016/j.jinf.2007.02.006; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 2012, FEMS IMMUNOL MED MIC, V65, P158, DOI 10.1111/j.1574-695X.2012.00938.x	47	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158164	10.1371/journal.pone.0158164	http://dx.doi.org/10.1371/journal.pone.0158164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355425	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400034
J	Pessina, F; Navarria, P; Cozzi, L; Ascolese, AM; Maggi, G; Riva, M; Masci, G; D'Agostino, G; Finocchiaro, G; Santoro, A; Bello, L; Scorsetti, M				Pessina, Federico; Navarria, Pierina; Cozzi, Luca; Ascolese, Anna Maria; Maggi, Giulia; Riva, Marco; Masci, Giovanna; D'Agostino, Giuseppe; Finocchiaro, Giovanna; Santoro, Armando; Bello, Lorenzo; Scorsetti, Marta			Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases	PLOS ONE			English	Article							CEREBRAL METASTASES; PROGNOSTIC-FACTORS; RADIOTHERAPY; CAVITY; MARGIN	Purpose The aim of this study was to evaluate the benefit of a combined treatment, surgery followed by adjuvant hypofractionated stereotactic radiosurgery (HSRS) on the tumor bed, in oligometastatic patients with single, large brain metastasis (BM). Methods and Materials Fom January 2011 to March 2015, 69 patients underwent complete surgical resection followed by HSRS with a total dose of 30Gy in 3 daily fractions. Clinical outcome was evaluated by neurological examination and MRI 2 months after radiotherapy and then every 3 months. Local progression was defined as radiographic increase of the enhancing abnormality in the irradiated volume, and brain distant progression as the presence of new brain metastases or leptomeningeal enhancement outside the irradiated volume. Surgical morbidity and radiation-therapy toxicity, local control (LC), brain distant progression (BDP), and overall survival (OS) were evaluated. Results The median preoperative volume and maximum diameter of BM was 18.5cm(3) (range 4.1-64.2cm(3)) and 3.6cm (range 2.1-5-4cm); the median CTV was 29.0cm(3) (range 4.1-203.1cm(3)) and median PTV was 55.2cm(3) (range 17.2-282.9cm(3)). The median follow-up time was 24 months (range 4-33 months). The 1-and 2-year LC in site of treatment was 100%; the median, 1-and 2-year BDP was 11.9 months, 19.6% and 33.0%; the median, 1- and 2-year OS was 24 months (range 4-33 months), 91.3% and 73.0%. No severe postoperative morbidity or radiation therapy toxicity occurred in our series. Conclusions Multimodal approach, surgery followed by HSRS, can be an effective treatment option for selected patients with single, large brain metastases from different solid tumors.	[Pessina, Federico; Riva, Marco; Bello, Lorenzo] Humanitas Canc Ctr & Res Hosp, Neurosurg Oncol Dept, Milan, Italy; [Navarria, Pierina; Cozzi, Luca; Ascolese, Anna Maria; Maggi, Giulia; D'Agostino, Giuseppe; Scorsetti, Marta] Humanitas Canc Ctr & Res Hosp, Radiotherapy & Radiosurg Dept, Milan, Italy; [Masci, Giovanna; Finocchiaro, Giovanna; Santoro, Armando] Humanitas Canc Ctr & Res Hosp, Dept Hematol & Oncol, Milan, Italy; [Cozzi, Luca; Scorsetti, Marta] Humanitas Univ, Dept Biomed Sci, Rozzano Milan, Italy	Humanitas University	Cozzi, L (corresponding author), Humanitas Canc Ctr & Res Hosp, Radiotherapy & Radiosurg Dept, Milan, Italy.; Cozzi, L (corresponding author), Humanitas Univ, Dept Biomed Sci, Rozzano Milan, Italy.	luca.cozzi@humanitas.it	Finocchiaro, Giovanna/AAB-7967-2020; Santoro, Armando/J-9594-2018; Pessina, Federico/HDN-3388-2022; Pessina, Federico/K-7198-2016; Navarria, Pierina/AAB-2595-2019; Scorsetti, Marta/AAB-7024-2019; Riva, Marco/AAC-1357-2019; Bello, Lorenzo/AAB-2884-2022; DAgostino, Giuseppe Roberto/HHS-5585-2022; cozzi, luca/GZL-4895-2022	Santoro, Armando/0000-0003-1709-9492; Pessina, Federico/0000-0002-8717-4999; Pessina, Federico/0000-0002-8717-4999; Navarria, Pierina/0000-0002-6913-1442; Riva, Marco/0000-0003-4643-6451; Bello, Lorenzo/0000-0001-6797-7105; cozzi, luca/0000-0001-7862-898X; D'AGOSTINO, GIUSEPPE ROBERTO/0000-0002-2884-0410; masci, giovanna/0000-0002-0928-1764; Finocchiaro, Giovanna/0000-0001-6663-1989; Scorsetti, Marta/0000-0003-0320-559X				Berghoff AS, 2013, NEURO-ONCOLOGY, V15, P1664, DOI 10.1093/neuonc/not112; Blonigen BJ, 2010, INT J RADIAT ONCOL, V77, P996, DOI 10.1016/j.ijrobp.2009.06.006; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Choi CYH, 2012, INT J RADIAT ONCOL, V84, P688, DOI 10.1016/j.ijrobp.2012.01.028; Choi CYH, 2012, INT J RADIAT ONCOL, V84, P336, DOI 10.1016/j.ijrobp.2011.12.009; Chow E, 2005, J PAIN SYMPTOM MANAG, V30, P18, DOI 10.1016/j.jpainsymman.2005.02.009; Eaton BR, 2015, J NEURO-ONCOL, V123, P103, DOI 10.1007/s11060-015-1767-4; Esposito M, 2015, PHYS MEDICA; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Jagannathan J, 2009, J NEUROSURG, V111, P431, DOI 10.3171/2008.11.JNS08818; Kamp MA, 2015, ACTA NEUROCHIR, V157, P905, DOI 10.1007/s00701-015-2405-9; Kelly PJ, 2012, INT J RADIAT ONCOL, V82, P95, DOI 10.1016/j.ijrobp.2010.10.043; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Lin XL, 2015, J CLIN ONCOL, V33, P3475, DOI 10.1200/JCO.2015.60.9503; Ling DC, 2015, NEUROSURGERY, V76, P150, DOI 10.1227/NEU.0000000000000584; Mathieu D, 2008, NEUROSURGERY, V62, P817, DOI 10.1227/01.neu.0000316899.55501.8b; Minniti G, 2013, INT J RADIAT ONCOL, V86, P623, DOI 10.1016/j.ijrobp.2013.03.037; Nieder C, 1997, INT J RADIAT ONCOL, V39, P25, DOI 10.1016/S0360-3016(97)00154-5; Patchell RA, 2003, CANCER TREAT REV, V29, P533, DOI 10.1016/S0305-7372(03)00105-1; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Patel AJ, 2015, J NEUROSURG, V122, P1132, DOI 10.3171/2014.9.JNS13939; Prabhu R, 2012, INT J RADIAT ONCOL, V83, P61; Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6; Sperduto PW, 2010, INT J RADIAT ONCOL, V77, P655, DOI 10.1016/j.ijrobp.2009.08.025; Steinmann D, 2012, J CANCER RES CLIN, V138, P1523, DOI 10.1007/s00432-012-1227-x; Vogelbaum MA, 2006, J NEUROSURG, V104, P907, DOI 10.3171/jns.2006.104.6.907; Wang CC, 2012, J NEURO-ONCOL, V106, P601, DOI 10.1007/s11060-011-0697-z; Yoo H, 2009, J NEUROSURG, V110, P730, DOI 10.3171/2008.8.JNS08448	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157869	10.1371/journal.pone.0157869	http://dx.doi.org/10.1371/journal.pone.0157869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348860	Green Published, gold, Green Submitted			2022-12-27	WOS:000378801200017
J	Markunas, CA; Wilcox, AJ; Xu, ZL; Joubert, BR; Harlid, S; Panduri, V; Haberg, SE; Nystad, W; London, SJ; Sandler, DP; Lie, RT; Wade, PA; Taylor, JA				Markunas, Christina A.; Wilcox, Allen J.; Xu, Zongli; Joubert, Bonnie R.; Harlid, Sophia; Panduri, Vijayalakshmi; Haberg, Siri E.; Nystad, Wenche; London, Stephanie J.; Sandler, Dale P.; Lie, Rolv T.; Wade, Paul A.; Taylor, Jack A.			Maternal Age at Delivery Is Associated with an Epigenetic Signature in Both Newborns and Adults	PLOS ONE			English	Article							DNA METHYLATION CHANGES; DEVELOPMENTAL ORIGINS; NORWEGIAN MOTHER; CHILD COHORT; PREGNANCY; EXPRESSION; SMOKING; RISK; PERSPECTIVE; POPULATION	Offspring of older mothers are at increased risk of adverse birth outcomes, childhood cancers, type 1 diabetes, and neurodevelopmental disorders. The underlying biologic mechanisms for most of these associations remain obscure. One possibility is that maternal aging may produce lasting changes in the epigenetic features of a child's DNA. To test this, we explored the association of mothers' age at pregnancy with methylation in her offspring, using blood samples from 890 Norwegian newborns and measuring DNA methylation at more than 450,000 CpG sites across the genome. We examined replication of a maternal-age finding in an independent group of 1062 Norwegian newborns, and then in 200 US middle-aged women. Older maternal age was significantly associated with reduced methylation at four adjacent CpGs near the 2nd exon of KLHL35 in newborns (p-values ranging from 3x10(-6) to 8x10(-7)). These associations were replicated in the independent set of newborns, and replicated again in women 40 to 60 years after their birth. This study provides the first example of parental age permanently affecting the epigenetic profile of offspring. While the specific functions of the affected gene are unknown, this finding opens the possibility that a mother's age at pregnancy could affect her child's health through epigenetic mechanisms.	[Markunas, Christina A.; Wilcox, Allen J.; Xu, Zongli; Joubert, Bonnie R.; London, Stephanie J.; Sandler, Dale P.; Taylor, Jack A.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Harlid, Sophia; Panduri, Vijayalakshmi; Wade, Paul A.; Taylor, Jack A.] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Haberg, Siri E.; Nystad, Wenche; Lie, Rolv T.] Norwegian Inst Publ Hlth, Oslo, Norway; [Lie, Rolv T.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Markunas, Christina A.] RTI Int, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH); University of Bergen; Research Triangle Institute	Taylor, JA (corresponding author), NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA.; Taylor, JA (corresponding author), NIEHS, Epigenet & Stem Cell Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.	taylor@niehs.nih.gov	Harlid, Sophia/AAJ-5809-2021; Wade, Paul A/D-2374-2019; London, Stephanie/C-3734-2019; Wilcox, Allen J/C-7723-2019; taylor, jack a/C-7154-2019	Harlid, Sophia/0000-0001-8540-6891; Wade, Paul A/0000-0002-6042-357X; London, Stephanie/0000-0003-4911-5290; Wilcox, Allen J/0000-0002-3376-1311; taylor, jack a/0000-0001-5303-6398; Sandler, Dale/0000-0002-6776-0018; xu, zongli/0000-0002-9034-8902; Joubert, Bonnie/0000-0001-7952-1180; Markunas, Christina/0000-0003-3401-733X	Intramural Research Program of the NIH, National Institute of Environmental Health Science, Sister Study [Z01 ES044005]; Intramural Research Program of the NIH, National Institute of Environmental Health Science, MoBa [Z01-ES-49019]; Intramural Research Program of the NIH, National Institute of Environmental Health Science, Norway Facial Clefts Study; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101965, ZIAES049032, ZIAES044005, ZIAES044003, ZIAES049033, ZIAES049019, ZIAES049027] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health Science, Sister Study; Intramural Research Program of the NIH, National Institute of Environmental Health Science, MoBa; Intramural Research Program of the NIH, National Institute of Environmental Health Science, Norway Facial Clefts Study; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/, Z01 ES044005, Sister Study (DPS); Z01-ES-49019, MoBa (SJL); Norway Facial Clefts Study (AJW)). The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research (https://www.regjeringen.no/en/dep/kd/id586/), NIH/NIEHS (http://www.niehs.nih.gov/, contract no N01-ES-75558), NIH/NINDS (http://www.ninds.nih.gov/, grant no. 1 UO1 NS 047537-01), and the Norwegian Research Council/FUGE (http://www.forskningsradet.no/prognett-fuge/Home_page/1226993493114, grant no. 151918/S10 (WN)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Cardwell CR, 2010, DIABETES, V59, P486, DOI 10.2337/db09-1166; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Haberg SE, 2011, J ALLERGY CLIN IMMUN, V127, P262, DOI 10.1016/j.jaci.2010.10.004; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Harlid S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118757; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Joubert BR, 2014, CANCER EPIDEM BIOMAR, V23, P1007, DOI 10.1158/1055-9965.EPI-13-1256; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892; Milekic MH, 2014, MOL PSYCHIAT; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Seoud MAF, 2002, AM J PERINAT, V19, P1, DOI 10.1055/s-2002-20175; Shelton JF, 2010, AUTISM RES, V3, P30, DOI 10.1002/aur.116; Shitani M, 2012, TUMOR BIOL, V33, P1307, DOI 10.1007/s13277-012-0378-3; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Venables WN., 2002, MODERN APPL STAT S 4; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Xu ZL, 2014, CARCINOGENESIS, V35, P356, DOI 10.1093/carcin/bgt391; Yip BH, 2006, INT J EPIDEMIOL, V35, P1495, DOI 10.1093/ije/dyl177; Yue MX, 2012, J ASSIST REPROD GEN, V29, P643, DOI 10.1007/s10815-012-9780-4	34	43	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156361	10.1371/journal.pone.0156361	http://dx.doi.org/10.1371/journal.pone.0156361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383059	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400003
J	Sapir-Hen, L; Dayan, T; Khalaily, H; Munro, ND				Sapir-Hen, Lidar; Dayan, Tamar; Khalaily, Hamoudi; Munro, Natalie D.			Human Hunting and Nascent Animal Management at Middle Pre-Pottery Neolithic Yiftah'el, Israel	PLOS ONE			English	Article							BROAD-SPECTRUM REVOLUTION; GOATS CAPRA-HIRCUS; NEAR-EAST; DOMESTICATION; ORIGINS; INTENSIFICATION; EXPLOITATION; AGRICULTURE; PRESSURE; SHEEP	The current view for the southern Levant is that wild game hunting was replaced by herd management over the course of the Pre-Pottery Neolithic B period, but there is significant debate over the timing, scale and origin of this transition. To date, most relevant studies focus either on wild game exploitation in the periods prior to domestication or on classic markers of domestication of domestic progenitor species over the course of the PPNB. We studied the faunal remains from the 2007-2008 excavations of the Middle PPNB (MPPNB) site of Yiftah'el, Northern Israel. Our analysis included a close examination of the timing and impact of the trade-off between wild game and domestic progenitor taxa that reflects the very beginning of this critical transition in the Mediterranean zone of the southern Levant. Our results reveal a direct trade-off between the intensive hunting of wild ungulates that had been staples for millennia, and domestic progenitor taxa. We suggest that the changes in wild animal use are linked to a region-wide shift in the relationship between humans and domestic progenitor species including goat, pig and cattle.	[Sapir-Hen, Lidar] Tel Aviv Univ, Dept Archaeol & Ancient Near Eastern Cultures, Tel Aviv, Israel; [Sapir-Hen, Lidar; Dayan, Tamar] Tel Aviv Univ, Steinhardt Museum Nat Hist, Tel Aviv, Israel; [Dayan, Tamar] Tel Aviv Univ, Dept Zool, Tel Aviv, Israel; [Khalaily, Hamoudi] Israel Antiqu Author, Jerusalem, Israel; [Munro, Natalie D.] Univ Connecticut, Dept Anthropol, Storrs, CT USA	Tel Aviv University; Tel Aviv University; Tel Aviv University; University of Connecticut	Sapir-Hen, L (corresponding author), Tel Aviv Univ, Dept Archaeol & Ancient Near Eastern Cultures, Tel Aviv, Israel.; Sapir-Hen, L (corresponding author), Tel Aviv Univ, Steinhardt Museum Nat Hist, Tel Aviv, Israel.	lidarsap@post.tau.ac.il		Munro, Natalie/0000-0003-1690-6133; Sapir-Hen, Lidar/0000-0002-6184-4560	Israel Antiquities Authority	Israel Antiquities Authority	Assemblage analysis was funded by Israel Antiquities Authority (to TD and LS-H), excavation license A-5252/98. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NEO LITHICS; Arbuckle B. S., 2014, BIOARCHAEOL NEAR E, V8, P53; Bar-Oz G, 2004, EPIPALEOLITHIC SUBSI; Bar-Oz G, 2007, J ARCHAEOL SCI, V34, P946, DOI 10.1016/j.jas.2006.09.006; Bar-Yosef O., 2000, ARCHAEOZOOLOGY NEAR, P185; BarYosef O, 1995, SCH AM RES, V354, P39; Belfer-Cohen A, 2011, CURR ANTHROPOL, V52, pS209, DOI 10.1086/658861; Brown TA, 2009, TRENDS ECOL EVOL, V24, P103, DOI 10.1016/j.tree.2008.09.008; Clutton-Brock J., 1979, Proceedings of the Prehistoric Society, V45, P135; Clutton-Brock J., 1987, NATURAL HIST DOMESTI; Conolly J, 2011, J ARCHAEOL SCI, V38, P538, DOI 10.1016/j.jas.2010.10.008; Davis S., 1982, PALEORIENT, V8, P5; Davis S.J.M., 1994, Memoires et Travaux du Centre de Recherche Francais de Jerusalem, V8, P83; Davis SJM, 2005, J ARCHAEOL SCI, V32, P1408, DOI 10.1016/j.jas.2005.03.018; DAVIS SJM, 1981, PALEOBIOLOGY, V7, P101, DOI 10.1017/S0094837300003821; DAYAN T, 1994, J ARCHAEOL SCI, V21, P633, DOI 10.1006/jasc.1994.1062; Dobney K., 1988, CIRCAEA, V5, P79; Ducos P., 2003, NEOLITHIC SITE ABU G, P103; EDGE WD, 1990, J MAMMAL, V71, P156, DOI 10.2307/1382162; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Goring-Morris A.N., 2014, NEOLITHIC TRANSITION, P59; Grayson D.K., 1984, QUANTITATIVE ZOOARCH; Grigson C., 1989, BAR International Series, P77; Grigson Caroline, 2003, BAR International Series, V1134, P187; Haber A, 2004, J ARCHAEOL SCI, V31, P1587, DOI 10.1016/j.jas.2004.04.001; Hesse B., 1984, ANIMALS ARCHAEOLOGY, P243; Hongo H., 1998, MASCA RES PAPERS SCI, V15, P77; Horwitz L.K., 2003, Paleorient, V29, P19, DOI 10.3406/paleo.2003.4753; Horwitz Liora Kolska, 2000, Paleorient, V25, P63; Horwitz LK., 2003, NEOLITHIC SITE ABU G, P87; Khalaily H, 2014, STONE TOOLS TRANSITI, P219; Khalaily H, 2007, PALEORIENT, V33, P5, DOI DOI 10.3406/PALE0.2007.5218; Khalaily H., 2008, NEOLITHICS, V2, P3; Khalaily H, IAA REPORTS IN PRESS; Legge T., 1996, ORIGINS SPREAD AGR P, P238; Marom N, 2009, FARMING, V2009, P1; Marom N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055958; Martin L, 2013, PUBL INST ARCHAEOL, V59, P49; Meadow RH., 1999, HISTORICI ANIMALIUM, P285; Mendelssohn H., 1999, MAMMALIA OF ISRAEL; Munro N, 2009, VERTEBR PALEOBIOL PA, P141, DOI 10.1007/978-1-4020-9699-0_10; Munro ND, 2009, J ARCHAEOL SCI, V36, P752, DOI 10.1016/j.jas.2008.10.020; Munro ND, 2004, CURR ANTHROPOL, V45, pS5, DOI 10.1086/422084; MUNRO ND, 2004, PETITS ANIMAUX SOC H, P515; Munroa ND, 2005, J ARCHAEOL SCI, V32, P223, DOI 10.1016/j.jas.2004.08.007; Namdar L., SALVAGE EXCAVATION T; Payne S., 1973, ANATOL STUD, V23, P281, DOI [10.2307/3642547, DOI 10.2307/3642547]; Peters Joris, 2000, Paleorient, V25, P27; Poduska KM, 2012, RADIOCARBON, V54, P887, DOI 10.1017/S0033822200047536; Sapir-Hen L, IAA REPORTS IN PRESS; Sapir-Hen L, 2009, J ARCHAEOL SCI, V36, P1538, DOI 10.1016/j.jas.2009.03.015; Silver I.A, 1969, SCI ARCHAEOLOGY SURV, V2nd, P283; Slon V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089242; Stiner MC, 2014, P NATL ACAD SCI USA, V111, P8404, DOI 10.1073/pnas.1322723111; Stiner MC, 2002, J ARCHAEOL METHOD TH, V9, P181, DOI 10.1023/A:1016530308865; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Stiner MC, 2000, CURR ANTHROPOL, V41, P39, DOI 10.1086/300102; Stutz AJ, 2009, J HUM EVOL, V56, P294, DOI 10.1016/j.jhevol.2008.10.004; Tchernov Eitan, 1993, Oxbow Monograph, V34, P189; Tchernov Eitan, 1993, P10; Uerpmann M., 1994, QALAAT AL BAHRAIN TH, V30(1), P417; Vigne Jean-Denis, 2007, Anthropozoologica, V42, P9; Vigne Jean-Denis, 2005, P1; Vigne JD, 2011, CURR ANTHROPOL, V52, pS255, DOI 10.1086/659306; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; von den Driesch A., 1997, PREHISTORY JORDAN 2, P511; von den Driesch A, 1976, GUIDE MESUREMENT ANI; Wasse, 2002, LEVANT, V34, P59, DOI [10.1179/lev.2002.34.1.59, DOI 10.1179/LEV.2002.34.1.59]; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Wolverton S, 2008, AM ANTIQUITY, V73, P179, DOI 10.2307/25470475; Yeshurun R, 2014, J HUM EVOL, V70, P16, DOI 10.1016/j.jhevol.2014.02.011; Zeder M.A., 2006, RECENT ADV AGEING SE, P297; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zeder MA, 2001, J ARCHAEOL SCI, V28, P61, DOI 10.1006/jasc.1999.0555; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P181; Zeder MA, 2011, CURR ANTHROPOL, V52, pS221, DOI 10.1086/659307	77	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156964	10.1371/journal.pone.0156964	http://dx.doi.org/10.1371/journal.pone.0156964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383247	Green Submitted, gold, Green Published			2022-12-27	WOS:000379809400008
J	Hughes, N; Sciberras, E; Goldfeld, S				Hughes, Nathan; Sciberras, Emma; Goldfeld, Sharon			Family and Community Predictors of Comorbid Language, Socioemotional and Behavior Problems at School Entry	PLOS ONE			English	Article							CHILDREN; DIFFICULTIES; CHILDHOOD; MALTREATMENT; DISORDERS; STRENGTHS; HEALTH; SKILLS	Objectives To identify the prevalence and family and community-level predictors of comorbid speech-language difficulties and socioemotional and behavioral (SEB) difficulties across a population of children at school entry. Methods The School Entry Health Questionnaire is a parent survey of children's health and wellbeing, completed by all children starting school in Victoria, Australia (N = 53256). It includes parental report of speech-language difficulties, the Strengths and Difficulties Questionnaire (behavior), and numerous family and community variables. Following univariate analysis, family and community risk characteristics were entered into a multinomial logistic regression model to identify the associated relative risk of comorbid speech/language and SEB needs. The influence of experiencing multiple risk factors was also examined. Results 20.4% (n = 10,868) began school with either speech-language or SEB difficulties, with 3.1% (n = 1670) experiencing comorbid needs. Five factors predicted comorbidity: the child having witnessed violence; a history of parent mental illness; living in more deprived communities; and the educational attainment of each parent (independently). The relative risk of comorbidity was 6.1 (95% Confidence Interval: 3.9, 9.7) when a child experienced four or more risk factors, compared to those with no risk factors. Conclusions The risk of comorbidity in early childhood is associated with a range of family and community factors, and elevated by the presence of multiple factors. Children growing up in families experiencing multiple, complex needs are therefore at heightened risk of the early development of difficulties likely to impact upon schooling. Early identification of these children offers opportunities for appropriate and timely health and education intervention.	[Hughes, Nathan; Sciberras, Emma; Goldfeld, Sharon] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Hughes, Nathan] Univ Birmingham, Birmingham, W Midlands, England; [Hughes, Nathan; Goldfeld, Sharon] Univ Melbourne, Melbourne, Vic, Australia; [Sciberras, Emma] Deakin Univ, Melbourne, Vic, Australia; [Sciberras, Emma; Goldfeld, Sharon] Royal Childrens Hosp, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Birmingham; University of Melbourne; Deakin University; Royal Children's Hospital Melbourne	Goldfeld, S (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Goldfeld, S (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.; Goldfeld, S (corresponding author), Royal Childrens Hosp, Melbourne, Vic, Australia.	sharon.goldfeld@rch.org.au	; Hughes, Nathan/O-8600-2014	Sciberras, Emma/0000-0003-2812-303X; Hughes, Nathan/0000-0002-5859-808X; Goldfeld, Sharon/0000-0001-6520-7094	Marie Curie International Outgoing Fellowship from the European Commission [PIOF-GA-2012-331494]; Australian National Health and Medical Research Council [1037159]; Australian National Health and Medical Research Council Career Development Fellowship [1082922]; NHMRC [1023493]	Marie Curie International Outgoing Fellowship from the European Commission; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	NH is funded by a Marie Curie International Outgoing Fellowship from the European Commission (grant number PIOF-GA-2012-331494). ES is funded through an Early Career Fellowship in Population Health from the Australian National Health and Medical Research Council (1037159). SG is funded through an Australian National Health and Medical Research Council Career Development Fellowship (1082922). The authors also acknowledge the support of the NHMRC-funded Centre of Research Excellence in Child Language (1023493).	Allen G., 2011, EARLY INTERVENTION N; Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Australian Bureau of Statistics, 2006, INF PAP INTR SOC IND; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Benner GJ, 2002, J EMOT BEHAV DISORD, V10, P43, DOI 10.1177/106342660201000105; Bishop DVM, 2014, PSYCHOL PRESS CLASS, P1; Carpenter JL, 2011, EARLY CHILD DEV CARE, V181, P1021, DOI 10.1080/03004430.2010.509795; CHRISTOPOULOS C, 1987, J MARRIAGE FAM, V49, P611, DOI 10.2307/352206; Clegg J, 2015, J CHILD PSYCHOL PSYC, V56, P67, DOI 10.1111/jcpp.12281; Corso PS, 2008, AM J PUBLIC HEALTH, V98, P1094, DOI 10.2105/AJPH.2007.119826; Department for Communities and Local Government, 2014, UND TROUBL FAM; Department of Human Services, 2012, FAM MULT COMPL NEEDS; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; FITZGERALD HE, 1993, CHILD DEV, V64, P110, DOI 10.2307/1131440; Fuchs S, 2013, CHILD PSYCHIAT HUM D, V44, P493, DOI 10.1007/s10578-012-0343-9; Gilliam W, 2000, EARLY CHILD DEV CARE, V162, P9, DOI DOI 10.1080/0300443001620102; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hartas D, 2011, BRIT J SPEC EDUC, V38, P83, DOI 10.1111/j.1467-8578.2011.00507.x; Hawes DJ, 2004, AUST NZ J PSYCHIAT, V38, P644, DOI 10.1111/j.1440-1614.2004.01427.x; Massa J, 2008, INT J LANG COMM DIS, V43, P99, DOI 10.1080/13682820701261827; Mok PLH, 2014, J CHILD PSYCHOL PSYC, V55, P516, DOI 10.1111/jcpp.12190; Morris K., 2008, THINK FAMILY LIT REV; Nelson JR, 2005, J SPEC EDUC, V39, P97; Pike A, 2006, INT J BEHAV DEV, V30, P55, DOI 10.1177/0165025406062124; Plomin R, 2002, J CHILD PSYCHOL PSYC, V43, P619, DOI 10.1111/1469-7610.00051; Rankin J, 2004, M COMPLEX NEEDS FUTU; Reilly S, 2010, PEDIATRICS, V126, pE1530, DOI 10.1542/peds.2010-0254; RUTTER M, 1979, CHILD DEV, V50, P283, DOI 10.2307/1129404; St Clair MC, 2011, J COMMUN DISORD, V44, P186, DOI 10.1016/j.jcomdis.2010.09.004; State of Victoria Department of Education, 2015, SCH ENTR HLTH QUEST; Tomblin JB, 2012, TOP LANG DISORD, V32, P198, DOI 10.1097/TLD.0b013e318261c264	33	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158802	10.1371/journal.pone.0158802	http://dx.doi.org/10.1371/journal.pone.0158802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27379668	Green Published, Green Accepted, gold			2022-12-27	WOS:000379798700047
J	Kyabayinze, DJ; Zongo, I; Cunningham, J; Gatton, M; Angutoko, P; Ategeka, J; Compaore, YD; Muehlenbachs, A; Mulondo, J; Nakalembe, M; Some, FA; Ouattara, A; Rouamba, N; Ouedraogo, JB; Hopkins, H; Bell, D				Kyabayinze, Daniel J.; Zongo, Issaka; Cunningham, Jane; Gatton, Michelle; Angutoko, Patrick; Ategeka, John; Compaore, Yves-Daniel; Muehlenbachs, Atis; Mulondo, Jerry; Nakalembe, Miriam; Some, Fabrice A.; Ouattara, Aminata; Rouamba, Noel; Ouedraogo, Jean-Bosco; Hopkins, Heidi; Bell, David			HRP2 and pLDH-Based Rapid Diagnostic Tests, Expert Microscopy, and PCR for Detection of Malaria Infection during Pregnancy and at Delivery in Areas of Varied Transmission: A Prospective Cohort Study in Burkina Faso and Uganda	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; POLYMERASE-CHAIN-REACTION; LOW-BIRTH-WEIGHT; INTENSITY; AFRICA; NANORO; IMPACT; SITES; BLOOD; WOMEN	Background Intermittent screening and treatment (IST) of malaria during pregnancy has been proposed as an alternative to intermittent preventive treatment in pregnancy (IPTp), where IPTp is failing due to drug resistance. However, the antenatal parasitaemias are frequently very low, and the most appropriate screening test for IST has not been defined. Methodology/Principal Findings We conducted a multi-center prospective study of 990 HIV-uninfected women attending ANC in two different malaria transmission settings at Tororo District Hospital, eastern Uganda and Colsama Health Center in western Burkina Faso. Women were enrolled in the study in the second or third trimester of pregnancy and followed to delivery, generating 2,597 blood samples for analysis. Screening tests included rapid diagnostic tests (RDTs) targeting histidine-rich protein 2 (HRP2) and parasite lactate dehydrogenase (pLDH) and microscopy, compared to nPCR as a reference standard. At enrolment, the proportion of pregnant women who were positive for P. falciparum by HRP2/pan pLDH RDT, Pf pLDH/pan pLDH RDT, microscopy and PCR was 38%, 29%, 36% and 44% in Uganda and 21%, 16%, 15% and 35% in Burkina Faso, respectively. All test positivity rates declined during follow-up. In comparison to PCR, the sensitivity of the HRP2/pan pLDH RDT, Pf pLDH/pan pLDH RDT and microscopy was 75.7%, 60.1% and 69.7% in Uganda, 55.8%, 42.6% and 55.8% in Burkina Faso respectively for all antenatal visits. Specificity was greater than 96% for all three tests. Comparison of accuracy using generalized estimating equation revealed that the HRP2-detecting RDT was the most accurate test in both settings. Conclusions/Significance The study suggests that HRP2-based RDTs are the most appropriate point-of-care test currently available for use during pregnancy especially for symptomatic women, but will still miss some PCR-positive women. The clinical significance of these very low density infections needs to be better defined.	[Kyabayinze, Daniel J.; Angutoko, Patrick; Ategeka, John; Mulondo, Jerry; Hopkins, Heidi] Fdn Innovat New Diagnost, Kampala, Uganda; [Zongo, Issaka; Compaore, Yves-Daniel; Some, Fabrice A.; Ouattara, Aminata; Rouamba, Noel; Ouedraogo, Jean-Bosco] Direct Reg Ouest, IRSS, Bobo Dioulasso, Burkina Faso; [Cunningham, Jane] WHO Special Programme Res & Training Trop Dis TDR, World Bank, UNDP, UNICEF, Geneva, Switzerland; [Gatton, Michelle] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Muehlenbachs, Atis] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Nakalembe, Miriam] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Kampala, Uganda; [Hopkins, Heidi; Bell, David] Fdn Innovat New Diagnost, Geneva, Switzerland; [Cunningham, Jane] WHO, GMP, Geneva, Switzerland; [Muehlenbachs, Atis] Ctr Dis Control & Prevent, Atlanta, GA USA; [Hopkins, Heidi] London Sch Trop Med & Hyg, London, England; [Bell, David] Global Good Fund, Intellectual Ventures Lab, Bellevue, WA USA	Foundation For Innovative New Diagnostics; The World Bank; World Health Organization; Queensland University of Technology (QUT); University of Washington; University of Washington Seattle; Makerere University; Foundation For Innovative New Diagnostics; World Health Organization; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; Intellectual Ventures	Kyabayinze, DJ (corresponding author), Fdn Innovat New Diagnost, Kampala, Uganda.	daniel.kyabayinze@finddx.org	COMPAORE, Yves Daniel/HIK-2384-2022; Gatton, Michelle/H-3139-2019	COMPAORE, Yves Daniel/0000-0001-8848-2187; Gatton, Michelle/0000-0003-1188-609X; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Kyabayinze, Daniel/0000-0002-0539-1341; SOME, Anyirekun Fabrice/0000-0002-1530-1493; Hopkins, Heidi/0000-0003-1076-6758	Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland; Bill and Melinda Gates Foundation; UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR)	Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR)(World Health OrganizationSpecial Programme for Research & Training in Tropical Diseases (TDR))	This study was funded by the Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland, through grants from the Bill and Melinda Gates Foundation and UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; [Anonymous], 2012, INT PREV TREATM MAL; [Anonymous], 2009, MAL MICR QUAL ASS MA; ARCHIBALD H. MUNRO, 1956, BULL WORLD HEALTH ORGAN, V15, P842; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Desai M, 2015, LANCET, V386, P2507, DOI 10.1016/S0140-6736(15)00310-4; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; JELLIFFE EF, 1968, B WORLD HEALTH ORGAN, V38, P69; Kamya MR, 2015, AM J TROP MED HYG, V92, P903, DOI 10.4269/ajtmh.14-0312; Kattenberg JH, 2012, AM J TROP MED HYG, V87, P251, DOI 10.4269/ajtmh.2012.12-0125; Kattenberg JH, 2012, TROP MED INT HEALTH, V17, P550, DOI 10.1111/j.1365-3156.2012.02975.x; Knottnerus A, 2008, J CLIN EPIDEMIOL, V61, P323, DOI 10.1016/j.jclinepi.2007.11.006; Kyabayinze DJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-306; Ministry of Health, 2013, ANN HLTH STAT; Rogerson SJ, 2003, J CLIN MICROBIOL, V41, P1370, DOI 10.1128/JCM.41.4.1370-1374.2003; Rosen M, 2015, OBARE METHOD CALCULA; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Slater HC, 2015, NATURE, V528, pS94, DOI 10.1038/nature16040; SPITZ A J, 1959, Bull World Health Organ, V21, P242; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; WHO/AFRO, 2004, AFRMALO401 WHOAFRO R	26	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0156954	10.1371/journal.pone.0156954	http://dx.doi.org/10.1371/journal.pone.0156954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380525	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000379798700004
J	Holter, JC; Ueland, T; Norseth, J; Brunborg, C; Froland, SS; Husebye, E; Aukrust, P; Heggelund, L				Holter, Jan C.; Ueland, Thor; Norseth, Jon; Brunborg, Cathrine; Froland, Stig S.; Husebye, Einar; Aukrust, Pal; Heggelund, Lars			Vitamin D Status and Long-Term Mortality in Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D DEFICIENCY; D SUPPLEMENTATION; RISK; ASSOCIATION; PREVENTION; RESPONSES; INNATE; PHASE; KABUL	Background Low vitamin D status has been associated with short-term (30-day) mortality in hospitalized adults with community-acquired pneumonia (CAP). Data on its prevalence in these patients are scarce, and impact on long-term prognosis is unknown. We examined the prevalence of vitamin D deficiency and inadequacy and their effect on long-term mortality in hospitalized adults with CAP. Methods Secondary follow-up analysis of data from a prospectively recruited (January 2008-January 2011) well-defined cohort of 241 hospital survivors of CAP (Norway, latitude 60 degrees N). Serum 25-hydroxyvitamin D levels, demographic, clinical, and laboratory data were measured within 48 hours of admission. The etiology of CAP was established in 63% of patients through extensive microbiological investigations. Mortality data were obtained from the national Cause of Death Registry. Explanatory strategy and Cox regression models were used to explore the association between vitamin D status and all-cause mortality. Results Median age was 66 years. Eighty-seven (36%) patients were vitamin D deficient (<30 nmol/L), 81 (34%) were inadequate (30-49 nmol/L), and 73 (30%) were sufficient (>= 50 nmol/L). Seventy-two patients died over a median of 1839 days (range 1-2520 days), corresponding to cumulative 5-year survival rates of 66.2%(95% CI 56.2-76.2%), 77.0% (67.6-86.4%), and 77.8% (67.8-87.8%) for vitamin D deficient, inadequate, and sufficient patients, respectively. After adjusting for confounders (age, chronic obstructive pulmonary disease, immunocompromization and season), vitamin D deficiency, but not inadequacy, was significantly associated with higher mortality compared to patients with sufficiency (HR 1.91, 95% CI 1.06-3.45; P = .031). Conclusions There is a high prevalence of vitamin D deficiency and inadequacy among hospitalized adults with CAP. The results of this study also suggest that vitamin D deficiency is associated with an increased risk of mortality way beyond the short-term in these patients.	[Holter, Jan C.; Husebye, Einar; Heggelund, Lars] Vestre Viken Hosp Trust, Drammen Hosp, Dept Internal Med, Drammen, Norway; [Holter, Jan C.; Ueland, Thor; Froland, Stig S.; Aukrust, Pal] Natl Hosp Norway, Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Holter, Jan C.; Ueland, Thor; Froland, Stig S.; Husebye, Einar; Aukrust, Pal; Heggelund, Lars] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Ueland, Thor; Aukrust, Pal] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Norseth, Jon] Vestre Viken Hosp Trust, Baerum Hosp, Clin Med Diagnost, Rud, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Res Support Serv, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Froland, Stig S.; Aukrust, Pal] Natl Hosp Norway, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Holter, JC (corresponding author), Vestre Viken Hosp Trust, Drammen Hosp, Dept Internal Med, Drammen, Norway.; Holter, JC (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway.; Holter, JC (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	jancho@mail.uio.no	Heggelund, Lars/GSN-0026-2022		Vestre Viken Hospital Trust	Vestre Viken Hospital Trust	This study was funded by Vestre Viken Hospital Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Cangemi R, 2015, AM J CARDIOL, V116, P647, DOI 10.1016/j.amjcard.2015.05.028; Charan J, 2012, J PHARMACOL PHARMACO, V3, P300, DOI 10.4103/0976-500X.103685; Choudhary N, 2012, INDIAN PEDIATR, V49, P449, DOI 10.1007/s13312-012-0073-x; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Corrales-Medina VF, 2011, J INFECTION, V63, P187, DOI 10.1016/j.jinf.2011.06.009; Guertler C, 2011, EUR RESPIR J, V37, P1439, DOI 10.1183/09031936.00121510; Hewison M, 2012, P NUTR SOC, V71, P50, DOI 10.1017/S0029665111001650; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holter JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148741; Holter JC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0803-5; Jovanovich AJ, 2014, NUTRIENTS, V6, P2196, DOI 10.3390/nu6062196; Kim HJ, 2015, INT J TUBERC LUNG D, V19, P729, DOI 10.5588/ijtld.14.0696; Lamberg-Allardt C, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.22671; Larose TL, 2014, J EPIDEMIOL COMMUN H, V68, P165, DOI 10.1136/jech-2013-202587; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Leow L, 2011, RESPIROLOGY, V16, P611, DOI 10.1111/j.1440-1843.2011.01924.x; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Manaseki-Holland S, 2010, TROP MED INT HEALTH, V15, P1148, DOI 10.1111/j.1365-3156.2010.02578.x; Martineau AR, 2015, LANCET RESP MED, V3, P120, DOI 10.1016/S2213-2600(14)70255-3; Mortensen EM, 2012, SEMIN RESP CRIT CARE, V33, P319, DOI 10.1055/s-0032-1315644; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Olliver M, 2013, J INFECT DIS, V208, P1474, DOI 10.1093/infdis/jit355; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Pletz MW, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-53; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Remmelts HHF, 2012, CLIN INFECT DIS, V55, P1488, DOI 10.1093/cid/cis751; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sandvall B, 2013, CLIN INFECT DIS, V56, P1145, DOI 10.1093/cid/cis1207; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Scott MG, 2015, CLIN CHEM, V61, P462, DOI 10.1373/clinchem.2014.222521; Silva MC, 2015, NUTR RES, V35, P91, DOI 10.1016/j.nutres.2014.12.008; Walden AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13812; Watkins RR, 2015, CAN J PHYSIOL PHARM, V93, P363, DOI 10.1139/cjpp-2014-0352; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869; Yaktine AL., 2011, COMMITTEE REV DIETAR; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022847	45	15	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158536	10.1371/journal.pone.0158536	http://dx.doi.org/10.1371/journal.pone.0158536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367810	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900039
J	Marconi, DG; Resende, BD; Rauber, E; Soares, PD; Fernandes, JM; Mehta, N; Carvalho, AL; Kupelian, PA; Chen, A				Marconi, Daniel Grossi; Resende, Bruno da Costa; Rauber, Erick; Soares, Paula de Cassia; Fernandes Junior, Jose Maria; Mehta, Niraj; Carvalho, Andre Lopes; Kupelian, Patrick A.; Chen, Allen			Head and Neck Non-Melanoma Skin Cancer Treated By Superficial X-Ray Therapy: An Analysis of 1021 Cases	PLOS ONE			English	Article							DERMATOLOGICAL TRAINING CENTERS; MOHS MICROGRAPHIC SURGERY; SQUAMOUS-CELL CARCINOMAS; BASAL-CELL; RADIATION-THERAPY; IONIZING-RADIATION; RECURRENCE RATES; RADIOTHERAPY; EXPERIENCE; LESIONS	Introduction To report a single-institutional experience with the use of Superficial X-Ray Therapy (SXRT) for head and neck non-melanoma skin cancer (N-MSC) and to compare outcomes by prescribed fractionation schedules. Materials and Methods The medical records of 597 patients with 1021 lesions (720 BCC, 242 SCC, 59 SCC in situ) treated with kilovoltage radiation from 1979-2013 were retrospectively reviewed. The majority of patients were treated according to 1 of 3 institutional protocols based on the discretion of the radiation oncologist: 1) 22 x 2.5 Gy; 2) 20 x 2.5 Gy; 3) 30 x 2.0 Gy. "T" stage at first presentation was as follows: Tis (59); T1 (765); T2 (175); T3 (6), T4 (9); Tx, (7). All patients were clinical N0 and M0 at presentation. Chi-square test was used to evaluate any potential association between variables. The Kaplan-Meier method was used to analyze survival with the Log Rank test used for comparison. A Cox Regression analysis was performed for multivariate analysis. Results The median follow up was 44 months. No significant difference was observed among the 3 prescribed fractionation schemes (p = 0.78) in terms of RTOG toxicity. There were no failures among SCC in situ, 37 local failures (23 BCC, 14 SCC), 5 regional failures (all SCC) and 2 distant failures (both SCC). For BCC, the 5-year LC was 96% and the 10-year LC was 94%. For SCC the corresponding rates of local control were 92% and 87%, respectively (p = 0.03). The use of > 2.0 Gy daily was significantly associated with improved LC on multivariate analysis (HR: 0.17; CI 95%: 0.05-0.59). Conclusion SXRT for N-MSC of the head and neck is well tolerated, achieves excellent local control, and should continue to be recommended in the management of this disease. Fractionation schedules using > 2.0 Gy daily appear to be associated with improved LC.	[Marconi, Daniel Grossi; Resende, Bruno da Costa; Rauber, Erick; Soares, Paula de Cassia; Fernandes Junior, Jose Maria] Barretos Canc Hosp, Dept Radiat Oncol, Barretos, Brazil; [Mehta, Niraj] South Florida Radiat Oncol, Miami, FL USA; [Carvalho, Andre Lopes] Barretos Canc Hosp, Head & Neck Div, Barretos, Brazil; [Kupelian, Patrick A.; Chen, Allen] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; University of California System; University of California Los Angeles	Marconi, DG (corresponding author), Barretos Canc Hosp, Dept Radiat Oncol, Barretos, Brazil.	dgmarconi@gmail.com	Carvalho, Andre Lopes/S-7053-2016; MARCONI, DANIEL GROSSI/M-9484-2013; Kupelian, Patrick/AAU-6311-2021	Carvalho, Andre Lopes/0000-0001-7214-6402; 				ASHBY MA, 1989, CANCER, V63, P1863; Caccialanza M, 2005, INT J DERMATOL, V44, P513, DOI 10.1111/j.1365-4632.2005.02103.x; Caccialanza M, 2003, EUR J DERMATOL, V13, P462; Caccialanza M, 2009, J EUR ACAD DERMATOL, V23, P1044, DOI 10.1111/j.1468-3083.2009.03247.x; Cognetta AB, 2012, J AM ACAD DERMATOL, V67, P1235, DOI 10.1016/j.jaad.2012.06.001; de Launey JW, 1998, J DERMATOL, V37, P71; GOLDSCHMIDT H, 1986, ARCH DERMATOL, V122, P1385, DOI 10.1001/archderm.122.12.1385; GOLDSCHMIDT H, 1994, J AM ACAD DERMATOL, V30, P157, DOI 10.1016/S0190-9622(94)70014-1; Hernandez-Machin B, 2007, INT J DERMATOL, V46, P453, DOI 10.1111/j.1365-4632.2006.03108.x; Huynh NT, 2002, J DERMATOL, V43, P15; Jay L, 2001, INT J RADIAT ONCOL, V51, P748; KINGERY FAJ, 1986, J AM ACAD DERMATOL, V14, P1108, DOI 10.1016/S0190-9622(86)70134-5; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P253, DOI 10.1016/j.jaad.2005.02.059; Leibovitch I, 2005, J AM ACAD DERMATOL, V52, P997, DOI 10.1016/j.jaad.2004.12.033; Mendenhall WM, 2009, LARYNGOSCOPE, V119, P1994, DOI 10.1002/lary.20608; Panizzon R., 1991, MODERN DERMATOLOGIC; Panizzon R, 1982, P 16 INT C DERM, P482; ROWE DE, 1989, J DERMATOL SURG ONC, V15, P315, DOI 10.1111/j.1524-4725.1989.tb03166.x; Schalock PC, 2006, J AM ACAD DERMATOL, V55, P912, DOI 10.1016/j.jaad.2005.10.044; Schulte KW, J AM ACAD DERMATOL, V53, P993; Silva JJ, 2000, INT J RADIAT ONCOL, V47, P451, DOI 10.1016/S0360-3016(00)00410-7; STOLL HL, 1964, ARCH DERMATOL, V90, P577, DOI 10.1001/archderm.1964.01600060043007; Thom GA, AUSTRALAS J DERMATOL, V44, P174; Zagrodnik B, 2003, CANCER, V98, P2708, DOI 10.1002/cncr.11798; Zagrodnik B, 2003, CANCER, V98	25	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156544	10.1371/journal.pone.0156544	http://dx.doi.org/10.1371/journal.pone.0156544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367229	gold, Green Published, Green Submitted			2022-12-27	WOS:000378914900005
J	Papworth, DJ; Marini, S; Conversi, A				Papworth, Danny J.; Marini, Simone; Conversi, Alessandra			A Novel, Unbiased Analysis Approach for Investigating Population Dynamics: A Case Study on Calanus finmarchicus and Its Decline in the North Sea	PLOS ONE			English	Article							LONG-TERM CHANGES; MARINE PLANKTON ECOSYSTEMS; REGIME SHIFTS; PHYTOPLANKTON BIOMASS; NORWEGIAN SEA; BOTTOM-UP; ENVIRONMENTAL-CONDITIONS; TROPHIC INTERACTIONS; COD RECRUITMENT; TRANS-ATLANTIC	Marine populations are controlled by a series of drivers, pertaining to both the physical environment and the biological environment (trophic predator-prey interactions). There is heated debate over drivers, especially when trying to understand the causes of major ecosystem events termed regime shifts. In this work, we have researched and developed a novel methodology based on Genetic Programming (GP) for distinguishing which drivers can influence species abundance. This methodology benefits of having no a priori assumptions either on the ecological parameters used or on the underlying mathematical relationships among them. We have validated this methodology applying it to the North Sea pelagic ecosystem. We use the target species Calanus finmarchicus, a key copepod in temperate and subarctic ecosystems, along with 86 biological, hydrographical and climatic time series, ranging from local water nutrients and fish predation, to large scale climate pressure patterns. The chosen study area is the central North Sea, from 1972 to 2011, during which period there was an ecological regime shift. The GP based analysis identified 3 likely drivers of C. finmarchicus abundance, which highlights the importance of considering both physical and trophic drivers: temperature, North Sea circulation (net flow into the North Atlantic), and predation (herring). No large scale climate patterns were selected, suggesting that when there is availability of both data types, local drivers are more important. The results produced by the GP based procedure are consistent with the literature published to date, and validate the use of GP for interpreting species dynamics. We propose that this methodology holds promises for the highly non-linear field of ecology.	[Papworth, Danny J.] Univ Plymouth, Sch Marine Sci & Engn, Fac Sci & Technol, Plymouth PL4 8AA, Devon, England; [Marini, Simone; Conversi, Alessandra] CNR Natl Res Council Italy, ISMAR Marine Sci Inst La Spezia, I-19032 Lerici, SP, Italy; [Conversi, Alessandra] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England	University of Plymouth; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); University of Plymouth	Conversi, A (corresponding author), CNR Natl Res Council Italy, ISMAR Marine Sci Inst La Spezia, I-19032 Lerici, SP, Italy.; Conversi, A (corresponding author), Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England.	a.conversi@ismar.cnr.it	Marini, Simone/C-3872-2012; Marini, Simone/AAA-3513-2022; Conversi, Alessandra/G-3899-2011	Marini, Simone/0000-0003-0665-7815; Marini, Simone/0000-0003-0665-7815; Conversi, Alessandra/0000-0002-8566-8282	European Union [PIEF-GA-2010-275790]	European Union(European Commission)	AC has received partial funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no PIEF-GA-2010-275790, Marie Curie project SYNRESH.; The authors wish to especially thank David Johns and Darren Stevens for help accessing the CPR data, as well as all those at the Sir Alister Hardy Foundation for Ocean Science who support and maintain the CPR dataset. They are particularly thankful to Morten Skogen for providing the North Atlantic and English Channel flow data. They thank Beatriz Roel and Sophie Pitois from CEFAS for advice on fisheries data, and finally ICES and NOAA for supplying data on nutrients, hydrography and climate. The research leading to these results has received partial funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no PIEF-GA-2010-275790, Marie Curie project SYNRESH. The authors have no conflict of interest to declare.	Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; Alheit J, 2009, INT J EARTH SCI, V98, P261, DOI 10.1007/s00531-007-0232-9; Alvarez-Fernandez S, 2012, MAR ECOL PROG SER, V462, P21, DOI 10.3354/meps09817; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Augusto DA, 2000, NEUR NETW 2000 P 6 B; Batten SD, 2003, J PLANKTON RES, V25, P697, DOI 10.1093/plankt/25.7.697; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2004, MAR ECOL PROG SER, V284, P35, DOI 10.3354/meps284035; Beaugrand G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0272; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0264; Beaugrand G, 2014, MAR ECOL PROG SER, V502, P85, DOI 10.3354/meps10693; Beaugrand G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3350; Beaugrand G, 2012, ICES J MAR SCI, V69, P1549, DOI 10.1093/icesjms/fss153; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; Bergmeir C, 2012, INFORM SCIENCES, V191, P192, DOI 10.1016/j.ins.2011.12.028; Blenckner Thorsten, 2012, ENCY THEORETICAL ECO, P609; Cao HQ, 2014, IEEE T EVOLUT COMPUT, V18, P793, DOI 10.1109/TEVC.2013.2286404; Casini M, 2010, MAR ECOL PROG SER, V413, P241, DOI 10.3354/meps08592; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Castellani C, 2008, J PLANKTON RES, V30, P1095, DOI 10.1093/plankt/fbn074; Clark RA, 2001, J PLANKTON RES, V23, P27, DOI 10.1093/plankt/23.1.27; COLEBROOK J M, 1975, Bulletins of Marine Ecology, V8, P123; Conversi A, 1998, ICES J MAR SCI, V55, P739, DOI 10.1006/jmsc.1998.0394; Conversi A, 2009, JOURNAL OF GEOPHYSIC, V114; Conversi A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0279; Conversi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010633; Corgnati L, 2014, COMPUTER VISION ANAL; Corriveau G, 2013, APPL SOFT COMPUT, V13, P9, DOI 10.1016/j.asoc.2012.08.046; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dippner JW, 2013, J MARINE SYST, V111, P263, DOI 10.1016/j.jmarsys.2012.09.009; Dippner JW, 2012, J MARINE SYST, V105, P115, DOI 10.1016/j.jmarsys.2012.07.001; Drinkwater KF, 2010, J MARINE SYST, V79, P374, DOI 10.1016/j.jmarsys.2008.12.014; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Fauchald P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022729; Fauchald P, 2010, ECOLOGY, V91, P2191, DOI 10.1890/09-1500.1; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Gardmark A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0262; Goberville E, 2014, J MARINE SYST, V129, P189, DOI 10.1016/j.jmarsys.2013.05.008; Greene CH, 2003, PROG OCEANOGR, V58, P301, DOI 10.1016/j.pocean.2003.08.009; Greene CH, 2013, LIMNOL OCEANOGR, V58, P803, DOI 10.4319/lo.2013.58.3.0803; Greene CH, 2012, OCEANOGRAPHY, V25, P208, DOI 10.5670/oceanog.2012.64; Guyon I., 2006, FEATURE EXTRACTION F, V207; Harms JH, 2000, ICES J MAR SCI, V57, P1694, DOI 10.1006/jmsc.2000.0981; Harris V, 2014, J MARINE SYST, V133, P55, DOI 10.1016/j.jmarsys.2013.07.001; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Head EJH, 2013, PROG OCEANOGR, V114, P46, DOI 10.1016/j.pocean.2013.05.004; Heath MR, 2007, FISH OCEANOGR, V16, P169, DOI 10.1111/j.1365-2419.2006.00423.x; Heath Michael R., 1999, Fisheries Oceanography, V8, P163, DOI 10.1046/j.1365-2419.1999.00008.x; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Helaouet P, 2016, J MARINE SYST, V153, P18, DOI 10.1016/j.jmarsys.2015.09.001; Helaouet P, 2011, PROG OCEANOGR, V91, P217, DOI 10.1016/j.pocean.2010.11.003; Hjermann DO, 2013, MAR ECOL PROG SER, V480, P263, DOI 10.3354/meps10315; Huang CJ, 2012, NEURAL COMPUT APPL, V21, P2057, DOI 10.1007/s00521-011-0628-0; Hunt GL, 2006, PROG OCEANOGR, V68, P115, DOI 10.1016/j.pocean.2006.02.008; HUTHNANCE J.M., 1991, OCEAN SHORELINE MANA, V16, P199, DOI DOI 10.1016/0951-8312(91)90005-M; IBANEZ F, 1993, CR ACAD SCI III-VIE, V316, P745; ICES, 2012, REP HERR ASS WORK GR; ICES, 2012, REP WORK GROUP ASS D; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Jonasdottir SH, 2011, J PLANKTON RES, V33, P85, DOI 10.1093/plankt/fbq085; Kala R, 2012, EXPERT SYST APPL, V39, P3817, DOI 10.1016/j.eswa.2011.09.090; Kehayias G, 2005, J MAR BIOL ASSOC UK, V85, P1525, DOI 10.1017/S0025315405012737; Kimmel DG, 2008, MAR ECOL PROG SER, V366, P111, DOI 10.3354/meps07523; Kirby RR, 2007, MAR ECOL PROG SER, V330, P31, DOI 10.3354/meps330031; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Kirby RR, 2009, ECOSYSTEMS, V12, P548, DOI 10.1007/s10021-009-9241-9; Knight J. R., 2006, GEOPHYS RES LETT, V33, P1, DOI DOI 10.1029/2006GL026242; Kohavi R., 2001, INT JOINT C ART INT; Koza JR, 2010, GENET PROGRAM EVOL M, V11, P251, DOI 10.1007/s10710-010-9112-3; Koza JR, 1992, GENETIC PROGRAMMING; Lassalle G, 2013, ICES J MAR SCI, V70, P135, DOI 10.1093/icesjms/fss168; Lauria V, 2013, MAR ECOL PROG SER, V488, P11, DOI 10.3354/meps10401; Lauria V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047408; Lefebvre M., 2007, APPL PROBABILITY STA; Link JS, 2010, ICES J MAR SCI, V67, P787, DOI 10.1093/icesjms/fsp258; Llope M, 2009, LIMNOL OCEANOGR, V54, P512, DOI 10.4319/lo.2009.54.2.0512; Lones MA, 2014, IEEE T EVOLUT COMPUT, V18, P559, DOI 10.1109/TEVC.2013.2281532; Luczak C, 2012, BIOL LETTERS, V8, P821, DOI 10.1098/rsbl.2012.0474; Maar M, 2013, PROG OCEANOGR, V111, P24, DOI 10.1016/j.pocean.2012.10.004; Mackas DL, 2012, PROG OCEANOGR, V97, P31, DOI 10.1016/j.pocean.2011.11.005; Mackinson S, 2009, ECOL MODEL, V220, P2972, DOI 10.1016/j.ecolmodel.2008.10.021; Marini Simone, 2012, Evolutionary Computation, Machine Learning and Data Mining in Bioinformatics. Proceedings of the 10th European Conference, EvoBIO 2012, P50, DOI 10.1007/978-3-642-29066-4_5; McQuatters-Gollop A, 2007, LIMNOL OCEANOGR, V52, P635, DOI 10.4319/lo.2007.52.2.0635; Melle W, 2014, PROG OCEANOGR, V129, P244, DOI 10.1016/j.pocean.2014.04.026; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Moller EF, 2012, LIMNOL OCEANOGR, V57, P211, DOI 10.4319/lo.2012.57.1.0211; Moloney CL, 2011, J MARINE SYST, V84, P106, DOI 10.1016/j.jmarsys.2010.06.012; MULLIN MM, 1989, FISH B-NOAA, V87, P633; Muttil N, 2005, ECOL MODEL, V189, P363, DOI 10.1016/j.ecolmodel.2005.03.018; Nejstgaard JC, 1997, MAR ECOL PROG SER, V147, P197, DOI 10.3354/meps147197; Nelson GC, 2006, ECOL SOC, V11; O'Connor MI, 2015, GLOBAL ECOL BIOGEOGR, V24, P64, DOI 10.1111/geb.12218; Olsen EM, 2011, P ROY SOC B-BIOL SCI, V278, P504, DOI 10.1098/rspb.2010.1465; OSPAR, 2010, QUAL STAT REP 2010; OSPAR Commission, 2000, QUAL STAT REP 2000; Owens NJP, 2013, J MARINE SYST, V128, P240, DOI 10.1016/j.jmarsys.2013.05.003; Parker G, 2008, 2008 WORLD AUTOMATION CONGRESS PROCEEDINGS, VOLS 1-3, P411; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; Payne MR, 2009, ICES J MAR SCI, V66, P272, DOI 10.1093/icesjms/fsn211; Pershing AJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0265; Petursdottir H, 2012, ICES J MAR SCI, V69, P1277, DOI 10.1093/icesjms/fss125; Pierson JJ, 2013, J PLANKTON RES, V35, P504, DOI 10.1093/plankt/fbt022; Pitois SG, 2012, MAR ECOL PROG SER, V456, P169, DOI 10.3354/meps09710; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Planque B, 2000, ICES J MAR SCI, V57, P1528, DOI 10.1006/jmsc.2000.0970; Poli R., 2008, FIELD GUIDE GENETIC; Prokopchuk I, 2006, ICES J MAR SCI, V63, P117, DOI 10.1016/j.icesjms.2005.08.005; Raab K, 2012, MAR ECOL PROG SER, V470, P101, DOI 10.3354/meps09919; Raab K, 2011, J SEA RES, V65, P131, DOI 10.1016/j.seares.2010.09.002; Raitsos DE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022484; Record NR, 2010, J MARINE SYST, V82, P96, DOI 10.1016/j.jmarsys.2010.04.001; Reid PC, 2003, FISH OCEANOGR, V12, P260, DOI 10.1046/j.1365-2419.2003.00252.x; Reid PC, 2012, J MAR BIOL ASSOC UK, V92, P1435, DOI 10.1017/S0025315412000549; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Reygondeau G, 2011, GLOBAL CHANGE BIOL, V17, P756, DOI 10.1111/j.1365-2486.2010.02310.x; Reygondeau G, 2011, J PLANKTON RES, V33, P119, DOI 10.1093/plankt/fbq091; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Richardson AJ, 2004, DEEP-SEA RES PT I, V51, P1283, DOI 10.1016/j.dsr.2004.04.002; Rosenblatt AE, 2013, ROLES LARGE TOP PRED; Schluter MH, 2012, J SEA RES, V67, P91, DOI 10.1016/j.seares.2011.11.001; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Simonsen CS, 2006, MAR BIOL, V149, P937, DOI 10.1007/s00227-005-0172-5; Soiland H, 2000, ICES J MAR SCI, V57, P816, DOI 10.1006/jmsc.2000.0567; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Tande KS, 2000, ICES J MAR SCI, V57, P1527, DOI 10.1006/jmsc.2000.0983; Usov N, 2013, HYDROBIOLOGIA, V706, P11, DOI 10.1007/s10750-012-1435-z; Utne KR, 2012, MAR BIOL RES, V8, P527, DOI 10.1080/17451000.2011.642804; van Deurs M, 2009, MAR ECOL PROG SER, V381, P249, DOI 10.3354/meps07960; Vladislavleva E, 2013, RENEW ENERG, V50, P236, DOI 10.1016/j.renene.2012.06.036; Vladislavleva E, 2010, IEEE T EVOLUT COMPUT, V14, P252, DOI 10.1109/TEVC.2009.2029697	141	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158230	10.1371/journal.pone.0158230	http://dx.doi.org/10.1371/journal.pone.0158230			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27366910	gold, Green Submitted, Green Published			2022-12-27	WOS:000378914900023
J	Valbuena, R; Heiskanen, J; Aynekulu, E; Pitkanen, S; Packalen, P				Valbuena, Ruben; Heiskanen, Janne; Aynekulu, Ermias; Pitkanen, Sari; Packalen, Petteri			Sensitivity of Above-Ground Biomass Estimates to Height-Diameter Modelling in Mixed-Species West African Woodlands	PLOS ONE			English	Article							FOREST BIOMASS; ALLOMETRIC EQUATIONS; TREE ALLOMETRY; RANDOM-COEFFICIENTS; ERROR PROPAGATION; VOLUME EQUATIONS; SUDANIAN SAVANNA; CARBON STOCKS; PINE; PREDICTION	It has been suggested that above-ground biomass (AGB) inventories should include tree height (H), in addition to diameter (D). As H is a difficult variable to measure, H-D models are commonly used to predict H. We tested a number of approaches for H-D modelling, including additive terms which increased the complexity of the model, and observed how differences in tree-level predictions of H propagated to plot-level AGB estimations. We were especially interested in detecting whether the choice of method can lead to bias. The compared approaches listed in the order of increasing complexity were: (B0) AGB estimations from D-only; (B1) involving also H obtained from a fixed-effects H-D model; (B2) involving also species; (B3) including also between-plot variability as random effects; and (B4) involving multilevel nested random effects for grouping plots in clusters. In light of the results, the modelling approach affected the AGB estimation significantly in some cases, although differences were negligible for some of the alternatives. The most important differences were found between including H or not in the AGB estimation. We observed that AGB predictions without H information were very sensitive to the environmental stress parameter (E), which can induce a critical bias. Regarding the H-D modelling, the most relevant effect was found when species was included as an additive term. We presented a two-step methodology, which succeeded in identifying the species for which the general H-D relation was relevant to modify. Based on the results, our final choice was the single-level mixed-effects model (B3), which accounts for the species but also for the plot random effects reflecting site-specific factors such as soil properties and degree of disturbance.	[Valbuena, Ruben; Pitkanen, Sari; Packalen, Petteri] Univ Eastern Finland, Sch Forest Sci, Joensuu, Finland; [Heiskanen, Janne] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Aynekulu, Ermias] World Agroforestry Ctr ICRAF, Nairobi, Kenya	University of Eastern Finland; University of Helsinki; CGIAR; World Agroforestry (ICRAF)	Valbuena, R (corresponding author), Univ Eastern Finland, Sch Forest Sci, Joensuu, Finland.	rubenval@uef.fi	Valbuena, Ruben RV/D-8066-2017; Valbuena, Ruben/I-6127-2019; Heiskanen, Janne/K-4668-2019; Aynekulu, Ermias/M-1825-2017	Valbuena, Ruben RV/0000-0003-0493-7581; Valbuena, Ruben/0000-0003-0493-7581; Heiskanen, Janne/0000-0002-3899-8860; Aynekulu, Ermias/0000-0002-1955-6995; Packalen, Petteri/0000-0003-1804-0011	Ministry for Foreign Affairs of Finland	Ministry for Foreign Affairs of Finland	This work is part of the Building Biocarbon and Rural Development in West Africa (BIODEV) project funded by the Ministry for Foreign Affairs of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WARS FRAM REDD; Baker TR, 2009, BIOGEOSCIENCES, V6, P297, DOI 10.5194/bg-6-297-2009; Banin L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1179, DOI 10.1111/j.1466-8238.2012.00778.x; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; Boffa J. M., 1999, AGROFORESTRY PARKLAN; Calama R, 2004, CAN J FOREST RES, V34, P150, DOI [10.1139/x03-199, 10.1139/X03-199]; Castedo-Dorado F, 2006, FOREST ECOL MANAG, V229, P202, DOI 10.1016/j.foreco.2006.04.028; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Ciais P, 2011, PHILOS T R SOC A, V369, P2038, DOI 10.1098/rsta.2010.0328; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Coble DW, 2011, SOUTH J APPL FOR, V35, P12, DOI 10.1093/sjaf/35.1.12; Coulibaly-Lingani P, 2011, FOREST POLICY ECON, V13, P292, DOI 10.1016/j.forpol.2011.02.005; Cuny HE, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.160, 10.1038/nplants.2015.160]; CURTIS RO, 1967, FOREST SCI, V13, P365; Eerikainen K, 2009, FOREST SCI, V55, P480; Fayolle A, 2013, FOREST ECOL MANAG, V305, P29, DOI 10.1016/j.foreco.2013.05.036; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Feldpausch TR, 2011, BIOGEOSCIENCES, V8, P1081, DOI 10.5194/bg-8-1081-2011; Flores O, 2011, METHODS ECOL EVOL, V2, P214, DOI 10.1111/j.2041-210X.2010.00068.x; Greenhill AG., 1881, P CAMBRIDGE PHILOS S, V4, P65, DOI DOI 10.1051/JPHYSTAP:018820010033701; Guendehou GHS, 2012, SOUTH FORESTS, V74, P77, DOI 10.2989/20702620.2012.701432; Henry M, 2011, SILVA FENN, V45, P477, DOI 10.14214/sf.38; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUANG SM, 1992, CAN J FOREST RES, V22, P1297, DOI 10.1139/x92-172; ICRAF World Agroforestry Centre-CGIAR, 2015, TREE FUNCT ATTR EC D; IPCC, 2006, IPCC GUIDELINES NATL; Jayaraman K, 2001, FOREST ECOL MANAG, V142, P155, DOI 10.1016/S0378-1127(00)00347-9; Jones A., 2013, SOIL ATLAS OF AFRICA; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; King DA, 1996, J TROP ECOL, V12, P25, DOI 10.1017/S0266467400009299; Kuyah S, 2015, AGROFOREST SYST, V89, P125, DOI 10.1007/s10457-014-9747-9; Kuyah S, 2012, AGR ECOSYST ENVIRON, V158, P216, DOI 10.1016/j.agee.2012.05.011; Lappi J, 2006, MANAG FOR ECOSYST, V10, P85; LAPPI J, 1991, FOREST SCI, V37, P781; LAPPI J, 1988, FOREST SCI, V34, P907; Larsen DR, 1987, HEIGHT DIAMETER EQUA; Marshall AR, 2012, BIOL CONSERV, V154, P20, DOI 10.1016/j.biocon.2012.03.017; Mehtatalo L., 2004, PREDICTING STAND CHA; Mehtatalo L, 2012, LMFOR FUNCTIONS FORE; Mehtatalo L, 2015, CAN J FOREST RES, V45, P826, DOI 10.1139/cjfr-2015-0054; Meng SX, 2008, FOREST ECOL MANAG, V256, P570, DOI 10.1016/j.foreco.2008.05.002; MEYER HANS ARTHUR, 1940, JOUR FOREST, V38, P415; Molto Q, 2014, BIOGEOSCIENCES, V11, P3121, DOI 10.5194/bg-11-3121-2014; Molto Q, 2013, METHODS ECOL EVOL, V4, P175, DOI 10.1111/j.2041-210x.2012.00266.x; Nelson BW, 1999, FOREST ECOL MANAG, V117, P149, DOI 10.1016/S0378-1127(98)00475-7; Nygard R, 2000, ANN FOR SCI, V57, P143; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro J, 2000, MIXED EFFECTS MODELS; RCore Team, 2020, R LANG ENV STAT COMP; Ribeiro SC, 2011, FOREST ECOL MANAG, V262, P491, DOI 10.1016/j.foreco.2011.04.017; Rutishauser E, 2013, FOREST ECOL MANAG, V307, P219, DOI 10.1016/j.foreco.2013.07.013; Sampaio E, 2010, FOREST ECOL MANAG, V259, P1135, DOI 10.1016/j.foreco.2009.12.028; Sawadogo L, 2002, ANN FOREST SCI, V59, P185, DOI 10.1051/forest:2002005; Sawadogo Louis, 2010, Journal of Forestry Research (Harbin), V21, P475, DOI 10.1007/s11676-010-0101-4; Schmidt M, 2011, EUR J FOREST RES, V130, P303, DOI 10.1007/s10342-010-0434-8; Sexton JO, 2016, NAT CLIM CHANGE, V6, P192, DOI [10.1038/NCLIMATE2816, 10.1038/nclimate2816]; Sharma M, 2007, FOREST ECOL MANAG, V249, P187, DOI 10.1016/j.foreco.2007.05.006; Sileshi GW, 2014, FOREST ECOL MANAG, V329, P237, DOI 10.1016/j.foreco.2014.06.026; Temesgen H, 2004, EUR J FOR RES, V123, P45, DOI 10.1007/s10342-004-0020-z; Temesgen H, 2015, SCAND J FOREST RES, V30, P326, DOI 10.1080/02827581.2015.1012114; Tesfaye MA, 2016, ANN FOREST SCI, V73, P411, DOI 10.1007/s13595-015-0533-2; United Nations Development Programme, 2010, 3970 UNDP PIMS SUBPR; Vagen T.-G., 2010, LAND DEGRADATION SUR; Valentini R, 2014, BIOGEOSCIENCES, V11, P381, DOI 10.5194/bg-11-381-2014; Vargas-Larreta B, 2009, FORESTRY, V82, P445, DOI 10.1093/forestry/cpp016; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]; Zeide B., 2002, General Technical Report - Southern Research Station, USDA Forest Service, P463; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zianis D., 2005, Silva Fennica Monographs, P1	74	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158198	10.1371/journal.pone.0158198	http://dx.doi.org/10.1371/journal.pone.0158198			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367857	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900020
J	Huang, WY; Wang, B; Wright, JS; Chen, RY				Huang, Wenyu; Wang, Bin; Wright, Jonathon S.; Chen, Ruyan			On the Non-Stationary Relationship between the Siberian High and Arctic Oscillation	PLOS ONE			English	Article							ASIAN WINTER MONSOON; SEA-ICE; VARIABILITY; TEMPERATURE; PACIFIC; CLIMATE; PRECIPITATION; CIRCULATION	An area-weighted kappa-means clustering method based on pattern correlations is proposed and used to explore the relationship between the Siberian High (SH) and Arctic Oscillation (AO) during the winter months (December-January-February) of 1948-2014. Five regimes are identified. Four of these five regimes (comprising 171 of 201 months) show a negative correlation between the SH and AO indices, while the last regime (30 months) shows a positive correlation. The location of the SH shifts southward into China under two of the four negative-correlation regimes (117 months), with pressure variations over the center of activity for the SH opposite to pressure variations over the climatological center of the SH (which is used to define the SH index). Adjusting the SH index to account for these spatial shifts suggests positive rather than negative correlations between major variations in the SH and AO under these regimes. Under one of the two remaining negative-correlation regimes, pressure anomalies are weak over the Arctic Ocean. In total, only one regime comprising 21 of 201 months strictly obeys the negative correlation between the SH and AO reported by previous studies. The climate regime characterized by an intensified SH is associated with a greater frequency of cold surges over northern and southeastern China, and the weakening of the East Asian winter monsoon during the 1980s was accompanied by a sharp reduction in the occurrence of this regime.	[Huang, Wenyu; Wang, Bin; Wright, Jonathon S.; Chen, Ruyan] Tsinghua Univ, Ctr Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing, Peoples R China; [Wang, Bin] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modeling Atmospher Sci & Geop, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Huang, WY (corresponding author), Tsinghua Univ, Ctr Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing, Peoples R China.	huangwenyu@mail.tsinghua.edu.cn	Huang, Wenyu/J-4257-2019; Wang, Bin/P-9121-2014; Huang, Wenyu/M-7584-2014; Wang, Bin/D-9724-2012	Huang, Wenyu/0000-0001-9722-5502; Wang, Bin/0000-0001-7374-3786; Huang, Wenyu/0000-0001-9722-5502; Wang, Bin/0000-0002-3133-7197; Wright, Jonathon/0000-0001-6551-7017; Chen, Ruyan/0000-0001-9855-4914	National Basic Research Program of China [2015CB953703, 2014CB441302]; National Natural Science Foundation of China [41505063]; China Meteorological Welfare Research Fund [GYHY201406007]; Tsinghua University Initiative Scientific Research Program [20131089356]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Meteorological Welfare Research Fund; Tsinghua University Initiative Scientific Research Program	This work was supported by the National Basic Research Program of China (2015CB953703, 2014CB441302), the National Natural Science Foundation of China (41505063), the China Meteorological Welfare Research Fund (GYHY201406007), and the Tsinghua University Initiative Scientific Research Program (20131089356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambaum MHP, 2001, J CLIMATE, V14, P3495, DOI 10.1175/1520-0442(2001)014<3495:AOONAO>2.0.CO;2; Budikova D, 2012, GEOGR COMPASS, V6, P401, DOI 10.1111/j.1749-8198.2012.00498.x; Cassou C, 2004, J CLIMATE, V17, P1055, DOI 10.1175/1520-0442(2004)017<1055:NAWCRS>2.0.CO;2; Chen W, 2000, ADV ATMOS SCI, V17, P48; Cho MH, 2014, ASIA-PAC J ATMOS SCI, V50, P15, DOI 10.1007/s13143-014-0046-1; Cohen J, 2001, GEOPHYS RES LETT, V28, P299, DOI 10.1029/2000GL011927; DING YH, 1990, METEOROL ATMOS PHYS, V44, P281; Dunn-Sigouin E, 2013, J GEOPHYS RES-ATMOS, V118, P1179, DOI 10.1002/jgrd.50143; Estivill-Castro V, 2001, ALGORITHMICA, V30, P216, DOI 10.1007/s00453-001-0010-1; Gong DY, 2001, GEOPHYS RES LETT, V28, P2073, DOI 10.1029/2000GL012311; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Huang W, 2016, J GEOPHYS RES ATMOSP; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jeong JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023024; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kirsten M., 1998, Inductive Logic Programming. 8th International Conference, ILP-98. Proceedings, P261, DOI 10.1007/BFb0027330; Overland JE, 1999, J CLIMATE, V12, P1542, DOI 10.1175/1520-0442(1999)012<1542:DVOTAL>2.0.CO;2; Pak G, 2014, J CLIMATE, V27, P8185, DOI 10.1175/JCLI-D-13-00500.1; Park TW, 2011, J CLIMATE, V24, P68, DOI 10.1175/2010JCLI3529.1; Rawat R, 2011, LECT NOTES COMPUT SC, V6612, P29, DOI 10.1007/978-3-642-20291-9_6; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Riddle EE, 2013, CLIM DYNAM, V40, P1749, DOI 10.1007/s00382-012-1493-y; SAHSAMANOGLOU HS, 1991, INT J CLIMATOL, V11, P827, DOI 10.1002/joc.3370110803; Takaya K, 2005, J ATMOS SCI, V62, P4423, DOI 10.1175/JAS3629.1; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Wang B, 2000, J CLIMATE, V13, P1517, DOI 10.1175/1520-0442(2000)013<1517:PEATHD>2.0.CO;2; Wang L, 2010, ADV ATMOS SCI, V27, P855, DOI 10.1007/s00376-009-9094-3; Wu BY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015373; Wu BY, 2002, ADV ATMOS SCI, V19, P297; Zhang XB, 2011, WIRES CLIM CHANGE, V2, P851, DOI 10.1002/wcc.147	32	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158122	10.1371/journal.pone.0158122	http://dx.doi.org/10.1371/journal.pone.0158122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362556	Green Submitted, gold, Green Published			2022-12-27	WOS:000378865200042
J	Kitahara, T; Okamoto, H; Fukushima, M; Sakagami, M; Ito, T; Yamashita, A; Ota, I; Yamanaka, T				Kitahara, Tadashi; Okamoto, Hidehiko; Fukushima, Munehisa; Sakagami, Masaharu; Ito, Taeko; Yamashita, Akinori; Ota, Ichiro; Yamanaka, Toshiaki			A Two-Year Randomized Trial of Interventions to Decrease Stress Hormone Vasopressin Production in Patients with Meniere's Disease-A Pilot Study	PLOS ONE			English	Article							ENDOLYMPHATIC HYDROPS; INNER-EAR; SLEEP-DEPRIVATION; EXCESS DIURESIS; SAC; NATRIURESIS; AQUAPORIN-2; PROGRESSION; EXPRESSION; SURGERY	Meniere's disease, a common inner ear condition, has an incidence of 15-50 per 100,000. Because mental/physical stress and subsequent increase in the stress hormone vasopressin supposedly trigger Meniere's disease, we set a pilot study to seek new therapeutic interventions, namely management of vasopressin secretion, to treat this disease. We enrolled 297 definite Meniere's patients from 2010 to 2012 in a randomized-controlled and open-label trial, assigning Group-I (control) traditional oral medication, Group-II abundant water intake, Group-III tympanic ventilation tubes and Group-IV sleeping in darkness. Two hundred sixty-three patients completed the planned 2-year-follow-up, which included assessment of vertigo, hearing, plasma vasopressin concentrations and changes in stress/psychological factors. At 2 years, vertigo was completely controlled in 54.3% of patients in Group-I, 81.4% in Group-II, 84.1% in Group-III, and 80.0% in Group-IV (statistically I < II = III = IV). Hearing was improved in 7.1% of patients in Group-I, 35.7% in Group-II, 34.9% in Group-III, and 31.7% in Group-IV (statistically I < II = III = IV). Plasma vasopressin concentrations decreased more in Groups-II, -III, and -IV than in Groups-I (statistically I < II = III = IV), although patients' stress/psychological factors had not changed. Physicians have focused on stress management for Meniere's disease. However, avoidance of stress is unrealistic for patients who live in demanding social environments. Our findings in this pilot study suggest that interventions to decrease vasopressin secretion by abundant water intake, tympanic ventilation tubes and sleeping in darkness is feasible in treating Meniere's disease, even though these therapies did not alter reported mental/physical stress levels.	[Kitahara, Tadashi; Sakagami, Masaharu; Ito, Taeko; Yamashita, Akinori; Ota, Ichiro; Yamanaka, Toshiaki] Nara Med Univ, Dept Otolaryngol, Kashihara, Nara, Japan; [Kitahara, Tadashi; Fukushima, Munehisa] Osaka Rosai Hosp, Dept Otolaryngol, Sakai, Osaka, Japan; [Okamoto, Hidehiko] Okazaki Res Inst, Dept Physiol, Okazaki, Aichi, Japan	Nara Medical University; Osaka Rosai Hospital	Kitahara, T (corresponding author), Nara Med Univ, Dept Otolaryngol, Kashihara, Nara, Japan.; Kitahara, T (corresponding author), Osaka Rosai Hosp, Dept Otolaryngol, Sakai, Osaka, Japan.	tkitahara@naramed-u.ac.jp	Ito, Taeko/Q-4244-2019; Okamoto, Hidehiko/A-7934-2008	Ito, Taeko/0000-0002-3680-1024; Ota, Ichiro/0000-0003-3815-8877; Okamoto, Hidehiko/0000-0003-2799-3340	JSPS KAKENHI Grant; Japan AMED; Grants-in-Aid for Scientific Research [26861426] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan AMED; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI Grant (2016-2018) and by Grant-in-Aid for Research on Intractable Vestibular Disorder from Japan AMED (2015-2017). The funders above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2007, J NEUROENDOCRINOL, V19, P901, DOI 10.1111/j.1365-2826.2007.01601.x; Arts HA, 1997, OTOLARYNG CLIN N AM, V30, P987; Claes J, 2000, ACTA OTO-LARYNGOL, P34; Foster CA, 2013, OTOL NEUROTOL, V34, P1210, DOI 10.1097/MAO.0b013e31829e83df; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Hallpike CS., 1938, J LARYNGOL OTOL, V53, P625, DOI [10.1017/S0022215100003947, DOI 10.1017/S0022215100003947]; Horii A, 2004, ACTA OTO-LARYNGOL, V124, P50, DOI 10.1080/03655230410017661; Hornibrook J, 2011, ACTA OTO-LARYNGOL, V131, P613, DOI 10.3109/00016489.2010.541940; Ishiyama Gail, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P332, DOI 10.1097/01.moo.0000244191.51560.22; Kalsbeek A, 2010, J NEUROENDOCRINOL, V22, P362, DOI 10.1111/j.1365-2826.2010.01956.x; Kamperis K, 2010, AM J PHYSIOL-RENAL, V299, pF404, DOI 10.1152/ajprenal.00126.2010; Kimura RS, 1997, EUR ARCH OTO-RHINO-L, V254, P213, DOI 10.1007/BF00874091; Kitahara T, 2008, J NEUROENDOCRINOL, V20, P1295, DOI 10.1111/j.1365-2826.2008.01792.x; Kumagami H, 1998, PFLUG ARCH EUR J PHY, V436, P970, DOI 10.1007/s004240050731; Lim JS, 2003, LARYNGOSCOPE, V113, P1321, DOI 10.1097/00005537-200308000-00011; Liu F, 1997, EUR ARCH OTO-RHINO-L, V254, P95, DOI 10.1007/BF01526188; Maekawa C, 2010, J NEUROENDOCRINOL, V22, P1157, DOI 10.1111/j.1365-2826.2010.02060.x; Mahler B, 2012, AM J PHYSIOL-RENAL, V302, pF236, DOI 10.1152/ajprenal.00283.2011; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Naganuma H, 2006, LARYNGOSCOPE, V116, P1455, DOI 10.1097/01.mlg.0000225904.78569.0c; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Nakayama M, 2010, J CLIN SLEEP MED, V6, P445; Sajjadi H, 2008, LANCET, V372, P406, DOI 10.1016/S0140-6736(08)61161-7; Sasaki S, 2007, CURR OPIN NEPHROL HY, V16, P348, DOI 10.1097/MNH.0b013e32818b27bf; SILVERSTEIN H, 1989, OTOLARYNG HEAD NECK, V100, P6, DOI 10.1177/019459988910000102; Silverstein Herbert, 2003, Ear Nose Throat J, V82, P185; STAHLE J, 1978, ARCH OTOLARYNGOL, V104, P99; Suzuki M, 2003, NEUROREPORT, V14, P1951, DOI 10.1097/00001756-200310270-00014; Takahashi M, 2005, ORL-J OTO-RHIN-LARYN, V67, P300, DOI 10.1159/000089412; Takeda T, 2000, HEARING RES, V140, P1, DOI 10.1016/S0378-5955(99)00180-X; TAKEDA T, 1995, ACTA OTO-LARYNGOL, P219; Takeda T, 2006, HEARING RES, V218, P89, DOI 10.1016/j.heares.2006.05.001; THOMSEN J, 1981, ARCH OTOLARYNGOL, V107, P271; Thomsen J, 1998, ACTA OTO-LARYNGOL, V118, P769, DOI 10.1080/00016489850182413; van Cruijsen N, 2005, OTOL NEUROTOL, V26, P1214, DOI 10.1097/01.mao.0000179528.24909.ba; Yamakawa K., 1938, J OTORHINOLARYNGOL S, V44, P2310; Yamane Takahiro, 2013, Shinrigaku Kenkyu, V83, P556; Yamasoba T, 1999, HUM GENE THER, V10, P769, DOI 10.1089/10430349950018526	38	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158309	10.1371/journal.pone.0158309	http://dx.doi.org/10.1371/journal.pone.0158309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362705	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200055
J	Mariapun, J; Hairi, NN; Ng, CW				Mariapun, Jeevitha; Hairi, Noran N.; Ng, Chiu-Wan			Are the Poor Dying Younger in Malaysia? An Examination of the Socioeconomic Gradient in Mortality	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; HEALTH; GROWTH; INEQUALITIES; DETERMINANTS; CHILDREN; EQUITY; TRENDS	Introduction Socioeconomic inequalities in health represent unfairness in the health distribution of a population. Efforts to produce information on mortality distributions in many low and middle income countries (LMICs) are mostly hampered by lack of data disaggregated by socioeconomic groups. In this paper we describe how mortality statistics obtained from multiple data sources were combined to provide an evaluation of the socioeconomic distribution of mortality in Malaysia, a LMIC located in the Asia Pacific region. Methods This study has an ecological design. As a measure of socioeconomic status, we used principal component analysis to construct a socioeconomic index using census data. Districts were ranked according to the standardised median index of households and assigned to each individual in the 5-year mortality data. The mortality indicators of interest were potential years of life lost (PYLL), standardised mortality ratio (SMR), infant mortality rate (IMR) and under-5 mortality rate (U5MR). Both socioeconomic status and mortality outcomes were used compute the concentration index which provided the summary measure of the magnitude of inequality. Results Socially disadvantaged districts were found to have worse mortality outcomes compared to more advantaged districts. The values of the concentration index for the overall population of the Peninsula are C = -0.1334 (95% CI: -0.1605 to -0.1063) for the PYLL, C = -0.0685 (95% CI: -0.0928 to -0.0441) for the SMR, C = -0.0997 (95% CI: -0.1343 to -0.0652) for the IMR and C = -0.1207 (95% CI: -0.1523 to -0.0891) for the U5MR. Mortality outcomes within ethnic groups were also found to be less favourable among the poor. Conclusion The findings of this study suggest that socioeconomic inequalities disfavouring the poor exist in Malaysia.	[Mariapun, Jeevitha; Hairi, Noran N.; Ng, Chiu-Wan] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Ng, CW (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur 50603, Malaysia.	chiuwan.ng@ummc.edu.my	NG, CHIU WAN/B-9222-2010; Mariapun, Jeevitha/AAL-1607-2020; HAIRI, NORAN/B-9339-2010; NG, CHIU WAN/B-5218-2010	Mariapun, Jeevitha/0000-0003-3421-0527; HAIRI, NORAN/0000-0002-2692-9016; NG, CHIU WAN/0000-0002-7687-2310	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant [E000010-20001]; University of Malaya Grand Challenge PEACE grant [GC001A-14HTM]; Ministry of Education High Impact Research STeMM grant [E000010-20001]	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant; University of Malaya Grand Challenge PEACE grant; Ministry of Education High Impact Research STeMM grant	This study was a part of the STeMM Programme supported by the University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (Grant number E000010-20001). NNH's work was supported by the University of Malaya Grand Challenge PEACE grant (GC001A-14HTM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This study is supported by the Ministry of Education High Impact Research STeMM grant (E000010-20001). NNH's work is supported by the University of Malaya Grand Challenge PEACE grant (GC001A-14HTM).	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; [Anonymous], 2012, LEV TRENDS CHILD MOR; [Anonymous], 2008, ANAL HLTH EQUITY USI; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Chee HL, 2005, ACHIEVING MDGS HLTH; Chiu-Wan Ng, 2012, ASSESSING FAIR FINAN; Daniels Norman, 2008, JUST HLTH M HLTH NEE; Department of Statistics M, 1999, IMPR DEM STAT SAB SA; Department of Statistics Malaysia, 2013, HOUS INC BAS AM SURV; Department of Statistics Malaysia, 2011, POPULATION DISTRIBUT; Economic Planning Unit, 2004, MAL 30 YEARS POV RED; Faaland J., 2003, GROWTH ETHNIC INEQUA; Fam S-F, 2011, INT J ARTS SCI, V4, P257; Faudzi A., 2011, MED J MALAYS, V66, P33; Griffiths C., 2006, HLTH STAT Q, V31, P34; Helgeson VS, 2009, PSYCHOL GENDER; Houweling TAJ, 2006, J EPIDEMIOL COMMUN H, V60, P62, DOI 10.1136/jech.2005.036079; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; ICSU I, 2015, REV TARG SUST DEV GO; Institute for Public health, 2012, REP GLOB AD TOB SURV; Kakwani N, 1980, ECONOMETRICA, P437; Kaplan GA, 2001, AM J PUBLIC HEALTH, V91, P351, DOI 10.2105/AJPH.91.3.351; Malaysia DoS, 2013, VIT STAT 2012; Marmot M, 2014, AM J PUBLIC HEALTH, V104, pS517, DOI 10.2105/AJPH.2014.302200; Marmot Michael, 2004, SIGNIFICANCE, V1, P150, DOI DOI 10.1111/J.1740-9713.2004.00058.X; Menon J, 2014, J ASIA PAC ECON, V19, P247, DOI 10.1080/13547860.2013.820471; Merican M I, 2004, Med J Malaysia, V59, P84; Nagaraj S, 2008, J POPUL RES, V25, P183, DOI 10.1007/BF03031948; Ng C.W., 2014, NAT POP C INT POP DY; References Blaxter M, 1981, HLTH CHILDREN REV RE; Reidpath Daniel D, 2007, Int J Equity Health, V6, P16, DOI 10.1186/1475-9276-6-16; Roslan A. H., 2001, INCOME INEQUALITY PO; Saari MY, 2015, WORLD DEV, V76, P311, DOI 10.1016/j.worlddev.2015.07.015; Sastry N, 2004, DEMOGRAPHY, V41, P443, DOI 10.1353/dem.2004.0027; Savedoff WD, 2011, ACHIEVING UNIVERSAL; United Nations Economic Planning Unit Malaysia, 2015, MAL MILL DEV GOALS 2; United Nations General Assembly, 2014, A68970 UN GEN ASS; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; World Health Organization, 2014, WORLD HLTH STAT 2014; Yu CP, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-15	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158685	10.1371/journal.pone.0158685	http://dx.doi.org/10.1371/journal.pone.0158685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362581	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200108
J	Korber, I; Katayama, S; Einarsdottir, E; Krjutskov, K; Hakala, P; Kere, J; Lehesjoki, AE; Joensuu, T				Korber, Inken; Katayama, Shintaro; Einarsdottir, Elisabet; Krjutskov, Kaarel; Hakala, Paula; Kere, Juha; Lehesjoki, Anna-Elina; Joensuu, Tarja			Gene-Expression Profiling Suggests Impaired Signaling via the Interferon Pathway in Cstb(-/-) Microglia	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; CYSTATIN-B DEFICIENCY; I INTERFERONS; MOUSE MODEL; DISEASE; EPM1; DIFFERENTIATION; NORMALIZATION; INFLAMMATION; MACROPHAGES	Progressive myoclonus epilepsy of Unverricht-Lundborg type (EPM1, OMIM254800) is an autosomal recessive neurodegenerative disorder characterized by stimulus-sensitive and action-activated myoclonus, tonic-clonic epileptic seizures, and ataxia. Loss-of-function mutations in the gene encoding the cysteine protease inhibitor cystatin B (CSTB) underlie EPM1. The deficiency of CSTB in mice (Cstb(-/-) mice) generates a phenotype resembling the symptoms of EPM1 patients and is accompanied by microglial activation at two weeks of age and an upregulation of immune system-associated genes in the cerebellum at one month of age. To shed light on molecular pathways and processes linked to CSTB deficiency in microglia we characterized the transcriptome of cultured Cstb(-/-) mouse microglia using microarray hybridization and RNA sequencing (RNA-seq). The gene expression profiles obtained with these two techniques were in good accordance and not polarized to either pro- or anti-inflammatory status. In Cstb(-/-) microglia, altogether 184 genes were differentially expressed. Of these, 33 genes were identified by both methods. Several interferon-regulated genes were weaker expressed in Cstb(-/-) microglia compared to control. This was confirmed by quantitative real-time PCR of the transcripts Irf7 and Stat1. Subsequently, we explored the biological context of CSTB deficiency in microglia more deeply by functional enrichment and canonical pathway analysis. This uncovered a potential role for CSTB in chemotaxis, antigen-presentation, and in immune-and defense response-associated processes by altering JAK-STAT pathway signaling. These data support and expand the previously suggested involvement of inflammatory processes to the disease pathogenesis of EPM1 and connect CSTB deficiency in microglia to altered expression of interferon-regulated genes.	[Korber, Inken; Einarsdottir, Elisabet; Hakala, Paula; Kere, Juha; Lehesjoki, Anna-Elina; Joensuu, Tarja] Folkhalsan Inst Genet, Helsinki, Finland; [Korber, Inken; Einarsdottir, Elisabet; Hakala, Paula; Kere, Juha; Lehesjoki, Anna-Elina; Joensuu, Tarja] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Korber, Inken; Hakala, Paula; Lehesjoki, Anna-Elina; Joensuu, Tarja] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Katayama, Shintaro; Einarsdottir, Elisabet; Krjutskov, Kaarel; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Krjutskov, Kaarel] Competence Ctr Hlth Technol, Tartu, Estonia	University of Helsinki; University of Helsinki; Karolinska Institutet	Joensuu, T (corresponding author), Folkhalsan Inst Genet, Helsinki, Finland.; Joensuu, T (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland.; Joensuu, T (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	tarja.joensuu@helsinki.fi	Kere, Juha/AAX-9117-2021; Joensuu, Tarja/F-3059-2011; Kere, Juha/A-9179-2008; Katayama, Shintaro/F-2958-2010	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Katayama, Shintaro/0000-0001-7581-5157; Einarsdottir, Elisabet/0000-0003-3101-2285	Folkhalsan Research Foundation; Sigrid Juselius Foundation; Academy of Finland [137950]; Epilepsiatutkimussaatio; Doctoral Programme in Biomedicine; Swedish Research Council; Karolinska Institutet Distinguished Professor Award; Strategic Research Program funding on Diabetes; EU FP7-PEOPLE-IAPP grant SARM [324509]; SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [b2014069]	Folkhalsan Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Epilepsiatutkimussaatio; Doctoral Programme in Biomedicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet Distinguished Professor Award; Strategic Research Program funding on Diabetes; EU FP7-PEOPLE-IAPP grant SARM; SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX)	This study was funded by the Folkhalsan Research Foundation, the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation), and Academy of Finland (project 137950) (http://www.aka.fi/en); and Epilepsiatutkimussaatio (www.epilepsia.fi) and the Doctoral Programme in Biomedicine (http://www.helsinki.fi/dpbm) to I.K. Work in the J.K. laboratory was supported by the Swedish Research Council (http://www.vr.se/inenglish), the Karolinska Institutet Distinguished Professor Award, Strategic Research Program funding on Diabetes to Karolinska Institutet (http://www.ki.se/en/srp-diabetes), and EU FP7-PEOPLE-2012-IAPP grant SARM (324509) (http://www.ec.europa.eu/research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The computations were performed on resources provided by SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under Project b2014069. We would like to thank Per Harald Jonson, PhD, for commenting on the manuscript.	Ahn J, 2015, BIOCHEM BIOPH RES CO, V466, P52, DOI 10.1016/j.bbrc.2015.08.104; Alakurtti K, 2005, EUR J HUM GENET, V13, P208, DOI 10.1038/sj.ejhg.5201300; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Ceru S, 2010, J BIOL CHEM, V285, P10078, DOI 10.1074/jbc.M109.034793; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Franceschetti S, 2007, NEUROBIOL DIS, V25, P675, DOI 10.1016/j.nbd.2006.11.006; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hofer MJ, 2010, J NEUROSCI, V30, P1149, DOI 10.1523/JNEUROSCI.3711-09.2010; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Inacio AR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0427-0; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Joensuu T, 2007, EUR J HUM GENET, V15, P185, DOI 10.1038/sj.ejhg.5201723; Joensuu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089321; Kalviainen R, 2008, EPILEPSIA, V49, P549, DOI 10.1111/j.1528-1167.2008.01546.x; Katayama S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1671-5; Katayama S, 2013, BIOINFORMATICS, V29, P2943, DOI 10.1093/bioinformatics/btt511; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koskenkorva P, 2012, AM J NEURORADIOL, V33, P878, DOI 10.3174/ajnr.A2882; Krjutskov K, 2016, HUM REPROD, V31, P844, DOI 10.1093/humrep/dew008; Kuo Ping-Chang, 2016, J Am Heart Assoc, V5, DOI 10.1161/JAHA.115.002610; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Ma CY, 2014, DEVELOPMENT, V141, P4697, DOI 10.1242/dev.117937; Maher K, 2014, J BIOL CHEM, V289, P31736, DOI 10.1074/jbc.M114.609396; Maher K, 2014, FEBS LETT, V588, P720, DOI 10.1016/j.febslet.2014.01.015; Manninen O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090709; Manninen O, 2013, RADIOLOGY, V269, P232, DOI 10.1148/radiol.13122458; Mascalchi M, 2002, NEUROLOGY, V58, P1686, DOI 10.1212/WNL.58.11.1686; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Nallar SC, 2014, J INTERF CYTOK RES, V34, P559, DOI 10.1089/jir.2014.0021; Okuneva O, 2015, GLIA, V63, P400, DOI 10.1002/glia.22760; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Prinz M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00067; Rinne R, 2002, ANN MED, V34, P380, DOI 10.1080/078538902320772124; RITONJA A, 1985, BIOCHEM BIOPH RES CO, V131, P1187, DOI 10.1016/0006-291X(85)90216-5; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shannon P, 2002, J NEUROPATH EXP NEUR, V61, P1085, DOI 10.1093/jnen/61.12.1085; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Tegelberg S, 2012, J NEUROPATH EXP NEUR, V71, P40, DOI 10.1097/NEN.0b013e31823e68e1; Tohonen V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9207; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Wang JP, 2002, P NATL ACAD SCI USA, V99, P16209, DOI 10.1073/pnas.252454799; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	57	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158195	10.1371/journal.pone.0158195	http://dx.doi.org/10.1371/journal.pone.0158195			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355630	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400037
J	King, AC; Hekler, EB; Grieco, LA; Winter, SJ; Sheats, JL; Buman, MP; Banerjee, B; Robinson, TN; Cirimele, J				King, Abby C.; Hekler, Eric B.; Grieco, Lauren A.; Winter, Sandra J.; Sheats, Jylana L.; Buman, Matthew P.; Banerjee, Banny; Robinson, Thomas N.; Cirimele, Jesse			Effects of Three Motivationally Targeted Mobile Device Applications on Initial Physical Activity and Sedentary Behavior Change in Midlife and Older Adults: A Randomized Trial	PLOS ONE			English	Article							HEALTH; INTERVENTIONS; MORTALITY; MEDICINE; DISEASE; TIME	Background While there has been an explosion of mobile device applications (apps) promoting healthful behaviors, including physical activity and sedentary patterns, surprisingly few have been based explicitly on strategies drawn from behavioral theory and evidence. Objective This study provided an initial 8-week evaluation of three different customized physical activity-sedentary behavior apps drawn from conceptually distinct motivational frames in comparison with a commercially available control app. Study Design and Methods Ninety-five underactive adults ages 45 years and older with no prior smartphone experience were randomized to use an analytically framed app, a socially framed app, an affectively framed app, or a diet-tracker control app. Daily physical activity and sedentary behavior were measured using the smartphone's built-in accelerometer and daily self-report measures. Results Mixed-effects models indicated that, over the 8-week period, the social app users showed significantly greater overall increases in weekly accelerometry-derived moderate to vigorous physical activity relative to the other three arms (P values for between-arm differences = .04-.005; Social vs. Control app: d = 1.05, CI = 0.44,1.67; Social vs. Affect app: d = 0.89, CI = 0.27,1.51; Social vs. Analytic app: d = 0.89, CI = 0.27,1.51), while more variable responses were observed among users of the other two motivationally framed apps. Social app users also had significantly lower overall amounts of accelerometry-derived sedentary behavior relative to the other three arms (P values for between-arm differences = .02-.001; Social vs. Control app: d = 1.10, CI = 0.48,1.72; Social vs. Affect app: d = 0.94, CI = 0.32,1.56; Social vs. Analytic app: d = 1.24, CI = 0.59,1.89). Additionally, Social and Affect app users reported lower overall sitting time compared to the other two arms (P values for between-arm differences <.001; Social vs. Control app: d = 1.59, CI = 0.92, 2.25; Social vs. Analytic app: d = 1.89, CI = 1.17, 2.61; Affect vs. Control app: d = 1.19, CI = 0.56, 1.81; Affect vs. Analytic app: d = 1.41, CI = 0.74, 2.07). Conclusion The results provide initial support for the use of a smartphone-delivered social frame in the early induction of both physical activity and sedentary behavior changes. The information obtained also sets the stage for further investigation of subgroups that might particularly benefit from different motivationally framed apps in these two key health promotion areas.	[King, Abby C.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Dept Med, Stanford, CA 94305 USA; [King, Abby C.] Stanford Univ, Div Epidemiol, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Hekler, Eric B.; Grieco, Lauren A.; Winter, Sandra J.; Sheats, Jylana L.; Buman, Matthew P.; Robinson, Thomas N.] Stanford Univ, Stanford Prevent Res Ctr, Dept Med, Sch Med, Stanford, CA 94305 USA; [Banerjee, Banny] Stanford Univ, Sch Earth Energy & Environm Sci, Stanford, CA 94305 USA; [Robinson, Thomas N.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Cirimele, Jesse] Stanford Univ, Dept Comp Sci, Sch Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	King, AC (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Dept Med, Stanford, CA 94305 USA.; King, AC (corresponding author), Stanford Univ, Div Epidemiol, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA.	king@stanford.edu	King, Abby/AAD-5257-2021; Buman, Matthew/AAJ-4447-2020	Buman, Matthew/0000-0002-5130-3162; King, Abby/0000-0002-7949-8811; Hekler, Eric B/0000-0002-7434-0775	US Public Health Service grant from the National Heart, Lung, & Blood Institute of the National Institutes of Health (NIH) [RC1 HL099340]; US Public Health Service Grant [1U54EB020405]; US Public Health Service grant from the National Heart, Lung, & Blood Institute [5T32L007034]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020405] Funding Source: NIH RePORTER	US Public Health Service grant from the National Heart, Lung, & Blood Institute of the National Institutes of Health (NIH); US Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); US Public Health Service grant from the National Heart, Lung, & Blood Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by US Public Health Service grant #RC1 HL099340 from the National Heart, Lung, & Blood Institute of the National Institutes of Health (NIH) awarded to Dr. King; US Public Health Service Grant 1U54EB020405 supporting The National Center for Mobility Data Integration and Insight; and US Public Health Service grant #5T32L007034 from the National Heart, Lung, & Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A, 2006, PERSPECT PSYCHOL SCI, V1, P164, DOI 10.1111/j.1745-6916.2006.00011.x; Barradas S, 2013, 34 ANN M SCI SESS SO; Bassett DR, 2010, MED SCI SPORT EXER, V42, P1819, DOI 10.1249/MSS.0b013e3181dc2e54; Bickmore T, 2010, APPL ARTIF INTELL, V24, P648, DOI 10.1080/08839514.2010.492259; Bond DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100821; Bort-Roig J, 2014, SPORTS MED, V44, P671, DOI 10.1007/s40279-014-0142-5; Burke LE, 2015, CIRCULATION, V132, P1157, DOI 10.1161/CIR.0000000000000232; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Cialdini R.B., 2006, SOC INFLUENCE, V1, p3, DOI [10.1080/15534510500181459, DOI 10.1080/15534510500181459]; Direito A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-646; Dunton GF, 2009, ANN BEHAV MED, V38, P249, DOI 10.1007/s12160-009-9141-4; EFRON B, 1971, BIOMETRIKA, V58, P403, DOI 10.2307/2334377; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Gabriele JM, 2005, ANN BEHAV MED, V29, P210, DOI 10.1207/s15324796abm2903_7; Hekler EB, 2011, CHI 2011, V2011; Hekler EB, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3505; Hekler EB, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-109; Hekler EB, 2012, PSYCHOL HEALTH, V27, P1009, DOI 10.1080/08870446.2011.645213; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; King AC, 2008, ANN BEHAV MED, V35, P251, DOI 10.1007/s12160-008-9032-0; King AC, 2008, AM J PREV MED, V34, P138, DOI 10.1016/j.amepre.2007.09.025; King AC, 2015, AM J PREV MED, V48, P630, DOI 10.1016/j.amepre.2014.10.005; King AC, 2014, ANN BEHAV MED, V47, P71, DOI 10.1007/s12160-013-9530-6; King AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062613; King AC, 2010, AM J PREV MED, V38, P17, DOI 10.1016/j.amepre.2009.08.032; Larsen RN, 2015, CLIN SCI, V129, P117, DOI 10.1042/CS20140790; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; de Rezende LFM, 2016, AM J PREV MED, V51, P253, DOI 10.1016/j.amepre.2016.01.022; Maibach E, 2009, PREV MED, V49, P326, DOI 10.1016/j.ypmed.2009.06.028; Metzler MM, 2003, AM J PUBLIC HEALTH, V93, P803, DOI 10.2105/AJPH.93.5.803; Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664; Middelweerd A, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0097-9; Miller W.R., 2008, MANUAL MOTIVATIONAL; Nahum-Shani I, HLTH PSYCHO IN PRESS; Norman GJ, 2007, AM J PREV MED, V33, P336, DOI 10.1016/j.amepre.2007.05.007; Pew Research Center, 2015, SMARTPH US 2015 PEW; Physical Activity Guidelines Advisory Committee, 2008, REP PHYS ACT GUID AD; Pivarnik JM, 2003, MED SCI SPORT EXER, V35, P1004, DOI 10.1249/01.MSS.0000069747.55950.B1; Pulsford RM, 2015, INT J EPIDEMIOL, V44, P1909, DOI 10.1093/ije/dyv191; Raudenbush SW, 2001, PSYCHOL METHODS, V6, P387, DOI 10.1037//1082-989X.6.4.387; Redfern J, 2014, EUR J PREV CARDIOL, V21, P492, DOI 10.1177/2047487312449416; Rosenberger ME, 2016, MED SCI SPORT EXER, V48, P457, DOI 10.1249/MSS.0000000000000778; Spring B, 2013, IEEE PULSE, V4, P34, DOI 10.1109/MPUL.2013.2279620; Spring B, 2012, ARCH INTERN MED, V172, P789, DOI 10.1001/archinternmed.2012.1044; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Umstattd MR, 2008, AM J HEALTH BEHAV, V32, P115; VELICER W, 2011, ANN BEHAV MED S1, V41, pS146; Winter SJ, 2014, NHLBI CARD EP BIOST	49	71	72	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0156370	10.1371/journal.pone.0156370	http://dx.doi.org/10.1371/journal.pone.0156370			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352250	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900002
J	Putzhammer, R; Doppler, C; Jakschitz, T; Heinz, K; Forste, J; Danzl, K; Messner, B; Bernhard, D				Putzhammer, Raphaela; Doppler, Christian; Jakschitz, Thomas; Heinz, Katharina; Foerste, Juliane; Danzl, Katarina; Messner, Barbara; Bernhard, David			Vapours of US and EU Market Leader Electronic Cigarette Brands and Liquids Are Cytotoxic for Human Vascular Endothelial Cells	PLOS ONE			English	Article							RISK-ASSESSMENT; SMOKE; NICOTINE; SAFETY; IDENTIFICATION; PRODUCTS; EXTRACT; MASS	The present study was conducted to provide toxicological data on e-cigarette vapours of different e-cigarette brands and liquids from systems viewed as leaders in the e-cigarette market and to compare e-cigarette vapour toxicity to the toxicity of conventional strong high-nicotine cigarette smoke. Using an adapted version of a previously constructed cigarette smoke constituent sampling device, we collected the hydrophilic fraction of e-cigarette vapour and exposed human umbilical vein endothelial cells (HUVECs) to the mixture of compounds present in the vapour of 4 different single-use e-cigarettes, 6 different liquid vapours produced by the same refillable e-cigarette, and one e-cigarette with an exchangeable liquid cartridge. After incubation of cells with various concentrations and for various periods of time we analysed cell death induction, proliferation rates, the occurrence of intracellular reactive oxygen species, cell morphology, and we also measured e-cigarette heating coil temperatures. Overall, conventional cigarette smoke extract showed the most severe impact on endothelial cells. However, some e-cigarette vapour extracts showed high cytotoxicity, inhibition of cell proliferation, and alterations in cell morphology, which were comparable to conventional high-nicotine cigarettes. The vapours generated from different liquids using the same e-cigarette show substantial differences, pointing to the liquids as an important source for toxicity. E-cigarette vapour-mediated induction of oxidative stress was significant in one out of the 11 analysed vapours. There is a high variability in the acute cytotoxicity of e-cigarette vapours depending on the liquid and on the e-cigarettes used. Some products showed toxic effects close to a conventional high-nicotine cigarette. Liquid nicotine, menthol content, and the formation of acute intracellular reactive oxygen species do not seem to be the central elements in e-cigarette vapour toxicity.	[Putzhammer, Raphaela; Doppler, Christian; Heinz, Katharina; Foerste, Juliane; Danzl, Katarina; Bernhard, David] Med Univ Innsbruck, Univ Clin Cardiac Surg, Cardiac Surg Res Lab, Innsbruck, Austria; [Putzhammer, Raphaela; Foerste, Juliane] MCI Management Ctr Innsbruck, Biotechnol, Innsbruck, Austria; [Jakschitz, Thomas] Austrian Drug Screening Inst GmbH, Innsbruck, Austria; [Messner, Barbara] Med Univ Vienna, Dept Cardiac Surg, Cardiac Surg Res Lab, Vienna, Austria	Medical University of Innsbruck; Medical University of Vienna	Bernhard, D (corresponding author), Med Univ Innsbruck, Univ Clin Cardiac Surg, Cardiac Surg Res Lab, Innsbruck, Austria.	david.bernhard@i-med.ac.at	Messner, Barbara/GLS-8150-2022	Messner, Barbara/0000-0001-8331-6497; Bernhard, David/0000-0002-2383-6607	official funds of the laboratory (internal sources of the Medical University of Innsbruck); ADSI	official funds of the laboratory (internal sources of the Medical University of Innsbruck); ADSI	This project was financed by the official funds of the laboratory (internal sources of the Medical University of Innsbruck) and private funds of the corresponding author (DB). The authors have no other financial relationships relevant to this article to disclose. ADSI provided support in the form of salaries for one author [TJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of TJ are articulated in the 'author contributions' section.	Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Bernhard D, 2007, CURR MED CHEM, V14, P1703; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bernhard D, 2005, FASEB J, V19, P1096, DOI 10.1096/fj.04-3192com; Bernhard D, 2003, FASEB J, V17, P2302, DOI 10.1096/fj.03-0312fje; Bernhard David, 2004, Journal of Pharmacological and Toxicological Methods, V50, P45, DOI 10.1016/j.vascn.2004.01.003; Bertholon JF, 2013, RESPIRATION, V86, P433, DOI 10.1159/000353253; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Cervellati F, 2014, TOXICOL IN VITRO, V28, P999, DOI 10.1016/j.tiv.2014.04.012; Chausse P, 2015, CHEST, V148, pE29, DOI 10.1378/chest.15-0497; Cheah NP, 2014, TOB CONTROL, V23, P119, DOI 10.1136/tobaccocontrol-2012-050483; Costigan S, 2015, REGUL TOXICOL PHARM, V72, P361, DOI 10.1016/j.yrtph.2015.05.018; Csordas A, 2013, NAT REV CARDIOL, V10, P219, DOI 10.1038/nrcardio.2013.8; Drummond M Bradley, 2014, Ann Am Thorac Soc, V11, P236, DOI 10.1513/AnnalsATS.201311-391FR; El Golli N, 2016, LIFE SCI, V146, P131, DOI 10.1016/j.lfs.2015.12.049; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Geiss O, 2016, INT J HYG ENVIR HEAL, V219, P268, DOI 10.1016/j.ijheh.2016.01.004; Gillman IG, 2016, REGUL TOXICOL PHARM, V75, P58, DOI 10.1016/j.yrtph.2015.12.019; Goniewicz ML, 2015, INT J DRUG POLICY, V26, P583, DOI 10.1016/j.drugpo.2015.01.020; Hadwiger ME, 2010, J CHROMATOGR A, V1217, P7547, DOI 10.1016/j.chroma.2010.10.018; Harrell PT, 2014, OTOLARYNG HEAD NECK, V151, P381, DOI 10.1177/0194599814536847; Hutzler C, 2014, ARCH TOXICOL, V88, P1295, DOI 10.1007/s00204-014-1294-7; Lerner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116732; Lerner CA, 2015, ENVIRON POLLUT, V198, P100, DOI 10.1016/j.envpol.2014.12.033; Messner B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.162; Messner B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058342; Messner B, 2009, ARTERIOSCL THROM VAS, V29, P1392, DOI 10.1161/ATVBAHA.109.190082; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Shen YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep23984; Strasser AA, 2009, EXP CLIN PSYCHOPHARM, V17, P405, DOI 10.1037/a0017649; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987	33	64	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157337	10.1371/journal.pone.0157337	http://dx.doi.org/10.1371/journal.pone.0157337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351725	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900008
J	Satue, M; Rodrigo, MJ; Otin, S; Bambo, MP; Fuertes, MI; Ara, JR; Martin, J; Polo, V; Larrosa, JM; Pablo, L; Garcia-Martin, E				Satue, Maria; Jesus Rodrigo, Maria; Otin, Sofia; Pilar Bambo, Maria; Isabel Fuertes, Maria; Ramon Ara, Jose; Martin, Jesus; Polo, Vicente; Manuel Larrosa, Jose; Pablo, Luis; Garcia-Martin, Elena			Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; GRAY-MATTER ATROPHY; COLOR-VISION; NEURODEGENERATION; THICKNESS; INFLAMMATION; DISABILITY; PATHOLOGY; REPRODUCIBILITY	Aim To evaluate structural changes in the retina and their correlation with visual dysfunction in patients with multiple sclerosis. Methods Patients with multiple sclerosis (n = 84) and healthy controls (n = 84) underwent structural evaluation of the retinal nerve fiber layer, and macular and ganglion cell layer thicknesses using Spectral domain optical coherence tomography (SD-OCT). All subjects underwent high and low contrast visual acuity, color vision (using the Farnsworth and L'Anthony desaturated D15 color tests), and contrast sensitivity vision using the Pelli Robson chart and CSV 1000E test. Results Macular, retinal nerve fiber layer, and ganglion cell layer thinning was observed in multiple sclerosis patients compared to healthy controls (p<0.05). High-and low-contrast visual acuity and contrast sensitivity vision at four different spatial frequencies were significantly reduced in comparison with healthy subjects (p<0.05). Macular, retinal nerve fiber layer and ganglion cell layer measurements correlated with high and low contrast visual acuity, and contrast sensitivity vision. Contrast sensitivity vision was the functional parameter that most strongly correlated with the structural measurements in multiple sclerosis and was associated with ganglion cell layer measurements. The L'Anthony color vision score (age-corrected color confusion index) was associated with macular measurements. Conclusions Patients with multiple sclerosis had visual dysfunction that correlated with structural changes evaluated by SD-OCT. Macular and ganglion cell layer measurements may be good indicators of visual impairment in multiple sclerosis patients.	[Satue, Maria; Jesus Rodrigo, Maria; Otin, Sofia; Pilar Bambo, Maria; Isabel Fuertes, Maria; Polo, Vicente; Manuel Larrosa, Jose; Pablo, Luis; Garcia-Martin, Elena] Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Satue, Maria; Jesus Rodrigo, Maria; Otin, Sofia; Pilar Bambo, Maria; Isabel Fuertes, Maria; Ramon Ara, Jose; Martin, Jesus; Polo, Vicente; Manuel Larrosa, Jose; Pablo, Luis; Garcia-Martin, Elena] Aragon Hlth Res Inst IACS IIS Aragon, Zaragoza, Spain; [Ramon Ara, Jose; Martin, Jesus] Miguel Servet Univ Hosp, Dept Neurol, Zaragoza, Spain	Miguel Servet University Hospital; Miguel Servet University Hospital	Satue, M (corresponding author), Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain.; Satue, M (corresponding author), Aragon Hlth Res Inst IACS IIS Aragon, Zaragoza, Spain.	mariasatue@gmail.com	rodrigo, maria jesus/AAE-4101-2020	rodrigo, maria jesus/0000-0002-4009-3075; Larrosa, Jose Manuel/0000-0003-4403-4854; Satue, Maria/0000-0002-1609-5994; Otin Mallada, Sofia Zaira/0000-0002-6591-0801; Larrosa Poves, Jose Manuel/0000-0002-6745-7668; Polo Llorens, Vicente/0000-0002-1402-3129; GARCIA-MARTIN, ELENA/0000-0001-6258-2489; Ara Callizo, Jose Ramon/0000-0002-9788-2083; Perez-Olivan, Susana/0000-0003-3513-4714; Pablo, Luis/0000-0003-2389-8282; Bambo, Maria Pilar/0000-0001-5320-7839				Balcer LJ, 2010, NEUROLOGY, V74, pS16, DOI 10.1212/WNL.0b013e3181dbb664; Bock M, 2012, BRIT J OPHTHALMOL, V96, P62, DOI 10.1136/bjo.2010.193581; BOWMAN KJ, 1982, ACTA OPHTHALMOL, V60, P907; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Davies EC, 2011, J NEURO-OPHTHALMOL, V31, P260, DOI 10.1097/WNO.0b013e318221b434; Fairless R, 2012, J NEUROSCI, V32, P5585, DOI 10.1523/JNEUROSCI.5705-11.2012; Filippi M, 2010, NEUROLOGY, V75, P1988, DOI 10.1212/WNL.0b013e3181ff96f6; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Garcia-Martin E, 2013, NEUROLOGY, V81, P76, DOI 10.1212/WNL.0b013e318299ccd9; Garcia-Martin E, 2011, INVEST OPHTH VIS SCI, V52, P4124, DOI 10.1167/iovs.10-6643; Gonzalez-Lopez JJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/128517; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gundogan FC, 2013, INDIAN J OPHTHALMOL, V61, P100, DOI 10.4103/0301-4738.99842; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Leat SJ, 1999, OPTOMETRY VISION SCI, V76, P198, DOI 10.1097/00006324-199904000-00023; Martinez-Lapiscina Elena H, 2014, BMC Res Notes, V7, P910, DOI 10.1186/1756-0500-7-910; MCDONALD WI, 1992, J NEUROL NEUROSUR PS, V55, P747, DOI 10.1136/jnnp.55.9.747; Narayanan D, 2014, MULT SCLER J, V20, P1331, DOI 10.1177/1352458514523498; Palace J, 2007, J NEUROL SCI, V259, P46, DOI 10.1016/j.jns.2006.05.072; Pitt D, 2010, ARCH NEUROL-CHICAGO, V67, P812, DOI 10.1001/archneurol.2010.148; Saidha S, 2013, JAMA NEUROL, V70, P34, DOI 10.1001/jamaneurol.2013.573; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Schinzel J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-31; Schuman JS, 1996, OPHTHALMOLOGY, V103, P1889, DOI 10.1016/S0161-6420(96)30410-7; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Villoslada P, 2012, MULT SCLER J, V18, P991, DOI 10.1177/1352458511431972; VINGRYS AJ, 1988, INVEST OPHTH VIS SCI, V29, P50; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032	35	16	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157293	10.1371/journal.pone.0157293	http://dx.doi.org/10.1371/journal.pone.0157293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351450	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900006
J	Liu, LN; Duan, XG; Wu, J				Liu, Lina; Duan, Xuguo; Wu, Jing			L-Tryptophan Production in Escherichia coli Improved by Weakening the Pta-AckA Pathway	PLOS ONE			English	Article							ACETYL PHOSPHATE; AMINO-ACIDS; PHOSPHOTRANSACETYLASE; MUTANT; HYPERPRODUCTION; ACCUMULATION; EXPRESSION; STRAINS; OPERON; GROWTH	Acetate accumulation during the fermentation process of Escherichia coli FB-04, an L-tryptophan production strain, is detrimental to L-tryptophan production. In an initial attempt to reduce acetate formation, the phosphate acetyltransferase gene (pta) from E. coli FB-04 was deleted, forming strain FB-04(Delta pta). Unfortunately, FB-04(Delta pta) exhibited a growth defect. Therefore, pta was replaced with a pta variant (pta1) from E. coli CCTCC M 2016009, forming strain FB-04(pta1). Pta1 exhibits lower catalytic capacity and substrate affinity than Pta because of a single amino acid substitution (Pro69Leu). FB-04(pta1) lacked the growth defect of FB-04(Delta pta) and showed improved fermentation performance. Strain FB-04(pta1) showed a 91% increase in L-tryptophan yield in flask fermentation experiments, while acetate production decreased by 35%, compared with its parent FB-04. Throughout the fed-batch fermentation process, acetate accumulation by FB-04(pta1) was slower than that by FB-04. The final L-tryptophan titer of FB-04(pta1) reached 44.0 g/L, representing a 15% increase over that of FB-04. Metabolomics analysis showed that the pta1 genomic substitution slightly decreased carbon flux through glycolysis and significantly increased carbon fluxes through the pentose phosphate and common aromatic pathways. These results indicate that this strategy enhances L-tryptophan production and decreases acetate accumulation during the L-tryptophan fermentation process.	[Liu, Lina; Duan, Xuguo; Wu, Jing] Jiangnan Univ, State Key Lab Food Sci & Technol, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Liu, Lina; Duan, Xuguo; Wu, Jing] Jiangnan Univ, Sch Biotechnol, Minist Educ, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Liu, Lina; Duan, Xuguo; Wu, Jing] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, 1800 Lihu Ave, Wuxi 214122, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, 1800 Lihu Ave, Wuxi 214122, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, 1800 Lihu Ave, Wuxi 214122, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	jingwu@jiangnan.edu.cn	liu, li/HGC-0900-2022; Wu, Jing/GZK-5063-2022	Duan, Xuguo/0000-0002-2136-0449	National Science Fund for Distinguished Young Scholars [31425020]; National Natural Science Foundation of China [31271813, 31401636]; project of outstanding scientific and technological innovation group of Jiangsu Province; Natural Science Foundation of Jiangsu Province [BK20140142]; 111 Project [111-2-06]; Research and Innovation Project for College Graduates of Jiangsu Province [KYLX15-1143]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of outstanding scientific and technological innovation group of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); 111 Project(Ministry of Education, China - 111 Project); Research and Innovation Project for College Graduates of Jiangsu Province	This work was supported by the National Science Fund for Distinguished Young Scholars (31425020) to JW, The National Natural Science Foundation of China (31271813 and 31401636) to JW, The project of outstanding scientific and technological innovation group of Jiangsu Province (Jing Wu) to JW, The Natural Science Foundation of Jiangsu Province (BK20140142) to JW, The 111 Project (No. 111-2-06) to JW, The Research and Innovation Project for College Graduates of Jiangsu Province (no. KYLX15-1143) to LL. The authors would also like to thank Shanghai ProfLeader Biotech Co, Ltd for assistance with the GC-MS experiments and data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Science Fund for Distinguished Young Scholars (31425020), the National Natural Science Foundation of China (31271813 and 31401636), the project of outstanding scientific and technological innovation group of Jiangsu Province (Jing Wu), the Natural Science Foundation of Jiangsu Province (BK20140142), the 111 Project (No. 111-2-06), and the Research and Innovation Project for College Graduates of Jiangsu Province (no. KYLX15-1143). We would also like to thank Shanghai ProfLeader Biotech Co, Ltd for assistance with the GC-MS experiments and data analysis.	AZUMA S, 1993, APPL MICROBIOL BIOT, V39, P471, DOI 10.1007/BF00205035; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAUER KA, 1990, APPL ENVIRON MICROB, V56, P1296, DOI 10.1128/AEM.56.5.1296-1302.1990; Bongaerts J, 2001, METAB ENG, V3, P289, DOI 10.1006/mben.2001.0196; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castano-Cerezo S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-54; CHAN EC, 1993, APPL MICROBIOL BIOT, V40, P301, DOI 10.1007/BF00170384; Chang DE, 1999, J BACTERIOL, V181, P6656, DOI 10.1128/JB.181.21.6656-6663.1999; Flores N, 1996, NAT BIOTECHNOL, V14, P620, DOI 10.1038/nbt0596-620; Gao XF, 2010, ANAL CHEM, V82, P6447, DOI 10.1021/ac1006552; Gu PF, 2013, APPL MICROBIOL BIOT, V97, P4121, DOI 10.1007/s00253-012-4665-0; Gu PF, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-30; HAHM DH, 1994, APPL MICROBIOL BIOT, V42, P100, DOI 10.1007/s002530050223; HAN K, 1992, BIOTECHNOL BIOENG, V39, P663, DOI 10.1002/bit.260390611; Ikeda M, 2006, APPL MICROBIOL BIOT, V69, P615, DOI 10.1007/s00253-005-0252-y; Ikeda M, 1999, APPL ENVIRON MICROB, V65, P2497; KAKUDA H, 1994, J BIOCHEM-TOKYO, V116, P916, DOI 10.1093/oxfordjournals.jbchem.a124616; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Madyagol M, 2011, FOLIA MICROBIOL, V56, P253, DOI 10.1007/s12223-011-0035-z; MAYER MAG, 1995, MICROBIOL-UK, V141, P2891, DOI 10.1099/13500872-141-11-2891; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Phue JN, 2010, BIOTECHNOL LETT, V32, P1897, DOI 10.1007/s10529-010-0369-7; Ramalingam S, 2007, BIOCHEM ENG J, V33, P34, DOI 10.1016/j.bej.2006.09.019; Schmid JW, 2004, METAB ENG, V6, P364, DOI 10.1016/j.ymben.2004.06.003; SHIMIZU M, 1969, BIOCHIM BIOPHYS ACTA, V191, P550, DOI 10.1016/0005-2744(69)90348-9; Suarez DC, 2000, PROCESS BIOCHEM, V35, P1051, DOI 10.1016/S0032-9592(00)00140-0; TRIBE DE, 1979, APPL ENVIRON MICROB, V38, P181, DOI 10.1128/AEM.38.2.181-190.1979; Villas-Boas SG, 2007, ANAL BIOCHEM, V370, P87, DOI 10.1016/j.ab.2007.06.028; Wang J, 2013, APPL MICROBIOL BIOT, V97, P7587, DOI 10.1007/s00253-013-5026-3; Zhao ZJ, 2011, J IND MICROBIOL BIOT, V38, P1921, DOI 10.1007/s10295-011-0978-8	32	23	28	8	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158200	10.1371/journal.pone.0158200	http://dx.doi.org/10.1371/journal.pone.0158200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348810	Green Published, Green Submitted, gold			2022-12-27	WOS:000378801200049
J	Phairoh, P; Suthibatpong, T; Rattanarojpong, T; Jongruja, N; Senapin, S; Choowongkomon, K; Khunrae, P				Phairoh, Panapat; Suthibatpong, Thana; Rattanarojpong, Triwit; Jongruja, Nujarin; Senapin, Saengchan; Choowongkomon, Kiattawee; Khunrae, Pongsak			ICP35 Is a TREX-Like Protein Identified in White Spot Syndrome Virus	PLOS ONE			English	Article							AICARDI-GOUTIERES SYNDROME; EXONUCLEASE TREX1; ESCHERICHIA-COLI; PENAEUS-MONODON; GENOME SEQUENCE; DNA; SHRIMP; PURIFICATION; LUPUS; GENE	ICP35 is a non-structural protein from White spot syndrome virus believed to be important in viral replication. Since ICP35 was found to localize in the host nucleus, it has been speculated that the function of ICP35 might be involved in the interaction of DNA. In this study, we overexpressed, purified and characterized ICP35. The thioredoxin-fused ICP35 (thio-ICP35) was strongly expressed in E. coli and be able to form itself into dimers. Investigation of the interaction between ICP35 and DNA revealed that ICP35 can perform DNase activity. Structural model of ICP35 was successfully built on TREX1, suggesting that ICP35 might adopt the folding similar to that of TREX1 protein. Several residues important for dimerization in TREX1 are also conserved in ICP35. Residue Asn126 and Asp132, which are seen to be in close proximity to metal ions in the ICP35 model, were shown through site-directed mutagenesis to be critical for DNase activity.	[Phairoh, Panapat; Rattanarojpong, Triwit; Jongruja, Nujarin; Khunrae, Pongsak] King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Microbiol, Bangkok 10140, Thailand; [Suthibatpong, Thana] King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Phys, Bangkok 10140, Thailand; [Senapin, Saengchan] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani 12120, Thailand; [Senapin, Saengchan] Mahidol Univ, Ctr Excellence Shrimp Mol Biol & Biotechnol, 272 Rama 6 Rd, Bangkok, Thailand; [Choowongkomon, Kiattawee] Kasetsart Univ, Fac Sci, Dept Biochem, Bangkok 10900, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Kasetsart University	Khunrae, P (corresponding author), King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Microbiol, Bangkok 10140, Thailand.	pongsak.khu@kmutt.ac.th	Senapin, Saengchan/F-1323-2011; choowongkomon, kiattawee/M-6528-2014	Senapin, Saengchan/0000-0002-5599-4343; choowongkomon, kiattawee/0000-0002-2421-7859	National Research Council of Thailand [55000579, 56000166]; Faculty of Science, KMUTT, Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Faculty of Science, KMUTT, Thailand	This study was financially supported by National Research Council of Thailand (Grant No. 55000579 and 56000166). PP was funded by a scholarship from the Faculty of Science, KMUTT, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyakova NV, 2010, BIOL BULL+, V37, P464, DOI 10.1134/S1062359010050043; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; CH W, 1995, DIS AQUAT ORGAN, V23, P239, DOI [10.3354/dao023239, DOI 10.3354/DAO023239]; Chen LL, 2002, VIROLOGY, V301, P136, DOI 10.1006/viro.2002.1536; Chen LL, 2002, VIROLOGY, V293, P44, DOI 10.1006/viro.2001.1273; Farshadzadeh Z, 2010, JUNDISHAPUR J MICROB, V3, P53; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Grieves JL, 2015, P NATL ACAD SCI USA, V112, P5117, DOI 10.1073/pnas.1423804112; Kang ST, 2013, J VIROL, V87, P13263, DOI 10.1128/JVI.01732-13; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; Kong B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085890; LaVallie ER, 2000, METHOD ENZYMOL, V326, P322; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Miyazaki T, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.547331; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Wang ZZ, 2008, BIOSCI BIOTECH BIOCH, V72, P1550, DOI 10.1271/bbb.80057; WONGTEERASUPAYA C, 1995, DIS AQUAT ORGAN, V21, P69, DOI 10.3354/dao021069; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Zhan WB, 1998, J AQUAT ANIM HEALTH, V10, P405, DOI 10.1577/1548-8667(1998)010&lt;0405:WSSVIO&gt;2.0.CO;2	22	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158301	10.1371/journal.pone.0158301	http://dx.doi.org/10.1371/journal.pone.0158301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348862	Green Published, gold, Green Submitted			2022-12-27	WOS:000378801200061
J	King, EM; Oomeer, S; Gilson, R; Copas, A; Beddows, S; Soldan, K; Jit, M; Edmunds, WJ; Sonnenberg, P				King, Eleanor M.; Oomeer, Soonita; Gilson, Richard; Copas, Andrew; Beddows, Simon; Soldan, Kate; Jit, Mark; Edmunds, W. John; Sonnenberg, Pam			Oral Human Papillomavirus Infection in Men Who Have Sex with Men: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HPV INFECTION; RISK-FACTORS; NATURAL-HISTORY; HIGH PREVALENCE; NECK-CANCER; CLEARANCE; COHORT; WOMEN; EPIDEMIOLOGY; HEAD	Background The epidemiology of oral human papillomavirus (HPV) infection in men who have sex with men (MSM) differs from anogenital HPV infection. The impact of HPV vaccination has, to date, largely focussed on anogenital outcomes. Vaccination of MSM in the UK has been recommended and, if implemented, baseline estimates of oral HPV prevalence will be useful. Methods We searched Medline, Embase and psycINFO databases for studies reporting prevalence, incidence, and clearance of oral HPV infection in MSM. We performed a random-effects meta-analysis and meta-regression on prevalence estimates and summarised within-study risk factors for oral HPV DNA detection and incidence/clearance rates. We also performed a meta-analysis of the effect of MSM on oral HPV prevalence compared to heterosexual men. Results 26 publications were identified. The pooled prevalence of oral HPV16 from twelve estimates was 3.0% (95% CI 0.5-5.5) in HIV-negative and 4.7% (95% CI 2.1-7.3) in HIV-positive MSM. Median age of study participants explained 38% of heterogeneity (p<0.01) in HPV prevalence estimates (pooled = 17% and 29% in HIV-negative and HIV-positive, respectively; 22 estimates). Nine studies compared MSM to heterosexual men and found no difference in oral HPV prevalence (pooled OR 1.07 (95% CI 0.65-1.74)). The clearance rate was higher than incidence within studies. Type-specific concordance between oral and anogenital sites was rare. Conclusion There was substantial heterogeneity between estimates of oral HPV prevalence in MSM populations that was partly explained by HIV status and median age.	[King, Eleanor M.; Gilson, Richard; Copas, Andrew; Sonnenberg, Pam] UCL, Res Dept Infect & Populat Hlth, London WC1E 6JB, England; [Oomeer, Soonita; Gilson, Richard] Cent & North West London NHS Fdn Trust, Mortimer Market Ctr, London WC1E 6JB, England; [Beddows, Simon] Publ Hlth England, Virus Reference Dept, 61 Colindale Ave, London NW9 5EQ, England; [Soldan, Kate] Publ Hlth England, Ctr Communicable Dis Surveillance & Control CIDSC, 61 Colindale Ave, London NW9 5EQ, England; [Jit, Mark] Publ Hlth England, Modelling & Econ Unit, 61 Colindale Ave, London NW9 5EQ, England; [Jit, Mark; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England	University of London; University College London; Public Health England; Public Health England; Public Health England; University of London; London School of Hygiene & Tropical Medicine	Sonnenberg, P (corresponding author), UCL, Res Dept Infect & Populat Hlth, London WC1E 6JB, England.	p.sonnenberg@ucl.ac.uk	Jit, Mark/HDM-7797-2022	Beddows, Simon/0000-0002-6879-6215; Sonnenberg, Pam/0000-0002-1067-1583; Copas, Andrew/0000-0001-8968-5963; Jit, Mark/0000-0001-6658-8255; Soldan, Kate/0000-0002-0361-3174	MRC studentship	MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Eleanor King was funded on an MRC studentship.	Anic GM, 2012, J INFECT DIS, V205, P789, DOI 10.1093/infdis/jir851; Antonsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091761; Beachler DC, 2015, AM J EPIDEMIOL, V181, P40, DOI 10.1093/aje/kwu247; Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Blas MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139524; Chung CH, 2014, ORAL ONCOL, V50, P364, DOI 10.1016/j.oraloncology.2013.09.003; Colon-Lopez V, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-7; Coutlee F, 1997, SEX TRANSM DIS, V24, P23, DOI 10.1097/00007435-199701000-00006; D'Souza G, 2005, J CLIN MICROBIOL, V43, P5526, DOI 10.1128/JCM.43.11.5526-5535.2005; D'Souza G, 2014, CANCERS; D'Souza G, 2011, PREV MED, V53, pS5, DOI 10.1016/j.ypmed.2011.08.001; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Darwich L, 2014, CLIN MICROBIOL INFEC, V20, pO585, DOI 10.1111/1469-0691.12523; Del Mistro A, 2012, SEX TRANSM DIS, V39, P894, DOI 10.1097/OLQ.0b013e31826ef2da; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Gaester K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06592; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; King EM, 2015, SEX TRANSM INFECT, V91, P284, DOI 10.1136/sextrans-2014-051955; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2011, CANCER EPIDEM BIOMAR, V20, P172, DOI 10.1158/1055-9965.EPI-10-0682; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Mooij SH, 2013, AIDS; Mooij SH, 2016, AIDS, V30, P121, DOI 10.1097/QAD.0000000000000909; Mooij SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098955; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Ong JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102138; Ong JJ, 2014, J CLIN MICROBIOL, V52, P2206, DOI 10.1128/JCM.00286-14; Palmer E, 2014, INT J CANCER, V135, P2437, DOI 10.1002/ijc.28886; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Read TRH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049324; Sammarco ML, 2016, J MED VIROL, V88, P911, DOI 10.1002/jmv.24406; Sirera G, 2006, AIDS, V20, P1201, DOI 10.1097/01.aids.0000226963.10342.f4; van Aar F, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0668-z; van Monsjou HS, 2010, ORAL ONCOL, V46, P780, DOI 10.1016/j.oraloncology.2010.08.011; van Rijn VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092208; Videla S, 2013, SEX TRANSM DIS, V40, P3, DOI 10.1097/OLQ.0b013e31827e87bd; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Zou HC, 2014, J INFECT DIS, V209, P642, DOI 10.1093/infdis/jit626	48	40	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157976	10.1371/journal.pone.0157976	http://dx.doi.org/10.1371/journal.pone.0157976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384050	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000379809400032
J	Leem, YE; Jeong, HJ; Kim, HJ; Koh, J; Kang, K; Bae, GU; Cho, H; Kang, JS				Leem, Young-Eun; Jeong, Hyeon-Ju; Kim, Hyun-Ji; Koh, Jewoo; Kang, KyeongJin; Bae, Gyu-Un; Cho, Hana; Kang, Jong-Sun			Cdo Regulates Surface Expression of Kir2.1 K+ Channel in Myoblast Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; RECTIFYING POTASSIUM CHANNEL; MYOGENIC DIFFERENTIATION; TERMINAL DIFFERENTIATION; P38-ALPHA/BETA MAPK; SIGNALING PATHWAY; GOLGI EXPORT; RECEPTOR CDO; ER EXPORT; PROTEIN	A potassium channel Kir2.1-associated membrane hyperpolarization is required for myogenic differentiation. However the molecular regulatory mechanisms modulating Kir2.1 channel activities in early stage of myogenesis are largely unknown. A cell surface protein, Cdo functions as a component of multiprotein cell surface complexes to promote myogenesis. In this study, we report that Cdo forms a complex with Kir2.1 during myogenic differentiation, and is required for the channel activity by enhancing the surface expression of Kir2.1 in the early stage of differentiation. The expression of a constitutively active form of the upstream kinase for p38MAPK, MKK6(EE) can restore Kir2.1 activities in Cdo-depleted C2C12 cells, while the treatment with a p38MAPK inhibitor, SB203580 exhibits a similar effect of Cdo depletion on Kir2.1 surface expression. Furthermore, Cdo(-/-) primary myoblasts, which display a defective differentiation program, exhibit a defective Kir2.1 activity. Taken together, our results suggest that a promyogenic Cdo signaling is critical for Kir2.1 activities in the induction of myogenic differentiation.	[Leem, Young-Eun; Jeong, Hyeon-Ju; Kang, Jong-Sun] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea; [Kim, Hyun-Ji; Koh, Jewoo; Cho, Hana] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Kang, KyeongJin] Sungkyunkwan Univ, Sch Med, Dept Anat, Suwon, South Korea; [Leem, Young-Eun; Jeong, Hyeon-Ju; Kim, Hyun-Ji; Koh, Jewoo; Kang, KyeongJin; Cho, Hana; Kang, Jong-Sun] Samsung Biomed Res Inst, Suwon, South Korea; [Bae, Gyu-Un] Sookmyung Womens Univ, Res Ctr Cell Fate Control, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sookmyung Women's University	Kang, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea.; Cho, H (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon, South Korea.; Cho, H; Kang, JS (corresponding author), Samsung Biomed Res Inst, Suwon, South Korea.	hanacho@skku.edu; kangj01@skku.edu		Cho, Hana/0000-0002-9394-8671	National Research Foundation of Korea (NRF) grant - Korea Government (MSIP) [NRF-2011-0017315, NRF-2013M3A9B1069776]; Samsung Biomedical Research Institute	National Research Foundation of Korea (NRF) grant - Korea Government (MSIP); Samsung Biomedical Research Institute(Samsung)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (NRF-2011-0017315 to JSK) (NRF-2013M3A9B1069776 to JSK). Samsung Biomedical Research Institute provided support in the form of salaries for authors YEL, HJJ, HJK, JK, KJK, HC and JSK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bae GU, 2010, MOL BIOL CELL, V21, P2399, DOI 10.1091/mbc.E09-12-1011; Bae GU, 2009, MOL CELL BIOL, V29, P4130, DOI 10.1128/MCB.00199-09; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Boyer SB, 2009, J CELL PHYSIOL, V218, P385, DOI 10.1002/jcp.21610; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Cabane C, 2003, AM J PHYSIOL-CELL PH, V284, pC658, DOI 10.1152/ajpcell.00078.2002; Chae KS, 2005, NEUROSCIENCE, V135, P1013, DOI 10.1016/j.neuroscience.2005.06.060; Chae KS, 2005, J NEUROCHEM, V94, P367, DOI 10.1111/j.1471-4159.2005.03201.x; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; Jones SVP, 2003, MOL PHARMACOL, V64, P987, DOI 10.1124/mol.64.4.987; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Klein H, 1999, J MEMBRANE BIOL, V167, P43, DOI 10.1007/s002329900470; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Lee HJ, 2012, MOL BIOL CELL, V23, P1376, DOI 10.1091/mbc.E11-07-0634; Leem YE, 2011, CELL SIGNAL, V23, P2021, DOI 10.1016/j.cellsig.2011.07.016; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200; Liu JH, 1998, J PHYSIOL-LONDON, V510, P467, DOI 10.1111/j.1469-7793.1998.467bk.x; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Tran P, 2012, J BIOL CHEM, V287, P11602, DOI 10.1074/jbc.M112.351601; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Ruppersberg JP, 1996, NEUROPHARMACOLOGY, V35, P887, DOI 10.1016/0028-3908(96)00092-5; Ruppersberg JP, 2000, PFLUG ARCH EUR J PHY, V441, P1, DOI 10.1007/s004240000380; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; SARGIACOMO M, 1989, J MEMBRANE BIOL, V107, P277, DOI 10.1007/BF01871942; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tong YH, 2001, J GEN PHYSIOL, V117, P103, DOI 10.1085/jgp.117.2.103; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Wischmeyer E, 1996, P NATL ACAD SCI USA, V93, P5819, DOI 10.1073/pnas.93.12.5819; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	54	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158707	10.1371/journal.pone.0158707	http://dx.doi.org/10.1371/journal.pone.0158707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380411	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700043
J	Jayanti, A; Foden, P; Wearden, A; Mitra, S				Jayanti, Anuradha; Foden, Philip; Wearden, Alison; Mitra, Sandip			Illness Beliefs in End Stage Renal Disease and Associations with Self-Care Modality Choice	PLOS ONE			English	Article							SHORT DAILY HEMODIALYSIS; CHRONIC KIDNEY-DISEASE; DIALYSIS PATIENTS; COMMON-SENSE; IN-CENTER; PERCEPTIONS; HOME; REPRESENTATIONS; SYMPTOMS; SURVIVAL	Background Interest in self-care haemodialysis (HD) has increased because it improves patients'clinical and quality-of-life outcomes. Patients who undertake self-management for haemodialysis may hold illness beliefs differently to those choosing institutional care at the time of making the modality choice or moulded by their illness and dialysis treatment experience. Illness perceptions amongst predialysis patients and in those undertaking fully-assisted and self-care haemodialysis are being investigated in a combined cross-sectional and longitudinal study. Study Design The study data are derived from the BASIC-HHD study, a multicentre observational study on factors influencing home haemodialysis uptake. 535 patients were enrolled into three groups: Predialysis CKD-5 group, prevalent 'in-centre' HD and self-care HD groups (93% at home). We explore illness perceptions in the cross-sectional analyses of the three study groups, using the revised Illness Perception Questionnaire (IPQ-R). Predialysis patients' illness beliefs were reassessed prospectively, typically between 4 and 12 months after dialysis commencement. Results Illness belief subscales are significantly different between in-centre and self-care HD groups. In a step-wise hierarchical regression analysis, after adjustment for age, education, marital status, diabetes, dialysis vintage, depression, anxiety scores, and IPQ-R subscales, personal control (p = 0.01) and illness coherence (p = 0.04) are significantly higher in the self-care HD group. In the predialysis group, no significant associations were found between illness representations and modality choices. In prospectively observed predialysis group, scores for personal control, treatment control, timeline cyclical and emotional representations reduced significantly after commencing dialysis and increased significantly for illness coherence. Conclusions Illness beliefs differ between hospital and self-care haemodialysis patients. Patient's affect and neurocognitive ability may have an important role in determining illness beliefs. The impact of modality upon illness representations may also be significant and remains to be explored.	[Jayanti, Anuradha; Mitra, Sandip] Cent Manchester Hosp NHS Trust, Dept Nephrol, Manchester, Lancs, England; [Foden, Philip] Univ Manchester, Dept Biostat, Manchester, Lancs, England; [Wearden, Alison] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Jayanti, A (corresponding author), Cent Manchester Hosp NHS Trust, Dept Nephrol, Manchester, Lancs, England.	anu_5577@yahoo.co.in			Baxter Clinical Evidence Council; NIHR-CLAHRC for Greater Manchester, UK; Manchester Academic Health Science Centre (MAHSC), NIHR; Baxter	Baxter Clinical Evidence Council; NIHR-CLAHRC for Greater Manchester, UK; Manchester Academic Health Science Centre (MAHSC), NIHR; Baxter	The research is funded by Baxter Clinical Evidence Council and NIHR-CLAHRC for Greater Manchester, UK. This funding has been secured through open competition. The study was initiated and designed by the investigators. Baxter Clinical Evidence Council partly funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the contributions of all research team members who have played a crucial role in data acquisition. We also acknowledge the support of Manchester Academic Health Science Centre (MAHSC), NIHR and the funding support from Baxter for the BASIC-HHD study. We thank principal investigators from all participating centres for their contribution to facilitating the study locally.	Byrne M, 2005, J PSYCHOSOM RES, V58, P403, DOI 10.1016/j.jpsychores.2004.11.010; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Chilcot J, 2012, SEMIN DIALYSIS, V25, P59, DOI 10.1111/j.1525-139X.2011.00987.x; Chilcot J, 2011, J HEALTH PSYCHOL, V16, P1127, DOI 10.1177/1359105311401672; Chilcot J, 2011, AM J NEPHROL, V33, P358, DOI 10.1159/000326752; Chilcot J, 2010, J PSYCHOSOM RES, V68, P203, DOI 10.1016/j.jpsychores.2009.08.010; Clark S, 2014, SEMIN DIALYSIS, V27, P42, DOI 10.1111/sdi.12159; Finkelstein FO, 2012, KIDNEY INT, V82, P561, DOI 10.1038/ki.2012.168; Fischer M, 2010, BRIT J HEALTH PSYCH, V15, P887, DOI 10.1348/135910710X492693; Griva K, 2010, J PSYCHOSOM RES, V69, P363, DOI 10.1016/j.jpsychores.2010.04.008; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hall PA, 2006, HEALTH PSYCHOL, V25, P778, DOI 10.1037/0278-6133.25.6.778; Halm EA, 2006, CHEST, V129, P573, DOI 10.1378/chest.129.3.573; Jaber BL, 2011, CLIN J AM SOC NEPHRO, V6, P1049, DOI 10.2215/CJN.10451110; Jansen DL, 2013, BRIT J HEALTH PSYCH, V18, P244, DOI 10.1111/bjhp.12002; Jayanti A, 2014, HEMODIAL INT, V18, P767, DOI 10.1111/hdi.12176; Jayanti A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-197; Komenda P, 2012, KIDNEY INT, V81, P307, DOI 10.1038/ki.2011.338; LEVENTHAL H, 1992, COGNITIVE THER RES, V16, P143, DOI 10.1007/BF01173486; Malmstrom RK, 2008, NEPHROL DIAL TRANSPL, V23, P1990, DOI 10.1093/ndt/gfm910; McFarlane PA, 2003, KIDNEY INT, V64, P1004, DOI 10.1046/j.1523-1755.2003.00157.x; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nesrallah GE, 2012, J AM SOC NEPHROL, V23, P696, DOI 10.1681/ASN.2011070676; Parfeni M, 2013, NEPHROL DIAL TRANSPL, V28, P2407, DOI 10.1093/ndt/gft194; Petrie KJ, 2006, CLIN MED, V6, P536, DOI 10.7861/clinmedicine.6-6-536; Rao A, 2015, NEPHRON, V129, P31, DOI 10.1159/000370272; Rocco MV, 2015, AM J KIDNEY DIS, V66, P459, DOI 10.1053/j.ajkd.2015.02.331; Searle A, 2007, J PSYCHOSOM RES, V63, P175, DOI 10.1016/j.jpsychores.2007.02.006; Suri RS, 2013, J AM SOC NEPHROL, V24, P498, DOI 10.1681/ASN.2012060595; Tasmoc A, 2013, ARCH MED SCI, V9, P831, DOI 10.5114/aoms.2013.38678; Tennankore KK, 2012, NAT REV NEPHROL, V8, P515, DOI 10.1038/nrneph.2012.145; Timmers L, 2008, PSYCHOL HEALTH, V23, P679, DOI 10.1080/14768320701246535; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085	33	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0154299	10.1371/journal.pone.0154299	http://dx.doi.org/10.1371/journal.pone.0154299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27368055	Green Submitted, Green Published, gold			2022-12-27	WOS:000378914900002
J	Thompson, M; Elliott, C; Willis, C; Ward, R; Falkmer, M; Falkmer, T; Gubbay, A; Girdler, S				Thompson, Melanie; Elliott, Catherine; Willis, Claire; Ward, Roslyn; Falkmer, Marita; Falkmer, Torbjorn; Gubbay, Anna; Girdler, Sonya			Can, Want and Try: Parents' Viewpoints Regarding the Participation of Their Child with an Acquired Brain Injury	PLOS ONE			English	Article							Q-METHODOLOGY; PHYSICAL-DISABILITIES; YOUTH; INTERVENTION; THERAPY; WORKING; LIFE	Background Acquired brain injury (ABI) is a leading cause of permanent disability, currently affecting 20,000 Australian children. Community participation is essential for childhood development and enjoyment, yet children with ABI can often experience barriers to participation. The factors which act as barriers and facilitators to community participation for children with an ABI are not well understood. Aim To identify the viewpoints of parents of children with an ABI, regarding the barriers and facilitators most pertinent to community participation for their child. Methods Using Q-method, 41 parents of children with moderate/severe ABI sorted 37 statements regarding barriers and facilitators to community participation. Factor analysis identified three viewpoints. Results This study identified three distinct viewpoints, with the perceived ability to participate decreasing with a stepwise trend from parents who felt their child and family "can" participate in viewpoint one, to "want" in viewpoint two and "try" in viewpoint three. Conclusions Findings indicated good participation outcomes for most children and families, however some families who were motivated to participate experienced significant barriers. The most significant facilitators included child motivation, supportive relationships from immediate family and friends, and supportive community attitudes. The lack of supportive relationships and attitudes was perceived as a fundamental barrier to community participation. Significance This research begins to address the paucity of information regarding those factors that impact upon the participation of children with an ABI in Australia. Findings have implications for therapists, service providers and community organisations.	[Thompson, Melanie; Elliott, Catherine; Falkmer, Marita; Falkmer, Torbjorn; Girdler, Sonya] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia; [Willis, Claire] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA, Australia; [Ward, Roslyn; Gubbay, Anna] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia	Curtin University; University of Western Australia; University of Western Australia	Girdler, S (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia.	sonya.girdler@curtin.edu.au	Willis, Claire/AAM-9564-2020; Girdler, Sonya/ABC-9629-2021; Ward, Roslyn/AAE-6164-2022; Elliott, Catherine/B-6718-2014	Willis, Claire/0000-0002-3794-2902; Girdler, Sonya/0000-0001-7992-0800; Elliott, Catherine/0000-0002-5324-8216; Ward, Roslyn/0000-0003-4488-1199	Princess Margaret Hospital Foundation (PMHF) via the PMHF top-up scholarship	Princess Margaret Hospital Foundation (PMHF) via the PMHF top-up scholarship	Princess Margaret Hospital Foundation (PMHF) is acknowledged for their support via the PMHF top-up scholarship. PMHF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge all parents and families who generously contributed their time to participate in this research. Additionally, we would like to acknowledge the Participate Project Steering Group, whose expertise and contributions were invaluable. All staff in the Acquired Brain Injury team at PMH are thanked for their help in piloting and collecting and supporting this research. The Princess Margaret Hospital Foundation (PMHF) is acknowledged for their support via the PMHF top-up scholarship and the Telethon Kids Institute for additional data analysis.	Anderson V, 2006, AM J PHYS MED REHABI, V19, P191; Andrews J, 2014, DISABILITY REHABILIT, V1; [Anonymous], 1960, EDUCATIONAL AND PSYC, DOI [DOI 10.1177/001316446002000116, 10.1177/001316446002000116]; Australian Government, 2007, DIS AUSTR AQ BRAIN I; Australian Institute of Health and Welfare, 2004, CHILDR DIS AUSTR; Barbosa JC, 1998, ACAD EMERG MED, V5, P1032, DOI 10.1111/j.1553-2712.1998.tb02786.x; Barr M, 2011, J INTELL DISABIL RES, V55, P1020, DOI 10.1111/j.1365-2788.2011.01425.x; Bedell G, 2012, ARCH PHYS MED REHABI; Blosser J, 1996, PAEDIAT TAUMATIC BRI; Brown S.R., 1980, POLITICAL SUBJECTIVI; Brown SR, 1996, QUAL HEALTH RES, V6, P561, DOI 10.1177/104973239600600408; Bult MK, 2011, RES DEV DISABIL, V32, P1521, DOI 10.1016/j.ridd.2011.01.045; Buttimer J, 2005, J INTELLECT DISABILI, V9, P25, DOI 10.1177/1744629505049728; Case-Smith J, 2010, OCCUPATIONAL THERAPY, P62; Case-Smith J., 2010, OCCUPATIONAL THERAPY; Centre for Disease Control and Prevention, 2009, HLTH DAT INT NAT CTR; Combes H, 2004, J APPL RES INTELLECT, V17, P149, DOI 10.1111/j.1468-3148.2004.00191.x; Corr S., 2001, BRIT J OCCUP THER, V64, P293, DOI DOI 10.1177/030802260106400605; Corr S, 2006, RES OCCUPATIONAL THE, P389; Darrah J, 2011, DEV MED CHILD NEUROL, V53, P615, DOI 10.1111/j.1469-8749.2011.03959.x; Dempsey I, 2005, COMMUNITY DISABILITY, DOI Sydney; DENNIS KE, 1986, ADV NURS SCI, V8, P6, DOI 10.1097/00012272-198604000-00003; DIMDI, 2005, INT CLASS FUNCT DIS; Donner J. C., 2001, SOCIAL DEV PAPERS, V36, P24; Eccles J.S., 2002, REV RES ED, V26, P113, DOI [10.3102/0091732X026001113, DOI 10.3102/0091732X026001113]; Fink N, 2012, DEV NEUROREHABIL, V15, P336, DOI 10.3109/17518423.2012.655798; Finkelstein V., 1991, SOCIAL WORK DISABLED, P69; Foo WS, 2012, DEV NEUROREHABIL, V15, P1, DOI 10.3109/17518423.2011.623142; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Graham F, 2009, AUST OCCUP THER J, V56, P16, DOI 10.1111/j.1440-1630.2008.00736.x; Granlund M, 2012, AM J PHYS MED REHAB, V91, pS84, DOI 10.1097/PHM.0b013e31823d5376; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI 10.1007/BF02289162; Havens CA., 2005, COMMUNICATION; Heah Tom, 2007, Can J Occup Ther, V74, P38; Hutzler Y, 2002, ADAPT PHYS ACT Q, V19, P300, DOI 10.1123/apaq.19.3.300; Imms C, 2009, DISABIL REHABIL, V31, P2204, DOI 10.3109/09638280902971406; Jobling A, 2001, Downs Syndr Res Pract, V6, P117, DOI 10.3104/perspectives.102; King G, 2003, PHYS OCCUPATIONAL TH, V23; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Law MC, 2011, DEV MED CHILD NEUROL, V53, P621, DOI 10.1111/j.1469-8749.2011.03962.x; Letts L, 2007, QUALITATIVE REV FORM, V31, P357; Maxwell G, 2012, DEV NEUROREHABIL, V15, P274, DOI 10.3109/17518423.2012.689780; Mckenzie A, 2012, CONSUMER COMMUNITY P; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Oates A, 2011, DISABIL REHABIL, V33, P1880, DOI 10.3109/09638288.2011.553701; Palisano RJ, 2012, DISABIL REHABIL, V34, P1041, DOI 10.3109/09638288.2011.628740; Patterson J, 1996, ARCH PEDIAT ADOL MED, V150, P692, DOI 10.1001/archpedi.1996.02170320038006; Rosenbaum P., 1998, FAMILY CENTRED SERVI, V18, P1, DOI [10.1080/J006v18n01, DOI 10.1080/J006V18N01, DOI 10.1080/J006v18n01_01]; Sayers Menear Kristi, 2007, Downs Syndr Res Pract, V12, P60; Schmolk P, 2013, PQ METHOD; Shinebourne P., 2009, INT J QUAL METH, V8, P93, DOI [DOI 10.1177/160940690900800109, 10.1177/160940690900800109]; Simpkins Sandra D, 2005, New Dir Youth Dev, P51, DOI 10.1002/yd.107; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Toronto Aquired Brain Injury Network, 2005, DEF ACQ BRAIN INJ TO; Viscardis L., 1998, PHYSICAL OCCUPATIONA, V18, P41, DOI [DOI 10.1080/J006V18N01_03, 10.1080/J006v18n01_03]; Wagman P, 2012, SCAND J OCCUP THER, V19, P377, DOI 10.3109/11038128.2011.645552; Watts S., 2012, DOING Q METHODOLOGIC; WHO, 2001, WHO INT CLASS FUNCT; Wilcock A. A., 2015, OCCUPATIONAL PERSPEC; Willis CE, 2014, 26 ANN EUR AC CHILDH; Yan-Ting Chee D, 2014, DEV NEUROREHABILITAT, V1	62	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157951	10.1371/journal.pone.0157951	http://dx.doi.org/10.1371/journal.pone.0157951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367231	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900015
J	Bar-Lev, Y; Moshitch-Moshkovitz, S; Tsarfaty, G; Kaufman, D; Horev, J; Resau, JH; Tsarfaty, I				Bar-Lev, Yamit; Moshitch-Moshkovitz, Sharon; Tsarfaty, Galia; Kaufman, Dafna; Horev, Judith; Resau, James H.; Tsarfaty, Ilan			Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice	PLOS ONE			English	Article							MITOCHONDRIAL CARRIER HOMOLOG; RENAL LIPID-ACCUMULATION; ELEMENT-BINDING PROTEINS; DIET-INDUCED OBESITY; SKELETAL-MUSCLE; NONALCOHOLIC STEATOHEPATITIS; DIABETES-MELLITUS; BETA-OXIDATION; ADIPOSE-TISSUE; LIVER-DISEASE	Objective Metabolic dysfunctions, such as fatty liver, obesity and insulin resistance, are among the most common contemporary diseases worldwide, and their prevalence is continuously rising. Mimp/Mtch2 is a mitochondrial carrier protein homologue, which localizes to the mitochondria and induces mitochondrial depolarization. Mimp/Mtch2 single-nucleotide polymorphism is associated with obesity in humans and its loss in mice muscle protects from obesity. Our aim was to study the effects of Mimp/Mtch2 overexpression in vivo. Methods Transgenic mice overexpressing Mimp/Mtch2-GFP were characterized and monitored for lipid accumulation, weight and blood glucose levels. Transgenic mice liver and kidneys were used for gene expression analysis. Results Mimp/Mtch2-GFP transgenic mice express high levels of fatty acid synthase and of beta-oxidation genes and develop fatty livers and kidneys. Moreover, high-fat diet-fed Mimp/Mtch2 mice exhibit high blood glucose levels. Our results also show that Mimp/Mtch2 is involved in lipid accumulation and uptake in cells and perhaps in human obesity. Conclusions Mimp/Mtch2 alters lipid metabolism and may play a role in the onset of obesity and development of insulin resistance.	[Bar-Lev, Yamit; Horev, Judith; Tsarfaty, Ilan] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Moshitch-Moshkovitz, Sharon] Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Tsarfaty, Galia] Sheba Med Ctr, Dept Diagnost Imaging, Ramat Gan, Israel; [Kaufman, Dafna; Resau, James H.] Van Andel Res Inst, Grand Rapids, MI 49503 USA	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Van Andel Institute	Tsarfaty, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.	ilants@post.tau.ac.il		Tsarfaty, Ilan/0000-0002-5230-7093; Bar-Lev, Yamit/0000-0002-2850-859X	United States-Israel Binational Science Foundation (BSF) [2009293]; Breast Cancer Research Foundation (BCRF)	United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Breast Cancer Research Foundation (BCRF)	Funding provided by United States-Israel Binational Science Foundation (BSF), No. 2009293 and Breast Cancer Research Foundation (BCRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Bobulescu IA, 2008, AM J PHYSIOL-RENAL, V294, pF1315, DOI 10.1152/ajprenal.00550.2007; Bonnet F, 2000, DIABETES METAB, V26, P254; BRADY LJ, 1985, BIOCHEM J, V231, P439, DOI 10.1042/bj2310439; Buzaglo-Azriel L, 2016, CELL REP, V14, P1602, DOI 10.1016/j.celrep.2016.01.046; Chalasani N, 2003, HEPATOLOGY, V37, P544, DOI 10.1053/jhep.2003.50095; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Edvardsson U, 2003, PROTEOMICS, V3, P468, DOI 10.1002/pmic.200390061; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Fall T, 2012, DIABET MED; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Fisler JS, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-38; Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005; He MA, 2010, ARTERIOSCL THROM VAS, V30, P327, DOI 10.1161/ATVBAHA.109.196196; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2003, J BIOL CHEM, V278, P36652, DOI 10.1074/jbc.M306540200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Kim JJP, 2002, CURR OPIN STRUC BIOL, V12, P721, DOI 10.1016/S0959-440X(02)00390-1; Kulyte A, 2011, J CLIN ENDOCR METAB, V96, pE1661, DOI 10.1210/jc.2010-3050; Leibowitz-Amit R, 2006, CANCER RES, V66, P8687, DOI 10.1158/0008-5472.CAN-05-2294; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Maryanovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8901; Moshitch-Moshkovitz S, 2006, NEOPLASIA, V8, P353, DOI 10.1593/neo.05634; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Reisin E, 2009, MED CLIN N AM, V93, P733, DOI 10.1016/j.mcna.2009.02.010; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schmid PM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-48; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; SILVERMAN JF, 1989, PATHOL ANNU, V24, P275; Spencer MW, 2004, AM J NEPHROL, V24, P20, DOI 10.1159/000075362; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yerushalmi GM, 2002, NEOPLASIA, V4, P510, DOI 10.1038/sj.neo.7900272; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157850	10.1371/journal.pone.0157850	http://dx.doi.org/10.1371/journal.pone.0157850			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359329	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200026
J	Gertz, EM; Chowdhury, SA; Lee, WJ; Wangsa, D; Heselmeyer-Haddad, K; Ried, T; Schwartz, R; Schaffer, AA				Gertz, E. Michael; Chowdhury, Salim Akhter; Lee, Woei-Jyh; Wangsa, Darawalee; Heselmeyer-Haddad, Kerstin; Ried, Thomas; Schwartz, Russell; Schaffer, Alejandro A.			FISHtrees 3.0: Tumor Phylogenetics Using a Ploidy Probe	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CELL GENETIC-ANALYSIS; COPY NUMBER CHANGES; CLONAL EVOLUTION; CANCER PROGRESSION; MAXIMUM-LIKELIHOOD; ONCOGENETIC TREE; MODELS; HETEROGENEITY; MUTATIONS	Advances in fluorescence in situ hybridization (FISH) make it feasible to detectmultiple copy-number changes in hundreds of cells of solid tumors. Studies using FISH, sequencing, and other technologies have revealed substantial intra-tumor heterogeneity. The evolution of subclones in tumors may bemodeled by phylogenies. Tumors often harbor aneuploid or polyploid cell populations. Using a FISH probe to estimate changes in ploidy can guide the creation of trees that model changes in ploidy and individual gene copy-number variations. We present FISHtrees 3.0, which implements a ploidy-based tree building method based on mixed integer linear programming (MILP). The ploidy-based modeling in FISHtrees includes a new formulation of the problem of merging trees for changes of a single gene into trees modeling changes in multiple genes and the ploidy. When multiple samples are collected from each patient, varying over time or tumor regions, it is useful to evaluate similarities in tumor progression among the samples. Therefore, we further implemented in FISHtrees 3.0 a new method to build consensus graphs for multiple samples. We validate FISHtrees 3.0 on a simulated data and on FISH data from paired cases of cervical primary and metastatic tumors and on paired breast ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). Tests on simulated data show improved accuracy of the ploidy-based approach relative to prior ploidyless methods. Tests on real data further demonstrate novel insights these methods offer into tumor progression processes. Trees for DCIS samples are significantly less complex than trees for paired IDC samples. Consensus graphs show substantial divergence among most paired samples from both sets. Low consensus between DCIS and IDC trees may help explain the difficulty in finding biomarkers that predict which DCIS cases are at most risk to progress to IDC. The FISHtrees software is available at ftp://ftp.ncbi.nih.gov/pub/FISHtrees.	[Gertz, E. Michael] US Natl Inst Hlth, Natl Ctr Biotechnol Informat, Computat Biol Branch, 31 Ctr Dr, Bethesda, MD 20892 USA; [Chowdhury, Salim Akhter; Schwartz, Russell] Carnegie Mellon Univ, Computat Biol Dept, Pittsburgh, PA USA; [Chowdhury, Salim Akhter] Carnegie Mellon Univ Pittsburgh, Joint PhD Program Computat Biol, Pittsburgh, PA USA; [Wangsa, Darawalee; Heselmeyer-Haddad, Kerstin; Ried, Thomas] US Natl Inst Hlth, Sect Canc Genom, Genet Branch, Ctr Canc Res,Natl Canc Inst, Bethesda, MD USA; [Schwartz, Russell] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA USA; [Chowdhury, Salim Akhter] Simons Fdn, Simons Ctr Data Anal, New York, NY USA; [Chowdhury, Salim Akhter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ USA; [Lee, Woei-Jyh] Univ Maryland, Robert H Smith Sch Business, Dept Decis Operat & Informat Technol, College Pk, MD USA	National Institutes of Health (NIH) - USA; Carnegie Mellon University; Carnegie Mellon University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Carnegie Mellon University; Princeton University; University System of Maryland; University of Maryland College Park	Gertz, EM (corresponding author), US Natl Inst Hlth, Natl Ctr Biotechnol Informat, Computat Biol Branch, 31 Ctr Dr, Bethesda, MD 20892 USA.	gertz@ncbi.nlm.nih.gov	Schwartz, Russell/A-1998-2016; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Schwartz, Russell/0000-0002-4970-2252; 	Intramural Research Program of the National Institutes of Health, NLM and NCI; U.S. National Institutes of Health [1R01CA140214]; NATIONAL CANCER INSTITUTE [ZIABC010834] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NLM and NCI; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, NLM and NCI, and by U.S. National Institutes of Health award 1R01CA140214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg T, 2009, MATH PROGRAM COMPUT, V1, P1, DOI 10.1007/s12532-008-0001-1; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Beerenwinkel N, 2005, BIOINFORMATICS, V21, P2106, DOI 10.1093/bioinformatics/bti274; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Carraro DM, 2014, BIOSCIENCE REP, V34, P18, DOI 10.1042/BSR20130077; Catanzaro D, 2016, IEEE ACM T COMPUT BI, V13, P643, DOI 10.1109/TCBB.2015.2476808; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chowdhury SA, 2013, BIOINFORMATICS, V31, pi258; Chowdhury SA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003740; Chowdhury SA, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/btt205; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Desper R, 1999, J COMPUT BIOL, V6, P37, DOI 10.1089/cmb.1999.6.37; Diaz-Uriarte R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0466-7; Ding L, 2013, CANCER LETT, V340, P212, DOI 10.1016/j.canlet.2012.12.028; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; El-Kebir M, 2015, BIOINFORMATICS, V31, P62, DOI 10.1093/bioinformatics/btv261; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Farahani HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065773; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2009, BIOINFORMATICS, V25, P2809, DOI 10.1093/bioinformatics/btp505; Hainke K, 2012, BIOMETRICAL J, V54, P617, DOI 10.1002/bimj.201100186; Hajirasouliha I, 2014, BIOINFORMATICS, V30, P78, DOI 10.1093/bioinformatics/btu284; Heselmeyer-Haddad K, 2002, CANCER RES, V62, P2365; Heselmeyer-Haddad K, 2012, AM J PATHOL, V181, P1807, DOI 10.1016/j.ajpath.2012.07.012; Heselmeyer-Haddad KM, 2014, AM J PATHOL, V184, P2671, DOI 10.1016/j.ajpath.2014.06.030; Hjelm M, 2006, J COMPUT BIOL, V13, P853, DOI 10.1089/cmb.2006.13.853; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Janocko LE, 2001, CYTOMETRY, V46, P136, DOI 10.1002/cyto.1098; Jiao W, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-35; Karp R, 1971, NETWORKS, V1, P265, DOI DOI 10.1002/NET.3230010305; Klein CA, 2013, NATURE, V501, P365, DOI 10.1038/nature12628; Kostadinov RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003553; Lecca P, 2015, FRONT GENET, V6, DOI [10.3339/fgene.2015.00309, 10.3389/fgene.2015.00309]; Lin Y, 2012, IEEE ACM T COMPUT BI, V9, P1014, DOI 10.1109/TCBB.2011.157; Malikic S, 2015, BIOINFORMATICS, V31, P1349, DOI 10.1093/bioinformatics/btv003; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Niknafs N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004416; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pennington Gregory, 2007, J Bioinform Comput Biol, V5, P407, DOI 10.1142/S021972000700259X; Polyak K, 2008, CLIN CANCER RES, V14, P339, DOI 10.1158/1078-0432.CCR-07-2188; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; Ramazzotti D, 2015, BIOINFORMATICS, V31, P3016, DOI 10.1093/bioinformatics/btv296; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sprouffske K, 2011, CANCER PREV RES, V4, P1135, DOI 10.1158/1940-6207.CAPR-10-0374; Strino F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt641; Szabo A, 2002, MATH BIOSCI, V176, P219, DOI 10.1016/S0025-5564(02)00086-X; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Turajlic S, 2015, BBA-REV CANCER, V1855, P264, DOI 10.1016/j.bbcan.2015.03.005; Von Heydebreck A, 2004, BIOSTATISTICS, V5, P545, DOI 10.1093/biostatistics/kxh007; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Wangsa D, 2016, INT J CANCER, V138, P98, DOI 10.1002/ijc.29691; Wangsa D, 2009, AM J PATHOL, V175, P2637, DOI 10.2353/ajpath.2009.090289; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zare H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003703; Zhou J, 2015, LECT N BIOINFORMAT, V9289, P108, DOI 10.1007/978-3-662-48221-6_8	74	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158569	10.1371/journal.pone.0158569	http://dx.doi.org/10.1371/journal.pone.0158569			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362268	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200093
J	Kho, AT; Sharma, S; Davis, JS; Spina, J; Howard, D; McEnroy, K; Moore, K; Sylvia, J; Qiu, WL; Weiss, ST; Tantisira, KG				Kho, Alvin T.; Sharma, Sunita; Davis, Joshua S.; Spina, Joseph; Howard, Dagnie; McEnroy, Kevin; Moore, Kip; Sylvia, Jody; Qiu, Weiliang; Weiss, Scott T.; Tantisira, Kelan G.			Circulating MicroRNAs: Association with Lung Function in Asthma	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; ALVEOLAR EPITHELIAL-CELLS; MANAGEMENT PROGRAM CAMP; DISEASE PROGRESSION; STORAGE-CONDITIONS; ALLERGIC RHINITIS; UP-REGULATION; T-CELLS; EXPRESSION; PATHWAY	Background MicroRNAs are key transcriptional and network regulators previously associated with asthma susceptibility. However, their role in relation to asthma severity has not been delineated. Objective We hypothesized that circulating microRNAs could serve as biomarkers of changes in lung function in asthma patients. Methods We isolated microRNAs from serum samples obtained at randomization for 160 participants of the Childhood Asthma Management Program. Using a TaqMan microRNA array containing 754 microRNA primers, we tested for the presence of known asthma microRNAs, and assessed the association of the individual microRNAs with lung function as measured by FEV1/FVC, FEV1% and FVC%. We further tested the subset of FEV1/FVC microRNAs for sex-specific and lung developmental associations. Results Of the 108 well-detected circulating microRNAs, 74 (68.5%) had previously been linked to asthma susceptibility. We found 22 (20.3%), 4 (3.7%) and 8 (7.4%) microRNAs to be associated with FEV1/FVC, FEV1% and FVC%, respectively. 8 (of 22) FEV1/FVC, 3 (of 4) FEV1% and 1 (of 8) FVC% microRNAs had functionally validated target genes that have been linked via genome wide association studies to asthma and FEV1 change. Among the 22 FEV1/FVC microRNAs, 9 (40.9%) remain associated with FEV1/FVC in boys alone in a sex-stratified analysis (compared with 3 FEV1/FVC microRNAs in girls alone), 7 (31.8%) were associated with fetal lung development, and 3 (13.6%) in both. Ontology analyses revealed enrichment for pathways integral to asthma, including PPAR signaling, G-protein coupled signaling, actin and myosin binding, and respiratory system development. Conclusions Circulating microRNAs reflect asthma biology and are associated with lung function differences in asthmatics. They may represent biomarkers of asthma severity.	[Kho, Alvin T.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Kho, Alvin T.; Davis, Joshua S.; Spina, Joseph; McEnroy, Kevin; Moore, Kip; Sylvia, Jody; Qiu, Weiliang; Weiss, Scott T.; Tantisira, Kelan G.] Harvard Med Sch, Boston, MA 02115 USA; [Davis, Joshua S.; Spina, Joseph; McEnroy, Kevin; Moore, Kip; Sylvia, Jody; Qiu, Weiliang; Weiss, Scott T.; Tantisira, Kelan G.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Tantisira, Kelan G.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Davis, Joshua S.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02115 USA; [Howard, Dagnie] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Weiss, Scott T.] Partners HealthCare Syst, Partners Personalized Med, Boston, MA 02115 USA; [Sharma, Sunita] Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Oregon Health & Science University; Partners Healthcare System; University of Colorado System; University of Colorado Anschutz Medical Campus	Tantisira, KG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Tantisira, KG (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA.; Tantisira, KG (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	kelan.tantisira@channing.harvard.edu			National Institutes of Health grants [R01 HL127332, R01 HL129935, U01 HL65899, R01 HL092197, R01 NR013391, K25 HL091124, T32 HL007427]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092197, U01HL065899, R01HL127332, K25HL091124, T32HL007427, R01HL129935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013391] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work is supported by the National Institutes of Health grants R01 HL127332, R01 HL129935, U01 HL65899, R01 HL092197, R01 NR013391, K25 HL091124 (ATK) and T32 HL007427 (JSD).; This work is supported by the NIH grants R01 HL127332, R01 HL129935, U01 HL65899, R01 HL092197, R01 NR013391, K25 HL091124 (ATK) and T32 HL007427 (JSD). This manuscript is subject to the NIH public access policy.	[Anonymous], 2007, J ALLERGY CLIN IMMUN, V120, P1330, DOI [10.1016/j.jaci.2007.09.043, DOI 10.1016/J.JACI.2007.09.043]; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Benayoun L, 2001, AM J RESP CRIT CARE, V164, P1487, DOI 10.1164/ajrccm.164.8.2101070; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhargava M, 2013, AM J PHYSIOL-LUNG C, V305, pL604, DOI 10.1152/ajplung.00079.2013; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bovell LC, 2013, CLIN CANCER RES, V19, P3955, DOI 10.1158/1078-0432.CCR-12-3302; Callari M, 2013, ANAL BIOCHEM, V437, P123, DOI 10.1016/j.ab.2013.03.002; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Cho WCS, 2011, EXPERT REV MOL DIAGN, V11, P763, DOI [10.1586/erm.11.71, 10.1586/ERM.11.71]; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Foshay Kara M, 2007, Curr Stem Cell Res Ther, V2, P264, DOI 10.2174/157488807782793781; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959, DOI 10.1164/ajrccm.159.3.9804060; Gappa M, 2006, EUR RESPIR MONOGR, P22, DOI 10.1183/1025448x.00037003; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Good P, 2005, PERMUTATION PARAMETR; Grasedieck S, 2012, LEUKEMIA, V26, P2414, DOI 10.1038/leu.2012.106; Grasedieck S, 2013, BLOOD, V121, P4977, DOI 10.1182/blood-2013-01-480079; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hromadnikova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113735; Hu RX, 2014, FASEB J, V28, P2347, DOI 10.1096/fj.13-247247; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Jardim MJ, 2012, AM J RESP CELL MOL, V47, P536, DOI 10.1165/rcmb.2011-0160OC; Johnson RA, 2002, APPLIED MULTIVARIATE; Ke XF, 2014, BIOCHEM BIOPH RES CO, V450, P1297, DOI 10.1016/j.bbrc.2014.06.125; Kho AT, 2010, AM J RESP CRIT CARE, V181, P54, DOI 10.1164/rccm.200907-1063OC; Khoshgoo N, 2013, PEDIATR PULM, V48, P317, DOI 10.1002/ppul.22739; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Lasser Cecilia, 2013, Methods Mol Biol, V1024, P109, DOI 10.1007/978-1-62703-453-1_9; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Liu F, 2012, MOL MED REP, V6, P1178, DOI 10.3892/mmr.2012.1030; Lv YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mi Shuangli, 2013, Microrna, V2, P63, DOI 10.2174/2211536611302010007; Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Mraz M, 2009, BIOCHEM BIOPH RES CO, V390, P1, DOI 10.1016/j.bbrc.2009.09.061; Nadrop B, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00009; Nakano T, 2013, J ALLERGY CLIN IMMUN, V132, P1224, DOI 10.1016/j.jaci.2013.06.041; Nicodemus-Johnson J, 2013, J ALLERGY CLIN IMMUN, V131, P1496, DOI 10.1016/j.jaci.2013.01.037; Panganiban RP, 2016, J ALLERGY CLIN IMMUN, V137, P1423, DOI 10.1016/j.jaci.2016.01.029; Panganiban RPL, 2012, AM J CLIN EXP IMMUNO, V1, P154; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Perry MM, 2014, AM J RESP CELL MOL, V50, P7, DOI 10.1165/rcmb.2013-0067OC; Pinkerton M, 2013, J ALLERGY CLIN IMMUN, V132, P217, DOI 10.1016/j.jaci.2013.03.006; Plank M, 2013, CLIN EXP ALLERGY, V43, P981, DOI [10.1111/cea.12135, 10.1111/cea.12170]; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Rayner KJ, 2013, J LIPID RES, V54, P1174, DOI 10.1194/jlr.R034991; Reuter S, 2014, J IMMUNOL, V193, P485, DOI 10.4049/jimmunol.1400013; Rodrigo GJ, 2015, CHEST, V147, P388, DOI 10.1378/chest.14-1698; Seumois G, 2012, AM J CLIN EXP IMMUNO, V1, P70; Sharma S, 2010, AM J RESP CRIT CARE, V181, P328, DOI 10.1164/rccm.200907-1009OC; Shen Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0750-1; Shrivastava S, 2013, HEPATOLOGY, V58, P863, DOI 10.1002/hep.26296; Solberg OD, 2012, AM J RESP CRIT CARE, V186, P965, DOI 10.1164/rccm.201201-0027OC; Suojalehto H, 2014, INT ARCH ALLERGY IMM, V163, P168, DOI 10.1159/000358486; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tantisira KG, 2003, THORAX, V58, P1036, DOI 10.1136/thorax.58.12.1036; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang L, 2015, CELL PHYSIOL BIOCHEM, V35, P2285, DOI 10.1159/000374032; Williams AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005889; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yamamoto M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-655; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang MF, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-21; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	82	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157998	10.1371/journal.pone.0157998	http://dx.doi.org/10.1371/journal.pone.0157998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362794	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200034
J	Petrova, L; Gran, C; Bjoras, M; Doetsch, PW				Petrova, Lucy; Gran, Christine; Bjoras, Magnar; Doetsch, Paul W.			Efficient and Reliable Production of Vectors for the Study of the Repair, Mutagenesis, and Phenotypic Consequences of Defined DNA Damage Lesions in Mammalian Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL MUTAGENESIS; ENDONUCLEASE-III; OXIDIZED BASES; N-GLYCOSYLASE; STRANDED-DNA; URACIL; ASSAYS; DIHYDROURACIL; SUBSTRATE; BYPASS	Mammalian cells are constantly and unavoidably exposed to DNA damage from endogenous and exogenous sources, frequently to the detriment of genomic integrity and biological function. Cells acquire a large number of chemically diverse lesions per day, and each can have a different genetic fate and biological consequences. However, our knowledge of how and when specific lesions are repaired or how they may compromise the fidelity of DNA replication or transcription and lead to deleterious biological endpoints in mammalian cells is limited. Studying individual lesions requires technically challenging approaches for the targeted introduction of defined lesions into relevant DNA sequences of interest. Here, we present a systematic analysis of factors influencing yield and an improved, efficient and reliable protocol for the production of mammalian expression phagemid vectors containing defined DNA base modifications in any sequence position of either complementary DNA strand. We applied our improved protocol to study the transcriptional mutagenesis-mediated phenotypic consequences of the common oxidative lesion 5-hydroxyuracil, placed in the G12 mutational hotspot of the KRAS oncogene. 5-OHU induced sustained oncogenic signaling in Neil1(-/-)Neil2(-/-) mouse cells. The resulting advance in technology will have broad applicability for investigation of single lesion DNA repair, mutagenesis, and DNA damage responses in mammalian cells.	[Petrova, Lucy] Emory Univ, Program Genet & Mol Biol, Atlanta, GA USA; [Petrova, Lucy; Doetsch, Paul W.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Gran, Christine; Bjoras, Magnar] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Gran, Christine; Bjoras, Magnar] Univ Oslo, Oslo, Norway; [Bjoras, Magnar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Trondheim, Norway; [Doetsch, Paul W.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Doetsch, Paul W.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Doetsch, Paul W.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); Emory University; Emory University; Emory University	Doetsch, PW (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.; Doetsch, PW (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.; Doetsch, PW (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.; Doetsch, PW (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA.	medpwd@emory.edu	Bjørås, Magnar/N-9286-2017		National Institutes of Health [ES011163 CA120288]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by National Institutes of Health ES011163 CA120288.	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bregeon D, 2003, MOL CELL, V12, P959, DOI 10.1016/S1097-2765(03)00360-5; Bregeon D, 2004, BIOTECHNIQUES, V37, P760, DOI 10.2144/04375ST01; Bregeon D, 2006, METHOD ENZYMOL, V409, P345, DOI 10.1016/S0076-6879(05)09020-8; Bregeon D, 2011, NAT REV CANCER, V11, P218, DOI 10.1038/nrc3006; Bregeon D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000577; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Dizdaroglu M, 1996, NUCLEIC ACIDS RES, V24, P418, DOI 10.1093/nar/24.3.418; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Hegde ML, 2013, P NATL ACAD SCI USA, V110, pE3090, DOI 10.1073/pnas.1304231110; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kiss-Toth E, 2001, ANAL BIOCHEM, V288, P230, DOI 10.1006/abio.2000.4858; Kuznetsov NA, 2007, BIOCHEMISTRY-US, V46, P424, DOI 10.1021/bi060787r; Liu J, 1998, NUCLEIC ACIDS RES, V26, P1707, DOI 10.1093/nar/26.7.1707; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luhnsdorf B, 2012, ANAL BIOCHEM, V425, P47, DOI 10.1016/j.ab.2012.03.001; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shivji MKK, 1999, METH MOL B, V113, P373; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Venkhataraman R, 2001, NUCLEIC ACIDS RES, V29, P407, DOI 10.1093/nar/29.2.407; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Zhou BS, 2009, ANAL BIOCHEM, V389, P177, DOI 10.1016/j.ab.2009.03.044	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158581	10.1371/journal.pone.0158581	http://dx.doi.org/10.1371/journal.pone.0158581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362559	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200097
J	Si, WK; Chung, JW; Cho, J; Baeg, JY; Jang, ES; Yoon, H; Kim, J; Shin, CM; Park, YS; Hwang, JH; Jeong, SH; Kim, N; Lee, DH; Lim, S; Kim, JW				Si, Won Keun; Chung, Jung Wha; Cho, Junhyeon; Baeg, Joo Yeong; Jang, Eun Sun; Yoon, Hyuk; Kim, Jaihwan; Shin, Cheol Min; Park, Young Soo; Hwang, Jin-Hyeok; Jeong, Sook-Hyang; Kim, Nayoung; Lee, Dong Ho; Lim, Soo; Kim, Jin-Wook			Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes	PLOS ONE			English	Article							FATTY LIVER; DIAGNOSTIC-VALUE; VIRAL-HEPATITIS; CIRRHOSIS; MELLITUS; FIBROSIS; ALCOHOL; CANCER; COHORT; SYNERGISM	Epidemiological data indicate that type 2 diabetes is associated with increased risk of hepatocellular carcinoma (HCC). However, risk stratification for HCC has not been fully elucidated in diabetic population. The aim of this study was to identify potential predictors of HCC in diabetic patients without chronic viral hepatitis. A cohort of 3,544 diabetic patients without chronic viral hepatitis or alcoholic cirrhosis was established and subjects were randomly allocated into a derivation and a validation set. A scoring system was developed by using potential predictors of increased risk of HCC from the Cox proportional hazards model. The performance of the scoring system was tested for validation by using receiver operating characteristics analysis. During median follow-up of 55 months, 36 cases of HCC developed (190 per 100,000 person-years). The 5- and 10-year cumulative incidences of HCC were 1.0%, and 2.2%, respectively. Multivariate Cox regression analysis showed that age > 65 years, low triglyceride levels and high gamma-glutamyl transferase levels were independently associated with an increased risk of HCC. DM-HCC risk score, a weighted sum of scores from these 3 parameters, predicted 10-year development of HCC with area under the receiver operating characteristics curve of 0.86, and discriminated different risk categories for HCC in the derivation and validation cohort. In conclusion, old age, low triglyceride level and high gamma-glutamyl transferase level may help to identify individuals at high risk of developing HCC in diabetic patients without chronic viral hepatitis or alcoholic cirrhosis.	[Si, Won Keun; Chung, Jung Wha; Cho, Junhyeon; Baeg, Joo Yeong; Jang, Eun Sun; Yoon, Hyuk; Kim, Jaihwan; Shin, Cheol Min; Park, Young Soo; Hwang, Jin-Hyeok; Jeong, Sook-Hyang; Kim, Nayoung; Lee, Dong Ho; Lim, Soo; Kim, Jin-Wook] Seoul Natl Univ, Bundang Hosp, Dept Med, Seongnam, South Korea; [Jang, Eun Sun; Yoon, Hyuk; Kim, Jaihwan; Shin, Cheol Min; Park, Young Soo; Hwang, Jin-Hyeok; Jeong, Sook-Hyang; Kim, Nayoung; Lee, Dong Ho; Lim, Soo; Kim, Jin-Wook] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Med, Seongnam, South Korea.; Kim, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kimjw@snubh.org	Yoon, Hyuk/AAT-4978-2020	Yoon, Hyuk/0000-0002-2657-0349; Kim, Nayoung/0000-0002-9397-0406; Kim, Jin-Wook/0000-0003-0934-3344	National Research Foundation of Korea (NRF) - Korean Government [2013R1A1A2061509]	National Research Foundation of Korea (NRF) - Korean Government(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant to J-W Kim, funded by the Korean Government (2013R1A1A2061509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami HO, 1996, J NATL CANCER I, V88, P1472, DOI 10.1093/jnci/88.20.1472; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Atreja A, 2008, AM J GASTROENTEROL, V103, P2171, DOI 10.1111/j.1572-0241.2008.01890.x; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen HF, 2010, HEPATOLOGY, V52, P155, DOI 10.1002/hep.23641; Cui R, 2003, BRIT J CANCER, V88, P1878, DOI 10.1038/sj.bjc.6601018; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Dixon JB, 2006, OBES SURG, V16, P1278, DOI 10.1381/096089206778663805; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ghadir MR, 2010, HEPAT MON, V10, P285; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x; Koh WP, 2013, BRIT J CANCER, V108, P1182, DOI 10.1038/bjc.2013.25; Koruk M, 2003, J CLIN GASTROENTEROL, V37, P177, DOI 10.1097/00004836-200308000-00017; Lai MS, 2006, HEPATOLOGY, V43, P1295, DOI 10.1002/hep.21208; LaVecchia C, 1997, INT J CANCER, V73, P204, DOI 10.1002/(SICI)1097-0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-#; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Li Q, 2012, INT J CANCER, V131, P1197, DOI 10.1002/ijc.27337; Li YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105728; Lin CC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-381; Mancebo A, 2013, CLIN GASTROENTEROL H, V11, P95, DOI 10.1016/j.cgh.2012.09.007; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Singal AG, 2015, CLIN GASTROENTEROL H, V13, P2140, DOI 10.1016/j.cgh.2015.08.014; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; TESCHKE R, 1983, GUT, V24, P625, DOI 10.1136/gut.24.7.625; Testino G, 2014, WORLD J GASTROENTERO, V20, P15943, DOI 10.3748/wjg.v20.i43.15943; Tietge UJF, 1998, HEPATO-GASTROENTEROL, V45, P2255; van Soest EM, 2005, GUT, V54, P1062, DOI 10.1136/gut.2004.063685; Wang CG, 2012, INT J CANCER, V130, P1639, DOI 10.1002/ijc.26165; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; XU KC, 1992, AM J GASTROENTEROL, V87, P991; Yang SW, 2015, J GASTROEN HEPATOL, V30, P1175, DOI 10.1111/jgh.12921; Yang WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027326; Yoo S, 2013, STUD HEALTH TECHNOL, V192, P1015, DOI 10.3233/978-1-61499-289-9-1015; Yoo S, 2012, HEALTHC INFORM RES, V18, P145, DOI 10.4258/hir.2012.18.2.145; Yuan JM, 2004, CANCER, V101, P1009, DOI 10.1002/cncr.20427; Zhang XD, 2014, HEPATOLOGY, V60, P2008, DOI 10.1002/hep.27199; Zheng Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084776	47	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158066	10.1371/journal.pone.0158066	http://dx.doi.org/10.1371/journal.pone.0158066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359325	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200037
J	Smalley, C; Bechelli, J; Rockx-Brouwer, D; Saito, T; Azar, SR; Ismail, N; Walker, DH; Fang, R				Smalley, Claire; Bechelli, Jeremy; Rockx-Brouwer, Dedeke; Saito, Tais; Azar, Sasha R.; Ismail, Nahed; Walker, David H.; Fang, Rong			Rickettsia australis Activates Inflammasome in Human and Murine Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NLRP3 INFLAMMASOME; GAMMA-INTERFERON; DENDRITIC CELLS; MELANOMA 2; EXPRESSION; MODEL; INTERLEUKIN-10; INVOLVEMENT; INFECTIONS	Rickettsiae actively escape from vacuoles and replicate free in the cytoplasm of host cells, where inflammasomes survey the invading pathogens. In the present study, we investigated the interactions of Rickettsia australis with the inflammasome in both mouse and human macrophages. R. australis induced a significant level of IL-1 beta secretion by human macrophages, which was significantly reduced upon treatment with an inhibitor of caspase-1 compared to untreated controls, suggesting caspase-1-dependent inflammasome activation. Rickettsia induced significant secretion of IL-1 beta and IL-18 in vitro by infected mouse bone marrow-derived macrophages (BMMs) as early as 8-12 h post infection (p.i.) in a dose-dependent manner. Secretion of these cytokines was accompanied by cleavage of caspase-1 and was completely abrogated in BMMs deficient in caspase-1/caspase-11 or apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC), suggesting that R. australis activate the ASC-dependent inflammasome. Interestingly, in response to the same quantity of rickettsiae, NLRP3(-/-) BMMs significantly reduced the secretion level of IL-1 beta compared to wild type (WT) controls, suggesting that NLRP3 inflammasome contributes to cytosolic recognition of R. australis in vitro. Rickettsial load in spleen, but not liver and lung, of R. australis-infected NLRP3(-/-) mice was significantly greater compared to WT mice. These data suggest that NLRP3 inflammasome plays a role in host control of bacteria in vivo in a tissue-specific manner. Taken together, our data, for the first time, illustrate the activation of ASC-dependent inflammasome by R. australis in macrophages in which NLRP3 is involved.	[Smalley, Claire; Bechelli, Jeremy; Rockx-Brouwer, Dedeke; Saito, Tais; Azar, Sasha R.; Walker, David H.; Fang, Rong] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Ismail, Nahed] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Rockx-Brouwer, Dedeke] Intravacc, Bilthoven, Netherlands	University of Texas System; University of Texas Medical Branch Galveston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fang, R (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.	rofang@utmb.edu	Fang, Rong/ABD-6123-2020; Bechelli, Jeremy/ABC-6193-2020	Azar, Sasha/0000-0002-9182-216X; Fang, Rong/0000-0003-0213-0960; Bechelli, Jeremy/0000-0002-8786-7795	National Institute of Allergy and Infectious Diseases [AI101413]; Pre-Doctoral McLaughlin Fellowship Award from the University of Texas Medical Branch at Galveston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101413] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pre-Doctoral McLaughlin Fellowship Award from the University of Texas Medical Branch at Galveston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI101413 from the National Institute of Allergy and Infectious Diseases. Claire Smalley is supported by Pre-Doctoral McLaughlin Fellowship Award from the University of Texas Medical Branch at Galveston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant AI101413 from the National Institute of Allergy and Infectious Diseases. Claire Smalley is supported by a Pre-Doctoral McLaughlin Fellowship Award from the University of Texas Medical Branch at Galveston.	Cai SS, 2012, J IMMUNOL, V188, P5623, DOI 10.4049/jimmunol.1200195; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Casson CN, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00111; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Cragun WC, 2010, ARCH DERMATOL, V146, P641, DOI 10.1001/archdermatol.2010.48; de Sousa R, 2007, J INFECT DIS, V196, P770, DOI 10.1086/519739; Eremeeva ME, 1999, RICKETTSIAE RICKETTS, P128; Fang R, 2007, INFECT IMMUN, V75, P3112, DOI 10.1128/IAI.00007-07; Fang R, 2012, AM J PATHOL, V181, P185, DOI 10.1016/j.ajpath.2012.03.020; Fang R, 2009, INFECT IMMUN, V77, P3838, DOI 10.1128/IAI.00349-09; FENG HM, 1993, AM J PATHOL, V142, P1471; Feng HM, 1997, J IMMUNOL, V158, P5314; FENG HM, 1994, INFECT IMMUN, V62, P1952, DOI 10.1128/IAI.62.5.1952-1960.1994; Graves S, 2009, ANN NY ACAD SCI, V1166, P151, DOI 10.1111/j.1749-6632.2009.04530.x; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Johnston L, 2015, IMMUNOBIOLOGY, V220, P1305, DOI 10.1016/j.imbio.2015.07.014; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Jordan JM, 2007, J INFECT DIS, V196, P629, DOI 10.1086/519686; Jordan JM, 2009, J INFECT DIS, V199, P236, DOI 10.1086/595833; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuo J, 2015, INFECT IMMUN, V83, P2917, DOI 10.1128/IAI.02968-14; Melehani JH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004970; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Radulovic S, 2002, INFECT IMMUN, V70, P2576, DOI 10.1128/IAI.70.5.2576-2582.2002; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Valbuena G, 2003, AM J PATHOL, V163, P1357, DOI 10.1016/S0002-9440(10)63494-3; Walker DH, 2007, CLIN INFECT DIS, V45, pS39, DOI 10.1086/518145; WALKER DH, 1994, LAB INVEST, V70, P358; Walker DH, 2000, LAB INVEST, V80, P1361, DOI 10.1038/labinvest.3780144; Walker DH, 1999, MODERN PATHOL, V12, P529; Walker DH, 2001, INFECT IMMUN, V69, P1841, DOI 10.1128/IAI.69.3.1841-1846.2001; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Xin LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034062; Yang Q, 2015, AM J PATHOL, V185, P446, DOI 10.1016/j.ajpath.2014.10.005; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	44	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157231	10.1371/journal.pone.0157231	http://dx.doi.org/10.1371/journal.pone.0157231			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362650	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200010
J	Edmondson, R; Adcock, AF; Yang, LJ				Edmondson, Rasheena; Adcock, Audrey F.; Yang, Liju			Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated Proteins	PLOS ONE			English	Article							III BETA-TUBULIN; BASEMENT-MEMBRANE MATRIX; 3-DIMENSIONAL 3D CULTURE; EMBRYONIC STEM-CELLS; BREAST-CANCER; IN-VITRO; GENE-EXPRESSION; TUMOR SPHEROIDS; P53 ISOFORMS; GROWTH	This study investigated the effects of matrix on the behaviors of 3D-cultured cells of two prostate cancer cell lines, LNCaP and DU145. Two biologically-derived matrices, Matrigel and Cultrex BME, and one synthetic matrix, the Alvetex scaffold, were used to culture the cells. The cell proliferation rate, cellular response to anti-cancer drugs, and expression levels of proteins associated with drug sensitivity/ resistance were examined and compared amongst the 3D-cultured cells on the three matrices and 2D-cultured cells. The cellular responses upon treatment with two common anti-cancer drugs, Docetaxel and Rapamycin, were examined. The expressions of epidermal growth factor receptor (EGFR) and beta-III tubulin in DU145 cells and p53 in LNCaP cells were examined. The results showed that the proliferation rates of cells cultured on the three matrices varied, especially between the synthetic matrix and the biologically-derived matrices. The drug responses and the expressions of drug sensitivity-associated proteins differed between cells on various matrices as well. Among the 3D cultures on the three matrices, increased expression of beta-III tubulin in DU145 cells was correlated with increased resistance to Docetaxel, and decreased expression of EGFR in DU145 cells was correlated with increased sensitivity to Rapamycin. Increased expression of a p53 dimer in 3D-cultured LNCaP cells was correlated with increased resistance to Docetaxel. Collectively, the results showed that the matrix of 3D cell culture models strongly influences cellular behaviors, which highlights the imperative need to achieve standardization of 3D cell culture technology in order to be used in drug screening and cell biology studies.	[Edmondson, Rasheena; Adcock, Audrey F.; Yang, Liju] N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise BRITE, Durham, NC 27707 USA	University of North Carolina; North Carolina Central University	Yang, LJ (corresponding author), N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise BRITE, Durham, NC 27707 USA.	lyang@nccu.edu			NSF (CBET) [1159871]	NSF (CBET)(National Science Foundation (NSF))	NSF (CBET #1159871).; This research was supported by NSF (CBET #1159871).	Adcock A.F., 2015, J ANAL BIOANAL TECH, V6, DOI [10.4172/2155-9872.1000249, DOI 10.4172/2155-9872.1000249]; Alessandri M, 2014, MATRIX BIOL, V33, P68, DOI 10.1016/j.matbio.2013.08.001; Avery-Kiejda KA, 2014, CARCINOGENESIS, V35, P586, DOI 10.1093/carcin/bgt411; Babichenko II, 2014, INT J CLIN EXP PATHO, V7, P9090; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Bar J, 2004, ONCOGENE, V23, P2128, DOI 10.1038/sj.onc.1207325; Bhadriraju K, 2002, DRUG DISCOV TODAY, V7, P612, DOI 10.1016/S1359-6446(02)02273-0; Bialkowska A, 2015, INTESTINAL TUMORIGEN; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Chambers KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111029; Chitcholtan K, 2013, EXP CELL RES, V319, P75, DOI 10.1016/j.yexcr.2012.09.012; Chitcholtan K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-38; Corning, 2015, CORN MATR MATR 2015; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Engelman JA, 2008, CANCER CELL, V13, P375, DOI 10.1016/j.ccr.2008.04.008; Fallica B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048024; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Gaglia G, 2013, P NATL ACAD SCI USA, V110, P15497, DOI 10.1073/pnas.1311126110; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Glaysher Sharon, 2014, BMC Res Notes, V7, P397, DOI 10.1186/1756-0500-7-397; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Gurski L.A., 2010, ONCOL ISSUES, V25, P20, DOI [10.1080/10463356.2010.11883480, DOI 10.1080/10463356.2010.11883480]; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Holmes B, 2015, TISSUE ENG PT A, V21, P403, DOI [10.1089/ten.TEA.2014.0138, 10.1089/ten.tea.2014.0138]; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jaganathan H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06468; Januchowski R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/365867; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kibbey Maura C., 1994, Journal of Tissue Culture Methods, V16, P227, DOI 10.1007/BF01540656; Kim JW, 2011, ANTICANCER RES, V31, P3237; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KWOK TT, 1985, INT J CANCER, V35, P675, DOI 10.1002/ijc.2910350517; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Lieberman MA, 2012, MARKS BASIC MED BIOC; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Lipski R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042615; Liu CF, 2013, PROSTATE, V73, P418, DOI 10.1002/pros.22583; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Liu TR, 2011, MOL CANCER THER, V10, P1460, DOI 10.1158/1535-7163.MCT-10-0925; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Magdolen V, 2012, KALLIKREIN-RELATED PEPTIDASES, VOL 2: NOVEL CANCER-RELATED BIOMARKERS, P1; Makinoshima H, 2015, J BIOL CHEM, V290, P17495, DOI 10.1074/jbc.M115.660498; Maria OM, 2011, INT J BIOCHEM CELL B, V43, P622, DOI 10.1016/j.biocel.2011.01.001; McCarroll JA, 2015, ONCOTARGET, V6, P2235, DOI 10.18632/oncotarget.2946; Morse DL, 2005, MOL CANCER THER, V4, P1495, DOI 10.1158/1535-7163.MCT-05-0130; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Okorokov AL, 2006, EMBO J, V25, P5191, DOI 10.1038/sj.emboj.7601382; Olivier M, 2009, CANCER GENE THER, V16, P1, DOI 10.1038/cgt.2008.69; Patra B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21061; Ploussard G, 2010, CANCER RES, V70, P9253, DOI 10.1158/0008-5472.CAN-10-1447; Price KJ, 2012, BIOCHEM BIOPH RES CO, V427, P343, DOI 10.1016/j.bbrc.2012.09.059; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; REPROCELL, 2015, WHAT IS ALV; Fernandez-Fernandez MR, 2011, PROTEIN ENG DES SEL, V24, P41, DOI 10.1093/protein/gzq074; Sahoo SK, 2005, BIOMACROMOLECULES, V6, P1132, DOI 10.1021/bm0492632; Schmid K, 2010, BRIT J CANCER, V103, P622, DOI 10.1038/sj.bjc.6605761; Seto B, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-29; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Sieh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040217; Sodunke TR, 2007, BIOMATERIALS, V28, P4006, DOI 10.1016/j.biomaterials.2007.05.021; Song SM, 2015, CLIN CANCER RES, V21, P2580, DOI 10.1158/1078-0432.CCR-14-2191; Stengel C, 2010, BRIT J CANCER, V102, P316, DOI 10.1038/sj.bjc.6605489; Suh Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.548; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tome-Garcia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099525; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-37; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Webber MM, 1995, CLIN CANCER RES, V1, P1089; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wong S, 2007, MONOLITHIC 3D INTEGR	90	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158116	10.1371/journal.pone.0158116	http://dx.doi.org/10.1371/journal.pone.0158116			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352049	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900033
J	Lam, RS; O'Brien-Simpson, NM; Holden, JA; Lenzo, JC; Fong, SB; Reynolds, EC				Lam, Roselind S.; O'Brien-Simpson, Neil M.; Holden, James A.; Lenzo, Jason C.; Fong, Shao B.; Reynolds, Eric C.			Unprimed, M1 and M2 Macrophages Differentially Interact with Porphyromonas gingivalis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALTERNATIVE ACTIVATION; PERIODONTAL-DISEASE; SUBGINGIVAL PLAQUE; MOUSE MACROPHAGES; CELL-DEATH; LIPOPOLYSACCHARIDE; VIRULENCE; RESPONSES; INTERLEUKIN-4	Porphyromonas gingivalis is a keystone pathogen in the development of chronic periodontitis. Tissue macrophages are amongst the first immune cells to respond to bacteria and depending on the cytokine profile at the infection site, macrophages are primed to react to infection in different ways. Priming of naive macrophages with IFN-gamma produces a classical pro-inflammatory, antibacterial M1 macrophage after TLR ligation, whereas priming with IL-4 induces an anti-inflammatory tissue-repair M2 phenotype. Previous work has shown that M1 are preferentially generated in gingival tissue following infection with P. gingivalis. However, few studies have investigated the interactions of macrophage subsets with P. gingivalis cells. The aim of this study was to determine the ability of naive, M1 and M2 macrophages to phagocytose P. gingivalis and investigate how this interaction affects both the bacterial cell and the macrophage. M1 and M2 macrophages were both found to have enhanced phagocytic capacity compared with that of naive macrophages, however only the naive and M1 macrophages were able to produce a respiratory burst in order to clear the bacteria from the phagosome. P. gingivalis was found to persist in naive and M2, but not M1 macrophages for 24 hours. Phagocytosis of P. gingivalis also induced high levels of TNF-alpha, IL-12 and iNOS in M1 macrophages, but not in naive or M2 macrophages. Furthermore, infection of macrophages with P. gingivalis at high bacteria to macrophage ratios, while inducing an inflammatory response, was also found to be deleterious to macrophage longevity, with high levels of apoptotic cell death found in macrophages after infection. The activation of M1 macrophages observed in this study may contribute to the initiation and maintenance of a pro-inflammatory state during chronic periodontitis.	[Lam, Roselind S.; O'Brien-Simpson, Neil M.; Holden, James A.; Lenzo, Jason C.; Fong, Shao B.; Reynolds, Eric C.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Inst Bio21, Melbourne, Vic, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu	O'Brien-Simpson, Neil/B-2901-2009	O'Brien-Simpson, Neil/0000-0001-8462-5603; Fong, Shao/0000-0002-0065-7884; Lenzo, Jason/0000-0002-0564-9250	Australian Government, Department of Industry, Innovation and Science [20080108]	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science)	Supported by the Australian Government, Department of Industry, Innovation and Science Grant ID 20080108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HOST PARASITE INTERA; Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bodet C, 2005, MICROBES INFECT, V7, P448, DOI 10.1016/j.micinf.2004.11.021; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Chapple CC, 1998, J PATHOL, V186, P281; DEBINSKI W, 1995, J BIOL CHEM, V270, P16775, DOI 10.1074/jbc.270.28.16775; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gemmell E, 2001, J PERIODONTAL RES, V36, P92, DOI 10.1034/j.1600-0765.2001.360205.x; Gordon S, 1998, RES IMMUNOL, V149, P685, DOI 10.1016/S0923-2494(99)80039-X; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Griffen AL, 1999, J CLIN MICROBIOL, V37, P4028, DOI 10.1128/JCM.37.12.4028-4033.1999; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Holden JA, 2014, INFECT IMMUN, V82, P4190, DOI 10.1128/IAI.02325-14; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; Jones KJ, 2010, J PERIODONTOL, V81, P1850, DOI 10.1902/jop.2010.100226; Komiya A, 2000, J PERIODONTOL, V71, P760, DOI 10.1902/jop.2000.71.5.760; Lam RS, 2014, J IMMUNOL, V193, P2349, DOI 10.4049/jimmunol.1400853; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lappin DF, 2000, J PERIODONTAL RES, V35, P369, DOI 10.1034/j.1600-0765.2000.035006369.x; Lenzo JC, 2016, INFECT IMMUN, DOI [10.1128/IAI.01482-15, DOI 10.1128/IAI.01482-15]; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mathur A, 1996, J PERIODONTAL RES, V31, P489, DOI 10.1111/j.1600-0765.1996.tb01414.x; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; O'Brien-Simpson NM, 2000, INFECT IMMUN, V68, P2704, DOI 10.1128/IAI.68.5.2704-2712.2000; O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009; Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Slocum C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004215; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tam V, 2009, INFECT IMMUN, V77, P1451, DOI 10.1128/IAI.01377-08; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Wiebe C B, 2000, J Can Dent Assoc, V66, P594; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; YAHARA I, 1982, J CELL BIOL, V92, P69, DOI 10.1083/jcb.92.1.69; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Yu T, 2016, J PERIODONTOL, V87, P1092, DOI 10.1902/jop.2016.160081; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	55	46	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158629	10.1371/journal.pone.0158629	http://dx.doi.org/10.1371/journal.pone.0158629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383471	Green Published, gold			2022-12-27	WOS:000379809400067
J	Palomaki, J; Yan, J; Modic, D; Laakasuo, M				Palomaki, Jussi; Yan, Jeff; Modic, David; Laakasuo, Michael			"To Bluff like a Man or Fold like a Girl?" - Gender Biased Deceptive Behavior in Online Poker	PLOS ONE			English	Article							DECISION-MAKING; EXPERIENCE; WOMEN; DONT; MEN	Evolutionary psychology suggests that men are more likely than women to deceive to bolster their status and influence. Also gender perception influences deceptive behavior, which is linked to pervasive gender stereotypes: women are typically viewed as weaker and more gullible than men. We assessed bluffing in an online experiment (N = 502), where participants made decisions to bluff or not in simulated poker tasks against opponents represented by avatars. Participants bluffed on average 6% more frequently at poker tables with femaleonly avatars than at tables with male-only or gender mixed avatars-a highly significant effect in games involving repeated decisions. Nonetheless, participants did not believe the avatar genders affected their decisions. Males bluffed 13% more frequently than females. Unlike most economic games employed exclusively in research contexts, online poker is played for money by tens of millions of people worldwide. Thus, gender effects in bluffing have significant monetary consequences for poker players.	[Palomaki, Jussi; Laakasuo, Michael] Univ Helsinki, Inst Behav Sci, Cognit Sci, Helsinki, Finland; [Yan, Jeff] Univ Lancaster, Sch Comp & Commun, Lancaster, England; [Modic, David] Univ Cambridge, Comp Lab, Cambridge, England	University of Helsinki; Lancaster University; University of Cambridge	Palomaki, J (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Sci, Helsinki, Finland.	jussi.palomaki@helsinki.fi	Palomaki, Jussi/I-5961-2018	Palomaki, Jussi/0000-0001-6063-0926; Modic, David/0000-0001-9320-9345	EPSRC (Engineering and Physical Sciences Research Council) [EP/K033476/1]; EPSRC [EP/K033476/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K033476/1] Funding Source: researchfish	EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was part of an EPSRC (Engineering and Physical Sciences Research Council)-funded research project "The Deterrence of Deception in Socio-Technical Systems" (EP/K033476/1) (http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/K033476/1); CO-Principal Investigator: JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel BL, 2012, INT GAMBL STUD, V12, P367, DOI 10.1080/14459795.2012.680900; AYRES I, 1995, AM ECON REV, V85, P304; Baumeister R. F., 2007, IS THERE ANYTHING GO; Buss David M., 1999, EVOLUTIONARY PSYCHOL; Chen B., 2006, MATH POKER; Cosmides L., 2005, HDB EVOLUTIONARY PSY, P584; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dreber A, 2008, ECON LETT, V99, P197, DOI 10.1016/j.econlet.2007.06.027; Dunbar R.I.M., 2004, THE HUMAN STORY; Eckel CC, 2001, ECON INQ, V39, P171, DOI 10.1093/ei/39.2.171; Erat S, 2012, MANAGE SCI, V58, P723, DOI 10.1287/mnsc.1110.1449; Golder SA, 2004, P 2004 ACM C COMP SU; Gupta ND, 2013, ECON INQ, V51, P816, DOI 10.1111/j.1465-7295.2011.00378.x; Holm H., 2004, INT C EXP EC SCI NEW; Holm HJ, 2000, GAME ECON BEHAV, V32, P292, DOI 10.1006/game.1998.0685; Hussain Z, 2008, CYBERPSYCHOL BEHAV, V11, P47, DOI 10.1089/cpb.2007.0020; Ingen C. van, 2008, Leisure/Loisir, V32, P3; Kray LJ, 2014, ORGAN BEHAV HUM DEC, V125, P61, DOI 10.1016/j.obhdp.2014.06.002; Kray LJ, 2005, RES ORGAN BEHAV, V26, P103, DOI 10.1016/S0191-3085(04)26004-X; Kruger D.J., 2007, EVOL PSYCHOL-US, V5, P555, DOI [10.1177/147470490700500306, DOI 10.1177/147470490700500306, DOI 10.1177/147470490]; Laakasuo M, 2015, J GAMBL STUD, V31, P933, DOI 10.1007/s10899-014-9454-5; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; MILLER G, 2008, MORAL PSYCHOL, V1, P209; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Palomaki J, 2016, PERS INDIV DIFFER, V98, P266, DOI 10.1016/j.paid.2016.03.089; Palomaki J, 2013, INT GAMBL STUD, V13, P255, DOI 10.1080/14459795.2013.780631; Palomaki J, 2013, J GAMBL STUD, V29, P491, DOI 10.1007/s10899-012-9311-3; Prentice DA, 2002, PSYCHOL WOMEN QUART, V26, P269, DOI 10.1111/1471-6402.t01-1-00066; Scharlemann JPW, 2001, J ECON PSYCHOL, V22, P617, DOI 10.1016/S0167-4870(01)00059-9; Schlicht EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011663; Simonsen S. S., 2012, International Journal of Humanities and Social Science, V2, P94; Slonim R, 2010, J ECON BEHAV ORGAN, V76, P385, DOI 10.1016/j.jebo.2010.06.016; Solnick SJ, 1999, ORGAN BEHAV HUM DEC, V79, P199, DOI 10.1006/obhd.1999.2843; Solnick SJ, 2001, ECON INQ, V39, P189, DOI 10.1093/ei/39.2.189; Thorpe EO., 1966, BEAT THE DEALER; TOOKE W, 1991, ETHOL SOCIOBIOL, V12, P345, DOI 10.1016/0162-3095(91)90030-T; Trivers Robert, 2011, DECEIT SELF DECEPTIO; Valenzuela A, 2007, SEX ROLES, V57, P293, DOI 10.1007/s11199-007-9263-8; Van Kempen Luuk., 2003, J INT DEV, V15, P157; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Whitty MT, 2012, J AM SOC INF SCI TEC, V63, P208, DOI 10.1002/asi.21648; Whitty MT, 2012, RES000224022 ESRC U; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; Wolkomir M, 2012, QUAL SOCIOL, V35, P407, DOI 10.1007/s11133-012-9235-3	44	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157838	10.1371/journal.pone.0157838	http://dx.doi.org/10.1371/journal.pone.0157838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383472	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400028
J	Waruru, A; Muttai, H; Ng'ang'a, L; Ackers, M; Kim, A; Miruka, F; Erick, O; Okonji, J; Ayuaya, T; Schwarcz, S				Waruru, Anthony; Muttai, Hellen; Ng'ang'a, Lucy; Ackers, Marta; Kim, Andrea; Miruka, Fredrick; Erick, Opiyo; Okonji, Julie; Ayuaya, Tolbert; Schwarcz, Sandra			Positive Predictive Value of the WHO Clinical and Immunologic Criteria to Predict Viral Load Failure among Adults on First, or Second-Line Antiretroviral Therapy in Kenya	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; DRIED BLOOD SPOTS; PLASMA; RNA	Routine HIV viral load (VL) monitoring is the standard of care for persons receiving antiretroviral therapy (ART) in developed countries. Although the World Health Organization recommends annual VL monitoring of patients on ART, recognizing difficulties in conducting routine VL testing, the WHO continues to recommend targeted VL testing to confirm treatment failure for persons who meet selected immunologic and clinical criteria. Studies have measured positive predictive value (PPV), negative predictive value, sensitivity and specificity of these criteria among patients receiving first-line ART but not specifically among those on second-line or subsequent regimens. Between 2008 and 2011, adult ART patients in Nyanza, Kenya who met national clinical or immunologic criteria for treatment failure received targeted VL testing. We calculated PPV and 95% confidence intervals (CI) of these criteria to detect virologic treatment failure among patients receiving a) first-line ART, b) second/subsequent ART, and c) any regimen. Of 12,134 patient specimens tested, 2,874 (23.7%) were virologically confirmed as treatment failures. The PPV for 2,834 first-line ART patients who met either the clinical or immunologic criteria for treatment failure was 34.4% (95% CI 33.2-35.7), 33.1% (95% CI 24.7-42.3) for the 40 patients on second-line/subsequent regimens, and 33.4%(95% CI 33.1-35.6) for any ART. PPV, regardless of criteria, for first-line ART patients was lowest among patients over 44 years old and highest for patients aged 15 to 34 years. PPV of immunological and clinical criteria for correctly identifying treatment failure was similarly low for adult patients receiving either first-line or second-line/subsequent ART regimens. Our data confirm the inadequacy of clinical and immunologic criteria to correctly identify treatment failure and support the implementation of routine VL testing.	[Waruru, Anthony; Muttai, Hellen; Ng'ang'a, Lucy; Miruka, Fredrick] CDC, US Ctr Dis Control & Prevent, Nairobi, Kenya; [Ackers, Marta; Kim, Andrea] CDC, US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Erick, Opiyo; Okonji, Julie; Ayuaya, Tolbert] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Schwarcz, Sandra] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Schwarcz, Sandra] Univ Calif San Francisco, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; San Francisco Department of Public Health; University of California System; University of California San Francisco	Waruru, A (corresponding author), CDC, US Ctr Dis Control & Prevent, Nairobi, Kenya.	awaruru@cdc.gov	Waruru, Anthony/U-7217-2019; Muttai, Hellen/ABH-7164-2020	Waruru, Anthony/0000-0002-4281-6345; Simangan, Mon Erick/0000-0002-2480-245X	University of California San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. [NIMH R25MH064712]; NIH Office of AIDS Research-supported OCTAVE Project; NIMH [R25MH064712-08]; Fogarty International Center AITRP Program [D43TW00003]; US President's Emergency Plan for AIDS Relief from US Centers for Disease Control and Prevention, Division of Global HIV and TB [3U19C1000323]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	University of California San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S.; NIH Office of AIDS Research-supported OCTAVE Project; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fogarty International Center AITRP Program; US President's Emergency Plan for AIDS Relief from US Centers for Disease Control and Prevention, Division of Global HIV and TB; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this work was provided by the University of California San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH R25MH064712, The NIH Office of AIDS Research-supported OCTAVE Project, NIMH-supported UCSF ITAPS Program (R25MH064712-08), the Fogarty International Center AITRP Program (D43TW00003), and the US President's Emergency Plan for AIDS Relief through cooperative agreement (3U19C1000323) from the US Centers for Disease Control and Prevention, Division of Global HIV and TB.; This publication was made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreement 3U19C1000323from the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA)	[Anonymous], 2017, 2013 UNAIDS REP GLOB; Chaiwarith R, 2007, INT J INFECT DIS, V11, P413, DOI 10.1016/j.ijid.2006.11.003; Fiscus SA, 1998, J CLIN MICROBIOL, V36, P258, DOI 10.1128/JCM.36.1.258-260.1998; Garrido C, 2009, J CLIN MICROBIOL, V47, P1031, DOI 10.1128/JCM.02099-08; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Meya D, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-3; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; National AIDS and STI Control Program, 2014, KEN AIDS IND SURV 20; National AIDS and STI Control Programme, 2014, GUIDELINES USE ANTIR; National AIDS and STI Control Programme, 2011, GUID ANT THER KEN; Office of U.S. Global AIDS Coordinator and the Bureau of Public Affairs USSD, ANN REP C PRES EM PL; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Rewari BB, 2010, JAIDS-J ACQ IMM DEF, V55, P610, DOI 10.1097/QAI.0b013e3181f43a31; Reynolds SJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-381; Roche Molecular Systems Inc, 1996, ROCH MOL DIAGN; Rutherford GW, 2013, 7 INT AIDS SOC IAS C; Schmitz ME, 2014, INT AIDS SOC C MELB; Stata Coorporation, 1985, STAT; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158881	10.1371/journal.pone.0158881	http://dx.doi.org/10.1371/journal.pone.0158881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383834	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400090
J	Gharaee-Kermani, M; Moore, BB; Macoska, JA				Gharaee-Kermani, Mehrnaz; Moore, Bethany B.; Macoska, Jill A.			Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; PULMONARY-FIBROSIS; MOLECULAR TARGETS; OXIDATIVE STRESS; EGR-1 GENE; TGF-BETA; EXPRESSION; LIVER; FIBROBLASTS	Background Resveratrol, a phytoalexin found in berries, peanuts, grapes, and red wine, inhibits oxidation, inflammation, and cell proliferation and collagen synthesis in multiple cell types and or animal models. It represses collagen deposition in the vasculature, heart, lung, kidney, liver, and esophagus in animal models and may have some utility as an anti-fibrotic. Recent studies have shown that increased collagen deposition and tissue stiffness in the peri-urethral area of the prostate are associated with lower urinary tract dysfunction (LUTD) and urinary obstructive symptoms. The aim of this study was to determine whether Resveratrol might be useful to inhibit or revert TGF beta- and/or CXCL12-mediated myofibroblast phenoconversion of prostate fibroblasts in vitro, and therefore whether the use of anti-fibrotic therapeutics might be efficacious for the treatment of LUTD. Methods Primary prostate and lung tissues were explanted and fibroblast monolayers expanded in vitro. Primary and N1 immortalized prostate stromal fibroblasts, as well as primary fibroblasts cultured from a normal lung and one affected by idiopathic pulmonary fibrosis (IPF) for comparison, were grown in serum-free defined media supplemented with vehicle, TGF beta or CXCL12, pre- or post-treatment with Resveratrol, and were evaluated using immunofluorescence for alpha smooth muscle actin (alpha SMA) and collagen I (COL1) protein expression and assessed for cell proliferation, apoptosis, and COL1 and EGR1 transcript expression. Results This study showed that low concentrations of Resveratrol (<= 50 mu M) had no effect on N1 or primary prostate fibroblast cell proliferation, apoptosis, or COL1 or EGR1 gene transcription but repressed and reversed myofibroblast phenoconversion. As expected, these same effects were observed for IPF lung fibroblasts though higher levels of Resveratrol (>= 100uM) were required. Taken together, these data suggest that, like lung fibroblasts, prostate fibroblast to myofibroblast phenoconversion can be both repressed and reversed by Resveratrol treatment. Thus, anti-fibrotic therapeutics might be efficacious for the treatment of LUTD.	[Gharaee-Kermani, Mehrnaz; Macoska, Jill A.] Univ Massachusetts, Dept Biol, Ctr Personalized Canc Therapy, Boston, MA 02125 USA; [Moore, Bethany B.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Boston; University of Michigan System; University of Michigan	Macoska, JA (corresponding author), Univ Massachusetts, Dept Biol, Ctr Personalized Canc Therapy, Boston, MA 02125 USA.	Jill.Macoska@umb.edu		Moore, Bethany/0000-0003-3051-745X	Grant NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) [DK104310]; Grant NIH/NCATS (National Center for Advancing Translational Sciences) [UL1TR000433]; National Institutes of Health / National Institute of Diabetes and Digestive and Kidney Diseases award [U54DK104310]; National Center for Advancing Translational Sciences of the National Institutes of Health award [UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK104310] Funding Source: NIH RePORTER	Grant NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases); Grant NIH/NCATS (National Center for Advancing Translational Sciences); National Institutes of Health / National Institute of Diabetes and Digestive and Kidney Diseases award; National Center for Advancing Translational Sciences of the National Institutes of Health award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) DK104310 (JAM); and Grant NIH/NCATS (National Center for Advancing Translational Sciences) UL1TR000433 (MG-K).; This work was supported by National Institutes of Health / National Institute of Diabetes and Digestive and Kidney Diseases award U54DK104310 (JAM) and the National Center for Advancing Translational Sciences of the National Institutes of Health award UL1TR000433 (MG-K).	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Akgedik R, 2012, INFLAMMATION, V35, P1732, DOI 10.1007/s10753-012-9491-0; Bai YH, 2014, BIOCHEM PHARMACOL, V92, P484, DOI 10.1016/j.bcp.2014.09.002; Begley L, 2005, AGING CELL, V4, P291, DOI 10.1111/j.1474-9726.2005.00173.x; Begley LA, 2007, J BIOL CHEM, V282, P26767, DOI 10.1074/jbc.M700440200; Bhattacharyya S, 2008, AM J PATHOL, V173, P1085, DOI 10.2353/ajpath.2008.080382; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Bhattacharyya S, 2011, MATRIX BIOL, V30, P235, DOI 10.1016/j.matbio.2011.03.005; Bishayee A, 2010, LIVER INT, V30, P1103, DOI 10.1111/j.1478-3231.2010.02295.x; Chen KH, 2011, CHEM-BIOL INTERACT, V190, P45, DOI 10.1016/j.cbi.2011.01.033; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Chen TS, 2015, AM J PHYSIOL-HEART C, V308, pH424, DOI 10.1152/ajpheart.00454.2014; Conte E, 2015, HISTOL HISTOPATHOL, V30, P523, DOI 10.14670/HH-30.523; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Detlefsen S, 2005, VIRCHOWS ARCH, V447, P800, DOI 10.1007/s00428-005-0032-1; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Dyson OF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033364; Faghihzadeh F, 2014, NUTR RES, V34, P837, DOI 10.1016/j.nutres.2014.09.005; Fagone E, 2011, EXP LUNG RES, V37, P162, DOI 10.3109/01902148.2010.524722; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Garcia P, 2012, AM J PHYSIOL-GASTR L, V302, pG326, DOI 10.1152/ajpgi.00083.2011; Gharaee-Kermani M, 2009, CURR MED CHEM, V16, P1400, DOI 10.2174/092986709787846497; Gharaee-Kermani M, 2013, PROSTATE, V73, P1123, DOI 10.1002/pros.22662; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Goldacre MJ, 2009, BEST PRACT RES CL GA, V23, P793, DOI 10.1016/j.bpg.2009.10.008; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hollingsworth JM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4474; Ji Q, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1119-y; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; Macoska JA, 2004, CANCER GENET CYTOGEN, V154, P36, DOI 10.1016/j.cancergencyto.2004.02.013; Miloso M, 1999, NEUROSCI LETT, V264, P141, DOI 10.1016/S0304-3940(99)00194-9; Novelle MG, 2015, AGEING RES REV, V21, P1, DOI 10.1016/j.arr.2015.01.002; Novo E, 2009, INT J BIOCHEM CELL B, V41, P2089, DOI 10.1016/j.biocel.2009.03.010; Park JH, 2012, MOL CELL BIOCHEM, V368, P61, DOI 10.1007/s11010-012-1342-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Quinones A, 2003, LIFE SCI, V72, P2975, DOI 10.1016/S0024-3205(03)00230-3; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Rossler OG, 2015, EXP CELL RES, V332, P116, DOI 10.1016/j.yexcr.2015.01.013; Royce SG, 2011, PATHOBIOL AGING AGE, V1, DOI [10.3402/PBA.v1i0.7134, 10.3402/pba.v1i0.7134]; Schmatz R, 2012, BIOCHIMIE, V94, P374, DOI 10.1016/j.biochi.2011.08.005; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Sener G, 2007, PULM PHARMACOL THER, V20, P642, DOI 10.1016/j.pupt.2006.07.003; Tome-Carneiro J, 2013, CURR PHARM DESIGN, V19, P6064, DOI 10.2174/13816128113199990407; Tsang SW, 2015, BIOMED PHARMACOTHER, V71, P91, DOI 10.1016/j.biopha.2015.02.013; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhang YQ, 2015, CLIN NUTR, V34, P752, DOI 10.1016/j.clnu.2014.08.014	55	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158357	10.1371/journal.pone.0158357	http://dx.doi.org/10.1371/journal.pone.0158357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367854	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900030
J	Dey, J; Kerwin, WS; Grenley, MO; Casalini, JR; Tretyak, I; Ditzler, SH; Thirstrup, DJ; Frazier, JP; Pierce, DW; Carleton, M; Klinghoffer, RA				Dey, Joyoti; Kerwin, William S.; Grenley, Marc O.; Casalini, Joseph R.; Tretyak, Ilona; Ditzler, Sally H.; Thirstrup, Derek J.; Frazier, Jason P.; Pierce, Daniel W.; Carleton, Michael; Klinghoffer, Richard A.			A Platform for Rapid, Quantitative Assessment of Multiple Drug Combinations Simultaneously in Solid Tumors In Vivo	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; NAB-PACLITAXEL; CANCER; INHIBITION; NAVITOCLAX; MELANOMA; SURVIVAL; THERAPY; PREDICT; AGENTS	While advances in high-throughput screening have resulted in increased ability to identify synergistic anti-cancer drug combinations, validation of drug synergy in the in vivo setting and prioritization of combinations for clinical development remain low-throughput and resource intensive. Furthermore, there is currently no viable method for prospectively assessing drug synergy directly in human patients in order to potentially tailor therapies. To address these issues we have employed the previously described CIVO platform and developed a quantitative approach for investigating multiple combination hypotheses simultaneously in single living tumors. This platform provides a rapid, quantitative and cost effective approach to compare and prioritize drug combinations based on evidence of synergistic tumor cell killing in the live tumor context. Using a gemcitabine resistant model of pancreatic cancer, we efficiently investigated nine rationally selected Abraxane-based combinations employing only 19 xenografted mice. Among the drugs tested, the BCL2/BCLxL inhibitor ABT-263 was identified as the one agent that synergized with Abraxane (R) to enhance acute induction of localized apoptosis in this model of human pancreatic cancer. Importantly, results obtained with CIVO accurately predicted the outcome of systemic dosing studies in the same model where superior tumor regression induced by the Abraxane/ABT-263 combination was observed compared to that induced by either single agent. This supports expanded use of CIVO as an in vivo platform for expedited in vivo drug combination validation and sets the stage for performing toxicity-sparing drug combination studies directly in cancer patients with solid malignancies.	[Dey, Joyoti; Kerwin, William S.; Grenley, Marc O.; Casalini, Joseph R.; Tretyak, Ilona; Ditzler, Sally H.; Thirstrup, Derek J.; Frazier, Jason P.; Carleton, Michael; Klinghoffer, Richard A.] Presage Biosci Inc, Seattle, WA USA; [Pierce, Daniel W.] Celgene Corp, San Francisco, CA USA	Bristol-Myers Squibb; Celgene Corporation	Klinghoffer, RA (corresponding author), Presage Biosci Inc, Seattle, WA USA.	rich.klinghoffer@presagebio.com			Celgene Corporation	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation)	Funding for this study was provided in part by Celgene Corporation.	Amundson SA, 2000, CANCER RES, V60, P6101; Bhaw-Luximon A, 2015, CANCER LETT, V369, P266, DOI 10.1016/j.canlet.2015.09.007; Brower V, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju417; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Chen NH, 2015, CANCER CHEMOTH PHARM, V76, P699, DOI 10.1007/s00280-015-2833-5; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cioffi M, 2015, CLIN CANCER RES, V21, P2325, DOI 10.1158/1078-0432.CCR-14-1399; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Klinghoffer RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7489; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Ocal O, 2015, DIS MODEL MECH, V8, P1201, DOI 10.1242/dmm.020933; Ocana A, 2011, JNCI-J NATL CANCER I, V103, P16, DOI 10.1093/jnci/djq463; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Tan N, 2011, CLIN CANCER RES, V17, P1394, DOI 10.1158/1078-0432.CCR-10-2353; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Villarroel MC, 2011, MOL CANCER THER, V10, P3, DOI 10.1158/1535-7163.MCT-10-0893; Volk LD, 2011, NEOPLASIA, V13, P327, DOI 10.1593/neo.101490; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120913; Wong M, 2012, MOL CANCER THER, V11, P1026, DOI 10.1158/1535-7163.MCT-11-0693	27	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158617	10.1371/journal.pone.0158617	http://dx.doi.org/10.1371/journal.pone.0158617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359113	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200102
J	Lai, HM; Liu, AKL; Ng, WL; DeFelice, J; Lee, WS; Li, H; Li, W; Ng, HM; Chang, RCC; Lin, B; Wu, WT; Gentleman, SM				Lai, Hei Ming; Liu, Alan King Lun; Ng, Wai-Lung; DeFelice, John; Lee, Wing Sang; Li, Heng; Li, Wen; Ng, Ho Man; Chang, Raymond Chuen-Chung; Lin, Bin; Wu, Wutian; Gentleman, Steve M.			Rationalisation and Validation of an Acrylamide-Free Procedure in Three-Dimensional Histological Imaging	PLOS ONE			English	Article							INTACT TISSUE; VOLUME	Three-dimensional visualization of intact tissues is now being achieved by turning tissues transparent. CLARITY is a unique tissue clearing technique, which features the use of detergents to remove lipids from fixed tissues to achieve optical transparency. To preserve tissue integrity, an acrylamide-based hydrogel has been proposed to embed the tissue. In this study, we examined the rationale behind the use of acrylamide in CLARITY, and presented evidence to suggest that the omission of acrylamide-hydrogel embedding in CLARITY does not alter the preservation of tissue morphology and molecular information in fixed tissues. We therefore propose a novel and simplified workflow for formaldehyde-fixed tissue clearing, which will facilitate the laboratory implementation of this technique. Furthermore, we have investigated the basic tissue clearing process in detail and have highlighted some areas for targeted improvement of technologies essential for the emerging subject of three-dimensional histology.	[Lai, Hei Ming; Liu, Alan King Lun; Li, Heng; Li, Wen; Ng, Ho Man; Chang, Raymond Chuen-Chung; Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Pokfulam, Hong Kong, Peoples R China; [Lai, Hei Ming; Liu, Alan King Lun; DeFelice, John; Gentleman, Steve M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, Neuropathol Unit, London, England; [Ng, Wai-Lung] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Lee, Wing Sang] Univ Hong Kong, Electron Microscope Unit, Pokfulam, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China; [Lin, Bin] Hong Kong Polytech Univ, Sch Optometry, Hong Kong, Hong Kong, Peoples R China; [Wu, Wutian] Jinan Univ, Joint Lab, Guangzhou, Guangdong, Peoples R China; [Wu, Wutian] Jinan Univ, GHM Inst CNS Regenerat, Univ Hong Kong, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; Imperial College London; University of Oxford; University of Hong Kong; University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University; Jinan University; Jinan University; University of Hong Kong	Lai, HM; Wu, WT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Pokfulam, Hong Kong, Peoples R China.; Lai, HM; Gentleman, SM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, Neuropathol Unit, London, England.; Wu, WT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China.; Wu, WT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China.; Wu, WT (corresponding author), Jinan Univ, Joint Lab, Guangzhou, Guangdong, Peoples R China.; Wu, WT (corresponding author), Jinan Univ, GHM Inst CNS Regenerat, Univ Hong Kong, Guangzhou, Guangdong, Peoples R China.	lsc_laiheiming@hotmail.com; wtwu@hku.hk; s.gentleman@imperial.ac.uk	Ng, Wai-Lung/K-7407-2019; Liu, Alan King Lun/A-2210-2015; Chang, Raymond Chuen-Chung/C-1107-2009; Lin, Bin/E-9871-2010	Ng, Wai-Lung/0000-0003-2892-6318; Liu, Alan King Lun/0000-0001-6109-1338; Chang, Raymond Chuen-Chung/0000-0001-8538-7993; Lin, Bin/0000-0003-1309-3480; Lai, Hei Ming/0000-0001-5150-7918	Parkinson's UK [K-1403]; Alzheimer's Research UK Imperial College London Network Centre Grant [ARUK-2014NC-IMP]; Parkinson&quot;s UK [K-1403] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); Alzheimer's Research UK Imperial College London Network Centre Grant; Parkinson&quot;s UK(Parkinson&apos;s UK)	We thank Ms. W. M. Wong for her assistance in experimental work, Mr. F. Xie and Mr. W. W. Yan for discussion and advices on the topic of data analysis and optical imaging, and Mr. D. Buchwell who constructed the electrophoretic cell. The work was funded through an innovation grant (K-1403) from Parkinson's UK and the Alzheimer's Research UK Imperial College London Network Centre Grant (ARUK-2014NC-IMP). The authors would like to thank Steve Rothery and other staff at the Imperial FILM facility, the University of Hong Kong LKS Faculty of Medicine Faculty Core Facility, and the staff of the Parkinson's UK Tissue Bank for their assistance. Finally, we thank all tissue donors and their families who have kindly donated their post-mortem tissues to the Parkinson's UK Tissue Bank which greatly facilitated our study.	Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DUTKIEWICZ J, 1983, J MACROMOL SCI CHEM, VA20, P957, DOI 10.1080/00222338308060804; ELKAREH AW, 1993, BIOPHYS J, V64, P1638, DOI 10.1016/S0006-3495(93)81532-7; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; JOSSANG T, 1988, J PROTEIN CHEM, V7, P165, DOI 10.1007/BF01025246; Li J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10640; Lin WC., 1957, J CHIN CHEM SOC-TAIP, V4, P28; Lu K, 2010, J AM CHEM SOC, V132, P3388, DOI 10.1021/ja908282f; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; MCDONALD CJ, 1979, MACROMOLECULES, V12, P203, DOI 10.1021/ma60068a007; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Toews J, 2008, ANAL CHIM ACTA, V618, P168, DOI 10.1016/j.aca.2008.04.049; Treweek JB, 2015, NAT PROTOC, V10, P1860, DOI 10.1038/nprot.2015.122; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	18	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158628	10.1371/journal.pone.0158628	http://dx.doi.org/10.1371/journal.pone.0158628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359336	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200103
J	Liu, K; Cui, MY; Cao, P; Wang, JB				Liu, Kai; Cui, Meng-Ying; Cao, Peng; Wang, Jiang-Bo			Iterative Bayesian Estimation of Travel Times on Urban Arterials: Fusing Loop Detector and Probe Vehicle Data	PLOS ONE			English	Article							TRAFFIC FLOW MODEL; ALGORITHM; TRAJECTORIES; SYSTEMS	On urban arterials, travel time estimation is challenging especially from various data sources. Typically, fusing loop detector data and probe vehicle data to estimate travel time is a troublesome issue while considering the data issue of uncertain, imprecise and even conflicting. In this paper, we propose an improved data fusing methodology for link travel time estimation. Link travel times are simultaneously pre-estimated using loop detector data and probe vehicle data, based on which Bayesian fusion is then applied to fuse the estimated travel times. Next, Iterative Bayesian estimation is proposed to improve Bayesian fusion by incorporating two strategies: 1) substitution strategy which replaces the lower accurate travel time estimation from one sensor with the current fused travel time; and 2) specially-designed conditions for convergence which restrict the estimated travel time in a reasonable range. The estimation results show that, the proposed method outperforms probe vehicle data based method, loop detector based method and single Bayesian fusion, and the mean absolute percentage error is reduced to 4.8%. Additionally, iterative Bayesian estimation performs better for lighter traffic flows when the variability of travel time is practically higher than other periods.	[Liu, Kai; Wang, Jiang-Bo] Dalian Univ Technol, Sch Transportat & Logist, Dalian 116024, Peoples R China; [Cui, Meng-Ying] Univ Minnesota, Coll Sci & Engn, Minneapolis, MN 55455 USA; [Cao, Peng] Southwest Jiaotong Univ, Sch Transportat & Logist, Natl United Engn Lab Integrated & Intelligent Tra, Chengdu 610031, Peoples R China	Dalian University of Technology; University of Minnesota System; University of Minnesota Twin Cities; Southwest Jiaotong University	Cao, P (corresponding author), Southwest Jiaotong Univ, Sch Transportat & Logist, Natl United Engn Lab Integrated & Intelligent Tra, Chengdu 610031, Peoples R China.	caopeng@home.swjtu.edu.cn	Liu, Kai/F-8122-2017	Liu, Kai/0000-0002-3361-4741	National Natural Science Foundation of China [51008050, 51378091]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Fundamental Research Funds for the Central Universities [DUT12ZD203, DUT15QY14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (51008050, 51378091), http://www.nsfc.gov.cn/; the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; and the Fundamental Research Funds for the Central Universities (DUT12ZD203, DUT15QY14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskar A, 2011, COMPUT-AIDED CIV INF, V26, P433, DOI 10.1111/j.1467-8667.2010.00697.x; Cao P, 2014, PROCD SOC BEHV, V138, P137, DOI 10.1016/j.sbspro.2014.07.189; Cao P, 2014, TRANSPORT RES REC, P103, DOI 10.3141/2421-12; Choi K, 2002, ITS J, V7, P235, DOI 10.1080/10248070290258813; Cohen S, 2015, TRANSP RES PROC, V10, P245, DOI 10.1016/j.trpro.2015.09.074; Coifman B, 2002, TRANSPORT RES A-POL, V36, P351, DOI 10.1016/S0965-8564(01)00007-6; Cui MY, 2014, ASCE P 10 AS PAC TRA, P25; El Faouzi N. E., 2006, P TRANSP RES BOARD 8; El Faouzi NE, 2011, INFORM FUSION, V12, P4, DOI 10.1016/j.inffus.2010.06.001; Gupta AK, 2015, NONLINEAR DYNAM, V79, P663, DOI 10.1007/s11071-014-1693-6; Hazelton M. L., 2004, J DATA SCI, V2, P231; Hellinga BR, 2002, TRANSPORT RES C-EMER, V10, P257, DOI 10.1016/S0968-090X(02)00003-7; Hellinga B, 2008, TRANSPORT RES C-EMER, V16, P768, DOI 10.1016/j.trc.2008.04.002; Hellinga Bruce, 1999, J TRANSPORTATION ENG, V125, P1; Houbraken M, 2015, 2015 INTERNATIONAL CONFERENCE ON MODELS AND TECHNOLOGIES FOR INTELLIGENT TRANSPORTATION SYSTEMS (MT-ITS), P127, DOI 10.1109/MTITS.2015.7223247; Jenelius E, 2013, TRANSPORT RES B-METH, V53, P64, DOI 10.1016/j.trb.2013.03.008; Li BB, 2012, TRANSPORT RES B-METH, V46, P85, DOI 10.1016/j.trb.2011.08.001; Lim S, 2011, IET INTELL TRANSP SY, V5, P302, DOI 10.1049/iet-its.2011.0014; Liu K, 2007, J E ASIA SOC TRANSPO, V7, P116; Liu K, 2009, J INTELL TRANSPORT S, V13, P16, DOI 10.1080/15472450802644447; Maskell S, 2008, INFORM FUSION, V9, P259, DOI 10.1016/j.inffus.2007.02.003; Mehran B, 2012, TRANSPORT RES C-EMER, V20, P144, DOI 10.1016/j.trc.2011.05.006; Miwa T., 2008, INT J ITS RES, V2, P21; Mori U, 2015, TRANSPORTMETRICA A, V11, P119, DOI 10.1080/23249935.2014.932469; Nagatani T, 2014, PHYSICA A, V403, P110, DOI 10.1016/j.physa.2014.02.033; Pearl J., 1991, PROBABILISTIC REASON; Petty KF, 1998, TRANSPORT RES A-POL, V32, P1, DOI 10.1016/S0965-8564(97)00015-3; Sanwal K. K., 1995, UCBITSPWP9511; Tang TQ, 2016, PHYSICA A, V441, P221, DOI 10.1016/j.physa.2015.09.003; Tang TQ, 2014, NETW SPAT ECON, V14, P465, DOI 10.1007/s11067-014-9244-8; Transportation Research Board, 2010, HIGHW CAP MAN 2010; van Lint JWC, 2003, TRANSPORT RES REC, P41, DOI 10.3141/1855-05; Zheng F, 2010, P TRANSP RES BOARD 8; Zheng FF, 2013, TRANSPORT RES C-EMER, V31, P145, DOI 10.1016/j.trc.2012.04.007	34	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158123	10.1371/journal.pone.0158123	http://dx.doi.org/10.1371/journal.pone.0158123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362654	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200043
J	Hu, SD; Zou, ZY; Li, H; Zou, GJ; Li, Z; Xu, J; Wang, LD; Du, XH				Hu, Shidong; Zou, Zhenyu; Li, Hao; Zou, Guijun; Li, Zhao; Xu, Jian; Wang, Lingde; Du, Xiaohui			The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients	PLOS ONE			English	Article							ABSOLUTE MONOCYTE; FOLLICULAR LYMPHOMA; CADHERIN PROMOTES; COLON-CANCER; CELLS; DISEASE; GROWTH; TRIAL	Background Colorectal cancer (CRC) is the third most common malignancy in males and the second most common in females worldwide. Distant metastases have a strong negative impact on the prognosis of CRC patients. The most common site of CRC metastases is the liver. Both disease progression and metastasis have been related to the patient's peripheral blood monocyte count. We therefore performed a case-control study to assess the relationship between the preoperative peripheral blood monocyte count and colorectal liver metastases (CRLM). Methods Clinical data from 117 patients with colon cancer and 93 with rectal cancer who were admitted to the Chinese People's Liberation Army General Hospital (Beijing, China) between December 2003 and May 2015 were analysed retrospectively, with the permission of both the patients and the hospital. Results Preoperative peripheral blood monocyte counts, the T and N classifications of the primary tumour and its primary site differed significantly between the two groups (P < 0.001, P < 0.001, P = 0.002, P < 0.001), whereas there were no differences in the sex, age, degree of tumour differentiation or largest tumour diameter. Lymph node metastasis and a high preoperative peripheral blood monocyte count were independent risk factors for liver metastasis (OR: 2.178, 95% CI: 1.148 similar to 4.134, P = 0.017; OR: 12.422, 95% CI: 5.076 similar to 30.398, P < 0.001), although the risk was lower in patients with rectal versus colon cancer (OR: 0.078, 95% CI: 0.020 similar to 0.309, P < 0.001). Primary tumour site (P<0.001), degree of tumour differentiation (P = 0.009), T, N and M classifications, TNM staging and preoperative monocyte counts (P<0.001) were associated with the 5-year overall survival (OS) of CRC patients. A preoperative peripheral blood monocyte count > 0.505 x 10(9) cells/L, high T classification and liver metastasis were independent risk factors for 5-year OS (RR: 2.737, 95% CI: 1.573 similar to 4.764, P <0.001; RR: 2.687, 95% CI: 1.498 similar to 4.820, P = 0.001; RR: 4.928, 95% CI: 2.871 similar to 8.457, P < 0.001). Conclusions The demonstrated association between preoperative peripheral blood monocyte count and liver metastasis in patients with CRC recommends the former as a useful predictor of postoperative prognosis in CRC patients.	[Hu, Shidong; Zou, Zhenyu; Zou, Guijun; Xu, Jian; Wang, Lingde; Du, Xiaohui] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China; [Li, Hao] Chinese Peoples Liberat Army Air Force Gen Hosp, Dept Gen Surg, Beijing, Peoples R China; [Li, Zhao] Chinese Peoples Liberat Army 474 Hosp, Dept Gen Surg, Urumqi, Xinjiang, Peoples R China	Chinese People's Liberation Army General Hospital; Air Force General Hospital PLA	Du, XH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China.	duxiaohui301@sina.com			Natural Science Foundation of China [61170123]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Science Foundation of China (no. 61170123) (URL: http://www.nsfc.gov.cn/).	Adam R, 2004, ANN ONCOL, V15, P103, DOI 10.1093/annonc/mdh912; Bie YC, 2015, ONCOL LETT, V10, P67, DOI 10.3892/ol.2015.3198; Chen MH, 2009, J CANCER RES CLIN, V135, P1783, DOI 10.1007/s00432-009-0625-1; Chen XB, 2012, MOL BIOL REP, V39, P6707, DOI 10.1007/s11033-012-1494-2; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Ganti SN, 2015, SCI REP-UK, V5, DOI 10.1038/srep12255; Gustafson MP, 2015, CLIN CANCER RES, V21, P4224, DOI 10.1158/1078-0432.CCR-15-0260; Heeren AM, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1009296; Hur K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju492; Kemeny NE, 2013, J CLIN ONCOL, V31, P1913, DOI 10.1200/JCO.2013.49.4500; Marcheselli L, 2015, BRIT J HAEMATOL, V169, P544, DOI 10.1111/bjh.13332; Sasaki A, 2006, SURGERY, V139, P755, DOI 10.1016/j.surg.2005.10.009; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Sun LC, 2011, AM J PATHOL, V179, P380, DOI 10.1016/j.ajpath.2011.03.046; Tadmor T, 2015, MAYO CLIN PROC, V90, P756, DOI 10.1016/j.mayocp.2015.03.025; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang LG, 2012, CANCER EPIDEMIOL, V36, pE61, DOI 10.1016/j.canep.2011.05.002; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Ye LC, 2013, J CLIN ONCOL, V31, P1931, DOI 10.1200/JCO.2012.44.8308; Zhao W, 2015, ONCOL LETT, V10, P233, DOI 10.3892/ol.2015.3207	23	17	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157486	10.1371/journal.pone.0157486	http://dx.doi.org/10.1371/journal.pone.0157486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355390	gold, Green Submitted, Green Published			2022-12-27	WOS:000378859400015
J	Li, XH; Fang, YS; Li, X; Liang, JR; Jiang, DH; Geng, Y; Ning, W				Li, Xiaohe; Fang, Yinshan; Li, Xue; Liang, Jiurong; Jiang, Dianhua; Geng, Yan; Ning, Wen			Apical Secretion of FSTL1 in the Respiratory Epithelium for Normal Lung Development	PLOS ONE			English	Article							FOLLISTATIN-LIKE 1; BONE MORPHOGENETIC PROTEIN-4; TRANSGENIC MICE; EXPRESSION; GROWTH; GENE; CLONING; ANTAGONIST; FRP	Follistatin-like 1 (FSTL1) is a secreted bone morphogenetic protein (BMP) antagonist, and it plays a crucial role in normal lung development. Deletion of Fstl1 leads to postnatal death in mice due to respiratory failure. To further explore the role of FSTL1 in mouse lung development, we created a transgene SFTPC-Fstl1 allele mouse displaying significant epithelial overexpression of Fstl1 in all stages of lung development. However, epithelial overexpression of Fstl1 did not alter lung morphogenesis, epithelial differentiation and lung function. Moreover, we found that FSTL1 function was blocked by the epithelial polarization, which was reflected by the remarkable apical secretion of FSTL1 and the basolateral BMP signaling. Taken together, this study demonstrates that tightly spatial interaction of FSTL1 and BMP signaling plays an essential role in lung development.	[Li, Xiaohe; Fang, Yinshan; Li, Xue; Geng, Yan; Ning, Wen] Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Liang, Jiurong; Jiang, Dianhua; Geng, Yan] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Geng, Yan] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China	Nankai University; Cedars Sinai Medical Center; Jiangnan University	Geng, Y; Ning, W (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Tianjin 300071, Peoples R China.; Geng, Y (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.; Geng, Y (corresponding author), Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China.	gengyan@jiangnan.edu.cn; ningwen108@nankai.edu.cn	Geng, Yan/ABH-7789-2022; Liang, Carol Jiurong/AAI-4963-2021; Fang, Yinshan/AAU-4250-2021; Jiang, Dianhua/B-1421-2009	Jiang, Dianhua/0000-0002-4508-3829; Liang, Jiurong/0000-0001-5179-5016; Geng, Yan/0000-0001-8861-7686	National Natural Science Foundation of China (NSFC) [81430001, 31471373, 31271559, 31201020]; 111 project of China [B08011]; NIH [R01 HL122068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122068] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 111 project of China(Ministry of Education, China - 111 Project); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China (NSFC) grants 81430001, 31471373, 31271559, 31201020 and 111 project of China (B08011). This work was also supported in part by NIH grant R01 HL122068 (to D. J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Bragg AD, 2001, MECH DEVELOP, V109, P13, DOI 10.1016/S0925-4773(01)00508-1; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; Chaly Y, 2014, IMMUNOL RES, V59, P266, DOI 10.1007/s12026-014-8526-z; Chinoy MR, 2003, FRONT BIOSCI-LANDMRK, V8, pD392, DOI 10.2741/974; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; Dong YY, 2015, J EXP MED, V212, P235, DOI 10.1084/jem.20121878; Donovan J, 2005, CURR PROTOC NEUROSCI, V4; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Liu S, 2010, AM J PHYSIOL-ENDOC M, V299, pE351, DOI 10.1152/ajpendo.00005.2010; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Okabayashi K, 1999, BIOCHEM BIOPH RES CO, V254, P42, DOI 10.1006/bbrc.1998.9892; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Patel K, 1996, DEV BIOL, V178, P327, DOI 10.1006/dbio.1996.0222; Saitoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062659; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; Sylva M, 2013, BIRTH DEFECTS RES C, V99, P61, DOI 10.1002/bdrc.21030; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Weaver M, 1999, DEVELOPMENT, V126, P4005; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Wilson DC, 2010, ARTHRITIS RHEUM-US, V62, P2510, DOI 10.1002/art.27485; Xu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032554, 10.1371/journal.pone.0038665]; Zhou L, 1996, DEV BIOL, V175, P227, DOI 10.1006/dbio.1996.0110; ZWIJSEN A, 1994, EUR J BIOCHEM, V225, P937, DOI 10.1111/j.1432-1033.1994.0937b.x	31	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158385	10.1371/journal.pone.0158385	http://dx.doi.org/10.1371/journal.pone.0158385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355685	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400057
J	Mowlaboccus, S; Perkins, TT; Smith, H; Sloots, T; Tozer, S; Prempeh, LJ; Tay, CY; Peters, F; Speers, D; Keil, AD; Kahler, CM				Mowlaboccus, Shakeel; Perkins, Timothy T.; Smith, Helen; Sloots, Theo; Tozer, Sarah; Prempeh, Lydia-Jessica; Tay, Chin Yen; Peters, Fanny; Speers, David; Keil, Anthony D.; Kahler, Charlene M.			Temporal Changes in BEXSERO (R) Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia	PLOS ONE			English	Article							MENINGOCOCCAL SEROGROUP-B; STRAIN COVERAGE; QUANTITATIVE ASSESSMENT; MULTICOMPONENT VACCINE; POPULATION-STRUCTURE; UNITED-STATES; DISEASE; 4CMENB; PROTEIN; SURVEILLANCE	Neisseria meningitidis is the causative agent of invasive meningococcal disease (IMD). The BEXSERO (R) vaccine which is used to prevent serogroup B disease is composed of four sub-capsular protein antigens supplemented with an outer membrane vesicle. Since the sub-capsular protein antigens are variably expressed and antigenically variable amongst meningococcal isolates, vaccine coverage can be estimated by the meningococcal antigen typing system (MATS) which measures the propensity of the strain to be killed by vaccinated sera. Whole genome sequencing (WGS) which identifies the alleles of the antigens that may be recognised by the antibody response could represent, in future, an alternative estimate of coverage. In this study, WGS of 278 meningococcal isolates responsible for 62% of IMD inWestern Australia from 2000-2014 were analysed for association of genetic lineage (sequence type [ST], clonal complex [cc]) with BEXSERO (R) antigen sequence type (BAST) and MATS to predict the annual vaccine coverage. A hyperendemic period of IMD between 2000-05 was caused by cc41/44 with the major sequence type of ST-146 which was not predicted by MATS or BAST to be covered by the vaccine. An increase in serogroup diversity was observed between 2010-14 with the emergence of cc11 serogroup W in the adolescent population and cc23 serogroup Y in the elderly. BASTs were statistically associated with clonal complex although individual antigens underwent antigenic drift from the major type. BAST and MATS predicted an annual range of 44-91% vaccine coverage. Periods of low vaccine coverage in years post-2005 were not a result of the resurgence of cc41/44: ST-146 but were characterised by increased diversity of clonal complexes expressing BASTs which were not predicted by MATS to be covered by the vaccine. The driving force behind the diversity of the clonal complex and BAST during these periods of low vaccine coverage is unknown, but could be due to immune selection and inter-strain competition with carriage of non-disease causing meningococci.	[Mowlaboccus, Shakeel; Perkins, Timothy T.; Prempeh, Lydia-Jessica; Tay, Chin Yen; Peters, Fanny; Kahler, Charlene M.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Sch Pathol & Lab Med, Perth, WA, Australia; [Smith, Helen] Hlth Support Queensland Dept Hlth, Publ Hlth Microbiol Forens & Sci Serv, Brisbane, Qld, Australia; [Sloots, Theo; Tozer, Sarah] Royal Childrens Hosp, Sir Albert Sakzewski Virus Res Ctr, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [Speers, David] PathWest Lab Med WA, QEII Med Ctr, Dept Microbiol, Perth, WA, Australia; [Keil, Anthony D.] PathWest Lab Med WA, Princess Margaret Hosp Children, Dept Microbiol, Perth, WA, Australia; [Kahler, Charlene M.] Telethon Kids Inst, Perth, WA, Australia	University of Western Australia; Royal Children's Hospital Brisbane; Telethon Kids Institute	Kahler, CM (corresponding author), Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Sch Pathol & Lab Med, Perth, WA, Australia.; Kahler, CM (corresponding author), Telethon Kids Inst, Perth, WA, Australia.	charlene.kahler@uwa.edu.au	Tay, Alfred Chin Yen/H-5938-2014; Kahler, Charlene M/H-5159-2014; Tay, Chin Yen/AAZ-8785-2021	Tay, Alfred Chin Yen/0000-0001-9705-4010; Kahler, Charlene M/0000-0003-4322-3055; Tay, Chin Yen/0000-0001-9705-4010; Tozer, Sarah/0000-0002-3001-7642; Mowlaboccus, Shakeel/0000-0001-9408-6068	Amanda Young Foundation; National Health and Medical Research Council of Australia [APP1003697]; International Postgraduate Research Student award from the University of Western Australia; Novartis; Wellcome Trust; European Union	Amanda Young Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); International Postgraduate Research Student award from the University of Western Australia; Novartis(Novartis); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission)	This work was supported by grant funding from the Amanda Young Foundation (http://www.amandayoungfoundation.org.au/), a not-for-profit, charitable organisation of Western Australia awarded to C.M.K. C.M.K. is also supported by the National Health and Medical Research Council of Australia (APP1003697). S.M. is supported by an International Postgraduate Research Student award from the University of Western Australia. H.S., T.S. and S.T. were supported by funding from Novartis. This publication made use of the Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford. The development of this site has been funded by the Wellcome Trust and European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant funding from the Amanda Young Foundation (http://www.amandayoungfoundation.org.au/), a not-for-profit, charitable organisation of Western Australia awarded to C.M.K. C.M.K. is also supported by the National Health and Medical Research Council of Australia (APP1003697). S.M. is supported by an International Postgraduate Research Student award from the University of Western Australia. H.S., T.S. and S.T. were supported by funding from Novartis. Thanks to David Atlas, Jane Bew, and other scientific staff at the PathWest Laboratory Medicine WA microbiology laboratory at the Princess Margaret Hospital for Children, for serogrouping, storage and data collection of the meningococcal isolates. This publication made use of the Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford. The development of this site has been funded by the Welcome Trust and European Union. We would like to thank Dr Geoff Coombs for editing the manuscript.	Araya P, 2015, EMERG INFECT DIS, V21, P339, DOI 10.3201/eid2102.140746; Bambini S, 2014, CLIN VACCINE IMMUNOL, V21, P966, DOI 10.1128/CVI.00825-13; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Barra GN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066006; Boan P, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0686-x; Corvisy R, 2015, COMMUN DIS INTELL, V39, pE46; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Elias J, 2010, EMERG INFECT DIS, V16, P464, DOI 10.3201/eid1603.091102; Fagnocchi L, 2013, INFECT IMMUN, V81, P560, DOI 10.1128/IAI.01085-12; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Harrison LH, 2010, J INFECT DIS, V201, P1208, DOI 10.1086/651505; Harrison LH, 2001, JAMA-J AM MED ASSOC, V286, P694, DOI 10.1001/jama.286.6.694; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Levy C, 2010, PEDIATR INFECT DIS J, V29, P618, DOI 10.1097/INF.0b013e3181d3ce32; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Maiden MCJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0147; Maiden MCJ, 2008, CURR OPIN MICROBIOL, V11, P467, DOI 10.1016/j.mib.2008.09.002; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin DR, 2006, CLIN VACCINE IMMUNOL, V13, P486, DOI 10.1128/CVI.13.4.486-491.2006; Medini D, 2015, VACCINE, V33, P2629, DOI 10.1016/j.vaccine.2015.04.015; Nissen M TS, 2012, 18 INT PATH NEISS C; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Sorhouet-Pereira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058065; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Wang X, 2015, J INFECT DIS, V211, P1887, DOI 10.1093/infdis/jiu842; Watkins ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045349; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Xie OL, 2013, VACCINE, V31, P2852, DOI 10.1016/j.vaccine.2013.04.036; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	34	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158315	10.1371/journal.pone.0158315	http://dx.doi.org/10.1371/journal.pone.0158315			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355628	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400049
J	Pimpin, L; Wu, JHY; Haskelberg, H; Del Gobbo, L; Mozaffarian, D				Pimpin, Laura; Wu, Jason H. Y.; Haskelberg, Hila; Del Gobbo, Liana; Mozaffarian, Dariush			Is Butter Back? A Systematic Review and Meta-Analysis of Butter Consumption and Risk of Cardiovascular Disease, Diabetes, and Total Mortality	PLOS ONE			English	Article							TRANS-PALMITOLEIC ACID; OLIVE OIL CONSUMPTION; BETA-CELL FUNCTION; FATTY-ACIDS; INSULIN SENSITIVITY; DIETARY PATTERNS; TREND ESTIMATION; SATURATED FAT; FOOD SOURCES; DAIRY FOODS	Background Dietary guidelines recommend avoiding foods high in saturated fat. Yet, emerging evidence suggests cardiometabolic benefits of dairy products and dairy fat. Evidence on the role of butter, with high saturated dairy fat content, for total mortality, cardiovascular disease, and type 2 diabetes remains unclear. We aimed to systematically review and meta-analyze the association of butter consumption with all-cause mortality, cardiovascular disease, and diabetes in general populations. Methods and Findings We searched 9 databases from inception to May 2015 without restriction on setting, or language, using keywords related to butter consumption and cardiometabolic outcomes. Prospective cohorts or randomized clinical trials providing estimates of effects of butter intake on mortality, cardiovascular disease including coronary heart disease and stroke, or diabetes in adult populations were included. One investigator screened titles and abstracts; and two reviewed full-text articles independently in duplicate, and extracted study and participant characteristics, exposure and outcome definitions and assessment methods, analysis methods, and adjusted effects and associated uncertainty, all independently in duplicate. Study quality was evaluated by a modified Newcastle-Ottawa score. Random and fixed effects meta-analysis pooled findings, with heterogeneity assessed using the I-2 statistic and publication bias by Egger's test and visual inspection of funnel plots. We identified 9 publications including 15 country-specific cohorts, together reporting on 636,151 unique participants with 6.5 million person-years of follow-up and including 28,271 total deaths, 9,783 cases of incident cardiovascular disease, and 23,954 cases of incident diabetes. No RCTs were identified. Butter consumption was weakly associated with all-cause mortality (N = 9 country-specific cohorts; per 14g(1 tablespoon)/day: RR = 1.01, 95% CI = 1.00, 1.03, P = 0.045); was not significantly associated with any cardiovascular disease (N = 4; RR = 1.00, 95% CI = 0.98, 1.02; P = 0.704), coronary heart disease (N = 3; RR = 0.99, 95% CI = 0.96, 1.03; P = 0.537), or stroke (N = 3; RR = 1.01, 95% CI = 0.98, 1.03; P = 0.737), and was inversely associated with incidence of diabetes (N = 11; RR = 0.96, 95% CI = 0.93, 0.99; P = 0.021). We did not identify evidence for heterogeneity nor publication bias. Conclusions This systematic review and meta-analysis suggests relatively small or neutral overall associations of butter with mortality, CVD, and diabetes. These findings do not support a need for major emphasis in dietary guidelines on either increasing or decreasing butter consumption, in comparison to other better established dietary priorities; while also highlighting the need for additional investigation of health and metabolic effects of butter and dairy fat.	[Pimpin, Laura; Del Gobbo, Liana; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA; [Wu, Jason H. Y.; Haskelberg, Hila] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Del Gobbo, Liana] Stanford Sch Med, Cardiovasc Med, Palo Alto, CA USA	Tufts University; George Institute for Global Health; University of Sydney; Stanford University	Mozaffarian, D (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.	Dariush.Mozaffarian@tufts.edu	Mozaffarian, Dariush/ABC-2822-2020; Wu, Jason/J-2936-2019	Wu, Jason/0000-0003-2073-3562; Pimpin, Laura/0000-0001-5021-0143	Circulating Dietary and Metabolic Fatty Acids, Major CVD Outcomes and Healthy Aging [5R01HL085710-08]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085710] Funding Source: NIH RePORTER	Circulating Dietary and Metabolic Fatty Acids, Major CVD Outcomes and Healthy Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant number 5R01HL085710-08: Circulating Dietary and Metabolic Fatty Acids, Major CVD Outcomes and Healthy Aging. The funders had no role in the study data collection and analysis, decision to publish, or preparation of the manuscript.	Aune D, 2013, AM J CLIN NUTR, V98, P1066, DOI 10.3945/ajcn.113.059030; Avalos EE, 2013, PUBLIC HEALTH NUTR, V16, P2055, DOI 10.1017/S1368980012004168; Bentley J, 2014, FOOD AV PER CAP DAT; Bittman M., 2014, NEW YORK TIMES; Bjornshave Ann, 2014, Rev Diabet Stud, V11, P153, DOI 10.1900/RDS.2014.11.153; Bonham MP, 2013, LIPIDS, V48, P39, DOI 10.1007/s11745-012-3735-5; Bryan Walsh, 2014, TIME MAGAZINE; Buijsse B, 2015, EUR J CLIN NUTR, V69, P455, DOI 10.1038/ejcn.2014.249; Chen M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0215-1; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Cormick G, 2015, COCHRANE DB SYST REV, V6, DOI 10.1002/; Deeks J J, 2003, Health Technol Assess, V7, piii; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dietary Guidelines Advisory Committee, 2015, RAPP ACT 2015 REP PE; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ejtahed HS, 2012, NUTRITION, V28, P539, DOI 10.1016/j.nut.2011.08.013; Ericson U, 2015, AM J CLIN NUTR, V101, P1065, DOI 10.3945/ajcn.114.103010; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Fortes C, 2000, EPIDEMIOLOGY, V11, P440, DOI 10.1097/00001648-200007000-00013; Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y; Goldbohm RA, 2011, AM J CLIN NUTR, V93, P615, DOI 10.3945/ajcn.110.000430; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Guasch-Ferre M, 2015, AM J CLIN NUTR, V102, P479, DOI 10.3945/ajcn.115.112029; Guasch-Ferre M, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-78; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701; Hu D, 2014, NUTR METAB CARDIOVAS, V24, P460, DOI 10.1016/j.numecd.2013.12.006; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Jacobs DR, 2003, AM J CLIN NUTR, V78, p508S, DOI 10.1093/ajcn/78.3.508S; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kratz M, 2014, AM J CLIN NUTR, V99, P1385, DOI 10.3945/ajcn.113.075457; Larsson SC, 2009, EPIDEMIOLOGY, V20, P355, DOI 10.1097/EDE.0b013e3181935dd5; Lopez S, 2008, AM J CLIN NUTR, V88, P638, DOI 10.1093/ajcn/88.3.638; Martinez-Gonzalez MA, 2014, CIRCULATION, V130, P18, DOI 10.1161/CIRCULATIONAHA.113.006921; Micha R, 2010, LIPIDS, V45, P893, DOI 10.1007/s11745-010-3393-4; Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094; Mozaffarian D, 2013, AM J CLIN NUTR, V97, P854, DOI 10.3945/ajcn.112.045468; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Mozaffarian D, 2010, JAMA-J AM MED ASSOC, V304, P681, DOI 10.1001/jama.2010.1116; O'Sullivan TA, 2013, AM J PUBLIC HEALTH, V103, pE31, DOI 10.2105/AJPH.2013.301492; Onakpoya IJ, 2011, NUTR REV, V69, P335, DOI 10.1111/j.1753-4887.2011.00397.x; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Otto MCD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000092; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Qin LQ, 2015, ASIA PAC J CLIN NUTR, V24, P90, DOI 10.6133/apjcn.2015.24.1.09; Reid IR, 2013, NUTRIENTS, V5, P2522, DOI 10.3390/nu5072522; Schulz M, 2008, BRIT J NUTR, V100, P942, DOI 10.1017/S0007114508966149; Sluik D, 2014, DIABETOLOGIA, V57, P63, DOI 10.1007/s00125-013-3074-y; Sonestedt E, 2011, EUR J EPIDEMIOL, V26, P609, DOI 10.1007/s10654-011-9589-y; Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109; United States Department of Agriculture, 2014, HOUS USDA FOODS FACT; van Schalkwijk DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100376; Whiteman D, 1999, PUBLIC HEALTH NUTR, V2, P477, DOI 10.1017/S136898009900066X; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563; Zazpe I, 2011, BRIT J NUTR, V105, P765, DOI 10.1017/S0007114510004149; Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212	59	121	123	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158118	10.1371/journal.pone.0158118	http://dx.doi.org/10.1371/journal.pone.0158118			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355649	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400028
J	Weston, W; Smedley, J; Bennett, A; Mortimer, K				Weston, William; Smedley, James; Bennett, Andrew; Mortimer, Kevin			The Cooking and Pneumonia Study (CAPS) in Malawi: Implementation of Remote Source Data Verification	PLOS ONE			English	Article								Background Source data verification (SDV) is a data monitoring procedure which compares the original records with the Case Report Form (CRF). Traditionally, on-site SDV relies on monitors making multiples visits to study sites requiring extensive resources. The Cooking And Pneumonia Study (CAPS) is a 24-month village-level cluster randomized controlled trial assessing the effectiveness of an advanced cook-stove intervention in preventing pneumonia in children under five in rural Malawi (www.capstudy.org). CAPS used smartphones to capture digital images of the original records on an electronic CRF (eCRF). In the present study, descriptive statistics are used to report the experience of electronic data capture with remote SDV in a challenging research setting in rural Malawi. Methods At three monthly intervals, fieldworkers, who were employed by CAPS, captured pneumonia data from the original records onto the eCRF. Fieldworkers also captured digital images of the original records. Once Internet connectivity was available, the data captured on the eCRF and the digital images of the original records were uploaded to a web-based SDV application. This enabled SDV to be conducted remotely from the UK. We conducted SDV of the pneumonia data (occurrence, severity, and clinical indicators) recorded in the eCRF with the data in the digital images of the original records. Result 664 episodes of pneumonia were recorded after 6 months of follow-up. Of these 664 episodes, 611 (92%) had a finding of pneumonia in the original records. All digital images of the original records were clear and legible. Conclusion Electronic data capture using eCRFs on mobile technology is feasible in rural Malawi. Capturing digital images of the original records in the field allows remote SDV to be conducted efficiently and securely without requiring additional field visits. We recommend these approaches in similar settings, especially those with health endpoints.	[Weston, William; Smedley, James; Bennett, Andrew; Mortimer, Kevin] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine	Weston, W (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.	William.Weston@lstmed.ac.uk; Kevin.Mortimer@lstmed.ac.uk		Mortimer, Kevin/0000-0002-8118-8871	Medical Research Council; Wellcome Trust; UKAID (Joint Global Trials Health Scheme); CAPS KM; MRC [MR/L002515/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UKAID (Joint Global Trials Health Scheme); CAPS KM; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CAPS is funded by the Medical Research Council (www.mrc.ac.uk/), Wellcome Trust (www.wellcome.ac.uk/) and UKAID (Joint Global Trials Health Scheme). As principal investigator of CAPS KM received all funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breslauer C., 2006, MONITOR, P43; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Eisenstein EL, 2005, AM HEART J, V149, P482, DOI 10.1016/j.ahj.2004.04.049; Jetter JJ, 2009, BIOMASS BIOENERG, V33, P294, DOI 10.1016/j.biombioe.2008.05.014; King C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25878; Medical Research Council (MRC), 2009, CLIN TRIALS SER MRC; Nahm ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003049; Piddock Katy C, 2014, Ann Am Thorac Soc, V11, P915, DOI 10.1513/AnnalsATS.201311-413OC; Romieu I, 2009, AM J RESP CRIT CARE, V180, P649, DOI 10.1164/rccm.200810-1556OC; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; United Nations Development Programme (UNDP), 2015, AB MAL; Walther B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025348; World Health Organisation (WHO), 2005, WHO HDB IMCI INT MAN; World Health Organisation (WHO), 2005, HLTH MAN INF B	15	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0155966	10.1371/journal.pone.0155966	http://dx.doi.org/10.1371/journal.pone.0155966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355447	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400005
J	Baek, SY; Jang, KH; Choi, EH; Ryu, SH; Kim, SK; Lee, JH; Lim, YJ; Lee, J; Jun, J; Kwak, M; Lee, YS; Hwang, JS; Maran, BAV; Chang, CY; Kim, IH; Hwang, UW				Baek, Su Youn; Jang, Kuem Hee; Choi, Eun Hwa; Ryu, Shi Hyun; Kim, Sang Ki; Lee, Jin Hee; Lim, Young Jin; Lee, Jimin; Jun, Jumin; Kwak, Myounghai; Lee, Young-Sup; Hwang, Jae-Sam; Maran, Balu Alagar Venmathi; Chang, Cheon Young; Kim, Il-Hoi; Hwang, Ui Wook			DNA Barcoding of Metazoan Zooplankton Copepods from South Korea	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; CALANOID COPEPODS; COMPARATIVE PHYLOGEOGRAPHY; SPECIES IDENTIFICATION; ESTUARINE COPEPOD; ACARTIA-TONSA; CRUSTACEA; AMPLIFICATION; SEA	Copepods, small aquatic crustaceans, are the most abundant metazoan zooplankton and outnumber every other group of multicellular animals on earth. In spite of ecological and biological importance in aquatic environment, their morphological plasticity, originated from their various lifestyles and their incomparable capacity to adapt to a variety of environments, has made the identification of species challenging, even for expert taxonomists. Molecular approaches to species identification have allowed rapid detection, discrimination, and identification of cryptic or sibling species based on DNA sequence data. We examined sequence variation of a partial mitochondrial cytochrome C oxidase I gene (COI) from 133 copepod individuals collected from the Korean Peninsula, in order to identify and discriminate 94 copepod species covering six copepod orders of Calanoida, Cyclopoida, Harpacticoida, Monstrilloida, Poecilostomatoida and Siphonostomatoida. The results showed that there exists a clear gap with ca. 20 fold difference between the averages of within-specific sequence divergence (2.42%) and that of between-specific sequence divergence (42.79%) in COI, suggesting the plausible utility of this gene in delimitating copepod species. The results showed, with the COI barcoding data among 94 copepod species, that a copepod species could be distinguished from the others very clearly, only with four exceptions as followings: Mesocyclops dissimilis-Mesocyclops pehpeiensis (0.26% K2P distance in percent) and Oithona davisae-Oithona similis (1.1%) in Cyclopoida, Ostrincola japonica-Pseudomyicola spinosus (1.5%) in Poecilostomatoida, and Hatschekia japonica-Caligus quadratus (5.2%) in Siphonostomatoida. Thus, it strongly indicated that COI may be a useful tool in identifying various copepod species and make an initial progress toward the construction of a comprehensive DNA barcode database for copepods inhabiting the Korean Peninsula.	[Baek, Su Youn; Kim, Sang Ki; Lee, Jin Hee; Lee, Young-Sup; Hwang, Ui Wook] Kyungpook Natl Univ, Sch Life Sci, Grad Sch, Daegu, South Korea; [Jang, Kuem Hee; Choi, Eun Hwa; Lim, Young Jin; Maran, Balu Alagar Venmathi; Hwang, Ui Wook] Kyungpook Natl Univ, Dept Biol, Teachers Coll, Daegu, South Korea; [Jang, Kuem Hee; Choi, Eun Hwa; Lim, Young Jin; Maran, Balu Alagar Venmathi; Hwang, Ui Wook] Kyungpook Natl Univ, Inst Phylogen & Evolut, Daegu, South Korea; [Ryu, Shi Hyun] Nakdonggang Natl Inst Biol Resources, Freshwater Biodivers Res Div, Sangju, Gyeongsangbuk D, South Korea; [Lee, Jimin] Korea Inst Ocean Sci & Technol, Marine Ecosyst Res Div, Ansan, South Korea; [Jun, Jumin; Kwak, Myounghai] Natl Inst Biol Resources, Biol Resources Res Dept, Inchon, South Korea; [Hwang, Jae-Sam] Rural Dev Adm, Natl Acad Agr Sci, Dept Agr Biol, Jeonju, South Korea; [Chang, Cheon Young] Daegu Univ, Coll Nat Sci, Dept Biol Sci, Gyongsan, South Korea; [Kim, Il-Hoi] Gangneung Wonju Natl Univ, Dept Biol, Kangnung, Gangwon Do, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Korea Institute of Ocean Science & Technology (KIOST); National Institute of Biological Resources; Rural Development Administration (RDA), Republic of Korea; Daegu University; Kangnung Wonju National University	Hwang, UW (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Grad Sch, Daegu, South Korea.; Hwang, UW (corresponding author), Kyungpook Natl Univ, Dept Biol, Teachers Coll, Daegu, South Korea.; Hwang, UW (corresponding author), Kyungpook Natl Univ, Inst Phylogen & Evolut, Daegu, South Korea.	uwhwang@knu.ac.kr	Venmathi Maran, Balu Alagar/G-5163-2014	Venmathi Maran, Balu Alagar/0000-0003-1090-5295	"Origin of Biological Diversity of Korea: Molecular Phylogenetic Analyses of Major Korean Taxa" - National Institute of Biological Resources (NIBR) [2013-02-013]; "Cooperative Research Program for Agriculture Science Technology Development (National Agricultural Genome Program, Project title: De novo genome annotation for centipede, Scolopendra subspinipes'') Rural Development Administration, Republic of Korea [PJ010338]	"Origin of Biological Diversity of Korea: Molecular Phylogenetic Analyses of Major Korean Taxa" - National Institute of Biological Resources (NIBR); "Cooperative Research Program for Agriculture Science Technology Development (National Agricultural Genome Program, Project title: De novo genome annotation for centipede, Scolopendra subspinipes'') Rural Development Administration, Republic of Korea	This present work was carried out with the support of "Origin of Biological Diversity of Korea: Molecular Phylogenetic Analyses of Major Korean Taxa" funded by the National Institute of Biological Resources (NIBR No. 2013-02-013), and "Cooperative Research Program for Agriculture Science & Technology Development (National Agricultural Genome Program, Project title: De novo genome annotation for centipede, Scolopendra subspinipes, Project No. PJ010338)" Rural Development Administration, Republic of Korea.	Aarbakke ONS, 2014, J EXP MAR BIOL ECOL, V461, P479, DOI 10.1016/j.jembe.2014.10.006; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; Blanco-Bercial L, 2011, MOL PHYLOGENET EVOL, V59, P103, DOI 10.1016/j.ympev.2011.01.008; Boxshall G. A., 2004, INTRO COPEPOD DIVERS; Boxshall GA, 1997, SYSTEMATICS ASS SPEC, V55, P156; Boxshall GA, 2015, COPEPODA WORLD REGIS; Bradford-Grieve JM, 2010, INVERTEBR SYST, V24, P291, DOI 10.1071/IS10007; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; Burton RS, 2007, GENE, V403, P53, DOI 10.1016/j.gene.2007.07.026; Castellani C, 2012, J MAR BIOL ASSOC UK, V92, P99, DOI 10.1017/S0025315411000932; Caudill CC, 2004, HYDROBIOLOGIA, V511, P91, DOI 10.1023/B:HYDR.0000014032.05680.9d; Cepeda GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035861; Chang CY, 2005, KEY KOREAN FRESHWATE; Chen G, 2011, MOL ECOL, V20, P2425, DOI 10.1111/j.1365-294X.2011.05079.x; Cheng Fangping, 2013, Advances in Polar Science, V24, P119, DOI 10.3724/SP.J.1085.2013.00119; Cornils A, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-19; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Eyun SI, 2007, ZOOL SCI, V24, P265, DOI 10.2108/zsj.24.265; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goetze E, 2005, EVOLUTION, V59, P2378; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ho JS, 2001, HYDROBIOLOGIA, V453, P1, DOI 10.1023/A:1013139212227; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Huys R, 2009, ZOOTAXA, P1; Hwang Ui Wook, 2002, Korean Journal of Systematic Zoology, V18, P165; Hwang Ui-Wook, 1999, Korean Journal of Parasitology, V37, P215, DOI 10.3347/kjp.1999.37.4.215; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Hwang UW, 2001, MOL PHYLOGENET EVOL, V19, P345, DOI 10.1006/mpev.2001.0940; Jang KH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-167; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozol R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045710; Laakmann S, 2013, MOL ECOL RESOUR, V13, P862, DOI 10.1111/1755-0998.12139; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavrov DV, 2013, MOL BIOL EVOL, V30, P865, DOI 10.1093/molbev/mss274; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Lim JT, 2006, MOL CELLS, V22, P314; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Machida RJ, 2006, MAR BIOL, V148, P1071, DOI 10.1007/s00227-005-0140-0; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; Machida RJ, 2002, MAR BIOTECHNOL, V4, P406, DOI 10.1007/s10126-002-0033-x; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; Matthews B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026700; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Park SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-343; Pond DW, 2011, LIMNOL OCEANOGR, V56, P1310, DOI 10.4319/lo.2011.56.4.1310; Saiz E, 2011, HYDROBIOLOGIA, V666, P181, DOI 10.1007/s10750-010-0421-6; Schminke HK, 2007, J PLANKTON RES, V29, pI149, DOI 10.1093/plankt/fbl073; Shao R, 2007, PARASITOLOGY, V134, P153, DOI 10.1017/S0031182006001429; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Soh HY, 2012, ZOOTAXA, P229; Suarez-Morales E., 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V70, P107; Suarez-Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022915; Sukhikh N, 2013, J NAT HIST, V47, P753, DOI 10.1080/00222933.2012.716865; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Woo HJ, 2007, MOL CELLS, V23, P182	64	23	27	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157307	10.1371/journal.pone.0157307	http://dx.doi.org/10.1371/journal.pone.0157307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383475	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400010
J	EL-Manzalawy, Y; Abbas, M; Malluhi, Q; Honavar, V				EL-Manzalawy, Yasser; Abbas, Mostafa; Malluhi, Qutaibah; Honavar, Vasant			FastRNABindR: Fast and Accurate Prediction of Protein-RNA Interface Residues	PLOS ONE			English	Article							ACCESSIBLE SURFACE-AREA; DNA-BINDING RESIDUES; SECONDARY STRUCTURE; SITES; SERVER; PROPENSITY; GENERATION; BLAST; PLUS	A wide range of biological processes, including regulation of gene expression, protein synthesis, and replication and assembly of many viruses are mediated by RNA-protein interactions. However, experimental determination of the structures of protein-RNA complexes is expensive and technically challenging. Hence, a number of computational tools have been developed for predicting protein-RNA interfaces. Some of the state-of-the-art protein-RNA interface predictors rely on position-specific scoring matrix (PSSM)-based encoding of the protein sequences. The computational efforts needed for generating PSSMs severely limits the practical utility of protein-RNA interface prediction servers. In this work, we experiment with two approaches, random sampling and sequence similarity reduction, for extracting a representative reference database of protein sequences from more than 50 million protein sequences in UniRef100. Our results suggest that random sampled databases produce better PSSM profiles (in terms of the number of hits used to generate the profile and the distance of the generated profile to the corresponding profile generated using the entire UniRef100 data as well as the accuracy of the machine learning classifier trained using these profiles). Based on our results, we developed FastRNABindR, an improved version of RNABindR for predicting protein-RNA interface residues using PSSM profiles generated using 1% of the UniRef100 sequences sampled uniformly at random. To the best of our knowledge, FastRNABindR is the only protein-RNA interface residue prediction online server that requires generation of PSSM profiles for query sequences and accepts hundreds of protein sequences per submission. Our approach for determining the optimal BLAST database for a protein-RNA interface residue classification task has the potential of substantially speeding up, and hence increasing the practical utility of, other amino acid sequence based predictors of protein-protein and protein-DNA interfaces.	[EL-Manzalawy, Yasser; Honavar, Vasant] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [EL-Manzalawy, Yasser] Al Azhar Univ, Syst & Comp Engn, Cairo, Egypt; [Abbas, Mostafa; Malluhi, Qutaibah] Qatar Univ, Coll Engn, KINDI Ctr Comp Res, Duha, Qatar	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Egyptian Knowledge Bank (EKB); Al Azhar University; Qatar University	EL-Manzalawy, Y (corresponding author), Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA.; EL-Manzalawy, Y (corresponding author), Al Azhar Univ, Syst & Comp Engn, Cairo, Egypt.	yme2@psu.edu	El-Manzalawy, Yasser/ABE-3489-2020; Honavar, Vasant G/K-9835-2015	Honavar, Vasant G/0000-0001-5399-3489	Edward Frymoyer Endowed Professorship in Information Sciences and Technology; Center for Big Data Analytics and Discovery Informatics - Institute for Cyberscience; Huck Institutes of the Life Sciences; Social Science Research Institute; College of Information Sciences and Technology at the Pennsylvania State University; NPRP grant from the Qatar National Research Fund [4-1454-1-233]	Edward Frymoyer Endowed Professorship in Information Sciences and Technology; Center for Big Data Analytics and Discovery Informatics - Institute for Cyberscience; Huck Institutes of the Life Sciences; Social Science Research Institute; College of Information Sciences and Technology at the Pennsylvania State University; NPRP grant from the Qatar National Research Fund(Qatar National Research Fund (QNRF))	This work was supported in part by the Edward Frymoyer Endowed Professorship in Information Sciences and Technology held by Vasant Honavar and the Center for Big Data Analytics and Discovery Informatics which is co-sponsored by the Institute for Cyberscience, the Huck Institutes of the Life Sciences, the Social Science Research Institute, and the College of Information Sciences and Technology at the Pennsylvania State University. This work was also supported by NPRP grant No. 4-1454-1-233 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caragea C, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P320; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Chen YC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn008; Darling AE., 2003, 4 INT C LIN CLUST CL; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faraggi E, 2014, PROTEINS, V82, P3170, DOI 10.1002/prot.24682; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hauser M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-248; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Ke A, 2004, METHODS, V34, P408, DOI 10.1016/j.ymeth.2004.03.027; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551; Marchanka A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8024; Miao ZC, 2015, NUCLEIC ACIDS RES, V43, P5340, DOI 10.1093/nar/gkv446; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Nagarajan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091140; Nguyen MN, 2006, PROTEINS, V63, P542, DOI 10.1002/prot.20883; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Perez-Cano L, 2010, PROTEINS, V78, P25, DOI 10.1002/prot.22527; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Schlessinger A, 2006, BIOINFORMATICS, V22, P891, DOI 10.1093/bioinformatics/btl032; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Towfic F, 2010, INT J DATA MIN BIOIN, V4, P21, DOI 10.1504/IJDMB.2010.030965; Tuszynska I, 2014, METHODS, V65, P310, DOI 10.1016/j.ymeth.2013.09.014; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Walia R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057792; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375	51	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158445	10.1371/journal.pone.0158445	http://dx.doi.org/10.1371/journal.pone.0158445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383535	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400048
J	Zhang, W; Zhong, L; Wang, J; Han, JY				Zhang, Wei; Zhong, Liang; Wang, Jing; Han, Jianyong			Distinct MicroRNA Expression Signatures of Porcine Induced Pluripotent Stem Cells under Mouse and Human ESC Culture Conditions	PLOS ONE			English	Article							DLK1-DIO3 REGION; SELF-RENEWAL; DIFFERENTIATION; IDENTIFICATION; TARGETS; TRANSITION; CLUSTER; MIR-302; PATHWAY; KINASE	It is well known that microRNAs play a very important role in regulating reprogramming, pluripotency and cell fate decisions. Porcine induced pluripotent stem cells (piPSCs) are now available for studying the pluripotent regulation network in pigs. Two types of piPSCs have been derived from human and mouse embryonic stem cell (ESC) culture conditions: hpiPSCs and mpiPSCs, respectively. The hpiPSCs were morphologically similar to human ESCs, and the mpiPSCs resembled mouse ESCs. However, our current understanding of the role of microRNAs in the development of piPSCs is still very limited. Here, we performed small RNA sequencing to profile the miRNA expression in porcine fibroblasts (pEFs), hpiPSCs and mpiPSCs. There were 22 differential expressed (DE) miRNAs down-regulated in both types of piPSCs compared with pEFs, such as ssc-miR-145-5p and ssc-miR-98. There were 27 DE miRNAs up-regulated in both types of piPSCs compared with pEFs. Among these up-regulated DE miRNAs in piPSCs, ssc-miR-217, ssc-miR-216, ssc-miR-142-5p, ssc-miR-182, ssc-miR-183 and ssc-miR-96-5p have much higher expression levels in mpiPSCs, while ssc-miR-106a, ssc-miR-363, ssc-miR-146b, ssc-miR-195, ssc-miR-497, ssc-miR-935 and ssc-miR-20b highly expressed in hpiPSCs. Quantitative stem-loop RTPCR was performed to confirm selected DE miRNAs expression levels. The results were consistent with small RNA sequencing. Different expression patterns were observed for key miRNA clusters, such as the miR-17-92 cluster, the let-7 family, the miR-106a-363 cluster and the miR-182-183 cluster, in the mpiPSCs and hpiPSCs. Novel miRNAs were also predicted in this study, including a putative porcine miR-302 cluster: ssc_38503, ssc_38503 and ssc_38501 (which resemble human miR-302a and miR-302b) found in both types of piPSCs. The miR-106a-363 cluster and putative miR-302 cluster increased the reprogramming efficiency of pEFs. The study revealed significant differences in the miRNA signatures of hpiPSCs and mpiPSCs under different pluripotent states that were derived from different culture conditions. These differentially expressed miRNAs may play important roles in pluripotent regulation in pigs, and this information will facilitate the understanding of the mechanism of pluripotency in pigs.	[Zhang, Wei; Zhong, Liang; Wang, Jing; Han, Jianyong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China	China Agricultural University	Han, JY (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.	hanjy@cau.edu.cn	Zhong, Liang/AAO-1379-2020; zhang, wei/J-1685-2019	wang, jing/0000-0002-7120-0857	China National Key Research Program [SQ2016ZY05002032-02]; China National Basic Research Program [2011CBB01001]; Program for New Century Excellent Talents in University [NCET-11-0482]; State Key Laboratories for Agrobiotechnology, China Agricultural University [2015SKLAB1-4]; National Thousand Talents Program of China	China National Key Research Program; China National Basic Research Program(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratories for Agrobiotechnology, China Agricultural University; National Thousand Talents Program of China	This study was supported by grants from China National Key Research Program (SQ2016ZY05002032-02), China National Basic Research Program (2011CBB01001), National Thousand Talents Program of China, Program for New Century Excellent Talents in University (NCET-11-0482), and by Research Programs from the State Key Laboratories for Agrobiotechnology, China Agricultural University (2015SKLAB1-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravalli RN, 2012, VET J, V194, P369, DOI 10.1016/j.tvjl.2012.05.013; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen GF, 2014, CELL RES, V24, P1121, DOI 10.1038/cr.2014.112; Cheng D, 2012, CELL REPROGRAM, V14, P312, DOI 10.1089/cell.2012.0025; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Gao J, 2011, J CELL BIOCHEM, V112, P1844, DOI 10.1002/jcb.23106; Greve TS, 2013, ANNU REV CELL DEV BI, V29, P213, DOI 10.1146/annurev-cellbio-101512-122343; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grunhagen J, 2015, J BONE MINER RES, V30, P796, DOI 10.1002/jbmr.2412; Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jouneau A, 2012, RNA, V18, P253, DOI 10.1261/rna.028878.111; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li L, 2015, CELL MOL BIOL LETT, V20, P385, DOI 10.1515/cmble-2015-0023; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li W, 2011, CELL RES, V21, P550, DOI 10.1038/cr.2011.25; Li XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066688; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma KY, 2014, MOL CELL BIOCHEM, V389, P209, DOI 10.1007/s11010-013-1942-x; Mackowiak Sebastian D, 2011, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1210s36; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sladitschek HL, 2015, CELL SYST BIOL, P11; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tang XL, 2014, NUCLEIC ACIDS RES, V42, P2988, DOI 10.1093/nar/gkt1275; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsai ZY, 2010, J CELL BIOCHEM, V109, P93, DOI 10.1002/jcb.22385; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang YM, 2013, CELL REP, V4, P99, DOI 10.1016/j.celrep.2013.05.027; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wei Q, 2015, THORAC CANCER, V6, P2, DOI 10.1111/1759-7714.12164; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124562; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhou L, 2011, STEM CELLS, V29, P972, DOI 10.1002/stem.637	64	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158655	10.1371/journal.pone.0158655	http://dx.doi.org/10.1371/journal.pone.0158655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384321	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400073
J	Dai, HY; Wu, GD; Wu, M; Zhi, DG				Dai, Hongying; Wu, Guodong; Wu, Michael; Zhi, Degui			An Optimal Bahadur-Efficient Method in Detection of Sparse Signals with Applications to Pathway Analysis in Sequencing Association Studies	PLOS ONE			English	Article							WEIGHTED Z-TEST; COMBINING PROBABILITIES; ASYMPTOTIC OPTIMALITY; BIOLOGICAL PATHWAYS; INDEPENDENT TESTS; FISHERS METHOD; MODELS	Next-generation sequencing data pose a severe curse of dimensionality, complicating traditional "single marker-single trait" analysis. We propose a two-stage combined p-value method for pathway analysis. The first stage is at the gene level, where we integrate effects within a gene using the Sequence Kernel Association Test (SKAT). The second stage is at the pathway level, where we perform a correlated Lancaster procedure to detect joint effects from multiple genes within a pathway. We show that the Lancaster procedure is optimal in Bahadur efficiency among all combined p-value methods. The Bahadur efficiency, lim(epsilon -> 0) N-(2)/N-(1) = phi(12)(theta), compares sample sizes among different statistical tests when signals become sparse in sequencing data, i.e. epsilon -> 0. The optimal Bahadur efficiency ensures that the Lancaster procedure asymptotically requires a minimal sample size to detect sparse signals (P-N(i) < epsilon -> 0). The Lancaster procedure can also be applied to meta-analysis. Extensive empirical assessments of exome sequencing data show that the proposed method outperforms Gene Set Enrichment Analysis (GSEA). We applied the competitive Lancaster procedure to meta-analysis data generated by the Global Lipids Genetics Consortium to identify pathways significantly associated with high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and total cholesterol.	[Dai, Hongying] Childrens Mercy Hosp, Hlth Serv & Outcomes Res, Kansas City, MO 64108 USA; [Dai, Hongying] Univ Missouri, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA; [Wu, Guodong] Lovelace Resp Res Inst, Albuquerque, NM USA; [Wu, Michael] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Biostat & Biomath Program, 1124 Columbia St, Seattle, WA 98104 USA; [Zhi, Degui] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Lovelace Respiratory Research Institute; Fred Hutchinson Cancer Center; University of Alabama System; University of Alabama Birmingham	Dai, HY (corresponding author), Childrens Mercy Hosp, Hlth Serv & Outcomes Res, Kansas City, MO 64108 USA.; Dai, HY (corresponding author), Univ Missouri, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA.	hdai@cmh.edu	Wu, Guodong/U-6549-2018; Wu, Michael/X-5084-2019	Wu, Michael/0000-0002-3357-6570; Dai, Hongying/0000-0003-1395-7904; Wu, Guodong/0000-0003-1550-5952	NHGRI of the National Institutes of Health [R01HG008115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008115] Funding Source: NIH RePORTER	NHGRI of the National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by NHGRI of the National Institutes of Health under award number R01HG008115 (D.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; There are no competing interests to this work. We thank three reviewers for their constructive comments, which helped us improve the manuscript. This work is supported by NHGRI of the National Institutes of Health under award number R01HG008115 (D.Z.). We also thank David Williams and the Medical Writing Center at Children's Mercy Hospital for their comments, support, and assistance with the manuscript, which significantly enhanced readability of our work.	BAHADUR RR, 1967, ANN MATH STAT, V38, P303, DOI 10.1214/aoms/1177698949; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen Z, 2011, J EVOLUTION BIOL, V24, P926, DOI 10.1111/j.1420-9101.2010.02226.x; Dai H, 2014, STAT ITS INTERFACE; DAI H., 2012, J BIOM BIOSTAT, P3, DOI DOI 10.4172/2155-6180.1000E117; Dai HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00032; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; GOOD IJ, 1955, J ROY STAT SOC B, V17, P264; He XM, 1996, ANN I STAT MATH, V48, P295, DOI 10.1007/BF00054792; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KILLEEN TJ, 1972, ANN MATH STAT, V43, P181, DOI 10.1214/aoms/1177692712; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; LITTELL RC, 1973, J AM STAT ASSOC, V68, P193, DOI 10.2307/2284167; LITTELL RC, 1971, J AM STAT ASSOC, V66, P802, DOI 10.2307/2284230; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Rosenbaum PR, 2015, J AM STAT ASS, V110; SAVAGE IR, 1969, SANKHYA SER A, V31, P107; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu GD, 2013, GENET EPIDEMIOL, V37, P478, DOI 10.1002/gepi.21728; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]	31	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0152667	10.1371/journal.pone.0152667	http://dx.doi.org/10.1371/journal.pone.0152667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380176	Green Published, gold, Green Submitted			2022-12-27	WOS:000379798700001
J	Liu, ZX; Li, HH; Fan, XH; Huang, W; Yang, JY; Li, CD; Wen, ZX; Li, YH; Guan, RX; Guo, Y; Chang, RZ; Wang, DC; Wang, SM; Qiu, LJ				Liu, Zhangxiong; Li, Huihui; Fan, Xuhong; Huang, Wen; Yang, Jiyu; Li, Candong; Wen, Zixiang; Li, Yinghui; Guan, Rongxia; Guo, Yong; Chang, Ruzhen; Wang, Dechun; Wang, Shuming; Qiu, Li-Juan			Phenotypic Characterization and Genetic Dissection of Growth Period Traits in Soybean (Glycine max) Using Association Mapping	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECOMBINANT INBRED LINES; AGRONOMIC TRAITS; QTL ANALYSIS; PHOTOPERIOD-SENSITIVITY; YIELD COMPONENTS; SEED YIELD; MATURITY; POPULATIONS; L.	The growth period traits are important traits that affect soybean yield. The insights into the genetic basis of growth period traits can provide theoretical basis for cultivated area division, rational distribution, and molecular breeding for soybean varieties. In this study, genome-wide association analysis (GWAS) was exploited to detect the quantitative trait loci (QTL) for number of days to flowering (ETF), number of days from flowering tomaturity (FTM), and number of days to maturity (ETM) using 4032 single nucleotide polymorphism (SNP) markers with 146 cultivars mainly from Northeast China. Results showed that abundant phenotypic variation was presented in the population, and variation explained by genotype, environment, and genotype by environment interaction were all significant for each trait. The whole accessions could be clearly clustered into two subpopulations based on their genetic relatedness, and accessions in the same group were almost from the same province. GWAS based on the unified mixed model identified 19 significant SNPs distributed on 11 soybean chromosomes, 12 of which can be consistently detected in both planting densities, and 5 of which were pleotropic QTL. Of 19 SNPs, 7 SNPs located in or close to the previously reported QTL or genes controlling growth period traits. The QTL identified with high resolution in this study will enrich our genomic understanding of growth period traits and could then be explored as genetic markers to be used in genomic applications in soybean breeding.	[Liu, Zhangxiong; Li, Huihui; Li, Yinghui; Guan, Rongxia; Guo, Yong; Chang, Ruzhen; Qiu, Li-Juan] Chinese Acad Agr Sci, Natl Key Facil Gene Resources & Genet Improvement, Key Lab Crop Germplasm Utilizat, Minist Agr,Inst Crop Sci, Beijing, Peoples R China; [Fan, Xuhong; Wang, Shuming] Jilin Acad Agr Sci, Inst Soybean Res, Changchun, Peoples R China; [Huang, Wen] Tonghua Acad Agr Sci, Meihekou, Peoples R China; [Yang, Jiyu] Jilin City Acad Agr Sci, Jilin, Peoples R China; [Li, Candong] Jiamusi Branch Heilongjiang Agr Sci, Jiamusi, Peoples R China; [Wen, Zixiang; Wang, Dechun] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Jilin Academy of Agricultural Sciences; Michigan State University	Qiu, LJ (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Gene Resources & Genet Improvement, Key Lab Crop Germplasm Utilizat, Minist Agr,Inst Crop Sci, Beijing, Peoples R China.; Wang, SM (corresponding author), Jilin Acad Agr Sci, Inst Soybean Res, Changchun, Peoples R China.	shumingw@263.net; qiulijuan@caas.cn			Crop Germplasm Resources Protection [2014NWB030, 2015NWB030-05]; Platform of National Crop Germplasm Resources of China [2014-004, 2015-004]; National Key Technology RD Program [2011BAD35B06-2-9]; Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS)	Crop Germplasm Resources Protection; Platform of National Crop Germplasm Resources of China; National Key Technology RD Program(National Key Technology R&D Program); Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS)	This work was supported by the Crop Germplasm Resources Protection (2014NWB030, 2015NWB030-05), Platform of National Crop Germplasm Resources of China (2014-004, 2015-004), The National Key Technology R&D Program (2011BAD35B06-2-9), and The Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS).	Akond M., 2013, J PLANT GENOME SCI, V1, P80, DOI DOI 10.5147/JPGS.2013.0090; [Anonymous], 1977, **NON-TRADITIONAL**; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Chen QS., 2007, SCI AGR SINICA, V6, P399; [陈学珍 Chen Xuezhen], 2004, [分子植物育种, Molecular Plant Breeding], V2, P247; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2010, THEOR APPL GENET, V120, P1005, DOI 10.1007/s00122-009-1228-6; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Csanadi G, 2001, THEOR APPL GENET, V103, P912, DOI 10.1007/s001220100621; Vieira Antonio José Dias, 2006, Braz. J. Plant Physiol., V18, P281, DOI 10.1590/S1677-04202006000200004; Du WJ, 2009, J GENET GENOMICS, V36, P721, DOI 10.1016/S1673-8527(08)60165-4; Eskandari M, 2013, THEOR APPL GENET, V126, P1677, DOI 10.1007/s00122-013-2083-z; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan CM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-9; Funatsuki H, 2005, THEOR APPL GENET, V111, P851, DOI 10.1007/s00122-005-0007-2; Gai Junyi, 2007, Frontiers of Agriculture in China, V1, P1, DOI 10.1007/s11703-007-0001-3; Garner WW, 1919, J AGRIC RES, V18, P0553; Githiri SM, 2007, J HERED, V98, P360, DOI 10.1093/jhered/esm042; Guzman PS, 2007, CROP SCI, V47, P111, DOI 10.2135/cropsci2006.01.0003; Han YP, 2012, THEOR APPL GENET, V125, P671, DOI 10.1007/s00122-012-1859-x; Hao DR, 2012, EUPHYTICA, V186, P919, DOI 10.1007/s10681-012-0697-x; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Hartwig E. E., 1973, AGRONOMY, P187; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hwang EY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1; Hyten DL, 2004, THEOR APPL GENET, V109, P552, DOI 10.1007/s00122-004-1661-5; Kabelka EA, 2004, CROP SCI, V44, P784, DOI 10.2135/cropsci2004.0784; Kantolic AG, 2005, FIELD CROP RES, V93, P212, DOI 10.1016/j.fcr.2004.10.001; Khan NA, 2008, THEOR APPL GENET, V117, P479, DOI 10.1007/s00122-008-0792-5; Kisha TJ, 1997, CROP SCI, V37, P1317, DOI 10.2135/cropsci1997.0011183X003700040048x; Komatsu K, 2011, BREEDING SCI, V61, P646, DOI 10.1270/jsbbs.61.646; Kong FJ, 2014, CROP SCI, V54, P2529, DOI 10.2135/cropsci2014.03.0228; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Korir PC, 2013, THEOR APPL GENET, V126, P1659, DOI 10.1007/s00122-013-2082-0; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Li DD, 2008, CROP SCI, V48, P571, DOI 10.2135/cropsci2007.06.0361; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, J HERED, V101, P251, DOI 10.1093/jhered/esp113; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mansur LM, 1996, CROP SCI, V36, P1327, DOI 10.2135/cropsci1996.0011183X003600050042x; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; MCBLAIN BA, 1987, CAN J PLANT SCI, V67, P105, DOI 10.4141/cjps87-012; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Molnar SJ, 2003, GENOME, V46, P1024, DOI [10.1139/g03-079, 10.1139/G03-079]; NEI M, 1972, THEOR POPUL BIOL, V3, P460, DOI 10.1016/0040-5809(72)90017-2; Norman A.G., 1978, SOYBEAN PHYSL AGRONO; Orf JH, 1999, CROP SCI, V39, P1642, DOI 10.2135/cropsci1999.3961642x; Palomeque L, 2009, THEOR APPL GENET, V119, P417, DOI 10.1007/s00122-009-1049-7; Panthee DR, 2007, PLANT BREEDING, V126, P51, DOI 10.1111/j.1439-0523.2006.01305.x; Pooprompan P., 2006, Kasetsart Journal, Natural Sciences, V40, P573; Pritchard JK, 2000, GENETICS, V155, P945; Raman H, 2010, GENOME, V53, P957, DOI 10.1139/G10-058; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Raychaudhuri S, 2011, CELL, V147, P57, DOI 10.1016/j.cell.2011.09.011; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1139/G06-112; Reyna N, 2001, CROP SCI, V41, P1317, DOI 10.2135/cropsci2001.4141317x; Roberts EH, 1996, THEOR APPL GENET, V93, P519, DOI 10.1007/BF00417943; Rossi ME, 2013, THEOR APPL GENET, V126, P1809, DOI 10.1007/s00122-013-2094-9; SAINDON G, 1989, CROP SCI, V29, P1361, DOI 10.2135/cropsci1989.0011183X002900060006x; Sayama T, 2010, BREEDING SCI, V60, P380, DOI 10.1270/jsbbs.60.380; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Sun DH, 2006, THEOR APPL GENET, V112, P665, DOI 10.1007/s00122-005-0169-y; Sun YN, 2012, MOL BIOL REP, V39, P9435, DOI 10.1007/s11033-012-1808-4; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; Woodworth C. M., 1923, J AM SOC AGRON, V15, P485; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhai H, 2014, PLOS ONE, V9, P1; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhao C, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0704-9; Zuo QM, 2013, PLANT BREEDING, P1	83	8	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158602	10.1371/journal.pone.0158602	http://dx.doi.org/10.1371/journal.pone.0158602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367048	Green Submitted, Green Published, gold			2022-12-27	WOS:000378914900044
J	Woo, HC; White, P; Ng, HK; Lai, CWK				Woo, Hoi-Chi; White, Peter; Ng, Ho-Kwan; Lai, Christopher W. K.			Development of Kinematic Graphs of Median Nerve during Active Finger Motion: Implications of Smartphone Use	PLOS ONE			English	Article							CARPAL-TUNNEL-SYNDROME; ULTRASOUND ASSESSMENT; GENERAL-POPULATION; FLEXOR TENDON; RISK-FACTORS; DEFORMATION; DISPLACEMENT; PATHOPHYSIOLOGY; PREVALENCE; MOVEMENT	Background Certain hand activities cause deformation and displacement of the median nerve at the carpal tunnel due to the gliding motion of tendons surrounding it. As smartphone usage escalates, this raises the public's concern whether hand activities while using smartphones can lead to median nerve problems. Objective The aims of this study were to 1) develop kinematic graphs and 2) investigate the associated deformation and rotational information of median nerve in the carpal tunnel during hand activities. Methods Dominant wrists of 30 young adults were examined with ultrasonography by placing a transducer transversely on their wrist crease. Ultrasound video clips were recorded when the subject performing 1) thumb opposition with the wrist in neutral position, 2) thumb opposition with the wrist in ulnar deviation and 3) pinch grip with the wrist in neutral position. Six still images that were separated by 0.2-second intervals were then captured from the ultrasound video for the determination of 1) cross-sectional area (CSA), 2) flattening ratio (FR), 3) rotational displacement (RD) and 4) translational displacement (TD) of median nerve in the carpal tunnel, and these collected information of deformation, rotational and displacement of median nerve were compared between 1) two successive time points during a single hand activity and 2) different hand motions at the same time point. Finally, kinematic graphs were constructed to demonstrate the mobility of median nerve during different hand activities. Results Performing different hand activities during this study led to a gradual reduction in CSA of the median nerve, with thumb opposition together with the wrist in ulnar deviation causing the greatest extent of deformation of the median nerve. Thumb opposition with the wrist in ulnar deviation also led to the largest extent of TD when compared to the other two hand activities of this study. Kinematic graphs showed that the motion pathways of median nerve during different hand activities were complex. Conclusion We observed that the median nerve in the carpal tunnel was rotated, deformed and displaced during the hand activities that people may be performed when using a smartphone, suggesting an increased risk of carpal tunnel syndrome (CTS). In addition, the kinematic graphs of median nerve developed in the present study provide new clues for further studies on the pathophysiology of CTS, and alerting smartphone users to establish proper postural habits when using handheld electronic devices.	[Woo, Hoi-Chi; White, Peter; Ng, Ho-Kwan; Lai, Christopher W. K.] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Lai, CWK (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.	chris.lai@polyu.edu.hk	Lai, Christopher Wai Keung/A-3852-2014	Lai, Christopher Wai Keung/0000-0002-8010-7232; White, Peter/0000-0001-6744-6566				Aboonq MS, 2015, NEUROSCIENCES, V20, P4; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Bathala L, 2014, MUSCLE NERVE, V49, P284, DOI 10.1002/mus.23912; Cartwright MS, 2008, MUSCLE NERVE, V37, P566, DOI 10.1002/mus.21009; Chemali KR, 2005, CLEV CLIN J MED, V72, P37, DOI 10.3949/ccjm.72.1.37; Drake R. L., 2010, GRAYS ANATOMY STUDEN; Eleftheriou A, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-16; Ettema AM, 2008, J BIOMECH, V41, P292, DOI 10.1016/j.jbiomech.2007.09.017; Ettema AM, 2007, CLIN ANAT, V20, P292, DOI 10.1002/ca.20379; Fung BKK, 2007, J HAND SURG-ASIAN-PA, V12, P13, DOI 10.1142/S0218810407003341; Goetz JE, 2013, ANN BIOMED ENG, V41, P2099, DOI 10.1007/s10439-013-0809-3; Hedrick W., 2005, ULTRASOUND PHYS INST, V4th ed; HSIEH YH, 2010, FORMOS J MUSCULOSKEL, V1, P16; Ibrahim I, 2012, Open Orthop J, V6, P69, DOI 10.2174/1874325001206010069; Inal EE, 2015, MUSCLE NERVE, V52, P183, DOI 10.1002/mus.24695; Katz JN, 2002, NEW ENGL J MED, V346, P1807, DOI 10.1056/NEJMcp013018; Keir PJ, 1997, J HAND SURG-AM, V22, P628, DOI 10.1016/S0363-5023(97)80119-0; Klauser AS, 2009, RADIOLOGY, V250, P171, DOI 10.1148/radiol.2501080397; Ko Cheolwoong, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P343, DOI 10.1080/10255840701430480; Lai WKC, 2014, MANUAL THER, V19, P608, DOI 10.1016/j.math.2014.06.005; LeBlanc KE, 2011, AM FAM PHYSICIAN, V83, P952; Maghsoudipour M, 2008, J OCCUP REHABIL, V18, P152, DOI 10.1007/s10926-008-9125-4; Moghtaderi A, 2005, ACTA NEUROL SCAND, V112, P375, DOI 10.1111/j.1600-0404.2005.00528.x; Mondelli M, 2002, NEUROLOGY, V58, P289, DOI 10.1212/WNL.58.2.289; Nadar MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079273; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Shim JM, 2012, J PHYS THER SCI, V24, P1251, DOI 10.1589/jpts.24.1251; Toge Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083565; van Doesburg MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037081; van Doesburg MHM, 2012, J ORTHOP RES, V30, P643, DOI 10.1002/jor.21562; van Doesburg MHM, 2010, J ORTHOP RES, V28, P1387, DOI 10.1002/jor.21131; Wang YX, 2014, ACAD RADIOL, V21, P472, DOI 10.1016/j.acra.2013.12.012; Wang YX, 2014, ULTRASOUND MED BIOL, V40, P53, DOI 10.1016/j.ultrasmedbio.2013.09.009; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4; Wong SM, 2004, RADIOLOGY, V232, P93, DOI 10.1148/radiol.2321030071; Wong SM, 2002, ARTHRITIS RHEUM, V46, P1914, DOI 10.1002/art.10385; Yoshii Y, 2013, J ORTHOP RES, V31, P1876, DOI 10.1002/jor.22462; Yoshii Y, 2009, J BONE JOINT SURG AM, V91A, P2922, DOI 10.2106/JBJS.H.01653	38	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158455	10.1371/journal.pone.0158455	http://dx.doi.org/10.1371/journal.pone.0158455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367447	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900036
J	Golpe, R; Mateos-Colino, A; Testa-Fernandez, A; Pena-Seijo, M; Rodriguez-Enriquez, M; Gonzalez-Juanatey, C; Martin-Vazquez, FJ; Pose-Reino, A; Dominguez-Pin, N; Garnacho-Gayarre, N; Perez-de-Llano, LA				Golpe, Rafael; Mateos-Colino, Alfonso; Testa-Fernandez, Ana; Pena-Seijo, Marta; Rodriguez-Enriquez, Manuel; Gonzalez-Juanatey, Carlos; Martin-Vazquez, Francisco J.; Pose-Reino, Antonio; Dominguez-Pin, Nuria; Garnacho-Gayarre, Nuria; Perez-de-Llano, Luis A.			Blood Pressure Profile and Hypertensive Organ Damage in COPD Patients and Matched Controls. The RETAPOC Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; MORTALITY; MORBIDITY; RISK	Background Several studies suggest that there is a pathogenic link between chronic obstructive pulmonary disease (COPD) and cardiovascular diseases. On the other hand, increased sympathetic tone has been described in several respiratory diseases. Our objective was to determine whether hypertension mediated by sympathetic overactivity is a mechanism that explains the association between COPD and cardiovascular diseases. Methods Prospective nested case-control observational study; 67 COPD patients were matched 1:1 by sex and age to controls with smoking history. 24 hour-blood pressure monitoring, urinary catecholamines and their metabolites measurement, echocardiography, carotid ultrasound examination, nocturnal oximetry and retinography were performed. Findings classic cardiovascular risk factors and comorbidities were similarly distributed between cases and controls. No significant differences for blood pressure variables (difference for mean systolic blood pressure: -0.13 mmHg; 95% CI: -4.48,4.20; p = 0.94; similar results for all blood presssure variables) or catecholamines values were found between both groups. There was a tendency for lower left ventricle ejection fraction in the COPD cases, that approached statistical significance (64.8 +/- 7.4 vs 67.1 +/- 6.2, p = 0.05). There were no differences in the retinal arteriovenous ratio, the carotid intima-media thickness, or the number of carotid plaques, between cases and controls. Fibrinogen values were higher in the COPD group (378.4 +/- 69.6 vs 352.2 +/- 45.6 mg/dL, p = 0.01) and mean nocturnal oxygen saturation values were lower for COPD patients (89.0 +/- 4.07 vs 92.3 +/- 2.2%, p < 0.0001). Interpretation Hypertension induced by sympathetic overactivity does not seem to be a mechanism that could explain the association between COPD and cardiovascular disease.	[Golpe, Rafael; Perez-de-Llano, Luis A.] Univ Hosp Lucus Augusti, Resp Med Serv, Lugo, Spain; [Mateos-Colino, Alfonso; Dominguez-Pin, Nuria] Univ Hosp Lucus Augusti, Internal Med Serv, Lugo, Spain; [Testa-Fernandez, Ana; Gonzalez-Juanatey, Carlos] Univ Hosp Lucus Augusti, Serv Cardiol, Lugo, Spain; [Pena-Seijo, Marta] Complexo Hosp Univ Santiago, Internal Med Serv, Santiago De Compostela, Spain; [Rodriguez-Enriquez, Manuel] Univ Hosp Lucus Augusti, Ophthalmol Serv, Lugo, Spain; [Martin-Vazquez, Francisco J.] Galician Hlth Serv, EOXI Lugo Cervo & Monforte Lemos, Lugo, Spain; [Garnacho-Gayarre, Nuria] Univ Hosp Lucus Augusti, Lab Serv, Calle Dr Ulises Romero 1, Lugo 27003, Spain	Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo	Golpe, R (corresponding author), Univ Hosp Lucus Augusti, Resp Med Serv, Lugo, Spain.	rafagolpe@gmail.com	Golpe, Rafael/AAA-4736-2019	Golpe, Rafael/0000-0002-3759-5322	Servicio Galego de Saude	Servicio Galego de Saude	This work was supported by Servicio Galego de Saude. The funder had no role in study design, data collection and anaylis, decision to publish or preparation of the manuscript.	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Aidar NA, 2009, ARQ BRAS CARDIOL, V93, P275, DOI 10.1590/S0066-782X2009000900012; Anderson WJ, 2013, CHEST, V143, P91, DOI 10.1378/chest.12-0775; Ashley C, 2010, J PHYSIOL-LONDON, V588, P701, DOI 10.1113/jphysiol.2009.185348; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; BERGER M, 1985, J AM COLL CARDIOL, V6, P359, DOI 10.1016/S0735-1097(85)80172-8; Cao JJ, 2007, CIRCULATION, V116, P32, DOI 10.1161/CIRCULATIONAHA.106.645606; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; Curtin F, 1996, J AFFECT DISORDERS, V38, P173, DOI 10.1016/0165-0327(96)00011-0; Fatouleh R, 2011, J PHYSIOL-LONDON, V589, P4997, DOI 10.1113/jphysiol.2011.210534; Gaisl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126613; Hansell AL, 2003, EUR RESPIR J, V22, P809, DOI 10.1183/09031936.03.00031403; Heindl S, 2001, AM J RESP CRIT CARE, V164, P597, DOI 10.1164/ajrccm.164.4.2007085; HOFFORD JM, 1990, AM REV RESPIR DIS, V141, P902, DOI 10.1164/ajrccm/141.4_Pt_1.902; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; Izquierdo Jose Luis, 2010, Int J Chron Obstruct Pulmon Dis, V5, P387; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; KIRCHER BJ, 1990, AM J CARDIOL, V66, P493, DOI 10.1016/0002-9149(90)90711-9; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mapel Douglas W, 2005, COPD, V2, P35; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Neter J., 1996, APPL LINEAR STAT MOD; Pose-Reino A, 2005, J HYPERTENS, V23, P843, DOI 10.1097/01.hjh.0000163154.35577.8e; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sakamaki F, 1999, CHEST, V116, P1575, DOI 10.1378/chest.116.6.1575; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; van Gestel AJR, 2012, DISCOV MED, V14, P359; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; World Health Organization, WORLD HLTH STAT 2008	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157932	10.1371/journal.pone.0157932	http://dx.doi.org/10.1371/journal.pone.0157932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362479	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200030
J	Irz, X; Leroy, P; Requillart, V; Soler, LG				Irz, Xavier; Leroy, Pascal; Requillart, Vincent; Soler, Louis-Georges			Beyond Wishful Thinking: Integrating Consumer Preferences in the Assessment of Dietary Recommendations	PLOS ONE			English	Article							POTENTIAL CONSUMPTION IMPACTS; COST CONSTRAINT; ENERGY DENSITY; HEALTHY DIET; FOOD; NUTRITION; AMERICANS; SELECTION; OBESITY; NORMS	Convenience, taste, and prices are the main determinants of food choices. Complying with dietary recommendations therefore imposes a "taste cost" on consumers, potentially hindering adoption of those recommendations. The study presents and applies a new methodology, based on economic theory, to quantify this taste cost and assess the health and welfare effects of different dietary recommendations. Then, by comparison of those effects, we identify socially desirable recommendations that are most compatible with consumer preferences (i.e., that best balance health benefits against"taste cost") and should be prioritized for promotion. The methodology proceeds in three-steps: first, an economic-behavioral model simulates how whole diets would change if consumers complied with dietary recommendations; second, an epidemiological model estimates the number of deaths avoided (DA) due to the dietary change; third, an efficiency analysis weighs the health benefits against the taste and policy costs of each recommendation. The empirical model is calibrated using French data. We find that recommendations to reduce consumption of red meat and soft-drinks, or raise consumption of milk products and fish/seafood impose relatively moderate taste costs. By comparison, recommendations related to F&V consumption and, to a lesser extent, butter/cream/cheese, snacks, and all meats impose larger taste costs on consumers. The F&V recommendation is the costliest for consumers to comply with, but it also reduces diet-related mortality the most, so that a large budget could be allocated to promoting F&V consumption while keeping this policy cost-beneficial. We conclude that promotion of most dietary recommendations improves social welfare. Our framework complements the programming models available in nutrition and public health: those models are best used to identify dietary targets, following which our framework identifies cost-beneficial ways of moving towards those targets.	[Irz, Xavier] Nat Resources Inst Finland Luke, Econ & Soc Res Unit, Helsinki, Finland; [Leroy, Pascal; Soler, Louis-Georges] INRA, INRA ALISS, UR 1303, Ivry, France; [Requillart, Vincent] Univ Toulouse Capitole, INRA, Toulouse Sch Econ, Toulouse, France	Natural Resources Institute Finland (Luke); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics	Irz, X (corresponding author), Nat Resources Inst Finland Luke, Econ & Soc Res Unit, Helsinki, Finland.	xavier.irz@luke.fi	Irz, Xavier/ABH-7230-2020; Irz, Xavier/AAI-7950-2020	Irz, Xavier/0000-0001-5659-5291	project ANR-ALID-OCAD (Foundation Daniel and Nina Carasso) in France; project FOODPOL-DIDIT (Foundation Daniel and Nina Carasso) in France; project EraNet SUSDIET (Foundation Daniel and Nina Carasso) in France; project Vastuufoorumi (MAKERA fund) in Finland; project EraNet SUSDIET (MAKERA fund) in Finland; EU [633692]	project ANR-ALID-OCAD (Foundation Daniel and Nina Carasso) in France(French National Research Agency (ANR)); project FOODPOL-DIDIT (Foundation Daniel and Nina Carasso) in France; project EraNet SUSDIET (Foundation Daniel and Nina Carasso) in France; project Vastuufoorumi (MAKERA fund) in Finland; project EraNet SUSDIET (MAKERA fund) in Finland; EU(European Commission)	This research was partially funded by projects ANR-ALID-OCAD, FOODPOL-DIDIT, and EraNet SUSDIET (Foundation Daniel and Nina Carasso) in France, projects Vastuufoorumi and EraNet SUSDIET (MAKERA fund) in Finland, as well as EU Horizon 2020 Programme under Grant Agreement no 633692 (SUSFANS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors do not have any conflict of interest to declare. They want to thank Olivier Allais for providing some of the data and parameters upon which the empirical model is based. All the authors are responsible for the design and implementation of the study, as well as the writing and final content of the article. This research was partially funded by: Projects ANR-ALID-OCAD, FOODPOL-DIDIT, and EraNet SUSDIET (Foundation Daniel and Nina Carasso) in France; Projects Vastuufoorumi and EraNet SUSDIET (MAKERA fund) in Finland; And EU Horizon 2020 Programme under Grant Agreement no 633692 (SUSFANS).	Allais O, 2010, AM J AGR ECON, V92, P228, DOI 10.1093/ajae/aap004; Arnoult MH, 2010, LAND USE POLICY, V27, P1046, DOI 10.1016/j.landusepol.2010.02.001; Buttriss JL, 2014, NUTR BULL, V39, P115, DOI 10.1111/nbu.12076; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Capacci S, 2011, J HEALTH ECON, V30, P87, DOI 10.1016/j.jhealeco.2010.10.006; Conforti P, 2000, PUBLIC HEALTH NUTR, V3, P367, DOI 10.1017/S1368980000000410; Darmon N, 2006, J NUTR EDUC BEHAV, V38, P82, DOI 10.1016/j.jneb.2005.11.028; Darmon N, 2003, APPETITE, V41, P315, DOI 10.1016/S0195-6663(03)00113-2; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; de Abreu D, 2013, CLIN NUTR, V32, P783, DOI 10.1016/j.clnu.2012.11.022; DGCA, 2015, SCI REP 2015 DIET GU; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; GLANZ K, 1998, J AM DIET ASSOC, V98, P1118; Guenther PM, 2009, FASEB J, V23; HENSON S, 1991, J AGR ECON, V42, P380, DOI 10.1111/j.1477-9552.1991.tb00362.x; Irz X, 2015, J HEALTH ECON, V39, P188, DOI 10.1016/j.jhealeco.2014.09.002; Jou J, 2012, HEALTH POLICY, V107, P83, DOI 10.1016/j.healthpol.2012.05.011; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Maillot M, 2007, AM J CLIN NUTR, V86, P690; Maillot M, 2010, AM J CLIN NUTR, V91, P421, DOI 10.3945/ajcn.2009.28426; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Martin Ambroise, 2001, Sciences des Aliments, V21, P309, DOI 10.3166/sda.21.317-319; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Nesheim MC, 2014, AM J CLIN NUTR, V99, P973, DOI 10.3945/ajcn.114.086488; Popkin BM, 2015, LANCET DIABETES ENDO; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Scarborough P, 2012, J EPIDEMIOL COMMUN H, V66, P420, DOI 10.1136/jech.2010.114520; Shankar B, 2008, REV AGR ECON, V30, P151, DOI 10.1111/j.1467-9353.2007.00397.x; Srinivasan CS, 2006, FOOD POLICY, V31, P53, DOI 10.1016/j.foodpol.2005.08.002; Stigler GJ, 1945, J FARM ECON, V27, P303, DOI 10.2307/1231810; Treich N., 2015, FUTURIBLES, P61; Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311; Webb D, 2015, ADV NUTR, V6, P391, DOI 10.3945/an.115.008441; WHO Dietary Norms, 2006, 2006 ANN M AUG 12 18	38	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158453	10.1371/journal.pone.0158453	http://dx.doi.org/10.1371/journal.pone.0158453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362764	Green Published, gold			2022-12-27	WOS:000378865200077
J	Lange, M; Weihmann, F; Schliebner, I; Horbach, R; Deising, HB; Wirsel, SGR; Peiter, E				Lange, Mario; Weihmann, Fabian; Schliebner, Ivo; Horbach, Ralf; Deising, Holger B.; Wirsel, Stefan G. R.; Peiter, Edgar			The Transient Receptor Potential (TRP) Channel Family in Colletotrichum graminicola: A Molecular and Physiological Analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CA2+ SIGNATURES; CALCIUM; YEAST; GROWTH; PROTEIN; EXPRESSION; GENE; PATHOGENICITY; GERMINATION	Calcium (Ca2+) is a universal second messenger in all higher organisms and centrally involved in the launch of responses to environmental stimuli. Ca2+ signals in the cytosol are initiated by the activation of Ca2+ channels in the plasma membrane and/or in endomembranes. Yeast (Saccharomyces cerevisiae) contains a Ca2+-permeable channel of the TRP family, TRPY1, which is localized in the vacuolar membrane and contributes to cytosolic free Ca2+ ([Ca2+](cyt)) elevations, for example in response to osmotic upshock. A TRPY1 homologue in the rice blast fungus is known to be important for growth and pathogenicity. To determine the role of the TRP channel family in the maize pathogen Colletotrichum graminicola, proteins homologous to TRPY1 were searched. This identified not one, but four genes in the C. graminicola genome, which had putative orthologs in other fungi, and which we named CgTRPF1 through 4. The topology of the CgTRPF proteins resembled that of TRPY1, albeit with a variable number of transmembrane (TM) domains additional to the six-TM-domain core and a diverse arrangement of putatively Ca2+-binding acidic motifs. All CgTRPF genes were expressed in axenic culture and throughout the infection of maize. Like TRPY1, all TRPF proteins of C. graminicola were localized intracellularly, albeit three of them were found not in large vacuoles, but co-localized in vesicular structures. Deletion strains for the CgTRPF genes were not altered in processes thought to involve Ca2+ release from internal stores, i.e. spore germination, the utilization of complex carbon sources, and the generation of tip-focussed [Ca2+](cyt) spikes. Heterologous expression of CgTRPF1 through 4 in a tryp1. yeast mutant revealed that none of the channels mediated the release of Ca2+ in response to osmotic upshock. Accordingly, aequorin-based [Ca2+](cyt) measurements of C. graminicola showed that in this fungus, osmotic upshock-triggered [Ca2+](cyt) elevations were generated entirely by influx of Ca2+ from the extracellular space. Cgtrpf mutants did not show pathogenicity defects in leaf infection assays. In summary, our study reveals major differences between different fungi in the contribution of TRP channels to Ca2+-mediated signal transduction.	[Lange, Mario; Peiter, Edgar] Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nut Sci IAEW, Plant Nutr Lab, Halle, Germany; [Weihmann, Fabian; Schliebner, Ivo; Horbach, Ralf; Deising, Holger B.; Wirsel, Stefan G. R.] Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nut Sci IAEW, Phytopathol & Plant Protect, Halle, Germany; [Lange, Mario; Schliebner, Ivo; Horbach, Ralf; Deising, Holger B.; Wirsel, Stefan G. R.; Peiter, Edgar] Univ Halle Wittenberg, Interdisciplinary Ctr Crop Plant Res IZN, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Peiter, E (corresponding author), Univ Halle Wittenberg, Fac Nat Sci 3, Inst Agr & Nut Sci IAEW, Plant Nutr Lab, Halle, Germany.; Peiter, E (corresponding author), Univ Halle Wittenberg, Interdisciplinary Ctr Crop Plant Res IZN, Halle, Germany.	edgar.peiter@landw.uni-halle.de	Peiter, Edgar/C-2577-2013	Peiter, Edgar/0000-0002-9104-3238; Deising, Holger Bruno/0000-0001-5789-4269; Wirsel, Stefan/0000-0003-2043-9494	Deutsche Forschungsgemeinschaft (DFG) [PE1500/2-1, FOR 666]; Ministry of Agriculture and the Environment of the Federal State of Sachsen-Anhalt	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Agriculture and the Environment of the Federal State of Sachsen-Anhalt	This work was supported by a grant (PE1500/2-1 within the Research Unit FOR 666) from the Deutsche Forschungsgemeinschaft (DFG) to EP and by a grant from the Ministry of Agriculture and the Environment of the Federal State of Sachsen-Anhalt to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarouki E, 2014, MOL MICROBIOL, V92, P338, DOI 10.1111/mmi.12561; ALLEN DG, 1977, SCIENCE, V195, P996, DOI 10.1126/science.841325; Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Behr M, 2010, MOL PLANT MICROBE IN, V23, P879, DOI 10.1094/MPMI-23-7-0879; Bergstrom GC, 1999, PLANT DIS, V83, P596, DOI 10.1094/PDIS.1999.83.7.596; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bowman BJ, 2011, EUKARYOT CELL, V10, P654, DOI 10.1128/EC.00239-10; Cai XJ, 2012, PURINERG SIGNAL, V8, P11, DOI 10.1007/s11302-011-9261-8; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; Dadacz-Narloch B, 2011, PLANT CELL, V23, P2696, DOI 10.1105/tpc.111.086751; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Harren K, 2013, EUKARYOT CELL, V12, P712, DOI 10.1128/EC.00338-12; Horbach R, 2009, PLANT CELL, V21, P3379, DOI 10.1105/tpc.108.064188; Hu Y, 2014, FUNGAL GENET BIOL, V73, P12, DOI 10.1016/j.fgb.2014.09.005; Ihara M, 2013, J BIOL CHEM, V288, P15303, DOI 10.1074/jbc.M112.434795; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Jung C, 2009, PFLUG ARCH EUR J PHY, V459, P105, DOI 10.1007/s00424-009-0706-7; Kim HS, 2015, FUNGAL GENET BIOL, V82, P145, DOI 10.1016/j.fgb.2015.07.003; Kim HS, 2012, FUNGAL GENET BIOL, V49, P589, DOI 10.1016/j.fgb.2012.05.011; Krijger JJ, 2008, MOL PLANT MICROBE IN, V21, P1325, DOI 10.1094/MPMI-21-10-1325; Lange M, 2016, FUNGAL GENET BIOL, V91, P55, DOI 10.1016/j.fgb.2016.04.001; Lange M, 2014, CURR GENET, V60, P343, DOI 10.1007/s00294-014-0429-y; Lange M, 2014, ANAL BIOCHEM, V453, P58, DOI 10.1016/j.ab.2014.02.023; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Lingner U, 2011, PLANT PHYSIOL, V156, P1565, DOI 10.1104/pp.111.178624; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Ludwig N, 2014, MOL PLANT MICROBE IN, V27, P315, DOI 10.1094/MPMI-09-13-0267-R; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; MINET M, 1992, PLANT J, V2, P417; Munch S, 2011, MOL PLANT PATHOL, V12, P43, DOI 10.1111/j.1364-3703.2010.00651.x; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nelson G, 2004, MOL MICROBIOL, V52, P1437, DOI 10.1111/j.1365-2958.2004.04066.x; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Oliveira-Garcia E, 2013, PLANT CELL, V25, P2356, DOI 10.1105/tpc.112.103499; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Peiter E, 2005, FEBS LETT, V579, P5697, DOI 10.1016/j.febslet.2005.09.058; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Peiter E, 2011, CELL CALCIUM, V50, P120, DOI 10.1016/j.ceca.2011.02.002; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042404; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Schliebner I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-842; Schulz TA, 2004, BIOCHEMISTRY-US, V43, P3987, DOI 10.1021/bi036082w; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; Silverman-Gavrila LB, 2002, J CELL SCI, V115, P5013, DOI 10.1242/jcs.00180; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Steinhorst L, 2013, BBA-MOL CELL RES, V1833, P1573, DOI 10.1016/j.bbamcr.2012.10.009; Su ZW, 2009, J MEMBRANE BIOL, V227, P141, DOI 10.1007/s00232-009-9153-9; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Walters JRF, 2006, J BONE MINER RES, V21, P1770, DOI 10.1359/JBMR.060721; Wang S, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-219; Warwar V, 1996, APPL ENVIRON MICROB, V62, P74, DOI 10.1128/AEM.62.1.74-79.1996; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Werner S, 2007, MOL PLANT MICROBE IN, V20, P1555, DOI 10.1094/MPMI-20-12-1555; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yu QL, 2014, INT J MED MICROBIOL, V304, P339, DOI 10.1016/j.ijmm.2013.11.022; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001; Zhou XL, 2005, EUR BIOPHYS J BIOPHY, V34, P413, DOI 10.1007/s00249-005-0465-0; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	71	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158561	10.1371/journal.pone.0158561	http://dx.doi.org/10.1371/journal.pone.0158561			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359114	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200091
J	Li, D; Shi, JJ; Du, YH; Chen, KM; Liu, ZP; Li, B; Li, J; Tao, F; Gu, H; Jiang, CZ; Fang, JM				Li, Dong; Shi, Jiejun; Du, Yanhua; Chen, Kaiming; Liu, Zhenping; Li, Bing; Li, Jie; Tao, Fei; Gu, Hua; Jiang, Cizhong; Fang, Jianmin			Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER; ANGIOGENESIS; CHROMATIN; TUMORIGENESIS; HETEROGENEITY; ACETYLATION; METHYLATION; MUTATIONS; PROGNOSIS	Tumor cells become resistant after long-term use of anti-VEGF (vascular endothelial growth factor) agents. Our previous study shows that treatment with a VEGF inhibitor (VEGF-Trap) facilitates to develop tumor resistance through regulating angiogenesis-related genes. However, the underlying molecular mechanisms remain elusive. Histone modifications as a key epigenetic factor play a critical role in regulation of gene expression. Here, we explore the potential epigenetic gene regulatory functions of key histone modifications during tumor resistance in a mouse Lewis lung carcinoma (LLC) cell line. We generated high resolution genome-wide maps of key histone modifications in sensitive tumor sample (LLC-NR) and resistant tumor sample (LLC-R) after VEGF-Trap treatment. Profiling analysis of histone modifications shows that histone modification levels are effectively predictive for gene expression. Composition of promoters classified by histone modification state is different between LLC-NR and LLC-R cell lines regardless of CpG content. Histone modification state change between LLC-NR and LLC-R cell lines shows different patterns in CpG-rich and CpG-poor promoters. As a consequence, genes with different level of CpG content whose gene expression level are altered are enriched in distinct functions. Notably, histone modification state change in promoters of angiogenesis-related genes consists with their expression alteration. Taken together, our findings suggest that treatment with anti-VEGF therapy results in extensive histone modification state change in promoters with multiple functions, particularly, biological processes related to angiogenesis, likely contributing to tumor resistance development.	[Li, Dong; Chen, Kaiming; Li, Jie; Tao, Fei; Gu, Hua; Fang, Jianmin] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Shi, Jiejun; Du, Yanhua; Liu, Zhenping; Li, Bing; Jiang, Cizhong] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Fang, JM (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.; Jiang, CZ (corresponding author), Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China.	czjiang@tongji.edu.cn; jfang@tongji.edu.cn	Shi, Jiejun/P-3329-2019	Shi, Jiejun/0000-0001-9777-1183	National Key Basic Research Program of China (973 Program), China [2015CB553706, SQ2015CB050449]; National Natural Science Foundation of China, China [31270987, 31470896]; Shanghai Committee of Science and Technology, China [10PJ1409400, 12431901000]; Suzhou Science and Technology Project, China [ZXY2012029]	National Key Basic Research Program of China (973 Program), China; National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Suzhou Science and Technology Project, China	This study was supported by grants from National Key Basic Research Program of China (973 Program), China (2015CB553706 and SQ2015CB050449), National Natural Science Foundation of China, China (31270987 and 31470896), grants from Shanghai Committee of Science and Technology, China (10PJ1409400, 12431901000) (http://www.stcsm.gov.cn), and Suzhou Science and Technology Project, China (ZXY2012029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from National Key Basic Research Program of China (973 Program), China (2015CB553706), National Natural Science Foundation of China, China (31270987 and 31470896) and Suzhou Science and Technology Project, China (ZXY2012029).	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Chakraborty S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099743; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Fontanini G, 1997, CLIN CANCER RES, V3, P861; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Hong JP, 2013, INT J MOL MED, V31, P1436, DOI 10.3892/ijmm.2013.1337; Hong SD, 2015, J CANCER RES CLIN, V141, P909, DOI 10.1007/s00432-014-1862-5; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Jakopovic M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00261; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Joukov V, 1996, EMBO J, V15, P290; Kanayasu-Toyoda T, 2015, J CELL PHYSIOL, V230, P2763, DOI 10.1002/jcp.25002; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Khuri FR, 2000, J CLIN ONCOL, V18, P2798, DOI 10.1200/JCO.2000.18.15.2798; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Kim J, 2012, EPIGENETICS-US, V7, P191, DOI 10.4161/epi.7.2.18973; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SY, 2015, MOL CARCINOGEN, V54, P93, DOI 10.1002/mc.22077; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li D, 2014, CANCER LETT, V346, P45, DOI 10.1016/j.canlet.2013.12.004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pallis AG, 2013, CRIT REV ONCOL HEMAT, V86, P130, DOI 10.1016/j.critrevonc.2012.10.003; Qiao YB, 2015, J BIOL CHEM, V290, P2508, DOI 10.1074/jbc.M114.603761; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Savant S, 2015, CELL REP, V12, P1761, DOI 10.1016/j.celrep.2015.08.024; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shin MR, 2015, INT ENDOD J, V48, P705, DOI 10.1111/iej.12396; Spaans JN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00233; Tudisco L, 2014, EPIGENETICS-US, V9, P600, DOI 10.4161/epi.27835; WILLIAMS DE, 1981, J THORAC CARDIOV SUR, V82, P70; Wilting RH, 2012, DRUG RESIST UPDATE, V15, P21, DOI 10.1016/j.drup.2012.01.008; Yang AN, 2011, CANCER RES, V71, P3573, DOI 10.1158/0008-5472.CAN-10-4489; Zhang B, 2013, GENOME RES, V23, P917, DOI 10.1101/gr.149674.112	41	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158214	10.1371/journal.pone.0158214	http://dx.doi.org/10.1371/journal.pone.0158214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362259	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200049
J	Soumiya, H; Godai, A; Araiso, H; Mori, S; Furukawa, S; Fukumitsu, H				Soumiya, Hitomi; Godai, Ayumi; Araiso, Hiromi; Mori, Shingo; Furukawa, Shoei; Fukumitsu, Hidefumi			Neonatal Whisker Trimming Impairs Fear/Anxiety-Related Emotional Systems of the Amygdala and Social Behaviors in Adult Mice	PLOS ONE			English	Article							MOUSE CEREBRAL-CORTEX; RAT BARREL CORTEX; SOMATOSENSORY CORTEX; MATERNAL SEPARATION; CRITICAL PERIOD; PLASTICITY; VIBRISSAE; LAYER; DEPRIVATION; EXPERIENCE	Abnormalities in tactile perception, such as sensory defensiveness, are common features in autism spectrum disorder (ASD). While not a diagnostic criterion for ASD, deficits in tactile perception contribute to the observed lack of social communication skills. However, the influence of tactile perception deficits on the development of social behaviors remains uncertain, as do the effects on neuronal circuits related to the emotional regulation of social interactions. In neonatal rodents, whiskers are the most important tactile apparatus, so bilateral whisker trimming is used as a model of early tactile deprivation. To address the influence of tactile deprivation on adult behavior, we performed bilateral whisker trimming in mice for 10 days after birth (BWT10 mice) and examined social behaviors, tactile discrimination, and c-Fos expression, a marker of neural activation, in adults after full whisker regrowth. Adult BWT10 mice exhibited significantly shorter crossable distances in the gap-crossing test than age-matched controls, indicating persistent deficits in whisker-dependent tactile perception. In contrast to controls, BWT10 mice exhibited no preference for the social compartment containing a conspecific in the three-chamber test. Furthermore, the development of amygdala circuitry was severely affected in BWT10 mice. Based on the c-Fos expression pattern, hyperactivity was found in BWT10 amygdala circuits for processing fear/anxiety-related responses to height stress but not in circuits for processing reward stimuli during whisker-dependent cued learning. These results demonstrate that neonatal whisker trimming and concomitant whisker-dependent tactile discrimination impairment severely disturbs the development of amygdala-dependent emotional regulation.	[Soumiya, Hitomi; Godai, Ayumi; Araiso, Hiromi; Mori, Shingo; Furukawa, Shoei; Fukumitsu, Hidefumi] Gifu Pharmaceut Univ, Mol Biol Lab, Dept Biofunct Anal, Gifu, Japan	Gifu Pharmaceutical University	Fukumitsu, H (corresponding author), Gifu Pharmaceut Univ, Mol Biol Lab, Dept Biofunct Anal, Gifu, Japan.	hfukumi@gifu-pu.ac.jp			JSPS KAKENHI Grant [24591519]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24591519. There was no additional external funding received for this study.	AHL AS, 1986, VET RES COMMUN, V10, P245, DOI 10.1007/BF02213989; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Arnett MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109116; Baranek Grace T, 2008, Phys Occup Ther Pediatr, V28, P79; Bowlby J., 1969, ATTACHMENT AND LOSS; Carvell GE, 1996, J NEUROSCI, V16, P2750; Cascio CJ, 2010, J NEURODEV DISORD, V2, P62, DOI 10.1007/s11689-010-9046-3; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Foss-Feig JH, 2012, RES AUTISM SPECT DIS, V6, P337, DOI 10.1016/j.rasd.2011.06.007; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; KATZ RJ, 1976, BEHAV BIOL, V17, P399, DOI 10.1016/S0091-6773(76)90753-7; Landers MS, 2012, DEV NEUROSCI-BASEL, V34, P101, DOI 10.1159/000336732; Landers MS, 1999, J NEUROSCI, V19, P5131; Lee LJ, 2009, EXP NEUROL, V219, P524, DOI 10.1016/j.expneurol.2009.07.012; Long JM, 2004, GENES BRAIN BEHAV, V3, P51, DOI 10.1046/j.1601-183x.2003.00045.x; LONG SY, 1972, ANIM BEHAV, V20, P10, DOI 10.1016/S0003-3472(72)80167-2; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Maciag CM, 2002, NEUROPSYCHOPHARMACOL, V26, P574, DOI 10.1016/S0893-133X(01)00398-0; Macri S, 2004, BEHAV BRAIN RES, V154, P231, DOI 10.1016/j.bbr.2004.02.009; Maravall M, 2004, J NEUROPHYSIOL, V92, P144, DOI 10.1152/jn.00598.2003; Maroun M, 2003, J NEUROSCI, V23, P4406; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Miyazaki T, 2012, J CLIN INVEST, V122, P2690, DOI 10.1172/JCI63060; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Papaioannou S, 2013, BRAIN BEHAV, V3, P24, DOI 10.1002/brb3.102; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petersen CCH, 2014, ANNU REV NEUROSCI, V37, P183, DOI 10.1146/annurev-neuro-062012-170344; Rebsam A, 2002, J NEUROSCI, V22, P8541; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Sehara K, 2010, J NEUROSCI, V30, P3082, DOI 10.1523/JNEUROSCI.6096-09.2010; Shishelova A Yu, 2006, Neurosci Behav Physiol, V36, P883, DOI 10.1007/s11055-006-0102-0; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Soumiya H, 2011, J NEUROSCI RES, V89, P1342, DOI 10.1002/jnr.22636; STROZIK E, 1981, LAB ANIM, V15, P309, DOI 10.1258/002367781780953040; Sullivan RM, 2003, SOMATOSENS MOT RES, V20, P157, DOI 10.1080/0899022031000105190; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Venerosi A, 2003, PHARMACOL BIOCHEM BE, V74, P671, DOI 10.1016/S0091-3057(02)01068-7; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; WOLFFGRAMM J, 1991, PHARMACOL BIOCHEM BE, V38, P389, DOI 10.1016/0091-3057(91)90297-F; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	51	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158583	10.1371/journal.pone.0158583	http://dx.doi.org/10.1371/journal.pone.0158583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362655	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200098
J	Uboni, A; Horstkotte, T; Kaarlejarvi, E; Seveque, A; Stammler, F; Olofsson, J; Forbes, BC; Moen, J				Uboni, Alessia; Horstkotte, Tim; Kaarlejarvi, Elina; Seveque, Anthony; Stammler, Florian; Olofsson, Johan; Forbes, Bruce C.; Moen, Jon			Long-Term Trends and Role of Climate in the Population Dynamics of Eurasian Reindeer	PLOS ONE			English	Article							SEMI-DOMESTICATED REINDEER; RANGIFER-TARANDUS; SPATIAL SYNCHRONY; ARCTIC OSCILLATION; CARIBOU; SCALE; SNOW; RESPONSES; DECLINES; WEATHER	Temperature is increasing in Arctic and sub-Arctic regions at a higher rate than anywhere else in the world. The frequency and nature of precipitation events are also predicted to change in the future. These changes in climate are expected, together with increasing human pressures, to have significant impacts on Arctic and sub-Arctic species and ecosystems. Due to the key role that reindeer play in those ecosystems, it is essential to understand how climate will affect the region's most important species. Our study assesses the role of climate on the dynamics of fourteen Eurasian reindeer (Rangifer tarandus) populations, using for the first time data on reindeer abundance collected over a 70-year period, including both wild and semi-domesticated reindeer, and covering more than half of the species' total range. We analyzed trends in population dynamics, investigated synchrony among population growth rates, and assessed the effects of climate on population growth rates. Trends in the population dynamics were remarkably heterogeneous. Synchrony was apparent only among some populations and was not correlated with distance among population ranges. Proxies of climate variability mostly failed to explain population growth rates and synchrony. For both wild and semi-domesticated populations, local weather, biotic pressures, loss of habitat and human disturbances appear to have been more important drivers of reindeer population dynamics than climate. In semi-domesticated populations, management strategies may have masked the effects of climate. Conservation efforts should aim to mitigate human disturbances, which could exacerbate the potentially negative effects of climate change on reindeer populations in the future. Special protection and support should be granted to those semi-domesticated populations that suffered the most because of the collapse of the Soviet Union, in order to protect the livelihood of indigenous peoples that depend on the species, and the multi-faceted role that reindeer exert in Arctic ecosystems.	[Uboni, Alessia; Kaarlejarvi, Elina; Seveque, Anthony; Olofsson, Johan; Moen, Jon] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Horstkotte, Tim] Univ Turku, Dept Geog & Geol, Turku, Finland; [Kaarlejarvi, Elina] Vrije Univ Brussel, Plant Biol & Nat Management, Brussels, Belgium; [Stammler, Florian; Forbes, Bruce C.] Univ Lapland, Arctic Ctr, Rovaniemi, Finland; [Uboni, Alessia] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden	Umea University; University of Turku; Vrije Universiteit Brussel; University of Lapland; Swedish University of Agricultural Sciences	Uboni, A (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.; Uboni, A (corresponding author), Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden.	auboni@mtu.edu	Uboni, Alessia/N-3443-2019; Forbes, Bruce C./L-4431-2013; Olofsson, Johan/A-9362-2009; Stammler, Florian M/L-4454-2013; Stammler, Florian/H-8183-2016	Forbes, Bruce C./0000-0002-4593-5083; Horstkotte, Tim/0000-0003-3951-5370; Seveque, Anthony/0000-0003-4363-4137; Stammler, Florian/0000-0002-6243-773X	Swedish Research Council Formas [2012-170]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was funded by the Swedish Research Council Formas, grant number 2012-170 awarded to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes R, 2002, ECOL LETT, V5, P445, DOI 10.1046/j.1461-0248.2002.00340.x; Alaruikka Y, 1964, SUOMEN POROTALOUS; Ambaum MHP, 2001, J CLIMATE, V14, P3495, DOI 10.1175/1520-0442(2001)014<3495:AOONAO>2.0.CO;2; [Anonymous], 2001, RESSURSREGNSKAP REIN; Bartsch A, 2010, ECOL APPL, V20, P2346, DOI 10.1890/09-1927.1; Baskin Leonid M., 2005, Rangifer, V25, P51; Bastille-Rousseau G, 2013, CAN J ZOOL, V91, P820, DOI 10.1139/cjz-2013-0154; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Berg A, 2008, FOREST ECOL MANAG, V256, P1009, DOI 10.1016/j.foreco.2008.06.003; Berteaux D, 2006, CLIM RES, V32, P151, DOI 10.3354/cr032151; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bragina EV, 2015, CONSERV BIOL, V29, P844, DOI 10.1111/cobi.12450; CAFF International Secretariat, 2010, ARCT BIOD TRENDS 201; Deser C, 2004, J CLIMATE, V17, P3109, DOI 10.1175/1520-0442(2004)017<3109:PICVLB>2.0.CO;2; Forbes B. C., 2006, REINDEER MANAGEMENT, P245, DOI [10.1007/3-540-31392-3, DOI 10.1007/3-540-31392-3]; Forbes BC, 1999, POLAR RES, V18, P367, DOI 10.1111/j.1751-8369.1999.tb00316.x; Forbes BC, 2013, ECOL SOC, V18, DOI 10.5751/ES-05791-180436; Forbes BC, 2009, P NATL ACAD SCI USA, V106, P22041, DOI 10.1073/pnas.0908286106; Forbes BC, 2009, GEOGR COMPASS, V3, P1356, DOI 10.1111/j.1749-8198.2009.00250.x; Fox J., 2018, R COMPANION APPL REG, VThird; Gottel H, 2008, CLIMATIC CHANGE, V87, P35, DOI 10.1007/s10584-007-9341-5; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; Hausner VH, 2011, ECOL SOC, V16, DOI 10.5751/ES-04193-160304; Heggberget Thrine Moen, 2002, Rangifer, V22, P13; HELLE T, 1993, ARCTIC, V46, P72; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; Helle Timo, 2004, Suomen Riista, V50, P18; Hobbs NT, 2012, ECOL APPL, V22, P1640, DOI 10.1890/11-1309.1; Hurrell JW, 1996, GEOPHYS RES LETT, V23, P665, DOI 10.1029/96GL00459; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jernsletten J.-L. L., 2002, SUSTAINABLE REINDEER; Joly K, 2011, ECOGRAPHY, V34, P345, DOI 10.1111/j.1600-0587.2010.06377.x; Kaarlejarvi E, 2013, FUNCT ECOL, V27, P1244, DOI 10.1111/1365-2435.12113; Klein DR, 2000, POLAR RES-SWEDEN, V19, P91, DOI 10.1111/j.1751-8369.2000.tb00332.x; Klokov Konstantin B., 2012, Rangifer, V32, P19; Kolpaschikov L, 2015, ECOL SOC, V20, DOI 10.5751/ES-07129-200109; Krupnik I, 2000, POLAR RES, V19, P49, DOI 10.1111/j.1751-8369.2000.tb00327.x; Kumpula J, 2003, POLAR RES, V22, P225, DOI 10.1111/j.1751-8369.2003.tb00109.x; Kumpula T, 2012, REMOTE SENS-BASEL, V4, P1046, DOI 10.3390/rs4041046; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Lillegard M, 2005, OIKOS, V109, P342, DOI 10.1111/j.0030-1299.2005.13816.x; Lundholm M, 2011, INTRO RS TIME SERIES, P1; Moen J, 2008, AMBIO, V37, P304, DOI 10.1579/0044-7447(2008)37[304:CCEOTE]2.0.CO;2; Moen Jon, 2006, Conservation Biology Series (Cambridge), V11, P50; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Post, 2013, ECOLOGY CLIMATE CHAN; Post E, 2004, P NATL ACAD SCI USA, V101, P9286, DOI 10.1073/pnas.0305029101; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Post E, 2008, P ROY SOC B-BIOL SCI, V275, P2005, DOI 10.1098/rspb.2008.0463; Post E, 2006, QUATERN INT, V151, P99, DOI 10.1016/j.quaint.2006.01.016; R Core Team, 2021, R LANGUAGE ENV STAT; Ranta Esa, 2006, P1; Rees WG, 2008, CLIMATIC CHANGE, V87, P199, DOI 10.1007/s10584-007-9345-1; Safronov V, 2005, EKOLOGIYA ISPOLZOVAN; Schaefer JA, 2007, J WILDLIFE MANAGE, V71, P1753, DOI 10.2193/2005-479; Skarin A, 2014, POLAR BIOL, V37, P1041, DOI 10.1007/s00300-014-1499-5; Stammler Florian, 2005, REINDEER NOMADS MEET; Stenseth NC, 2005, J ANIM ECOL, V74, P1195, DOI 10.1111/j.1365-2656.2005.01005.x; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Stien A, 2012, BIOL LETT; Syroechkovskii EE, 2000, WILD DOMESTIC REINDE; Tatusko RL, 1990, COOPERATION CLIMATE; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Turi J, 2002, NO TIMBERLINE FOREST; Tveraa T, 2007, OIKOS, V116, P706, DOI [10.1111/j.2006.0030-1299.15257.x, 10.1111/j.0030-1299.2007.15257.x]; Tyler NJC, 2010, ECOL MONOGR, V80, P197, DOI 10.1890/09-1070.1; van de Pol M, 2013, ECOGRAPHY, V36, P249, DOI 10.1111/j.1600-0587.2012.00143.x; Vikhamar-Schuler D, 2013, ANN GLACIOL, V54, P214, DOI 10.3189/2013AoG62A306; Volodina O, 2010, STATUS GAME ANIMAL R; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Weir JN, 2007, WILDLIFE BIOL, V13, P66, DOI 10.2981/0909-6396(2007)13[66:EOMDOW]2.0.CO;2; Weladji RB, 2003, OECOLOGIA, V136, P317, DOI 10.1007/s00442-003-1257-9; Wolfe SA, 2000, POLAR RES, V19, P63, DOI 10.1111/j.1751-8369.2000.tb00329.x; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Yuzhakov AA, 2006, NENETS ABORIGINAL BR	76	42	43	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158359	10.1371/journal.pone.0158359	http://dx.doi.org/10.1371/journal.pone.0158359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362499	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200063
J	Zhang, YZ; Li, XH; Hao, ZK; Xi, RC; Cai, YJ; Liao, XR				Zhang, Yanzhou; Li, Xunhang; Hao, Zhikui; Xi, Ruchun; Cai, Yujie; Liao, Xiangru			Hydrogen Peroxide-Resistant CotA and YjqC of Bacillus altitudinis Spores Are a Promising Biocatalyst for Catalyzing Reduction of Sinapic Acid and Sinapine in Rapeseed Meal	PLOS ONE			English	Article							MANGANESE CATALASE; GLUCOSE-OXIDASE; LACCASE; SUBTILIS; DEGRADATION; CATHODES; ENZYME; DEHYDROGENASE; LICHENIFORMIS; TEMPERATURE	For the more efficient detoxification of phenolic compounds, a promising avenue would be to develop a multi-enzyme biocatalyst comprising peroxidase, laccase and other oxidases. However, the development of this multi-enzyme biocatalyst is limited by the vulnerability of fungal laccases and peroxidases to hydrogen peroxide (H2O2)-induced inactivation. Therefore, H2O2-resistant peroxidase and laccase should be exploited. In this study, H2O2-stable CotA and YjqC were isolated from the outer coat of Bacillus altitudinis SYBC hb4 spores. In addition to the thermal and alkali stability of catalytic activity, CotA also exhibited a much higher H2O2 tolerance than fungal laccases from Trametes versicolor and Trametes trogii. YjqC is a sporulation-related manganese (Mn) catalase with striking peroxidase activity for sinapic acid (SA) and sinapine (SNP). In contrast to the typical heme-containing peroxidases, the peroxidase activity of YjqC was also highly resistant to inhibition by H2O2 and heat. CotA could also catalyze the oxidation of SA and SNP. CotA had a much higher affinity for SA than B. subtilis CotA. CotA and YjqC rendered from B. altitudinis spores had promising laccase and peroxidase activities for SA and SNP. Specifically, the B. altitudinis spores could be regarded as a multi-enzyme biocatalyst composed of CotA and YjqC. The B. altitudinis spores were efficient for catalyzing the degradation of SA and SNP in rapeseed meal. Moreover, efficiency of the spore-catalyzed degradation of SA and SNP was greatly improved by the presence of 15 mM H2O2. This effect was largely attributed to synergistic biocatalysis of the H2O2-resistant CotA and YjqC toward SA and SNP.	[Zhang, Yanzhou; Li, Xunhang; Cai, Yujie; Liao, Xiangru] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Li, Xunhang] Jiangxi Agr Univ, Biosci & Engn Coll, Nanchang 330045, Peoples R China; [Hao, Zhikui] Taizhou Vocat & Tech Coll, Inst Appl Biotechnol, Taizhou 318000, Peoples R China; [Xi, Ruchun] South China Agr Univ, Coll Forestry, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou 510642, Guangdong, Peoples R China	Jiangnan University; Jiangxi Agricultural University; South China Agricultural University	Liao, XR (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	Microfer@126.com			Fundamental Research Funds for the Central Universities; Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province [BY2014023-28]; Agricultural Support Project, Wuxi Science & Technology Development [CLE01N1310]; Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou [1302ky08]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province; Agricultural Support Project, Wuxi Science & Technology Development; Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou	This work was supported by the Fundamental Research Funds for the Central Universities. The research was funded by Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province (BY2014023-28) and Agricultural Support Project, Wuxi Science & Technology Development (CLE01N1310). This work was also financially supported by the Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou (No. 1302ky08).	Abhyankar W, 2011, PROTEOMICS, V11, P4541, DOI 10.1002/pmic.201100003; Amo T, 2002, J BACTERIOL, V184, P3305, DOI 10.1128/JB.184.12.3305-3312.2002; Bao X, 2014, ENZYME MICROB TECH, V54, P51, DOI 10.1016/j.enzmictec.2013.10.003; Chagas PMB, 2015, INT J BIOL MACROMOL, V81, P568, DOI 10.1016/j.ijbiomac.2015.08.061; Brander S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099402; Checinska A, 2012, APPL ENVIRON MICROB, V78, P6413, DOI 10.1128/AEM.01211-12; Chen B, 2015, INT J BIOL MACROMOL, V76, P39, DOI 10.1016/j.ijbiomac.2015.02.019; Crestini C, 2011, BIOORGAN MED CHEM, V19, P5071, DOI 10.1016/j.bmc.2011.05.058; Fan LL, 2015, APPL MICROBIOL BIOT, V99, P9483, DOI 10.1007/s00253-015-6720-0; Gashtasbi F, 2014, ENZYME MICROB TECH, V64-65, P17, DOI 10.1016/j.enzmictec.2014.05.006; Gunne M, 2013, J BIOTECHNOL, V168, P252, DOI 10.1016/j.jbiotec.2013.06.011; Handtke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085625; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Khattab RY, 2014, J AM OIL CHEM SOC, V91, P89, DOI 10.1007/s11746-013-2345-6; Knecht LD, 2011, ANAL BIOANAL CHEM, V400, P977, DOI 10.1007/s00216-011-4835-4; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Liu Y, 2015, INT J SYST EVOL MICR, V65, P2769, DOI 10.1099/ijs.0.000336; Loncar N, 2015, APPL MICROBIOL BIOT, V99, P3351, DOI 10.1007/s00253-015-6512-6; Loncar N, 2015, APPL MICROBIOL BIOT, V99, P2225, DOI 10.1007/s00253-014-6060-5; Lu DB, 2012, BIODEGRADATION, V23, P209, DOI 10.1007/s10532-011-9500-2; Lu L, 2012, BIORESOURCE TECHNOL, V115, P35, DOI 10.1016/j.biortech.2011.07.111; Martins LO, 2015, CELL MOL LIFE SCI, V72, P911, DOI 10.1007/s00018-014-1822-x; Milton RD, 2014, J ELECTROCHEM SOC, V161, pH3011, DOI 10.1149/2.0031413jes; Milton RD, 2014, CHEM COMMUN, V50, P94, DOI 10.1039/c3cc47689h; Milton RD, 2013, PHYS CHEM CHEM PHYS, V15, P19371, DOI 10.1039/c3cp53351d; Minh HNT, 2011, APPL MICROBIOL BIOT, V90, P1409, DOI 10.1007/s00253-011-3183-9; Niciforovic N, 2014, REV FOOD SCI FOOD SA, V13, P1541; Niu Y, 2014, PLOS ONE, V10; Niwa T, 1999, FEBS LETT, V459, P43, DOI 10.1016/S0014-5793(99)01216-8; Prasetyo EN, 2015, INT J ENVIRON SCI TE, V12, P1343, DOI 10.1007/s13762-014-0526-y; Rao MA, 2014, CHEMOSPHERE, V107, P145, DOI 10.1016/j.chemosphere.2013.12.059; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Scodeller P, 2010, J AM CHEM SOC, V132, P11132, DOI 10.1021/ja1020487; Smyk B, 2015, J MOL LIQ, V208, P1, DOI 10.1016/j.molliq.2015.03.058; Tan IS, 2014, ENV MICROBIOL REP, V6, P212, DOI 10.1111/1758-2229.12130; Touahar IE, 2014, SCI TOTAL ENVIRON, V481, P90, DOI 10.1016/j.scitotenv.2014.01.132; Whittaker JW, 2012, ARCH BIOCHEM BIOPHYS, V525, P111, DOI 10.1016/j.abb.2011.12.008; Xie T, 2015, J STRUCT BIOL, V190, P155, DOI 10.1016/j.jsb.2015.03.005; Yadav S, 2015, J ENVIRON SCI-CHINA, V33, P229, DOI 10.1016/j.jes.2015.01.018; Zhang C, 2013, J AGR FOOD CHEM, V61, P5468, DOI 10.1021/jf4010498; Zhang C, 2012, BIORESOURCE TECHNOL, V126, P80, DOI 10.1016/j.biortech.2012.09.055; Zhang YZ, 2016, ANN MICROBIOL, V66, P559, DOI 10.1007/s13213-015-1135-9; Zhang YZ, 2016, ANN MICROBIOL, V66, P131, DOI 10.1007/s13213-015-1089-y	44	10	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158351	10.1371/journal.pone.0158351	http://dx.doi.org/10.1371/journal.pone.0158351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362423	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200062
J	West, BT; Sakshaug, JW; Aurelien, GAS				West, Brady T.; Sakshaug, Joseph W.; Aurelien, Guy Alain S.			How Big of a Problem is Analytic Error in Secondary Analyses of Survey Data?	PLOS ONE			English	Article							COMPLEX SAMPLE DESIGN; SURVEY WEIGHTS; REGRESSION; MODEL	Secondary analyses of survey data collected from large probability samples of persons or establishments further scientific progress in many fields. The complex design features of these samples improve data collection efficiency, but also require analysts to account for these features when conducting analysis. Unfortunately, many secondary analysts from fields outside of statistics, biostatistics, and survey methodology do not have adequate training in this area, and as a result may apply incorrect statistical methods when analyzing these survey data sets. This in turn could lead to the publication of incorrect inferences based on the survey data that effectively negate the resources dedicated to these surveys. In this article, we build on the results of a preliminary meta-analysis of 100 peer-reviewed journal articles presenting analyses of data from a variety of national health surveys, which suggested that analytic errors may be extremely prevalent in these types of investigations. We first perform a meta-analysis of a stratified random sample of 145 additional research products analyzing survey data from the Scientists and Engineers Statistical Data System (SESTAT), which describes features of the U.S. Science and Engineering workforce, and examine trends in the prevalence of analytic error across the decades used to stratify the sample. We once again find that analytic errors appear to be quite prevalent in these studies. Next, we present several example analyses of real SESTAT data, and demonstrate that a failure to perform these analyses correctly can result in substantially biased estimates with standard errors that do not adequately reflect complex sample design features. Collectively, the results of this investigation suggest that reviewers of this type of research need to pay much closer attention to the analytic methods employed by researchers attempting to publish or present secondary analyses of survey data.	[West, Brady T.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI 48109 USA; [Sakshaug, Joseph W.] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England; [Sakshaug, Joseph W.] Inst Employment Res, Nurnberg, Germany; [Aurelien, Guy Alain S.] Univ Maryland, Joint Program Survey Methodol, College Pk, MD USA	University of Michigan System; University of Michigan; University of Manchester; University System of Maryland; University of Maryland College Park	West, BT (corresponding author), Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI 48109 USA.	bwest@umich.edu	PAN, ZEQIANG/X-6341-2018	Sakshaug, Joseph/0000-0001-7520-353X	National Center for Science and Engineering Statistics [NCSE-1424081]; Direct For Social, Behav & Economic Scie [1424081] Funding Source: National Science Foundation	National Center for Science and Engineering Statistics(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Funded by Grant Number NCSE-1424081, from the National Center for Science and Engineering Statistics. Web site: http://www.nsf.gov/statistics/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biemer PP, 2010, PUBLIC OPIN QUART, V74, P817, DOI 10.1093/poq/nfq058; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Bollen KA, 2016, ANNU REV STAT APPL, V3, P375, DOI 10.1146/annurev-statistics-011516-012958; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Chambers RL, 2003, ANAL SURVEY DATA; Cochran WG., 1963, SAMPLING TECHNIQUES; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Deming WE, 1944, AM SOCIOL REV, V9, P359, DOI 10.2307/2085979; DUMOUCHEL WH, 1983, J AM STAT ASSOC, V78, P535, DOI 10.2307/2288115; Fuller W.A., 1984, SURV METHODOL, V10, P97; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Groves R.M., 2004, SURVEY ERRORS SURVEY; Groves RM, 2009, SURVEY METHODOLOGY; Hall D, 2011, P SECTION SURVEY RES, P3954; Hansen M.H., 1953, SAMPLE SURVEY METHOD, VI; HANSEN MH, 1983, J AM STAT ASSOC, V78, P776, DOI 10.2307/2288182; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Kish L, 1965, SURVEY SAMPLING; Korn E. L., 1999, ANAL HLTH SURVEYS; KOTT PS, 1991, AM STAT, V45, P107, DOI 10.2307/2684369; Lan F., 2013, SCI ENG STAT DATA SY; Little RJ, 2004, J AM STAT ASSOC, V99, P546, DOI 10.1198/016214504000000467; Little RJ, 2012, J OFF STAT, V28, P309; Neyman J, 1935, ANN MATH STAT, V6, P111, DOI 10.1214/aoms/1177732585; Pfeffermann D, 1998, J ROY STAT SOC B, V60, P23, DOI 10.1111/1467-9868.00106; Pfeffermann D, 2011, SURV METHODOL, V37, P115; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Sakshaug JW, 2014, AM J PUBLIC HEALTH, V104, P15, DOI 10.2105/AJPH.2013.301515; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; Smith TW, 2011, INT J PUBLIC OPIN R, V23, P464, DOI 10.1093/ijpor/edq052; Valliant R., 2013, PRACTICAL TOOLS DESI; West BT, 2012, STATA J, V12, P718, DOI 10.1177/1536867X1201200410; West BT, 2012, 2012 INT TOT SURV ER; West BT, 2016, TOTAL SURVE IN PRESS; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8	35	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158120	10.1371/journal.pone.0158120	http://dx.doi.org/10.1371/journal.pone.0158120			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355817	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400029
J	Chassanidis, C; Boutou, E; Voskaridou, E; Balassopoulou, A				Chassanidis, Christos; Boutou, Effrossyni; Voskaridou, Ersi; Balassopoulou, Angeliki			Development of a High-Resolution Melting Approach for Scanning Beta Globin Gene Point Mutations in the Greek and Other Mediterranean Populations	PLOS ONE			English	Article							THALASSEMIA; HEMOGLOBINOPATHIES	Beta-thalassaemia is one of the most common autosomal recessive disorders worldwide. The disease's high incidence, which is observed in the broader Mediterranean area has led to the establishment of molecular diagnostics' assays to prevent affected births. Therefore, the development of a reliable, cost-effective and rapid scanning method for beta globin gene point mutations, easily adapted to a routine laboratory, is absolutely essential. Here, we describe, for the first time, the development of a High-Resolution Melting Analysis (HRMA) approach, suitable for scanning the particularly heterogeneous beta globin gene mutations present in the Greek population, and thus adaptable to the Mediterranean and other areas where these mutations have been identified. Within this context, beta globin gene regions containing mutations frequently identified in the Greek population were divided in ten overlapping amplicons. Our reactions' setup allowed for the simultaneous amplification of multiple primer sets and partial multiplexing, thereby resulting in significant reduction of the experimental time. DNA samples from beta-thalassaemia patients/carriers with defined genotypes were tested. Distinct genotypes displayed distinguishable melting curves, enabling accurate detection of mutations. The described HRMA can be adapted to a high-throughput level. It represents a rapid, simple, cost-effective, reliable, highly feasible and sensitive method for beta-thalassaemia gene scanning.	[Chassanidis, Christos; Boutou, Effrossyni; Balassopoulou, Angeliki] Laikon Gen Hosp, Thalassaemia & Hemoglobinopathies Ctr, Mol Genet Lab, Athens, Greece; [Voskaridou, Ersi] Laikon Gen Hosp, Thalassaemia & Hemoglobinopathies Ctr, Athens, Greece	Laiko General Hospital; Laiko General Hospital	Chassanidis, C; Balassopoulou, A (corresponding author), Laikon Gen Hosp, Thalassaemia & Hemoglobinopathies Ctr, Mol Genet Lab, Athens, Greece.	xxmbgcc@gmail.com; angbalip@gmail.com		Voskaridou, Ersi/0000-0002-0979-5722; Boutou, Effrossyni/0000-0003-0343-2434	ThalaMoSS (THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia) from Seventh Framework Programme (EU) [306201]	ThalaMoSS (THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia) from Seventh Framework Programme (EU)	This work was supported by the ThalaMoSS (THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia) 306201 grant from Seventh Framework Programme (EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouti I, 2008, EUR J HAEMATOL, V80, P346, DOI 10.1111/j.1600-0609.2007.01017.x; Boussiou M, 2008, BLOOD CELL MOL DIS, V40, P317, DOI 10.1016/j.bcmd.2007.11.003; Cao A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011775; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Er TK, 2012, CLIN CHIM ACTA, V414, P197, DOI 10.1016/j.cca.2012.09.012; Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013; Hex X, 2010, GENET TEST MOL BIOMA, V14, P851, DOI [10.1089/gtmb.2010.0048, DOI 10.1089/GTMB.2010.0048]; Joly P, 2011, CLIN CHIM ACTA, V412, P1257, DOI 10.1016/j.cca.2011.03.025; Ladis V, 2013, EUR J HAEMATOL, V90, P313, DOI 10.1111/ejh.12076; Lin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102243; Loukopoulos Dimitris, 2011, Indian J Med Res, V134, P572; Prajantasen T, 2015, CLIN CHIM ACTA, V441, P56, DOI 10.1016/j.cca.2014.12.015; Saetung R, 2013, SE ASIAN J TROP MED, V44, P1055; Samara M, 2007, AM J HEMATOL, V82, P634, DOI 10.1002/ajh.20889; Shih HC, 2009, CLIN BIOCHEM, V42, P1667, DOI 10.1016/j.clinbiochem.2009.07.017; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P137, DOI 10.1017/CBO9780511596582.012; Thein SL, 1998, BAILLIERE CLIN HAEM, V11, P91, DOI 10.1016/S0950-3536(98)80071-1; Thein SL, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011700; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; Vinciguerra M, 2015, INT J LAB HEMATOL; Voskaridou E, 2012, ANN HEMATOL, V91, P1451, DOI 10.1007/s00277-012-1465-7; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019	22	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157393	10.1371/journal.pone.0157393	http://dx.doi.org/10.1371/journal.pone.0157393			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351925	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900010
J	Siemerink, MJ; Hughes, MR; Dallinga, MG; Gora, T; Cait, J; Vogels, IMC; Yetin-Arik, B; Van Noorden, CJF; Klaassen, I; McNagny, KM; Schlingemann, RO				Siemerink, Martin J.; Hughes, Michael R.; Dallinga, Marchien G.; Gora, Tomek; Cait, Jessica; Vogels, Ilse M. C.; Yetin-Arik, Bahar; Van Noorden, Cornelis J. F.; Klaassen, Ingeborg; McNagny, Kelly M.; Schlingemann, Reinier O.			CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TIP CELLS; ANGIOGENESIS; EXPRESSION; VASCULARIZATION; QUANTIFICATION; PERMEABILITY; INFLAMMATION; FILOPODIA; MICE	The sialomucins CD34 and podocalyxin (PODXL) are anti-adhesive molecules expressed at the luminal membrane of endothelial cells of small blood vessels and facilitate vascular lumen formation in the developing mouse aorta. CD34 transcript and protein levels are increased during human angiogenesis, its expression is particularly enriched on endothelial tip cell filopodia and CD34 is a marker for tip cells in vitro. Here, we investigated whether CD34 merely marks endothelial tip cells or has a functional role in tip cells and angiogenesis. We assessed that silencing CD34 in human microvascular endothelial cells has little effect on endothelial cell migration or invasion, but has a significant effect on vascular-endothelial growth factor-induced angiogenic sprouting activity in vitro. In vivo, the absence of CD34 reduced the density of filopodia on retinal endothelial tip cells in neonatal mice, but did not influence the overall architecture of the retinal vascular network. In oxygen-induced retinopathy, Cd34(-/-) mice showed normal intra-retinal regenerative angiogenesis but the number of pathological epi-retinal neovascular tufts were reduced. We conclude that CD34 is not essential for developmental vascularization in the retina, but its expression promotes the formation of pathological, invasive vessels during neovascularization.	[Siemerink, Martin J.; Dallinga, Marchien G.; Gora, Tomek; Vogels, Ilse M. C.; Yetin-Arik, Bahar; Van Noorden, Cornelis J. F.; Klaassen, Ingeborg; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Ocular Angiogenesis Grp, Amsterdam, Netherlands; [Siemerink, Martin J.; Dallinga, Marchien G.; Gora, Tomek; Vogels, Ilse M. C.; Yetin-Arik, Bahar; Van Noorden, Cornelis J. F.; Klaassen, Ingeborg; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Siemerink, Martin J.; Dallinga, Marchien G.; Gora, Tomek; Vogels, Ilse M. C.; Yetin-Arik, Bahar; Van Noorden, Cornelis J. F.; Klaassen, Ingeborg; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Amsterdam, Netherlands; [Hughes, Michael R.; McNagny, Kelly M.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Hughes, Michael R.; Cait, Jessica; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Cait, Jessica; McNagny, Kelly M.] Univ British Columbia, Dept Expt Med, Vancouver, BC, Canada	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; University of British Columbia; University of British Columbia	Schlingemann, RO (corresponding author), Univ Amsterdam, Acad Med Ctr, Ocular Angiogenesis Grp, Amsterdam, Netherlands.; Schlingemann, RO (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands.; Schlingemann, RO (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Amsterdam, Netherlands.	r.schlingemann@amc.uva.nl	Hughes, Michael/N-6039-2015; McNagny, Kelly/P-5239-2014; Klaassen, Ingeborg/F-7333-2015	Hughes, Michael/0000-0002-7925-6070; McNagny, Kelly/0000-0003-4737-3499; Klaassen, Ingeborg/0000-0003-1695-9403	Dutch Cancer Society (KWF); Centre for Blood Research at the University of British Columbia; Heart and Stroke Foundation of Canada; Edmond and Marianne Blaauw Fonds	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Centre for Blood Research at the University of British Columbia; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Edmond and Marianne Blaauw Fonds	MJS received support from the Dutch Cancer Society (KWF). MRH and JC received a PDF-summer student award (2014) from the Centre for Blood Research at the University of British Columbia (http://cbr.ubc.ca/). This study was partially supported by a Grant In-Aid to KMM from the Heart and Stroke Foundation of Canada (BC/Yukon) (www.heartandstroke.com). KMM is a Senior Scholar of the Michael Smith Foundation for Health Research (http://www.msfhr.org/). This study was supported by the Edmond and Marianne Blaauw Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; BAUMHUETER S, 1994, BLOOD, V84, P2554; Blanchet MR, 2007, BLOOD, V110, P2005, DOI 10.1182/blood-2006-12-062448; Blanchet MR, 2010, J IMMUNOL, V184, P1292, DOI 10.4049/jimmunol.0900808; Budd S, 2009, EXP EYE RES, V89, P718, DOI 10.1016/j.exer.2009.06.011; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chieco P, 2013, PROG HISTOCHEM CYTO, V47, P211, DOI 10.1016/j.proghi.2012.09.001; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Drew E, 2005, IMMUNITY, V22, P43, DOI 10.1016/j.immuni.2004.11.014; FINA L, 1990, BLOOD, V75, P2417; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hellwig SMM, 1997, CANCER LETT, V120, P203, DOI 10.1016/S0304-3835(97)00310-8; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; ITO A, 1995, LAB INVEST, V72, P532; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; KLOSOVSKII B N, 1963, Arkh Patol, V35(3), P38; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Koziol A, 2012, FASEB J, V26, P4481, DOI 10.1096/fj.12-205906; Maltby S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018160; Maltby S, 2010, AM J PATHOL, V177, P1244, DOI 10.2353/ajpath.2010.100191; MARINPADILLA M, 1985, J COMP NEUROL, V241, P237, DOI 10.1002/cne.902410210; Nielsen JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000237; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; Phng LK, 2013, DEVELOPMENT, V140, P4031, DOI 10.1242/dev.097352; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; SCHLINGEMANN RO, 1990, LAB INVEST, V62, P690; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; SCHOEFL GI, 1963, VIRCHOWS ARCH A, V337, P97, DOI 10.1007/BF00963592; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Testa JE, 2009, AM J PHYSIOL-LUNG C, V297, pL251, DOI 10.1152/ajplung.90565.2008; Wood HB, 1997, BLOOD, V90, P2300; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196	41	17	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157902	10.1371/journal.pone.0157902	http://dx.doi.org/10.1371/journal.pone.0157902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352134	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900023
J	Fuwa, M; Ueda, K; Akaishi, T; Yamashita, N; Kirihara, T; Shimazaki, A; Mano, H; Kawazu, K				Fuwa, Masahiro; Ueda, Kenji; Akaishi, Takahiro; Yamashita, Naoko; Kirihara, Tomoko; Shimazaki, Atsushi; Mano, Hidetoshi; Kawazu, Kouichi			Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; INDIVIDUAL COMPONENTS; INTRAOCULAR-PRESSURE; OPHTHALMIC SOLUTION; TIMOLOL; ADHERENCE; MULTICENTER; MEDICATION; BIOAVAILABILITY	Purpose To compare the safety and efficacy of fixed-dose tafluprost/timolol combination (Taf/T-FDC) with those of fixed-dose latanoprost/timolol combination (Lat/T-FDC) by measuring the intraocular pressure (IOP)-lowering effect, ocular pharmacokinetics, and ocular surface toxicity. Methods The IOP-lowering effect of Taf/T-FDC and Lat/T-FDC in ocular normotensive monkeys was evaluated at 4 and 8 h after instillation in study A, at 12, 14, 16, and 18 h after instillation in study B, and at 24, 26, 28, and 30 h after instillation in study C. Drug penetration into the eye was evaluated by measuring the concentrations of timolol, tafluprost acid (active metabolic form of tafluprost), and latanoprost acid (active metabolic form of latanoprost) using liquid chromatography coupled with tandem mass spectrometry after single instillation of Taf/T-FDC or Lat/T-FDC to Sprague Dawley rats. Cytotoxicity following 1-30 min exposure of SV40-transformed human corneal epithelial cells to Taf/T-FDC or Lat/T-FDC was analyzed using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetra-zolium assays. Undiluted and 10-fold diluted solutions of each FDC were evaluated. Results The IOP-lowering effect of Taf/T-FDC was almost equivalent to that of Lat/T-FDC at 4-8 h after instillation. The peak IOP reduction of Taf/T-FDC and Lat/T-FDC was observed at 8 h after instillation, and there is no difference between the two. The difference between them was observed at 24-30 h after instillation, and Taf/T-FDC demonstrated a significantly greater IOP-lowering effect than Lat/T-FDC at 24-30 h after instillation. The IOP-lowering effect of Taf/T-FDC was sustained up to 30 h after instillation, while that of Lat/T-FDC had almost disappeared at 28 h after instillation. Timolol concentrations in aqueous humor after Taf/T-FDC instillation were higher than those after Lat/T-FDC instillation (C-max, 3870 ng/mL vs 1330 ng/mL; AUC(inf), 3970 ng.h/mL vs 1250 ng.h/mL). The concentrations of tafluprost acid and latanoprost acid in aqueous humor after instillation of Taf/T-FDC and Lat/T-FDC, respectively, were similar to those after instillation of mono-preparations of tafluprost and latanoprost, respectively. The cytotoxic effect of Taf/T-FDC to the human corneal epithelial cells was significantly lower than that of Lat/T-FDC at all evaluated time points in both undiluted and 10-fold diluted FDCs. Conclusion Taf/T-FDC provides increased IOP-lowering effect duration and lower potential ocular surface toxicity than Lat/T-FDC.x	[Fuwa, Masahiro; Ueda, Kenji; Akaishi, Takahiro; Yamashita, Naoko; Kirihara, Tomoko; Shimazaki, Atsushi; Mano, Hidetoshi; Kawazu, Kouichi] Santen Pharmaceut Co Ltd, Global Res & Dev, Ikoma, Nara, Japan	Santen Pharmaceutical Co Ltd	Fuwa, M (corresponding author), Santen Pharmaceut Co Ltd, Global Res & Dev, Ikoma, Nara, Japan.	Masahiro.Fuwa@santen.co.jp			Santen Pharmaceutical Co., Ltd.	Santen Pharmaceutical Co., Ltd.	The funder provided support in the form of salaries for authors [MF, KU, TA, NY, TK, AS, HM, KK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors received no specific funding for this work. Santen Pharmaceutical Co., Ltd. provided support in the form of salaries for authors [MF, KU, TA, NY, TK, AS, HM, KK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSON DR, 1989, AM J OPHTHALMOL, V108, P485, DOI 10.1016/0002-9394(89)90423-6; [Anonymous], 1989, INT J PHARM, V57, P163; Asada H, 2010, YAKUGAKU ZASSHI, V130, P867, DOI 10.1248/yakushi.130.867; Asrani S, 2000, J GLAUCOMA, V9, P134; Baudouin C, 2005, CURR OPIN ALLERGY CL, V5, P459, DOI 10.1097/01.all.0000183112.86181.9e; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; Diestelhorst M, 2006, OPHTHALMOLOGY, V113, P70, DOI 10.1016/j.ophtha.2005.06.027; Diestelhorst M, 2004, BRIT J OPHTHALMOL, V88, P199, DOI 10.1136/bjo.2003.018234; Dietlein TS, 2006, GRAEF ARCH CLIN EXP, V244, P859, DOI 10.1007/s00417-005-0142-0; Djafari F, 2009, J GLAUCOMA, V18, P238, DOI 10.1097/IJG.0b013e3181815421; Erb C, 2008, GRAEF ARCH CLIN EXP, V246, P1593, DOI 10.1007/s00417-008-0881-9; Fechtner Robert D, 2004, Curr Opin Ophthalmol, V15, P132, DOI 10.1097/00055735-200404000-00013; Francis BA, 2004, J CLIN PHARM THER, V29, P375, DOI 10.1111/j.1365-2710.2004.00574.x; Garcia-Feijoo J, 2012, CLIN OPHTHALMOL, V6, P441, DOI 10.2147/OPTH.S29158; Higashiyama M, 2004, INT J PHARM, V272, P91, DOI 10.1016/j.ijpharm.2003.11.035; Kuwayama Y, 2013, J EYE, V30, P1185; KYYRONEN K, 1990, J PHARM SCI, V79, P688, DOI 10.1002/jps.2600790808; Laurence J, 1993, J Glaucoma, V2, P177; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Mundorf TK, 2004, CLIN THER, V26, P541, DOI 10.1016/S0149-2918(04)90056-2; Nelson J D, 1995, Trans Am Ophthalmol Soc, V93, P709; Noecker RJ, 2004, CORNEA, V23, P490, DOI 10.1097/01.ico.0000116526.57227.82; Offord EA, 1999, INVEST OPHTH VIS SCI, V40, P1091; Olthoff CMG, 2005, OPHTHALMOLOGY, V112, P953, DOI 10.1016/j.ophtha.2004.12.035; Pauly A, 2012, INVEST OPHTH VIS SCI, V53, P8172, DOI 10.1167/iovs.12-10766; Robin AL, 2005, OPHTHALMOLOGY, V112, P863, DOI 10.1016/j.ophtha.2004.12.026; Robin AL, 2007, AM J OPHTHALMOL, V144, P533, DOI 10.1016/j.ajo.2007.06.012; Shedden A, 2001, CLIN THER, V23, P440, DOI 10.1016/S0149-2918(01)80048-5; Singh K, 2011, INDIAN J OPHTHALMOL, V59, pS88, DOI 10.4103/0301-4738.73691; Takagi Y, 2004, EXP EYE RES, V78, P767, DOI 10.1016/j.exer.2003.12.007; Ueda K., 2013, J EYE, V30, P1761; Ung C, 2013, OPHTHALMOLOGY, V120, P1150, DOI 10.1016/j.ophtha.2012.11.026; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Xing Y, 2014, INT J OPHTHALMOL-CHI, V7, P879, DOI 10.3980/j.issn.2222-3959.2014.05.26; Zhao JL, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-23; Zimmerman T J, 1983, Surv Ophthalmol, V28 Suppl, P252, DOI 10.1016/0039-6257(83)90142-X; 1998, AM J OPHTHALMOLOGY, V126, P498	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158797	10.1371/journal.pone.0158797	http://dx.doi.org/10.1371/journal.pone.0158797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383260	gold, Green Published, Green Submitted			2022-12-27	WOS:000379809400085
J	Roberts, P; Henshilwood, CS; van Niekerk, KL; Keene, P; Gledhill, A; Reynard, J; Badenhorst, S; Lee-Thorp, J				Roberts, Patrick; Henshilwood, Christopher S.; van Niekerk, Karen L.; Keene, Petro; Gledhill, Andrew; Reynard, Jerome; Badenhorst, Shaw; Lee-Thorp, Julia			Climate, Environment and Early Human Innovation: Stable Isotope and Faunal Proxy Evidence from Archaeological Sites (98-59ka) in the Southern Cape, South Africa	PLOS ONE			English	Article							MIDDLE STONE-AGE; MODERN HUMAN-BEHAVIOR; BLOMBOS CAVE; HOWIESONS POORT; STILL BAY; ADDITIONAL EVIDENCE; KLIPDRIFT SHELTER; FOOD SELECTION; OSTRICH; KA	The Middle Stone Age (MSA) of southern Africa, and in particular its Still Bay and Howiesons Poort lithic traditions, represents a period of dramatic subsistence, cultural, and technological innovation by our species, Homo sapiens. Climate change has frequently been postulated as a primary driver of the appearance of these innovative behaviours, with researchers invoking either climate instability as a reason for the development of buffering mechanisms, or environmentally stable refugia as providing a stable setting for experimentation. Testing these alternative models has proved intractable, however, as existing regional palaeoclimatic and palaeoenvironmental records remain spatially, stratigraphically, and chronologically disconnected from the archaeological record. Here we report high-resolution records of environmental shifts based on stable carbon and oxygen isotopes in ostrich eggshell (OES) fragments, faunal remains, and shellfish assemblages excavated from two key MSA archaeological sequences, Blombos Cave and Klipdrift Shelter. We compare these records with archaeological material remains in the same strata. The results from both sites, spanning the periods 98-73 ka and 72-59 ka, respectively, show significant changes in vegetation, aridity, rainfall seasonality, and sea temperature in the vicinity of the sites during periods of human occupation. While these changes clearly influenced human subsistence strategies, we find that the remarkable cultural and technological innovations seen in the sites cannot be linked directly to climate shifts. Our results demonstrate the need for scale-appropriate, on-site testing of behavioural-environmental links, rather than broader, regional comparisons.	[Roberts, Patrick; Lee-Thorp, Julia] Univ Oxford, Sch Archaeol, Res Lab Archaeol & Hist Art, Dyson Perrins Bldg,South Parks Rd, Oxford, England; [Henshilwood, Christopher S.; van Niekerk, Karen L.; Keene, Petro; Reynard, Jerome] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Henshilwood, Christopher S.; van Niekerk, Karen L.] Univ Bergen, Dept Archaeol Hist Cultural Studies & Relig, Bergen, Norway; [Gledhill, Andrew] Univ Bradford, Div Geog Archaeol & Environm Sci, Bradford, W Yorkshire, England; [Reynard, Jerome] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Badenhorst, Shaw] Ditsong Natl Museum Nat Hist, Archaeozool & Large Mammal Sect, Paul Kruger St, Pretoria, South Africa; [Badenhorst, Shaw] Univ South Africa, Dept Anthropol & Archaeol, Durban, South Africa	University of Oxford; University of Witwatersrand; University of Bergen; University of Bradford; University of Witwatersrand; University of South Africa	Roberts, P (corresponding author), Univ Oxford, Sch Archaeol, Res Lab Archaeol & Hist Art, Dyson Perrins Bldg,South Parks Rd, Oxford, England.	patrick.roberts@rlaha.ox.ac.uk	Henshilwood, Christopher S/K-3806-2014; van Niekerk, Karen/J-3511-2015; Badenhorst, Shaw/HGC-7123-2022; Reynard, Jerome/AGV-6706-2022	Henshilwood, Christopher S/0000-0002-2818-293X; van Niekerk, Karen/0000-0003-2261-6861; Badenhorst, Shaw/0000-0002-6651-9660; Reynard, Jerome/0000-0002-7092-2188; Roberts, Patrick/0000-0002-4403-7548	Clarendon Fund; Natural Environmental Research Council; National Research Foundation/Department of Science and Technology at the University of the Witwatersrand, South Africa; University of Bergen, Norway; University of Oxford; NERC [NE/G005338/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005338/1] Funding Source: researchfish	Clarendon Fund; Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Research Foundation/Department of Science and Technology at the University of the Witwatersrand, South Africa; University of Bergen, Norway; University of Oxford; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research would not have been possible without financial support from the Clarendon Fund, University of Oxford, and a Natural Environmental Research Council studentship to PR. Financial support for the KDS and BBC projects was provided to CSH by a National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa, and by the University of Bergen, Norway.	Ambrose SH., 2022, SOCIAL ECOLOGICAL MO, P3, DOI [DOI 10.1515/9781474470957-003, 10.1515/9781474470957-003]; Bar-Matthews M, 2010, QUATERNARY SCI REV, V29, P2131, DOI 10.1016/j.quascirev.2010.05.009; Barbour MM, 2007, FUNCT PLANT BIOL, V34, P83, DOI 10.1071/FP06228; Blinkhom J, 2015, PALAEOGEOGR PALAEOCL, V417, P80, DOI 10.1016/j.palaeo.2014.10.026; BROOKS AS, 1990, SCIENCE, V248, P60, DOI 10.1126/science.248.4951.60; BUYS D, 1990, S AFR J WILDL RES, V20, P16; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; Chase BM, 2010, J ARCHAEOL SCI, V37, P1359, DOI 10.1016/j.jas.2009.12.040; COHEN AL, 1995, HOLOCENE, V5, P304, DOI 10.1177/095968369500500305; Compton JS, 2011, QUATERNARY SCI REV, V30, P506, DOI 10.1016/j.quascirev.2010.12.012; Cooper RG, 2010, TROP ANIM HEALTH PRO, V42, P363, DOI 10.1007/s11250-009-9428-2; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; D'Errico F, 2001, ANTIQUITY, V75, P309, DOI 10.1017/S0003598X00060968; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; DEACON HJ, 2001, HUMAN ROOTS AFRICA A, P55; Driver J. C., 2005, CROW CANYON ARCHAEOL; Ecker M, 2015, CHANCING CLIMATES EC, V33; Faith JT, 2011, PALAEOGEOGR PALAEOCL, V306, P219, DOI 10.1016/j.palaeo.2011.04.025; Fisher EC, 2010, QUATERNARY SCI REV, V29, P1382, DOI 10.1016/j.quascirev.2010.01.015; FLANAGAN LB, 1991, PLANT PHYSIOL, V96, P588, DOI 10.1104/pp.96.2.588; Gonfiantini R., 1965, ISOTOPES RAD SOIL PL, P405; Henshilwood C.S., 2005, TOOLS SYMBOLS EARLY, P441; Henshilwood C. S., 2008, S AFRICAN ARCHAEOLOG, V10, P35; Henshilwood C. S., 2011, HOMOSYMBOLICUS DAWN, P75; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2011, CURR ANTHROPOL, V52, P361, DOI 10.1086/660022; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Henshilwood CS, 2013, ENCY GLOBAL ARCHAEOL, P240; Henshilwood CS, 2012, J WORLD PREHIST, V52, P361; Hillestad-Nel TH, 2007, SO CAPE S AFRICA NYA, V68, P52; Hoffmann V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137847; Inskeep R.R., 1987, BAR INT SERIES, V357; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2006, J HUM EVOL, V51, P255, DOI 10.1016/j.jhevol.2006.03.007; Jacobs Z, 2013, J ARCHAEOL SCI, V40, P579, DOI 10.1016/j.jas.2012.06.037; Johnson BJ, 1998, GEOCHIM COSMOCHIM AC, V62, P2451, DOI 10.1016/S0016-7037(98)00175-6; Johnson BJ, 1997, PALAEOGEOGR PALAEOCL, V136, P121, DOI 10.1016/S0031-0182(97)00043-6; Jones H. L., 2001, THESIS; Klein R.G., 1984, ANAL ANIMAL BONES AR; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Klein RG, 1974, ANN S AFR MUS, V65, P99; Lee-Thorp JA, 2015, AFR ARCHAEOL REV, V32, P793, DOI 10.1007/s10437-015-9202-y; Lombard M, 2007, S AFR ARCHAEOL BULL, V62, P62, DOI 10.2307/20474947; Lombard M, 2011, J ARCHAEOL SCI, V38, P1918, DOI 10.1016/j.jas.2011.04.001; MILTON SJ, 1994, J WILDLIFE MANAGE, V58, P234, DOI 10.2307/3809386; Mitchell PJ., 1996, AFR ARCHAEOL REV, V13, P35, DOI DOI 10.1007/BF01956132; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Reynard JP, 2016, PALAEOGEOGR PALAEOCL, V449, P349, DOI 10.1016/j.palaeo.2016.02.035; Rundel PW, 1999, PLANT ECOL, V142, P133, DOI 10.1023/A:1009878429455; SAUER E.G.F., 1966, OSTRICH J AFRICAN OR, P183; Sealy J, 1996, S AFR J SCI, V92, P441; Segalen L, 2006, EARTH PLANET SC LETT, V244, P725, DOI 10.1016/j.epsl.2005.12.012; Segalen L, 2009, PALAEOGEOGR PALAEOCL, V277, P191, DOI 10.1016/j.palaeo.2009.03.018; Sharp Z., 2007, PRINCIPLES STABLE IS; SINCLAIR ARE, 1978, IBIS, V120, P480, DOI 10.1111/j.1474-919X.1978.tb06813.x; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Stynder DD, 2009, QUATERNARY RES, V71, P62, DOI 10.1016/j.yqres.2008.06.003; Thompson JC, 2014, J ARCHAEOL SCI, V41, P214, DOI 10.1016/j.jas.2013.08.017; Thompson JC, 2011, J HUM EVOL, V60, P746, DOI 10.1016/j.jhevol.2011.01.013; Tribolo C, 2006, ARCHAEOMETRY, V48, P341, DOI 10.1111/j.1475-4754.2006.00260.x; Vaesen K, 2016, P NATL ACAD SCI USA, V113, pE2241, DOI 10.1073/pnas.1520288113; Van Niekerk K. L., 2011, THESIS; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; VOGEL JC, 1978, S AFR J SCI, V74, P209; VONSCHIRNDING Y, 1982, ARCHAEOMETRY, V24, P3, DOI 10.1111/j.1475-4754.1982.tb00643.x; West AG, 2014, J GEOCHEM EXPLOR, V145, P213, DOI 10.1016/j.gexplo.2014.06.009; WILLIAMS JB, 1993, ECOLOGY, V74, P390, DOI 10.2307/1939301; Zeder MA, 2012, J ANTHROPOL ARCHAEOL, V31, P241, DOI 10.1016/j.jaa.2012.03.003; Ziegler M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2897	78	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157408	10.1371/journal.pone.0157408	http://dx.doi.org/10.1371/journal.pone.0157408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383620	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400011
J	Sada, K; Nishikawa, T; Kukidome, D; Yoshinaga, T; Kajihara, N; Sonoda, K; Senokuchi, T; Motoshima, H; Matsumura, T; Araki, E				Sada, Kiminori; Nishikawa, Takeshi; Kukidome, Daisuke; Yoshinaga, Tomoaki; Kajihara, Nobuhiro; Sonoda, Kazuhiro; Senokuchi, Takafumi; Motoshima, Hiroyuki; Matsumura, Takeshi; Araki, Eiichi			Hyperglycemia Induces Cellular Hypoxia through Production of Mitochondrial ROS Followed by Suppression of Aquaporin-1	PLOS ONE			English	Article							DIABETIC COMPLICATIONS; ENDOTHELIAL-CELLS; EXPRESSION; PIMONIDAZOLE; ACTIVATION; MELLITUS; DAMAGE; MICE	We previously proposed that hyperglycemia-induced mitochondrial reactive oxygen species (mtROS) generation is a key event in the development of diabetic complications. Interestingly, some common aspects exist between hyperglycemia and hypoxia-induced phenomena. Thus, hyperglycemia may induce cellular hypoxia, and this phenomenon may also be involved in the pathogenesis of diabetic complications. In endothelial cells (ECs), cellular hypoxia increased after incubation with high glucose (HG). A similar phenomenon was observed in glomeruli of diabetic mice. HG-induced cellular hypoxia was suppressed by mitochondria blockades or manganese superoxide dismutase (MnSOD) overexpression, which is a specific SOD for mtROS. Overexpression of MnSOD also increased the expression of aquaporin-1 (AQP1), a water and oxygen channel. AQP1 overexpression in ECs suppressed hyperglycemia-induced cellular hypoxia, endothelin-1 and fibronectin overproduction, and apoptosis. Therefore, hyperglycemia-induced cellular hypoxia and mtROS generation may promote hyperglycemic damage in a coordinated manner.	[Sada, Kiminori; Nishikawa, Takeshi; Kukidome, Daisuke; Yoshinaga, Tomoaki; Kajihara, Nobuhiro; Sonoda, Kazuhiro; Senokuchi, Takafumi; Motoshima, Hiroyuki; Matsumura, Takeshi; Araki, Eiichi] Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan; [Nishikawa, Takeshi; Senokuchi, Takafumi] Kumamoto Univ, Fac Life Sci, Dept Mol Diabetol, Kumamoto, Japan	Kumamoto University; Kumamoto University	Nishikawa, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan.; Nishikawa, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Mol Diabetol, Kumamoto, Japan.	t-nishikawa@kumamed.jp; t-nishikawa@kumamed.jp		sada, kiminori/0000-0001-9663-6035	Japan Society for the Promotion of Science, Japan [26461340, 15K09393]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan (no. 26461340 to TN and no. 15K09393 to DK). The URL of the funder is https://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x; ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Bae EH, 2008, AM J PHYSIOL-RENAL, V294, pF272, DOI 10.1152/ajprenal.00352.2007; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Goto H, 2008, BIOCHEM BIOPH RES CO, V366, P814, DOI 10.1016/j.bbrc.2007.12.041; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ivanov II, 2004, BIOCHEM BIOPH RES CO, V322, P746, DOI 10.1016/j.bbrc.2004.07.187; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lai EY, 2012, AM J PHYSIOL-RENAL, V303, pF64, DOI 10.1152/ajprenal.00005.2012; Madonna R, 2010, INT J IMMUNOPATH PH, V23, P755, DOI 10.1177/039463201002300309; Madonna R, 2015, CURR DRUG TARGETS, V16, P361, DOI 10.2174/1389450116666141219115720; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Nishikawa T, 2003, DIABETES CARE, V26, P1507, DOI 10.2337/diacare.26.5.1507; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Su X, 2004, RESP PHYSIOL NEUROBI, V142, P1, DOI 10.1016/j.resp.2004.05.001; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948	22	66	70	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158619	10.1371/journal.pone.0158619	http://dx.doi.org/10.1371/journal.pone.0158619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383386	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400066
J	Sudah, M; Masarwah, A; Kainulainen, S; Pitkanen, M; Matikka, H; Dabravolskaite, V; Aaltomaa, S; Vanninen, R				Sudah, Mazen; Masarwah, Amro; Kainulainen, Sakari; Pitkanen, Marja; Matikka, Hanna; Dabravolskaite, Vaiva; Aaltomaa, Sirpa; Vanninen, Ritva			Comprehensive MR Urography Protocol: Equally Good Diagnostic Performance and Enhanced Visibility of the Upper Urinary Tract Compared to Triple-Phase CT Urography	PLOS ONE			English	Article							ACUTE FLANK PAIN; UROTHELIAL CARCINOMA	Objectives To prospectively compare the diagnostic performance and the visualization of the upper urinary tract (UUT) using a comprehensive 3.0T-magnetic resonance urography (MRU) protocol versus triple-phase computed tomography urography (CTU). Methods During the study period (January-2014 through December-2015), all consecutive patients in our tertiary university hospital scheduled by a urologist for CTU to exclude UUT malignancy were invited to participate. Diagnostic performance and visualization scores of 3.0T-MRU were compared to CTU using Wilcoxon matched-pairs test. Results Twenty patients (39 UUT excreting units) were evaluated. 3.0T-MRU and CTU achieved equal diagnostic performances. The benign etiology of seven UUT obstructions was clarified equally with both methods. Another two urinary tract malignant tumors and one benign extraurinary tumor were detected and confirmed. Diagnostic visualization was slightly better in the intrarenal cavity areas with CTU but worsened towards distal ureter. MRU showed consistently slightly better visualization of the ureter. In the comparison, full 100% visualizations were detected in all areas in 93.6%(with 3.0T-MRU) and 87.2%(with CTU) and > 75% visualization in 100% (3.0T-MRU) and 93.6%(CTU). Mean CTU effective radiation dose was 9.2 mSv. Conclusions Comprehensive 3.0T-MRU is an accurate imaging modality achieving comparable performance with CTU; since it does not entail exposure to radiation, it has the potential to become the primary investigation technique in selected patients.	[Sudah, Mazen; Masarwah, Amro; Kainulainen, Sakari; Pitkanen, Marja; Matikka, Hanna; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland; [Masarwah, Amro; Dabravolskaite, Vaiva; Vanninen, Ritva] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland; [Aaltomaa, Sirpa] Kuopio Univ Hosp, Dept Surg, Urol Unit, Kuopio, Finland; [Vanninen, Ritva] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Vanninen, Ritva] Univ Eastern Finland, Ctr Eastern Finland, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland	Sudah, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland.	mazen.sudah@kuh.fi		Matikka, Hanna/0000-0001-7237-9660	Kuopio University Hospital (VTR) [5063534]; Radiological Society of Finland; Instrumentarium Science Foundation; Finnish Medical Foundation	Kuopio University Hospital (VTR); Radiological Society of Finland; Instrumentarium Science Foundation; Finnish Medical Foundation	This study was supported by Kuopio University Hospital (VTR funding no. 5063534), and in part by grants (MS) from the Radiological Society of Finland, the Instrumentarium Science Foundation and the Finnish Medical Foundation. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Abou El-Ghar ME, 2008, BRIT J RADIOL, V81, P624, DOI 10.1259/bjr/30109090; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Childs DD, 2013, J COMPUT ASSIST TOMO, V37, P29, DOI 10.1097/RCT.0b013e3182711fd9; Chlapoutakis K, 2010, EUR J RADIOL, V73, P334, DOI 10.1016/j.ejrad.2008.10.026; Dickerson EC, 2015, RADIOGRAPHICS, V35, P1208, DOI 10.1148/rg.2015140223; Dicuio Mauro, 2005, Arch Ital Urol Androl, V77, P60; Dillman JR, 2007, J COMPUT ASSIST TOMO, V31, P750, DOI 10.1097/RCT.0b013e318033df36; Hilton S, 2014, SURG ONCOL CLIN N AM, V23, P863, DOI 10.1016/j.soc.2014.06.001; Martingano P, 2013, RADIOL MED, V118, P1184, DOI 10.1007/s11547-013-0955-6; McTavish JD, 2002, RADIOLOGY, V225, P783, DOI 10.1148/radiol.2253011515; Metser U, 2012, RADIOLOGY, V264, P110, DOI 10.1148/radiol.12111623; O'Connor OJ, 2010, AM J ROENTGENOL, V195, pW201, DOI 10.2214/AJR.09.4176; Riccabona M, 2010, PEDIATR RADIOL, V40, P1315, DOI 10.1007/s00247-010-1686-7; Roupret M, 2015, GUIDELINES UROTHELIA; Silverman SG, 2009, RADIOLOGY, V250, P309, DOI 10.1148/radiol.2502080534; Soher Brian J, 2007, Magn Reson Imaging Clin N Am, V15, P277, DOI 10.1016/j.mric.2007.06.002; Sudah M, 2002, RADIOLOGY, V223, P98, DOI 10.1148/radiol.2231010341; Sudah M, 2001, AM J ROENTGENOL, V176, P105, DOI 10.2214/ajr.176.1.1760105; Takahashi N, 2008, RADIOLOGY, V247, P451, DOI 10.1148/radiol.2472070798; Takahashi N, 2010, J UROLOGY, V183, P1330, DOI 10.1016/j.juro.2009.12.031; Takeuchi M, 2015, AM J ROENTGENOL, V205, pW320, DOI 10.2214/AJR.14.14075; Van der Molen AJ, 2008, EUR RADIOL, V18, P4, DOI 10.1007/s00330-007-0792-x; van der Molen AJ, 2012, AM J ROENTGENOL, V198, P1256, DOI 10.2214/AJR.11.8255	23	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158673	10.1371/journal.pone.0158673	http://dx.doi.org/10.1371/journal.pone.0158673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384417	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400074
J	Kempster, RM; Egeberg, CA; Hart, NS; Ryan, L; Chapuis, L; Kerr, CC; Schmidt, C; Huveneers, C; Gennari, E; Yopak, KE; Meeuwig, JJ; Collin, SP				Kempster, Ryan M.; Egeberg, Channing A.; Hart, Nathan S.; Ryan, Laura; Chapuis, Lucille; Kerr, Caroline C.; Schmidt, Carl; Huveneers, Charlie; Gennari, Enrico; Yopak, Kara E.; Meeuwig, Jessica J.; Collin, Shaun P.			How Close is too Close? The Effect of a Non-Lethal Electric Shark Deterrent on White Shark Behaviour	PLOS ONE			English	Article							PROTECTIVE GILL NETS; NEW-SOUTH-WALES; CARCHARODON-CARCHARIAS; DASYATIS-SABINA; STEREO-VIDEO; AFRICA; FISH; PATTERNS; CAUGHT; FIELDS	Sharks play a vital role in the health of marine ecosystems, but the potential threat that sharks pose to humans is a reminder of our vulnerability when entering the ocean. Personal shark deterrents are being marketed as the solution to mitigate the threat that sharks pose. However, the effectiveness claims of many personal deterrents are based on our knowledge of shark sensory biology rather than robust testing of the devices themselves, as most have not been subjected to independent scientific studies. Therefore, there is a clear need for thorough testing of commercially available shark deterrents to provide the public with recommendations of their effectiveness. Using a modified stereo-camera system, we quantified behavioural interactions between white sharks (Carcharodon carcharias) and a baited target in the presence of a commercially available, personal electric shark deterrent (Shark Shield Freedom7 (TM)). The stereo-camera system enabled an accurate assessment of the behavioural responses of C. carcharias when encountering a non-lethal electric field many times stronger than what they would naturally experience. Upon their first observed encounter, all C. carcharias were repelled at a mean (+/- std. error) proximity of 131 (+/- 10.3) cm, which corresponded to a mean voltage gradient of 9.7 (+/- 0.9) V/m. With each subsequent encounter, their proximity decreased by an average of 11.6 cm, which corresponded to an increase in tolerance to the electric field by an average of 2.6 (+/- 0.5) V/m per encounter. Despite the increase in tolerance, sharks continued to be deterred from interacting for the duration of each trial when in the presence of an active Shark Shield (TM). Furthermore, the findings provide no support to the theory that electric deterrents attract sharks. The results of this study provide quantitative evidence of the effectiveness of a non-lethal electric shark deterrent, its influence on the behaviour of C. carcharias, and an accurate method for testing other shark deterrent technologies.	[Kempster, Ryan M.; Egeberg, Channing A.; Hart, Nathan S.; Ryan, Laura; Chapuis, Lucille; Kerr, Caroline C.; Schmidt, Carl; Yopak, Kara E.; Meeuwig, Jessica J.; Collin, Shaun P.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Kempster, Ryan M.; Egeberg, Channing A.; Hart, Nathan S.; Ryan, Laura; Chapuis, Lucille; Kerr, Caroline C.; Schmidt, Carl; Yopak, Kara E.; Collin, Shaun P.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Hart, Nathan S.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Huveneers, Charlie] Flinders Univ S Australia, Sch Biol Sci, Bedford Pk, SA 5042, Australia; [Gennari, Enrico] Oceans Res, Mossel Bay, South Africa; [Gennari, Enrico] South African Inst Aquat Biodivers, Private Bag 1015, Grahamstown, South Africa; [Meeuwig, Jessica J.] Univ Western Australia, Sch Anim Biol, Ctr Marine Futures, Crawley, WA, Australia	University of Western Australia; University of Western Australia; Macquarie University; Flinders University South Australia; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; University of Western Australia	Kempster, RM (corresponding author), Univ Western Australia, Oceans Inst, Crawley, WA, Australia.; Kempster, RM (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	ryankempster@supportoursharks.com	Collin, Shaun/K-8827-2012; Hart, Nathan S/B-8564-2011; Chapuis, Lucille/A-6535-2010; Yopak, Kara E/A-5549-2012	Collin, Shaun/0000-0001-6236-0771; Hart, Nathan S/0000-0002-7289-9399; Chapuis, Lucille/0000-0003-3001-983X; Yopak, Kara E/0000-0002-7870-9066; Meeuwig, Jessica/0000-0003-1169-8785; Huveneers, Charlie/0000-0001-8937-1358; Ryan, Laura/0000-0002-3436-2048; Gennari, Enrico/0000-0002-4334-727X	University of Western Australia; West Australian State Government Shark Hazard Mitigation Applied Research Program; South African Department of Environmental Affairs: Biodiversity and Coastal Research, Oceans and Coasts Branch; UWA Neuroecology Group	University of Western Australia; West Australian State Government Shark Hazard Mitigation Applied Research Program; South African Department of Environmental Affairs: Biodiversity and Coastal Research, Oceans and Coasts Branch; UWA Neuroecology Group	This study was funded by The University of Western Australia and the West Australian State Government Shark Hazard Mitigation Applied Research Program. The UWA Neuroecology Group would also like to express sincere gratitude and appreciation for the continued support and generous financial assistance provided by Craig and Katrina Burton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by The University of Western Australia and the West Australian State Government Shark Hazard Mitigation Applied Research Program. The UWA Neuroecology Group would also like to express sincere gratitude and appreciation for the continued support and generous financial assistance provided by Craig and Katrina Burton. Without which, completion of this research would not have been possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors wish to thank the South African Department of Environmental Affairs: Biodiversity and Coastal Research, Oceans and Coasts Branch for their support and help in conducting this research. The authors also wish to thank all of the interns at the Oceans Research campus in Mossel Bay for all of their help and hard work during this investigation. Finally, the authors would like to thank the anonymous reviewers for their thorough and critical feedback of this research, which ultimately resulted in a much improved final manuscript.	Atwood TB, 2015, NAT CLIM CHANGE, V5, P1038, DOI 10.1038/NCLIMATE2763; Bedore CN, 2013, PHYSIOL BIOCHEM ZOOL, V86, P298, DOI 10.1086/669973; Bikson M., 2004, REV HAZARDS ASS EXPO; Brill R, 2009, FISH B-NOAA, V107, P298; Broad A, 2010, MAR ECOL PROG SER, V408, P295, DOI 10.3354/meps08591; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Cisneros-Montemayor A. M., 2013, ORYX, V47, P1; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Cliff G, 1996, GREAT WHITE SHARKS, P351, DOI 10.1016/B978-012415031-7/50033-1; CLIFF G, 1995, S AFR J MARINE SCI, V15, P105; CLIFF G, 1992, AUST J MAR FRESH RES, V43, P263; DUDLEY SFJ, 1993, S AFR J MARINE SCI, V13, P237, DOI 10.2989/025776193784287356; Dudley SFJ, 1997, OCEAN COAST MANAGE, V34, P1, DOI 10.1016/S0964-5691(96)00061-0; Dunbrack RL, 2006, FISH RES, V82, P327, DOI 10.1016/j.fishres.2006.08.017; Egeberg CA, 2014, MAR FRESHWATER RES, V65, P1003, DOI 10.1071/MF13213; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Gallagher AJ, 2011, CURR ISSUES TOUR, V14, P797, DOI 10.1080/13683500.2011.585227; Hart NS, 2015, INTEGR ZOOL, V10, P38, DOI 10.1111/1749-4877.12095; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; House D., 2014, W AUSTR SHARK HAZARD; Huveneers C, 2012, EFFECTS SHARK SHIELD; Huveneers C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062730; Jordan LK, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot002; Jordan LK, 2011, J EXP MAR BIOL ECOL, V409, P345, DOI 10.1016/j.jembe.2011.09.016; Kajiura SM, 2003, MAR BIOL, V143, P603, DOI 10.1007/s00227-003-1099-3; Kajiura SM, 2009, ZOOLOGY, V112, P241, DOI 10.1016/j.zool.2008.07.001; Kalmijn A.J., 1974, P147; Kalmijn A.J., 1972, BIOELECTRIC FIELDS S; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1981, ANN BIOMED ENG, V9, P363, DOI 10.1007/BF02364656; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; KALMIJN AJ, 1988, DETECT WEAK ELECTR, P151; Kalmijn AJ, 1973, ELECTROORIENTATION S; Kempster RM, 2016, MAR FRESHWATER RES, V67, P187, DOI 10.1071/MF14245; Kempster R. M., 2013, BRAIN BEHAV EVOLUT, V81, P1; Kempster RM, 2014, ROLE ELECTRORECEPTIO; Kempster RM, 2014, EARTHSCAN OCEAN, P213; Kempster RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052551; Kimber JA, 2014, ANIM COGN, V17, P55, DOI 10.1007/s10071-013-0637-8; Kock A., 2006, WWF S AFRICA REPORT, P1; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Letessier T.B., 2013, METHODS OCEANOGR, V8, P41, DOI [10.1016/j.mio.2013.11.003, DOI 10.1016/J.MIO.2013.11.003]; Letessier TB, 2015, J EXP MAR BIOL ECOL, V466, P120, DOI 10.1016/j.jembe.2015.02.013; Marcotte MM, 2008, MAR TECHNOL SOC J, V42, P53, DOI 10.4031/002533208786829133; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; McGowan DW, 2009, J EXP BIOL, V212, P1544, DOI 10.1242/jeb.025247; Muter BA, 2013, CONSERV BIOL, V27, P187, DOI 10.1111/j.1523-1739.2012.01952.x; O'Connell CP, 2014, OCEAN COAST MANAGE, V97, P2, DOI 10.1016/j.ocecoaman.2012.11.005; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; Ryklief R, 2014, AFR J MAR SCI, V36, P449, DOI 10.2989/1814232X.2014.967296; SeaGIS, 2016, CAL STER CAM CAL; Sisneros JA, 2002, J PHYSIOL-PARIS, V96, P379, DOI 10.1016/S0928-4257(03)00016-0; Sisneros JA, 2002, BRAIN BEHAV EVOLUT, V59, P130, DOI 10.1159/000064160; Smit CE, 2003, ESTIMATING PROBABILI, P59; Smith E., 1974, T KOREAN I ELECT ENG, V65, P1; Smith E. D., 1991, Power Engineering Journal, V5, P167, DOI 10.1049/pe:19910036; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; West JG, 2011, MAR FRESHWATER RES, V62, P744, DOI 10.1071/MF10181; Wetherbee Bradley M., 1994, Pacific Science, V48, P95; Zintzen V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048522	63	22	22	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157717	10.1371/journal.pone.0157717	http://dx.doi.org/10.1371/journal.pone.0157717			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27368059	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900012
J	Shen, ZR; Shi, KD; Yu, YH; Yu, XN; Lin, YC; Yao, K				Shen, Zeren; Shi, Keda; Yu, Yinhui; Yu, Xiaoning; Lin, Yuchen; Yao, Ke			Small Incision Lenticule Extraction (SMILE) versus Femtosecond Laser-Assisted In Situ Keratomileusis (FS-LASIK) for Myopia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							REFRACTIVE SURGERY; CLINICAL-OUTCOMES; ASTIGMATISM; ABERRATIONS; PLATFORMS; EFFICACY; SAFETY; BIAS	Purpose The goal of this study was to compare small incision lenticule extraction (SMILE) with femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for treating myopia. Methods The CENTRAL, EMBASE, PubMed databases and a Chinese database (SinoMed) were searched in May of 2016. Twelve studies with 1,076 eyes, which included three randomized controlled trials (RCTs) and nine cohorts, met our inclusion criteria. The overall quality of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group framework. Data were extracted and analysed at three to six months postoperatively. Primary outcome measures included a loss of one or more lines of best spectacle corrected visual acuity (BSCVA), uncorrected visual acuity (UCVA) of 20/20 or better, mean logMAR UCVA, postoperative mean spherical equivalent (SE) and postoperative refraction within +/- 1.0 D of the target refraction. Secondary outcome measures included ocular surface disease index (OSDI), tear breakup time (TBUT) and Schirmer's 1 test (S1T) as dry eye parameters, along with corneal sensitivity. Results The overall quality of evidence was considered to be low to very low. Pooled results revealed no significant differences between the two groups with regard to a loss of one or more lines in the BSCVA (OR 1.71; 95% CI: 0.81, 3.63; P = 0.16), UCVA of 20/20 or better (OR 0.71; 95% CI: 0.44, 1.15; P = 0.16), logMAR UCVA (MD 0.00; 95% CI: -0.03, 0.04; P = 0.87), postoperative refractive SE (MD -0.00; 95% CI: -0.05, 0.05; P = 0.97) or postoperative refraction within +/- 1.0 D of the target refraction (OR 0.78; 95% CI: 0.22, 2.77; P = 0.70) within six months postoperatively. The pooled analysis also indicated that the FS-LASIK group suffered more severely from dry eye symptoms (OSDI; MD -6.68; 95% CI: -11.76, -2.00; P = 0.006) and lower corneal sensitivity (MD 12.40; 95% CI: 10.23, 14.56; P < 0.00001) at six months postoperatively. Conclusions In conclusion, both FS-LASIK and SMILE are safe, effective and predictable surgical options for treating myopia. However, dry eye symptoms and loss of corneal sensitivity may occur less frequently after SMILE than after FS-LASIK.	[Shen, Zeren; Yu, Yinhui; Yu, Xiaoning; Lin, Yuchen; Yao, Ke] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China; [Shi, Keda] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yao, K (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China.	xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Yao, Ke/0000-0002-6764-7365	Zhejiang Key Laboratory Fund of China [2011E10006]; Project of National Clinical Key Discipline of Chinese Ministry of Health	Zhejiang Key Laboratory Fund of China; Project of National Clinical Key Discipline of Chinese Ministry of Health	This work was supported by Zhejiang Key Laboratory Fund of China (2011E10006) and Project of National Clinical Key Discipline of Chinese Ministry of Health. KY is the recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2013, J CATARACT REFR SURG, V39, P1647, DOI 10.1016/j.jcrs.2013.04.044; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blanton CL, 2015, US OPHTHALMIC REV, V8, P23; Bohac M, 2014, GRAEF ARCH CLIN EXP, V252, P1679, DOI 10.1007/s00417-014-2776-2; Chan TCY, 2016, BRIT J OPHTHALMOL, V100, P553, DOI 10.1136/bjophthalmol-2015-307238; Chen SH, 2012, J REFRACT SURG, V28, P15, DOI 10.3928/1081597X-20111228-02; Denoyer A, 2015, OPHTHALMOLOGY, V122, P669, DOI 10.1016/j.ophtha.2014.10.004; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ganesh S, 2014, J REFRACT SURG, V30, P590, DOI 10.3928/1081597X-20140814-02; Gimeno FL, 2011, J CATARACT REFR SURG, V37, P538, DOI 10.1016/j.jcrs.2010.10.039; Gyldenkerne A, 2015, J REFRACT SURG, V31, P223, DOI 10.3928/1081597X-20150303-01; Hall RC, 2014, J CATARACT REFR SURG, V40, P423, DOI 10.1016/j.jcrs.2013.08.056; He M, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0129-5; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hu Y. K., 2013, INT EYE SCI, V13, P2074, DOI 10.3980/j.issn.1672-5123.2013.10.402-s2.0-84886264746; Lee JK, 2015, CURR OPIN OPHTHALMOL, V26, P260, DOI 10.1097/ICU.0000000000000158; Li MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077797; Li WJ, 2014, INT EYE SCI, V14, P1971; Liang JW, 2014, EJSO-EUR J SURG ONC, V40, P1614, DOI 10.1016/j.ejso.2014.04.009; Lin FY, 2014, J REFRACT SURG, V30, P248, DOI 10.3928/1081597X-20140320-03; Liu ML, 2016, CORNEA, V35, P210, DOI 10.1097/ICO.0000000000000707; Moher D, 2009, PLOS MED, DOI [10.1097/MD.0000000000017117, DOI 10.1097/MD.0000000000017117]; Petznick A, 2013, CLIN OPHTHALMOL, V7, P591, DOI 10.2147/OPTH.S42266; Rosman M, 2013, J CATARACT REFR SURG, V39, P1066, DOI 10.1016/j.jcrs.2013.02.038; Sandoval HP, 2005, J CATARACT REFR SURG, V31, P221, DOI 10.1016/j.jcrs.2004.08.047; Sefat SM, 2015, CURR EYE RES, V3683, P1; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Shen Y, 2014, J REFRACT SURG, V30, P310, DOI 10.3928/1081597X-20140422-01; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sugar Alan, 2002, Curr Opin Ophthalmol, V13, P246, DOI 10.1097/00055735-200208000-00011; Vestergaard AH, 2014, J CATARACT REFR SURG, V40, P403, DOI 10.1016/j.jcrs.2013.07.053; Wells G, 2008, NEWCASTLE OTTAWA SCA; Wilson SE, 2001, AM J OPHTHALMOL, V132, P405, DOI 10.1016/S0002-9394(01)00995-3; Xia L, 2016, CURR EYE RES, V1, P1; Yao PJ, 2013, J REFRACT SURG, V29, P669, DOI 10.3928/1081597X-20130806-01; Yu CQ, 2014, J CATARACT REFR SURG, V40, P412, DOI 10.1016/j.jcrs.2013.08.050; Zhang JM, 2016, CORNEA, V35, P523, DOI 10.1097/ICO.0000000000000782; Zhang YJ, 2016, J REFRACT SURG, V32, P256, DOI 10.3928/1081597X-20151111-06; Zhao LQ, 2010, OPHTHALMOLOGY, V117, P1912, DOI 10.1016/j.ophtha.2010.02.004	42	52	54	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158176	10.1371/journal.pone.0158176	http://dx.doi.org/10.1371/journal.pone.0158176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367803	gold, Green Submitted, Green Published			2022-12-27	WOS:000378914900019
J	Godoi, D; Barela, JA				Godoi, Daniela; Barela, Jose A.			Optical Flow Structure Effects in Children's Postural Control	PLOS ONE			English	Article							VISUAL INFORMATION; PERIPHERAL-VISION; BODY SWAY; STANCE; ADAPTATION; SENSITIVITY; INFANTS; BALANCE; INTEGRATION; PERCEPTION	The aim of this study was to investigate the effect of distance and optic flow structure on visual information and body sway coupling in children and young adults. Thirty children (from 4 to 12 years of age) and 10 young adults stood upright inside of a moving room oscillating at 0.2 Hz, at 0.25 and 1.5 m from the front wall, and under three optical flow conditions (global, central, and peripheral). Effect of distance and optic flow structure on the coupling of visual information and body sway is age-dependent, with 4-year-olds being more affected at 0.25 m distance than older children and adults are. No such difference was observed at 1.5 m from the front wall. Moreover, 4-year-olds' sway was larger and displayed higher variability. These results suggest that despite being able to accommodate change resulting from varying optic flow conditions, young children have difficulty in dodging stronger visual stimuli. Lastly, difference in sway performance may be due to immature inter-modality sensory reweighting.	[Godoi, Daniela] Fed Univ Sao Carlos UFSCar, Ctr Biol Sci & Hlth, Dept Phys Educ, Sao Carlos, SP, Brazil; [Barela, Jose A.] Cruzeiro Sul Univ UNICSUL, Inst Phys Act & Sport Sci, Sao Paulo, SP, Brazil; [Barela, Jose A.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Phys Educ, Rio Claro, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Cruzeiro do Sul; Universidade Estadual Paulista	Godoi, D (corresponding author), Fed Univ Sao Carlos UFSCar, Ctr Biol Sci & Hlth, Dept Phys Educ, Sao Carlos, SP, Brazil.	danielagodoij@gmail.com	Barela, José A/F-4284-2012; Godoi Jacomassi, Daniela/O-4220-2014	Barela, José A/0000-0003-0951-254X; Godoi Jacomassi, Daniela/0000-0002-7043-7529				Bair WN, 2011, GAIT POSTURE, V34, P183, DOI 10.1016/j.gaitpost.2011.04.007; Barela AMF, 2009, MOTOR CONTROL, V13, P119, DOI 10.1123/mcj.13.2.119; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Barela JA, 2000, INFANT BEHAV DEV, V23, P285, DOI 10.1016/S0163-6383(01)00045-5; Barela JA, 2011, J VISION, V11, DOI 10.1167/11.12.10; BERTENTHAL BI, 1989, DEV PSYCHOL, V25, P936, DOI 10.1037/0012-1649.25.6.936; Ellemberg D, 2004, VISION RES, V44, P2403, DOI 10.1016/j.visres.2004.05.006; FIGURA F, 1991, J SPORT MED PHYS FIT, V31, P235; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Freitas Junior PB, 2004, NEUROSCI LETT, V369, P64, DOI 10.1016/j.neulet.2004.07.075; Godoi D, 2008, DEV PSYCHOBIOL, V50, P77, DOI 10.1002/dev.20272; Gunn A, 2002, NEUROREPORT, V13, P843, DOI 10.1097/00001756-200205070-00021; Higgins CI, 1996, DEV PSYCHOL, V32, P836, DOI 10.1037/0012-1649.32.5.836; Jeka J, 2000, EXP BRAIN RES, V134, P107, DOI 10.1007/s002210000412; Jeka JJ, 2008, EXP BRAIN RES, V191, P453, DOI 10.1007/s00221-008-1539-x; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Metcalfe JS, 2005, DEV PSYCHOBIOL, V46, P19, DOI 10.1002/dev.20037; Ferronato PAM, 2011, MOTOR CONTROL, V15, P481, DOI 10.1123/mcj.15.4.481; Nougier V, 1997, GAIT POSTURE, V5, P34, DOI 10.1016/S0966-6362(96)01071-5; Nougier V, 1998, J EXP CHILD PSYCHOL, V68, P202, DOI 10.1006/jecp.1997.2427; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Polastri PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082215; Polastri PF, 2012, EXP BRAIN RES, V223, P99, DOI 10.1007/s00221-012-3244-z; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; Rinaldi NM, 2009, NEUROSCI LETT, V467, P225, DOI 10.1016/j.neulet.2009.10.042; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; Schmuckler MA, 1997, J EXP PSYCHOL HUMAN, V23, P528, DOI 10.1037/0096-1523.23.2.528; Schoner G, 1998, ECOL PSYCHOL, V10, P323, DOI 10.1207/s15326969eco103&4_9; Sparto PJ, 2006, EXP BRAIN RES, V168, P505, DOI 10.1007/s00221-005-0109-8; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; STOFFREGEN TA, 1985, J EXP PSYCHOL HUMAN, V11, P554, DOI 10.1037/0096-1523.11.5.554; STOFFREGEN TA, 1986, PERCEPT PSYCHOPHYS, V39, P355, DOI 10.3758/BF03203004; TAGUCHI K, 1988, INT CONGR SER, V812, P59; Usui N, 1995, DEV MED CHILD NEUROL, V37, P985; Williams AM, 1999, INDIRECT THEORIES PE, P3; Wolff DR, 1998, J ORTHOPAED RES, V16, P271, DOI 10.1002/jor.1100160215; WOOLLACOTT M, 1987, J MOTOR BEHAV, V19, P167	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158416	10.1371/journal.pone.0158416	http://dx.doi.org/10.1371/journal.pone.0158416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352305	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900058
J	Peverill, RE; Chou, B; Donelan, L; Mottram, PM; Gelman, JS				Peverill, Roger E.; Chou, Bon; Donelan, Lesley; Mottram, Philip M.; Gelman, John S.			Possible Mechanisms Underlying Aging-Related Changes in Early Diastolic Filling and Long Axis Motion-Left Ventricular Length and Blood Pressure	PLOS ONE			English	Article							TRANSMITRAL FLOW VELOCITY; AGE-RELATED-CHANGES; DOPPLER-ECHOCARDIOGRAPHY; HEALTHY-SUBJECTS; HEART-RATE; REFERENCE VALUES; MITRAL ANNULUS; RELAXATION; DYSFUNCTION; HUMANS	Background The transmitral E wave and the peak velocity of early diastolic mitral annular motion (e') both decrease with age, but the mechanisms underlying these age-related changes are incompletely understood. This study investigated the possible contributions of blood pressure (BP) and left ventricular end-diastolic length (LVEDL) to age-related reductions in E and e'. Methods The study group were 82 healthy adult subjects <55 years of age who were not obese or hypertensive. Transmitral flow and mitral annular motion were recorded using pulsed-wave Doppler. LVEDL was measured from the mitral annular plane to the apical endocardium. Results Age was positively correlated with diastolic BP and septal wall thickness (SWT), inversely correlated with LVEDL (beta = -0.25) after adjustment for sex and body surface area, but was not related to left ventricular end-diastolic diameter (LVEDD). Age was also inversely correlated with E (r = -0.36), septal e'(r = -0.53) and lateral e'(r = -0.53). On multivariable analysis, E was inversely correlated with diastolic BP and LVEDD, septal e' was inversely correlated with diastolic BP and positively correlated with SWT and LVEDL, after adjusting for body mass index, whilst lateral e' was inversely correlated with diastolic BP and positively correlated with LVEDL. Conclusion The above findings are consistent with higher BP being a contributor to age-related reductions in both E and e' and shortening of LVEDL with age being a contributor to the age-related reduction in e'. An implication of these findings is that slowing of myocyte relaxation is unlikely to be the sole, and may not be the main, mechanism underlying age-related decreases in E and e'.	[Peverill, Roger E.] Monash Univ, Monash Cardiovasc Res Ctr, Monash Heart, Clayton, Vic, Australia; Monash Univ, Dept Med, Sch Clin Sci, Monash Med Ctr, Clayton, Vic, Australia; Monash Hlth, Clayton, Vic, Australia	Monash University; Monash University	Peverill, RE (corresponding author), Monash Univ, Monash Cardiovasc Res Ctr, Monash Heart, Clayton, Vic, Australia.	roger.peverill@monash.edu		Peverill, Roger/0000-0002-3319-5356				Alam M, 1999, J AM SOC ECHOCARDIOG, V12, P618, DOI 10.1053/je.1999.v12.a99246; Appleton C. P., 2008, KLEIN GARCIA DIASTOL, P115; Batterham A, 2008, EUR J ECHOCARDIOGR, V9, P542, DOI 10.1093/ejechocard/jen114; BENJAMIN EJ, 1992, AM J CARDIOL, V70, P508, DOI 10.1016/0002-9149(92)91199-E; Biering-Sorensen T, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002687; BONOW RO, 1988, J AM COLL CARDIOL, V11, P50, DOI 10.1016/0735-1097(88)90166-0; Borlaug BA, 2007, J AM COLL CARDIOL, V50, P1570, DOI 10.1016/j.jacc.2007.07.032; CAPASSO JM, 1983, AM J PHYSIOL, V245, pH72, DOI 10.1152/ajpheart.1983.245.1.H72; Carrick-Ranson G, 2012, AM J PHYSIOL-HEART C, V303, P315, DOI 10.1152/ajpheart.00142.2012; Chahal NS, 2010, EUR J ECHOCARDIOGR, V11, P51, DOI 10.1093/ejechocard/jep164; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Chirinos JA, 2013, HYPERTENSION, V61, P296, DOI 10.1161/HYPERTENSIONAHA.111.00530; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; CHOONG CY, 1988, CIRCULATION, V78, P672, DOI 10.1161/01.CIR.78.3.672; Chung CS, 2008, AM J PHYSIOL-HEART C, V294, pH1589, DOI 10.1152/ajpheart.00990.2007; COURTOIS M, 1992, CIRCULATION, V85, P1132, DOI 10.1161/01.CIR.85.3.1132; COURTOIS M, 1988, CIRCULATION, V78, P661, DOI 10.1161/01.CIR.78.3.661; Dalen H, 2010, CIRC-CARDIOVASC IMAG, V3, P614, DOI 10.1161/CIRCIMAGING.109.926022; Davies CH, 1996, CARDIOVASC RES, V31, P152, DOI 10.1016/0008-6363(95)00187-5; De Mey S, 2001, AM J PHYSIOL-HEART C, V280, pH2936, DOI 10.1152/ajpheart.2001.280.6.H2936; de Simone G, 2005, HYPERTENSION, V45, P64, DOI 10.1161/01.HYP.0000150108.37527.57; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; DOWNES TR, 1989, AM J CARDIOL, V64, P523, DOI 10.1016/0002-9149(89)90433-5; Edner M, 2000, Eur J Echocardiogr, V1, P87, DOI 10.1053/euje.2000.0013; FERRARA N, 1995, J MOL CELL CARDIOL, V27, P1141, DOI 10.1016/0022-2828(95)90050-0; Franklin SS, 1997, CIRCULATION, V96, P308; FREEMAN GL, 1987, CIRC RES, V61, P455, DOI 10.1161/01.RES.61.3.455; Gardin JM, 1998, AM J CARDIOL, V82, P345, DOI 10.1016/S0002-9149(98)00339-7; GENOVESIEBERT A, 1991, J HYPERTENS, V9, P345, DOI 10.1097/00004872-199104000-00006; Gibson DG, 2003, HEART, V89, P231, DOI 10.1136/heart.89.2.231; GILBERT JC, 1989, CIRC RES, V64, P827, DOI 10.1161/01.RES.64.5.827; GILLEBERT TC, 1991, AM J PHYSIOL, V261, pH805, DOI 10.1152/ajpheart.1991.261.3.H805; GRAETTINGER WF, 1987, J AM COLL CARDIOL, V10, P1280, DOI 10.1016/S0735-1097(87)80132-8; GROSSMAN W, 1977, CIRCULATION, V56, P845, DOI 10.1161/01.CIR.56.5.845; Hees PS, 2002, AM J CARDIOL, V90, P1231, DOI 10.1016/S0002-9149(02)02840-0; Hees PS, 2004, AM J PHYSIOL-HEART C, V286, pH782, DOI 10.1152/ajpheart.01092.2002; Henein M, 2002, EUR HEART J, V23, P162, DOI 10.1053/euhj.2001.3032; HIROTA Y, 1980, CIRCULATION, V62, P756, DOI 10.1161/01.CIR.62.4.756; Iketani T, 1998, JPN CIRC J, V62, P581, DOI 10.1253/jcj.62.581; Jasaityte R, 2014, ULTRASOUND MED BIOL, V40, P37, DOI 10.1016/j.ultrasmedbio.2013.09.005; KAPUKU GK, 1993, AM HEART J, V125, P1710, DOI 10.1016/0002-8703(93)90763-Y; Kasner M, 2007, CIRCULATION, V116, P637, DOI 10.1161/CIRCULATIONAHA.106.661983; KITZMAN DW, 1991, J AM COLL CARDIOL, V18, P1243, DOI 10.1016/0735-1097(91)90542-H; KLEIN AL, 1994, MAYO CLIN PROC, V69, P212, DOI 10.1016/S0025-6196(12)61059-3; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; Liu CY, 2013, J AM COLL CARDIOL, V62, P1280, DOI 10.1016/j.jacc.2013.05.078; MANTERO A, 1995, EUR HEART J, V16, P94, DOI 10.1093/eurheartj/16.1.94; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; Mellor KM, 2014, AGE, V36, P1155, DOI 10.1007/s11357-014-9630-7; Mogelvang R, 2009, EUR HEART J, V30, P731, DOI 10.1093/eurheartj/ehn596; Muller-Brunotte R, 2003, J HUM HYPERTENS, V17, P841, DOI 10.1038/sj.jhh.1001622; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Mureddu GF, 1997, HYPERTENSION, V29, P544, DOI 10.1161/01.HYP.29.2.544; Mureddu GF, 1996, AM J CARDIOL, V77, P509, DOI 10.1016/S0002-9149(97)89346-0; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nikitin NP, 2005, AGE AGEING, V34, P343, DOI 10.1093/ageing/afi043; Nooyens ACJ, 2009, PUBLIC HEALTH NUTR, V12, P862, DOI 10.1017/S1368980008003091; Oh JK, 2011, CIRC-CARDIOVASC IMAG, V4, P444, DOI 10.1161/CIRCIMAGING.110.961623; Ohte N, 1998, AM J CARDIOL, V82, P1414, DOI 10.1016/S0002-9149(98)00651-1; Oki T, 1999, J AM SOC ECHOCARDIOG, V12, P476, DOI 10.1016/S0894-7317(99)70084-2; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Ommen SR, 2000, CIRCULATION, V102, P1788; Paulus WJ, 2007, EUR HEART J; Pela G, 2004, J AM SOC ECHOCARDIOG, V17, P205, DOI 10.1016/j.echo.2003.12.004; Peterson LR, 2004, J AM COLL CARDIOL, V43, P1399, DOI 10.1016/j.jacc.2003.10.062; Peverill RE, 2004, J AM SOC ECHOCARDIOG, V17, P1146, DOI 10.1016/j.echo.2004.06.007; Popovic ZB, 2006, AM J PHYSIOL-HEART C, V290, pH1454, DOI 10.1152/ajpheart.00902.2005; Prasad A, 2005, CIRCULATION, V111, P1499, DOI 10.1161/01.CIR.0000159353.31271.F2; Prasad A, 2007, AM J CARDIOL, V99, P1629, DOI 10.1016/j.amjcard.2007.01.050; Rodriguez L, 1996, AM HEART J, V131, P982, DOI 10.1016/S0002-8703(96)90183-0; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Slotwiner DJ, 1998, AM J CARDIOL, V82, P621, DOI 10.1016/S0002-9149(98)00390-7; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Solomon SD, 2007, LANCET, V369, P2079, DOI 10.1016/S0140-6736(07)60980-5; Solomon SD, 2010, HYPERTENSION, V55, P241, DOI 10.1161/HYPERTENSIONAHA.109.138529; SPIRITO P, 1988, BRIT HEART J, V59, P672; STARLING MR, 1987, CIRCULATION, V76, P1274, DOI 10.1161/01.CIR.76.6.1274; Subherwal S, 2010, AM HEART J, V159, P1081, DOI 10.1016/j.ahj.2010.02.024; Svealv BG, 2006, EUR J ECHOCARDIOGR, V7, P298, DOI 10.1016/j.euje.2005.06.008; SWINNE CJ, 1992, AM J CARDIOL, V69, P823, DOI 10.1016/0002-9149(92)90518-4; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Yamakado T, 1997, CIRCULATION, V95, P917; Yamakado T, 1998, AM HEART J, V135, P584, DOI 10.1016/S0002-8703(98)70271-6; Yano M, 2001, AM J PHYSIOL-HEART C, V280, pH1846, DOI 10.1152/ajpheart.2001.280.4.H1846	86	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158302	10.1371/journal.pone.0158302	http://dx.doi.org/10.1371/journal.pone.0158302			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351745	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900052
J	Xue, MF; Gong, SL; Dai, JP; Chen, G; Hu, JY				Xue, MingFeng; Gong, SuiLiang; Dai, JiaPing; Chen, Gang; Hu, JunYu			The Treatment of Fibrosis of Joint Synovium and Frozen Shoulder by Smad4 Gene Silencing in Rats	PLOS ONE			English	Article							TGF-BETA; DIFFERENTIATION; CELLS	Soft tissue fibrosis at the joint induced by inflammation is the pathological basis of frozen shoulder. In the present study, we utilized a lentiviral approach to silence the Smad4 gene in an in vitro fibrosis model of fibroblasts and an in vivo frozen shoulder model. We observed the change in the fibrosis process and the biological indicators of frozen shoulder. The in vitro fibrosis models (Rat myoblasts L6, Rat synovial cell RSC-364 and Rat chondrocytes RCs) were established using TGF-beta 1 induction, and the effect of Smad4 gene silencing on fibrosis was analyzed. The method of Kanno A was employed to establish a rat model of frozen shoulder, and Smad4 in the relevant part was knocked down with the lentiviral approach. We then examined the abduction and rotation angles and the length of synovial intima and measured the inflammatory factors in effusion and the fibrotic markers of tissues. We found that Smad4 knockdown suppressed the proliferation and expression of fibrotic markers in L6, RSC-364 and RCs cells induced by TGF-beta 1. MMP activity measurements showed that Smad4 knockdown significantly reversed the decrease in MMP activity in these three cell lines that were induced by TGF-beta 1. Furthermore, using lentivirus in the rat frozen shoulder model, we found that Smad4 silencing attenuated the inflammatory response and fibrosis. It significantly inhibited the increase of the Vimentin, a-SMA, collagen I and III, Lama1 and Timp1 proteins in synovial tissue as well as the inflammatory factors of TNF-alpha, IL-1 alpha/beta, IL-6 and IL-10 in effusion. MMP acidity assays revealed that Smad4 silencing inhibited MMP activity in the synovial, cartilage and ligament tissues in the model animals. The assessment of the phosphorylated Smad2/3 in the nuclei isolated from the synovial tissues showed that Smad4 silencing significantly inhibited the phosphorylation and subsequent nuclear translocation of Smad2/3 proteins. Moreover, Smad4-shRNA lentivirus inhibited the decrease in both the abduction and rotation angles caused by immobilization as well as the decrease in the length of the synovial intima. Based on shoulder movement data, Smad4 knockdown can increase the rotation limitation caused by immobilization. In summary, Smad4 silencing can suppress chronic inflammation and fibrosis in joint tissues by inhibiting the TGF-beta/Smad pathway and can play a positive role in the prevention and treatment of joint stiffness.	[Xue, MingFeng; Gong, SuiLiang; Dai, JiaPing; Chen, Gang; Hu, JunYu] Jiaxing Second Hosp, Dept Orthopaed Surg, Jia Xing 31400, Peoples R China		Gong, SL (corresponding author), Jiaxing Second Hosp, Dept Orthopaed Surg, Jia Xing 31400, Peoples R China.	suiliangg55@163.com			Jia Xing Science & Technology Bureau [2012AY1071-7]	Jia Xing Science & Technology Bureau	This study was supported by Fund of Jia Xing Science & Technology Bureau (2012AY1071-7).	Asghari MH, 2015, RES PHARM SCI, V10, P429; [陈疾忤 Chen Jiwu], 2004, [中国临床解剖学杂志, Chinese Journal of Clinical Anatomy], V22, P55; Foster W, 2003, J ORTHOP RES, V21, P798, DOI 10.1016/S0736-0266(03)00059-7; Goto Y, 2004, CELL TISSUE RES, V315, P209, DOI 10.1007/s00441-003-0824-z; Hand GCR, 2007, J BONE JOINT SURG BR, V89B, P928, DOI 10.1302/0301-620X.89B7.19097; Hao JM, 1999, J MOL CELL CARDIOL, V31, P667, DOI 10.1006/jmcc.1998.0902; Kanno A, 2010, J SHOULDER ELB SURG, V19, P700, DOI 10.1016/j.jse.2010.02.004; Kopp J, 2005, J BIOL CHEM, V280, P21570, DOI 10.1074/jbc.m502071200; [李宏云 LI Hong-yun], 2009, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V29, P1363; Li YC, 2016, AM J PHYSIOL-GASTR L, V310, pG262, DOI 10.1152/ajpgi.00257.2015; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Omari A, 2001, J SHOULDER ELB SURG, V10, P353, DOI 10.1067/mse.2001.115986; Pennison M, 2007, CURR OPIN ONCOL, V19, P579, DOI 10.1097/CCO.0b013e3282f0ad0e; Piersma B, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00059; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002	15	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158093	10.1371/journal.pone.0158093	http://dx.doi.org/10.1371/journal.pone.0158093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351864	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900031
J	Campbell, NG; Kaneko, M; Shintani, Y; Narita, T; Sawhney, V; Coppen, SR; Yashiro, K; Mathur, A; Suzuki, K				Campbell, Niall G.; Kaneko, Masahiro; Shintani, Yasunori; Narita, Takuya; Sawhney, Vinit; Coppen, Steven R.; Yashiro, Kenta; Mathur, Anthony; Suzuki, Ken			Cell Size Critically Determines Initial Retention of Bone Marrow Mononuclear Cells in the Heart after Intracoronary Injection: Evidence from a Rat Model	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; ISCHEMIC CARDIOMYOPATHY; THERAPY; DELIVERY; MICROVASCULATURE; TRANSPLANTATION; ENGRAFTMENT; INFUSION; DISEASE	Intracoronary injection of bone marrow mononuclear cells (BMMNC) is an emerging treatment for heart failure. Initial donor cell retention in the heart is the key to the success of this approach, but this process remains insufficiently characterized. Although it is assumed that cell size of injected cells may influence their initial retention, no scientific evidence has been reported. We developed a unique model utilizing an ex-vivo rat heart perfusion system, enabling quantitative assessment of retention of donor cells after intracoronary injection. The initial (5 minutes after intracoronary injection) retention rate of BMMNC was as low as approximately 20% irrespective of donor cell doses injected (1x10(6), 8x10(6), 4x10(7)). Quantitative cell-size assessment revealed a positive relationship between the size of BMMNC and retention ratio; larger subpopulations of BMMNC were more preferentially retained compared to smaller ones. Furthermore, a larger cell type-bone marrow-derived mesenchymal stromal cells (median size = 11.5 mu m versus 7.0 mu m for BMMNC)-had a markedly increased retention rate (77.5 +/- 1.8%). A positive relationship between the cell size and retention ratio was also seen in mesenchymal stromal cells. Flow-cytometric studies showed expression of cell-surface proteins, including integrins and selectin-ligands, was unchanged between pre-injection BMMNC and those exited from the heart, suggesting that biochemical interaction between donor cells and host coronary endothelium is not critical for BMMNC retention. Histological analyses showed that retained BMMNC and mesenchymal stromal cells were entrapped in the coronary vasculature and did not extravasate by 60 minutes after transplantation. Whilst BMMNC did not change coronary flow after intracoronary injection, mesenchymal stromal cells reduced it, suggesting coronary embolism, which was supported by the histological finding of intravascular cell-clump formation. These data indicate that cell-size dependent, passive (mechanical), intravascular entrapment is responsible for the initial donor cell retention after intracoronary injection of BMMNC in the heart having normal vasculatures (at least).	[Campbell, Niall G.; Kaneko, Masahiro; Shintani, Yasunori; Narita, Takuya; Sawhney, Vinit; Coppen, Steven R.; Yashiro, Kenta; Mathur, Anthony; Suzuki, Ken] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Suzuki, K (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	ken.suzuki@qmul.ac.uk		MAthur, Anthony/0000-0001-7941-9653; Campbell, Niall/0000-0003-4269-3848; Shintani, Yasunori/0000-0001-9579-0727	British Heart Foundation Clinical Research Fellowship [FS/08/072]; National Institute for Health Research; British Heart Foundation [PG/12/10/29389, RG/15/3/31236] Funding Source: researchfish	British Heart Foundation Clinical Research Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This project was funded by British Heart Foundation Clinical Research Fellowship (FS/08/072 awarded to NGC), and also supported by the National Institute for Health Research-funded Barts Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal MR, 2015, CIRC RES, V117, P558, DOI 10.1161/CIRCRESAHA.114.304792; Assmus B, 2015, EUR HEART J; Bartolucci J, 2015, REV MED CHILE, V143, P415, DOI 10.4067/S0034-98872015000400001; BASSINGT.JB, 1974, MICROVASC RES, V7, P229, DOI 10.1016/0026-2862(74)90008-9; Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Choudry F, 2016, EUR HEART J, V37, P256, DOI 10.1093/eurheartj/ehv493; Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372; Doyle B, 2007, J NUCL MED, V48, P1708, DOI 10.2967/jnumed.107.042838; Fisher SA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007888.pub2; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fukushima S, 2011, J HEART LUNG TRANSPL, V30, P227, DOI 10.1016/j.healun.2010.09.002; Goebel S, 2003, J VASC RES, V40, P442, DOI 10.1159/000073909; Hedrich O, 2004, CORONARY ARTERY DIS, V15, P291, DOI 10.1097/01.mca.0000136186.85058.b8; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Kaneko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076908; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Makela J, 2009, SCAND CARDIOVASC J, V43, P366, DOI 10.3109/14017430903045350; Martino H, 2015, EUR HEART J, V36, P2898, DOI 10.1093/eurheartj/ehv477; Mathiasen AB, 2015, EUR HEART J, V36, P1744, DOI 10.1093/eurheartj/ehv136; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; ONO T, 1986, SCAN ELECTRON MICROS, V1986, P263; Penicka M, 2007, HEART, V93, P837, DOI 10.1136/hrt.2006.091934; Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110; Shiraishi M, 2016, J CLIN INVEST; Surder D, 2013, CIRCULATION, V127, P1968, DOI 10.1161/CIRCULATIONAHA.112.001035; Tanol N, 2014, MOL THER, V22, P1864, DOI 10.1038/mt.2014.110; Taylor DA, 2015, CELL TRANSPLANT; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; van der Spoel TIG, 2012, J CELL MOL MED, V16, P2768, DOI 10.1111/j.1582-4934.2012.01594.x	33	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158232	10.1371/journal.pone.0158232	http://dx.doi.org/10.1371/journal.pone.0158232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380410	gold, Green Submitted, Green Published			2022-12-27	WOS:000379798700023
J	Sato, A; Kamekura, R; Kawata, K; Kawada, M; Jitsukawa, S; Yamashita, K; Sato, N; Himi, T; Ichimiya, S				Sato, Akinori; Kamekura, Ryuta; Kawata, Koji; Kawada, Masaya; Jitsukawa, Sumito; Yamashita, Keiji; Sato, Noriyuki; Himi, Tetsuo; Ichimiya, Shingo			Novel Mechanisms of Compromised Lymphatic Endothelial Cell Homeostasis in Obesity: The Role of Leptin in Lymphatic Endothelial Cell Tube Formation and Proliferation	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; HEREDITARY LYMPHEDEMA; SOLUBLE RECEPTOR; EXPRESSION; IL-6; ANGIOGENESIS; IDENTIFICATION; INFLAMMATION; DYSFUNCTION	Leptin is a hormone produced by adipose tissue that regulates various physiological processes. Recent studies have shown that the level of circulating leptin is elevated in obese patients and have suggested a relationship between obesity and postoperative lymphedema. However, the mechanisms by which postoperative lymphedema develops in obese patients and the mechanisms by which leptin regulates lymphatic endothelial cell homeostasis such as tube formation and cell proliferation remain unknown. Here we report that leptin regulates tube formation and cell proliferation in human dermal lymphatic endothelial cells (HDLECs) by activation of the signal transducer and activator of transcription 3 pathway, which is downstream signaling of the leptin receptor. Additionally, we found that upregulation of suppressor of cytokine signaling 3 underlies the mechanisms by which a high dose of leptin inhibits cell proliferation and tube formation. Leptin also enhanced expression of the proinflammatory cytokine IL-6 in HDLECs. Interestingly, IL-6 rescues the compromised cell proliferation and tube formation caused by treatment with a high dose of leptin in an autocrine or paracrine manner. Taken together, our findings reveal a novel mechanism by which compromised HDLECs maintain their homeostasis during inflammation mediated by leptin and IL-6. Thus, regulating the level of leptin or IL-6 may be a viable strategy to reduce the incidence of postoperative lymphedema.	[Sato, Akinori; Kamekura, Ryuta; Kawata, Koji; Jitsukawa, Sumito; Yamashita, Keiji; Ichimiya, Shingo] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Human Immunol, Sapporo, Hokkaido, Japan; [Sato, Akinori; Sato, Noriyuki] Sapporo Med Univ, Dept Pathol, Sch Med, Sapporo, Hokkaido, Japan; [Sato, Akinori; Kawada, Masaya] Tonan Hosp, KKR Sapporo Med Ctr, Div Breast Surg, Sapporo, Hokkaido, Japan; [Kamekura, Ryuta; Jitsukawa, Sumito; Yamashita, Keiji; Himi, Tetsuo] Sapporo Med Univ, Dept Otolaryngol, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Ichimiya, S (corresponding author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Human Immunol, Sapporo, Hokkaido, Japan.	ichimiya@sapmed.ac.jp			GSK Japan Research Grant; Japanese Society for the Promotion of Science (JSPS) [26893213, 15K10787, 15K16399, 15K20214, 26861398, 26293370, 26670746, 26670178, 23590405]	GSK Japan Research Grant; Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the GSK Japan Research Grant (R.K.) and the Japanese Society for the Promotion of Science (JSPS) grants #26893213 and #15K10787 (R.K.), #15K16399 (A.S.), #15K20214 (K.K.), #26861398 (K.Y.), #26293370 and #26670746 (T.H.), #26670178 and #23590405 (S.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2011, J CLIN IMMUNOL, V31, P472, DOI [10.1007/s10875-010-9456-8, 10.1007/s10875-010-9507-1]; Artwohl M, 2002, INT J OBESITY, V26, P577, DOI 10.1038/sj.ijo.0801947; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Basak S, 2012, EUR J OBSTET GYN R B, V164, P24, DOI 10.1016/j.ejogrb.2012.05.033; Bluyssen HAR, 2010, AM J PHYSIOL-CELL PH, V299, pC354, DOI 10.1152/ajpcell.00513.2009; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Brorson Hakan, 2006, Lymphatic Research and Biology, V4, P199, DOI 10.1089/lrb.2006.4404; CASLEYS.J, 1961, Q J EXP PHYSIOL CMS, V46, P101, DOI 10.1113/expphysiol.1961.sp001502; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Corrigan CJ, 2011, P NATL ACAD SCI USA, V108, P1579, DOI 10.1073/pnas.1014241108; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fenton JI, 2006, CARCINOGENESIS, V27, P1507, DOI 10.1093/carcin/bgl018; Ferla R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-303; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Huang F, 2010, ACTA BIOCH BIOPH SIN, V42, P325, DOI 10.1093/abbs/gmq025; Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019; Ji RC, 2005, HISTOL HISTOPATHOL, V20, P155, DOI 10.14670/HH-20.155; Kazmi A, 2013, J PAK MED ASSOC, V63, P245; Kim CY, 2014, J NUTR BIOCHEM, V25, P26, DOI 10.1016/j.jnutbio.2013.08.011; Korda M, 2008, AM J PHYSIOL-HEART C, V295, pH1514, DOI 10.1152/ajpheart.00479.2008; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kwan ML, 2010, ARCH SURG-CHICAGO, V145, P1055, DOI 10.1001/archsurg.2010.231; Laud K, 2002, MOL CELL ENDOCRINOL, V188, P219, DOI 10.1016/S0303-7207(01)00678-5; LEAK L V, 1970, Microvascular Research, V2, P361, DOI 10.1016/0026-2862(70)90031-2; LealCerro A, 1996, HORM METAB RES, V28, P711, DOI 10.1055/s-2007-979884; Li J, 2006, DRUG DISCOV TODAY DI, V3, P387, DOI DOI 10.1016/J.DDMEC.2006.09.003; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053176; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; McLoughlin RM, 2004, J IMMUNOL, V172, P5676, DOI 10.4049/jimmunol.172.9.5676; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Ogata F, 2015, BRIT J DERMATOL, V172, P1286, DOI 10.1111/bjd.13482; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Park Hyeong-Kyu, 2014, F1000Prime Rep, V6, P73, DOI 10.12703/P6-73; Paskett ED, 2007, CANCER EPIDEM BIOMAR, V16, P775, DOI 10.1158/1055-9965.EPI-06-0168; Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399; Ridner SH, 2011, SUPPORT CARE CANCER, V19, P853, DOI 10.1007/s00520-011-1089-9; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rose D P, 2004, Obes Rev, V5, P153, DOI 10.1111/j.1467-789X.2004.00142.x; Rose DP, 2002, INT J ONCOL, V21, P1285; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Skobe M, 2000, J INVEST DERM SYMP P, V5, P14, DOI 10.1046/j.1087-0024.2000.00001.x; Swenson KK, 2009, ONCOL NURS FORUM, V36, P185, DOI 10.1188/09.ONF.185-193; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; Teramo A, 2013, BLOOD, V121, P3843, DOI 10.1182/blood-2012-07-441378; Wagoner B, 2006, AM J PHYSIOL-REG I, V290, pR1557, DOI 10.1152/ajpregu.00860.2005; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; Yang WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075551	55	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158408	10.1371/journal.pone.0158408	http://dx.doi.org/10.1371/journal.pone.0158408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27366905	gold, Green Submitted, Green Published			2022-12-27	WOS:000378914900033
J	Carrier, M; Joint, M; Lutzing, R; Page, A; Rochette-Egly, C				Carrier, Marilyn; Joint, Mathilde; Lutzing, Regis; Page, Adeline; Rochette-Egly, Cecile			Phosphoproteome and Transcriptome of RA-Responsive and RA-Resistant Breast Cancer Cell Lines	PLOS ONE			English	Article							RETINOIC ACID RECEPTORS; SIGNALING NETWORKS; RNA-SEQ; PHOSPHORYLATION; NUCLEAR; BINDING; ALPHA; DIFFERENTIATION; EXPRESSION; PROTEOMICS	Retinoic acid (RA), the main active vitamin A metabolite, controls multiple biological processes such as cell proliferation and differentiation through genomic programs and kinase cascades activation. Due to these properties, RA has proven anti-cancer capacity. Several breast cancer cells respond to the antiproliferative effects of RA, while others are RA-resistant. However, the overall signaling and transcriptional pathways that are altered in such cells have not been elucidated. Here, in a large-scale analysis of the phosphoproteins and in a genome-wide analysis of the RA-regulated genes, we compared two human breast cancer cell lines, a RA-responsive one, the MCF7 cell line, and a RA-resistant one, the BT474 cell line, which depicts several alterations of the "kinome". Using high-resolution nano-LC-LTQ-Orbitrap mass spectrometry associated to phosphopeptide enrichment, we found that several proteins involved in signaling and in transcription, are differentially phosphorylated before and after RA addition. The paradigm of these proteins is the RA receptor alpha (RAR alpha), which was phosphorylated in MCF7 cells but not in BT474 cells after RA addition. The panel of the RA-regulated genes was also different. Overall our results indicate that RA resistance might correlate with the deregulation of the phosphoproteome with consequences on gene expression.	[Carrier, Marilyn; Lutzing, Regis; Rochette-Egly, Cecile] Univ Strasbourg, Dept Funct Genom & Canc, INSERM, IGBMC,U964,CNRS,UMR7104, 1 Rue Laurent Fries,BP 10142, F-67404 Strasbourg, France; [Joint, Mathilde; Page, Adeline] Univ Strasbourg, Prote Platform, INSERM, IGBMC,U964,CNRS,UMR7104, 1 Rue Laurent Fries,BP 10142, F-67404 Strasbourg, France; [Carrier, Marilyn] Univ Montreal, Inst Rech Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Page, Adeline] IBCP, SFR Biosci, Prot Sci Facil, F-69367 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Montreal	Rochette-Egly, C (corresponding author), Univ Strasbourg, Dept Funct Genom & Canc, INSERM, IGBMC,U964,CNRS,UMR7104, 1 Rue Laurent Fries,BP 10142, F-67404 Strasbourg, France.	cegly@igbmc.fr		Regis, Lutzing/0000-0002-9927-1825	CRE from the Agence Nationale pour la Recherche [ANR-09-BLAN-0297-01]; Association pour la recherche sur le Cancer [SL 220110603474, PJA20141201746]; Fondation pour la Recherche Medicale (FRM) [DEQ20090515423]; Institut National du Cancer [PL09-194]; ANR under the frame programme Investissements d'Avenir [ANR-10-IDEX-0002-02]; ARC; Canceropole Grand Est; Ligue nationale contre le cancer; CNRS, INSERM;  [ANR-10-LABX-0030-INRT]	CRE from the Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); ANR under the frame programme Investissements d'Avenir(French National Research Agency (ANR)); ARC(Australian Research Council); Canceropole Grand Est(Region Grand-Est); Ligue nationale contre le cancer(Ligue nationale contre le cancer); CNRS, INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); 	This work was supported by funds from CNRS, INSERM and by funds raised by CRE from the Agence Nationale pour la Recherche (ANR-09-BLAN-0297-01, www.agence-nationale-recherche.fr), the Association pour la recherche sur le Cancer (SL 220110603474 and PJA20141201746, www.fondation-arc.org), the Fondation pour la Recherche Medicale (FRM, DEQ20090515423, www.frm.org), and the Institut National du Cancer (PL09-194, www.e-cancer.fr). It was also supported by ANR-10-LABX-0030-INRT, a French State fund managed by the ANR under the frame programme Investissements d'Avenir labeled ANR-10-IDEX-0002-02. ARC supported the acquisition of the Orbitrap mass spectrometer. The Canceropole Grand Est supported MJ. The Ligue nationale contre le cancer supported MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Tanoury Z, 2014, J CELL SCI, V127, P2095, DOI 10.1242/jcs.145979; Al Tanoury Z, 2014, J CELL SCI, V127, P521, DOI 10.1242/jcs.131946; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Ali NA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0437-3; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Dickhut C, 2014, J PROTEOME RES, V13, P2761, DOI 10.1021/pr401181y; Duong V, 2011, BBA-MOL BASIS DIS, V1812, P1023, DOI 10.1016/j.bbadis.2010.10.007; Engholm-Keller K, 2011, J PROTEOMICS, V75, P317, DOI 10.1016/j.jprot.2011.07.024; Fadloun A, 2008, ONCOGENE, V27, P477, DOI 10.1038/sj.onc.1210657; Ferry C, 2011, P NATL ACAD SCI USA, V108, P20603, DOI 10.1073/pnas.1102572108; GAUB MP, 1992, EXP CELL RES, V201, P335, DOI 10.1016/0014-4827(92)90282-D; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jones KA, 2013, J PROTEOME RES, V12, P4351, DOI 10.1021/pr400307u; Kalli A, 2013, J PROTEOME RES, V12, P3071, DOI 10.1021/pr3011588; Kim BR, 2015, ONCOTARGET, V6, P31830, DOI 10.18632/oncotarget.5570; Lalevee S, 2010, METHODS MOL BIOL, V647, P251, DOI 10.1007/978-1-60761-738-9_15; Leitner A, 2011, ANAL CHIM ACTA, V703, P19, DOI 10.1016/j.aca.2011.07.012; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Moutier E, 2012, J BIOL CHEM, V287, P26328, DOI 10.1074/jbc.M112.361790; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Piskunov A, 2012, ONCOGENE, V31, P3333, DOI 10.1038/onc.2011.499; Piskunov A, 2014, SUBCELL BIOCHEM, V70, P103, DOI 10.1007/978-94-017-9050-5_6; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Tari AM, 2002, ONCOGENE, V21, P5224, DOI 10.1038/sj.onc.1205660; Tassy O, 2014, NUCLEIC ACIDS RES, V42, pD882, DOI 10.1093/nar/gkt807; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304	42	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157290	10.1371/journal.pone.0157290	http://dx.doi.org/10.1371/journal.pone.0157290			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362937	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200013
J	Jani, BD; Mair, FS; Roger, VL; Weston, SA; Jiang, RX; Chamberlain, AM				Jani, Bhautesh Dinesh; Mair, Frances S.; Roger, Veronique L.; Weston, Susan A.; Jiang, Ruoxiang; Chamberlain, Alanna M.			Comorbid Depression and Heart Failure: A Community Cohort Study	PLOS ONE			English	Article							MEDICAL-RECORDS LINKAGE; RISK PREDICTION MODELS; EVENT-FREE SURVIVAL; SOCIAL SUPPORT; HOSPITALIZED-PATIENTS; COGNITIVE THERAPY; OLDER PATIENTS; EPIDEMIOLOGY; SYMPTOMS; MORTALITY	Objective To examine the association between depression and clinical outcomes in heart failure (HF) in a community cohort. Patients and Methods HF patients in Minnesota, United States completed depression screening using the 9-item Patient Health Questionnaire (PHQ-9) between 1st Oct 2007 and 1st Dec 2011; patients with PHQ-9 >= 5 were labelled "depressed". We calculated the risk of death and first hospitalization within 2 years using Cox regression. Results were adjusted for 10 commonly used prognostic factors (age, sex, systolic blood pressure, estimated glomerular filtration rate, serum sodium, ejection fraction, blood urea nitrogen, brain natriuretic peptide, presence of diabetes and ischaemic aetiology). Area under the curve (AUC), integrated discrimination improvement (IDI) and net reclassification improvement (NRI) compared depression as a predictor against the aforementioned factors. Results 425 patients (mean age 74, 57.6% males) were included in the study; 179 (42.1%) had PHQ-9 >= 5. The adjusted hazard ratio of death was 2.02 (95% CI 1.34-3.04) and of hospitalization was 1.42 (95% CI 1.13-1.80) for those with compared to those without depression. Adding depression to the models did not appreciably change the AUC but led to statistically significant improvements in both the IDI (p = 0.001 and p = 0.005 for death and hospitalization, respectively) and NRI (for death and hospitalization, 35% (p = 0.002) and 27% (p = 0.007) were reclassified correctly, respectively). Conclusion Depression is frequent among community patients with HF and associated with increased risk of hospitalizations and death. Risk prediction for death and hospitalizations in HF patients can be improved by considering depression.	[Jani, Bhautesh Dinesh; Mair, Frances S.] Univ Glasgow, Inst Hlth & Wellbeing, Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [Roger, Veronique L.; Weston, Susan A.; Jiang, Ruoxiang; Chamberlain, Alanna M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Roger, Veronique L.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	University of Glasgow; Mayo Clinic; Mayo Clinic	Chamberlain, AM (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA.	chamberlain.alanna@mayo.edu	Roger, Veronique/AAV-5951-2020	Chamberlain, Alanna/0000-0003-1888-9584; Mair, Frances/0000-0001-9780-1135; Jani, Bhautesh/0000-0001-7348-514X	NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG034676] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; [Anonymous], 2012, POPULATION ESTIMATES; Betihavas V, 2012, AUST CRIT CARE, V25, P31, DOI 10.1016/j.aucc.2011.07.004; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Chung ML, 2013, QUAL LIFE RES, V22, P1555, DOI 10.1007/s11136-012-0294-4; Chung ML, 2013, HEART LUNG, V42, P85, DOI 10.1016/j.hrtlng.2012.12.003; Chung ML, 2011, HEART LUNG, V40, P492, DOI [10.1016/j.hrtlng.2010.08.001, 10.1016/j.hrtlng.2010.11.005]; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Cully JA, 2009, PRIM CARE COMPANION, V11, P103; Dekker RL, 2012, J CARD FAIL, V18, P10, DOI 10.1016/j.cardfail.2011.09.008; Dekker RL, 2011, HEART FAIL CLIN, V7, P127, DOI 10.1016/j.hfc.2010.10.001; Faris R, 2002, EUR J HEART FAIL, V4, P541, DOI 10.1016/S1388-9842(02)00101-0; Fraguas R, 2009, CONTEMP CLIN TRIALS, V30, P205, DOI 10.1016/j.cct.2009.01.007; Frasure-Smith N, 2009, CIRCULATION, V120, P134, DOI 10.1161/CIRCULATIONAHA.109.851675; Freedland KE, 2015, JAMA INTERN MED, V175, P1773, DOI 10.1001/jamainternmed.2015.5220; Fulop G, 2003, PSYCHOSOMATICS, V44, P367, DOI 10.1176/appi.psy.44.5.367; Giamouzis G, 2011, J CARD FAIL, V17, P54, DOI 10.1016/j.cardfail.2010.08.010; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Graven LJ, 2013, J CARDIOVASC NURS, V28, P429, DOI 10.1097/JCN.0b013e3182578b9d; Guha K, 2013, CURR CARDIOL REV, V9, P123, DOI 10.2174/1573403X11309020005; Health Quality Ontario, 2013, Ont Health Technol Assess Ser, V13, P1; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Jiang W, 2011, AM J CARDIOL, V107, P545, DOI 10.1016/j.amjcard.2010.10.013; Joynt KE, 2004, J CARD FAIL, V10, P258, DOI 10.1016/j.cardfail.2003.09.008; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Koenig HG, 1998, GEN HOSP PSYCHIAT, V20, P29, DOI 10.1016/S0163-8343(98)80001-7; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Moraska AR, 2013, CIRC-HEART FAIL, V6, P387, DOI 10.1161/CIRCHEARTFAILURE.112.000118; Nutter Andria L, 2010, Congest Heart Fail, V16, P196, DOI 10.1111/j.1751-7133.2010.00180.x; O'Connor CM, 2008, AM HEART J, V156, P662, DOI 10.1016/j.ahj.2008.04.030; Ouwerkerk W, 2014, JACC-HEART FAIL, V2, P429, DOI 10.1016/j.jchf.2014.04.006; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Raphael C, 2007, HEART, V93, P476, DOI 10.1136/hrt.2006.089656; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Sherwood A, 2007, ARCH INTERN MED, V167, P367, DOI 10.1001/archinte.167.4.367; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; Sullivan MJ, 2009, AM HEART J, V157, P84, DOI 10.1016/j.ahj.2008.08.033; Team RC, 2012, R LANG ENV STAT COMP; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	47	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158570	10.1371/journal.pone.0158570	http://dx.doi.org/10.1371/journal.pone.0158570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362359	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000378865200094
J	Prelog, M; Hilligardt, D; Schmidt, CA; Przybylski, GK; Leierer, J; Almanzar, G; El Hajj, N; Lesch, KP; Arolt, V; Zwanzger, P; Haaf, T; Domschke, K				Prelog, Martina; Hilligardt, Deborah; Schmidt, Christian A.; Przybylski, Grzegorz K.; Leierer, Johannes; Almanzar, Giovanni; El Hajj, Nady; Lesch, Klaus-Peter; Arolt, Volker; Zwanzger, Peter; Haaf, Thomas; Domschke, Katharina			Hypermethylation of FOXP3 Promoter and Premature Aging of the Immune System in Female Patients with Panic Disorder?	PLOS ONE			English	Article							REGULATORY T-CELLS; JUVENILE IDIOPATHIC ARTHRITIS; GENERALIZED ANXIETY DISORDER; CORONARY-HEART-DISEASE; TELOMERE LENGTH; THYMIC FUNCTION; TREG CELLS; LYMPHOCYTE SUBPOPULATIONS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES	Immunological abnormalities associated with pathological conditions, such as higher infection rates, inflammatory diseases, cancer or cardiovascular events are common in patients with panic disorder. In the present study, T cell receptor excision circles (TRECs), Fork-head-Box-Protein P3 gene (FOXP3) methylation of regulatory T cells (Tregs) and relative telomere lengths (RTLs) were investigated in a total and subsamples of 131 patients with panic disorder as compared to 131 age-and sex-matched healthy controls in order to test for a potential dysfunction and premature aging of the immune system in anxiety disorders. Significantly lower TRECs (p = 0.004) as well as significant hypermethylation of the FOXP3 promoter region (p = 0.005) were observed in female (but not in male) patients with panic disorder as compared to healthy controls. No difference in relative telomere length was discerned between patients and controls, but significantly shorter telomeres in females, smokers and older persons within the patient group. The presently observed reduced TRECs in panic disorder patients and FOXP3 hypermethylation in female patients with panic disorder potentially reflect impaired thymus and immunosuppressive Treg function, which might partly account for the known increased morbidity and mortality of anxiety disorders conferred by e.g. cancer and cardiovascular disorders.	[Prelog, Martina; Hilligardt, Deborah; Almanzar, Giovanni] Univ Hosp Wuerzburg, Dept Pediat, Wurzburg, Germany; [Schmidt, Christian A.; Przybylski, Grzegorz K.] Ernst Moritz Arndt Univ Greifswald, Clin Internal Med C, Greifswald, Germany; [Przybylski, Grzegorz K.] Polish Acad Sci, Inst Human Genet, Poznan, Poland; [Leierer, Johannes] Med Univ Innsbruck, Dept Internal Med, Innsbruck, Austria; [El Hajj, Nady; Haaf, Thomas] Univ Wurzburg, Inst Human Genet, Wurzburg, Germany; [Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Mol Psychiat, Wurzburg, Germany; [Arolt, Volker; Zwanzger, Peter] Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany; [Zwanzger, Peter] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Zwanzger, Peter] Kbo Inn Salzach Klinikum, Wasserburg, Germany; [Domschke, Katharina] Univ Hosp Wuerzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany	University of Wurzburg; Ernst Moritz Arndt Universitat Greifswald; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Medical University of Innsbruck; University of Wurzburg; University of Wurzburg; University of Munster; University of Munich; University of Wurzburg	Prelog, M (corresponding author), Univ Hosp Wuerzburg, Dept Pediat, Wurzburg, Germany.	Prelog_M@ukw.de	Almanzar, Giovanni/H-4725-2018; Lesch, Klaus-Peter/J-4906-2013	Lesch, Klaus-Peter/0000-0001-8348-153X; Leierer, Johannes/0000-0002-7884-9827; Przybylski, Grzegorz/0000-0001-5783-1567; El Hajj, Nady/0000-0003-3420-8531	Deutsche Forschungsgemeinschaft (DFG) [SFB-TRR-58]; Bavarian Innovation Fond	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bavarian Innovation Fond	This paper was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; SFB-TRR-58, projects C02 to KD and KPL, and A05 to KPL) and the Bavarian Innovation Fond to MP.	Albert CM, 2005, CIRCULATION, V111, P480, DOI 10.1161/01.CIR.0000153813.64165.5D; Almanzar G, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-57; Appay V, 2010, AGING-US, V2, P78, DOI 10.18632/aging.100122; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brennan AM, 2009, DIABETES CARE, V32, P926, DOI 10.2337/dc08-1979; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chalan Paulina, 2015, Curr Aging Sci, V8, P131; Cribbs AP, 2015, ARTHRITIS RHEUMATOL, V67, P1182, DOI 10.1002/art.39031; Dai RJ, 2014, THER CLIN RISK MANAG, V10, P151, DOI 10.2147/TCRM.S33517; Dalton VS, 2014, J AFFECT DISORDERS, V155, P1, DOI 10.1016/j.jad.2013.10.028; Denollet J, 2009, J CLIN EPIDEMIOL, V62, P452, DOI 10.1016/j.jclinepi.2008.08.006; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Duclot F, 2015, J EXP BIOL, V218, P21, DOI 10.1242/jeb.107086; Ferreira TB, 2011, J NEUROIMMUNOL, V238, P58, DOI 10.1016/j.jneuroim.2011.06.009; Garg SK, 2014, AGING CELL, V13, P441, DOI 10.1111/acel.12191; Geenen V, 2003, J ENDOCRINOL, V176, P305, DOI 10.1677/joe.0.1760305; Gimsa U, 2012, CYTOKINE, V59, P72, DOI 10.1016/j.cyto.2012.04.001; Goodwin RD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-878; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Harpaz I, 2013, EUR J IMMUNOL, V43, P758, DOI 10.1002/eji.201242613; Harris JM, 2005, CLIN IMMUNOL, V115, P138, DOI 10.1016/j.clim.2004.12.008; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hoen PW, 2013, PSYCHOL MED, V43, P689, DOI 10.1017/S0033291712001766; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Hong M, 2013, NEUROIMMUNOMODULAT, V20, P39, DOI 10.1159/000343100; Irie M, 2006, ATHEROSCLEROSIS, V185, P320; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Jia L, 2013, ATHEROSCLEROSIS, V228, P346, DOI 10.1016/j.atherosclerosis.2013.01.027; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kennedy A, 2014, EUR J IMMUNOL, V44, P2968, DOI 10.1002/eji.201444453; Kiecolt-Glaser JK, 2013, BRAIN BEHAV IMMUN, V34, P29, DOI 10.1016/j.bbi.2013.08.004; Kim S, 2012, IEEE INT SYMP INTELL, P7, DOI 10.1109/ISIC.2012.6398252; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Koppelstaetter C, 2005, MECH AGEING DEV, V126, P1331, DOI 10.1016/j.mad.2005.08.003; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; LaVia MF, 1996, PSYCHOSOM MED, V58, P138, DOI 10.1097/00006842-199603000-00007; Li XD, 2015, TRENDS IMMUNOL, V36, P344, DOI 10.1016/j.it.2015.04.006; Manfro GG, 2003, ARQ NEURO-PSIQUIAT, V61, P20, DOI 10.1590/S0004-282X2003000100004; Mayerl C, 2012, AUTOIMMUN REV, V11, P297, DOI 10.1016/j.autrev.2010.02.015; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morikawa H, 2014, IMMUNOL REV, V259, P192, DOI 10.1111/imr.12174; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nielsen CH, 2016, ARCH TOXICOL, V90, P231, DOI 10.1007/s00204-014-1426-0; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001; Prelog M, 2006, AUTOIMMUN REV, V5, P136, DOI 10.1016/j.autrev.2005.09.008; Prelog M, 2008, ARTHRITIS RHEUM-US, V58, P2153, DOI 10.1002/art.23599; Prelog Martina, 2011, Current Immunology Reviews, V7, P116, DOI 10.2174/157339511794474299; Rainbow DB, 2015, EUR J IMMUNOL, V45, P3200, DOI 10.1002/eji.201545646; Roberts S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.83; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Rubtsova K, 2015, J CLIN INVEST, V125, P2187, DOI 10.1172/JCI78082; Sahin M, 2013, HUM IMMUNOL, V74, P1061, DOI 10.1016/j.humimm.2013.05.009; Schmidt D, 2010, BRAIN BEHAV IMMUN, V24, P1097, DOI 10.1016/j.bbi.2010.04.014; Shalev I, 2014, MOL PSYCHIATR, P1; Takahashi R, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/943149; Thiel A, 2008, ACTA HAEMATOL-BASEL, V119, P22, DOI 10.1159/000117824; Tone M, 2011, NAT IMMUNOL, V12, P14, DOI 10.1038/ni0111-14; Vieira MMM, 2010, J NEUROIMMUNOL, V229, P212, DOI 10.1016/j.jneuroim.2010.07.018; Viveros MP, 2007, NEUROIMMUNOMODULAT, V14, P157, DOI 10.1159/000110640; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Vogelzangs N, 2010, J AFFECT DISORDERS, V125, P241, DOI 10.1016/j.jad.2010.02.112; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018	68	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157930	10.1371/journal.pone.0157930	http://dx.doi.org/10.1371/journal.pone.0157930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362416	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200029
J	Schleepen, TMJ; Van Mier, HI; De Smedt, B				Schleepen, Tamara M. J.; Van Mier, Hanneke I.; De Smedt, Bert			The Contribution of Numerical Magnitude Comparison and Phonological Processing to Individual Differences in Fourth Graders' Multiplication Fact Ability	PLOS ONE			English	Article							WORKING-MEMORY; NONWORD REPETITION; PROBLEM SIZE; CHILDREN; MATHEMATICS; SKILLS; LANGUAGE; REPRESENTATIONS; ASSOCIATION; PREDICTORS	Although numerical magnitude processing has been related to individual differences in arithmetic, its role in children's multiplication performance remains largely unknown. On the other hand, studies have indicated that phonological awareness is an important correlate of individual differences in children's multiplication performance, but the involvement of phonological memory, another important phonological processing skill, has not been studied in much detail. Furthermore, knowledge about the relative contribution of above mentioned processes to the specific arithmetic operation of multiplication in children is lacking. The present study therefore investigated for the first time the unique contributions of numerical magnitude comparison and phonological processing in explaining individual differences in 63 fourth graders' multiplication fact ability (mean age = 9.6 years, SD = .67). The results showed that children's multiplication fact competency correlated significantly with symbolic and nonsymbolic magnitude comparison as well as with phonological short-term memory. A hierarchical regression analysis revealed that, after controlling for intellectual ability and general reaction time, both symbolic and nonsymbolic magnitude comparison and phonological short-term memory accounted for unique variance in multiplication fact performance. The ability to compare symbolic magnitudes was found to contribute the most, indicating that the access to numerical magnitudes by means of Arabic digits is a key factor in explaining individual differences in children's multiplication fact ability.	[Schleepen, Tamara M. J.; Van Mier, Hanneke I.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [De Smedt, Bert] Katholieke Univ Leuven, Parenting & Special Educ Res Unit, Fac Psychol & Educ Sci, Leuven, Belgium	Maastricht University; KU Leuven	Schleepen, TMJ (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	tamara.schleepen@maastrichtuniversity.nl	De Smedt, Bert/U-6124-2019; De Smedt, Bert/Q-7020-2019; De Smedt, Bert/G-4729-2010	De Smedt, Bert/0000-0002-3313-3278; De Smedt, Bert/0000-0002-3313-3278	Research Foundation Flanders (FWO), Belgium [G.0946.12]	Research Foundation Flanders (FWO), Belgium(FWO)	This research was partially supported by grant G.0946.12 of the Research Foundation Flanders (FWO), Belgium (website: WWW.FWO.BE).; The authors would like to thank Dr. Judith Rispens for kindly providing the nonword repetition test and Sylvana Korycki, Esther Dassen and Tara Badzurek for their help in data collection. This research was partially supported by grant G.0946.12 of the Research Foundation Flanders (FWO) Belgium.	Adams JW, 1997, J EXP CHILD PSYCHOL, V67, P21, DOI 10.1006/jecp.1997.2397; Ansari D, 2002, TRENDS COGN SCI, V6, P511, DOI 10.1016/S1364-6613(02)02040-5; ASHCRAFT MH, 1982, DEV REV, V2, P213, DOI 10.1016/0273-2297(82)90012-0; Barnes MA, 2014, J EXP CHILD PSYCHOL, V119, P1, DOI 10.1016/j.jecp.2013.09.006; Barrouillet P, 2008, J EXP CHILD PSYCHOL, V99, P233, DOI 10.1016/j.jecp.2007.12.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bull R, 1997, J EXP CHILD PSYCHOL, V65, P1, DOI 10.1006/jecp.1996.2358; Campbell, 1995, MATH COGNITION, V1, P121, DOI DOI 10.3758/BF03197037; Carroll JM, 2004, J CHILD PSYCHOL PSYC, V45, P631, DOI 10.1111/j.1469-7610.2004.00252.x; Clark CAC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00107; Cooney JB, 1985, COGNITION INSTRUCT, V5, P323; De Brauwer J, 2006, J EXP CHILD PSYCHOL, V94, P43, DOI 10.1016/j.jecp.2005.11.004; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; De Smedt B, 2010, DEVELOPMENTAL SCI, V13, P508, DOI 10.1111/j.1467-7687.2009.00897.x; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P186, DOI 10.1016/j.jecp.2009.01.004; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S., 2011, NUMBER SENSE MIND CR; Dowker A., 2005, INDIVIDUAL DIFFERENC; Edwards J, 1998, APPL PSYCHOLINGUIST, V19, P279, DOI 10.1017/S0142716400010079; Estes KG, 2007, J SPEECH LANG HEAR R, V50, P177, DOI 10.1044/1092-4388(2007/015); Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Foy JG, 2001, APPL PSYCHOLINGUIST, V22, P301, DOI 10.1017/S0142716401003022; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; GATHERCOLE SE, 1989, J MEM LANG, V28, P200, DOI 10.1016/0749-596X(89)90044-2; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Geary DC, 2012, J LEARN DISABIL-US, V45, P291, DOI 10.1177/0022219410392046; Geary DC, 2004, J EXP CHILD PSYCHOL, V88, P121, DOI 10.1016/j.jecp.2004.03.002; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hecht SA, 2001, J EXP CHILD PSYCHOL, V79, P192, DOI 10.1006/jecp.2000.2586; Holloway ID, 2010, NEUROIMAGE, V49, P1006, DOI 10.1016/j.neuroimage.2009.07.071; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Imbo I, 2008, PSYCHOL RES-PSYCH FO, V72, P331, DOI 10.1007/s00426-007-0112-8; Ischebeck A, 2007, NEUROIMAGE, V36, P993, DOI 10.1016/j.neuroimage.2007.03.051; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P546, DOI 10.1016/j.jecp.2008.12.006; LEMAIRE P, 1995, J EXP PSYCHOL GEN, V124, P83, DOI 10.1037/0096-3445.124.1.83; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Linsen S, 2014, ACTA PSYCHOL, V145, P75, DOI 10.1016/j.actpsy.2013.10.008; Lonnemann J, 2011, J NEUROLINGUIST, V24, P583, DOI 10.1016/j.jneuroling.2011.02.004; Lyons IM, 2014, DEVELOPMENTAL SCI, V17, P714, DOI 10.1111/desc.12152; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Patel TK, 2004, J EDUC PSYCHOL, V96, P785, DOI 10.1037/0022-0663.96.4.785; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Prado J, 2014, DEVELOPMENTAL SCI, V17, P537, DOI 10.1111/desc.12140; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Raven JC., 1992, MANUAL RAVENS PROGR; Rispens J, 2015, J SPEECH LANG HEAR R, V58, P78, DOI 10.1044/2014_JSLHR-L-12-0393; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Sasanguie D, 2012, BRIT J DEV PSYCHOL, V30, P344, DOI 10.1111/j.2044-835X.2011.02048.x; Schneider M, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12372; Siegler R. S., 1996, EMERGING MINDS PROCE; Simmons F, 2008, EUR J COGN PSYCHOL, V20, P711, DOI 10.1080/09541440701614922; Simmons FR, 2012, J EXP CHILD PSYCHOL, V111, P139, DOI 10.1016/j.jecp.2011.08.011; Swanson L, 2007, INTELLIGENCE, V35, P151, DOI 10.1016/j.intell.2006.07.001; van den Bos KP, 2011, FAT FONEMISCHE ANAL; Vanbinst K, 2015, J EXP CHILD PSYCHOL, V133, P29, DOI 10.1016/j.jecp.2015.01.003; Vanbinst K, 2014, RES DEV DISABIL, V35, P3001, DOI 10.1016/j.ridd.2014.06.023; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wechsler D., 1991, WISC 3 WECHSLER INTE	62	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158335	10.1371/journal.pone.0158335	http://dx.doi.org/10.1371/journal.pone.0158335			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27359328	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200059
J	Tsuchida, J; Matsusaka, T; Ohtsuka, M; Miura, H; Okuno, Y; Asanuma, K; Nakagawa, T; Yanagita, M; Mori, K				Tsuchida, Junichi; Matsusaka, Taiji; Ohtsuka, Masato; Miura, Hiromi; Okuno, Yukiko; Asanuma, Katsuhiko; Nakagawa, Takahiko; Yanagita, Motoko; Mori, Kiyoshi			Establishment of Nephrin Reporter Mice and Use for Chemical Screening	PLOS ONE			English	Article							VITAMIN-D; TARGETED TRANSGENESIS; DIABETIC-NEPHROPATHY; GLOMERULAR SCLEROSIS; PODOCYTE; MOUSE; INJURY; EXPRESSION; DISEASE	Nephrin is a critical component of glomerular filtration barrier, which is important to maintain glomerular structure and avoid proteinuria. Downregulation of nephrin expression is commonly observed at early stage of glomerular disorders, suggesting that methods to increase nephrin expression in podocytes may have therapeutic utility. Here, we generated a knockin mouse line carrying single copy of 5.5 kb nephrin promoter controlling expression of enhanced green fluorescent protein (EGFP) at Rosa26 genomic locus (Nephrin-EGFP mouse). In these mice, EGFP was specifically expressed in podocytes. Next, we isolated and cultivated glomeruli from these mice, and developed a protocol to automatically quantitate EGFP expression in cultured glomeruli. EGFP signal was markedly reduced after 5 days of culture but reduction was inhibited by vitamin D treatment. We confirmed that vitamin D increased mRNA and protein expression of endogenous nephrin in cultivated glomeruli. Thus, we generated a mouse line converting nephrin promoter activity into fluorescence, which can be used to screen compounds having activity to enhance nephrin gene expression.	[Tsuchida, Junichi; Asanuma, Katsuhiko; Nakagawa, Takahiko; Yanagita, Motoko; Mori, Kiyoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, TMK Project, Kyoto, Japan; [Tsuchida, Junichi] Mitsubishi Tanabe Pharma Corp, Innovat Res Div, Res Unit Nephrol & Endocrinol Sci, Toda, Saitama, Japan; [Matsusaka, Taiji; Ohtsuka, Masato; Miura, Hiromi] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan; [Matsusaka, Taiji; Ohtsuka, Masato; Miura, Hiromi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Isehara, Kanagawa, Japan; [Okuno, Yukiko] Kyoto Univ, Grad Sch Med, Med Res Support Ctr, Kyoto, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Mori, Kiyoshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka, Japan; [Mori, Kiyoshi] Shizuoka Prefectural Gen Hosp, Dept Nephrol & Kidney Res, Shizuoka, Japan	Kyoto University; Mitsubishi Tanabe Pharma Corporation; Tokai University; Tokai University; Kyoto University; Kyoto University; University of Shizuoka; Shizuoka General Hospital	Mori, K (corresponding author), Kyoto Univ, Grad Sch Med, Med Innovat Ctr, TMK Project, Kyoto, Japan.; Mori, K (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka, Japan.; Mori, K (corresponding author), Shizuoka Prefectural Gen Hosp, Dept Nephrol & Kidney Res, Shizuoka, Japan.	mori@tmk.med.kyoto-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021; Mori, Kiyoshi/N-1267-2014	Mori, Kiyoshi/0000-0002-7285-8351; Yanagita, Motoko/0000-0002-0339-9008; Tsuchida, Junichi/0000-0003-1010-4084; Ohtsuka, Masato/0000-0002-6952-4238	Mitsubishi Tanabe Pharma Corporation (MTPC); Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23700514]; Takeda Science Foundation; Tokai University School of Medicine; MTPC; Ministry of Education, Culture, Sports, Science and Technology, Japan	Mitsubishi Tanabe Pharma Corporation (MTPC); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokai University School of Medicine; MTPC; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a research fund from Mitsubishi Tanabe Pharma Corporation (MTPC, KM), by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (KM, TM), by Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT, MO, 23700514), by Takeda Science Foundation (MO), and by 2011-2012 Tokai University School of Medicine, Project Research to M.O. MTPC provided support in the form of salaries for authors JT, KA, TN, and KM, but MTPC and other funders did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to RIKEN BioResource Center (a participant in the National BioResource Project of the MEXT, Japan) for providing FLPe mice. We also thank staffs of Support Center for Medical Research and Education, Tokai University for sequencing and generation of Tg mice. Screening compounds were kindly provided from Medical Research Support Center, Graduate School of Medicine, Kyoto University, which was supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also thank C. Nakano, Y. Ogawa and other lab members in TMK Project for technical assistance.	Asano T, 2005, J AM SOC NEPHROL, V16, P2257, DOI 10.1681/ASN.2004121134; Asanuma Katsuhiko, 2003, Clin Exp Nephrol, V7, P255, DOI 10.1007/s10157-003-0259-6; Da Sacco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081812; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Garsen M, 2015, J PATHOL, V237, P472, DOI 10.1002/path.4593; Itoh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106621; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Katsuya K, 2006, KIDNEY INT, V69, P2101, DOI 10.1038/sj.ki.5000398; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Lee HW, 2015, J AM SOC NEPHROL, V26, P2741, DOI 10.1681/ASN.2014090859; Matsui I, 2009, NEPHROL DIAL TRANSPL, V24, P2354, DOI 10.1093/ndt/gfp117; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Ohtsuka M, 2014, METHODS MOL BIOL, V1194, P3, DOI 10.1007/978-1-4939-1215-5_1; Ohtsuka M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq860; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; SATRIANO JA, 1993, J IMMUNOL, V150, P1971; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Wang Y, 2006, KIDNEY INT, V70, P882, DOI 10.1038/sj.ki.5001624; Wanner N, 2014, J AM SOC NEPHROL, V25, P707, DOI 10.1681/ASN.2013050452; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157497	10.1371/journal.pone.0157497	http://dx.doi.org/10.1371/journal.pone.0157497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362433	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200018
J	Dunham, Y; Dotsch, R; Clark, AR; Stepanova, EV				Dunham, Yarrow; Dotsch, Ron; Clark, Amelia R.; Stepanova, Elena V.			The Development of White-Asian Categorization: Contributions from Skin Color and Other Physiognomic Cues	PLOS ONE			English	Article							RACIAL PREFERENCE; RACE FACES; PRESCHOOL; IDENTIFICATION; PERCEPTION; IDENTITY; CHILDREN; MEMORY; BLACK; SHAPE	We examined the development of racial categorizations of faces spanning the European-East Asian ("White-Asian") categorical continuum in children between the ages of four and nine as well as adults. We employed a stimulus set that independently varied skin color and other aspects of facial physiognomy, allowing the contribution of each to be assessed independently and in interaction with each other. Results demonstrated substantial development across this age range in children's ability to draw on both sorts of cue, with over twice as much variance explained by stimulus variation in adults than children. Nonetheless, children were clearly sensitive to both skin color and other aspects of facial physiognomy, suggesting that understanding of the White-Asian category boundary develops in a somewhat different way than understanding of the White-Black category boundary, in which attention to features other than skin color appear only somewhat later. Discussion focuses on the implications of these findings for theories of social categorization.	[Dunham, Yarrow; Clark, Amelia R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Dotsch, Ron] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Stepanova, Elena V.] Univ So Mississippi, Dept Psychol, Hattiesburg, MS 39406 USA	Yale University; Utrecht University; University of Southern Mississippi	Dunham, Y (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	yarrow.dunham@yale.edu	Stepanova, Elena/AAG-8183-2019	Stepanova, Elena/0000-0003-2447-9717				Anzures G, 2013, VISUAL COGNITIO 0805, P1; Balas B, 2015, J EXP CHILD PSYCHOL, V130, P56, DOI 10.1016/j.jecp.2014.09.009; Balas B, 2011, DEVELOPMENTAL SCI, V14, P892, DOI 10.1111/j.1467-7687.2011.01039.x; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Bryk A. S., 1992, HIERARCHICAL LINEAR; Chen JM, 2012, J EXP SOC PSYCHOL, V48, P152, DOI 10.1016/j.jesp.2011.10.005; Clark KB, 1918, RACIAL IDENTIFICATIO; Cogsdill EJ, 2014, PSYCHOL SCI, V25, P1132, DOI 10.1177/0956797614523297; Corneille O, 2004, J PERS SOC PSYCHOL, V86, P236, DOI 10.1037/0022-3514.86.2.236; Craig BM, 2012, EMOTION, V12, P1303, DOI 10.1037/a0028622; CROOKS RC, 1970, J SOC ISSUES, V26, P137, DOI 10.1111/j.1540-4560.1970.tb01747.x; Dunham Y, 2013, CATEGORIES EXEMPLARS, P275; Dunham Y, 2015, DEVELOPMENTAL SCI, V18, P469, DOI 10.1111/desc.12228; Dyck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003628; Gaither SE, 2015, CURR DIR PSYCHOL SCI, V24, P114, DOI 10.1177/0963721414558115; Gelman A., 2007, DATA ANAL USING REGR; Guerrero S, 2010, COGNITIVE DEV, V25, P79, DOI 10.1016/j.cogdev.2009.07.001; Halberstadt J, 2011, PSYCHOL SCI, V22, P29, DOI 10.1177/0956797610390383; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; HIRSCHFELD LA, 1993, COGNITIVE PSYCHOL, V25, P317, DOI 10.1006/cogp.1993.1008; Ho AK, 2011, J PERS SOC PSYCHOL, V100, P492, DOI 10.1037/a0021562; HRABA J, 1970, J PERS SOC PSYCHOL, V16, P398, DOI 10.1037/h0030043; Johnson KL, 2012, J PERS SOC PSYCHOL, V102, P116, DOI 10.1037/a0025335; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; LEYENS JP, 1992, EUR J SOC PSYCHOL, V22, P549, DOI 10.1002/ejsp.2420220604; Montague DPF, 2001, DEV PSYCHOL, V37, P826, DOI 10.1037//0012-1649.37.6.826; Olson MA, 2003, PSYCHOL SCI, V14, P636, DOI 10.1046/j.0956-7976.2003.psci_1477.x; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pauker K, 2015, CHILD DEV PERSPECTIV; Pauker K, 2009, J SOC ISSUES, V65, P69, DOI 10.1111/j.1540-4560.2008.01588.x; RICE AS, 1974, J CROSS CULT PSYCHOL, V5, P100, DOI 10.1177/002202217400500107; Roesch EB, 2011, J NONVERBAL BEHAV, V35, P1, DOI 10.1007/s10919-010-0095-9; SNIJDERS TAB, 1994, SOCIOL METHOD RES, V22, P342, DOI 10.1177/0049124194022003004; Stepanova EV, 2012, J EXPT SOCIAL PSYCHO, P1; Strom MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041193; Todorov A, 2013, EMOTION	37	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158211	10.1371/journal.pone.0158211	http://dx.doi.org/10.1371/journal.pone.0158211			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355683	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400038
J	Kakuda, T; Shojo, H; Tanaka, M; Nambiar, P; Minaguchi, K; Umetsu, K; Adachi, N				Kakuda, Tsuneo; Shojo, Hideki; Tanaka, Mayumi; Nambiar, Phrabhakaran; Minaguchi, Kiyoshi; Umetsu, Kazuo; Adachi, Noboru			Multiplex APLP System for High-Resolution Haplogrouping of Extremely Degraded East-Asian Mitochondrial DNAs	PLOS ONE			English	Article							LENGTH POLYMORPHISM ANALYSIS; NATIVE-AMERICAN HAPLOGROUPS; PHYLOGENETIC ANALYSIS; JOMON SKELETONS; CONTROL REGION; HAN CHINESE; LINEAGES; SEQUENCE; POPULATIONS; DIVERSITY	Mitochondrial DNA (mtDNA) serves as a powerful tool for exploring matrilineal phylogeo-graphic ancestry, as well as for analyzing highly degraded samples, because of its polymorphic nature and high copy numbers per cell. The recent advent of complete mitochondrial genome sequencing has led to improved techniques for phylogenetic analyses based on mtDNA, and many multiplex genotyping methods have been developed for the hierarchical analysis of phylogenetically important mutations. However, few high-resolution multiplex genotyping systems for analyzing East-Asian mtDNA can be applied to extremely degraded samples. Here, we present a multiplex system for analyzing mitochondrial single nucleotide polymorphisms (mtSNPs), which relies on a novel amplified product-length polymorphisms (APLP) method that uses inosine-flapped primers and is specifically designed for the detailed haplogrouping of extremely degraded East-Asian mtDNAs. We used fourteen 6-plex polymerase chain reactions (PCRs) and subsequent electrophoresis to examine 81 haplogroup-defining SNPs and 3 insertion/deletion sites, and we were able to securely assign the studied mtDNAs to relevant haplogroups. Our system requires only 1x10(-13) g (100 fg) of crude DNA to obtain a full profile. Owing to its small amplicon size (< 110 bp), this new APLP system was successfully applied to extremely degraded samples for which direct sequencing of hypervariable segments using mini-primer sets was unsuccessful, and proved to be more robust than conventional APLP analysis. Thus, our new APLP system is effective for retrieving reliable data from extremely degraded East-Asian mtDNAs.	[Kakuda, Tsuneo; Shojo, Hideki; Tanaka, Mayumi; Adachi, Noboru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, 1110 Shimokato, Yamanashi 4093898, Japan; [Nambiar, Phrabhakaran] Univ Malaya, Fac Dent, Dept Gen Dent Practice & Oral & Maxillofacial Ima, Kuala Lumpur 50603, Malaysia; [Minaguchi, Kiyoshi] Tokai Univ, Sch Med, Dept Forens Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Umetsu, Kazuo] Yamagata Univ, Fac Med, Dept Forens Med, 2-2-2 Iida Nishi, Yamagata 9902331, Japan	University of Yamanashi; Universiti Malaya; Tokai University; Yamagata University	Adachi, N (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, 1110 Shimokato, Yamanashi 4093898, Japan.	nadachi@yamanashi.ac.jp	NAMBIAR, PHRABHAKARAN K N/B-9495-2010		Japan Society for the Promotion of Science [26440257, 25251043, 16H01954]; JSPS Core "Advanced Core Research Center for the History of Human Ecology in the North."; Grants-in-Aid for Scientific Research [25251043] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Core "Advanced Core Research Center for the History of Human Ecology in the North."; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 26440257, 25251043, 16H01954), and JSPS Core to Core Program (Advanced Research Networks) "Advanced Core Research Center for the History of Human Ecology in the North."	Adachi N, 2004, J ARCHAEOL SCI, V31, P1339, DOI 10.1016/j.jas.2004.02.011; Adachi N, 2013, DNA POLYM, V21, P130; Adachi N, 2014, LEGAL MED-TOKYO, V16, P52, DOI 10.1016/j.legalmed.2013.10.001; Adachi N, 2013, ANTHROPOL SCI, V121, P137, DOI 10.1537/ase.130313; Adachi N, 2011, AM J PHYS ANTHROPOL, V146, P346, DOI 10.1002/ajpa.21561; Adachi N, 2009, AM J PHYS ANTHROPOL, V138, P255, DOI 10.1002/ajpa.20923; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ballantyne KN, 2012, FORENSIC SCI INT-GEN, V6, P425, DOI 10.1016/j.fsigen.2011.08.010; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Coutinho A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093292; Delfin F, 2014, EUR J HUM GENET, V22, P228, DOI 10.1038/ejhg.2013.122; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Lee HY, 2013, LEGAL MED-TOKYO, V15, P50, DOI 10.1016/j.legalmed.2012.08.002; Lee HY, 2006, ELECTROPHORESIS, V27, P4408, DOI 10.1002/elps.200600151; Maruyama S, 2010, INT J LEGAL MED, V124, P165, DOI 10.1007/s00414-009-0355-6; Maruyama S, 2003, INT J LEGAL MED, V117, P218, DOI 10.1007/s00414-003-0379-2; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Ren Z, 2015, ELECTROPHORESIS, V36, P633, DOI 10.1002/elps.201400396; Sato T, 2009, ANTHROPOL SCI, V117, P171, DOI 10.1537/ase.081202; Sekiguchi Kazumasa, 2008, Legal Medicine, V10, P284, DOI 10.1016/j.legalmed.2008.02.002; Shinoda K, 2006, AM J PHYS ANTHROPOL, V131, P98, DOI 10.1002/ajpa.20408; Shinoda Ken-ichi, 2014, Bulletin of the National Science Museum Series D (Anthropology), V40, P1; Shojo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136995; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Sukernik RI, 2012, AM J PHYS ANTHROPOL, V148, P123, DOI 10.1002/ajpa.22050; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Umetsu K, 2001, ELECTROPHORESIS, V22, P3533, DOI 10.1002/1522-2683(200109)22:16<3533::AID-ELPS3533>3.0.CO;2-S; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; van Oven Mannis, 2011, Investig Genet, V2, P6, DOI 10.1186/2041-2223-2-6; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	34	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158463	10.1371/journal.pone.0158463	http://dx.doi.org/10.1371/journal.pone.0158463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355212	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400070
J	Kanaan, SB; Onat, OE; Balandraud, N; Martin, GV; Nelson, JL; Azzouz, DF; Auger, I; Arnoux, F; Martin, M; Roudier, J; Ozcelik, T; Lambert, NC				Kanaan, Sami B.; Onat, Onur E.; Balandraud, Nathalie; Martin, Gabriel V.; Nelson, J. Lee; Azzouz, Doua F.; Auger, Isabelle; Arnoux, Fanny; Martin, Marielle; Roudier, Jean; Ozcelik, Tayfun; Lambert, Nathalie C.			Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic Sclerosis	PLOS ONE			English	Article							SHARED EPITOPE; FEMALE PREDISPOSITION; DISEASE SEVERITY; PREDICTIVE-VALUE; SCLERODERMA; AUTOIMMUNITY; ASSOCIATION; ANTIBODIES; WOMEN; MEN	Background Autoimmune diseases, including rheumatoid arthritis (RA) and systemic sclerosis (SSc) are characterized by a strong genetic susceptibility from the Human Leucocyte Antigen (HLA) locus. Additionally, disorders of epigenetic processes, in particular non-random X chromosome inactivation (XCI), have been reported in many female-predominant autoimmune diseases. Here we test the hypothesis that women with RA or SSc who are strongly genetically predisposed are less susceptible to XCI bias. Methods Using methylation sensitive genotyping of the androgen receptor (AR) gene, XCI profiles were performed in peripheral blood mononuclear cells from 161 women with RA, 96 women with SSc and 100 healthy women. HLA-DRB1 and DQB1 were genotyped. Presence of specific autoantibodies was documented for patients. XCI skewing was defined as having a ratio >= 80:20 of cells inactivating the same X chromosome. Results 110 women with RA, 68 women with SSc, and 69 controls were informative for the AR polymorphism. Among them 40.9% of RA patients and 36.8% of SSc patients had skewed XCI compared to 17.4% of healthy women (P = 0.002 and 0.018, respectively). Presence of RAsusceptibility alleles coding for the " shared epitope" correlated with higher skewing among RA patients (P = 0.002) and such correlation was not observed in other women, healthy or with SSc. Presence of SSc-susceptibility alleles did not correlate with XCI patterns among SSc patients. Conclusion Data demonstrate XCI skewing in both RA and SSc compared to healthy women. Unexpectedly, skewed XCI occurs more often in women with RA carrying the shared epitope, which usually reflects severe disease. This reinforces the view that loss of mosaicism in peripheral blood may be a consequence of chronic autoimmunity.	[Kanaan, Sami B.; Balandraud, Nathalie; Martin, Gabriel V.; Azzouz, Doua F.; Auger, Isabelle; Arnoux, Fanny; Martin, Marielle; Roudier, Jean; Lambert, Nathalie C.] INSERM, UMRs1097, Sci Pk Luminy, F-13258 Marseille, France; [Kanaan, Sami B.; Martin, Gabriel V.; Azzouz, Doua F.; Auger, Isabelle; Arnoux, Fanny; Martin, Marielle; Roudier, Jean; Lambert, Nathalie C.] Aix Marseille Univ, Marseille, France; [Onat, Onur E.; Ozcelik, Tayfun] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Balandraud, Nathalie; Roudier, Jean] Hop St Marguerite, AP HM, Serv Rhumatol, Marseille, France; [Nelson, J. Lee] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Nelson, J. Lee] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Ihsan Dogramaci Bilkent University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Lambert, NC (corresponding author), INSERM, UMRs1097, Sci Pk Luminy, F-13258 Marseille, France.; Lambert, NC (corresponding author), Aix Marseille Univ, Marseille, France.	nathalie.lambert@inserm.fr	Lambert, Nathalie C/P-6816-2016; Balandraud, Nathalie/ABD-6012-2020; Onat, Onur Emre/J-8126-2012; AUGER, ISABELLE/P-6294-2016; roudier, jean/A-8654-2011	Lambert, Nathalie C/0000-0001-5817-8686; Balandraud, Nathalie/0000-0002-3839-0185; Onat, Onur Emre/0000-0002-7105-1572; AUGER, ISABELLE/0000-0002-1414-8095; roudier, jean/0000-0001-5435-8567	Arthritis Fondation Courtin; Groupe Francophone de Recherche sur la Sclerodermie; Association des Sclerodermiques de France; Institut National de la Sante et de la Recherche Medicale (INSERM)	Arthritis Fondation Courtin; Groupe Francophone de Recherche sur la Sclerodermie; Association des Sclerodermiques de France; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the Arthritis Fondation Courtin, Groupe Francophone de Recherche sur la Sclerodermie, Association des Sclerodermiques de France, and Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1991, J RHEUMATOL, V18, P1282; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Avouac J, 2006, ANN RHEUM DIS, V65, P845, DOI 10.1136/ard.2006.051391; Azzouz DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036870; Balandraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064108; Brix TH, 2005, J CLIN ENDOCR METAB, V90, P5949, DOI 10.1210/jc.2005-1366; Broen JCA, 2010, ANN RHEUM DIS, V69, P2213, DOI 10.1136/ard.2010.129999; Brown CJ, 2000, CLIN GENET, V58, P353, DOI 10.1034/j.1399-0004.2000.580504.x; Chabchoub G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2759; del Rincon I, 2002, ARTHRITIS RHEUM, V46, P1480, DOI 10.1002/art.10295; DELFORGE M, 1995, BLOOD, V86, P3660, DOI 10.1182/blood.V86.10.3660.bloodjournal86103660; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hamaguchi Y, 2010, J DERMATOL, V37, P42, DOI 10.1111/j.1346-8138.2009.00762.x; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; KUWANA M, 1994, ARTHRITIS RHEUM-US, V37, P75, DOI 10.1002/art.1780370111; KUWANA M, 1993, J CLIN INVEST, V92, P1296, DOI 10.1172/JCI116703; Lambert NC, 2009, ARTHRITIS RHEUM-US, V60, P3164, DOI 10.1002/art.24962; Lambert NC, 2000, ARTHRITIS RHEUM-US, V43, P2005, DOI 10.1002/1529-0131(200009)43:9<2005::AID-ANR11>3.0.CO;2-#; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; LeRoy EC, 2001, J RHEUMATOL; Lleo A, 2008, AUTOIMMUN REV, V7, P626, DOI 10.1016/j.autrev.2008.06.009; Loubiere LS, 2005, RHEUMATOLOGY, V44, P318, DOI 10.1093/rheumatology/keh489; MACGREGOR A, 1995, J RHEUMATOL, V22, P1032; Marotte H, 2006, ANN RHEUM DIS, V65, P905, DOI 10.1136/ard.2005.036913; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Ozbalkan Z, 2005, ARTHRITIS RHEUM-US, V52, P1564, DOI 10.1002/art.21026; Ozcelik T, 2006, EUR J HUM GENET, V14, P791, DOI 10.1038/sj.ejhg.5201614; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380511; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; REVEILLE JD, 1992, J CLIN INVEST, V90, P973, DOI 10.1172/JCI115974; Stewart JJ, 1998, IMMUNOL TODAY, V19, P352, DOI 10.1016/S0167-5699(98)01298-5; Uz E, 2008, CLIN REV ALLERG IMMU, V34, P352, DOI 10.1007/s12016-007-8044-z; Uz E, 2009, ARTHRITIS RHEUM-US, V60, P3410, DOI 10.1002/art.24956; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801	38	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158550	10.1371/journal.pone.0158550	http://dx.doi.org/10.1371/journal.pone.0158550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355582	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400076
J	King, BL; Yin, VP				King, Benjamin L.; Yin, Viravuth P.			A Conserved MicroRNA Regulatory Circuit Is Differentially Controlled during Limb/Appendage Regeneration	PLOS ONE			English	Article							ZEBRAFISH FIN REGENERATION; GENE-EXPRESSION; HEART REGENERATION; SMALL RNAS; PROLIFERATION; MIGRATION; BLASTEMA; SEQUENCE; TARGET; AMPUTATION	Background Although regenerative capacity is evident throughout the animal kingdom, it is not equally distributed throughout evolution. For instance, complex limb/appendage regeneration is muted in mammals but enhanced in amphibians and teleosts. The defining characteristic of limb/appendage regenerative systems is the formation of a dedifferentiated tissue, termed blastema, which serves as the progenitor reservoir for regenerating tissues. In order to identify a genetic signature that accompanies blastema formation, we employ next-generation sequencing to identify shared, differentially regulated mRNAs and noncoding RNAs in three different, highly regenerative animal systems: zebrafish caudal fins, bichir pectoral fins and axolotl forelimbs. Results These studies identified a core group of 5 microRNAs (miRNAs) that were commonly upregulated and 5 miRNAs that were commonly downregulated, as well as 4 novel tRNAs fragments with sequences conserved with humans. To understand the potential function of these miRNAs, we built a network of 1,550 commonly differentially expressed mRNAs that had functional relationships to 11 orthologous blastema-associated genes. As miR-21 was the most highly upregulated and most highly expressed miRNA in all three models, we validated the expression of known target genes, including the tumor suppressor, pdcd4, and TGF beta receptor subunit, tgfbr2 and novel putative target genes such as the anti-apoptotic factor, bcl2l13, Choline kinase alpha, chka and the regulator of G-protein signaling, rgs5. Conclusions Our extensive analysis of RNA-seq transcriptome profiling studies in three regenerative animal models, that diverged in evolution similar to 420 million years ago, reveals a common miRNA-regulated genetic network of blastema genes. These comparative studies extend our current understanding of limb/appendage regeneration by identifying previously unassociated blastema genes and the extensive regulation by miRNAs, which could serve as a foundation for future functional studies to examine the process of natural cellular reprogramming in an injury context.	[King, Benjamin L.; Yin, Viravuth P.] Kathryn W Davis Ctr Regenerat Biol & Med, Biol Lab, Salsbury Cove, ME USA; [King, Benjamin L.; Yin, Viravuth P.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA	University of Maine System; University of Maine Orono	Yin, VP (corresponding author), Kathryn W Davis Ctr Regenerat Biol & Med, Biol Lab, Salsbury Cove, ME USA.; Yin, VP (corresponding author), Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA.	vyin@mdibl.org	King, Benjamin/AAI-1492-2019	King, Benjamin/0000-0001-6463-1336	National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103423, P20 GM104318]; US Department of Defense [W81XWH-BAA-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104318, P20GM103423] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant numbers P20 GM103423 and P20 GM104318 to BLK and VPY, and US Department of Defense grant W81XWH-BAA-1 to VPY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 2000, BIOESSAYS, V22, P578, DOI 10.1002/(SICI)1521-1878(200006)22:6<578::AID-BIES11>3.0.CO;2-#; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Bai S, 2005, MATRIX BIOL, V24, P247, DOI 10.1016/j.matbio.2005.03.007; Beauchemin M, 2015, DEVELOPMENT, V142, P4026, DOI 10.1242/dev.126649; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Bouzaffour M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005824; Brockes JP, 2001, J ANAT, V199, P3; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Campbell LJ, 2011, DEV DYNAM, V240, P1826, DOI 10.1002/dvdy.22669; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Cuervo R, 2012, P NATL ACAD SCI USA, V109, P3838, DOI 10.1073/pnas.1006619109; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Dong W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050960; DOUGLAS BS, 1972, AUST PAEDIATR J, V8, P86; Dutta B, 2014, PROFILING CHROMATIN; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Enright AJ, 2004, GENOME BIOL, V5; Feng YH, 2012, INT J MOL MED, V29, P920, DOI 10.3892/ijmm.2012.910; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Granata A, 2014, BRIT J CANCER, V110, P330, DOI 10.1038/bjc.2013.729; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; ILLINGWORTH CM, 1974, J PEDIATR SURG, V9, P853, DOI 10.1016/S0022-3468(74)80220-4; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Kinoshita T, 2012, INT J ONCOL, V40, P1770, DOI 10.3892/ijo.2012.1390; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumps C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052321; Lackner S, 2013, DEV DYNAM, V242, P122, DOI 10.1002/dvdy.23909; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JY, 2015, J BIOL CHEM, V290, P10216, DOI 10.1074/jbc.M114.612572; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makino S, 2005, P NATL ACAD SCI USA, V102, P14599, DOI 10.1073/pnas.0507408102; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; McIntyre JC, 2010, J NEUROSCI RES, V88, P3243, DOI 10.1002/jnr.22497; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Nolte H, 2015, PROTEOMICS, V15, P739, DOI 10.1002/pmic.201400316; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2002, DEVELOPMENT, V129, P5141; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rojas-Munoz A, 2009, DEV BIOL, V327, P177, DOI 10.1016/j.ydbio.2008.12.012; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; STOCUM DL, 1984, DIFFERENTIATION, V27, P13, DOI 10.1111/j.1432-0436.1984.tb01403.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tarver JE, 2013, MOL BIOL EVOL, V30, P2369, DOI 10.1093/molbev/mst133; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; Tornini VA, 2014, DEV CELL, V29, P139, DOI 10.1016/j.devcel.2014.04.007; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; WHITE JA, 1994, DEVELOPMENT, V120, P1861; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu M, 2013, ONCOL REP, V30, P1398, DOI 10.3892/or.2013.2548; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018; Yoshinari N, 2011, BIOL BULL-US, V221, P62, DOI 10.1086/BBLv221n1p62; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247	78	34	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157106	10.1371/journal.pone.0157106	http://dx.doi.org/10.1371/journal.pone.0157106			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355827	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400009
J	Denis, MFL; Alvarez, HA; Lauri, N; Alvarez, CL; Chara, O; Schwarzbaum, PJ				Leal Denis, M. Florencia; Ariel Alvarez, H.; Lauri, Natalia; Alvarez, Cora L.; Chara, Osvaldo; Schwarzbaum, Pablo J.			Dynamic Regulation of Cell Volume and Extracellular ATP of Human Erythrocytes	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; MAXI-ANION CHANNEL; RED-BLOOD-CELLS; G-PROTEIN G(I); CHLORIDE CHANNELS; PANNEXIN 1; GOLDFISH HEPATOCYTES; NUCLEOTIDE RELEASE; OXYGEN DELIVERY; P2X(7) RECEPTOR	Introduction The peptide mastoparan 7 (MST7) triggered in human erythrocytes (rbcs) the release of ATP and swelling. Since swelling is a well-known inducer of ATP release, and extracellular (ATPe), interacting with P (purinergic) receptors, can affect cell volume (Vr), we explored the dynamic regulation between Vr and ATPe. Methods and Treatments We made a quantitative assessment of MST7-dependent kinetics of Vr and of [ATPe], both in the absence and presence of blockers of ATP efflux, swelling and P receptors. Results In rbcs 10 mu M MST7 promoted acute, strongly correlated changes in [ATPe] and Vr. Whereas MST7 induced increases of 10% in Vr and 190 nM in [ATPe], blocking swelling in a hyperosmotic medium + MST7 reduced [ATPe] by 40%. Pre-incubation of rbcs with 10 mu M of either carbenoxolone or probenecid, two inhibitors of the ATP conduit pannexin 1, reduced [ATPe] by 40-50% and swelling by 40-60%, while in the presence of 80 U/mL apyrase, an ATPe scavenger, cell swelling was prevented. While exposure to 10 mu M NF110, a blocker of ATP-P2X receptors mediating sodium influx, reduced [ATPe] by 48%, and swelling by 80%, incubation of cells in sodium free medium reduced swelling by 92%. Analysis and Discussion Results were analyzed by means of a mathematical model where ATPe kinetics and Vr kinetics were mutually regulated. Model dependent fit to experimental data showed that, upon MST7 exposure, ATP efflux required a fast 1960-fold increase of ATP permeability, mediated by two kinetically different conduits, both of which were activated by swelling and inactivated by time. Both experimental and theoretical results suggest that, following MST7 exposure, ATP is released via two conduits, one of which is mediated by pannexin 1. The accumulated ATPe activates P2X receptors, followed by sodium influx, resulting in cell swelling, which in turn further activates ATP release. Thus swelling and P2X receptors constitute essential components of a positive feedback loop underlying ATP-induced ATP release of rbcs.	[Leal Denis, M. Florencia; Lauri, Natalia; Alvarez, Cora L.; Schwarzbaum, Pablo J.] Univ Buenos Aires, CONICET, FFyB, Inst Quim & Fisicoquim Biol Prof AC Paladini, Buenos Aires, DF, Argentina; [Ariel Alvarez, H.; Chara, Osvaldo] Univ Nacl La Plata, CONICET, Inst Fis Liquidos & Sistemas Biol IFLYSIB, La Plata, Argentina; [Chara, Osvaldo] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp ZIH, Dresden, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Technische Universitat Dresden	Schwarzbaum, PJ (corresponding author), Univ Buenos Aires, CONICET, FFyB, Inst Quim & Fisicoquim Biol Prof AC Paladini, Buenos Aires, DF, Argentina.	pjs@qb.ffyb.uba.ar	Chara, Osvaldo/T-2798-2019; Alvarez, Hugo Ariel/E-3707-2016	Chara, Osvaldo/0000-0002-0868-2507; Alvarez, Hugo Ariel/0000-0002-6007-0452; Leal Denis, Florencia/0000-0002-6209-4378; schwarzbaum, pablo/0000-0002-5176-089X	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112 20110100639]; Universidad de Buenos Aires [20020130100027BA]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 2014-0327]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT)	This work was supported by Grant PIP 112 20110100639, Consejo Nacional de Investigaciones Cientificas y Tecnicas (PJS); Grant 20020130100027BA, Universidad de Buenos Aires (PJS); and Grant PICT 2014-0327, Agencia Nacional de Promocion Cientifica y Tecnica (PJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1992, No To Hattatsu, V24, P127; Alvarez CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096216; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Bencic DC, 1997, PHYSIOL ZOOL, V70, P621, DOI 10.1086/515873; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Brown A., 1982, ATP ATPASE DETERMINA, P223; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; CHOU CL, 1989, AM J PHYSIOL, V257, pF359, DOI 10.1152/ajprenal.1989.257.3.F359; Clapham DE, 1998, J GEN PHYSIOL, V111, P623, DOI 10.1085/jgp.111.5.623; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Dourado M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099596; Ellsworth ML, 2012, J PHYSIOL-LONDON, V590, P4985, DOI 10.1113/jphysiol.2012.233106; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Espelt MV, 2013, AM J PHYSIOL-CELL PH, V304, pC1013, DOI 10.1152/ajpcell.00254.2012; Furlow PW, 2015, NAT CELL BIOL, V17, P943, DOI 10.1038/ncb3194; Gonzalez-Alonso J, 2002, CIRC RES, V91, P1046, DOI 10.1161/01.RES.0000044939.73286.E2; Gorman MW, 2003, LUMINESCENCE, V18, P173, DOI 10.1002/bio.721; Guest GM, 1942, J CLIN INVEST, V21, P257, DOI 10.1172/JCI101297; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hellsten Y, 2012, J PHYSIOL-LONDON, V590, P5015, DOI 10.1113/jphysiol.2012.234963; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; Hisadome K, 2002, J GEN PHYSIOL, V119, P511, DOI 10.1085/jgp.20028540; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Islam MR, 2012, AM J PHYSIOL-CELL PH, V303, pC924, DOI 10.1152/ajpcell.00459.2011; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Jiang LH, 2012, CELL HEALTH CYTOSKEL, V4, P83, DOI 10.2147/CHC.S27196; Kunapuli S, 1998, BIOCH J; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Denis MFL, 2013, BBA-GEN SUBJECTS, V1830, P4692, DOI 10.1016/j.bbagen.2013.05.033; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Nakao S, 2011, BBA-BIOMEMBRANES, V1808, P490, DOI 10.1016/j.bbamem.2010.10.007; Nemutlu E, 2005, ANAL BIOANAL CHEM, V383, P833, DOI 10.1007/s00216-005-0063-0; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V287, pH748, DOI 10.1152/ajpheart.00161.2004; Olearczyk JJ, 2004, J PHARMACOL EXP THER, V309, P1079, DOI 10.1124/jpet.103.064709; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V286, pH940, DOI 10.1152/ajpheart.00677.2003; Pafundo DE, 2004, AM J PHYSIOL-REG I, V287, pR833, DOI 10.1152/ajpregu.00199.2004; Pafundo DE, 2008, AM J PHYSIOL-REG I, V294, pR220, DOI 10.1152/ajpregu.00522.2007; Pafundo DE, 2010, J BIOL CHEM, V285, P6134, DOI 10.1074/jbc.M109.078246; Park HS, 2000, BBA-MOL CELL BIOL L, V1484, P151, DOI 10.1016/S1388-1981(00)00002-0; Pirotton S, 1996, J AUTON PHARMACOL, V16, P353, DOI 10.1111/j.1474-8673.1996.tb00052.x; PONDER E, 1951, J GEN PHYSIOL, V34, P567, DOI 10.1085/jgp.34.5.567; Qiu F, 2011, FEBS LETT, V585, P3430, DOI 10.1016/j.febslet.2011.09.033; Roman RM, 1997, J BIOL CHEM, V272, P21970, DOI 10.1074/jbc.272.35.21970; Sabirov R, 2009, J PHYSIOL SCI, V59, P3, DOI 10.1007/s12576-008-0008-4; Sands JM, 1997, AM J PHYSIOL-RENAL, V273, pF321, DOI 10.1152/ajprenal.1997.273.3.F321; Schwarzbaum PJ, 1998, AM J PHYSIOL-REG I, V274, pR1031, DOI 10.1152/ajpregu.1998.274.4.R1031; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Shakulashvili N, 2000, J CHROMATOGR A, V895, P205, DOI 10.1016/S0021-9673(00)00669-5; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Sluyter R, 2007, AM J PHYSIOL-REG I, V293, pR2090, DOI 10.1152/ajpregu.00166.2007; Sprague R, 2005, PHARMACOL REP, V57, P222; Sprague RS, 2011, ACTA PHYSIOL, V202, P285, DOI 10.1111/j.1748-1716.2010.02182.x; Sprague RS, 2007, TRENDS ENDOCRIN MET, V18, P350, DOI 10.1016/j.tem.2007.08.008; Sprague RS, 2006, DIABETES, V55, P3588, DOI 10.2337/db06-0555; Sprague RS, 2012, MICROCIRCULATION, V19, P430, DOI 10.1111/j.1549-8719.2011.00158.x; Sprague RS, 2001, AM J PHYSIOL-CELL PH, V281, pC1158, DOI 10.1152/ajpcell.2001.281.4.C1158; Sridharan M, 2012, AM J PHYSIOL-HEART C, V302, pH553, DOI 10.1152/ajpheart.00998.2011; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Strehler B L, 1968, Methods Biochem Anal, V16, P99, DOI 10.1002/9780470110348.ch2; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Varela D, 2010, J BIOL CHEM, V285, P7566, DOI 10.1074/jbc.M109.063693; VAZQUEZ A, 1991, J BIOCHEM BIOPH METH, V23, P45, DOI 10.1016/0165-022X(91)90049-3; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; WILEY JS, 1979, BRIT J HAEMATOL, V41, P133, DOI 10.1111/j.1365-2141.1979.tb03689.x	81	23	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158305	10.1371/journal.pone.0158305	http://dx.doi.org/10.1371/journal.pone.0158305			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355484	Green Published, gold			2022-12-27	WOS:000378859400047
J	Helland, O; Popa, M; Bischof, K; Gjertsen, BT; McCormack, E; Bjorge, L				Helland, Oystein; Popa, Mihaela; Bischof, Katharina; Gjertsen, Bjorn Tore; McCormack, Emmet; Bjorge, Line			The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; PLATINUM; PACLITAXEL; MANAGEMENT; TRIAL; ANGIOGENESIS; CHEMOTHERAPY; CISPLATIN; THERAPY; LBH589	Background In most epithelial ovarian carcinomas (EOC), epigenetic changes are evident, and overexpression of histone deacetylases (HDACs) represents an important manifestation. In this study, we wanted to evaluate the effects of the novel HDAC inhibitor (HDACi) panobinostat, both alone and in combination with carboplatin, on ovarian cancer cell lines and in a murine bioluminescent orthotopic surgical xenograft model for EOC. Methods The effects of panobinostat, both alone and in combination with carboplatin, on proliferation and apoptosis in ovarian cancer cell lines, were evaluated using colony and WST-1 assays, Hoechst staining and flow cytometry analysis. In addition, mechanisms were characterised by western blotting and phosphoflow analysis. Immuno-deficient mice were engrafted orthotopically with SKOV-3(luc+) cells and serial bioluminescence imaging monitored the effects of treatment with panobinostat and/or carboplatin and/or surgery. Survival parameters were also measured. Results Panobinostat treatment reduced cell growth and diminished cell viability, as shown by the induced cell cycle arrest and apoptosis in vitro. We observed increased levels of cleaved PARP and caspase-3, downregulation of cdc2 protein kinase, acetylation of H2B and higher pH2AX expression. The combined administration of carboplatin and panobinostat synergistically increased the anti-tumour effects compared to panobinostat or carboplatin treatment alone. In our novel ovarian cancer model, the mice showed significantly higher rates of survival when treated with panobinostat, carboplatin or a combination of both, compared to the controls. Panobinostat was as efficient as carboplatin regarding prolongation of survival. No significant additional effect on survival was observed when surgery was combined with carboplatin/panobinostat treatment. Conclusions Panobinostat demonstrates effective in vitro growth inhibition in ovarian cancer cells. The efficacy of panobinostat and carboplatin was equal in the orthotopic EOC model used. We conclude that panobinostat is a promising therapeutic alternative that needs to be further assessed for the treatment of EOC.	[Helland, Oystein; Bischof, Katharina; Bjorge, Line] Haukeland Hosp, Dept Obstet & Gynecol, Jonas Liesvei 72, N-5058 Bergen, Norway; [Helland, Oystein; Bischof, Katharina; Gjertsen, Bjorn Tore; McCormack, Emmet; Bjorge, Line] Univ Bergen, Dept Clin Sci, PB 7804, N-5020 Bergen, Norway; [Popa, Mihaela] Haukeland Hosp, Laboratoriebygget, KinN Therapeut, N-5021 Bergen, Norway; [Gjertsen, Bjorn Tore; McCormack, Emmet] Haukeland Hosp, Dept Internal Med, Jonas Lies Vei 65, N-5021 Bergen, Norway; [Gjertsen, Bjorn Tore; Bjorge, Line] Univ Bergen, Ctr Canc Biomarkers CCBIO, N-5020 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Helland, O (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Jonas Liesvei 72, N-5058 Bergen, Norway.	Oystein.Helland@uib.no	Cormack, Emmet Mc/D-2922-2012; Gjertsen, Bjorn T/O-1542-2015; Bjorge, Line/C-1307-2017; Bjorge, Line/AAD-6179-2021; Gjertsen, Bjørn T/AAP-3281-2020	Cormack, Emmet Mc/0000-0002-7621-4625; Gjertsen, Bjorn T/0000-0001-9358-9704; Bjorge, Line/0000-0002-0240-2770; Bjorge, Line/0000-0002-0240-2770; Gjertsen, Bjørn T/0000-0001-9358-9704	University of Bergen [11754]; Norwegian Cancer Society [421828, 732200]; Helse Vest [911789, 911884, 911809]; Bergen Research Foundation	University of Bergen; Norwegian Cancer Society(Norwegian Cancer Society); Helse Vest; Bergen Research Foundation	This work was supported by The University of Bergen, award number 11754 and the Norwegian Cancer Society, award number 421828 to Oystein Helland; Helse Vest, award number 911789 and 911884, the Norwegian Cancer Society, award number 732200 and Bergen Research Foundation, no award number, to Emmet McCormack; The Norwegian Cancer Society, award number 421828 to Bjorn Tore Gjertsen; Helse Vest, award number 911809 to Line Bjorge. None of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne M, 2013, ONCOTARGETS THER, V6, P1613, DOI 10.2147/OTT.S30773; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bookman M A, 1999, Oncologist, V4, P87; Budman DR, 2011, INVEST NEW DRUG, V29, P1224, DOI 10.1007/s10637-010-9467-6; Chao HT, 2013, CANCER LETT, V329, P17, DOI 10.1016/j.canlet.2012.08.035; Chien WW, 2014, MOL CARCINOGEN, V53, P722, DOI 10.1002/mc.22024; Colombo N, 2007, CRIT REV ONCOL HEMAT, V64, P129, DOI 10.1016/j.critrevonc.2007.04.004; Colombo N, 2013, FUTURE ONCOL, V9, P19, DOI 10.2217/fon.13.206; Cooper AL, 2007, GYNECOL ONCOL, V104, P596, DOI 10.1016/j.ygyno.2006.09.011; Dickinson M, 2010, INVEST NEW DRUG, V28, pS3, DOI 10.1007/s10637-010-9596-y; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; du Bois A, 1999, ANN ONCOL, V10, P35, DOI 10.1023/A:1008355317514; Dunton CJ, 2002, ONCOLOGIST, V7, P11; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Firestone B, 2010, CURR OPIN PHARMACOL, V10, P391, DOI 10.1016/j.coph.2010.06.012; Garnock-Jones KP, 2015, DRUGS, V75, P695, DOI 10.1007/s40265-015-0388-8; GJERTSEN BT, 1994, J CELL SCI, V107, P3363; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Helland O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089527; Horowitz NS, 2004, GYNECOL ONCOL, V94, P67, DOI 10.1016/j.ygyno.2004.03.047; Jin Ke Long, 2008, J Gynecol Oncol, V19, P185, DOI 10.3802/jgo.2008.19.3.185; Joerger M, 2012, ANN ONCOL, V23, P313, DOI 10.1093/annonc/mds314; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Khot A, 2013, EXPERT OPIN INV DRUG, V22, P1211, DOI 10.1517/13543784.2013.815165; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Markman M, 2003, J CLIN ONCOL, V21, P2460, DOI 10.1200/JCO.2003.07.013; Marsoni S, 2008, EPIGENETICS-US, V3, P164, DOI 10.4161/epi.3.3.6253; Morgan RJ, 2011, J NATL COMPR CANC NE, V9, P82, DOI 10.6004/jnccn.2011.0008; Mutch DG, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31589; Nguyen HT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00071; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Poveda A, 2014, CANCER TREAT REV, V40, P366, DOI 10.1016/j.ctrv.2013.08.001; Prince HM, 2009, FUTURE ONCOL, V5, P601, DOI [10.2217/fon.09.36, 10.2217/FON.09.36]; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Qian XZ, 2006, MOL CANCER THER, V5, P2086, DOI 10.1158/1535-7163.MCT-06-0111; Schwartz PE, 2008, ONCOLOGY-NY, V22, P1025; Sehouli J, 2012, ANN ONCOL, V23, P556, DOI 10.1093/annonc/mdr321; Shan Z, 2012, ASIAN PAC J CANCER P, V13, P3977, DOI 10.7314/APJCP.2012.13.8.3977; Sharma S, 2013, INVEST NEW DRUG, V31, P974, DOI 10.1007/s10637-013-9930-2; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stuart GCE, 2011, INT J GYNECOL CANCER, V21, P750, DOI 10.1097/IGC.0b013e31821b2568; Su WH, 2012, TAIWAN J OBSTET GYNE, V51, P167, DOI 10.1016/j.tjog.2012.04.002; Takai N, 2004, CANCER-AM CANCER SOC, V101, P2760, DOI 10.1002/cncr.20709; Takai N, 2010, J ONCOL, V2010, DOI 10.1155/2010/458431; Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192; Wilson AJ, 2012, GYNECOL ONCOL, V127, P579, DOI 10.1016/j.ygyno.2012.09.016; Wilson PM, 2013, INVEST NEW DRUG, V31, P845, DOI 10.1007/s10637-012-9914-7; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583	58	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158208	10.1371/journal.pone.0158208	http://dx.doi.org/10.1371/journal.pone.0158208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352023	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900044
J	Lopes, JLS; Yoneda, JS; Martins, JM; DeMarco, R; Jameson, DM; Castro, AM; Bossolan, NRS; Wallace, BA; Araujo, APU				Lopes, Jose L. S.; Yoneda, Juliana S.; Martins, Julia M.; DeMarco, Ricardo; Jameson, David M.; Castro, Aline M.; Bossolan, Nelma R. S.; Wallace, B. A.; Araujo, Ana P. U.			Environmental Factors Modulating the Stability and Enzymatic Activity of the Petrotoga mobilis Esterase (PmEst)	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; PROTEIN SECONDARY STRUCTURE; SP NOV.; STRUCTURE PREDICTION; ENZYMES; LIPASES; FOLD; WELL	Enzymes isolated from thermophilic organisms found in oil reservoirs can find applications in many fields, including the oleochemical, pharmaceutical, bioenergy, and food/dairy industries. In this study, in silico identification and recombinant production of an esterase from the extremophile bacteria Petrotoga mobilis (designated PmEst) were performed. Then biochemical, bioinformatics and structural characterizations were undertaken using a combination of synchrotron radiation circular dichroism (SRCD) and fluorescence spectroscopies to correlate PmEst stability and hydrolytic activity on different substrates. The enzyme presented a high Michaelis-Menten constant (K-M 0.16 mM) and optimum activity at similar to 55 degrees C for p-nitrophenyl butyrate. The secondary structure of PmEst was preserved at acid pH, but not under alkaline conditions. PmEst was unfolded at high concentrations of urea or guanidine through apparently different mechanisms. The esterase activity of PmEst was preserved in the presence of ethanol or propanol and its melting temperature increased similar to 8 degrees C in the presence of these organic solvents. PmEst is a mesophilic esterase with substrate preference towards short-to medium-length acyl chains. The SRCD data of PmEst is in agreement with the prediction of an alpha/beta protein, which leads us to assume that it displays a typical fold of esterases from this family. The increased enzyme stability in organic solvents may enable novel applications for its use in synthetic biology. Taken together, our results demonstrate features of the PmEst enzyme that indicate it may be suitable for applications in industrial processes, particularly, when the use of polar organic solvents is required.	[Lopes, Jose L. S.; Yoneda, Juliana S.] Univ Sao Paulo, Inst Fis, CP 20516, BR-01498 Sao Paulo, Brazil; [Yoneda, Juliana S.; Wallace, B. A.] Univ London, Birkbeck Coll, Inst Struct & Mol Biol, London, England; [Martins, Julia M.; DeMarco, Ricardo; Bossolan, Nelma R. S.; Araujo, Ana P. U.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Jameson, David M.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Castro, Aline M.] Ctr Res & Dev, Div Biotechnol, Petrobras, Brazil	Universidade de Sao Paulo; University of London; Birkbeck University London; Universidade de Sao Paulo; University of Hawaii System; University of Hawaii Manoa	Araujo, APU (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.	anapaula@ifsc.usp.br	DeMarco, Ricardo/A-7773-2008; Araujo, Ana Paula U/I-6664-2012; CASTRO, ALINE M/C-4984-2015; Lopes, Jose L S/D-3213-2012; Bossolan, Nelma/P-1866-2015; Yoneda, Juliana S/F-2130-2015; Lopes, Jose Luiz S/AAC-2917-2021; Wallace, B A/C-3753-2008	DeMarco, Ricardo/0000-0001-8944-1301; Araujo, Ana Paula U/0000-0001-5455-084X; CASTRO, ALINE M/0000-0002-1355-8455; Lopes, Jose L S/0000-0003-1281-0521; Bossolan, Nelma/0000-0002-5484-9283; Yoneda, Juliana S/0000-0003-2814-3022; Wallace, B A/0000-0001-9649-5092	Biotechnology and Biological Sciences Research Council (BBSRC) [J019747]; Brazil National Council of Technological and Scientific Development (CNPq) [553056/2011-5, 407337/2013-0]; BBSRC [J019135/1, N012763]; BBSRC-Sao Paulo Research Foundation (FAPESP) [FAPPA 15/50347-2]; CNPq [553056/2011-5, 150304/2015-3]; Petrobras [2012/00187-0]; ISA Synchrotron (Aarhus, Denmark); Soleil Synchrotron (France); BBSRC [BB/J019747/1, BB/N012763/1, BB/J019135/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J019135/1, BBS/B/02959, BB/J019747/1, BB/N012763/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Brazil National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC-Sao Paulo Research Foundation (FAPESP)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); ISA Synchrotron (Aarhus, Denmark); Soleil Synchrotron (France); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful for the support of paired UK-Brazil partnering grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (grant J019747 to BAW) and Brazil National Council of Technological and Scientific Development (CNPq) to APUA, grants 553056/2011-5 and 407337/2013-0; BBSRC grant J019135/1 (to BAW), BBSRC-Sao Paulo Research Foundation (FAPESP) grant FAPPA 15/50347-2 and BBSRC N012763 (to APUA and BAW, respectively), and CNPq for postdoctoral fellowships (to JLSL and JSY, grants 150304/2015-3 and 553056/2011-5, respectively); Petrobras (grant 2012/00187-0) to NRSB providing a DTI fellowship (to JMM) and agreeing with the decision to publish; and SRCD beamtime grants from the ISA Synchrotron (Aarhus, Denmark) (to JLSL and BAW), and the Soleil Synchrotron (France) (to BAW). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alex Deepthy, 2014, Enzyme Res, V2014, P494682, DOI 10.1155/2014/494682; Alvarez Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092257; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Cardenas F, 2001, ENZYME MICROB TECH, V28, P145, DOI 10.1016/S0141-0229(00)00278-7; DAVEY ME, 1993, SYST APPL MICROBIOL, V16, P191; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Elmi F, 2005, J BACTERIOL, V187, P8470, DOI 10.1128/JB.187.24.8470-8476.2005; Fang YW, 2015, INT J BIOL MACROMOL, V80, P334, DOI 10.1016/j.ijbiomac.2015.06.045; Gobbetti M, 1997, J DAIRY SCI, V80, P3099, DOI 10.3168/jds.S0022-0302(97)76280-5; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Huber R., 2006, PROKARYOTES, V7, P899, DOI [DOI 10.1007/0-387-30747-8_38., 10.1007/0-387-30747-8_38, DOI 10.1007/0-387-30747-8_38]; James NG, 2011, ANAL BIOCHEM, V410, P70, DOI 10.1016/j.ab.2010.11.011; JAMESON DM, 1984, APPL SPECTROSC REV, V20, P55, DOI 10.1080/05704928408081716; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim MH, 2008, PROTEINS, V70, P578, DOI 10.1002/prot.21680; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; L'Haridon S, 2002, INT J SYST EVOL MICR, V52, P1715, DOI [10.1099/ijs.0.02153-0, 10.1099/00207713-52-5-1715]; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Levisson M, 2007, FEBS J, V274, P2832, DOI 10.1111/j.1742-4658.2007.05817.x; Li X, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-108; Lien T, 1998, INT J SYST BACTERIOL, V48, P1007, DOI 10.1099/00207713-48-3-1007; Lopes JLS, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/2/025003; Lopez-Lopez Olalla, 2014, Curr Protein Pept Sci, V15, P445; Miles AJ, 2005, PROTEIN SCI, V14, P368, DOI 10.1110/ps.041019905; Miranda-Tello E, 2004, INT J SYST EVOL MICR, V54, P169, DOI 10.1099/ijs.0.02702-0; Miranda-Tello E, 2007, INT J SYST EVOL MICR, V57, P40, DOI 10.1099/ijs.0.64516-0; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; OEHM HC, 1982, EUR J BIOCHEM, V129, P157, DOI 10.1111/j.1432-1033.1982.tb07034.x; Purwasena IA, 2014, ARCH MICROBIOL, V196, P313, DOI 10.1007/s00203-014-0972-4; Ross JA, 2008, PHOTOCH PHOTOBIO SCI, V7, P1301, DOI 10.1039/b804450n; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stefl M, 2011, ANAL BIOCHEM, V410, P62, DOI 10.1016/j.ab.2010.11.010; Synowiecki J, 2010, AFR J BIOTECHNOL, V9, P7020; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wallace BA, 2011, NUCL INSTRUM METH A, V649, P177, DOI 10.1016/j.nima.2010.10.135; Wallace BA, 2009, Q REV BIOPHYS, V42, P317, DOI 10.1017/S003358351000003X; Wallace BA, 2000, NAT STRUCT BIOL, V7, P708, DOI 10.1038/78915; Wallace BA, 2001, CURR OPIN CHEM BIOL, V5, P567, DOI 10.1016/S1367-5931(00)00243-X; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	43	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158146	10.1371/journal.pone.0158146	http://dx.doi.org/10.1371/journal.pone.0158146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351338	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900038
J	Yang, HK; Kim, JH; Hwang, JM				Yang, Hee Kyung; Kim, Jae Hyoung; Hwang, Jeong-Min			Abducens Nerve in Patients with Type 3 Duane's Retraction Syndrome	PLOS ONE			English	Article							DISSOCIATED VERTICAL DEVIATION; ABDUCTION	Background We have previously reported that the presence of the abducens nerve was variable in patients with type 3 Duane's retraction syndrome (DRS), being present in 2 of 5 eyes (40%) and absent in 3 (60%) on magnetic resonance imaging (MRI). The previous study included only 5 eyes with unilateral DRS type 3. Objectives To supplement existing scarce pathologic information by evaluating the presence of the abducens nerve using high resolution thin-section MRI system in a larger number of patients with DRS type 3, thus to provide further insight into the pathogenesis of DRS. Data Extraction A retrospective review of medical records on ophthalmologic examination and high resolution thin-section MRI at the brainstem level and orbit was performed. A total of 31 patients who showed the typical signs of DRS type 3, including abduction and adduction deficit, globe retraction, narrowing of fissure on adduction and upshoot and/or downshoot, were included. The abducens nerve and any other extraocular muscle abnormalities discovered by MRI were noted. Results DRS was unilateral in 26 patients (84%) and bilateral in 5 patients (16%). Two out of 5 bilateral patients had DRS type 3 in the right eye and DRS type 1 in the left eye. Of the 34 affected orbits with DRS type 3 in 31 patients, the abducens nerve was absent or hypoplastic in 31 eyes (91%) and present in 3 eyes (9%). Patients with a present abducens nerve showed more limitation in adduction compared to patients with an absent abducens nerve (P = 0.030). Conclusions The abducens nerve is absent or hypoplastic in 91% of DRS type 3. Patients with a present abducens nerve showed more prominent limitation of adduction. As DRS type 3 partly share the same pathophysiology with type 1 and 2 DRS, the classification of DRS may have to be revised according to MRI findings.	[Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea; [Kim, Jae Hyoung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Radiol, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea.	hjm@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2013R1A1A2010606]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (2013R1A1A2010606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayramlar H, 2003, J PEDIAT OPHTH STRAB, V40, P182, DOI 10.3928/0191-3913-20030501-19; Demer JL, 2007, INVEST OPHTH VIS SCI, V48, P5505, DOI 10.1167/iovs.07-0772; Denis D, 2007, J NEURORADIOLOGY, V34, P137, DOI 10.1016/j.neurad.2007.01.002; Denis D, 2008, J AAPOS, V12, P91, DOI 10.1016/j.jaapos.2007.07.012; DUANE A, 1905, ARCH OPHTHALMOL-CHIC, V34, P133; Gutowski N J, 2003, Neuromuscul Disord, V13, P573, DOI 10.1016/S0960-8966(03)00043-9; HUBER A, 1974, BRIT J OPHTHALMOL, V58, P293, DOI 10.1136/bjo.58.3.293; Jiao YH, 2009, J PEDIAT OPHTH STRAB, V46, P278, DOI 10.3928/01913913-20090903-05; Kim JH, 2008, EUR J NEUROL, V15, pE25, DOI 10.1111/j.1468-1331.2008.02075.x; Kim JH, 2006, ARCH OPHTHALMOL-CHIC, V124, P918, DOI 10.1001/archopht.124.6.918; Kim JH, 2012, OPHTHALMOLOGY, V119, P403, DOI 10.1016/j.ophtha.2011.08.001; Kim JH, 2009, J NEUROL, V256, P1920, DOI 10.1007/s00415-009-5224-1; Kim JH, 2006, J NEUROL, V253, P390, DOI 10.1007/s00415-005-0977-7; Kim JH, 2005, AM J NEURORADIOL, V26, P702; Kim JH, 2005, J NEUROL, V252, P224, DOI 10.1007/s00415-005-0585-6; Kim JH, 2005, OPHTHALMOLOGY, V112, P109, DOI 10.1016/j.ophtha.2004.06.040; MULHERN M, 1994, BRIT J OPHTHALMOL, V78, P588, DOI 10.1136/bjo.78.7.588; Parsa CF, 1998, AM J OPHTHALMOL, V125, P399, DOI 10.1016/S0002-9394(99)80158-5; RIMMER S, 1990, J CLIN NEURO-OPHTHAL, V10, P38; She HC, 2012, CHINESE MED J-PEKING, V125, P2929, DOI 10.3760/cma.j.issn.0366-6999.2012.16.024; Xia S, 2014, CLIN RADIOL, V69, pE191, DOI 10.1016/j.crad.2013.12.010; Yuksel D, 2010, VISION RES, V50, P2334, DOI 10.1016/j.visres.2010.08.019	22	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0150670	10.1371/journal.pone.0150670	http://dx.doi.org/10.1371/journal.pone.0150670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352171	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900001
J	Gheerbrant, E; Filippo, A; Schmitt, A				Gheerbrant, Emmanuel; Filippo, Andrea; Schmitt, Arnaud			Convergence of Afrotherian and Laurasiatherian Ungulate-Like Mammals: First Morphological Evidence from the Paleocene of Morocco	PLOS ONE			English	Article							OULED-ABDOUN BASIN; LOWER EOCENE; EARLY TERTIARY; ORIGINS; PROBOSCIDEA; ORDER	Molecular-based analyses showed that extant "ungulate" mammals are polyphyletic and belong to the two main clades Afrotheria (Paenungulata) and Laurasiatheria (Euungulata: Cetartiodactyla-Perissodactyla). However, paleontological and neontological studies hitherto failed to demonstrate the morphological convergence of African and Laurasian "ungulate" orders. They support an "Altungulata" group including the Laurasian order Perissodactyla and the African superorder Paenungulata and characterized especially by quadritubercular and bilophodont molars adapted for a folivorous diet. We report new critical fossils of one of the few known African condylarth-like mammal, the enigmatic Abdounodus from the middle Paleocene of Morocco. They show that Abdounodus and Ocepeia display key intermediate morphologies refuting the homology of the fourth main cusp of upper molars in Paenungulata and Perissodactyla: Paenungulates unexpectedly have a metaconule-derived pseudohypocone, instead of a cingular hypocone. Comparative and functional dental anatomy of Abdounodus demonstrates indeed the convergence of the quadritubercular and bilophodont pattern in "ungulates". Consistently with our reconstruction of the structural evolution of paenungulate bilophodonty, the phylogenetic analysis relates Abdounodus and Ocepeia to Paenungulata as stem taxa of the more inclusive new clade Paenungulatomorpha which is distinct from the Perissodactyla and Anthracobunidae. Abdounodus and Ocepeia help to identify the first convincing synapomorphy within the Afrotheria-i.e., the pseudohypocone-that demonstrates the morphological convergence of African and Laurasian ungulate-like placentals, in agreement with molecular phylogeny. Abdounodus and Ocepeia are the only known representatives of the early African ungulate radiation predating the divergence of extant paenungulate orders. Paenungulatomorpha evolved in Africa since the early Tertiary independently from laurasiatherian euungulates and "condylarths" such as apheliscids. The rapid early Tertiary radiation of the Afrotheria and Paenungulatomorpha, as illustrated by the Paleocene Moroccan mammals, is concurrent with that of the Laurasiatheria in a general, explosive mammal evolution in both the South and North Tethyan continents following the K/Pg event.	[Gheerbrant, Emmanuel; Filippo, Andrea; Schmitt, Arnaud] Univ Paris 04, CR2P Ctr Rech Paleobiodiversite & Paleoenvironnem, Museum Natl Hist Nat, CNRS,UPMC,MNHN,UMR 7207,CP38, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Gheerbrant, E (corresponding author), Univ Paris 04, CR2P Ctr Rech Paleobiodiversite & Paleoenvironnem, Museum Natl Hist Nat, CNRS,UPMC,MNHN,UMR 7207,CP38, Paris, France.	gheerbra@mnhn.fr	Gheerbrant, Emmanuel/F-6943-2010	Gheerbrant, Emmanuel/0000-0003-3355-458X				Arambourg C., 1952, NOTES ME MOIRES SERV, V92, P1; Benoit J, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1034358; BUTLER PM, 1952, P ZOOL SOC LOND, V121, P777, DOI 10.1111/j.1096-3642.1952.tb00784.x; Cooper LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109232; Cote S, 2007, P NATL ACAD SCI USA, V104, P5510, DOI 10.1073/pnas.0700441104; COURT N, 1993, J PALEONTOL, V67, P889, DOI 10.1017/S002233600003715X; Court N., 1992, Historical Biology, V6, P91; Crompton AW, 1971, ZOOLOGICAL J LINN S1, P65; Gheerbrant E, 2003, B SOC GEOL FR, V174, P279, DOI 10.2113/174.3.279; Gheerbrant E, 2005, GEODIVERSITAS, V27, P239; Gheerbrant E, 1996, NATURE, V383, P68, DOI 10.1038/383068a0; Gheerbrant E, 2001, J VERTEBR PALEONTOL, V21, P107, DOI 10.1671/0272-4634(2001)021[0107:FAACMP]2.0.CO;2; Gheerbrant E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089739; Gheerbrant E, 2012, PALAEONTOGR ABT A, V297, P151; Gheerbrant Emmanuel, 2010, P563; Gheerbrant E, 2009, P NATL ACAD SCI USA, V106, P10717, DOI 10.1073/pnas.0900251106; Ginsburg L, 1999, CR ACAD SCI II A, V328, P209, DOI 10.1016/S1251-8050(99)80098-6; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gunnell GF, 2010, CENOZOIC MAMMALS AFR, P123; Halliday TJD, 2017, BIOL REV, V92, P521, DOI 10.1111/brv.12242; Halliday TJD, 2016, BIOL J LINN SOC, V118, P152, DOI 10.1111/bij.12731; Hooker Jeremy J., 2005, P199; Hooker JJ, 2012, ZOOL J LINN SOC-LOND, V164, P856, DOI 10.1111/j.1096-3642.2011.00787.x; HOOKER JJ, 1984, ZOOL J LINN SOC-LOND, V82, P229, DOI 10.1111/j.1096-3642.1984.tb00545.x; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Kocsis L, 2014, PALAEOGEOGR PALAEOCL, V394, P74, DOI 10.1016/j.palaeo.2013.11.002; Kullmer O, 2009, AM J PHYS ANTHROPOL, V139, P600, DOI 10.1002/ajpa.21086; Linnaeus C, 1766, SYSTEMAE NATURAE; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; MAHBOUBI M, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V192, P15; Mao FY, 2016, HIST BIOL, V28, P787, DOI 10.1080/08912963.2015.1034120; McKenna M.C., 1977, GEOBIOS MEM SPEC, V1, P61; McKenna MC, 1997, CLASSIFICATION MAMMA; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nixon KC, 1999, WINCLADA BETA VERSIO; Noubhani Abdelmajid, 1997, Palaeo Ichthyologica, V8, P1; Pardini AT, 2007, P ROY SOC B-BIOL SCI, V274, P1333, DOI 10.1098/rspb.2007.0088; Polly PD, 2007, NATURE, V229, P413; Prothero D. R., 1993, MAMMAL PHYLOGENY, V2, P173; Prothero D. R., 1989, EVOLUTION PERISSODAC, P504; Robinson TJ, 2008, P NATL ACAD SCI USA, V105, P14477, DOI 10.1073/pnas.0807433105; Robinson TJ, 2004, CURR TOP DEV BIOL, V63, P37, DOI 10.1016/S0070-2153(04)63002-X; ROSE KD, 2006, BEGINNING AGE MAMMAL; Rose KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6570; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Tabuce R, 2007, P ROY SOC B-BIOL SCI, V274, P1159, DOI 10.1098/rspb.2006.0229; Thewissen J.G.M., 1992, Journal of Vertebrate Paleontology, V12, P494; von Koenigswald W, 2013, PALAEONTOL Z, V87, P141, DOI 10.1007/s12542-012-0142-4; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Welker F, 2015, NATURE, V522, P81, DOI 10.1038/nature14249; Wilson LAB, 2012, PALEOBIOLOGY, V38, P308, DOI 10.1666/11001.1; Yans J, 2014, GONDWANA RES, V25, P257, DOI 10.1016/j.gr.2013.04.004	56	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157556	10.1371/journal.pone.0157556	http://dx.doi.org/10.1371/journal.pone.0157556			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384169	gold, Green Submitted, Green Published			2022-12-27	WOS:000379809400015
J	Liu, R; Huang, Q; Shan, JJ; Duan, JA; Zhu, ZH; Liu, P; Bian, Y; Shang, EX; Qian, DW				Liu, Rui; Huang, Qiong; Shan, Jinjun; Duan, Jin-ao; Zhu, Zhenhua; Liu, Pei; Bian, Yong; Shang, Er-xin; Qian, Dawei			Metabolomics of the Antipyretic Effects of Bubali Cornu (Water Buffalo Horn) in Rats	PLOS ONE			English	Article							PATTERN-RECOGNITION APPROACH; MASS-SPECTROMETRY; ANIMAL HORNS; INDUCED INFLAMMATION; BIOCHEMICAL-CHANGES; FEBRILE RESPONSE; RHINOCEROS HORN; BAKERS-YEAST; FEVER; LYSOPHOSPHATIDYLCHOLINE	Bubali Cornu (water buffalo horn, WBH) has been used for thousands of years in traditional Chinese medicine (TCM) as an effective treatment for heat. In the present study, we have carried out a metabolomics profiling study on plasma and urine samples to explore potential biomarkers and determine how WBH exerts its antipyretic effects in yeast-induced pyrexia at a metabolomic level. Ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS), together with multivariate statistical analysis, was used to detect and identify potential biomarkers associated with pyrexia and with WBH treatment. In total, sixteen endogenous metabolites were identified in plasma samples and twenty-one metabolites were detected in urine samples. The biomarkers identified in this study, using metabolic pathway analysis (MetPA), are involved in glycerophospholipid, arachidonic acid, amino acid, sphingolipid, and purine metabolism, all of which are disturbed in rats with pyrexia. As a result, WBH affect arachidonic acid metabolism and oxidative stress in yeast-induced pyrexia rats chiefly. The present study determines the important substances underlying the antipyretic efficacy of WBH at a metabolic level. It might pave the way for further investigations into the mechanisms of action of other animal horn-derived traditional Chinese medicines (TCMs).	[Liu, Rui; Duan, Jin-ao; Zhu, Zhenhua; Liu, Pei; Bian, Yong; Shang, Er-xin; Qian, Dawei] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Nanjing, Jiangsu, Peoples R China; [Liu, Rui; Duan, Jin-ao; Zhu, Zhenhua; Liu, Pei; Bian, Yong; Shang, Er-xin; Qian, Dawei] Nanjing Univ Chinese Med, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Nanjing, Jiangsu, Peoples R China; [Liu, Rui] Nanjing Univ Chinese Med, Jiangsu Key Lab Res & Dev Marine Bioresource Phar, Nanjing, Jiangsu, Peoples R China; [Liu, Rui; Duan, Jin-ao; Zhu, Zhenhua; Liu, Pei; Shang, Er-xin; Qian, Dawei] Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing, Jiangsu, Peoples R China; [Huang, Qiong] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Shan, Jinjun] Nanjing Univ Chinese Med, Inst Pediat, Jiangsu Key Lab Pediat Resp Dis, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing Medical University; Nanjing University of Chinese Medicine	Liu, R; Duan, JA (corresponding author), Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Nanjing, Jiangsu, Peoples R China.; Liu, R; Duan, JA (corresponding author), Nanjing Univ Chinese Med, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Nanjing, Jiangsu, Peoples R China.; Liu, R (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab Res & Dev Marine Bioresource Phar, Nanjing, Jiangsu, Peoples R China.; Liu, R; Duan, JA (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing, Jiangsu, Peoples R China.	cpulr@126.com; dja@njutcm.edu.cn			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Technology Research Funds of State Administration of Traditional Chinese Medicine [201407002]; National Science Foundation of China [81202861, 81274017]; Doctoral Fund of Ministry of Education of China [20113237120011]; Flagship Major Development of Jiangsu Higher Education Institutions; Qin Lan Project	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Technology Research Funds of State Administration of Traditional Chinese Medicine; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Flagship Major Development of Jiangsu Higher Education Institutions; Qin Lan Project	This study was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Technology Research Funds of State Administration of Traditional Chinese Medicine (201407002), National Science Foundation of China (81202861 and 81274017), Doctoral Fund of Ministry of Education of China (20113237120011), and the Flagship Major Development of Jiangsu Higher Education Institutions, and Qin Lan Project.	Adham KG, 2012, NEUROENDOCRINOL LETT, V33, P713; Bayle MS, 2000, ACTA PAEDIATR, V89, P367, DOI 10.1080/080352500750028573; Brkic L, 2012, ATHEROSCLEROSIS, V224, P348, DOI 10.1016/j.atherosclerosis.2012.07.038; BUT PP, 1990, J ETHNOPHARMACOL, V30, P157; BUT PPH, 1991, J ETHNOPHARMACOL, V33, P45; Feleder C, 2007, AM J PHYSIOL-REG I, V293, pR1135, DOI 10.1152/ajpregu.00067.2007; Fraunberger P, 2002, CLIN CHEM LAB MED, V40, P304, DOI 10.1515/CCLM.2002.048; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100017; Gao XY, 2013, CHEM-BIOL INTERACT, V204, P39, DOI 10.1016/j.cbi.2013.04.001; Guan NZ, 2015, METABOLOMICS, V11, P1106, DOI 10.1007/s11306-014-0766-3; Kaneko K, 2011, J INVEST DERMATOL, V131, P1262, DOI 10.1038/jid.2011.37; Kondeti V, 2016, J ALLERGY CLIN IMMUN, V137, P289, DOI 10.1016/j.jaci.2015.06.030; Liu R, 2015, J LIQ CHROMATOGR R T, V38, P1185, DOI 10.1080/10826076.2015.1025142; Liu R, 2012, J LIQ CHROMATOGR R T, V35, P205, DOI 10.1080/10826076.2011.597070; Liu R, 2011, J SEP SCI, V34, P354, DOI 10.1002/jssc.201000617; Liu R, 2010, PEPTIDES, V31, P786, DOI 10.1016/j.peptides.2010.02.016; Liu R, 2010, AM J CHINESE MED, V38, P293, DOI 10.1142/S0192415X10007853; Liu SM, 2011, AM J CHINESE MED, V39, P95, DOI 10.1142/S0192415X11008671; Luo JY, 2011, J ETHNOPHARMACOL, V136, P210, DOI 10.1016/j.jep.2011.04.053; Hung ND, 2012, INFLAMM RES, V61, P473, DOI 10.1007/s00011-012-0434-x; Ferreira APO, 2012, INFLAMM RES, V61, P103, DOI 10.1007/s00011-011-0392-8; Panasenko OM, 2003, FREE RADICAL BIO MED, V34, P553, DOI 10.1016/S0891-5849(02)01358-8; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Schober C, 2009, BIOORG CHEM, V37, P202, DOI 10.1016/j.bioorg.2009.09.002; Strobel G, 2002, LIFE SCI, V71, P55, DOI 10.1016/S0024-3205(02)01620-X; Su SL, 2013, J PROTEOME RES, V12, P852, DOI 10.1021/pr300935x; [王斐 Wang Fei], 2005, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V21, P163; [王斐 WANG Fei], 2007, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V23, P36; Wang PC, 2015, AM J CHINESE MED, V43, P1281, DOI 10.1142/S0192415X15500731; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Zhang FS, 2013, J PHARMACEUT BIOMED, V81-82, P168, DOI 10.1016/j.jpba.2013.04.005; Zou LJ, 2013, SCI REP-UK, V3, DOI [10.1038/srep02243, 10.1038/srep03108]	33	12	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158478	10.1371/journal.pone.0158478	http://dx.doi.org/10.1371/journal.pone.0158478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384078	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400052
J	Xu, L; Zhang, G; Cui, HY				Xu, Li; Zhang, Guang; Cui, Haoyue			Dependence of Initial Value on Pattern Formation for a Logistic Coupled Map Lattice	PLOS ONE			English	Article							TURING PATTERNS; TIME-DELAY; SYSTEMS	The logistic coupled map lattices (LCML) have been widely investigated as well as their pattern dynamics. The patterns formation may depend on not only fluctuations of system parameters, but variation of the initial conditions. However, the mathematical discussion is quite few for the effect of initial values so far. The present paper is concerned with the pattern formation for a two-dimensional Logistic coupled map lattice, where any initial value can be linear expressed by corresponding eigenvectors, and patterns formation can be determined by selecting the corresponding eigenvectors. A set of simulations are conducted whose results demonstrate the fact. The method utilized in the present paper could be applied to other discrete systems as well.	[Xu, Li; Zhang, Guang; Cui, Haoyue] Tianjin Univ Commerce, Sch Sci, Tianjin, Peoples R China	Tianjin University of Commerce	Xu, L (corresponding author), Tianjin Univ Commerce, Sch Sci, Tianjin, Peoples R China.	beifang_xl@163.com		Zhang, Guang/0000-0001-9064-9345	national natural science foundation of China [11371277]; cultivation program for excellent youth teacher in university, Tianjin [507-125RCPY0314]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); cultivation program for excellent youth teacher in university, Tianjin	This work was financially supported by the national natural science foundation of China under grant No. 11371277 and cultivation program for excellent youth teacher in university with the grant number 507-125RCPY0314, Tianjin.	Almirantis Y, 2000, COMPUT CHEM, V24, P159, DOI 10.1016/S0097-8485(99)00057-1; Brovelli A, 2009, ENVIRON MODELL SOFTW, V24, P611, DOI 10.1016/j.envsoft.2008.10.001; DELCOURT F, 1995, APPL MICROBIOL BIOT, V43, P321, DOI [10.1007/BF00172832, 10.1007/s002530050410]; dos Santos AM, 2008, PHYSICA A, V387, P1655, DOI 10.1016/j.physa.2007.09.051; Enderlein J, 1996, J PHYS CHEM-US, V100, P19642, DOI 10.1021/jp9615870; FIELD RJ, 1985, OSCILLATIONS TRAVELL; Ide Y, 2016, PHYSICA A, V457, P331, DOI 10.1016/j.physa.2016.03.055; Kytta K, 2007, PHYSICA A, V385, P105, DOI 10.1016/j.physa.2007.06.034; Lagzi I, 2004, CHEM PHYS, V303, P151, DOI 10.1016/j.chemphys.2004.05.016; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Murray JD., 1989, MATH BIOL BIOMATHEMA, DOI [10.1007/978-3-662-08539-4, DOI 10.1007/978-3-662-08539-4]; Navickas Z, 2011, DISCRETE CONT DYN-B, V16, P927, DOI 10.3934/dcdsb.2011.16.927; Nomura A, 1997, J PHYS SOC JPN, V66, P598, DOI 10.1143/JPSJ.66.598; Rangarajan G, 2003, PHYS LETT A, V310, P415, DOI 10.1016/S0375-9601(03)00447-X; Skudarnov PV, 2002, INT J HEAT MASS TRAN, V45, P5191, DOI 10.1016/S0017-9310(02)00224-7; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Voroney JP, 1996, PHYSICA D, V99, P303, DOI 10.1016/S0167-2789(96)00132-7; White A, 1996, P ROY SOC B-BIOL SCI, V263, P325, DOI 10.1098/rspb.1996.0050; Xu L, 2010, PHYS LETT A, V374, P3447, DOI 10.1016/j.physleta.2010.06.065; Zhang YQ, 2014, PHYSICA A, V402, P104, DOI 10.1016/j.physa.2014.01.051	23	2	2	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158591	10.1371/journal.pone.0158591	http://dx.doi.org/10.1371/journal.pone.0158591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27382964	gold, Green Published, Green Submitted			2022-12-27	WOS:000379809400062
J	Ali-Saleh, M; Sarig, G; Ablin, JN; Brenner, B; Jacob, G				Ali-Saleh, Mais; Sarig, Galit; Ablin, Jacob N.; Brenner, Benjamin; Jacob, Giris			Inhalation of a Short-Acting beta(2)-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ORTHOSTATIC HYPERCOAGULABILITY; PULMONARY-EMBOLISM; BLOOD-COAGULATION; ENDOTHELIAL-CELLS; HUMAN ENDOTOXEMIA; ADRENALINE; STIMULATION; EXERCISE; RECEPTOR	Background Catecholamine infusion elicits an increase in clotting factors and this increase has been attributed to stimulation of beta(2)-adrenorecptors (beta 2AR). Accordingly, we tested the hypothesis that inhalation of a short-acting selective beta 2AR agonist can induce a procoagulant state in healthy individuals. Methods We recruited 23 healthy volunteers (nine females; mean age: 26 +/- 0.8 years; body mass index: 24.7 +/- 0.5 kg/m(2)) and randomly allocated them into two groups, the beta 2AR arm (seventeen subjects) and the saline arm (six subjects). Hemodynamics, plasma norepinephrine concentration, and procoagulant, anticoagulant, and fibrinolytic profiles of each participant were determined using specific assays before and after inhalation of either 2 mL nebulized normal saline or a mixture of 1 mL saline and 1 mL of salbutamol (5 mg salbutamol sulfate), a selective beta 2AR agonist, which were delivered by a nebulizer over ten minutes. Results Saline inhalation had no effect on the procoagulant, anticoagulant and fibrinolytic profiles of the six healthy volunteer in the study's saline arm. Salbutamol inhalation caused (a) a significant increase in the activity or levels of the procoagulant factors; FVIII increased by 11 +/- 3% (p = 0.04), von Willebrand factor increased by 7 +/- 1% (p = 0.03), and (b) a significant decrease in the activated partial prothrombin time from 27.4 +/- 0.4 seconds to 25.5 +/- 0.5 seconds (p<0.001) in the 17 volunteers in the study's beta 2AR arm. D-dimer and prothrombin fragments F1+2 were elevated by 200 +/- 90% and 505.0 +/- 300.0%, respectively. In addition, the activity of the anticoagulant protein C pathway (demonstrated by the protein C Global assay) decreased from 1.0 +/- 0.08 to 0.82 +/- 0.06 (p<0.001). Although plasma levels of tissue plasminogen activator decreased, all other indices of the fibrinolytic system did not change following salbutamol inhalation. Conclusion We found that a single inhalation of salbutamol, a short-acting beta 2AR agonist, activates the clotting system without affecting the fibrinolytic system. This induction of a procoagulant state in healthy subjects warrants further investigation in patients treated with these agents.	[Ali-Saleh, Mais; Ablin, Jacob N.; Jacob, Giris] Tel Aviv Univ, Internal Med, Tel Aviv Sourasky Med Ctr, Fac Med, Tel Aviv, Israel; [Ali-Saleh, Mais; Ablin, Jacob N.; Jacob, Giris] Tel Aviv Univ, J Recanati Auton Dysfunct Ctr, Tel Aviv Sourasky Med Ctr, Fac Med, Tel Aviv, Israel; [Sarig, Galit; Brenner, Benjamin] Technion IIT, Thrombosis & Hemostat Unit, Rambam Med Ctr, Ruth & Bruce Rappaport Fac Med, Haifa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Jacob, G (corresponding author), Tel Aviv Univ, Internal Med, Tel Aviv Sourasky Med Ctr, Fac Med, Tel Aviv, Israel.; Jacob, G (corresponding author), Tel Aviv Univ, J Recanati Auton Dysfunct Ctr, Tel Aviv Sourasky Med Ctr, Fac Med, Tel Aviv, Israel.	Jacobgi@tlvmc.gov	Ablin, Jacob/V-9716-2019	Ablin, Jacob/0000-0003-2523-4850	Tthe Yahel foundation	Tthe Yahel foundation	This work was supported by Tthe Yahel foundation, http://www.grg.co.il/yahel_foundation.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED T, 1993, NEW ENGL J MED, V329, P90, DOI 10.1056/NEJM199307083290204; Coelho MCA, 2015, EUR J ENDOCRINOL, V173, pM11, DOI 10.1530/EJE-15-0198; Anfossi G, 1996, EUR J CLIN INVEST, V26, P353, DOI 10.1046/j.1365-2362.1996.150293.x; BRETT JG, 1988, J CELL BIOL, V106, P2109, DOI 10.1083/jcb.106.6.2109; Brims FJ, 2009, THORAX; Carson JL, 1996, CHEST, V110, P1212, DOI 10.1378/chest.110.5.1212; CHANDLER WL, 1993, BLOOD, V81, P3293; Chandler WL, 1997, CIRCULATION, V96, P761; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; COLUCCI M, 1985, J CLIN INVEST, V75, P818, DOI 10.1172/JCI111777; Dab H, 2012, J RENIN-ANGIO-ALDO S, V13, P36, DOI 10.1177/1470320311428344; Dati F, 1997, CLIN CHEM, V43, P1719; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; Dunser Martin W, 2009, J Intensive Care Med, V24, P293, DOI 10.1177/0885066609340519; FORATTINI C, 1953, Endocrinol Sci Cost, V21, P373; FORWELL GD, 1957, J PHYSIOL-LONDON, V135, P371, DOI 10.1113/jphysiol.1957.sp005716; GADER AMA, 1974, THROMB RES, V4, P25, DOI 10.1016/0049-3848(74)90201-1; Giannarelli C, 2008, HYPERTENSION, V52, P314, DOI 10.1161/HYPERTENSIONAHA.108.111559; Hoppener MR, 2004, J THROMB HAEMOST, V2, P1316, DOI 10.1111/j.1538-7836.2004.00851.x; INGRAM GIC, 1977, BRIT J HAEMATOL, V35, P81, DOI 10.1111/j.1365-2141.1977.tb00565.x; Jacob G, 1998, J APPL PHYSIOL, V84, P914; Jacob G, 1999, CIRCULATION, V99, P1706, DOI 10.1161/01.CIR.99.13.1706; LARSSON PT, 1990, THROMB HAEMOSTASIS, V63, P482; Maes M, 2002, PSYCHOL MED, V32, P919, DOI 10.1017/S0033291702005925; MANNUCCI PM, 1974, NEW ENGL J MED, V290, P1259; Maris NA, 2007, CRIT CARE MED, V35, P57, DOI 10.1097/01.CCM.0000249827.29387.4E; Masoud M, 2008, HYPERTENSION, V51, P1545, DOI 10.1161/HYPERTENSIONAHA.108.112003; Masoud M, 2010, THROMB HAEMOSTASIS, V103, P284, DOI 10.1160/TH09-06-0370; O'Keefe Jr J.H., 2002, MAYO CLIN P; Ostrowski SR, 2013, J CRIT CARE, V28, P586, DOI 10.1016/j.jcrc.2013.04.010; Pinelli A, 2014, IN VIVO, V28, P99; Rao LVM, 2014, BLOOD, V124, P1553, DOI 10.1182/blood-2014-05-578328; Rizkallah J, 2009, CHEST, V135, P786, DOI 10.1378/chest.08-1516; Sarig G, 2006, THROMB HAEMOSTASIS, V96, P578, DOI 10.1160/TH06-05-0285; Shores M, 1998, SEMINARS CLIN NEUROP; Shusterman V, 2002, AM J PHYSIOL-HEART C, V282, pH2076, DOI 10.1152/ajpheart.00917.2001; van Mourik JA, 2002, HISTOCHEM CELL BIOL, V117, P113, DOI 10.1007/s00418-001-0368-9; vanderPoll T, 1997, J EXP MED, V185, P1143, DOI 10.1084/jem.185.6.1143; Vischer UM, 1997, THROMB HAEMOSTASIS, V77, P1182; von Kanel R, 2003, J APPL PHYSIOL, V94, P1455, DOI 10.1152/japplphysiol.00892.2002; von Kanel R, 2000, EUR J HAEMATOL, V65, P357, DOI 10.1034/j.1600-0609.2000.065006357.x; von Kanel R, 2008, EFFECT NATURAL HABIT; Wachholder K, 1960, MED EXPT INT J EXPT, V4, P151; Wallen NH, 1999, CLIN SCI, V97, P27, DOI 10.1042/CS19990013; Westfall TC, 2006, GOOD MAN GILLMANS PH, V11th, P237; William Tank A, 2015, COMPREHENSIVE PHYSL; YAMAZAKI H, 1971, THROMB DIATH HAEMOST, V26, P251, DOI 10.1055/s-0038-1653673; Yee A, 2014, SEMINARS THROMBOSIS	48	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158652	10.1371/journal.pone.0158652	http://dx.doi.org/10.1371/journal.pone.0158652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379911	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700039
J	Droit-Volet, S				Droit-Volet, Sylvie			Emotion and Implicit Timing	PLOS ONE			English	Article							SIMPLE REACTION-TIME; PERCEPTION; STIMULI; FEAR; RESPONSES; EXPLICIT	This study examined the effects of emotion on implicit timing. In the implicit timing task used, the participants did not receive any temporal instructions. Instead they were simply asked and trained to press a key as quickly as possible after a stimulus (response stimulus) that was separated from a preceding stimulus by a given temporal interval (reference interval duration). However, in the testing phase, the interval duration was the reference interval duration or a shorter or longer interval duration. In addition, the participants attended two sessions: a first baseline session in which no stimulus was presented during the inter-stimulus intervals, and a second emotional session in which emotional facial expressions (angry, neutral and sad facial expressions) were presented during these intervals. Results showed faster RTs for interval durations close to the reference duration in both the baseline and the emotional conditions and yielded a U-shaped curve. This suggests that implicit processing of time persists in emotional contexts. In addition, the RT was faster for the facial expressions of anger than for those of neutrality and sadness. However, the U-shaped RT curve did not peak clearly at a shorter interval duration for the angry than for the other facial expressions. This lack of time distortion in an implicit timing task in response to arousing emotional stimuli questions the idea of an automatic speeding-up of the interval clock system involved in the representation of time.	[Droit-Volet, Sylvie] Univ Clermont Auvergne, Lab Psychol Sociale & Cognit, CNRS, UMR 6024, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Clermont Auvergne (UCA)	Droit-Volet, S (corresponding author), Univ Clermont Auvergne, Lab Psychol Sociale & Cognit, CNRS, UMR 6024, Clermont Ferrand, France.	Sylvie.DROIT-VOLET@univ-bpclermont.fr			European Commission, Horizon research and innovation action (H-FETPROACT)	European Commission, Horizon research and innovation action (H-FETPROACT)	This work was supported by a grant (TIMESTORM) from European Commission, Horizon 2020 research and innovation action (H2020-FETPROACT-2014).	Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Cheng R.-K., 2016, TIMING TIME PERCEPT, V4, P99, DOI [10.1163/22134468-00002064, DOI 10.1163/22134468-00002064]; Coull J, 2009, PLOS ONE, V8; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Droit-Volet S, 2015, CONSCIOUS COGN, V38, P155, DOI 10.1016/j.concog.2015.02.021; Droit-Volet S, 2004, COGNITION EMOTION, V18, P849, DOI 10.1080/02699930341000194; Droit-Volet S., 2013, TIMING TIME PERCEPTI, V1, P1; Droit-Volet S, 2016, J EXPT CHILD PSYCHOL; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Droit-Volet S, 2019, TIME SOC, V28, P60, DOI 10.1177/0961463X16656852; Ekman P., 1976, PICTURES FACIAL AFFE; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Fayolle S, 2015, BEHAV PROCESS, V120, P135, DOI 10.1016/j.beproc.2015.09.014; Frijda N. H., 2007, LAWS EMOTION; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gil S, 2012, COGNITION EMOTION, V26, P847, DOI 10.1080/02699931.2011.625401; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Izard C. E., 1991, PSYCHOL EMOTIONS; Johnson KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123625; Judd C. M., 2011, DATA ANAL MODEL COMP; Laflamme V, 2015, ATTEN PERCEPT PSYCHO, V77, P1507, DOI 10.3758/s13414-015-0937-y; Los SA, 2001, J EXP PSYCHOL HUMAN, V27, P370, DOI 10.1037/0096-1523.27.2.370; Los SA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01058; Merchant H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003169; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Naugle KM, 2011, EMOTION, V11, P267, DOI 10.1037/a0022577; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Noulhiane M, 2007, EMOTION, V7, P697, DOI 10.1037/1528-3542.7.4.697; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Piras F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018203; Schirmer A., 2015, EMOTION; Tipples J, 2008, EMOTION, V8, P127, DOI 10.1037/1528-3542.8.1.127; Vallesi A, 2014, COGNITION, V130, P141, DOI 10.1016/j.cognition.2013.10.006; Vangkilde S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0054; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	41	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158474	10.1371/journal.pone.0158474	http://dx.doi.org/10.1371/journal.pone.0158474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27380409	Green Published, gold, Green Submitted			2022-12-27	WOS:000379798700033
J	Wiesinger, HP; Rieder, F; Kosters, A; Muller, E; Seynnes, OR				Wiesinger, Hans-Peter; Rieder, Florian; Koesters, Alexander; Mueller, Erich; Seynnes, Olivier R.			Are Sport-Specific Profiles of Tendon Stiffness and Cross-Sectional Area Determined by Structural or Functional Integrity?	PLOS ONE			English	Article							HUMAN ACHILLES-TENDON; LOAD-DISPLACEMENT PROPERTIES; TRICEPS SURAE APONEUROSIS; AGE-RELATED DIFFERENCES; MECHANICAL-PROPERTIES; PATELLAR TENDON; MORPHOLOGICAL PROPERTIES; MUSCLE; HYPERTROPHY; FATIGUE	The present study aimed to determine whether distinct sets of tendon properties are seen in athletes engaged in sports with contrasting requirements for tendon function and structural integrity. Patellar and Achilles tendon morphology and force-deformation relation were measured by combining ultrasonography, electromyography and dynamometry in elite ski jumpers, distance runners, water polo players and sedentary individuals. Tendon cross-sectional area normalized to body mass(2/3) was smaller in water polo players than in other athletes (patellar and Achilles tendon; -28 to -24%) or controls (patellar tendon only; -9%). In contrast, the normalized cross-sectional area was larger in runners (patellar tendon only; +26%) and ski jumpers (patellar and Achilles tendon; +21% and +13%, respectively) than in controls. Tendon stiffness normalized to body mass(2/3) only differed in ski jumpers, compared to controls (patellar and Achilles tendon; +11% and +27%, respectively) and to water polo players (Achilles tendon only; +23%). Tendon size appears as an adjusting variable to changes in loading volume and/or intensity, possibly to preserve ultimate strength or fatigue resistance. However, uncoupled morphological and mechanical properties indicate that functional requirements may also influence tendon adaptations.	[Wiesinger, Hans-Peter; Rieder, Florian; Koesters, Alexander; Mueller, Erich] Salzburg Univ, Dept Sport Sci & Kinesiol, Salzburg, Austria; [Seynnes, Olivier R.] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway	Salzburg University; Norwegian School of Sport Sciences	Wiesinger, HP (corresponding author), Salzburg Univ, Dept Sport Sci & Kinesiol, Salzburg, Austria.	hans-peter.wiesinger@sbg.ac.at	Wiesinger, Hans-Peter/AAQ-3994-2020	Wiesinger, Hans-Peter/0000-0001-8526-2832; Seynnes, Olivier/0000-0002-1289-246X; Rieder, Florian/0000-0003-1452-3411				Albracht K, 2013, EUR J APPL PHYSIOL, V113, P1605, DOI 10.1007/s00421-012-2585-4; [Anonymous], CONCEIVED DESIGNED E; Arampatzis A, 2007, J EXP BIOL, V210, P2743, DOI 10.1242/jeb.003814; Arampatzis A, 2007, J BIOMECH, V40, P1946, DOI 10.1016/j.jbiomech.2006.09.005; Arampatzis A, 2006, J EXP BIOL, V209, P3345, DOI 10.1242/jeb.02340; Basso O, 2001, KNEE SURG SPORT TR A, V9, P2, DOI 10.1007/s001670000133; BENNETT MB, 1986, J ZOOL, V209, P537, DOI 10.1111/j.1469-7998.1986.tb03609.x; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BUTLER DL, 1984, J BIOMECH, V17, P579, DOI 10.1016/0021-9290(84)90090-3; Carroll CC, 2008, J APPL PHYSIOL, V105, P1907, DOI 10.1152/japplphysiol.00059.2008; Cohen J.E., 1988, STAT POWER ANAL BEHA; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; Couppe C, 2014, AGE, V36, DOI 10.1007/s11357-014-9665-9; Dirnberger J, 2012, ISOKINET EXERC SCI, V20, P149, DOI 10.3233/IES-2012-0451; Edwards S, 2010, MED SCI SPORT EXER, V42, P2072, DOI 10.1249/MSS.0b013e3181e0550b; Finni T, 1998, VIVO MUSCLE DYNAMICS; Hansen P, 2003, J APPL PHYSIOL, V95, P2375, DOI 10.1152/japplphysiol.00503.2003; Heinemeier KM, 2011, J MUSCULOSKEL NEURON, V11, P115; Janssen I, 2013, MED SCI SPORT EXER, V45, P927, DOI 10.1249/MSS.0b013e31827f0314; Karamanidis K, 2006, J BIOMECH, V39, P406, DOI 10.1016/j.jbiomech.2004.12.017; Ker RF, 2000, J EXP BIOL, V203, P1317; KER RF, 1988, J ZOOL, V216, P309, DOI 10.1111/j.1469-7998.1988.tb02432.x; Kosters A, 2014, CLIN BIOMECH, V29, P323, DOI 10.1016/j.clinbiomech.2013.12.010; KOMI PV, 1990, J BIOMECH, V23, P23, DOI 10.1016/0021-9290(90)90038-5; KOMI PV, 1992, CLIN SPORT MED, V11, P521; Kongsgaard M, 2007, ACTA PHYSIOL, V191, P111, DOI 10.1111/j.1748-1716.2007.01714.x; Kongsgaard M, 2005, J APPL PHYSIOL, V99, P1965, DOI 10.1152/japplphysiol.00384.2005; Kubo K, 2007, MED SCI SPORT EXER, V39, P541, DOI 10.1249/01.mss.0000247006.24965.74; Kubo K, 2015, EUR J APPL PHYSIOL, V115, P1725, DOI 10.1007/s00421-015-3156-2; Kubo K, 2009, J APPL PHYSIOL, V106, P412, DOI 10.1152/japplphysiol.91381.2008; LaCroix AS, 2013, J APPL PHYSIOL, V115, P43, DOI 10.1152/japplphysiol.01449.2012; Lichtwark GA, 2006, J EXP BIOL, V209, P4379, DOI 10.1242/jeb.02434; Lichtwark GA, 2013, J EXP BIOL, V216, P4388, DOI 10.1242/jeb.094219; Magnusson SP, 2003, ACTA PHYSIOL SCAND, V177, P185, DOI 10.1046/j.1365-201X.2003.01048.x; Magnusson SP, 2003, EUR J APPL PHYSIOL, V90, P549, DOI 10.1007/s00421-003-0865-8; Magnusson SP, 2001, J PHYSIOL-LONDON, V531, P277, DOI 10.1111/j.1469-7793.2001.0277j.x; Meltzer S. J., 1907, Science New York N S, V25, DOI 10.1126/science.25.639.481; POLLOCK CM, 1994, AM J PHYSIOL, V266, pR1022, DOI 10.1152/ajpregu.1994.266.3.R1022; POLLOCK M, 1994, AM J PHYSIOL, V266, pR1016, DOI 10.1152/ajpregu.1994.266.3.R1016; Reeves ND, 2003, J PHYSIOL-LONDON, V548, P971, DOI 10.1113/jphysiol.2002.035576; Rieder F, 2016, SCAND J MED SCI SPOR, V26, P902, DOI 10.1111/sms.12522; Rosager S, 2002, SCAND J MED SCI SPOR, V12, P90, DOI 10.1034/j.1600-0838.2002.120205.x; Schechtman H, 1997, J BIOMECH, V30, P829, DOI 10.1016/S0021-9290(97)00033-X; SCOTT SH, 1990, MED SCI SPORT EXER, V22, P357; Seynnes OR, 2015, J APPL PHYSIOL, V118, P133, DOI 10.1152/japplphysiol.00849.2014; Seynnes OR, 2009, J APPL PHYSIOL, V107, P523, DOI 10.1152/japplphysiol.00213.2009; Seynnes OR, 2013, J APPL PHYSIOL, V115, P84, DOI 10.1152/japplphysiol.01417.2012; Stenroth L, 2012, J APPL PHYSIOL, V113, P1537, DOI 10.1152/japplphysiol.00782.2012; Szaro P, 2009, ANN ANAT, V191, P586, DOI 10.1016/j.aanat.2009.07.006; VISSER JJ, 1990, EUR J APPL PHYSIOL O, V61, P453, DOI 10.1007/BF00236067; WANG XT, 1995, J EXP BIOL, V198, P831; WANG XT, 1995, J EXP BIOL, V198, P847; Wiesinger HP, 2015, MED SCI SPORT EXER, V47, P1885, DOI 10.1249/MSS.0000000000000603	53	34	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158441	10.1371/journal.pone.0158441	http://dx.doi.org/10.1371/journal.pone.0158441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362657	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000378865200076
J	Yiangou, L; Montandon, R; Modrzynska, K; Rosen, B; Bushell, W; Hale, C; Billker, O; Rayner, JC; Pance, A				Yiangou, Loukia; Montandon, Ruddy; Modrzynska, Katarzyna; Rosen, Barry; Bushell, Wendy; Hale, Christine; Billker, Oliver; Rayner, Julian C.; Pance, Alena			A Stem Cell Strategy Identifies Glycophorin C as a Major Erythrocyte Receptor for the Rodent Malaria Parasite Plasmodium berghei	PLOS ONE			English	Article							SOUTHEAST-ASIAN OVALOCYTOSIS; PAPUA-NEW-GUINEA; BAND-3 AE1 GENE; RED-BLOOD-CELL; IN-VITRO; FALCIPARUM INVASION; DUFFY ANTIGEN; HEREDITARY SPHEROCYTOSIS; TARGETED INACTIVATION; POPULATION-GENETICS	The clinical complications of malaria are caused by the parasite expansion in the blood. Invasion of erythrocytes is a complex process that depends on multiple receptor-ligand interactions. Identification of host receptors is paramount for fighting the disease as it could reveal new intervention targets, but the enucleated nature of erythrocytes makes genetic approaches impossible and many receptors remain unknown. Host-parasite interactions evolve rapidly and are therefore likely to be species-specific. As a results, understanding of invasion receptors outside the major human pathogen Plasmodium falciparum is very limited. Here we use mouse embryonic stem cells (mESCs) that can be genetically engineered and differentiated into erythrocytes to identify receptors for the rodent malaria parasite Plasmodium berghei. Two proteins previously implicated in human malaria infection: glycophorin C (GYPC) and Band-3 (Slc4a1) were deleted in mESCs to generate stable cell lines, which were differentiated towards erythropoiesis. In vitro infection assays revealed that while deletion of Band-3 has no effect, absence of GYPC results in a dramatic decrease in invasion, demonstrating the crucial role of this protein for P. berghei infection. This stem cell approach offers the possibility of targeting genes that may be essential and therefore difficult to disrupt in whole organisms and has the potential to be applied to a variety of parasites in diverse host cell types.	[Yiangou, Loukia; Montandon, Ruddy; Modrzynska, Katarzyna; Billker, Oliver; Rayner, Julian C.; Pance, Alena] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England; [Rosen, Barry] Wellcome Trust Sanger Inst, Mouse Dev Genet & ES Cells Mutagenesis, Cambridge, England; [Bushell, Wendy] Wellcome Trust Sanger Inst, Cellular Genet, Cambridge, England; [Hale, Christine] Wellcome Trust Sanger Inst, Microbial Pathogenesis, Cambridge, England; [Yiangou, Loukia] Univ Cambridge, Dept Med, Anne McLaren Lab, Wellcome Trust MRC Stem Cell Inst, Cambridge, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; University of Cambridge	Rayner, JC; Pance, A (corresponding author), Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England.	julian.rayner@sanger.ac.uk; alena.pance@sanger.ac.uk	Pance, Alena/AAH-2878-2021	Pance, Alena/0000-0002-9017-2644; Billker, Oliver/0000-0003-1716-168X; Yiangou, Loukia/0000-0003-1477-005X; Rayner, Julian/0000-0002-9835-1014	Sanger Institute by the Wellcome Trust	Sanger Institute by the Wellcome Trust	This work was funded by core funding of the Sanger Institute by the Wellcome Trust.	Akimitsu N, 2004, PARASITOL RES, V93, P499, DOI 10.1007/s00436-004-1165-x; Allen SJ, 1999, AM J TROP MED HYG, V60, P1056, DOI 10.4269/ajtmh.1999.60.1056; Balu B, 2011, EUKARYOT CELL, V10, P1257, DOI 10.1128/EC.05099-11; Bartholdson SJ, 2013, CELL MICROBIOL, V15, P1304, DOI 10.1111/cmi.12151; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157; Carotta S, 2004, BLOOD, V104, P1873, DOI 10.1182/blood-2004-02-0570; Cromer D, 2006, INT J PARASITOL, V36, P1389, DOI 10.1016/j.ijpara.2006.07.009; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Egan ES, 2015, SCIENCE, V348, P711, DOI 10.1126/science.aaa3526; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Harvey KL, 2012, INT J PARASITOL, V42, P567, DOI 10.1016/j.ijpara.2012.02.011; Hassoun H, 1998, BLOOD, V91, P2146, DOI 10.1182/blood.V91.6.2146.2146_2146_2151; Hassoun H, 1998, BLOOD, V92, P1785, DOI 10.1182/blood.V92.5.1785.417k17_1785_1792; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Jarolim P, 1996, BLOOD, V88, P4366; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Kariuki MM, 2005, BIOCHEM BIOPH RES CO, V338, P1690, DOI 10.1016/j.bbrc.2005.10.154; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Malpede BM, 2013, J BIOL CHEM, V288, P12406, DOI 10.1074/jbc.M113.450643; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Ng S, 2015, STEM CELL REP, V4, P348, DOI 10.1016/j.stemcr.2015.01.002; Pasvol G, 2003, TRENDS PARASITOL, V19, P430, DOI 10.1016/j.pt.2003.08.005; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Ribeiro ML, 2000, BLOOD, V96, P1602; Satchwell TJ, 2015, HAEMATOLOGICA, V100, P133, DOI 10.3324/haematol.2014.114538; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh AP, 2005, MOL MICROBIOL, V55, P1925, DOI 10.1111/j.1365-2958.2005.04523.x; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Swardson-Olver CJ, 2002, BLOOD, V99, P2677, DOI 10.1182/blood.V99.8.2677; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Wilder JA, 2009, J HUM GENET, V54, P182, DOI 10.1038/jhg.2009.12; Williams TN, 2006, MOL BIOCHEM PARASIT, V149, P121, DOI 10.1016/j.molbiopara.2006.05.007; Yeung ATY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08908; Zimmerman PA, 2003, TRENDS PARASITOL, V19, P250, DOI 10.1016/S1471-4922(03)00112-0	51	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158238	10.1371/journal.pone.0158238	http://dx.doi.org/10.1371/journal.pone.0158238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362409	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200051
J	Korzyukov, Y; Hetzel, U; Kipar, A; Vapalahti, O; Hepojoki, J				Korzyukov, Yegor; Hetzel, Udo; Kipar, Anja; Vapalahti, Olli; Hepojoki, Jussi			Generation of Anti-Boa Immunoglobulin Antibodies for Serodiagnostic Applications, and Their Use to Detect Anti-Reptarenavirus Antibodies in Boa Constrictor	PLOS ONE			English	Article							INCLUSION-BODY DISEASE; IMMUNE-RESPONSE; FINGER PROTEIN; BOID SNAKES; ARENAVIRUSES; IDENTIFICATION; REPTILES; FUTURE; RNA	Immunoglobulins (Igs), the key effectors of the adaptive immune system, mediate the specific recognition of foreign structures, i.e. antigens. In mammals, IgM production commonly precedes the production of IgG in the response to an infection. The reptilian counterpart of IgG is IgY, but the exact kinetics of the reptilian immune response are less well known. Boid inclusion body disease (BIBD), an often fatal disease of captive boas and pythons has been linked to reptarenavirus infection, and BIBD is believed to be immunosuppressive. However, so far, the study of the serological response towards reptarenaviruses in BIBD has been hampered by the lack of reagents. Thus we set up a purification protocol for boa constrictor IgY and IgM, which should also be applicable for other snake species. We used centrifugal filter units, poly ethylene glycol precipitation and gel permeation chromatography to purify and separate the IgM and IgY fractions from boa constrictor serum, which we further used to immunise rabbits. We affinity purified IgM and IgY specific reagents from the produced antiserum, and labelled the reagents with horseradish peroxidase. Finally, using the sera of snakes with known exposure to reptarenaviruses we demonstrated that the newly generated reagents can be utilised for serodiagnostic purposes, such as immunoblotting and immunofluorescent staining. To our knowledge, this is the first report to show reptarenavirus-specific antibodies in boa constrictors.	[Korzyukov, Yegor; Vapalahti, Olli; Hepojoki, Jussi] Univ Helsinki, Med, Dept Virol, Helsinki, Finland; [Hetzel, Udo; Kipar, Anja] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland; [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Fac Vet Med, Helsinki, Finland; [Vapalahti, Olli] Univ Helsinki, Helsinki, Finland; [Vapalahti, Olli] Helsinki Univ Hosp, Dept Virol, Helsinki, Finland	University of Helsinki; University of Zurich; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Hepojoki, J (corresponding author), Univ Helsinki, Med, Dept Virol, Helsinki, Finland.	jussi.hepojoki@uzh.ch	Korzyukov, Yegor/G-9621-2018; Hepojoki, Jussi/W-4667-2017; Kipar, Anja/L-7214-2014	Korzyukov, Yegor/0000-0001-8723-0885; Hepojoki, Jussi/0000-0001-5699-214X; Kipar, Anja/0000-0001-7289-3459; Vapalahti, Olli/0000-0003-2270-6824	Jenny and Antti Wihuri Foundation; University of Helsinki Doctoral Programme in Biomedicine; Academy of Finland (Terveyden Tutkimuksen Toimikunta); Finnish Foundation of Veterinary Research	Jenny and Antti Wihuri Foundation; University of Helsinki Doctoral Programme in Biomedicine; Academy of Finland (Terveyden Tutkimuksen Toimikunta)(Academy of Finland); Finnish Foundation of Veterinary Research	The research described in the manuscript was funded by the following foundations and institutions: Jenny and Antti Wihuri Foundation (http://wihurinrahasto.fi/?lang=en), University of Helsinki Doctoral Programme in Biomedicine (http://www.helsinki.fi/dpbm/), Academy of Finland (Terveyden Tutkimuksen Toimikunta) (http://www.aka.fi/en/), and the Finnish Foundation of Veterinary Research (http://www.sels.fi/index_eng.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUPERIN DD, 1984, J VIROL, V52, P897, DOI 10.1128/JVI.52.3.897-904.1984; Bodewes R, 2013, J GEN VIROL, V94, P1206, DOI 10.1099/vir.0.051995-0; Brown DR, 2002, FRONT BIOSCI-LANDMRK, V7, pD1338, DOI 10.2741/brown; Chang LW, 2010, J EXOT PET MED, V19, P216, DOI 10.1053/j.jepm.2010.07.014; Charrel RN, 2011, ANTIVIR RES, V90, P102, DOI 10.1016/j.antiviral.2011.02.009; CLEGG JCS, 1991, VIRUS RES, V18, P151, DOI 10.1016/0168-1702(91)90015-N; Coico R, 2003, IMMUNOLOGY SHORT COU, P361; Fehling SK, 2012, VIRUSES-BASEL, V4, P2973, DOI 10.3390/v4112973; Gambon-Deza F, 2012, DEV COMP IMMUNOL, V38, P1, DOI 10.1016/j.dci.2012.03.001; GREY HM, 1963, J IMMUNOL, V91, P819; Hepojoki J, 2015, J VIROL, V89, P8657, DOI 10.1128/JVI.01112-15; Hepojoki J, 2015, J VIROL, V89, P1119, DOI 10.1128/JVI.03119-14; Hetzel U, 2013, J VIROL, V87, P10918, DOI 10.1128/JVI.01123-13; INGRAM GA, 1983, VET IMMUNOL IMMUNOP, V4, P479, DOI 10.1016/0165-2427(83)90008-9; Jaffredo T., 2006, ELS, DOI [10.1038/npg.els.0000521, DOI 10.1038/NPG.ELS.0000521]; KLUGER MJ, 1975, SCIENCE, V188, P166, DOI 10.1126/science.1114347; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; MARCHALONIS JJ, 1969, AUST J EXP BIOL MED, V47, P367, DOI 10.1038/icb.1969.40; Mindell DP, 1999, SYST BIOL, V48, P138, DOI 10.1080/106351599260490; OConnell KL, 1997, ELECTROPHORESIS, V18, P349, DOI 10.1002/elps.1150180309; Oldstone MBA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000523; Origgi FC, 2001, J CLIN MICROBIOL, V39, P3156, DOI 10.1128/JCM.39.9.3156-3163.2001; Pauly D, 2011, J VIS EXP; Pye GW, 2001, J ZOO WILDLIFE MED, V32, P196, DOI 10.1638/1042-7260(2001)032[0196:EIOBNC]2.0.CO;2; Pythoud C, 2012, J VIROL, V86, P7728, DOI 10.1128/JVI.00187-12; Radoshitzky SR, 2015, ARCH VIROL, V160, P1851, DOI 10.1007/s00705-015-2418-y; Ren H, 2016, ATLA-ALTERN LAB ANIM, V44, P11, DOI 10.1177/026119291604400111; SALVATO MS, 1989, VIROLOGY, V173, P1, DOI 10.1016/0042-6822(89)90216-X; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; SCHUMACHER J, 1994, J ZOO WILDLIFE MED, V25, P511; Stenglein MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004900; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Wang T, 2012, J IMMUNOL, V189, P3557, DOI 10.4049/jimmunol.1200212; Work TM, 2000, VET IMMUNOL IMMUNOP, V74, P179, DOI 10.1016/S0165-2427(00)00168-9; Wozniak E, 2000, VET PATHOL, V37, P449, DOI 10.1354/vp.37-5-449; Xing JJ, 2015, J VIROL, V89, P2944, DOI 10.1128/JVI.03349-14; Zhou X, 2012, VIRUSES-BASEL, V4, P2650, DOI 10.3390/v4112650; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315	38	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158417	10.1371/journal.pone.0158417	http://dx.doi.org/10.1371/journal.pone.0158417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355360	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000378859400063
J	Yu, CC; Hao, DJ; Huang, DG; Qian, LX; Feng, H; Li, HK; Zhao, SC				Yu, Cheng-Cheng; Hao, Ding-Jun; Huang, Da-Geng; Qian, Li-Xiong; Feng, Hang; Li, Hou-Kun; Zhao, Song-Chuan			Biomechanical Analysis of a Novel Prosthesis Based on the Physiological Curvature of Endplate for Cervical Disc Replacement	PLOS ONE			English	Article							2-YEAR FOLLOW-UP; POSTERIOR LONGITUDINAL LIGAMENT; RANDOMIZED-CONTROLLED-TRIALS; PRODISC-C; CLINICAL ARTICLE; ARTIFICIAL DISC; FINITE-ELEMENT; ARTHROPLASTY; FUSION; OUTCOMES	Study Design Biomechanical analysis of a novel prosthesis based on the physiological curvature of end-plate was performed. Objective To compare the biomechanical differences between a novel prosthesis based on the physiological curvature of the endplate and the Prestige LP prosthesis after cervical disc replacement (CDR). Summary of Background Data Artificial disc prostheses have been widely used to preserve the physiological function of treated and adjacent motion segments in CDR, while most of those present a flat surface instead of an arcuate surface which approximately similar to anatomic structures in vivo. We first reported a well-designed artificial disc prosthesis based on the physiological curvature of the endplate. Methods Three motion segments of 24 ovine cervical spines (C2-5) were evaluated in a robotic spine system with axial compressive loads of 50N. Testing conditions were as follows: 1) intact, 2) C3-4 CDR with artificial disc prosthesis based on the physiological curvature of the endplate, and 3) C3-4 CDR with the Prestige LP prosthesis. The range of motion (ROM) and the pressures on the inferior surface of the two prostheses were recorded and analyzed. Results As compared to the intact state, the ROM of all three segments had no significant difference in the replacement group. Additionally, there was no significant difference in ROM between the two prostheses. The mean pressure on the novel prosthesis was significantly less than the Prestige LP prosthesis. Conclusion ROM in 3 groups (intact group, CDR group with novel prosthesis and CDR group with Prestige LP) showed no significant difference. The mean pressure on the inferior surface of the novel prosthesis was significantly lower than the Prestige LP prosthesis. Therefore, the novel artificial disc prosthesis is feasible and effective, and can reduce the implant-bone interface pressure on the endplate, which may be one possible reason of prosthesis subsidence.	[Yu, Cheng-Cheng; Hao, Ding-Jun; Huang, Da-Geng; Qian, Li-Xiong; Feng, Hang; Li, Hou-Kun; Zhao, Song-Chuan] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Spine Surg, Honghui Hosp, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Hao, DJ (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Spine Surg, Honghui Hosp, Xian, Shaanxi, Peoples R China.	yccxiafeng@163.com		Hao, Dingjun/0000-0002-6555-9521				Anderson PA, 2004, SPINE, V29, P2779, DOI 10.1097/01.brs.0000146460.11591.8a; Barrey C, 2012, EUR SPINE J, V21, P432, DOI 10.1007/s00586-011-1974-4; Bertagnoli R, 2005, ORTHOP CLIN N AM, V36, P389, DOI 10.1016/j.ocl.2005.03.003; Chen F, 2013, ARCH ORTHOP TRAUM SU, V133, P473, DOI 10.1007/s00402-013-1689-6; Cheng CC, 2007, SPINE, V32, P1852, DOI 10.1097/BRS.0b013e31811ece5a; Completo A, 2015, J NEUROSURG-SPINE, V22, P639, DOI 10.3171/2014.10.SPINE14217; Coric D, 2013, J NEUROSURG-SPINE, V18, P36, DOI 10.3171/2012.9.SPINE12555; Coric D, 2011, J NEUROSURG-SPINE, V15, P348, DOI 10.3171/2011.5.SPINE10769; Cunningham BW, 2010, SPINE J, V10, P341, DOI 10.1016/j.spinee.2010.01.006; Daentzer D, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0018-4; Fontes RBD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139283; Di Martino A, 2015, EUR SPINE J, V24, pS810, DOI 10.1007/s00586-015-4258-6; Gornet MF, 2015, J NEUROSURG-SPINE, V23, P558, DOI 10.3171/2015.1.SPINE14589; Hu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149312; Kandziora F, 2001, SPINE, V26, P1028, DOI 10.1097/00007632-200105010-00008; Lin CY, 2009, SPINE, V34, P1554, DOI 10.1097/BRS.0b013e3181aa643b; McAfee PC, 2003, SPINE, V28, pS176, DOI 10.1097/01.BRS.0000092219.28382.0C; Pelle DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112454; Ren CP, 2014, EUR SPINE J, V23, P1115, DOI 10.1007/s00586-014-3220-3; Roellinghof M, 2012, ACTA ORTHOP BELG, V78, P369; Sasso RC, 2007, SPINE, V32, P2933, DOI 10.1097/BRS.0b013e31815d0034; Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5; Shi JS, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0330-5; Terai T, 2011, CLIN ORTHOP RELAT R, V469, P682, DOI 10.1007/s11999-010-1646-4; Thaler M, 2013, EUR SPINE J, V22, P759, DOI 10.1007/s00586-012-2594-3; Tian W, 2014, J SPINAL DISORD TECH; Virk SS, 2014, ORTHOPEDICS, V37, P547, DOI 10.3928/01477447-20140728-08; Wilke H J, 1998, Eur Spine J, V7, P148, DOI 10.1007/s005860050045; Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009; Wu AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000665; Yin S, 2013, CLIN ORTHOP RELAT R, V471, P1904, DOI 10.1007/s11999-013-2830-0; Yu CC, 2016, MED SCI MONITOR, V22, P1843, DOI 10.12659/MSM.899138; Zhang XK, 2008, J SPINAL DISORD TECH, V21, P400, DOI 10.1097/BSD.0b013e318157d382; Zhang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117826	34	5	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158234	10.1371/journal.pone.0158234	http://dx.doi.org/10.1371/journal.pone.0158234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355319	gold, Green Submitted, Green Published			2022-12-27	WOS:000378859400041
J	Chen, YL; Lee, CT; Lu, CC; Yang, SC; Chen, WL; Lee, YC; Yang, CH; Peng, SL; Su, WC; Chow, NH; Ho, CL				Chen, Yi-Lin; Lee, Chung-Ta; Lu, Cheng-Chan; Yang, Shu-Ching; Chen, Wan-Li; Lee, Yang-Cheng; Yang, Chung-Hsien; Peng, Shu-Ling; Su, Wu-Chou; Chow, Nan-Haw; Ho, Chung-Liang			Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis	PLOS ONE			English	Article							CELL LUNG-CANCER; POLYMERASE-CHAIN-REACTION; RESPONSE EVALUATION CRITERIA; EGFR MUTATIONS; PCR CLAMP; ADENOCARCINOMA; GEFITINIB; CHEMOTHERAPY; SURVIVAL; THERAPY	Analyzing EGFR mutations and detecting ALK gene fusion are indispensable when planning to treat pulmonary adenocarcinoma. Malignant pleural effusion (MPE) is a devastating complication of lung cancer and sometimes the only source for mutation analysis. The percentage of tumor cells in the pleural effusion may be low; therefore, mutant enrichment is required for a successful analysis. The EGFR mutation status in MPE was determined using three methods: (1) PCR sequencing of genomic DNA (direct sequencing), (2) mutantenriched PCR sequencing of genomic DNA using peptide nucleic acid (PNA-sequencing), and (3) PCR sequencing of cDNA after reverse transcription for cellular RNA (RNA-sequencing). RT-PCR was also used to test cases for ALK gene fusion. PNA-sequencing and RNA-sequencing had similar analytical sensitivities (< 1%), which indicates similar enrichment capabilities. The clinical sensitivity in 133 cases when detecting the common EGFR exon 19 and exon 21 mutations was 56.4% (75/133) for direct sequencing, 63.2%(84/133) for PNA-sequencing, and 65.4%(87/133) for RNA-sequencing. RT-PCR and sequencing showed 5 cases (3.8%) with ALK gene fusion. All had wildtype EGFR. For EGFR analysis of MPE, RNA-sequencing is at least as sensitive as PNA-sequencing but not limited to specific mutations. Detecting ALK fusion can be incorporated in the same RNA workflow. Therefore, RNA is a better source for comprehensive molecular diagnoses in MPE.	[Chen, Yi-Lin; Lee, Chung-Ta; Lu, Cheng-Chan; Yang, Shu-Ching; Chen, Wan-Li; Peng, Shu-Ling; Su, Wu-Chou; Chow, Nan-Haw; Ho, Chung-Liang] Natl Cheng Kung Univ Hosp, Dept Pathol, Mol Diagnost Lab, Tainan, Taiwan; [Chen, Yi-Lin; Ho, Chung-Liang] Natl Cheng Kung Univ Hosp, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Chen, Yi-Lin; Lee, Chung-Ta; Lu, Cheng-Chan; Yang, Shu-Ching; Chen, Wan-Li; Su, Wu-Chou; Chow, Nan-Haw; Ho, Chung-Liang] Natl Cheng Kung Univ Hosp, Res Ctr Clin Med, Coll Med, Mol Med Core Lab, Tainan, Taiwan; [Lee, Chung-Ta; Lu, Cheng-Chan; Su, Wu-Chou; Chow, Nan-Haw; Ho, Chung-Liang] Natl Cheng Kung Univ Hosp, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Lu, Cheng-Chan; Su, Wu-Chou; Chow, Nan-Haw; Ho, Chung-Liang] Natl Cheng Kung Univ Hosp, Coll Med, Inst Mol Med, Tainan, Taiwan; [Lee, Yang-Cheng] Tainan Municipal Hosp, Dept Internal Med, Div Hematol Oncol, Tainan, Taiwan; [Yang, Chung-Hsien] Yuans Gen Hosp, Kaohsiung, Taiwan; [Chen, Yi-Lin; Lu, Cheng-Chan; Yang, Shu-Ching; Chen, Wan-Li] Assoc Med Technologists, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Ho, CL (corresponding author), Natl Cheng Kung Univ Hosp, Dept Pathol, Mol Diagnost Lab, Tainan, Taiwan.; Ho, CL (corresponding author), Natl Cheng Kung Univ Hosp, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.; Ho, CL (corresponding author), Natl Cheng Kung Univ Hosp, Res Ctr Clin Med, Coll Med, Mol Med Core Lab, Tainan, Taiwan.; Ho, CL (corresponding author), Natl Cheng Kung Univ Hosp, Coll Med, Inst Mol Med, Tainan, Taiwan.	clh9@mail.ncku.edu.tw		Yang, James Chih-Hsin/0000-0002-5586-5138; Su, Wu-Chou/0000-0003-2953-4105	National Cheng Kung University Hospital (NCKUH) [10502004, NCKUH-10502008]	National Cheng Kung University Hospital (NCKUH)	This study was supported by intramural grants National Cheng Kung University Hospital (NCKUH)-10502004 and NCKUH-10502008.	[Anonymous], 2012, J HEMATOL ONCOL, V5, P1; Araki T, 2011, ONCOL REP, V26, P1213, DOI 10.3892/or.2011.1391; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gridelli C, 2011, LUNG CANCER, V71, P249, DOI 10.1016/j.lungcan.2010.12.008; Guo HS, 2012, ONCOL REP, V27, P880, DOI 10.3892/or.2011.1559; Hung Ming-Szu, 2006, Chang Gung Med J, V29, P373; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Kimura H, 2006, BRIT J CANCER, V95, P1390, DOI 10.1038/sj.bjc.6603428; Kimura H, 2006, CANCER SCI, V97, P642, DOI 10.1111/j.1349-7006.2006.00216.x; Kobayashi K, 2013, TARGET ONCOL, V8, P27, DOI 10.1007/s11523-013-0258-9; Krawczyk P, 2015, J CANCER RES CLIN, V141, P61, DOI 10.1007/s00432-014-1789-x; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Kubo A, 2011, INTERNAL MED, V50, P745, DOI 10.2169/internalmedicine.50.4652; Lee HJ, 2013, KOREAN J PATHOL, V47, P52, DOI 10.4132/KoreanJPathol.2013.47.1.52; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069016; Liu HP, 2010, J THORAC ONCOL, V5, P1175, DOI 10.1097/JTO.0b013e3181e2f4d6; Lv C, 2013, WORLD J SURG ONCOLOG, V11; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Miyazawa H, 2008, CANCER SCI, V99, P595, DOI 10.1111/j.1349-7006.2007.00706.x; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nishino M, 2010, AM J ROENTGENOL, V195, pW221, DOI 10.2214/AJR.09.3928; Sanders HR, 2011, CANCER GENET-NY, V204, P45, DOI 10.1016/j.cancergencyto.2010.08.024; Shamblin CJ, 2013, CURR PULMONOL REP, V2, P79, DOI 10.1007/s13665-013-0041-5; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Skronski M, 2013, ADV EXP MED BIOL, V756, P321, DOI 10.1007/978-94-007-4549-0_39; Smits AJJ, 2012, CELL ONCOL, V35, P189, DOI 10.1007/s13402-012-0078-4; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tanaka T, 2007, CANCER SCI, V98, P246, DOI 10.1111/j.1349-7006.2006.00377.x; Teckle P, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-106; Tsai TH, 2012, EUR RESPIR J, V39, P677, DOI 10.1183/09031936.00043511; William WN, 2013, J THORAC ONCOL, V8, P222, DOI 10.1097/JTO.0b013e3182774108; Won JK, 2015, ANN ONCOL, V26, P348, DOI 10.1093/annonc/mdu530; Wu SG, 2008, EUR RESPIR J, V32, P924, DOI 10.1183/09031936.00167407; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906	41	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158125	10.1371/journal.pone.0158125	http://dx.doi.org/10.1371/journal.pone.0158125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352172	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900034
J	Salinero, MC; Michalski, F				Salinero, Maria Celeste; Michalski, Fernanda			Implications of Scientific Collaboration Networks on Studies of Aquatic Vertebrates in the Brazilian Amazon	PLOS ONE			English	Article							SOTALIA-FLUVIATILIS; PODOCNEMIS-UNIFILIS; NATIVE AMAZONIANS; CONSERVATION; GAME; BIODIVERSITY; TRENDS; PREDATION; PATTERNS; ANIMALS	The quantity of wildlife extracted from the Amazon has increased in the past decades as a consequence of an increase in human population density and income growth. To evaluate the spatial distribution of studies on subsistence and/or commercial hunting conducted in the Brazilian Amazon, we selected eight mid-sized and large-bodied aquatic vertebrate species with a history of human exploitation in the region. We used a combination of searches in the gray and scientific literature from the past 24 years to provide an updated distributional map of studies on the target species. We calculated the distances between the study sites and the locations of the research institutes/universities that the first and last authors of the same study were affiliated to. For the period of 1990 to 2014, we found 105 studies on the subsistence and/or commercial hunting of aquatic vertebrates in the Brazilian Amazon in 271 locations that involved 43 institutions (37 Brazilian and 6 international). The spatial distribution of the studies across the Brazilian Amazon varied, but over 80% took place in the northeast and central Amazon, encompassing three States of the Legal Brazilian Amazon (Amazonas, 51.42%; Para, 19.05%; and Amapa, 16.19%). Over half of the research study sites (52.91%) were within 500 km of the research institute/university of the first or last authors. Some research institutes/universities did not have any inter-institutional collaborations, while others collaborated with eight or more institutes. Some research institutes/universities conducted many studies, had an extensive collaboration network, and contributed greatly to the network of studies on Amazonian aquatic vertebrates. Our research contributes to the knowledge of studies on the subsistence and/or commercial hunting of the most exploited aquatic vertebrates of the Brazilian Amazon, illustrates the impact that collaboration networks have on research, and highlights potential areas for improvement and the generation of new collaborations.	[Salinero, Maria Celeste; Michalski, Fernanda] Univ Fed Amapa, Lab Ecol & Conservacao Vertebrados, Macapa, Amapa, Brazil; [Salinero, Maria Celeste; Michalski, Fernanda] Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil; [Michalski, Fernanda] Inst Procarnivoros, Atibaia, SP, Brazil	Fundacao Universidade Federal do Amapa; Fundacao Universidade Federal do Amapa	Michalski, F (corresponding author), Univ Fed Amapa, Lab Ecol & Conservacao Vertebrados, Macapa, Amapa, Brazil.; Michalski, F (corresponding author), Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil.; Michalski, F (corresponding author), Inst Procarnivoros, Atibaia, SP, Brazil.	fmichalski@gmail.com	Vicent, David/O-2255-2014; SALINERO-FORT, MIGUEL A./GOP-2536-2022; Michalski, Fernanda/J-4691-2012	Vicent, David/0000-0002-6663-0350; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Michalski, Fernanda/0000-0002-8074-9964; Lahoz, Carlos/0000-0001-5690-7558; Gomez Campelo, Paloma/0000-0003-2299-1741	Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES) [88881.030414/2013-01]	Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MS received an MSc scholarship from the Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES). This work was partially funded by a research grant to FM (Project 88881.030414/2013-01) from the Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" - CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RRN, 2008, HUM ECOL, V36, P443, DOI 10.1007/s10745-008-9174-5; Alves RRN, 2012, HUM ECOL, V40, P751, DOI 10.1007/s10745-012-9516-1; Baia PC, 2010, REV BIOL TROP, V58, P1079; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Bian J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111928; Coway-Gomez K, 2007, CHELONIAN CONSERV BI, V6, P199; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Da Silveira R, 1999, BIOL CONSERV, V88, P103, DOI 10.1016/S0006-3207(98)00084-6; ESRI, 2009, ARCGIS DESKT REL 9 3; FAO, FAO FOR MAN WORK PAP; Glanzel W, 2002, LIBR TRENDS, V50, P461; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leimu R, 2005, BIOSCIENCE, V55, P438, DOI 10.1641/0006-3568(2005)055[0438:DSCITI]2.0.CO;2; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; Martin AR, 2004, MAR MAMMAL SCI, V20, P189, DOI 10.1111/j.1748-7692.2004.tb01150.x; Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Alves RRN, 2012, ENVIRON MONIT ASSESS, V184, P6877, DOI 10.1007/s10661-011-2465-0; Alves RRN, 2010, HUM ECOL, V38, P691, DOI 10.1007/s10745-010-9352-0; Norris D, 2013, ZOOLOGIA-CURITIBA, V30, P482, DOI 10.1590/S1984-46702013000500003; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Peres CA, 2011, CONSERV BIOL, V25, P1124, DOI 10.1111/j.1523-1739.2011.01770.x; Pfaff A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129460; R Development Core Team, 2014, R 3 1 1 LANG ENV STA; REDFORD KH, 1987, AM ANTHROPOL, V89, P650, DOI 10.1525/aa.1987.89.3.02a00070; REDFORD KH, 1993, CONSERV BIOL, V7, P248, DOI 10.1046/j.1523-1739.1993.07020248.x; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; ROSAS FCW, 1994, MAMMAL REV, V24, P49, DOI 10.1111/j.1365-2907.1994.tb00134.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schneider L, 2011, CHELONIAN CONSERV BI, V10, P149, DOI 10.2744/CCB-0848.1; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; Somaweera R, 2013, HERPETOL MONOGR, V27, P23, DOI 10.1655/HERPMONOGRAPHS-D-11-00001; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; Uddin S, 2012, SCIENTOMETRICS, V90, P687, DOI 10.1007/s11192-011-0511-x; Verissimo A, 2011, AREAS PROTEGIDAS AMA; Visser J. A., 2000, AM J DISTANCE ED, V14, P21, DOI [10.1080/08923640009527062, DOI 10.1080/08923640009527062, 10.1080/]; Wright SJ, 2003, PERSPECT PLANT ECOL, V6, P73, DOI 10.1078/1433-8319-00043	47	18	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158413	10.1371/journal.pone.0158413	http://dx.doi.org/10.1371/journal.pone.0158413			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27352247	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900057
J	Vallerie, SN; Kramer, F; Barnhart, S; Kanter, JE; Breyer, RM; Andreasson, KI; Bornfeldt, KE				Vallerie, Sara N.; Kramer, Farah; Barnhart, Shelley; Kanter, Jenny E.; Breyer, Richard M.; Andreasson, Katrin I.; Bornfeldt, Karin E.			Myeloid Cell Prostaglandin E-2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes	PLOS ONE			English	Article							RESPONSE FACTOR-I; ATHEROSCLEROTIC LESIONS; GENE-EXPRESSION; ACCELERATED ATHEROSCLEROSIS; HUMAN MACROPHAGES; IMMUNE-RESPONSES; PERITONEAL-MACROPHAGES; SIGNALING PATHWAY; PLAQUE REGRESSION; CYCLIC-AMP	Type 1 diabetes mellitus (T1DM) is associated with cardiovascular complications induced by atherosclerosis. Prostaglandin E-2 (PGE(2)) is often raised in states of inflammation, including diabetes, and regulates inflammatory processes. In myeloid cells, a key cell type in atherosclerosis, PGE(2) acts predominately through its Prostaglandin E Receptor 4 (EP4; Ptger4) to modulate inflammation. The effect of PGE(2)-mediated EP4 signaling specifically in myeloid cells on atherosclerosis in the presence and absence of diabetes is unknown. Because diabetes promotes atherosclerosis through increased arterial myeloid cell accumulation, we generated a myeloid cell-targeted EP4-deficient mouse model (EP4(M-/-)) of T1DM-accelerated atherogenesis to investigate the relationship between myeloid cell EP4, inflammatory phenotypes of myeloid cells, and atherogenesis. Diabetic mice exhibited elevated plasma PGE metabolite levels and elevated Ptger4 mRNA in macrophages, as compared with non-diabetic littermates. PGE(2) increased II6, II1b, II23 and Ccr7 mRNA while reducing Tnfa mRNA through EP4 in isolated myeloid cells. Consistently, the stimulatory effect of diabetes on peritoneal macrophage II6 was mediated by PGE(2)-EP4, while PGE(2)-EP4 suppressed the effect of diabetes on Tnfa in these cells. In addition, diabetes exerted effects independent of myeloid cell EP4, including a reduction in macrophage Ccr7 levels and increased early atherogenesis characterized by relative lesional macrophage accumulation. These studies suggest that this mouse model of T1DM is associated with increased myeloid cell PGE(2)-EP4 signaling, which is required for the stimulatory effect of diabetes on IL-6, markedly blunts the effect of diabetes on TNF-alpha and does not modulate diabetes-accelerated atherogenesis.	[Vallerie, Sara N.; Kramer, Farah; Barnhart, Shelley; Kanter, Jenny E.; Bornfeldt, Karin E.] Univ Washington, UW Diabet Inst, Dept Med, Seattle, WA 98109 USA; [Bornfeldt, Karin E.] Univ Washington, UW Diabet Inst, Dept Pathol, Seattle, WA 98109 USA; [Breyer, Richard M.] Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA; [Andreasson, Katrin I.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University; Stanford University	Bornfeldt, KE (corresponding author), Univ Washington, UW Diabet Inst, Dept Med, Seattle, WA 98109 USA.; Bornfeldt, KE (corresponding author), Univ Washington, UW Diabet Inst, Dept Pathol, Seattle, WA 98109 USA.	bornf@u.washington.edu	Bornfeldt, Karin/AAI-2241-2019	Bornfeldt, Karin/0000-0001-9208-6523; Kanter, Jenny/0000-0003-3212-772X	National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases [R01HL062887, P01HL092969, R01HL126028, DP3DK108209]; Diabetes Research Center at the University of Washington [P30DK017047]; American Heart Association [14GRNT20410033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007028, R01HL126028, P01HL092969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Research Center at the University of Washington; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases under award numbers R01HL062887, P01HL092969, R01HL126028, DP3DK108209, and the Diabetes Research Center at the University of Washington (P30DK017047), and by the American Heart Association (14GRNT20410033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; AXELROD L, 1986, DIABETES, V35, P1004, DOI 10.2337/diabetes.35.9.1004; Babaev VR, 2008, CELL METAB, V8, P492, DOI 10.1016/j.cmet.2008.09.005; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; CHASE HP, 1979, J PEDIATR-US, V94, P185, DOI 10.1016/S0022-3476(79)80819-7; Chen LH, 2014, P NATL ACAD SCI USA, V111, P6828, DOI 10.1073/pnas.1401797111; Chen SSH, 2009, DIABETIC MED, V26, P182, DOI 10.1111/j.1464-5491.2008.02658.x; Cote SC, 2009, MOL IMMUNOL, V46, P2682, DOI 10.1016/j.molimm.2008.08.269; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Distel E, 2014, CIRC RES, V115, P759, DOI 10.1161/CIRCRESAHA.115.304164; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; ESMATJES E, 1987, DIABETES CARE, V10, P428, DOI 10.2337/diacare.10.4.428; Faour WH, 2005, J BIOL CHEM, V280, P9536, DOI 10.1074/jbc.M414067200; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; Hoggatt J, 2013, NATURE, V495, P365, DOI 10.1038/nature11929; Ikushima YM, 2013, BLOOD, V121, P1995, DOI 10.1182/blood-2012-06-437889; Jia ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093182; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanter JE, 2013, TRENDS ENDOCRIN MET, V24, P137, DOI 10.1016/j.tem.2012.10.002; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Koulis C, 2014, CLIN SCI, V127, P485, DOI 10.1042/CS20140045; Lamharzi N, 2004, DIABETES, V53, P3217, DOI 10.2337/diabetes.53.12.3217; Ma WY, 2005, J NEUROCHEM, V93, P664, DOI 10.1111/j.1471-4159.2005.03050.x; MacDougall ED, 2006, AM J PATHOL, V168, P2064, DOI 10.2353/ajpath.2006.051009; Minami M, 2008, J BIOL CHEM, V283, P9692, DOI 10.1074/jbc.M709663200; Mohamed R, 2013, LAB INVEST, V93, P933, DOI 10.1038/labinvest.2013.85; MOURITSANDERSEN T, 1986, PROSTAG LEUKOTR ESS, V22, P335, DOI 10.1016/0262-1746(86)90144-7; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nakatsuji M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005542; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Nathan DM, 2014, DIABETES, V63, P282, DOI 10.2337/db13-0782; Nishizawa T, 2014, CELL REP, V7, P356, DOI 10.1016/j.celrep.2014.03.028; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Poloso NJ, 2013, MOL IMMUNOL, V54, P284, DOI 10.1016/j.molimm.2012.12.010; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; QIU ZH, 1993, J BIOL CHEM, V268, P24506; Raychaudhuri Nupur, 2010, PLoS One, V5, pe15296, DOI 10.1371/journal.pone.0015296; Renard CB, 2004, J CLIN INVEST, V114, P659, DOI 10.1172/JCI200417867; Schiffmann S, 2014, BIOCHEM PHARMACOL, V87, P625, DOI 10.1016/j.bcp.2013.12.006; Schneider A, 2004, GENESIS, V40, P7, DOI 10.1002/gene.20048; Shao SY, 2012, CELL IMMUNOL, V280, P16, DOI 10.1016/j.cellimm.2012.11.001; Sharma A, 2015, DIABETES, V64, P3937, DOI 10.2337/db15-0472; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tang EHC, 2011, CARDIOVASC RES, V89, P234, DOI 10.1093/cvr/cvq262; Tang EHC, 2011, ARTERIOSCL THROM VAS, V31, P261, DOI 10.1161/ATVBAHA.110.216580; Vennemann A, 2012, DIABETES, V61, P1879, DOI 10.2337/db11-1396; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Wen YS, 2006, ENDOCRINOLOGY, V147, P2518, DOI 10.1210/en.2005-0519; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Zhu XC, 2006, J IMMUNOL, V177, P4299, DOI 10.4049/jimmunol.177.7.4299	60	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158316	10.1371/journal.pone.0158316	http://dx.doi.org/10.1371/journal.pone.0158316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351842	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900053
J	Fukunaga, A; Kosaki, RK; Wagner, D; Kane, C				Fukunaga, Atsuko; Kosaki, Randall K.; Wagner, Daniel; Kane, Corinne			Structure of Mesophotic Reef Fish Assemblages in the Northwestern Hawaiian Islands	PLOS ONE			English	Article							CORALS CNIDARIA ANTIPATHARIA; BLACK CORALS; SCLERACTINIAN CORALS; QUANTILE REGRESSION; CANONICAL-ANALYSIS; AUAU CHANNEL; DEEP; DIVERSITY; ECOLOGY; HABITAT	Mesophotic coral ecosystems (MCEs) support diverse communities of marine organisms with changes in community structure occurring along a depth gradient. In recent years, MCEs have gained attention due to their depths that provide protection from natural and anthropogenic stressors and their relative stability over evolutionary time periods, yet ecological structures of fish assemblages in MCEs remain largely un-documented. Here, we investigated composition and trophic structure of reef fish assemblages in the Northwestern Hawaiian Islands (NWHI) along a depth gradient from 1 to 67 m. The structure of reef fish assemblages as a whole showed a clear gradient from shallow to mesophotic depths. Fish assemblages at mesophotic depths had higher total densities than those in shallower waters, and were characterized by relatively high densities of planktivores and invertivores and relatively low densities of herbivores. Fishes that typified assemblages at mesophotic depths included six species that are endemic to the Hawaiian Islands. The present study showed that mesophotic reefs in the NWHI support unique assemblages of fish that are characterized by high endemism and relatively high densities of planktivores. Our findings underscore the ecological importance of these undersurveyed ecosystems and warrant further studies of MCEs.	[Fukunaga, Atsuko; Kosaki, Randall K.; Wagner, Daniel] NOAA, Papahanaumokuakea Marine Natl Monument, Honolulu, HI USA; [Kane, Corinne] Washington State Univ, Vancouver, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; Washington State University	Fukunaga, A (corresponding author), NOAA, Papahanaumokuakea Marine Natl Monument, Honolulu, HI USA.	atsuko.fukunaga@noaa.gov		Kosaki, Randall/0000-0003-1363-5702; Fukunaga, Atsuko/0000-0003-2175-6635	National Oceanic and Atmospheric Administration's (NOAA's) Office of National Marine Sanctuaries, through the Papahanaumokuakea Marine National Monument	National Oceanic and Atmospheric Administration's (NOAA's) Office of National Marine Sanctuaries, through the Papahanaumokuakea Marine National Monument	This work was funded in part by National Oceanic and Atmospheric Administration's (NOAA's) Office of National Marine Sanctuaries, through the Papahanaumokuakea Marine National Monument. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the officers and crew of the NOAA ship Hi'ialakai, and J. Leonard, B. Hauk, K. Keogh, G. McFall, R. Boland, A. Montgomery, Y. Papastamatiou, K. Lopes, C. Clark, J. Bostick, E. Kehn, R. Pyle and S. Harris for field support. We also thank M. J. Anderson for initial R codes for quantile regression and three anonymous reviewers for their comments that improved this manuscript. This work was funded in part by NOAA's Office of National Marine Sanctuaries, through the Papahanaumokuakea Marine National Monument. The scientific results and conclusions, as well as any views or opinions expressed herein, are those of the authors and do not necessarily reflect the views of NOAA or the Department of Commerce.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2008, J EXP MAR BIOL ECOL, V366, P16, DOI 10.1016/j.jembe.2008.07.006; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Arreola-Robles JL, 2002, B MAR SCI, V70, P1; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Behrens MD, 2007, CAN J FISH AQUAT SCI, V64, P867, DOI 10.1139/F07-063; Behrens MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045901; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2015, SCI REP-UK, V5, DOI 10.1038/srep07652; Bongaerts P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-205; Brazeau DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065845; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; BROCK VE, 1968, PAC SCI, V22, P373; Brokovich E, 2006, ECOL INDIC, V6, P494, DOI 10.1016/j.ecolind.2005.07.002; Brokovich E, 2010, MAR ECOL PROG SER, V399, P69, DOI 10.3354/meps08354; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Bryan DR, 2013, J APPL ICHTHYOL, V29, P108, DOI 10.1111/j.1439-0426.2012.02055.x; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Carassou L, 2008, AQUAT LIVING RESOUR, V21, P1, DOI 10.1051/alr:2008017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colvocoresses J, 2007, FISH RES, V85, P130, DOI 10.1016/j.fishres.2007.01.012; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; Feitoza BM, 2005, B MAR SCI, V76, P725; FRICKE H, 1985, MAR BIOL, V88, P175, DOI 10.1007/BF00397165; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Gorley C.K., 2006, GETTING STARTED PRIM; Greenwood NDW, 2010, CORAL REEFS, V29, P785, DOI 10.1007/s00338-010-0626-1; Grigg Richard W., 2008, V1, P573, DOI 10.1007/978-1-4020-6847-8_14; Grigg RW, 2006, CORAL REEFS, V25, P77, DOI 10.1007/s00338-005-0073-6; HIATT RW, 1960, ECOL MONOGR, V30, P66; Hilting AK, 2013, MAR BIOL, V160, P1681, DOI 10.1007/s00227-013-2220-x; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; HOBSON ES, 1974, FISH B-NOAA, V72, P915; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoover J.P., 1993, HAWAIIS FISH; Hurley KKC, 2016, CORAL REEFS, V35, P103, DOI 10.1007/s00338-015-1382-z; Kahng S., 2012, P 12 INT COR REEF S; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kahng SE, 2006, CORAL REEFS, V25, P254, DOI 10.1007/s00338-006-0098-5; Kane C, 2014, B MAR SCI, V90, P693, DOI 10.5343/bms.2013.1053; KOSAKI R K, 1991, Pacific Science, V45, P186; Kosaki RK, 2017, MAR BIODIVERS, V47, P783, DOI 10.1007/s12526-016-0510-5; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; LIDDELL W D, 1988, Palaios, V3, P413, DOI 10.2307/3514787; Lindfield SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092628; Locker SD, 2010, CORAL REEFS, V29, P329, DOI 10.1007/s00338-010-0613-6; MCGEHEE MA, 1994, MAR ECOL PROG SER, V105, P243, DOI 10.3354/meps105243; Menza C, 2008, REV BIOL TROP, V56, P11; Nanami A, 2002, ENVIRON BIOL FISH, V63, P353, DOI 10.1023/A:1014952932694; Parrish FA, 2004, MAR BIOL, V144, P1065, DOI 10.1007/s00227-003-1288-0; Pearson R, 2015, MAR ECOL PROG SER, V532, P184, DOI 10.3354/meps11351; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Pyle Richard L., 1996, Global Biodiversity, V6, P3; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Russ GR, 2003, CORAL REEFS, V22, P63, DOI 10.1007/s00338-003-0286-5; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Tenggardjaja KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115493; THRESHER RE, 1986, B MAR SCI, V38, P253; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Wagner D, 2012, CORAL REEFS, V31, P795, DOI 10.1007/s00338-012-0882-3; Wagner D, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00024; Wagner Daniel, 2015, Marine Biodiversity Records, V8, pe54, DOI 10.1017/S1755267215000202; Wagner Daniel, 2014, Marine Biodiversity Records, V7, pe68, DOI 10.1017/S1755267214000785; Wagner D, 2011, INVERTEBR BIOL, V130, P211, DOI 10.1111/j.1744-7410.2011.00233.x; Wagner D, 2011, PAC SCI, V65, P249, DOI 10.2984/65.2.249; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516	73	37	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157861	10.1371/journal.pone.0157861	http://dx.doi.org/10.1371/journal.pone.0157861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383614	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400029
J	Gan, N; Xiong, YY; Jiao, T				Gan, Ning; Xiong, Yaoyang; Jiao, Ting			Accuracy of Intraoral Digital Impressions for Whole Upper Jaws, Including Full Dentitions and Palatal Soft Tissues	PLOS ONE			English	Article							DENTAL IMPRESSIONS	Intraoral digital impressions have been stated to meet the clinical requirements for some teeth-supported restorations, though fewer evidences were proposed for larger scanning range. The aim of this study was to compare the accuracy (trueness and precision) of intraoral digital impressions for whole upper jaws, including the full dentitions and palatal soft tissues, as well as to determine the effect of different palatal vault height or arch width on accuracy of intraoral digital impressions. Thirty-two volunteers were divided into three groups according to the palatal vault height or arch width. Each volunteer received three scans with TRIOS intraoral scanner and one conventional impression of whole upper jaw. Three-dimensional (3D) images digitized from conventional gypsum casts by a laboratory scanner were chose as the reference models. All datasets were imported to a specific software program for 3D analysis by "best fit alignment" and "3D compare" process. Color-coded deviation maps showed qualitative visualization of the deviations. For the digital impressions for palatal soft tissues, trueness was (130.54 +/- 33.95) mu m and precision was (55.26 +/- 11.21) mu m. For the digital impressions for upper full dentitions, trueness was (80.01 +/- 17.78) mu m and precision was (59.52 +/- 11.29) mu m. Larger deviations were found between intraoral digital impressions and conventional impressions in the areas of palatal soft tissues than that in the areas of full dentitions (p<0.001). Precision of digital impressions for palatal soft tissues was slightly better than that for full dentitions (p = 0.049). There was no significant effect of palatal vault height on accuracy of digital impressions for palatal soft tissues (p>0.05), but arch width was found to have a significant effect on precision of intraoral digital impressions for full dentitions (p = 0.016). A linear correlation was found between arch width and precision of digital impressions for whole upper jaws (r = 0.326, p = 0.034 for palatal soft tissues and r = 0.485, p = 0.002 for full dentitions). It was feasible to use the intraoral scanner to obtain digital impressions for whole upper jaws. Wider dental arch contributed to lower precision of an intraoral digital impression. It should be confirmed in further studies that whether accuracy of digital impressions for whole upper jaws is clinically acceptable.	[Gan, Ning; Xiong, Yaoyang; Jiao, Ting] Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Peoples Hosp 9,Shanghai Key Lab Stomatol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xiong, YY; Jiao, T (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Peoples Hosp 9,Shanghai Key Lab Stomatol, Shanghai, Peoples R China.	jiao_ting@126.com; yaoyang_x@163.com			National Natural Science Foundation of China [81100774]; Shanghai Science and Technology Commission [114119a3900, 14411964200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (Project Number: 81100774; URL: http://www.nsfc.gov.cn/), and Shanghai Science and Technology Commission Funded Projects (Project Number: 114119a3900, 14411964200; URL: http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Silva JSAE, 2014, CLIN ORAL INVEST, V18, P515, DOI 10.1007/s00784-013-0987-2; [Anonymous], 572531994 DIN ISO; Berrendero S, 2016, CLIN ORAL INVESTIG; Brawek PK, 2013, CLIN ORAL INVEST, V17, P2119, DOI 10.1007/s00784-013-0923-5; Ender A, 2013, J PROSTHET DENT, V109, P121, DOI 10.1016/S0022-3913(13)60028-1; Flugge TV, 2013, AM J ORTHOD DENTOFAC, V144, P471, DOI 10.1016/j.ajodo.2013.04.017; Gjelvold B, 2015, J PROSTHODONT; Goodacre CJ, 2012, J PROSTHET DENT, V107, P34, DOI 10.1016/S0022-3913(12)60015-8; Jiao T, 2014, INT J PROSTHODONT, V27, P480, DOI 10.11607/ijp.3733; Kattadiyil MT, 2014, J PROSTHET DENT, V112, P444, DOI 10.1016/j.prosdent.2014.03.022; Lee SJ, 2015, CLIN ORAL IMPLAN RES, V26, P715, DOI 10.1111/clr.12375; Mehl A, 2009, Int J Comput Dent, V12, P11; Michalakis KX, 2012, J PROSTHET DENT, V108, P189, DOI 10.1016/S0022-3913(12)60146-2; Moreno A, 2013, IMPLANT DENT, V22, P320, DOI 10.1097/ID.0b013e3182980fe9; Patzelt SBM, 2013, J AM DENT ASSOC, V144, P914, DOI 10.14219/jada.archive.2013.0209; Quaas S, 2007, J DENT, V35, P903, DOI 10.1016/j.jdent.2007.08.008; Rudolph H, 2007, COMPUT BIOL MED, V37, P579, DOI 10.1016/j.compbiomed.2006.05.006; Seelbach P, 2013, CLIN ORAL INVEST, V17, P1759, DOI 10.1007/s00784-012-0864-4; Su TS, 2015, J PROSTHODONTIC RES; Svanborg P, 2014, INT J DENT, V2014, DOI 10.1155/2014/534382; Syrek A, 2010, J DENT, V38, P553, DOI 10.1016/j.jdent.2010.03.015; Takanashi T, 2009, J PROSTHODONT RES, V53, P95, DOI 10.1016/j.jpor.2008.10.002; Yan H, 2005, MED STAT, P258	23	79	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158800	10.1371/journal.pone.0158800	http://dx.doi.org/10.1371/journal.pone.0158800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383409	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400086
J	Iwai, Y; Shibuya, K; Misawa, S; Sekiguchi, Y; Watanabe, K; Amino, H; Kuwabara, S				Iwai, Yuta; Shibuya, Kazumoto; Misawa, Sonoko; Sekiguchi, Yukari; Watanabe, Keisuke; Amino, Hiroshi; Kuwabara, Satoshi			Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							EXCITABILITY PROPERTIES; MODEL	Wide-spread fasciculations are a characteristic feature in amyotrophic lateral sclerosis (ALS), suggesting motor axonal hyperexcitability. Previous excitability studies have shown increased nodal persistent sodium conductances and decreased potassium currents in motor axons of ALS patients, both of the changes inducing hyperexcitability. Altered axonal excitability potentially contributes to motor neuron death in ALS, but the relationship of the extent of motor neuronal death and abnormal excitability has not been fully elucidated. We performed multiple nerve excitability measurements in the median nerve at the wrist of 140 ALS patients and analyzed the relationship of compound muscle action potential (CMAP) amplitude (index of motor neuronal loss) and excitability indices, such as strength-duration time constant, threshold electrotonus, recovery cycle and current-threshold relationships. Compared to age-matched normal controls (n = 44), ALS patients (n = 140) had longer strength-duration time constant (SDTC: a measure of nodal persistent sodium current; p < 0.05), greater threshold changes in depolarizing threshold electrotonus (p < 0.05) and depolarizing current threshold relationship (i.e. less accommodation; (p < 0.05), greater superexcitability (a measure of fast potassium current; p < 0.05) and reduced late subexcitability (a measure of slow potassium current; p < 0.05), suggesting increased persistent sodium currents and decreased potassium currents. The reduced potassium currents were found even in the patient subgroups with normal CMAP (> 5mV). Regression analyses showed that SDTC (R = -0.22) and depolarizing threshold electrotonus (R = -0.22) increased with CMAP decline. These findings suggest that motor nerve hyperexcitability occurs in the early stage of the disease, and precedes motor neuronal loss in ALS. Modulation of altered ion channel function could be a treatment option for ALS.	[Iwai, Yuta; Shibuya, Kazumoto; Misawa, Sonoko; Sekiguchi, Yukari; Watanabe, Keisuke; Amino, Hiroshi; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan	Chiba University	Shibuya, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan.	kazumoto@net.email.ne.jp		Kuwabara, Satoshi/0000-0002-4716-8578	Ministry of Education, Culture, Sports, Science, and Technology of Japan [30375753, 70282481]; International Federation of Clinical Neurophysiology Research Scholarship	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Federation of Clinical Neurophysiology Research Scholarship	SM and SK receive research support from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (SM, 30375753, SK, 70282481). KS is a recipient of International Federation of Clinical Neurophysiology Research Scholarship.	[Anonymous], 1901, ARCH ITAL BIOL; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Charcot J-M, 1869, ARCH PHYSL NORM PATH, V2, P744; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; Cheah BC, 2012, CLIN NEUROPHYSIOL, V123, P2460, DOI 10.1016/j.clinph.2012.06.020; Cheah BC, 2011, AMYOTROPH LATERAL SC, V12, P33, DOI 10.3109/17482968.2010.531742; de Carvalho M, 2000, MUSCLE NERVE, V23, P344, DOI 10.1002/(SICI)1097-4598(200003)23:3<344::AID-MUS5>3.0.CO;2-N; de Carvalho M, 2016, CLIN NEUROPHYSIOL, V127, P2257, DOI 10.1016/j.clinph.2016.02.011; de Carvalho M, 2013, JAMA NEUROL, V70, P1562, DOI 10.1001/jamaneurol.2013.4437; Devlin AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6999; Dong H, 2014, NEUROSCIENCE, V272, P141, DOI 10.1016/j.neuroscience.2014.04.032; Kanai K, 2006, BRAIN, V129, P953, DOI 10.1093/brain/awl024; Kanai Kazuaki, 2011, Rinsho Shinkeigaku, V51, P1118; Kanouchi T, 2012, J NEUROL NEUROSUR PS, V83, P739, DOI 10.1136/jnnp-2011-301826; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Kuo JJ, 2005, J PHYSIOL-LONDON, V563, P843, DOI 10.1113/jphysiol.2004.074138; Kuwabara S, 2014, CLIN NEUROPHYSIOL, V125, P872, DOI 10.1016/j.clinph.2013.11.014; Kuwabara S, 2011, J NEUROL NEUROSUR PS, V82, P1181, DOI 10.1136/jnnp-2011-300691; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Nwosu VK, 2010, AMYOTROPH LATERAL SC, V11, P392, DOI 10.3109/17482960903452283; Regan RF, 1995, BRAIN RES, V705, P188, DOI 10.1016/0006-8993(95)01170-6; Salkind NJ., 2013, STAT PEOPLE WHO THIN; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Sekiguchi T, 2014, J NEUROL NEUROSUR PS, V85, P85, DOI 10.1136/jnnp-2013-305617; Shibuya K, 2015, AMYOTROPH LATERAL SC, V16, P1; Shibuya K, 2013, J NEUROL NEUROSUR PS, V84, P969, DOI 10.1136/jnnp-2012-304109; Shibuya K, 2011, EXP NEUROL, V232, P149, DOI 10.1016/j.expneurol.2011.08.015; Tomlinson SE, 2010, BRAIN, V133, P3530, DOI 10.1093/brain/awq318; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07; Vucic S, 2006, CLIN NEUROPHYSIOL, V117, P1458, DOI 10.1016/j.clinph.2006.04.016; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019	33	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158596	10.1371/journal.pone.0158596	http://dx.doi.org/10.1371/journal.pone.0158596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383069	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400063
J	Bennani-Baiti, B; Dietzel, M; Baltzer, PA				Bennani-Baiti, Barbara; Dietzel, Matthias; Baltzer, Pascal Andreas			MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer	PLOS ONE			English	Article							REDUCING SALPINGO-OOPHORECTOMY; CONTRAST-MEDIUM ENHANCEMENT; MAMMOGRAPHIC DENSITY; FIBROGLANDULAR TISSUE; REPLACEMENT THERAPY; MUTATION CARRIERS; RISK; BRCA1; WOMEN; IMPACT	Background Previously, a strong positive association between background parenchymal enhancement (BPE) at magnetic resonance imaging (MRI) and breast cancer was reported in high-risk populations. We sought to determine, whether this was also true for non-high-risk patients. Methods 540 consecutive patients underwent breast MRI for assessment of breast findings (BI-RADS 0-5, non-high-risk screening (no familial history of breast cancer, no known genetic mutation, no prior chest irradiation, or previous breast cancer diagnosis)) and subsequent histological work-up. For this IRB-approved study, BPE and fibroglandular tissue FGT were retrospectively assessed by two experienced radiologists according to the BI-RADS lexicon. Pearson correlation coefficients were calculated to explore associations between BPE, FGT, age and final diagnosis of breast cancer. Subsequently, multivariate logistic regression analysis, considering covariate colinearities, was performed, using final diagnosis as the target variable and BPE, FGT and age as covariates. Results Age showed a moderate negative correlation with FGT (r = -0.43, p<0.001) and a weak negative correlation with BPE (r = -0.28, p<0.001). FGT and BPE correlated moderately (r = 0.35, p<0.001). Final diagnosis of breast cancer displayed very weak negative correlations with FGT (r = -0.09, p = 0.046) and BPE (r = -0.156, p<0.001) and weak positive correlation with age (r = 0.353, p<0.001). On multivariate logistic regression analysis, the only independent covariate for prediction of breast cancer was age (OR 1.032, p<0.001). Conclusions Based on our data, neither BPE nor FGT independently correlate with breast cancer risk in non-high-risk patients at MRI. Our model retained only age as an independent risk factor for breast cancer in this setting.	[Bennani-Baiti, Barbara; Baltzer, Pascal Andreas] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria; [Bennani-Baiti, Barbara] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna Gen Hosp AKH, Vienna, Austria; [Dietzel, Matthias] Univ Erlangen Nurnberg, Dept Radiol, Nurnberg, Germany	University of Vienna; Medical University of Vienna; University of Erlangen Nuremberg	Bennani-Baiti, B; Baltzer, PA (corresponding author), Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria.; Bennani-Baiti, B (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna Gen Hosp AKH, Vienna, Austria.	barbara.bennani-baiti@meduniwien.ac.at; pascal.baltzer@meduniwien.ac.at		Baltzer, Pascal/0000-0002-3755-5398	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna. The authors received no other specific funding for this work.	Baltzer PA, 2011, ROFO-FORTSCHR RONTG, V183, P441, DOI 10.1055/s-0029-1246072; Bhatia S, 2015, CANCER-AM CANCER SOC, V121, P648, DOI 10.1002/cncr.29096; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Byrne C, 2001, CANCER CAUSE CONTROL, V12, P103, DOI 10.1023/A:1008935821885; Cubuk R, 2010, RADIOL MED, V115, P434, DOI 10.1007/s11547-010-0513-4; Deleo MJ, 2015, AM J ROENTGENOL, V204, P669, DOI 10.2214/AJR.13.12146; Delille JP, 2005, RADIOLOGY, V235, P36, DOI 10.1148/radiol.2351040012; DeMartini WB, 2012, AM J ROENTGENOL, V198, pW373, DOI 10.2214/AJR.10.6272; Dolan NC, 2015, ANN INTERN MED, V162, P729, DOI 10.7326/M15-0821; Dontchos BN, 2015, RADIOLOGY, V276, P371, DOI 10.1148/radiol.2015142304; Faresjo T, 2010, INT J ENV RES PUB HE, V7, P325, DOI 10.3390/ijerph7010325; Fridlich R, 2015, DNA REPAIR, V30, P11, DOI 10.1016/j.dnarep.2015.03.002; Gorrini C, 2014, P NATL ACAD SCI USA, V111, P4472, DOI 10.1073/pnas.1324136111; Hansen NL, 2014, J MAGN RESON IMAGING, V40, P483, DOI 10.1002/jmri.24495; King V, 2011, RADIOLOGY, V260, P50, DOI 10.1148/radiol.11102156; Ko ES, 2011, EUR J RADIOL, V80, P719, DOI 10.1016/j.ejrad.2010.07.019; Kuhl CK, 1997, RADIOLOGY, V203, P137, DOI 10.1148/radiology.203.1.9122382; Lee EYHP, 2014, P NATL ACAD SCI USA, V111, P4353, DOI 10.1073/pnas.1403033111; Lehman CD, 2014, ACR PRACTICE PARAMET; Morris C, 2013, ACR BI RADS1 MAGNETI; MullerSchimpfle M, 1997, RADIOLOGY, V203, P145; Price ER, 2014, EUR RADIOL, V24, P162, DOI 10.1007/s00330-013-2993-9; Ramadan S, 2015, RADIOLOGY, V275, P675, DOI 10.1148/radiol.15140967; Reichenbach JR, 1999, J COMPUT ASSIST TOMO, V23, P407, DOI 10.1097/00004728-199905000-00015; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Singer CF, 2015, WIEN KLIN WOCHENSCHR, V127, P981, DOI 10.1007/s00508-015-0880-x; Talele Anjali C, 2003, Breast J, V9, P237, DOI 10.1046/j.1524-4741.2003.09322.x; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; van der Velden BHM, 2015, RADIOLOGY, V276, P675, DOI 10.1148/radiol.15142192; Wei J, 2004, MED PHYS, V31, P933, DOI 10.1118/1.1668512; Wu S, 2013, INT SOC MAGN RES MED; WU SD, 2013, MED PHYS, V40, DOI DOI 10.1118/1; Wu SD, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0577-0; Wu SD, 2013, MED PHYS, V40, DOI 10.1118/1.4829496; Wu SD, 2012, LECT NOTES COMPUT SC, V7511, P437, DOI 10.1007/978-3-642-33418-4_54	37	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158573	10.1371/journal.pone.0158573	http://dx.doi.org/10.1371/journal.pone.0158573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379395	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700035
J	Piepenbrink, MS; Samuel, M; Zheng, B; Carter, B; Fucile, C; Bunce, C; Kiebala, M; Khan, AA; Thakar, J; Maggirwar, SB; Morse, D; Rosenberg, AF; Haughey, NJ; Valenti, W; Keefer, MC; Kobie, JJ				Piepenbrink, Michael S.; Samuel, Memorie; Zheng, Bo; Carter, Brittany; Fucile, Christopher; Bunce, Catherine; Kiebala, Michelle; Khan, Atif A.; Thakar, Juilee; Maggirwar, Sanjay B.; Morse, Diane; Rosenberg, Alexander F.; Haughey, Norman J.; Valenti, William; Keefer, Michael C.; Kobie, James J.			Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users	PLOS ONE			English	Article							BLOOD B-CELLS; DRUG-USERS; IMMUNE ACTIVATION; MICROBIAL TRANSLOCATION; OPIOID RECEPTORS; HIGH-RISK; RHEUMATOID-ARTHRITIS; HIV-1 INFECTION; EFFICACY TRIAL; VACCINE	Background Injection drug use is a growing major public health concern. Injection drug users (IDUs) have a higher incidence of co-morbidities including HIV, Hepatitis, and other infections. An effective humoral response is critical for optimal homeostasis and protection from infection; however, the impact of injection heroin use on humoral immunity is poorly understood. We hypothesized that IDUs have altered B cell and antibody profiles. Methods and Findings A comprehensive systems biology-based cross-sectional assessment of 130 peripheral blood B cell flow cytometry- and plasma-based features was performed on HIV-/Hepatitis C-, active heroin IDUs who participated in a syringe exchange program (n = 19) and healthy control subjects (n = 19). The IDU group had substantial polydrug use, with 89% reporting cocaine injection within the preceding month. IDUs exhibited a significant, 2-fold increase in total B cells compared to healthy subjects, which was associated with increased activated B cell subsets. Although plasma total IgG titers were similar between groups, IDUs had significantly higher IgG3 and IgG4, suggestive of chronic B cell activation. Total IgM was also increased in IDUs, as well as HIV Envelope-specific IgM, suggestive of increased HIV exposure. IDUs exhibited numerous features suggestive of systemic inflammation, including significantly increased plasma sCD40L, TNF-alpha, TGF-alpha, IL-8, and ceramide metabolites. Machine learning multivariate analysis distilled a set of 10 features that classified samples based on group with absolute accuracy. Conclusions These results demonstrate broad alterations in the steady-state humoral profile of IDUs that are associated with increased systemic inflammation. Such dysregulation may impact the ability of IDUs to generate optimal responses to vaccination and infection, or lead to increased risk for inflammation-related co-morbidities, and should be considered when developing immune-based interventions for this growing population.	[Piepenbrink, Michael S.; Zheng, Bo; Bunce, Catherine; Valenti, William; Keefer, Michael C.; Kobie, James J.] Univ Rochester, Dept Med, Div Infect Dis, Rochester, NY 14627 USA; [Samuel, Memorie] Howard Univ, Sch Med, Washington, DC 20059 USA; [Carter, Brittany] Texas A&M Univ, Sch Med, Bryan, TX USA; [Fucile, Christopher; Rosenberg, Alexander F.] Univ Rochester, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY USA; [Kiebala, Michelle; Khan, Atif A.; Thakar, Juilee; Maggirwar, Sanjay B.] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA; [Morse, Diane] Univ Rochester, Dept Psychiat, Rochester, NY USA; [Morse, Diane] Univ Rochester, Dept Med, Rochester, NY USA; [Haughey, Norman J.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Valenti, William] Trillium Hlth, Rochester, NY USA	University of Rochester; Howard University; Texas A&M University System; Texas A&M University College Station; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Johns Hopkins University	Kobie, JJ (corresponding author), Univ Rochester, Dept Med, Div Infect Dis, Rochester, NY 14627 USA.	james_kobie@urmc.rochester.edu	Khan, Atif/I-4947-2019; Piepenbrink, Michael/GPK-5944-2022	Khan, Atif/0000-0002-6006-2620; Morse, Diane/0000-0001-9603-0324	National Institutes of Health (NIH) grants [1R01AI117787, 1R21AI116285]; HIV Vaccines Trials Network Research and Mentorship Program (RAMP) [5UM1AI068614]; University of Rochester Center for AIDS Research [5P30AI078498]; University of Rochester HIV/AIDS Clinical Trials Unit; Units for HIV/AIDS Clinical Trials Networks [5UM1AI069511]; PhRMA informatics research starter award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117787, P30AI078498, R21AI116285, UM1AI069511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066801] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Vaccines Trials Network Research and Mentorship Program (RAMP); University of Rochester Center for AIDS Research; University of Rochester HIV/AIDS Clinical Trials Unit; Units for HIV/AIDS Clinical Trials Networks; PhRMA informatics research starter award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants (1R01AI117787 and 1R21AI116285 to JK); the HIV Vaccines Trials Network Research and Mentorship Program (RAMP) (5UM1AI068614 to MS and BC); and funding through the University of Rochester Center for AIDS Research (5P30AI078498 to JK and JT); PhRMA informatics research starter award (to JT) and the University of Rochester HIV/AIDS Clinical Trials Unit; Units for HIV/AIDS Clinical Trials Networks (5UM1AI069511 to JK and MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; BAGASRA O, 1989, CLIN EXP IMMUNOL, V77, P289; Bandaru VVR, 2013, NEUROLOGY, V81, P1492, DOI 10.1212/WNL.0b013e3182a9565e; Bandaru VVR, 2013, NEUROLOGY IN PRESS; Baral S, 2007, LANCET INFECT DIS, V7, P667, DOI 10.1016/S1473-3099(07)70237-2; Bergman BC, 2015, AM J PHYSIOL-ENDOC M, V309, pE398, DOI 10.1152/ajpendo.00134.2015; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buettner M, 2014, AM J KIDNEY DIS, V63, P945, DOI 10.1053/j.ajkd.2014.01.428; Chan YY, 2015, PSYCHIAT RES, V226, P230, DOI 10.1016/j.psychres.2014.12.053; Chen SL, 2012, J NEUROIMMUNE PHARM, V7, P1025, DOI 10.1007/s11481-012-9400-1; Cheng GLF, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.36; Cheng JM, 2015, ATHEROSCLEROSIS, V243, P560, DOI 10.1016/j.atherosclerosis.2015.10.022; Cognasse F, 2007, EXP HEMATOL, V35, P1376, DOI 10.1016/j.exphem.2007.05.021; Corey L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7732; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Davidson DC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-144; Dettmeyer R, 2009, FORENSIC SCI INT, V187, P42, DOI 10.1016/j.forsciint.2009.02.014; Dwyer R, 2009, DRUG ALCOHOL DEPEN, V100, P9, DOI 10.1016/j.drugalcdep.2008.08.016; Fink K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00078; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Fugelstad A, 2014, SCAND J PUBLIC HEALT, V42, P364, DOI 10.1177/1403494814525006; Goldkorn Tzipora, 2013, Handb Exp Pharmacol, P93, DOI 10.1007/978-3-7091-1511-4_5; Tucker RDGY, 2014, ANAEROBE, V30, P108, DOI 10.1016/j.anaerobe.2014.09.005; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, P215, DOI 10.1176/appi.neuropsych.23.2.215; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; Hernandez-Corbacho MJ, 2015, J BIOL CHEM, V290, P25356, DOI 10.1074/jbc.M115.658658; Hidalgo-Munoz AR, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00020; Jamali A, 2007, COMP IMMUNOL MICROB, V30, P71, DOI 10.1016/j.cimid.2006.10.002; Jego G, 2001, BLOOD, V97, P1817, DOI 10.1182/blood.V97.6.1817; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Kakazu E, 2016, J LIPID RES, V57, P233, DOI 10.1194/jlr.M063412; Kamath GR, 2014, VACCINE, V32, P2265, DOI 10.1016/j.vaccine.2014.02.072; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kassambara A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004077; Kaushik KS, 2011, J MED MICROBIOL, V60, P408, DOI 10.1099/jmm.0.027540-0; Kiebala M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130061; Kobie JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035356; Kobie JJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3542; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kovacs GG, 2015, NEUROBIOL AGING, V36, P3100, DOI 10.1016/j.neurobiolaging.2015.07.018; Kuramoto SJ, 2011, DRUG ALCOHOL DEPEN, V118, P237, DOI 10.1016/j.drugalcdep.2011.03.030; Larsen PJ, 2014, MOL METAB, V3, P252, DOI 10.1016/j.molmet.2014.01.011; Lavender TW, 2013, CLIN MED, V13, P511, DOI 10.7861/clinmedicine.13-5-511; Leng SX, 2015, AIDS RES HUM RETROV, V31, P1257, DOI [10.1089/aid.2015.0134, 10.1089/AID.2015.0134]; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Liu RX, 2015, HEPATOLOGY, V62, P1779, DOI 10.1002/hep.28020; Machowska A, 2016, TRANSL RES, V167, P204, DOI 10.1016/j.trsl.2015.06.012; McCarthy L, 2001, DRUG ALCOHOL DEPEN, V62, P111, DOI 10.1016/S0376-8716(00)00181-2; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Meacham MC, 2015, SUBST USE MISUSE, V50, P1351, DOI 10.3109/10826084.2015.1013132; Mielke MM, 2015, AGING CELL, V14, P1014, DOI 10.1111/acel.12369; Mielke MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073094; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Murphy EL, 2001, CLIN INFECT DIS, V33, P35, DOI 10.1086/320879; Narvaez JCM, 2013, NEUROSCI LETT, V544, P80, DOI 10.1016/j.neulet.2013.03.045; Neri M, 2013, INT J MOL SCI, V14, P19831, DOI 10.3390/ijms141019831; Palmer CD, 2014, AIDS, V28, P2162, DOI 10.1097/QAD.0000000000000386; Pereira J, 2011, PLATELETS, V22, P596, DOI 10.3109/09537104.2011.578181; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Reece AS, 2014, J CLIN PHARM THER, V39, P158, DOI 10.1111/jcpt.12121; Regan PM, 2012, J CELL PHYSIOL, V227, P2832, DOI 10.1002/jcp.24004; Reichel M, 2015, BBA-MOL CELL BIOL L, V1851, P1501, DOI 10.1016/j.bbalip.2015.08.005; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rivera IG, 2015, TOXINS, V7, P1457, DOI 10.3390/toxins7051457; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rudd RA, 2014, MMWR-MORBID MORTAL W, V63, P849; Sacerdote P, 2008, BRAIN BEHAV IMMUN, V22, P606, DOI 10.1016/j.bbi.2007.12.013; Schneider-Schaulies J, 2015, BIOL CHEM, V396, P585, DOI 10.1515/hsz-2014-0273; Serre K, 2012, BLOOD, V120, P4552, DOI 10.1182/blood-2012-03-417733; TAUB DD, 1991, P NATL ACAD SCI USA, V88, P360, DOI 10.1073/pnas.88.2.360; Todd DJ, 2011, ARTHRITIS RHEUM-US, V63, P894, DOI 10.1002/art.30213; Tomescu C, 2015, JAIDS-J ACQ IMM DEF, V68, P264, DOI 10.1097/QAI.0000000000000470; Tomescu C, 2010, AIDS, V24, P2151, DOI 10.1097/QAD.0b013e32833dfc20; Toskulkao T, 2010, NEUROCHEM INT, V56, P285, DOI 10.1016/j.neuint.2009.10.013; van Holst Ruth Janke, 2011, Curr Drug Abuse Rev, V4, P42; Vassallo M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-174; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; Warshow UM, 2012, J VIRAL HEPATITIS, V19, P501, DOI 10.1111/j.1365-2893.2011.01574.x; Yao ZQ, 2013, ARCH IMMUNOL THER EX, V61, P193, DOI 10.1007/s00005-013-0219-0; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730	89	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158641	10.1371/journal.pone.0158641	http://dx.doi.org/10.1371/journal.pone.0158641			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379802	Green Published, gold, Green Submitted			2022-12-27	WOS:000379798700038
J	Kim, WS; Cho, S; Baek, D; Bang, H; Paik, NJ				Kim, Won-Seok; Cho, Sungmin; Baek, Dongyoub; Bang, Hyunwoo; Paik, Nam-Jong			Upper Extremity Functional Evaluation by Fugl-Meyer Assessment Scoring Using Depth-Sensing Camera in Hemiplegic Stroke Patients	PLOS ONE			English	Article							UPPER-LIMB DEXTERITY; RECOVERY; SENSOR	Virtual home-based rehabilitation is an emerging area in stroke rehabilitation. Functional assessment tools are essential to monitor recovery and provide current function-based rehabilitation. We developed the Fugl-Meyer Assessment (FMA) tool using Kinect (Microsoft, USA) and validated it for hemiplegic stroke patients. Forty-one patients with hemiplegic stroke were enrolled. Thirteen of 33 items were selected for upper extremity motor FMA. One occupational therapist assessed the motor FMA while recording upper extremity motion with Kinect. FMA score was calculated using principal component analysis and artificial neural network learning from the saved motion data. The degree of jerky motion was also transformed to jerky scores. Prediction accuracy for each of the 13 items and correlations between real FMA scores and scores using Kinect were analyzed. Prediction accuracies ranged from 65% to 87% in each item and exceeded 70% for 9 items. Correlations were high for the summed score for the 13 items between real FMA scores and scores obtained using Kinect (Pearson's correlation coefficient = 0.873, P<0.0001) and those between total upper extremity scores (66 in full score) and scores using Kinect (26 in full score) (Pearson's correlation coefficient = 0.799, P<0.0001). Log transformed jerky scores were significantly higher in the hemiplegic side (1.81 +/- 0.76) compared to non-hemiplegic side (1.21 +/- 0.43) and showed significant negative correlations with Brunnstrom stage (3 to 6; Spearman correlation coefficient = -0.387, P = 0.046). FMA using Kinect is a valid way to assess upper extremity function and can provide additional results for movement quality in stroke patients. This may be useful in the setting of unsupervised home-based rehabilitation.	[Kim, Won-Seok; Paik, Nam-Jong] Seoul Natl Univ, Dept Rehabil Med, Coll Med, Bundang Hosp, Songnam, Gyeonggi Do, South Korea; [Cho, Sungmin; Baek, Dongyoub; Bang, Hyunwoo] Seoul Natl Univ, Dept Mech & Aerosp Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Paik, NJ (corresponding author), Seoul Natl Univ, Dept Rehabil Med, Coll Med, Bundang Hosp, Songnam, Gyeonggi Do, South Korea.	njpaik@snu.ac.kr	, 김원석/AAJ-2334-2020; Paik, Nam-Jong/D-5798-2012; Cho, Sungmin/AAM-3840-2021	, 김원석/0000-0002-1199-5707; Paik, Nam-Jong/0000-0002-5193-8678; 	Microsoft Research, under ICT/SW Creative research program [NIPA-2014-(H0510-14-1014), NIPA-2013(H0503-13-1018)]; Ministry of Science, ICT and Future Planning (MSIP), Korea	Microsoft Research, under ICT/SW Creative research program; Ministry of Science, ICT and Future Planning (MSIP), Korea	This research was supported by the The Ministry of Science, ICT and Future Planning (MSIP), Korea and Microsoft Research, under ICT/SW Creative research program supervised by the National ICT Industry Promotion Agency (NIPA) [NIPA-2014-(H0510-14-1014)] and [NIPA-2013(H0503-13-1018)], which were received by N-J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2010, 2010 SECOND INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE, COMMUNICATION SYSTEMS AND NETWORKS (CICSYN), P44, DOI 10.1109/CICSyN.2010.9; Adams RJ, 2015, IEEE T NEUR SYS REH, V23, P287, DOI 10.1109/TNSRE.2014.2360149; Barton G, 2007, GAIT POSTURE, V25, P374, DOI 10.1016/j.gaitpost.2006.05.003; Brainin M, 2007, LANCET NEUROL, V6, P553, DOI 10.1016/S1474-4422(07)70005-4; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; Caimmi M, 2008, NEUROREHAB NEURAL RE, V22, P31, DOI 10.1177/1545968307302923; Centers for Disease Control and Prevention (CDC), 2007, MMWR MORBIDITY MORTA, V56, P504; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gabel M, ENG MED BIOL SOC EMB, P1964; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Guna J, 2014, SENSORS-BASEL, V14, P3702, DOI 10.3390/s140203702; Hsieh YW, 2007, STROKE, V38, P3052, DOI 10.1161/STROKEAHA.107.490730; KITAZAWA S, 1993, INT CONGR SER, V1024, P11; Kong KH, 2013, NEUROREHABILITATION, V32, P345, DOI 10.3233/NRE-130854; Kong KH, 2011, NEUROREHABILITATION, V28, P105, DOI 10.3233/NRE-2011-0639; Kowalczewski J, 2011, IEEE ENG MED BIO, P7332, DOI 10.1109/IEMBS.2011.6091710; Kurillo G, 2013, TECHNOL HEALTH CARE, V21, P641, DOI 10.3233/THC-130764; Lambercy O, 2013, IEEE INT C REHABIL R, V2013, P1; Lu Y, 1998, IEEE WORLD CONGRESS ON COMPUTATIONAL INTELLIGENCE, P1816, DOI 10.1109/IJCNN.1998.687133; Nguyen GH, 2008, INT C PATT RECOG, P3759; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Olesh EV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104487; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rohrer B, 2002, J NEUROSCI, V22, P8297; Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507; Tresilian JR, 1997, BRAIN, V120, P2093, DOI 10.1093/brain/120.11.2093; Yu H, 2005, P 2005 INT C COMM CI; Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24	30	60	63	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158640	10.1371/journal.pone.0158640	http://dx.doi.org/10.1371/journal.pone.0158640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367518	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900047
J	Saharia, KK; Petrovas, C; Ferrando-Martinez, S; Leal, M; Luque, R; Ive, P; Luetkemeyer, A; Havlir, D; Koup, RA				Saharia, Kapil K.; Petrovas, Constantinos; Ferrando-Martinez, Sara; Leal, Manuel; Luque, Rafael; Ive, Prudence; Luetkemeyer, Anne; Havlir, Diane; Koup, Richard A.			Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4(+) T-Cells	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DISEASE PROGRESSION; LATENT INFECTION; HIV-INFECTION; EXHAUSTION; RESPONSES; CTLA-4; PD-1; MICE; BLOCKADE	Background Little is known about the expression of inhibitory molecules cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed-death-1 (PD-1) on Mycobacterium tuberculosis (Mtb)-specific CD4 T-cells and how their expression is impacted by TB treatment. Methods Cryopreserved PBMCs from HIV-TB co-infected and TB mono-infected patients with untreated and treated tuberculosis (TB) disease were stimulated for six hours with PPD and stained. Using polychromatic flow cytometry, we characterized the differentiation state, cytokine profile, and inhibitory molecule expression on PPD-specific CD4 T-cells. Results In our HIV-TB co-infected cohort, TB treatment increased the proportion of PPD-specific CD4 T-cells co-producing IFN-gamma(+) IL-2(+) TNF-alpha(+) and IFN-gamma(+) IL-2(+) (p = 0.0004 and p = 0.0002, respectively) while decreasing the proportion of PPD-specific CD4 T-cells co-producing IFN-gamma(+) MIP1-beta(+) TNF-alpha(+) and IFN-gamma(+) MIP1-beta(+). The proportion of PPD-specific CD4 T-cells expressing an effector memory phenotype decreased (63.6% vs 51.6%, p = 0.0015) while the proportion expressing a central memory phenotype increased (7.8% vs. 21.7%, p = 0.001) following TB treatment. TB treatment reduced the proportion of PPD-specific CD4 T-cells expressing CTLA-4 (72.4% vs. 44.3%, p = 0.0005) and PD-1 (34.5% vs. 29.2%, p = 0.03). Similar trends were noted in our TB mono-infected cohort. Conclusion TB treatment alters the functional profile of Mtb-specific CD4 T-cells reflecting shifts towards a less differentiated maturational profile and decreases PD-1 and CTLA-4 expression. These could serve as markers of reduced mycobacterial burden. Further study is warranted.	[Saharia, Kapil K.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Saharia, Kapil K.] Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA; [Saharia, Kapil K.; Petrovas, Constantinos; Ferrando-Martinez, Sara; Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Ferrando-Martinez, Sara] Hosp Gen Univ Gregorio Maranon, Lab InmunoBiol Mol, Madrid, Spain; [Ferrando-Martinez, Sara] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Ferrando-Martinez, Sara; Leal, Manuel] Virgen del Rocio Univ Hosp, Inst Biomed Seville, IBiS, Lab Immunovirol,Clin Unit Infect Dis Microbiol &, Seville, Spain; [Luque, Rafael] Virgen del Rocio Univ Hosp, Dept Infect Dis Microbiol & Prevent Med, Seville, Spain; [Ive, Prudence] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Clin HIV Res Unit, Johannesburg, South Africa; [Luetkemeyer, Anne; Havlir, Diane] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94143 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); General University Gregorio Maranon Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; University of Witwatersrand; University of California System; University of California San Francisco	Saharia, KK (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.; Saharia, KK (corresponding author), Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA.; Saharia, KK (corresponding author), NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	ksaharia@ihv.umaryland.edu			Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIAID, NIH [UM1 AI068634, UM1 AI068636, UM1 AI106701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068636, UM1AI069463, ZIAAI005014, UM1AI069496, UM1AI068634] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Additional support was provided under Award Number UM1 AI068634, UM1 AI068636 and UM1 AI106701 funded by NIAID, NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blair DA, 2011, J IMMUNOL, V187, P2310, DOI 10.4049/jimmunol.1100363; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Caruso AM, 1999, J IMMUNOL, V162, P5407; Ciuffreda D, 2008, EUR J IMMUNOL, V38, P2665, DOI 10.1002/eji.200838336; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Heuts F, 2013, P NATL ACAD SCI USA, V110, P6482, DOI 10.1073/pnas.1219985110; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Kirman J, 1999, INFECT IMMUN, V67, P3786, DOI 10.1128/IAI.67.8.3786-3792.1999; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Lin PL, 2012, AIDS RES HUM RETROV, V28, P1693, DOI [10.1089/aid.2012.0028, 10.1089/AID.2012.0028]; Lodi S, 2013, THORAX, V68, P207, DOI 10.1136/thoraxjnl-2012-201740; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Schuetz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027284; Singh A, 2013, J INFECT DIS, V208, P603, DOI 10.1093/infdis/jit206; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Yang BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063261	40	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158262	10.1371/journal.pone.0158262	http://dx.doi.org/10.1371/journal.pone.0158262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367521	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900027
J	Yoon, Y; Kim, BH				Yoon, Young; Kim, Beom Heyn			Secret Forwarding of Events over Distributed Publish/Subscribe Overlay Network	PLOS ONE			English	Article							COMPLEX NETWORK; DESIGN	Publish/subscribe is a communication paradigm where loosely-coupled clients communicate in an asynchronous fashion. Publish/subscribe supports the flexible development of large-scale, event-driven and ubiquitous systems. Publish/subscribe is prevalent in a number of application domains such as social networking, distributed business processes and real-time mission-critical systems. Many publish/subscribe applications are sensitive to message loss and violation of privacy. To overcome such issues, we propose a novel method of using secret sharing and replication techniques. This is to reliably and confidentially deliver decryption keys along with encrypted publications even under the presence of several Byzantine brokers across publish/subscribe overlay networks. We also propose a framework for dynamically and strategically allocating broker replicas based on flexibly definable criteria for reliability and performance. Moreover, a thorough evaluation is done through a case study on social networks using the real trace of interactions among Facebook users.	[Yoon, Young] Hongik Univ, Dept Comp Engn, Seoul, South Korea; [Kim, Beom Heyn] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	Hongik University; University of Toronto	Yoon, Y (corresponding author), Hongik Univ, Dept Comp Engn, Seoul, South Korea.	young.yoon@hongik.ac.kr			Hongik University	Hongik University	This work was supported by the Hongik University new faculty research support fund (http://www.hongik.ac.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon J., 2008, P 2 INT C DISTR EV B, P23, DOI DOI 10.1145/1385989.1385993; Carzaniga A, 2001, ACM T COMPUT SYST, V19, P332, DOI 10.1145/380749.380767; Corsaro A, 2010, DATA DISTRIBUTION SE; Cully B., 2008, P NSDI, P161; Eugster PT, 2003, ACM COMPUT SURV, V35, P114, DOI 10.1145/857076.857078; Fawcett T., 1999, P 5 ACM SIGKDD INT C, P53, DOI [10.1145/312129.312195, DOI 10.1016/J.EC0LENG.2010.11.031]; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Ion M, 2012, COMPUT NETW, V56, P2014, DOI 10.1016/j.comnet.2012.02.013; Jacobsen H.-A., 2010, PRINCIPLES APPL DIST, P164; Jokela P, 2009, ACM SIGCOMM COMP COM, V39, P195, DOI 10.1145/1594977.1592592; Kazemzadeh RS, 2009, SYM REL DIST SYST, P41, DOI 10.1109/SRDS.2009.32; Koenig I., 2007, GARTN EV PROC SUMM; Lagar-Cavilla HA, 2009, EUROSYS'09: PROCEEDINGS OF THE FOURTH EUROSYS CONFERENCE, P1; Lazowska E., 1984, QUANTITATIVE SYSTEM; Li SYR, 2003, IEEE T INFORM THEORY, V49, P371, DOI 10.1109/TIT.2002.807285; Minami Kazuhiro, 2008, P 7 ACM WORKSH PRIV, P95, DOI DOI 10.1145/1456403.1456419; Ming Li, 2011, Proceedings of the 25th IEEE International Parallel & Distributed Processing Symposium (IPDPS 2011), P1254, DOI 10.1109/IPDPS.2011.119; Muhl G, 2005, LECT NOTES COMPUT SC, V3648, P664; Nabeel M., 2012, P 17 ACM S ACC CONR, P133, DOI DOI 10.1145/2295136.2295164; Popa RA, 2011, SOSP 11: PROCEEDINGS OF THE TWENTY-THIRD ACM SYMPOSIUM ON OPERATING SYSTEMS PRINCIPLES, P85; SHAMIR A, 1979, COMMUN ACM, V22, P612, DOI 10.1145/359168.359176; Srivatsa M, 2011, ACM T COMPUT SYST, V29, DOI 10.1145/2063509.2063510; Sunoh Choi, 2010, Database and Expert Systems Applications. Proceedings 21st International Conference, DEXA 2010, P368, DOI 10.1007/978-3-642-15364-8_32; Tock Y, 2005, HIERARCHICAL CLUSTER; Wilson C, 2009, EUROSYS'09: PROCEEDINGS OF THE FOURTH EUROSYS CONFERENCE, P205; Wun A., 2007, DEBS 07, P116, DOI DOI 10.1145/1266894.1266917; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Yoon Y, 2011, INT CON DISTR COMP S, P800, DOI 10.1109/ICDCS.2011.93	32	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158516	10.1371/journal.pone.0158516	http://dx.doi.org/10.1371/journal.pone.0158516			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367610	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900038
J	Smirnova, DS; Volodin, IA; Demina, TS; Volodina, EV				Smirnova, Darya S.; Volodin, Ilya A.; Demina, Tatyana S.; Volodina, Elena V.			Acoustic Structure and Contextual Use of Calls by Captive Male and Female Cheetahs (Acinonyx jubatus)	PLOS ONE			English	Article							AGE-CLASS DIFFERENCES; CAT FELIS-CATUS; ALARM CALLS; RED DEER; GAZELLA-SUBGUTTUROSA; VOCAL DEVELOPMENT; VOICE BREAKING; DOMESTIC CATS; ORAL CALLS; BODY-SIZE	The vocal repertoire of captive cheetahs (Acinonyx jubatus) and the specific role of meow vocalizations in communication of this species attract research interest about two dozen years. Here, we expand this research focus for the contextual use of call types, sex differences and individual differences at short and long terms. During 457 trials of acoustic recordings, we collected calls (n = 8120) and data on their contextual use for 13 adult cheetahs (6 males and 7 females) in four Russian zoos. The cheetah vocal repertoire comprised 7 call types produced in 8 behavioural contexts. Context-specific call types (chirr, growl, howl and hiss) were related to courting behaviour (chirr) or to aggressive behaviour (growl, howl and hiss). Other call types (chirp, purr and meow) were not context-specific. The values of acoustic variables differed between call types. The meow was the most often call type. Discriminant function analysis revealed a high potential of meows to encode individual identity and sex at short terms, however, the vocal individuality was unstable over years. We discuss the contextual use and acoustic variables of call types, the ratios of individual and sex differences in calls and the pathways of vocal ontogeny in the cheetah with relevant data on vocalization of other animals.	[Smirnova, Darya S.] Russian State Agrarian Univ, Moscow Timiryazev Agr Acad, Dept Anim Sci, Moscow, Russia; [Volodin, Ilya A.] Lomonosov Moscow State Univ, Fac Biol, Dept Vertebrate Zool, Moscow, Russia; [Volodin, Ilya A.; Demina, Tatyana S.; Volodina, Elena V.] Moscow Zoo, Sci Res Dept, Moscow, Russia	Russian State Agrarian University - Moscow Timiryazev Agricultural Academy; Lomonosov Moscow State University	Volodin, IA (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Dept Vertebrate Zool, Moscow, Russia.; Volodin, IA (corresponding author), Moscow Zoo, Sci Res Dept, Moscow, Russia.	volodinsvoc@gmail.com	Volodina, Elena V./Q-7903-2018; Volodin, Ilya/Q-7903-2018	Volodina, Elena V./0000-0001-9755-4576; Volodin, Ilya/0000-0001-6278-0354	Russian Science Foundation [14-14-00237]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation (http://www.rscf.ru/) funding to IAV, DSS and EVV, grant number 14-14-00237. This research received no additional funding from any public, commercial or not-for-profit sectors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 1969, THE SPOTTED SPHINX; Adamson J, 1972, PIPPAS CHALLENGE; Adret P, 2012, J ORNITHOL, V153, P535, DOI 10.1007/s10336-011-0774-2; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; Castro-Prieto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049129; Chabert T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15547; Charruau P, 2011, MOL ECOL, V20, P706, DOI 10.1111/j.1365-294X.2010.04986.x; Chulkina MM, 2006, ZOOL ZH, V85, P544; Darden SK, 2003, J MAMMAL, V84, P1417, DOI 10.1644/BEM-031; Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098; Efremova KO, 2016, J MORPHOL, V277, P826, DOI 10.1002/jmor.20538; Efremova KO, 2011, NATURWISSENSCHAFTEN, V98, P919, DOI 10.1007/s00114-011-0843-7; Eklund R., 2010, PROCEEDINGS FROM FON, P17; Eklund R., 2012, P FONETIK 2012, P37; Eklund R., 2012, P FONETIK 2012, P41; Ellis SLH, 2015, ANTHROZOOS, V28, P625, DOI 10.1080/08927936.2015.1070005; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Fichtel C, 2001, BEHAVIOUR, V138, P97, DOI 10.1163/15685390151067094; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Frey R, 2013, J MORPHOL, V274, P307, DOI 10.1002/jmor.20092; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; Garcia M, 2016, ETHOLOGY, V122, P329, DOI 10.1111/eth.12472; Gogoleva SS, 2008, BIOACOUSTICS, V18, P99, DOI 10.1080/09524622.2008.9753595; Hudson PE, 2012, J EXP BIOL, V215, P2425, DOI 10.1242/jeb.066720; Hudson PE, 2011, J ANAT, V218, P375, DOI 10.1111/j.1469-7580.2011.01344.x; Johnson S, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00357.1; Jorgensen DD, 1998, ETHOLOGY, V104, P729, DOI 10.1111/j.1439-0310.1998.tb00107.x; JURGENS U, 1979, BEHAVIOUR, V69, P89; Klenova AV, 2014, BIOACOUSTICS, V23, P247, DOI 10.1080/09524622.2014.900648; Klenova AV, 2012, ACTA ETHOL, V15, P141, DOI 10.1007/s10211-011-0120-y; Klenova AV, 2010, BEHAVIOUR, V147, P505, DOI 10.1163/000579509X12591315521811; Klenova AV, 2009, J ETHOL, V27, P401, DOI 10.1007/s10164-008-0133-9; Krengel A, 2015, CLIN VACCINE IMMUNOL, V22, P611, DOI 10.1128/CVI.00705-14; Leuchtenberger C, 2016, BIOACOUSTICS, V25, P279, DOI 10.1080/09524622.2016.1157704; Marker LL, 2003, J MAMMAL, V84, P840, DOI 10.1644/BRB-036; Matrosova VA, 2007, BEHAV ECOL SOCIOBIOL, V62, P181, DOI 10.1007/s00265-007-0452-9; Matrosova VA, 2011, NATURWISSENSCHAFTEN, V98, P181, DOI 10.1007/s00114-010-0757-9; Matrosova VA, 2010, NATURWISSENSCHAFTEN, V97, P707, DOI 10.1007/s00114-010-0686-7; Matrosova VA, 2010, J MAMMAL, V91, P620, DOI 10.1644/09-MAMM-A-143.1; Matrosova VA, 2009, J MAMMAL, V90, P158, DOI 10.1644/08-MAMM-A-032.1; McComb K, 2009, CURR BIOL, V19, pR507, DOI 10.1016/j.cub.2009.05.033; MEROLA M, 1994, CONSERV BIOL, V8, P961, DOI 10.1046/j.1523-1739.1994.08040961.x; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Mills MGL, 2014, J ZOOL, V292, P136, DOI 10.1111/jzo.12087; Moreno-Gomez FN, 2015, J ACOUST SOC AM, V138, P1614, DOI 10.1121/1.4929750; Nicastro N, 2004, J COMP PSYCHOL, V118, P287, DOI 10.1037/0735-7036.118.3.287; Nicastro N, 2003, J COMP PSYCHOL, V117, P44, DOI 10.1037/0735-7036.117.1.44; Patel R, 2010, ETHOLOGY, V116, P554, DOI 10.1111/j.1439-0310.2010.01769.x; Peters G, 2002, MAMMAL REV, V32, P245, DOI 10.1046/j.1365-2907.2002.00113.x; PETERS G, 1978, Z ZOOL SPIXIANA, V1, P1; Peters Gustav, 1999, Journal of Mammalian Evolution, V6, P129, DOI 10.1023/A:1020620121416; PONTIER D, 1995, OIKOS, V73, P299, DOI 10.2307/3545954; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; Riede T., 2013, NOVA ACTA LEOPOLDINA, V380, P295; Ruiz-Miranda CR, 1998, ZOO BIOL, V17, P1, DOI 10.1002/(SICI)1098-2361(1998)17:1<1::AID-ZOO1>3.0.CO;2-D; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Scantlebury DM, 2014, SCIENCE, V346, P79, DOI 10.1126/science.1256424; Schassburger R.M., 1987, MAN WOLF ADV ISSUES, P313; Scheumann M, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-36; Schneiderova I, 2015, ZOO BIOL, V34, P503, DOI 10.1002/zoo.21233; Schneiderova I, 2014, ACTA THERIOL, V59, P149, DOI 10.1007/s13364-013-0141-1; Sibiryakova OV, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-014-0094-5; SISSOM DEF, 1991, J ZOOL, V223, P67, DOI 10.1111/j.1469-7998.1991.tb04749.x; Smirnova D.S., 2015, Nauchnye Issledovaniya v Zoologicheskikh Parkakh, V31, P104; SOLOW AR, 1990, ECOLOGY, V71, P2379, DOI 10.2307/1938650; Swan DC, 2008, J MAMMAL, V89, P889, DOI 10.1644/07-MAMM-A-228.1; Swanson A, 2014, J ANIM ECOL, V83, P1418, DOI 10.1111/1365-2656.12231; Titze IR, 1994, PRINCIPLES VOICE PRO; Voigt CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101917; Volodin IA, 2009, ZH OBSHCH BIOL, V70, P210; VOLODIN IA, 2008, CASARCA B GOOSE SWAN, V11, P22; Volodin IA, 2001, ENTOMOL REV, V81, pS346; Volodin IA, 2016, MAMM BIOL, V81, P10, DOI 10.1016/j.mambio.2015.09.002; Volodin IA, 2015, ACTA ETHOL, V18, P19, DOI 10.1007/s10211-013-0179-8; Volodin IA, 2015, ETHOLOGY, V121, P103, DOI 10.1111/eth.12321; Volodin IA, 2011, ETHOLOGY, V117, P294, DOI 10.1111/j.1439-0310.2011.01874.x; Volodina E. V., 2006, Razprave - Razred za Naravoslovne Vede, Slovenska Akademija Znanosti in Umetnosti, V47, P257; Volodina E.V., 1997, SCI RESEARCHES ZOOS, V8, P149; Volodina E.V., 1998, SCI RESEARCHES ZOOS, V10, P143; Volodina E.V., 1996, SCI RESEARCHES ZOOS, V6, P142; Volodina E. V., 2000, ENTOMOLOGICAL REV S2, V80, pS368; Volodina EV, 2010, BIOACOUSTICS, V20, P87; Volodina EV, 1994, SCI RES ZOOS, V4, P70; Volodina EV, 1994, SCI RES ZOOS, V4, P92; Weissengruber GE, 2002, J ANAT, V201, P195, DOI 10.1046/j.1469-7580.2002.00088.x; Welch RJ, 2015, J ARID ENVIRON, V114, P91, DOI 10.1016/j.jaridenv.2014.11.012; Wielebnowski N, 1998, ZOO BIOL, V17, P193, DOI 10.1002/(SICI)1098-2361(1998)17:3<193::AID-ZOO4>3.0.CO;2-4; Wilden I., 1998, Bioacoustics, V9, P171; WILDT DE, 1993, ZOO BIOL, V12, P45, DOI 10.1002/zoo.1430120107; Yeon SC, 2011, BEHAV PROCESS, V87, P183, DOI 10.1016/j.beproc.2011.03.003; Yin S, 2002, J COMP PSYCHOL, V116, P189, DOI 10.1037//0735-7036.116.2.189; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016; Zaytseva AS, 2015, BEHAV PROCESS, V118, P130, DOI 10.1016/j.beproc.2015.06.012	97	15	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158546	10.1371/journal.pone.0158546	http://dx.doi.org/10.1371/journal.pone.0158546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362643	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200087
J	Diop, A; Sambe-Ba, B; Seck, A; Dia, ML; Timbine, LG; Niang, AA; Ndiaye, EM; Sonko, MA; Wane, AA; Bercion, R; Ndiaye, O; Cisse, MF; Gassama-Sow, A				Diop, Amadou; Sambe-Ba, Bissoume; Seck, Abdoulaye; Dia, Mouhamadou Lamine; Timbine, Lassina Gadi; Niang, Aissatou Ameth; Ndiaye, El Hadji Momar; Sonko, Mouhamadou Abdoulaye; Wane, Abdoul Aziz; Bercion, Raymond; Ndiaye, Ousmane; Cisse, Moussa Fafa; Gassama-Sow, Amy			First Description of the Extended Spectrum-Beta-Lactamase Gene bla(CTX-M-109) in Salmonella Grumpensis Strains Isolated from Neonatal Nosocomial Infections in Dakar, Senegal	PLOS ONE			English	Article							ESCHERICHIA-COLI; CTX-M; RESISTANCE; OUTBREAK; EPIDEMIOLOGY; INTEGRONS; SHIGELLA; TANZANIA	Nosocomial infections are very common in African hospitals, particularly in neonatal units. These infections are most often caused by bacteria such as Escherichia coli, Klebsiella spp and Staphylococcus spp. Salmonella strains are rarely involved in nosocomial infections. Here, we report the first description of S. Grumpensis in neonatal infections in Senegal. Seventeen Salmonella strains were isolated from hospitalized infants' stool samples. The following resistance phenotype was described in strains: AMX(R)TIC(R)CF(R)FOX(R)CFX(R)CTX(R-)CAZ(R)IMP(S)ATM(R)NA(R)NOR(R)CIP(R)TM(R)GM(R)TE(R)SXT(R). All isolates were susceptible to imipenem, 15 out of 17 produced an extended spectrum beta-lactamase (ESBL). bla(OXA-1), bla(SHV-1), bla(TEM-1), bla(CTX-M1) genes were detected in strains 8, 13, 5 and 8, respectively. blaCTX-M1 sequencing revealed the presence of blaCTX-M-109. Thirteen of the 17 Salmonella Grumpensis strains were analyzed by PFGE. These 13 isolates belonged to a single pulsotype and were genotypically identical. This is the first report of neonatal S. Grumpensis infections in Senegal, and the first report of blaCTX-M-109 in the genus Salmonella.	[Diop, Amadou; Sambe-Ba, Bissoume; Timbine, Lassina Gadi; Niang, Aissatou Ameth; Wane, Abdoul Aziz; Gassama-Sow, Amy] Inst Pasteur, UBE, Dakar, Senegal; [Seck, Abdoulaye; Bercion, Raymond] Inst Pasteur, LABM, Dakar, Senegal; [Dia, Mouhamadou Lamine] Virol Ctr Hosp Natl FANN, Lab Bacteriol, Dakar, Senegal; [Diop, Amadou; Ndiaye, El Hadji Momar; Sonko, Mouhamadou Abdoulaye; Cisse, Moussa Fafa] Virol Ctr Hosp Natl Enfants Albert Royer Fann Dak, Lab Bacteriol, Dakar, Senegal; [Ndiaye, Ousmane] Ctr Hosp Abass Ndao, Unite Neonatol, Dakar, Senegal; [Diop, Amadou; Seck, Abdoulaye; Dia, Mouhamadou Lamine; Ndiaye, Ousmane; Cisse, Moussa Fafa] Pharm & Odontol Univ Cheikh Anta Diop Dakar, Fac Med, Dakar, Senegal; [Gassama-Sow, Amy] Univ Cheikh Anta Diop Dakar, Ecole Super Polytech, Dept Genie Chim & Biol Appl, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar	Gassama-Sow, A (corresponding author), Univ Cheikh Anta Diop Dakar, Ecole Super Polytech, Dept Genie Chim & Biol Appl, Dakar, Senegal.	gassama@pasteur.sn			Institut Pasteur de Dakar	Institut Pasteur de Dakar	We are very grateful to Institut Pasteur de Dakar for his support	Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Cabrera R, 2004, ANTIMICROB AGENTS CH, V48, P3934, DOI 10.1128/AAC.48.10.3934-3939.2004; Cavallo JD, 2010, COMITE ANTIBIOGRAMME; Danzmann L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-98; Denno DM, 2012, CID, V55, P97; Di Conza JA, 2005, ANTIMICROB AGENTS CH, V49, P3014, DOI 10.1128/AAC.49.7.3014-3017.2005; Garnier F, 2006, ANTIMICROB AGENTS CH, V50, P3200, DOI 10.1128/AAC.00293-06; Gassama-Sow A, 2010, J INFECT DEV COUNTR, V4, P207, DOI 10.3855/jidc.583; Hartman AB, 2003, J CLIN MICROBIOL, V41, P1023, DOI 10.1128/JCM.41.3.1023-1032.2003; Inweregbu K, 2005, CRITICAL CARE PAIN, V5, DOI [10.1093/bjaceaccp/mki006, DOI 10.1093/BJACEACCP/MKI006]; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; Kim J, 2005, AGENTS CHEMOTHER, V49, P572; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Livermore DM, 2005, J ANTIMICROB CHEMOTH, V56, P451, DOI 10.1093/jac/dki239; Mendonca N, 2007, ANTIMICROB AGENTS CH, V51, P1946, DOI 10.1128/AAC.01412-06; Ndugulile F, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-86; Olmsted R. N., 1996, APIC INFECT CONTROL, pA1; Ploy MC, 2000, ANTIMICROB AGENTS CH, V44, P2684, DOI 10.1128/AAC.44.10.2684-2688.2000; Popoff M.Y., 2001, ANTIGENIC FORMULAS S, V8th ed.; PRINCEDAVID M, 1987, MED MALADIES INFECT, V17, P124, DOI 10.1016/S0399-077X(87)80343-8; Ramdani-Bouguessa N, 2006, J CLIN MICROBIOL, V44, P4584, DOI 10.1128/JCM.01445-06; Sambe-Ba B, 2013, J GLOB ANTIMICROB RE, V1, P231, DOI 10.1016/j.jgar.2013.06.004; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shin JH, 2008, MICROB DRUG RESIST, V14, P221, DOI 10.1089/mdr.2008.0834; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17; Sow AG, 2007, J INFECT DEV COUNTR, V1, P284; Su LH, 2004, CLIN INFECT DIS, V39, P546, DOI 10.1086/422726; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Tatsuya A, 2012, J ANTIMICROB CHEMOTH, V67, P101, DOI [10.1093/jac/dkr414, DOI 10.1093/JAC/DKR414]; THONG KL, 1995, J CLIN MICROBIOL, V33, P1938, DOI 10.1128/JCM.33.7.1938-1941.1995; Uwaezuoke SN, 2013, NIGERIAN J PAEDIAT, V40, P125; Vaagland H, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-35; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Weill FX, 2006, J CLIN MICROBIOL, V44, P700, DOI 10.1128/JCM.44.3.700-708.2006; Weill FX, 2004, FEMS MICROBIOL LETT, V238, P353, DOI 10.1016/j.femsle.2004.07.058; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; Zhao WH, 2013, CRIT REV MICROBIOL, V39, P79, DOI 10.3109/1040841X.2012.691460	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157683	10.1371/journal.pone.0157683	http://dx.doi.org/10.1371/journal.pone.0157683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355480	Green Submitted, gold, Green Published			2022-12-27	WOS:000378859400016
J	Morales, I; Cooper, J; Amador, JA; Boving, TB				Morales, Ivan; Cooper, Jennifer; Amador, Jose A.; Boving, Thomas B.			Modeling Nitrogen Losses in Conventional and Advanced Soil-Based Onsite Wastewater Treatment Systems under Current and Changing Climate Conditions	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY; TRANSPORT; RATES	Most of the non-point source nitrogen (N) load in rural areas is attributed to onsite wastewater treatment systems (OWTS). Nitrogen compounds cause eutrophication, depleting the oxygen in marine ecosystems. OWTS rely on physical, chemical and biological soil processes to treat wastewater and these processes may be affected by climate change. We simulated the fate and transport of N in different types of OWTS drainfields, or soil treatment areas (STA) under current and changing climate scenarios, using 2D/3D HYDRUS software. Experimental data from a mesocosm-scale study, including soil moisture content, and total N, ammonium (NH4+) and nitrate (NO3-) concentrations, were used to calibrate the model. A water content-dependent function was used to compute the nitrification and denitrification rates. Three types of drainfields were simulated: (1) a pipe-and-stone (P&S), (2) advanced soil drainfields, pressurized shallow narrow drainfield (PSND) and (3) Geomat (GEO), a variation of SND. The model was calibrated with acceptable goodness-of-fit between the observed and measured values. Average root mean square error (RSME) ranged from 0.18 and 2.88 mg L-1 for NH4+ and 4.45 mg L-1 to 9.65 mg L-1 for NO3- in all drainfield types. The calibrated model was used to estimate N fluxes for both conventional and advanced STAs under current and changing climate conditions, i.e. increased soil temperature and higher water table. The model computed N losses from nitrification and denitrification differed little from measured losses in all STAs. The modeled N losses occurred mostly as NO3- in water outputs, accounting for more than 82% of N inputs in all drainfields. Losses as N-2 were estimated to be 10.4% and 9.7% of total N input concentration for SND and Geo, respectively. The highest N-2 losses, 17.6%, were estimated for P&S. Losses as N-2 increased to 22%, 37% and 21% under changing climate conditions for Geo, PSND and P&S, respectively. These findings can provide practitioners with guidelines to estimate N removal efficiencies for traditional and advanced OWTS, and predict N loads and spatial distribution for identifying non-point sources. Our results show that N losses on OWTS can be modeled successfully using HYDRUS. Furthermore, the results suggest that climate change may increase the removal of N as N-2 in the drainfield, with the magnitude of the effect depending on a drainfield type.	[Morales, Ivan; Boving, Thomas B.] Univ Rhode Isl, Dept Civil & Environm Engn, Kingston, RI 02881 USA; [Cooper, Jennifer; Amador, Jose A.] Univ Rhode Isl, Lab Soil Ecol & Microbiol, Kingston, RI 02881 USA; [Boving, Thomas B.] Univ Rhode Isl, Dept Geosci, Kingston, RI 02881 USA	University of Rhode Island; University of Rhode Island; University of Rhode Island	Boving, TB (corresponding author), Univ Rhode Isl, Dept Civil & Environm Engn, Kingston, RI 02881 USA.; Boving, TB (corresponding author), Univ Rhode Isl, Dept Geosci, Kingston, RI 02881 USA.	boving@uri.edu	Boving, Thomas/X-7438-2019		U.S. Department of Agriculture - Multistate Project [NE 1045]	U.S. Department of Agriculture - Multistate Project	Funded by U.S. Department of Agriculture - Multistate Project (NE 1045). http://www.nrcs.usda.gov/wps/portal/nrcs/detail/ne/programs/farmbill/?cid=stelprdb1242732.	Anderson D. L., 1994, P 7 INT S IND SMALL, P209; Beach D. N, 2001, THESIS; Beal CD, 2005, AUST J SOIL RES, V43, P781, DOI 10.1071/SR05018; Beggs R.A., 2004, 10 NAT S IND SMALL C; Birkham TK, 2007, VADOSE ZONE J, V6, P67, DOI 10.2136/vzj2006.0005; Bollmann A, 1997, SOIL BIOL BIOCHEM, V29, P1067, DOI 10.1016/S0038-0717(97)00007-2; Bradshaw JK, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0150; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Breve MA, 1994, THESIS; Brooks R.H., 1966, J IRR DRAIN DIV-ASCE, V92, P61, DOI [DOI 10.1061/JRCEA4.0000425, 10.1061/JRCEA4.0000425]; Burks D.B., 1994, ONSITE WASTEWATER TR; Carlile BL, 1980, P 6 NAT C IND ONS WA, P371; Cooper JA, 2015, J ENV QUAL; Cote CM, 2003, IRRIGATION SCI, V22, P143, DOI 10.1007/s00271-003-0080-8; Curds C.R., 1983, ECOLOGICAL ASPECTS U, V2; Doran JW, 1988, TILLAGE TRAFFIC CROP, P49; Fischer E., 1999, THESIS; GELHAR LW, 1992, WATER RESOUR RES, V28, P1955, DOI 10.1029/92WR00607; Geza M, 2014, ENVIRON MODEL ASSESS, V19, P243, DOI 10.1007/s10666-013-9392-0; GIBLIN AE, 1990, BIOGEOCHEMISTRY, V10, P309; Gill LW, 2007, J ENVIRON QUAL, V36, P1843, DOI 10.2134/jeq2007.0064; Gill LW, 2009, WATER RES, V43, P2739, DOI 10.1016/j.watres.2009.03.024; Grady CP., 2011, BIOL WASTEWATER TREA; GRANT RF, 1995, SOIL BIOL BIOCHEM, V27, P1117, DOI 10.1016/0038-0717(95)00038-G; Harden HS, 2008, WATER RES, V42, P2585, DOI 10.1016/j.watres.2008.01.008; Hargett D. L., 1985, On-site waste water treatment., P131; Hassan G, 2008, MODELING EFFLUENT DI, P1937; Heatwole KK, 2007, J CONTAM HYDROL, V91, P184, DOI 10.1016/j.jconhyd.2006.08.012; Holden S.A., 2004, ON SITE WASTEWATER T, P432; Holden SA, 2004, EFFECTIVENESS SHALLO; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; Loomis GW, 2001, ON-SITE WASTEWATER TREATMENT, PROCEEDINGS, P506; MALHI SS, 1982, SOIL BIOL BIOCHEM, V14, P393, DOI 10.1016/0038-0717(82)90011-6; McCray J., 2010, QUANTITATIVE TOOLS D; McCray JE, 2005, GROUND WATER, V43, P628, DOI 10.1111/j.1745-6584.2005.0077.x; MILLINGTON R. J., 1960, Transactions 7th int. Congr. Soil Sci., V1, P97; Morales I, 2014, WATER-SUI, V6, P818, DOI 10.3390/w6040818; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Poeter EP, 1999, COMPUT GEOSCI, V25, P457, DOI 10.1016/S0098-3004(98)00149-6; POWELSON DK, 1994, WATER RES, V28, P2175, DOI 10.1016/0043-1354(94)90029-9; PROSSER JI, 1990, ADV MICROB ECOL, V11, P263; Radcliffe DE, 2014, MODEL TEST PROPOSED, P97; RENEAU RB, 1989, J ENVIRON QUAL, V18, P135, DOI 10.2134/jeq1989.00472425001800020001x; Schaap MG, 2001, J HYDROL, V251, P163, DOI 10.1016/S0022-1694(01)00466-8; SELIM HM, 1987, SOIL SCI SOC AM J, V51, P876, DOI 10.2136/sssaj1987.03615995005100040007x; Siegrist R.L., 2001, NAT RES NEEDS C RISK; SIMUNEK J, 1995, WATER POLLUTION III, P21; SimUnek J., 2012, TECHNICAL MANUAL; Simunek J, 2008, VADOSE ZONE J, V7, P587, DOI 10.2136/vzj2007.0077; Standley L., 2008, WASTEWATER CONTAMINA; Stevik TK, 2004, WATER RES, V38, P1355, DOI 10.1016/j.watres.2003.12.024; STEWART LW, 1988, J ENVIRON QUAL, V17, P499, DOI 10.2134/jeq1988.00472425001700030026x; Swartz CH, 2006, ENVIRON SCI TECHNOL, V40, P4894, DOI 10.1021/es052595+; Tchobanoglous G., 2003, WASTEWATER ENG TREAT, V4th; Tucholke M. B., 2007, NAT ONS WAST REC ASS; Tyler E.J., 1977, P 2 NAT HOM SEW TREA, P5; Tyler K, 1960, SOIL SCI SOC AM; U. S. EPA, 2015, WAT ASS TRACK ENV RE; U.S. EPA (United States Environmental Protection Agency), 2006, WAD STREAMS ASS COLL; Valiela I, 2002, APPL GEOCHEM, V17, P935, DOI 10.1016/S0883-2927(02)00073-2; Vanderborght J, 2007, VADOSE ZONE J, V6, P29, DOI 10.2136/vzj2006.0096; VANGENUCHTEN MT, 1989, SOIL SCI SOC AM J, V53, P1303, DOI 10.2136/sssaj1989.03615995005300050001x; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Weast R, 1985, CRC HDB CHEM PHYS RE; Youssef MA, 2005, T ASAE, V48, P611, DOI 10.13031/2013.18335	66	13	13	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158292	10.1371/journal.pone.0158292	http://dx.doi.org/10.1371/journal.pone.0158292			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355369	gold, Green Submitted, Green Published			2022-12-27	WOS:000378859400045
J	Okumura, N; Kakutani, K; Inoue, R; Matsumoto, D; Shimada, T; Nakahara, M; Kiyanagi, Y; Itoh, T; Koizumi, N				Okumura, Naoki; Kakutani, Kazuya; Inoue, Ryota; Matsumoto, Daiki; Shimada, Tomoki; Nakahara, Makiko; Kiyanagi, Yumiko; Itoh, Takehiro; Koizumi, Noriko			Generation and Feasibility Assessment of a New Vehicle for Cell-Based Therapy for Treating Corneal Endothelial Dysfunction	PLOS ONE			English	Article							INTRAOCULAR IRRIGATING SOLUTIONS; PROLIFERATIVE CAPACITY; ROCK INHIBITOR; IN-VITRO; TRANSPLANTATION; KERATOPLASTY; MEMBRANE; CULTURE; EXPANSION; SURVIVAL	The corneal endothelium maintains corneal transparency by its pump and barrier functions; consequently, its decompensation due to any pathological reason causes severe vision loss due to corneal haziness. Corneal transplantation is the only therapeutic choice for treating corneal endothelial dysfunction, but associated problems, such as a shortages of donor corneas, the difficulty of the surgical procedure, and graft failure, still need to be resolved. Regenerative medicine is attractive to researchers as a means of providing innovative therapies for corneal endothelial dysfunction, as it now does for other diseases. We previously demonstrated the successful regeneration of corneal endothelium in animal models by injecting cultured corneal endothelial cells (CECs) in combination with a Rho kinase (ROCK) inhibitor. The purpose of the present study was to optimize the vehicle for clinical use in cell-based therapy. Our screening of cell culture media revealed that RELAR medium promoted CEC adhesion. We then modified RELAR medium by removing hormones, growth factors, and potentially toxic materials to generate a cell therapy vehicle (CTV) composed of amino acid, salts, glucose, and vitamins. Injection of CECs in CTV enabled efficient engraftment and regeneration of the corneal endothelium in the rabbit corneal endothelial dysfunction model, with restoration of a transparent cornea. The CECs retained > 85% viability after a 24 hour preservation as a cell suspension in CTV at 4 degrees C and maintained their potency to regenerate the corneal endothelium in vivo. The vehicle developed here is clinically applicable for cell-based therapy aimed at treating the corneal endothelium. Our strategy involves the generation of vehicle from a culture medium appropriate for a given cell type by removing materials that are not favorable for clinical use.	[Okumura, Naoki; Kakutani, Kazuya; Inoue, Ryota; Matsumoto, Daiki; Shimada, Tomoki; Nakahara, Makiko; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Kiyanagi, Yumiko; Itoh, Takehiro] Cell Sci & Technol Inst Inc, Sendai, Miyagi, Japan	Doshisha University	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Program for the Strategic Research Foundation at Private Universities from Ministry of Education, Culture, Sports, Science and Technology http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm.	ARAIE M, 1990, ARCH OPHTHALMOL-CHIC, V108, P882, DOI 10.1001/archopht.1990.01070080126049; ARAIE M, 1988, INVEST OPHTH VIS SCI, V29, P1884; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Broggi A, 2015, MOL IMMUNOL, V63, P127, DOI 10.1016/j.molimm.2014.06.037; EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432; ENGELMANN K, 1989, IN VITRO CELL DEV B, V25, P1065; ENGELMANN K, 1995, CORNEA, V14, P62; Eye Bank Association of America, 2013, EYE BANKING STATISTI; GLASSER DB, 1985, AM J OPHTHALMOL, V99, P321, DOI 10.1016/0002-9394(85)90363-0; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kang R, 2014, MOL MED, V20, P466, DOI 10.2119/molmed.2014.00117; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Kruse FE, 2014, CURR OPIN OPHTHALMOL, V25, P325, DOI 10.1097/ICU.0000000000000072; LAND W, 1994, TRANSPLANTATION, V57, P211, DOI 10.1097/00007890-199401001-00010; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Nakahara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069009; Okumura N, 2015, INVEST OPHTH VIS SCI, V56, P2933, DOI 10.1167/iovs.14-15163; Okumura N, 2014, CORNEA, V33, pS37, DOI 10.1097/ICO.0000000000000229; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Patel SV, 2012, EXP EYE RES, V95, P40, DOI 10.1016/j.exer.2011.05.013; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Price MO, 2013, CURR OPIN OPHTHALMOL, V24, P329, DOI 10.1097/ICU.0b013e32836229ab; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Shima N, 2011, INVEST OPHTH VIS SCI, V52, P8711, DOI 10.1167/iovs.11-7592; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Turner N.A., 2015, J MOL CELL CARDIOL; Veldman PB, 2014, CURR OPIN OPHTHALMOL, V25, P306, DOI 10.1097/ICU.0000000000000073; YAMANE I, 1981, EXP CELL RES, V134, P470, DOI 10.1016/0014-4827(81)90448-1; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158427	10.1371/journal.pone.0158427	http://dx.doi.org/10.1371/journal.pone.0158427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355373	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400064
J	Tan, MSF; White, AP; Rahman, S; Dykes, GA				Tan, Michelle S. F.; White, Aaron P.; Rahman, Sadequr; Dykes, Gary A.			Role of Fimbriae, Flagella and Cellulose on the Attachment of Salmonella Typhimurium ATCC 14028 to Plant Cell Wall Models	PLOS ONE			English	Article							O-ANTIGEN CAPSULE; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI O157-H7; BIOFILM FORMATION; LISTERIA-MONOCYTOGENES; GENETIC-ANALYSIS; RDAR MORPHOTYPE; HUMAN PATHOGENS; COLONIZATION; VEGETABLES	Cases of foodborne disease caused by Salmonella are frequently associated with the consumption of minimally processed produce. Bacterial cell surface components are known to be important for the attachment of bacterial pathogens to fresh produce. The role of these extracellular structures in Salmonella attachment to plant cell walls has not been investigated in detail. We investigated the role of flagella, fimbriae and cellulose on the attachment of Salmonella Typhimurium ATCC 14028 and a range of isogenic deletion mutants (Delta fliC fljB, Delta bcsA, Delta csgA, Delta csgA bcsA and Delta csgD) to bacterial cellulose (BC)-based plant cell wall models [BC-Pectin (BCP), BC-Xyloglucan (BCX) and BC-Pectin-Xyloglucan (BCPX)] after growth at different temperatures (28 degrees C and 37 degrees C). We found that all three cell surface components were produced at 28 degrees C but only the flagella was produced at 37 degrees C. Flagella appeared to be most important for attachment (reduction of up to 1.5 log CFU/cm(2)) although both cellulose and fimbriae also aided in attachment. The csgD deletion mutant, which lacks both cellulose and fimbriae, showed significantly higher attachment as compared to wild type cells at 37 degrees C. This may be due to the increased expression of flagella-related genes which are also indirectly regulated by the csgD gene. Our study suggests that bacterial attachment to plant cell walls is a complex process involving many factors. Although flagella, cellulose and fimbriae all aid in attachment, these structures are not the only mechanism as no strain was completely defective in its attachment.	[Tan, Michelle S. F.; Rahman, Sadequr] Monash Univ, Sch Sci, Bandar Sunway, Selangor, Malaysia; [White, Aaron P.] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Dykes, Gary A.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia	Monash University; Monash University Sunway; University of Saskatchewan; Curtin University	Dykes, GA (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA, Australia.	gary.dykes@curtin.edu.au		Dykes, Gary/0000-0001-5014-9282				Aruscavage D, 2006, J FOOD SCI, V71, pR89, DOI 10.1111/j.1750-3841.2006.00157.x; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Barak JD, 2012, ANNU REV PHYTOPATHOL, V50, P241, DOI 10.1146/annurev-phyto-081211-172936; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Bordas MA, 1996, APPL ENVIRON MICROB, V62, P3650, DOI 10.1128/AEM.62.10.3650-3654.1996; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Cevallos-Cevallos JM, 2012, INT J FOOD MICROBIOL, V160, P58, DOI 10.1016/j.ijfoodmicro.2012.09.021; Chanliaud E, 1999, PLANT J, V20, P25, DOI 10.1046/j.1365-313X.1999.00571.x; Charkowski AO, 2002, APPL ENVIRON MICROB, V68, P3114, DOI 10.1128/AEM.68.6.3114-3120.2002; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Cybulska J, 2010, INT AGROPHYS, V24, P107; Cybulska J, 2010, J FOOD ENG, V96, P287, DOI 10.1016/j.jfoodeng.2009.08.001; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gu GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027340; Heaton JC, 2008, J APPL MICROBIOL, V104, P613, DOI 10.1111/j.1365-2672.2007.03587.x; HERMAN KM, 2008, INT C EM INF DIS ATL; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x; Huang SW., 2004, WRS0406 USDA EC RES, P3; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Jacxsens L, 2010, FOOD RES INT, V43, P1925, DOI 10.1016/j.foodres.2009.07.009; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; KODAKA H, 1982, J CLIN MICROBIOL, V16, P948, DOI 10.1128/JCM.16.5.948-952.1982; Kroupitski Y, 2009, J APPL MICROBIOL, V106, P1876, DOI 10.1111/j.1365-2672.2009.04152.x; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Krtinic G, 2010, EUR J CLIN MICROBIOL, V29, P1321, DOI 10.1007/s10096-010-1001-4; Lapidot A, 2009, J FOOD PROTECT, V72, P618, DOI 10.4315/0362-028X-72.3.618; Lu L, 2001, AM J CLIN NUTR, V73, p1124S; MacKenzie KD, 2015, INFECT IMMUN, V83, P2312, DOI 10.1128/IAI.00137-15; Marshall JM, 2015, INFECT IMMUN, V83, P3946, DOI 10.1128/IAI.00634-15; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mika F, 2013, INT J MOL SCI, V14, P4560, DOI 10.3390/ijms14034560; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Ogasawara H, 2011, J BACTERIOL, V193, P2587, DOI 10.1128/JB.01468-10; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Reina LD, 2002, J FOOD PROTECT, V65, P1881, DOI 10.4315/0362-028X-65.12.1881; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 1998, J BACTERIOL, V180, P722; Saggers EJ, 2008, J APPL MICROBIOL, V105, P1239, DOI 10.1111/j.1365-2672.2008.03795.x; Shaw RK, 2011, ENV MICROBIOL REP, V3, P569, DOI 10.1111/j.1758-2229.2011.00263.x; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solomon EB, 2005, J FOOD PROTECT, V68, P906, DOI 10.4315/0362-028X-68.5.906; Takeuchi K, 2000, J FOOD PROTECT, V63, P1433, DOI 10.4315/0362-028X-63.10.1433; Tan MSF, 2016, APPL ENVIRON MICROB, V82, P680, DOI 10.1128/AEM.02609-15; Tan MSF, 2013, FOODBORNE PATHOG DIS, V10, P992, DOI 10.1089/fpd.2013.1536; Tan MSF, 2016, FOOD CONTROL, V67, P119, DOI 10.1016/j.foodcont.2016.02.039; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; Tyler HL, 2008, ANNU REV PHYTOPATHOL, V46, P53, DOI 10.1146/annurev.phyto.011708.103102; Viazis S, 2011, FOOD MICROBIOL, V28, P149, DOI 10.1016/j.fm.2010.09.009; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Warriner K, 2010, CURR OPIN BIOTECH, V21, P131, DOI 10.1016/j.copbio.2010.01.004; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; White AP, 2007, CAN J MICROBIOL, V53, P56, DOI 10.1139/W06-102; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Whitney SEC, 1999, PLANT PHYSIOL, V121, P657, DOI 10.1104/pp.121.2.657; Wiedemann A, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00791; Yaron S, 2014, MICROB BIOTECHNOL, V7, P496, DOI 10.1111/1751-7915.12186; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x; Zorraquino V, 2013, J BACTERIOL, V195, P417, DOI 10.1128/JB.01789-12	65	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158311	10.1371/journal.pone.0158311	http://dx.doi.org/10.1371/journal.pone.0158311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355584	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400048
J	Teng, YL; Chen, CL; Lou, SZ; Wang, WT; Wu, JY; Ma, HI; Chen, VCH				Teng, Ya-Ling; Chen, Chiung-Ling; Lou, Shu-Zon; Wang, Wei-Tsan; Wu, Jui-Yen; Ma, Hui-Ing; Chen, Vincent Chin-Hung			Postural Stability of Patients with Schizophrenia during Challenging Sensory Conditions: Implication of Sensory Integration for Postural Control	PLOS ONE			English	Article							NEUROLOGICAL SOFT SIGNS; MOVEMENT-DISORDERS; COGNITIVE FUNCTIONS; VISUAL INFORMATION; BALANCE CONTROL; DYSFUNCTION; CEREBELLAR; SWAY; ABNORMALITIES; SENSITIVITY	Postural dysfunctions are prevalent in patients with schizophrenia and affect their daily life and ability to work. In addition, sensory functions and sensory integration that are crucial for postural control are also compromised. This study intended to examine how patients with schizophrenia coordinate multiple sensory systems to maintain postural stability in dynamic sensory conditions. Twenty-nine patients with schizophrenia and 32 control subjects were recruited. Postural stability of the participants was examined in six sensory conditions of different level of congruency of multiple sensory information, which was based on combinations of correct, removed, or conflicting sensory inputs from visual, somatosensory, and vestibular systems. The excursion of the center of pressure was measured by posturography. Equilibrium scores were derived to indicate the range of anterior-posterior (AP) postural sway, and sensory ratios were calculated to explore ability to use sensory information to maintain balance. The overall AP postural sway was significantly larger for patients with schizophrenia compared to the controls [patients (69.62 +/- 8.99); controls (76.53 +/- 7.47); t(1,59) = -3.28, p<0.001]. The results of mixed-model ANOVAs showed a significant interaction between the group and sensory conditions [F-5,F-295 = 5.55, p<0.001]. Further analysis indicated that AP postural sway was significantly larger for patients compared to the controls in conditions containing unreliable somatosensory information either with visual deprivation or with conflicting visual information. Sensory ratios were not significantly different between groups, although small and non-significant difference in inefficiency to utilize vestibular information was also noted. No significant correlations were found between postural stability and clinical characteristics. To sum up, patients with schizophrenia showed increased postural sway and a higher rate of falls during challenging sensory conditions, which was independent of clinical characteristics. Patients further demonstrated similar pattern and level of utilizing sensory information to maintain balance compared to the controls.	[Teng, Ya-Ling; Ma, Hui-Ing] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan; [Teng, Ya-Ling; Chen, Chiung-Ling; Lou, Shu-Zon] Chung Shan Med Univ, Dept Occupat Therapy, Coll Med Sci & Technol, Taichung, Taiwan; [Teng, Ya-Ling; Chen, Chiung-Ling] Chung Shan Med Univ Hosp, Occupat Therapy Room, Taichung, Taiwan; [Wang, Wei-Tsan] Cen Der Hosp, Dept Psychiat, Taichung, Taiwan; [Wu, Jui-Yen] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Ma, Hui-Ing] Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan; [Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Chiayi, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Sch Med, Taoyuan, Taiwan	National Cheng Kung University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Ma, HI (corresponding author), Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan.; Ma, HI (corresponding author), Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan.	huingma@mail.ncku.edu.tw		Teng, Ya-Ling/0000-0002-8496-3861				Ahlgren-Rimpilainen A, 2010, J NERV MENT DIS, V198, P601, DOI 10.1097/NMD.0b013e3181ea16bc; Allain H, 2003, PSYCHOPHARMACOLOGY, V165, P419, DOI 10.1007/s00213-002-1272-2; Andreasen NC, 2008, BIOL PSYCHIAT, V64, P81, DOI 10.1016/j.biopsych.2008.01.003; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Bernard JA, 2014, HUM BRAIN MAPP, V35, P4064, DOI 10.1002/hbm.22458; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P274, DOI 10.1016/j.apmr.2003.06.016; Brandt T, 1996, NEUROLOGY, V46, P1515, DOI 10.1212/WNL.46.6.1515; BROEKEMA V, 1975, J ABNORM PSYCHOL, V84, P30, DOI 10.1037/h0076250; Cantor-Graae E, 2000, ACTA PSYCHIAT SCAND, V101, P142, DOI 10.1034/j.1600-0447.2000.90054.x; Caron O, 1997, J BIOMECH, V30, P1169, DOI 10.1016/S0021-9290(97)00094-8; Chang BP, 2005, J ABNORM PSYCHOL, V114, P85, DOI 10.1037/0021-843X.114.1.85; Chaudhry H, 2011, J BODYW MOV THER, V15, P82, DOI 10.1016/j.jbmt.2008.03.003; Corbeil P, 2012, PSYCHOPHARMACOLOGY, V222, P59, DOI 10.1007/s00213-011-2623-7; de Groot MH, 2013, DRUG AGING, V30, P901, DOI 10.1007/s40266-013-0113-9; DWORKIN RH, 1994, SCHIZOPHRENIA BULL, V20, P235, DOI 10.1093/schbul/20.2.235; Fong SSM, 2011, RES DEV DISABIL, V32, P2376, DOI 10.1016/j.ridd.2011.07.025; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Fujino H, 2015, PSYCHIAT QUART, V86, P603, DOI 10.1007/s11126-015-9355-5; Gao KM, 2008, J CLIN PSYCHOPHARM, V28, P203, DOI 10.1097/JCP.0b013e318166c4d5; Gebhardt S, 2006, EUR CHILD ADOLES PSY, V15, P371, DOI 10.1007/s00787-006-0544-5; Gervin M, 1998, AM J PSYCHIAT, V155, P1202, DOI 10.1176/ajp.155.9.1202; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Ho BC, 2004, BIOL PSYCHIAT, V55, P1146, DOI 10.1016/j.biopsych.2004.02.020; Ismail B, 1998, AM J PSYCHIAT, V155, P84, DOI 10.1176/ajp.155.1.84; Janno S, 2004, AM J PSYCHIAT, V161, P160, DOI 10.1176/appi.ajp.161.1.160; Jeon HJ, 2007, PSYCHIAT RES, V152, P155, DOI 10.1016/j.psychres.2006.09.001; Kent JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041808; Kinney DK, 1999, SCHIZOPHR RES, V35, P99, DOI 10.1016/S0920-9964(98)00121-2; Koreki A, 2011, J CLIN PSYCHOPHARM, V31, P16, DOI 10.1097/JCP.0b013e318205e192; Kubota F, 1999, BIOL PSYCHIAT, V45, P412, DOI 10.1016/S0006-3223(97)00523-4; Lacour M, 1997, EXP BRAIN RES, V115, P300, DOI 10.1007/PL00005698; Le Seac'h A, 2012, PSYCHIAT RES, V198, P230, DOI 10.1016/j.psychres.2011.12.039; Lenzenweger MF, 2000, SCHIZOPHR RES, V42, P111, DOI 10.1016/S0920-9964(99)00120-6; LEVY DL, 1983, SCHIZOPHRENIA BULL, V9, P383, DOI 10.1093/schbul/9.3.383; Manzoni D, 2005, CEREBELLUM, V4, P178, DOI 10.1080/14734220500193493; Marvel CL, 2004, SCHIZOPHR RES, V68, P363, DOI 10.1016/j.schres.2003.09.003; Matsuura Y, 2015, GAIT POSTURE, V41, P847, DOI 10.1016/j.gaitpost.2015.03.006; Nashner LM, 2014, BALANCE FUNCTION ASS, P451; Nasrallah HA, 2005, J CLIN PSYCHIAT, V66, P34; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pappa S, 2009, PSYCHOL MED, V39, P1065, DOI 10.1017/S0033291708004716; Picard H, 2008, SCHIZOPHRENIA BULL, V34, P155, DOI 10.1093/schbul/sbm049; Picard HJ, 2009, PROG NEURO-PSYCHOPH, V33, P676, DOI 10.1016/j.pnpbp.2009.03.012; Shumway-Cook A, 2001, MOTOR CONTROL; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Stensdotter AK, 2013, GAIT POSTURE, V38, P918, DOI 10.1016/j.gaitpost.2013.04.017; Stensdotter AK, 2013, J MOTOR BEHAV, V45, P279, DOI 10.1080/00222895.2013.791241; Sullivan EV, 2004, AM J PSYCHIAT, V161, P751, DOI 10.1176/appi.ajp.161.4.751; Tadin D, 2006, J NEUROSCI, V26, P11403, DOI 10.1523/JNEUROSCI.2592-06.2006; Tsunoda K, 2010, INT J GERIATR PSYCH, V25, P1259, DOI 10.1002/gps.2465; Turner R, 2004, J NEUROPSYCH CLIN N, V16, P400, DOI 10.1176/appi.neuropsych.16.4.400; Varambally S, 2006, ACTA PSYCHIAT SCAND, V114, P352, DOI 10.1111/j.1600-0447.2006.00837.x	52	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158219	10.1371/journal.pone.0158219	http://dx.doi.org/10.1371/journal.pone.0158219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355830	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400039
J	Meng, K; Li, XM; Wang, SY; Zhong, CY; Yang, ZN; Feng, LY; Liu, QZ				Meng, Kun; Li, Xiaomei; Wang, Shengya; Zhong, Chunyan; Yang, Zhouning; Feng, Lingyan; Liu, Qingzhen			The Strica Homolog AaCASPS16 Is Involved in Apoptosis in the Yellow Fever Vector, Aedes albopictus	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CASPASE ACTIVATION; DROSOPHILA-MELANOGASTER; IN-VIVO; INHIBITION; MECHANISMS; MOSQUITO; GENES; DRONC; MODEL	Caspases are a family of cysteine proteases playing essential roles during apoptosis. Seven caspases identified in Drosophila were Dronc, Dredd, Strica, Dcp-1, Decay, Drice and Damm. Among them, Strica is an insect-specific caspase containing a long serine- and threonine- rich prodomain, of which function is not yet well studied. Here we identified a homolog of strica from Aedes albopictus, named as Aacasps16. Aacasps16 encoded a protein containing a putative serine- and threonine-rich prodomain and a well conserved caspase catalytic domain. AaCASPS16 shared high identity with dipteran insects Strica homologs. Alignment showed that the closest relative of AaCASPS16 was Aedes aegypti AeCASPS16. The expression profiles of Aacasps16 during developmental and adult stages were analyzed. Purified recombinant AaCASPS16 exhibited the highest caspase activity to WEHD, which is the substrate preferred by human caspase-9. AaCASPS16 induced apoptosis when over-expressed in C6/36 cells. AaCASPS16 was processed during apoptosis induced by actinomycin D and ultraviolet irradiation treatment, whereas partial silencing of Aacasps16 reduced actinomycin D- and ultraviolet irradiation-triggered apoptosis in C6/36 cells. Taken together, our study identified AaCASPS16 as a novel apoptotic caspase in Aedes albopictus.	[Liu, Qingzhen] Wuhan Univ, State Key Lab Virol, Wuhan, Peoples R China; Wuhan Univ, Modern Virol Res Ctr, Coll Life Sci, Wuhan, Peoples R China	Wuhan University; Wuhan University	Liu, QZ (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan, Peoples R China.	qzhliu@whu.edu.cn		Meng, Kun/0000-0002-6541-9510	National Natural Science Foundation of China [31370186]; Chinese 111 project from The Department of Science & Technology, Ministry of Education [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 project from The Department of Science & Technology, Ministry of Education	This project was supported by the grant from National Natural Science Foundation of China (#31370186; recipient: Qingzhen Liu; http://www.nsfc.gov.cn/publish/portal1/) and is partially supported by the Chinese 111 project from The Department of Science & Technology, Ministry of Education (#B06018;recipient: Hongbing Shu; http://www.dost.moe.edu.cn/dostmoe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Baum JS, 2007, CELL DEATH DIFFER, V14, P1508, DOI 10.1038/sj.cdd.4402155; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bryant B, 2008, INSECT BIOCHEM MOLEC, V38, P331, DOI 10.1016/j.ibmb.2007.11.012; Denault Jean-Bernard, 2004, IDrugs, V7, P315; Denton D, 2013, BBA-MOL CELL RES, V1833, P3499, DOI 10.1016/j.bbamcr.2013.06.014; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Doumanis J, 2001, CELL DEATH DIFFER, V8, P387, DOI 10.1038/sj.cdd.4400864; Fiandalo MV, 2013, APOPTOSIS, V18, P766, DOI 10.1007/s10495-013-0821-y; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Girard YA, SALIVARY GLAND MORPH; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101; Kale A, 2015, CELL DEATH DIFFER; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; Lee GG, 2013, J COMP NEUROL, V521, P3972, DOI 10.1002/cne.23387; Leulier F, 2006, CELL DEATH DIFFER, V13, P1663, DOI 10.1038/sj.cdd.4401868; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; O'Neill K, 2015, P NATL ACAD SCI USA, V112, pE1152, DOI 10.1073/pnas.1424469112; Ocampo CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061187; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Pop C, 2008, METHOD ENZYMOL, V446, P351, DOI 10.1016/S0076-6879(08)01621-2; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393	31	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157846	10.1371/journal.pone.0157846	http://dx.doi.org/10.1371/journal.pone.0157846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351972	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900021
J	Srinivasan, R; Gothandam, KM				Srinivasan, Ramachandran; Gothandam, Kodiveri Muthukalianan			Synergistic Action of D-Glucose and Acetosyringone on Agrobacterium Strains for Efficient Dunaliella Transformation	PLOS ONE			English	Article							MEDIATED GENETIC-TRANSFORMATION; GREEN FLUORESCENT PROTEIN; TIME PCR ASSAY; CHLAMYDOMONAS-REINHARDTII; BINDING-PROTEIN; SUGAR BINDING; COPY NUMBER; TUMEFACIENS; ALGA; EXPRESSION	An effective transformation protocol for Dunaliella, a beta-carotene producer, was developed using the synergistic mechanism of D-glucose and Acetosyringone on three different Agrobacterium strains (EHA105, GV3101 and LBA4404). In the present study, we investigated the pre-induction of Agrobacterium strains harboring pMDC45 binary vector in TAP media at varying concentrations of D-glucose (5 mM, 10 mM, and 15mM) and 100 mu M of Acetosyringone for co-cultivation. Induction of Agrobacterium strains with 10 mM D-glucose and 100 mu M Acetosyringone showed higher rates of efficiency compared to other treatments. The presence of GFP and HPT transgenes as a measure of transformation efficiency from the transgenic lines were determined using fluorescent microscopy, PCR, and southern blot analyzes. Highest transformation rate was obtained with the Agrobacterium strain LBA4404 (181 +/- 3.78 cfu per 10(6) cells) followed by GV3101 (128 +/- 5.29 cfu per 10(6) cells) and EHA105 (61 +/- 5.03 cfu per 10(6) cells). However, the Agrobacterium strain GV3101 exhibited more efficient single copy transgene (HPT) transfer into the genome of D. salina than LBA4404. Therefore, future studies dealing with genetic modifications in D. salina can utilize GV3101 as an optimal Agrobacterium strain for gene transfer.	[Srinivasan, Ramachandran; Gothandam, Kodiveri Muthukalianan] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India	Vellore Institute of Technology	Gothandam, KM (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India.	gothandam@gmail.com	Kodiveri Muthukaliannan, Gothandam/C-5734-2014; KM, Gothandam/ABI-2215-2020; Srinivasan, Ramachandran/AAC-3202-2022	Kodiveri Muthukaliannan, Gothandam/0000-0003-1576-5324; Srinivasan, Ramachandran/0000-0001-7248-142X	Council for Scientific and Industrial Research, India [38(1327)/12/EMR-II]	Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by Council for Scientific and Industrial Research (Grant No. 38(1327)/12/EMR-II dated 03.04.2012), India. Funders have no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anila N, 2016, PHOTOSYNTH RES, V127, P321, DOI 10.1007/s11120-015-0188-8; Anila N, 2011, EUR J PHYCOL, V46, P36, DOI 10.1080/09670262.2010.550386; Anila N, 2013, J APPL PHYCOL, V25, P121, DOI 10.1007/s10811-012-9845-x; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; Cha TS, 2012, WORLD J MICROB BIOT, V28, P1771, DOI 10.1007/s11274-011-0991-0; Cha TS, 2011, J MICROBIOL METH, V84, P430, DOI 10.1016/j.mimet.2011.01.005; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cheng RB, 2012, MICROBIOL RES, V167, P179, DOI 10.1016/j.micres.2011.05.003; Chetty VJ, 2013, PLANT CELL REP, V32, P239, DOI 10.1007/s00299-012-1358-1; DOTY SL, 1993, J BACTERIOL, V175, P7880, DOI 10.1128/JB.175.24.7880-7886.1993; Fang L, 2012, PLANT BIOTECHNOL J, V10, P1129, DOI 10.1111/pbi.12000; Feng SY, 2009, MOL BIOL REP, V36, P1433, DOI 10.1007/s11033-008-9333-1; Ortiz-Matamoros MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132693; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Gao R, 2005, J BACTERIOL, V187, P2182, DOI 10.1128/JB.187.6.2182-2189.2005; Guo SL, 2013, J BIOTECHNOL, V163, P61, DOI 10.1016/j.jbiotec.2012.10.020; Harris EH, 2009, CHLAMYDOMONAS SOURCE, DOI [10.1016/0092-8674(90)90467-S, DOI 10.1016/0092-8674(90)90467-S]; Hawkins RL, 1999, CURR MICROBIOL, V38, P335, DOI 10.1007/PL00006813; He FL, 2009, J BACTERIOL, V191, P5802, DOI 10.1128/JB.00451-09; Hu XZ, 2013, P NATL ACAD SCI USA, V110, P678, DOI 10.1073/pnas.1215033110; Ingham DJ, 2001, BIOTECHNIQUES, V31, P132, DOI 10.2144/01311rr04; Jeon K, 2013, KOREAN J CHEM ENG, V30, P1626, DOI 10.1007/s11814-013-0098-4; Kathiresan S, 2009, J PHYCOL, V45, P642, DOI 10.1111/j.1529-8817.2009.00688.x; KROES HW, 1971, LIMNOL OCEANOGR, V16, P869, DOI 10.4319/lo.1971.16.6.0869; Kumar SV, 2004, PLANT SCI, V166, P731, DOI 10.1016/j.plantsci.2003.11.012; Maliakal S, 2001, J PHYCOL, V37, P1010, DOI 10.1046/j.1529-8817.2001.00120.x; Mason Giovanna, 2002, BMC Biotechnol, V2, P20, DOI 10.1186/1472-6750-2-20; NEUHAUS G, 1984, EMBO J, V3, P2169, DOI 10.1002/j.1460-2075.1984.tb02108.x; Ohnuma M, 2008, PLANT CELL PHYSIOL, V49, P117, DOI 10.1093/pcp/pcm157; Orset S, 1999, J PHYCOL, V35, P520, DOI 10.1046/j.1529-8817.1999.3530520.x; Peng WT, 1998, J BACTERIOL, V180, P5632, DOI 10.1128/JB.180.21.5632-5638.1998; Prasad B, 2014, APPL MICROBIOL BIOT, V98, P8629, DOI 10.1007/s00253-014-5900-7; Pratheesh PT, 2014, MOL BIOTECHNOL, V56, P507, DOI 10.1007/s12033-013-9720-2; Rajam MV, 2007, INDUCTION AGROBACTER, V92; Rathod J, 2013, PHOTOSYNTH RES, V118, P141, DOI 10.1007/s11120-013-9930-2; Rogers SO., 1994, PLANT MOL BIOL, V1, P183, DOI 10.1007/978-94-011-0511-8_12; Sanitha M, 2014, POL J MICROBIOL, V63, P387; SHIMODA N, 1990, P NATL ACAD SCI USA, V87, P6684, DOI 10.1073/pnas.87.17.6684; Simon DP, 2015, ALGAL RES, V11, P121, DOI 10.1016/j.algal.2015.06.007; Subramoni S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00322; Tan CP, 2005, J MICROBIOL, V43, P361; ten Lohuis MR, 1998, PLANT J, V13, P427; Toyoda-Yamamoto A, 2000, MOL GEN GENET, V263, P939, DOI 10.1007/PL00008694; Wang P, 2006, J AGR FOOD CHEM, V54, P10033, DOI 10.1021/jf0611769; Weng H, 2004, PLANT MOL BIOL REP, V22, P289, DOI 10.1007/BF02773139; Yang LT, 2005, PLANT CELL REP, V23, P759, DOI 10.1007/s00299-004-0881-0; Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07	48	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158322	10.1371/journal.pone.0158322	http://dx.doi.org/10.1371/journal.pone.0158322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351975	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900054
J	Choi, HY; Ko, ES; Han, BK; Kim, EJ; Kim, SM; Lim, Y; Kim, RB				Choi, Hye Young; Ko, Eun Sook; Han, Boo-Kyung; Kim, Eun Ju; Kim, Sun Mi; Lim, Yaeji; Kim, Rock Bum			Prognostic Significance of Transverse Relaxation Rate (R2*) in Blood Oxygenation Level-Dependent Magnetic Resonance Imaging in Patients with Invasive Breast Cancer	PLOS ONE			English	Article							DUCTAL CARCINOMA; HUMAN TUMORS; PREDICTIVE-VALUE; BOLD CONTRAST; HYPOXIA; MRI; EXPRESSION; CHEMOTHERAPY; PARAMETERS; THERAPY	Objective To examine the relationship between magnetic resonance transverse relaxation rate (R2*) and prognostic factors. Materials and Methods A total of 159 women with invasive ductal carcinomas (IDCs) underwent breast magnetic resonance imaging (MRI) including blood oxygenation level-dependent (BOLD) sequence at 3 T. The distribution of the measured R2* values were analyzed, and the correlation between R2* and various prognostic factors (age, tumor size, histologic grade, lymphovascular invasion, and axillary lymph node status, as well as expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, p53, and Ki-67) were retrospectively assessed using patient medical records. Results The baseline R2* values of the IDCs were very heterogeneous with wide range among the patients. The mean R2* value was (32.8 +/- 14.0) Hz with a median of 29.3 Hz (range 13.5-109.4 Hz). In multivariate analysis, older age was associated with decreased R2* value (P = 0.011) and IDCs with p53-overexpression showed higher R2* values than those without p53-overexpression group (P = 0.031). Other prognostic factors were not significantly correlated with R2* value. Conclusion In this study, R2* values were significantly correlated with age and expression of p53. Further studies are necessary to determine the prognostic value of BOLD-MRI.	[Choi, Hye Young] Gyeongsang Natl Univ Hosp, Dept Radiol, Jinju, South Korea; [Choi, Hye Young] Grad Sch Med, Jinju, South Korea; [Ko, Eun Sook; Han, Boo-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Eun Ju] Philips Healthcare Korea, Dept Clin Sci, MR, Seoul, South Korea; [Kim, Sun Mi] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Lim, Yaeji] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Kim, Rock Bum] Gyeongsang Natl Univ Hosp, Reg Cardiocerebrovasc Ctr, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Philips; Philips Healthcare; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Gyeongsang National University; Gyeongsang National University Hospital	Ko, ES (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.	mathilda0330@gmail.com			Philips Healthcare Korea	Philips Healthcare Korea	Philips Healthcare Korea provided support by way of salary to EJK. The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; El Khouli RH, 2010, RADIOLOGY, V256, P64, DOI 10.1148/radiol.10091367; Fischer DR, 2005, EUR RADIOL, V15, P829, DOI 10.1007/s00330-004-2484-0; Gennari R, 2004, CANCER-AM CANCER SOC, V101, P1302, DOI 10.1002/cncr.20535; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Jiang L, 2013, J MAGN RESON IMAGING, V37, P1083, DOI 10.1002/jmri.23891; Kim HS, 2010, BREAST CANCER RES TR, V121, P777, DOI 10.1007/s10549-009-0560-5; Kim JY, 2015, MAGN RESON IMAGING, V33, P72, DOI 10.1016/j.mri.2014.08.034; Krause BJ, 2006, Q J NUCL MED MOL IM, V50, P28; Kumar R, 2001, SEMIN ONCOL, V28, P27, DOI 10.1016/S0093-7754(01)90279-9; Lee DS, 2011, JPN J CLIN ONCOL, V41, P854, DOI 10.1093/jjco/hyr066; Li SP, 2010, RADIOLOGY, V257, P643, DOI 10.1148/radiol.10100421; Liu M, 2013, EUR RADIOL, V23, P3221, DOI 10.1007/s00330-013-2937-4; McPhail LD, 2010, RADIOLOGY, V254, P110, DOI 10.1148/radiol.2541090395; Ovrebo KM, 2012, RADIOTHER ONCOL, V102, P429, DOI 10.1016/j.radonc.2011.11.013; Padhani A, 2010, RADIOLOGY, V254, P1, DOI 10.1148/radiol.091669; Padhani AR, 2007, EUR RADIOL, V17, P861, DOI 10.1007/s00330-006-0431-y; Padhani AR, 2005, P 13 M ISMRM BERK; Perini R, 2008, CANCER METAST REV, V27, P615, DOI 10.1007/s10555-008-9147-6; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakow-Penner R, 2010, J MAGN RESON IMAGING, V32, P120, DOI 10.1002/jmri.22227; Robinson SP, 2006, NEW TECHNIQUES ONCOL, P257; Schnitt S J, 2001, J Natl Cancer Inst Monogr, P22; Shin S, 2015, BREAST CANCER RES TR, V149, P751, DOI 10.1007/s10549-015-3278-6; STONE HB, 1993, RADIAT RES, V136, P422, DOI 10.2307/3578556; Taylor NJ, 2001, J MAGN RESON IMAGING, V14, P156, DOI 10.1002/jmri.1166; VAUPEL P, 1991, CANCER RES, V51, P3316; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Xiang L, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-32; Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295; Zhao DW, 2009, MAGN RESON MED, V62, P357, DOI 10.1002/mrm.22020; Zheng LF, 2015, AM J TRANSL RES, V7, P535	33	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158500	10.1371/journal.pone.0158500	http://dx.doi.org/10.1371/journal.pone.0158500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384310	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400054
J	Green, G; Carmona, R; Zakeri, K; Lee, CH; Borgan, S; Marhoon, Z; Sharabi, A; Mell, LK				Green, Garrett; Carmona, Ruben; Zakeri, Kaveh; Lee, Chih-Han; Borgan, Saif; Marhoon, Zaid; Sharabi, Andrew; Mell, Loren K.			Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review	PLOS ONE			English	Review							CLINICAL-TRIALS; ENDOMETRIAL CANCER; COMPETING RISKS; END-POINTS	As genetic information becomes more readily available, there is increasing demand from both patients and providers to develop personalized approaches to cancer care. Investigators are increasingly reporting numbers of studies correlating genomic signatures and other biomarkers to survival endpoints. The extent to which cancer-specific and non-specific effects are reported in contemporary studies is unknown. In this review of 85 high-impact studies associating genetic biomarkers with cancer outcomes, 95% reported significant associations with event-free survival outcomes, yet less than half reported effects on a cancer-specific endpoint. This methodology leaves open the possibility that observed associations are unrelated to cancer.	[Green, Garrett; Carmona, Ruben; Zakeri, Kaveh; Lee, Chih-Han; Borgan, Saif; Marhoon, Zaid; Sharabi, Andrew; Mell, Loren K.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Mell, LK (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	lmell@ucsd.edu		Green, Garrett/0000-0002-3263-1654				Carmona R, 2014, INT J RADIAT ONCOL, V89, P888, DOI 10.1016/j.ijrobp.2014.03.047; Chibon F, 2013, EUR J CANCER, V49, P2000, DOI 10.1016/j.ejca.2013.02.021; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Ferreira-Gonzalez I, 2007, J CLIN EPIDEMIOL, V60, P651, DOI 10.1016/j.jclinepi.2006.10.020; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Mathoulin-Pelissier S, 2008, J CLIN ONCOL, V26, P3721, DOI 10.1200/JCO.2007.14.1192; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mell LK, 2007, NEW ENGL J MED, V357, P2201; Mell LK, 2014, J CLIN ONCOL, V32, P1089, DOI 10.1200/JCO.2013.54.4429; Mell LK, 2013, JNCI-J NATL CANCER I, V105, P1656, DOI 10.1093/jnci/djt279; Mell LK, 2012, CONTEMP CLIN TRIALS, V33, P920, DOI 10.1016/j.cct.2012.05.013; Mell LK, 2010, J CLIN ONCOL, V28, P4297, DOI 10.1200/JCO.2010.30.2802; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Thomson Reuters, 2013, J CITATION REPORTS; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yothers G, 2013, J CLIN ONCOL, V31, P4512, DOI 10.1200/JCO.2012.47.3116; Zakeri K, 2013, CONTEMP CLIN TRIALS, V34, P74, DOI 10.1016/j.cct.2012.09.008	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156489	10.1371/journal.pone.0156489	http://dx.doi.org/10.1371/journal.pone.0156489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383192	Green Published, gold			2022-12-27	WOS:000379809400005
J	Sansoe, G; Aragno, M; Mastrocola, R; Mengozzi, G; Parola, M				Sansoe, Giovanni; Aragno, Manuela; Mastrocola, Raffaella; Mengozzi, Giulio; Parola, Maurizio			Alpha-2A Adrenoceptor Agonist Guanfacine Restores Diuretic Efficiency in Experimental Cirrhotic Ascites: Comparison with Clonidine	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; REFRACTORY ASCITES; URINE COLLECTION; SODIUM-EXCRETION; LIVER-CIRRHOSIS; KIDNEY-FUNCTION; RENAL-FUNCTION; HYPERTENSION; ALPHA-2-ADRENOCEPTOR; PATHOGENESIS	Background In human cirrhosis, adrenergic hyperfunction causes proximal tubular fluid retention and contributes to diuretic-resistant ascites, and clonidine, a sympatholytic drug, improves natriuresis in difficult-to-treat ascites. Aim To compare clonidine (aspecific alpha(2)-adrenoceptor agonist) to SSP-002021R (prodrug of guanfacine, specific alpha(2A)-receptor agonist), both associated with diuretics, in experimental cirrhotic ascites. Methods and Results Six groups of 12 rats were studied: controls (G1); controls receiving furosemide and potassium canrenoate (G2); rats with ascitic cirrhosis due to 14-week CCl4 treatment (G3); cirrhotic rats treated (over the 11th-14th CCl4 weeks) with furosemide and canrenoate (G4), furosemide, canrenoate and clonidine (G5), or diuretics and SSP002021R (G6). Three rats of each group had their hormonal status and renal function assessed at the end of 11th, 12th, 13th, and 14th weeks of respective treatments. Cirrhotic rats in G3 and G4 gained weight over the 12th-14th CCl4 weeks. In G4, brief increase in sodium excretion over the 11th-12th weeks preceded worsening of inulin clearance and natriuresis (diuretic resistance). In comparison with G4, the addition of clonidine (G5) or guanfacine (G6) to diuretics improved, respectively, sodium excretion over the 11th-12th CCl4 weeks, or GFR and electrolytes excretion over the 13th-14th CCl4 weeks. Natriuretic responses in G5 and G6 were accompanied by reduced catecholamine serum levels. Conclusions alpha(2A)-receptor agonists restore glomerular filtration rate and natriuresis, and delay diuretic-resistant ascites in experimental advanced cirrhosis. Clonidine ameliorates diuretic-dependent natriuresis just for a short time.	[Sansoe, Giovanni] Gradenigo Hosp, Div Gastroenterol, Turin, Italy; [Aragno, Manuela; Mastrocola, Raffaella; Parola, Maurizio] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Mengozzi, Giulio] San Giovanni Battista Hosp, Clin Biochem Lab, Turin, Italy	Humanitas Hospital Gradenigo; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Sansoe, G (corresponding author), Gradenigo Hosp, Div Gastroenterol, Turin, Italy.	giovannisan@iol.it	Mengozzi, Giulio/AAY-5322-2020	Mengozzi, Giulio/0000-0003-0431-8369; Sansoe', Giovanni/0000-0003-2328-1768; ARAGNO, Manuela/0000-0002-0453-5235	pharmaceutical company Shire	pharmaceutical company Shire	This study was funded by the pharmaceutical company Shire. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Bakris GL, 2010, HYPERTENSION, V56, P824, DOI 10.1161/HYPERTENSIONAHA.110.156976; Bekheirnia MR, 2006, CURR OPIN PHARMACOL, V6, P202, DOI 10.1016/j.coph.2005.09.008; Boyer TD, 2003, GASTROENTEROLOGY, V124, P1700, DOI 10.1016/S0016-5085(03)00377-9; Cardenas A, 2011, GUT, V60, P412, DOI 10.1136/gut.2009.179937; COLE BR, 1972, NEW ENGL J MED, V287, P1109, DOI 10.1056/NEJM197211302872202; ESLER M, 1992, ANN INTERN MED, V116, P446, DOI 10.7326/0003-4819-116-6-446; Fairbanks CA, 2009, PHARMACOL THERAPEUT, V123, P224, DOI 10.1016/j.pharmthera.2009.04.001; Figueroa XF, 2001, BRIT J PHARMACOL, V134, P957, DOI 10.1038/sj.bjp.0704320; Gines P, 1998, HEPATOLOGY, V28, P851, DOI 10.1002/hep.510280337; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; GINES P, 1991, NEW ENGL J MED, V325, P829, DOI 10.1056/NEJM199109193251201; GOLDSTEIN DS, 1985, ANN INTERN MED, V102, P42, DOI 10.7326/0003-4819-102-1-42; HENRIKSEN JH, 1994, SEMIN LIVER DIS, V14, P35, DOI 10.1055/s-2007-1007296; Huang LP, 1996, AM J PHYSIOL-RENAL, V270, pF1015, DOI 10.1152/ajprenal.1996.270.6.F1015; Intengan HD, 1997, J PHARMACOL EXP THER, V281, P48; Lenaerts A, 2006, HEPATOLOGY, V44, P844, DOI 10.1002/hep.21355; Link RE, 1996, SCIENCE, V273, P803, DOI 10.1126/science.273.5276.803; PROCTOR E, 1982, GASTROENTEROLOGY, V83, P1183; ROSE BD, 2001, CLIN PHYSL ACID BASE, P285; Saiz J, 2008, PHARMACOL REP, V60, P391; Sansoe G, 2007, GUT, V56, P1117, DOI 10.1136/gut.2006.109728; Sansoe G, 2006, AM J PHYSIOL-RENAL, V290, pF1337, DOI 10.1152/ajprenal.00435.2005; Sansoe G, 2005, J HEPATOL, V43, P791, DOI 10.1016/j.jhep.2005.04.017; Sansoe G, 2005, J INTERN MED, V257, P358, DOI 10.1111/j.1365-2796.2005.01459.x; Sansoe G, 2004, J HEPATOL, V40, P417, DOI 10.1016/j.jhep.2003.11.010; Sansoe G, 2010, J HEPATOL, V53, P856, DOI 10.1016/j.jhep.2010.05.021; Sansoe G, 2016, CLIN SCI, V130, P117, DOI 10.1042/CS20150479; SCHNURR E, 1980, CLIN NEPHROL, V13, P26; Schrier RW, 2001, SEMIN NEPHROL, V21, P157, DOI 10.1053/snep.2001.20933; Singh V, 2013, AM J GASTROENTEROL, V108, P560, DOI 10.1038/ajg.2013.9; SMYTH DD, 1985, AM J PHYSIOL, V248, pF767, DOI 10.1152/ajprenal.1985.248.6.F767; Turban S, 2003, AM J PHYSIOL-RENAL, V285, pF843, DOI 10.1152/ajprenal.00110.2003; UHLEN S, 1991, BRIT J PHARMACOL, V104, P657, DOI 10.1111/j.1476-5381.1991.tb12485.x; Yang YY, 2010, GUT, V59, P1545, DOI 10.1136/gut.2010.210732	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158486	10.1371/journal.pone.0158486	http://dx.doi.org/10.1371/journal.pone.0158486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384184	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400053
J	van der Meij, E; Anema, JR; Otten, RHJ; Huirne, JAF; Schaafsma, FG				van der Meij, Eva; Anema, Johannes R.; Otten, Rene H. J.; Huirne, Judith A. F.; Schaafsma, Frederieke G.			The Effect of Perioperative E-Health Interventions on the Postoperative Course: A Systematic Review of Randomised and Non-Randomised Controlled Trials	PLOS ONE			English	Review							RECOVERY OUTCOMES; MANAGEMENT INTERVENTION; TELEHEALTH INTERVENTION; HOME TELEREHABILITATION; PATIENT EDUCATION; SURGERY PATIENTS; CARE; PROGRAM; PAIN; CONVALESCENCE	Background E-health interventions have become increasingly popular, including in perioperative care. The objective of this study was to evaluate the effect of perioperative e-health interventions on the postoperative course. Methods We conducted a systematic review and searched for relevant articles in the PUBMED, EMBASE, CINAHL and COCHRANE databases. Controlled trials written in English, with participants of 18 years and older who underwent any type of surgery and which evaluated any type of e-health intervention by reporting patient-related outcome measures focusing on the period after surgery, were included. Data of all included studies were extracted and study quality was assessed by using the Downs and Black scoring system. Findings A total of 33 articles were included, reporting on 27 unique studies. Most studies were judged as having a medium risk of bias (n = 13), 11 as a low risk of bias, and three as high risk of bias studies. Most studies included patients undergoing cardiac (n = 9) or orthopedic surgery (n = 7). All studies focused on replacing (n = 11) or complementing (n = 15) perioperative usual care with some form of care via ICT; one study evaluated both type of interventions. Interventions consisted of an educational or supportive website, telemonitoring, telerehabilitation or teleconsultation. All studies measured patient-related outcomes focusing on the physical, the mental or the general component of recovery. 11 studies (40.7%) reported outcome measures related to the effectiveness of the intervention in terms of health care usage and costs. 25 studies (92.6%) reported at least an equal (n = 8) or positive (n = 17) effect of the e-health intervention compared to usual care. In two studies (7.4%) a positive effect on any outcome was found in favour of the control group. Conclusion Based on this systematic review we conclude that in the majority of the studies e-health leads to similar or improved clinical patient-related outcomes compared to only face to face perioperative care for patients who have undergone various forms of surgery. However, due to the low ormoderate quality of many studies, the results should be interpreted with caution.	[van der Meij, Eva; Huirne, Judith A. F.] Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [van der Meij, Eva; Anema, Johannes R.; Schaafsma, Frederieke G.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Otten, Rene H. J.] Vrije Univ, Med Lib, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van der Meij, E (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands.; van der Meij, E (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	ev.vandermeij@vumc.nl			ZonMw [837002409]; organization for health research and development in the Netherlands	ZonMw(Netherlands Organization for Health Research and Development); organization for health research and development in the Netherlands	This study was carried out with funding of ZonMw (project number 837002409), an organization for health research and development in the Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barello S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02013; Barnason S, 2006, HEART LUNG, V35, P225, DOI 10.1016/j.hrtlng.2005.10.003; Barnason S, 2009, HEART LUNG, V38, P459, DOI 10.1016/j.hrtlng.2009.01.010; Barnason S, 2009, HEART LUNG, V38, P364, DOI 10.1016/j.hrtlng.2009.01.005; Bisgaard T, 2004, BRIT J SURG, V91, P1473, DOI 10.1002/bjs.4720; Bouwsma EVA, 2014, J OCCUP REHABIL, V24, P425, DOI 10.1007/s10926-013-9475-4; Callesen T, 1999, EUR J SURG, V165, P236; Cleeland CS, 2011, J CLIN ONCOL, V29, P994, DOI 10.1200/JCO.2010.29.8315; Cochrane Consumers and Communication Review Groups, 2013, DAT EXTR TEMPL; Cook DJ, 2013, J AM COLL SURGEONS, V217, P648, DOI 10.1016/j.jamcollsurg.2013.05.003; D'Haese PF, 2012, MED IMAGE ANAL, V16, P744, DOI 10.1016/j.media.2010.07.009; de la Torre-Diez I, 2015, TELEMED E-HEALTH, V21, P81, DOI 10.1089/tmj.2014.0053; de Visser H, 2011, MED J AUSTRALIA, V194, pS38; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duplaga M, 2013, TELEMED E-HEALTH, V19, P683, DOI 10.1089/tmj.2012.0306; Eaton L, 2012, SURG OBES RELAT DIS, V8, P225, DOI 10.1016/j.soard.2011.10.015; Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006; Ellison LM, 2007, ARCH SURG-CHICAGO, V142, P1177, DOI 10.1001/archsurg.142.12.1177; Ellison LM, 2004, J AM COLL SURGEONS, V199, P523, DOI 10.1016/j.jamcollsurg.2004.06.022; Eng Janice J, 2007, Top Spinal Cord Inj Rehabil, V13, P1, DOI 10.1310/sci1301-1; Eriksson L, 2009, J TELEMED TELECARE, V15, P215, DOI 10.1258/jtt.2009.081003; Fairbrother P, 2014, J CLIN NURS, V23, P132, DOI 10.1111/jocn.12137; Flodgren G, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002098.pub2; Gandsas A, 2007, J AM COLL SURGEONS, V205, P72, DOI 10.1016/j.jamcollsurg.2007.01.070; Goldsmith DM, 1999, J AM MED INFORM ASSN, P780; Halimi F, 2008, EUROPACE, V10, P1392, DOI 10.1093/europace/eun250; Heikkinen K, 2012, INT J ORTHOP TRAUMA, V16, P13, DOI 10.1016/j.ijotn.2011.04.004; Heikkinen Katja, 2012, J Perioper Pract, V22, P226; Heikkinen K, 2011, ORTHOP NURS, V30, P20, DOI 10.1097/NOR.0b013e318205747f; Hering Keith, 2005, AANA J, V73, P29; Keeping-Burke L, 2013, RES NURS HEALTH, V36, P540, DOI 10.1002/nur.21571; Koertke H, 2006, TELEMED J E-HEALTH, V12, P475, DOI 10.1089/tmj.2006.12.475; Kok PE, 2011, J CLIN NURS, V20, P2997, DOI 10.1111/j.1365-2702.2011.03743.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mahmud N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008881; Martorella Geraldine, 2012, J Med Internet Res, V14, pe177, DOI 10.2196/jmir.2070; Miller C, 2007, HEART LUNG, V36, P418, DOI 10.1016/j.hrtlng.2007.02.011; Neary PM, 2010, SURG INNOV, V17, P236, DOI 10.1177/1553350610374603; Noordegraaf AV, 2014, BJOG-INT J OBSTET GY, V121, P1127, DOI 10.1111/1471-0528.12661; Noordegraaf AV, 2014, BJOG-INT J OBSTET GY, V121, P487, DOI 10.1111/1471-0528.12494; Pagliari Claudia, 2005, J Med Internet Res, V7, pe9, DOI 10.2196/jmir.7.1.e9; Palombo D, 2009, ANN VASC SURG, V23, P76, DOI 10.1016/j.avsg.2008.06.013; Piqueras M, 2013, J REHABIL MED, V45, P392, DOI 10.2340/16501977-1119; Pombo N, 2014, TECHNOL HEALTH CARE, V22, P63, DOI 10.3233/THC-130774; Russell TG, 2011, J BONE JOINT SURG AM, V93A, P113, DOI 10.2106/JBJS.I.01375; Sharareh B, 2014, J ARTHROPLASTY, V29, P918, DOI 10.1016/j.arth.2013.09.019; Stomberg Margareta Warren, 2012, Perspect Health Inf Manag, V9, P1; Tang C, 2016, J AM MED INFORM ASSN, V23, P2, DOI 10.1093/jamia/ocv198; Tousignant M, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3844; Tousignant M, 2011, J TELEMED TELECARE, V17, P195, DOI 10.1258/jtt.2010.100602; Tran TT, 2014, SURGERY, V156, P20, DOI 10.1016/j.surg.2014.03.024; Van Den Brink JL, 2007, J AM MED INFORM ASSN, V14, P198, DOI 10.1197/jamia.M2199; Yin B, 2015, J BONE JOINT SURG AM, V97A, P964, DOI 10.2106/JBJS.N.01174; Zahlmann G, 2002, GRAEF ARCH CLIN EXP, V240, P17, DOI 10.1007/s00417-001-0396-0; Zimmerman L, 2007, J CARDIOVASC NURS, V22, P493, DOI 10.1097/01.JCN.0000297379.06379.b6; Zimmerman Lani, 2004, Outcomes Manag, V8, P5; Zimmerman L, 2011, HEART LUNG, V40, P429, DOI 10.1016/j.hrtlng.2010.07.018	57	39	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158612	10.1371/journal.pone.0158612	http://dx.doi.org/10.1371/journal.pone.0158612			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383239	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400065
J	Beck, B; Ham, DJ; Best, SA; Carstairs, GL; Savage, RJ; Straney, L; Caldwell, JN				Beck, Ben; Ham, Daniel J.; Best, Stuart A.; Carstairs, Greg L.; Savage, Robert J.; Straney, Lahn; Caldwell, Joanne N.			Predicting Endurance Time in a Repetitive Lift and Carry Task Using Linear Mixed Models	PLOS ONE			English	Article							HANDLING TASKS; WORK; FREQUENCY; FATIGUE; BACK; PERFORMANCE; STRENGTH; DURATION; MUSCLES; SPINE	Objectives Repetitive manual handling tasks account for a substantial portion of work-related injuries. However, few studies report endurance time in repetitive manual handling tasks. Consequently, there is little guidance to inform expected work time for repetitive manual handling tasks. We aimed to investigate endurance time and oxygen consumption of a repetitive lift and carry task using linear mixed models. Methods Fourteen male soldiers (age 22.4 +/- 4.5 yrs, height 1.78 +/- 0.04 m, body mass 76.3 +/- 10.1 kg) conducted four assessment sessions that consisted of one maximal box lifting session and three lift and carry sessions. The relationships between carry mass (range 17.5-37.5 kg) and the duration of carry, and carry mass and oxygen consumption, were assessed using linear mixed models with random effects to account for between-subject variation. Results Results demonstrated that endurance time was inversely associated with carry mass (R-2 = 0.24), with significant individual-level variation (R-2 = 0.85). Normalising carry mass to performance in a maximal box lifting test improved the prediction of endurance time (R-2 = 0.40). Oxygen consumption presented relative to total mass (body mass, external load and carried mass) was not significantly related to lift and carry mass (beta(1) = 0.16, SE = 0.10, 95% CI: -0.04, 0.36, p = 0.12), indicating that there was no change in oxygen consumption relative to total mass with increasing lift and carry mass. Conclusion Practically, these data can be used to guide work-rest schedules and provide insight into methods assessing the physical capacity of workers conducting repetitive manual handling tasks.	[Beck, Ben; Ham, Daniel J.; Best, Stuart A.; Carstairs, Greg L.; Savage, Robert J.] Def Sci & Technol Grp, Land Div, Fishermans Bend, Australia; [Beck, Ben; Straney, Lahn] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Caldwell, Joanne N.] Univ Wollongong, Fac Hlth & Behav Sci, Ctr Human & Appl Physiol, Wollongong, NSW, Australia	Defence Science & Technology; Monash University; University of Wollongong	Beck, B (corresponding author), Def Sci & Technol Grp, Land Div, Fishermans Bend, Australia.; Beck, B (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	ben.beck@monash.edu	Beck, Ben/ABD-5556-2020	Beck, Ben/0000-0003-3262-5956; Ham, Daniel/0000-0002-4552-8373; Caldwell Odgers, Joanne Nellie/0000-0002-5359-2455				Beck B., 2015, ERGONOMICS IN PRESS; Beck B, 2016, APPL ERGON, V55, P124, DOI 10.1016/j.apergo.2016.02.002; Bernard B., 1997, MUSCULOSKELETAL DISO; Best SA, 2011, 2 INT C SOLD PHYS PE; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonato P, 2002, IEEE T NEUR SYS REH, V10, P38, DOI 10.1109/TNSRE.2002.1021585; Choobineh A, 2007, J OCCUP HEALTH, V49, P418, DOI 10.1539/joh.49.418; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Dempsey PG, 1998, ERGONOMICS, V41, P73, DOI 10.1080/001401398187332; Dolan P, 1998, J BIOMECH, V31, P713, DOI 10.1016/S0021-9290(98)00086-4; GENAIDY AM, 1993, ERGONOMICS, V36, P509, DOI 10.1080/00140139308967909; GENAIDY AM, 1989, ERGONOMICS, V32, P51, DOI 10.1080/00140138908966067; Kemp PA, 2010, AM J PREV MED, V38, pS148, DOI 10.1016/j.amepre.2009.10.011; KRUEGER GP, 1989, WORK STRESS, V3, P129, DOI 10.1080/02678378908256939; LEGG SJ, 1985, ERGONOMICS, V28, P309, DOI 10.1080/00140138508963138; LEGG SJ, 1981, ERGONOMICS, V24, P907, DOI 10.1080/00140138108924913; Lotters F, 2003, SCAND J WORK ENV HEA, V29, P431; Mamansari DU, 1996, APPL ERGON, V27, P53, DOI 10.1016/0003-6870(95)00055-0; Marras WS, 2006, CLIN BIOMECH, V21, P345, DOI 10.1016/j.clinbiomech.2005.10.004; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Savage RJ, 2014, J STRENGTH COND RES, V28, P767, DOI 10.1519/JSC.0b013e3182a364a6; Sawka M, 2003, 507AFPAM48152ITBMED5; SNOOK SH, 1991, ERGONOMICS, V34, P1197, DOI 10.1080/00140139108964855; Sparto PJ, 1997, J ORTHOP SPORT PHYS, V25, P3, DOI 10.2519/jospt.1997.25.1.3; YATES JW, 1980, ERGONOMICS, V23, P37, DOI 10.1080/00140138008924716; ZHU ZX, 1990, ERGONOMICS, V33, P875, DOI 10.1080/00140139008925295	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158418	10.1371/journal.pone.0158418	http://dx.doi.org/10.1371/journal.pone.0158418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27379902	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700029
J	Oliveira, MP; Soares, JBRC; Oliveira, MF				Oliveira, Matheus P.; Correa Soares, Juliana B. R.; Oliveira, Marcus F.			Sexual Preferences in Nutrient Utilization Regulate Oxygen Consumption and Reactive Oxygen Species Generation in Schistosoma mansoni: Potential Implications for Parasite Redox Biology	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; ENERGY-METABOLISM; ENZYMATIC CHARACTERIZATION; CARBOHYDRATE-METABOLISM; INTERMEDIATE PRODUCTION; PARAGONIMUS-WESTERMANI; SUPEROXIDE-PRODUCTION	Schistosoma mansoni, one of the causative agents of human schistosomiasis, has a unique antioxidant network that is key to parasite survival and a valuable chemotherapeutic target. The ability to detoxify and tolerate reactive oxygen species increases along S. mansoni development in the vertebrate host, suggesting that adult parasites are more exposed to redox challenges than young stages. Indeed, adult parasites are exposed to multiple redox insults generated from blood digestion, activated immune cells, and, potentially, from their own parasitic aerobic metabolism. However, it remains unknown how reactive oxygen species are produced by S. mansoni metabolism, as well as their biological effects on adult worms. Here, we assessed the contribution of nutrients and parasite gender to oxygen utilization pathways, and reactive oxygen species generation in whole unpaired adult S. mansoni worms. We also determined the susceptibilities of both parasite sexes to a pro-oxidant challenge. We observed that glutamine and serum importantly contribute to both respiratory and non-respiratory oxygen utilization in adult worms, but with different proportions among parasite sexes. Analyses of oxygen utilization pathways revealed that respiratory rates were high in male worms, which contrast with high non-respiratory rates in females, regardless nutritional sources. Interestingly, mitochondrial complex I-III activity was higher than complex IV specifically in females. We also observed sexual preferences in substrate utilization to sustain hydrogen peroxide production towards glucose in females, and glutamine in male worms. Despite strikingly high oxidant levels and hydrogen peroxide production rates, female worms were more resistant to a pro-oxidant challenge than male parasites. The data presented here indicate that sexual preferences in nutrient metabolism in adult S. mansoni worms regulate oxygen utilization and reactive oxygen species production, which may differently contribute to redox biology among parasite sexes.	[Oliveira, Matheus P.; Correa Soares, Juliana B. R.; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Bioquim Resposta Estresse, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Oliveira, MF (corresponding author), Univ Fed Rio de Janeiro, Lab Bioquim Resposta Estresse, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.	maroli@bioqmed.ufrj.br	Oliveira, Marcus/G-3158-2011	Oliveira, Marcus/0000-0002-9890-8425; Pinto De Oliveira, Matheus/0000-0002-2124-8799	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [402409/2012-4]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/102.333/2013, E-26/111.169/2011]; CNPq [307636/2012-7, 160357/2012-8]; PAPD-FAPERJ [E26/102.752/11]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PAPD-FAPERJ	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/) grant 402409/2012-4 and the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br/) grants E-26/102.333/2013 and E-26/111.169/2011. MFO was a research scholar from CNPq (grant 307636/2012-7), JBRCS was a PAPD-FAPERJ fellow (grant E26/102.752/11), and MPO is a CNPq fellow (grant 160357/2012-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger HM, 2002, INT J PARASITOL, V32, P1285, DOI 10.1016/S0020-7519(02)00108-X; Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Anderson L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004334; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Aragon AD, 2008, MOL BIOCHEM PARASIT, V162, P134, DOI 10.1016/j.molbiopara.2008.08.004; AW TY, 1994, J CLIN INVEST, V94, P2426, DOI 10.1172/JCI117610; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BOROS DL, 1989, CLIN MICROBIOL REV, V2, P250, DOI 10.1128/CMR.2.3.250-269.1989; BOUT DT, 1981, J IMMUNOL, V127, P1; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; Bruce J.I., 1972, International J Parasit, V2, P425, DOI 10.1016/0020-7519(72)90086-0; BRUCE JI, 1974, COMP BIOCHEM PHYSIOL, V49, P157, DOI 10.1016/0305-0491(74)90235-1; BUEDING E, 1968, COMP BIOCHEM PHYSIOL, V24, P511, DOI 10.1016/0010-406X(68)91003-7; BUEDING E, 1953, BRIT J PHARM CHEMOTH, V8, P15, DOI 10.1111/j.1476-5381.1953.tb00741.x; BUEDING E, 1952, J BIOL CHEM, V196, P615; BUEDING E, 1950, J GEN PHYSIOL, V33, P475, DOI 10.1085/jgp.33.5.475; Cioli D, 2014, MOL BIOCHEM PARASIT, V195, P23, DOI 10.1016/j.molbiopara.2014.06.002; CLEGG JA, 1965, EXP PARASITOL, V16, P133, DOI 10.1016/0014-4894(65)90037-8; COLES G C, 1973, International Journal for Parasitology, V3, P505, DOI 10.1016/0020-7519(73)90047-7; COLES GC, 1972, NATURE, V240, P488, DOI 10.1038/240488a0; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A; CORNFORD EM, 1974, EXP PARASITOL, V36, P210, DOI 10.1016/0014-4894(74)90060-5; CORNFORD EM, 1974, GEN COMP ENDOCR, V23, P286, DOI 10.1016/0016-6480(74)90072-0; CORNFORD EM, 1988, J PARASITOL, V74, P116, DOI 10.2307/3282487; CORNFORD EM, 1979, J PARASITOL, V65, P357, DOI 10.2307/3280273; CORNFORD EM, 1987, EXP PARASITOL, V64, P448, DOI 10.1016/0014-4894(87)90059-2; CORNFORD EM, 1985, COMP BIOCHEM PHYS B, V82, P25, DOI 10.1016/0305-0491(85)90122-1; CORNFORD EM, 1981, SCIENCE, V213, P1269, DOI 10.1126/science.7268436; CORNFORD EM, 1985, MOL BIOCHEM PARASIT, V17, P131, DOI 10.1016/0166-6851(85)90012-X; Soares JBRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120600; Soares JBRC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000477; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P334, DOI 10.1016/0003-9861(84)90206-6; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P343, DOI 10.1016/0003-9861(84)90207-8; el-Din SHS, 2011, EXP PARASITOL, V128, P230, DOI 10.1016/j.exppara.2011.03.006; ESPARZA I, 1988, IMMUNOBIOLOGY, V177, P105, DOI 10.1016/S0171-2985(88)80032-9; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Fitzpatrick JM, 2007, FASEB J, V21, P823, DOI 10.1096/fj.06-7314com; Fitzpatrick JM, 2004, MOL BIOCHEM PARASIT, V136, P191, DOI 10.1016/j.molbiopara.2004.03.014; Forbes RA, 2001, CIRC RES, V88, P802, DOI 10.1161/hh0801.089342; FOSTER LA, 1989, EXP PARASITOL, V69, P44, DOI 10.1016/0014-4894(89)90170-7; FRAPPIER F, 1988, BIOCHEM PHARMACOL, V37, P2864, DOI 10.1016/0006-2952(88)90053-6; FUJIMOTO D, 1969, J BIOL CHEM, V244, P205; Furukawa S, 2000, NUTRITION, V16, P323, DOI 10.1016/S0899-9007(00)00228-8; Furukawa S, 2000, SHOCK, V13, P274, DOI 10.1097/00024382-200004000-00004; GAZZINELLI G, 1985, J IMMUNOL, V135, P2121; GIBIAN MJ, 1976, BIOCHEMISTRY-US, V15, P4209, DOI 10.1021/bi00664a012; Girardini JE, 2005, EXP PARASITOL, V110, P157, DOI 10.1016/j.exppara.2005.02.011; Girardini JE, 2002, MOL BIOCHEM PARASIT, V124, P37, DOI 10.1016/S0166-6851(02)00158-5; GOLDRING OL, 1976, CLIN EXP IMMUNOL, V26, P181; Goncalves RLS, 2011, J BIOENERG BIOMEMBR, V43, P651, DOI 10.1007/s10863-011-9398-8; Goossens V, 1996, J BIOL CHEM, V271, P192, DOI 10.1074/jbc.271.1.192; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; HALANGK W, 1985, BIOMED BIOCHIM ACTA, V44, P411; Hamdan FF, 1999, J BIOL CHEM, V274, P21746, DOI 10.1074/jbc.274.31.21746; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Hey-Mogensen M, 2014, FREE RADICAL BIO MED, V72, P149, DOI 10.1016/j.freeradbiomed.2014.04.007; Hoffmann KF, 2004, PARASITOLOGY, V128, pS11, DOI 10.1017/S0031182004006213; HOSONO R, 1982, EXP GERONTOL, V17, P163, DOI 10.1016/0531-5565(82)90052-3; Huang SCC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002996; HUANG TY, 1980, INT J BIOCHEM, V12, P457, DOI 10.1016/0020-711X(80)90128-7; Ismail M, 1999, AM J TROP MED HYG, V60, P932, DOI 10.4269/ajtmh.1999.60.932; KATZ IR, 1980, J NEUROCHEM, V35, P760, DOI 10.1111/j.1471-4159.1980.tb03721.x; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; KUNTZ RE, 1980, J PARASITOL, V66, P364, DOI 10.2307/3280844; Kwatia MA, 2000, J PARASITOL, V86, P908, DOI 10.1645/0022-3395(2000)086[0908:MAECOS]2.0.CO;2; LANE CA, 1987, PARASITOLOGY, V94, P233, DOI 10.1017/S0031182000053919; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; Maglioni S, 2014, EXP GERONTOL, V56, P89, DOI 10.1016/j.exger.2014.03.026; Mair GR, 2004, FASEB J, V18, P114, DOI 10.1096/fj.03-0429com; Martins D, 2014, ANTIOXID REDOX SIGN, V21, P1490, DOI 10.1089/ars.2013.5575; Mei HP, 1996, INFECT IMMUN, V64, P4299, DOI 10.1128/IAI.64.10.4299-4306.1996; Mei HP, 1997, EXP PARASITOL, V86, P69, DOI 10.1006/expr.1997.4150; Messerli SM, 2006, MOL BIOCHEM PARASIT, V150, P367, DOI 10.1016/j.molbiopara.2006.08.003; MEYER F, 1970, BIOCHIM BIOPHYS ACTA, V210, P257, DOI 10.1016/0005-2760(70)90170-0; MKOJI GM, 1988, INT J PARASITOL, V18, P661, DOI 10.1016/0020-7519(88)90101-4; MKOJI GM, 1988, INT J PARASITOL, V18, P667, DOI 10.1016/0020-7519(88)90102-6; MKOJI GM, 1989, BIOCHEM PHARMACOL, V38, P4307, DOI 10.1016/0006-2952(89)90530-3; NARE B, 1990, EXP PARASITOL, V70, P389, DOI 10.1016/0014-4894(90)90122-S; NEWPORT GR, 1982, AM J TROP MED HYG, V31, P349, DOI 10.4269/ajtmh.1982.31.349; Okumura-Noji K, 2013, FASEB J, V27, P1236, DOI 10.1096/fj.12-219816; Oliveira MF, 2004, J INFECT DIS, V190, P843, DOI 10.1086/422759; Oliveira MF, 2002, FEBS LETT, V512, P139, DOI 10.1016/S0014-5793(02)02243-3; Oliveira MF, 2000, MOL BIOCHEM PARASIT, V111, P217, DOI 10.1016/S0166-6851(00)00299-1; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Pearce EJ, 2015, CELL MICROBIOL, V17, P796, DOI 10.1111/cmi.12444; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Pelletier M, 2012, SEMIN IMMUNOL, V24, P384, DOI 10.1016/j.smim.2013.01.002; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Piacenza L, 2013, ANTIOXID REDOX SIGN, V19, P723, DOI 10.1089/ars.2012.4618; PINO ECD, 1966, EXP PARASITOL, V18, P320, DOI 10.1016/0014-4894(66)90033-6; Pon LA, 2007, METHOD CELL BIOL, V80, P1; Ponsot E, 2005, J CELL PHYSIOL, V203, P479, DOI 10.1002/jcp.20245; PRICHARD RK, 1971, EXP PARASITOL, V29, P215, DOI 10.1016/0014-4894(71)90027-0; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Ramirez B, 2007, EXPERT OPIN DRUG DIS, V2, pS53, DOI 10.1517/17460441.2.S1.S53; Rasmussen UF, 2004, COMP BIOCHEM PHYS A, V137, P435, DOI 10.1016/j.cbpb.2003.11.002; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; RUMJANEK FD, 1980, MOL BIOCHEM PARASIT, V1, P31, DOI 10.1016/0166-6851(80)90039-0; Saeed HM, 2002, FEBS LETT, V519, P205, DOI 10.1016/S0014-5793(02)02755-2; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Sayed AA, 2006, J BIOL CHEM, V281, P17001, DOI 10.1074/jbc.M512601200; SAZ HJ, 1966, PHARMACOL REV, V18, P871; SCHILLER EL, 1975, J PARASITOL, V61, P385, DOI 10.2307/3279308; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SEED JL, 1978, J PARASITOL, V64, P283, DOI 10.2307/3279674; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; SKELLY PJ, 1993, MOL BIOCHEM PARASIT, V60, P93, DOI 10.1016/0166-6851(93)90032-S; SMITH JM, 1989, AM J TROP MED HYG, V40, P186, DOI 10.4269/ajtmh.1989.40.186; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; SUN JC, 2015, PLOS COMPUT BIOL, V11, DOI DOI 10.1371/JOURNAL.PONE.0129626; Sun J, 2014, PARASITOL RES, V113, P881, DOI 10.1007/s00436-013-3719-2; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; TAKAMIYA S, 1994, ARCH BIOCHEM BIOPHYS, V312, P142, DOI 10.1006/abbi.1994.1292; Takamiya S, 2010, INT J PARASITOL, V40, P1651, DOI 10.1016/j.ijpara.2010.07.009; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; THOMPSON DP, 1984, MOL BIOCHEM PARASIT, V13, P39, DOI 10.1016/0166-6851(84)90100-2; THOR H, 1982, J BIOL CHEM, V257, P2419; TIELENS AGM, 1984, MOL BIOCHEM PARASIT, V13, P301, DOI 10.1016/0166-6851(84)90121-X; TIELENS AGM, 1981, MOL BIOCHEM PARASIT, V3, P205, DOI 10.1016/0166-6851(81)90052-9; TIELENS AGM, 1989, INT J PARASITOL, V19, P447, DOI 10.1016/0020-7519(89)90102-1; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; TZENG WF, 1994, J MOL CELL CARDIOL, V26, P889, DOI 10.1006/jmcc.1994.1106; UGLEM GL, 1975, J PARASITOL, V61, P390, DOI 10.2307/3279309; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; VANOORDT BEP, 1985, MOL BIOCHEM PARASIT, V16, P117, DOI 10.1016/0166-6851(85)90080-5; WARREN KS, 1978, NATURE, V273, P609, DOI 10.1038/273609a0; Yanase S, 1999, MUTAT RES-FUND MOL M, V426, P31, DOI 10.1016/S0027-5107(99)00079-2; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; YAZDANBAKHSH M, 1987, J IMMUNOL, V138, P3443; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zelck UE, 2004, PARASITOLOGY, V128, P493, DOI 10.1017/S0031182004004895; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	151	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158429	10.1371/journal.pone.0158429	http://dx.doi.org/10.1371/journal.pone.0158429			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380021	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700030
J	Pozdzik, AA; Giordano, L; Li, G; Antoine, MH; Quellard, N; Godet, J; De Prez, E; Husson, C; Decleves, AE; Arlt, VM; Goujon, JM; Brocheriou-Spelle, I; Ledbetter, SR; Caron, N; Nortier, JL				Pozdzik, Agnieszka A.; Giordano, Laetitia; Li, Gang; Antoine, Marie-Helene; Quellard, Nathalie; Godet, Julie; De Prez, Eric; Husson, Cecile; Decleves, Anne-Emilie; Arlt, Volker M.; Goujon, Jean-Michel; Brocheriou-Spelle, Isabelle; Ledbetter, Steven R.; Caron, Nathalie; Nortier, Joelle L.			Blocking TGF-beta Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFR beta plus Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROXIMAL TUBULE INJURY; TUBULOINTERSTITIAL FIBROSIS; RENAL FIBROSIS; MYOFIBROBLAST TRANSITION; MESENCHYMAL TRANSITION; DIABETIC-NEPHROPATHY; CHINESE HERBS; DNA-ADDUCTS; MECHANISMS	Background The platelet-derived growth factor receptor beta (PDGFR beta)+ perivascular cell activation becomes increasingly recognized as a main source of scar-associated kidney myofibroblasts and recently emerged as a new cellular therapeutic target. Aims In this regard, we first confirmed the presence of PDGFR beta+ perivascular cells in a human case of end-stage aristolochic acid nephropathy (AAN) and thereafter we focused on the early fibrosis events of transforming growth factor beta (TGF beta) inhibition in a rat model of AAN. Materials and Methods Neutralizing anti-TGF beta antibody (1D11) and its control isotype (13C4) were administered (5 mg/kg, i.p.) at Days -1, 0, 2 and 4; AA (15 mg/kg, sc) was injected daily. Results At Day 5, 1D11 significantly suppressed p-Smad2/3 signaling pathway improving renal function impairment, reduced the score of acute tubular necrosis, peritubular capillaritis, interstitial inflammation and neoangiogenesis. 1D11 markedly decreased interstitial edema, disruption of tubular basement membrane loss of brush border, cytoplasmic edema and organelle ultrastructure alterations (mitochondrial disruption and endoplasmic reticulum edema) in proximal tubular epithelial cells. Moreover, 1D11 significantly inhibited p-PERK activation and attenuated dysregulation of unfolded protein response (UPR) pathways, endoplasmic reticulum and mitochondrial proteostasis in vivo and in vitro. Conclusions The early inhibition of p-Smad2/3 signaling pathway improved acute renal function impairment, partially prevented epithelial-endothelial axis activation by maintaining PTEC proteostasis and reduced early PDGFR beta+ pericytes-derived myofibroblasts accumulation.	[Pozdzik, Agnieszka A.; Antoine, Marie-Helene; De Prez, Eric; Husson, Cecile; Nortier, Joelle L.] ULB, Fac Med, Dept Biochem, Lab Expt Nephrol, Brussels, Belgium; [Pozdzik, Agnieszka A.; Nortier, Joelle L.] ULB, Erasme Hosp, Dept Nephrol, Brussels, Belgium; [Giordano, Laetitia; Decleves, Anne-Emilie; Caron, Nathalie] Univ Namur, URPHYM, Lab Gen Physiol, Namur, Belgium; [Li, Gang; Ledbetter, Steven R.] Genzyme Corp, Cell Biol, CardioMetabol & Renal Res, Framingham, MA 01701 USA; [Quellard, Nathalie; Godet, Julie; Goujon, Jean-Michel] CHU La Miletrie, Pathol & Electron Microscopy, Poitiers, France; [Quellard, Nathalie; Godet, Julie; Goujon, Jean-Michel] INSERM, U1082, Poitiers, France; [Arlt, Volker M.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Analyt & Environm Sci Div, London, England; [Brocheriou-Spelle, Isabelle] Tenon Hosp, Dept Pathol, Paris, France	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Namur; Sanofi-Aventis; Genzyme Corporation; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Pozdzik, AA (corresponding author), ULB, Fac Med, Dept Biochem, Lab Expt Nephrol, Brussels, Belgium.; Pozdzik, AA (corresponding author), ULB, Erasme Hosp, Dept Nephrol, Brussels, Belgium.	agapozdzik@gmail.com		Nortier, Joelle/0000-0003-3609-8217	Cancer Research UK [C313/A14329]; Cancer Research UK [14329] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The work at King's College London was supported by Cancer Research UK (grant C313/A14329).	Baudoux TER, 2012, KIDNEY INT, V82, P1105, DOI 10.1038/ki.2012.264; Benigni A, 2003, J AM SOC NEPHROL, V14, P1816, DOI 10.1097/01.ASN.0000074238.61967.B7; Benigni A, 2006, NEPHRON EXP NEPHROL, V104, pE158, DOI 10.1159/000094967; Bonventre JV, 2014, NEPHRON CLIN PRACT, V127, P61, DOI 10.1159/000363673; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Colson C R, 1999, Nephrol Dial Transplant, V14 Suppl 4, P16; COSYNS JP, 1994, KIDNEY INT, V45, P1680, DOI 10.1038/ki.1994.220; Crawford C, 2011, ACTA PHYSIOL, V202, P241, DOI 10.1111/j.1748-1716.2011.02310.x; Dahly AJ, 2002, AM J PHYSIOL-REG I, V283, pR757, DOI 10.1152/ajpregu.00098.2002; DASCH JR, 1989, J IMMUNOL, V142, P1536; Debelle FD, 2002, J AM SOC NEPHROL, V13, P431, DOI 10.1681/ASN.V132431; Declves AE, 2012, NEPHROL DIAL TRANSPL, V27, P3771, DOI 10.1093/ndt/gfs098; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Duffield JS, 2011, KIDNEY INT, V79, P494, DOI 10.1038/ki.2010.338; Eddy AA, 2014, KIDNEY INT SUPPL, V4, P2, DOI 10.1038/kisup.2014.2; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Geevarghese A, 2014, TRANSL RES, V163, P296, DOI 10.1016/j.trsl.2014.01.011; Gewin L, 2012, J AM SOC NEPHROL, V23, P2001, DOI 10.1681/ASN.2012020139; Gewin L, 2012, SEMIN NEPHROL, V32, P228, DOI 10.1016/j.semnephrol.2012.04.001; Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67; Kelly FJ, 1999, J AM SOC NEPHROL, V10, P1264; Kida Y, 2011, CLIN EXP PHARMACOL P, V38, P417, DOI 10.1111/j.1440-1681.2011.05531.x; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Lazzeri E, 2010, CURR OPIN NEPHROL HY, V19, P248, DOI 10.1097/MNH.0b013e32833680dc; Lebeau C, 2005, NEPHROL DIAL TRANSPL, V20, P2321, DOI 10.1093/ndt/gfi042; Lebeau C, 2001, KIDNEY INT, V60, P1332, DOI 10.1046/j.1523-1755.2001.00938.x; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li J, 2009, J RECEPT SIG TRANSD, V29, P280, DOI 10.1080/10799890903078465; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu BT, 2014, WIRES RNA, V5, P301, DOI 10.1002/wrna.1212; Ma LJ, 2004, KIDNEY INT, V65, P106, DOI 10.1111/j.1523-1755.2004.00381.x; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327; Molitoris BA, 2014, J CLIN INVEST, V124, P2355, DOI 10.1172/JCI72269; Neelisetty S, 2015, KIDNEY INT, V88, P503, DOI 10.1038/ki.2015.51; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Pozdzik AA, 2008, NEPHROL DIAL TRANSPL, V23, P2480, DOI 10.1093/ndt/gfn140; Pozdzik AA, 2010, HISTOPATHOLOGY, V56, P449, DOI 10.1111/j.1365-2559.2010.03509.x; Schmeiser HH, 2014, INT J CANCER, V135, P502, DOI 10.1002/ijc.28681; Stachurska A, 2011, TOXICOL LETT, V204, P118, DOI 10.1016/j.toxlet.2011.04.022; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Tanjore H, 2013, BBA-MOL BASIS DIS, V1832, P940, DOI 10.1016/j.bbadis.2012.11.011; Verma SK, 2015, SEMIN NEPHROL, V35, P96, DOI 10.1016/j.semnephrol.2015.01.010; Wen YJ, 2008, TRANSL RES, V152, P38, DOI 10.1016/j.trsl.2008.05.002; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Xavier S, 2015, J AM SOC NEPHROL, V26, P817, DOI 10.1681/ASN.2013101137; Yamamoto S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08505; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yu L, 2004, KIDNEY INT, V66, P1774, DOI 10.1111/j.1523-1755.2004.00901.x; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Zhu J, 2014, J INVEST DERMATOL, V134, P895, DOI 10.1038/jid.2013.484	66	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157288	10.1371/journal.pone.0157288	http://dx.doi.org/10.1371/journal.pone.0157288			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379382	Green Published, gold, Green Submitted			2022-12-27	WOS:000379798700005
J	Zhang, XB; Tang, QL; Wang, XJ; Wang, ZX				Zhang, Xiaobing; Tang, Qiaoling; Wang, Xujing; Wang, Zhixing			Structure of Exogenous Gene Integration and Event-Specific Detection in the Glyphosate-Tolerant Transgenic Cotton Line BG2-7	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; T-DNA INTEGRATION; REAL-TIME PCR; QUANTITATIVE PCR; MAIZE; SEQUENCES; BT11; CANOLA; POLLEN; GENOME	In this study, the flanking sequence of an inserted fragment conferring glyphosate tolerance on transgenic cotton line BG2-7 was analyzed by thermal asymmetric interlaced polymerase chain reaction (TAIL-PCR) and standard PCR. The results showed apparent insertion of the exogenous gene into chromosome D10 of the Gossypium hirsutum L. genome, as the left and right borders of the inserted fragment are nucleotides 61,962,952 and 61,962,921 of chromosome D10, respectively. In addition, a 31-bp cotton microsatellite sequence was noted between the genome sequence and the 5' end of the exogenous gene. In total, 84 and 298 bp were deleted from the left and right borders of the exogenous gene, respectively, with 30 bp deleted from the cotton chromosome at the insertion site. According to the flanking sequence obtained, several pairs of event-specific detection primers were designed to amplify sequence between the 5' end of the exogenous gene and the cotton genome junction region as well as between the 3' end and the cotton genome junction region. Based on screening tests, the 5'-end primers GTCATAACGTGACTCCCTTAA TTCTCC/CCTATTACACGGCTATGC and 3'-end primers TCCTTTCGCTTTCTTCCCTT/ACACTTACATGGCGTCTTCT were used to detect the respective BG2-7 event-specific primers. The limit of detection of the former primers reached 44 copies, and that of the latter primers reached 88 copies. The results of this study provide useful data for assessment of BG2-7 safety and for accelerating its industrialization.	[Zhang, Xiaobing; Tang, Qiaoling; Wang, Xujing; Wang, Zhixing] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China; [Zhang, Xiaobing] Hebei Acad Sci, Inst Biol, Shijiazhuan, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Wang, XJ; Wang, ZX (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	xujingwang0514@126.com; wangcotton@126.com		Zhang, Xiao Bing/0000-0001-7517-613X	Genetically Modified Major Projects [2012ZX08011-003, 2014ZX08011-004B]	Genetically Modified Major Projects	This work was supported by the Genetically Modified Major Projects (No. 2012ZX08011-003 and No. 2014ZX08011-004B).	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; [Anonymous], 2015, THESIS; Christou P., 2002, TRANSGENIC RES, V11, P3, DOI [DOI 10.1023/A:1013903300469, 10.1023/A:1013903300469]; De Buck S, 1999, PLANT J, V20, P295, DOI 10.1046/j.1365-313X.1999.t01-1-00602.x; Kyndt T, 2015, P NATL ACAD SCI USA, V112, P5844, DOI 10.1073/pnas.1419685112; Lee SH, 2006, J AGR FOOD CHEM, V54, P1124, DOI 10.1021/jf052199a; Li Yi, 2012, [Frontiers in Biology, 生物学前沿], V7, P557; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Marmiroli N, 2008, ANAL BIOANAL CHEM, V392, P369, DOI 10.1007/s00216-008-2303-6; PARKER JD, 1991, NUCLEIC ACIDS RES, V19, P3055, DOI 10.1093/nar/19.11.3055; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Singh RJ, 2013, ENVIRON MONIT ASSESS, V185, P485, DOI 10.1007/s10661-012-2569-1; Taverniers I, 2005, J AGR FOOD CHEM, V53, P3041, DOI 10.1021/jf0483467; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099651; Windels P, 2003, PLANT PHYSIOL, V133, P2061, DOI 10.1104/pp.103.027532; Wu G, 2010, FOOD CHEM, V119, P417, DOI 10.1016/j.foodchem.2009.08.031; Xu WT, 2009, J AGR FOOD CHEM, V57, P395, DOI 10.1021/jf802323m; Yang LT, 2006, J AGR FOOD CHEM, V54, P9735, DOI 10.1021/jf061918y; Yang LT, 2005, TRANSGENIC RES, V14, P817, DOI 10.1007/s11248-005-0010-z; Yang LT, 2005, J AGR FOOD CHEM, V53, P6222, DOI 10.1021/jf050095u; Yang LT, 2005, PLANT CELL REP, V24, P237, DOI 10.1007/s00299-005-0929-9; Zhang Baohong, 2013, Methods Mol Biol, V958, P3, DOI 10.1007/978-1-62703-212-4_1; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang XB, 2015, CROP J, V3, P163, DOI 10.1016/j.cj.2014.11.001; [赵建华 Zhao Jianhua], 2013, [分子植物育种, Molecular Plant Breeding], V11, P701; Zhu CF, 2010, J GENET GENOMICS, V37, P189, DOI 10.1016/S1673-8527(09)60037-0; Zimmermann A, 2000, LEBENSM-WISS TECHNOL, V33, P210, DOI 10.1006/fstl.2000.0637	29	5	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158384	10.1371/journal.pone.0158384	http://dx.doi.org/10.1371/journal.pone.0158384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379683	Green Published, gold, Green Submitted			2022-12-27	WOS:000379798700027
J	Olivera-La Rosa, A; Corradi, G; Villacampa, J; Marti-Vilar, M; Arango, OE; Rossello, J				Olivera-La Rosa, Antonio; Corradi, Guido; Villacampa, Javier; Marti-Vilar, Manuel; Eduardo Arango, Olber; Rossello, Jaume			Effects of Suboptimally Presented Erotic Pictures on Moral Judgments: A Cross-Cultural Comparison	PLOS ONE			English	Article							GENDER-DIFFERENCES; DECISION-MAKING; SEX-DIFFERENCES; DISGUST; INTERFERES; RESPONSES; EXPOSURE; STIMULI; AROUSAL; EMPATHY	Previous research has identified a set of core factors that influence moral judgments. The present study addresses the interplay between moral judgments and four factors: (a) incidental affects, (b) sociocultural context, (c) type of dilemma, and (d) participant's sex. We asked participants in two different countries (Colombia and Spain) to judge the acceptability of actions in response to personal and impersonal moral dilemmas. Before each dilemma an affective prime (erotic, pleasant or neutral pictures) was presented suboptimally. Our results show that: a) relative to neutral priming, erotic primes increase the acceptance of harm for a greater good (i.e., more utilitarian judgments), b) relative to Colombians, Spanish participants rated causing harm as less acceptable, c) relative to impersonal dilemmas, personal dilemmas reduced the acceptance of harm, and d) relative to men, women were less likely to consider harm acceptable. Our results are congruent with findings showing that sex is a crucial factor in moral cognition, and they extend previous research by showing the interaction between culture and incidental factors in the making of moral judgments.	[Olivera-La Rosa, Antonio; Eduardo Arango, Olber] Fdn Univ Luis Amigo, Dept Psychol & Social Sci, Medellin, Colombia; [Olivera-La Rosa, Antonio; Corradi, Guido; Villacampa, Javier; Rossello, Jaume] Univ Balearic Isl, CSIC, Human Evolut & Cognit Grp, Associated Grp,IFISC, Palma De Mallorca, Spain; [Marti-Vilar, Manuel] Univ Valencia, Dept Basic Psychol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Valencia	Olivera-La Rosa, A (corresponding author), Fdn Univ Luis Amigo, Dept Psychol & Social Sci, Medellin, Colombia.; Olivera-La Rosa, A (corresponding author), Univ Balearic Isl, CSIC, Human Evolut & Cognit Grp, Associated Grp,IFISC, Palma De Mallorca, Spain.	antonio.oliverade@amigo.edu.co	Rosselló, Jaume/AAA-6333-2020; Rosa, Antonio Olivera-La/AAZ-1370-2020; Corradi, Guido/D-5161-2019; Corradi, Guido/AAK-3101-2021	Rosselló, Jaume/0000-0003-4010-7868; Rosa, Antonio Olivera-La/0000-0001-7637-8518; Corradi, Guido/0000-0001-9163-6829; Corradi, Guido/0000-0001-9163-6829	Spanish Government: Ministry of Economy and Competitiveness [FFI2013-44007-P]; Ministerio de Economia y Competitividad of the Spanish Government [FFI2013-44007-P]	Spanish Government: Ministry of Economy and Competitiveness(Spanish Government); Ministerio de Economia y Competitividad of the Spanish Government(Spanish Government)	This study was supported by the research project FFI2013-44007-P (Spanish Government: Ministry of Economy and Competitiveness). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the research project FFI2013-44007-P funded by the Ministerio de Economia y Competitividad of the Spanish Government (http://www.mineco.gob.es). We would also like to acknowledge Astrid Restrepo, Juliana Medina, Laura Betancur, Luisa Barrientos, Luis Felipe Sarmiento and Arnau Centelles for help in the experimental procedures. We also thank Gordon Ingram and Marcos Nadal for their helpful comments.	Ariely D, 2006, J BEHAV DECIS MAKING, V19, P87, DOI 10.1002/bdm.501; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bartels DM, 2008, COGNITION, V108, P381, DOI 10.1016/j.cognition.2008.03.001; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Christensen JF, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00607; Conway P, 2013, J PERS SOC PSYCHOL, V104, P216, DOI 10.1037/a0031021; Cote S, 2013, J PERS SOC PSYCHOL, V104, P490, DOI 10.1037/a0030931; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Escriva M. V. M, 1998, IBERPSICOLOGIA REV E, V3, P1; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; Flexas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080154; Friesdorf R, 2015, PERS SOC PSYCHOL B, V41, P696, DOI 10.1177/0146167215575731; Fumagalli M, 2010, COGN PROCESS, V11, P219, DOI 10.1007/s10339-009-0335-2; GANTIVA DÍAZ CARLOS ANDRÉS, 2011, Act.Colom.Psicol., V14, P103; Gillath O, 2008, PERS SOC PSYCHOL B, V34, P1057, DOI 10.1177/0146167208318141; Gillath O, 2007, J SEX RES, V44, P111, DOI 10.1080/00224490701263579; Gillath O, 2012, SOC COGN AFFECT NEUR, V7, P924, DOI 10.1093/scan/nsr065; Gilligan Carol., 1982, DIFFERENT VOICE; Gray K, 2011, J PERS SOC PSYCHOL, V101, P1207, DOI 10.1037/a0025883; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; HAIDT J, 1993, J PERS SOC PSYCHOL, V65, P613, DOI 10.1037/0022-3514.65.4.613; Hall JA, 2000, GENDER DIFFERENCES N; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Han H, 2014, BEHAV BRAIN RES, V259, P215, DOI 10.1016/j.bbr.2013.11.012; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Jaffee S, 2000, PSYCHOL BULL, V126, P703, DOI 10.1037//0033-2909.126.5.703; Kagerer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107795; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Laier C, 2014, ARCH SEX BEHAV, V43, P473, DOI 10.1007/s10508-013-0119-8; Landy JF, 2015, PERSPECT PSYCHOL SCI, V10, P518, DOI 10.1177/1745691615583128; Lang P.J, 1998, INT EFFECTIVE PICTUR; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; McGuire J, 2009, J EXP SOC PSYCHOL, V45, P577, DOI 10.1016/j.jesp.2009.01.002; Molto J, 1999, REV PSICOLOGIA GEN A, V52, P58; Murnen SK, 1997, SEX ROLES, V37, P135, DOI 10.1023/A:1025639609402; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Nevala J, 2006, JRL, V17, P476, DOI [10.3200/JRLP.140.2.133-153, DOI 10.3200/JRLP.140.2.133-153]; Ong HH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00194; Prinz J. J., 2008, MORAL PSYCHOL, V1, P367; Pryor PL, 2000, J PSYCHOL, V134, P645, DOI 10.1080/00223980009598243; R. Core Team, 2015, R A LANGUAGE AND ENV; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Shweder R., 1997, MORALITY HLTH, V119, P119; Spiering M, 2003, J SEX RES, V40, P134, DOI 10.1080/00224490309552175; Stellar JE, 2012, EMOTION, V12, P449, DOI 10.1037/a0026508; Strohminger N, 2011, COGNITION, V119, P295, DOI 10.1016/j.cognition.2010.12.012; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Vila J., 2001, REV PSICOLOG A GEN A, V54, P635, DOI DOI 10.6018/analesps.29.3.153591; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x	54	4	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158690	10.1371/journal.pone.0158690	http://dx.doi.org/10.1371/journal.pone.0158690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0TX	27367795	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900049
J	Disayabutr, S; Kim, EK; Cha, SI; Green, G; Naikawadi, RP; Jones, KD; Golden, JA; Schroeder, A; Matthay, MA; Kukreja, J; Erle, DJ; Collard, HR; Wolters, PJ				Disayabutr, Supparerk; Kim, Eun Kyung; Cha, Seung-Ick; Green, Gary; Naikawadi, Ram P.; Jones, Kirk D.; Golden, Jeffrey A.; Schroeder, Aaron; Matthay, Michael A.; Kukreja, Jasleen; Erle, David J.; Collard, Harold R.; Wolters, Paul J.			miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							REPLICATIVE SENESCENCE; P53; EXPRESSION; BIOMARKER; CANCER; IDENTIFICATION; NORMALIZATION; PATHOGENESIS; ASSOCIATION; MUTATIONS	Pathologic features of idiopathic pulmonary fibrosis (IPF) include genetic predisposition, activation of the unfolded protein response, telomere attrition, and cellular senescence. The mechanisms leading to alveolar epithelial cell (AEC) senescence are poorly understood. MicroRNAs (miRNAs) have been reported as regulators of cellular senescence. Senescence markers including p16, p21, p53, and senescence-associated beta-galactosidase (SA-beta gal) activity were measured in type II AECs from IPF lungs and unused donor lungs. miRNAs were quantified in type II AECs using gene expression arrays and quantitative RTPCR. Molecular markers of senescence (p16, p21, and p53) were elevated in IPF type II AECs. SA-beta gal activity was detected in a greater percentage in type II AECs isolated from IPF patients (23.1%) compared to patients with other interstitial lung diseases (1.2%) or normal controls (0.8%). The relative levels of senescence-associated miRNAs miR-34a, miR-34b, and miR-34c, but not miR-20a, miR-29c, or miR-let-7f were significantly higher in type II AECs from IPF patients. Overexpression of miR-34a, miR-34b, or miR-34c in lung epithelial cells was associated with higher SA-beta gal activity (27.8%, 35.1%, and 38.2%, respectively) relative to control treated cells (8.8%). Targets of miR-34 miRNAs, including E2F1, c-Myc, and cyclin E2, were lower in IPF type II AECs. These results show that markers of senescence are uniquely elevated in IPF type II AECs and suggest that the miR-34 family of miRNAs regulate senescence in IPF type II AECs.	[Disayabutr, Supparerk; Kim, Eun Kyung; Cha, Seung-Ick; Green, Gary; Naikawadi, Ram P.; Golden, Jeffrey A.; Schroeder, Aaron; Matthay, Michael A.; Erle, David J.; Collard, Harold R.; Wolters, Paul J.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA; [Kim, Eun Kyung] CHA Univ, Coll Med, CHA Bundang Med Ctr, Dept Internal Med, Songnam, South Korea; [Cha, Seung-Ick] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea; [Jones, Kirk D.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Kukreja, Jasleen] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Disayabutr, Supparerk] Mahidol Univ, Siriraj Hosp, Fac Med, Div Resp Dis & TB,Dept Med, Bangkok, Thailand	University of California System; University of California San Francisco; Pochon Cha University; Kyungpook National University; Kyungpook National University Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mahidol University	Wolters, PJ (corresponding author), Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA.	paul.wolters@ucsf.edu			NIH [HL104422, HL108794, HL51856]; Nina Ireland Program in Lung Health	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nina Ireland Program in Lung Health	This work was supported in part by NIH grants HL104422 and HL108794 (PJW), and HL51856 (MAM) and the Nina Ireland Program in Lung Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Cha SI, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-105; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Hanak V, 2008, CHEST, V134, P133, DOI 10.1378/chest.07-3005; Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kropski JA, 2015, AM J RESP CRIT CARE, V191, P417, DOI 10.1164/rccm.201406-1162OC; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Kuwano K, 1996, AM J RESP CRIT CARE, V154, P477, DOI 10.1164/ajrccm.154.2.8756825; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71, DOI 10.1152/ajplung.00212.2010; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Noppe G, 2009, CYTOM PART A, V75A, P910, DOI 10.1002/cyto.a.20796; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; PINES J, 1994, NATURE, V369, P520, DOI 10.1038/369520a0; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rokavec M, 2014, J MOL CELL BIOL, V6, P214, DOI 10.1093/jmcb/mju003; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Stuart BD, 2014, LANCET RESP MED, V2, P557, DOI 10.1016/S2213-2600(14)70124-9; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006	53	82	85	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158367	10.1371/journal.pone.0158367	http://dx.doi.org/10.1371/journal.pone.0158367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362652	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200065
J	Kandalepas, PC; Mitchell, JW; Gillette, MU				Kandalepas, Patty C.; Mitchell, Jennifer W.; Gillette, Martha U.			Melatonin Signal Transduction Pathways Require E-Box-Mediated Transcription of Per1 and Per2 to Reset the SCN Clock at Dusk	PLOS ONE			English	Article							SUPRACHIASMATIC CIRCADIAN CLOCK; MPER2 ANTISENSE OLIGONUCLEOTIDES; MESSENGER-RNA LEVELS; PHASE-SHIFTS; SLICE PREPARATION; ACTIVITY RHYTHMS; PERIOD HOMOLOGS; RAT; LIGHT; ENTRAINMENT	Melatonin is released from the pineal gland into the circulatory system at night in the absence of light, acting as "hormone of darkness" to the brain and body. Melatonin also can regulate circadian phasing of the suprachiasmatic nucleus (SCN). During the day-to-night transition, melatonin exposure advances intrinsic SCN neural activity rhythms via the melatonin type-2 (MT2) receptor and downstream activation of protein kinase C (PKC). The effects of melatonin on SCN phasing have not been linked to daily changes in the expression of core genes that constitute the molecular framework of the circadian clock. Using real-time RT-PCR, we found that melatonin induces an increase in the expression of two clock genes, Period 1 (Per1) and Period 2 (Per2). This effect occurs at CT 10, when melatonin advances SCN phase, but not at CT 6, when it does not. Using anti-sense oligodeoxynucleotides (a ODNs) to Per 1 and Per 2, as well as to E-box enhancer sequences in the promoters of these genes, we show that their specific induction is necessary for the phase-altering effects of melatonin on SCN neural activity rhythms in the rat. These effects of melatonin on Per1 and Per2 were mediated by PKC. This is unlike day-active non-photic signals that reset the SCN clock by non-PCK signal transduction mechanisms and by decreasing Per1 expression. Rather, this finding extends roles for Per1 and Per2, which are critical to photic phase-resetting, to a nonphotic zeitgeber, melatonin, and suggest that the regulation of these clock gene transcripts is required for clock resetting by diverse regulatory cues.	[Kandalepas, Patty C.; Gillette, Martha U.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Mitchell, Jennifer W.; Gillette, Martha U.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gillette, MU (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.; Gillette, MU (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.	mgillett@illinois.edu			National Heart, Lung and Blood Institute [HL086870]; National Science Foundation [IOS 1354913]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086870] Funding Source: NIH RePORTER; Direct For Biological Sciences [1354913] Funding Source: National Science Foundation	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by The National Heart, Lung and Blood Institute (HL086870) and the National Science Foundation (IOS 1354913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Karen Weis for help with tissue collection, Ghazal Naseri Kouzehgarani for statistical consultation, Deavid Earnest for the gift of the original SCN2.2 cell line, and Ann Benefiel and Maureen Holtz for preparing the manuscript. Support from The National Heart, Lung and Blood Institute (HL086870) and the National Science Foundation (IOS 1354913) is gratefully acknowledged.	Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Benloucif S, 1996, J BIOL RHYTHM, V11, P113, DOI 10.1177/074873049601100204; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; CASSONE VM, 1986, PHYSIOL BEHAV, V36, P1111, DOI 10.1016/0031-9384(86)90488-9; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dobler G, 2012, EPIDEMIOLOGY DISTRIB; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; Dubocovich ML, 1996, BEHAV BRAIN RES, V73, P141; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Fukuhara C, 2001, NEUROSCI LETT, V314, P119, DOI 10.1016/S0304-3940(01)02304-7; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gillette MU, 1996, BEHAV BRAIN RES, V73, P135; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Hamada T, 2004, NEUROSCI LETT, V362, P87, DOI 10.1016/j.neulet.2004.02.061; HATTON GI, 1980, BRAIN RES BULL, V5, P405, DOI 10.1016/S0361-9230(80)80010-4; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Hunt AE, 2001, AM J PHYSIOL-CELL PH, V280, pC110, DOI 10.1152/ajpcell.2001.280.1.C110; Hurst WJ, 2002, BIOCHEM BIOPH RES CO, V298, P133, DOI 10.1016/S0006-291X(02)02346-X; Hurst WJ, 2001, THESIS; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LEWY AJ, 1992, CHRONOBIOL INT, V9, P380, DOI 10.3109/07420529209064550; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; MCARTHUR AJ, 1991, BRAIN RES, V565, P158, DOI 10.1016/0006-8993(91)91748-P; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; Mendoza JY, 2004, NEUROSCIENCE, V127, P529, DOI 10.1016/j.neuroscience.2004.05.026; Nagy AD, 2015, CHRONOBIOL INT, V32, P447, DOI 10.3109/07420528.2014.992525; Pfeffer M, 2012, CHRONOBIOL INT, V29, P415, DOI 10.3109/07420528.2012.667859; Pitrosky B, 1999, AM J PHYSIOL-REG I, V277, pR812, DOI 10.1152/ajpregu.1999.277.3.R812; Poirel VJ, 2003, NEUROSCIENCE, V120, P745, DOI 10.1016/S0306-4522(03)00344-0; PROSSER RA, 1989, P NATL ACAD SCI USA, V86, P6812, DOI 10.1073/pnas.86.17.6812; PROSSER RA, 1989, J NEUROSCI, V9, P1073; REDMAN J, 1983, SCIENCE, V219, P1089, DOI 10.1126/science.6823571; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; Slotten HA, 1999, J BIOL RHYTHM, V14, P347, DOI 10.1177/074873099129000759; Sugiyama T, 2004, BIOCHEM BIOPH RES CO, V323, P479, DOI 10.1016/j.bbrc.2004.08.126; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tischkau SA, 2005, METHOD ENZYMOL, V393, P593, DOI 10.1016/S0076-6879(05)93031-0; Tischkau SA, 2004, NEURON, V43, P539, DOI 10.1016/j.neuron.2004.07.027; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; VANECEK J, 1987, BRAIN RES, V435, P359, DOI 10.1016/0006-8993(87)91625-8; Wakamatsu H, 2001, NEUROREPORT, V12, P127, DOI 10.1097/00001756-200101220-00033; WEAVER DR, 1989, J NEUROSCI, V9, P2581; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	55	36	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157824	10.1371/journal.pone.0157824	http://dx.doi.org/10.1371/journal.pone.0157824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362940	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200024
J	Sjostrom, S; Kallner, HK; Simeonova, E; Madestam, A; Gemzell-Danielsson, K				Sjostrom, Susanne; Kallner, Helena Kopp; Simeonova, Emilia; Madestam, Andreas; Gemzell-Danielsson, Kristina			Medical Abortion Provided by Nurse-Midwives or Physicians in a High Resource Setting: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							ACTING REVERSIBLE CONTRACEPTION; UNINTENDED PREGNANCY; UNITED-STATES; POSTABORTION CONTRACEPTION; SAFE ABORTION; CARE; CHOICE; COHORT; TRIAL	Objective The objective of the present study is to calculate the cost-effectiveness of early medical abortion performed by nurse-midwifes in comparison to physicians in a high resource setting where ultrasound dating is part of the protocol. Non-physician health care professionals have previously been shown to provide medical abortion as effectively and safely as physicians, but the cost-effectiveness of such task shifting remains to be established. Study design A cost effectiveness analysis was conducted based on data from a previously published randomized-controlled equivalence study including 1180 healthy women randomized to the standard procedure, early medical abortion provided by physicians, or the intervention, provision by nurse-midwifes. A 1.6% risk difference for efficacy defined as complete abortion without surgical interventions in favor of midwife provision was established which means that for every 100 procedures, the intervention treatment resulted in 1.6 fewer incomplete abortions needing surgical intervention than the standard treatment. The average direct and indirect costs and the incremental cost-effectiveness ratio (ICER) were calculated. The study was conducted at a university hospital in Stockholm, Sweden. Results The average direct costs per procedure were EUR 45 for the intervention compared to EUR 58.3 for the standard procedure. Both the cost and the efficacy of the intervention were superior to the standard treatment resulting in a negative ICER at EUR -831 based on direct costs and EUR -1769 considering total costs per surgical intervention avoided. Conclusion Early medical abortion provided by nurse-midwives is more cost-effective than provision by physicians. This evidence provides clinicians and decision makers with an important tool that may influence policy and clinical practice and eventually increase numbers of abortion providers and reduce one barrier to women's access to safe abortion.	[Sjostrom, Susanne; Kallner, Helena Kopp; Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Kallner, Helena Kopp] Karolinska Inst, Dept Clin Sci, Danderyds Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Simeonova, Emilia] Johns Hopkins Univ, Carey Sch Business, Baltimore, MD USA; [Madestam, Andreas] Stockholm Univ, Dept Econ, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet; Johns Hopkins University; Stockholm University	Sjostrom, S (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden.	susanne.sjostrom@ki.se	Kallner, Helena Kopp/AAD-4423-2020	Kallner, Helena Kopp/0000-0001-7184-9165	Swedish Research Council, Vetenskapsradet; Council for Working Life and Social Research	Swedish Research Council, Vetenskapsradet(Swedish Research Council); Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by the Swedish Research Council, Vetenskapsradet, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html 521-2009-2605 to KGD and the Council for Working Life and Social Research http://www.hb.se/en/Research/Financiers/FAS-Swedish-council-for-working-life-and-social-research-/ 1404/08 to KGD. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acharya R, 2015, REPROD HEALTH MATTER, V22, P36, DOI 10.1016/S0968-8080(14)43787-X; Collumbien M., 2004, COMP QUANTIFICATION, P1255; Culwell KR, 2013, INT J GYNECOL OBSTET, V121, pS16, DOI 10.1016/j.ijgo.2013.02.003; Fiala C, 2003, EUR J OBSTET GYN R B, V109, P190, DOI 10.1016/S0301-2115(03)00012-5; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Ganatra B, 2015, LANCET GLOB HEALTH, V3, pE512, DOI 10.1016/S2214-109X(15)00145-X; Grimes CE, 2014, TROP DOCT, V44, P128, DOI 10.1177/0049475514535575; Harper CC, 2015, LANCET, V386, P562, DOI 10.1016/S0140-6736(14)62460-0; Henry N, 2015, J FAM PLAN REPROD H, V41, P109, DOI 10.1136/jfprhc-2014-100878; Hu Delphine, 2010, Afr J Reprod Health, V14, P85; Hwang AC, 2005, PERSPECT SEX REPRO H, V37, P92, DOI 10.1363/3709205; Jones RK, 2014, PERSPECT SEX REPRO H, V46, P3, DOI 10.1363/46e0414; Kallner HK, 2015, BJOG-INT J OBSTET GY, V122, P510, DOI 10.1111/1471-0528.12982; Kilander H, 2016, ACTA OBSTET GYN SCAN, V95, P565, DOI 10.1111/aogs.12874; Loi UR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1502-2; Maxwell L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1875-2; Niinimaki M, 2009, BJOG-INT J OBSTET GY, V116, P984, DOI 10.1111/j.1471-0528.2009.02161.x; Rausch M, 2012, FERTIL STERIL, V97, P355, DOI 10.1016/j.fertnstert.2011.11.044; Robson SC, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13530; Rose SB, 2015, HUM REPROD, V30, P214, DOI 10.1093/humrep/deu283; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Trussell J, 2013, CONTRACEPTION, V87, P154, DOI 10.1016/j.contraception.2012.07.016; Warriner IK, 2011, LANCET, V377, P1155, DOI 10.1016/S0140-6736(10)62229-5; Weitz TA, 2013, AM J PUBLIC HEALTH, V103, P454, DOI 10.2105/AJPH.2012.301159; World Health Organization, SAF AB TECHN POL GUI	26	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158645	10.1371/journal.pone.0158645	http://dx.doi.org/10.1371/journal.pone.0158645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362270	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200104
J	Fuentes, MMPB; Delean, S; Grayson, J; Lavender, S; Logan, M; Marsh, H				Fuentes, Mariana M. P. B.; Delean, Steven; Grayson, Jillian; Lavender, Sally; Logan, Murray; Marsh, Helene			Spatial and Temporal Variation in the Effects of Climatic Variables on Dugong Calf Production	PLOS ONE			English	Article							TORRES STRAIT; LIFE-HISTORY; SEAGRASS COMMUNITIES; AERIAL SURVEYS; CONSERVATION; QUEENSLAND; ABUNDANCE; SUSTAINABILITY; AUSTRALIA; DYNAMICS	Knowledge of the relationships between environmental forcing and demographic parameters is important for predicting responses from climatic changes and to manage populations effectively. We explore the relationships between the proportion of sea cows (Dugong dugon) classified as calves and four climatic drivers (rainfall anomaly, Southern Oscillation El Nino Index [SOI], NINO 3.4 sea surface temperature index, and number of tropical cyclones) at a range of spatially distinct locations in Queensland, Australia, a region with relatively high dugong density. Dugong and calf data were obtained from standardized aerial surveys conducted along the study region. A range of lagged versions of each of the focal climatic drivers (1 to 4 years) were included in a global model containing the proportion of calves in each population crossed with each of the lagged versions of the climatic drivers to explore relationships. The relative influence of each predictor was estimated via Gibbs variable selection. The relationships between the proportion of dependent calves and the climatic drivers varied spatially and temporally, with climatic drivers influencing calf counts at sub-regional scales. Thus we recommend that the assessment of and management response to indirect climatic threats on dugongs should also occur at sub-regional scales.	[Fuentes, Mariana M. P. B.; Grayson, Jillian; Marsh, Helene] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia; [Fuentes, Mariana M. P. B.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Delean, Steven] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Delean, Steven] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Lavender, Sally] CSIRO Oceans & Atmosphere Flagship, Aspendale, Vic, Australia; [Logan, Murray] Australian Inst Marine Sci, Townsville, Qld, Australia; [Marsh, Helene] James Cook Univ, Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia	James Cook University; State University System of Florida; Florida State University; University of Adelaide; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Institute of Marine Science; James Cook University	Marsh, H (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia.; Marsh, H (corresponding author), James Cook Univ, Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia.	helene.marsh@jcu.edu.au		Lavender, Sally/0000-0003-4785-1569; Logan, Murray/0000-0001-5102-3972	Australian Fisheries Management Authority; Australian National Parks and Wildlife Service; CRC Torres Strait; Australian Marine Mammal Centre; National Environmental Research Program; Torres Strait Regional Authority	Australian Fisheries Management Authority; Australian National Parks and Wildlife Service; CRC Torres Strait(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Marine Mammal Centre; National Environmental Research Program; Torres Strait Regional Authority	Funding intitutions include: the Australian Fisheries Management Authority, http://www.afma.gov.au/; Australian National Parks and Wildlife Service, http://www.australia.gov.au/about-australia/australian-story/national-parks; CRC Torres Strait, http://rrrc.org.au/crc-torres-strait/; the Australian Marine Mammal Centre, http://www.marinemammals.gov.au/; the National Environmental Research Program, https://www.environment.gov.au/science/nerp; and the Torres Strait Regional Authority, http://www.tsra.gov.au/.	Albert S, 2005, MAR POLLUT BULL, V51, P428, DOI 10.1016/j.marpolbul.2004.10.016; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Boyd Ian L., 1999, P218; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Coles RG, 2015, ESTUAR COAST SHELF S, V153, pA1, DOI 10.1016/j.ecss.2014.07.020; Collier CJ, 2014, MAR POLLUT BULL, V83, P483, DOI 10.1016/j.marpolbul.2014.03.050; Crainiceanu C. M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I14; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Daniell JJ, 2008, CONT SHELF RES, V28, P2188, DOI 10.1016/j.csr.2008.03.036; Dellaportas P, 2002, STAT COMPUT, V12, P27, DOI 10.1023/A:1013164120801; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Fuentes MMPB, 2011, J BIOGEOGR, V38, P1886, DOI 10.1111/j.1365-2699.2011.02541.x; GBRMPA (Great Barrier Reef Marine Park Authority), 2014, GREAT BARR REEF OUTL; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Green D, 2010, CLIMATIC CHANGE, V102, P405, DOI 10.1007/s10584-009-9756-2; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heihsohn G.E., 1974, Biological Conserv, V6, P143; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Limpus C, 2000, ATMOS OCEAN SCI LIB, V21, P399; LIMPUS CJ, 1988, AUST WILDLIFE RES, V15, P157; Lough JM, 2015, CORAL REEFS, V34, P739, DOI 10.1007/s00338-015-1297-8; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Lyons MB, 2013, ESTUAR COAST SHELF S, V120, P42, DOI 10.1016/j.ecss.2013.01.015; MARSH H, 1989, AUST WILDLIFE RES, V16, P429; Marsh H, 2004, ANIM CONSERV, V7, P435, DOI 10.1017/S1367943004001635; MARSH H, 1989, AUST WILDLIFE RES, V16, P639; MARSH H, 1984, AUST J ZOOL, V32, P767, DOI 10.1071/ZO9840767; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Marsh H, 1997, CONSERV BIOL, V11, P1375, DOI 10.1046/j.1523-1739.1997.95309.x; Marsh H, 1999, MAR FRESHWATER RES, V50, P979, DOI 10.1071/MF99080; MARSH H, 1990, AUST WILDLIFE RES, V17, P511; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Marsh H, 1981, THE DUGONG; MARSH HE, 1989, MAR MAMMAL SCI, V5, P78, DOI 10.1111/j.1748-7692.1989.tb00215.x; Marsh H, 2008, CONT SHELF RES, V28, P2152, DOI 10.1016/j.csr.2008.03.023; Marsh H, 2015, BIOL CONSERV, V192, P324, DOI 10.1016/j.biocon.2015.10.007; McKenzie L., 2014, REEF RESC MAR MON PR; Meager JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094849; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Poiner IR, 1996, STAT MARINE ENV REP; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; R Foundation for Statistical Computing, 2014, LANG ENV STAT COMP; Rasheed MA, 2014, MAR POLLUT BULL, V83, P491, DOI 10.1016/j.marpolbul.2014.02.013; Saint-Cast F, 2008, CONT SHELF RES, V28, P2214, DOI 10.1016/j.csr.2008.03.035; Schumann N, 2013, AUST J ZOOL, V61, P146, DOI 10.1071/ZO12131; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sobtzick S., 2012, AERIAL SURVEY URBAN; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Tuljapurkar S., 1997, STRUCTURED POPULATIO; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; Y-S Su, 2014, R2JAGS, pA	55	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0155675	10.1371/journal.pone.0155675	http://dx.doi.org/10.1371/journal.pone.0155675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355367	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000378859400004
J	Betancourt, T; Fawzi, MCS; Stevenson, A; Kanyanganzi, F; Kirk, C; Ng, L; Mushashi, C; Bizimana, JI; Beardslee, W; Raviola, G; Smith, S; Kayiteshonga, Y; Binagwaho, A				Betancourt, Theresa; Fawzi, Mary C. Smith; Stevenson, Anne; Kanyanganzi, Fredrick; Kirk, Catherine; Ng, Lauren; Mushashi, Christina; Bizimana, Justin I.; Beardslee, William; Raviola, Giuseppe; Smith, Stephanie; Kayiteshonga, Yvonne; Binagwaho, Agnes			Ethics in Community-Based Research with Vulnerable Children: Perspectives from Rwanda	PLOS ONE			English	Article							MENTAL-HEALTH; SOLDIERS; GENOCIDE; RISK	A "risk of harm" protocol to identify youth in need of immediate emergency assistance in a study on mental health and HIV in Rwanda among 680 youth ages 10-17 is described. Cases are presented that describe the experience in using this protocol to ensure safety of participants, with ethical and logistical challenges considered. Among the population of the study, 3.2% were deemed "risk of harm." The most prevalent presenting problem was non-fatal suicidal behavior (91% of risk of harm cases), with 36% having a history of a reported previous attempt. Challenges included: acute food insecurity/significant poverty; lack of support/adequate supervision from family members; family violence; alcohol abuse; and HIV-related stigma. Development of a "risk of harm" protocol and collaboration between study staff, community leadership, health authorities, and health workers are critical to ensuring participants' safety in research among vulnerable populations.	[Betancourt, Theresa; Stevenson, Anne; Kirk, Catherine; Ng, Lauren] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Fawzi, Mary C. Smith; Raviola, Giuseppe; Smith, Stephanie; Binagwaho, Agnes] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Kanyanganzi, Fredrick; Mushashi, Christina] Partners Hlth Rwanda Inshuti Mu Buzima PIH IMB, Kigali, Rwanda; [Bizimana, Justin I.; Kayiteshonga, Yvonne; Binagwaho, Agnes] Minist Hlth, Govt Rwanda, Kigali, Rwanda; [Beardslee, William] Boston Childrens Hosp, Boston, MA USA; [Raviola, Giuseppe; Smith, Stephanie] Partners Hlth, Boston, MA USA; [Binagwaho, Agnes] Dartmouth Coll, Hanover, NH 03755 USA; [Kayiteshonga, Yvonne; Binagwaho, Agnes] Univ Global Hlth Equ, Kigali, Rwanda; [Kayiteshonga, Yvonne] Rwanda Biomed Ctr, Kigali, Rwanda	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Partners Healthcare System; Dartmouth College; Rwanda Biomedical Center	Betancourt, T (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	theresa_betancourt@harvard.edu	Kirk, Catherine/T-2596-2019; Raviola, Giuseppe/AAE-9002-2021	Kirk, Catherine/0000-0001-9103-2611; Raviola, Giuseppe/0000-0003-3379-0371	Harvard University Center for AIDS Research [2P30AI060354-07]; Peter C. Alderman Foundation; Harvard Center on the Developing Child; Julie Henry Faculty Development Fund; FXB Center for Health and Human Rights; National Institute of Mental Health [K01MH077246-05, R34MH084679-02, T32MH093310]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH093310, R34MH084679] Funding Source: NIH RePORTER	Harvard University Center for AIDS Research; Peter C. Alderman Foundation; Harvard Center on the Developing Child; Julie Henry Faculty Development Fund; FXB Center for Health and Human Rights; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by the Harvard University Center for AIDS Research (http://cfar.globalhealth.harvard.edu/; HU CFAR NIH/NIAID fund 2P30AI060354-07) with additional support to the overall research program in Rwanda from the Peter C. Alderman Foundation (http://www.petercaldermanfoundation.org/), the Harvard Center on the Developing Child (http://developingchild.harvard.edu/), the Julie Henry Faculty Development Fund, and the FXB Center for Health and Human Rights (http://fxb.harvard.edu/). This publication was additionally supported by grants K01MH077246-05, R34MH084679-02, and T32MH093310 from the National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	10Wassenaar D. R., 2012, OXFORD HDB INT PSYCH, P268; Achenbach T. M., 1991, MANUAL SELF REPORT 1; Betancourt T, 2014, PEDIATRICS, V134, pE464, DOI 10.1542/peds.2013-2734; Betancourt TS, 2010, J AM ACAD CHILD PSY, V49, P606, DOI 10.1016/j.jaac.2010.03.008; Betancourt TS, 2010, CHILD DEV, V81, P1077, DOI 10.1111/j.1467-8624.2010.01455.x; Betancourt TS, 2014, GLOBAL MENTAL HLTH T; Binagwaho A, 2012, PASSAUER DISKUSSIONS; Dyregrov A, 2000, J TRAUMA STRESS, V13, P3, DOI 10.1023/A:1007759112499; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; FENDRICH M, 1990, AM J EPIDEMIOL, V131, P538, DOI 10.1093/oxfordjournals.aje.a115529; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Kabeera B, 2008, INT SOC WORK, V51, P324, DOI 10.1177/0020872807088079; Richardson H.S., 2012, MORAL ENTANGLEMENTS, VVolume 253; Rwanda Ministry of Health, 2010, RWAND COMM BAS HLTH; Tangwa G, 2009, ACTA TROP, V1125, pS16; Thomas G, 2011, QUAL INQ, V17, P511, DOI 10.1177/1077800411409884; WHO Regional Office for Africa, 2009, WHO COUNTRY COOPERAT; World Health Organization, 2011, MENT HLTH ATL RWAND; World Medical Association, 2013, 64 WMA GEN ASS	20	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157042	10.1371/journal.pone.0157042	http://dx.doi.org/10.1371/journal.pone.0157042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27351337	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900005
J	Gaio, V; Nunes, B; Pechirra, P; Conde, P; Guiomar, R; Dias, CM; Barreto, M				Gaio, Vania; Nunes, Baltazar; Pechirra, Pedro; Conde, Patricia; Guiomar, Raquel; Dias, Carlos Matias; Barreto, Marta			Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study	PLOS ONE			English	Article							VIRUS; SUSCEPTIBILITY	Background Recent studies suggest an association between the Interferon Inducible Transmembrane 3 (IFITM3) rs12252 variant and the course of influenza infection. However, it is not clear whether the reported association relates to influenza infection severity. The aim of this study was to estimate the hospitalization risk associated with this variant in Influenza Like Illness (ILI) patients during the H1N1 pandemic influenza. Methods A case-control genetic association study was performed, using nasopharyngeal/oropharyngeal swabs collected during the H1N1 pandemic influenza. Laboratory diagnosis of influenza infection was performed by RT-PCR, the IFITM3 rs12252 was genotyped by RFLP and tested for association with hospitalization. Conditional logistic regression was performed to calculate the confounder-adjusted odds ratio of hospitalization associated with IFITM3 rs12252. Results We selected 312 ILI cases and 624 matched non-hospitalized controls. Within ILI Influenza A(H1N1)pdm09 positive patients, no statistical significant association was found between the variant and the hospitalization risk (Adjusted OR: 0.73 (95% CI: 0.33-1.50)). Regarding ILI Influenza A(H1N1) pdm09 negative patients, CT/CC genotype carriers had a higher risk of being hospitalized than patients with TT genotype (Adjusted OR: 2.54 (95% CI: 1.54-4.19)). Conclusions The IFITM3 rs12252 variant was associated with respiratory infection hospitalization but not specifically in patients infected with Influenza A(H1N1) pdm09.	[Gaio, Vania; Nunes, Baltazar; Dias, Carlos Matias; Barreto, Marta] Inst Nacl Saude Doutor Ricardo Jorge, Dept Epidemiol, P-1649016 Lisbon, Portugal; [Pechirra, Pedro; Conde, Patricia; Guiomar, Raquel] Inst Nacl Saude Doutor Ricardo Jorge, Dept Doencas Infeciosas, P-1649016 Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; Instituto Nacional de Saude Dr. Ricardo Jorge	Barreto, M (corresponding author), Inst Nacl Saude Doutor Ricardo Jorge, Dept Epidemiol, P-1649016 Lisbon, Portugal.	marta.barreto@insa.min-saude.pt	Nunes, Baltazar/V-8903-2019; Dias, Carlos/I-6335-2012; Barreto, Marta/F-5591-2012	Nunes, Baltazar/0000-0001-6230-7209; Dias, Carlos/0000-0002-0206-5874; Gaio, Vania/0000-0001-7626-4991; Conde, Patricia/0000-0002-9346-305X; Guiomar, Raquel/0000-0002-4563-6315; Pechirra, Pedro/0000-0001-6352-1100; Barreto, Marta/0000-0001-6464-548X	National Health Institute Doutor Ricardo Jorge; National Institute of Health Doctor Ricardo Jorge (INSA)	National Health Institute Doutor Ricardo Jorge; National Institute of Health Doctor Ricardo Jorge (INSA)	This study was funded by the National Health Institute Doutor Ricardo Jorge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge all the Colleagues from Infectious Disease Department from National Institute of Health Doctor Ricardo Jorge (INSA) that supported influenza A(H1N1)pdm09 diagnosis during 2009 Pandemia and 2009/2010 influenza season, to address the excess samples sent to National Influenza Reference Laboratory at INSA.	[Anonymous], 2012, EURO SURVEILL, P17; Arcanjo AC, 2014, ACTA BIOCHIM POL, V61, P403; Bautista E., 2010, CLIN ASPECTS PANDEMI; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; European Centre for Disease Prevention and Control (ECDC), 2009, OV SURV INFL 2009 20; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Froes Filipe, 2014, Rev. Port. Sau. Pub., V32, P55; Graffelman J, 2012, HARDYWEINBERG GRAPHI; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; World Health Organization, 2010, PAND H1N1 2009; Yang X, 2015, INTERFERON INDUCIBLE; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433	20	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158181	10.1371/journal.pone.0158181	http://dx.doi.org/10.1371/journal.pone.0158181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351739	gold, Green Submitted, Green Published			2022-12-27	WOS:000378858900041
J	Usui-Ouchi, A; Ouchi, Y; Kiyokawa, M; Sakuma, T; Ito, R; Ebihara, N				Usui-Ouchi, Ayumi; Ouchi, Yasuo; Kiyokawa, Masatoshi; Sakuma, Toshiro; Ito, Rei; Ebihara, Nobuyuki			Upregulation of Mir-21 Levels in the Vitreous Humor Is Associated with Development of Proliferative Vitreoretinal Disease	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIUM RPE; DIABETIC-RETINOPATHY; TGF-BETA; THERAPEUTIC TARGET; EXPRESSION; MICRORNAS; CELLS; FIBROSIS	MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by post transcriptional inhibition of mRNA translation. Dysregulation of miRNAs, including circulating miRNAs, has been reported to play an important role in the development of various diseases, including fibrotic diseases. Aberrant expression of miRNAs in the vitreous humor of vitreoretinal diseased eyes has been reported. However, the expression pattern of miRNAs present in the vitreous humor of proliferative vitreoretinal disease (PVD) patients, including proliferative diabetic retinopathy (PDR), and proliferative vitreoretinopathy (PVR), remains unknown. To investigate the factors important for the development of PVD, we characterized the miRNAs present in the vitreous humor of PVD patients and analyzed the expression profiles of 377 miRNAs using quantitative polymerase chain reaction-based miRNA arrays. The expression of a specific subset of miRNAs, previously reported to be associated with the development of angiogenesis and fibrosis, was significantly altered in the vitreous of PVD patients. Among these miRNAs, we identified miR-21 as a candidate fibrotic miRNA with an important role in the pathogenesis of PVD. Increased miR-21 levels in the vitreous were associated with retinal fibrosis, including PVR and PDR. Because epithelial-mesenchymal transition (EMT) of retinal pigment epithelial cells (RPECs) plays a critical role in retinal fibrosis, the expression of miR-21 in human RPECs was determined. Its expression in RPECs was induced by transforming growth factor-beta, a key growth factor involved in fibrogenesis, and was enhanced by high glucose culture conditions, suggesting that miR-21 expression positively correlates with disease progression. Gain- and loss-of-function studies revealed that miR-21 promoted cell proliferation and migration of ARPE-19 cells without affecting EMT-related gene expression. Together, our studies have identified miR-21 as a potential disease-modifying miRNA in the vitreous humor that is involved in the development of retinal fibrosis and may be a novel marker of PVD.	[Usui-Ouchi, Ayumi; Kiyokawa, Masatoshi; Sakuma, Toshiro; Ito, Rei; Ebihara, Nobuyuki] Juntendo Univ, Urayasu Hosp, Dept Ophthalmol, Chiba, Japan; [Ouchi, Yasuo] Univ Tokyo, Div Innate Regulat Int Res & Dev, Ctr Mucosal Vaccine, Inst Med Sci, Tokyo, Japan	Juntendo University; University of Tokyo	Usui-Ouchi, A (corresponding author), Juntendo Univ, Urayasu Hosp, Dept Ophthalmol, Chiba, Japan.	ausui@juntendo.ac.jp			JSPS KAKENHI [26861469]; Grants-in-Aid for Scientific Research [26870683] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B), grant number (26861469).	Abu El-Asrar Ahmed M., 2007, International Ophthalmology, V27, P11, DOI 10.1007/s10792-007-9053-x; Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Biasutto L, 2013, EXP CELL RES, V319, P2113, DOI 10.1016/j.yexcr.2013.05.005; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Burgos R, 1997, DIABETOLOGIA, V40, P1107, DOI 10.1007/s001250050794; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Chang SH, 2011, TRENDS MOL MED, V17, P650, DOI 10.1016/j.molmed.2011.06.008; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Dunmire JJ, 2013, EXP EYE RES, V108, P68, DOI 10.1016/j.exer.2012.10.016; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Gomez IG, 2015, J CLIN INVEST, V125, P141, DOI 10.1172/JCI75852; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hirota K, 2015, GRAEF ARCH CLIN EXP, V253, P335, DOI 10.1007/s00417-014-2692-5; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Madhyastha R, 2014, BIOCHEM BIOPH RES CO, V451, P615, DOI 10.1016/j.bbrc.2014.08.035; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pottier N, 2014, TRENDS PHARMACOL SCI, V35, P119, DOI 10.1016/j.tips.2014.01.003; Ragusa M, 2015, CANCER BIOL THER, V16, P1387, DOI 10.1080/15384047.2015.1046021; Ragusa M, 2013, MOL VIS, V19, P430; Rayner KJ, 2013, J LIPID RES, V54, P1174, DOI 10.1194/jlr.R034991; Saika S, 2005, LAB INVEST, V85, P838, DOI 10.1038/labinvest.3700294; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Scian MJ, 2011, AM J TRANSPLANT, V11, P2110, DOI 10.1111/j.1600-6143.2011.03666.x; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tosi GM, 2014, J CELL PHYSIOL, V229, P1577, DOI 10.1002/jcp.24606; Tuo JS, 2014, AM J OPHTHALMOL, V157, P728, DOI 10.1016/j.ajo.2013.12.014; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vettori Serena, 2012, Open Rheumatol J, V6, P130, DOI 10.2174/1874312901206010130; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wang JY, 2013, CELL BIOCHEM BIOPHYS, V67, P537, DOI 10.1007/s12013-013-9539-2; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yamada M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-95; Zhao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108005; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Zhou Y, 2013, AM J PATHOL, V183, P1183, DOI 10.1016/j.ajpath.2013.06.032; Zhu HL, 2013, J CLIN IMMUNOL, V33, P1100, DOI 10.1007/s10875-013-9896-z	49	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158043	10.1371/journal.pone.0158043	http://dx.doi.org/10.1371/journal.pone.0158043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351379	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900027
J	Henmyr, V; Lind-Hallden, C; Hallden, C; Sall, T; Carlberg, D; Bachert, C; Cardell, LO				Henmyr, Viktor; Lind-Hallden, Christina; Hallden, Christer; Sall, Torbjorn; Carlberg, Daniel; Bachert, Claus; Cardell, Lars-Olaf			Chronic Rhinosinusitis Patients Show Accumulation of Genetic Variants in PARS2	PLOS ONE			English	Article							ASSOCIATION	Genetic studies of chronic rhinosinusitis (CRS) have identified a total of 53 CRS-associated SNPs that were subsequently evaluated for their reproducibility in a recent study. The rs2873551 SNP in linkage disequilibrium with PARS2 showed the strongest association signal. The present study aims to comprehensively screen for rare variants in PARS2 and evaluate for accumulation of such variants in CRS-patients. Sanger sequencing and long-range PCR were used to screen for rare variants in the putative promoter region and coding sequence of 310 CRS-patients and a total of 21 variants were detected. The mutation spectrum was then compared with data from European populations of the 1000Genomes project (EUR) and the Exome Aggregation Consortium (ExAC). The CRS population showed a significant surplus of low-frequency variants compared with ExAC data. Haplotype analysis of the region showed a significant excess of rare haplotypes in the CRS population compared to the EUR population. Two missense mutations were also genotyped in the 310 CRS patients and 372 CRS-negative controls, but no associations with the disease were found. This is the first re-sequencing study in CRS research and also the first study to show an association of rare variants with the disease.	[Henmyr, Viktor; Lind-Hallden, Christina; Hallden, Christer; Carlberg, Daniel] Kristianstad Univ, Biomed, Kristianstad, Sweden; [Henmyr, Viktor; Sall, Torbjorn] Lund Univ, Dept Biol, Lund, Sweden; [Bachert, Claus] Univ Hosp Ghent, Upper Airways Res Lab, Ghent, Belgium; [Bachert, Claus; Cardell, Lars-Olaf] Karolinska Inst, CLINTEC, Div ENT Dis, Huddinge, Sweden	Kristianstad University; Lund University; Ghent University; Ghent University Hospital; Karolinska Institutet	Henmyr, V (corresponding author), Kristianstad Univ, Biomed, Kristianstad, Sweden.; Henmyr, V (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	viktor.henmyr@hkr.se	Bachert, Claus/J-8825-2012	Carlberg, Daniel/0000-0002-8098-6396				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bosse Y, 2009, HUM GENET, V125, P305, DOI 10.1007/s00439-009-0626-9; Bousquet PJ, 2009, ALLERGY, V64, P1656, DOI 10.1111/j.1398-9995.2009.02169.x; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Fokkens W, 2007, RHINOLOGY, P1; Henmyr V, 2014, J ALLERGY CLIN IMMUN, V133, P273, DOI 10.1016/j.jaci.2013.08.011; Hsu J, 2013, J ALLERGY CLIN IMMUN, V131, P977, DOI 10.1016/j.jaci.2013.01.028; Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Nilsson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053975; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sofou K, 2015, MOL GENET GENOM MED, V3, P59, DOI 10.1002/mgg3.115	18	2	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158202	10.1371/journal.pone.0158202	http://dx.doi.org/10.1371/journal.pone.0158202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348859	Green Published, Green Submitted, gold			2022-12-27	WOS:000378801200050
J	Gefter, L; Morioka-Douglas, N; Srivastava, A; Rodriguez, E				Gefter, Liana; Morioka-Douglas, Nancy; Srivastava, Ashini; Rodriguez, Eunice			Supporting At-Risk Youth and Their Families to Manage and Prevent Diabetes: Developing a National Partnership of Medical Residency Programs and High Schools	PLOS ONE			English	Article							HEALTH BEHAVIORS; ADOLESCENTS; SERVICES; DISEASE; TEXT; RACE	Background The Stanford Youth Diabetes Coaches Program (SYDCP) is a school based health program in which Family Medicine residents train healthy at-risk adolescents to become diabetes self-management coaches for family members with diabetes. This study evaluates the impact of the SYDCP when disseminated to remote sites. Additionally, this study aims to assess perceived benefit of enhanced curriculum. Methods From 2012-2015, 10 high schools and one summer camp in the US and Canada and five residency programs were selected to participate. Physicians and other health providers implemented the SYDCP with racial/ethnic-minority students from low-income communities. Student coaches completed pre- and posttest surveys which included knowledge, health behavior, and psychosocial asset questions (i.e., worth and resilience), as well as open-ended feedback questions. T-test pre-post comparisons were used to determine differences in knowledge and psychosocial assets, and open and axial coding methods were used to analyze qualitative data. Results A total of 216 participating high school students completed both pre-and posttests, and 96 nonparticipating students also completed pre- and posttests. Student coaches improved from pre- to posttest significantly on knowledge (p<0.005 in 2012-13, 2014 camp, and 2014-15); worth (p<0.1 in 2014-15); problem solving (p<0.005 in 2014 camp and p<0.1 in 2014-15); and self-efficacy (p<0.05 in 2014 camp). Eighty-two percent of student coaches reported that they considered making a behavior change to improve their own health as a result of program participation. Qualitative feedback themes included acknowledgment of usefulness and relevance of the program, appreciation for physician instructors, knowledge gain, pride in helping family members, improved relationships and connectedness with family members, and lifestyle improvements. Conclusion Overall, when disseminated, this program can increase health knowledge and some psychosocial assets of at-risk youth and holds promise to empower these youth with health literacy and encourage them to adopt healthy behaviors.	[Gefter, Liana; Morioka-Douglas, Nancy] Stanford Univ, Sch Med, Dept Med, Ctr Primary Care Res,Div Gen Med Disciplines, Stanford, CA USA; [Srivastava, Ashini; Rodriguez, Eunice] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA USA	Stanford University; Stanford University	Gefter, L (corresponding author), Stanford Univ, Sch Med, Dept Med, Ctr Primary Care Res,Div Gen Med Disciplines, Stanford, CA USA.	lianagefter@gmail.com			California HealthCare Foundation [08-1783]; Goldman Sachs Philanthropy Fund	California HealthCare Foundation; Goldman Sachs Philanthropy Fund	This project was funded by the California HealthCare Foundation (grant 08-1783) (http://www.chcf.org/), Goldman Sachs Philanthropy Fund (private donation) (http://www.goldmansachs.com/citizenship/goldman-sachs-gives/index.html), and anonymous private funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Brown BD, 2010, DIABETES EDUCATOR, V36, P924, DOI 10.1177/0145721710382582; Burnet DL, 2011, J NATL MED ASSOC, V103, P269, DOI 10.1016/S0027-9684(15)30290-X; California Healthy Kids Survey California State of Education, 2011, AB THE CHKS; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Corbin J, 2014, BASICS QUALITATIVE R; DeBar LL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-711; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Fassnacht DB, 2015, J NUTR EDUC BEHAV, V47, P75, DOI 10.1016/j.jneb.2014.08.006; Gefter L, 2015, FAM MED, V47, P803; Gefter L, 2014, DIABETES EDUCATOR, V40, P786, DOI 10.1177/0145721714549676; Greenberg MT, 2003, AM PSYCHOL, V58, P466, DOI 10.1037/0003-066X.58.6-7.466; Hoyt LT, 2012, J ADOLESCENT HEALTH, V50, P66, DOI 10.1016/j.jadohealth.2011.05.002; Irons M, 2015, J URBAN HEALTH, P1; Leffert N, 1998, APPL DEV SCI, V2; Lim MSC, 2012, J EPIDEMIOL COMMUN H, V66, P69, DOI 10.1136/jech.2009.100396; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; Paradis AD, 2011, CHILD ADOL MENT H-UK, V16, P30, DOI 10.1111/j.1475-3588.2010.00577.x; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Rothman RL, 2005, DIABETES EDUCATOR, V31, P215, DOI 10.1177/0145721705275002; Scales P.C., 2003, SEARCH I INSIGHTS EV, V1, P1; Shaw M, 2009, DIABETES CARE, V32, P45, DOI 10.2337/dc08-0808; Shaw-Perry M, 2007, J NATL MED ASSOC, V99, P368; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Wild LG, 2004, J CHILD PSYCHOL PSYC, V45, P1454, DOI 10.1111/j.1469-7610.2004.00330.x	29	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158477	10.1371/journal.pone.0158477	http://dx.doi.org/10.1371/journal.pone.0158477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383902	gold, Green Submitted, Green Published			2022-12-27	WOS:000379809400051
J	Grams, L; Garrido, G; Villacieros, J; Ferro, A				Grams, Lena; Garrido, Guadalupe; Villacieros, Jorge; Ferro, Amelia			Marginal Micronutrient Intake in High-Performance Male Wheelchair Basketball Players: A Dietary Evaluation and the Effects of Nutritional Advice	PLOS ONE			English	Article							SPINAL-CORD-INJURY; ATHLETIC PERFORMANCE; ENERGY-EXPENDITURE; SPORTS; GAMES; EXERCISE; DENSITY; HEALTH; RISK	Wheelchair basketball has evolved into a high-performance sport over several years, and small variations in player performance can determine the difference between winning and losing. Therefore, adequate micronutrient intake may influence this difference if performance-promoting macronutrient intake and physical fitness are equal between teams. Seventeen elite male wheelchair basketball players belonging to the Spanish National Team participated in this study. Macro-and micronutrient intake were determined using a food-weighing diary over three consecutive days during three training camps in two consecutive years. Current Dietary Reference Intake levels were used to determine the adequacy of intake of seventeen micronutrients of particular interest for athletes. After categorizing the consumed foods into fourteen food groups according to the National Nutrient Database for Standard References (USDA) these groups were used to identify the best predictors of the adequacy of intake for each micronutrient. Total energy intake correlated positively with the adequacy of all micronutrient intake levels, except for vitamins A and E. Five B vitamins and phosphorus, selenium, and iron showed 100% adequacy. All other micronutrient intake levels were found to be inadequate, e.g., vitamin E (51% adequacy) and calcium (73%). The fruit, fish and cereal food groups were found to be predictors of adequate intake of most micronutrients. Together with energy intake (p = .009,eta(2) = 0.49), the intake of the fruit (p = .032,eta(2) = 0.39) and egg (p = .036, Kendall's W = 0.42) food groups increased significantly over time, along with improved iodine (p = .008, W = 0.61) and magnesium (p = .030, W = 0.44) adequacy levels. Because the adequacy of micronutrient intake correlates positively with energy intake (R = 0.64, p<.001), a varied diet that includes cereals, fish and fruits is especially important for players with low levels of energy intake. Supplements may be a possible solution if adequate micronutrient intake cannot be achieved through regular dietary intake alone. However, dietary analyses should be conducted on a regular basis throughout the year to improve the nutritional knowledge of the athletes and assure adequate micronutrient intake.	[Grams, Lena; Garrido, Guadalupe] Tech Univ Madrid, Dept Hlth & Human Performance, Fac Phys Act & Sport Sci, Madrid, Spain; [Villacieros, Jorge; Ferro, Amelia] Tech Univ Madrid, Dept Sports, Fac Phys Act & Sport Sci, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Ferro, A (corresponding author), Tech Univ Madrid, Dept Sports, Fac Phys Act & Sport Sci, Madrid, Spain.	amelia.ferro@upm.es	Ferro, Amelia/K-7746-2012	Ferro, Amelia/0000-0002-9585-8725; GARRIDO PASTOR, M. GUADALUPE/0000-0002-2695-9741; VILLACIEROS RODRIGUEZ, JORGE/0000-0002-5904-0774	Ministry of Economy and Competitiveness' (MINECO) National Plan RDI [DEP2012-38785]; Higher Sport Council (CSD)	Ministry of Economy and Competitiveness' (MINECO) National Plan RDI; Higher Sport Council (CSD)	This study was supported by the Ministry of Economy and Competitiveness' (MINECO) National Plan R&D&I 2012-2016 (DEP2012-38785). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Higher Sport Council (CSD) for their support and the Spanish Sports Federation for People with Physical Disabilities (FEDDF) and their wheelchair basketball players for participating in the study.	Abel T, 2008, SPINAL CORD, V46, P785, DOI 10.1038/sc.2008.54; Bernardi M, 2010, MED SCI SPORT EXER, V42, P1200, DOI 10.1249/MSS.0b013e3181c67d82; Garcia RB, 2011, NUTR HOSP, V26, P945, DOI [10.3305/nh.2011.26.5.5056, 10.1590/S0212-16112011000500004]; Broad E, 2014, SPORTS NUTR PARALYMP, P23, DOI DOI 10.1201/BL6375-4; Calvo MS, 2013, ANN NY ACAD SCI, V1301, P29, DOI 10.1111/nyas.12300; Canda Alicia, 2009, Journal of Physiological Anthropology, V28, P71, DOI 10.2114/jpa2.28.71; Collins EG, 2010, MED SCI SPORT EXER, V42, P691, DOI 10.1249/MSS.0b013e3181bb902f; Croft L, 2010, INT J SPORT PHYSIOL, V5, P301, DOI 10.1123/ijspp.5.3.301; Deakin V., 2011, Sport and exercise nutrition, P66; Derman W, 2014, PM&R, V6, pS23, DOI 10.1016/j.pmrj.2014.05.016; Flueck JL, 2016, SPINAL IN PRESS 0315; Glaser R M, 1985, Exerc Sport Sci Rev, V13, P263; Gleeson M, 2013, NESTLE NUTR WORKS SE, V75, P85, DOI 10.1159/000345822; Goktepe AS, 2004, AM J PHYS MED REHAB, V83, P279, DOI 10.1097/01.PHM.0000118036.20170.6C; Goosey-Tolfrey V, 2010, DISABIL REHABIL, V32, P2237, DOI 10.3109/09638288.2010.491577; Goosey-Tolfrey VL, 2010, ADAPT PHYS ACT Q, V27, P47, DOI 10.1123/apaq.27.1.47; Halliday TM, 2011, MED SCI SPORT EXER, V43, P335, DOI 10.1249/MSS.0b013e3181eb9d4d; Hemila H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000980.pub4; Institute of Medicine, 2001, DIETARY REFERENCE IN; Institute of Medicine, 2011, DIETARY REFERENCE IN; Institute of Medicine, 2000, DRI DIET REF INT APP; Kreider RB, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-7; Krempien JL, 2011, INT J SPORT NUTR EXE, V21, P417, DOI 10.1123/ijsnem.21.5.417; Krempien JL, 2012, EAT BEHAV, V13, P36, DOI 10.1016/j.eatbeh.2011.11.005; Leicht CA, 2012, SCAND J MED SCI SPOR, V22, P729, DOI 10.1111/j.1600-0838.2011.01328.x; Lin VWH, 2002, ARCH PHYS MED REHAB, V83, P806, DOI 10.1053/apmr.2002.32644; Miyahara K, 2008, J BONE MINER METAB, V26, P101, DOI 10.1007/s00774-007-0789-1; Molina-Lopez J, 2013, NUTR HOSP, V28, P1065, DOI 10.3305/nh.2013.28.4.6600; Murphy SP, 2011, J AM DIET ASSOC, V111, P1065, DOI 10.1016/j.jada.2011.04.004; National Research Council, 2006, DIETARY REFERENCE IN; Perret C., 2015, DISABIL REHABIL, P1; Perret C, 2011, J SPINAL CORD MED, V34, P569, DOI 10.1179/2045772311Y.0000000026; Price M, 2010, SPORTS MED, V40, P681, DOI 10.2165/11531960-000000000-00000; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Ruohola JP, 2006, J BONE MINER RES, V21, P1483, DOI 10.1359/JBMR.060607; Thomas DT, 2016, J ACAD NUTR DIET, V116, P501, DOI 10.1016/j.jand.2015.12.006; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955	37	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157931	10.1371/journal.pone.0157931	http://dx.doi.org/10.1371/journal.pone.0157931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383836	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400031
J	Kopiez, R; Wolf, A; Platz, F; Mons, J				Kopiez, Reinhard; Wolf, Anna; Platz, Friedrich; Mons, Jan			Replacing the Orchestra? - The Discernibility of Sample Library and Live Orchestra Sounds	PLOS ONE			English	Article							DISCRIMINATION	Recently, musical sounds from pre-recorded orchestra sample libraries (OSL) have become indispensable in music production for the stage or popular charts. Surprisingly, it is unknown whether human listeners can identify sounds as stemming from real orchestras or OSLs. Thus, an internet-based experiment was conducted to investigate whether a classic orchestral work, produced with sounds from a state-of-the-art OSL, could be reliably discerned from a live orchestra recording of the piece. It could be shown that the entire sample of listeners (N = 602) on average identified the correct sound source at 72.5%. This rate slightly exceeded Alan Turing's well-known upper threshold of 70% for a convincing, simulated performance. However, while sound experts tended to correctly identify the sound source, participants with lower listening expertise, who resembled the majority of music consumers, only achieved 68.6%. As non-expert listeners in the experiment were virtually unable to tell the real-life and OSL sounds apart, it is assumed that OSLs will become more common in music production for economic reasons.	[Kopiez, Reinhard; Wolf, Anna; Mons, Jan] Univ Mus Drama & Media, Hannover, Germany; [Platz, Friedrich] State Univ Mus & Performing Arts, Stuttgart, Germany		Kopiez, R (corresponding author), Univ Mus Drama & Media, Hannover, Germany.	reinhard.kopiez@hmtm-hannover.de	Wolf, Anna/AAX-5289-2021; Platz, Friedrich/N-9224-2015	Wolf, Anna/0000-0002-6196-6488; Platz, Friedrich/0000-0002-9758-9434; Kopiez, Reinhard/0000-0003-3356-3478				[Anonymous], 2012, DBSONIC V 4 501 COMP; Bacal J, 2002, VIENNA INSTRUMENTS; Batzdorf N, 2003, FIELD TEXT VIENNA SY; Bi J, 2006, SENSORY DISCRIMINATION TESTS AND MEASUREMENTS: STATISTICAL PRINCIPLES, PROCEDURES AND TABLES, P1; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; COOPER M., 2014, NY TIMES; d'Escrivan Julio, 2012, MUSIC TECHNOLOGY; DIVENYI PL, 1974, J ACOUST SOC AM, V56, P144, DOI 10.1121/1.1903245; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Ennis JM, 2011, J SENS STUD, V26, P371, DOI 10.1111/j.1745-459X.2011.00353.x; Gatys L.A., 2015, PREPRINT; Hahnel T, 2013, MUSIC SCI, V17, P410, DOI 10.1177/1029864913492531; Irish D, 2005, GAME PRODUCERS HDB; Kendall RA, 1999, MUSIC PERCEPT, V16, P327; Lebrecht N., 2014, 1 RING WORDS NOW RIN; Macmillan NA, 2005, DETECTION THEORY USE; Massey H., 2009, BEHIND THE GLASS, VII; Massey Howard, 2000, GLASS TOP RECORD PRO; Maxwell S. E., 2004, DESIGNING EXPT ANAL; McGuire S, 2007, AUDIO SAMPLING PRACT; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Munte TF, 2001, NATURE, V409, P580, DOI 10.1038/35054668; Nager W, 2003, COGNITIVE BRAIN RES, V17, P83, DOI 10.1016/S0926-6410(03)00083-1; Oehler M, 2007, P 123 CONV AUD ENV S; Oehler M, 2008, P 10 INT C MUS PERC; Reips U.-D., 2012, APA HDB RES METHODS, V2, P291, DOI [DOI 10.1037/13620-017, 10.1037/13620-017]; Reips UD, 2002, SOC SCI COMPUT REV, V20, P241, DOI 10.1177/08939302020003002; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Russell JH, 2007, WALL STREET J; Smith P., 2003, HANSEL GRETEL ORCHES; Sorkin RD, 1999, BEHAV RES METH INS C, V31, P46, DOI 10.3758/BF03207691; Stewart D, 2003, VIENNA SYMPHONIC LIB; Stravinsky I, 2013, SACRE PRINTEMPS; SUEN CY, 1972, PERCEPT PSYCHOPHYS, V11, P417, DOI 10.3758/BF03206282; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Wright BA, 2003, P INT C AUD DISPL JU	36	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158324	10.1371/journal.pone.0158324	http://dx.doi.org/10.1371/journal.pone.0158324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27382932	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400042
J	Patil, N; Skjonsfjell, ETB; Van den Brande, N; Panduro, EAC; Claessens, R; Guizar-Sicairos, M; Van Mele, B; Breiby, DW				Patil, Nilesh; Skjonsfjell, Eirik Torbjorn Bakken; Van den Brande, Niko; Panduro, Elvia Anabela Chavez; Claessens, Raf; Guizar-Sicairos, Manuel; Van Mele, Bruno; Breiby, Dag Werner			X-Ray Nanoscopy of a Bulk Heterojunction	PLOS ONE			English	Article							POLYMER SOLAR-CELLS; SELF-ORGANIZATION; PHASE RETRIEVAL; THIN-FILMS; MICROSCOPY; BLENDS; PERFORMANCE; MORPHOLOGY; RESOLUTION; DIFFUSION	Optimizing the morphology of bulk heterojunctions is known to significantly improve the photovoltaic performance of organic solar cells, but available quantitative imaging techniques are few and have severe limitations. We demonstrate X-ray ptychographic coherent diffractive imaging applied to all-organic blends. Specifically, the phase-separated morphology in bulk heterojunction photoactive layers for organic solar cells, prepared from a 50: 50 blend of poly(3-hexylthiophene) (P3HT) and phenyl-C61-butyric acid methyl ester (PCBM) and thermally treated for different annealing times is imaged to high resolution. Moreover, using a fast-scanning calorimetry chip setup, the nano-morphological changes caused by repeated thermal annealing applied to the same sample could be monitored. X-ray ptychography resolves to better than 100 nm the phase-segregated domains of electron donor and electron acceptor materials over a large field of view within the active layers. The quantitative phase contrast images further allow us to estimate the local volume fraction of PCBM across the photovoltaically active layers. The volume fraction gradient for different regions provides insight on the PCBM diffusion across the depletion zone surrounding PCBM aggregates. Phase contrast X-ray microscopy is under rapid development, and the results presented here are promising for future studies of organic-organic blends, also under in situ conditions, e.g., for monitoring the structural stability during UV-Vis irradiation.	[Patil, Nilesh; Skjonsfjell, Eirik Torbjorn Bakken; Panduro, Elvia Anabela Chavez; Breiby, Dag Werner] Norwegian Univ Sci & Technol NTNU, Dept Phys, N-7491 Trondheim, Norway; [Van den Brande, Niko; Claessens, Raf; Van Mele, Bruno] Vrije Univ Brussel, Phys Chem & Polymer Sci FYSC, B-1050 Brussels, Belgium; [Guizar-Sicairos, Manuel] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Breiby, Dag Werner] Univ Coll Southeast Norway, Dept Micro & Nanosyst Technol IMST, Campus Vestfold, N-3184 Borre, Norway	Norwegian University of Science & Technology (NTNU); Vrije Universiteit Brussel; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University College of Southeast Norway	Patil, N; Breiby, DW (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Phys, N-7491 Trondheim, Norway.; Breiby, DW (corresponding author), Univ Coll Southeast Norway, Dept Micro & Nanosyst Technol IMST, Campus Vestfold, N-3184 Borre, Norway.	nilesh.v.patil@ntnu.no; dag.breiby@ntnu.no	Guizar-Sicairos, Manuel/I-4899-2013; Guizar-Sicairos, Manuel/AAB-3793-2019; Patil, Nilesh/A-2897-2012; Van Mele, Bruno/AAU-2109-2021	Guizar-Sicairos, Manuel/0000-0002-8293-3634; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Patil, Nilesh/0000-0002-5130-689X; Claessens, Raf/0000-0002-5157-0359; Skjonsfjell, Eirik/0000-0002-6130-5348; Van den Brande, Niko/0000-0002-5324-6261	European Community [262348]; EU [234648/O70]; Norwegian PhD Network on Nanotechnology for Microsystems - Research Council of Norway, Division for Science [221860/F40]	European Community(European Commission); EU(European Commission); Norwegian PhD Network on Nanotechnology for Microsystems - Research Council of Norway, Division for Science	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 262348 (for ESMI). The M-ERA. NET project "RADESOL" is funded under the EU Seventh Framework Programme (FP7/2007-2013), grant agreement no. 234648/O70. Partial funding for this work was obtained from Norwegian PhD Network on Nanotechnology for Microsystems, sponsored by the Research Council of Norway, Division for Science, contract no. 221860/F40.	Aasmundtveit KE, 1999, SYNTHETIC MET, V101, P561, DOI 10.1016/S0379-6779(98)00315-4; Als-Nielsen J., 2011, ELEMENTS MODERN XRAY, DOI 10.1002/9781119998365; Berriman GA, 2015, AIP ADV, V5, DOI 10.1063/1.4932212; Bo Floystad J., 2015, ADV ENG MATER, V17, P545; Boudouris BW, 2011, MACROMOLECULES, V44, P6653, DOI 10.1021/ma201316a; Breiby DW, 2008, J APPL CRYSTALLOGR, V41, P262, DOI 10.1107/S0021889808001064; Burke KB, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265710; Campoy-Quiles M, 2008, NAT MATER, V7, P158, DOI 10.1038/nmat2102; Chen DA, 2011, NANO LETT, V11, P561, DOI 10.1021/nl103482n; Chiu MY, 2008, ADV MATER, V20, P2573, DOI 10.1002/adma.200703097; Chushkin Y, 2014, J SYNCHROTRON RADIAT, V21, P594, DOI 10.1107/S1600577514003440; Coffey DC, 2007, NANO LETT, V7, P738, DOI 10.1021/nl062989e; Collins BA, 2012, NAT MATER, V11, P536, DOI [10.1038/nmat3310, 10.1038/NMAT3310]; Collins BA, 2010, J PHYS CHEM LETT, V1, P3160, DOI 10.1021/jz101276h; Esmaeili M, 2013, MACROMOLECULES, V46, P434, DOI 10.1021/ma3021163; Felten A, 2007, NANO LETT, V7, P2435, DOI 10.1021/nl071134e; Giewekemeyer K, 2011, OPT EXPRESS, V19, P1037, DOI 10.1364/OE.19.001037; Grevin B, 2003, J CHEM PHYS, V118, P7097, DOI 10.1063/1.1561435; Guizar-Sicairos M, 2008, OPT EXPRESS, V16, P7264, DOI 10.1364/OE.16.007264; Guizar-Sicairos M, 2014, OPT EXPRESS, V22, P14859, DOI 10.1364/OE.22.014859; Guizar-Sicairos M, 2011, OPT EXPRESS, V19, P21345, DOI 10.1364/OE.19.021345; Henrich B, 2009, NUCL INSTRUM METH A, V607, P247, DOI 10.1016/j.nima.2009.03.200; Holler M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03857; Hoppe H, 2004, ADV FUNCT MATER, V14, P1005, DOI 10.1002/adfm.200305026; Hoydalsvik K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4884598; Huang XJ, 2014, OPT EXPRESS, V22, P12634, DOI 10.1364/OE.22.012634; Klimov E, 2006, MACROMOLECULES, V39, P4493, DOI 10.1021/ma052590x; Krebs FC, 2009, J MATER CHEM, V19, P5442, DOI 10.1039/b823001c; Labram JG, 2011, ADV ENERGY MATER, V1, P1176, DOI 10.1002/aenm.201100413; Labram JG, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075344; Li G, 2005, NAT MATER, V4, P864, DOI 10.1038/nmat1500; Li G, 2012, NAT PHOTONICS, V6, P153, DOI [10.1038/NPHOTON.2012.11, 10.1038/nphoton.2012.11]; McNeill CR, 2007, MACROMOLECULES, V40, P3263, DOI 10.1021/ma070132d; McNeill CR, 2006, SMALL, V2, P1432, DOI 10.1002/smll.200600300; McNeill CR, 2006, NANO LETT, V6, P1202, DOI 10.1021/nl060583w; Miao JW, 2015, SCIENCE, V348, P530, DOI 10.1126/science.aaa1394; Nguyen LH, 2007, ADV FUNCT MATER, V17, P1071, DOI 10.1002/adfm.200601038; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; Pedersen EBL, 2015, NANOSCALE, V7, P13765, DOI 10.1039/c5nr02824h; Rodenburg JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034801; Rodenburg JM, 2004, APPL PHYS LETT, V85, P4795, DOI 10.1063/1.1823034; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Shapiro DA, 2014, NAT PHOTONICS, V8, P765, DOI [10.1038/nphoton.2014.207, 10.1038/NPHOTON.2014.207]; Swinnen A, 2006, ADV FUNCT MATER, V16, P760, DOI 10.1002/adfm.200500812; Thibault P, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063004; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Treat ND, 2013, MACROMOLECULES, V46, P1002, DOI 10.1021/ma302337p; van Bavel SS, 2009, NANO LETT, V9, P507, DOI 10.1021/nl8014022; Van den Brande N, 2015, POLYMER, V57, P39, DOI 10.1016/j.polymer.2014.12.015; Van den Brande N, 2015, CRYST GROWTH DES, V15, P5614, DOI 10.1021/acs.cgd.5b01331; Vila-Comamala J, 2011, OPT EXPRESS, V19, P21333, DOI 10.1364/OE.19.021333; Watts B, 2009, MACROMOLECULES, V42, P8392, DOI 10.1021/ma901444u; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Wodo O, 2013, ENERG ENVIRON SCI, V6, P3060, DOI 10.1039/c3ee41224e; Yang X, 2007, MACROMOLECULES, V40, P1353, DOI 10.1021/ma0618732; Zhao JB, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.27	56	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158345	10.1371/journal.pone.0158345	http://dx.doi.org/10.1371/journal.pone.0158345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367796	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900029
J	Yean, CYS; Raju, KS; Xavier, R; Subramaniam, S; Gopinath, SCB; Chinni, SV				Yean, Cheryl Yeap Soo; Raju, Kishanraj Selva; Xavier, Rathinam; Subramaniam, Sreeramanan; Gopinath, Subash C. B.; Chinni, Suresh V.			Molecular Detection of Methicillin-Resistant Staphylococcus aureus by Non-Protein Coding RNA-Mediated Monoplex Polymerase Chain Reaction	PLOS ONE			English	Article							LEVEL MUPIROCIN RESISTANCE; EXFOLIATIVE TOXINS; BACILLUS-SUBTILIS; NONCODING RNAS; MULTIPLEX PCR; MESSENGER-RNA; HUT OPERON; DNA PROBE; GENE; IDENTIFICATION	Non-protein coding RNA (npcRNA) is a functional RNA molecule that is not translated into a protein. Bacterial npcRNAs are structurally diversified molecules, typically 50-200 nucleotides in length. They play a crucial physiological role in cellular networking, including stress responses, replication and bacterial virulence. In this study, by using an identified npcRNA gene (Sau-02) in Methicillin-resistant Staphylococcus aureus (MRSA), we identified the Gram-positive bacteria S. aureus. A Sau-02-mediated monoplex Polymerase Chain Reaction (PCR) assay was designed that displayed high sensitivity and specificity. Fourteen different bacteria and 18 S. aureus strains were tested, and the results showed that the Sau-02 gene is specific to S. aureus. The detection limit was tested against genomic DNA from MRSA and was found to be similar to 10 genome copies. Further, the detection was extended to whole-cell MRSA detection, and we reached the detection limit with two bacteria. The monoplex PCR assay demonstrated in this study is a novel detection method that can replicate other npcRNA-mediated detection assays.	[Yean, Cheryl Yeap Soo; Raju, Kishanraj Selva; Xavier, Rathinam; Chinni, Suresh V.] AIMST Univ, Fac Sci Appl, Dept Biotechnol, Bedong, Malaysia; [Subramaniam, Sreeramanan] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Inst Nano Elect Engn, Kangar, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Arau, Perlis, Malaysia	AIMST University; Universiti Sains Malaysia; Universiti Malaysia Perlis; Universiti Malaysia Perlis	Chinni, SV (corresponding author), AIMST Univ, Fac Sci Appl, Dept Biotechnol, Bedong, Malaysia.	v_suresh@aimst.edu.my	Chinni, Venkata Suresh/A-7313-2011; Raju, Kishan Raj Selva/AAV-1811-2020; Subramaniam, Sreeramanan/AAA-5094-2022; Subramaniam, Sreeramanan Sree/I-1130-2012; Yeap, Cheryl S.Y./AAY-4517-2021; Gopinath, Subash/D-2953-2015	Raju, Kishan Raj Selva/0000-0003-2874-7440; Subramaniam, Sreeramanan Sree/0000-0003-4392-285X; Yeap, Cheryl S.Y./0000-0002-7384-9254; Gopinath, Subash/0000-0002-8347-4687; Suresh Chinni, Venkata/0000-0002-4697-2994	Fundamental Research Grant Scheme (Ministry of Higher Education, Malaysia) [FRGS/1/2014/SG03/AIMST/02/2]	Fundamental Research Grant Scheme (Ministry of Higher Education, Malaysia)	SVC thanks Fundamental Research Grant Scheme (FRGS/1/2014/SG03/AIMST/02/2, Ministry of Higher Education, Malaysia (http://portal.mygrants.gov.my/main.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qatouseh LF, 2010, J MOL MED, V88, P565, DOI 10.1007/s00109-010-0597-2; ARCHER GL, 1990, ANTIMICROB AGENTS CH, V34, P1720, DOI 10.1128/AAC.34.9.1720; Chen C, 2015, INFECT IMMUN, V83, P3302, DOI 10.1128/IAI.00159-15; Chinni SV, 2010, NUCLEIC ACIDS RES, V38, P5893, DOI 10.1093/nar/gkq281; Cleven BEE, 2006, J CLIN MICROBIOL, V44, P2389, DOI 10.1128/JCM.02291-05; DELENCASTRE H, 1991, ANTIMICROB AGENTS CH, V35, P632, DOI 10.1128/AAC.35.4.632; Delport JA, 2016, J MED MICROBIOL; Fournier P-E, 2014, GENOME MED, P6; Gopinath SCB, 2008, NUCLEIC ACIDS RES, V36, P3463, DOI 10.1093/nar/gkn199; Gopinath SCB, 2010, MOL CANCER RES, V8, P1536, DOI 10.1158/1541-7786.MCR-10-0242; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; HODGSON JE, 1994, ANTIMICROB AGENTS CH, V38, P1205, DOI 10.1128/AAC.38.5.1205; Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P66, DOI 10.2471/BLT.15.152710; Hrdlickova B, 2014, BBA-MOL BASIS DIS, V1842, P1910, DOI 10.1016/j.bbadis.2014.03.011; JOHNSON WM, 1991, J CLIN MICROBIOL, V29, P426, DOI 10.1128/JCM.29.3.426-430.1991; Krishnan PU, 2002, J CLIN PATHOL, V55, P745, DOI 10.1136/jcp.55.10.745; Kumarevel TS, 2004, NUCLEIC ACIDS RES, V32, P3904, DOI 10.1093/nar/gkh725; Lakshmipriya T, 2013, ANALYST, V138, P2863, DOI 10.1039/c3an00298e; LIGOZZI M, 1991, ANTIMICROB AGENTS CH, V35, P575, DOI 10.1128/AAC.35.3.575; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Nadzirah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139766; Nithya R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118668; Panda RK, 2016, J CLIN DIAGN RES, V10, pDC19, DOI 10.7860/JCDR/2016/17476.7278; PANLILIO AL, 1992, INFECT CONT HOSP EP, V13, P582; Perumal V, 2016, BIOSENS BIOELECTRON, V78, P14, DOI 10.1016/j.bios.2015.10.083; Pillai Manju M, 2012, J Lab Physicians, V4, P83, DOI 10.4103/0974-2727.105587; Proctor R. A., 2014, FRONT CELL INFECT MI, V4, DOI [10.3389/fcimb.2014.0009925120957, DOI 10.3389/FCIMB.2014.0009925120957]; Rasmussen AKI, 2010, J CLIN MICROBIOL, V48, P4253, DOI 10.1128/JCM.00088-10; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Seyedmonir E, 2015, B ENVIRON CONTAM TOX, V95, P131, DOI 10.1007/s00128-015-1510-z; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; UNAL S, 1992, J CLIN MICROBIOL, V30, P1685, DOI 10.1128/JCM.30.7.1685-1691.1992; VANNUFFEL P, 1995, J CLIN MICROBIOL, V33, P2864, DOI 10.1128/JCM.33.11.2864-2867.1995; Vannuffel P, 1998, J CLIN MICROBIOL, V36, P2366, DOI 10.1128/JCM.36.8.2366-2368.1998; Vijian D, 2016, BIOSENS BIOELECTRON, V77, P805, DOI 10.1016/j.bios.2015.10.057; Xu Z, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00947; Zhao WH, 2010, CRIT REV MICROBIOL, V36, P245, DOI 10.3109/1040841X.2010.481763	39	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158736	10.1371/journal.pone.0158736	http://dx.doi.org/10.1371/journal.pone.0158736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367909	Green Submitted, Green Published, gold			2022-12-27	WOS:000378914900051
J	Zhang, ZS; Pei, J; Wang, D; Gan, Q; Ye, J; Yue, J; Wang, BZ; Povoski, SP; Martin, EW; Hitchcock, CL; Yilmaz, A; Tweedle, MF; Shao, PF; Xu, RX				Zhang, Zeshu; Pei, Jing; Wang, Dong; Gan, Qi; Ye, Jian; Yue, Jian; Wang, Benzhong; Povoski, Stephen P.; Martin, Edward W., Jr.; Hitchcock, Charles L.; Yilmaz, Alper; Tweedle, Michael F.; Shao, Pengfei; Xu, Ronald X.			A Wearable Goggle Navigation System for Dual-Mode Optical and Ultrasound Localization of Suspicious Lesions: Validation Studies Using Tissue-Simulating Phantoms and an Ex Vivo Human Breast Tissue Model	PLOS ONE			English	Article							NEAR-INFRARED FLUORESCENCE; LYMPH-NODE BIOPSY; INDOCYANINE-GREEN; GUIDED SURGERY; RE-EXCISION; SPECIMEN; PATIENT; FUSION	Surgical resection remains the primary curative treatment for many early-stage cancers, including breast cancer. The development of intraoperative guidance systems for identifying all sites of disease and improving the likelihood of complete surgical resection is an area of active ongoing research, as this can lead to a decrease in the need of subsequent additional surgical procedures. We develop a wearable goggle navigation system for dual-mode optical and ultrasound imaging of suspicious lesions. The system consists of a light source module, a monochromatic CCD camera, an ultrasound system, a Google Glass, and a host computer. It is tested in tissue-simulating phantoms and an ex vivo human breast tissue model. Our experiments demonstrate that the surgical navigation system provides useful guidance for localization and core needle biopsy of simulated tumor within the tissue-simulating phantom, as well as a core needle biopsy and subsequent excision of Indocyanine Green (ICG)-fluorescing sentinel lymph nodes. Our experiments support the contention that this wearable goggle navigation system can be potentially very useful and fully integrated by the surgeon for optimizing many aspects of oncologic surgery. Further engineering optimization and additional in vivo clinical validation work is necessary before such a surgical navigation system can be fully realized in the everyday clinical setting.	[Zhang, Zeshu; Wang, Dong; Gan, Qi; Ye, Jian; Shao, Pengfei; Xu, Ronald X.] Univ Sci & Technol China, Sch Engn Sci, Hefei, Peoples R China; [Pei, Jing; Yue, Jian; Wang, Benzhong] Anhui Med Univ, Dept Surg, Hefei, Peoples R China; [Wang, Dong; Yilmaz, Alper; Xu, Ronald X.] Ohio State Univ, Coll Engn, Columbus, OH 43210 USA; [Povoski, Stephen P.; Martin, Edward W., Jr.] Ohio State Univ, Dept Surg, Div Surg Oncol, Wexner Med Ctr, Columbus, OH 43210 USA; [Hitchcock, Charles L.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Tweedle, Michael F.] Ohio State Univ, Coll Med, Dept Radiol, Wright Ctr Innovat, Columbus, OH 43210 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Shao, PF; Xu, RX (corresponding author), Univ Sci & Technol China, Sch Engn Sci, Hefei, Peoples R China.; Xu, RX (corresponding author), Ohio State Univ, Coll Engn, Columbus, OH 43210 USA.; Povoski, SP (corresponding author), Ohio State Univ, Dept Surg, Div Surg Oncol, Wexner Med Ctr, Columbus, OH 43210 USA.	stephen.povoski@osu.edu; spf@ustc.edu.cn; xu.202@osu.edu	Yilmaz, Alper/B-5609-2013	Yilmaz, Alper/0000-0003-0755-2628	OSUCCC Intramural Research Program Pelotonia Award; Fundamental Research Funds for the Central University; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	OSUCCC Intramural Research Program Pelotonia Award; Fundamental Research Funds for the Central University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an OSUCCC Intramural Research Program Pelotonia Award.; We are grateful for the contributions of Xiaojun Xu and Jun Xu at the First Affiliated Hospital of Anhui Medical University for their clinical suggestions. We also thank Chuanzhen Hu and Chuanli Xiao at the University of Science and Technology of China for their technical support. The work reported in this manuscript is partially supported by the Fundamental Research Funds for the Central University and an OSUCCC Intramural Research Program Pelotonia Award.	Aoyama K, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-157; Bani MR, 2009, EJSO-EUR J SURG ONC, V35, P32, DOI 10.1016/j.ejso.2008.04.008; Bass SS, 2001, J AM COLL SURGEONS, V192, P9, DOI 10.1016/S1072-7515(00)00771-7; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Clarke GM, 2006, PHYS MED BIOL, V51, P5089, DOI 10.1088/0031-9155/51/20/002; Dixon BJ, 2014, AM J RHINOL ALLERGY, V28, P433, DOI 10.2500/ajra.2014.28.4067; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Fleming FJ, 2004, EJSO-EUR J SURG ONC, V30, P233, DOI 10.1016/j.ejso.2003.11.008; Gioux S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106014; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hwang AD, 2014, OPTOMETRY VISION SCI, V91, P1021, DOI 10.1097/OPX.0000000000000326; Kaplan I, 2002, MAGN RESON IMAGING, V20, P295, DOI 10.1016/S0730-725X(02)00490-3; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Liu Y, 2013, ANALYST, V138, P2254, DOI 10.1039/c3an00165b; Liu Y, 2011, SURGERY, V149, P689, DOI 10.1016/j.surg.2011.02.007; Marks L, 2013, CURR OPIN UROL, V23, P43, DOI 10.1097/MOU.0b013e32835ad3ee; Meyer JS, 1998, J SURG ONCOL, V69, P212, DOI 10.1002/(SICI)1096-9098(199812)69:4<212::AID-JSO4>3.0.CO;2-V; Mieog JSD, 2010, MOL IMAGING, V9, P223, DOI 10.2310/7290.2010.00014; Mothes H, 2004, J TRAUMA, V57, P1018, DOI 10.1097/01.TA.0000123041.47008.70; Muensterer OJ, 2014, INT J SURG, V12, P281, DOI 10.1016/j.ijsu.2014.02.003; Murawa D, 2009, BRIT J SURG, V96, P1289, DOI 10.1002/bjs.6721; Ogasawara Y, 2008, WORLD J SURG, V32, P1924, DOI 10.1007/s00268-008-9519-7; Povoski SP, 2006, ANN SURG ONCOL, V13, P1412, DOI 10.1245/s10434-006-9022-z; Povoski SP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-254; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Schiller DE, 2008, ANN SURG ONCOL, V15, P833, DOI 10.1245/s10434-007-9711-2; Shao PF, 2014, ANN BIOMED ENG, V42, P2228, DOI 10.1007/s10439-014-1062-0; Sonn GA, 2013, J UROLOGY, V189, P86, DOI 10.1016/j.juro.2012.08.095; Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Waljee JF, 2008, ANN SURG ONCOL, V15, P1297, DOI 10.1245/s10434-007-9777-x; Xing Y, 2006, BRIT J SURG, V93, P539, DOI 10.1002/bjs.5209; Xu RX, 2007, EXPERT REV MED DEVIC, V4, P83, DOI 10.1586/17434440.4.1.83; Xu RX, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3147424; Zhang ZS, 2016, SPIE BIOS	37	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0157854	10.1371/journal.pone.0157854	http://dx.doi.org/10.1371/journal.pone.0157854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367051	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900014
J	de Castro, DB; Pinto, RC; de Albuquerque, BC; Sadahiro, M; Braga, JU				de Castro, Daniel Barros; Pinto, Rosemary Costa; de Albuquerque, Bernardino Claudio; Sadahiro, Megumi; Braga, Jose Ueleres			The Socioeconomic Factors and the Indigenous Component of Tuberculosis in Amazonas	PLOS ONE			English	Article							SOCIAL DETERMINANTS; BRAZILIAN AMAZON; RISK-FACTORS	Despite the availability of tuberculosis prevention and control services throughout Amazonas, high rates of morbidity and mortality from tuberculosis remain in the region. Knowledge of the social determinants of tuberculosis in Amazonas is important for the establishment of public policies and the planning of effective preventive and control measures for the disease. To analyze the relationship of the spatial distribution of the incidence of tuberculosis in municipalities and regions of Amazonas to the socioeconomic factors and indigenous tuberculosis component, from 2007 to 2013. An ecological study was conducted based on secondary data from the epidemiological surveillance of tuberculosis. A linear regression model was used to analyze the relationship of the annual incidence of tuberculosis to the socioeconomic factors, performance indicators of health services, and indigenous tuberculosis component. The distribution of the incidence of tuberculosis in the municipalities of Amazonas was positively associated with the Gini index and the population attributable fraction of tuberculosis in the indigenous peoples, but negatively associated with the proportion of the poor and the unemployment rate. The spatial distribution of tuberculosis in the different regions of Amazonas was heterogeneous and closely related with the socioeconomic factors and indigenous component of tuberculosis.	[de Castro, Daniel Barros; Pinto, Rosemary Costa; de Albuquerque, Bernardino Claudio; Sadahiro, Megumi] Hlth Surveillance Fdn Amazonas State, Manaus, Amazonas, Brazil; [de Castro, Daniel Barros; Braga, Jose Ueleres] Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil; [Braga, Jose Ueleres] PVS PECTI SAUDE Res Fdn State Amazonas, Manaus, Amazonas, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro	Braga, JU (corresponding author), Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), PVS PECTI SAUDE Res Fdn State Amazonas, Manaus, Amazonas, Brazil.	ueleres@gmail.com	Braga, Jose Ueleres/AAB-1326-2021	Braga, Jose Ueleres/0000-0001-5247-007X	Government of the State of Amazonas, through the Research Foundation of the State of Amazonas	Government of the State of Amazonas, through the Research Foundation of the State of Amazonas	This work was supported by the Government of the State of Amazonas, through the Research Foundation of the State of Amazonas, by providing scholarships. DBC is a fellow of the RH-PhD program from the Research Foundation for the State of Amazonas-FAPEAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante JM, 2000, B PNEUMOLOGIA SANITA, V8, P5; [Anonymous], 2012, CENS DEM 2010 CAR GE; Baruzzi R G, 2001, Cad Saude Publica, V17, P407, DOI 10.1590/S0102-311X2001000200015; Basta RC, 2006, INT J TUBERC LUNG D, V10, P1354; Bhargava A, 2014, NATL MED J INDIA, V27, P128; Braga JU, 2007, REV SAUDE PUBL, V41; Brasil, 2011, MAN REC CONTR TUB BR; Brasil, 2015, IND DES SIST UN SAUD; Brasil, 2014, 44 MIN SAUD; Buchillet, 1998, Cad Saude Publica, V14, P181, DOI 10.1590/S0102-311X1998000100026; Costa DC, 1987, CAD SAUDE PUBLICA, V3, P388; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Rios DPG, 2013, REV PANAM SALUD PUBL, V33, P22, DOI 10.1590/S1020-49892013000100004; Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008; Holtgrave DR, 2004, AM J PREV MED, V26, P159, DOI 10.1016/j.amepre.2003.10.014; Instituto Brasileiro de Geografiae Estatistica. (IBGE), 2013, PROJ POP BRAS UN FED; IPEA-INSTITUTO DE PESQUISA ECONOMICA APLICADA, 2017, IND DES HUM MUN BRAS; Kawatsu Lisa, 2015, Kekkaku, V90, P395; Leung CC, 2004, INT J TUBERC LUNG D, V8, P958; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Marreiro LS, 2003, TUBERCULOSE MANAUS E, V237; Nazareth T, 2011, REV PARANA DESENVOLV, P201; Programa das Nacoes Unidas para o desenvolvimento (PNUD), 2013, ATL DES HUM BRAS; Santos RV, 2011, CAD SAUDE PUBLICA, V27, P1049, DOI 10.1590/S0102-311X2011000600001; Sousa AO, 1997, P NATL ACAD SCI USA, V94, P13227, DOI 10.1073/pnas.94.24.13227; Suk JE, 2009, EMERG INFECT DIS, V15, P1812, DOI 10.3201/eid1511.090916; Tanrikulu AC, 2008, PUBLIC HEALTH, V122, P613, DOI 10.1016/j.puhe.2007.09.005; WHO, 2014, GLOB TUB REP 2014	28	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158574	10.1371/journal.pone.0158574	http://dx.doi.org/10.1371/journal.pone.0158574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362428	Green Submitted, gold, Green Published			2022-12-27	WOS:000378865200095
J	Dhawan, U; Pan, HA; Lee, CH; Chu, YH; Huang, GS; Lin, YR; Chen, WL				Dhawan, Udesh; Pan, Hsu An; Lee, Chia Hui; Chu, Ying Hao; Huang, Guewha Steven; Lin, Yan Ren; Chen, Wen Liang			Spatial Control of Cell-Nanosurface Interactions by Tantalum Oxide Nanodots for Improved Implant Geometry	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX STIFFNESS; OSTEOBLAST-LIKE CELLS; TOPOGRAPHICAL CONTROL; SURFACE-TOPOGRAPHY; CYTOCHALASIN-D; TITANIUM; NANOTOPOGRAPHY; ADHESION; MODULATION; INDUCTION	Nanotopological cues can be exploited to understand the nature of interactions between cells and their microenvironment to generate superior implant geometries. Nanosurface parameters which modulate the cell behavior and characteristics such as focal adhesions, cell morphology are not clearly understood. Here, we studied the role of different nanotopographic dimensions in modulating the cell behavior, characteristics and ultimately the cell fate and accordingly, a methodology to improve implant surface geometry is proposed. Tantalum oxide nanodots of 50, 100nm dot diameter with an inter-dot spacing of 20, 70nm and heights 40, 100nm respectively, were engineered on Silicon substrates. MG63 cells were cultured for 72 hours and the modulation in morphology, focal adhesions, cell extensible area, cell viability, transcription factors and genes responsible for bone protein secretion as a function of the nanodot diameter, inter-dot distance and nanodot height were evaluated. Nanodots of 50nm diameter with a 20nm inter-dot spacing and 40nm height enhanced cell spreading area by 40%, promoted cell viability by 70% and upregulated transcription factors and genes twice as much, as compared to the 100nm nanodots with 70nm inter-dot spacing and 100nm height. Favorable interactions between cells and all dimensions of 50nm nanodot diameter were observed, determined with Scanning electron microscopy and Immunofluorescence staining. Nanodot height played a vital role in controlling the cell fate. Dimensions of nanodot features which triggered a transition in cell characteristics or behavior was also defined through statistical analysis. The findings of this study provide insights in the parameters of nanotopographic features which can vitally control the cell fate and should therefore be taken into account when designing implant geometries.	[Dhawan, Udesh; Pan, Hsu An; Lee, Chia Hui; Chu, Ying Hao] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu, Taiwan; [Huang, Guewha Steven] Hokan Life Technol, Taichung, Taiwan; [Lin, Yan Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Lin, Yan Ren] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Lin, Yan Ren] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Wen Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Changhua Christian Hospital; Kaohsiung Medical University; Chung Shan Medical University; National Yang Ming Chiao Tung University	Lin, YR (corresponding author), Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan.; Lin, YR (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.; Lin, YR (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, WL (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	h6213.lac@gmail.com; wenurea@yahoo.com.tw	Lin, Yan-Ren/AAU-4136-2020; Ying-Hao, Chu/A-4204-2008	Lin, Yan-Ren/0000-0002-9015-2678; Ying-Hao, Chu/0000-0002-3435-9084; Dhawan, Udesh/0000-0002-0393-9414; Chen, Wen Liang/0000-0003-4308-3128	National Science Council of Taiwan, Republic of China [104-2314-B-271-010, 104-2622-E-009-016-CC2]	National Science Council of Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was funded by National Science Council of Taiwan, Republic of China grants 104-2314-B-271-010 and 104-2622-E-009-016-CC2. The commercial affiliation, Hokan Life Technology, did not provide any funding for conducting this study. This commercial affiliation did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation, Hokan Life Technology, did not provide financial support in the form of author' salaries and/or research materials. The specific role of the author, Guewha Steven Huang, is mentioned in the "authors' contribution" section.	Abrams GA, 2003, UROL RES, V31, P341, DOI 10.1007/s00240-003-0347-9; Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009; ARONSON AS, 1985, SKELETAL RADIOL, V14, P207, DOI 10.1007/BF00355566; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046; Barthes J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/921905; Bencharit S, 2014, CLIN IMPLANT DENT R, V16, P817, DOI 10.1111/cid.12059; Bergmair I, 2010, MICROELECTRON ENG, V87, P1008, DOI 10.1016/j.mee.2009.11.109; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]; CLARK P, 1987, DEVELOPMENT, V99, P439; Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]; Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498; Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7; Dhawan U, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0144-y; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hung YC, 2010, LAB CHIP, V10, P1189, DOI 10.1039/b921354f; Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4; Kim DH, 2012, INTEGR BIOL-UK, V4, P1019, DOI 10.1039/c2ib20067h; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Kim DH, 2012, IEEE INT C NAN; Kumar S, 2016, J BIOMED MATER RES B, V104, P732, DOI 10.1002/jbm.b.33549; Lee CH, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-250; Lu J, 2012, TISSUE ENG PT A, V18, P1389, DOI [10.1089/ten.tea.2011.0268, 10.1089/ten.TEA.2011.0268]; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Mohiuddin M, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-394; Nazneen F, 2012, J BIOMED MATER RES B, V100B, P1989, DOI 10.1002/jbm.b.32772; Paganias CG, 2012, INDIAN J ORTHOP, V46, P505, DOI 10.4103/0019-5413.101032; Pamukcu Guven E, 2013, J APPL ORAL SCI, V21, P351, DOI [10.1590/1679-775720130047, 10.1590/1678-775720130047]; Pan HA, 2013, BIOMATERIALS, V34, P841, DOI 10.1016/j.biomaterials.2012.09.078; Pan HA, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/33/335703; Pan HA, 2012, BIOMATERIALS, V33, P20, DOI 10.1016/j.biomaterials.2011.09.054; Pan HA, 2009, NANOSCALE RES LETT, V4, P903, DOI 10.1007/s11671-009-9333-7; Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Squire MW, 1996, BIOMATERIALS, V17, P725, DOI 10.1016/0142-9612(96)86743-3; Tamjid E, 2013, J BIOMED MATER RES A, V101, P2796, DOI 10.1002/jbm.a.34584; Tamplenizza M, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-35; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Tsai WB, 2009, ACTA BIOMATER, V5, P1442, DOI 10.1016/j.actbio.2009.01.002; Wallace JM, 2010, LANGMUIR, V26, P7349, DOI 10.1021/la100006a; Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021; Zhao MZ, 2013, J MATER CHEM B, V1, P1926, DOI 10.1039/c3tb00266g	45	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158425	10.1371/journal.pone.0158425	http://dx.doi.org/10.1371/journal.pone.0158425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362432	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200073
J	McGowan, I; Cranston, RD; Mayer, KH; Febo, I; Duffill, K; Siegel, A; Engstrom, JC; Nikiforov, A; Park, SY; Brand, RM; Jacobson, C; Giguere, R; Dolezal, C; Frasca, T; Leu, CS; Schwartz, JL; Carballo-Dieguez, A				McGowan, Ian; Cranston, Ross D.; Mayer, Kenneth H.; Febo, Irma; Duffill, Kathryn; Siegel, Aaron; Engstrom, Jarret C.; Nikiforov, Alexyi; Park, Seo-Young; Brand, Rhonda M.; Jacobson, Cindy; Giguere, Rebecca; Dolezal, Curtis; Frasca, Timothy; Leu, Cheng-Shiun; Schwartz, Jill L.; Carballo-Dieguez, Alex			Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; NEW-YORK-CITY; HIV PREVENTION; HUMAN-PAPILLOMAVIRUS; HOMOSEXUAL-MEN; PREEXPOSURE PROPHYLAXIS; UNITED-STATES; PLACEBO GEL; ANAL SEX; INFECTION	Objectives The purpose of Project Gel was to determine the safety and acceptability of rectal microbicides in young men who have sex with men (MSM) and transgender women (TGW) at risk of HIV infection. Methods MSM and TGW aged 18-30 years were enrolled at three sites; Pittsburgh, PA; Boston, MA; and San Juan, PR. Stage 1A was a cross-sectional assessment of sexual health and behavior in MSM and TGW. A subset of participants from Stage 1A were then enrolled in Stage 1B, a 12-week evaluation of the safety and acceptability of a placebo rectal gel. This was followed by the final phase of the study (Stage 2) in which a subset of participants from Stage 1B were enrolled into a Phase 1 rectal safety and acceptability evaluation of tenofovir (TFV) 1% gel. Results 248 participants were enrolled into Stage 1A. Participants' average age was 23.3 years. The most common sexually transmitted infection (STIs) at baseline were Herpes simplex (HSV)-2 (16.1% by serology) and rectal Chlamydia trachomatis (CT) (10.1% by NAAT). 134 participants were enrolled into Stage 1B. During the 12 week period of follow-up 2 HIV, 5 rectal CT, and 5 rectal Neisseria gonorrhea infections were detected. The majority of adverse events (AEs) were infections (N = 56) or gastrointestinal (N = 46) and were mild (69.6%) or moderate (28.0%). Of the participants who completed Stage 1B, 24 were enrolled into Stage 2 and randomized (1:1) to receive TFV or placebo gel. All participants completed Stage 2. The majority of AEs were gastrointestinal (N = 10) and of mild (87.2%) or moderate (10.3%) severity. Conclusions In this study we were able to enroll a sexually active population of young MSM and TGW who were willing to use rectal microbicides. TFV gel was safe and acceptable and should be further developed as an alternative HIV prevention intervention for this population.	[McGowan, Ian; Cranston, Ross D.; Park, Seo-Young; Brand, Rhonda M.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [McGowan, Ian; Duffill, Kathryn; Siegel, Aaron; Engstrom, Jarret C.; Nikiforov, Alexyi; Brand, Rhonda M.; Jacobson, Cindy] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Febo, Irma] Univ Puerto Rico, Dept Pediat, Gama Project, Med Sci Campus, San Juan, PR 00936 USA; [Giguere, Rebecca; Dolezal, Curtis; Frasca, Timothy; Leu, Cheng-Shiun; Carballo-Dieguez, Alex] Columbia Univ, New York, NY USA; [Giguere, Rebecca; Dolezal, Curtis; Frasca, Timothy; Leu, Cheng-Shiun; Carballo-Dieguez, Alex] NY State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY USA; [Schwartz, Jill L.] CONRAD, Arlington, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Columbia University; New York State Psychiatry Institute	McGowan, I (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.; McGowan, I (corresponding author), Magee Womens Res Inst, Pittsburgh, PA 15213 USA.	imcgowan@pitt.edu	M, i/HCI-9242-2022; M, Ian/AAP-1032-2021	M, Ian/0000-0002-6470-8476; Cranston, Ross/0000-0002-2687-6217	Project Gel through R01 mechanism [5R01HD059533]; NIH institute: Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH institute: National Institute of Mental Health; NIH institute: National Institute of Nursing Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R01HD059533]; National Institute of Mental Health; National Institute of Nursing Health; CONRAD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	Project Gel through R01 mechanism; NIH institute: Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH institute: National Institute of Mental Health; NIH institute: National Institute of Nursing Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Nursing Health; CONRAD(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Project Gel was funded through an R01 mechanism (5R01HD059533). Three NIH institutes provided support for the study: The Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov), The National Institute of Mental Health (http://www.nimh.nih.gov), and The National Institute of Nursing Health (http://www.ninr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Project Gel participants for volunteering their time for this study. Support for this study was received from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (5R01HD059533), the National Institute of Mental Health, the National Institute of Nursing Health, and CONRAD, who provided TFV gel and the Universal Placebo gel.	Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bartnof H S, 1999, BETA, V12, P66; Bauermeister J, 2016, AIDS EDUC PREV, V28, P1, DOI 10.1521/aeap.2016.28.1.1; Bekker LG, 2015, J INT AIDS SOC, V18, P1, DOI 10.7448/IAS.18.2.20027; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bohl DD, 2011, SEX TRANSM DIS, V38, P617, DOI 10.1097/OLQ.0b013e31820a8c10; Brennan J, 2012, AM J PUBLIC HEALTH, V102, P1751, DOI 10.2105/AJPH.2011.300433; Burgener A, 2014, AIDS RES HUM RETROV, V30, pA229, DOI 10.1089/aid.2014.5502.abstract; Carballo-Dieguez A, 2007, SEX TRANSM DIS, V34, P224, DOI 10.1097/01.olq.0000233715.59239.83; Carballo-Dieguez A, 2007, AIDS BEHAV, V11, P271, DOI 10.1007/s10461-006-9128-0; Carballo-Dieguez A, 2014, AIDS BEHAV, V18, P1734, DOI 10.1007/s10461-014-0793-0; Carballo-Dieguez A, 2014, AIDS BEHAV, V18, P1726, DOI 10.1007/s10461-014-0768-1; CarballoDieguez A, 1996, AM J PUBLIC HEALTH, V86, P1619, DOI 10.2105/AJPH.86.11.1619; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Dolezal C, 2015, AIDS EDUC PREV, V27, P289, DOI 10.1521/aeap.2015.27.4.289; Dudareva-Vizule S, 2014, SEX TRANSM INFECT, V90, P46, DOI 10.1136/sextrans-2012-050929; Exner TM, 2008, AIDS EDUC PREV, V20, P148, DOI 10.1521/aeap.2008.20.2.148; Frasca T, 2016, ARCH SEX BEHAV; Frieden TR, 2015, NEW ENGL J MED, V373, P2281, DOI 10.1056/NEJMms1513641; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Giguere R, 2015, J SEX RES, P1; Gross M, 1999, SEX TRANSM DIS, V26, P572, DOI 10.1097/00007435-199911000-00006; Hill C., 2009, EURO SURVEILL, V14, P19418; Janicke David M., 1996, Emergency Medicine Clinics of North America, V14, P757, DOI 10.1016/S0733-8627(05)70278-9; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kinsler JJ, 2012, AIDS BEHAV, V16, P1436, DOI 10.1007/s10461-011-0045-5; KLEIN EJ, 1977, ANN INTERN MED, V86, P340, DOI 10.7326/0003-4819-86-3-340; Koblin BA, 2000, AIDS, V14, P1793, DOI 10.1097/00002030-200008180-00015; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McGowan I, 2007, JAIDS-J ACQ IMM DEF, V46, P417, DOI 10.1097/QAI.0b013e318156ef16; McGowan I, 2006, BIOLOGICALS, V34, P241, DOI 10.1016/j.biologicals.2006.08.002; Mcgowan I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125363; McGowan I, 2014, EXPERT OPIN DRUG DEL, V11, P69, DOI 10.1517/17425247.2013.860132; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Nagle D, 1996, PRIMARY CARE, V23, P609, DOI 10.1016/S0095-4543(05)70350-X; NELSON RL, 1995, DIS COLON RECTUM, V38, P341, DOI 10.1007/BF02054218; Newman PA, 2015, AIDS BEHAV; Orroth KK, 2000, AIDS, V14, P1429, DOI 10.1097/00002030-200007070-00017; OWEN WF, 1980, ANN INTERN MED, V92, P805, DOI 10.7326/0003-4819-92-6-805; Patton ME, 2014, CLIN INFECT DIS, V58, P1564, DOI 10.1093/cid/ciu184; Peinado Jesus, 2013, J Int Assoc Provid AIDS Care, V12, P278, DOI 10.1177/1545109712473650; QUINN TC, 1981, AM J MED, V71, P395, DOI 10.1016/0002-9343(81)90167-4; QUINN TC, 1983, NEW ENGL J MED, V309, P576, DOI 10.1056/NEJM198309083091002; Ramaswamy M, 2006, SEX TRANSM DIS, V33, P96, DOI 10.1097/01.olq.0000187211.61052.c7; Rebe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138315; Rees H, 2015, C RETR OPP INF SEATT; Schmelzer M, 2004, APPL NURS RES, V17, P265, DOI 10.1016/S0897-1897(04)00080-1; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Schwartz JL, 2007, CONTRACEPTION, V75, P136, DOI 10.1016/j.contraception.2006.09.003; Tang EC, 2016, SEX TRANSM INFECT, V92, P200, DOI 10.1136/sextrans-2015-052028; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; VIAMONTE M, 1993, DIS COLON RECTUM, V36, P801, DOI 10.1007/BF02047374; WEXNER SD, 1986, DIS COLON RECTUM, V29, P719, DOI 10.1007/BF02555318; Zanoni BC, 2014, AIDS PATIENT CARE ST, V28, P128, DOI 10.1089/apc.2013.0345; Zou HC, 2014, J INFECT DIS, V209, P642, DOI 10.1093/infdis/jit626	60	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158310	10.1371/journal.pone.0158310	http://dx.doi.org/10.1371/journal.pone.0158310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362788	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200056
J	Kang, YN; Li, H; Wu, J; Xu, XT; Sun, X; Zhao, XD; Xu, NJ				Kang, Yani; Li, Hua; Wu, Jun; Xu, Xiaoting; Sun, Xue; Zhao, Xiaodong; Xu, Nianjun			Transcriptome Profiling Reveals the Antitumor Mechanism of Polysaccharide from Marine Algae Gracilariopsis lemaneiformis	PLOS ONE			English	Article							RED ALGA; CANCER; APOPTOSIS; PRODUCTS; THERAPY	Seaweed is one of the important biomass producers and possesses active metabolites with potential therapeutic effects against tumors. The red alga Gracilariopsis lemaneiformis (Gp. lemaneiformis) possesses antitumor activity, and the polysaccharide of Gp. lemaneiformis (PGL) has been demonstrated to be an ingredient with marked anticancer activity. However, the anticancer mechanism of PGL remains to be elucidated. In this study, we analyzed the inhibitory effect of PGL on the cell growth of 3 human cancer cell lines and found that PGL inhibited cell proliferation, reduced cell viability, and altered cell morphology in a time- and concentration-dependent manner. Our transcriptome analysis indicates that PGL can regulate the expression of 758 genes, which are involved in apoptosis, the cell cycle, nuclear division, and cell death. Furthermore, we demonstrated that PGL induced apoptosis and cell cycle arrest and modulated the expression of related genes in the A549 cell line. Our work provides a framework to understand the effects of PGL on cancer cells, and can serve as a resource for delineating the antitumor mechanisms of Gp. lemaneiformis.	[Kang, Yani; Xu, Xiaoting; Sun, Xue; Xu, Nianjun] Ningbo Univ, Key Lab Marine Biotechnol Zhejiang Prov, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China; [Kang, Yani; Li, Hua; Wu, Jun; Zhao, Xiaodong] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Sch Biomed Engn, BioID Ctr, Shanghai, Peoples R China	Ningbo University; Shanghai Jiao Tong University	Xu, NJ (corresponding author), Ningbo Univ, Key Lab Marine Biotechnol Zhejiang Prov, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China.	xunianjun@nbu.edu.cn	Kang, Yani/AAQ-1503-2020	Kang, Yani/0000-0002-6753-386X; LI, HUA/0000-0003-2153-2500	SMC-Morningstar Excellent Young Scholars Program of Shanghai Jiao Tong University [15X100090011]; National Natural Science Foundation of China [91229123, 41376151, 31072229, 31501054]	SMC-Morningstar Excellent Young Scholars Program of Shanghai Jiao Tong University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by SMC-Morningstar Excellent Young Scholars Program of Shanghai Jiao Tong University (15X100090011) and National Natural Science Foundation of China (91229123, 41376151, 31072229 and 31501054).	Arakaki N, 2015, PHYTOTAXA, V208, P175, DOI 10.11646/phytotaxa.208.2.7; [陈美珍 CHEN Meizhen], 2008, [中国海洋药物, Chinese Journal of Marine Drugs], V27, P46; Cui L, 2013, J THORAC DIS, V5, P698, DOI 10.3978/j.issn.2072-1439.2013.10.10; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Raposo MFD, 2015, MAR DRUGS, V13, P2967, DOI 10.3390/md13052967; Fan YL, 2012, ADV MATER RES-SWITZ, V468-471, P1941, DOI 10.4028/www.scientific.net/AMR.468-471.1941; Han Z, 2015, PHYS CHEM CHEM PHYS, V17, P21576, DOI 10.1039/c5cp02139a; Harada H, 1997, BIOL PHARM BULL, V20, P541, DOI 10.1248/bpb.20.541; Hornburger MC, 2014, FASEB J, V28, P1938, DOI 10.1096/fj.13-235754; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indovina P, 2015, ONCOTARGET, V6, P17873, DOI 10.18632/oncotarget.4286; Kang Y, 2015, J FISHERIES CHINA, V39; Khanavi M, 2010, BIOL RES, V43, P31, DOI [10.4067/S0716-97602010000100005, /S0716-97602010000100005]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim R, 2002, CANCER CHEMOTH PHARM, V50, P343, DOI 10.1007/s00280-002-0522-7; Landstrom FJ, 2015, ACTA OTO-LARYNGOL, V135, P1070, DOI 10.3109/00016489.2015.1049663; Li YH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0537-8; Liao XB, 2015, FOOD FUNCT, V6, P2542, DOI [10.1039/c4fo01185f, 10.1039/C4FO01185F]; [卢佳芳 LU Jia-Fang], 2009, [海洋与湖沼, Oceanologia et Limnologia Sinica], V40, P484; Nickles D, 2012, MOL CELL BIOL, V32, P3372, DOI 10.1128/MCB.06739-11; Rodrigues D, 2015, MAR DRUGS, V13, P713, DOI 10.3390/md13020713; Ropellato J, 2015, CARBOHYD POLYM, V117, P476, DOI 10.1016/j.carbpol.2014.09.089; Sun Y, 2015, J BIOCH MOL TOXICOLO; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang XM, 2014, INT J BIOL MACROMOL, V69, P542, DOI 10.1016/j.ijbiomac.2014.06.017; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Xiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089534; Xiong ZQ, 2013, MAR DRUGS, V11, P700, DOI 10.3390/md11030700; Yusup A, 2011, EVIDENCE BASED COMPL, V2012; Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026	31	18	20	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158279	10.1371/journal.pone.0158279	http://dx.doi.org/10.1371/journal.pone.0158279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355352	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400043
J	Paez-Ribes, M; Man, S; Xu, P; Kerbel, RS				Paez-Ribes, Marta; Man, Shan; Xu, Ping; Kerbel, Robert S.			Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note	PLOS ONE			English	Article							NUDE-MOUSE MODEL; PHASE-III; COLON-CANCER; MICE; COMBINATION; SUNITINIB; SPECIMENS; IMMUNODEFICIENCY; CAPECITABINE; PATHOLOGY	Several approaches are being evaluated to improve the historically limited value of studying transplanted primary tumors derived by injection of cells from established cell lines for predicting subsequent cancer therapy outcomes in patients and clinical trials. These approaches include use of genetically engineered mouse models (GEMMs) of spontaneous tumors, or patient tumor tissue derived xenografts (PDXs). Almost all such therapy studies utilizing such models involve treatment of established primary tumors. An alternative approach we have developed involves transplanted human tumor xenografts derived from established cell lines to treat mice with overt visceral metastases after primary tumor resection. The rationale is to mimic the more challenging circumstance of treating patients with late stage metastatic disease. These metastatic models entail prior in vivo selection of heritable, phenotypically stable variants with increased aggressiveness for spontaneous metastasis; they were derived by orthotopic injection of tumor cells followed by primary tumor resection and serial selection of distant spontaneous metastases, from which variant cell lines having a more aggressive heritable metastatic phenotype were established. We attempted to adopt this strategy for breast cancer PDXs. We studied five breast cancer PDXs, with the emphasis on two, called HCI-001 and HCI-002, both derived from triple negative breast cancer patients. However significant technical obstacles were encountered. These include the inherent slow growth rates of PDXs, the rarity of overt spontaneous metastases (detected in only 3 of 144 mice), very high rates of tumor regrowths at the primary tumor resection site, the failure of the few human PDX metastases isolated to manifest a more aggressive metastatic phenotype upon re-transplantation into new hosts, and the formation of metastases which were derived from de novo mouse thymomas arising in aged SCID mice that we used for the experiments. We discuss several possible strategies that may be employed to overcome these limitations. Uncovering the basis of the failure to detect a high rate of overt spontaneous distant metastases having a heritable phenotype in PDX models may reveal new insights into the biology and treatment of advanced metastatic disease.	[Paez-Ribes, Marta; Man, Shan; Xu, Ping; Kerbel, Robert S.] Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada; [Kerbel, Robert S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Kerbel, RS (corresponding author), Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada.; Kerbel, RS (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	robert.kerbel@sri.utoronto.ca			Canadian Breast Cancer Foundation (CBCF); Canadian Institutes of Health Research (CIHR); Beatriu de Pinos fellowship (Generalitat de Catalunya)	Canadian Breast Cancer Foundation (CBCF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Beatriu de Pinos fellowship (Generalitat de Catalunya)(Generalitat de Catalunya)	This work was supported by grants from the Canadian Breast Cancer Foundation (CBCF), and the Canadian Institutes of Health Research (CIHR) to RSK. Additionally, author MPR was a recipient of a Beatriu de Pinos fellowship (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cassandra Cheng for her excellent secretarial assistance, Erin Smith-Silk for her excellent help with the animal work, Jordi Sol for his artistic contribution, Alana Welm for generously providing the PDX tumors used in this study and Florence TH Wu for critical reading of the manuscript and helpful suggestions. MPR was a recipient of a Beatriu de Pinos fellowship (Generalitat de Catalunya). This work was supported by grants from the Canadian Breast Cancer Foundation (CBCF), and the Canadian Institutes of Health Research (CIHR) to RSK.	Adelaye-Ogala RM SL, AACR ANN MEETING2015; An ZL, 1999, CLIN EXP METASTAS, V17, P265, DOI 10.1023/A:1006654600095; Barrios CH, 2010, BREAST CANCER RES TR, V121, P121, DOI 10.1007/s10549-010-0788-0; Bayoumi Y, 2014, BREAST CANCER-TARGET, V6, P151, DOI 10.2147/BCTT.S69309; Bergh J, 2012, J CLIN ONCOL, V30, P921, DOI 10.1200/JCO.2011.35.7376; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Crown JP, 2013, J CLIN ONCOL, V31, P2870, DOI 10.1200/JCO.2012.43.3391; Cruz-Munoz W, 2008, CANCER RES, V68, P4500, DOI 10.1158/0008-5472.CAN-08-0041; CUSTER RP, 1985, AM J PATHOL, V120, P464; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dominici LS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3197; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; FU XY, 1993, ANTICANCER RES, V13, P901; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; FURUKAWA T, 1993, INT J CANCER, V53, P608, DOI 10.1002/ijc.2910530414; Guerin E, 2013, CANCER RES, V73, P2743, DOI 10.1158/0008-5472.CAN-12-4183; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Hashimoto K, 2010, MOL CANCER THER, V9, P996, DOI 10.1158/1535-7163.MCT-09-0960; Hiroshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117417; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2015, NAT REV CANCER, V15, P451, DOI 10.1038/nrc3972; Jedeszko C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010722; Kato C, 2009, LAB ANIM-UK, V43, P402, DOI 10.1258/la.2009.009012; Kerbel RS, 2015, NAT REV CLIN ONCOL, V12, P313, DOI 10.1038/nrclinonc.2015.89; Kerbel RS, 1990, ADV CANC RES; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Milsom CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071270; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Simkens LHJ, 2015, LANCET, V385, P1843, DOI 10.1016/S0140-6736(14)62004-3; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; WAGHORNE C, 1988, CANCER RES, V48, P6109; WANG XE, 1992, ANTICANCER RES, V12, P1403; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	37	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158034	10.1371/journal.pone.0158034	http://dx.doi.org/10.1371/journal.pone.0158034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355476	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400025
J	Zhang, YZ; Mu, Q; Zhou, Z; Song, HB; Zhang, Y; Wu, F; Jiang, M; Wang, F; Zhang, W; Li, L; Shao, L; Wang, XL; Li, SW; Yang, LJ; Wu, Q; Zhang, MX; Tang, DQ				Zhang, Yuzhu; Mu, Qian; Zhou, Zheng; Song, Haibo; Zhang, Yuan; Wu, Fei; Jiang, Miao; Wang, Fang; Zhang, Wen; Li, Liang; Shao, Lei; Wang, Xingli; Li, Shiwu; Yang, Lijun; Wu, Qi; Zhang, Mingxiang; Tang, Dongqi			Protective Effect of Irisin on Atherosclerosis via Suppressing Oxidized Low Density Lipoprotein Induced Vascular Inflammation and Endothelial Dysfunction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; CIRCULATING IRISIN; OBESITY; PATHOPHYSIOLOGY; EXERCISE; FAMILY; INJURY; RISK; FLOW	Irisin, a newly discovered myokine, is considered as a promising candidate for the treatment of metabolic disturbances and cardiovascular diseases. In the present study, we used two animal models, apolipoprotein E-deficient mice fed on a high-cholesterol diet and a mouse carotid partial ligation model to test the anti-atherosclerotic effect of irisin. Irisin treatment (0.5 mu g/g body weight/day) significantly reduced the severity of aortic atherosclerosis in apolipoprotein E-deficient mice fed on a high-cholesterol diet and suppressed carotid neointima formation in a carotid partial ligation model. It was associated with decreased inflammation and cell apoptosis in aortic tissues. In addition, in a cell culture model, irisin restored ox-LDL-induced human umbilical vein endothelial cell dysfunction by reducing the levels of inflammatory genes via inhibiting the reactive oxygen species (ROS)/p38 MAPK/NF-kappa B signaling pathway activation and inhibiting cell apoptosis via up-regulating Bcl-2 and down-regulating Bax and caspase-3 expression. Our study demonstrated that irisin significantly reduced atherosclerosis in apolipoprotein E-deficient mice via suppressing ox-LDL-induced cell inflammation and apoptosis, which might have a direct therapeutic effect on atherosclerotic diseases.	[Zhang, Yuzhu; Mu, Qian; Song, Haibo; Zhang, Yuan; Wu, Fei; Jiang, Miao; Wang, Fang; Zhang, Wen; Li, Liang; Shao, Lei; Tang, Dongqi] Shandong Univ, Hosp 2, Ctr Stem Cell & Regenerat Med, Jinan, Peoples R China; [Zhou, Zheng] Community Hlth Ctr Qingdao, Chaohu Rd, Qingdao, Peoples R China; [Wang, Xingli; Zhang, Mingxiang] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China; [Li, Shiwu; Yang, Lijun] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Wu, Qi] Shandong Univ, Sch Med, Dept Anat, Jinan, Peoples R China	Shandong University; Shandong University; State University System of Florida; University of Florida; Shandong University	Tang, DQ (corresponding author), Shandong Univ, Hosp 2, Ctr Stem Cell & Regenerat Med, Jinan, Peoples R China.	tangdq@sdu.edu.cn	Zhang, Yuan/B-3806-2019		Tai shan Scholar Fund; National Natural Science Foundation of China [81570407]; Major State Basic Research Development Program of China (973 Program) [2015CB553600]	Tai shan Scholar Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Tai shan Scholar Fund, the National Natural Science Foundation of China [81570407], and the Major State Basic Research Development Program of China (973 Program) [2015CB553600].	[Anonymous], 1996, JAMA, V276, P241; Aronis KN, 2015, INT J OBESITY, V39, P156, DOI 10.1038/ijo.2014.101; Belardinelli R, 2001, J AM COLL CARDIOL, V37, P1891, DOI 10.1016/S0735-1097(01)01236-0; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chen CH, 2000, CIRCULATION, V101, P171, DOI 10.1161/01.CIR.101.2.171; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Gu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065477; Held C, 2012, EUR HEART J, V33, P452, DOI 10.1093/eurheartj/ehr432; Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Napoli C, 2001, J CELL BIOCHEM, V82, P674, DOI 10.1002/jcb.1198; Nunez Gabriel, 1994, Trends in Cell Biology, V4, P399, DOI 10.1016/0962-8924(94)90053-1; Ou HC, 2009, J APPL PHYSIOL, V106, P1674, DOI 10.1152/japplphysiol.91415.2008; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2007, ROLE MYOKINES EXERCI, P1093; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rizza S, 2015, ATHEROSCLEROSIS, V239, P459, DOI 10.1016/j.atherosclerosis.2015.01.029; Saing L, 2016, CLIN EXP PHARM PHYSL, V43, P720, DOI [10.1111/1440-1681.12374, DOI 10.1111/1440-1681.12374]; SCHRECK R, 1990, NUCLEIC ACIDS RES, V18, P6497, DOI 10.1093/nar/18.22.6497; Song HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110273; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Stewart R, 2013, EUR HEART J, V34, P3286, DOI 10.1093/eurheartj/eht258; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Sullivan CJ, 2002, ARTERIOSCL THROM VAS, V22, P1100, DOI 10.1161/01.ATV.0000023230.17493.E3; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Tao LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026055; Xiang L, 2014, ATHEROSCLEROSIS, V235, P328, DOI 10.1016/j.atherosclerosis.2014.04.036; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	44	75	87	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158038	10.1371/journal.pone.0158038	http://dx.doi.org/10.1371/journal.pone.0158038			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355581	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400026
J	Kawanishi, Y; Saijo, Y; Yoshioka, E; Nakagi, Y; Yoshida, T; Miyamoto, T; Sengoku, K; Ito, Y; Miyashita, C; Araki, A; Kishi, R				Kawanishi, Yasuyuki; Saijo, Yasuaki; Yoshioka, Eiji; Nakagi, Yoshihiko; Yoshida, Takahiko; Miyamoto, Toshinobu; Sengoku, Kazuo; Ito, Yoshiya; Miyashita, Chihiro; Araki, Atsuko; Kishi, Reiko			The Association between Prenatal Yoga and the Administration of Ritodrine Hydrochloride during Pregnancy: An Adjunct Study of the Japan Environment and Children's Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRETERM BIRTH; OBSTETRICAL PRACTICE; GYNECOLOGY JSOG; LABOR; PREVENTION; GUIDELINES; EFFICACY; THERAPY; EDITION	Introduction While the beneficial effects of prenatal yoga have been reported in recent years, little is known about its effectiveness in pregnant Japanese women. Despite several adverse effects, ritodrine hydrochloride is frequently prescribed to suppress preterm labor in Japan, and its usage may therefore indicate cases of preterm labor. This study aimed to clarify the association between prenatal yoga and ritodrine hydrochloride use during pregnancy. Methods An observational study was conducted as an adjunct study by the Hokkaido unit of the Japan Environment and Children's Study. Information on prenatal yoga practice was collected using a self-questionnaire between March 21, 2012, and July 7, 2015, targeting women who had recently delivered. Ritodrine hydrochloride use was identified from medical records. A total of 2,692 women were analyzed using logistic regression models that adjusted for possible confounders. Results There were 567 (21.1%) women who practiced prenatal yoga, which was associated with a lower risk of ritodrine hydrochloride use (adjusted odds ratio [OR] 0.77; 95% CI 0.61-0.98). This was especially evident in women with a total practice duration that exceeded 900 minutes throughout their pregnancy (adjusted OR 0.54; 95% CI 0.38-0.76). A sensitivity analysis that excluded patients with threatened abortion during the study period produced similar results. Conclusions Prenatal yoga was associated with a lower risk of ritodrine hydrochloride use, particularly in women with more than 900 minutes of practice time over the course of their pregnancy. Prenatal yoga may be a beneficial option for pregnant women in the selection of alternative therapies.	[Kawanishi, Yasuyuki; Saijo, Yasuaki; Yoshioka, Eiji; Nakagi, Yoshihiko; Yoshida, Takahiko] Asahikawa Med Univ, Dept Hlth Sci, Asahikawa, Hokkaido, Japan; [Miyamoto, Toshinobu; Sengoku, Kazuo] Asahikawa Med Univ, Dept Obstet & Gynecol, Asahikawa, Hokkaido, Japan; [Ito, Yoshiya] Japanese Red Cross Hokkaido Coll Nursing, Fac Nursing, Kitami, Hokkaido, Japan; [Miyashita, Chihiro; Araki, Atsuko; Kishi, Reiko] Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan	Asahikawa Medical College; Asahikawa Medical College; Hokkaido University	Kawanishi, Y (corresponding author), Asahikawa Med Univ, Dept Hlth Sci, Asahikawa, Hokkaido, Japan.	y-kawani@asahikawa-med.ac.jp	Yoshioka, Eiji/AAY-5495-2020; Ikeda-Araki, Atsuko/A-4105-2012; Saijo, Yasuaki/J-3796-2019	Ikeda-Araki, Atsuko/0000-0002-3065-262X; Saijo, Yasuaki/0000-0002-6211-8202; Yoshioka, Eiji/0000-0003-3316-1057	Ministry of the Environment, Japan; Asahikawa Medical University	Ministry of the Environment, Japan(Ministry of the Environment, Japan); Asahikawa Medical University	This study was partly supported by a grant for the Japan Environment & Children's Study from the Ministry of the Environment, Japan. The adjunct study on prenatal yoga was supported by a grant for Innovative Research in Life Science from Asahikawa Medical University.	Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Chuntharapat Songporn, 2008, Complement Ther Clin Pract, V14, P105, DOI 10.1016/j.ctcp.2007.12.007; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cunningham FG, 2010, WILLIAMS OBSTET, Vxv; Environment. Mot, JAP ENV CHILDR STUD; Field T, 2012, J BODYW MOV THER, V16, P204, DOI 10.1016/j.jbmt.2011.08.002; GIBBS RS, 1993, AM J OBSTET GYNECOL, V169, P460, DOI 10.1016/0002-9378(93)90341-F; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gyetvai K, 1999, OBSTET GYNECOL, V94, P869, DOI 10.1016/S0029-7844(99)00329-4; Kawagoe Y, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/965060; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Kawanishi Y, 2015, EFFECTS PRENATAL YOG, V62, P221, DOI DOI 10.11236/JPH.62.5_; Kiecolt-Glaser JK, 2014, J CLIN ONCOL, V32, P1040, DOI 10.1200/JCO.2013.51.8860; Lamont RF, 2000, BRIT J OBSTET GYNAEC, V107, P439, DOI 10.1111/j.1471-0528.2000.tb13259.x; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Martins RF, 2014, J ALTERN COMPLEM MED, V20, P24, DOI 10.1089/acm.2012.0715; Michikawa T, 2015, J EPIDEMIOL, V25, P452, DOI 10.2188/jea.JE20140186; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Minakami H, 2011, J OBSTET GYNAECOL RE, V37, P1174, DOI 10.1111/j.1447-0756.2011.01653.x; Murase N., 2003, J HLTH WELFARE STAT, V49, P1; Nakajima Y, 2011, J OBSTET GYNAECOL RE, V37, P629, DOI 10.1111/j.1447-0756.2010.01403.x; Narendran S, 2005, J ALTERN COMPLEM MED, V11, P237, DOI 10.1089/acm.2005.11.237; National Center for Complementary and Integrative Health (NCCIH), YOG FOR HLTH 2013; Neilson JP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004352.pub3; Rakhshani A, 2012, PREV MED, V55, P333, DOI 10.1016/j.ypmed.2012.07.020; Robinson JN, 2015, RISK FACTORS PRETERM; Satyapriya M, 2013, COMPLEMENT THER CLIN, V19, P230, DOI 10.1016/j.ctcp.2013.06.003; Satyapriya M, 2009, INT J GYNECOL OBSTET, V104, P218, DOI 10.1016/j.ijgo.2008.11.013; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Steel A, 2014, MIDWIFERY, V30, P1157, DOI 10.1016/j.midw.2014.03.015; Steinborn A, 1999, CYTOKINE, V11, P66, DOI 10.1006/cyto.1998.0399; Steinborn A, 1998, OBSTET GYNECOL, V91, P329, DOI 10.1016/S0029-7844(97)00680-7; Sun YC, 2010, MIDWIFERY, V26, pE31, DOI 10.1016/j.midw.2009.01.005; TUCKER JM, 1991, OBSTET GYNECOL, V77, P343; Vesalainen RK, 1999, BRIT J OBSTET GYNAEC, V106, P238, DOI 10.1111/j.1471-0528.1999.tb08237.x; Yasuda R, 2012, J OBSTET GYNAECOL RE, V38, P574, DOI 10.1111/j.1447-0756.2011.01756.x	39	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158155	10.1371/journal.pone.0158155	http://dx.doi.org/10.1371/journal.pone.0158155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348869	Green Published, Green Submitted, gold			2022-12-27	WOS:000378801200039
J	Eggink, H; Brand, P; Reimink, R; Bekhof, J				Eggink, Hendriekje; Brand, Paul; Reimink, Roelien; Bekhof, Jolita			Clinical Scores for Dyspnoea Severity in Children: A Prospective Validation Study	PLOS ONE			English	Article							RESPIRATORY ASSESSMENT MEASURE; ACUTE ASTHMA SEVERITY; PRESCHOOL-CHILDREN; HYPOXEMIA; SYMPTOMS	Background In acute dyspnoeic children, assessment of dyspnoea severity and treatment response is frequently based on clinical dyspnoea scores. Our study aim was to validate five commonly used paediatric dyspnoea scores. Methods Fifty children aged 0-8 years with acute dyspnoea were clinically assessed before and after bronchodilator treatment, a subset of 27 children were videotaped and assessed twice by nine observers. The observers scored clinical signs necessary to calculate the Asthma Score (AS), Asthma Severity Score (ASS), Clinical Asthma Evaluation Score 2 (CAES-2), Pediatric Respiratory Assessment Measure (PRAM) and respiratory rate, accessory muscle use, decreased breath sounds (RAD). Results A total of 1120 observations were used to assess fourteen measurement properties within domains of validity, reliability and utility. All five dyspnoea scores showed overall poor results, scoring insufficiently on more than half of the quality criteria for measurement properties. The AS and PRAM were the most valid with good values on six and moderate values on three properties. Poor results were mainly due to insufficient measurement properties in the validity and reliability domains whereas utility properties were moderate to good in all scores. Conclusion This study shows that commonly used dyspnoea scores show insufficient validity and reliability to allow for clinical use without caution.	[Eggink, Hendriekje; Brand, Paul; Reimink, Roelien; Bekhof, Jolita] Isala, Princess Amalia Childrens Clin, Zwolle, Netherlands; [Eggink, Hendriekje; Brand, Paul] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen	Bekhof, J (corresponding author), Isala, Princess Amalia Childrens Clin, Zwolle, Netherlands.	j.bekhof@isala.nl	Brand, Paul/ABB-3693-2021					Arnold DH, 2011, ANN ALLERG ASTHMA IM, V107, P22, DOI 10.1016/j.anai.2011.03.011; Bekhof J, 2015, ARCH DIS CHILD, V100, P649, DOI 10.1136/archdischild-2014-307143; Bekhof J, 2014, PAEDIATR RESPIR REV, V15, P98, DOI 10.1016/j.prrv.2013.08.004; Birken CS, 2004, J CLIN EPIDEMIOL, V57, P1177, DOI 10.1016/j.jclinepi.2004.02.016; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; BISHOP J, 1992, J CLIN EPIDEMIOL, V45, P71, DOI 10.1016/0895-4356(92)90190-X; Chalut DS, 2000, J PEDIATR-US, V137, P762, DOI 10.1067/mpd.2000.110121; de Vet HW, 2011, MEASUREMENT MED PRAC; Ducharme FM, 2008, J PEDIATR-US, V152, P476, DOI 10.1016/j.jpeds.2007.08.034; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; HURWITZ ME, 1984, ANN EMERG MED, V13, P1040, DOI 10.1016/S0196-0644(84)80066-9; KEREM E, 1991, PEDIATRICS, V87, P481; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Qureshi F, 1998, NEW ENGL J MED, V339, P1030, DOI 10.1056/NEJM199810083391503; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; VANDERWINDT DAWM, 1994, J CLIN EPIDEMIOL, V47, P635, DOI 10.1016/0895-4356(94)90211-9; Zhang L, 2011, INT J TUBERC LUNG D, V15, P317	18	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157724	10.1371/journal.pone.0157724	http://dx.doi.org/10.1371/journal.pone.0157724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27382963	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400022
J	Hill, NR; Fatoba, ST; Oke, JL; Hirst, JA; O'Callaghan, CA; Lasserson, DS; Hobbs, FDR				Hill, Nathan R.; Fatoba, Samuel T.; Oke, Jason L.; Hirst, Jennifer A.; O'Callaghan, Christopher A.; Lasserson, Daniel S.; Hobbs, F. D. Richard			Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GLOMERULAR-FILTRATION-RATE; CROSS-SECTIONAL SURVEY; CHRONIC RENAL-DISEASE; QUALITY-OF-LIFE; RISK-FACTORS; ADULT-POPULATION; CARDIOVASCULAR RISK; SERUM CREATININE; PRIMARY-CARE; NATIONAL-HEALTH	Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and is an independent risk factor for cardiovascular disease (CVD). All stages of CKD are associated with increased risks of cardiovascular morbidity, premature mortality, and/or decreased quality of life. CKD is usually asymptomatic until later stages and accurate prevalence data are lacking. Thus we sought to determine the prevalence of CKD globally, by stage, geographical location, gender and age. A systematic review and meta-analysis of observational studies estimating CKD prevalence in general populations was conducted through literature searches in 8 databases. We assessed pooled data using a random effects model. Of 5,842 potential articles, 100 studies of diverse quality were included, comprising 6,908,440 patients. Global mean(95% CI) CKD prevalence of 5 stages 13.4% (11.7-15.1%), and stages 3-5 was 10 .6%(9.2-12.2%). Weighting by study quality did not affect prevalence estimates. CKD prevalence by stage was Stage-1 (eGFR>90 +ACR>30): 3.5% (2.8-4.2%); Stage-2 (eGFR 60-89+ACR>30): 3.9% (2.7-5.3%); Stage-3 (eGFR 30-59): 7.6% (6.4-8.9%); Stage-4 = (eGFR 29-15): 0.4% (0.3-0.5%); and Stage-5 (eGFR<15): 0.1% (0.1-0.1%). CKD has a high global prevalence with a consistent estimated global CKD prevalence of between 11 to 13% with the majority stage 3. Future research should evaluate intervention strategies deliverable at scale to delay the progression of CKD and improve CVD outcomes.	[Hill, Nathan R.; Fatoba, Samuel T.; Oke, Jason L.; Hirst, Jennifer A.; Lasserson, Daniel S.; Hobbs, F. D. Richard] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [O'Callaghan, Christopher A.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Oxford; University of Oxford	Hill, NR (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	Nathan.Hill@phc.ox.ac.uk	Lasserson, Daniel S/T-8978-2017; Hill, Nathan/B-9679-2014; Roberts, Nia Wyn/F-9842-2010	hobbs, richard/0000-0001-7976-7172; Hill, Nathan/0000-0001-7927-8678; Lasserson, Daniel/0000-0001-8274-5580; Hirst, Jennifer/0000-0002-8416-2159; Roberts, Nia Wyn/0000-0002-1142-6440	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford; NIHR Oxford Diagnostic Evidence Co-operative and NIHR Oxford BRC; National Institute for Health Research (NIHR) School for Primary Care Research (SPCR); MRC [G116/165] Funding Source: UKRI; Medical Research Council [G116/165] Funding Source: researchfish; National Institute for Health Research [IS-SPC-0514-10043, NF-SI-0611-10273, 12/01/52] Funding Source: researchfish	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford; NIHR Oxford Diagnostic Evidence Co-operative and NIHR Oxford BRC; National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	NH is funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford. FDRH is part funded as Director of the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR), Theme Leader in the NIHR Oxford Biomedical Research Centre (BRC), and Director of the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Oxford. DSL is part funded by the NIHR Oxford Diagnostic Evidence Co-operative and NIHR Oxford BRC. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2003, KIDNEY INT, V64, P610, DOI 10.1046/j.1523-1755.2003.00109.x; Aitken Grant R, 2014, BMJ Open, V4, pe005480, DOI 10.1136/bmjopen-2014-005480; Anesi A, 2012, RIV ITALIANA MED LAB, V8, P45; Anupama Y J, 2014, Indian J Nephrol, V24, P214, DOI 10.4103/0971-4065.132990; Arnal LML, 2008, NEFROLOGIA, V28, P329; Arora P, 2013, CAN MED ASSOC J, V185, pE417, DOI 10.1503/cmaj.120833; Barahimi H, 2011, IRAN J KIDNEY DIS, V5, P26; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Browne GM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-144; Bruce MA, 2013, J INVEST MED, V61, P701, DOI 10.2310/JIM.0b013e3182880bf5; Carlos ZS, 2011, REV MED CHILE, V139, P1176, DOI DOI 10.4067/S0034-98872011000900010; Carrero JJ, 2010, KIDNEY BLOOD PRESS R, V33, P383, DOI 10.1159/000320389; Cea-Calvo L, 2007, MED CLIN-BARCELONA, V129, P681, DOI 10.1157/13112509; Cepoi V, 2012, INT UROL NEPHROL, V44, P213, DOI 10.1007/s11255-011-9923-z; Chen J, 2005, KIDNEY INT, V68, P2837, DOI 10.1111/j.1523-1755.2005.00757.x; Chen N, 2009, NEPHROL DIAL TRANSPL, V24, P2117, DOI 10.1093/ndt/gfn767; Chen W, 2011, NEPHROL DIAL TRANSPL, V26, P1592, DOI 10.1093/ndt/gfq608; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chin HJ, 2008, NEPHROL DIAL TRANSPL, V23, P2810, DOI 10.1093/ndt/gfn132; Chudek J, 2014, NEPHROL DIAL TRANSPL, V29, P1073, DOI 10.1093/ndt/gft351; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Covic A, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P922; Crews DC, 2010, AM J KIDNEY DIS, V55, P992, DOI 10.1053/j.ajkd.2009.12.032; de Francisco ALM, 2007, NEFROLOGIA, V27, P300; de Lusignan S, 2012, NEPHRON CLIN PRACT, V120, pc107; Denburg MR, 2011, PHARMACOEPIDEM DR S, V20, P1138, DOI 10.1002/pds.2203; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Elorza-Ricart JM, 2012, HIPERTENSION RIESGO, V29, P118, DOI DOI 10.1016/J.HIPERT.2012.07.005; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Etgen T, 2012, AM J NEPHROL, V35, P474, DOI 10.1159/000338135; Fleet JL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-81; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Gallieni M, 2013, NEPHROLOGY, V18, P798, DOI 10.1111/nep.12142; Gambaro G, 2010, CLIN J AM SOC NEPHRO, V5, P1946, DOI 10.2215/CJN.02400310; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gao S, 2007, J AM SOC NEPHROL, V18, P2953, DOI 10.1681/ASN.2007030360; Gharbi MB, 2016, KIDNEY INT, V89, P1363, DOI 10.1016/j.kint.2016.02.019; Giavarina D, 2010, CLIN NEPHROL, V74, P358; Gifford FJ, 2011, QJM-INT J MED, V104, P1045, DOI 10.1093/qjmed/hcr122; Global Burden of Disease Study C, 2015, LANCET, V386, P743, DOI [10.1016/S0140-6736(15)60692-4, DOI 10.1016/S0140-6736(15)60692-4, 10.1016/s0140-6736(15)60692-4]; Glynn L G, 2009, Ir Med J, V102, P285; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gu DF, 2013, CHINESE MED J-PEKING, V126, P1213, DOI 10.3760/cma.j.issn.0366-6999.20123504; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hooi LS, 2013, KIDNEY INT, V84, P1034, DOI 10.1038/ki.2013.220; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-44; Hsu CC, 2006, AM J KIDNEY DIS, V48, P727, DOI 10.1053/j.ajkd.2006.07.018; [黄文瀚 Huang Wenhan], 2014, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V34, P725; Huda MN, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/267329; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Iseki K, 2009, CLIN EXP NEPHROL, V13, P44, DOI 10.1007/s10157-008-0080-3; Jessani S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-90; Jiang LP, 2010, NEPHRON CLIN PRACT, V114, pC295, DOI 10.1159/000276582; Jose MD, 2009, NEPHROLOGY, V14, P743, DOI 10.1111/j.1440-1797.2009.01198.x; Juutilainen A, 2012, EUR J EPIDEMIOL, V27, P305, DOI 10.1007/s10654-012-9652-3; Kang HT, 2013, NEPHROL DIAL TRANSPL, V28, P927, DOI 10.1093/ndt/gfs535; KDOQI KDOQI, 2012, CHRON KIDN DIS EV CL; KDOQI KDOQI, 2002, CHRON KIDN DIS EV CL; Khajehdehi P, 2014, IRAN J KIDNEY DIS, V8, P109; Kim S, 2009, J KOREAN MED SCI, V24, pS11, DOI 10.3346/jkms.2009.24.S1.S11; Kramer H, 2008, CLIN J AM SOC NEPHRO, V3, P1391, DOI 10.2215/CJN.04160907; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li ZY, 2006, CLIN CHIM ACTA, V366, P209, DOI 10.1016/j.cca.2005.10.011; Liang Y, 2013, ASIA-PAC J PUBLIC HE, V25, p15S, DOI 10.1177/1010539513495270; Lin B, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-36; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047100; Lu C, 2010, J HUAZHONG U SCI-MED, V30, P604, DOI 10.1007/s11596-010-0550-1; Maple-Brown LJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-346; Matsha TE, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-75; Matsushita K, 2012, AM J KIDNEY DIS, V60, P241, DOI 10.1053/j.ajkd.2012.03.016; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Minutolo R, 2008, AM J KIDNEY DIS, V52, P444, DOI 10.1053/j.ajkd.2008.03.002; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Najafi I, 2012, ARCH IRAN MED, V15, pVI, DOI 012152/AIM.003; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; NICE NIfCE, 2008, CG73 CHRON KIDN DIS; Nitsch D, 2006, NEPHROL DIAL TRANSPL, V21, P935, DOI 10.1093/ndt/gfk021; Nomura I, 2009, VASC HEALTH RISK MAN, V5, P315; Nongpiur ME, 2010, OPHTHALMOLOGY, V117, P477, DOI 10.1016/j.ophtha.2009.07.029; O'Callaghan CA, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000308; Ohno Y, 2012, NEPHROL DIAL TRANSPL, V27, P395; Ong-Ajyooth L, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-35; Otero A, 2010, NEFROLOGIA, V30, P78, DOI 10.3265/Nefrologia.pre2009.Dic.5732; Pani A, 2014, J AM SOC NEPHROL, V25, P1533, DOI 10.1681/ASN.2013060591; Porta JMP, 2009, ATEN PRIM, V41, P600, DOI 10.1016/j.aprim.2008.11.010; Peralta CA, 2010, NEPHROL DIAL TRANSPL, V25, P3934, DOI 10.1093/ndt/gfq299; Perkovic V, 2008, KIDNEY INT, V73, P473, DOI 10.1038/sj.ki.5002701; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Ponte B, 2013, NEPHROL DIAL TRANSPL, V28, P2329, DOI 10.1093/ndt/gft206; Prodjosudjadi W, 2009, NEPHROLOGY, V14, P669, DOI 10.1111/j.1440-1797.2009.01137.x; Robles NR, 2013, J NEPHROL, V26, P675, DOI 10.5301/jn.5000221; Rothenbacher D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-343; Rutkowski B, 2008, BLOOD PURIFICAT, V26, P381, DOI 10.1159/000137275; Ryan TP, 2007, AM J MED, V120, P981, DOI 10.1016/j.amjmed.2007.05.012; Sabanayagam C, 2010, NEPHROL DIAL TRANSPL, V25, P2564, DOI 10.1093/ndt/gfq084; Safarinejad MR, 2009, J NEPHROL, V22, P99; Sahin I, 2009, RENAL FAILURE, V31, P920, DOI 10.3109/08860220903219265; Seck SM, 2014, IRAN J KIDNEY DIS, V8, P286; Shan Y, 2010, NEPHROLOGY, V15, P354, DOI 10.1111/j.1440-1797.2009.01249.x; Sharma SK, 2013, J NEPAL MED ASSOC, V52, P205, DOI 10.31729/jnma.548; Sharma SK, 2010, AM J KIDNEY DIS, V56, P915, DOI 10.1053/j.ajkd.2010.06.022; Shin SY, 2014, J CLIN LAB ANAL, V28, P320, DOI 10.1002/jcla.21688; Singh NP, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-4; Stengel B, 2011, NEPHROL DIAL TRANSPL, V26, P3286, DOI 10.1093/ndt/gfr323; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suleymanlar G, 2011, NEPHROL DIAL TRANSPL, V26, P1862, DOI 10.1093/ndt/gfq656; Sumaili EK, 2010, NEPHROL THER, V6, P232, DOI 10.1016/j.nephro.2010.03.008; Tanaka H, 2006, KIDNEY INT, V69, P369, DOI 10.1038/sj.ki.5000050; Tanner RM, 2013, AM J KIDNEY DIS, V61, P395, DOI 10.1053/j.ajkd.2012.10.018; Tomonaga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067848; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; van Blijderveen J, 2014, INT UROL NEPHROL, V46, P583, DOI 10.1007/s11255-013-0563-3; Van Pottelbergh G, 2012, AGE AGEING, V41, P231, DOI 10.1093/ageing/afr154; Vinhas J, 2011, NEPHRON CLIN PRACT, V119, pC35, DOI 10.1159/000324218; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; Xu Guo, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P408, DOI 10.3969/j.issn.1672-7347.2014.04.015; Zhang L, 2012, LANCET, V380, P650; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang LX, 2007, NEPHROL DIAL TRANSPL, V22, P1093, DOI 10.1093/ndt/gfl763; Zhang QL, 2009, PREV MED, V48, P122, DOI 10.1016/j.ypmed.2008.10.026	133	1647	1743	21	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158765	10.1371/journal.pone.0158765	http://dx.doi.org/10.1371/journal.pone.0158765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383068	Green Published, gold			2022-12-27	WOS:000379809400083
J	Magallon, S; Narbona, J; Crespo-Eguilaz, N				Magallon, Sara; Narbona, Juan; Crespo-Eguilaz, Nerea			Acquisition of Motor and Cognitive Skills through Repetition in Typically Developing Children	PLOS ONE			English	Article							MIRROR-DRAWING TEST; PURDUE PEGBOARD; PROCEDURAL MEMORY; BRAIN-DEVELOPMENT; NORMS; AGE; ADOLESCENTS; CEREBELLUM; MODULARITY; CHILDHOOD	Background Procedural memory allows acquisition, consolidation and use of motor skills and cognitive routines. Automation of procedures is achieved through repeated practice. In children, improvement in procedural skills is a consequence of natural neurobiological development and experience. Methods The aim of the present research was to make a preliminary evaluation and description of repetition-based improvement of procedures in typically developing children (TDC). Ninety TDC children aged 6-12 years were asked to perform two procedural learning tasks. In an assembly learning task, which requires predominantly motor skills, we measured the number of assembled pieces in 60 seconds. In a mirror drawing learning task, which requires more cognitive functions, we measured time spent and efficiency. Participants were tested four times for each task: three trials were consecutive and the fourth trial was performed after a 10-minute nonverbal interference task. The influence of repeated practice on performance was evaluated by means of the analysis of variance with repeated measures and the paired-sample test. Correlation coefficients and simple linear regression test were used to examine the relationship between age and performance. Results TDC achieved higher scores in both tasks through repetition. Older children fitted more pieces than younger ones in assembling learning and they were faster and more efficient at the mirror drawing learning task. Conclusions These findings indicate that three consecutive trials at a procedural task increased speed and efficiency, and that age affected basal performance in motor-cognitive procedures.	[Magallon, Sara] Univ Leeds, Fac Med & Hlth, Sch Psychol, Lifton Pl, Leeds LS2 9JZ, W Yorkshire, England; [Magallon, Sara; Narbona, Juan; Crespo-Eguilaz, Nerea] Univ Navarra, Fac Educ & Psychol, Campus Univ, Navarra 31080, Spain; [Narbona, Juan; Crespo-Eguilaz, Nerea] Univ Navarra, Fac Med, Unit Paediat Neurol, Av Pio 12,36, Navarra 31008, Spain	University of Leeds; University of Navarra; University of Navarra	Magallon, S (corresponding author), Univ Leeds, Fac Med & Hlth, Sch Psychol, Lifton Pl, Leeds LS2 9JZ, W Yorkshire, England.; Magallon, S (corresponding author), Univ Navarra, Fac Educ & Psychol, Campus Univ, Navarra 31080, Spain.	S.Magallon@leeds.ac.uk	Crespo-Eguilaz, Nerea/L-1752-2017; MAGALLON, SARA/K-8287-2017	Crespo-Eguilaz, Nerea/0000-0003-3778-7655; MAGALLON, SARA/0000-0001-9269-1336	Marie Curie - Intra-European Fellowships for career development (IEF); Navarra Government Predoctoral Grant; School of Psychology of the University of Leeds; "Pre-doctoral grant from the Government of Navarra"; Marie-Curie Actions (European Commission)	Marie Curie - Intra-European Fellowships for career development (IEF); Navarra Government Predoctoral Grant; School of Psychology of the University of Leeds; "Pre-doctoral grant from the Government of Navarra"; Marie-Curie Actions (European Commission)	This study was supported by Marie Curie - Intra-European Fellowships for career development (IEF), Navarra Government Predoctoral Grant, School of Psychology of the University of Leeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the "Pre-doctoral grant from the Government of Navarra". We are very grateful to the children, parents and teachers who participated in this project for their generous cooperation. Finally, we are immensely grateful to the School of Psychology of the University of Leeds, and the Marie-Curie Actions (European Commission) for funding the publication of the paper.	Balinsky B, 1940, PEDAGOG SEMIN J GEN, V56, P207; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Bo J, 2012, J SPORT EXERCISE PSY; Capio CM, 2012, BMC SPORTS SCI MED R, V4, DOI 10.1186/1758-2555-4-1; Carlson Neil R., 2006, FISIOLOGIA CONDUCTA; Cavaco S, 2004, BRAIN, V127, P1853, DOI 10.1093/brain/awh208; Chan JSY, 2015, HUM MOVEMENT SCI, V42, P261, DOI 10.1016/j.humov.2015.06.002; Chang SH, 2010, DEV MED CHILD NEUROL, V52, P244, DOI 10.1111/j.1469-8749.2009.03478.x; Clark JE, 2012, J SPORT EXERCISE PSY; Clinton RJ, 1930, J EDUC PSYCHOL, V21, P221, DOI 10.1037/h0072249; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; COSTA LD, 1963, J CONSULT PSYCHOL, V27, P133, DOI 10.1037/h0040737; Crespo-Eguilaz N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00449; De Guise E, 2001, DEV NEUROPSYCHOL, V19, P253, DOI 10.1207/S15326942DN1903_2; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Dunn LlM, 2006, TEST VOCABULARIO IMA; Dunn R, 1845, LANCET, V2, P588; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P1, DOI 10.2277/ 0521600812; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gofer-Levi M, 2014, RES DEV DISABIL, V35, P1952, DOI 10.1016/j.ridd.2014.04.017; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; HEINDEL WC, 1988, BEHAV NEUROSCI, V102, P141, DOI 10.1037/0735-7044.102.1.141; Hollingshead AB, 1957, 2 FACTORS INDEX SOCI; Homma Shinji, 2006, Journal of Smooth Muscle Research, V42, P9, DOI 10.1540/jsmr.42.9; Julius MS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00225; Karatekin C, 2007, J EXP CHILD PSYCHOL, V96, P107, DOI 10.1016/j.jecp.2006.05.005; Kaufman A. S., 1993, KAUFMAN ADOLESCENT A; Kaufman AS, 1990, MANUAL KAUFMAN BRIEF; Kharraz-Tavakol OD, 2000, NEUROSCI LETT, V282, P33, DOI 10.1016/S0304-3940(00)00851-X; KNIGHTS RM, 1968, PERCEPT MOTOR SKILL, V26, P643, DOI 10.2466/pms.1968.26.2.643; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Louis ED, 2015, PEDIATR NEUROL, V52, P187, DOI 10.1016/j.pediatrneurol.2014.10.017; Lum J, 2010, AUST J PSYCHOL, V62, P139, DOI 10.1080/00049530903150547; Magallon S, 2015, J CHILD NEUROLOGY; Magallon S, 2009, REV NEUROLOGIA S2, V48, P71; Marks R, 1996, PERCEPT MOTOR SKILL, V83, P715, DOI 10.2466/pms.1996.83.3.715; Mayor-Dubois C, 2016, CHILD NEUROPSYCHOL, V22, P718, DOI 10.1080/09297049.2015.1058347; Mergl R, 1999, J NEUROSCI METH, V90, P157, DOI 10.1016/S0165-0270(99)00080-1; Meulemans T, 1998, J EXP CHILD PSYCHOL, V69, P199, DOI 10.1006/jecp.1998.2442; Milner B., 1965, COGNITIVE PROCESSES; Mizuno K, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-17; Molinari M, 1997, BRAIN, V120, P1753, DOI 10.1093/brain/120.10.1753; MOSCOVITCH M, 1995, J CLIN EXP NEUROPSYC, V17, P276, DOI 10.1080/01688639508405123; Murphy KL, 2002, RES Q EXERCISE SPORT, V73, pA51; NELSON CA, 1995, DEV PSYCHOL, V31, P723, DOI 10.1037/0012-1649.31.5.723; O'Donnell KJ, 2002, DEV MED CHILD NEUROL, V44, P76, DOI 10.1017/S0012162201001712; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; RAPIN I, 1966, DEV MED CHILD NEUROL, V8, P45; REDDON JR, 1988, PERCEPT MOTOR SKILL, V66, P503, DOI 10.2466/pms.1988.66.2.503; Rourke B. P., 1995, SYNDROME NONVERBAL L; Rourke B.P., 1989, NONVERBAL LEARNING D; Rourke BP, 1996, TOP LANG DISORD, V16, P30, DOI 10.1097/00011363-199602000-00005; Rourke BP., 1987, CLIN NEUROPSYCHOL, V1, P209, DOI [DOI 10.1080/13854048708520056, 10.1080/13854048708520056]; Schacter D.L., 1995, MEMORY WARS; Schacter DL, 1984, INFANT MEMORY, P173; Sidaway B, 2012, J SPORT EXERCISE PSY; Smith PJ, 2009, J SPORT EXERCISE PSY; Soprano A., 2007, MEMORIA NINO DESARRO, P1; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Starch D, 1910, PSYCHOL BULL, V7, P20, DOI 10.1037/h0063796; Sullivan KI, 2008, PHYS THER, V88, P720, DOI 10.2522/ptj.20070196; Tallet J, 2015, SOCIOAFFECTIVE NEURO, V5, DOI 10.3402/snp.v5.28004; Thomas KM, 2004, J COGNITIVE NEUROSCI, V16, P1339, DOI 10.1162/0898929042304688; Tiffin J, 1968, PURDUE PEGBOARD EXAM; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; TULVING E, 1987, HUM NEUROBIOL, V6, P67; Vakil E, 1997, J GERONTOL B-PSYCHOL, V52, pP229, DOI 10.1093/geronb/52B.5.P229; Vicari S, 2005, J NEUROL NEUROSUR PS, V76, P1392, DOI 10.1136/jnnp.2004.061093; Vicari S, 2003, NEUROPSYCHOLOGIA, V41, P108, DOI 10.1016/S0028-3932(02)00082-9; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; Wechsler D., 1991, WISC 3 WECHSLER INTE; Whipple G. E, 1921, MANUAL MENTAL PHYS T; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; WILLINGHAM DB, 1993, PSYCHOBIOLOGY, V21, P173; Yoakum C, 1913, J EDUC PSYCHOL, V4, P283; Yoshiuchi K, 1997, AM J HYPERTENS, V10, P243, DOI 10.1016/S0895-7061(96)00382-2	82	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158684	10.1371/journal.pone.0158684	http://dx.doi.org/10.1371/journal.pone.0158684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27384671	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400076
J	Metzgar, D; Frinder, MW; Rothman, RE; Peterson, S; Carroll, KC; Zhang, SX; Avornu, GD; Rounds, MA; Carolan, HE; Toleno, DM; Moore, D; Hall, TA; Massire, C; Richmond, GS; Gutierrez, JR; Sampath, R; Ecker, DJ; Blyn, LB				Metzgar, David; Frinder, Mark W.; Rothman, Richard E.; Peterson, Stephen; Carroll, Karen C.; Zhang, Sean X.; Avornu, Gideon D.; Rounds, Megan A.; Carolan, Heather E.; Toleno, Donna M.; Moore, David; Hall, Thomas A.; Massire, Christian; Richmond, Gregory S.; Gutierrez, Jose R.; Sampath, Rangarajan; Ecker, David J.; Blyn, Lawrence B.			The IRIDICA BAC BSI Assay: Rapid, Sensitive and Culture-Independent Identification of Bacteria and Candida in Blood	PLOS ONE			English	Article							REAL-TIME PCR; CRITICALLY-ILL; MOLECULAR DIAGNOSIS; MASS-SPECTROMETRY; STREAM INFECTIONS; SEPSIS; PATHOGENS; THERAPY; IMPACT	Bloodstream infection (BSI) and sepsis are rising in incidence throughout the developed world. The spread of multi-drug resistant organisms presents increasing challenges to treatment. Surviving BSI is dependent on rapid and accurate identification of causal organisms, and timely application of appropriate antibiotics. Current culture-based methods used to detect and identify agents of BSI are often too slow to impact early therapy and may fail to detect relevant organisms in many positive cases. Existing methods for direct molecular detection of microbial DNA in blood are limited in either sensitivity (likely the result of small sample volumes) or in breadth of coverage, often because the PCR primers and probes used target only a few specific pathogens. There is a clear unmet need for a sensitive molecular assay capable of identifying the diverse bacteria and yeast associated with BSI directly from uncultured whole blood samples. We have developed a method of extracting DNA from larger volumes of whole blood (5 ml per sample), amplifying multiple widely conserved bacterial and fungal genes using a mismatch-and background-tolerant PCR chemistry, and identifying hundreds of diverse organisms from the amplified fragments on the basis of species-specific genetic signatures using electrospray ionization mass spectrometry (PCR/ESI-MS). We describe the analytical characteristics of the IRIDICA BAC BSI Assay and compare its preclinical performance to current standard-of-care methods in a collection of prospectively collected blood specimens from patients with symptoms of sepsis. The assay generated matching results in 80% of culture-positive cases (86% when common contaminants were excluded from the analysis), and twice the total number of positive detections. The described method is capable of providing organism identifications directly from uncultured blood in less than 8 hours. Disclaimer: The IRIDICA BAC BSI Assay is not available in the United States.	[Metzgar, David; Frinder, Mark W.; Rounds, Megan A.; Carolan, Heather E.; Toleno, Donna M.; Moore, David; Hall, Thomas A.; Massire, Christian; Richmond, Gregory S.; Gutierrez, Jose R.; Sampath, Rangarajan; Ecker, David J.; Blyn, Lawrence B.] Ibis Biosci, Carlsbad, CA USA; [Rothman, Richard E.; Peterson, Stephen; Avornu, Gideon D.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Carroll, Karen C.; Zhang, Sean X.] Johns Hopkins Univ Hosp, Clin Microbiol Lab, Baltimore, MD 21287 USA; [Rounds, Megan A.] Illumina, San Diego, CA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Illumina	Metzgar, D (corresponding author), Ibis Biosci, Carlsbad, CA USA.	david.l.metzgar@abbott.com		Ecker, David/0000-0003-4350-9037	Middle Atlantic RCE Program; NIAID/NIH [2 U54 AI057168]; Ibis Biosciences, a division of Abbott Laboratories; IRIDICA BAC BSI Assay	Middle Atlantic RCE Program; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ibis Biosciences, a division of Abbott Laboratories; IRIDICA BAC BSI Assay	This work was funded in part by the Middle Atlantic RCE Program, NIAID/NIH 2 U54 AI057168, and in part by Ibis Biosciences, a division of Abbott Laboratories, which manufactures and markets the IRIDICA System and the IRIDICA BAC BSI Assay. Abbott employees, as detailed in the Competing Interests Statement, were partly or entirely responsible for study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bacconi A, 2014, J CLIN MICROBIOL, V52, P3164, DOI 10.1128/JCM.00801-14; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Cruz AT, 2007, J CLIN MICROBIOL, V45, P2745, DOI 10.1128/JCM.00359-07; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Ecker DJ, 2009, METHODS MOL BIOL, V551, P71, DOI 10.1007/978-1-60327-999-4_7; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Eshoo MW, 2010, J CLIN MICROBIOL, V48, P472, DOI 10.1128/JCM.01669-09; Fenollar F, 2007, INT J ANTIMICROB AG, V30, pS7, DOI 10.1016/j.ijantimicag.2007.06.024; Fitting C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038916; Fraser A, 2006, AM J MED, V119, P970, DOI 10.1016/j.amjmed.2006.03.034; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Jordana-Lluch E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140865; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; Kane TD, 1998, ANN SURG, V227, P1, DOI 10.1097/00000658-199801000-00001; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Lamy B, 2002, CLIN INFECT DIS, V35, P842, DOI 10.1086/342383; Lehmann LE, 2010, INTENS CARE MED, V36, P49, DOI 10.1007/s00134-009-1608-z; Liesenfeld O, 2014, EUR J MICROBIOL IMMU, V4, P1, DOI 10.1556/EuJMI.4.2014.1.1; Lodes U, 2012, LANGENBECK ARCH SURG, V397, P447, DOI 10.1007/s00423-011-0870-z; Lyle N, 2013, CURR INFECT DIS REP, V15, P372, DOI 10.1007/s11908-013-0350-4; McEnroe RJ, 2005, EP7A2 CLSI; Metzgar D, 2012, ADV TECHNIQUES DIAGN, P441; Metzgar D, 2013, VIRULENCE, V4, P752, DOI 10.4161/viru.26652; Metzgar D, 2013, J CLIN MICROBIOL, V51, P2670, DOI 10.1128/JCM.00966-13; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Pien BC, 2010, AM J MED, V123, P819, DOI 10.1016/j.amjmed.2010.03.021; Rantakokko-Jalava K, 2000, J CLIN MICROBIOL, V38, P32; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; Rhodes J, 2010, AM J TROP MED HYG, V83, P301, DOI 10.4269/ajtmh.2010.09-0584; Riedel S, 2013, CLIN LAB MED, V33, P413, DOI 10.1016/j.cll.2013.03.006; Riedel S, 2010, J INFECT CHEMOTHER, V16, P301, DOI 10.1007/s10156-010-0069-1; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sampath R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036528; Schmid A, 2002, Eur J Health Econ, V3, P77; Schreiber J, 2013, MED KLIN-INTENSIVMED, V108, P311, DOI 10.1007/s00063-013-0227-1; SMARON MF, 1985, J CLIN MICROBIOL, V21, P298, DOI 10.1128/JCM.21.3.298-301.1985; Valles J, 2003, CHEST, V123, P1615, DOI 10.1378/chest.123.5.1615; Vincent JL, 2015, CRIT CARE MED, V43, P2283, DOI 10.1097/CCM.0000000000001249; Weinstein M. P., 2011, Journal of Clinical Microbiology, V49, pS26, DOI 10.1128/JCM.00765-11; Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Wolk DM, 2012, J MOL DIAGN, V14, P295, DOI 10.1016/j.jmoldx.2012.02.005; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x	49	50	51	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158186	10.1371/journal.pone.0158186	http://dx.doi.org/10.1371/journal.pone.0158186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384540	gold, Green Submitted, Green Published			2022-12-27	WOS:000379809400037
J	Arsenijevic, J; Pavlova, M; Rechel, B; Groot, W				Arsenijevic, Jelena; Pavlova, Milena; Rechel, Bernd; Groot, Wim			Catastrophic Health Care Expenditure among Older People with Chronic Diseases in 15 European Countries	PLOS ONE			English	Article							PREVENTING CHRONIC DISEASES; NONCOMMUNICABLE DISEASES; ECONOMIC BURDEN; HOUSEHOLDS; IMPOVERISHMENT; PROTECTION; PRIORITY; EXPENSES; ILLNESS; POLICY	Introduction It is well-known that the prevalence of chronic diseases is high among older people, especially those who are poor. Moreover, chronic diseases can result in catastrophic health expenditure. The relationship between chronic diseases and their financial burden on households is thus double-sided, as financial difficulties can give rise to, and result from, chronic diseases. Our aim was to examine the levels of catastrophic health expenditure imposed by private out-of-pocket payments among older people diagnosed with diabetes mellitus, cardiovascular diseases and cancer in 15 European countries. Methods The SHARE dataset for individuals aged 50+ and their households, collected in 2010-2012 was used. The total number of participants included in this study was N = 51,661. The sample consisted of 43.8% male and 56.2% female participants. The average age was 67 years. We applied an instrumental variable approach for binary instrumented variables known as a treatment-effect model. Results We found that being diagnosed with diabetes mellitus and cardiovascular diseases was associated with catastrophic health expenditure among older people even in comparatively wealthy countries with developed risk-pooling mechanisms. When compared to the Netherlands (the country with the lowest share of out-of-pocket payments as a percentage of total health expenditure in our study), older people diagnosed with diabetes mellitus in Portugal, Poland, Denmark, Italy, Switzerland, Belgium, the Czech Republic and Hungary were more likely to experience catastrophic health expenditure. Similar results were observed for diagnosed cardiovascular diseases. In contrast, cancer was not associated with catastrophic health expenditure. Discussion Our study shows that older people with diagnosed chronic diseases face catastrophic health expenditure even in some of the wealthiest countries in Europe. The effect differs across chronic diseases and countries. This may be due to different socio-economic contexts, but also due to the specific characteristics of the different health systems. In view of the ageing of European populations, it will be crucial to strengthen the mechanisms for financial protection for older people with chronic diseases.	[Arsenijevic, Jelena; Pavlova, Milena; Groot, Wim] Maastricht Univ, Fac Hlth Med & Life Sci, Med Ctr, Dept Hlth Serv Res,CAPHRI, Maastricht, Netherlands; [Rechel, Bernd] London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London, England; [Groot, Wim] Maastricht Univ, Top Inst Evidence Based Educ Res TIER, Maastricht, Netherlands	Maastricht University; European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; Maastricht University	Arsenijevic, J (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Med Ctr, Dept Hlth Serv Res,CAPHRI, Maastricht, Netherlands.	j.arsenijevic@maastrichtuniversity.nl	Pavlova, Milena/B-4778-2011	Pavlova, Milena/0000-0002-6082-8446; Arsenijevic, Jelena/0000-0003-3405-849X; Rechel, Bernd/0000-0001-8020-3956	Theme 8 Socio-economic Sciences and Humanities, Project ASSPRO CEE [217431]; School for Public Health and Primary Care (CAPHRI), Maastricht University [CAP12.5326]; European Commission under the 7th Framework Programme	Theme 8 Socio-economic Sciences and Humanities, Project ASSPRO CEE; School for Public Health and Primary Care (CAPHRI), Maastricht University; European Commission under the 7th Framework Programme	The study is financed by the European Commission under the 7th Framework Programme, Theme 8 Socio-economic Sciences and Humanities, Project ASSPRO CEE 2007 (Grant Agreement no. 217431). The views expressed in this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission or its services. Also, the study is supported by the School for Public Health and Primary Care (CAPHRI), Maastricht University under the travel grant, reference CAP12.5326.	Abegunde DO, 2008, SOC SCI MED, V66, P2296, DOI 10.1016/j.socscimed.2008.01.041; Abma TA, 2013, CROSSING CULTURES HL; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; [Anonymous], 2010, WORLD HLTH REP; Barnieh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090434; Basu S, 2013, PUBLIC HEALTH NUTR, V16, P179, DOI [10.1017/S1368980012002881, 10.1017/S1368980012003758]; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bihan H, 2005, DIABETES CARE, V28, P2680, DOI 10.2337/diacare.28.11.2680; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Busse R., 2010, TACKLING CHRONIC DIS; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Combes JB, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-10; Essue B, 2011, J HEALTH SERV RES PO, V16, P226, DOI 10.1258/jhsrp.2011.010159; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Gotsadze G, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-69; Habicht J, 2006, HEALTH POLICY PLANN, V21, P421, DOI 10.1093/heapol/czl026; Harbers M.M., 2012, INFORM INDICATORS DA; Haughton J., 2009, HDB POVERTY INEQUALI; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Karami M, 2009, J RES HEALTH SCI, V9, P36; Kawabata K, 2002, B WORLD HEALTH ORGAN, V80, P612; Kenkel DS, 2014, J HUM RESOUR, V49, P1094; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Luczak J, 2012, HEALTH POLICY, V105, P256, DOI 10.1016/j.healthpol.2012.01.004; Ludwig J., 2013, LONG TERM NEIGHBORHO; Malter F., 2013, SHARE WAVE 4 INNOVAT; Mayer-Foulkes DA, 2012, GLOB ECON J, V12, DOI 10.1515/1524-5861.1889; Morabia A, 2006, SOZ PRAVENTIV MED, V51, P74, DOI 10.1007/s00038-005-0015-7; Murphy A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-38; Olejaz M., 2012, DENMARK HLTH SYSTEM; Organization WH, 2005, DES HLTH FIN SYST RE; Osborn R, 2014, HEALTH AFFAIR, V33, P2247, DOI 10.1377/hlthaff.2014.0947; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; Russell S, 2005, HEALTH POLICY PLANN, V20, P277, DOI 10.1093/heapol/czi035; Saksena P, 2010, DRIVERS CATASTROPHIC; Sargent-Cox K, 2011, SOC SCI MED, V73, P1105, DOI 10.1016/j.socscimed.2011.06.063; Schoenberg NE, 2007, GERONTOLOGIST, V47, P423, DOI 10.1093/geront/47.4.423; Smith O, 2013, EUROPE CENT ASIA REP, P1, DOI 10.1596/978-0-8213-9883-8; Stuck S., 2012, SHARE RELEASE GUIDE; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Suhrcke M, 2005, CONTRIBUTION HLTH EC; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Tambor M, 2013, HEALTH POLICY, V113, P284, DOI 10.1016/j.healthpol.2013.09.011; Tambor M, 2011, EUR J PUBLIC HEALTH, V21, P585, DOI 10.1093/eurpub/ckq139; Van Kippersluis H, 2013, WHY RICH DRINK MORE; Verhagen I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-227; Wagstaff A, 2014, WORLD BANK POLICY RE; Wong YN, 2010, ONCOLOGIST, V15, P566, DOI 10.1634/theoncologist.2009-0307; Wooldridge J. M., 2016, INTRO ECONOMETRICS M; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006	57	47	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157765	10.1371/journal.pone.0157765	http://dx.doi.org/10.1371/journal.pone.0157765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27379926	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000379798700009
J	Garcia-Concejo, A; Jimenez-Gonzalez, A; Rodriguez, RE				Garcia-Concejo, Adrian; Jimenez-Gonzalez, Ada; Rodriguez, Raquel E.			mu Opioid Receptor Expression after Morphine Administration Is Regulated by miR-212/132 Cluster	PLOS ONE			English	Article							MICRORNAS	Since their discovery, miRNAs have emerged as a promising therapeutical approach in the treatment of several diseases, as demonstrated by miR-212 and its relation to addiction. Here we prove that the miR-212/132 cluster can be regulated by morphine, through the activation of mu opioid receptor (Oprm1). The molecular pathways triggered after morphine administration also induce changes in the levels of expression of oprm1. In addition, miR-212/132 cluster is actively repressing the expression of mu opioid receptor by targeting a sequence in the 3' UTR of its mRNA. These findings suggest that this cluster is closely related to opioid signaling, and function as a post-transcriptional regulator, modulating morphine response in a dose dependent manner. The regulation of miR-212/132 cluster expression is mediated by MAP kinase pathway, CaMKII-CaMKIV and PKA, through the phosphorylation of CREB. Moreover, the regulation of both oprm1 and of the cluster promoter is mediated by MeCP2, acting as a transcriptional repressor on methylated DNA after prolonged morphine administration. This mechanism explains the molecular signaling triggered by morphine as well as the regulation of the expression of the mu opioid receptor mediated by morphine and the implication of miR-212/132 in these processes.	[Garcia-Concejo, Adrian; Jimenez-Gonzalez, Ada; Rodriguez, Raquel E.] INCyL, C Pintor Fernando Gallego,1, Salamanca 37007, Spain; [Rodriguez, Raquel E.] Univ Salamanca, Fac Med, Dept Biochem & Mol Biol, C Alfonso X El Sabio,0 S-N Campus Miguel Unamun, Salamanca 37007, Spain; [Garcia-Concejo, Adrian; Jimenez-Gonzalez, Ada; Rodriguez, Raquel E.] Hosp Univ Salamanca, Inst Biomed Res Salamanca IBSAL, Edificio Virgen Vega Decima Planta, Salamanca 37007, Spain	University of Salamanca; University of Salamanca	Rodriguez, RE (corresponding author), INCyL, C Pintor Fernando Gallego,1, Salamanca 37007, Spain.; Rodriguez, RE (corresponding author), Univ Salamanca, Fac Med, Dept Biochem & Mol Biol, C Alfonso X El Sabio,0 S-N Campus Miguel Unamun, Salamanca 37007, Spain.; Rodriguez, RE (corresponding author), Hosp Univ Salamanca, Inst Biomed Res Salamanca IBSAL, Edificio Virgen Vega Decima Planta, Salamanca 37007, Spain.	requelmi@usal.es		Rodriguez Rodriguez, Raquel/0000-0003-1805-3066; Garcia-Concejo, Adrian/0000-0002-7269-5783; Jimenez-Gonzalez, Ada/0000-0001-7702-6135	Ministerio Espanol de Economia y Competitividad [SAF 2013-48776-P]; Junta de Castilla y Leon [SA106UIH]	Ministerio Espanol de Economia y Competitividad(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by the grant from Ministerio Espanol de Economia y Competitividad (SAF 2013-48776-P) and Junta de Castilla y Leon (SA106UIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bijkerk R, 2016, KIDNEY INT, V89, P1268, DOI 10.1016/j.kint.2016.01.029; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Chang YY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0301-9; Chen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082288; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; de Chevigny A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00006; Doench JG, 2004, GENES DEV, V18; Formisano L, 2007, P NATL ACAD SCI USA, V104, P4170, DOI 10.1073/pnas.0611704104; Garcia-Perez D, 2015, ADDICT BIOL, V20, P104, DOI 10.1111/adb.12083; Gonzalez-Nunez V, 2013, MOL MED, V19, P7, DOI 10.2119/molmed.2012.00318; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; He XJ, 2011, ZEBRAFISH, V8, P1, DOI 10.1089/zeb.2010.0680; Hollander JA, 2010, NAT NEUROSCIENCE, V466; Hwang CK, 2004, J BIOL CHEM, V279; Im HI, 2010, NAT NEUROSCIENCE, V13; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jimenez-Gonzalez A, 2016, BBA-GEN SUBJECTS, V1860, P1308, DOI 10.1016/j.bbagen.2016.03.001; Kawamata T, 2010, TRENDS BIOCH SCI, V35; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kumarswamy R, 2014, EUR HEART J, V35, P3224, DOI 10.1093/eurheartj/ehu344; Lopez-Bellido R, 2012, PLOS ONE, V7; Luo J, 2014, INT J CLIN EXP MED, V7; Ma W, 2001, EUR J NEUROSCI, V14; Sanchez-Simon FM, 2010, EUR J NEUROSCI, V32, P550, DOI 10.1111/j.1460-9568.2010.07317.x; Marron Fdez de Velasco E, 2011, ZEBRAFISH; Mohammed J, 2014, RNA, V20; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Murthy KS, 1996, MOL PHARM, V50; Nasevicius A, 2000, NAT GENETICS, V26; Nestler EJ, 1996, MOL PSYCHIATR, V1, P190; Numakawa T, 2011, NEUROCHEM INT, V59, P551, DOI 10.1016/j.neuint.2011.06.009; Park IK, 1995, J BIOL CHEM, V270; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Ryazansky SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-371; Sanchez-Simon FM, 2010, MOL PHARM, V78; Sidhu K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00068; Song RH, 2015, J THEOR BIOL, V380, P271, DOI 10.1016/j.jtbi.2015.05.025; Tebar F, 2002, FEBS LETT, V517, P206, DOI 10.1016/S0014-5793(02)02624-8; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Zhang XM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/732397; Zhou Z, 2006, NEURON, V52	50	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157806	10.1371/journal.pone.0157806	http://dx.doi.org/10.1371/journal.pone.0157806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380026	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700010
J	Cao, J; Zhu, X; Zhao, XK; Li, XF; Xu, R				Cao, Jian; Zhu, Xuan; Zhao, Xiaokun; Li, Xue-Feng; Xu, Ran			Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SUPPRESSOR-CELLS; INFLAMMATION; SURVIVAL; MEN; INFILTRATION; ASSOCIATION; IMMUNITY; OUTCOMES; ANTIGEN; SCORE	An unprecedented advance has been seen in castration-resistant prostate cancer (CRPC) treatments in the past few years. With a number of novel agents were approved, there is a pressing need to develop improved prognostic biomarkers to facilitate the personalised selection and sequencing of these novel agents. Emerging evidence indicates that the neutrophil-to-lymphocyte ratio (NLR) is associated with poorer survival in patients with prostate cancer (PCa). However, the importance of the NLR for the prediction of the PSA response (PSARS) and biochemical recurrence (BCR) has been largely neglected. Here, we conducted a systematic review and meta-analysis to evaluate the prognostic value of the NLR for the PSARS, BCR, and survival in PCa. A systematic database search was performed using Embase, PubMed, the Cochrane Library, and the China National Knowledge Infrastructure (CNKI). A meta-analysis was performed by pooling hazard ratios (HRs), odds ratios (ORs) and the corresponding 95% confidence intervals (CIs). A total of 22 studies were included in the meta-analysis. Our results suggest that an elevated NLR predicts a lower PSARS rate (OR = 1.69, 95% CI: 1.40-1.98) and a higher possibility of BCR (HR = 1.12, 95% CI: 1.02-1.21). Additionally, we confirmed that an elevated NLR was a prognostic predictor of shorter overall survival (OS) in both metastatic castration-resistant PCa (mCRPC) (HR = 1.45, 95% CI: 1.32-1.59) and localized PCa (LPC) (HR = 1.12, 95% CI: 1.01-1.23) and that it predicted worse progression-free survival (PFS) in CRPC (HR = 1.42, 95% CI: 1.23-1.61) and poorer recurrence-free survival (RFS) (HR = 1.38, 95% CI: 1.01-1.75) in LPC. Our results suggest that an elevated NLR might be employed as a prognostic marker of biochemical changes and prognosis to facilitate risk stratification and decision making for individual treatment of PCa patients. The potential mechanisms underlying these associations and future research directions are also discussed.	[Cao, Jian; Zhu, Xuan; Zhao, Xiaokun; Xu, Ran] Cent South Univ, Dept Urol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Cao, Jian; Li, Xue-Feng] Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	Central South University; University of Edinburgh	Xu, R (corresponding author), Cent South Univ, Dept Urol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	ddf20@sina.com			China Scholarship Council [201506370137]	China Scholarship Council(China Scholarship Council)	Jian Cao is sponsored by the China Scholarship Council (201506370137) as a visiting researcher in at the University of Edinburgh (http://www.csc.edu.cn/). The funder (China Scholarship Council) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahig H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1599-9; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Chung CH, 2008, ONCOLOGIST, V13, P725, DOI 10.1634/theoncologist.2008-0012; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flammiger A, 2012, APMIS, V120, P901, DOI 10.1111/j.1600-0463.2012.02924.x; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Kawahara T, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2134-3; Kim J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6058147; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Kwon YS, 2016, CLIN GENITOURIN CANC, V14, pE1, DOI 10.1016/j.clgc.2015.07.018; Lee H, 2016, WORLD J UROL, V34, P821, DOI 10.1007/s00345-015-1701-6; Leibowitz-Amit R, 2014, ANN ONCOL, V25, P657, DOI 10.1093/annonc/mdt581; Li J, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/691380; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Li XF, 2015, J HEPATOL, V62, P131, DOI 10.1016/j.jhep.2014.08.023; Linton A, 2013, CLIN GENITOURIN CANC, V11, P423, DOI 10.1016/j.clgc.2013.04.020; Lorente D, 2015, ANN ONCOL, V26, P750, DOI 10.1093/annonc/mdu587; McDonald AC, 2014, PROSTATE, V74, P561, DOI 10.1002/pros.22782; McLachlan JM, 2015, CANC TREAT COMMUN, V4, P81, DOI DOI 10.1016/J.CTRC.2015.06.001; Minardi D, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1036-1; Mottet N., 2016, UPDATE, DOI [10.1016/j.eururo.2007.09.002, DOI 10.1016/J.EURURO.2007.09.002]; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Ness N, 2014, PROSTATE, V74, P1452, DOI 10.1002/pros.22862; Nuhn P, 2014, BJU INT, V114, pE11, DOI 10.1111/bju.12531; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pezaro C, 2014, INTERN MED J, V44, P433, DOI 10.1111/imj.12407; POTOSKY AL, 1990, J NATL CANCER I, V82, P1624, DOI 10.1093/jnci/82.20.1624; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Poyet C, 2015, J UROLOGY, V193, pE817, DOI 10.1016/j.juro.2015.02.2358; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Ramanathan S, 2008, ARCH IMMUNOL THER EX, V56, P311, DOI 10.1007/s00005-008-0033-2; Shafique K, 2012, PROSTATE CANCER P D, V15, P195, DOI 10.1038/pcan.2011.60; Sharma V, 2015, J UROLOGY, V193, pE55, DOI 10.1016/j.juro.2015.02.252; Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P317, DOI 10.1016/j.clgc.2014.03.005; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sumbul AT, 2014, INT UROL NEPHROL, V46, P1531, DOI 10.1007/s11255-014-0664-7; Sutton AJAK, 2000, METHODS METAANALYSIS; Tazzyman S, 2013, SEMIN CANCER BIOL, V23, P149, DOI 10.1016/j.semcancer.2013.02.003; Templeton AJ, 2014, CANCER-AM CANCER SOC, V120, P3346, DOI 10.1002/cncr.28890; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; van Soest RJ, 2015, ANN ONCOL, V26, P743, DOI 10.1093/annonc/mdu569; Wei Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092079; Wu CT, 2012, J MOL MED, V90, P1343, DOI 10.1007/s00109-012-0916-x; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981; Yao A, 2015, INT J UROL, V22, P827, DOI 10.1111/iju.12839; Yin XT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002544; Zhang GM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001473; [张姣 Zhang Jiao], 2015, [肿瘤, Tumor], V35, P333; Zhang Y, 2013, CANCER IMMUNOL IMMUN, V62, P87, DOI 10.1007/s00262-012-1313-6	59	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158770	10.1371/journal.pone.0158770	http://dx.doi.org/10.1371/journal.pone.0158770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27368058	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900052
J	Gao, SK; Tang, YL; Wei, K; Wang, XY; Yang, ZQ; Zhang, YL				Gao, Shangkun; Tang, Yanlong; Wei, Ke; Wang, Xiaoyi; Yang, Zhongqi; Zhang, Yanlong			Relationships between Body Size and Parasitic Fitness and Offspring Performance of Sclerodermus pupariae Yang et Yao (Hymenoptera: Bethylidae)	PLOS ONE			English	Article							AGRILUS-PLANIPENNIS COLEOPTERA; LIFE-HISTORY TRAITS; SEX-RATIO; DEVELOPMENTAL STRATEGIES; HOST SIZE; FECUNDITY; BEHAVIOR; BUPRESTIDAE; LONGEVITY; EVOLUTION	The relationship between body size and fitness in parasitoid wasps has several effects on parasitic ability, reproductive behavior in female wasps, and progeny fitness. Female wasps with various body sizes were obtained by mass-rearing a gregarious ectoparasitoid, Sclerodermus pupariae, which is one of the excellent parasites to control the larvae and pupae of Buprestidae and Cerambycidae. We investigated the effects of body size of adult females introduced on Thyestilla gebleri (Coleoptera: Cerambycidae) larvae on their paralysis time, pre-oviposition period, oviposition period and fecundity, and the related fitness of their offspring. Results showed that small female wasps needed more time to paralyze a host and had a higher mortality rate than large female wasps. More offspring were produced by large female wasps than by small female wasps, and the percentage and body size of female offspring was not affected by maternal body size. The duration of the egg stage was not affected by foundress size, nor was that of the pupal stage, but the duration of the larval stage and generation time of small female wasps was longer than that of large females. Our findings suggest that the parasitic fitness and offspring performance are affected by maternal size, and there is need to choose reasonable body size of female wasps, to optimally utilize mass rearing and to control target pests with the lowest mortality cost.	[Yang, Zhongqi] China State Forestry Adm, Key Lab Forest Protect, Beijing, Peoples R China; Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Yang, ZQ (corresponding author), China State Forestry Adm, Key Lab Forest Protect, Beijing, Peoples R China.	yangzhqi@126.com		Wang, Xiaoyi/0000-0001-8136-6642	State Key Program of National Natural Science Foundation of China [31230015]; National Natural Science Foundation of China [31370654]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Zhongqi Yang received the State Key Program of National Natural Science Foundation of China (No. 31230015). The funder had an important role in study design. Xiaoyi Wang received the National Natural Science Foundation of China (Grant No. 31370654). The funder had an important role in data analysis.	Andreas M, 2013, BIOLOGIA, V68, P170, DOI 10.2478/s11756-012-0139-1; BLACKBURN TM, 1991, FUNCT ECOL, V5, P65, DOI 10.2307/2389556; CHARNOV E L, 1982; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; Charnov EL, THEORY SEX ALLOCATIO; Chen J., 1995, PLANT PROT, V17, P26; Dai Ping-Li, 2005, Chinese Bulletin of Entomology, V42, P308; Dor A, 2013, CAN J ZOOL, V91, P545, DOI 10.1139/cjz-2012-0308; Elzinga JA, 2003, ENTOMOL EXP APPL, V108, P95, DOI 10.1046/j.1570-7458.2003.00072.x; Fidgen JG, 2000, ECOL ENTOMOL, V25, P156, DOI 10.1046/j.1365-2311.2000.00248.x; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Gauld I. D., 1988, HYMENOPTERA; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HAMMERSTEIN P, 1981, ANIM BEHAV, V29, P193, DOI 10.1016/S0003-3472(81)80166-2; Harvey JA, 1999, J INSECT PHYSIOL, V45, P173, DOI 10.1016/S0022-1910(98)00113-9; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Harvey JA, 2004, ENVIRON ENTOMOL, V33, P1488, DOI 10.1603/0046-225X-33.5.1488; Harvey JA, 2004, ECOL ENTOMOL, V29, P35, DOI 10.1111/j.0307-6946.2004.00568.x; Harvey JA, 2002, ECOLOGY, V83, P2439, DOI 10.1890/0012-9658(2002)083[2439:TDSOEW]2.0.CO;2; Henry LM, 2005, ENTOMOL EXP APPL, V116, P167, DOI 10.1111/j.1570-7458.2005.00318.x; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051246; Jervis M. A., 1996, P63; Johnson DW, 2011, J EVOLUTION BIOL, V24, P1653, DOI 10.1111/j.1420-9101.2011.02298.x; Karsai I, 1991, P 4 EUR C ENT 13 INT, P504; Kasamatsu E, 2015, PHYSIOL ENTOMOL, V40, P223, DOI 10.1111/phen.12106; KAZMER DJ, 1995, ECOLOGY, V76, P412, DOI 10.2307/1941200; Lauziere I, 2000, ANN ENTOMOL SOC AM, V93, P103, DOI 10.1603/0013-8746(2000)093[0103:EOFBSA]2.0.CO;2; LEATHER SR, 1988, OIKOS, V51, P386, DOI 10.2307/3565323; Li Guo-Qing, 2006, Acta Ecologica Sinica, V26, P1261; Lin Fangfang, 2015, Nanjing Nongye Daxue Xuebao, V38, P584; Mackauer M., 1997, Ecological Studies, V130, P191; Mayhew PJ, 1999, J ANIM ECOL, V68, P906, DOI 10.1046/j.1365-2656.1999.00338.x; Messina FJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P227; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nakamatsu Y, 2004, ANN ENTOMOL SOC AM, V97, P994, DOI 10.1603/0013-8746(2004)097[0994:FRUOHT]2.0.CO;2; Olson DM, 1998, ENVIRON ENTOMOL, V27, P508, DOI 10.1093/ee/27.2.508; OSBORNE L L, 1987, Journal of the North American Benthological Society, V6, P115, DOI 10.2307/1467221; Petersen G, 1996, ANIM BEHAV, V51, P1363, DOI 10.1006/anbe.1996.0139; Quicke D. L. J., 1997, PARASITIC WASPS; ROSENHEIM JA, 1992, ECOL ENTOMOL, V17, P263, DOI 10.1111/j.1365-2311.1992.tb01057.x; Sagarra LA, 2001, B ENTOMOL RES, V91, P363, DOI 10.1079/BER2001121; SANDLAN KP, 1982, ANN ENTOMOL SOC AM, V75, P217, DOI 10.1093/aesa/75.3.217; Santolamazza-Carbone S, 2007, ENTOMOL EXP APPL, V125, P23, DOI 10.1111/j.1570-7458.2007.00595.x; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Stearns S.C., 1992, pi; STONE GN, 1989, J EXP BIOL, V147, P303; Strand MR, 2000, PARASITOID POPULATION BIOLOGY, P139; Tang XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5942; Tang Yan-Long, 2012, Acta Entomologica Sinica, V55, P55; TAYLOR PD, 1981, NATURE, V291, P64, DOI 10.1038/291064a0; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; Waage JK, 1986, FAMILY PLANNINGIN PA; Wang Xiao-Yi, 2010, Acta Entomologica Sinica, V53, P675; Wei K, 2013, J APPL ENTOMOL, V137, P469, DOI 10.1111/jen.12031; Wei K, 2016, ECOL ENTOMOL; Wei K, 2014, ECOL ENTOMOL, V39, P101, DOI 10.1111/een.12074; West SA, 1996, J ANIM ECOL, V65, P631, DOI 10.2307/5742; Wu Hui, 2008, Acta Entomologica Sinica, V51, P46; Wu W., 2008, J SOUTHWET FOR COLL, V28, P24; Yang ZQ, 2014, BIOL CONTROL, V68, P117, DOI 10.1016/j.biocontrol.2013.06.010; Yang ZQ, 2012, ANN ENTOMOL SOC AM, V105, P619, DOI 10.1603/AN12017; Zeng CH, 1997, J SICHUAN FOR SCI TE, V18, P14; Zhang XZ, 1980, ENTOMOL KNOWL, V27, P71; Zhou Na, 2006, Natural Enemies of Insects, V28, P97; Zhu L., 2003, J SICHUAN FORESTRY S, V24, P18	67	25	26	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0156831	10.1371/journal.pone.0156831	http://dx.doi.org/10.1371/journal.pone.0156831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367523	Green Submitted, Green Published, gold			2022-12-27	WOS:000378914900007
J	Peng, HY; Cheng, YC; Hsu, YM; Wu, GH; Kuo, CC; Liou, JP; Chang, JY; Jin, SLC; Shiah, SG				Peng, Hsuan-Yu; Cheng, Yun-Ching; Hsu, Yuan-Ming; Wu, Guan-Hsun; Kuo, Ching-Chuan; Liou, Jing-Ping; Chang, Jang-Yang; Jin, Shiow-Lian Catherine; Shiah, Shine-Gwo			MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							IMMUNE-SYSTEM; IN-VIVO; CANCER; STAT3; HEAD; NECK; ACTIVATION; 5-FLUOROURACIL; REQUIREMENT; PROGRESSION	Microtubule inhibitors have been shown to inhibit Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signal transduction pathway in various cancer cells. However, little is known of the mechanism by which the microtubule inhibitors inhibit STAT3 activity. In the present study, we examined the effect of a novel small-molecule microtubule inhibitor, MPT0B098, on STAT3 signaling in oral squamous cell carcinoma (OSCC). Treatment of various OSCC cells with MPT0B098 induced growth inhibition, cell cycle arrest and apoptosis, as well as increased the protein level of SOCS3. The accumulation of SOCS3 protein enhanced its binding to JAK2 and TYK2 which facilitated the ubiquitination and degradation of JAK2 and TYK2, resulting in a loss of STAT3 activity. The inhibition of STAT3 activity led to sensitization of OSCC cells to MPT0B098 cytotoxicity, indicating that STAT3 is a key mediator of drug resistance in oral carcinogenesis. Moreover, the combination of MPT0B098 with the clinical drug cisplatin or 5-FU significantly augmented growth inhibition and apoptosis in OSCC cells. Taken together, our results provide a novel mechanism for the action of MPT0B098 in which the JAK2/STAT3 signaling pathway is suppressed through the modulation of SOCS3 protein level. The findings also provide a promising combinational therapy of MPT0B098 for OSCC.	[Peng, Hsuan-Yu; Hsu, Yuan-Ming; Wu, Guan-Hsun; Chang, Jang-Yang; Shiah, Shine-Gwo] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Peng, Hsuan-Yu; Jin, Shiow-Lian Catherine] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Cheng, Yun-Ching] Show Chwan Mem Hosp, Dept Med Res, Changhua, Taiwan; [Kuo, Ching-Chuan] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan; [Liou, Jing-Ping] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Chang, Jang-Yang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Div Hematol & Oncol,Dept Internal Med, Tainan, Taiwan	National Health Research Institutes - Taiwan; National Central University; Show Chwan Memorial Hospital; National Health Research Institutes - Taiwan; Taipei Medical University; National Cheng Kung University; National Cheng Kung University Hospital	Shiah, SG (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.	davidssg@nhri.org.tw		Shiah, Shine-Gwo/0000-0002-1003-973X	National RNAi Core Facility at Academia Sinica, Taiwan	National RNAi Core Facility at Academia Sinica, Taiwan	We are grateful for the support of the National RNAi Core Facility at Academia Sinica, Taiwan with the shRNA clones (such as SOCS3, STAT3 and pLKO_TRC vector).	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Bendell JC, 2014, CANCER CHEMOTH PHARM, V74, P125, DOI 10.1007/s00280-014-2480-2; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Brown ME, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0505-7; Bu LL, 2015, ONCOTARGET, V6, P41944, DOI 10.18632/oncotarget.5986; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chang JY, 2010, MEDCHEMCOMM, V1, P152, DOI 10.1039/c0md00052c; Cheng YC, 2013, MOL CANCER THER, V12, P1202, DOI 10.1158/1535-7163.MCT-12-0778; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Fang LA, 2011, TOXICOL APPL PHARM, V251, P8, DOI 10.1016/j.taap.2010.11.007; Gkouveris I, 2014, ONCOL REP, V32, P2175, DOI 10.3892/or.2014.3440; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; Jerjes W, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-9; Keil F, 2013, EUR J CANCER, V49, P352, DOI 10.1016/j.ejca.2012.08.004; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Macha MA, 2011, HEAD NECK-J SCI SPEC, V33, P482, DOI 10.1002/hed.21468; Masuda M, 2010, CURR CANCER DRUG TAR, V10, P117, DOI 10.2174/156800910790980197; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Nishi M, 2009, FEBS LETT, V583, P1243, DOI 10.1016/j.febslet.2009.03.041; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Sen M, 2012, CANCER DISCOV, V2, P694, DOI 10.1158/2159-8290.CD-12-0191; Shiah SG, 2014, CANCER RES, V74, P7560, DOI 10.1158/0008-5472.CAN-14-0978; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Siavash H, 2004, CRIT REV ORAL BIOL M, V15, P298, DOI 10.1177/154411130401500505; Sivanantham B, 2016, ACS COMB SCI, V18, P22, DOI 10.1021/acscombsci.5b00043; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Vuong BQ, 2004, MOL CELL BIOL, V24, P9092, DOI 10.1128/MCB.24.20.9092-9101.2004; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang N, 2008, MOLECULES, V13, P1551, DOI 10.3390/molecules13081551; Zou TT, 2008, FEBS LETT, V582, P4015, DOI 10.1016/j.febslet.2008.10.055	37	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158440	10.1371/journal.pone.0158440	http://dx.doi.org/10.1371/journal.pone.0158440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367272	gold, Green Published, Green Submitted			2022-12-27	WOS:000378914900035
J	Adams, VM; Pressey, RL; Alvarez-Romero, JG				Adams, Vanessa M.; Pressey, Robert L.; Alvarez-Romero, Jorge G.			Using Optimal Land-Use Scenarios to Assess Trade-Offs between Conservation, Development, and Social Values	PLOS ONE			English	Article							ECOSYSTEM SERVICES; BIODIVERSITY CONSERVATION; FIRE MANAGEMENT; LANDSCAPES; PRIORITIES; ABATEMENT; TOOL	Development of land resources can contribute to increased economic productivity but can also negatively affect the extent and condition of native vegetation, jeopardize the persistence of native species, reduce water quality, and erode ecosystem services. Spatial planning must therefore balance outcomes for conservation, development, and social goals. One approach to evaluating these trade-offs is scenario planning. In this paper we demonstrate methods for incorporating stakeholder preferences into scenario planning through both defining scenario objectives and evaluating the scenarios that emerge. In this way, we aim to develop spatial plans capable of informing actual land-use decisions. We used a novel approach to scenario planning that couples optimal land-use design and social evaluation of environmental outcomes. Four land-use scenarios combined differences in total clearing levels (10% and 20%) in our study region, the Daly Catchment Australia, with the presence or absence of spatial precincts to concentrate irrigated agriculture. We used the systematic conservation planning tool Marxan with Zones to optimally plan for multiple land-uses that met objectives for both conservation and development. We assessed the performance of the scenarios in terms of the number of objectives met and the degree to which existing land-use policies were compromised (e.g., whether clearing limits in existing guidelines were exceeded or not). We also assessed the land-use scenarios using expected stakeholder satisfaction with changes in the catchment to explore how the scenarios performed against social preferences. There were a small fraction of conservation objectives with high conservation targets (100%) that could not be met due to current land uses; all other conservation and development objectives were met in all scenarios. Most scenarios adhered to the existing clearing guidelines with only marginal exceedances of limits, indicating that the scenario objectives were compatible with existing policy. We found that two key stakeholder groups, agricultural and Indigenous residents, had divergent satisfaction levels with the amount of clearing and agricultural development. Based on the range of benefits and potential adverse impacts of each scenario, we suggest that the 10% clearing scenarios are most aligned with stakeholder preferences and best balance preferences across stakeholder groups. Our approach to scenario planning is applicable generally to exploring the potential conflicts between goals for conservation and development. Our case study is particularly relevant to current discussion about increased agricultural and pastoral development in northern Australia.	[Adams, Vanessa M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia; [Adams, Vanessa M.; Pressey, Robert L.; Alvarez-Romero, Jorge G.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia; [Adams, Vanessa M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	Charles Darwin University; James Cook University; University of Queensland	Adams, VM (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia.; Adams, VM (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia.; Adams, VM (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	v.adams@uq.edu.au	Adams, Vanessa M./A-3834-2012; Alvarez-Romero, Jorge G./A-4557-2009	Adams, Vanessa M./0000-0002-3509-7901; Alvarez-Romero, Jorge G./0000-0002-1141-0588	Australian Government's National Environmental Research Program (NERP); Australian Research Council Centre of Excellence for Coral Reef Studies	Australian Government's National Environmental Research Program (NERP)(Australian Government); Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	This research was conducted with the support of funding from the Australian Government's National Environmental Research Program (NERP), specifically the Northern Australia NERP Hub. RLP and JGAR also acknowledge the support of the Australian Research Council Centre of Excellence for Coral Reef Studies.	Adams VM, 2014, ECOL SOC, V19, DOI 10.5751/ES-07168-190453; Adams VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096479; Adams VM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025018; Adams VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025447; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2005, EC HUM WELL BEING SY; Auge AA, 2013, COASTGIS 2013 11 INT; Babbar-Sebens M, 2015, ENVIRON MODELL SOFTW, V69, P111, DOI 10.1016/j.envsoft.2015.03.011; Bohensky E, 2011, GLOBAL ENVIRON CHANG, V21, P876, DOI 10.1016/j.gloenvcha.2011.03.009; Bryan BA, 2011, CONSERV BIOL, V25, P172, DOI 10.1111/j.1523-1739.2010.01560.x; Carlson MJ, 2011, ECOL SOC, V16, DOI 10.5751/ES-04267-160308; Chatto R., 2003, DISTRIBUTION STATUS; Commonwealth of Australia, 2015, OUR N OUR FUT WHIT P; Costanza R, 2007, ECOL ECON, V61, P267, DOI 10.1016/j.ecolecon.2006.02.023; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; DCCEE, 2011, METH SAV BURN; Department of Prime Minister & Cabinet (DPMC), 2014, GREEN PAP DEV NO AUS; DLRM, 2013, VEG MAPP DAL RIV CAT; Fitzsimons James, 2012, Ecological Management & Restoration, V13, P51, DOI 10.1111/j.1442-8903.2011.00624.x; Francis SR, 2011, ECOL SOC, V16, DOI 10.5751/ES-04532-160418; Greiner R, 2015, AGR SYST, V137, P154, DOI 10.1016/j.agsy.2015.04.005; Heckbert S, 2012, AUSTRAL ECOL, V37, P724, DOI 10.1111/j.1442-9993.2012.02408.x; Jackson S, 2012, HUM ECOL, V40, P893, DOI 10.1007/s10745-012-9518-z; Kennard MJ, 2010, IDENTIFYING HIGH CON; Larson S, 2013, ECOL ECON, V94, P9, DOI 10.1016/j.ecolecon.2013.07.005; Malinga R, 2013, ECOL SOC, V18, DOI 10.5751/ES-05494-180410; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Northern Territory Government, 2014, IP414 NO TERR GOV DE; NRETAS, 2010, ARTS SPORT CLEAR GUI; NRETAS, 2009, REC SIT CONS SIGN BI; Pantus FJ, 2011, 9781921576423 C DARW; Pascoe-Bell A, 2011, IDENTIFICATION POTEN; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Pressey R. L., 2009, ORYX, V43, P451; Pressey RL, 2013, BIOL CONSERV, V166, P155, DOI 10.1016/j.biocon.2013.06.025; Reed MS, 2008, BIOL CONSERV, V141, P2417, DOI 10.1016/j.biocon.2008.07.014; Reichert P, 2015, J ENVIRON MANAGE, V154, P316, DOI 10.1016/j.jenvman.2015.01.053; Reyers B, 2012, LANDSCAPE ECOL, V27, P1121, DOI 10.1007/s10980-012-9761-0; Salter JD, 2009, J ENVIRON MANAGE, V90, P2090, DOI 10.1016/j.jenvman.2007.08.023; Stoeckl N, 2013, BIOL CONSERV, V159, P214, DOI 10.1016/j.biocon.2012.12.007; Vihervaara P, 2012, FOREST POLICY ECON, V14, P58, DOI 10.1016/j.forpol.2011.08.008; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Whitehead AL, 2014, CONSERV BIOL, V28, P992, DOI 10.1111/cobi.12257; Zander KK, 2010, ECOL ECON, V69, P2417, DOI 10.1016/j.ecolecon.2010.07.010; Zander KK, 2010, J ENVIRON MANAGE, V91, P2519, DOI 10.1016/j.jenvman.2010.07.012	48	25	26	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158350	10.1371/journal.pone.0158350	http://dx.doi.org/10.1371/journal.pone.0158350			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362347	Green Published, Green Accepted, gold			2022-12-27	WOS:000378865200061
J	Gariou-Papalexiou, A; Giardini, MC; Augustinos, AA; Drosopoulou, E; Lanzavecchia, SB; Cladera, JL; Caceres, C; Bourtzis, K; Mavragani-Tsipidou, P; Zacharopoulou, A				Gariou-Papalexiou, Angeliki; Giardini, Maria Cecilia; Augustinos, Antonios A.; Drosopoulou, Elena; Lanzavecchia, Silvia B.; Cladera, Jorge L.; Caceres, Carlos; Bourtzis, Kostas; Mavragani-Tsipidou, Penelope; Zacharopoulou, Antigone			Cytogenetic Analysis of the South American Fruit Fly Anastrepha fraterculus (Diptera: Tephritidae) Species Complex: Construction of Detailed Photographic Polytene Chromosome Maps of the Argentinian Af. sp.1 Member	PLOS ONE			English	Article							CERATITIS-CAPITATA DIPTERA; BACTROCERA-OLEAE DIPTERA; ANOPHELES-GAMBIAE; MATING COMPATIBILITY; SEX-CHROMOSOMES; METAPHASE KARYOTYPES; POPULATION-GENETICS; RIBOSOMAL DNA; DROSOPHILA; DORSALIS	Genetic and cytogenetic studies constitute a significant basis for understanding the biology of insect pests and the design and the construction of genetic tools for biological control strategies. Anastrepha fraterculus is an important pest of the Tephritidae family. It is distributed from southern Texas through eastern Mexico, Central America and South America causing significant crop damage and economic losses. Currently it is considered as a species complex; until now seven members have been described based on multidisciplinary approaches. Here we report the cytogenetic analysis of an Argentinian population characterized as Af.sp.1 member of the Anastrepha fraterculus species complex. The mitotic karyotype and the first detailed photographic maps of the salivary gland polytene chromosomes are presented. The mitotic metaphase complement consists of six (6) pairs of chromosomes, including one pair of heteromorphic sex chromosomes, with the male being the heterogametic sex. The analysis of the salivary gland polytene complement shows a total number of five long chromosomes that correspond to the five autosomes of the mitotic karyotype and a heterochromatic network corresponding to the sex chromosomes. Comparison of the polytene chromosome maps between this species and Anastrepha ludens shows significant similarity. The polytene maps presented here are suitable for cytogenetic studies that could shed light on the species limits within this species complex and support the development of genetic tools for sterile insect technique (SIT) applications.	[Gariou-Papalexiou, Angeliki; Augustinos, Antonios A.; Zacharopoulou, Antigone] Univ Patras, Dept Biol, Patras, Greece; [Giardini, Maria Cecilia; Lanzavecchia, Silvia B.; Cladera, Jorge L.] Inst Nacl Tecnol Agr, Inst Genet EA Favret, Hurlingham, Provincia Bueno, Argentina; [Augustinos, Antonios A.; Caceres, Carlos; Bourtzis, Kostas] Joint FAO IAEA Div Nucl Techn Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Drosopoulou, Elena; Mavragani-Tsipidou, Penelope] Aristotle Univ Thessaloniki, Fac Sci, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece	University of Patras; Instituto Nacional de Tecnologia Agropecuaria (INTA); International Atomic Energy Agency; Aristotle University of Thessaloniki	Zacharopoulou, A (corresponding author), Univ Patras, Dept Biol, Patras, Greece.	zacharop@upatras.gr	Drosopoulou, Elena/AAX-6493-2020; Augustinos, Antonios/C-1318-2019; DROSOPOULOU, ELENA/N-2176-2015	Drosopoulou, Elena/0000-0001-9805-0572; Augustinos, Antonios/0000-0003-3682-6077; Lanzavecchia, Silvia/0000-0001-5965-4082	Directo Council of the Natinal Institute of Agricultural Technology, Argentina (I.N.T.A.) [1126]; International Atomic Energy Agency (IAEA) [16974]; Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture; INTA (Instituto Nacional Tecnologia Agropecuaria)	Directo Council of the Natinal Institute of Agricultural Technology, Argentina (I.N.T.A.); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture; INTA (Instituto Nacional Tecnologia Agropecuaria)	This work was funded by 1126: Directo Council of the Natinal Institute of Agricultural Technology, Argentina (I.N.T.A.) (www.inta.gob.ar), and 16974: International Atomic Energy Agency (IAEA) (cra.iaea.org).; We gratefully acknowledge the Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture for funding this work through CRP and SSA projects. We also thank INTA (Instituto Nacional Tecnologia Agropecuaria) for allocating funds for MCG (travel and stay in Greece and Austria).	Allinghi A, 2007, FLA ENTOMOL, V90, P27, DOI 10.1653/0015-4040(2007)90[27:CACOAL]2.0.CO;2; [Anonymous], 1992, DROSOPHILA INVERSION; Ashburner M, 1982, GENETICS BIOL DROSOP; Augustinos AA, 2015, ZOOKEYS, P273, DOI 10.3897/zookeys.540.9857; Augustinos AA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S16; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Baimai V, 1999, ZOOL STUD, V38, P110; BAIMAI V, 1995, GENOME, V38, P1015, DOI 10.1139/g95-134; Baimai V, 2000, BIOL J LINN SOC, V69, P399, DOI 10.1111/j.1095-8312.2000.tb01213.x; Baimai Visut, 2000, Cytologia (Tokyo), V65, P409, DOI 10.1508/cytologia.65.409; Baker AC, 1944, REV STUDIES MEXICAN; Basso A, 2003, J ECON ENTOMOL, V96, P1237, DOI 10.1603/0022-0493-96.4.1237; BEDO DG, 1987, GENOME, V29, P598, DOI 10.1139/g87-101; BEDO DG, 1989, CHROMOSOMA, V98, P443, DOI 10.1007/BF00292790; BEDO DG, 1986, CAN J GENET CYTOL, V28, P180, DOI 10.1139/g86-025; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Brirzova R, 2013, FLA ENTOMOL, V96, P1107, DOI 10.1653/024.096.0351; BUSH GUY L., 1962, PSYCHE, V69, P87, DOI 10.1155/1962/20495; Caceres C, 2009, BIOL J LINN SOC, V97, P152, DOI 10.1111/j.1095-8312.2008.01193.x; Canal NA, 2015, ZOOKEYS, P41, DOI 10.3897/zookeys.540.6012; Carson Hampton L., 1992, P407; Cecilia GM, 2009, CARYOLOGIA, V62, P204, DOI 10.1080/00087114.2004.10589686; Giardini MC, 2015, ZOOKEYS, P83, DOI 10.3897/zookeys.540.6058; Cladera JL, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S12; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143; Craddock EM, 2016, GENETICA, V144, P107, DOI 10.1007/s10709-016-9882-5; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Devescovi F, 2014, ENTOMOL EXP APPL, V152, P238, DOI 10.1111/eea.12219; Dias VS, 2016, BIOL J LINN SOC, V117, P725, DOI 10.1111/bij.12712; Drosopoulou E, 2011, GENETICA, V139, P723, DOI 10.1007/s10709-011-9575-z; Drosopoulou E, 2010, ANN ENTOMOL SOC AM, V103, P1003, DOI 10.1603/AN10059; Drosopoulou E, 2014, GENOME, V57, P573, DOI 10.1139/gen-2014-0172; Drosopoulou E, 2012, GENETICA, V140, P169, DOI 10.1007/s10709-012-9668-3; Drosopoulou E, 2011, GENETICA, V139, P1449, DOI 10.1007/s10709-012-9644-y; Dutra VS, 2012, ANN ENTOMOL SOC AM, V105, P529, DOI 10.1603/AN11180; Dutra VS, 2011, ANN ENTOMOL SOC AM, V104, P16, DOI 10.1603/AN10105; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Garcia-Martinez V, 2009, GENOME, V52, P20, DOI 10.1139/G08-099; Gariou-Papalexiou A, 2002, GENETICA, V116, P59, DOI 10.1023/A:1020959608886; Goday C, 2006, CYTOGENET GENOME RES, V114, P70, DOI 10.1159/000091931; Hernandez-Ortiz V, 2004, B ENTOMOL RES, V94, P487, DOI 10.1079/BER2004325; Hernandez-Ortiz Vicente, 1994, Folia Entomologica Mexicana, V88, P89; Hernandez-Ortiz V, 2015, ZOOKEYS, P95, DOI 10.3897/zookeys.540.6027; Hernandez-Ortiz V, 2012, ANN ENTOMOL SOC AM, V105, P305, DOI 10.1603/AN11123; Hunwattanakul N, 2008, KASETSART J NATSCI, V28, P142; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kounatidis I, 2008, GENOME, V51, P479, DOI 10.1139/G08-032; Kulathinal RJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000550; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Lefevre G, 1976, GENETICS BIOL DROSOP; MALAVASI A, 1983, GENETICA, V60, P207, DOI 10.1007/BF00122375; Manni M, 2015, ZOOKEYS, P157, DOI 10.3897/zookeys.540.6713; Mason JM, 2010, DNA REPLICATION CURR; Mavragani-Tsipidou P, 2002, GENETICA, V116, P45, DOI 10.1023/A:1020907624816; Mavragani-Tsipidou P, 2014, PROTOCOLS CYTOGENETI, P1; MAVRAGANITSIPIDOU P, 1992, GENOME, V35, P373, DOI 10.1139/g92-056; Mendes L.O.T., 1958, BRAGANTIA, V17, P29, DOI [10.1590/S0006-87051958000100034, DOI 10.1590/S0006-87051958000100034]; MORGANTE JS, 1980, ANN ENTOMOL SOC AM, V73, P622, DOI 10.1093/aesa/73.6.622; Muller H. J., 1940, The New Systematics Oxford, V1940, P185; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Norrbom AL, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P299; Ovruski S, 2003, J ECON ENTOMOL, V96, P1108, DOI 10.1603/0022-0493-96.4.1108; Pardue ML, 1975, METHOD CELL BIOL, P1; Petit-Marty N, 2004, ANN ENTOMOL SOC AM, V97, P1320, DOI 10.1603/0013-8746(2004)097[1320:SBAMCA]2.0.CO;2; Petrarca V, 2000, MED VET ENTOMOL, V14, P149, DOI 10.1046/j.1365-2915.2000.00231.x; Procunier W.S., 1993, Insect Molecular Biology, V2, P163, DOI 10.1111/j.1365-2583.1993.tb00136.x; RADU M, 1975, CYTOLOGIA, V40, P823, DOI 10.1508/cytologia.40.823; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Robinson AS, 2002, GENETICA, V116, P1, DOI 10.1023/A:1020943122999; Rosetto M, 2000, GENOME, V43, P707, DOI 10.1139/gen-43-4-707; Rull J, 2012, B ENTOMOL RES, V102, P435, DOI 10.1017/S0007485312000016; Rull J, 2013, ENTOMOL EXP APPL, V148, P213, DOI 10.1111/eea.12094; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schutze MK, 2014, SYST ENTOMOL; Segura DF, 2011, BIOL J LINN SOC, V102, P346, DOI 10.1111/j.1095-8312.2010.01590.x; Selivon D, 2005, NEOTROP ENTOMOL, V34, P273, DOI 10.1590/S1519-566X2005000200015; Selivon D, 1997, BRAZ J GENET, V20, P651, DOI 10.1590/S0100-84551997000400015; Selivon D, 2005, ANN ENTOMOL SOC AM, V98, P367, DOI 10.1603/0013-8746(2005)098[0367:AGCOTC]2.0.CO;2; Selivon D, 1997, BRAZ J GENET, V20, P587, DOI 10.1590/S0100-84551997000400006; Selivon D, 1998, ANN ENTOMOL SOC AM, V91, P473, DOI 10.1093/aesa/91.4.473; Selivon D, 2007, GENET MOL BIOL, V30, P1082, DOI 10.1590/S1415-47572007000600009; Sharakhova MV, 2014, MED VET ENTOMOL, V28, P337, DOI 10.1111/mve.12037; Sharakhova MV, 2006, J MED ENTOMOL, V43, P861, DOI 10.1603/0022-2585(2006)43[861:ASCPFT]2.0.CO;2; Sharakhova MV, 2011, INFECT GENET EVOL, V11, P746, DOI 10.1016/j.meegid.2010.06.015; Zepeda-Cisneros CS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S1; Smith-Caldas Martha R. B., 2001, Neotropical Entomology, V30, P565, DOI 10.1590/S1519-566X2001000400009; Stanyon R, 2008, CHROMOSOME RES, V16, P17, DOI 10.1007/s10577-007-1209-z; Stone A., 1942, FRUIT FLIES GENUS AN; Sturtevant AH, 1941, GENETICS, V26, P517; Sutton BD, 2015, ZOOKEYS, P175, DOI 10.3897/zookeys.540.6147; Sved JA, 2016, EVOLUTION, V70, P229, DOI 10.1111/evo.12831; Tsoumani KT, 2011, MOL GENET GENOMICS, V285, P33, DOI 10.1007/s00438-010-0583-y; Tsoumani KT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137050; Vanickova L, 2015, J APPL ENTOMOL, V139, P679, DOI 10.1111/jen.12204; Vanickova L, 2015, ZOOKEYS, P193, DOI 10.3897/zookeys.540.9649; Vanickova L, 2012, J CHEM ECOL, V38, P1133, DOI 10.1007/s10886-012-0177-8; Ventura M, 2004, GENOME RES, V14, P1696, DOI 10.1101/gr.2608804; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Vera MT, 2006, ANN ENTOMOL SOC AM, V99, P387, DOI 10.1603/0013-8746(2006)099[0387:MIAPOT]2.0.CO;2; White I.M., 1992, P1; Willhoeft U, 1996, GENETICS, V144, P737; Willhoeft U, 1996, GENOME, V39, P884, DOI 10.1139/g96-111; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30; YOON JS, 1975, EVOLUTION, V29, P249, DOI 10.1111/j.1558-5646.1975.tb00205.x; ZACHAROPOULOU A, 1992, CHROMOSOMA, V101, P448, DOI 10.1007/BF00582839; Zacharopoulou A, 2013, J ECON ENTOMOL, V106, P995, DOI 10.1603/EC12379; Zacharopoulou A, 2011, ANN ENTOMOL SOC AM, V104, P306, DOI 10.1603/AN10113; ZACHAROPOULOU A, 1990, GENOME, V33, P184, DOI 10.1139/g90-030; Zacharopoulou A, 2011, GENETICA, V139, P79, DOI 10.1007/s10709-010-9495-3; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhao JT, 1998, GENOME, V41, P510, DOI 10.1139/gen-41-4-510; Zhimulev IF, 2004, INT REV CYTOL, V241, P203, DOI 10.1016/S0074-7696(04)41004-3; Zucchi RA, 2000, MOSCAS DAS FRUTAS IM, P41	119	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157192	10.1371/journal.pone.0157192	http://dx.doi.org/10.1371/journal.pone.0157192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362546	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200009
J	Holzinger, D; Danilovic, I; Seemann, R; Kornek, G; Engelmann, J; Pillerstorff, R; Holawe, S; Psyrri, A; Erovic, BM; Farwell, G; Perisanidis, C				Holzinger, Daniel; Danilovic, Ivan; Seemann, Rudolf; Kornek, Gabriela; Engelmann, Johannes; Pillerstorff, Robert; Holawe, Simone; Psyrri, Amanda; Erovic, Boban M.; Farwell, Gregory; Perisanidis, Christos			Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FIBRIN(OGEN); SURGERY; BINDING	Background We aimed to determine the prognostic significance of pretreatment plasma fibrinigen in patients with oral and oropharyngeal squamous cell carcinoma (OOSCC). Methods A cohort of 183 patients with locally advanced OOSCC receiving preoperative chemoradiotherapy was retrospectively examined. Using ROC curve analysis, a pretreatment plasma fibrinogen cutoff value of 447mg/dL was determined. The primary endpoints were overall survival and recurrence-free survival. A secondary endpoint was to determine whether pretreatment plasma fibrinogen could predict treatment response to neoadjuvant chemoradiotherapy. Cox regression models and Kaplan-Meier curves were used for survival analyses. Results Seventy-one patients had an elevated pretreatment plasma fibrinogen (fibrinogen >447mg/dL). Patients with high fibrinogen showed significantly higher pathologic stages after neoadjuvant treatment than those with low fibrinogen (p = 0.037). In univariate analysis, elevated fibrinogen was associated with poor overall survival (p = 0.005) and recurrence-free survival (p = 0.008) Multivariate analysis revealed that elevated fibrinogen remained an independent risk factor for death (hazard ratio 1.78, 95% CI 1.09-2.90, p = 0.021) and relapse (hazard ratio 1.78, 95% CI 1.11-2.86, p = 0.016). Conclusion Elevated pretreatment plasma fibrinogen is associated with lack of response to neoadjuvant chemoradiotherapy and reduced OS and RFS in patients with OOSCC. Thus, plasma fibrinogen may emerge as a novel prognostic indicator and a potential therapeutic target in OOSCC.	[Holzinger, Daniel; Danilovic, Ivan; Seemann, Rudolf; Engelmann, Johannes; Pillerstorff, Robert; Holawe, Simone; Perisanidis, Christos] Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria; [Kornek, Gabriela] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Psyrri, Amanda] Attikon Univ Hosp, Dept Internal Med 2, Div Oncol, Athens, Greece; [Erovic, Boban M.] Med Univ Vienna, Dept Otolaryngol Head & Neck Surg, Vienna, Austria; [Farwell, Gregory] Univ Calif Davis, Dept Otolaryngol Head & Neck Surg, Sacramento, CA 95817 USA	Medical University of Vienna; Medical University of Vienna; University Hospital Attikon; Medical University of Vienna; University of California System; University of California Davis	Perisanidis, C (corresponding author), Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria.	christos.perisanidis@meduniwien.ac.at	Erovic, Boban/S-7824-2018	Erovic, Boban/0000-0002-7404-2583; Holzinger, Daniel/0000-0002-2924-0193; Seemann, Rudolf/0000-0003-4234-4090				CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Driemel O, 2009, STRAHLENTHER ONKOL, V185, P296, DOI 10.1007/s00066-009-1914-y; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freier K, 2008, ORAL ONCOL, V44, P116, DOI 10.1016/j.oraloncology.2007.01.006; Jagielska B, 2011, NEOPLASMA, V58, P129, DOI 10.4149/neo_2011_02_129; Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Palumbo JS, 2010, THROMB RES, V125, pS39, DOI 10.1016/S0049-3848(10)70011-6; Peng P, 2014, INT J ORAL MAX SURG, V43, P393, DOI 10.1016/j.ijom.2013.09.011; Perisanidis C, 2015, CANCER TREAT REV, V41, P960, DOI 10.1016/j.ctrv.2015.10.002; Perisanidis C, 2013, OR SURG OR MED OR PA, V115, P293, DOI 10.1016/j.oooo.2012.03.033; Russmueller G, 2015, ORAL ONCOL, V51, P247, DOI 10.1016/j.oraloncology.2014.11.010; Sahni A, 2008, J THROMB HAEMOST, V6, P176; Sahni A, 2006, BLOOD, V107, P126, DOI 10.1182/blood-2005-06-2460; Shu YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-566; Staton CA, 2003, EXPERT OPIN BIOL TH, V3, P1105, DOI 10.1517/eobt.3.7.1105.21272; Steinbrecher KA, 2010, CANCER RES, V70, P2634, DOI 10.1158/0008-5472.CAN-09-3465; Tang LQ, 2014, BRIT J CANCER, V111, P1102, DOI 10.1038/bjc.2014.393; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Zheng S, 2009, CANCER SCI, V100, P859, DOI 10.1111/j.1349-7006.2009.01115.x	23	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158697	10.1371/journal.pone.0158697	http://dx.doi.org/10.1371/journal.pone.0158697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362659	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200109
J	Lu, Y; Qian, YJ; Zhang, JL; Gong, M; Wang, YT; Gu, N; Ma, L; Xu, M; Ma, JQ; Zhang, WB; Pan, YC; Wang, L				Lu, Yun; Qian, Yajing; Zhang, Jinglu; Gong, Miao; Wang, Yuting; Gu, Ning; Ma, Lan; Xu, Min; Ma, Junqing; Zhang, Weibing; Pan, Yongchu; Wang, Lin			Genetic Variants of BMP2 and Their Association with the Risk of Non-Syndromic Tooth Agenesis	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; CHINESE HAN POPULATION; SIGNALING PATHWAYS; COMPLEX DISEASE; STEM-CELLS; MSX1; OLIGODONTIA; HYPODONTIA; FAMILIES; POLYMORPHISMS	Non-syndromic tooth agenesis (or non-syndromic congenitally missing tooth) is one of the most common congenital defects in humans affecting the craniofacial function and appearance. Single nucleotide polymorphisms (SNPs) have been associated with an individual's susceptibility to these anomalies. The aim of the present study was therefore to investigate the roles of the potentially functional SNPs of BMP2 in the occurrence of tooth agenesis. Overall, four potentially functional SNPs of BMP2 (rs15705, rs235768, rs235769 and rs3178250) were selected, and their associations with the susceptibility of tooth agenesis were evaluated in a case-control study of 335 non-syndromic tooth agenesis cases and 444 healthy controls. The SNPs rs15705 and rs3178250 were found to be associated with an individual's risk of tooth agenesis (P = 0.046 and P = 0.039, respectively). Both SNPs showed an increased risk of mandibular incisor agenesis (rs15705, AA/AC vs. CC = 1.58, 95% CI = [1.06-2.34], P = 0.024; rs3178250, TT/TC vs. CC = 1.60, 95% CI = [1.08-2.37], P = 0.020). Bioinformatics analysis indicated that these two SNPs located at the 3'-untranslated region (3'-UTR) of BMP2 might alter the binding ability of miR-1273d and miR-46395p, respectively, which was confirmed by luciferase activity assays in the 293A and COS7 cell lines (P < 0.001 in 293A and P < 0.01 in COS7 for miR-1273d; and P < 0.001 in both cells for miR-4639-5p). Furthermore, BMP2 mRNA expression decreased after transfecting either miR-1273d or miR-4639-5p into these two cell lines (P < 0.01 in 293A and P < 0.001 in COS7 for miR-1273d, and P < 0.01 in both cell lines for miR-4639-5p). Taken together, our findings indicate that rs15705 and rs317250 are associated with the susceptibility of non-syndromic tooth agenesis by possibly affecting miRNAs and mRNA interaction.	[Lu, Yun; Qian, Yajing; Zhang, Jinglu; Gong, Miao; Wang, Yuting; Gu, Ning; Ma, Lan; Xu, Min; Ma, Junqing; Zhang, Weibing; Pan, Yongchu; Wang, Lin] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Lu, Yun; Qian, Yajing; Gong, Miao; Wang, Yuting; Gu, Ning; Xu, Min; Ma, Junqing; Zhang, Weibing; Pan, Yongchu; Wang, Lin] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Orthodont, Nanjing, Jiangsu, Peoples R China; [Lu, Yun] Dalian Med Univ, Coll Stomatol, Dept Orthodont, Dalian, Peoples R China; [Zhang, Jinglu] Nanjing Med Univ, Affiliated Hosp Stomatol, Inst Stomatol, Orofacial Pain & TMD Res Unit, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Dalian Medical University; Nanjing Medical University	Pan, YC; Wang, L (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.; Pan, YC; Wang, L (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Orthodont, Nanjing, Jiangsu, Peoples R China.	panyongchu@njmu.edu.cn; lw603@njmu.edu.cn			National Natural Science Foundation of China [81570959, 81230022, 81170981, 81200808, 81400546]; Ph.D. Programs Foundation of Ministry of Education of China [20113234110003, 20123234120004]; China Postdoctoral Science Foundation Special Funded Project [201104537, 20100481164]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD-2014-37]; Natural Science Foundation of Jiangsu Province [BK2012447, 15KJA320002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation Special Funded Project; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was funded by the National Natural Science Foundation of China, http://www.nsfc.gov.cn/, 81570959 to Yongchu Pan, 81230022 to Lin Wang, 81170981 to Lin Wang, 81200808 to Yongchu Pan, 81400546 to Lan Ma; Ph.D. Programs Foundation of Ministry of Education of China, http://www.cutech.edu.cn/cn/index.htm, 20113234110003 to Lin Wang, 20123234120004 to Yongchu Pan; China Postdoctoral Science Foundation Special Funded Project, http://jj.chinapostdoctor.org.cn/V1/Program2/Default.aspx, 201104537 to Yongchu Pan, 20100481164 to Yongchu Pan; the Priority Academic Program Development of Jiangsu Higher Education Institutions, http://www.ec.js.edu.cn/, PAPD-2014-37 to Lin Wang; and the Natural Science Foundation of Jiangsu Province, http://www.jstd.gov.cn/, BK2012447 to Yongchu Pan, 15KJA320002 to Lin Wang.	Acevedo AC, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0154-5; Alshaiji Jasem M, 2014, Cutis, V94, pE18; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Devaney JM, 2009, J CELL BIOCHEM, V107, P1073, DOI 10.1002/jcb.22209; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Feng XY, 2013, EUR J ORAL SCI, V121, P412, DOI 10.1111/eos.12078; Fritz DT, 2006, MOL ENDOCRINOL, V20, P1574, DOI 10.1210/me.2005-0469; Gong M, 2015, EUR REV MED PHARMACO, V19, P2188; Greenblatt MB, 2015, J BIOL CHEM, V290, P284, DOI 10.1074/jbc.M114.599274; Haga S, 2013, J HUM GENET, V58, P799, DOI 10.1038/jhg.2013.106; Halicioglu Koray, 2013, Eur J Dent, V7, pS111, DOI 10.4103/1305-7456.119087; Iohara K, 2004, J DENT RES, V83, P590, DOI 10.1177/154405910408300802; Khalaf K, 2014, J ORTHOD, V41, P299, DOI 10.1179/1465313314Y.0000000116; Lai LH, 2015, PLAST RECONSTR SURG, V135, p142E, DOI 10.1097/PRS.0000000000000779; Liu HC, 2012, EUR J ORAL SCI, V120, P378, DOI 10.1111/j.1600-0722.2012.00986.x; Lopez SIN, 2013, TWIN RES HUM GENET, V16, P1112, DOI 10.1017/thg.2013.69; Lyngstadaas SP, 1996, J MED GENET, V33, P137, DOI 10.1136/jmg.33.2.137; Ma L, 2014, J DENT RES, V93, P559, DOI 10.1177/0022034514527617; Massink MPG, 2015, AM J HUM GENET, V97, P621, DOI 10.1016/j.ajhg.2015.08.014; Mostowska A, 2012, ARCH ORAL BIOL, V57, P790, DOI 10.1016/j.archoralbio.2012.01.003; Mu Y, 2012, GENET MOL RES, V11, P4110, DOI 10.4238/2012.September.25.5; Mu YD, 2013, GENET MOL RES, V12, P4446, DOI 10.4238/2013.October.10.10; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Saadi I, 2013, DEVELOPMENT, V140, P2697, DOI 10.1242/dev.088393; Song SJ, 2014, HUM GENET, V133, P117, DOI 10.1007/s00439-013-1360-x; Suzuki T, 2001, BRIT J ORAL MAX SURG, V39, P289, DOI 10.1054/bjom.2000.0568; Tasli PN, 2014, APPL BIOCHEM BIOTECH, V172, P3016, DOI 10.1007/s12010-013-0706-0; Vogel P, 2015, VET PATHOL, V52, P224, DOI 10.1177/0300985814528218; Yuan GH, 2015, DEVELOPMENT, V142, P128, DOI 10.1242/dev.117887; Zhang J, 2015, CHIN J DENT RES, V18, P59, DOI 10.3290/j.cjdr.a33969,PubMed:25815384; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zou Chuan, 2015, Shanghai Kou Qiang Yi Xue, V24, P83	33	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158273	10.1371/journal.pone.0158273	http://dx.doi.org/10.1371/journal.pone.0158273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362534	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200053
J	Matkovich, SJ; Grubb, DR; McMullen, JR; Woodcock, EA				Matkovich, Scot J.; Grubb, David R.; McMullen, Julie R.; Woodcock, Elizabeth A.			Chronic Contractile Dysfunction without Hypertrophy Does Not Provoke a Compensatory Transcriptional Response in Mouse Hearts	PLOS ONE			English	Article							POTENTIAL CANDIDATE GENES; B SPLICE VARIANT; CARDIAC CONTRACTILITY; PHOSPHOLIPASE C-BETA-1; EXPRESSION ANALYSIS; FAILURE; ACTIVATION; GROWTH; CARDIOMYOPATHY; PATHWAYS	Diseased myocardium from humans and experimental animal models shows heightened expression and activity of a specific subtype of phospholipase C (PLC), the splice variant PLC beta 1b. Previous studies from our group showed that increasing PLC beta 1b expression in adult mouse hearts by viral transduction was sufficient to cause sustained contractile dysfunction of rapid onset, which was maintained indefinitely in the absence of other pathological changes in the myocardium. We hypothesized that impaired contractility alone would be sufficient to induce a compensatory transcriptional response. Unbiased, comprehensive mRNA-sequencing was performed on 6 biological replicates of rAAV6-treated blank, PLC beta 1b and PLC beta 1a (closely related but inactive splice variant) hearts 8 weeks after injection, when reduced contractility was manifest in PLC beta 1b hearts without evidence of induced hypertrophy. Expression of PLC beta 1b resulted in expression changes in only 9 genes at FDR<0.1 when compared with control and these genes appeared unrelated to contractility. Importantly, PLC beta 1a caused similar mild expression changes to PLC beta 1b, despite a complete lack of effect of this isoform on cardiac contractility. We conclude that contractile depression caused by PLC beta 1b activation is largely independent of changes in the transcriptome, and thus that lowered contractility is not sufficient in itself to provoke measurable transcriptomic alterations. In addition, our data stress the importance of a stringent control group to filter out transcriptional changes unrelated to cardiac function.	[Matkovich, Scot J.] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Grubb, David R.; McMullen, Julie R.; Woodcock, Elizabeth A.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Washington University (WUSTL); Baker Heart and Diabetes Institute	Matkovich, SJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	smatkovi@dom.wustl.edu	Matkovich, Scot J/B-9077-2009; Matkovich, Scot J/AFP-0908-2022	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857	Australian National Health and Medical Research Council (NHMRC) [1002328, 10007712, 1022678]; Victorian Government's Operational Infrastructure Support Program; Baker IDI Heart and Diabetes Institute	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Baker IDI Heart and Diabetes Institute	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC) #1002328, #10007712, #1022678. EAW and JRM are Fellows of the NHMRC #586621, #1078985, respectively. Support was received from the Victorian Government's Operational Infrastructure Support Program and from a Commercialization Grant provided by the Baker IDI Heart and Diabetes Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; BAHK YY, 1994, J BIOL CHEM, V269, P8240; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chen HB, 2013, EUR REV MED PHARMACO, V17, P903; Chen J, 2013, GENET MOL RES, V12, P4687, DOI 10.4238/2013.October.18.7; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Florea S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0279-z; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Grubb DR, 2016, J MOL CELL CARDIOL, V93, P12, DOI 10.1016/j.yjmcc.2016.02.015; Grubb DR, 2015, J MOL CELL CARDIOL, V84, P95, DOI 10.1016/j.yjmcc.2015.04.016; Grubb DR, 2015, BIOCHEM BIOPH RES CO, V461, P519, DOI 10.1016/j.bbrc.2015.04.060; Haghighi K, 2014, J MOL CELL CARDIOL, V77, P160, DOI 10.1016/j.yjmcc.2014.10.005; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Matkovich SJ, 2014, P NATL ACAD SCI USA, V111, P12264, DOI 10.1073/pnas.1410622111; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Moore-Morris T, 2015, J MOL MED, V93, P823, DOI 10.1007/s00109-015-1314-y; Roe AT, 2015, CURR PHARM DESIGN, V21, P431; Rowell J, 2014, PHYSIOL GENOMICS, V46, P779, DOI 10.1152/physiolgenomics.00054.2014; Sipido KR, 2010, CIRC RES, V106, P230, DOI 10.1161/CIRCRESAHA.109.210740; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Song MS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1855; Syed F, 2004, CIRC RES, V95, P1200, DOI 10.1161/01.RES.0000150366.08972.7f; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Westenbrink BD, 2015, CIRC RES, V116, pE28, DOI 10.1161/CIRCRESAHA.116.304682; Woodcock EA, 2009, J MOL CELL CARDIOL, V47, P676, DOI 10.1016/j.yjmcc.2009.08.020; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563; Zhang Y, 2011, J BIOL CHEM, V286, P26943, DOI 10.1074/jbc.M111.234757; Ziolo MT, 2014, ANTIOXID REDOX SIGN, V21, P2044, DOI 10.1089/ars.2014.5873	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158317	10.1371/journal.pone.0158317	http://dx.doi.org/10.1371/journal.pone.0158317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359099	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200058
J	Shi, L; Qin, EQ; Zhou, JN; Zhao, JJ; Nie, WM; Jiang, TJ; Chen, WW; Wu, D; Huang, L; Liu, LY; Lv, LP; Zhao, M; Zhang, Z; Wang, FS				Shi, Lei; Qin, Enqiang; Zhou, Junnian; Zhao, Juanjuan; Nie, Weimin; Jiang, Tianjun; Chen, Weiwei; Wu, Dan; Huang, Lei; Liu, Liying; Lv, Liping; Zhao, Min; Zhang, Zheng; Wang, Fusheng			HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells	PLOS ONE			English	Article							C VIRUS; MORPHOGENIC PROTEIN; LIVER FIBROSIS; COINFECTION; MECHANISMS; REGENERATION; PROGRESSION; INFECTION; ADHESION; BIOLOGY	Accelerated fibrosis in patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) has been a major cause of mortality in the highly active anti-retroviral therapy (HAART) era. However, the role of co-infection in accelerating the progression of liver fibrosis, particularly with regard to the effects of co-infection on hepatic stellate cells (HSCs), remains unclear. We hypothesized that HIV and HCV induce liver fibrosis synergistically by altering the regulation of epimorphin production, and thereby indirectly alter HSC function. Here, we examined the effects of epimorphin on HSC proliferation and invasion, and the changes in fibrogenesis-related gene activity in HSCs (LX2) in the presence of inactivated CXCR4-tropic HIV and HCV (JFH1). The combination of HIV and HCV significantly increased epimorphin expression, which increased the proliferation and invasion capabilities of HSCs. Epimorphin also induced the expression of profibrogenic tissue inhibitor of metalloproteinase 1 (TIMP1) in an extracellular signal-regulated kinase (ERK)-dependent manner. These data indicated that the effects of HIV/HCV co-infection on hepatic fibrosis might be mediated in part by EPM. Strategies to limit the expression of EPM might represent a novel therapeutic approach to prevent the progression of hepatic fibrosis during HIV/HCV co-infection.	[Shi, Lei; Zhang, Zheng; Wang, Fusheng] Med Sch Chinese PLA, Beijing, Peoples R China; [Shi, Lei; Qin, Enqiang; Nie, Weimin; Jiang, Tianjun; Chen, Weiwei; Wu, Dan; Huang, Lei; Zhao, Min; Wang, Fusheng] Beijing 302 Hosp, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China; [Zhou, Junnian; Lv, Liping] Beijing Inst Transfus Med, Beijing, Peoples R China; [Zhao, Juanjuan; Zhang, Zheng] Beijing 302 Hosp, Res Ctr Clin & Translat Med, Beijing, Peoples R China; [Liu, Liying] Beijing 302 Hosp, Tumor Radiotherapy Ctr, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Zhang, Z; Wang, FS (corresponding author), Med Sch Chinese PLA, Beijing, Peoples R China.; Wang, FS (corresponding author), Beijing 302 Hosp, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China.; Zhang, Z (corresponding author), Beijing 302 Hosp, Res Ctr Clin & Translat Med, Beijing, Peoples R China.	zhangzheng1975@yahoo.com.cn; fswang302@163.com	lei, huang/AFS-7785-2022; zhang, zheng/V-9479-2018; Zhou, Junnian/CAI-2072-2022	Zhou, Junnian/0000-0002-7782-234X	National Nature Science Foundation of China [81200303, 81470097]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (no. 81200303 and no. 81470097) (http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China [grant numbers 81200303, 81470097].	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Herrmann J, 2007, J CELL MOL MED, V11, P704, DOI 10.1111/j.1582-4934.2007.00060.x; Hirai Y, 2007, J CELL SCI, V120, P2032, DOI 10.1242/jcs.006247; Hirose M, 1996, BIOCHEM BIOPH RES CO, V225, P155, DOI 10.1006/bbrc.1996.1146; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Jia YL, 2011, HEPATOLOGY, V54, P1808, DOI 10.1002/hep.24562; Jia YL, 2011, J CELL PHYSIOL, V226, P2807, DOI 10.1002/jcp.22625; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Mastroianni CM, 2014, INT J MOL SCI, V15, P9184, DOI 10.3390/ijms15069184; Miura K, 2003, BIOCHEM BIOPH RES CO, V311, P415, DOI 10.1016/j.bbrc.2003.09.225; Miura K, 2007, J HEPATOL, V47, P834, DOI 10.1016/j.jhep.2007.07.024; Nakamura T, 2000, HEPATOLOGY, V32, P247, DOI 10.1053/jhep.2000.9109; Pascual-Pareja JF, 2009, AIDS, V23, P971, DOI 10.1097/QAD.0b013e328329f994; Pritchett J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100091; Radisky DC, 2003, TRENDS CELL BIOL, V13, P426, DOI 10.1016/S0962-8924(03)00146-6; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Watanabe S, 1998, BIOCHEM BIOPH RES CO, V250, P486, DOI 10.1006/bbrc.1998.9339; World Health Organization, GLOB HLTH OBS HIV AI; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yoshino R, 2006, HEPATOL RES, V34, P238, DOI 10.1016/j.hepres.2005.12.011; Zhou JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009732	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158386	10.1371/journal.pone.0158386	http://dx.doi.org/10.1371/journal.pone.0158386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362846	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200067
J	Gall, C; Schmidt, S; Schittkowski, MP; Antal, A; Ambrus, GG; Paulus, W; Dannhauer, M; Michalik, R; Mante, A; Bola, M; Lux, A; Kropf, S; Brandt, SA; Sabel, BA				Gall, Carolin; Schmidt, Sein; Schittkowski, Michael P.; Antal, Andrea; Ambrus, Geza Gergely; Paulus, Walter; Dannhauer, Moritz; Michalik, Romualda; Mante, Alf; Bola, Michal; Lux, Anke; Kropf, Siegfried; Brandt, Stephan A.; Sabel, Bernhard A.			Alternating Current Stimulation for Vision Restoration after Optic Nerve Damage: A Randomized Clinical Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; BRAIN-STIMULATION; ELECTRICAL-STIMULATION; IMPROVES VISION; FIELDS; EEG	Background Vision loss after optic neuropathy is considered irreversible. Here, repetitive transorbital alternating current stimulation (rtACS) was applied in partially blind patients with the goal of activating their residual vision. Methods We conducted a multicenter, prospective, randomized, double-blind, sham-controlled trial in an ambulatory setting with daily application of rtACS (n = 45) or sham-stimulation (n = 37) for 50 min for a duration of 10 week days. A volunteer sample of patients with optic nerve damage (mean age 59.1 yrs) was recruited. The primary outcome measure for efficacy was super-threshold visual fields with 48 hrs after the last treatment day and at 2-months follow-up. Secondary outcome measures were near-threshold visual fields, reaction time, visual acuity, and resting-state EEGs to assess changes in brain physiology. Results The rtACS-treated group had a mean improvement in visual field of 24.0% which was significantly greater than after sham-stimulation (2.5%). This improvement persisted for at least 2 months in terms of both within-and between-group comparisons. Secondary analyses revealed improvements of near-threshold visual fields in the central 5 degrees and increased thresholds in static perimetry after rtACS and improved reaction times, but visual acuity did not change compared to shams. Visual field improvement induced by rtACS was associated with EEG power-spectra and coherence alterations in visual cortical networks which are interpreted as signs of neuromodulation. Current flow simulation indicates current in the frontal cortex, eye, and optic nerve and in the subcortical but not in the cortical regions. Conclusion rtACS treatment is a safe and effective means to partially restore vision after optic nerve damage probably by modulating brain plasticity. This class 1 evidence suggests that visual fields can be improved in a clinically meaningful way.	[Gall, Carolin; Michalik, Romualda; Bola, Michal; Sabel, Bernhard A.] Univ Magdeburg, Fac Med, Inst Med Psychol, Magdeburg, Germany; [Schmidt, Sein; Mante, Alf; Brandt, Stephan A.] Charite, Dept Neurol, Berlin, Germany; [Schittkowski, Michael P.] Univ Gottingen, Dept Ophthalmol, Univ Med Ctr, Gottingen, Germany; [Antal, Andrea; Ambrus, Geza Gergely; Paulus, Walter] Univ Gottingen, Dept Clin Neurophysiol, Univ Med Ctr, Gottingen, Germany; [Dannhauer, Moritz] Univ Utah, Ctr Integrat Biomed Comp, Salt Lake City, UT USA; [Dannhauer, Moritz] Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT USA; [Lux, Anke; Kropf, Siegfried] Univ Magdeburg, Inst Biometry & Med Informat, Magdeburg, Germany	Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen; University of Gottingen; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Otto von Guericke University	Gall, C (corresponding author), Univ Magdeburg, Fac Med, Inst Med Psychol, Magdeburg, Germany.	imp@med.ovgu.de	Paulus, Walter/A-3544-2009; Ambrus, Géza Gergely/G-2716-2014; Schmidt, Sein/AFR-1244-2022; Schmidt, Sein/AAT-2308-2021; Schittkowski, Michael P./J-8747-2019	Paulus, Walter/0000-0001-5549-8377; Ambrus, Géza Gergely/0000-0002-8400-8178; Bola, Michal/0000-0002-4609-8029	German Federal Education and Research Ministry, grant ERA-net Neuron (BMBF) [01EW1210]; University of Magdeburg (LOM-grant); German Research Foundation [BR 1691/8-1]; National Institute of General Medical Sciences of the National Institutes of Health (USA) [P41 GM103545-17]; EBS (Germany); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103545] Funding Source: NIH RePORTER	German Federal Education and Research Ministry, grant ERA-net Neuron (BMBF)(Federal Ministry of Education & Research (BMBF)); University of Magdeburg (LOM-grant); German Research Foundation(German Research Foundation (DFG)); National Institute of General Medical Sciences of the National Institutes of Health (USA); EBS (Germany); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded in part, by the German Federal Education and Research Ministry, grant ERA-net Neuron (BMBF 01EW1210) to BAS and CG, by the University of Magdeburg (LOM-grant to MB), by the German Research Foundation, Grant number BR 1691/8-1 to SS, and by the National Institute of General Medical Sciences of the National Institutes of Health (USA) under grant number P41 GM103545-17 to MD, and by EBS (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Antal A, 2011, RESTOR NEUROL NEUROS, V29, P365, DOI 10.3233/RNN-2011-0609; Bola Michal, 2014, Neurology, V83, P542, DOI 10.1212/WNL.0000000000000672; Bola M, 2015, CORTEX, V67, P134, DOI 10.1016/j.cortex.2015.03.020; Bola M, 2015, NEUROIMAGE, V114, P398, DOI 10.1016/j.neuroimage.2015.03.057; Chrysikou EG, 2011, RESTOR NEUROL NEUROS, V29, P375, DOI 10.3233/RNN-2011-0610; Connell N, 2014, NEUROLOGY, V83, P484, DOI 10.1212/WNL.0000000000000664; Dannhauer M, 2011, HUM BRAIN MAPP, V32, P1383, DOI 10.1002/hbm.21114; Eichelbaum S, 2014, NEUROIMAGE, V101, P513, DOI 10.1016/j.neuroimage.2014.04.085; Foik AT, 2015, INVEST OPHTH VIS SCI, V56, P1711, DOI 10.1167/iovs.14-15617; Gall C, 2015, CONTEMP CLIN TRIALS, V43, P231, DOI 10.1016/j.cct.2015.06.005; Gall C, 2013, NEUROPSYCHOLOGIA, V51, P2271, DOI 10.1016/j.neuropsychologia.2013.06.028; Gall C, 2011, BRAIN STIMUL, V4, P175, DOI 10.1016/j.brs.2011.07.003; Gall C, 2009, INVEST OPHTH VIS SCI, V50, P2765, DOI 10.1167/iovs.08-2519; Ghaffarieh A, 2012, INT REV NEUROBIOL, V105, P1, DOI 10.1016/B978-0-12-398309-1.00002-0; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Haueisen J, 2002, NEUROIMAGE, V15, P159, DOI 10.1006/nimg.2001.0962; Kasten E, 1998, NAT MED, V4, P1083, DOI 10.1038/2079; Laczo B, 2012, BRAIN STIMUL, V5, P484, DOI 10.1016/j.brs.2011.08.008; Lindenblatt G, 2001, PHYS MED BIOL, V46, P3051, DOI 10.1088/0031-9155/46/11/319; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Merlet I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057330; Nair DG, 2011, RESTOR NEUROL NEUROS, V29, P411, DOI 10.3233/RNN-2011-0612; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Plow EB, 2012, NEUROREHAB NEURAL RE, V26, P616, DOI 10.1177/1545968311431963; Poggel DA, 2004, NEUROLOGY, V63, P2069, DOI 10.1212/01.WNL.0000145773.26378.E5; Raz N, 2012, ANN NEUROL, V71, P531, DOI 10.1002/ana.22692; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Sabel BA, 2014, JAMA OPHTHALMOL, V132, P381, DOI 10.1001/jamaophthalmol.2013.7963; Sabel BA, 2011, RESTOR NEUROL NEUROS, V29, P493, DOI 10.3233/RNN-2011-0624; Sabel BA, 2011, PROG BRAIN RES, V192, P199, DOI 10.1016/B978-0-444-53355-5.00013-0; Sahraie A, 2013, INVEST OPHTH VIS SCI, V54, P3579, DOI 10.1167/iovs.12-11231; Schatz A, 2011, INVEST OPHTH VIS SCI, V52, P4485, DOI 10.1167/iovs.10-6932; Schmidt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00325; Schmidt S, 2013, BRAIN STIMUL, V6, P87, DOI 10.1016/j.brs.2012.03.008; Schmidt SL, 2014, BRAIN STIMUL, V7, P878, DOI 10.1016/j.brs.2014.07.033; Song SB, 2011, RESTOR NEUROL NEUROS, V29, P427, DOI 10.3233/RNN-2011-0614; Vosskuhl J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00257; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	39	71	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0156134	10.1371/journal.pone.0156134	http://dx.doi.org/10.1371/journal.pone.0156134			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355577	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000378859400006
J	Vega, Y; Delgado, E; de la Barrera, J; Carrera, C; Zaballos, A; Cuesta, I; Marino, A; Ocampo, A; Miralles, C; Perez-Castro, S; Alvarez, H; Lopez-Miragaya, I; Garcia-Bodas, E; Diez-Fuertes, F; Thomson, MM				Vega, Yolanda; Delgado, Elena; de la Barrera, Jorge; Carrera, Cristina; Zaballos, Angel; Cuesta, Isabel; Marino, Ana; Ocampo, Antonio; Miralles, Celia; Perez-Castro, Sonia; Alvarez, Hortensia; Lopez-Miragaya, Isabel; Garcia-Bodas, Elena; Diez-Fuertes, Francisco; Thomson, Michael M.			Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; MESSENGER-RNA; TYPE-1 INFECTION; DISEASE PROGRESSION; T-CELLS; TAT; REV; IDENTIFICATION; TRANSCRIPTS; ENV	HIV-1 RNAs are generated through a complex splicing mechanism, resulting in a great diversity of transcripts, which are classified in three major categories: unspliced, singly spliced (SS), and doubly spliced (DS). Knowledge on HIV-1 RNA splicing in vivo and by non-subtype B viruses is scarce. Here we analyze HIV-1 RNA splice site usage in CD4(+-)CD25(+) lymphocytes from HIV-1-infected individuals through pyrosequencing. HIV-1 DS and SS RNAs were amplified by RT-PCR in 19 and 12 samples, respectively. 13,108 sequences from HIV-1 spliced RNAs, derived from viruses of five subtypes (A, B, C, F, G), were identified. In four samples, three of non-B subtypes, five 3' splice sites (3' ss) mapping to unreported positions in the HIV-1 genome were identified. Two, designated A4i and A4j, were used in 22% and 25% of rev RNAs in two viruses of subtypes B and A, respectively. Given their close proximity (one or two nucleotides) to A4c and A4d, respectively, they could be viewed as variants of these sites. Three 3' ss, designated A7g, A7h, and A7i, located 20, 32, and 18 nucleotides downstream of A7, respectively, were identified in a subtype C (A7g, A7h) and a subtype G (A7i) viruses, each in around 2% of nef RNAs. The new splice sites or variants of splice sites were associated with the usual sequence features of 3'ss. Usage of unusual 3' ss A4d, A4e, A5a, A7a, and A7b was also detected. A4f, previously identified in two subtype C viruses, was preferentially used by rev RNAs of a subtype C virus. These results highlight the great diversity of in vivo splice site usage by HIV-1 RNAs. The fact that four of five newly identified splice sites or variants of splice sites were detected in non-subtype B viruses allows anticipating an even greater diversity of HIV-1 splice site usage than currently known.	[Vega, Yolanda; Delgado, Elena; Carrera, Cristina; Garcia-Bodas, Elena; Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, HIV Biol & Variabil Unit, Madrid, Spain; [de la Barrera, Jorge; Cuesta, Isabel] Inst Salud Carlos III, Ctr Nacl Microbiol, Bioinformat Unit, Madrid, Spain; [Zaballos, Angel] Inst Salud Carlos III, Ctr Nacl Microbiol, Genom Unit, Madrid, Spain; [Marino, Ana; Alvarez, Hortensia] Hosp Arquitecto Marcide, Ferrol, A Coruna, Spain; [Ocampo, Antonio; Miralles, Celia; Perez-Castro, Sonia; Lopez-Miragaya, Isabel] Complejo Hosp Univ Vigo, Vigo, Pontevedra, Spain; [Diez-Fuertes, Francisco] Inst Salud Carlos III, Ctr Nacl Microbiol, AIDS Immunopathogenesis Unit, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Complejo Hospitalario Universitario de Ferrol; Complexo Hospitalario Universitario de Vigo; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Thomson, MM (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, HIV Biol & Variabil Unit, Madrid, Spain.	mthomson@isciii.es	Thomson, Michael M/P-8949-2017; CARRERA, CRISTINA/N-1887-2019; Cuesta de la Plaza, Isabel/C-1628-2018; Díez-Fuertes, Francisco/AAA-9427-2019; Delgado, Elena/E-2785-2019	Thomson, Michael M/0000-0002-0622-7527; CARRERA, CRISTINA/0000-0003-1608-8820; Cuesta de la Plaza, Isabel/0000-0002-7911-9041; Díez-Fuertes, Francisco/0000-0003-2413-9229; OCAMPO HERMIDA, ANTONIO/0000-0002-3176-9758; PEREZ CASTRO, SONIA/0000-0003-1734-1904; Zaballos, Angel/0000-0002-7555-5815; Delgado, Elena/0000-0002-0754-8533	Sara Borrell postdoctoral Program of the Spanish Government [2012 CD12/00515]; Ministerio de Economia y Competitividad, Spain [SAF2010-20961, SAF2013-48488-P]; Instituto de Salud Carlos III [MPY 1194/12]	Sara Borrell postdoctoral Program of the Spanish Government; Ministerio de Economia y Competitividad, Spain; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Francisco Diez-Fuertes is supported by the Sara Borrell postdoctoral Program of the Spanish Government 2012 CD12/00515. This work was also supported by Ministerio de Economia y Competitividad, Spain (URL: http://www.mineco.gob.es/portal/site/mineco/) Grant # SAF2010-20961, Grant # SAF2013-48488-P to MMT and Instituto de Salud Carlos III (URL: http://www.isciii.es) Grant # MPY 1194/12 to MMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink TEM, 2008, J VIROL, V82, P3090, DOI 10.1128/JVI.01479-07; ARENS M, 1993, AIDS RES HUM RETROV, V9, P1257, DOI 10.1089/aid.1993.9.1257; ARRIGO SJ, 1990, J VIROL, V64, P4585, DOI 10.1128/JVI.64.9.4585-4588.1990; Asparuhova MB, 2007, J GENE MED, V9, P323, DOI 10.1002/jgm.1027; Bagnarelli P, 1996, J VIROL, V70, P7603, DOI 10.1128/JVI.70.11.7603-7613.1996; Bakkour N, 2007, PLOS PATHOG, V3, P1530, DOI 10.1371/journal.ppat.0030159; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; Berkhout B, 1996, ARCH VIROL, V141, P839, DOI 10.1007/BF01718159; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Bilodeau PS, 1999, J VIROL, V73, P9764, DOI 10.1128/JVI.73.12.9764-9772.1999; BORVAK J, 1995, J IMMUNOL, V155, P3196; Brachtel EF, 2002, AIDS RES HUM RETROV, V18, P785, DOI 10.1089/08892220260139521; BRUGGEMAN LA, 1994, VIROLOGY, V202, P940, DOI 10.1006/viro.1994.1416; BUTERA ST, 1994, J VIROL, V68, P2726, DOI 10.1128/JVI.68.4.2726-2730.1994; Carrera C, 2010, AIDS RES HUM RETROV, V26, P815, DOI 10.1089/aid.2010.0011; Chang ST, 2011, MBIO, V2, DOI 10.1128/mBio.00134-11; Comar M, 1997, J CLIN INVEST, V100, P893, DOI 10.1172/JCI119605; Delgado E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030574; Erkelenz S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0154-8; FURTADO MR, 1995, J VIROL, V69, P2092, DOI 10.1128/JVI.69.4.2092-2100.1995; FURTADO MR, 1991, VIROLOGY, V185, P258, DOI 10.1016/0042-6822(91)90773-5; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Habara Y, 2008, J BIOCHEM, V143, P303, DOI 10.1093/jb/mvm227; Jacquenet S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-33; Jacquenet S, 2001, NUCLEIC ACIDS RES, V29, P464, DOI 10.1093/nar/29.2.464; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lutzelberger M, 2006, J BIOL CHEM, V281, P18644, DOI 10.1074/jbc.M513698200; Madsen JM, 2005, J VIROL, V79, P10478, DOI 10.1128/JVI.79.16.10478-10486.2005; Madsen JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-10; Mandal D, 2008, J VIROL, V82, P1600, DOI 10.1128/JVI.02295-07; Mandal D, 2010, J VIROL, V84, P12790, DOI 10.1128/JVI.01257-10; MICHAEL NL, 1991, J VIROL, V65, P7084, DOI 10.1128/JVI.65.12.7084-.1991; MICHAEL NL, 1992, J VIROL, V66, P310, DOI 10.1128/JVI.66.1.310-316.1992; MICHAEL NL, 1995, J VIROL, V69, P1868, DOI 10.1128/JVI.69.3.1868-1877.1995; Mueller N, 2014, VIROLOGY, V468, P609, DOI 10.1016/j.virol.2014.09.018; NEUMANN M, 1994, AIDS RES HUM RETROV, V10, P1531, DOI 10.1089/aid.1994.10.1531; Ocwieja KE, 2012, NUCLEIC ACIDS RES, V40, P10345, DOI 10.1093/nar/gks753; OREILLY MM, 1995, VIROLOGY, V213, P373, DOI 10.1006/viro.1995.0010; Pasternak AO, 2010, AIDS, V24, P1641, DOI 10.1097/QAD.0b013e32833b3171; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; RAMILO O, 1993, J IMMUNOL, V150, P5202; RIGGS NL, 1994, VIROLOGY, V202, P264, DOI 10.1006/viro.1994.1342; ROBERTGUROFF M, 1990, J VIROL, V64, P3391, DOI 10.1128/JVI.64.7.3391-3398.1990; SAKSELA K, 1995, ANN INTERN MED, V123, P641, DOI 10.7326/0003-4819-123-9-199511010-00001; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; Saltarelli MJ, 1996, AIDS RES HUM RETROV, V12, P1443, DOI 10.1089/aid.1996.12.1443; SCHNITTMAN SM, 1991, AIDS RES HUM RETROV, V7, P361, DOI 10.1089/aid.1991.7.361; SCHWARTZ S, 1991, VIROLOGY, V183, P677, DOI 10.1016/0042-6822(91)90996-O; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; SESHAMMA T, 1992, P NATL ACAD SCI USA, V89, P10663, DOI 10.1073/pnas.89.22.10663; SHELLEY CS, 1987, NUCLEIC ACIDS RES, V15, P3787, DOI 10.1093/nar/15.9.3787; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; Smith CW, NATURE, V342, P243; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; SMITH J, 1992, J GEN VIROL, V73, P1825, DOI 10.1099/0022-1317-73-7-1825; Sonza S, 2002, J VIROL, V76, P12611, DOI 10.1128/JVI.76.24.12611-12621.2002; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; STAFFA A, 1994, J VIROL, V68, P3071, DOI 10.1128/JVI.68.5.3071-3079.1994; Stellbrink HJ, 1997, AIDS, V11, P1103, DOI 10.1097/00002030-199709000-00004; Stoltzfus CM, 2009, ADV VIRUS RES, V74, P1, DOI 10.1016/S0065-3527(09)74001-1; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Swanson AK, 1998, J BIOL CHEM, V273, P34551, DOI 10.1074/jbc.273.51.34551; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vega Y, 2013, AIDS RES HUM RETROV, V29, P1075, DOI [10.1089/aid.2013.0053, 10.1089/AID.2013.0053]; Wentz MP, 1997, J VIROL, V71, P8542, DOI 10.1128/JVI.71.11.8542-8551.1997; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Zhabokritsky A, 2014, RNA, V20, P1238, DOI 10.1261/rna.043141.113	75	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158525	10.1371/journal.pone.0158525	http://dx.doi.org/10.1371/journal.pone.0158525			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355361	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400073
J	Fu, D; Zhao, YQ; Shen, JK; Cai, ZD; Hua, YQ				Fu, Dong; Zhao, Yiqiong; Shen, Jiakang; Cai, Zhengdong; Hua, Yingqi			Comparison of Venous Thromboembolism after Total Artificial Joint Replacement between Musculoskeletal Tumors and Osteoarthritis of the Knee by a Single Surgeon	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARIN; RISK-FACTORS; ORTHOPEDIC ONCOLOGY; PULMONARY-EMBOLISM; CANCER-PATIENTS; LOWER-EXTREMITY; PREVENTION; ARTHROPLASTY; DISEASE	The purpose of this study was to compare and evaluate the event of VTE (Venous Thromboembolism Event) after total artificial joint replacement between two groups diagnosed with either musculoskeletal tumors or osteoarthritis (OA) of the knee. From 2004 to 2014, a total of 1,402 patients (308 in tumor group, 1,094 in OA group) were involved in this study. The rate of asymptomatic DVT (Deep vein thrombosis) was significantly higher in tumor group when compared with OA group. Though both the incidence of symptomatic DVT and PE (Pulmonary embolism) were slightly higher in tumor group, no significant difference was detected. Tumor patients suffered an almost equal risk of VTE compared with OA patients except a higher rate of asymptomatic DVT after total artificial joint replacement. For patients with tumor, no significant association was observed between any potential risk factor and DVT.	[Fu, Dong; Shen, Jiakang; Cai, Zhengdong; Hua, Yingqi] Shanghai Jiao Tong Univ, Dept Orthoped, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200080, Peoples R China; [Zhao, Yiqiong] Tongji Univ, Peoples Hosp 10, Shanghai 200072, Peoples R China	Shanghai Jiao Tong University; Tongji University	Fu, D (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200080, Peoples R China.	fudongshenanfang@126.com		Fu, Dong/0000-0002-1585-504X				Anderson FA, 2003, CHEST, V124, p349S, DOI 10.1378/chest.124.6_suppl.349S; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Benevenia J, 2004, CLIN ORTHOP RELAT R, P87; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; CLAGETT GP, 1988, ANN SURG, V208, P227, DOI 10.1097/00000658-198808000-00016; Engbers MJ, 2010, J THROMB HAEMOST, V8, P2105, DOI 10.1111/j.1538-7836.2010.03986.x; Fox EA, 2005, THROMB HAEMOSTASIS, V94, P362, DOI 10.1160/TH05-04-0266; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; House of Commons Health Committee, 2005, 2 HOUS COMM HLTH COM; Hutten BA, 2000, J CLIN ONCOL, V18, P3078, DOI 10.1200/JCO.2000.18.17.3078; Lewis VO, 2009, J BONE JOINT SURG AM, V91A, P1546, DOI 10.2106/JBJS.I.00375; Lin PP, 1998, J SURG ONCOL, V68, P41; Maletis GB, 2012, J BONE JOINT SURG AM, V94A, P714, DOI 10.2106/JBJS.J.01759; Melero MJ, 2012, MEDICINA-BUENOS AIRE, V72, P361; Mitchell SY, 2007, J BONE JOINT SURG AM, V89A, P2433, DOI 10.2106/JBJS.F.01308; Nathan SS, 2006, J BONE JOINT SURG AM, V88A, P1066, DOI 10.2106/JBJS.D.02926; Papp DF, 2007, J BONE JOINT SURG AM, V89A, P103, DOI 10.2106/JBJS.G.00711; Ramo BA, 2011, J BONE JOINT SURG AM, V93A, P847, DOI 10.2106/JBJS.H.01640; Ruggieri P, 2010, J SURG ONCOL, V102, P375, DOI 10.1002/jso.21645; Sakon M, 2006, J THROMB HAEMOST, V4, P581, DOI 10.1111/j.1538-7836.2006.01786.x; Scharschmidt T, 2010, J SURG ONCOL, V102, P549, DOI 10.1002/jso.21669; Schellong SM, 2007, J THROMB HAEMOST, V5, P1431, DOI 10.1111/j.1538-7836.2007.02570.x; SHEN VS, 1980, SOUTHERN MED J, V73, P841, DOI 10.1097/00007611-198007000-00005; Shi DQ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/712895; Tateishi U, 2007, RADIOLOGY, V245, P839, DOI 10.1148/radiol.2453061538; Trc T, 2007, ACTA CHIR ORTHOP TR, V74, P126; Tuy B, 2009, CLIN ORTHOP RELAT R, V467, P239, DOI 10.1007/s11999-008-0607-7; VANDERPOLL T, 1990, NEW ENGL J MED, V322, P1622, DOI 10.1056/NEJM199006073222302; White RH, 2003, THROMB HAEMOSTASIS, V90, P446, DOI 10.1160/TH03-03-0152; Yamaguchi T, 2013, BONE JOINT J, V95B, P1280, DOI 10.1302/0301-620X.95B9.30905; Zoller B, 2012, AM J CARDIOVASC DIS, V2, P171	32	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158215	10.1371/journal.pone.0158215	http://dx.doi.org/10.1371/journal.pone.0158215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352130	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900045
J	Necka, EA; Cacioppo, S; Norman, GJ; Cacioppo, JT				Necka, Elizabeth A.; Cacioppo, Stephanie; Norman, Greg J.; Cacioppo, John T.			Measuring the Prevalence of Problematic Respondent Behaviors among MTurk, Campus, and Community Participants	PLOS ONE			English	Article							MECHANICAL TURK	The reliance on small samples and underpowered studies may undermine the replicability of scientific findings. Large sample sizes may be necessary to achieve adequate statistical power. Crowdsourcing sites such as Amazon's Mechanical Turk (MTurk) have been regarded as an economical means for achieving larger samples. Because MTurk participants may engage in behaviors which adversely affect data quality, much recent research has focused on assessing the quality of data obtained from MTurk samples. However, participants from traditional campus-and community-based samples may also engage in behaviors which adversely affect the quality of the data that they provide. We compare an MTurk, campus, and community sample to measure how frequently participants report engaging in problematic respondent behaviors. We report evidence that suggests that participants from all samples engage in problematic respondent behaviors with comparable rates. Because statistical power is influenced by factors beyond sample size, including data integrity, methodological controls must be refined to better identify and diminish the frequency of participant engagement in problematic respondent behaviors.	[Necka, Elizabeth A.; Norman, Greg J.; Cacioppo, John T.] Univ Chicago, Chicago, IL 60637 USA; [Cacioppo, Stephanie] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Necka, EA (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	enecka@uchicago.edu		Necka, Elizabeth/0000-0002-9749-5710	National Science Foundation [SMA-1353248]	National Science Foundation(National Science Foundation (NSF))	Funding was provided in part by the National Science Foundation Grant SMA-1353248 (http://www.nsf.gov/dir/index.jsp?org=SBE) to JTC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amazon, 2014, AM MECH TURK REQ UI; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Campbell W. K., 1999, REV GEN PSYCHOL, V3, P23, DOI DOI 10.1037/1089-2680.3.1.23; Chandler J, 2015, PSYCHOL SCI, V26, P1131, DOI 10.1177/0956797615585115; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; Clifford Scott., 2014, J EXP POLITICAL SCI, V1, P120, DOI [10.1017/xps.2014.5, DOI 10.1017/XPS.2014.5]; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Curran PG, 2016, J EXP SOC PSYCHOL, V66, P4, DOI 10.1016/j.jesp.2015.07.006; Edlund JE, 2015, METHODOLOGICAL ISSUE, V19, P191; Edlund JE, 2009, PERS SOC PSYCHOL B, V35, P635, DOI 10.1177/0146167208331255; Epley N, 2006, PERS SOC PSYCHOL B, V32, P641, DOI 10.1177/0146167205284007; Epley N, 2000, J PERS SOC PSYCHOL, V79, P861, DOI 10.1037//0022-3514.79.6.861; Funder DC, 2014, PERS SOC PSYCHOL REV, V18, P3, DOI 10.1177/1088868313507536; Goodman JK, 2013, J BEHAV DECIS MAK; Horton J. J., 2010, P 11 ACM C EL COMM, P209, DOI DOI 10.1145/1807342.1807376; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ipeirotis P., 2010, CEDER1001 NYU; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kapelner A, 2010, P CROWDCONF 2010; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; KRUEGER J, 1994, J PERS SOC PSYCHOL, V67, P596, DOI 10.1037/0022-3514.67.4.596; Kumar N., 2013, EFFECTIVE USE AMAZON; Litman L, 2015, BEHAV RES METHODS, V47, P519, DOI 10.3758/s13428-014-0483-x; Mason W., 2010, SIGKDD EXPLORATIONS, V11, P100, DOI [DOI 10.1145/1809400.1809422, 10.1145/1600150.1600175]; McAuliffe TL, 2014, AIDS BEHAV, V14, P1320; McShane BB, 2014, PERSPECT PSYCHOL SCI, V9, P612, DOI 10.1177/1745691614548513; Nichols AL, 2008, J GEN PSYCHOL, V135, P151, DOI 10.3200/GENP.135.2.151-166; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Peer E, 2014, BEHAV RES METHODS, V46, P1023, DOI 10.3758/s13428-013-0434-y; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Ross J, 2010, WHO ARE TURKERS WORK, P1; Staffelbach M, 2014, COLL INT C MIT; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; Woods AT, 2015, PEERJ, V3, DOI 10.7717/peerj.1058	39	107	107	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157732	10.1371/journal.pone.0157732	http://dx.doi.org/10.1371/journal.pone.0157732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27351378	gold, Green Published, Green Submitted			2022-12-27	WOS:000378858900016
J	Achakulvisut, T; Acuna, DE; Ruangrong, T; Kording, K				Achakulvisut, Titipat; Acuna, Daniel E.; Ruangrong, Tulakan; Kording, Konrad			Science Concierge: A Fast Content-Based Recommendation System for Scientific Publications	PLOS ONE			English	Article								Finding relevant publications is important for scientists who have to cope with exponentially increasing numbers of scholarly material. Algorithms can help with this task as they help for music, movie, and product recommendations. However, we know little about the performance of these algorithms with scholarly material. Here, we develop an algorithm, and an accompanying Python library, that implements a recommendation system based on the content of articles. Design principles are to adapt to new content, provide near-real time suggestions, and be open source. We tested the library on 15K posters from the Society of Neuroscience Conference 2015. Human curated topics are used to cross validate parameters in the algorithm and produce a similarity metric that maximally correlates with human judgments. We show that our algorithm significantly outperformed suggestions based on keywords. The work presented here promises to make the exploration of scholarly material faster and more accurate.	[Achakulvisut, Titipat] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Acuna, Daniel E.] Syracuse Univ, Sch Informat Studies, Syracuse, NY USA; [Ruangrong, Tulakan] Mahidol Univ, Dept Biomed Engn, Nakhon Pathom, Thailand; [Kording, Konrad] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA	Northwestern University; Syracuse University; Mahidol University; Shirley Ryan AbilityLab	Achakulvisut, T (corresponding author), Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA.	titipat.a@u.northwestern.edu	Kording, Konrad/A-1233-2007; Acuna, Daniel/O-8006-2016	Kording, Konrad/0000-0001-8408-4499; Acuna, Daniel/0000-0002-7765-1595; Achakulvisut, Titipat/0000-0002-2124-2979	Royal Thai Government Scholarship [50AC002]; John Templeton Foundation grant through the Metaknowledge Research Network	Royal Thai Government Scholarship; John Templeton Foundation grant through the Metaknowledge Research Network	TA received Royal Thai Government Scholarship #50AC002. DA and KK received support by the John Templeton Foundation grant through the Metaknowledge Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho A. V., 1976, SIAM Journal on Computing, V5, P115, DOI 10.1137/0205011; Ali M., 2011, PARALLEL COLLABORATI; Bell Robert M., 2007, SIGKDD EXPLOR NEWSL, V9, P75, DOI [DOI 10.1145/1345448.1345465, 10.1145/1345448.1345465]; Bishop C. M, 2006, PATTERN RECOGNITION; Chavalarias D, 2010, J CLIN EPIDEMIOL, V63, P1205, DOI 10.1016/j.jclinepi.2009.12.011; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Friedman J., 2001, SPRINGER SERIES STAT, V1; Gipp B., 2009, P INT C EM TRENDS CO, P309; Hoffman M., 2010, ADV NEURAL INFORM PR, P856; Hopcroft J., 2014, FDN DATA SCI; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lavrenko V., 2001, SIGIR Forum, P120; Lee M, 2005, COGNITIVE SCI; Li Lihong, 2010, P 19 INT C WORLD WID, P661, DOI DOI 10.1145/1772690.1772758; Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265; Manning C. D., 2008, INTRO INFORM RETRIEV, V1; Mikolov T., 2013, P ICLR WORKSH POST S; Pennington J, 2014, EMNLP, V14, P1532, DOI DOI 10.3115/V1/D14-1162; Petersen AM, 2011, P NATL ACAD SCI USA, V108, P18, DOI 10.1073/pnas.1016733108; Pincombe Brandon, 2004, COMP HUMAN LATENT SE; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Rocchio J.J., 1971, SMART RETRIEVAL SYST; Shakhnarovish D., 2005, NEAREST NEIGHBOR MET; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang C., 2011, P 17 ACM SIGKDD INT, P448, DOI DOI 10.1145/2020408.2020480; Wesley-Smith I, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16 COMPANION), P389, DOI 10.1145/2872518.2890517; Yoneya T, 2007, GENOME INFORM SER, V18, P267	27	49	50	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158423	10.1371/journal.pone.0158423	http://dx.doi.org/10.1371/journal.pone.0158423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383424	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400047
J	de Souza, JG; Robinson, M; Corteletti, R; Cardenas, ML; Wolf, S; Iriarte, J; Mayle, F; DeBlasis, P				de Souza, Jonas Gregorio; Robinson, Mark; Corteletti, Rafael; Cardenas, Macarena Lucia; Wolf, Sidnei; Iriarte, Jose; Mayle, Francis; DeBlasis, Paulo			Understanding the Chronology and Occupation Dynamics of Oversized Pit Houses in the Southern Brazilian Highlands	PLOS ONE			English	Article							CAL. BC; SEQUENCE; SITE	A long held view about the occupation of southern proto-Je pit house villages of the southern Brazilian highlands is that these sites represent cycles of long-term abandonment and reoccupation. However, this assumption is based on an insufficient number of radiocarbon dates for individual pit houses. To address this problem, we conducted a programme of comprehensive AMS radiocarbon dating and Bayesian modelling at the deeply stratified oversized pit House 1, Baggio I site (Cal. A. D. 1395-1650), Campo Belo do Sul, Santa Catarina state, Brazil. The stratigraphy of House 1 revealed an unparalleled sequence of twelve well preserved floors evidencing a major change in occupation dynamics including five completely burnt collapsed roofs. The results of the radiocarbon dating allowed us to understand for the first time the occupation dynamics of an oversized pit house in the southern Brazilian highlands. The Bayesian model demonstrates that House 1 was occupied for over two centuries with no evidence of major periods of abandonment, calling into question previous models of long-term abandonment. In addition, the House 1 sequence allowed us to tie transformations in ceramic style and lithic technology to an absolute chronology. Finally, we can provide new evidence that the emergence of oversized domestic structures is a relatively recent phenomenon among the southern proto-Je. As monumental pit houses start to be built, small pit houses continue to be inhabited, evidencing emerging disparities in domestic architecture after AD 1000. Our research shows the importance of programmes of intensive dating of individual structures to understand occupation dynamics and site permanence, and challenges long held assumptions that the southern Brazilian highlands were home to marginal cultures in the context of lowland South America.	[de Souza, Jonas Gregorio; Robinson, Mark; Iriarte, Jose] Univ Exeter, Dept Archaeol, Exeter, Devon, England; [Corteletti, Rafael; DeBlasis, Paulo] Univ Sao Paulo MAE USP, Museu Arqueol & Etnol, Sao Paulo, Brazil; [Cardenas, Macarena Lucia; Mayle, Francis] Univ Reading, Dept Geog & Environm Sci, Reading, Berks, England; [Wolf, Sidnei] Ctr Univ Univates, Lajeado, Brazil	University of Exeter; University of Reading; Universidade do Vale do Taquari	de Souza, JG (corresponding author), Univ Exeter, Dept Archaeol, Exeter, Devon, England.	jgd203@exeter.ac.uk	Corteletti, Rafael/C-4616-2014; Wolf, Sidnei/C-2935-2017	Corteletti, Rafael/0000-0001-5606-9910; Wolf, Sidnei/0000-0001-8546-7002; Robinson, Mark/0000-0002-1520-8459; Iriarte, Jose/0000-0002-8155-5360; Gregorio de Souza, Jonas/0000-0001-6032-4443	Wenner-Gren Foundation Dissertation Fieldwork Grant [9042]; Arts and Humanities Research Council [AH/K004212/1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [12/51328-3]; AHRC [AH/K004212/1] Funding Source: UKRI	Wenner-Gren Foundation Dissertation Fieldwork Grant; Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	JGD was funded by a Wenner-Gren Foundation Dissertation Fieldwork Grant entitled 'House Architecture and Community Organization: Exploring Alternative Pathways to Complexity in the Southern Brazilian Highlands' (Gr. 9042) (http://www.wennergren.org/grantees/gregorio-de-souza-jonas). This paper was developed in the context of project 'Je Landscapes of southern Brazil: Ecology, History and Power in a Transitional Landscape during the Late Holocene' funded by the Arts and Humanities Research Council (AH/K004212/1) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (12/51328-3)(http://gtr.rcuk.ac.uk/projects?ref=AH/K004212/1) granted to JI, FM and PD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. M., 1999, ARCHAEOLOGY HOUSEHOL, P20; Araujo Astolfo G M, 2007, REV ARQUEOLOGIA, V20, P9, DOI [DOI 10.24885/sab.v20i1.225, 10.24885/sab.v20i1.225, DOI 10.24885/SAB.V20I1.225]; Bayliss A, 2015, WORLD ARCHAEOL, V47, P677, DOI 10.1080/00438243.2015.1067640; Bayliss A, 2009, RADIOCARBON, V51, P123, DOI 10.1017/S0033822200033750; Beber M. V., 2005, DOCUMENTOS, V10, P5; Becker I.I.B., 1988, DOCUMENTOS, V2, P5; Buck C.E., 1996, BAYESIAN APPROACH IN; Burger Richard L., 1995, CHAVIN ORIGINS ANDEA; Burley D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120795; Chirikure S, 2013, ANTIQUITY, V87, P854, DOI 10.1017/S0003598X00049516; Cope S. M, 2010, REV ARQUEOL, V23, P98; Cope S. M., 2002, PESQUI ANTROPOL, V58, P121; Cope S.M., 2006, THESIS; Corteletti R, 2015, J ARCHAEOL SCI, V58, P46, DOI 10.1016/j.jas.2015.03.017; De Masi M. A. N., 2009, REV ARQUEOL, V22, P99; DEAL M, 1985, J ANTHROPOL ARCHAEOL, V4, P243, DOI 10.1016/0278-4165(85)90008-X; DeBlasis P, 2007, ARQUEOLOGIA SURAMERI, V3, P29, DOI DOI 10.1590/S0102-; Diehl MW, 1998, AM ANTIQUITY, V63, P617, DOI 10.2307/2694111; Dillehay TD, 2004, J SOC ARCHAEOL, V4, P239, DOI 10.1177/1469605304042396; Hayden B, 1996, AM ANTIQUITY, V61, P341, DOI 10.2307/282430; Hayden B., 1982, J ANTHROPOL ARCHAEOL, V1, P132, DOI [DOI 10.1016/0278-4165(82)90018-6, 10.1016/0278-4165(82)90018-6]; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Iriarte J, 2007, ENVIRON ARCHAEOL, V12, P115, DOI 10.1179/174963107x226390; Iriarte J, 2013, J ANTHROPOL ARCHAEOL, V32, P74, DOI 10.1016/j.jaa.2012.10.003; Iriarte J, 2008, ANTIQUITY, V82, P947, DOI 10.1017/S0003598X00097702; Izumi S., 1972, EXCAVATIONS KOTOSH P; Jazwa CS, 2013, RADIOCARBON, V55, P185, DOI 10.1017/S0033822200047901; Jolkesky M. P. V, 2010, THESIS; Kern A. A., 1989, VERITAS, V35, P99; Marcus J, 2004, P NATL ACAD SCI USA, V101, P18257, DOI 10.1073/pnas.0408551102; McAnany PA, 2009, ARCHAEOL DIALOG, V16, P1, DOI 10.1017/S1380203809002748; Mergen Natalia M., 2013, PESQUISAS ANTROPOLOG, V70, P65, DOI DOI 10.5935/0553-8467.20170005; Michczynski A, 2007, RADIOCARBON, V49, P393, DOI 10.1017/S0033822200042326; Milheira RG, 2010, ARQUEOLOGIA GUARANI; Montgomery B., 1993, ABANDONMENT SETTLEME, P157, DOI [DOI 10.1017/CB09780511735240.012, 10.1017/CBO9780511735240.012, DOI 10.1017/CBO9780511735240.012]; Muller L, 2008, THESIS; Noelli FS, 2005, GLOBAL ARCHAEOLOGICAL THEORY, P167, DOI 10.1007/0-306-48652-0_12; Nunn PD, 2013, J PAC ARCHAEOL, V4, P21; Overholtzer L, 2015, J ANTHROPOL ARCHAEOL, V37, P37, DOI 10.1016/j.jaa.2014.11.001; Plunket Patricia, 2002, DOMESTIC RITUAL ANCI; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reis MJ, 2007, PROBLEMATICA ARQUEOL; Richards Colin, 1984, NEOLITHIC STUDIES RE, V133, P189; Richter T, 2013, J QUATERNARY SCI, V28, P467, DOI 10.1002/jqs.2629; Riris P, 2015, INTERNET ARCHAEOLOGY, V38; Saldanha J.D. M., 2005, THESIS; Sara-Lafosse RVC, 2007, J ANTHROPOL ARCHAEOL, V26, P150, DOI 10.1016/j.jaa.2006.07.002; Schmitz P. I., 2013, PESQUI ANTROPOL, V70, P133; Schmitz P. I., 2002, PESQUISAS ANTROPOLOG, V58, P11; Schmitz PI, 2013, PESQUISAS ANTROPOLOG, V70, P7; Schmitz PI., 2006, XOKLENG 2860 AC TERR, P14; Schmitz PI, 2013, PESQUI ANTROPOL, V70, P35; Stevanovic M, 1997, J ANTHROPOL ARCHAEOL, V16, P334, DOI 10.1006/jaar.1997.0310; Stevenson Marc G., 1982, J ANTHROPOL ARCHAEOL, V1, P237, DOI DOI 10.1016/0278-4165(82)90014-9; Steward JH, 1946, HDB S AM INDIANS; Telford RJ, 2004, HOLOCENE, V14, P296, DOI 10.1191/0959683604hl707fa; Walker WH, 2002, AM ANTHROPOL, V104, P159, DOI 10.1525/aa.2002.104.1.159; Walker William H., 1995, EXPANDING ARCHAEOLOG, P67; Whittle A., 2011, GATHERING TIME DATIN; Whittle A, 2008, CAMB ARCHAEOL J, V18, P65, DOI 10.1017/S0959774308000061; Whittle A, 2007, CAMB ARCHAEOL J, V17, P123, DOI 10.1017/S0959774307000200; WILSHUSEN RH, 1986, J FIELD ARCHAEOL, V13, P244	64	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158127	10.1371/journal.pone.0158127	http://dx.doi.org/10.1371/journal.pone.0158127			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27384341	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000379809400035
J	Derbre, F; Droguet, M; Leon, K; Troadec, S; Pennec, JP; Giroux-Metges, MA; Rannou, F				Derbre, Frederic; Droguet, Mickael; Leon, Karelle; Troadec, Samuel; Pennec, Jean-Pierre; Giroux-Metges, Marie-Agnes; Rannou, Fabrice			Single Muscle Immobilization Decreases Single-Fibre Myosin Heavy Chain Polymorphism: Possible Involvement of p38 and JNK MAP Kinases	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; SOLEUS MUSCLE; GENE-EXPRESSION; SHORTENING VELOCITY; THYROID-HORMONE; SKINNED FIBERS; MESSENGER-RNA; MOTOR UNITS; BED-REST	Purpose Muscle contractile phenotype is affected during immobilization. Myosin heavy chain (MHC) isoforms are the major determinant of the muscle contractile phenotype. We therefore sought to evaluate the effects of muscle immobilization on both the MHC composition at single-fibre level and the mitogen-activated protein kinases (MAPK), a family of intracellular signaling pathways involved in the stress-induced muscle plasticity. Methods The distal tendon of female Wistar rat Peroneus Longus (PL) was cut and fixed to the adjacent bone at neutral muscle length. Four weeks after the surgery, immobilized and contralateral PL were dissociated and the isolated fibres were sampled to determine MHC composition. Protein kinase 38 (p38), extracellular signal-regulated kinases (ERK1/2), and c-Jun-NH2-terminal kinase (JNK) phosphorylations were measured in 6-and 15-day immobilized and contralateral PL. Results MHC distribution in immobilized PL was as follows: I = 0%, IIa = 11.8 +/- 2.8%, IIx = 53.0 +/- 6.1%, IIb = 35.3 +/- 7.3% and I = 6.1 +/- 3.9%, IIa = 22.1 +/- 3.4%, IIx = 46.6 +/- 4.5%, IIb = 25.2 +/- 6.6% in contralateral muscle. The MHC composition in immobilized muscle is consistent with a faster contractile phenotype according to the Hill's model of the force-velocity relationship. Immobilized and contralateral muscles displayed a polymorphism index of 31.1% (95% CI 26.1-36.0) and 39.3% (95% CI 37.0-41.5), respectively. Significant increases in p38 and JNK phosphorylation were observed following 6 and 15 days of immobilization. Conclusions Single muscle immobilization at neutral length induces a shift of MHC composition toward a faster contractile phenotype and decreases the polymorphic profile of single fibres. Activation of p38 and JNK could be a potential mechanism involved in these contractile phenotype modifications during muscle immobilization.	[Derbre, Frederic] Univ Rennes 2, Lab Movement Sport & Hlth Sci M2S, ENS Rennes, EA1274, Rennes, France; [Droguet, Mickael; Leon, Karelle; Troadec, Samuel; Pennec, Jean-Pierre; Giroux-Metges, Marie-Agnes; Rannou, Fabrice] Sch Med, Dept Physiol, EA1274 M2S, Brest, France	Ecole Normale Superieure de Rennes (ENS Rennes); Universite Rennes 2; CHU Brest; Universite de Franche-Comte	Rannou, F (corresponding author), Sch Med, Dept Physiol, EA1274 M2S, Brest, France.	fabrice.rannou@chu-brest.fr	Rannou, Fabrice/AAI-1924-2021; Derbre, Frederic/R-8776-2017	Droguet, Mickael/0000-0002-5408-8859; Derbre, Frederic/0000-0002-1531-6425				Andersen JL, 1999, J APPL PHYSIOL, V86, P455, DOI 10.1152/jappl.1999.86.2.455; Baldwin KM, 2001, J APPL PHYSIOL, V90, P345, DOI 10.1152/jappl.2001.90.1.345; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boppart MD, 2001, AM J PHYSIOL-CELL PH, V280, pC352, DOI 10.1152/ajpcell.2001.280.2.C352; Borina E, 2010, SCAND J MED SCI SPOR, V20, P65, DOI 10.1111/j.1600-0838.2009.01029.x; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Caiozzo VJ, 2003, AM J PHYSIOL-REG I, V285, pR570, DOI 10.1152/ajpregu.00646.2002; Caiozzo VJ, 1997, AM J PHYSIOL-CELL PH, V273, pC944, DOI 10.1152/ajpcell.1997.273.3.C944; Caiozzo VJ, 1998, J APPL PHYSIOL, V85, P2237, DOI 10.1152/jappl.1998.85.6.2237; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Canepari M, 2010, SCAND J MED SCI SPOR, V20, P10, DOI 10.1111/j.1600-0838.2009.00965.x; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Childs TE, 2003, AM J PHYSIOL-CELL PH, V285, pC391, DOI 10.1152/ajpcell.00478.2002; Clark BC, 2009, MED SCI SPORT EXER, V41, P1869, DOI 10.1249/MSS.0b013e3181a645a6; D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276; Derbre F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046668; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; FILIPPI GM, 1994, EXP BRAIN RES, V101, P406; FISCHBACH GD, 1969, J PHYSIOL-LONDON, V201, P305, DOI 10.1113/jphysiol.1969.sp008757; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; FURBY A, 1993, MUSCLE NERVE, V16, P720, DOI 10.1002/mus.880160706; GALLER S, 1994, J PHYSIOL-LONDON, V478, P513, DOI 10.1113/jphysiol.1994.sp020270; Giroux-Metges MA, 2005, EXP NEUROL, V194, P495, DOI 10.1016/j.expneurol.2005.03.008; Glaser BW, 2010, EXP PHYSIOL, V95, P211, DOI 10.1113/expphysiol.2009.049023; Higginson J, 2002, PFLUG ARCH EUR J PHY, V445, P437, DOI 10.1007/s00424-002-0939-1; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hokari F, 2010, J APPL PHYSIOL, V109, P332, DOI 10.1152/japplphysiol.00335.2009; Jakubiec-Puka A, 1999, ACTA BIOCHIM POL, V46, P823, DOI 10.18388/abp.1999_4154; Jankala H, 1997, J APPL PHYSIOL, V82, P977, DOI 10.1152/jappl.1997.82.3.977; Kim J, 2009, KOREAN J PHYSIOL PHA, V13, P491, DOI 10.4196/kjpp.2009.13.6.491; Koh TJ, 1998, J PHYSIOL-LONDON, V508, P267, DOI 10.1111/j.1469-7793.1998.267br.x; Kostovski E, 2013, AM J PHYSIOL-ENDOC M, V305, pE1071, DOI 10.1152/ajpendo.00132.2013; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; LETERME D, 1994, PFLUG ARCH EUR J PHY, V429, P274, DOI 10.1007/BF00374323; Maffei M, 2014, ACTA PHYSIOL, V212, P316, DOI 10.1111/apha.12320; Meissner JD, 2011, NUCLEIC ACIDS RES, V39, P5907, DOI 10.1093/nar/gkr162; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Narici MV, 2011, EUR J APPL PHYSIOL, V111, P403, DOI 10.1007/s00421-010-1556-x; NICKS DK, 1989, J ANAT, V163, P1; Oishi Y, 1998, ACTA PHYSIOL SCAND, V162, P127; PATTULLO MC, 1992, EXP PHYSIOL, V77, P433, DOI 10.1113/expphysiol.1992.sp003604; PETIT J, 1993, J APPL PHYSIOL, V74, P1131, DOI 10.1152/jappl.1993.74.3.1131; Porter CM, 2000, J BIOL CHEM, V275, P3543, DOI 10.1074/jbc.275.5.3543; RANATUNGA KW, 1990, J MUSCLE RES CELL M, V11, P240, DOI 10.1007/BF01843577; Rannou F, 2012, J APPL PHYSIOL, V112, P1454, DOI 10.1152/japplphysiol.00944.2011; Rannou F, 2009, J PHYSIOL-LONDON, V587, P5249, DOI 10.1113/jphysiol.2009.176446; Rannou F, 2011, J APPL PHYSIOL, V111, P495, DOI 10.1152/japplphysiol.01136.2010; Scharf M, 2013, MOL CELL BIOL, V33, P2586, DOI 10.1128/MCB.01692-12; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shi H, 2008, FASEB J, V22, P2990, DOI 10.1096/fj.07-097600; STARON RS, 1993, HISTOCHEMISTRY, V100, P149, DOI 10.1007/BF00572901; Stevens L, 1999, AM J PHYSIOL-CELL PH, V277, pC1044, DOI 10.1152/ajpcell.1999.277.6.C1044; TABARY JC, 1972, J PHYSIOL-LONDON, V224, P231, DOI 10.1113/jphysiol.1972.sp009891; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; TALMADGE RJ, 1995, J APPL PHYSIOL, V78, P1256, DOI 10.1152/jappl.1995.78.4.1256; Trappe S, 2004, J PHYSIOL-LONDON, V557, P501, DOI 10.1113/jphysiol.2004.062166; Wall BT, 2014, ACTA PHYSIOL, V210, P600, DOI 10.1111/apha.12190; Wretman C, 2000, ACTA PHYSIOL SCAND, V170, P45	60	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158630	10.1371/journal.pone.0158630	http://dx.doi.org/10.1371/journal.pone.0158630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383612	gold, Green Submitted, Green Published			2022-12-27	WOS:000379809400068
J	Kim, KH; Yoon, HS; Yoon, H; Chung, WS; Sim, BS; Ryu, DR; Lee, DH				Kim, Kwang Hyun; Yoon, Hyun Suk; Yoon, Hana; Chung, Woo Sik; Sim, Bong Suk; Ryu, Dong-Ryeol; Lee, Dong Hyeon			Risk Factors for Developing Metabolic Acidosis after Radical Cystectomy and Ileal Neobladder	PLOS ONE			English	Article							CONTINENT URINARY-DIVERSION; RENAL-FUNCTION; ORTHOTOPIC NEOBLADDER; DIABETES-MELLITUS; LONG-TERM; BASE; COMPLICATIONS; ELECTROLYTE; BICARBONATE; PROGRESSION	Purpose To investigate the serial changes of metabolic acidosis and identify associated risk factors in patients who underwent radical cystectomy and ileal neobladder. Material and Methods From January 2010 to August 2014, 123 patients who underwent radical cystectomy and ileal neobladder reconstruction for bladder cancer were included in this study. Metabolic acidosis was defined as a serum bicarbonate level less than 22 mEq/L and impaired renal function was defined as a GFR <50ml/min. The presence of metabolic acidosis was evaluated at 1 month, 1 year, and 2 years after surgery. Multivariate logistic regression analysis was conducted to identify risk factors associated with development of metabolic acidosis. Results Metabolic acidosis was observed in 52%, 19.5%, and 7.3% of patients at 1 month, 1 year, and 2 years after surgery, respectively. At 1 month after surgery, impaired renal function was the only independent risk factor associated with metabolic acidosis (OR 3.87, P = 0.046). At 1 year after surgery, diabetes was the only independent risk factor associated with metabolic acidosis (OR 5.68, P = 0.002). At 2 years post-surgery, both age and diabetes were significant risk factors associated with metabolic acidosis. Conclusion Approximately, half of patients experienced metabolic acidosis one month after ileal neobladder reconstruction. Preoperative impaired renal function was the most significant risk factor for developing metabolic acidosis in the early postoperative period. However, the incidence of metabolic acidosis decreased to less than 20% 1 year after surgery, and diabetes was an independent risk factor during this period.	[Kim, Kwang Hyun; Yoon, Hyun Suk; Yoon, Hana; Chung, Woo Sik; Sim, Bong Suk; Lee, Dong Hyeon] Ewha Womans Univ, Sch Med, Dept Urol, Seoul, South Korea; [Ryu, Dong-Ryeol] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, DH (corresponding author), Ewha Womans Univ, Sch Med, Dept Urol, Seoul, South Korea.	leedohn@ewha.ac.kr		Ryu, Dong-Ryeol/0000-0002-5309-7606; Yoon, Hyun Suk/0000-0003-1806-3539; Kim, Kwang Hyun/0000-0002-6264-5109				Ahmadi H, 2013, J UROLOGY, V189, P1782, DOI 10.1016/j.juro.2012.11.078; BARADA K, 1994, J CLIN INVEST, V93, P2725, DOI 10.1172/JCI117287; Caravaca F, 1999, AM J KIDNEY DIS, V33, P892, DOI 10.1016/S0272-6386(99)70422-1; Chen W, 2015, AM J KIDNEY DIS, V65, P240, DOI 10.1053/j.ajkd.2014.07.007; Dash RP, 2015, EUR J PHARMACOL, V767, P67, DOI 10.1016/j.ejphar.2015.10.009; Davidsson T, 1996, BRIT J UROL, V78, P64, DOI 10.1046/j.1464-410X.1996.05212.x; DEFRONZO RA, 1980, KIDNEY INT, V17, P118, DOI 10.1038/ki.1980.14; Grocela JA, 1999, UROLOGY, V54, P373, DOI 10.1016/S0090-4295(99)00095-3; Gupta A, 2014, J CLIN ONCOL, V32, P3291, DOI 10.1200/JCO.2013.54.3173; Hautmann RE, 2003, J UROLOGY, V169, P834, DOI 10.1097/01.ju.0000029010.97686.eb; Hautmann RE, 2007, UROLOGY, V69, P17, DOI 10.1016/j.urology.2006.05.058; Hautmann RE, 2013, EUR UROL, V63, P67, DOI 10.1016/j.eururo.2012.08.050; Hautmann RE, 2011, J UROLOGY, V185, P2207, DOI 10.1016/j.juro.2011.02.006; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jin XD, 2012, EUR UROL, V61, P491, DOI 10.1016/j.eururo.2011.09.004; Karet FE, 2009, J AM SOC NEPHROL, V20, P251, DOI 10.1681/ASN.2008020166; Kovesdy CP, 2012, NEPHROL DIAL TRANSPL, V27, P3056, DOI 10.1093/ndt/gfs291; Kristjansson A, 1997, J UROLOGY, V157, P2099, DOI 10.1016/S0022-5347(01)64684-6; Marangella M, 2008, BJU INT, V101, P1571, DOI 10.1111/j.1464-410X.2007.07403.x; Mills RD, 1999, J UROLOGY, V161, P1057, DOI 10.1016/S0022-5347(01)61590-8; Miyake H, 2004, INT J UROL, V11, P83, DOI 10.1111/j.1442-2042.2004.00749.x; Nam JK, 2013, YONSEI MED J, V54, P690, DOI 10.3349/ymj.2013.54.3.690; Nieuwenhuijzen JA, 2008, EUR UROL, V53, P834, DOI 10.1016/j.eururo.2007.09.008; Nyman U, 2011, SCAND J CLIN LAB INV, V71, P129, DOI 10.3109/00365513.2010.543143; Palmer BF, 2015, NEW ENGL J MED, V373, P548, DOI 10.1056/NEJMra1503102; Racioppi M, 1999, UROLOGY, V54, P629, DOI 10.1016/S0090-4295(99)00317-9; Studer UE, 2004, BJU INT, V93, P183, DOI 10.1111/j.1464-410X.2004.04641.x; Studer UE, 2006, J UROLOGY, V176, P161, DOI 10.1016/S0022-5347(06)00573-8; Thurairaja R, 2008, BJU INT, V102, P1307, DOI 10.1111/j.1464-410X.2008.07975.x; Wild GE, 1999, DIGEST DIS SCI, V44, P407, DOI 10.1023/A:1026631207219	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158220	10.1371/journal.pone.0158220	http://dx.doi.org/10.1371/journal.pone.0158220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384686	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400038
J	Petersen, AM; Earp, NC; Redmond, ME; Postlethwait, JH; von Hippel, FA; Buck, CL; Cresko, WA				Petersen, Ann M.; Earp, Nathanial C.; Redmond, Mandy E.; Postlethwait, John H.; von Hippel, Frank A.; Buck, C. Loren; Cresko, William A.			Perchlorate Exposure Reduces Primordial Germ Cell Number in Female Threespine Stickleback	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; GASTEROSTEUS-ACULEATUS L.; SEX-DETERMINATION; AMMONIUM-PERCHLORATE; THYROID-FUNCTION; KIDNEY HYPERTROPHY; MODEL ORGANISM; RAINBOW-TROUT; ZEBRAFISH; MECHANISMS	Perchlorate is a common aquatic contaminant that has long been known to affect thyroid function in vertebrates, including humans. More recently perchlorate has been shown to affect primordial sexual differentiation in the aquatic model fishes zebrafish and threespine stickleback, but the mechanism has been unclear. Stickleback exposed to perchlorate from fertilization have increased androgen levels in the embryo and disrupted reproductive morphologies as adults, suggesting that perchlorate could disrupt the earliest stages of primordial sexual differentiation when primordial germ cells (PGCs) begin to form the gonad. Female stickleback have three to four times the number of PGCs as males during the first weeks of development. We hypothesized that perchlorate exposure affects primordial sexual differentiation by reducing the number of germ cells in the gonad during an important window of stickleback sex determination at 14-18 days post fertilization (dpf). We tested this hypothesis by quantifying the number of PGCs at 16 dpf in control and 100 mg/L perchlorate-treated male and female stickleback. Perchlorate exposure from the time of fertilization resulted in significantly reduced PGC number only in genotypic females, suggesting that the masculinizing effects of perchlorate observed in adult stickleback may result from early changes to the number of PGCs at a time critical for sex determination. To our knowledge, this is the first evidence of a connection between an endocrine disruptor and reduction in PGC number prior to the first meiosis during sex determination. These findings suggest that a mode of action of perchlorate on adult reproductive phenotypes in vertebrates, including humans, such as altered fecundity and sex reversal or intersex gonads, may stem from early changes to germ cell development.	[Petersen, Ann M.; Earp, Nathanial C.; Redmond, Mandy E.; Cresko, William A.] Univ Oregon, Dept Biol, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Postlethwait, John H.] Univ Oregon, Dept Biol, Inst Neurosci, Eugene, OR 97403 USA; [von Hippel, Frank A.; Buck, C. Loren] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86001 USA; [Buck, C. Loren] No Arizona Univ, Ctr Bioengn Innovat, Flagstaff, AZ 86001 USA; [Petersen, Ann M.] Oregon State Univ Cascades, Dept Integrat Biol, Bend, OR 97703 USA	University of Oregon; University of Oregon; Northern Arizona University; Northern Arizona University; Oregon State University; Oregon State University Cascades	Cresko, WA (corresponding author), Univ Oregon, Dept Biol, Inst Ecol & Evolut, Eugene, OR 97403 USA.	wcresko@uoregon.edu	Cresko, William/H-4010-2014	Cresko, William/0000-0002-3496-8074; Buck, Charles Loren/0000-0001-6008-7257	NIH [1RO1ES017039]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085318] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the NIH, grant number 1RO1ES017039. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Poh Kheng Loi for expertise in histology preparations, and Ruth Bremiller, Yi-Lin Yan, and Catherine Wilson for helpful discussion and technical expertise. Funding was provided by NIH grant number 1RO1ES017039. All research protocols were approved by the University of Oregon Animal Care and Use Committee (protocol #10-16R). All authors on this manuscript declare that we have no actual or potential competing financial interests.	Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ben Hamida F, 2001, ANN ENDOCRINOL-PARIS, V62, P446; Bernhardt R, 2008, BEHAVIOUR; Bernhardt RR, 2006, ENVIRON TOXICOL CHEM, V25, P2087, DOI 10.1897/05-454R.1; Bernhardt RR, 2011, ENVIRON TOXICOL CHEM, V30, P1468, DOI 10.1002/etc.521; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Blount BC, 2007, J EXPO SCI ENV EPID, V17, P400, DOI 10.1038/sj.jes.7500535; Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; BORG B, 1993, CAN J ZOOL, V71, P2327, DOI 10.1139/z93-326; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Brent GA, 2010, J CLIN ENDOCR METAB, V95, P3154, DOI 10.1210/jc.2010-0979; Capps T, 2004, J AQUAT ANIM HEALTH, V16, P145, DOI 10.1577/H04-019.1; Carr JA, 2011, GEN COMP ENDOCR, V170, P299, DOI 10.1016/j.ygcen.2010.06.001; Cheng GJ, 2002, BIOL REPROD, V66, P77, DOI 10.1095/biolreprod66.1.77; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Crane HM, 2005, ENVIRON HEALTH PERSP, V113, P396, DOI 10.1289/ehp.7333; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dranow DB, 2013, DEV BIOL, V376, P43, DOI 10.1016/j.ydbio.2013.01.016; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Fenton SE, 2002, TOXICOL SCI, V67, P63, DOI 10.1093/toxsci/67.1.63; Furin CG, 2015, GEN COMP ENDOCR, V219, P24, DOI 10.1016/j.ygcen.2015.04.002; Furin CG, 2015, GEN COMP ENDOCR, V219, P36, DOI 10.1016/j.ygcen.2015.02.016; Gimeno S, 1996, NATURE, V384, P221, DOI 10.1038/384221a0; Goleman WL, 2002, ENVIRON TOXICOL CHEM, V21, P590, DOI 10.1897/1551-5028(2002)021<0590:ERCOAP>2.0.CO;2; Goto R, 2012, DEV BIOL, V370, P98, DOI 10.1016/j.ydbio.2012.07.010; Grandjean P, 2008, NEW ENGL J MED, V359, P1523, DOI 10.1056/NEJMc081629; Griffiths R, 2000, J FISH BIOL, V57, P1331, DOI 10.1111/j.1095-8649.2000.tb00490.x; Hahlbeck E, 2004, AQUAT TOXICOL, V70, P311, DOI 10.1016/j.aquatox.2004.10.004; Hahlbeck E, 2004, AQUAT TOXICOL, V70, P287, DOI 10.1016/j.aquatox.2004.10.003; HAMAGUCHI S, 1982, CELL TISSUE RES, V227, P139; HERPIN A, 2007, BMC DEV BIOL, V7; Herpin A, 2009, MOL CELL ENDOCRINOL, V306, P51, DOI 10.1016/j.mce.2009.02.004; Iguchi T, 2001, HORM BEHAV, V40, P248, DOI 10.1006/hbeh.2001.1675; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kirk AB, 2006, ANAL CHIM ACTA, V567, P4, DOI 10.1016/j.aca.2006.03.047; Kobayashi T, 2004, MOL REPROD DEV, V67, P91, DOI 10.1002/mrd.20003; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lewis ZR, 2008, J MORPHOL, V269, P909, DOI 10.1002/jmor.10608; Lokman PM, 2007, REPRODUCTION, V133, P955, DOI 10.1530/REP-06-0229; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Milnes MR, 2006, ENVIRON RES, V100, P3, DOI 10.1016/j.envres.2005.04.002; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Morrish BC, 2002, REPRODUCTION, V124, P447, DOI 10.1530/rep.0.1240447; Mukhi S, 2007, TOXICOL SCI, V96, P246, DOI 10.1093/toxsci/kfm001; NAKAMURA M, 1985, DEV GROWTH DIFFER, V27, P701; Patino R, 2003, ENVIRON TOXICOL CHEM, V22, P1115, DOI [10.1897/1551-5028(2003)022&lt;1115:EOAPOT&gt;2.0.CO;2, 10.1002/etc.5620220520]; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Petersen AM, 2015, GEN COMP ENDOCR, V210, P130, DOI 10.1016/j.ygcen.2014.10.015; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Schug TT, 2015, ENDOCRINOLOGY, V156, P1941, DOI 10.1210/en.2014-1734; Sharma P, 2013, GEN COMP ENDOCR, V184, P111, DOI 10.1016/j.ygcen.2012.12.018; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Silveira PP, 2007, J PEDIAT, V83, P494, DOI [10.2223/JPED.1728, 10.1590/S0021-75572007000800004]; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Smith PN, 2001, ECOTOXICOLOGY, V10, P305, DOI 10.1023/A:1016715502717; Takeuchi Y, 2002, BIOL REPROD, V67, P1087, DOI 10.1095/biolreprod67.4.1087; Trumpolt CW, 2005, REMEDIATION, V16, P65, DOI 10.1002/rem.20071; Tzung KW, 2015, STEM CELL REP, V5, P156, DOI 10.1016/j.stemcr.2015.07.001; Urbansky ET, 2002, ENVIRON SCI POLLUT R, V9, P187, DOI 10.1007/BF02987487; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Wester PW, 2003, IDENTIFICATION ENDOC; Wilson CA, 2014, GENETICS, V198, P1291, DOI 10.1534/genetics.114.169284; Woodling JD, 2006, COMP BIOCHEM PHYS C, V144, P10, DOI 10.1016/j.cbpc.2006.04.019	75	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157792	10.1371/journal.pone.0157792	http://dx.doi.org/10.1371/journal.pone.0157792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383240	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400026
J	Wakura, D; Kotani, T; Takeuchi, T; Komori, T; Yoshida, S; Makino, S; Hanafusa, T				Wakura, Daisuke; Kotani, Takuya; Takeuchi, Tohru; Komori, Tsuyoshi; Yoshida, Shuzo; Makino, Shigeki; Hanafusa, Toshiaki			Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?	PLOS ONE			English	Article							CRITERIA; CLASSIFICATION; SYNOVITIS	Background It is difficult to differentiate polymyalgia rheumatica (PMR) from elderly-onset rheumatoid arthritis (EORA) in clinical practice. We compared FDG-PET/CT findings between patients with PMR and those with EORA and extracted factors useful for differentiating the two disorders. Methods We compared abnormal FDG accumulation sites and maximum standardized uptake value (SUVmax) between 15 patients with PMR and 7 with EORA in whom FDG-PET/CT was performed. Results The proportion of patients in the PMR group with abnormal FDG accumulation at the following 9 sites on FDG-PET/CT was significantly higher than that in the EORA group: periarticular region of the scapulohumeral joint, enthesis of the pectineus muscle, vicinity of the enthesis of the rectus femoris muscle, lateral side of the greater trochanter, ischial tuberosity, hip joint, spinous process of the lower cervical vertebra, intervertebral joint of the lumbar vertebra, and spinous process of the lumbar vertebra. The PET/CT score was evaluated at 9 sites consisting of the abovementioned sites. The median score in the PMR group was 8, which was significantly higher than that of 0 in the EORA group (P = 0.0003). ROC curve analysis was performed with the PET/CT scores, and a score of 5 was shown to maximize the area under the ROC curve (sensitivity: 86.7%, specificity: 86.7%). Conclusions FDG-PET/CT is useful for differentiating PMR from EORA. In patients with PMR, abnormal FDG accumulation was observed at the entheses, suggesting the presence of enthesitis in addition to bursitis and synovitis.	[Wakura, Daisuke; Kotani, Takuya; Takeuchi, Tohru; Yoshida, Shuzo; Makino, Shigeki; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan; [Komori, Tsuyoshi] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka, Japan	Osaka Medical College; Osaka Medical College	Kotani, T (corresponding author), Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan.	in1242@poh.osaka-med.ac.jp						Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BIRD HA, 1979, ANN RHEUM DIS, V38, P434, DOI 10.1136/ard.38.5.434; Blockmans D, 2007, RHEUMATOLOGY, V46, P672, DOI 10.1093/rheumatology/kel376; Blockmans D, 1999, RHEUMATOLOGY, V38, P444, DOI 10.1093/rheumatology/38.5.444; Camellino D, 2012, RHEUMATOLOGY, V51, P77, DOI 10.1093/rheumatology/keq450; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Hochberg M.C., 2011, RHEUMATOLOGY; INOUE K, 1987, ANN RHEUM DIS, V46, P908, DOI 10.1136/ard.46.12.908; KOSKI JM, 1992, BRIT J RHEUMATOL, V31, P201; Mavragani CP, 1999, EXP GERONTOL, V34, P463, DOI 10.1016/S0531-5565(98)00072-2; Mori Shunsuke, 2007, Mod Rheumatol, V17, P369, DOI 10.1007/s10165-007-0595-6; Takahashi H, 2015, MOD RHEUMATOL, V25, P546, DOI 10.3109/14397595.2014.978936; Taniguchi Y, 2011, CLIN NUCL MED, V36, P121, DOI 10.1097/RLU.0b013e318203bb97; Turkcapar N, 2006, ARCH GERONTOL GERIAT, V42, P225, DOI 10.1016/j.archger.2005.07.003; Yamashita H, 2013, JOINT BONE SPINE, V80, P171, DOI 10.1016/j.jbspin.2012.04.006	16	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158509	10.1371/journal.pone.0158509	http://dx.doi.org/10.1371/journal.pone.0158509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384410	Green Submitted, gold, Green Published			2022-12-27	WOS:000379809400055
J	Kim, S; Park, J; Na, J; Jung, GY; Hwang, J				Kim, Sobin; Park, Jungyun; Na, Jeongkyeong; Jung, Gyoo Yeol; Hwang, Jungwook			Simultaneous Determination of Multiple microRNA Levels Utilizing Biotinylated Dideoxynucleotides and Mass Spectrometry	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DISEASE; PCR; MS	MicroRNAs (miRNAs) are important regulators of gene translation and have been suggested as potent biomarkers in various disease states. In this study, we established an efficient method for simultaneous determination of multiple miRNA levels, employing the previously developed SPC-SBE (solid phase capture-single base extension) approach and MALDI-TOF mass spectrometry (MS). In this approach, we first perform reverse transcription of miRNAs extracted using stem-loop primers. Then the cDNA is co-amplified with competitors, synthetic oligonucleotides whose sequences precisely match cDNA except for one base, and the amplicons serve as templates for a multiplexed SBE reaction. Extension products are isolated using SPC and quantitatively analyzed with MALDI-TOF MS to determine multiple miRNA levels. Here we demonstrated concurrent analysis of four miRNA levels utilizing the approach. Furthermore, we showed the presented method significantly facilitated MS analysis of peak area ratio owing to SPC. The SPC process allowed effective removal of irrelevant reaction components prior to MS and promoted MS sample purification. Data obtained in this study was verified with RT-qPCR and agreement was shown on one order of magnitude scale, suggesting the SPC-SBE and MS approach has strong potential as a viable tool for high throughput miRNA analysis.	[Kim, Sobin; Park, Jungyun; Hwang, Jungwook] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea; [Hwang, Jungwook] Hanyang Univ, Coll Med, Dept Med Genet, Seoul, South Korea; [Na, Jeongkyeong; Jung, Gyoo Yeol] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeongbuk, South Korea; [Jung, Gyoo Yeol] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang, Gyeongbuk, South Korea	Hanyang University; Hanyang University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, S; Hwang, J (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea.; Hwang, J (corresponding author), Hanyang Univ, Coll Med, Dept Med Genet, Seoul, South Korea.	kimsobin@gmail.com; jwhwang@hanyang.ac.kr	Jung, Gyoo Yeol/R-7194-2019; Hwang, Jungwook/P-1614-2015	Hwang, Jungwook/0000-0002-2290-1649	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01058878]; Medical Research Center - National Research Foundation of the Korea (NRF) of the Ministry of Science, ICT and Future Planning, Republic of Korea [2008-0062287]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education; Medical Research Center - National Research Foundation of the Korea (NRF) of the Ministry of Science, ICT and Future Planning, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01058878 to J.H.) and by a grant from the Medical Research Center (2008-0062287 to J.H.) funded by the National Research Foundation of the Korea (NRF) of the Ministry of Science, ICT and Future Planning, Republic of Korea.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; de Planell-Saguer M, 2013, CLIN BIOCHEM, V46, P869, DOI 10.1016/j.clinbiochem.2013.02.017; Ding CM, 2003, P NATL ACAD SCI USA, V100, P3059, DOI 10.1073/pnas.0630494100; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Duffield DS, 2010, RNA, V16, P1285, DOI 10.1261/rna.1859810; Duncan Mark W., 2008, Briefings in Functional Genomics & Proteomics, V7, P355, DOI 10.1093/bfgp/eln041; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kim S, 2003, NAT REV GENET, V4, P1001, DOI 10.1038/nrg1230; Kim S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf084; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Meyer K, 2004, CLIN CHEM, V50, P391, DOI 10.1373/clinchem.2003.026799; Misra A, 2007, CLIN CHEM, V53, P933, DOI 10.1373/clinchem.2006.080739; Omahen DA, 2011, NEUROSURGERY, V69, P440, DOI 10.1227/NEU.0b013e318215a3b3; Pager CT, 2009, PROG MOL BIOL TRANSL, V90, P187, DOI 10.1016/S1877-1173(09)90005-9; Sauer S, 2006, CLIN CHIM ACTA, V363, P95, DOI 10.1016/j.cccn.2005.05.040; Szajli E, 2008, MOL CELL PROTEOMICS, V7, P2410, DOI 10.1074/mcp.M800108-MCP200; Tian T, 2015, ORG BIOMOL CHEM, V13, P2226, DOI 10.1039/c4ob02104e; Waldman SA, 2008, CLIN CHEM, V54, P943, DOI 10.1373/clinchem.2008.105353; Wang Gang, 2013, Methods Mol Biol, V1024, P211, DOI 10.1007/978-1-62703-453-1_17; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341	24	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0153201	10.1371/journal.pone.0153201	http://dx.doi.org/10.1371/journal.pone.0153201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380276	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700002
J	Rose, SMSF; Eslinger, JG; Zimmerman, L; Scaccia, J; Lai, BS; Lewis, C; Alisic, E				Rose, Sophia Miryam Schussler-Fiorenza; Eslinger, Jessica G.; Zimmerman, Lindsey; Scaccia, Jamie; Lai, Betty S.; Lewis, Catrin; Alisic, Eva			Adverse Childhood Experiences, Support, and the Perception of Ability to Work in Adults with Disability	PLOS ONE			English	Article							RETROSPECTIVE REPORTS; MENTAL-DISORDERS; SOCIAL-RELATIONS; ABUSE; HEALTH; VICTIMIZATION; MALTREATMENT; EMPLOYMENT; IMPACT; PSYCHOPATHOLOGY	Objective To examine the impact of adverse childhood experiences (ACEs) and support on self-reported work inability of adults reporting disability. Participants Adults (ages 18-64) who participated in the Behavioral Risk Factor Surveillance System in 2009 or 2010 and who reported having a disability (n = 13,009). Design and Main Outcome Measures The study used a retrospective cohort design with work inability as the main outcome. ACE categories included abuse (sexual, physical, emotional) and family dysfunction (domestic violence, incarceration, mental illness, substance abuse, divorce). Support included functional (perceived emotional/social support) and structural (living with another adult) support. Logistic regression was used to adjust for potential confounders (age, sex and race) and to evaluate whether there was an independent effect of ACEs on work inability after adding other important predictors (support, education, health) to the model. Results ACEs were highly prevalent with almost 75% of the sample reporting at least one ACE category and over 25% having a high ACE burden (4 or more categories). ACEs were strongly associated with functional support. Participants experiencing a high ACE burden had a higher adjusted odds ratio (OR) [95% confidence interval] of 1.9 [1.5-2.4] of work inability (reference: zero ACEs). Good functional support (adjusted OR 0.52 [0.42-0.63]) and structural support (adjusted OR 0.48 [0.41-0.56]) were protective against work inability. After adding education and health to the model, ACEs no longer appeared to have an independent effect. Structural support remained highly protective, but functional support only appeared to be protective in those with good physical health. Conclusions ACEs are highly prevalent in working-age US adults with a disability, particularly young adults. ACEs are associated with decreased support, lower educational attainment and worse adult health. Health care providers are encouraged to screen for ACEs. Addressing the effects of ACEs on health and support, in addition to education and retraining, may increase ability to work in those with a disability.	[Rose, Sophia Miryam Schussler-Fiorenza] Vet Affairs Palo Alto Hlth Care Syst, Spinal Cord Injury Serv, Palo Alto, CA 94304 USA; [Rose, Sophia Miryam Schussler-Fiorenza] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Eslinger, Jessica G.] Univ Kentucky, Coll Med, Dept Psychiat, Ctr Trauma & Children, Lexington, KY USA; [Zimmerman, Lindsey] Vet Affairs Palo Alto Hlth Care Syst, Natl Ctr Posttraumat Stress Disorders, Disseminat & Training Div, Menlo Pk, CA USA; [Zimmerman, Lindsey] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Scaccia, Jamie] Adler Sch Profess Psychol, Chicago, IL USA; [Lai, Betty S.] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA; [Lewis, Catrin] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Natl Ctr Mental Hlth, Cardiff, S Glam, Wales; [Alisic, Eva] Monash Univ, Accid Res Ctr, Melbourne, Vic, Australia; [Alisic, Eva] Univ Childrens Hosp Zurich, Dept Psychosomat & Psychiat, Zurich, Switzerland	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Washington; University of Washington Seattle; University System of Georgia; Georgia State University; Cardiff University; Monash University; University Children's Hospital Zurich	Rose, SMSF (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Spinal Cord Injury Serv, Palo Alto, CA 94304 USA.; Rose, SMSF (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.	cms@alumni.med.upenn.edu	Schussler-Fiorenza Rose, Sophia Miryam/E-6411-2013	Schussler-Fiorenza Rose, Sophia Miryam/0000-0002-6311-6671; Alisic, Eva/0000-0002-7225-606X	Department of Veteran Affairs Office of Academic Affiliations Advanced Fellowship Program in Spinal Cord Injury Medicine (SMS-FR); Ruth L. Kirschstein National Research Service Award Institutional Research Training grant [T32AA00745530]	Department of Veteran Affairs Office of Academic Affiliations Advanced Fellowship Program in Spinal Cord Injury Medicine (SMS-FR); Ruth L. Kirschstein National Research Service Award Institutional Research Training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the Department of Veteran Affairs Office of Academic Affiliations Advanced Fellowship Program in Spinal Cord Injury Medicine (SMS-FR) http://www.va.gov/oaa/specialfellows/programs/SF_SCIMinfo.asp?p=16 and the Ruth L. Kirschstein National Research Service Award Institutional Research Training grant T32AA00745530 (LZ) http://grants.nih.gov/grants/guide/pa-files/PA-14-015.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraido-Lanza AF, 2006, ARTHRIT RHEUM-ARTHR, V55, P442, DOI 10.1002/art.21981; Allwood MA, 2013, J RES CRIME DELINQ, V50, P551, DOI 10.1177/0022427812471177; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anda RF, 2008, AM J PREV MED, V34, P396, DOI 10.1016/j.amepre.2008.02.002; Anda Robert F, 2004, Perm J, V8, P30; Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; [Anonymous], 2009, BEH RISK FACT SURV S; Avlund K, 2004, J GERONTOL B-PSYCHOL, V59, pS44, DOI 10.1093/geronb/59.1.S44; Barnow BS, 2008, MON LABOR REV, P131; Brault M., 2012, AM DISABILITY 2010; Brouwer S, 2010, J OCCUP REHABIL, V20, P104, DOI 10.1007/s10926-009-9214-z; Carroll DD, 2014, MMWR-MORBID MORTAL W, V63, P407; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2014, OV BRFSS 2009; Clarke P, 2014, DISABIL HEALTH J, V7, pS15, DOI 10.1016/j.dhjo.2013.08.008; Colman RA, 2004, CHILD ABUSE NEGLECT, V28, P1133, DOI 10.1016/j.chiabu.2004.02.005; Cornelius LR, 2011, J OCCUP REHABIL, V21, P259, DOI 10.1007/s10926-010-9261-5; Currie J, 2010, CHILD MALTREATMENT, V15, P111, DOI 10.1177/1077559509355316; Druss BG, 2009, MOL PSYCHIATR, V14, P728, DOI 10.1038/mp.2008.13; Dube SR, 2004, CHILD ABUSE NEGLECT, V28, P729, DOI 10.1016/j.chiabu.2003.08.009; Eaker ED, 2007, PSYCHOSOM MED, V69, P509, DOI 10.1097/PSY.0b013e3180f62357; Erickson WA, 2009, GUIDE DISABILITY STA; Felitti Vincent J, 2010, Perm J, V14, P24; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fergusson DM, 2000, PSYCHOL MED, V30, P529, DOI 10.1017/S0033291799002111; Ford ES, 2011, PREV MED, V53, P188, DOI 10.1016/j.ypmed.2011.06.015; Ford E, 2011, J AFFECT DISORDERS, V133, P320, DOI 10.1016/j.jad.2011.03.017; Garner AS, 2012, PEDIATRICS, V129, pE224, DOI 10.1542/peds.2011-2662; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Hadi F, 2014, ANXIETY STRESS COPIN, V27, P156, DOI 10.1080/10615806.2013.832219; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Harkonmaki K, 2007, J EPIDEMIOL COMMUN H, V61, P479, DOI 10.1136/jech.2006.052670; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; Lund T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075860; McLaughlin KA, 2010, PSYCHOL MED, V40, P847, DOI 10.1017/S0033291709991115; Mersky JP, 2010, CHILD YOUTH SERV REV, V32, P1086, DOI 10.1016/j.childyouth.2009.10.018; Moak ZB, 2010, J PUBLIC HEALTH-UK, V32, P191, DOI 10.1093/pubmed/fdp093; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Nemeroff CB, 2003, P NATL ACAD SCI USA, V100, P14293, DOI 10.1073/pnas.2336126100; Nikulina V, 2013, NEUROPSYCHOLOGY, V27, P417, DOI 10.1037/a0032811; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Okoro C, 2007, OCCUP MED-OXFORD, V57, P217, DOI 10.1093/occmed/kql177; Ottomanelli L, 2014, ARCH PHYS MED REHAB, V95, P784, DOI 10.1016/j.apmr.2013.11.012; Rose SMSF, 2014, PM&R, V6, P670, DOI 10.1016/j.pmrj.2014.01.013; Sachs-Ericsson N, 2011, PSYCHOL VIOLENCE, V1, P106, DOI 10.1037/a0023139; Sansone RA, 2005, INT J PSYCHIAT MED, V35, P395, DOI 10.2190/3XUR-1PWJ-0DT3-BJFJ; Schussler-Fiorenza Rose SM, 2013, POPULATION HLTH MATT, V26; Smith DL, 2008, DISABIL REHABIL, V30, P1039, DOI 10.1080/09637480701539542; Smith DL, 2008, SEX DISABIL, V26, P15, DOI 10.1007/s11195-007-9064-6; Szklo M, 2003, EPIDEMIOLOGY BASICS; Tam TW, 2003, AM J DRUG ALCOHOL AB, V29, P829, DOI 10.1081/ADA-120026263; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wacholder S, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq510; Weinberg CR, 2012, AM J EPIDEMIOL, V175, P602, DOI 10.1093/aje/kwr495; Widom CS, 2008, CHILD ABUSE NEGLECT, V32, P785, DOI 10.1016/j.chiabu.2007.12.006; Widom CS, 2006, PSYCHOL ADDICT BEHAV, V20, P394, DOI 10.1037/0893-164X.20.4.394; Widom CS, 1997, PSYCHOL ASSESSMENT, V9, P34, DOI 10.1037/1040-3590.9.1.34; Widom CS, 1996, PSYCHOL ASSESSMENT, V8, P412, DOI 10.1037/1040-3590.8.4.412; World Health Organization, 2014, COMM LANG FUNCT DIS; World Health Organization, 2001, INT CLASS FUNCT DIS	65	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157726	10.1371/journal.pone.0157726	http://dx.doi.org/10.1371/journal.pone.0157726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27379796	Green Published, Green Accepted, gold			2022-12-27	WOS:000379798700008
J	de Souza, EN; Boerder, K; Matwin, S; Worm, B				de Souza, Erico N.; Boerder, Kristina; Matwin, Stan; Worm, Boris			Improving Fishing Pattern Detection from Satellite AIS Using Data Mining and Machine Learning	PLOS ONE			English	Article							MONITORING SYSTEMS VMS; SPATIAL-DISTRIBUTION; PURSE-SEINERS; HUMAN IMPACT; VESSEL; IDENTIFICATION; TRAJECTORIES; MODEL; SCALE; CATCH	A key challenge in contemporary ecology and conservation is the accurate tracking of the spatial distribution of various human impacts, such as fishing. While coastal fisheries in national waters are closely monitored in some countries, existing maps of fishing effort elsewhere are fraught with uncertainty, especially in remote areas and the High Seas. Better understanding of the behavior of the global fishing fleets is required in order to prioritize and enforce fisheries management and conservation measures worldwide. Satellite-based Automatic Information Systems (S-AIS) are now commonly installed on most ocean-going vessels and have been proposed as a novel tool to explore the movements of fishing fleets in near real time. Here we present approaches to identify fishing activity from S-AIS data for three dominant fishing gear types: trawl, longline and purse seine. Using a large dataset containing worldwide fishing vessel tracks from 2011-2015, we developed three methods to detect and map fishing activities: for trawlers we produced a Hidden Markov Model (HMM) using vessel speed as observation variable. For longliners we have designed a Data Mining (DM) approach using an algorithm inspired from studies on animal movement. For purse seiners a multi-layered filtering strategy based on vessel speed and operation time was implemented. Validation against expert-labeled datasets showed average detection accuracies of 83% for trawler and longliner, and 97% for purse seiner. Our study represents the first comprehensive approach to detect and identify potential fishing behavior for three major gear types operating on a global scale. We hope that this work will enable new efforts to assess the spatial and temporal distribution of global fishing effort and make global fisheries activities transparent to ocean scientists, managers and the public.	[de Souza, Erico N.; Matwin, Stan] Dalhousie Univ, Fac Comp Sci, Big Data Analyt Inst, Halifax, NS, Canada; [Boerder, Kristina; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Matwin, Stan] Polish Acad Sci, Inst Comp Sci, Warsaw, Poland	Dalhousie University; Dalhousie University; Polish Academy of Sciences; Institute of Computer Science of the Polish Academy of Sciences	de Souza, EN (corresponding author), Dalhousie Univ, Fac Comp Sci, Big Data Analyt Inst, Halifax, NS, Canada.; Boerder, K (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	erico.souza@dal.ca; kristina.boerder@dal.ca			NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); National Science and Engineering Council of Canada	NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST); National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was partly funded by the NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST) and the National Science and Engineering Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly funded by the NSERC CREATE Transatlantic Ocean System Science and Technology (TOSST) and the National Science and Engineering Council of Canada. We are grateful for AIS data access and technical support from Exact Earth and MEOPAR and the help of Ron Pelot and Casey Hilliard, as well as a a number of fishermen, fisheries experts and fisheries observers who provided labeling information. We further thank Paul Woods, David Kroodsma, Derek Tittensor and Douglas McCauley for helpful discussion.	Alemany D, 2013, ICES J MAR SCI, V70, P123, DOI 10.1093/icesjms/fss166; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Bez N, 2011, CAN J FISH AQUAT SCI, V68, P1998, DOI 10.1139/F2011-114; Cairns WR, 2005, J NAVIGATION, V58, P181, DOI 10.1017/S0373463305003267; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carson-Jackson J, 2012, J NAVIGATION, V65, P303, DOI 10.1017/S037346331100066X; Cervera MA, 2011, INT J SATELL COMM N, V29, P117, DOI 10.1002/sat.957; Cervera MA, 2008, 2008 10TH INTERNATIONAL WORKSHOP ON SIGNAL PROCESSING FOR SPACE COMMUNICATIONS, P135; Chang SK, 2014, CAN J FISH AQUAT SCI, V71, P1363, DOI 10.1139/cjfas-2013-0552; Charles C, 2014, CAN J FISH AQUAT SCI, V71, P1817, DOI 10.1139/cjfas-2013-0572; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Gerritsen H, 2011, ICES J MAR SCI, V68, P245, DOI 10.1093/icesjms/fsq137; Ghahramani Z, 2001, INT J PATTERN RECOGN, V15, P9, DOI 10.1142/S0218001401000836; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; JOHNSON AR, 1992, ECOLOGY, V73, P1968, DOI 10.2307/1941448; Lavielle M, 1999, STOCH PROC APPL, V83, P79, DOI 10.1016/S0304-4149(99)00023-X; Lavielle M, 2005, SIGNAL PROCESS, V85, P1501, DOI 10.1016/j.sigpro.2005.01.012; LEE J, 2010, J CONSEIL, V67, P1260, DOI DOI 10.1093/ICESJMS/FSQ010; Lehner S., 2009, P OCEANS 2009 EUROPE, P1, DOI [10.1109/OCEANSE.2009.5278254, DOI 10.1109/OCEANSE.2009.5278254]; Liu B, 2015, 2015 18TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P1113; Liu B, 2014, IEEE INT CONF BIG DA, P603, DOI 10.1109/BigData.2014.7004281; Mazzarella F, 2014, 2014 17TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION); McCauley DJ, 2016, SCIENCE, V351, P1148, DOI 10.1126/science.aad5686; Natale F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130746; Pallotta G, 2013, ENTROPY-SWITZ, V15, P2218, DOI 10.3390/e15062218; Peel D, 2011, CAN J FISH AQUAT SCI, V68, P1252, DOI 10.1139/F2011-055; Lamigueiro OP, 2012, J STAT SOFTW, V50, P1; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Skaar KL, 2011, ICES J MAR SCI, V68, P1615, DOI 10.1093/icesjms/fsr091; Soleimani BH, 2015, 2015 18TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P1100; Torgo L., 2010, DATA MINING R LEARNI; Trebilco R, 2011, BIOL CONSERV, V144, P1758, DOI 10.1016/j.biocon.2011.02.024; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Vermard Y, 2010, ECOL MODEL, V221, P1757, DOI 10.1016/j.ecolmodel.2010.04.005; Walker E, 2010, ECOL MODEL, V221, P2008, DOI 10.1016/j.ecolmodel.2010.05.007; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	38	83	85	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158248	10.1371/journal.pone.0158248	http://dx.doi.org/10.1371/journal.pone.0158248			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367425	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900026
J	Ayllnon, D; Gil-Pita, R; Seoane, F				Ayllnon, David; Gil-Pita, Roberto; Seoane, Fernando			Detection and Classification of Measurement Errors in Bioimpedance Spectroscopy	PLOS ONE			English	Article							ELECTRICAL-IMPEDANCE TOMOGRAPHY; ELECTRODE MISMATCH; BODY; SELECTION	Bioimpedance spectroscopy (BIS) measurement errors may be caused by parasitic stray capacitance, impedance mismatch, cross-talking or their very likely combination. An accurate detection and identification is of extreme importance for further analysis because in some cases and for some applications, certain measurement artifacts can be corrected, minimized or even avoided. In this paper we present a robust method to detect the presence of measurement artifacts and identify what kind of measurement error is present in BIS measurements. The method is based on supervised machine learning and uses a novel set of generalist features for measurement characterization in different immittance planes. Experimental validation has been carried out using a database of complex spectra BIS measurements obtained from different BIS applications and containing six different types of errors, as well as error-free measurements. The method obtained a low classification error (0.33%) and has shown good generalization. Since both the features and the classification schema are relatively simple, the implementation of this pre-processing task in the current hardware of bioimpedance spectrometers is possible.	[Ayllnon, David] Fonetic, R&D Dept, Madrid 28037, Spain; [Ayllnon, David; Gil-Pita, Roberto] Univ Alcala De Henares, Signal Theory & Commun Dept, Alcala De Henares, Spain; [Seoane, Fernando] Univ Boras, Fac Care Sci Work Life & Social Welf, Boras, Sweden; [Seoane, Fernando] Royal Inst Technol, Sch Technol & Hlth, Huddinge, Sweden	Universidad de Alcala; University of Boras; Royal Institute of Technology	Ayllnon, D (corresponding author), Fonetic, R&D Dept, Madrid 28037, Spain.; Ayllnon, D (corresponding author), Univ Alcala De Henares, Signal Theory & Commun Dept, Alcala De Henares, Spain.	david.ayllon@uah.es	Seoane, Fernando/L-3113-2015; Gil-Pita, Roberto/N-3748-2014	Seoane, Fernando/0000-0002-6995-967X; Gil-Pita, Roberto/0000-0002-1790-3834				Al-Hatib F, 1998, PHYSIOL MEAS, V19, P285, DOI 10.1088/0967-3334/19/2/015; Aristovich KY, 2016, NEUROIMAGE, V124, P204, DOI 10.1016/j.neuroimage.2015.08.071; Atefi SR, 2012, IEEE ENG MED BIO, P3368, DOI 10.1109/EMBC.2012.6346687; Avila ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126268; Ayllon D, 2014, ENG APPL ARTIF INTEL, V34, P37, DOI 10.1016/j.engappai.2014.05.006; Ayllon D, 2009, IEEE ENG MED BIO, P3779, DOI 10.1109/IEMBS.2009.5334494; Bogonez-Franco P, 2009, PHYSIOL MEAS, V30, P573, DOI 10.1088/0967-3334/30/7/004; Bolton MP, 1998, PHYSIOL MEAS, V19, P235, DOI 10.1088/0967-3334/19/2/011; Brusco MJ, 2014, COMPUT STAT DATA AN, V77, P38, DOI 10.1016/j.csda.2014.03.001; Buendia R, 2014, PHYSIOL MEAS, V35, P1373, DOI 10.1088/0967-3334/35/7/1373; Buendia R, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/11/115802; Buendia R, 2013, THESIS; Buendia R., 2011, J ELECT BIOIMPEDANCE, V2, P72, DOI DOI 10.5617/JEB.197; Buendia R, 2012, MED ENG PHYS, V34, P1024, DOI 10.1016/j.medengphy.2012.05.011; Cole KS., 1940, QUANT BIOL, V8, P110, DOI [10.1101/SQB.1940.008.01.013, DOI 10.1101/SQB.1940.008.01.013]; Davies SJ, 2014, KIDNEY INT, V86, P489, DOI 10.1038/ki.2014.207; Duda R.O., 2006, PATTERN CLASSIFICATI; Ernstbrunner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111139; Grimnes S, 2011, BIOIMPEDANCE BIOELEC, P283; Haupt R.L., 2004, PRACTICAL GENETIC AL, VSecond, DOI DOI 10.1002/0471671746; Leonhardt S, 2012, INTENS CARE MED, V38, P1917, DOI 10.1007/s00134-012-2684-z; Liu H., 2012, FEATURE SELECTION KN; Mosteller F., 1968, HDB SOCIAL PSYCHOL; Paterno AS, 2012, WORLD C MED PHYS BIO, P957; Piccoli A, 1998, INT J OBESITY, V22, P97, DOI 10.1038/sj.ijo.0800551; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; Scharfetter H, 1998, PHYSIOL MEAS, V19, P247, DOI 10.1088/0967-3334/19/2/012; Seoane F, 2015, BIOMED RES IN PRESS; Seoane F, 2010, IEEE ENG MED BIO, P3495, DOI 10.1109/IEMBS.2010.5627790; Tan CJ, 2014, NEUROCOMPUTING, V125, P217, DOI 10.1016/j.neucom.2012.12.057; Tronstad S, 2014, J ELEC BIOIMP, V5, P14, DOI [10.5617/jeb.830, DOI 10.5617/JEB.830]; Ye J., 2007, C P 24 INT C MACH LE, P1087; Zhang YD, 2014, KNOWL-BASED SYST, V64, P22, DOI 10.1016/j.knosys.2014.03.015	33	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0156522	10.1371/journal.pone.0156522	http://dx.doi.org/10.1371/journal.pone.0156522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362862	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200002
J	Buijs, RVC; Zeebregts, CJ; Willems, TP; Vainas, T; Tielliu, IFJ				Buijs, Ruben V. C.; Zeebregts, Clark J.; Willems, Tineke P.; Vainas, Tryfon; Tielliu, Ignace F. J.			Endograft Sizing for Endovascular Aortic Repair and Incidence of Endoleak Type 1A	PLOS ONE			English	Article							ANEURYSM REPAIR; NECK ANGULATION; VALVE-REPLACEMENT; MANAGEMENT; EUROSTAR; ANATOMY; HOSTILE	Objective In endovascular aortic aneurysm repair (EVAR), proximal type 1A endoleaks can occur as a result of hostile neck anatomy or over- or undersizing of the endograft. As the current standard is based on the diameter or average of the short and long axes in a central lumen reconstruction image, it can falter in irregularly shaped aortic necks. An alternative method is circumference-based, therefore minimizing the measurement error. In this study we aimed to assess the degree of discrepancy between both methods and the association of this discrepancy with the occurrence of endoleak type 1A. Methods All patients with early (< 30 days post-operative) endoleak type 1A after elective EVAR at our center between 2004 and 2016 were identified for a retrospective case-control study. Control patients were matched based on hostile neck anatomy, such as calcification, thrombus, reverse taper, and beta-angulation. The aortic neck diameter was measured using the traditional, diameter-based method as well as an alternative method, based on the circumference of the aortic neck. Results In 482 EVAR patients, 18 early endoleak type 1A cases were found (3.9%). After exclusion, 12 cases remained and 48 matching controls were found. No significant differences were found between the two measuring methods at any level below the renal arteries. The interobserver variability was significant for the D(mean) (0.4 +/- 1.69 mm, P = .02) and was larger than the D(circ) method (-0.1 +/- 1.03 mm, P = .35). In only four out of 12 cases the endograft size was 10-20% larger than the D(mean) and D(circ) measurements. The differences between the diameter of the D(mean) and D(circ) and the chosen endograft were smaller for the case group (-8 +/- 25.6% and -7 +/- 24%) than for the control group. (-12.4 +/- 12.4% and -11 +/- 10.7%). Conclusion The difference between the D(mean) and D(circ) methods for aortic neck measurement was not large enough to play a significant role in the incidence of endoleak type 1A. Inadequate oversizing and considerable beta-angulation of the aortic neck may have been the cause of endoleak type 1A in this population. Robust and well-investigated sizing methods are paramount for accurate endograft sizing and prevention of endoleak type 1A. Therefore the lack of studies in this field and a sizeable inter-observer variability do not justify the widespread reliance on the traditional diameter-based methods for endograft sizing.	[Buijs, Ruben V. C.; Zeebregts, Clark J.; Vainas, Tryfon; Tielliu, Ignace F. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Vasc Surg, Groningen, Netherlands; [Willems, Tineke P.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen	Tielliu, IFJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Vasc Surg, Groningen, Netherlands.	i.f.j.tielliu@umcg.nl						AbuRahma AF, 2011, J VASC SURG, V54, P13, DOI 10.1016/j.jvs.2010.12.010; AbuRahma AF, 2009, J VASC SURG, V50, P738, DOI 10.1016/j.jvs.2009.04.061; [Anonymous], ZEN FLEX PLANN SIZ; [Anonymous], AN AAA STENT GRAFT S; Baas AF, 2008, J VASC SURG, V47, P277, DOI 10.1016/j.jvs.2007.10.018; Dillavou ED, 2003, J VASC SURG, V38, P657, DOI 10.1016/S0741-5214(03)00738-9; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Franks SC, 2007, EUR J VASC ENDOVASC, V33, P154, DOI 10.1016/j.ejvs.2006.10.017; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Hobo R, 2007, J ENDOVASC THER, V14, P1, DOI 10.1583/06-1914.1; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Kaladji A, 2010, ANN VASC SURG, V24, P912, DOI 10.1016/j.avsg.2010.03.018; Koole D, 2013, J VASC SURG, V57, P77, DOI 10.1016/j.jvs.2012.07.003; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; Schultz CJ, 2010, EUR HEART J, V31, P849, DOI 10.1093/eurheartj/ehp534; Sternbergh WC, 2002, J VASC SURG, V35, P482, DOI 10.1067/mva.2002.119506; Tielliu IFJ, 2015, MED HYPOTHESES, V85, P230, DOI 10.1016/j.mehy.2015.05.004; van Keulen JW, 2010, EUR J VASC ENDOVASC, V40, P326, DOI 10.1016/j.ejvs.2010.05.009; van Keulen JW, 2010, J VASC SURG, V51, P821, DOI 10.1016/j.jvs.2009.10.114; van Marrewijk C, 2002, J VASC SURG, V35, P461, DOI 10.1067/mva.2002.118823; Van Prehn J, 2009, EUR J VASC ENDOVASC, V38, P42, DOI 10.1016/j.ejvs.2009.03.025; Veith FJ, 2002, J VASC SURG, V35, P1029, DOI 10.1067/mva.2002.123095; White GH, 1997, J ENDOVASC SURG, V4, P152, DOI 10.1583/1074-6218(1997)004<0152:EAACOE>2.0.CO;2	24	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158042	10.1371/journal.pone.0158042	http://dx.doi.org/10.1371/journal.pone.0158042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359115	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200036
J	Cason, AM; Kohtz, A; Aston-Jones, G				Cason, Angie M.; Kohtz, Amy; Aston-Jones, Gary			Role of Corticotropin Releasing Factor 1 Signaling in Cocaine Seeking during Early Extinction in Female and Male Rats	PLOS ONE			English	Article							STRESS-INDUCED REINSTATEMENT; INDUCED RELAPSE; DRUG-SEEKING; PREFRONTAL CORTEX; STRIA TERMINALIS; HEROIN-SEEKING; BED NUCLEUS; OXYTOCIN; BEHAVIOR; AMYGDALA	Locus coeruleus norepinephrine (LC-NE) and corticotropin releasing factor (CRF) neurons are involved in stress responses, including stress's ability to drive drug relapse. Previous animal studies indicate that female rats exhibit greater drug seeking than male rats during initial drug abstinence. Moreover, females are more sensitive to the effect of stress to drive drug seeking than males. Finally, LC-NE neurons are more sensitive to CRF in females compared to males. We hypothesized that increased drug seeking in females on extinction day one (ED1) is due to increased response to the stress of early withdrawal and is dependent upon the increased response of LC in females to CRF. We predicted that LC-NE neurons would exhibit Fos activation on ED1, and that blocking CRF1 signaling would decrease drug seeking on ED1 measured by responding on an active lever previously associated with cocaine self-administration. After chronic cocaine self-administration, female and male rats underwent a test for initial extinction responding by measuring lever pressing in the absence of cocaine. Prior to this Extinction Day 1 (ED1) session, rats were injected with vehicle or the selective CRF1 antagonist (CP) to measure effects of CRF antagonism on drug seeking during early abstinence. ED1 increased corticosterone in female rats, in proportion to lever responding in male and female, indicating that ED1 was stressful. Pretreatment with CP decreased cocaine seeking on ED1 more effectively in female compared to male rats. This increase in responding was associated with an increase in activation of LC NE neurons. Together, these findings indicate that stress, and signaling at CRF receptors in LC, may be involved in the increased drug seeking during initial abstinence.	[Cason, Angie M.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Kohtz, Amy; Aston-Jones, Gary] Rutgers State Univ, Rutgers Biomed & Hlth Sci, Brain Hlth Inst, Piscataway, NJ USA	Medical University of South Carolina; Rutgers State University New Brunswick; Rutgers State University Medical Center	Cason, AM (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	casona@musc.edu		Kohtz, Amy/0000-0002-7625-6534	National Institute on Drug Abuse [P50DA 016511]; PHS grant [P50 DA 016511]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA016511] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); PHS grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute on Drug Abuse grant, PHS grant P50DA 016511. https://www.drugabuse.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by PHS grant P50 DA 016511.	ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P313, DOI 10.1111/j.1748-1716.1966.tb03318.x; Anker JJ, 2010, DRUG ALCOHOL DEPEN, V107, P264, DOI 10.1016/j.drugalcdep.2009.11.002; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Bentzley BS, 2014, P NATL ACAD SCI USA, V111, P11822, DOI 10.1073/pnas.1406324111; Bjorklund A, 1984, CLASSICAL TRANSMIT 2; Brady KT, 2005, AM J PSYCHIAT, V162, P1483, DOI 10.1176/appi.ajp.162.8.1483; Buffalari DM, 2012, PHYSIOL BEHAV, V105, P209, DOI 10.1016/j.physbeh.2011.08.020; Capriles N, 2003, PSYCHOPHARMACOLOGY, V168, P66, DOI 10.1007/s00213-002-1283-z; Curtis AL, 2006, NEUROPSYCHOPHARMACOL, V31, P544, DOI 10.1038/sj.npp.1300875; Erb S, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0006.1999; Erb S, 2000, NEUROPSYCHOPHARMACOL, V23, P138, DOI 10.1016/S0893-133X(99)00158-X; Erb S, 2001, Stress, V4, P289; Erb S, 1998, J NEUROSCI, V18, P5529, DOI 10.1523/JNEUROSCI.18-14-05529.1998; Feltenstein MW, 2011, PSYCHOPHARMACOLOGY, V216, P53, DOI 10.1007/s00213-011-2187-6; Feltenstein MW, 2009, PSYCHONEUROENDOCRINO, V34, P343, DOI 10.1016/j.psyneuen.2008.09.014; Fuchs RA, 2005, PSYCHOPHARMACOLOGY, V179, P662, DOI 10.1007/s00213-004-2080-7; Hearing MC, 2008, PSYCHOPHARMACOLOGY, V150, P317; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kippin TE, 2005, PSYCHOPHARMACOLOGY, V182, P245, DOI 10.1007/s00213-005-0071-y; Kosten TA, 2008, AM J DRUG ALCOHOL AB, V34, P473, DOI 10.1080/00952990802082206; Koya E, 2009, NEUROPHARMACOLOGY, V56, P177, DOI 10.1016/j.neuropharm.2008.04.022; Le AD, 2000, PSYCHOPHARMACOLOGY, V150, P317, DOI 10.1007/s002130000411; Leri F, 2002, J NEUROSCI, V22, P5713; Li Chiang-shan Ray, 2005, Gend Med, V2, P174, DOI 10.1016/S1550-8579(05)80046-4; Liberzon I, 1997, NEUROPSYCHOPHARMACOL, V17, P353, DOI 10.1016/S0893-133X(97)00070-5; McFarland K, 2001, J NEUROSCI, V21, P8655; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Morales-Rivera A, 2014, PSYCHOPHARMACOLOGY, V231, P4145, DOI 10.1007/s00213-014-3553-y; Przegalinski E, 2005, NEUROPEPTIDES, V39, P525, DOI 10.1016/j.npep.2005.07.002; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shaham Y, 1997, J NEUROSCI, V17, P2605; Shaham Y, 2000, EUR J NEUROSCI, V12, P292, DOI 10.1046/j.1460-9568.2000.00899.x; Sinha R, 2007, EXP CLIN PSYCHOPHARM, V15, P445, DOI 10.1037/1064-1297.15.5.445; Smith RJ, 2011, BIOL PSYCHIAT, V70, P712, DOI 10.1016/j.biopsych.2011.06.010; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; VALENTINO RJ, 1992, NEUROSCIENCE, V48, P689, DOI 10.1016/0306-4522(92)90412-U; VALENTINO RJ, 1983, BRAIN RES, V270, P363, DOI 10.1016/0006-8993(83)90615-7; Van Bockstaele EJ, 2010, BRAIN RES, V1314, P162, DOI 10.1016/j.brainres.2009.09.036; Windle RJ, 2004, J NEUROSCI, V24, P2974, DOI 10.1523/JNEUROSCI.3432-03.2004; Zhou LY, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu009	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158577	10.1371/journal.pone.0158577	http://dx.doi.org/10.1371/journal.pone.0158577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362504	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200096
J	Chae, EY; Moon, WK; Kim, HH; Kim, WH; Cha, JH; Shin, HJ; Choi, WJ; Han, W; Noh, DY; Lee, SB; Ahn, SH				Chae, Eun Young; Moon, Woo Kyung; Kim, Hak Hee; Kim, Won Hwa; Cha, Joo Hee; Shin, Hee Jung; Choi, Woo Jung; Han, Wonshik; Noh, Dong-Young; Lee, Sae Byul; Ahn, Sei Hyun			Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer	PLOS ONE			English	Article							RT-PCR ASSAY; GENE-EXPRESSION; ECONOMIC-ANALYSIS; DUCTAL CARCINOMA; CHEMOTHERAPY; SUBTYPES; RISK; SONOGRAPHY; THERAPY; RELAPSE	A multigene expression assay corresponds to the likelihood of breast cancer recurrence after the initial diagnosis and can be used to guide the decision for additional chemotherapy. However, only few studies have investigated the associations between the imaging features of breast cancer and the results of multigene expression assays. Our study was to identify the relationship between imaging features on ultrasound (US) and the recurrence score (RS) on a 21-gene expression assay in patients with oestrogen receptor (ER)-positive, HER2-negative breast cancer. 267 patients with ER-positive, HER-negative invasive breast cancer who underwent examinations using US and Oncotype DX assay were included. US images were independently reviewed by dedicated breast radiologists who were blind to the RS. Tumour roundness was measured using a laboratory-developed software program. The pathological data were reviewed, including immunohistochemistry results. Univariate analysis was performed to assess the associations between the RS and each variable. Multiple logistic regression analysis was used to identify independent predictors of high RS. Of 267 patients, 147 (55%) had low, 96 (36%) intermediate, and 24 (9%) had high RS. According to the univariate analysis, parallel orientation, presence of calcification in the mass, and tumour roundness were positively associated with high RS. Multiple logistic regression analysis showed that parallel orientation (OR = 5.53) and tumour roundness (OR = 1.70 per 10 increase) were associated with high RS. Parallel orientation and tumour roundness are independent variables that may predict high RS in patients with ER-positive, HER2-negative breast cancer.	[Chae, Eun Young; Kim, Hak Hee; Cha, Joo Hee; Shin, Hee Jung; Choi, Woo Jung] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea; [Chae, Eun Young; Kim, Hak Hee; Cha, Joo Hee; Shin, Hee Jung; Choi, Woo Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Moon, Woo Kyung; Kim, Won Hwa] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul Natl Univ Hosp, Seoul, South Korea; [Han, Wonshik; Noh, Dong-Young] Seoul Natl Univ, Coll Med, Dept Surg, Seoul Natl Univ Hosp, Seoul, South Korea; [Lee, Sae Byul; Ahn, Sei Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Asan Medical Center	Kim, HH (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea.; Kim, HH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.; Moon, WK (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul Natl Univ Hosp, Seoul, South Korea.	moonwk@snu.ac.kr; hhkim@amc.seoul.kr	Han, Wonshik/B-3699-2008	Han, Wonshik/0000-0001-7310-0764				American college of radiology, 2013, BI RADS ULTR BI RADS; Ashraf AB, 2014, RADIOLOGY, V272, P374, DOI 10.1148/radiol.14131375; Bae MS, 2015, ACTA RADIOL, V56, P269, DOI 10.1177/0284185114524197; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Blaichman J, 2012, AM J ROENTGENOL, V199, pW402, DOI 10.2214/AJR.11.7374; Cancello G, 2013, ANN ONCOL, V24, P661, DOI 10.1093/annonc/mds430; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hong AS, 2005, AM J ROENTGENOL, V184, P1260, DOI 10.2214/ajr.184.4.01841260; Hornberger J, 2005, AM J MANAG CARE, V11, P313; Irshad A, 2013, AM J ROENTGENOL, V200, P284, DOI 10.2214/AJR.12.8781; Lamb PM, 2000, CLIN RADIOL, V55, P40, DOI 10.1053/crad.1999.0333; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lyman GH, 2007, CANCER-AM CANCER SOC, V109, P1011, DOI 10.1002/cncr.22506; Montemurro F, 2007, EUR RADIOL, V17, P1490, DOI 10.1007/s00330-006-0505-x; National omprehensive cancer network, 2014, NCCN CLINICAL PRACTI; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; STAVROS AT, 1995, RADIOLOGY, V196, P123, DOI 10.1148/radiology.196.1.7784555; Tang G, 2011, J CLIN ONCOL, V29, P4365, DOI 10.1200/JCO.2011.35.3714; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tsoi DT, 2010, ONCOLOGIST, V15, P457, DOI 10.1634/theoncologist.2009-0275; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wang X, 2008, J DIGIT IMAGING, V21, P170, DOI 10.1007/s10278-008-9105-4; Yepes MM, 2014, BREAST CANCER RES TR, V148, P117, DOI 10.1007/s10549-014-3143-z	32	15	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158461	10.1371/journal.pone.0158461	http://dx.doi.org/10.1371/journal.pone.0158461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362843	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200078
J	Santacana, M; Arias, B; Mitjans, M; Bonillo, A; Montoro, M; Rosado, S; Guillamat, R; Valles, V; Perez, V; Forero, CG; Fullana, MA				Santacana, Marti; Arias, Barbara; Mitjans, Marina; Bonillo, Albert; Montoro, Maria; Rosado, Silvia; Guillamat, Roser; Valles, Vicenc; Perez, Victor; Forero, Carlos G.; Fullana, Miquel A.			Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment	PLOS ONE			English	Article							SELF-REPORT VERSION; ANXIETY DISORDERS; NEUROTROPHIC FACTOR; PSYCHOLOGICAL TREATMENT; EXPOSURE THERAPY; DSM-IV; POLYMORPHISM; SEVERITY; THERAPYGENETICS; RELIABILITY	Background Anxiety disorders are highly prevalent and result in low quality of life and a high social and economic cost. The efficacy of cognitive-behavioural therapy (CBT) for anxiety disorders is well established, but a substantial proportion of patients do not respond to this treatment. Understanding which genetic and environmental factors are responsible for this differential response to treatment is a key step towards "personalized medicine". Based on previous research, our objective was to test whether the BDNF Val66Met polymorphism and/or childhood maltreatment are associated with response trajectories during exposure-based CBT for panic disorder (PD). Method We used Growth Mixture Modeling to identify latent classes of change (response trajectories) in patients with PD (N = 97) who underwent groupmanualized exposure-based CBT. We conducted logistic regression to investigate the effect on these trajectories of the BDNF Val66Met polymorphism and two different types of childhood maltreatment, abuse and neglect. Results We identified two response trajectories ("high response" and "low response"), and found that they were not significantly associated with either the genetic (BDNF Val66Met polymorphism) or childhood trauma-related variables of interest, nor with an interaction between these variables. Conclusions We found no evidence to support an effect of the BDNF gene or childhood trauma-related variables on CBT outcome in PD. Future studies in this field may benefit from looking at other genotypes or using different (e.g. whole-genome) approaches.	[Santacana, Marti; Montoro, Maria; Guillamat, Roser; Valles, Vicenc] Consorci Sanitari Terrassa, Dept Mental Hlth, Terrassa, Spain; [Santacana, Marti; Fullana, Miquel A.] Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Cerdanyola Del Valles, Spain; [Arias, Barbara] Univ Barcelona, Dept Anim Biol, Anthropol Unit, Barcelona, Spain; [Arias, Barbara; Mitjans, Marina; Perez, Victor] Inst Salud Carlos III, CIBERSAM Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Mitjans, Marina] Max Planck Inst Expt Med, Clin Neurosci, Gottingen, Germany; [Bonillo, Albert] Univ Autonoma Barcelona, Dept Psychobiol & Methodol Hlth Sci, Cerdanyola Del Valles, Spain; [Rosado, Silvia; Perez, Victor; Fullana, Miquel A.] Hosp del Mar, Inst Neuropsychiat & Addict, Barcelona, Spain; [Forero, Carlos G.] Inst Salud Carlos III, CIBERESP Ctr Invest Biomed Red Epidemiol & Salud, Madrid, Spain; [Forero, Carlos G.] IMIM Inst Hosp del Mar Invest Med, Hlth Serv Res Grp, Barcelona, Spain; [Forero, Carlos G.] Univ Pompeu Fabra, Dept Expt & Life Sci DCEXS, Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Max Planck Society; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Fullana, MA (corresponding author), Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Cerdanyola Del Valles, Spain.; Fullana, MA (corresponding author), Hosp del Mar, Inst Neuropsychiat & Addict, Barcelona, Spain.; Forero, CG (corresponding author), Inst Salud Carlos III, CIBERESP Ctr Invest Biomed Red Epidemiol & Salud, Madrid, Spain.; Forero, CG (corresponding author), IMIM Inst Hosp del Mar Invest Med, Hlth Serv Res Grp, Barcelona, Spain.; Forero, CG (corresponding author), Univ Pompeu Fabra, Dept Expt & Life Sci DCEXS, Barcelona, Spain.	cgarcia@imim.es; miguelangelfullana@gmail.com	Bonillo, Albert/H-9927-2015; Mitjans, Marina/C-4758-2018; Fullana, Miguel A/D-3288-2011; Arias, Barbara/U-7560-2017; Garcia Forero, Carlos/B-4771-2009	Bonillo, Albert/0000-0002-6141-9708; Mitjans, Marina/0000-0001-5543-7320; Fullana, Miguel A/0000-0003-3863-5223; Arias, Barbara/0000-0001-9181-2132; Garcia Forero, Carlos/0000-0002-5245-0076; Perez, Victor/0000-0002-5825-2337; Montoro Ruiz, Maria/0000-0002-2088-1007	Carlos III Health Institute/Fondo Europeo de Desarrollo Regional [PI12/00273]; Spanish Ministry of Economy and Competitivity PN -Carlos III Health Institute/Fondo Europeo de Dessarrollo Regional [PI1200018]; Centro de Investigacion Biomedica en Red - Salud Mental; University and Research Secretariat, Ministry of the Vice-presidency [2014 SGR 1636]; University and Research Secretariat, Ministry of the Economy and Finance of the Catalan Government [2014 SGR 1636]	Carlos III Health Institute/Fondo Europeo de Desarrollo Regional; Spanish Ministry of Economy and Competitivity PN -Carlos III Health Institute/Fondo Europeo de Dessarrollo Regional; Centro de Investigacion Biomedica en Red - Salud Mental; University and Research Secretariat, Ministry of the Vice-presidency; University and Research Secretariat, Ministry of the Economy and Finance of the Catalan Government	This work was supported by a grant from Carlos III Health Institute/Fondo Europeo de Desarrollo Regional (www.isciii.es) to MAF (PI12/00273). The authors of this report would also like to thank the support of the Spanish Ministry of Economy and Competitivity PN 2008-2011 -Carlos III Health Institute/Fondo Europeo de Dessarrollo Regional-(PI1200018; www.mineco.gob.es), Centro de Investigacion Biomedica en Red - Salud Mental- (www.cibersam.es), and the Universities and Research Secretariat, Ministry of the Vice-presidency and of the Economy and Finance of the Catalan Government (2014 SGR 1636; http://universitatsirecerca.gencat.cat/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden LE, 2006, J COGN PSYCHOTHER, V20, P7, DOI 10.1891/jcop.20.1.7; Alemany S, 2011, BRIT J PSYCHIAT, V199, P38, DOI 10.1192/bjp.bp.110.083808; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bobes J, 1998, EUR PSYCHIAT, V13, P158, DOI 10.1016/S0924-9338(98)80141-7; Bobes J. G, 2002, BANCO INSTRUMENTOS B; Bruce LC, 2013, DEPRESS ANXIETY, V30, P662, DOI 10.1002/da.22112; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Clark, 2010, THESIS; Craske M. G., 2007, MASTERY YOUR ANXIETY; Craske MG, 2009, BEHAV RES THER, V47, P931, DOI 10.1016/j.brat.2009.07.012; da Luz ACDD, 2013, NEUROPSYCHOBIOLOGY, V68, P129, DOI 10.1159/000353269; Eley TC, 2012, MOL PSYCHIATR, V17, P236, DOI 10.1038/mp.2011.132; Eley TC, 2014, DEPRESS ANXIETY, V31, P617, DOI 10.1002/da.22292; Felmingham KL, 2013, BIOL PSYCHIAT, V73, P1059, DOI 10.1016/j.biopsych.2012.10.033; Fullana MA, 2012, EUR PSYCHIAT, V27, P386, DOI 10.1016/j.eurpsy.2011.09.005; Hedman E, 2012, ACTA PSYCHIAT SCAND, V126, P126, DOI 10.1111/j.1600-0447.2012.01834.x; Hernandez A, 2013, J INTERPERS VIOLENCE, V28, P1498, DOI 10.1177/0886260512468240; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hofmann SG, 2014, J CONSULT CLIN PSYCH, V82, P375, DOI 10.1037/a0035491; Houck PR, 2002, DEPRESS ANXIETY, V15, P183, DOI 10.1002/da.10049; Hovens JGFM, 2016, DEPRESS ANXIETY, V33, P27, DOI 10.1002/da.22429; Hudson JL, 2013, J CHILD PSYCHOL PSYC, V54, P1086, DOI 10.1111/jcpp.12092; Ishiguro S, 2011, EUR J CLIN PHARMACOL, V67, P1213, DOI 10.1007/s00228-011-1073-9; Joesch JM, 2013, DEPRESS ANXIETY, V30, P1099, DOI 10.1002/da.22149; Keers R, 2011, PHARMACOGENOMICS J, V11, P138, DOI 10.1038/tpj.2010.14; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Knuts I, 2014, EUR NEUROPSYCHOPHARM, V24, P1222, DOI 10.1016/j.euroneuro.2014.05.007; Labonte B, 2012, ARCH GEN PSYCHIAT, V69, P722, DOI 10.1001/archgenpsychiatry.2011.2287; Lereya ST, 2015, LANCET PSYCHIAT, V2, P524, DOI 10.1016/S2215-0366(15)00165-0; Lester KJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.33; Lester KJ, 2016, BRIT J PSYCHIAT, V208, P182, DOI 10.1192/bjp.bp.114.154997; Lester KJ, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-4; Li XB, 2014, CHILD ABUSE NEGLECT, V38, P788, DOI 10.1016/j.chiabu.2013.09.002; Loerinc AG, 2015, CLIN PSYCHOL REV, V42, P72, DOI 10.1016/j.cpr.2015.08.004; Lonsdorf TB, 2015, SOC COGN AFFECT NEUR, V10, P664, DOI 10.1093/scan/nsu102; Lonsdorf TB, 2010, BEHAV NEUROSCI, V124, P9, DOI 10.1037/a0018261; Lutz W, 2014, J CONSULT CLIN PSYCH, V82, P287, DOI 10.1037/a0035535; McLachlan GJ, 2004, FINITE MIXTURE MODEL, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; Muth?n B., 2001, NEW DEV TECHNIQUES S, V2, P1, DOI DOI 10.4324/9781410601858-6; Nagin DS, 2014, ANN NUTR METAB, V65, P205, DOI 10.1159/000360229; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; National Institute for Health and Care Excellence, 2016, NICE GUID PLAC UNKN; National Institute of Health, 2015, NAT I MENT HLTH STRA; Naumova OY, 2012, DEV PSYCHOPATHOL, V24, P143, DOI 10.1017/S0954579411000605; Notaras M, 2015, MOL PSYCHIATR, V20, P916, DOI 10.1038/mp.2015.27; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Perna G, 2005, NEUROPSYCHOPHARMACOL, V30, P2230, DOI 10.1038/sj.npp.1300822; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Prats E, 2014, ACTAS ESP PSIQUIATRI, V42, P176; Roberts S, 2015, DEPRESS ANXIETY, V32, P861, DOI 10.1002/da.22430; Santacana M, 2014, COMPR PSYCHIAT, V55, P1467, DOI 10.1016/j.comppsych.2014.04.007; Schulz A, 2014, INT J METH PSYCH RES, V23, P387, DOI 10.1002/mpr.1447; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Stein MB, 2006, PSYCHOPHARMACOLOGY, V187, P68, DOI 10.1007/s00213-006-0349-8; Stulz N, 2007, J CLIN PSYCHOL, V63, P817, DOI 10.1002/jclp.20397; Stulz N, 2010, J CONSULT CLIN PSYCH, V78, P409, DOI 10.1037/a0019267; Sunderland M, 2012, BEHAV RES THER, V50, P374, DOI 10.1016/j.brat.2012.03.005; Tietjen GE, 2010, HEADACHE, V50, P20, DOI 10.1111/j.1526-4610.2009.01556.x; Wardenaar KJ, 2014, DEPRESS ANXIETY, V31, P778, DOI 10.1002/da.22228; Yu H, 2009, J NEUROSCI, V29, P4056, DOI 10.1523/JNEUROSCI.5539-08.2009	66	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158224	10.1371/journal.pone.0158224	http://dx.doi.org/10.1371/journal.pone.0158224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355213	Green Published, Green Submitted, gold			2022-12-27	WOS:000378859400040
J	Wang, HY; Hsieh, CH; Wen, CN; Wen, YH; Chen, CH; Lu, JJ				Wang, Hsin-Yao; Hsieh, Chia-Hsun; Wen, Chiao-Ni; Wen, Ying-Hao; Chen, Chun-Hsien; Lu, Jang-Jih			Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; GENE-EXPRESSION ANALYSIS; YOUDEN INDEX; SENSITIVITY; SPECIFICITY; COMBINATION; MICROARRAY; PREDICTION	Background Analytic measurement of serum tumour markers is one of commonly used methods for cancer risk management in certain areas of the world (e.g. Taiwan). Recently, cancer screening based on multiple serum tumour markers has been frequently discussed. However, the risk-benefit outcomes appear to be unfavourable for patients because of the low sensitivity and specificity. In this study, cancer screening models based on multiple serum tumour markers were designed using machine learning methods, namely support vector machine (SVM), k-nearest neighbour (KNN), and logistic regression, to improve the screening performance for multiple cancers in a large asymptomatic population. Methods AFP, CEA, CA19-9, CYFRA21-1, and SCC were determined for 20 696 eligible individuals. PSA was measured in men and CA15-3 and CA125 in women. A variable selection process was applied to select robust variables from these serum tumour markers to design cancer detection models. The sensitivity, specificity, positive predictive value (PPV), negative predictive value, area under the curve, and Youden index of the models based on single tumour markers, combined test, and machine learning methods were compared. Moreover, relative risk reduction, absolute risk reduction (ARR), and absolute risk increase (ARI) were evaluated. Results To design cancer detection models using machine learning methods, CYFRA21-1 and SCC were selected for women, and all tumour markers were selected for men. SVM and KNN models significantly outperformed the single tumour markers and the combined test for men. All 3 studied machine learning methods outperformed single tumour markers and the combined test for women. For either men or women, the ARRs were between 0.003-0.008; the ARIs were between 0.119-0.306. Conclusion Machine learning methods outperformed the combined test in analysing multiple tumour markers for cancer detection. However, cancer screening based solely on the application of multiple tumour markers remains unfavourable because of the inadequate PPV, ARR, and ARI, even when machine learning methods were incorporated into the analysis.	[Wang, Hsin-Yao; Wen, Chiao-Ni; Wen, Ying-Hao; Lu, Jang-Jih] Chang Gung Mem Hosp Linkou, Dept Lab Med, Taoyuan, Taiwan; [Hsieh, Chia-Hsun] Chang Gung Mem Hosp Linkou, Dept Internal Med, Dept Hematol Oncol, Taoyuan, Taiwan; [Hsieh, Chia-Hsun] Chang Gung Univ, Taoyuan, Taiwan; [Chen, Chun-Hsien] Chang Gung Univ, Dept Informat Management, Taoyuan, Taiwan; [Lu, Jang-Jih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Lu, JJ (corresponding author), Chang Gung Mem Hosp Linkou, Dept Lab Med, Taoyuan, Taiwan.; Chen, CH (corresponding author), Chang Gung Univ, Dept Informat Management, Taoyuan, Taiwan.; Lu, JJ (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan.	cchen@mail.cgu.edu.tw; janglu45@gmail.com	Wang, Hsin-Yao/ADR-9738-2022; Hsieh, Jason Chia-Hsun/G-5059-2010; Wang, Hsin-Yao/AAF-6727-2022	Wang, Hsin-Yao/0000-0001-5581-6793; Hsieh, Jason Chia-Hsun/0000-0002-5547-409X; Wang, Hsin-Yao/0000-0001-5581-6793; Chen, Chun-Hsien/0000-0001-8353-0215				Abrao MS, 1999, INT J GYNECOL OBSTET, V66, P19, DOI 10.1016/S0020-7292(99)00046-6; Becker N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-138; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P853, DOI 10.1007/0-387-25465-X_40; Chen FY, 2015, STAT MED, V34, P1560, DOI 10.1002/sim.6432; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Cruz JA, 2006, CANCER INFORM, V2, P59; DUK JM, 1990, GYNECOL ONCOL, V39, P186, DOI 10.1016/0090-8258(90)90430-S; Erbagci AB, 1999, DIS MARKERS, V15, P259, DOI 10.1155/1999/960934; Fan XJ, 2012, BRIT J CANCER, V106, P1735, DOI 10.1038/bjc.2012.82; Farquad MAH, 2012, DECIS SUPPORT SYST, V53, P226, DOI 10.1016/j.dss.2012.01.016; Gjavotchanoff R, 2015, INT J WOMENS HEALTH, V7, P205, DOI 10.2147/IJWH.S75288; Gonzalez-Velez H, 2009, APPL INTELL, V30, P191, DOI 10.1007/s10489-007-0085-8; Gupta D, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-13; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Kim SY, 2011, KOREAN J RADIOL, V12, P588, DOI 10.3348/kjr.2011.12.5.588; Koga Y, 2014, ANTICANCER RES, V34, P169; Li DL, 2013, CHINESE MED J-PEKING, V126, P1150, DOI 10.3760/cma.j.issn.0366-6999.20123102; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56; Saito M, 2005, INT J GYNECOL CANCER, V15, P37, DOI 10.1111/j.1048-891X.2005.15004.x; Sharma S, 2009, INDIAN J MED PAEDIAT, V30, P1, DOI 10.4103/0971-5851.56328; Tang YC, 2009, IEEE T SYST MAN CY B, V39, P281, DOI 10.1109/TSMCB.2008.2002909; TOUITOU Y, 1989, BRIT J CANCER, V60, P419, DOI 10.1038/bjc.1989.297; Tsao KC, 2006, J CLIN LAB ANAL, V20, P42, DOI 10.1002/jcla.20102; Verplancke T, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-56; Wan XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031989; Wang H, 2011, MED ONCOL, V28, pS613, DOI 10.1007/s12032-010-9663-4; Wen YH, 2015, CLIN CHIM ACTA, V450, P273, DOI 10.1016/j.cca.2015.09.004; Wild N, 2010, CLIN CANCER RES, V16, P6111, DOI 10.1158/1078-0432.CCR-10-0119	30	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158285	10.1371/journal.pone.0158285	http://dx.doi.org/10.1371/journal.pone.0158285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355357	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400044
J	Wang, XG; Lu, XK; Wang, JJ; Wang, DL; Yin, ZJ; Fan, WL; Wang, S; Ye, WW				Wang, Xiaoge; Lu, Xuke; Wang, Junjuan; Wang, Delong; Yin, Zujun; Fan, Weili; Wang, Shuai; Ye, Wuwei			Mining and Analysis of SNP in Response to Salinity Stress in Upland Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC-VARIATION; SALT TOLERANCE; CROP PLANTS; RICE; MUTATION; METHYLATION; ADAPTATION; DAMAGE	Salinity stress is a major abiotic factor that affects crop output, and as a pioneer crop in saline and alkaline land, salt tolerance study of cotton is particularly important. In our experiment, four salt-tolerance varieties with different salt tolerance indexes including CRI35 (65.04%), Kanghuanwei164 (56.19%), Zhong9807 (55.20%) and CRI44 (50.50%), as well as four salt-sensitive cotton varieties including Hengmian3 (48.21%), GK50 (40.20%), Xin-yan96-48 (34.90%), ZhongS9612 (24.80%) were used as the materials. These materials were divided into salt-tolerant group (ST) and salt-sensitive group (SS). Illumina Cotton SNP 70K Chip was used to detect SNP in different cotton varieties. SNPv (SNP variation of the same seedling pre- and after-salt stress) in different varieties were screened; polymorphic SNP and SNPr (SNP related to salt tolerance) were obtained. Annotation and analysis of these SNPs showed that (1) the induction efficiency of salinity stress on SNPv of cotton materials with different salt tolerance index was different, in which the induction efficiency on salt-sensitive materials was significantly higher than that on salt-tolerant materials. The induction of salt stress on SNPv was obviously biased. (2) SNPv induced by salt stress may be related to the methylation changes under salt stress. (3) SNPr may influence salt tolerance of plants by affecting the expression of salt-tolerance related genes.	[Wang, Xiaoge; Lu, Xuke; Wang, Junjuan; Wang, Delong; Yin, Zujun; Fan, Weili; Wang, Shuai; Ye, Wuwei] Chinese Acad Agr Sci, Key Lab Cotton Genet Improvement, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Ye, WW (corresponding author), Chinese Acad Agr Sci, Key Lab Cotton Genet Improvement, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	yew158@163.com			National High-tech Research and Development Program of China (863 Program) [2013AA102601]	National High-tech Research and Development Program of China (863 Program)	This work was supported by the National High-tech Research and Development Program of China (863 Program): 2013AA102601.	Anderson JT, 2011, TRENDS GENET, V27, P258, DOI 10.1016/j.tig.2011.04.001; [Anonymous], 2015, PLOS ONE, V11; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Colautti RI, 2012, CURR OPIN PLANT BIOL, V15, P199, DOI 10.1016/j.pbi.2012.01.016; Duan DD, 2015, SCI CHINA LIFE SCI, V58, P827, DOI 10.1007/s11427-015-4907-3; Fam SS, 2003, CURR MED CHEM, V10, P1723, DOI 10.2174/0929867033457115; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Garg B, 2012, MOL BIOL REP, V39, P10865, DOI 10.1007/s11033-012-1983-3; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hainaut P, 2004, TOXICOL APPL PHARM, V197, P153; Jaiswal V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129400; JONES PA, 1992, BIOESSAYS, V14, P33, DOI 10.1002/bies.950140107; Khan MH, 2008, ACTA PHYSIOL PLANT, V30, P81, DOI 10.1007/s11738-007-0093-7; Li F, 2015, NATURE BIOTECHNOLOGY, V33; Li Z, 2015, INT J CANCER, V138, P74, DOI [10.1002/ijc.29677, DOI 10.1002/IJC.29677]; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; Marcos-Carcavilla A, 2010, CELL STRESS CHAPERON, V15, P67, DOI 10.1007/s12192-009-0123-z; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Nasu S, 2002, DNA RES, V9, P163, DOI 10.1093/dnares/9.5.163; Nybom Hilde, 2014, Investig Genet, V5, P1, DOI 10.1186/2041-2223-5-1; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Roorkiwal M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00248; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Tuteja N, 2008, CRITICAL REV BIOCH M, V36, P337; Tzuri G, 2015, PLANT J, V83, P940, DOI 10.1111/tpj.12950; Wu Y, 2012, PLOS ONE, V8; Xing AQ, 2015, J EXP BOT, V66, P3791, DOI 10.1093/jxb/erv182; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; You J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01092; Zhang Lina, 2010, Biodiversity Science, V18, P137; Zhao YL, 2010, AGR SCI CHINA, V9, P783, DOI 10.1016/S1671-2927(09)60155-3	34	9	9	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158142	10.1371/journal.pone.0158142	http://dx.doi.org/10.1371/journal.pone.0158142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355327	Green Submitted, Green Published, gold			2022-12-27	WOS:000378859400031
J	Dutta, S; Choudhury, D; Roy, S; Dattagupta, JK; Biswas, S				Dutta, Sruti; Choudhury, Debi; Roy, Sumana; Dattagupta, Jiban Kanti; Biswas, Sampa			Mutation in the Pro-Peptide Region of a Cysteine Protease Leads to Altered Activity and Specificity-A Structural and Biochemical Approach	PLOS ONE			English	Article							HUMAN PROCATHEPSIN L; CONFORMATIONAL DIVERSITY; CRYSTAL-STRUCTURE; PAPAIN; INHIBITION; CATHEPSINS; PROSEQUENCE; SOFTWARE; PROTEINS; SUBSITE	Papain-like proteases contain an N-terminal pro-peptide in their zymogen form that is important for correct folding and spatio-temporal regulation of the proteolytic activity of these pro teases. Catalytic removal of the pro-peptide is required for the protease to become active. In this study, we have generated three different mutants of papain (186F, 186L and 186A) by replacing the residue 186 in its pro-peptide region, which blocks the specificity determining S2-subsite of the catalytic cleft of the protease in its zymogen form with a view to investigate the effect of mutation on the catalytic activity of the protease. Steady-state enzyme kinetic analyses of the corresponding mutant proteases with specific peptide substrates show significant alteration of substrate specificity-186F and 186L have 2.7 and 29.1 times higher k(cat)/K-m values compared to the wild-type against substrates having Phe and Leu at P2 position, respectively, while 186A shows lower catalytic activity against majority of the substrates tested. Far-UV CD scan and molecular mass analyses of the mature form of the mutant pro teases reveal similar CD spectra and intact masses to that of the wild-type. Crystal structures of zymogens of 186F and 186L mutants suggest that subtle reorganization of active site residues, including water, upon binding of the pro-peptide may allow the enzyme to achieve discriminatory substrate selectivity and catalytic efficiency. However, accurate and reliable predictions on alteration of substrate specificity require atomic resolution structure of the catalytic domain after zymogen activation, which remains a challenging task. In this study we demonstrate that through single amino acid substitution in pro-peptide, it is possible to modify the substrate specificity of papain and hence the pro-peptide of a protease can also be a useful target for altering its catalytic activity/specificity.	[Dutta, Sruti; Choudhury, Debi; Roy, Sumana; Dattagupta, Jiban Kanti; Biswas, Sampa] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, 1-AF Bidhannagar, Kolkata 700064, India	Saha Institute of Nuclear Physics	Biswas, S (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, 1-AF Bidhannagar, Kolkata 700064, India.	sampa.biswas@saha.ac.in			DBT, Govt. of India [BT/PR13895/BRB/10/789/2010]	DBT, Govt. of India(Department of Biotechnology (DBT) India)	The authors thank the beam-line staffs of BM14, at the ESRF for help during data collection and DBT, Govt. of India, for financial support and for providing access to the beam-line. MALDI-TOF experiments were carried out at IPLS-DBT facility of Calcutta University, Kolkata. This project was supported by institutional grant (MSACR project) and funding from DBT, Govt. of India (BT/PR13895/BRB/10/789/2010 dt. 15-06-2011).; We thank the beam-line staffs of BM14, at the ESRF for help during data collection and DBT, Govt. of India for financial support and for providing access to the beam-line. MALDI-TOF experiments were carried out at IPLS-DBT facility of Calcutta University, Kolkata. This project was supported by institutional grant (MSACR project) and funding from DBT, Govt. of India (BT/PR13895/BRB/10/789/2010 dt. 15-06-2011).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Chan VJ, 1999, BIOCHEM J, V340, P113, DOI 10.1042/0264-6021:3400113; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Choudhury D, 2010, PROTEIN ENG DES SEL, V23, P457, DOI 10.1093/protein/gzq016; Choudhury D, 2009, PHYTOCHEMISTRY, V70, P465, DOI 10.1016/j.phytochem.2009.02.001; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cygler M, 1997, BIOCHIMIE, V79, P645, DOI 10.1016/S0300-9084(97)83497-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; Grzonka Z., 2007, IND ENZYMES STRUCTUR, V1st ed., P181; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Kaulmann G, 2006, PROTEIN SCI, V15, P2619, DOI 10.1110/ps.062401806; Khan AR, 1998, PROTEIN SCI, V7, P815; KHOURI HE, 1991, BIOCHEMISTRY-US, V30, P8929, DOI 10.1021/bi00101a003; LaLonde JM, 1999, BIOCHEMISTRY-US, V38, P862, DOI 10.1021/bi9822271; Lecaille F, 2002, BIOCHEMISTRY-US, V41, P8447, DOI 10.1021/bi025638x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; MOLE JE, 1973, BIOCHEMISTRY-US, V12, P816, DOI 10.1021/bi00729a005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; Steverding D, 2006, MINI-REV MED CHEM, V6, P1025, DOI 10.2174/138955706778195207; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; VERNET T, 1990, J BIOL CHEM, V265, P16661; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Yang JS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002612	32	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158024	10.1371/journal.pone.0158024	http://dx.doi.org/10.1371/journal.pone.0158024			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352302	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900025
J	Zhang, MX; Zhang, J; Zhang, H; Tang, H				Zhang, Ming-xue; Zhang, Jie; Zhang, Hong; Tang, Hua			miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway	PLOS ONE			English	Article							PROTEIN-KINASE-C; HUMAN HEPATOCELLULAR-CARCINOMA; CELL-CYCLE PROGRESSION; PKC-ETA EXPRESSION; DOWN-REGULATION; CANCER-CELLS; MCF-7 CELLS; P53; APOPTOSIS; PROLIFERATION	MicroRNA (miRNA) may function as an oncogene or a tumor suppressor in tumorigenesis. However, the mechanism of miRNAs in adenoid cystic carcinoma (ACC) is unclear. Here, we provide evidence that miR-24-3p was downreglated and functions as a tumor suppressor in human lacrimal adenoid cystic carcinoma by suppressing proliferation and migration/invasion while promoting apoptosis. miR-24-3p down-regulated protein kinase C eta (PRKCH) by binding to its untranslated region (3'UTR). PRKCH increased the of the cell growth and migration/invasion in ACC cells and suppressed the expression of p53 and p21 in both mRNA and protein level. The overexpression of miR-24-3p decreased its malignant phenotype. Ectopic expression of PRKCH counteracted the suppression of malignancy induced by miR-24-3p, as well as ectopic expression of miR-24-3p rescued the suppression of PRKCH in the p53/p21 pathway. These results suggest that miR-24-3p promotes the p53/p21 pathway by down-regulating PRKCH expression in lacrimal adenoid cystic carcinoma cells.	[Zhang, Ming-xue; Zhang, Jie; Zhang, Hong] TianJin Med Univ, Hosp 2, Dept Ophthalmol, Tianjin, Peoples R China; [Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin, Peoples R China; [Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Dept Microbiol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Zhang, H (corresponding author), TianJin Med Univ, Hosp 2, Dept Ophthalmol, Tianjin, Peoples R China.; Tang, H (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin, Peoples R China.; Tang, H (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Microbiol, Tianjin, Peoples R China.	eyezhanghong@163.com; htang2002@yahoo.com			National Natural Science Foundation of China [91029714, 31270818, 81572790]; Natural Science Foundation of Tianjin [12JCZDJC25100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (Nos: 91029714; 31270818; 81572790) and the Natural Science Foundation of Tianjin (12JCZDJC25100).	Abu-Ghanem S, 2007, CANCER BIOL THER, V6, P1375; Aeder SE, 2004, ONCOGENE, V23, P9062, DOI 10.1038/sj.onc.1208093; Akkaraju GR, 2000, BIOCHEM BIOPH RES CO, V279, P103, DOI 10.1006/bbrc.2000.3903; Besson A, 2000, MOL CELL BIOL, V20, P4580, DOI 10.1128/MCB.20.13.4580-4590.2000; Brenner W, 2003, ANTICANCER RES, V23, P4001; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Esmaeli B, 2004, OPHTHAL PLAST RECONS, V20, P22, DOI 10.1097/01.IOP.0000105518.72611.4F; Fima E, 2001, ONCOGENE, V20, P6794, DOI 10.1038/sj.onc.1204885; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gao R, 2015, ONCOTARGET, V6, P6014, DOI 10.18632/oncotarget.3338; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Ho DH, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0145-7; Hong CF, 2016, J BIOL CHEM, V291, P1877, DOI 10.1074/jbc.M115.667568; Hussaini IM, 2000, J BIOL CHEM, V275, P22348, DOI 10.1074/jbc.M003203200; Karp G, 2007, CANCER LETT, V246, P173, DOI 10.1016/j.canlet.2006.02.012; Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Koren R, 2004, ONCOL REP, V11, P321; Krasnitsky E, 2012, ANTICANCER RES, V32, P1507; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lee JH, 2010, MOL CELLS, V30, P327, DOI 10.1007/s10059-010-0131-y; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lian JW, 2016, ONCOTARGET, V7, P2672, DOI 10.18632/oncotarget.6603; Liang SH, 2001, EUR J BIOCHEM, V268, P2779, DOI 10.1046/j.1432-1327.2001.02227.x; Lin Z, 2010, CHIN J STOMATOL RES, V4, P563; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lu HC, 2009, PATHOLOGY, V41, P626, DOI 10.3109/00313020903273076; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Pal D, 2013, BIOCHIM BIOPHYS ACTA, V1830, P5; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Ren ZJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.327; Rotem-Dai N, 2009, EXP CELL RES, V315, P2616, DOI 10.1016/j.yexcr.2009.06.004; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Sestini S, 2015, ONCOTARGET, V6, P32868, DOI 10.18632/oncotarget.5210; Shahaf G, 2012, EXP CELL RES, V318, P789, DOI 10.1016/j.yexcr.2012.01.018; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Sonnemann J, 2004, MOL CANCER THER, V3, P773; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Tamarkin A, 2011, EXP CELL RES, V317, P1465, DOI 10.1016/j.yexcr.2011.03.021; Tang JL, 2016, CANCER LETT, V371, P301, DOI 10.1016/j.canlet.2015.11.043; Vargas-Lopes C, 2011, J NEUROCHEM, V116, P281, DOI 10.1111/j.1471-4159.2010.07102.x; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang YQ, 2015, J BIOL CHEM, V290, P3308, DOI 10.1074/jbc.M114.611525; Weis E, 2009, ARCH OPHTHALMOL-CHIC, V127, P1016, DOI 10.1001/archophthalmol.2009.209; White VA, 2012, SAUDI J OPHTHALMOL, V26, P133, DOI 10.1016/j.sjopt.2012.02.012; Xu D, 2016, AM J PHYSIOL-RENAL, V310, pF821, DOI 10.1152/ajprenal.00522.2015; Zaidi SK, 2009, CANCER RES, V69, P8249, DOI 10.1158/0008-5472.CAN-09-1567; Zeng J, 2010, GRAEF ARCH CLIN EXP, V248, P1345, DOI 10.1007/s00417-010-1349-2; Zhang HT, 2016, BBA-MOL CELL RES, V1863, P335, DOI 10.1016/j.bbamcr.2015.12.001; Zheng HY, 2016, ONCOTARGET, V7, P4647, DOI 10.18632/oncotarget.6615; Zhou Quan, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P106, DOI 10.3760/cma.j.issn.0529-5807.2013.02.008; Zurgil U, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.481	54	21	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158433	10.1371/journal.pone.0158433	http://dx.doi.org/10.1371/journal.pone.0158433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351203	Green Submitted, gold, Green Published			2022-12-27	WOS:000378858900059
J	Nakazawa, M; Matsubara, H; Matsushita, Y; Watanabe, M; Vo, N; Yoshida, H; Yamaguchi, M; Kataoka, T				Nakazawa, Mako; Matsubara, Hisanori; Matsushita, Yuka; Watanabe, Megumi; Vo, Nicole; Yoshida, Hideki; Yamaguchi, Masamitsu; Kataoka, Takao			The Human Bcl-2 Family Member Bcl-rambo Localizes to Mitochondria and Induces Apoptosis and Morphological Aberrations in Drosophila	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ACUTE LYMPHOBLASTIC-LEUKEMIA; OUTER-MEMBRANE; PROTEIN FAMILY; MECHANISMS; EXPRESSION; HOMOLOG; GENES; CASPASES; DISEASE	Bcl-2 family proteins play a central role in regulating apoptosis. We previously reported that human Bcl-rambo, also termed BCL2L13, localized to mitochondria and induced apoptosis when overexpressed in human embryonic kidney 293T cells. However, the physiological function of Bcl-rambo currently remains unclear. In the present study, human Bcl-rambo was ectopically expressed in Drosophila melanogaster. Bcl-rambo mainly localized to the mitochondria of Drosophila Schneider 2 (S2) cells. The overexpression of Bcl-rambo, but not Bcl-rambo lacking a C-terminal transmembrane domain, induced apoptosis in S2 cells. Moreover, the ectopic expression of Bcl-rambo by a GAL4-UAS system induced aberrant morphological changes characterized by atrophied wing, split thorax, and rough eye phenotypes. Bcl-rambo induced the activation of effector caspases in eye imaginal discs. The rough eye phenotype induced by Bcl-rambo was partly rescued by the co-expression of p35, Diap1, and Diap2. By using this Drosophila model, we showed that human Bcl-rambo interacted genetically with Drosophila homologues of adenine nucleotide translocators and the autophagy-related 8 protein. The results of the present study demonstrated that human Bcl-rambo localized to mitochondria and at least regulated an apoptosis signaling pathway in Drosophila.	[Nakazawa, Mako; Matsubara, Hisanori; Matsushita, Yuka; Watanabe, Megumi; Vo, Nicole; Yoshida, Hideki; Yamaguchi, Masamitsu; Kataoka, Takao] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Vo, Nicole; Yoshida, Hideki; Yamaguchi, Masamitsu; Kataoka, Takao] Kyoto Inst Technol, CAIRP, Sakyo Ku, Kyoto 6068585, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology	Kataoka, T (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.; Kataoka, T (corresponding author), Kyoto Inst Technol, CAIRP, Sakyo Ku, Kyoto 6068585, Japan.	takao.kataoka@kit.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750	NOVARTIS Foundation (Japan); Ministry of Education, Science, Sports and Culture of Japan; Japan Science and Technology Agency; JSPS Core-to-Core Program; B. Asia-Africa Science Platforms	NOVARTIS Foundation (Japan)(Novartis); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); B. Asia-Africa Science Platforms	This work was partly supported by a research grant from the NOVARTIS Foundation (Japan) for the Promotion of Science (to TK) and Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan, Japan Science and Technology Agency and JSPS Core-to-Core Program, B. Asia-Africa Science Platforms. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bauer R, 2009, EMBO J, V28, P3706, DOI 10.1038/emboj.2009.305; Boumela I, 2014, CURR MED CHEM, V21, P1361, DOI 10.2174/09298673113206660278; Brachmann CB, 2000, CURR BIOL, V10, P547, DOI 10.1016/S0960-9822(00)00474-7; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Brill E, 2010, CANCER RES, V70, P6891, DOI 10.1158/0008-5472.CAN-10-0745; Brun S, 2002, ONCOGENE, V21, P6458, DOI 10.1038/sj.onc.1205839; Calleja M, 2000, DEVELOPMENT, V127, P3971; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Colussi PA, 2000, J CELL BIOL, V148, P703, DOI 10.1083/jcb.148.4.703; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Darding M, 2012, CELL DEATH DIFFER, V19, P58, DOI 10.1038/cdd.2011.163; Denton D, 2013, BBA-MOL CELL RES, V1833, P3499, DOI 10.1016/j.bbamcr.2013.06.014; Doumanis J, 2007, CELL DEATH DIFFER, V14, P907, DOI 10.1038/sj.cdd.4402082; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galindo KA, 2009, DEVELOPMENT, V136, P275, DOI 10.1242/dev.019042; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gaumer S, 2000, CELL DEATH DIFFER, V7, P804, DOI 10.1038/sj.cdd.4400714; Heitzler P, 1996, GENETICS, V143, P1271; Holleman A, 2006, BLOOD, V107, P769, DOI 10.1182/blood-2005-07-2930; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; Jenkins VK, 2013, TRENDS CELL BIOL, V23, P567, DOI 10.1016/j.tcb.2013.07.005; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Kataoka T, 2001, J BIOL CHEM, V276, P19548, DOI 10.1074/jbc.M010520200; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim JY, 2012, FEBS LETT, V586, P3142, DOI 10.1016/j.febslet.2012.08.015; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kraut R, 2011, J NEUROCHEM, V116, P764, DOI 10.1111/j.1471-4159.2010.07022.x; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Morimura S, 1996, DEV BIOL, V177, P136, DOI 10.1006/dbio.1996.0151; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Quinn L, 2003, EMBO J, V22, P3568, DOI 10.1093/emboj/cdg355; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Schouten M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12448; Senoo-Matsuda N, 2005, EMBO J, V24, P2700, DOI 10.1038/sj.emboj.7600721; Sevrioukov EA, 2007, GENESIS, V45, P184, DOI 10.1002/dvg.20279; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Song ZW, 2000, MOL CELL BIOL, V20, P2907, DOI 10.1128/MCB.20.8.2907-2914.2000; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Takahashi Y, 1999, NUCLEIC ACIDS RES, V27, P510, DOI 10.1093/nar/27.2.510; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Vartiainen S, 2014, DIS MODEL MECH, V7, P635, DOI 10.1242/dmm.016527; Wang ZG, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0678-5; Yacobi-Sharon K, 2013, DEV CELL, V25, P29, DOI 10.1016/j.devcel.2013.02.002; Yang YL, 2010, LEUKEMIA RES, V34, P18, DOI 10.1016/j.leukres.2009.07.023; Yi P, 2003, FEBS LETT, V534, P61, DOI 10.1016/S0014-5793(02)03778-X; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang H, 2000, J BIOL CHEM, V275, P27303; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118	58	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157823	10.1371/journal.pone.0157823	http://dx.doi.org/10.1371/journal.pone.0157823			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348811	Green Submitted, Green Published, gold			2022-12-27	WOS:000378801200016
J	Gerke, O; Wings, O				Gerke, Oliver; Wings, Oliver			Multivariate and Cladistic Analyses of Isolated Teeth Reveal Sympatry of Theropod Dinosaurs in the Late Jurassic of Northern Germany	PLOS ONE			English	Article							MEGALOSAURUS-BUCKLANDII; JUVENILE SPECIMEN; CRANIAL OSTEOLOGY; EVOLUTION; IDENTIFICATION; MESOEUCROCODYLIA; TYRANNOSAURIDAE; THALATTOSUCHIA; PHYLOGENY; ANATOMY	Remains of theropod dinosaurs are very rare in Northern Germany because the area was repeatedly submerged by a shallow epicontinental sea during the Mesozoic. Here, 80 Late Jurassic theropod teeth are described of which the majority were collected over decades from marine carbonates in nowadays abandoned and backfilled quarries of the 19th century. Eighteen different morphotypes (A-R) could be distinguished and 3D models based on micro-CT scans of the best examples of all morphotypes are included as supplements. The teeth were identified with the assistance of discriminant function analysis and cladistic analysis based on updated datamatrices. The results show that a large variety of theropod groups were present in the Late Jurassic of northern Germany. Identified specimens comprise basal Tyrannosauroidea, as well as Allosauroidea, Megalosauroidea cf. Marshosaurus, Megalosauridae cf. Torvosaurus and probably Ceratosauria. The formerly reported presence of Dromaeosauridae in the Late Jurassic of northern Germany could not be confirmed. Some teeth of this study resemble specimens described as pertaining to Carcharo-dontosauria (morphotype A) and Abelisauridae (morphotype K). This interpretation is however, not supported by discriminant function analysis and cladistic analysis. Two smaller morphotypes (N and Q) differ only in some probably size-related characteristics from larger morphotypes (B and C) and could well represent juveniles of adult specimens. The similarity of the northern German theropods with groups from contemporaneous localities suggests faunal exchange via land-connections in the Late Jurassic between Germany, Portugal and North America.	[Gerke, Oliver; Wings, Oliver] Landesmuseum Hannover, Dept Nat Hist, Willy Brandt Allee 5, Hannover, Germany		Gerke, O (corresponding author), Landesmuseum Hannover, Dept Nat Hist, Willy Brandt Allee 5, Hannover, Germany.	oliver.gerke@t-online.de	Wings, Oliver/ABC-9644-2021		Volkswagen Foundation	Volkswagen Foundation(Volkswagen)	The Volkswagen Foundation provided funding for our research in the "Europasaurus-Project" in the initiative "Research in Museums". The Volkswagen Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2012, UEXKULL PSYCHOSOMATI, V2nd; Allain R, 2005, LIFE O PAST, P72; ANTUNES MT, 1991, CR ACAD SCI II, V313, P113; Araujo R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01924; Baszio Sven, 1997, Courier Forschungsinstitut Senckenberg, V196, P33; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Benson RBJ, 2009, PALAEONTOLOGY, V52, P857, DOI 10.1111/j.1475-4983.2009.00884.x; Boslaugh S., 2008, STAT NUTSHELL; Brauns D, 1874, OBERE JURA NORDWESTL; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Brusatte SL, 2013, ACTA PALAEONTOL POL, V58, P47, DOI 10.4202/app.2011.0141; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Buffetaut E, 2012, ORYCTOS, V10, P1; Carballido JL, 2013, J SYSTEMATIC PALAEON, P1, DOI DOI 10.1080/14772019.2013.764935; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Chiappe LM, 2010, NEUES JAHRB GEOL P-A, V258, P257, DOI 10.1127/0077-7749/2010/0125; Chure DJ, 2001, NEUES JAHRB GEOL P-M, P565; Credner H, 1863, UEBER GLIEDERUNG OBE; Credner H, 1864, Z DTSCH GEOL GES, V16, P196; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; De Andrade MB, 2010, J VERTEBR PALEONTOL, V30, P1451, DOI 10.1080/02724634.2010.501442; Dubbers H., 1888, OBERE JURA NORDOSTFL; Everitt B.S., 2005, R S PLUS COMPANION M; Ezcurra MD, 2012, P GEOLOGIST ASSOC, V123, P500, DOI 10.1016/j.pgeola.2011.12.003; Fanti F, 2007, ACTA PALAEONTOL POL, V52, P155; Farlow J.O., 1991, Modern Geology, V16, P161; Farlow James O., 2002, Historical Biology, V16, P21; Fastnacht M, 2005, ACTA PALAEONTOL POL, V50, P273; Fellows I, 2012, J STAT SOFTW, V49, P1; Fischer R., 1991, ARBEITSKREIS PAL ONT, V19, P21; Forster JR., 2007, DINOSAURS MORRISON F; Galton P.M., 1979, Brigham Young University Geology Studies, V26, P1; GERKE O, 2014, J VERTEBR PALEONTOL, V2014, P137; Gohlich UB, 2006, NATURE, V440, P329, DOI 10.1038/nature04579; Gohlich UB, 2006, ARCHAEOPTERYX, V24, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gramann F., 1997, Z DT GEOL GES, V148, P165, DOI 10.1127/zdgg/148/1997/165; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer O, 2015, REFERENCE MANUAL VER; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Helbig M, 2013, JGR JGR JAVA GUI R R; Hendrickx C, 2014, DRYAD DIGITAL REPOSI; Hendrickx C, 2015, ACTA PALAEONTOL POL, V60, P627, DOI 10.4202/app.00056.2013; Hendrickx C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088905; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; Herrmann A, 1971, BEIHEFTE GEOL JB, V95, P1; Hocking T, 2014, DIRECTLABELS DIRECT; Hwang SH., 2007, THESIS; Hwang SH, 2011, BIOL REV, V86, P183, DOI 10.1111/j.1469-185X.2010.00142.x; IBM Support Portal, QUADR DISCR AN SPSS; Janensch W., 1925, PALAEONTOGRAPHICA S7, V1, P1; Janensch W., 1920, SITZUNGSBERICHTE GES, V1920, P225; Jansen M, 2014, PALAEONTOLOGY, V57, P743, DOI 10.1111/pala.12085; JENSEN JA, 1985, GREAT BASIN NAT, V45, P710; Karl H-V, 2006, CLAUSTHALER GEOWISSE, V5, P59; Kear BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084041; la Grange A, 2009, J STAT SOFTW, V30, P1; Lallensack J.N., 2015, PALAEONTOL ELECTRON, V18, P1, DOI DOI 10.26879/529; Larson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054329; Larson DW, 2008, CAN J EARTH SCI, V45, P1455, DOI 10.1139/E08-070; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Longrich NR, 2009, P NATL ACAD SCI USA, V106, P5002, DOI 10.1073/pnas.0811664106; Lotze F, 1968, NEUES JB GEOLOGIE PA, V1968, P730; Luppold FW, 2015, GEOLOGISCHE OBJEKTE, P1; Madsen J H, 1976, UTAH GEOLOGY, V3, P51; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; Madzia D, 2014, ACTA PALAEONTOL POL, V59, P855, DOI 10.4202/app.2012.0111; Marpmann JS, 2015, J SYST PALAEONTOL, V13, P221, DOI 10.1080/14772019.2013.875074; Martin T, ACTA PALAEO IN PRESS; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; Mirisola A, 2012, DEDUCERPLUGINSCALING; Mudroch A, 2001, FISCHZAHNE OBERJURA; Mudroch Alexander, 1996, Geologica et Palaeontologica, V30, P239; Munster G Gz, 1846, BEITRAGE PETREFACTEN, P36; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Osi A, 2010, CRETACEOUS RES, V31, P304, DOI 10.1016/j.cretres.2010.01.001; Pape H, 1970, MITTEILUNGEN GEOLOGI, V9, P41; Pienkowski G., 2008, GEOL SOC LONDON, V2, P823; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rauhut OWM, 2011, SPEC PAP PALAEONTOL, P195, DOI 10.1111/j.1475-4983.2011.01084.x; Rauhut OWM, 2012, P GEOLOGIST ASSOC, V123, P779, DOI 10.1016/j.pgeola.2012.05.008; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut Oliver W.M., 2000, P75; Rauhut OWM, 2004, J VERTEBR PALEONTOL, V24, P894, DOI 10.1671/0272-4634(2004)024[0894:PAAOGS]2.0.CO;2; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Rauhut OWM, 2002, CRETACEOUS RES, V23, P255, DOI 10.1006/cres.2002.1003; RICHTER A, 2013, J VERTEBR PALEONTOL, V2013, P198; Roemer FA, 1838, VERSTEINERUNGEN NORD; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sankey JT, 2002, J PALEONTOL, V76, P751, DOI 10.1666/0022-3360(2002)076<0751:STABTF>2.0.CO;2; SAS Institute Inc, 2014, JMP 11 MULT METH; Schweigert G., 1999, OSNABRUCKER NATURWIS, V25, P25; Serrano-Martinez A, 2015, P GEOLOGIST ASSOC, V126, P107, DOI 10.1016/j.pgeola.2014.10.005; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Smith JB, 2006, NATURWISSENSCHAFTEN, V93, P242, DOI 10.1007/s00114-006-0092-3; Smith JP, 1893, THESIS; *SPSS INC, 2006, SPSS WIND VERS 15 0; Strombeck Av, 1832, ARCH MINERALOGIE GEO, V4, P395; Struckmann C., 1878, OBERE JURA UMGEBUNG; Thies D, 1995, J VERTEBR PALEONTOL, V15, P463, DOI 10.1080/02724634.1995.10011242; Thies Detlev, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V205, P393; Torices A, 2015, ACTA PALAEONTOL POL, V60, P611, DOI 10.4202/app.2012.0121; Torices A, 2014, CAN J EARTH SCI, V51, DOI 10.1139/cjes-2014-0072; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Turner AH, 2012, B AM MUS NAT HIST, P5; van der Lubbe T, 2009, ACTA PALAEONTOL POL, V54, P401, DOI 10.4202/app.2008.0007; Venables WN., 2002, MODERN APPL STAT S 4; von Huene F, 1923, BULL GEOL SOC AM, V34, P449; von Koenen A, 1906, GEOLOGISCHE KARTE PR, DOI Berlin; von Koenen A, 1911, GEOLOGISCHE KARTE PR; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; Williamson TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093190; Windolf R., 1997, 1 TREFF DEUTSCHSPR P, P33; Wings O., 2015, 12 S MES TERR EC SHE, P99; Wings O, 2012, IFUNDAMENTAL, V20, P281; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Ziegler P. A., 1990, GEOLOGICAL ATLAS W C; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179; Zinke Jens, 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P163; [No title captured]	127	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158334	10.1371/journal.pone.0158334	http://dx.doi.org/10.1371/journal.pone.0158334			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383054	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400043
J	Liu, HD; Li, P; Zhu, MY; Wang, XF; Lu, JW; Yu, TW				Liu, Haodong; Li, Peng; Zhu, Mengyao; Wang, Xiaofei; Lu, Jianwei; Yu, Tianwei			Nonlinear Network Reconstruction from Gene Expression Data Using Marginal Dependencies Measured by DCOL	PLOS ONE			English	Article							REGULATORY NETWORKS; R-PACKAGE; COEXPRESSION; PATTERNS; ADAMS; FGF10	Reconstruction of networks from high-throughput expression data is an important tool to identify new regulatory relations. Given that nonlinear and complex relations exist between biological units, methods that can utilize nonlinear dependencies may yield insights that are not provided by methods using linear associations alone. We have previously developed a distance to measure predictive nonlinear relations, the Distance based on Conditional Ordered List (DCOL), which is sensitive and computationally efficient on large matrices. In this study, we explore the utility of DCOL in the reconstruction of networks, by combining it with local false discovery rate (lfdr)-based inference. We demonstrate in simulations that the new method named nlnet is effective in recovering hidden nonlinear modules. We also demonstrate its utility using a single cell RNA seq dataset.	[Liu, Haodong; Zhu, Mengyao; Lu, Jianwei] Tongji Univ, Sch Software Engn, Shanghai, Peoples R China; [Li, Peng] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Wang, Xiaofei] Shandong Univ Sci & Technol, Coll Informat Sci & Engn, Qingdao, Shandong, Peoples R China; [Lu, Jianwei] Tongji Univ, Inst Translat Med, Shanghai, Peoples R China; [Yu, Tianwei] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Tongji University; Tongji University; Shandong University of Science & Technology; Tongji University; Emory University; Rollins School Public Health	Lu, JW (corresponding author), Tongji Univ, Sch Software Engn, Shanghai, Peoples R China.; Lu, JW (corresponding author), Tongji Univ, Inst Translat Med, Shanghai, Peoples R China.; Yu, TW (corresponding author), Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	jwlu33@gmail.com; tianwei.yu@emory.edu		Yu, Tianwei/0000-0003-2502-1628	NIH [P30AI50409]; 973 Program of the Ministry of Science and Technology of China [2013CB967101]; Natural Science Foundation of China [41476120, 61572362, 81571347, 21477087]; Shanghai Eastern Scholar program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Program of the Ministry of Science and Technology of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Eastern Scholar program	This work was partially supported by NIH grant P30AI50409, 973 Program (No. 2013CB967101) of the Ministry of Science and Technology of China, Natural Science Foundation of China No. 41476120, No. 61572362, No. 81571347 and No. 21477087, and the Shanghai Eastern Scholar program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030790; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boscolo R, 2008, IEEE ACM T COMPUT BI, V5, P15, DOI 10.1109/TCBB.2007.1056; Burns JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9557; Ceci M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144031; Chen J, 2011, BIOMETRICS, V67, P299, DOI 10.1111/j.1541-0420.2010.01413.x; Chen XH, 2006, BIOINFORMATICS, V22, P2952, DOI 10.1093/bioinformatics/btl491; Cho DY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002820; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Hase T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003361; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li KC, 2002, P NATL ACAD SCI USA, V99, P16875, DOI 10.1073/pnas.252466999; Li YP, 2015, G3-GENES GENOM GENET, V5, P1075, DOI 10.1534/g3.115.018127; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Lin JT, 2013, DEV GROWTH DIFFER, V55, P368, DOI 10.1111/dgd.12051; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Moayedi Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004055; Okano T, 2011, J NEUROSCI, V31, P18104, DOI 10.1523/JNEUROSCI.3619-11.2011; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Qin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3633; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Shpargel KB, 2004, ACTA OTO-LARYNGOL, V124, P242, DOI 10.1080/00016480410016162; Siegenthaler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090481; Slowik Amber D, 2013, Trends Dev Biol, V7, P73; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Thompson D, 2015, ANNU REV CELL DEV BI, V31, P399, DOI 10.1146/annurev-cellbio-100913-012908; Urness LD, 2015, DEV BIOL, V400, P59, DOI 10.1016/j.ydbio.2015.01.015; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Wang JX, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt147; Wang K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/918954; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yan X, 2010, DEV DYNAM, V239, P2256, DOI 10.1002/dvdy.22360; Yu TW, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S13-S6; Yu TW, 2013, IEEE ACM T COMPUT BI, V10, P1080, DOI 10.1109/TCBB.2013.99; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao J, 2016, P NATL ACAD SCI USA, V113, P5130, DOI 10.1073/pnas.1522586113	49	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158247	10.1371/journal.pone.0158247	http://dx.doi.org/10.1371/journal.pone.0158247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380516	gold, Green Published, Green Submitted			2022-12-27	WOS:000379798700024
J	Liu, YZ; Han, YW; Chen, RS; Zhang, HJ; Liu, SM; Liang, F				Liu, Yingzhu; Han, Yanwei; Chen, Rongsheng; Zhang, Haijun; Liu, Simin; Liang, Feng			In situ Immobilization of Copper Nanoparticles on Polydopamine Coated Graphene Oxide for H2O2 Determination	PLOS ONE			English	Article							HYDROGEN-PEROXIDE SENSOR; GLASSY-CARBON ELECTRODE; CU NANOPARTICLES; GREEN SYNTHESIS; NANOCOMPOSITE; GLUCOSE; EFFICIENT; COMPOSITE; COATINGS	Nanostructured electrochemical sensors often suffer from irreversible aggregation and poor adhesion to the supporting materials, resulting in reduced sensitivity and selectivity over time. We describe a versatile method for fabrication of a H2O2 sensor by immobilizing copper nanoparticles (Cu NPs; 20 nm) on graphene oxide ( GO) sheets via in-situ reduction of copper(II) on a polydopamine (PDA) coating on a glassy carbon electrode. The PDA film with its amino groups and catechol groups acts as both a reductant and an adhesive that warrants tight bonding between the Cu NPs and the support. The modified electrode, best operated at a working voltage of -0.4 V ( vs. Ag/AgCl), has a linear response to H2O2 in the 5 mu M to 12 mM concentration range, a sensitivity of 141.54 mu A.mM(-1).cm(-2), a response time of 4 s, and a 1.4 mu M detection limit ( at an S/N ratio of 3). The sensor is highly reproducible and selective ( with minimal interference to ascorbic acid and uric acid). The method was applied to the determination of H2O2 in sterilant by the standard addition method and gave recoveries between 97% and 99%.	[Liu, Yingzhu; Han, Yanwei; Chen, Rongsheng; Zhang, Haijun; Liu, Simin; Liang, Feng] Wuhan Univ Sci & Technol, Sch Chem Engn & Technol, State Key Lab Refractories & Met, Wuhan 430081, Peoples R China; [Chen, Rongsheng; Liang, Feng] Wuhan Univ, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China; [Chen, Rongsheng] Chinese Acad Sci, Key Lab Inorgan Coating Mat, Shanghai 200050, Peoples R China	Wuhan University of Science & Technology; Wuhan University; Chinese Academy of Sciences	Chen, RS; Liang, F (corresponding author), Wuhan Univ Sci & Technol, Sch Chem Engn & Technol, State Key Lab Refractories & Met, Wuhan 430081, Peoples R China.; Chen, RS; Liang, F (corresponding author), Wuhan Univ, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China.; Chen, RS (corresponding author), Chinese Acad Sci, Key Lab Inorgan Coating Mat, Shanghai 200050, Peoples R China.	chenrs@wust.edu.cn; feng_liang@whu.edu.cn	Liang, Feng/GZK-4305-2022; Liu, Simin/I-3391-2012; Zhang, Haijun/C-2168-2016; Liang, Feng/A-4823-2011	Liu, Simin/0000-0002-8696-4833; Liang, Feng/0000-0002-3974-2621	National Natural Science Foundation of China [21105077, 21372183]; Open Funds of Key Laboratory of Analytical Chemistry for Biology and Medicine of Ministry of Education [ACBM2014001]; Open Funds of Key Laboratory of Inorganic Coating Materials of Chinese Academy of Sciences [KLICM-2013-05]; Hubei Provincial Natural Science Foundation of China [2013CFB328]; Wuhan Applied Basic Research Programs of China [2015060101010069]; Open Funds of the State Key Laboratory of Electroanalytical Chemistry [SKLEAC201609]; Thousand Youth Talents Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funds of Key Laboratory of Analytical Chemistry for Biology and Medicine of Ministry of Education; Open Funds of Key Laboratory of Inorganic Coating Materials of Chinese Academy of Sciences; Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Applied Basic Research Programs of China; Open Funds of the State Key Laboratory of Electroanalytical Chemistry; Thousand Youth Talents Program	R.S.C. acknowledges support by the National Natural Science Foundation of China under award number 21105077, the Open Funds of Key Laboratory of Analytical Chemistry for Biology and Medicine of Ministry of Education under contract number ACBM2014001, and the Open Funds of Key Laboratory of Inorganic Coating Materials of Chinese Academy of Sciences KLICM-2013-05. F.L. thanks the National Natural Science Foundation of China under award number 21372183, Hubei Provincial Natural Science Foundation of China 2013CFB328, Wuhan Applied Basic Research Programs of China 2015060101010069, and the Open Funds of the State Key Laboratory of Electroanalytical Chemistry SKLEAC201609. S.M.L. acknowledges support by the Thousand Youth Talents Program.	Alegret S, 2007, COMP ANAL C, V49, P1; Butwong N, 2014, J ELECTROANAL CHEM, V717, P41, DOI 10.1016/j.jelechem.2013.12.028; Chuah YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18162; Ensafi AA, 2014, SENSOR ACTUAT B-CHEM, V196, P398, DOI 10.1016/j.snb.2014.02.028; Freire RLH, 2014, J PHYS CHEM C, V118, P19051, DOI 10.1021/jp5033228; Harris D.C., 2002, QUANTITATIVE CHEM AN, V6th ed.; Heli H, 2014, ELECTROCHIM ACTA, V123, P518, DOI 10.1016/j.electacta.2014.01.032; Karuppiah C, 2014, SENSOR ACTUAT B-CHEM, V196, P450, DOI 10.1016/j.snb.2014.02.034; Kivrak H, 2015, ELECTROCHIM ACTA, V176, P497, DOI 10.1016/j.electacta.2015.06.151; Kumar GG, 2014, RSC ADV, V4, P7944, DOI 10.1039/c3ra45596c; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lin YQ, 2014, SENSOR ACTUAT B-CHEM, V202, P527, DOI 10.1016/j.snb.2014.05.113; Liu HY, 2013, ANAL CHEM, V85, P3385, DOI 10.1021/ac303789x; Liu MM, 2013, BIOSENS BIOELECTRON, V45, P206, DOI 10.1016/j.bios.2013.02.010; Lorestani F, 2015, SENSOR ACTUAT B-CHEM, V208, P389, DOI 10.1016/j.snb.2014.11.074; Mahmoudian MR, 2014, SENSOR ACTUAT B-CHEM, V201, P526, DOI 10.1016/j.snb.2014.05.030; Mane GP, 2012, ADV FUNCT MATER, V22, P3596, DOI 10.1002/adfm.201200207; Murali S, 2015, RSC ADV, V5, P4286, DOI 10.1039/c4ra12989j; Qiu HW, 2015, CHEMPHYSCHEM, V16, P2953, DOI 10.1002/cphc.201500502; Rong JP, 2014, NANO LETT, V14, P473, DOI 10.1021/nl403404v; Su L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24420; Tahir D, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/17/175002; Tahirovic A, 2007, TALANTA, V72, P1378, DOI 10.1016/j.talanta.2007.01.072; Wang Y., 2007, SCI STKE, V2007, P1, DOI DOI 10.4018/JCINI.2007100101; Wu MY, 2013, J AM CHEM SOC, V135, P12048, DOI 10.1021/ja4054465; Xu HL, 2011, CHEM MATER, V23, P5105, DOI 10.1021/cm2028417; Yan YH, 2013, ANAL CHEM, V85, P8483, DOI 10.1021/ac401668e; Yang J, 2015, ANAL LETT, V48, P2031, DOI 10.1080/00032719.2015.1010120; Yang W, 2016, CARBON, V96, P947, DOI 10.1016/j.carbon.2015.10.059; Yang Y, 2015, MICROCHIM ACTA, V182, P2241, DOI 10.1007/s00604-015-1558-9; Yin ZJ, 2011, BIOSENS BIOELECTRON, V26, P1970, DOI 10.1016/j.bios.2010.08.049; Zaino LP, 2014, CHEMELECTROCHEM, V1, P1570, DOI 10.1002/celc.201402111; Zeng T, 2013, APPL CATAL B-ENVIRON, V134, P26, DOI 10.1016/j.apcatb.2012.12.037; Zhang C, 2015, MICROCHIM ACTA, V182, P1811, DOI 10.1007/s00604-015-1511-y; Zhang MY, 2014, J ELECTROANAL CHEM, V730, P10, DOI 10.1016/j.jelechem.2014.07.020; Zhang TT, 2008, SENSORS-BASEL, V8, P5141, DOI 10.3390/s8085141	36	19	19	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157926	10.1371/journal.pone.0157926	http://dx.doi.org/10.1371/journal.pone.0157926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380524	Green Published, gold, Green Submitted			2022-12-27	WOS:000379798700014
J	Corten, R; Rosenkranz, S; Buskens, V; Cook, KS				Corten, Rense; Rosenkranz, Stephanie; Buskens, Vincent; Cook, Karen S.			Reputation Effects in Social Networks Do Not Promote Cooperation: An Experimental Test of the Raub & Weesie Model	PLOS ONE			English	Article							EVOLUTION; DILEMMAS; DYNAMICS; BEHAVIOR; GAMES	Despite the popularity of the notion that social cohesion in the form of dense social networks promotes cooperation in Prisoner's Dilemmas through reputation, very little experimental evidence for this claim exists. We address this issue by testing hypotheses from one of the few rigorous game-theoretic models on this topic, the Raub & Weesie model, in two incentivized lab experiments. In the experiments, 156 subjects played repeated two-person PDs in groups of six. In the "atomized interactions" condition, subjects were only informed about the outcomes of their own interactions, while in the "embedded" condition, subjects were informed about the outcomes of all interactions in their group, allowing for reputation effects. The design of the experiments followed the specification of the RW model as closely as possible. For those aspects of the model that had to be modified to allow practical implementation in an experiment, we present additional analyses that show that these modifications do not affect the predictions. Contrary to expectations, we do not find that cooperation is higher in the embedded condition than in the atomized interaction. Instead, our results are consistent with an interpretation of the RW model that includes random noise, or with learning models of cooperation in networks.	[Corten, Rense; Buskens, Vincent] Univ Utrecht, Dept Sociol, Utrecht, Netherlands; [Rosenkranz, Stephanie] Univ Utrecht, Utrecht Sch Econ, Utrecht, Netherlands; [Cook, Karen S.] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA	Utrecht University; Utrecht University; Stanford University	Corten, R (corresponding author), Univ Utrecht, Dept Sociol, Utrecht, Netherlands.	r.corten@uu.nl	Buskens, Vincent/B-3134-2012; Buskens, Vincent/N-8762-2019	Buskens, Vincent/0000-0002-4483-7238; Buskens, Vincent/0000-0002-4483-7238	Netherlands Organization for Scientific Research [446-09-023]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Funding was provided by Netherlands Organization for Scientific Research, www.nwo.nl, grant number 446-09-023, received by RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn TK, 2009, J POLIT, V71, P398, DOI 10.1017/S0022381609090355; Andreoni J, 1993, EC J; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Balliet D, 2010, J CONFLICT RESOLUT, V54, P39, DOI 10.1177/0022002709352443; Burt R.S., 1996, TRUST ORG FRONTIERS, P68, DOI [DOI 10.4135/9781452243610.n5, DOI 10.4135/9781452243610.N5]; Buskens V, 2003, GAME ECON BEHAV, V42, P235, DOI 10.1016/S0899-8256(02)00563-8; Buskens V., 2002, SOCIAL NETWORKS TRUS, V30; Buskens V., 2002, GROUP COHESION TRUST, V19, P167, DOI [DOI 10.1016/S0882-6145(02)19007-2, 10.1016/S0882-6145(02)19007-2]; Buskens V, 2010, SOC NETWORKS, V32, P301, DOI 10.1016/j.socnet.2010.05.001; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; Coleman J., 1990, FDN SOCIAL THEORY; Corten Rense, 2009, P 1 INT C REP THEORY, V9, P20; Cuesta JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07843; Dal Bo P, 2005, AM ECON REV, V95, P1591; Dal Bo P, 2011, AM ECON REV, V101, P411, DOI 10.1257/aer.101.1.411; Ding S, 2015, CHAOS SOLITON FRACT, V71, P91, DOI 10.1016/j.chaos.2014.12.014; Ellickson R., 1991, ORDER WITHOUT LAW; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Friedman J.W., 1977, OLIGOPOLY THEORY GAM; Gallo E, 2015, P NATL ACAD SCI USA, V112, P3647, DOI 10.1073/pnas.1415883112; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; GREIF A, 1989, J ECON HIST, V49, P857, DOI 10.1017/S0022050700009475; GREIF A, 1994, J POLIT ECON, V102, P912, DOI 10.1086/261959; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Homans George C., 1951, HUMAN GROUP; Kagel JH, 1995, HDB EXPT EC; Kirchkamp O, 2007, GAME ECON BEHAV, V58, P269, DOI 10.1016/j.geb.2006.04.002; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Kosfeld M., 2004, REV NETW ECON, V3, P20; KREPS DM, 1982, J ECON THEORY, V27, P253, DOI 10.1016/0022-0531(82)90030-8; MACAULAY S, 1963, AM SOCIOL REV, V28, P55, DOI 10.2307/2090458; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Normann HT, 2012, INT J GAME THEORY, V41, P707, DOI 10.1007/s00182-012-0341-y; Nowak M, 1992, NATURE; Ostrom E., 1990, GOVERNING COMMONS EV; Parsons T, 1937, STRUCTURE SOCIAL ACT, V1; Pennisi E, 2005, SCIENCE, V309, P93, DOI 10.1126/science.309.5731.93; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; RAPOPORT A, 1995, RATION SOC, V7, P431, DOI 10.1177/104346319500700407; RAUB W, 1990, AM J SOCIOL, V96, P626, DOI 10.1086/229574; Riedl A., 2002, EXCLUSION COOPERATIO; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; Taylor Michael, 1976, ANARCHY COOPERATION; Ultee Wout, 1996, SOCIOLOGIE VRAGEN UI; Uzzi B, 1997, ADMIN SCI QUART, V42, P35, DOI 10.2307/2393808; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Voss T., 2001, SOCIAL NORMS, P105; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	51	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0155703	10.1371/journal.pone.0155703	http://dx.doi.org/10.1371/journal.pone.0155703			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0TX	27366907	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900003
J	Deng, YL; Chang, L; Yang, M; Huo, M; Zhou, RL				Deng, Yaling; Chang, Lei; Yang, Meng; Huo, Meng; Zhou, Renlai			Gender Differences in Emotional Response: Inconsistency between Experience and Expressivity	PLOS ONE			English	Article							SEX-DIFFERENCES; TIME-COURSE; INTENSITY; FEMALES; MALES	The present study investigated gender differences in both emotional experience and expressivity. Heart rate (HR) was recorded as an indicator of emotional experience while the participants watched 16 video clips that induced eight types of emotion (sadness, anger, horror, disgust, neutrality, amusement, surprise, and pleasure). We also asked the participants to report valence, arousal, and motivation as indicators of emotional expressivity. Overall, the results revealed gender differences in emotional experience and emotional expressivity. When watching videos that induced anger, amusement, and pleasure, men showed larger decreases in HR, whereas women reported higher levels of arousal. There was no gender difference in HR when the participants watched videos that induced horror and disgust, but women reported lower valence, higher arousal, and stronger avoidance motivation than did men. Finally, no gender difference was observed in sadness or surprise, although there was one exception-women reported higher arousal when watching videos that induced sadness. The findings suggest that, when watching videos that induce an emotional response, men often have more intense emotional experiences, whereas women have higher emotional expressivity, particularly for negative emotions. In addition, gender differences depend on the specific emotion type but not the valence.	[Deng, Yaling; Zhou, Renlai] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Deng, Yaling; Zhou, Renlai] Nanjing Univ, Sch Social & Behav Sci, Dept Psychol, Nanjing, Jiangsu, Peoples R China; [Deng, Yaling; Yang, Meng; Zhou, Renlai] Beijing Normal Univ, Res Ctr Emot Regulat, Beijing, Peoples R China; [Chang, Lei] Univ Macau, Dept Psychol, Taipa, Macau, Peoples R China; [Huo, Meng] Univ Texas Austin, Dept Human Dev & Family Sci, Austin, TX 78712 USA	Beijing Normal University; Nanjing University; Beijing Normal University; University of Macau; University of Texas System; University of Texas Austin	Zhou, RL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Zhou, RL (corresponding author), Nanjing Univ, Sch Social & Behav Sci, Dept Psychol, Nanjing, Jiangsu, Peoples R China.; Zhou, RL (corresponding author), Beijing Normal Univ, Res Ctr Emot Regulat, Beijing, Peoples R China.	rlzhou@nju.edu.cn	Zhou, Renlai/ABA-1226-2021; Chang, Lei/AAB-4014-2020	Zhou, Renlai/0000-0001-7035-7097; Chang, Lei/0000-0001-6457-0254	National Basic Research Program of China [2011CB505101]; Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu [2015ZSJDXM001]	National Basic Research Program of China(National Basic Research Program of China); Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu	The work was supported by the National Basic Research Program of China (No. 2011CB505101) and the Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu (2015ZSJDXM001) to Professor Renlai Zhou, as well as the Shangshan funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett LF, 1998, COGNITION EMOTION, V12, P579, DOI 10.1080/026999398379574; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Bluhm R, 2013, NEUROETHICS-NETH, V6, P319, DOI 10.1007/s12152-011-9143-3; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Brody LR., 2000, HDB EMOTIONS, V2, P325; Carvalho S, 2012, APPL PSYCHOPHYS BIOF, V37, P279, DOI 10.1007/s10484-012-9201-6; Christie IC, 2004, INT J PSYCHOPHYSIOL, V51, P143, DOI 10.1016/j.ijpsycho.2003.08.002; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Dichter GS, 2002, INT J PSYCHOPHYSIOL, V43, P191, DOI 10.1016/S0167-8760(01)00170-2; Evers C, 2014, BIOL PSYCHOL, V98, P43, DOI 10.1016/j.biopsycho.2013.11.003; Fernandez C, 2012, APPL PSYCHOPHYS BIOF, V37, P73, DOI 10.1007/s10484-012-9180-7; Fischer A.H., 2000, GENDER EMOTION SOCIA, P71, DOI [10.1017/CBO9780511628191.005, DOI 10.1017/CBO9780511628191, 10.1017/CBO9780511628191]; Fischer AH, 2004, EMOTION, V4, P87, DOI 10.1037/1528-3542.4.1.87; Fisher RJ, 2005, J CONSUM RES, V31, P850, DOI 10.1086/426621; Gard MG, 2007, EMOTION, V7, P429, DOI 10.1037/1528-3542.7.2.429; Gardener EKT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073475; Garnefski N, 2004, PERS INDIV DIFFER, V36, P267, DOI 10.1016/S0191-8869(03)00083-7; Gohier B, 2013, EUR PSYCHIAT, V28, P74, DOI 10.1016/j.eurpsy.2011.06.007; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; GROSSMAN M, 1993, J PERS SOC PSYCHOL, V65, P1010, DOI 10.1037/0022-3514.65.5.1010; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; HODES RL, 1985, PSYCHOPHYSIOLOGY, V22, P545, DOI 10.1111/j.1469-8986.1985.tb01649.x; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; McManis MH, 2001, PSYCHOPHYSIOLOGY, V38, P222, DOI 10.1111/1469-8986.3820222; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Tobin RM, 2000, J PERS SOC PSYCHOL, V79, P656, DOI 10.1037//0022-3514.79.4.656; Vigil JM, 2008, EVOL PSYCHOL, V6, P506; Vrana SR, 2002, COGNITION EMOTION, V16, P165, DOI 10.1080/02699930143000185; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; [蚁金瑶 Yi Jinyao], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P763; Zhang Z, 2001, CHIN J BEHAV MED SCI, V10, P19; 刘雷, 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P614	36	114	117	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158666	10.1371/journal.pone.0158666	http://dx.doi.org/10.1371/journal.pone.0158666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362361	Green Submitted, gold, Green Published			2022-12-27	WOS:000378865200105
J	Gomez, I; Ozen, G; Deschildre, C; Amgoud, Y; Boubaya, L; Gorenne, I; Benyahia, C; Roger, T; Leseche, G; Galardon, E; Topal, G; Jacob, MP; Longrois, D; Norel, X				Gomez, Ingrid; Ozen, Gulsev; Deschildre, Catherine; Amgoud, Yasmine; Boubaya, Lilia; Gorenne, Isabelle; Benyahia, Chabha; Roger, Thomas; Leseche, Guy; Galardon, Erwan; Topal, Gokce; Jacob, Marie-Paule; Longrois, Dan; Norel, Xavier			Reverse Regulatory Pathway (H2S/PGE(2)/MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity	PLOS ONE			English	Article							PROSTAGLANDIN-E SYNTHASE-1; MATRIX-METALLOPROTEINASE ACTIVITIES; HYDROGEN-SULFIDE; OXIDATIVE STRESS; ENDOGENOUS H2S; KAPPA-B; CELLS; PLAQUE; ARTERY; ATHEROSCLEROSIS	Hydrogen sulfide (H2S) is a mediator with demonstrated protective effects for the cardiovascular system. On the other hand, prostaglandin (PG)E-2 is involved in vascular wall remodeling by regulating matrix metalloproteinase (MMP) activities. We tested the hypothesis that endogenous H2S may modulate PGE(2), MMP-1 activity and endogenous tissue inhibitors of MMPs (TIMP-1/-2). This regulatory pathway could be involved in thinning of abdominal aortic aneurysm (AAA) and thickening of saphenous vein (SV) varicosities. The expression of the enzyme responsible for H2S synthesis, cystathionine-gamma-lyase (CSE) and its activity, were significantly higher in varicose vein as compared to SV. On the contrary, the endogenous H2S level and CSE expression were lower in AAA as compared to healthy aorta (HA). Endogenous H2S was responsible for inhibition of PGE(2) synthesis mostly in varicose veins and HA. A similar effect was observed with exogenous H2S and consequently decreasing active MMP-1/TIMP ratios in SV and varicose veins. In contrast, in AAA, higher levels of PGE(2) and active MMP-1/TIMP ratios were found versus HA. These findings suggest that differences in H2S content in AAA and varicose veins modulate endogenous PGE(2) production and consequently the MMP/TIMP ratio. This mechanism may be crucial in vascular wall remodeling observed in different vascular pathologies (aneurysm, varicosities, atherosclerosis and pulmonary hypertension).	[Gomez, Ingrid; Ozen, Gulsev; Deschildre, Catherine; Amgoud, Yasmine; Boubaya, Lilia; Benyahia, Chabha; Leseche, Guy; Jacob, Marie-Paule; Longrois, Dan; Norel, Xavier] INSERM, U1148, F-75018 Paris, France; [Gomez, Ingrid; Benyahia, Chabha; Norel, Xavier] Univ Paris 13, UMR S1148, F-75018 Paris, France; [Ozen, Gulsev; Topal, Gokce] Istanbul Univ, Fac Pharm, Dept Pharmacol, Istanbul, Turkey; [Roger, Thomas; Galardon, Erwan] Univ Paris 05, CNRS, UMR 8601, LCBPT,Sorbonne Paris Cite, F-75006 Paris, France; [Leseche, Guy] Univ Paris Diderot, Sorbonne Paris Cite, AP HP CHU X Bichat, Dept Vasc & Thorac Surg,UMR S1148, F-75018 Paris, France; [Gorenne, Isabelle; Longrois, Dan] Univ Paris Diderot, Sorbonne Paris Cite, AP HP CHU X Bichat, Dept Anesthesia & Intens Care,UMR S1148, F-75018 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Istanbul University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Norel, X (corresponding author), INSERM, U1148, F-75018 Paris, France.; Norel, X (corresponding author), Univ Paris 13, UMR S1148, F-75018 Paris, France.	xavier.norel@inserm.fr	Norel, Xavier/C-5978-2011; Galardon, Erwan/K-1063-2018; Ozen, Gulsev/AAD-4984-2020	Norel, Xavier/0000-0003-0734-3359; Galardon, Erwan/0000-0002-4371-6119; ingrid, gomez/0000-0002-8967-2481	INSERM (Institut National de la Sante et de la Recherche Medicale); Scientific and Technological Research Council of Turkey (TUBITAK) [BIDEB-2214]; Paris 13 University	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Paris 13 University	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale). Gulsev Ozen is a recipient of a postgraduate fellowship (BIDEB-2214) from the Scientific and Technological Research Council of Turkey (TUBITAK). Ingrid Gomez was supported by a PhD grant from Paris 13 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thanks Tariya Zaoui (CHU X. Bichat; Paris, France) for her help in obtaining the vascular preparations and Dr Mary Osborne-Pellegrin and Ben Ward, MSc (Infection, Immunity and Cardiovascular Science, University of Sheffield, UK) for his help in editing the manuscript. This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale). Gulsev Ozen is a recipient of a postgraduate fellowship (BIDEB-2214) from the Scientific and Technological Research Council of Turkey (TUBITAK). Ingrid Gomez was supported by a PhD grant from Paris 13 University.	Al-Magableh MR, 2015, HYPERTENS RES, V38, P13, DOI 10.1038/hr.2014.125; Annabi B, 2002, J VASC SURG, V35, P539, DOI 10.1067/mva.2002.121124; BADESCH DB, 1989, AM J RESP CELL MOL, V1, P489, DOI 10.1165/ajrcmb/1.6.489; Badier-Commander C, 2000, J PATHOL, V192, P105, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH670>3.0.CO;2-1; Badier-Commander C, 2001, J PATHOL, V193, P398, DOI 10.1002/path.819; Beltowski J, 2014, MOLECULES, V19, P21183, DOI 10.3390/molecules191221183; Benjamin Mina M, 2012, Exp Suppl, V103, P209, DOI 10.1007/978-3-0348-0364-9_7; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Burguera EF, 2014, OSTEOARTHR CARTILAGE, V22, P1026, DOI 10.1016/j.joca.2014.04.031; Camacho M, 2013, J LIPID RES, V54, P3506, DOI 10.1194/jlr.M042481; Cao RY, 2012, AM J PATHOL, V181, P313, DOI 10.1016/j.ajpath.2012.03.016; Cipollone F, 2001, CIRCULATION, V104, P921, DOI 10.1161/hc3401.093152; Cuccurullo C, 2006, ARTERIOSCL THROM VAS, V26, P2716, DOI 10.1161/01.ATV.0000249630.02085.12; Dejouvencel T, 2010, ARTERIOSCL THROM VAS, V30, P269, DOI 10.1161/ATVBAHA.109.198309; Deng DXF, 2006, ARTERIOSCL THROM VAS, V26, P1058, DOI 10.1161/01.ATV.0000208185.16371.97; Distrutti E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-36; Doeller JE, 2005, ANAL BIOCHEM, V341, P40, DOI 10.1016/j.ab.2005.03.024; Du CC, 2014, BIOCHEM BIOPH RES CO, V451, P239, DOI 10.1016/j.bbrc.2014.07.107; Gomez I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088021; Gomez I, 2013, INFLAMM RES, V62, P299, DOI 10.1007/s00011-012-0578-8; Gomez-Hernandez A, 2006, ATHEROSCLEROSIS, V187, P139, DOI 10.1016/j.atherosclerosis.2005.08.035; Heo SH, 2011, J CLIN NEUROL, V7, P69, DOI 10.3988/jcn.2011.7.2.69; Holmes DR, 1997, J VASC SURG, V25, P810, DOI 10.1016/S0741-5214(97)70210-6; Kalayarasan S, 2013, TOXICOL APPL PHARM, V271, P184, DOI 10.1016/j.taap.2013.04.021; Kucukguven A, 2013, CURR DRUG TARGETS, V14, P287; Li L, 2013, J CELL MOL MED, V17, P365, DOI 10.1111/jcmm.12016; Li Xiao-Hui, 2007, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V23, P75; Li XH, 2009, EXP BIOL MED, V234, P504, DOI 10.3181/0807-RM-230; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; LopezCandales A, 1997, AM J PATHOL, V150, P993; Mancini S, 2003, VASA-J VASCULAR DIS, V32, P26, DOI 10.1024/0301-1526.32.1.26; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Martelli A, 2013, PHARMACOL RES, V70, P27, DOI 10.1016/j.phrs.2012.12.005; Olson KR, 2015, ANTIOXID REDOX SIGN, V22, P377, DOI 10.1089/ars.2014.5930; Qipshidze N, 2012, INT J BIOL SCI, V8, P430, DOI 10.7150/ijbs.3632; Reilly JM, 1999, SURGERY, V126, P624, DOI 10.1016/S0039-6060(99)70114-5; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Shin DY, 2010, TOXICOL IN VITRO, V24, P1569, DOI 10.1016/j.tiv.2010.06.014; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Talaei F, 2012, J EXP BIOL, V215, P2912, DOI 10.1242/jeb.067363; Tyagi N, 2010, NEUROCHEM INT, V56, P301, DOI 10.1016/j.neuint.2009.11.002; VANDERWAL AC, 1993, ATHEROSCLEROSIS, V103, P55, DOI 10.1016/0021-9150(93)90039-W; Wang M, 2008, CIRCULATION, V117, P1302, DOI 10.1161/CIRCULATIONAHA.107.731398; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Webb GD, 2008, J PHARMACOL EXP THER, V324, P876, DOI 10.1124/jpet.107.133538; Wei LP, 2014, CELL SIGNAL, V26, P1476, DOI 10.1016/j.cellsig.2014.03.008; Xu WM, 2015, INT J MOL MED, V35, P177, DOI 10.3892/ijmm.2014.2007; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yokoyama U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036724; Zhang CY, 2013, ACTA PHARMACOL SIN, V34, P1301, DOI 10.1038/aps.2013.84	51	22	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158421	10.1371/journal.pone.0158421	http://dx.doi.org/10.1371/journal.pone.0158421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362269	Green Submitted, gold, Green Published			2022-12-27	WOS:000378865200071
J	Muller, A; Claes, L; Smits, D; Brahler, E; de Zwaan, M				Mueller, Astrid; Claes, Laurence; Smits, Dirk; Braehler, Elmar; de Zwaan, Martina			Prevalence and Correlates of Self-Harm in the German General Population	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; BARRATT IMPULSIVENESS SCALE; TERM-FOLLOW-UP; INJURIOUS-BEHAVIOR; EMERGENCY-DEPARTMENT; MUTILATIVE BEHAVIOR; BARIATRIC SURGERY; SUICIDE; NSSI; INVENTORY	The study aimed at evaluating the psychometric properties of the German version of the Self-Harm Inventory (SHI) and examining the lifetime prevalence and correlates of self-harm in a representative German population sample (N = 2,507; age mean = 48.79, SD = 18.11; range 14 to 94 years; 55.5% women) using the SHI. All participants answered the German SHI, the short form of the Barratt Impulsiveness Scale (BIS-15), the ultra-brief Patient Health Questionnaire for Depression and Anxiety (PHQ-4), and provided sociodemographic information. The one-factorial structure of the SHI was replicated using a confirmatory factor analysis. Internal consistency coefficients were sufficient and in line with previous studies. Almost half of the sample (49%) acknowledged at least one self-harming behavior over the life-span, most frequently indirect forms of self-harm. The rate of participants who engaged in at least one SHI behavior was higher among men than women (51.6% vs. 46.9%, respectively, chi(2) = 5.38, p = 0.020). Higher SHI scores were related to younger age, male gender, living alone, more symptoms of anxiety and depression (PHQ-4), higher impulsivity scores (BIS-15), and suffering from obesity grade 2. Women engaged more often in discreet forms of self-harm than men, e.g., preventing wounds from healing, exercising an injury, starving, and abusing laxatives. In terms of other indirect self-harming behaviors, men admitted more often driving recklessly, being promiscuous and losing a job on purpose, while women reported more frequently engaging in emotionally abusive relationships. With respect to direct self-harm, women were more likely to endorse suicide attempts and cutting, while men admitted more often head-banging. The findings suggest that self-harm constitutes a common problem. Future longitudinal studies are required to examine the natural course, sociodemographic and psychopathological risk factors, as well as possible time-trends of self-harming behaviors in more depth.	[Mueller, Astrid; de Zwaan, Martina] Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany; [Claes, Laurence; Smits, Dirk] Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Claes, Laurence] Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium; [Smits, Dirk] Odisee Univ Coll, Brussels, Belgium; [Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany	Hannover Medical School; KU Leuven; University of Antwerp; Leipzig University	Muller, A (corresponding author), Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany.	mueller.astrid@mh-hannover.de	Smits, Dirk/P-8501-2019; Braehler, Elmar/C-6535-2009	Smits, Dirk/0000-0001-5542-3252; Braehler, Elmar/0000-0002-2648-2728; Claes, Laurence/0000-0002-2287-3158				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andover MS, 2010, ARCH SUICIDE RES, V14, P79, DOI 10.1080/13811110903479086; Archer L., 2003, HIGHER ED SOCIAL CLA; Bilen K, 2011, EMERG MED J, V28, P1019, DOI 10.1136/emj.2010.102616; Bresin K, 2015, CLIN PSYCHOL REV, V38, P55, DOI 10.1016/j.cpr.2015.02.009; Briere J, 1998, AM J ORTHOPSYCHIAT, V68, P609, DOI 10.1037/h0080369; Brunner R, 2014, J CHILD PSYCHOL PSYC, V55, P337, DOI 10.1111/jcpp.12166; Carr MJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0753-5; Claes L, 2001, Eat Behav, V2, P263, DOI 10.1016/S1471-0153(01)00033-2; Claes L, 2007, PERS INDIV DIFFER, V42, P611, DOI 10.1016/j.paid.2006.07.021; Claes L, 2007, COMPR PSYCHIAT, V48, P137, DOI 10.1016/j.comppsych.2006.10.009; Claes L, 2015, EUR EAT DISORD REV, V23, P119, DOI 10.1002/erv.2341; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Fliege H, 2009, J PSYCHOSOM RES, V66, P477, DOI 10.1016/j.jpsychores.2008.10.013; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Gratz KL, 2001, J PSYCHOPATHOL BEHAV, V23, P253, DOI 10.1023/A:1012779403943; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; Hawton K, 2003, BRIT J PSYCHIAT, V182, P537, DOI 10.1192/bjp.182.6.537; Hawton K, 1997, BRIT J PSYCHIAT, V171, P556, DOI 10.1192/bjp.171.6.556; Hawton K, 2015, SOC PSYCH PSYCH EPID, V50, P695, DOI 10.1007/s00127-014-0990-1; Hawton K, 2013, J AFFECT DISORDERS, V151, P821, DOI 10.1016/j.jad.2013.08.020; Herpertz S, 1997, J PSYCHIAT RES, V31, P451, DOI 10.1016/S0022-3956(97)00004-6; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Klonsky ED, 2011, PSYCHOL MED, V41, P1981, DOI 10.1017/S0033291710002497; Klonsky ED, 2007, J CLIN PSYCHOL, V63, P1045, DOI 10.1002/jclp.20412; KOLB JE, 1980, ARCH GEN PSYCHIAT, V37, P37; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Latimer S, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-53; Madge N, 2011, EUR CHILD ADOLES PSY, V20, P499, DOI 10.1007/s00787-011-0210-4; Meule A, 2011, DIAGNOSTICA, V57, P126, DOI 10.1026/0012-1924/a000042; Mitchell JE, 2013, OBESITY, V21, P665, DOI 10.1002/oby.20066; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Muehlenkamp JJ, 2005, AM J ORTHOPSYCHIAT, V75, P324, DOI 10.1037/0002-9432.75.2.324; Nock MK, 2004, J CONSULT CLIN PSYCH, V72, P885, DOI 10.1037/0022-006X.72.5.885; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paul T, 2002, AM J PSYCHIAT, V159, P408, DOI 10.1176/appi.ajp.159.3.408; Plener PL, 2009, PSYCHOL MED, V39, P1549, DOI 10.1017/S0033291708005114; Plener PL, 2015, BORDER PERS DIS EMOT, V2, DOI 10.1186/s40479-014-0024-3; Plener PL, 2014, Z KINDER JUG-PSYCH, V42, P405, DOI 10.1024/1422-4917/a000319; Plener PL, 2013, SOC PSYCH PSYCH EPID, V48, P1439, DOI 10.1007/s00127-012-0645-z; Randall JR, 2014, PEERJ, V2, DOI 10.7717/peerj.667; Rawlings J, 2015, J AFFECT DISORDERS, V184, P29, DOI 10.1016/j.jad.2015.05.042; Sansone RA, 1998, J CLIN PSYCHOL, V54, P973, DOI 10.1002/(SICI)1097-4679(199811)54:7<973::AID-JCLP11>3.0.CO;2-H; Sansone RA, 2008, J PSYCHOSOM RES, V65, P441, DOI 10.1016/j.jpsychores.2008.05.029; Sansone Randy A, 2006, J Psychiatr Pract, V12, P148, DOI 10.1097/00131746-200605000-00003; Sansone RA, 2015, INT J PSYCHIAT CLIN, V19, P291, DOI 10.3109/13651501.2015.1074708; Sansone Randy A, 2006, Prim Care Companion J Clin Psychiatry, V8, P153; Sansone Randy A, 2007, Violence Vict, V22, P120, DOI 10.1891/088667007780482883; St Germain SA, 2012, PSYCHIAT RES, V197, P78, DOI 10.1016/j.psychres.2011.12.050; SWARTZ M, 1990, J PERSONALITY DISORD, V0004; Tindle HA, 2010, AM J MED, V123, P1036, DOI 10.1016/j.amjmed.2010.06.016; Ullrich S, 2009, J PERS DISORD, V23, P187, DOI 10.1521/pedi.2009.23.2.187; Zetterqvist M, 2015, CHILD ADOL PSYCH MEN, V9, DOI 10.1186/s13034-015-0062-7	53	24	24	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157928	10.1371/journal.pone.0157928	http://dx.doi.org/10.1371/journal.pone.0157928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0CH	27362348	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200028
J	Zhou, JF; Chiba, A; Scheffel, DLS; Hebling, J; Agee, K; Niu, LN; Tay, FR; Pashley, DH				Zhou, Jianfeng; Chiba, Ayaka; Scheffel, Debora L. S.; Hebling, Josimeri; Agee, Kelli; Niu, Li-na; Tay, Franklin R.; Pashley, David H.			Effects of a Dicalcium and Tetracalcium Phosphate-Based Desensitizer on In Vitro Dentin Permeability	PLOS ONE			English	Article							FLUORIDE VARNISH; CLINICAL-EVALUATION; HYPERSENSITIVITY; PREVALENCE; POPULATION; SENSITIVITY; EFFICACY; CEMENTS; TEETH; LASER	The present study evaluated the effectiveness of a dicalcium and tetracalcium phosphate-based desensitizer in reducing dentin permeability in vitro. Dentin fluid flow was measured before and after treatment of dentin with patent dentinal tubules using 1 or 3 applications of the dicalcium and tetracalcium phosphate containing agent Teethmate (TM) (TM) and comparing the results with two sodium fluoride varnishes Vella (TM) (VLA) and Vanish (TM) (VAN), after storage in artificial saliva for 24 h, 48 h and 7 days. Significant differences were observed among the 4 methods employed for reducing dentin permeability (p < 0.001) and the 3 post-treatment times (p < 0.001). VLA and VAN never achieved 50% permeability reductions consistently in any of the 3 time periods. Only the calcium phosphate-based desensitizer applied for 3 times consistently reduced dentin permeability by 50% after 24 h. When applied once, the permeability reduction of TM increased progressively over the 3 time periods. After 7 days, only one and three applications of the calcium phosphate-based desensitizer consistently reduced dentin permeability by more than 50%. Permeability reductions corresponded well with scanning electron microscopy examination of dentinal tubule orifice occlusion in dentin specimens treated with the agents. Overall, the dicalcium and tetracalcium phosphate-based desensitizer is effective in reducing dentin permeability via a tubule occlusion mechanism. The ability of the agent to reduce dentin permeability renders it to be potentially useful as a clinical dentin desensitizing agent, which has to be confirmed in future clinical studies. By contrast, the two sodium fluoride varnishes are not effective in dentin permeability reduction and should be considered as topical fluoride delivering agents rather than tubular orifice-blocking agents.	[Zhou, Jianfeng] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing, Peoples R China; [Chiba, Ayaka] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cariol & Operat Dent, Tokyo, Japan; [Scheffel, Debora L. S.; Hebling, Josimeri] Univ Estadual Paulista, UNESP, Araraquara Dent Sch, Dept Orthodont & Pediat Dent, Sao Paulo, Brazil; [Agee, Kelli; Tay, Franklin R.; Pashley, David H.] Augusta Univ, Dent Coll Georgia, Augusta, GA USA; [Niu, Li-na] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian, Peoples R China; [Niu, Li-na] Fourth Mil Med Univ, Sch Stomatol, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China; [Niu, Li-na] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Shaanxi Key Lab Oral Dis, Xian, Peoples R China	Peking University; Tokyo Medical & Dental University (TMDU); Universidade Estadual Paulista; University System of Georgia; Augusta University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Pashley, DH (corresponding author), Augusta Univ, Dent Coll Georgia, Augusta, GA USA.; Niu, LN (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian, Peoples R China.; Niu, LN (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China.; Niu, LN (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Shaanxi Key Lab Oral Dis, Xian, Peoples R China.	niulina831013@126.com; dpashley@gru.edu	Scheffel, Debora LS/C-9979-2012; niu, lina/GWR-3585-2022; Hebling, Josimeri/C-7738-2012; Hebling, Josimeri/AAH-1737-2019	Scheffel, Debora LS/0000-0001-9121-0799; Hebling, Josimeri/0000-0002-2846-2325; Tay, Franklin/0000-0003-3769-0626	Sao Paulo Research Foundation-FAPESP of J.H.'s sabbatical at The Dental College of Georgia at Augusta University [2014/17232-4, 2014/18160-7]; NIDCR [R01 DE015306]; National High Technology Research and Development Program of China grant [2015AA020942]; National Nature Science Foundation of China grant [81400555]	Sao Paulo Research Foundation-FAPESP of J.H.'s sabbatical at The Dental College of Georgia at Augusta University; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National High Technology Research and Development Program of China grant; National Nature Science Foundation of China grant	The authors thank Sao Paulo Research Foundation-FAPESP for partial financial support (Process 2014/17232-4 and 2014/18160-7) of J.H.'s sabbatical at The Dental College of Georgia at Augusta University. DHP and FRT were supported by NIDCR R01 DE015306. LNN was supported by National High Technology Research and Development Program of China grant 2015AA020942 and National Nature Science Foundation of China grant 81400555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ABSI EG, 1987, J CLIN PERIODONTOL, V14, P280, DOI 10.1111/j.1600-051X.1987.tb01533.x; Arends J, 1997, CARIES RES, V31, P201, DOI 10.1159/000262399; Ayad F, 2009, J Clin Dent, V20, P115; Bahsi E, 2012, EUR REV MED PHARMACO, V16, P1107; Bamise Cornelius T, 2007, Oral Health Prev Dent, V5, P49; Banomyong D, 2013, J INVESTIG CLIN DENT, V4, DOI 10.1111/j.2041-1626.2012.00144.x; Brannstrom M, 1965, Odontol Revy, V16, P293; BRANNSTROM M, 1962, ARCH ORAL BIOL, V7, P59, DOI 10.1016/0003-9969(62)90048-1; Bubteina N, 2015, DENTISTRY, V5, P330, DOI DOI 10.4172/2161-1122.1000330; Chabanski MB, 1996, J CLIN PERIODONTOL, V23, P989, DOI 10.1111/j.1600-051X.1996.tb00525.x; Chen WC, 2003, J BIOMED MATER RES A, V64A, P664, DOI 10.1002/jbm.a.10250; Chow LC, 2009, DENT MATER J, V28, P1; Chow LC, 2001, MONOGRAPHS ORAL SCI, V18, P17; Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017; Ding YJ, 2014, AM J DENT, V27, P79; Draenert ME, 2013, AM J DENT, V26, P21; FISCHER C, 1992, J DENT, V20, P272, DOI 10.1016/0300-5712(92)90043-C; FLYNN J, 1985, J DENT, V13, P230, DOI 10.1016/0300-5712(85)90004-1; Gaffar A, 1999, Compend Contin Educ Dent, V20, P27; Gillam DG, 2002, J ORAL REHABIL, V29, P226, DOI 10.1046/j.1365-2842.2002.00813.x; Gysi A, 1900, BR J DENT SCI, V43, P865; HANSEN EK, 1992, SCAND J DENT RES, V100, P305; Hirayama S, 2008, J RES NATL INST STAN, V113, P311, DOI 10.6028/jres.113.025; Hoang-Dao BT, 2009, J ORAL REHABIL, V36, P124, DOI 10.1111/j.1365-2842.2008.01907.x; Ishikawa K, 1999, J BIOMED MATER RES, V46, P504, DOI 10.1002/(SICI)1097-4636(19990915)46:4<504::AID-JBM8>3.0.CO;2-H; Kara C, 2009, J ENDODONT, V35, P971, DOI 10.1016/j.joen.2009.04.004; Kehua Q, 2009, INT DENT J, V59, P376, DOI 10.1922/IDJ_2293Xu05; LEVINE MJ, 1993, CRIT REV ORAL BIOL M, V4, P279, DOI 10.1177/10454411930040030401; Liu HC, 1998, J ENDODONT, V24, P45, DOI 10.1016/S0099-2399(98)80213-6; LUNDY T, 1969, ORAL SURG ORAL MED O, V27, P187, DOI 10.1016/0030-4220(69)90172-8; Mantzourani M, 2013, J DENT, V41, pS3, DOI 10.1016/S0300-5712(13)70002-2; Mehta D, 2014, ACTA ODONTOL SCAND, V72, P936, DOI 10.3109/00016357.2014.923112; Merika K, 2006, EUR J PROSTHODONT RE, V14, P38; Miles TS, 2004, CLIN ORAL PHYSL, P33; NARHI M, 1994, ARCH ORAL BIOL, V39, pS23, DOI 10.1016/0003-9969(94)90184-8; Nathoo S, 2009, J Clin Dent, V20, P123; Pashley D.H., 2008, INSIDE DENT, V29, P1; PASHLEY DH, 1994, ARCH ORAL BIOL, V39, pS73, DOI 10.1016/0003-9969(94)90191-0; Petersson LG, 2013, CLIN ORAL INVEST, V17, pS63, DOI 10.1007/s00784-012-0916-9; Que K, 2013, J ORAL REHABIL, V40, P24, DOI 10.1111/j.1365-2842.2012.02342.x; Rahiotis C, 2013, J ORAL REHABIL, V40, P948, DOI 10.1111/joor.12109; Rees J S, 2004, Int J Dent Hyg, V2, P64, DOI 10.1111/j.1601-5029.2004.00068.x; Rees JS, 2003, J DENT, V31, P453, DOI 10.1016/S0300-5712(03)00092-7; Ritter AV, 2006, J AM DENT ASSOC, V137, P1013, DOI 10.14219/jada.archive.2006.0324; Taani DQ, 2001, QUINTESSENCE INT, V32, P372; Taani SDMQ, 2002, J CLIN PERIODONTOL, V29, P118, DOI 10.1034/j.1600-051x.2002.290205.x; Thanatvarakorn O, 2013, DENT MATER J, V32, P615, DOI 10.4012/dmj.2013-073; Thanatvarakorn O, 2013, J BIOMED MATER RES B, V101B, P303, DOI 10.1002/jbm.b.32840; Udoye C I, 2006, Odontostomatol Trop, V29, P19; Verzak Z, 1998, COLLEGIUM ANTROPOL, V22, P259; West N, 2014, MONOGR ORAL SCI, V25, P108, DOI 10.1159/000360749; Ye W, 2012, J ORAL REHABIL, V39, P182, DOI 10.1111/j.1365-2842.2011.02248.x; Yilmaz HG, 2011, PHOTOMED LASER SURG, V29, P721, DOI 10.1089/pho.2010.2974	53	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158400	10.1371/journal.pone.0158400	http://dx.doi.org/10.1371/journal.pone.0158400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27359118	Green Submitted, Green Published, gold			2022-12-27	WOS:000378865200069
J	Hoseini, SG; Kelishadi, R; Kasaeian, A; Ataei, B; Yaran, M; Motlagh, ME; Heshmat, R; Ardalan, G; Safari, O; Qorbani, M; Mostafavi, SN				Hoseini, Shervin Ghaffari; Kelishadi, Roya; Kasaeian, Amir; Ataei, Behrooz; Yaran, Majid; Motlagh, Mohammad Esmaeil; Heshmat, Ramin; Ardalan, Gelayol; Safari, Omid; Qorbani, Mostafa; Mostafavi, Seyed Naseredin			Seroprevalence and Risk Factors of Varicella Zoster Infection in Iranian Adolescents: A Multilevel Analysis; The CASPIAN-III Study	PLOS ONE			English	Article							HERPES-ZOSTER; VIRUS; SEROEPIDEMIOLOGY; VACCINATION; IMPLEMENTATION; EPIDEMIOLOGY; TRANSMISSION; TEMPERATURE; STUDENTS; CHILDREN	The objective of this study was to evaluate the varicella zoster virus (VZV) immunity in Iranian adolescents. It was conducted as a primary study for vaccine implementation, and to investigate the association of climatic and socioeconomic factors with the epidemiology of this infection. In this cross-sectional study, anti VZV antibodies were measured in serum samples obtained in a national school-based health survey (CASPIAN-III). Association of demographic, socio-economic, and climate of the living region with the frequency of VZV was investigated by multivariate multilevel analysis. Overall, sera of 2753 individuals aged 10-18 were tested for VZV antibodies, from those 87.4% were positive. The prevalence was statistically different in four socio-geographic regions (P<0.001), varying between 85.24% in West region (mostly mountainous areas with cold climate) to 94.59% in Southeast region (subtropical climate). Among variables studied, only age and mean daily temperature of the living area were positively associated with the VZV seroprevalence. Our findings show that most Iranians develop immunity to VZV before the age of 10, but a substantial proportion of them are yet susceptible to the infection. Therefore, it seems that the best strategy to reduce the burden of the disease is to vaccinate high-risk adults, i.e. those without a history of varicella infection. The regional temperature might be the only determinant of VZV epidemiology in Iran.	[Hoseini, Shervin Ghaffari] Isfahan Univ Med Sci, Infect Dis & Trop Med Res Ctr, Esfahan, Iran; [Kelishadi, Roya; Ardalan, Gelayol; Mostafavi, Seyed Naseredin] Isfahan Univ Med Sci, Dept Pediat, Child Growth & Dev Res Ctr, Res Inst Primordial Prevent Noncommunicable Dis, Esfahan, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Ataei, Behrooz] Isfahan Univ Med Sci, Nosocomial Infect Res Ctr, Esfahan, Iran; [Yaran, Majid] Isfahan Univ Med Sci, Acquired Immunodeficiency Res Ctr, Esfahan, Iran; [Motlagh, Mohammad Esmaeil] Ahvaz Jundishapur Univ Med Sci, Dept Pediat, Ahvaz, Iran; [Heshmat, Ramin] Univ Tehran Med Sci, Chron Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran; [Safari, Omid] Alborz Univ Med Sci, Dept Pediat, Karaj, Iran; [Qorbani, Mostafa] Alborz Univ Med Sci, Dietary Supplements & Probiot Res Ctr, Karaj, Iran; [Qorbani, Mostafa] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran	Isfahan University Medical Science; Isfahan University Medical Science; Tehran University of Medical Sciences; Isfahan University Medical Science; Isfahan University Medical Science; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Tehran University of Medical Sciences; Tehran University of Medical Sciences	Mostafavi, SN (corresponding author), Isfahan Univ Med Sci, Dept Pediat, Child Growth & Dev Res Ctr, Res Inst Primordial Prevent Noncommunicable Dis, Esfahan, Iran.; Qorbani, M (corresponding author), Alborz Univ Med Sci, Dietary Supplements & Probiot Res Ctr, Karaj, Iran.; Qorbani, M (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.	mqorbani1379@yahoo.com; n_mostafavy@med.mui.ac.ir	Madihi, Yahya/C-6498-2018; Safari, Omid/U-8155-2017; Hoseini, Shervin Ghaffari/O-4481-2016; Kasaeian, Amir/C-8290-2017; motlagh, Mohammad Esmaiel/AAC-2653-2019; Qorbani, Mostafa/M-8171-2017; Kelishadi, Roya/E-6154-2012; Heshmat, Ramin/S-7435-2017	Madihi, Yahya/0000-0002-5188-0322; Safari, Omid/0000-0003-1610-4755; Hoseini, Shervin Ghaffari/0000-0003-4340-8949; Kasaeian, Amir/0000-0003-2018-9368; motlagh, Mohammad Esmaiel/0000-0002-2971-8660; Kelishadi, Roya/0000-0001-7455-1495; Shamlouei, Shakila/0000-0002-7409-1035; Qorbani, Mostafa/0000-0001-9465-7588	Alborz University of Medical Sciences [2015.65.786]; Isfahan University of Medical Sciences	Alborz University of Medical Sciences; Isfahan University of Medical Sciences	This study was financially supported by Alborz University of Medical Sciences (project number: 2015.65.786) and Isfahan University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram D S, 2000, Southeast Asian J Trop Med Public Health, V31, P646; Allami A, 2014, IRAN J MICROBIOL, V6, P372; Amiri M. J., 2010, Journal of Environmental Science and Technology, V3, P208; [Anonymous], 2014, WKLY EPIDEMIOL REC; [Anonymous], 2015, AN REP CLIM DAT; Ardakani AT, 2013, JUNDISHAPUR J MICROB, V6, DOI 10.5812//jjm.8388; Barazesh A, 2014, IRAN SOUTH MED J, V16, P459; Caro DH., 2012, IERI MONOGRAPH SERIE, V5, P9, DOI DOI 10.1787/9789264091504-EN; Carrillo-Santisteve P, 2014, CLIN MICROBIOL INFEC, V20, P86, DOI 10.1111/1469-0691.12580; Center for Communicable Disease Control, 2012, COMPR GUID COMM DIS; Chan JYC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-366; Critselis E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052016; Ehsanipour F, 2009, IRAN U MED SCI J, V16, P38; Farzadfar F, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-55; GARNETT GP, 1993, EPIDEMIOL INFECT, V110, P361, DOI 10.1017/S0950268800068308; Gnann John W Jr, 2012, Clin Obstet Gynecol, V55, P560, DOI 10.1097/GRF.0b013e3182510b67; Gould Dinah, 2014, Nurs Stand, V28, P52, DOI 10.7748/ns2014.04.28.33.52.e8249; Heywood AE, 2014, B WORLD HEALTH ORGAN, V92, P593, DOI 10.2471/BLT.13.132142; Kelishadi R, 2012, INT J PREVENTIVE MED, V3, P394; Kose S, 2013, J INFECT PUBLIC HEAL, V6, P115, DOI 10.1016/j.jiph.2012.10.003; Koturoglu G, 2011, PAEDIATR PERINAT EP, V25, P388, DOI 10.1111/j.1365-3016.2010.01180.x; Liyanage N P M, 2007, Indian J Med Sci, V61, P128; Lolekha S, 2001, AM J TROP MED HYG, V64, P131, DOI 10.4269/ajtmh.2001.64.131; Lowen Anice, 2009, PLoS Curr, V1, pRRN1002; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; Nichols RA, 2011, EPIDEMICS-NETH, V3, P12, DOI 10.1016/j.epidem.2010.11.003; Pourakbari B, 2012, IRAN J MICROBIOL, V4, P136; Sco Iran, 2014, ATL SEL RES 2011 NAT; Sharifi Zohreh, 2005, Iran J Allergy Asthma Immunol, V4, P95; Speed TP, 2004, ENCY STAT SCI; TAYLORWIEDEMAN J, 1989, JPN J MED SCI BIOL, V42, P1; Tseng H. F., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1201; Wharton M, 1996, INFECT DIS CLIN N AM, V10, P571, DOI 10.1016/S0891-5520(05)70313-5; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481; Yang YY, 2015, J AM ACAD DERMATOL, V73, P660, DOI 10.1016/j.jaad.2015.07.015; Ziyaeyan M, 2010, IRAN RED CRESCENT ME, V12, P176	38	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158398	10.1371/journal.pone.0158398	http://dx.doi.org/10.1371/journal.pone.0158398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355931	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400059
J	Lau, YL; Lee, WC; Gudimella, R; Zhang, GP; Ching, XT; Razali, R; Aziz, F; Anwar, A; Fong, MY				Lau, Yee-Ling; Lee, Wenn-Chyau; Gudimella, Ranganath; Zhang, GuiPing; Ching, Xiao-Teng; Razali, Rozaimi; Aziz, Farhanah; Anwar, Arif; Fong, Mun-Yik			Deciphering the Draft Genome of Toxoplasma gondii RH Strain	PLOS ONE			English	Article							DE-NOVO IDENTIFICATION; FAMILIES; ANTIGENS; TOXODB	Toxoplasmosis is a widespread parasitic infection by Toxoplasma gondii, a parasite with at least three distinct clonal lineages. This article reports the whole genome sequencing and de novo assembly of T. gondii RH (type I representative strain), as well as genome-wide comparison across major T. gondii lineages. Genomic DNA was extracted from tachyzoites of T. gondii RH strain and its identity was verified by PCR and LAMP. Subsequently, whole genome sequencing was performed, followed by sequence filtering, genome assembly, gene annotation assignments, clustering of gene orthologs and phylogenetic tree construction. Genome comparison was done with the already archived genomes of T. gondii. From this study, the genome size of T. gondii RH strain was found to be 69.35Mb, with a mean GC content of 52%. The genome shares high similarity to the archived genomes of T. gondii GT1, ME49 and VEG strains. Nevertheless, 111 genes were found to be unique to T. gondii RH strain. Importantly, unique genes annotated to functions that are potentially critical for T. gondii virulence were found, which may explain the unique phenotypes of this particular strain. This report complements the genomic archive of T. gondii. Data obtained from this study contribute to better understanding of T. gondii and serve as a reference for future studies on this parasite.	[Lau, Yee-Ling; Ching, Xiao-Teng; Fong, Mun-Yik] Univ Malaya, Fac Med, Dept Parasitol, TIDREC, Kuala Lumpur, Malaysia; [Lee, Wenn-Chyau] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Gudimella, Ranganath; Razali, Rozaimi; Aziz, Farhanah; Anwar, Arif] Univ Malaya, Sengen HIR, Kuala Lumpur, Malaysia; [Zhang, GuiPing] BGI Shenzhen, Shenzhen, Peoples R China	Universiti Malaya; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Universiti Malaya; Beijing Genomics Institute (BGI)	Lau, YL (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, TIDREC, Kuala Lumpur, Malaysia.	lauyeeling@um.edu.my	Lau, Yee Ling/C-6996-2009; LEE, Wenn-Chyau/AAR-4072-2020; RAZALI, ROZAIMI/O-8694-2017; Razali, Rozaimi/AAF-9115-2021; FONG, MUN YIK/B-5443-2010	Lau, Yee Ling/0000-0002-2037-2165; LEE, Wenn-Chyau/0000-0002-7324-5792; RAZALI, ROZAIMI/0000-0002-8996-3975; Razali, Rozaimi/0000-0002-8996-3975; 	University of Malaya High Impact Research (HIR) Grant UM-MOHE from the Ministry of Higher Education, Malaysia [UM.C/HIR/MOHE/MED/16]	University of Malaya High Impact Research (HIR) Grant UM-MOHE from the Ministry of Higher Education, Malaysia	This research project was supported by University of Malaya High Impact Research (HIR) Grant UM-MOHE (UM.C/HIR/MOHE/MED/16) from the Ministry of Higher Education, Malaysia.	Arrizabalaga G, 2004, INT J PARASITOL, V34, P361, DOI 10.1016/j.ijpara.2003.11.017; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BOHNE W, 1994, INFECT IMMUN, V62, P1761, DOI 10.1128/IAI.62.5.1761-1767.1994; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Boothroyd JC, 2009, INT J PARASITOL, V39, P935, DOI 10.1016/j.ijpara.2009.02.003; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; BULOW R, 1991, J IMMUNOL, V147, P3496; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Contini C., 2008, Parassitologia (Rome), V50, P45; Darde Marie-Laure, 2004, Annali dell'Istituto Superiore di Sanita, V40, P57; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Dixon SE, 2010, MOL BIOCHEM PARASIT, V173, P1, DOI 10.1016/j.molbiopara.2010.05.001; Doliwa C, 2013, PARASITE, V20, DOI 10.1051/parasite/2013020; DUBEY JP, 1980, AM J VET RES, V41, P427; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; Fatoohi AF, 2002, CLIN DIAGN LAB IMMUN, V9, P704, DOI 10.1128/CDLI.9.3.704-707.2002; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Ihara F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-248; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KAUFMAN HE, 1958, AM J OPHTHALMOL, V46, P255, DOI 10.1016/0002-9394(58)90805-5; Khan A, 2009, EUKARYOT CELL, V8, P1828, DOI 10.1128/EC.00150-09; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lau YL, 2010, J CLIN MICROBIOL, V48, P3698, DOI 10.1128/JCM.00462-10; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Paulsen I, 2007, NUCL SEQUENCES UNPUB; Pezzella-D'Alessandro N, 2001, J HISTOCHEM CYTOCHEM, V49, P445, DOI 10.1177/002215540104900404; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Sabin AB, 1941, J AMER MED ASSOC, V116, P801, DOI 10.1001/jama.1941.02820090001001; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Sauvage V, 2009, MOL BIOCHEM PARASIT, V167, P81, DOI 10.1016/j.molbiopara.2009.05.005; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SIBLEY LD, 1992, MOL BIOCHEM PARASIT, V51, P291, DOI 10.1016/0166-6851(92)90079-Y; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Villard O, 1997, INT J PARASITOL, V27, P1555, DOI 10.1016/S0020-7519(97)00144-6; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; Yang NH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-467; YASWEN P, 1990, P NATL ACAD SCI USA, V87, P7360, DOI 10.1073/pnas.87.19.7360	52	18	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157901	10.1371/journal.pone.0157901	http://dx.doi.org/10.1371/journal.pone.0157901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355363	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400023
J	Zittermann, A; Kuhn, J; Ernst, JB; Becker, T; Larisch, J; Dreier, J; Knabbe, C; Borgermann, J; Gummert, JF				Zittermann, Armin; Kuhn, Joachim; Ernst, Jana B.; Becker, Tobias; Larisch, Julia; Dreier, Jens; Knabbe, Cornelius; Boergermann, Jochen; Gummert, Jan F.			Circulating 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Concentrations and Postoperative Infections in Cardiac Surgical Patients: The CALCITOP-Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VITAMIN-D SUPPLEMENTATION; PRACTICE GUIDELINE SERIES; ANTIBIOTIC-PROPHYLAXIS; D DEFICIENCY; SURGERY; PREVENTION; METAANALYSIS; MORTALITY; SOCIETY	Background Vitamin D has immunomodulatory properties and seems to reduce the risk of infections. Whether low vitamin D concentrations are independent risk factors for nosocomial postoperative infections in surgical patients remains to be studied in detail. Methods In 3,340 consecutive cardiac surgical patients, we investigated the association of circulating 25-hydroxyvitamin D (25OHD; indicator of nutritional vitamin D status) and 1,25-dihydroxyvitamin D (1,25[OH](2)D; active vitamin D hormone) with nosocomicial infections. The primary endpoint was a composite of thoracic wound infection, sepsis, and broncho-pulmonary infection. Vitamin D status was measured on the last preoperative day. Infections were assessed until discharge. Logistic regression analysis was used to examine the association between vitamin D metabolite concentrations and the composite endpoint. Results The primary endpoint was reached by 5.6% (n = 186). In patients who reached and did not reach the endpoint, in-hospital mortality was 13.4% and 1.5%, respectively (P<0.001). Median (IQR) 25OHD and 1,25(OH) 2D concentrations were 43. 2 (29.7-61.9) nmol/l and 58.0 (38.5-77.5) pmol/l, respectively. Compared with the highest 1,25(OH)(2)D quintile (> 81.0 pmol/l), the multivariable-adjusted odds ratio of infection was 2.57 (95% CI: 1.47-4.49) for the lowest 1,25(OH)(2)D quintile (< 31.5 pmol/l) and 1.85 (95% CI: 1.05-3.25) for the second lowest quintile (31.5-49.0 pmol/l). There was no significant association between 25OHD concentrations and the primary endpoint. Conclusions Our data indicate an independent association of low 1,25(OH)(2)D levels with the risk of postoperative infections in cardiac surgical patients. Future studies should pay more attention on the clinical relevance of circulating 1,25(OH)(2)D and its regulation.	[Zittermann, Armin; Ernst, Jana B.; Becker, Tobias; Larisch, Julia; Boergermann, Jochen; Gummert, Jan F.] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Clin Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany; [Kuhn, Joachim; Dreier, Jens] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Inst Lab & Transfus Med, Bad Oeynhausen, Germany	Ruhr University Bochum; Ruhr University Bochum	Zittermann, A (corresponding author), Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Clin Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany.	azittermann@hdz-nrw.de						Avenell A, 2007, AGE AGEING, V36, P574, DOI 10.1093/ageing/afm091; Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Tran B, 2014, AM J CLIN NUTR, V99, P156, DOI 10.3945/ajcn.113.063271; Borgermann J, 2012, CRIT CARE MED, V40, P2073, DOI 10.1097/CCM.0b013e31824e8c42; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Braun LA, 2014, HEART LUNG CIRC, V23, P978, DOI 10.1016/j.hlc.2014.03.014; de Haan K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0660-4; Dini C, 2012, ANN I SUPER SANITA, V48, P319, DOI 10.4415/ANN_12_03_13; Docio S, 1998, J BONE MINER RES, V13, P544, DOI 10.1359/jbmr.1998.13.4.544; Eagle Kim A, 2004, J Am Coll Cardiol, V44, pe213; Edwards FH, 2006, ANN THORAC SURG, V81, P397, DOI 10.1016/j.athoracsur.2005.06.034; Engelman R, 2007, ANN THORAC SURG, V83, P1569, DOI 10.1016/j.athoracsur.2006.09.046; Fowler VG, 2005, CIRCULATION, V112, pI358, DOI 10.1161/CIRCULATIONAHA.104.525790; GALLIENI M, 1995, AM J PHYSIOL-RENAL, V268, pF746, DOI 10.1152/ajprenal.1995.268.4.F746; Holick MF., 2002, CURR OPIN ENDOCRINOL, V9, P87, DOI DOI 10.1097/00060793-200202000-00011; KRETER B, 1992, J THORAC CARDIOV SUR, V104, P590; Lador A, 2012, J ANTIMICROB CHEMOTH, V67, P541, DOI 10.1093/jac/dkr470; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; National Institute for Health and Clinical Excellence, 2008, SURGICAL SITE INFECT; PROVVEDINI DM, 1986, BONE, V7, P23; Roodnat JI, 2004, TRANSPLANTATION, V77, P483, DOI 10.1097/01.TP.0000110424.27977.A1; Scottish Intercollegiate Guidelines Network, 2008, ANTIBIOTIC PROPHYLAX; Segers P, 2006, JAMA-J AM MED ASSOC, V296, P2460, DOI 10.1001/jama.296.20.2460; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; Turan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063831; World Health Organization, 2002, PREVENTION OF HOSPIT; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388; Zittermann A, 2003, BRIT J NUTR, V89, P552, DOI 10.1079/BJN2003837; Zittermann A, 1998, EUR J CLIN NUTR, V52, P501, DOI 10.1038/sj.ejcn.1600591; Zittermann A, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0208-y; Zittermann A, 2015, J CLIN ENDOCR METAB, V100, P72, DOI 10.1210/jc.2014-3013; Zittermann A, 2013, EUR HEART J, V34, P1358, DOI 10.1093/eurheartj/ehs468; Zittermann A, 2012, SCAND CARDIOVASC J, V46, P359, DOI 10.3109/14017431.2012.725478; Zittermann A, 2010, NUTRIENTS, V2, P408, DOI 10.3390/nu2040408; Zittermann A, 2009, TRANSPLANTATION, V87, P118, DOI 10.1097/TP.0b013e31818c2708	38	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158532	10.1371/journal.pone.0158532	http://dx.doi.org/10.1371/journal.pone.0158532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355377	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400074
J	Jurczyk, J; Eckrot, A; Morgenstern, I				Jurczyk, Jan; Eckrot, Alexander; Morgenstern, Ingo			Quantifying Systemic Risk by Solutions of the Mean-Variance Risk Model	PLOS ONE			English	Article							PORTFOLIO SELECTION-PROBLEMS; HYBRID LOCAL SEARCH; CROSS-CORRELATIONS; OPTIMIZATION; TRANSITIONS; MARKET	The world is still recovering from the financial crisis peaking in September 2008. The triggering event was the bankruptcy of Lehman Brothers. To detect such turmoils, one can investigate the time-dependent behaviour of correlations between assets or indices. These cross-correlations have been connected to the systemic risks within markets by several studies in the aftermath of this crisis. We study 37 different US indices which cover almost all aspects of the US economy and show that monitoring an average investor's behaviour can be used to quantify times of increased risk. In this paper the overall investing strategy is approximated by the ground-states of the mean-variance model along the efficient frontier bound to real world constraints. Changes in the behaviour of the average investor is utlilized as a early warning sign.	[Jurczyk, Jan; Eckrot, Alexander; Morgenstern, Ingo] Univ Regensburg, Dept Phys, Regensburg, Germany	University of Regensburg	Jurczyk, J (corresponding author), Univ Regensburg, Dept Phys, Regensburg, Germany.	jan.jurczyk@ur.de						Bienstock D, 1996, MATH PROGRAM, V74, P121, DOI 10.1007/BF02592208; Billio, 2010, MEASURING SYSTEMIC R; Billio M, 2012, J FINANC ECON, V104, P535, DOI 10.1016/j.jfineco.2011.12.010; Bisias D, 2012, ANNU REV FINANC ECON, V4, P255, DOI 10.1146/annurev-financial-110311-101754; Cesarini F., 2009, EFFICIENT ALGORITHMS, P1; Cesarone F, 2011, ARXIV11053594, P1; Chang TJ, 2000, COMPUT OPER RES, V27, P1271, DOI 10.1016/S0305-0548(99)00074-X; Crama Y, 2003, EUR J OPER RES, V150, P546, DOI 10.1016/S0377-2217(02)00784-1; De Bandt O., 2000, SYSTEMIC RISK SURVEY; Di Gaspero L, 2007, LECT NOTES COMPUT SC, V4510, P44; Fieldsend JE, 2004, LECT NOTES COMPUT SC, V3177, P788; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Huang X, 2015, FINANCE EC DISCUSSIO, V2015, P1; Jobst N. J., 2001, Quantitative Finance, V1, P489, DOI 10.1088/1469-7688/1/5/301; Jurczyk J., 2015, MEASURING SWITCHING, P7; Kaufmann G., 2000, FINANCIAL MARKETS I, V9, P69, DOI DOI 10.1111/1468-0416.00036; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kritzman M, 2011, J PORTFOLIO MANAGE, V37, P112, DOI 10.3905/jpm.2011.37.4.112; Langfield S, 2016, ECON POLICY, V31, P51, DOI 10.1093/epolic/eiv019; Lehar A, 2005, J BANK FINANC, V29, P2577, DOI 10.1016/j.jbankfin.2004.09.007; Levy M, 2008, J ECON DYN CONTROL, V32, P137, DOI 10.1016/j.jedc.2007.01.023; Li D, 2006, MATH FINANC, V16, P83, DOI 10.1111/j.1467-9965.2006.00262.x; Mansini R, 1999, EUR J OPER RES, V114, P219, DOI 10.1016/S0377-2217(98)00252-5; Maringer D, 2003, OR SPECTRUM, V25, P481, DOI 10.1007/s00291-003-0139-1; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mervyn King, 1990, VOLATILITY LINKS STO; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Pais A, 2013, EUR FINANC MANAG, V19, P429, DOI 10.1111/j.1468-036X.2010.00603.x; Perignon C, 2008, J BANK FINANC, V32, P783, DOI 10.1016/j.jbankfin.2007.05.014; Podobnik B, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/68001; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Rama Cont, 2001, CONT RAM EMP PROP AS; Rodriguez-Moreno M, 2013, J BANK FINANC, V37, P1817, DOI 10.1016/j.jbankfin.2012.07.010; Rosenow B, 2002, EUROPHYS LETT, V59, P500, DOI 10.1209/epl/i2002-00135-4; Schaerf A., 2002, Computational Economics, V20, P177, DOI 10.1023/A:1020920706534; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scott KE, 2003, INDEP REV, V3, P371; Solnik B., 1996, FINANCIAL ANAL J, V52, P17, DOI [10.2469/faj.v52.n5.2021, DOI 10.2469/FAJ.V52.N5.2021]; Streichert F, 2003, OP RES P 2003 INT C, P1; Wang D, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046121; Wilcox D, 2007, PHYSICA A, V375, P584, DOI 10.1016/j.physa.2006.10.030; Zheng ZY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00888; Zhou XY, 2000, APPL MATH OPT, V42, P19, DOI 10.1007/s002450010003	46	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158444	10.1371/journal.pone.0158444	http://dx.doi.org/10.1371/journal.pone.0158444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AH	27351482	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900061
J	Nakamura, K; Kusama, K; Bai, R; Sakurai, T; Isuzugawa, K; Godkin, JD; Suda, Y; Imakawa, K				Nakamura, Keigo; Kusama, Kazuya; Bai, Rulan; Sakurai, Toshihiro; Isuzugawa, Kazuto; Godkin, James D.; Suda, Yoshihito; Imakawa, Kazuhiko			Induction of IFNT-Stimulated Genes by Conceptus-Derived Exosomes during the Attachment Period	PLOS ONE			English	Article							INTERFERON-TAU; TRANSCRIPTION FACTOR; PROTEOMIC ANALYSIS; EARLY-PREGNANCY; EXPRESSION; CELLS; BLOOD; IDENTIFICATION; ENDOMETRIUM; CHEMOKINE	Biochemical and/or physical communication between the conceptus and the uterine endometrium is required for conceptus implantation to the maternal endometrium, leading to placentation and the establishment of pregnancy. We previously reported that in vitro co-culture system with bovine trophoblast CT-1 cells, primary uterine endometrial epithelial cells (EECs), and uterine flushings (UFs) mimics in vivo conceptus attachment process. To identify molecules in UFs responsible for this change, we first characterized protein contents of UFs from day 17 cyclic (C17) and pregnant (P17) ewes through the use of two dimensional-Polyacrylamide Gel Electrophoresis (2D-PAGE), followed by Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) analysis. These analyses identified 266 proteins specific for P17 UFs, from which 172 proteins were identified as exosomal proteins. Among 172 exosomal proteins, 8 proteins that had been identified as exosomal proteins were chosen for further analysis, including macrophage-capping protein (CAPG), aldo-keto reductase family 1, member B1 protein (AKR1B1), bcl-2-like protein 15 (BCL2L15), carbonic anhydrase 2 (CA2), isocitrate dehydrogenase 2 (IDH2), eukaryotic translation elongation factor 2 (EEF2), moesin (MSN), and ezrin (EZR). CAPG and AKR1B1 were again confirmed in P15 and P17 UFs, and more importantly CAPG and AKR1B1, mRNA and protein, were found only in P15 and P17 conceptuses. Moreover, exosomes were isolated from C15, C17, P15, or P17 UFs. Only P15 and P17 exosomes, originated from the conceptus, contained interferon tau (IFNT) as well as CAPG and AKR1B1, and up-regulated STAT1, STAT2, MX1, MX2, BST2, and ISG15 transcripts in EECs. These observations indicate that in addition to endometrial derived exosomes previously described, conceptus-derived exosomes are present in UFs and could function to modify endometrial response. These results suggest that exosomes secreted from conceptuses as well as endometria are involved in cell to cell interactions for conceptus implantation to the maternal endometrium.	[Nakamura, Keigo; Imakawa, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Ibaraki, Japan; [Kusama, Kazuya; Bai, Rulan] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Theriogenol & Anim Breeding, Tokyo, Japan; [Sakurai, Toshihiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Occupat & Environm Hlth, Chiba, Japan; [Isuzugawa, Kazuto] Yokohama Univ Pharm, Dept Kampo Pharm, Yokohama, Kanagawa, Japan; [Godkin, James D.] Univ Tennessee, Dept Anim Sci, Knoxville, TN USA; [Suda, Yoshihito] Miyagi Univ, Dept Food Agr & Environm, Kurokawa, Miyagi, Japan	University of Tokyo; University of Tokyo; Tokyo University of Science; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Miyagi University	Imakawa, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Ibaraki, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Kusama, Kazuya/K-9716-2018; Imakawa, Kazuhiko/AAD-3211-2022	Kusama, Kazuya/0000-0002-9120-0475; 	Science and Technology Research Promotion Program for Ministry of Agriculture, Forestry and Fisheries [25030AB]; Japan Society for the Promotion of Science [15K18767, 15K07697]	Science and Technology Research Promotion Program for Ministry of Agriculture, Forestry and Fisheries; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Science and Technology Research Promotion Program for Ministry of Agriculture, Forestry and Fisheries (25030AB, http://www.maff.go.jp/e/index.html) (to KI), Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (15K18767, https://www.jsps.go.jp/english/index.html) (to KK), and Grants-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (15K07697, https://www.jsps.go.jp/english/index.html) (to TS). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Bai RL, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128652; Bai R, 2014, REPRODUCTION, V148, P119, DOI 10.1530/REP-13-0655; Bazer FW, 2015, AMINO ACIDS, V47, P449, DOI 10.1007/s00726-014-1905-x; Berrone E, 2015, J GEN VIROL IN PRESS; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cleys ER, 2014, MOL REPROD DEV, V81, P983, DOI 10.1002/mrd.22420; De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410; Dong J, 2015, TUMOUR BIOL IN PRESS; Forde N, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.129296; Gray CA, 2004, P NATL ACAD SCI USA, V101, P7982, DOI 10.1073/pnas.0402669101; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Imakawa K, 2006, MOL REPROD DEV, V73, P559, DOI 10.1002/mrd.20457; Imakawa K, 2002, ENDOCR J, V49, P195, DOI 10.1507/endocrj.49.195; Jeong W, 2015, BIOCHEM BIOPH RES CO; Kang S, 2010, J PROTEOME RES, V9, P5638, DOI 10.1021/pr1004532; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Koch JM, 2010, J PROTEOME RES, V9, P3878, DOI 10.1021/pr100096b; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McGuire WJ, 2002, DOMEST ANIM ENDOCRIN, V23, P383, DOI 10.1016/S0739-7240(02)00181-9; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; Nagaoka K, 2003, J BIOL CHEM, V278, P29048, DOI 10.1074/jbc.M300470200; Nagaoka K, 2003, BIOL REPROD, V68, P1413, DOI 10.1095/biolreprod.102.008912; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; Oliveira JF, 2008, ENDOCRINOLOGY, V149, P1252, DOI 10.1210/en.2007-0863; Prunotto M, 2013, J PROTEOMICS, V82, P193, DOI 10.1016/j.jprot.2013.01.012; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Romero JJ, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132860; Ruiz-Gonzalez I, 2015, REPRODUCTION, V149, P281, DOI 10.1530/REP-14-0538; Sakurai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100180; Sakurai T, 2010, ENDOCRINOLOGY, V151, P5873, DOI 10.1210/en.2010-0458; Shirasuna K, 2015, REPRODUCTION, V150, P217, DOI 10.1530/REP-15-0085; Skarzynski DJ, 2000, BIOL REPROD, V62, P1116, DOI 10.1095/biolreprod62.5.1116; Soung YH, 2015, BMB REP IN PRESS; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Tammali R, 2011, ANGIOGENESIS, V14, P209, DOI 10.1007/s10456-011-9206-4; Voisin SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016352; Xu SG, 2010, J CANCER RES CLIN, V136, P1545, DOI 10.1007/s00432-010-0812-0; Yamakoshi S, 2012, REPRODUCTION, V143, P377, DOI 10.1530/REP-11-0364; Yankey SJ, 2001, J ENDOCRINOL, V170, pR7, DOI 10.1677/joe.0.170R007; Zablocki GJ, 2011, CHEM-BIOL INTERACT, V191, P351, DOI 10.1016/j.cbi.2011.02.005	46	58	60	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158278	10.1371/journal.pone.0158278	http://dx.doi.org/10.1371/journal.pone.0158278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351483	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900050
J	Nunes, PC; Aquino, JD; Rockenbach, II; Stamford, TLM				Nunes, Polyana Campos; Aquino, Jailane de Souza; Rockenbach, Ismael Ivan; Montenegro Stamford, Tania Lucia			Physico-Chemical Characterization, Bioactive Compounds and Antioxidant Activity of Malay Apple [Syzygium malaccense (L.) Merr. & LM Perry]	PLOS ONE			English	Article							IN-VITRO ANTIOXIDANT; ACUTE LUNG INJURY; PHENOLIC-COMPOUNDS; CYANIDIN-3-O-GLUCOSIDE; CYANIDIN-3-GLUCOSIDE; ANTHOCYANINS; INFLAMMATION; POMEGRANATE	The purpose of this study was to evaluate the physico-chemical characteristics, bioactive compounds and antioxidant activity of Malay apple fruit (Syzygium malaccense) grown in Brazil with regard to the geographical origin and its peel fractions and edible portion analyzed independently. Fruit diameter, weight, yield, and centesimal composition, ascorbic acid, reductive sugars, total soluble solids, pH and fiber content were determined. Total phenolics (1293 mg gallic acid equivalent/100 g) and total anthocyanins (1045 mg/100 g) contents were higher in the peel, with the major anthocyanin identified using HPLC-DAD-MS/MS as cyanidin 3-glucoside. Higher values for DPPH antiradical scavenging activity (47.52 mu Mol trolox equivalent antioxidant capacity/g) and Ferric Reducing Antioxidant Potential (FRAP, 0.19 mM ferreous sulfate/g) were also observed in the peel fraction. All extracts tested showed the ability to inhibit oxidation in the beta-carotene/linoleic acid system. This study highlights the potential of Malay apple fruit as a good source of antioxidant compounds with potential benefits to human health.	[Nunes, Polyana Campos; Montenegro Stamford, Tania Lucia] Fed Univ Pernambuco UFPE, Ctr Hlth Sci, Dept Nutr, Recife, PE, Brazil; [Aquino, Jailane de Souza] Fed Univ Paraiba UFPB, Ctr Hlth Sci, Dept Nutr, Joao Pessoa, Paraiba, Brazil; [Rockenbach, Ismael Ivan] Fed Univ Paraiba UFPB, Ctr Technol & Reg Dev, Dept Food Technol, Joao Pessoa, Paraiba, Brazil	Universidade Federal de Pernambuco; Universidade Federal da Paraiba; Universidade Federal da Paraiba	Rockenbach, II (corresponding author), Fed Univ Paraiba UFPB, Ctr Technol & Reg Dev, Dept Food Technol, Joao Pessoa, Paraiba, Brazil.	ismael.rockenbach@gmail.com	Rockenbach, Ismael I/P-2188-2014	Rockenbach, Ismael I/0000-0001-8513-5411; Stamford, Tania Lucia Montenegro/0000-0001-5816-9413; de Souza Aquino, Jailane/0000-0002-7221-9867	National Council for Scientific and Technological Development-Brazil	National Council for Scientific and Technological Development-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a research fellowship from National Council for Scientific and Technological Development-Brazil (http://cnpq.br) awarded to PCN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2002, OFF METH AN, V16; Arumugam B, 2014, LWT-FOOD SCI TECHNOL, V59, P707, DOI 10.1016/j.lwt.2014.06.041; Azevedo JCS, 2010, THESIS; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Banerjee A, 2005, FOOD CHEM, V90, P727, DOI 10.1016/j.foodchem.2004.04.033; Benherlal PS, 2007, J SCI FOOD AGR, V87, P2560, DOI 10.1002/jsfa.2957; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Clerici MTPS, 2011, FOOD RES INT, V44, P1658, DOI 10.1016/j.foodres.2011.04.020; Corley J, 2015, BRIT J NUTR, V114, P1088, DOI 10.1017/S000711451500210X; Costa Raquel Silva, 2006, Rev. Bras. Frutic., V28, P117, DOI 10.1590/S0100-29452006000100032; Doshi P, 2006, INT J FOOD SCI TECH, V41, P1, DOI 10.1111/j.1365-2621.2006.01214.x; Faria AF, 2011, FOOD CHEM, V126, P1571, DOI 10.1016/j.foodchem.2010.12.007; Fu YH, 2014, BIOCHEM PHARMACOL, V90, P126, DOI 10.1016/j.bcp.2014.05.004; Ikram EHK, 2009, J FOOD COMPOS ANAL, V22, P388, DOI 10.1016/j.jfca.2009.04.001; [Institute of Medicine IOM], 2001, DIET REF INT VIT C V; Institute of Medicine, 2001, DIET REF INT EN CARB; Judprasong K, 2013, FOOD CHEM, V140, P507, DOI 10.1016/j.foodchem.2013.01.057; Khoshnam F, 2007, SCI HORTIC-AMSTERDAM, V114, P21, DOI 10.1016/j.scienta.2007.05.008; Lee J, 2005, J AOAC INT, V88, P1269; Longo L, 2007, INNOV FOOD SCI EMERG, V8, P329, DOI 10.1016/j.ifset.2007.03.023; Loypimai P, 2016, J FOOD SCI TECH MYS, V53, P461, DOI 10.1007/s13197-015-2002-1; MARCO GJ, 1968, J AM OIL CHEM SOC, V45, P594, DOI 10.1007/BF02668958; Morton JF, 1987, FRUITS WARM CLIMATES, P378; Oliveira FIP, 2011, FOOD BIOPROCESS TECH, V4, P610, DOI 10.1007/s11947-010-0351-3; Pratheeshkumar P, 2014, TOXICOL APPL PHARM, V280, P127, DOI 10.1016/j.taap.2014.06.028; Rabeque CS, 2011, ANC SCI LIFE, V30, P110; Rabeta MS, 2013, MALAY APPLE WATER AP, V20, P673; Radunic M, 2015, FOOD CHEM, V177, P53, DOI 10.1016/j.foodchem.2014.12.102; Reynertson KA, 2008, FOOD CHEM, V109, P883, DOI 10.1016/j.foodchem.2008.01.021; Rockenbach II, 2011, FOOD CHEM, V127, P174, DOI 10.1016/j.foodchem.2010.12.137; Rodrigues E, 2011, CIENCIA TECNOL ALIME, V31, P911, DOI 10.1590/S0101-20612011000400027; Satpathy G, 2011, FOOD RES INT, V44, P2076, DOI 10.1016/j.foodres.2011.01.040; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Song J, 2013, FOOD CHEM TOXICOL, V58, P306, DOI 10.1016/j.fct.2013.05.003; Tang L, 2016, FOOD CHEM, V196, P550, DOI 10.1016/j.foodchem.2015.09.089; Tsuda T, 1998, LIPIDS, V33, P583, DOI 10.1007/s11745-998-0243-5; [U. S. Department of Agriculture Agricultural Research Service USDA], 2014, FOOD GROUP 09 FRUITS; Xu YJ, 2014, HEART FAIL REV, V19, P113, DOI 10.1007/s10741-013-9379-6; Yan XR, 2015, J SURG RES, V199, P592, DOI 10.1016/j.jss.2015.06.013; Zanatta CF, 2007, FOOD CHEM, V101, P1526, DOI 10.1016/j.foodchem.2006.04.004	41	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158134	10.1371/journal.pone.0158134	http://dx.doi.org/10.1371/journal.pone.0158134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352306	Green Submitted, gold, Green Published			2022-12-27	WOS:000378858900036
J	Tsai, YJ; Hao, SP; Chen, CL; Wu, WB				Tsai, Yih-Jeng; Hao, Sheng-Po; Chen, Chih-Li; Wu, Wen-Bin			Thromboxane A(2) Regulates CXCL1 and CXCL8 Chemokine Expression in the Nasal Mucosa-Derived Fibroblasts of Chronic Rhinosinusitis Patients	PLOS ONE			English	Article							EPITHELIAL-CELLS; KAPPA-B; RECEPTOR; ACTIVATION; ALPHA; INTERLEUKIN-8; MODULATION; RELEASE; PGD(2); CRTH2	Background Chronic rhinosinusitis without nasal polyps (CRSsNP) is a common chronic disease and the etiology remains unclear. Thromboxane A(2) (TXA(2)) participates in platelet aggregation and tissue inflammation. In this study, the CXCL1/8 chemokine and TXA(2)-TP receptor expression in the CRSsNP mucosa was investigated. Experimental Approach Immunohistochemistry, chemokine release assay by ELISA, RT-PCR, Real-time PCR, Western blotting, pharmacological and siRNA knockdown analysis were applied in the CRSsNP tissue specimen and cultured nasal mucosa-derived fibroblasts. Results The immunohistochemistry results indicated that CXCL1 and CXCL8 were highly expressed in the CRSsNP mucosa compared with the controls; however, the TP receptors were expressed in both mucosa. Therefore, U46619 and IBOP, a TXA(2) analog and TP agonist, were used to explore the role of TP activation in CXCL1/8 expression; both of these induced CXCL1/8 mRNA and protein expression in CRSsNP mucosa-derived fibroblasts. U46619 phosphorylated PI-3K, cyclic AMP (cAMP)/PKA, PKC, and cAMP response element (CREB). Activation of cAMP/PKA, PKC, and CREB was the major pathway for cxcl1/8 gene transcription. Pharmacological and siRNA knockdown analyses revealed that activation of cAMP/PKA and PKC mu/PKD pathways were required for CREB phosphorylation and PKA/C crosstalked with the PI-3K pathway. Conclusion and Implications Our study provides the first evidence for abundant TP receptor and CXCL1/8 expression in human CRSsNP mucosa and for TXA2 stimulation inducing CXCL1/8 expression in nasal fibroblasts primarily through TP receptor, cAMP/PKA, PKC mu/PKD, and CREB-related pathways.	[Tsai, Yih-Jeng; Hao, Sheng-Po] Shin Kong Wu Ho Su Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Tsai, Yih-Jeng] Fu Jen Catholic Univ, Grad Inst Appl Sci & Engn, Dept Chem, Coll Sci & Engn, Taipei, Taiwan; [Tsai, Yih-Jeng] Fu Jen Catholic Univ, Grad Inst Basic Med, Taipei, Taiwan; [Tsai, Yih-Jeng; Hao, Sheng-Po; Chen, Chih-Li; Wu, Wen-Bin] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic University	Wu, WB (corresponding author), Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan.	wenbin@mail.fju.edu.tw	Wu, Wen-Bin/GLT-4711-2022		National Science Council [NSC 102-2320-B-030-013MY3]; Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-103-DR-25]	National Science Council(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital	This work was supported by grants from National Science Council (NSC 102-2320-B-030-013MY3) and Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302-103-DR-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VK, 2004, ANN OTO RHINOL LARYN, V113, P3, DOI 10.1177/00034894041130S502; Bachert C, 1999, INT ARCH ALLERGY IMM, V118, P375, DOI 10.1159/000024141; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen CP, 2010, N-S ARCH PHARMACOL, V381, P401, DOI 10.1007/s00210-010-0501-1; Dykewicz MS, 2010, J ALLERGY CLIN IMMUN, V125, pS103, DOI 10.1016/j.jaci.2009.12.989; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Honda T, 2015, ALLERGOL INT, V64, P11, DOI 10.1016/j.alit.2014.08.002; Idzko M, 2015, J ALLERGY CLIN IMMUN, V135, P1416, DOI 10.1016/j.jaci.2015.04.028; Jundi K, 2015, BIOMOLECULES, V5, P1386, DOI 10.3390/biom5031386; Kim SR, 2010, BIOCHEM BIOPH RES CO, V397, P413, DOI 10.1016/j.bbrc.2010.05.106; Li XY, 2010, J ALLERGY CLIN IMMUN, V125, P1061, DOI 10.1016/j.jaci.2010.02.023; Li XL, 2014, MOL CARCINOGEN, V53, P659, DOI 10.1002/mc.22020; Lo HM, 2013, INT J MOL SCI, V14, P10090, DOI 10.3390/ijms140510090; Maesako K, 1998, ACTA OTO-LARYNGOL, P61; Perez-Novo CA, 2010, ALLERGY, V65, P304, DOI 10.1111/j.1398-9995.2009.02204.x; Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Rudack C, 2007, CLIN EXP ALLERGY, V37, P1009, DOI 10.1111/j.1365-2222.2007.02686.x; Rudack C, 2006, CLIN EXP ALLERGY, V36, P748, DOI 10.1111/j.1365-2222.2006.02501.x; Shieh JM, 2014, CELL PHYSIOL BIOCHEM, V34, P1373, DOI 10.1159/000366344; Shirasaki H, 2007, PROSTAG LEUKOTR ESS, V76, P315, DOI 10.1016/j.plefa.2007.04.002; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Sun HX, 2008, CANCER PREV RES, V1, P316, DOI 10.1158/1940-6207.CAPR-07-0002; Tsai YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126853; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Wood AJ, 2010, POSTGRAD MED J, V86, P359, DOI 10.1136/pgmj.2009.094813; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamamoto M, 2009, INT ARCH ALLERGY IMM, V148, P127, DOI 10.1159/000155743; Yoshikawa M, 2013, ALLERGOL INT, V62, P495, DOI 10.2332/allergolint.13-OA-0572	32	4	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158438	10.1371/journal.pone.0158438	http://dx.doi.org/10.1371/journal.pone.0158438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351369	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900060
J	Harper, LD; Fothergill, M; West, DJ; Stevenson, E; Russell, M				Harper, Liam D.; Fothergill, Melissa; West, Daniel J.; Stevenson, Emma; Russell, Mark			Practitioners' Perceptions of the Soccer Extra-Time Period: Implications for Future Research	PLOS ONE			English	Article							UEFA CHAMPIONS LEAGUE; CARBOHYDRATE SUPPLEMENTATION; CAFFEINE INGESTION; SIMULATED SOCCER; MATCH-PLAY; PERFORMANCE; FATIGUE; FOOTBALL; STRATEGIES; EXERCISE	Qualitative research investigating soccer practitioners' perceptions can allow researchers to create practical research investigations. The extra-time period of soccer is understudied compared to other areas of soccer research. Using an open-ended online survey containing eleven main and nine sub questions, we gathered the perceptions of extra-time from 46 soccer practitioners, all working for different professional soccer clubs. Questions related to current practices, views on extra-time regulations, and ideas for future research. Using inductive content analysis, the following general dimensions were identified: 'importance of extra-time', 'rule changes', 'efficacy of extra-time hydro-nutritional provision', 'nutritional timing', 'future research directions', 'preparatory modulations' and 'recovery'. The majority of practitioners (63%) either agreed or strongly agreed that extra-time is an important period for determining success in knockout football match-play. When asked if a fourth substitution should be permitted in extra-time, 67% agreed. The use of hydro-nutritional strategies prior to extra-time was predominately considered important or very important. However; only 41% of practitioners felt that it was the most important time point for the use of nutritional products. A similar number of practitioners account (50%) and do not (50%) account for the potential of extra-time when training and preparing players and 89% of practitioners stated that extra-time influences recovery practices following matches. In the five minute break prior to extra-time, the following practices (in order of priority) were advocated to players: hydration, energy provision, massage, and tactical preparations. Additionally, 87% of practitioners advocate a particular nutritional supplementation strategy prior to extra-time. In order of importance, practitioners see the following as future research areas: nutritional interventions, fatigue responses, acute injury risk, recovery modalities, training paradigms, injury epidemiology, and environmental considerations. This study presents novel insight into the practitioner perceptions of extra-time and provides information to readers about current applied practices and potential future research opportunities.	[Harper, Liam D.; Fothergill, Melissa; Russell, Mark] Northumbria Univ, Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England; [West, Daniel J.; Stevenson, Emma] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Northumbria University; Newcastle University - UK	Harper, LD (corresponding author), Northumbria Univ, Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England.	liam.harper@northumbria.ac.uk	Russell, Mark/M-1652-2019; Harper, Liam/I-7866-2019; West, Daniel/O-4127-2014	Russell, Mark/0000-0002-7305-1090; Harper, Liam/0000-0002-2089-4799; West, Daniel/0000-0003-2246-4925				Akenhead R, 2015, INT J SPORT IN PRESS; Ali A, 2015, INT J SPORTS MED, V36, P433, DOI 10.1055/s-0034-1398580; Ali A. A., 2015, J AEROSP INFORM SYST, V12, P1, DOI [10.1111/jai.12926, DOI 10.1111/JAI.12926]; Arruda AFS, 2015, INT J SPORT PHYSIOL, V10, P248, DOI 10.1123/ijspp.2014-0148; Baker LB, 2015, NUTRIENTS, V7, P5733, DOI 10.3390/nu7075249; Bangsbo J, 2007, INT J SPORT PHYSIOL, V2, P111, DOI 10.1123/ijspp.2.2.111; Bengtsson H, 2013, BRIT J SPORT MED, V47, P743, DOI 10.1136/bjsports-2013-092383; Bishop D, 2008, SPORTS MED, V38, P253, DOI 10.2165/00007256-200838030-00005; Bradley PS, 2014, HUM MOVEMENT SCI, V33, P159, DOI 10.1016/j.humov.2013.07.024; Briggs MA, 2015, NUTRIENTS, V7, P8392, DOI 10.3390/nu7105400; Cohen DD, 2015, INT J SPORT PHYSIOL, V10, P325, DOI 10.1123/ijspp.2014-0088; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Doherty M, 2004, INT J SPORT NUTR EXE, V14, P626, DOI 10.1123/ijsnem.14.6.626; Drust B, 2013, J SPORT SCI, V31, P1377, DOI 10.1080/02640414.2013.828544; Dupont G, 2004, J STRENGTH COND RES, V18, P584; Folgado H, 2015, J SPORT SCI, V33, P1238, DOI 10.1080/02640414.2015.1022576; Foskett A, 2008, MED SCI SPORT EXER, V40, P96, DOI [10.1249/mss.0013e3181586b2c, 10.1249/mss.0b013e3181586b2c]; Gant N, 2010, INT J SPORT NUTR EXE, V20, P191, DOI 10.1123/ijsnem.20.3.191; Greig M, 2008, AM J SPORT MED, V36, P1403, DOI 10.1177/0363546508314413; Harper LD, 2015, J SCI MED S IN PRESS; Harper LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110995; Jones RI, 2015, J SPORT SCI, V33, P1305, DOI 10.1080/02640414.2015.1022572; Kamimori GH, 2002, INT J PHARM, V234, P159, DOI 10.1016/S0378-5173(01)00958-9; Kingsley M, 2014, J SCI MED SPORT, V17, P239, DOI 10.1016/j.jsams.2013.04.010; Levine BD, 2008, SCAND J MED SCI SPOR, V18, P76, DOI 10.1111/j.1600-0838.2008.00835.x; McCall A, 2015, BRIT J SPORT MED, V49, P603, DOI 10.1136/bjsports-2015-094747; McCall A, 2014, BRIT J SPORT MED, V48, P1352, DOI 10.1136/bjsports-2014-093439; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Mohr M, 2015, EUR J APPL IN PRESS; Mohr M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039202; Nedelec M, 2013, SPORTS MED, V43, P9, DOI 10.1007/s40279-012-0002-0; Patton MQ, 2015, QUALITATIVE RES EVAL, V4th; Pettersen SA, 2014, J SPORT SCI, V32, P1958, DOI 10.1080/02640414.2014.965189; Russell M, 2015, J SPORTS SC IN PRESS; Russell M, 2014, SPORTS MED, V44, P957, DOI 10.1007/s40279-014-0184-8; Small K, 2009, INT J SPORTS MED, V30, P573, DOI 10.1055/s-0029-1202822; Souglis AG, 2013, J STRENGTH COND RES, V27, P2235, DOI 10.1519/JSC.0b013e3182792147; Stellingwerff T, 2014, APPL PHYSIOL NUTR ME, V39, P998, DOI 10.1139/apnm-2014-0027; Stolen T, 2005, SPORTS MED, V35, P501; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Towlson C, 2013, J SPORT SCI, V31, P1393, DOI 10.1080/02640414.2013.792946	41	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157687	10.1371/journal.pone.0157687	http://dx.doi.org/10.1371/journal.pone.0157687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384693	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000379809400020
J	Mezuk, B; Choi, M; DeSantis, AS; Rapp, SR; Roux, AVD; Seeman, T				Mezuk, Briana; Choi, Moon; DeSantis, Amy S.; Rapp, Stephen R.; Roux, Ana V. Diez; Seeman, Teresa			Loneliness, Depression, and Inflammation: Evidence from the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; OLDER-ADULTS; SOCIAL SUPPORT; RISK-FACTORS; HEALTH; STRESS; SCALE; NEUROENDOCRINE; METAANALYSIS	Objective Both objective and subjective aspects of social isolation have been associated with alterations in immune markers relevant to multiple chronic diseases among older adults. However, these associations may be confounded by health status, and it is unclear whether these social factors are associated with immune functioning among relatively healthy adults. The goal of this study was to examine the associations between perceived loneliness and circulating levels of inflammatory markers among a diverse sample of adults. Methods Data come from a subset of the Multi-Ethnic Study of Atherosclerosis (n = 441). Loneliness was measured by three items derived from the UCLA Loneliness Scale. The association between loneliness and C-reactive protein (CRP) and fibrinogen was assessed using multivariable linear regression analyses. Models were adjusted for demographic and health characteristics. Results Approximately 50% of participants reported that they hardly ever felt lonely and 17.2% felt highly lonely. Individuals who were unmarried/unpartnered or with higher depressive symptoms were more likely to report being highly lonely. There was no relationship between perceived loneliness and ln(CRP) (beta = -0.051, p = 0.239) adjusting for demographic and health characteristics. Loneliness was inversely associated with ln(fibrinogen) (beta = -0.091, p = 0.040), although the absolute magnitude of this relationship was small. Conclusion These results indicate that loneliness is not positively associated with fibrinogen or CRP among relatively healthy middle-aged adults.	[Mezuk, Briana] Virginia Commonwealth Univ, Div Epidemiol, Dept Family Med & Populat Hlth, Sch Med, Richmond, VA 23284 USA; [Mezuk, Briana] Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA; [Choi, Moon] Korea Adv Inst Sci & Technol, Daejeon, South Korea; [DeSantis, Amy S.] RAND, Santa Monica, CA USA; [Rapp, Stephen R.] Wake Forest Sch Med, Dept Psychiat & Behav Med, Winston Salem, NC USA; [Roux, Ana V. Diez] Drexel Univ, Dept Epidemiol & Biostat, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA; [Seeman, Teresa] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA	Virginia Commonwealth University; University of Michigan System; University of Michigan; Korea Advanced Institute of Science & Technology (KAIST); RAND Corporation; Wake Forest University; Drexel University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mezuk, B (corresponding author), Virginia Commonwealth Univ, Div Epidemiol, Dept Family Med & Populat Hlth, Sch Med, Richmond, VA 23284 USA.; Mezuk, B (corresponding author), Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA.	bmezuk@vcu.edu	Mezuk, Briana/AAY-5321-2020; Choi, Moon/I-1607-2014	Mezuk, Briana/0000-0003-1798-2285; Choi, Moon/0000-0001-8002-0113	NIH (National Institute of Mental Health) [K01-MH093642]; NIH (National Heart, Lung, and Blood Institute) [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, R01-HL101161]; National Research Foundation of Korea [NRF-2015S1A5A8018593]; National Institute on Minority Health and Health Disparities [P60MD002249] Funding Source: NIH RePORTER	NIH (National Institute of Mental Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Foundation of Korea(National Research Foundation of Korea); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH (K01-MH093642 from the National Institute of Mental Health and grant R01-HL101161 and contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung, and Blood Institute). Additional support provided by the National Research Foundation of Korea (NRF-2015S1A5A8018593). The funders has no role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Alpass FM, 2003, AGING MENT HEALTH, V7, P212, DOI 10.1080/1360786031000101193; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Davidson Karina W, 2010, Cleve Clin J Med, V77 Suppl 3, pS20, DOI 10.3949/ccjm.77.s3.04; Elovainio M, 2015, J PSYCHIATR RES, V71, P120, DOI 10.1016/j.jpsychires.2015.09.017; Ford ES, 2006, ANN EPIDEMIOL, V16, P78, DOI 10.1016/j.annepidem.2005.08.005; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; Hackett RA, 2012, PSYCHONEUROENDOCRINO, V37, P1801, DOI 10.1016/j.psyneuen.2012.03.016; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hawkley LC, 2010, PSYCHOL AGING, V25, P132, DOI 10.1037/a0017805; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Jaremka LM, 2013, PSYCHOL SCI, V24, P1089, DOI 10.1177/0956797612464059; Jaremka LM, 2013, DEPRESS ANXIETY, V30, P288, DOI 10.1002/da.22078; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kivimaki M, 2014, MOL PSYCHIATR, V19, P149, DOI 10.1038/mp.2013.35; Luanaigh CO, 2008, INT J GERIATR PSYCH, V23, P1213, DOI 10.1002/gps.2054; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64; Mezuk B, 2010, BRAIN BEHAV IMMUN, V24, P1294, DOI 10.1016/j.bbi.2010.06.006; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Nausheen B, 2010, PSYCHOSOM MED, V72, P912, DOI 10.1097/PSY.0b013e3181f0bc1c; NEELEMAN J, 1994, SOC PSYCH PSYCH EPID, V29, P46; Peplau LA., 1985, SOCIAL SUPPORT THEOR, P269, DOI 10.1007/978-94-009-5115-0_15; Prince MJ, 1997, PSYCHOL MED, V27, P323, DOI 10.1017/S0033291796004485; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ranjit N, 2007, ARCH INTERN MED, V167, P174, DOI 10.1001/archinte.167.2.174; Rueggeberg R, 2012, PSYCHOSOM MED, V74, P937, DOI 10.1097/PSY.0b013e3182732dc6; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; SEEMAN TE, 1994, J GERONTOL, V49, pM97, DOI 10.1093/geronj/49.3.M97; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Shiovitz-Ezra S, 2010, INT PSYCHOGERIATR, V22, P455, DOI 10.1017/S1041610209991426; Steptoe A, 2004, PSYCHONEUROENDOCRINO, V29, P593, DOI 10.1016/S0306-4530(03)00086-6; Thurston RC, 2009, PSYCHOSOM MED, V71, P836, DOI 10.1097/PSY.0b013e3181b40efc; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234	38	28	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158056	10.1371/journal.pone.0158056	http://dx.doi.org/10.1371/journal.pone.0158056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0TX	27367428	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900016
J	Shimada, M; Matsuzaki, F; Kato, A; Kobayashi, J; Matsumoto, T; Komatsu, K				Shimada, Mikio; Matsuzaki, Fumio; Kato, Akihiro; Kobayashi, Junya; Matsumoto, Tomohiro; Komatsu, Kenshi			Induction of Excess Centrosomes in Neural Progenitor Cells during the Development of Radiation-Induced Microcephaly	PLOS ONE			English	Article							BREAKAGE SYNDROME GENE; DNA-DAMAGE; BRAIN-DEVELOPMENT; PLANAR DIVISIONS; CEREBRAL-CORTEX; AMPLIFICATION; APOPTOSIS; OVERDUPLICATION; NEUROGENESIS; DUPLICATION	The embryonic brain is one of the tissues most vulnerable to ionizing radiation. In this study, we showed that ionizing radiation induces apoptosis in the neural progenitors of the mouse cerebral cortex, and that the surviving progenitor cells subsequently develop a considerable amount of supernumerary centrosomes. When mouse embryos at Day 13.5 were exposed to gamma-rays, brains sizes were reduced markedly in a dose-dependent manner, and these size reductions persisted until birth. Immunostaining with caspase-3 antibodies showed that apoptosis occurred in 35% and 40% of neural progenitor cells at 4 h after exposure to 1 and 2 Gy, respectively, and this was accompanied by a disruption of the apical layer in which mitotic spindles were positioned in unirradiated mice. At 24 h after 1 Gy irradiation, the apoptotic cells were completely eliminated and proliferation was restored to a level similar to that of unirradiated cells, but numerous spindles were localized outside the apical layer. Similarly, abnormal cytokinesis, which included multipolar division and centrosome clustering, was observed in 19% and 24% of the surviving neural progenitor cells at 48 h after irradiation with 1 and 2 Gy, respectively. Because these cytokinesis aberrations derived from excess centrosomes result in growth delay and mitotic catastrophe-mediated cell elimination, our findings suggest that, in addition to apoptosis at an early stage of radiation exposure, radiation-induced centrosome overduplication could contribute to the depletion of neural progenitors and thereby lead to microcephaly.	[Shimada, Mikio; Kato, Akihiro; Kobayashi, Junya; Komatsu, Kenshi] Kyoto Univ, Dept Genome Repair Dynam, Ctr Radiat Biol, Kyoto, Japan; [Matsuzaki, Fumio] RIKEN, Lab Cell Asymmetry, Ctr Dev Biol, Kobe, Hyogo, Japan; [Matsumoto, Tomohiro] Kyoto Univ, Ctr Radiat Biol, Dept Radiat Syst Biol, Kyoto, Japan; [Shimada, Mikio] Tokyo Inst Technol, Inst Innovat Res, Lab Adv Nucl Energy, Tokyo, Japan; [Kato, Akihiro] Tohoku Med & Pharmaceut Univ, Div Radiat Biol & Med, Fac Med, Sendai, Miyagi, Japan	Kyoto University; RIKEN; Kyoto University; Tokyo Institute of Technology; Tohoku Medical & Pharmaceutical University	Komatsu, K (corresponding author), Kyoto Univ, Dept Genome Repair Dynam, Ctr Radiat Biol, Kyoto, Japan.	komatsu@house.rbc.kyoto-u.ac.jp	Kobayashi, Junya/AAX-6390-2021; Shimada, Mikio/E-1565-2015	Kobayashi, Junya/0000-0003-4645-7500; Shimada, Mikio/0000-0003-1980-9187; Matsuzaki, Fumio/0000-0001-7902-4520	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Brown JAL, 2010, ONCOGENE, V29, P5537, DOI 10.1038/onc.2010.302; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Dodson H, 2007, CELL CYCLE, V6, P364, DOI 10.4161/cc.6.3.3834; Gatz SA, 2011, J NEUROSCI, V31, P10088, DOI 10.1523/JNEUROSCI.1324-11.2011; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Li HZ, 2008, RADIAT RES, V169, P513, DOI 10.1667/RR1230.1; Li R, 2012, CELL RES, V22, P859, DOI 10.1038/cr.2012.3; Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Nowak E, 2006, RADIAT RES, V165, P155, DOI 10.1667/RR3496.1; O'Driscoll M, 2004, DNA REPAIR, V3, P1227, DOI 10.1016/j.dnarep.2004.03.025; Pao GM, 2014, P NATL ACAD SCI USA, V111, pE1240, DOI 10.1073/pnas.1400783111; Pulvers JN, 2009, DEVELOPMENT, V136, P1859, DOI 10.1242/dev.033498; Roque T, 2012, STEM CELLS, V30, P537, DOI 10.1002/stem.1010; Saha S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0783; Sessa A, 2010, GENE DEV, V24, P1816, DOI 10.1101/gad.575410; Shimada M, 2013, INT J RADIAT ONCOL, V86, P358, DOI 10.1016/j.ijrobp.2013.01.010; Shimada M, 2011, MUTAT RES-FUND MOL M, V716, P27, DOI 10.1016/j.mrfmmm.2011.07.017; Shimada M, 2010, CANCER SCI, V101, P2531, DOI 10.1111/j.1349-7006.2010.01702.x; Shimada M, 2009, CANCER RES, V69, P1768, DOI 10.1158/0008-5472.CAN-08-3016; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Takahashi I, 1996, BONE, V18, P341, DOI 10.1016/8756-3282(96)00012-9; Tauchi H, 2002, ONCOGENE, V21, P8967, DOI 10.1038/sj.onc.1206136; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; WOOD JW, 1967, AM J PUBLIC HEALTH N, V57, P1381, DOI 10.2105/AJPH.57.8.1381; Woodbine L, 2014, DNA REPAIR, V16, P84, DOI 10.1016/j.dnarep.2014.02.011	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158236	10.1371/journal.pone.0158236	http://dx.doi.org/10.1371/journal.pone.0158236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367050	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900024
J	Malausa, T; Delaunay, M; Fleisch, A; Groussier-Bout, G; Warot, S; Crochard, D; Guerrieri, E; Delvare, G; Pellizzari, G; Kaydan, MB; Al-Khateeb, N; Germain, JF; Brancaccio, L; Le Goff, I; Bessac, M; Ris, N; Kreiter, P				Malausa, Thibaut; Delaunay, Mathilde; Fleisch, Alexandre; Groussier-Bout, Geraldine; Warot, Sylvie; Crochard, Didier; Guerrieri, Emilio; Delvare, Gerard; Pellizzari, Giuseppina; Kaydan, M. Bora; Al-Khateeb, Nadia; Germain, Jean-Francois; Brancaccio, Lisa; Le Goff, Isabelle; Bessac, Melissa; Ris, Nicolas; Kreiter, Philippe			Investigating Biological Control Agents for Controlling Invasive Populations of the Mealybug Pseudococcus comstocki in France	PLOS ONE			English	Article							HEMIPTERA PSEUDOCOCCIDAE; MORPHOLOGICAL CHARACTERIZATION; NATURAL ENEMIES; HYMENOPTERA; PARASITOIDS; HOMOPTERA; IDENTIFICATION; PHYLOGENY; SEQUENCES; MARKERS	Pseudococcus comstocki (Hemiptera: Pseudococcidae) is a mealybug species native to Eastern Asia and present as an invasive pest in northern Italy and southern France since the start of the century. It infests apple and pear trees, grapevines and some ornamental trees. Biocontrol programmes against this pest proved successful in central Asia and North America in the second half of the 20th century. In this study, we investigated possible bio-control agents against P. comstocki, with the aim of developing a biocontrol programme in France. We carried out systematic DNA-barcoding at each step in the search for a specialist parasitoid. First we characterised the French target populations of P. comstocki. We then identified the parasitoids attacking P. comstocki in France. Finally, we searched for foreign mealybug populations identified a priori as P. comstocki and surveyed their hymenopteran parasitoids. Three mealybug species (P. comstocki, P. viburni and P. cryptus) were identified during the survey, together with at least 16 different parasitoid taxa. We selected candidate biological control agent populations for use against P. comstocki in France, from the species Allotropa burrelli (Hymenoptera: Platygastridae) and Acerophagus malinus (Hymenoptera: Encyrtidae). The coupling of molecular and morphological characterisation for both pests and natural enemies facilitated the programme development and the rejection of unsuitable or generalist parasitoids.	[Malausa, Thibaut; Delaunay, Mathilde; Fleisch, Alexandre; Groussier-Bout, Geraldine; Warot, Sylvie; Crochard, Didier; Brancaccio, Lisa; Le Goff, Isabelle; Bessac, Melissa; Ris, Nicolas; Kreiter, Philippe] Univ Nice Sophia Antipolis, INRA, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, F-06900 Sophia Antipolis, France; [Guerrieri, Emilio] CNR, Ist Protez Sostenibile Piante, Via Univ 133, I-80055 Naples, Italy; [Delvare, Gerard] Montpellier Supagro, CIRAD, CS 30016, UMR,CBGP,INRA, 755 Ave Campus Agropolis, F-34988 Montferrier Sur Lez, France; [Pellizzari, Giuseppina] Univ Padua, Dipartimento Agron Anim Alimenti Risorse Nat & Am, Viale Univ 16, I-35020 Legnaro, Italy; [Kaydan, M. Bora] Cukurova Univ, Imamoglu Vocat Sch, TR-01330 Adana, Turkey; [Al-Khateeb, Nadia] Lattakia Ctr Rearing Nat Enemies, Latakia, Syria; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, CS 30016, 755 Ave Campus Agropolis, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); University of Padua; Cukurova University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), Univ Nice Sophia Antipolis, INRA, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, F-06900 Sophia Antipolis, France.	thibaut.malausa@paca.inra.fr	Kaydan, Mehmet Bora/F-1310-2018; Malausa, Thibaut/X-1614-2018; Guerrieri, Emilio/ABB-7498-2020	Kaydan, Mehmet Bora/0000-0002-0677-255X; Malausa, Thibaut/0000-0003-1681-7958; Ris, Nicolas/0000-0003-1183-234X; Germain, Jean-Francois/0000-0001-7927-6031	French "Agence Nationale de la Recherche" [ANR-10-JCJC-1708 BICORAMICS]; EU [324475 COLBICS, 265865 PURE]; Turkey-France Cooperation grant CNRS-TUBITAK; INRA Plant Health and Environment Division	French "Agence Nationale de la Recherche"(French National Research Agency (ANR)); EU(European Commission); Turkey-France Cooperation grant CNRS-TUBITAK; INRA Plant Health and Environment Division	This work was funded by the French "Agence Nationale de la Recherche" (grant ANR-10-JCJC-1708 BICORAMICS), by the EU Seventh Framework Programme (grants Marie-Curie IAPP #324475 COLBICS and KBBE #265865 PURE), by a Turkey-France Cooperation grant CNRS-TUBITAK, and by the INRA Plant Health and Environment Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beardsley J. W. Jr., 1966, Insects of Micronesia, V6, P377; Belshaw R, 1997, MOL PHYLOGENET EVOL, V7, P281, DOI 10.1006/mpev.1996.0400; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Charles JG, NZ PLANT PROTECTION, V55, P37; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Cox J.M., 1989, Bulletin of the British Museum (Natural History) Entomology, V58, P1; ERVIN RT, 1983, J ECON ENTOMOL, V76, P605, DOI 10.1093/jee/76.3.605; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FUNASAKI G Y, 1988, Proceedings of the Hawaiian Entomological Society, V28, P105; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Guerrieri E, 2009, B INSECTOL, V62, P179; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hantzberg H., 2008, AFPP - 8eme Conference Internationale sur les Ravageurs en Agriculture, Montpellier SupAgro, France, 22-23 Octobre 2008, P573; Heraty J, 2004, SYST ENTOMOL, V29, P544, DOI 10.1111/j.0307-6970.2004.00267.x; Hoelmer KA, 2005, BIOL CONTROL, V34, P255, DOI 10.1016/j.biocontrol.2005.05.001; Kobakhidze D. N., 1965, Entomophaga, V10, P323, DOI 10.1007/BF02387071; Kreiter Philippe, 2005, Bulletin de la Societe Entomologique de France, V110, P132; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; MEYERDIRK DE, 1979, J ECON ENTOMOL, V72, P70, DOI 10.1093/jee/72.1.70; MEYERDIRK DE, 1981, J ECON ENTOMOL, V74, P79, DOI 10.1093/jee/74.1.79; Mills NJ, 2010, BIOL CONTROL, V52, P255, DOI 10.1016/j.biocontrol.2009.03.018; Moore D., 1988, Biocontrol News and Information, V9, P209; Nakaune R, 2008, ARCH VIROL, V153, P1827, DOI 10.1007/s00705-008-0188-5; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; Pellizzari G, 2012, B INSECTOL, V65, P209; ROSEN D, 1986, AGR ECOSYST ENVIRON, V15, P121, DOI 10.1016/0167-8809(86)90085-X; Rubtsov I., 1952, REV ENTOMOL URSS, V32, P96; Rubtsov I, 1957, ENTOMOPHAGA, V2, P125; Shashkova RV, 1977, ZASHCHITA RASTENII, V51; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sonina A, 1967, BIOL CONTROL COMSTOC, P61; Sonina A, 1965, SADOVODSTVO, V7, P19; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Triapitsyn SV, 2007, BIOL CONTROL, V41, P14, DOI 10.1016/j.biocontrol.2006.12.013; Williams D, 1992, MEALYBUGS CENTRAL SO; Williams D. J., 1990, The scale insects of the tropical South Pacific region. Part 3: the soft scales (Coccidae) and other families.; Williams D.J., 2004, MEALYBUGS SO ASIA, P896; Yigit A, 2013, TURK ENTOMOL DERG-TU, V37, P359	40	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157965	10.1371/journal.pone.0157965	http://dx.doi.org/10.1371/journal.pone.0157965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362639	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200032
J	Martin, R; Makino, H; Yavuz, AC; Ben-Amor, K; Roelofs, M; Ishikawa, E; Kubota, H; Swinkels, S; Sakai, T; Oishi, K; Kushiro, A; Knol, J				Martin, Rocio; Makino, Hiroshi; Yavuz, Aysun Cetinyurek; Ben-Amor, Kaouther; Roelofs, Mieke; Ishikawa, Eiji; Kubota, Hiroyuki; Swinkels, Sophie; Sakai, Takafumi; Oishi, Kenji; Kushiro, Akira; Knol, Jan			Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota	PLOS ONE			English	Article							SPECIES-SPECIFIC PRIMERS; FORMULA-FED INFANTS; CESAREAN-SECTION; INTESTINAL MICROBIOTA; FECAL MICROBIOTA; PREDOMINANT BACTERIA; COMMENSAL BACTERIA; HYGIENE HYPOTHESIS; VAGINAL MICROBIOTA; ALLERGIC DISEASES	Colonization of the infant gut is believed to be critically important for a healthy growth as it influences gut maturation, metabolic, immune and brain development in early life. Understanding factors that influence this process is important, since an altered colonization has been associated with a higher risk of diseases later in life. Fecal samples were collected from 108 healthy neonates in the first half year of life. The composition and functionality of the microbiota was characterized by measuring 33 different bacterial taxa by qPCR/RT qPCR, and 8 bacterial metabolites. Information regarding gender, place and mode of birth, presence of siblings or pets; feeding pattern and antibiotic use was collected by using questionnaires. Regression analysis techniques were used to study associations between microbiota parameters and confounding factors over time. Bacterial DNA was detected in most meconium samples, suggesting bacterial exposure occurs in utero. After birth, colonization by species of Bifidobacterium, Lactobacillus and Bacteroides was influenced by mode of delivery, type of feeding and presence of siblings, with differences found at species level and over time. Interestingly, infant-type bifidobacterial species such as B. breve or B. longum subsp infantis were confirmed as early colonizers apparently independent of the factors studied here, while B. animalis subsp. lactis presence was found to be dependent solely on the type of feeding, indicating that it might not be a common infant gut inhabitant. One interesting and rather unexpected confounding factor was gender. This study contributes to our understanding of the composition of the microbiota in early life and the succession process and the evolution of the microbial community as a function of time and events occurring during the first 6 months of life. Our results provide new insights that could be taken into consideration when selecting nutritional supplementation strategies to support the developing infant gut microbiome.	[Martin, Rocio; Yavuz, Aysun Cetinyurek; Ben-Amor, Kaouther; Roelofs, Mieke; Swinkels, Sophie; Knol, Jan] Nutricia Res, Utrecht, Netherlands; [Makino, Hiroshi; Ishikawa, Eiji; Kubota, Hiroyuki; Sakai, Takafumi; Oishi, Kenji; Kushiro, Akira] Yakult Cent Inst, Tokyo, Japan; [Knol, Jan] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands	Danone Nutricia; Yakult Honsha Company, Limited; Wageningen University & Research	Martin, R (corresponding author), Nutricia Res, Utrecht, Netherlands.	rocio.martin@danone.com	Knol, Jan/AAL-6487-2020; Knol, Jan/A-2178-2010	Knol, Jan/0000-0002-2103-5961; Knol, Jan/0000-0002-2103-5961; Ishikawa, Eiji/0000-0002-4179-9010	Yakult; Nutricia Research	Yakult; Nutricia Research(Danone Nutricia)	The study was funded by Yakult and Nutricia Research. The following authors are paid by Nutricia Research: RM, KBA, MR, SS, ACY, JK, whereas HM, HK, TS, EI, KO, AK are paid by Yakult. The specific roles of these authors are articulated in the 'author contributions' section.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Avershina E, 2014, FEMS MICROBIOL ECOL, V87, P280, DOI 10.1111/1574-6941.12223; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2015, CELL HOST MICROBE, V17, P852, DOI 10.1016/j.chom.2015.05.012; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Bergstrom A, 2014, APPL ENVIRON MICROB, V80, P2889, DOI 10.1128/AEM.00342-14; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; CHONAN O, 1995, BIOSCI BIOTECH BIOCH, V59, P236, DOI 10.1271/bbb.59.236; Darmasseelane K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087896; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Fan WG, 2014, J MICROBIOL BIOTECHN, V24, P133, DOI 10.4014/jmb.1309.09029; Fooladi Abbas Ali Imani, 2013, Inflammation & Allergy Drug Targets, V12, P410; Forsberg A, 2013, CLIN EXP ALLERGY, V43, P434, DOI 10.1111/cea.12082; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Hansen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133320; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hollister EB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0101-x; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jimenez E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-143; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Kikuchi E, 2002, MICROBIOL IMMUNOL, V46, P353, DOI 10.1111/j.1348-0421.2002.tb02706.x; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kubota H, 2010, APPL ENVIRON MICROB, V76, P5440, DOI 10.1128/AEM.03132-09; Lahtinen SJ, 2009, J ALLERGY CLIN IMMUN, V123, P499, DOI 10.1016/j.jaci.2008.11.034; Lambert P, 2005, STAT MED, V24, P3977, DOI 10.1002/sim.2396; Laursen MF, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0477-6; Lee SA, 2015, NUTR RES PRACT, V9, P242, DOI [10.4162/nrp.2015.9.3.242;, 10.4162/nrp.2015.9.3.242]; Li HT, 2012, AM J CLIN NUTR, V96, P215, DOI 10.3945/ajcn.112.038760; Lindberg E, 2011, CLIN MICROBIOL INFEC, V17, P1209, DOI 10.1111/j.1469-0691.2010.03426.x; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Makino H, 2011, APPL ENVIRON MICROB, V77, P6788, DOI 10.1128/AEM.05346-11; Markle JGM, 2014, GUT MICROBES, V5, P485, DOI 10.4161/gmic.29795; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Matsuki T, 1998, FEMS MICROBIOL LETT, V167, P113, DOI 10.1111/j.1574-6968.1998.tb13216.x; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Milani C, 2015, APPL ENVIRON MICROB, V81, P7078, DOI 10.1128/AEM.02037-15; Mueller NT, 2015, INT J OBESITY, V39, P665, DOI 10.1038/ijo.2014.180; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Munyaka PM, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00109; Nermes M, J ALLERGY CLIN IMMUN; Nermes Merja, 2013, ISRN Allergy, V2013, P827934, DOI 10.1155/2013/827934; Ouwehand AC, 2001, J ALLERGY CLIN IMMUN, V108, P144, DOI 10.1067/mai.2001.115754; Pelzer ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049965; Penders J, 2014, GUT MICROBES, V5, P239, DOI 10.4161/gmic.27905; Penders J, 2013, J ALLERGY CLIN IMMUN, V132, P601, DOI 10.1016/j.jaci.2013.05.043; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Roger LC, 2010, MICROBIOL-SGM, V156, P3329, DOI 10.1099/mic.0.043224-0; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Salminen S, 2004, GUT, V53, P1388, DOI 10.1136/gut.2004.041640; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Storro O, 2013, CURR OPIN ALLERGY CL, V13, P257, DOI 10.1097/ACI.0b013e328360968b; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Suzuki S, 2007, CLIN EXP ALLERGY, V37, P506, DOI 10.1111/j.1365-2222.2007.02676.x; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Tanaka S, 2009, FEMS IMMUNOL MED MIC, V56, P80, DOI 10.1111/j.1574-695X.2009.00553.x; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Thompson AL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00003; Tsuji H, 2012, BENEF MICROBES, V3, P113, DOI 10.3920/BM2011.0038; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Ventura M, 2001, APPL ENVIRON MICROB, V67, P2760, DOI 10.1128/AEM.67.6.2760-2765.2001; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wopereis H, 2014, PEDIAT ALLERG IMM-UK, V25, P428, DOI 10.1111/pai.12232; Yap GC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-193; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zanardo V, 2010, BIRTH-ISS PERINAT C, V37, P275, DOI 10.1111/j.1523-536X.2010.00421.x	91	170	181	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158498	10.1371/journal.pone.0158498	http://dx.doi.org/10.1371/journal.pone.0158498			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362264	gold, Green Published, Green Submitted			2022-12-27	WOS:000378865200082
J	Mitra, A; Herren, CD; Patel, IR; Coleman, A; Mukhopadhyay, S				Mitra, Arindam; Herren, Christopher D.; Patel, Isha R.; Coleman, Adam; Mukhopadhyay, Suman			Integration of AI-2 Based Cell-Cell Signaling with Metabolic Cues in Escherichia coli	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; RESPONSE REGULATOR; BIOFILM FORMATION; GLOBAL CONTROL; QUORUM; LUXS; SYSTEM; PROTEIN; COMMUNICATION; MOTILITY	The quorum sensing molecule Autoinducer-2 (AI-2) is generated as a byproduct of activated methyl cycle by the action of LuxS in Escherichia coli. AI-2 is synthesized, released and later internalized in a cell-density dependent manner. Here, by mutational analysis of the genes, uvrY and csrA, we describe a regulatory circuit of accumulation and uptake of AI-2. We constructed a single-copy chromosomal luxS-lacZ fusion in a luxS (+) merodiploid strain and evaluated its relative expression in uvrY and csrA mutants. At the entry of stationary phase, the expression of the fusion and AI-2 accumulation was positively regulated by uvrY and negatively regulated by csrA respectively. A deletion of csrA altered message stability of the luxS transcript and CsrA protein exhibited weak binding to 5' luxS regulatory region. DNA protein interaction and chromatin immunoprecipitation analysis confirmed direct interaction of UvrY with the luxS promoter. Additionally, reduced expression of the fusion in hfq deletion mutant suggested involvement of small RNA interactions in luxS regulation. In contrast, the expression of lsrA operon involved in AI-2 uptake, is negatively regulated by uvrY and positively by csrA in a cell-density dependent manner. The dual role of csrA in AI-2 synthesis and uptake suggested a regulatory crosstalk of cell signaling with carbon regulation in Escherichia coli. We found that the cAMP-CRP mediated catabolite repression of luxS expression was uvrY dependent. This study suggests that luxS expression is complex and regulated at the level of transcription and translation. The multifactorial regulation supports the notion that cell-cell communication requires interaction and integration of multiple metabolic signals.	[Mitra, Arindam; Herren, Christopher D.; Patel, Isha R.; Coleman, Adam; Mukhopadhyay, Suman] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Mitra, Arindam] Adamas Univ, Dept Microbiol, Kolkata, W Bengal, India; [Herren, Christopher D.] Kansas State Univ, Div Biol, Manhattan, KS USA; [Patel, Isha R.] US FDA, Div Mol Biol, Off Appl Res & Safety Assessment HFS 025, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Coleman, Adam] Maryland Dept Hlth & Mental Hyg, Div Newborn & Childhood Screening, Baltimore, MD USA; [Mukhopadhyay, Suman] NIAID, Div Microbiol & Infect Dis, NIH, Bethesda, MD USA	University System of Maryland; University of Maryland College Park; Kansas State University; US Food & Drug Administration (FDA); Maryland Department of Health & Mental Hygiene; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mukhopadhyay, S (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.; Mukhopadhyay, S (corresponding author), NIAID, Div Microbiol & Infect Dis, NIH, Bethesda, MD USA.	mukhopadhyays@mail.nih.gov	Mitra, Arindam/A-1379-2013	Mitra, Arindam/0000-0002-1591-6164	USDA-NRI-CSREES Competitive Grant [2004-35204-14749]; USDA-Animal Health [2002-1106-0195318]; Maryland Agriculture Experimental Station grant from the University of Maryland	USDA-NRI-CSREES Competitive Grant; USDA-Animal Health; Maryland Agriculture Experimental Station grant from the University of Maryland	This work was in part supported by USDA-NRI-CSREES Competitive Grant 2004-35204-14749, USDA-Animal Health 2002-1106-0195318 and Maryland Agriculture Experimental Station grant from the University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Ahmer BMM, 1999, MOL MICROBIOL, V31, P971, DOI 10.1046/j.1365-2958.1999.01244.x; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bhardwaj Ashima K, 2013, Recent Pat Antiinfect Drug Discov, V8, P68; Brito PH, 2013, GENOME BIOL EVOL, V5, P16, DOI 10.1093/gbe/evs122; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Keersmaecker SCJ, 2006, TRENDS MICROBIOL, V14, P114, DOI 10.1016/j.tim.2006.01.003; Dong YH, 2005, MOL MICROBIOL, V56, P1287, DOI 10.1111/j.1365-2958.2005.04612.x; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; Eriksson ARB, 1998, MOL PLANT MICROBE IN, V11, P743, DOI 10.1094/MPMI.1998.11.8.743; Fujii T, 2008, J BACTERIOL, V190, P7655, DOI 10.1128/JB.01489-07; GAFFNEY TD, 1994, MOL PLANT MICROBE IN, V7, P455, DOI 10.1094/MPMI-7-0455; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Hardie KR, 2003, MICROBIOL-SGM, V149, P715, DOI 10.1099/mic.0.25853-0; Herren CD, 2006, INFECT IMMUN, V74, P4900, DOI 10.1128/IAI.00412-06; IGO M M, 1990, New Biologist, V2, P5; Jang J, 2011, MICROBIOL-SGM, V157, P1466, DOI 10.1099/mic.0.043737-0; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Khorchid A, 2006, INT J BIOCHEM CELL B, V38, P307, DOI 10.1016/j.biocel.2005.08.018; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; LAVILLE J, 1992, P NATL ACAD SCI USA, V89, P1562, DOI 10.1073/pnas.89.5.1562; Lee J, 2013, NAT CHEM BIOL, V9, P339, DOI [10.1038/NCHEMBIO.1225, 10.1038/nchembio.1225]; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mitra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055492; Mizuno T, 1998, J BIOCHEM, V123, P555; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; Niu C, 2013, FEMS MICROBIOL ECOL, V83, P778, DOI 10.1111/1574-6941.12034; Palaniyandi S, 2013, VET MICROBIOL, V166, P567, DOI 10.1016/j.vetmic.2013.07.009; Palaniyandi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031348; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; PODKOVYROV SM, 1995, GENE, V156, P151, DOI 10.1016/0378-1119(95)00053-9; Queck SY, 2006, ENVIRON MICROBIOL, V8, P1017, DOI 10.1111/j.1462-2920.2006.00993.x; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Ray VA, 2012, MOL MICROBIOL, V86, P954, DOI 10.1111/mmi.12035; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sambrook J., 2001, MOL CLONING LAB MANU; Santiago-Rodriguez TM, 2014, FEMS MICROBIOL LETT, V350, P117, DOI 10.1111/1574-6968.12275; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Tsou AM, 2011, MICROBIOL-SGM, V157, P1620, DOI 10.1099/mic.0.046235-0; Vidal JE, 2011, INFECT IMMUN, V79, P4050, DOI 10.1128/IAI.05186-11; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; Wang L, 2005, J BACTERIOL, V187, P2066, DOI 10.1128/JB.187.6.2066-2076.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Yang Q, 2015, ENVIRON MICROBIOL, V17, P960, DOI 10.1111/1462-2920.12420; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	63	9	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0157532	10.1371/journal.pone.0157532	http://dx.doi.org/10.1371/journal.pone.0157532			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362507	gold, Green Submitted, Green Published			2022-12-27	WOS:000378865200019
J	Jian, HY; Zhang, YH; Qiu, XQ; Yan, HJ; Wang, QG; Zhang, H; Sun, H				Jian, Hongying; Zhang, Yonghong; Qiu, Xianqin; Yan, Huijun; Wang, Qigang; Zhang, Hao; Sun, Hang			Yalongjiang River Has Had an Important Role in the Dispersal and Divergence of Rosa soulieana in the Hengduan Mountains of China	PLOS ONE			English	Article							GENETIC DIVERSITY; AFLP; DIFFERENTIATION; CANINAE; DNA; CONSERVATION; POPULATIONS; COMPLEX; MARKERS; NUMBER	The Hengduan Mountains are the core of the Sino-Himalayan Floristic Region. Rosa soulieana Crep. is an important wild rose species that is widely distributed in the Hengduan Mountains. To provide better future utilization of this wild rose, and also to add some possible proof of the effect of geomorphological and ecological characteristics of the Hengduan Mountains on the current spatial distribution and genetic diversity of local species, the genetic diversity and genetic structure of 556 individuals from 37 populations of R. soulieana were studied using fluorescent amplified fragment length polymorphisms (AFLPs). R. soulieana showed a moderately high level of genetic diversity and a high level of genetic differentiation at the species level. The total percentage of polymorphic loci, total heterozygosity (Ht), Shannon index (I), and heterozygosity value within populations (Hs) were 97.8%, 0.253, 0.339, and 0.139, respectively. More than half of the total genetic variation (54.0%) occurred within populations, and the overall gene differentiation coefficient (Gst) was 0.451. The genetic differentiation among populations was positively and significantly correlated with geographic distance. The neighbor-joining cluster and the Bayesian analysis divided all the populations and individuals into 3 groups, and did not support the morphology based intraspecific varieties. The results confirmed that the ancient R. soulieana of the third group survived in northwestern Yunnan and Yalongjiang valley and then moved upnorth along the valley. The spatial distribution of the other two groups was the result of allopatric divergence due to long period of adaptation to the different climatic conditions of its distribution at either side of the Yalongjiang River.	[Jian, Hongying; Sun, Hang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Jian, Hongying; Qiu, Xianqin; Yan, Huijun; Wang, Qigang; Zhang, Hao] Yunnan Acad Agr Sci, Natl Engn Res Ctr Ornamental Hort, Flower Res Inst, Kunming, Peoples R China; [Zhang, Yonghong] Yunnan Normal Univ, Dept Life Sci, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Yunnan Academy of Agricultural Sciences; Yunnan Normal University	Sun, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	hsun@mail.kib.ac.cn			Major Program of National Natural Science Foundation of China [31590820, 31590823]; National Natural Science Foundation of China [31260198, 31460050]; Academic and Technical Talents Training Project of Yunnan Province [2013 HB092]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic and Technical Talents Training Project of Yunnan Province	This study was supported by Major Program of National Natural Science Foundation of China (31590820 to HS), Major Program of National Natural Science Foundation of China (31590823 to HS), National Natural Science Foundation of China (31260198 to HYJ), National Natural Science Foundation of China (31460050 Dr. Yonghong Zhang), Academic and Technical Talents Training Project of Yunnan Province (2013 HB092 to HYJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; [Anonymous], [No title captured]; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Basaki T, 2009, SCI HORTIC-AMSTERDAM, V120, P538, DOI 10.1016/j.scienta.2008.12.001; CHENG J, 2001, GEOSCIENCE, V15, P290; Soldati MC, 2013, BIOCHEM SYST ECOL, V47, P45, DOI 10.1016/j.bse.2012.10.011; De Cock K, 2008, ANN BOT-LONDON, V102, P685, DOI 10.1093/aob/mcn151; de Souza LB, 2013, GENET MOL BIOL, V36, P533, DOI [10.1590/S1415-47572013005000036, 10.1590/s1415-47572013005000036]; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Ghosh R., 2009, THESIS; Gu C., 2003, FLORA CHINA, V9, P339; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; He Y. H., 1994, Acta Horticulturae Sinica, V21, P158; HERRERA CM, 1984, OECOLOGIA, V63, P386, DOI 10.1007/BF00390670; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HURST C. C., 1928, ZEITSCHR INDUKT ABSTAM U VERERBUNGSL SUPPLEMENTB, V2, P866; Ikeda H, 2009, J PLANT RES, V122, P141, DOI 10.1007/s10265-008-0213-5; Jian HY, 2015, ACTA HORTIC, V1064, P39; Jian HY, 2013, GENET RESOUR CROP EV, V60, P115, DOI 10.1007/s10722-012-9820-z; Jian HY, 2015, PLANT SYST EVOL, V301, P1819, DOI 10.1007/s00606-015-1195-0; Jian HY, 2015, THESIS; Juan A, 2012, EUR J FOREST RES, V131, P845, DOI 10.1007/s10342-011-0558-5; Kato S, 2011, J PLANT RES, V124, P11, DOI 10.1007/s10265-010-0352-3; Kellner A, 2014, BOT J LINN SOC, V174, P240, DOI 10.1111/boj.12124; Ku T.C., 1985, FLORA REIPUBLICAE PO, V37, P360; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li B, 1989, MT RES, V7, P13; LI J, 1979, SCI SINICA, V22, P1314; MANTEL N, 1967, CANCER RES, V27, P209; Mikulicek P, 2013, BIOL J LINN SOC, V108, P151, DOI 10.1111/j.1095-8312.2012.01999.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEI M, 1974, GENETICS, V76, P379; Nybom H, 1997, PLANT SYST EVOL, V204, P207, DOI 10.1007/BF00989206; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pritchard JK, 2000, GENETICS, V155, P945; Prohens J, 2007, GENET RESOUR CROP EV, V54, P451, DOI 10.1007/s10722-006-9174-5; Reisch C, 2015, BOT J LINN SOC, V177, P112, DOI 10.1111/boj.12221; Rois AS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-205; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; Rusanov K, 2005, THEOR APPL GENET, V111, P804, DOI 10.1007/s00122-005-2066-9; SCHAAL BA, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P123; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Sun HL, 1988, FORMATION EVOLUTION; Vander Mijnsbrugge K, 2010, CONSERV GENET, V11, P2243, DOI 10.1007/s10592-010-0109-5; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang FY, 2008, BIOCHEM GENET, V46, P75, DOI 10.1007/s10528-007-9131-9; Wang W., 1994, VASCULAR PLANTS HENG, V2; WILSON E O, 1992; [伍翔宇 Wu Xiangyu], 2014, [园艺学报, Acta Horticulturae Sinica], V41, P2075; Wu ZY, 1988, J JPN BOT, V63, P1; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yu Yi, 2014, PLoS One, V9, pe107769, DOI 10.1371/journal.pone.0107769; Zhang L., 2005, SOIL ERODIBILITY ITS; Zhang X, 2015, BIOCHEM SYST ECOL, V58, P13, DOI 10.1016/j.bse.2014.10.015; Zhou SZ, 2006, QUATERN INT, V154, P44, DOI 10.1016/j.quaint.2006.02.002; [周志琼 ZHOU Zhi-Qiong], 2009, [生态学报, Acta Ecologica Sinica], V29, P1931	68	4	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158586	10.1371/journal.pone.0158586	http://dx.doi.org/10.1371/journal.pone.0158586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355209	Green Submitted, gold, Green Published			2022-12-27	WOS:000378859400080
J	Hadjichristodoulou, C; Mpalaouras, G; Vasilopoulou, V; Katsioulis, A; Rachiotis, G; Theodoridou, K; Tzanakaki, G; Syriopoulou, V; Theodoridou, M				Hadjichristodoulou, Christos; Mpalaouras, George; Vasilopoulou, Vasiliki; Katsioulis, Antonios; Rachiotis, George; Theodoridou, Kalliopi; Tzanakaki, Georgia; Syriopoulou, Vassiliki; Theodoridou, Maria			A Case-Control Study on the Risk Factors for Meningococcal Disease among Children in Greece	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; NEISSERIA-MENINGITIDIS; SOCIAL DEPRIVATION; PARENTAL SMOKING; CARRIAGE; SUSCEPTIBILITY; ASSOCIATION; POLYMORPHISMS; MUTATIONS; GENE	Purpose The aim of this study was to identify environmental or genetic risk factors that are associated with invasive meningococcal disease (IMD) in children in Greece. Methods A case-control study was performed in 133 children (44 cases and 89 controls) aged between 0-14 years, who were hospitalized in a children's hospital in Athens. Demographics and possible risk factors were collected by the use of a structured questionnaire. To investigate the association of mannose binding lectin (MBL) with IMD, a frequency analysis of the haplotypes of the MBL2 gene and quantitative measurement of MBL serum protein levels were performed using Nanogen NanoChipR 400 technology and immuno-enzyme techniques, respectively. Results The multivariate analysis revealed that changes in a child's life setting (relocation or vacation, OR = 7.16), paternal smoking (OR = 4.51), upper respiratory tract infection within the previous month (OR = 3.04) and the density of people in the house/100m(2) (OR = 3.16), were independent risk factors associated with IMD. Overall 18.8% of patients had a MBL2 genotype with low functionality compared to 10.1% of healthy controls, but this was not statistically significant (p = 0.189). Conclusion Prevention strategies aimed at reducing parental smoking and other risk factors identified in this study could decrease the risk of IMD among children in Greece.	[Hadjichristodoulou, Christos; Mpalaouras, George; Katsioulis, Antonios; Rachiotis, George] Univ Thessaly, Dept Hyg & Epidemiol, Fac Med, Larisa, Greece; [Vasilopoulou, Vasiliki; Theodoridou, Kalliopi; Syriopoulou, Vassiliki; Theodoridou, Maria] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Athens, Greece; [Tzanakaki, Georgia] Natl Sch Publ Hlth, Natl Reference Ctr Meningitis, Athens, Greece	University of Thessaly; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; National & Kapodistrian University of Athens	Hadjichristodoulou, C (corresponding author), Univ Thessaly, Dept Hyg & Epidemiol, Fac Med, Larisa, Greece.	xhatzi@med.uth.gr		Hadjichristodoulou, Christos/0000-0002-4769-8376				Baccarini C, 2013, HUM VACC IMMUNOTHER, V9, P162, DOI 10.4161/hv.22302; Bradley DT, 2012, INT J IMMUNOGENET, V39, P328, DOI 10.1111/j.1744-313X.2012.01095.x; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P27, DOI 10.1111/j.1574-695X.1999.tb01713.x; European Centre for Disease Prevention and Control, MEN DIS; Faber J, 2007, PEDIATR INFECT DIS J, V26, P243, DOI 10.1097/01.inf.0000256751.76218.7c; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; Fone DL, 2003, EPIDEMIOL INFECT, V130, P53, DOI 10.1017/S095026880200794X; Harrison LH, 2008, PEDIATR INFECT DIS J, V27, P193, DOI 10.1097/INF.0b013e31815c1b3a; Harrison LH, 2010, CLIN INFECT DIS, V50, pS37, DOI 10.1086/648963; Heyderman RS, 2004, ARCH DIS CHILD, V89, P1064, DOI 10.1136/adc.2003.036004; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Hubert B, 1997, Euro Surveill, V2, P69; Jones IR, 1997, BRIT MED J, V314, P794, DOI 10.1136/bmj.314.7083.794; KREMASTINOU J, 1994, SCAND J INFECT DIS, V26, P719, DOI 10.3109/00365549409008641; Kriz P, 2000, ARCH DIS CHILD, V83, P117, DOI 10.1136/adc.83.2.117; Lee CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000374; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Palumbo E, 2012, METHODS MOL BIOL, V799, P361, DOI 10.1007/978-1-61779-346-2_21; Pereiro I, 2004, J INFECTION, V48, P320, DOI 10.1016/j.jinf.2003.10.015; Reintjes R, 2005, EUR J EPIDEMIOL, V20, P629, DOI 10.1007/s10654-005-6586-z; Sommers LM, 1999, PEDIATR INFECT DIS J, V18, P902, DOI 10.1097/00006454-199910000-00013; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Stephens DS, 1999, LANCET, V353, P941, DOI 10.1016/S0140-6736(98)00279-7; Stuart J M, 2002, Commun Dis Public Health, V5, P327; SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8; Tan JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141620; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111; Vardar F, 2007, TURKISH J PEDIATR, V49, P270; Vasilopoulou VA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-214; World Health Organization, 1998, WHOEMCBAC983EN; World Health Organization, MENINGITIS OUTBREAK	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158524	10.1371/journal.pone.0158524	http://dx.doi.org/10.1371/journal.pone.0158524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351742	Green Submitted, gold, Green Published			2022-12-27	WOS:000378858900063
J	Kim, SH; An, GS; Choi, I; Koo, JW; Lee, K; Song, JJ				Kim, Shin Hye; An, Gwang Seok; Choi, Inyong; Koo, Ja-Won; Lee, Kyogu; Song, Jae-Jin			Pre-Treatment Objective Diagnosis and Post-Treatment Outcome Evaluation in Patients with Vascular Pulsatile Tinnitus Using Transcanal Recording and Spectro-Temporal Analysis	PLOS ONE			English	Article							SINUS DIVERTICULUM; BRAIN	Objective Although vascular pulsatile tinnitus (VPT) has been classified as "objective", VPT is not easily recognizable or documentable in most cases. In response to this, we have developed transcanal sound recording (TSR) and spectro-temporal analysis (STA) for the objective diagnosis of VPT. By refining our initial method, we were able to apply TSR/STA to post-treatment outcome evaluation, as well as pre-treatment objective diagnosis. Methods TSR was performed on seven VPT patients and five normal controls before and after surgical or interventional treatment. VPT was recorded using an inserted microphone with the subjects placed in both upright and supine positions with 1) a neutral head position, 2) head rotated to the tinnitus side, 3) head rotated to the non-tinnitus side, and 4) a neutral position with ipsi-lesional manual cervical compression. The recorded signals were analyzed in both time and time-frequency domains by performing a short-time Fourier transformation. Results The pre-treatment ear canal signals of all VPT patients demonstrated pulse-synchronous periodic structures and acoustic characteristics that were representative of their presumptive vascular pathologies, whereas those the controls exhibited smaller peaks and weak periodicities. Compared with the pre-treatment signals, the post-treatment signals exhibited significantly reduced peak-and root mean square amplitudes upon time domain analysis. Additionally, further sub-band analysis confirmed that the pulse-synchronous signal of all subjects was not identifiable after treatment and, in particular, that the signal decrement was statistically significant at low frequencies. Moreover, the post-treatment signals of the VPT subjects revealed no significant differences when compared to those of the control group. Conclusion We reconfirmed that the TSR/STA method is an effective modality to objectify VPT. In addition, the potential role of the TSR/STA method in the objective evaluation of treatment outcomes in patients with VPT was proven. Further studies incorporating a larger sample size and more refined recording techniques are warranted.	[Kim, Shin Hye; Koo, Ja-Won; Song, Jae-Jin] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Shin Hye] Korea Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [An, Gwang Seok; Lee, Kyogu] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Mus & Audio Res Grp, Seoul, South Korea; [Choi, Inyong] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA	Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); University of Iowa	Song, JJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea.; Lee, K (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Mus & Audio Res Grp, Seoul, South Korea.	kglee@snu.ac.kr; jjsong96@gmail.com	Song, Jae-Jin/E-4633-2017	Song, Jae-Jin/0000-0002-6631-3232	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea [HI14C2264]	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea	This work was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI14C2264) (https://www.htdream.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan SF, 2015, LARYNGOSCOPE, V125, P284, DOI 10.1002/lary.24822; Elgoyhen AB, 2015, NAT REV NEUROSCI, V16, P632, DOI 10.1038/nrn4003; Eisenman DJ, 2011, OTOL NEUROTOL, V32, P1116, DOI 10.1097/MAO.0b013e31822a1c7d; Kim CS, 2016, J NEUROSURG, V125, P441, DOI 10.3171/2015.6.JNS15961; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Liyanage SH, 2006, J LARYNGOL OTOL, V120, P93, DOI 10.1017/S0022215105001714; Madani G, 2009, CLIN RADIOL, V64, P319, DOI 10.1016/j.crad.2008.08.014; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Oliveira Carlos A, 2003, Int Tinnitus J, V9, P37; Sismanis A, 2011, CURR OPIN OTOLARYNGO, V19, P348, DOI 10.1097/MOO.0b013e3283493fd8; Song JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123538; Song JJ, 2016, OTOL NEUROTOL, V37, P613, DOI 10.1097/MAO.0000000000001005; Song JJ, 2015, NEUROSURGERY, V77, P709, DOI 10.1227/NEU.0000000000000902; Song JJ, 2015, BRAIN STRUCT FUNCT, V220, P571, DOI 10.1007/s00429-013-0648-x; Song JJ, 2014, BRAIN STRUCT FUNCT, V219, P1113, DOI 10.1007/s00429-013-0555-1; Song JJ, 2013, HEARING RES, V299, P1, DOI 10.1016/j.heares.2013.02.001; Song JJ, 2013, NEUROBIOL AGING, V34, P1853, DOI 10.1016/j.neurobiolaging.2013.01.014; Song JJ, 2012, J NUCL MED, V53, P1550, DOI 10.2967/jnumed.112.102939; Wee JH, 2012, OTOL NEUROTOL, V33, pE41, DOI 10.1097/MAO.0b013e318245cb22	19	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157722	10.1371/journal.pone.0157722	http://dx.doi.org/10.1371/journal.pone.0157722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351198	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900015
J	Sclip, A; Bacaj, T; Giam, LR; Sudhof, TC				Sclip, Alessandra; Bacaj, Taulant; Giam, Louise R.; Sudhof, Thomas C.			Extended Synaptotagmin (ESyt) Triple Knock-Out Mice Are Viable and Fertile without Obvious Endoplasmic Reticulum Dysfunction	PLOS ONE			English	Article							PLASMA MEMBRANE JUNCTIONS; CONTACT SITES; NEURAL ACTIVITY; C-2 DOMAINS; E-SYTS; ER; PROTEINS; CELLS; DENDRITES; NEURONS	Extended synaptotagmins (ESyts) are endoplasmic reticulum (ER) proteins composed of an N-terminal transmembrane region, a central SMP-domain, and five (ESyt1) or three C-terminal cytoplasmic C2-domains (ESyt2 and ESyt3). ESyts bind phospholipids in a Ca(2+)dependent manner via their C2-domains, are localized to ER-plasma membrane contact sites, and may catalyze lipid exchange between the plasma membrane and the ER via their SMP-domains. However, the overall function of ESyts has remained enigmatic. Here, we generated triple constitutive and conditional knock-out mice that lack all three ESyt isoforms; in addition, we produced knock-in mice that express mutant ESyt1 or ESyt2 carrying inactivating substitutions in the Ca2+-binding sites of their C2A-domains. Strikingly, all ESyt mutant mice, even those lacking all ESyts, were apparently normal and survived and bred in a manner indistinguishable from control mice. ESyt mutant mice displayed no major changes in brain morphology or synaptic protein composition, and exhibited no large alterations in stress responses. Thus, in mice ESyts do not perform an essential role in basic cellular functions, suggesting that these highly conserved proteins may perform a specialized role that may manifest only during specific, as yet untested challenges.	[Sclip, Alessandra; Bacaj, Taulant; Giam, Louise R.; Sudhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA; [Sclip, Alessandra; Sudhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, 265 Campus Dr, Stanford, CA USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.; Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, 265 Campus Dr, Stanford, CA USA.	tcs1@stanford.edu			Conte Center grant from the NIMH	Conte Center grant from the NIMH	This work was supported by a Conte Center grant from the NIMH to TCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, J NEUROSCI RES, V65, P236, DOI 10.1002/jnr.1147; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Aridor M, 2009, TRAFFIC, V10, P1669, DOI 10.1111/j.1600-0854.2009.00974.x; Banno T, 1998, J COMP NEUROL, V402, P252; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Fernandez-Busnadiego R, 2015, P NATL ACAD SCI USA, V112, pE2004, DOI 10.1073/pnas.1503191112; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; Herdman C, 2016, PHARMACOL RES, V107, P48, DOI 10.1016/j.phrs.2016.01.034; Herdman C, 2014, CELL CYCLE, V13, P2616, DOI 10.4161/15384101.2014.943573; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Idevall-Hagren O, 2015, EMBO J, V34, P2291, DOI 10.15252/embj.201591565; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kucharz K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005250; Levy A, 2015, CURR BIOL, V25, P2018, DOI 10.1016/j.cub.2015.06.015; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Metuzals J, 1997, J NEUROCYTOL, V26, P529, DOI 10.1023/A:1015482407202; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Pang ZP, 2010, J BIOL CHEM, V285, P33930, DOI 10.1074/jbc.M110.150151; Petersen OH, 2007, CELL CALCIUM, V42, P373, DOI 10.1016/j.ceca.2007.05.012; Petkovic M, 2014, NAT CELL BIOL, V16, P434, DOI 10.1038/ncb2937; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Reinisch KM, 2016, BBA-MOL CELL BIOL L, V1861, P924, DOI 10.1016/j.bbalip.2015.12.003; Ridge RW, 1999, PLANT CELL PHYSIOL, V40, P1253, DOI 10.1093/oxfordjournals.pcp.a029513; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROSENBLUTH J, 1962, J CELL BIOL, V13, P405, DOI 10.1083/jcb.13.3.405; Schauder CM, 2014, NATURE, V510, P552, DOI 10.1038/nature13269; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; TSUKITA S, 1976, J ELECTRON MICROSC, V25, P141; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weclewicz K, 1998, BRAIN RES BULL, V46, P353, DOI 10.1016/S0361-9230(98)00013-6; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Xu JJ, 2014, STRUCTURE, V22, P269, DOI 10.1016/j.str.2013.11.011	48	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0158295	10.1371/journal.pone.0158295	http://dx.doi.org/10.1371/journal.pone.0158295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP9FD	27348751	Green Published, gold, Green Submitted			2022-12-27	WOS:000378801200059
J	Aguirre, LF; Montano-Centellas, FA; Gavilanez, MM; Stevens, RD				Aguirre, Luis F.; Montano-Centellas, Flavia A.; Mercedes Gavilanez, M.; Stevens, Richard D.			Taxonomic and Phylogenetic Determinants of Functional Composition of Bolivian Bat Assemblages	PLOS ONE			English	Article							TROPICAL ELEVATIONAL GRADIENT; COMMUNITY STRUCTURE; BIODIVERSITY ASSESSMENT; ENVIRONMENTAL GRADIENT; NEOTROPICAL SAVANNA; DIVERSITY; CONSERVATION; FOREST; CHIROPTERA; DIMENSIONALITY	Understanding diversity patterns and the potential mechanisms driving them is a fundamental goal in ecology. Examination of different dimensions of biodiversity can provide insights into the relative importance of different processes acting upon biotas to shape communities. Unfortunately, patterns of diversity are still poorly understood in hyper-diverse tropical countries. Here, we assess spatial variation of taxonomic, functional and phylogenetic diversity of bat assemblages in one of the least studied Neotropical countries, Bolivia, and determine whether changes in biodiversity are explained by the replacement of species or functional groups, or by differences in richness (i.e., gain or loss of species or functional groups). Further, we evaluate the contribution of phylogenetic and taxonomic changes in the resulting patterns of functional diversity of bats. Using well-sampled assemblages from published studies we examine noctilionoid bats at ten study sites across five ecoregions in Bolivia. Bat assemblages differed from each other in all dimensions of biodiversity considered; however, diversity patterns for each dimension were likely structured by different mechanisms. Within ecoregions, differences were largely explained by species richness, suggesting that the gain or loss of species or functional groups (as opposed to replacement) was driving dissimilarity patterns. Overall, our results suggest that whereas evolutionary processes (i.e., historical connection and dispersal routes across Bolivia) create a template of diversity patterns across the country, ecological mechanisms modify these templates, decoupling the observed patterns of functional, taxonomic and phylogenetic diversity in Bolivian bats. Our results suggests that elevation represents an important source of variability among diversity patterns for each dimension of diversity considered. Further, we found that neither phylogenetic nor taxonomic diversity can fully account for patterns of functional diversity, highlighting the need for examining different dimensions of biodiversity of bats in hyperdiverse ecosystems.	[Aguirre, Luis F.] Univ Mayor San Simon, Ctr Biodiversidad & Genet, Cochabamba, Bolivia; [Montano-Centellas, Flavia A.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Mercedes Gavilanez, M.] Univ Cent Ecuador, Fac Ciencias Med, Escuela Ciencias Biol & Ambientales, Quito, Ecuador; [Stevens, Richard D.] Dept Nat Resources Management, Lubbock, TX USA; [Stevens, Richard D.] Texas Tech Univ Museum, Lubbock, TX 79409 USA	State University System of Florida; University of Florida; Universidad Central del Ecuador; Texas Tech University System; Texas Tech University	Montano-Centellas, FA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA.	flamontano@ufl.edu	Aguirre, Luis F./AAE-9255-2019; Montaño-Centellas, Flavia/K-8046-2019	Aguirre, Luis F./0000-0002-4194-1523; Montaño-Centellas, Flavia/0000-0003-3115-3950				Acosta LH, 2006, INVENTARIACION HIST; Aguirre LF, 2003, J TROP ECOL, V19, P367, DOI [10.1017/S0266467403003419, 10.1017/s0266467403003419]; Aguirre LF, 2002, J MAMMAL, V83, P775, DOI 10.1644/1545-1542(2002)083<0775:SOANSB>2.0.CO;2; [Anonymous], 2007, HIST NATURAL DISTRIB; [Anonymous], PACKAGE HIER PART R; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chen J, 2012, PACKAGE GUNIFRAC GEN; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Cisneros LM, 2015, DIVERS DISTRIB, V21, P523, DOI 10.1111/ddi.12277; Cisneros LM, 2014, J ANIM ECOL, V83, P1124, DOI 10.1111/1365-2656.12201; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; De la Riva I, 2014, HERPETOL MONOGR, V28, P46, DOI 10.1655/HERPMONOGRAPHS-D-13-00009; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Dreiss LM, 2015, ECOGRAPHY, V38, P876, DOI 10.1111/ecog.00971; Emmons Louise, 2006, Revista Boliviana de Ecologia y Conservacion Ambiental, V19, P47; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Flores-Saldaña Mónica Gabriela, 2008, Mastozool. neotrop., V15, P309; Gaston K., 2008, PATTERN PROCESS MACR; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Goslee SC, 2010, PLANT ECOL, V206, P279, DOI 10.1007/s11258-009-9641-0; Ibisch PL, 2003, ECORREGIONES ECOSIST, P47; Moya M. Isabel, 2008, Mastozool. neotrop., V15, P349; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Kalko Elisabeth K. V., 1997, P13; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kunz TH, 2009, ECOLOGICAL BEHAV MET; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Maechler M., 2015, PACKAGE CLUSTER FIND; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; R Development Core Team, 2014, R LANG ENV STAT COMP; RALPH CJ, 2004, MONITORING BIRD POPU; Sampaio EM, 2003, STUD NEOTROP FAUNA E, V38, P17, DOI 10.1076/snfe.38.1.17.14035; Scatena F.N., 2011, TROPICAL MONTANE CLO; Selaya AP, 2010, REV BOLIVIANA ECOLOG, V27, P25; Siles L, 2006, REV ELECT MANEJO FAU, P101; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevens RD, 2015, ECOGRAPHY, V38, P861, DOI 10.1111/ecog.00847; Stevens RD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1115, DOI 10.1111/geb.12192; Stevens RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056853; Stocks G, 2008, BIOTROPICA, V40, P397, DOI 10.1111/j.1744-7429.2007.00393.x; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Teran M., 2004, ESTRUCTURA COMP ENSA; Vargas A., 2000, ESTRUCTURA COMUNIDAD; Vargas Espinoza Aideé, 2008, Mastozool. neotrop., V15, P297; Velazco PM, 2013, MOL PHYLOGENET EVOL, V68, P683, DOI 10.1016/j.ympev.2013.04.016; Whitehurst AS, 2013, REMOTE SENS-BASEL, V5, P2014, DOI 10.3390/rs5042014; Willig MR, 2016, J TROP ECOL, V32, P421, DOI 10.1017/S0266467415000589; Wilson D. E., 2005, MAMMAL SPECIES WORLD	59	16	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158170	10.1371/journal.pone.0158170	http://dx.doi.org/10.1371/journal.pone.0158170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384441	Green Submitted, Green Published, gold			2022-12-27	WOS:000379809400036
J	Fabre-Nys, C; Chanvallon, A; Dupont, J; Lardic, L; Lomet, D; Martinet, S; Scaramuzzi, RJ				Fabre-Nys, Claude; Chanvallon, Audrey; Dupont, Joelle; Lardic, Lionel; Lomet, Didier; Martinet, Stephanie; Scaramuzzi, Rex J.			The "Ram Effect": A "Non-Classical" Mechanism for Inducing LH Surges in Sheep	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PLASMA LUTEINIZING-HORMONE; ILE-DE-FRANCE; ESTROUS-CYCLE; PREOPTIC AREA; TYROSINE-HYDROXYLASE; NORADRENERGIC PROJECTIONS; PROGESTERONE SECRETION; OVARIECTOMIZED EWES; ANOVULATORY EWES	During spring sheep do not normally ovulate but exposure to a ram can induce ovulation. In some ewes an LH surge is induced immediately after exposure to a ram thus raising questions about the control of this precocious LH surge. Our first aim was to determine the plasma concentrations of oestradiol (E2) E2 in anoestrous ewes before and after the "ram effect" in ewes that had a "precocious" LH surge (starting within 6 hours), a "normal" surge (between 6 and 28h) and "late" surge (not detected by 56h). In another experiment we tested if a small increase in circulating E2 could induce an LH surge in anoestrus ewes. The concentration of E2 significantly was not different at the time of ram introduction among ewes with the three types of LH surge. "Precocious" LH surges were not preceded by a large increase in E2 unlike "normal" surges and small elevations of circulating E2 alone were unable to induce LH surges. These results show that the "precocious" LH surge was not the result of E2 positive feedback. Our second aim was to test if noradrenaline (NA) is involved in the LH response to the "ram effect". Using double labelling for Fos and tyrosine hydroxylase (TH) we showed that exposure of anoestrous ewes to a ram induced a higher density of cells positive for both in the A1 nucleus and the Locus Coeruleus complex compared to unstimulated controls. Finally, the administration by retrodialysis into the preoptic area, of NA increased the proportion of ewes with an LH response to ram odor whereas treatment with the alpha 1 antagonist Prazosin decreased the LH pulse frequency and amplitude induced by a sexually active ram. Collectively these results suggest that in anoestrous ewes NA is involved in ram-induced LH secretion as observed in other induced ovulators.	[Fabre-Nys, Claude; Chanvallon, Audrey; Dupont, Joelle; Lardic, Lionel; Lomet, Didier; Martinet, Stephanie] Univ Tours, Inst Francais Cheval & Equitat, INRA, CNRS,UMR Physiol Reprod & Comportements 7247, F-37380 Nouzilly, France; [Scaramuzzi, Rex J.] Royal Vet Coll, Dept Comparat Biomed Sci, Hawkshead Lane South Mimms, London AL9 7TA, Herts, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; University of London; University of London Royal Veterinary College	Fabre-Nys, C (corresponding author), Univ Tours, Inst Francais Cheval & Equitat, INRA, CNRS,UMR Physiol Reprod & Comportements 7247, F-37380 Nouzilly, France.	claude.fabre@tours.inra.fr			Region Centre (Durarep) [2008 00030333]; Region Centre (Durarep 2) [2011 00064290]; European Union Framework 6 funding program [MEXC-CT-2006-042499]; EU Marie Curie Chair of Excellence [MEXC-CT-2006-042499]; "Convention Industrielle de Formation par la Recherche"; "Association Nationale de la Recherche et de la Technologie"	Region Centre (Durarep)(Region Centre-Val de Loire); Region Centre (Durarep 2)(Region Centre-Val de Loire); European Union Framework 6 funding program; EU Marie Curie Chair of Excellence; "Convention Industrielle de Formation par la Recherche"; "Association Nationale de la Recherche et de la Technologie"(French National Research Agency (ANR))	The research was supported by Grants from the Region Centre (Durarep No 2008 00030333 & Durarep 2 No 2011 00064290) and the European Union Framework 6 funding program (MEXC-CT-2006-042499). RJS was the recipient of an EU Marie Curie Chair of Excellence (MEXC-CT-2006-042499). AC was recipient of a PhD grant funded by the "Convention Industrielle de Formation par la Recherche" between the "Centre Interregional d'Information et de Recherche en Production Ovine" and the "Association Nationale de la Recherche et de la Technologie".	Acosta-Martinez M, 1999, NEUROCHEM INT, V35, P383, DOI 10.1016/S0197-0186(99)00077-7; ADAMS CE, 1973, J REPROD FERTIL, V33, P527, DOI 10.1530/jrf.0.0330527; ADAMS CE, 1981, J REPROD FERTIL, V63, P241, DOI 10.1530/jrf.0.0630241; BAIRD DT, 1976, ENDOCRINOLOGY, V98, P1490, DOI 10.1210/endo-98-6-1490; Bakker J, 2000, FRONT NEUROENDOCRIN, V21, P220, DOI 10.1006/frne.2000.0198; BANKS JA, 1980, ENDOCRINOLOGY, V106, P1677, DOI 10.1210/endo-106-6-1677; BARRACLOUGH CA, 1982, ENDOCR REV, V3, P91, DOI 10.1210/edrv-3-1-91; BAUM MJ, 1990, J NEUROENDOCRINOL, V2, P401, DOI 10.1111/j.1365-2826.1990.tb00425.x; Ben Said S, 2007, BIOL REPROD, V76, P673, DOI 10.1095/biolreprod.106.057406; BROWNGRANT K, 1973, J ENDOCRINOL, V57, P7, DOI 10.1677/joe.0.0570007; CARATY A, 1995, ENDOCRINOLOGY, V136, P3452, DOI 10.1210/en.136.8.3452; CARATY A, 1989, J ENDOCRINOL, V123, P375, DOI 10.1677/joe.0.1230375; Chanvallon A, 2011, ANIMAL, V5, P1594, DOI 10.1017/S1751731111000668; Chanvallon A, 2009, BEHAV BRAIN RES, V205, P272, DOI 10.1016/j.bbr.2009.08.013; Clarke IJ, 2006, DOMEST ANIM ENDOCRIN, V30, P260, DOI 10.1016/j.domaniend.2005.07.006; CONAWAY CH, 1971, BIOL REPROD, V4, P239, DOI 10.1093/biolreprod/4.3.239; CORKER CS, 1969, NATURE, V222, P1063, DOI 10.1038/2221063a0; DAY JR, 1988, BIOL REPROD, V38, P1019, DOI 10.1095/biolreprod38.5.1019; DUFYBARBE L, 1978, BIOL REPROD, V18, P118, DOI 10.1095/biolreprod18.1.118; DYRMUNDSSON OR, 1972, J AGR SCI-CAMBRIDGE, V79, P269, DOI 10.1017/S002185960003224X; ELIAS E, 1984, GEN COMP ENDOCR, V56, P258, DOI 10.1016/0016-6480(84)90039-X; Etgen AM, 2002, J NEUROENDOCRINOL, V14, P213, DOI 10.1046/j.0007-1331.2001.00764.x; Evans NP, 1997, ENDOCRINOLOGY, V138, P5408, DOI 10.1210/en.138.12.5408; Fabre-Nys C, 1991, NEUROENDOCRINE RES M, P295; Fabre-Nys C, 2015, NEUROREPORT, V26, P438, DOI 10.1097/WNR.0000000000000367; Fabre-Nys C, 2015, REPRODUCTION, V149, P511, DOI 10.1530/REP-14-0587; FabreNys C, 1997, EUR J NEUROSCI, V9, P1666, DOI 10.1111/j.1460-9568.1997.tb01524.x; Gelez H, 2006, NEUROSCIENCE, V140, P791, DOI 10.1016/j.neuroscience.2006.02.066; Gibson MJ, 1997, HORM BEHAV, V31, P212, DOI 10.1006/hbeh.1997.1387; GOODMAN AL, 1976, ENDOCRINOLOGY, V99, P852, DOI 10.1210/endo-99-3-852; Goodman R. L., 1994, PHYSL REPRODUCTION, P1919; GOODMAN RL, 1981, J ENDOCRINOL, V89, P229, DOI 10.1677/joe.0.0890229; Goodman RL, 2002, REPRODUCTION, P41; GOODMAN RL, 1980, BIOL REPROD, V23, P415, DOI 10.1095/biolreprod23.2.415; Gore A, 2001, J NEUROENDOCRINOL, V13, P239, DOI 10.1046/j.1365-2826.2001.00618.x; HARDY DF, 1970, PHYSIOL BEHAV, V5, P421, DOI 10.1016/0031-9384(70)90246-5; HAUGER RL, 1977, ENDOCRINOLOGY, V101, P807, DOI 10.1210/endo-101-3-807; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; JOCHLE W, 1975, J REPROD FERTIL, P165; KARSCH FJ, 1979, ENDOCRINOLOGY, V105, P421, DOI 10.1210/endo-105-2-421; Li Q, 2015, NEUROENDOCRINOLOGY, V101, P161, DOI 10.1159/000377702; LINDSAY DR, 1975, PHYSIOL BEHAV, V15, P423, DOI 10.1016/0031-9384(75)90208-5; Maeda K, 2010, BRAIN RES, V1364, P103, DOI 10.1016/j.brainres.2010.10.026; MARTIN GB, 1986, LIVEST PROD SCI, V15, P219, DOI 10.1016/0301-6226(86)90031-X; MAULEON P, 1965, ANN BIOL ANIM BIOCH, V5, P131, DOI 10.1051/rnd:19650109; MILLIGAN SR, 1978, J REPROD FERTIL, V54, P309, DOI 10.1530/jrf.0.0540309; MOENTER SM, 1990, ENDOCRINOLOGY, V127, P1375, DOI 10.1210/endo-127-3-1375; MONTGOMERY GW, 1985, J REPROD FERTIL, V73, P173, DOI 10.1530/jrf.0.0730173; Neill J.D., 1994, PHYSL REPROD, P585; OLDHAM CM, 1979, ANIM REPROD SCI, V1, P283, DOI 10.1016/0378-4320(79)90013-7; Papay R, 2006, J COMP NEUROL, V497, P209, DOI 10.1002/cne.20992; PEARCE DT, 1985, J REPROD FERTIL, V75, P79, DOI 10.1530/jrf.0.0750079; RANDEL RD, 1973, J ANIM SCI, V37, P128, DOI 10.2527/jas1973.371128x; Rawson JA, 2001, J NEUROENDOCRINOL, V13, P129, DOI 10.1046/j.1365-2826.2001.00588.x; Richard P., 1967, ATLAS STEREOTAXIQUE; SCARAMUZZI RJ, 1971, ENDOCRINOLOGY, V88, P1184, DOI 10.1210/endo-88-5-1184; SCOTT CJ, 1992, J NEUROENDOCRINOL, V4, P131, DOI 10.1111/j.1365-2826.1992.tb00356.x; SIGNORET JP, 1980, REPROD NUTR DEV, V20, P457, DOI 10.1051/rnd:19800305; SIGNORET JP, 1975, J ENDOCRINOL, V64, P589, DOI 10.1677/joe.0.0640589; Signoret JP, J REPROD FERT, V31, P327; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; Spies HG, 1997, BIOL REPROD, V56, P310, DOI 10.1095/biolreprod56.2.310; Szawka RE, 2013, ENDOCRINOLOGY, V154, P363, DOI 10.1210/en.2012-1302; TILLET Y, 1989, J COMP NEUROL, V290, P69, DOI 10.1002/cne.902900106; TILLET Y, 1993, J COMP NEUROL, V330, P195, DOI 10.1002/cne.903300205; Ungerfeld R, 2007, Soc Reprod Fertil Suppl, V64, P207; WEICK RF, 1973, ENDOCRINOLOGY, V93, P1140; Wersinger SR, 1997, BIOL REPROD, V56, P1407, DOI 10.1095/biolreprod56.6.1407; WILDT DE, 1981, BIOL REPROD, V25, P15, DOI 10.1095/biolreprod25.1.15; WRIGHT DE, 1993, BRAIN RES, V621, P272, DOI 10.1016/0006-8993(93)90116-5; WU CH, 1977, BIOL REPROD, V17, P304, DOI 10.1095/biolreprod17.2.304; XIA L, 1992, ENDOCRINOLOGY, V131, P2812, DOI 10.1210/en.131.6.2812; Yamada S, 2006, J REPROD DEVELOP, V52, P115, DOI 10.1262/jrd.17071; Yang SP, 1998, P SOC EXP BIOL MED, V218, P204, DOI 10.3181/00379727-218-44287; Yang SP, 1997, J MOL ENDOCRINOL, V19, P311, DOI 10.1677/jme.0.0190311; Yang SP, 1996, ENDOCRINOLOGY, V137, P2683, DOI 10.1210/en.137.7.2683; ZARROW MX, 1968, J ENDOCRINOL, V40, P343, DOI 10.1677/joe.0.0400343	77	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158530	10.1371/journal.pone.0158530	http://dx.doi.org/10.1371/journal.pone.0158530			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384667	Green Published, gold, Green Submitted			2022-12-27	WOS:000379809400057
J	Schrapers, P; Mebs, S; Goetzl, S; Hennig, SE; Dau, H; Dobbek, H; Haumann, M				Schrapers, Peer; Mebs, Stefan; Goetzl, Sebastian; Hennig, Sandra E.; Dau, Holger; Dobbek, Holger; Haumann, Michael			Axial Ligation and Redox Changes at the Cobalt Ion in Cobalamin Bound to Corrinoid Iron-Sulfur Protein (CoFeSP) or in Solution Characterized by XAS and DFT	PLOS ONE			English	Article							RAY-ABSORPTION SPECTROSCOPY; WOOD-LJUNGDAHL PATHWAY; ACETYL-COA SYNTHESIS; X-RAY; CLOSTRIDIUM-THERMOACETICUM; ELECTRONIC-STRUCTURE; METAL CENTERS; REDUCTIVE ACTIVATION; MANGANESE COMPLEX; B-12 COFACTORS	A cobalamin (Cbl) cofactor in corrinoid iron-sulfur protein (CoFeSP) is the primary methyl group donor and acceptor in biological carbon oxide conversion along the reductive acetylCoA pathway. Changes of the axial coordination of the cobalt ion within the corrin macrocycle upon redox transitions in aqua-, methyl-, and cyano-Cbl bound to CoFeSP or in solution were studied using X-ray absorption spectroscopy (XAS) at the Co K-edge in combination with density functional theory (DFT) calculations, supported by metal content and cobalt redox level quantification with further spectroscopic methods. Calculation of the highly variable pre-edge X-ray absorption features due to core-to-valence (ctv) electronic transitions, XANES shape analysis, and cobalt-ligand bond lengths determination from EXAFS has yielded models for the molecular and electronic structures of the cobalt sites. This suggested the absence of a ligand at cobalt in CoFeSP in a-position where the dimethylbenzimidazole (dmb) base of the cofactor is bound in Cbl in solution. As main species, (dmb) Co-III(OH2), (dmb) Co-II(OH2), and (dmb) Co-III(CH3) sites for solution Cbl and Co-III(OH2), Co-II(OH2), and Co-III(CH3) sites in CoFeSP-Cbl were identified. Our data support binding of a serine residue from the reductive-activator protein (RACo) of CoFeSP to the cobalt ion in the CoFeSP-RACo protein complex that stabilizes Co(II). The absence of an alpha-ligand at cobalt not only tunes the redox potential of the cobalamin cofactor into the physiological range, but is also important for CoFeSP reactivation.	[Schrapers, Peer; Mebs, Stefan; Dau, Holger; Haumann, Michael] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Goetzl, Sebastian; Hennig, Sandra E.; Dobbek, Holger] Humboldt Univ, Dept Biol, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013	Dau, Holger/0000-0001-6482-7494	Deutsche Forschungsgemeinschaft [Ha3265/2-1, Ha3265/6-1, Do785/5-2]; Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis-UniCat" [EXC 314]; Bundesministerium fur Bildung und Forschung [05K14KE1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis-UniCat"; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), Berlin Cluster of Excellence "Unifying Concepts in Catalysis-UniCat" (EXC 314), to HDo and HDa; Deutsche Forschungsgemeinschaft (http://www.dfg.de/), grants Ha3265/2-1 and Ha3265/6-1 and Bundesministerium fur Bildung und Forschung (http://pt.desy.de/), grant 05K14KE1, to MH; and Deutsche Forschungsgemeinschaft (http://www.dfg.de/), grant Do785/5-2, to HDo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES RH, 1976, ACCOUNTS CHEM RES, V9, P114, DOI 10.1021/ar50099a006; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Bengelsdorf FR, 2013, ENVIRON TECHNOL, V34, P1639, DOI 10.1080/09593330.2013.827747; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Brown KL, 1997, INORG CHEM, V36, P3666, DOI 10.1021/ic9615077; Champloy F, 2000, J SYNCHROTRON RADIAT, V7, P267, DOI 10.1107/S0909049500006336; Chandrasekaran P, 2013, INORG CHEM, V52, P6286, DOI 10.1021/ic3021723; Chandrasekaran P, 2011, DALTON T, V40, P11070, DOI 10.1039/c1dt11331c; Chernev P, 2014, INORG CHEM, V53, P12164, DOI 10.1021/ic502047q; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dereven'kov IA, 2016, COORDIN CHEM REV, V309, P68, DOI 10.1016/j.ccr.2015.11.001; Dittrich B, 2007, ANGEW CHEM INT EDIT, V46, P2935, DOI 10.1002/anie.200603901; Frisch G. W., 2013, GAUSSIAN 09; George SD, 2008, J PHYS CHEM A, V112, P12936, DOI 10.1021/jp803174m; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Giedyk M, 2015, CHEM SOC REV, V44, P3391, DOI 10.1039/c5cs00165j; Giorgetti M, 2000, J BIOL INORG CHEM, V5, P156, DOI 10.1007/s007750050360; Glendening E. D., 2004, NBO 5; Goetzl S, 2011, J MOL BIOL, V411, P96, DOI 10.1016/j.jmb.2011.05.025; HARDER SR, 1989, BIOCHEMISTRY-US, V28, P9080, DOI 10.1021/bi00449a019; Hennig SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5626; Hennig SE, 2012, P NATL ACAD SCI USA, V109, P5235, DOI 10.1073/pnas.1117126109; Herrmann Wolfgang, 2012, Subcell Biochem, V56, P301, DOI 10.1007/978-94-007-2199-9_16; JABLONSKI PE, 1993, J BIOL CHEM, V268, P325; Jensen KP, 2009, COORDIN CHEM REV, V253, P769, DOI 10.1016/j.ccr.2008.04.015; Jeoung JH, 2014, BIOL CHEM, V395, P545, DOI 10.1515/hsz-2013-0290; Klementiev KV, XANES DACTYLOSCOPE F; Klockenkamper R, 1996, TOTAL REFLECTION X R; Koningsberger D.C., 1988, X RAY ABSORPTION PRI; Koningsberger DC, 2000, TOP CATAL, V10, P143, DOI 10.1023/A:1019105310221; Kratky C., 1999, Chemistry and biochemistry of B12., P9; Krautler B, 2005, BIOCHEM SOC T, V33, P806; KRAUTLER B, 1994, INORG CHEM, V33, P4128; Krewald V, 2015, CHEM SCI, V6, P1676, DOI 10.1039/c4sc03720k; Kung Y, 2012, NATURE, V484, P265, DOI 10.1038/nature10916; Lambertz C, 2014, CHEM SCI, V5, P1187, DOI 10.1039/c3sc52703d; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leidel N, 2012, J AM CHEM SOC, V134, P14142, DOI 10.1021/ja304970p; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; Matthews RG, 2008, CURR OPIN STRUC BIOL, V18, P658, DOI 10.1016/j.sbi.2008.11.005; Mebs S, 2009, J PHYS CHEM A, V113, P8366, DOI 10.1021/jp902433x; Meister W, 2012, BIOCHEMISTRY-US, V51, P7040, DOI 10.1021/bi300795n; Menon S, 1998, BIOCHEMISTRY-US, V37, P5689, DOI 10.1021/bi9727996; Neese F, 2008, ORCA AN AB INITIO DF; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; Ragsdale SW, 2008, ANN NY ACAD SCI, V1125, P129, DOI 10.1196/annals.1419.015; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Rehr JJ, 2010, PHYS CHEM CHEM PHYS, V12, P5503, DOI 10.1039/b926434e; ROSSI M, 1985, J AM CHEM SOC, V107, P1729, DOI 10.1021/ja00292a046; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHEURING EM, 1994, BIOCHEMISTRY-US, V33, P6310, DOI 10.1021/bi00186a034; Scheuring EM, 1996, J PHYS CHEM-US, V100, P3344, DOI 10.1021/jp943066n; Seravalli J, 1999, BIOCHEMISTRY-US, V38, P5728, DOI 10.1021/bi982473c; Stich TA, 2006, J AM CHEM SOC, V128, P5010, DOI 10.1021/ja054690o; Stich TA, 2003, J AM CHEM SOC, V125, P5897, DOI 10.1021/ja029328d; Svetlitchnaia T, 2006, P NATL ACAD SCI USA, V103, P14331, DOI 10.1073/pnas.0601420103; Tomson NC, 2015, CHEM SCI, V6, P2474, DOI 10.1039/c4sc03294b; WIRT MD, 1995, BIOCHEMISTRY-US, V34, P5269, DOI 10.1021/bi00015a042; WIRT MD, 1993, J INORG BIOCHEM, V49, P265, DOI 10.1016/0162-0134(93)80062-E; YACHANDRA VK, 1995, METHOD ENZYMOL, V246, P638	67	17	17	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158681	10.1371/journal.pone.0158681	http://dx.doi.org/10.1371/journal.pone.0158681			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384529	Green Submitted, gold, Green Published			2022-12-27	WOS:000379809400075
J	Marci, R; Gentili, V; Bortolotti, D; Lo Monte, G; Caselli, E; Bolzani, S; Rotola, A; Di Luca, D; Rizzo, R				Marci, Roberto; Gentili, Valentina; Bortolotti, Daria; Lo Monte, Giuseppe; Caselli, Elisabetta; Bolzani, Silvia; Rotola, Antonella; Di Luca, Dario; Rizzo, Roberta			Presence of HHV-6A in Endometrial Epithelial Cells from Women with Primary Unexplained Infertility	PLOS ONE			English	Article							HUMAN-HERPESVIRUS 6; POLYMERASE-CHAIN-REACTION; MULTIPLE-SCLEROSIS; CELLULAR RECEPTOR; INFECTION; VIRUS; DNA; REACTIVATION; HUMAN-HERPESVIRUS-6; TISSUE	To elucidate the roles of human herpesvirus (HHV)-6 primary unexplained infertile women, a prospective randomized study was conducted on a cohort of primary unexplained infertile women and a cohort of control women, with at least one successful pregnancy. HHV-6 DNA was analyzed and the percentage and immune-phenotype of resident endometrial Natural Killer (NK) cells, as the first line of defense towards viral infections, was evaluated in endometrial biopsies. Cytokine levels in uterine flushing samples were analyzed. HHV-6A DNA was found in 43% of endometrial biopsies from primary unexplained infertile women, but not in control women. On the contrary, HHV-6B DNA was absent in endometrial biopsies, but present in PBMCs of both cohorts. Endometrial NK cells presented a different distribution in infertile women with HHV6-A infection compared with infertile women without HHV6-A infection. Notably, we observed a lower percentage of endometrial specific CD56brightCD16-NK cells. We observed an enhanced HHV-6A-specific endometrial NK cell response in HHV-6A positive infertile women, with a marked increase in the number of endometrial NK cells activating towards HHV-6A infected cells. The analysis of uterine flushing samples showed an increase in IL-10 levels and a decrease of IFN-gamma concentrations in infertile women with HHV6-A infection. Our study indicates, for the first time, that HHV-6A infection might be an important factor in female unexplained infertility development, with a possible role in modifying endometrial NK cells immune profile and ability to sustain a successful pregnancy.	[Marci, Roberto] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Gynecol & Obstet, Ferrara, Italy; [Marci, Roberto] Univ Geneva, Sch Med, Geneva, Switzerland; [Gentili, Valentina; Bortolotti, Daria; Caselli, Elisabetta; Bolzani, Silvia; Rotola, Antonella; Di Luca, Dario; Rizzo, Roberta] Univ Ferrara, Microbiol Sect, Dept Med Sci, Ferrara, Italy; [Lo Monte, Giuseppe] Brunico Hosp, Human Reprod Ctr, Brunico, BZ, Italy	University of Ferrara; University of Geneva; University of Ferrara	Rizzo, R (corresponding author), Univ Ferrara, Microbiol Sect, Dept Med Sci, Ferrara, Italy.	rbr@unife.it	Marci, Roberto/G-6927-2012; Gentili, Valentina/AAC-1028-2022; Bolzani, Silvia/O-5907-2017; Elisabetta, Caselli/H-1513-2012; Bortolotti, Daria/K-5125-2016; Rizzo, Roberta/K-4844-2016	Marci, Roberto/0000-0002-9230-6685; Gentili, Valentina/0000-0003-4572-5497; Bolzani, Silvia/0000-0002-1133-0326; Elisabetta, Caselli/0000-0001-6048-9141; Bortolotti, Daria/0000-0003-4496-9561; Rizzo, Roberta/0000-0001-9507-9126	Regione Emila Romagna-Young researcher Liberati grant	Regione Emila Romagna-Young researcher Liberati grant	Funded by Regione Emila Romagna-Young researcher Liberati grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Ahlqvist J, 2005, J NEUROVIROL, V11, P384, DOI 10.1080/13550280591002379; ANDO Y, 1992, LANCET, V340, P1289, DOI 10.1016/0140-6736(92)92990-W; Arena A, 1999, MICROBIOLOGICA, V22, P293; Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; AUBIN JT, 1991, J CLIN MICROBIOL, V29, P367, DOI 10.1128/JCM.29.2.367-372.1991; Baecher-Lind LE, 2010, OBSTET GYNECOL SURV, V65, P53, DOI 10.1097/OGX.0b013e3181c9e7a1; Baillargeon J, 2000, J CLIN VIROL, V16, P149, DOI 10.1016/S1386-6532(99)00086-4; Broccolo F, 2013, J MED VIROL, V85, P1925, DOI 10.1002/jmv.23670; Caselli E, 2007, NEW MICROBIOL, V30, P173; Caselli E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002951; CHEN M, 1994, AM J PATHOL, V145, P1509; CHEN M, 1994, J VIROL, V68, P1173, DOI 10.1128/JVI.68.2.1173-1178.1994; Costa C, 2010, TRANSPL P, V42, P1270, DOI 10.1016/j.transproceed.2010.03.086; De Filippis L, 2006, J CLIN VIROL, V37, pS27, DOI 10.1016/S1386-6532(06)70008-7; DIPAOLO JA, 1994, TOXICOL LETT, V72, P7, DOI 10.1016/0378-4274(94)90004-3; DiPaolo JA, 1996, TOXICOL LETT, V88, P1, DOI 10.1016/0378-4274(96)03710-1; Drago F, 2014, J AM ACAD DERMATOL, V71, P198, DOI 10.1016/j.jaad.2014.02.023; Gervasi MT, 2012, J MATERN-FETAL NEO M, V25, P2002, DOI 10.3109/14767058.2012.683899; Gibson CS, 2008, BJOG-INT J OBSTET GY, V115, P492, DOI 10.1111/j.1471-0528.2007.01653.x; Hill JA, 2014, TRANSPL INFECT DIS, V16, P477, DOI 10.1111/tid.12208; Inazawa N, 2015, J MED VIROL, V87, P1427, DOI 10.1002/jmv.24161; Ishida T, 2014, ALLERGY, V69, P798, DOI 10.1111/all.12410; Ishikawa K, 2002, J GASTROENTEROL, V37, P523, DOI 10.1007/s005350200081; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; LEACH CT, 1994, J INFECT DIS, V169, P1281, DOI 10.1093/infdis/169.6.1281; Leibovitch EC, 2014, CURR OPIN VIROL, V9, P127, DOI 10.1016/j.coviro.2014.09.016; Li C, 1997, CLIN EXP IMMUNOL, V109, P421, DOI 10.1046/j.1365-2249.1997.4661362.x; Maeda T, 1997, ACTA PAEDIATR JAPON, V39, P653; Miguel RDV, 2010, J VIROL, V84, P565, DOI 10.1128/JVI.01374-09; Naumenko V, 2014, ANDROLOGY-US, V2, P687, DOI 10.1111/j.2047-2927.2014.00232.x; Ohashi M, 2002, J MED VIROL, V67, P354, DOI 10.1002/jmv.10083; OKUNO T, 1995, J CLIN MICROBIOL, V33, P1968, DOI 10.1128/JCM.33.7.1968-1970.1995; Ozkan ZS, 2014, J REPROD IMMUNOL, V103, P53, DOI 10.1016/j.jri.2013.11.002; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; Pritchett JC, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/723062; Revest M, 2011, J CLIN VIROL, V51, P20, DOI 10.1016/j.jcv.2011.02.001; Rizzo R, 2012, J NEUROIMMUNOL, V251, P55, DOI 10.1016/j.jneuroim.2012.07.004; Romano N, 1996, J CLIN MICROBIOL, V34, P1589, DOI 10.1128/JCM.34.6.1589-1591.1996; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Siddon A, 2012, BRIT J HAEMATOL, V158, P635, DOI 10.1111/j.1365-2141.2012.09206.x; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Tang HM, 2013, P NATL ACAD SCI USA, V110, P9096, DOI 10.1073/pnas.1305187110; Tran-Thanh D, 2002, J MED VIROL, V68, P606, DOI 10.1002/jmv.10229; WANG H, 1994, J VIROL METHODS, V47, P297, DOI 10.1016/0166-0934(94)90026-4; Watanabe H, 2008, BRIT J DERMATOL, V158, P640, DOI 10.1111/j.1365-2133.2007.08382.x; Yadav M., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P86; Yadav M, 1996, CLIN DIAGN VIROL, V7, P23, DOI 10.1016/S0928-0197(96)00250-4	49	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158304	10.1371/journal.pone.0158304	http://dx.doi.org/10.1371/journal.pone.0158304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367597	Green Published, gold, Green Submitted			2022-12-27	WOS:000378914900028
J	Mackie, J; Szabo, EK; Urgast, DS; Ballou, ER; Childers, DS; MacCallum, DM; Feldmann, J; Brown, AJP				Mackie, Joanna; Szabo, Edina K.; Urgast, Dagmar S.; Ballou, Elizabeth R.; Childers, Delma S.; MacCallum, Donna M.; Feldmann, Joerg; Brown, Alistair J. P.			Host-Imposed Copper Poisoning Impacts Fungal Micronutrient Acquisition during Systemic Candida albicans Infections	PLOS ONE			English	Article							IRON; GENE; CERULOPLASMIN; METABOLISM; PROTEIN; EXPRESSION; TOLERANCE; TRANSPORT; VIRULENCE; HEPCIDIN	Nutritional immunity is a process whereby an infected host manipulates essential micronutrients to defend against an invading pathogen. We reveal a dynamic aspect of nutritional immunity during infection that involves copper assimilation. Using a combination of laser ablation inductively coupled mass spectrometry (LA-ICP MS) and metal mapping, immunohistochemistry, and gene expression profiling from infected tissues, we show that readjustments in hepatic, splenic and renal copper homeostasis accompany disseminated Candida albicans infections in the mouse model. Localized host-imposed copper poisoning manifests itself as a transient increase in copper early in the kidney infection. Changes in renal copper are detected by the fungus, as revealed by gene expression profiling and fungal virulence studies. The fungus responds by differentially regulating the Crp1 copper efflux pump (higher expression during early infection and down-regulation late in infection) and the Ctr1 copper importer (lower expression during early infection, and subsequent up-regulation late in infection) to maintain copper homeostasis during disease progression. Both Crp1 and Ctr1 are required for full fungal virulence. Importantly, copper homeostasis influences other virulence traits-metabolic flexibility and oxidative stress resistance. Our study highlights the importance of copper homeostasis for host defence and fungal virulence during systemic disease.	[Mackie, Joanna; Szabo, Edina K.; Ballou, Elizabeth R.; Childers, Delma S.; MacCallum, Donna M.; Brown, Alistair J. P.] Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen Fungal Grp, Foresterhill, Aberdeen AB25 2ZD, Scotland; [Urgast, Dagmar S.; Feldmann, Joerg] Univ Aberdeen, Coll Phys Sci, Dept Chem, Trace Element Speciat Lab, Aberdeen AB24 3UE, Scotland; [Szabo, Edina K.] Univ Calgary, Biol Sci, 507 Campus Dr NW, Calgary, AB T2N 1N4, Canada	University of Aberdeen; University of Aberdeen; University of Calgary	Mackie, J (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen Fungal Grp, Foresterhill, Aberdeen AB25 2ZD, Scotland.	joanna.potrykus.mackie@gmail.com	Feldmann, Jörg/AAT-3703-2020; MacCallum, Donna M./D-7897-2011	MacCallum, Donna M./0000-0003-4833-0378; Feldmann, Joerg/0000-0002-0524-8254; Brown, Alistair JP/0000-0003-1406-4251; Ballou, Elizabeth/0000-0001-8051-2302	European Research Council [ERC-2009-AdG-249793]; UK Biotechnology and Biological Research Council [BB/F00513X/1, BB/K017365/1]; UK Medical Research Council [MR/M026663/1, MR/N006364/1]; Wellcome Trust [097377]; Biotechnology and Biological Sciences Research Council [BB/K017365/1, BB/F00513X/1] Funding Source: researchfish; Medical Research Council [MR/M026663/1, MR/N006364/1] Funding Source: researchfish; National Centre for the Replacement [NC/K50046X/1] Funding Source: researchfish; BBSRC [BB/F00513X/1, BB/K017365/1] Funding Source: UKRI; MRC [MR/M026663/1, MR/N006364/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Research Council (http://erc.europa.eu/: STRIFE Advanced Grant ERC-2009-AdG-249793). A.J.P.B. was also supported by the UK Biotechnology and Biological Research Council (www.bbsrc.ac.uk: Research Grants BB/F00513X/1, BB/K017365/1), the UK Medical Research Council (www.mrc.ac.uk: Programme Grant MR/M026663/1; Centre Grant MR/N006364/1), and the Wellcome Trust (www.wellcome.ac.uk: Strategic Award 097377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS., 2012, ISRN INFLAMMATION, V2012, P953461, DOI [DOI 10.5402/2012/953461, 10.5402/2012/953461]; Amaravadi R, 1997, HUM GENET, V99, P329, DOI 10.1007/s004390050367; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Brooks C, 2011, AM J PHYSIOL-CELL PH, V300, pC447, DOI 10.1152/ajpcell.00402.2010; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Childers DS, 2016, PLOS PATHOG IN PRESS; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Eck R, 1999, MICROBIOL-UK, V145, P2415, DOI 10.1099/00221287-145-9-2415; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Ladomersky E, 2015, METALLOMICS, V7, P957, DOI 10.1039/c4mt00327f; Li CX, 2015, P NATL ACAD SCI USA, V112, pE5336, DOI 10.1073/pnas.1513447112; Linder MC, 2013, NUTRIENTS, V5, P4022, DOI 10.3390/nu5104022; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; Marvin ME, 2004, MICROBIOL-SGM, V150, P2197, DOI 10.1099/mic.0.27004-0; Marvin ME, 2003, MICROBIOL-SGM, V149, P1461, DOI 10.1099/mic.0.26172-0; MCMANUS JFA, 1950, J EXP MED, V91, P651, DOI 10.1084/jem.91.6.651; Meyer LA, 2001, J BIOL CHEM, V276, P36857, DOI 10.1074/jbc.M105361200; Navarathna DHMLP, 2010, FREE RADICAL BIO MED, V49, P1561, DOI 10.1016/j.freeradbiomed.2010.08.020; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Patterson MJ, 2013, ANTIOXID REDOX SIGN, V19, P2244, DOI 10.1089/ars.2013.5199; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Potrykus J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003910; Potrykus J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003676; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Ramirez MA, 2007, EUKARYOT CELL, V6, P280, DOI 10.1128/EC.00372-06; Riggle PJ, 2000, J BACTERIOL, V182, P4899, DOI 10.1128/JB.182.17.4899-4905.2000; Sandai D, 2012, MBIO, V3, DOI 10.1128/mBio.00495-12; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Shahana S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100390; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sun TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6550; Szabo EK, 2014, VIRULENCE, V5, P286, DOI 10.4161/viru.27046; Tapryal N, 2009, J BIOL CHEM, V284, P1873, DOI 10.1074/jbc.M804079200; Terada K, 1998, J BIOL CHEM, V273, P1815, DOI 10.1074/jbc.273.3.1815; Urgast DS, 2012, ANAL BIOANAL CHEM, V402, P287, DOI 10.1007/s00216-011-5461-x; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Wang HG, 2001, AM J KIDNEY DIS, V38, P1038, DOI 10.1053/ajkd.2001.28593; Weissman Z, 2000, P NATL ACAD SCI USA, V97, P3520, DOI 10.1073/pnas.97.7.3520; Wilson D, 2009, FEMS YEAST RES, V9, P688, DOI 10.1111/j.1567-1364.2009.00524.x; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; Xu WJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002076; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441	67	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158683	10.1371/journal.pone.0158683	http://dx.doi.org/10.1371/journal.pone.0158683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362522	Green Published, Green Submitted, gold			2022-12-27	WOS:000378865200107
J	Maheswaran, R; Pearson, T; Beevers, SD; Campbell, MJ; Wolfe, CD				Maheswaran, Ravi; Pearson, Tim; Beevers, Sean D.; Campbell, Michael J.; Wolfe, Charles D.			Air Pollution and Subtypes, Severity and Vulnerability to Ischemic Stroke-A Population Based Case-Crossover Study	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; HEMORRHAGIC STROKE; REFERENT SELECTION; RISK; CLASSIFICATION; ASSOCIATION; POLLUTANTS; EXPOSURE	Background and Purpose Few studies have examined the association between air pollutants and ischemic stroke subtypes. We examined acute effects of outdoor air pollutants (PM10, NO2, O-3, CO, SO2) on subtypes and severity of incident ischemic stroke and investigated if pre-existing risk factors increased susceptibility. Methods We used a time stratified case-crossover study and stroke cases from the South London Stroke Register set up to capture all incident cases of first ever stroke occurring amongst residents in a geographically defined area. The Oxford clinical and TOAST etiological classifications were used to classify subtypes. A pragmatic clinical classification system was used to assess severity. Air pollution concentrations from the nearest background air pollution monitoring stations to patients' residential postcode centroids were used. Lags from 0 to 6 days were investigated. Results There were 2590 incident cases of ischemic stroke (1995-2006). While there were associations at various lag times with several pollutants, overall, there was no consistent pattern between exposure and risk of ischemic stroke subtypes or severity. The possible exception was the association between NO2 exposure and small vessel disease stroke-adjusted odds ratio of 1.51 (1.12-2.02) associated with an inter-quartile range increase in the lag 0-6 day average for NO2. There were no clear associations in relation to pre-existing risk factors. Conclusions Overall, we found little consistent evidence of association between air pollutants and ischemic stroke subtypes and severity. There was however a suggestion that increasing NO2 exposure might be associated with higher risk of stroke caused by cerebrovascular small vessel disease.	[Maheswaran, Ravi; Pearson, Tim] Univ Sheffield, Sch Hlth & Related Res, Publ Hlth GIS Unit, Sheffield, S Yorkshire, England; [Beevers, Sean D.] Kings Coll London, Environm Res Grp, London, England; [Campbell, Michael J.] Univ Sheffield, Sch Hlth & Related Res, Design Trials & Stat Sect, Sheffield, S Yorkshire, England; [Wolfe, Charles D.] Kings Coll London, Div Hlth & Social Care Res, London, England; [Wolfe, Charles D.] Guys & St Thomas NHS Fdn Trust & Kings Coll Londo, NIHR, Biomed Res Ctr, London, England	University of Sheffield; University of London; King's College London; University of Sheffield; University of London; King's College London; University of London; King's College London	Maheswaran, R (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Publ Hlth GIS Unit, Sheffield, S Yorkshire, England.	r.maheswaran@sheffield.ac.uk	Campbell, Michael J/I-4253-2014; Fazli, Ghazal/AAE-8320-2022	Campbell, Michael J/0000-0003-3529-2739; Maheswaran, Ravi/0000-0002-3899-4421	Colt Foundation; Department of Health via the NIHR Comprehensive Biomedical Research Centre; King's College London; National Institute for Health Research [RP-PG-0407-10184, NF-SI-0510-10060] Funding Source: researchfish	Colt Foundation; Department of Health via the NIHR Comprehensive Biomedical Research Centre; King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	We would like to thank the Colt Foundation, which supported this study through a research grant (http://www.coltfoundation.org.uk/). CDW acknowledges financial support from the Department of Health via the NIHR Comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London (http://www.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Corea F, 2012, NEUROL INT, V4, P44, DOI 10.4081/ni.2012.e11; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Hajat C, 2001, J NEUROL SCI, V190, P79, DOI 10.1016/S0022-510X(01)00597-4; Henrotin JB, 2007, OCCUP ENVIRON MED, V64, P439, DOI 10.1136/oem.2006.029306; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Maheswaran R, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-23; Maheswaran R, 2012, STROKE, V43, P22, DOI 10.1161/STROKEAHA.110.610238; O'Donnell MJ, 2011, EPIDEMIOLOGY, V22, P422, DOI 10.1097/EDE.0b013e3182126580; Ponka A, 1996, AM J PUBLIC HEALTH, V86, P1273, DOI 10.2105/AJPH.86.9.1273; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.i4851, 10.1136/bmj.h1295]; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Strong M, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-38; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Villeneuve PJ, 2012, SCI TOTAL ENVIRON, V430, P193, DOI 10.1016/j.scitotenv.2012.05.002; Wang Y., 2014, J AM HEART ASSOC, V3; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Yang WS, 2014, INT J CARDIOL, V175, P307, DOI 10.1016/j.ijcard.2014.05.044	26	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158556	10.1371/journal.pone.0158556	http://dx.doi.org/10.1371/journal.pone.0158556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362783	Green Published, gold			2022-12-27	WOS:000378865200089
J	Marinelli, CV; Romani, C; Burani, C; McGowan, VA; Zoccolotti, P				Marinelli, Chiara Valeria; Romani, Cristina; Burani, Cristina; McGowan, Victoria A.; Zoccolotti, Pierluigi			Costs and Benefits of Orthographic Inconsistency in Reading: Evidence from a Cross-Linguistic Comparison	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; TRANSPARENT ORTHOGRAPHY; WORD RECOGNITION; GRAIN-SIZE; CHILDREN; ENGLISH; CONSISTENCY; ACQUISITION; GERMAN; LENGTH	We compared reading acquisition in English and Italian children up to late primary school analyzing RTs and errors as a function of various psycholinguistic variables and changes due to experience. Our results show that reading becomes progressively more reliant on larger processing units with age, but that this is modulated by consistency of the language. In English, an inconsistent orthography, reliance on larger units occurs earlier on and it is demonstrated by faster RTs, a stronger effect of lexical variables and lack of length effect (by fifth grade). However, not all English children are able to master this mode of processing yielding larger inter-individual variability. In Italian, a consistent orthography, reliance on larger units occurs later and it is less pronounced. This is demonstrated by larger length effects which remain significant even in older children and by larger effects of a global factor (related to speed of orthographic decoding) explaining changes of performance across ages. Our results show the importance of considering not only overall performance, but inter-individual variability and variability between conditions when interpreting cross-linguistic differences.	[Marinelli, Chiara Valeria] Univ Salento, Dept Hist Soc & Human Studies, Lab Appl Psychol & Intervent, Salento, Italy; [Marinelli, Chiara Valeria; Zoccolotti, Pierluigi] IRCCS Fdn Santa Lucia, Neuropsychol Res Ctr, Rome, Italy; [Romani, Cristina] Aston Univ, Birmingham, W Midlands, England; [Burani, Cristina] CNR, ISTC, Rome, Italy; [Burani, Cristina] Univ Trieste, Dept Life Sci, Trieste, Italy; [McGowan, Victoria A.] Univ Leicester, Leicester, Leics, England; [Zoccolotti, Pierluigi] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	University of Salento; IRCCS Santa Lucia; Aston University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Trieste; University of Leicester; Sapienza University Rome	Marinelli, CV (corresponding author), Univ Salento, Dept Hist Soc & Human Studies, Lab Appl Psychol & Intervent, Salento, Italy.; Marinelli, CV (corresponding author), IRCCS Fdn Santa Lucia, Neuropsychol Res Ctr, Rome, Italy.	chiaravaleria.marinelli@unisalento.it	marinelli, chiara valeria/GVS-8721-2022; Zoccolotti, Pierluigi/H-4437-2019; marinelli, chiara valeria/J-1331-2016	marinelli, chiara valeria/0000-0002-8806-5655; Zoccolotti, Pierluigi/0000-0002-6351-2455; marinelli, chiara valeria/0000-0002-8806-5655; McGowan, Victoria/0000-0003-1956-1599; Romani, Cristina/0000-0002-5693-4131	PRIN (Research Project of National Interest) [20128YAFKB_004]	PRIN (Research Project of National Interest)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The publication will be payed on the grant PRIN (Research Project of National Interest) n. 20128YAFKB_004 (prof. Pierluigi Zoccolotti). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R., 2006, J MEM LANG, V53, P496; Baayen R. H., 1993, CELEX LEXICAL DATABA; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barca L, 2007, READ WRIT, V20, P495, DOI 10.1007/s11145-006-9040-z; Bates E, 2001, MEM COGNITION, V29, P986, DOI 10.3758/BF03195761; Bertinetto P. M., 2005, COLFIS CORPUS LESSI; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brown GDA, 1999, J EXP CHILD PSYCHOL, V73, P208, DOI 10.1006/jecp.1999.2502; Bruck M, 1997, FOUNDATIONS OF READING ACQUISITION AND DYSLEXIA, P145; Burani C, 2002, BRAIN LANG, V81, P568, DOI 10.1006/brln.2001.2548; Burani C, 2014, READING ACQUISITION; Burani C, 2006, PSYCHON B REV, V13, P346, DOI 10.3758/BF03193855; Burani C, 2010, LINGUE LINGUAGGIO, V9, P177, DOI 10.1418/33326; COSSU G, 1995, READ WRIT, V7, P9, DOI 10.1007/BF01026945; De Cara B, 2002, BEHAV RES METH INS C, V34, P416, DOI 10.3758/BF03195470; De Luca M, 2010, CORTEX, V46, P1272, DOI 10.1016/j.cortex.2009.06.007; De Mauro Tullio, 1999, GRANDE DIZIONARIO IT; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Di Filippo G, 2006, CHILD NEUROPSYCHOL, V12, P141, DOI 10.1080/09297040500346571; Duncan LG, 2000, BRIT J PSYCHOL, V91, P145, DOI 10.1348/000712600161736; Ellis NC, 2004, READ RES QUART, V39, P438, DOI 10.1598/RRQ.39.4.5; Ellis NC, 2001, APPL PSYCHOLINGUIST, V22, P571, DOI 10.1017/S0142716401004052; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; Ferrand L, 2000, PSYCHON B REV, V7, P142, DOI 10.3758/BF03210733; Goswami U, 1997, EUR J PSYCHOL EDUC, V12, P273, DOI 10.1007/BF03172876; Hanley JR, 2004, Q J EXP PSYCHOL-A, V57, P1393, DOI 10.1080/02724980343000819; Hanna P.R., 1966, PHONEME GRAPHEME COR; Hoffman P, 2015, P NATL ACAD SCI USA, V112, pE3719, DOI 10.1073/pnas.1502032112; JARED D, 1990, J EXP PSYCHOL HUMAN, V16, P92, DOI 10.1037/0096-1523.16.1.92; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Landerl K, 2000, EUR J PSYCHOL EDUC, V15, P239, DOI 10.1007/BF03173177; LAXON V, 1992, BRIT J PSYCHOL, V83, P407, DOI 10.1111/j.2044-8295.1992.tb02450.x; Marinelli CV, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01843; Marinelli CV, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01353; Marinelli CV, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00903; Marinelli CV, 2011, NEUROPSYCHOLOGIA, V49, P1718, DOI 10.1016/j.neuropsychologia.2011.02.050; Myerson J, 2003, PSYCHON B REV, V10, P262, DOI 10.3758/BF03196491; Oney B, 1997, APPL PSYCHOLINGUIST, V18, P1, DOI 10.1017/S014271640000984X; Paizi D, 2013, J RES READ, V36, P303, DOI 10.1111/j.1467-9817.2011.01504.x; Patel TK, 2004, J EDUC PSYCHOL, V96, P785, DOI 10.1037/0022-0663.96.4.785; Paulesu E, 2006, DEVELOPMENTAL SCI, V9, P443, DOI 10.1111/j.1467-7687.2006.00525.x; PINHEIRO AMV, 1995, READ WRIT, V7, P111, DOI 10.1007/BF01026950; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Rau AK, 2015, J EXP CHILD PSYCHOL, V130, P92, DOI 10.1016/j.jecp.2014.09.012; Raven JC., 1984, MANUAL COLOURED PROG; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Rose Jim., 2006, INDEPENDENT REV TEAC; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Signorini A, 1997, APPL PSYCHOLINGUIST, V18, P319, DOI 10.1017/S014271640001050X; Spencer LH, 2003, BRIT J PSYCHOL, V94, P1, DOI 10.1348/000712603762842075; Tainturier Marie-Josu┐phe., 2001, HDB COGNITIVE NEUROP, P263, DOI DOI 10.4324/9781315783017; Thornton A. M., 1997, BDVDB BASE DATI VOCA; TREIMAN R, 1995, J EXP PSYCHOL GEN, V124, P107, DOI 10.1037/0096-3445.124.2.107; Weekes BS, 1997, Q J EXP PSYCHOL-A, V50, P439, DOI 10.1080/027249897392170; Wentink HWMJ, 1997, READ WRIT, V9, P163, DOI 10.1023/A:1007921805360; WIMMER H, 1993, APPL PSYCHOLINGUIST, V14, P1, DOI 10.1017/S0142716400010122; WIMMER H, 1994, COGNITION, V51, P91, DOI 10.1016/0010-0277(94)90010-8; Yap MJ, 2009, J MEM LANG, V60, P502, DOI 10.1016/j.jml.2009.02.001; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ziegler JC, 2001, PSYCHOL SCI, V12, P379, DOI 10.1111/1467-9280.00370; Zoccolotti P, 2008, EXP BRAIN RES, V186, P551, DOI 10.1007/s00221-007-1257-9; Zoccolotti P, 2009, READ WRIT, V22, P1053, DOI 10.1007/s11145-008-9144-8	63	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0157457	10.1371/journal.pone.0157457	http://dx.doi.org/10.1371/journal.pone.0157457			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355364	Green Published, Green Accepted, gold			2022-12-27	WOS:000378859400014
J	Ivanov, IV; Mackeben, M; Vollmer, A; Martus, P; Nguyen, NX; Trauzettel-Klosinski, S				Ivanov, Iliya V.; Mackeben, Manfred; Vollmer, Annika; Martus, Peter; Nguyen, Nhung X.; Trauzettel-Klosinski, Susanne			Eye Movement Training and Suggested Gaze Strategies in Tunnel Vision - A Randomized and Controlled Pilot Study	PLOS ONE			English	Article							VISUAL-ATTENTION; HOMONYMOUS HEMIANOPIA; RETINITIS-PIGMENTOSA; WALKING; SPEED; ORIENTATION; MECHANISMS; ONSETS; ADULTS	Purpose Degenerative retinal diseases, especially retinitis pigmentosa (RP), lead to severe peripheral visual field loss (tunnel vision), which impairs mobility. The lack of peripheral information leads to fewer horizontal eye movements and, thus, diminished scanning in RP patients in a natural environment walking task. This randomized controlled study aimed to improve mobility and the dynamic visual field by applying a compensatory Exploratory Saccadic Training (EST). Methods Oculomotor responses during walking and avoiding obstacles in a controlled environment were studied before and after saccade or reading training in 25 RP patients. Eye movements were recorded using a mobile infrared eye tracker (Tobii glasses) that measured a range of spatial and temporal variables. Patients were randomly assigned to two training conditions: Saccade (experimental) and reading (control) training. All subjects who first performed reading training underwent experimental training later (waiting list control group). To assess the effect of training on subjects, we measured performance in the training task and the following outcome variables related to daily life: Response Time (RT) during exploratory saccade training, Percent Preferred Walking Speed (PPWS), the number of collisions with obstacles, eye position variability, fixation duration, and the total number of fixations including the ones in the subjects' blind area of the visual field. Results In the saccade training group, RTs on average decreased, while the PPWS significantly increased. The improvement persisted, as tested 6 weeks after the end of the training. On average, the eye movement range of RP patients before and after training was similar to that of healthy observers. In both, the experimental and reading training groups, we found many fixations outside the subjects' seeing visual field before and after training. The average fixation duration was significantly shorter after the training, but only in the experimental training condition. Conclusions We conclude that the exploratory saccade training was beneficial for RP patients and resulted in shorter fixation durations after the training. We also found a significant improvement in relative walking speed during navigation in a real-world like controlled environment.	[Ivanov, Iliya V.; Vollmer, Annika; Trauzettel-Klosinski, Susanne] Univ Tubingen, Univ Eye Hosp, Ctr Ophthalmol, Vis Rehabil Res Unit, Tubingen, Germany; [Ivanov, Iliya V.] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, ZEISS Vis Sci Lab, Tubingen, Germany; [Mackeben, Manfred] Smith Kettlewell Eye Res Inst, 2232 Webster St, San Francisco, CA 94115 USA; [Vollmer, Annika; Nguyen, Nhung X.] Univ Tubingen, Univ Eye Hosp, Ctr Ophthalmol, Low Vis Clin, Tubingen, Germany; [Martus, Peter] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; The Smith-Kettlewell Eye Research Institute; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Ivanov, IV (corresponding author), Univ Tubingen, Univ Eye Hosp, Ctr Ophthalmol, Vis Rehabil Res Unit, Tubingen, Germany.; Ivanov, IV (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, ZEISS Vis Sci Lab, Tubingen, Germany.	iliya.ivanov@uni-tuebingen.de			Kniese Foundation; Funke Foundation; Stiftung Auge; Pro Retina; AKF-Programm, University Eye Hospital, University of Tuebingen [296-0-0]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen	Kniese Foundation; Funke Foundation; Stiftung Auge; Pro Retina; AKF-Programm, University Eye Hospital, University of Tuebingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	This work was supported by the Kniese Foundation; Funke Foundation; Stiftung Auge; and Pro Retina to ST-K. AKF-Programm, University Eye Hospital, University of Tuebingen, Grant Nr. 296-0-0 to IVI. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our anonymous reviewers for their helpful suggestions and criticism. This study was supported by: Kniese Foundation; Funke Foundation; Stiftung Auge; Pro Retina. AKF-Programm, University Eye Hospital, University of Tuebingen, Grant Nr. 296-0-0 to IVI.	Black A, 1996, CLIN EXP OPTOM, V80, P1, DOI DOI 10.1111/J.1444-0938.1997.TB04841.X; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; CLARKCARTER DD, 1986, ERGONOMICS, V29, P779, DOI 10.1080/00140138608968314; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Genensky SM, 1979, CPS100HEW; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; KROSE BJA, 1989, VISION RES, V29, P1607, DOI 10.1016/0042-6989(89)90142-9; Kuyk T, 2010, J VISUAL IMPAIR BLIN, V104, P215, DOI 10.1177/0145482X1010400405; LOWE J, 1992, OPTOMETRY VISION SCI, V69, P182, DOI 10.1097/00006324-199203000-00003; Luo G, 2008, J VISION, V8, DOI 10.1167/8.14.25; Mackeben M, 1998, VISION RES, V29, P1631; Mannan SK, 2010, J NEUROL, V257, P1812, DOI 10.1007/s00415-010-5615-3; Nguyen NX, 2011, ACTA OPHTHALMOL, V89, pE82, DOI 10.1111/j.1755-3768.2010.02081.x; Nguyen NX, 2012, OPHTHALMOLOGE, V109, P30; Pambakian ALM, 2000, J NEUROL NEUROSUR PS, V69, P751, DOI 10.1136/jnnp.69.6.751; Pambakian ALM, 2004, J NEUROL NEUROSUR PS, V75, P1443, DOI 10.1136/jnnp.2003.025957; Peli E, 2006, INV OPHTHALMOL VIS S, V47; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roth T, 2009, NEUROLOGY, V72, P324, DOI 10.1212/01.wnl.0000341276.65721.f2; RUBIN GS, 1992, VISION RES, V32, P895, DOI 10.1016/0042-6989(92)90032-E; RUBIN GS, 1994, VISION RES, V34, P1723, DOI 10.1016/0042-6989(94)90129-5; Schreij D, 2008, PERCEPT PSYCHOPHYS, V70, P208, DOI 10.3758/PP.70.2.208; Soong GP, 2001, OPTOMETRY VISION SCI, V78, P657, DOI 10.1097/00006324-200109000-00011; Stuart S, 2014, IEEE ENG MED BIO, P5739, DOI 10.1109/EMBC.2014.6944931; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; Turano KA, 2005, VISION RES, V45, P3117, DOI 10.1016/j.visres.2005.06.017; Turano KA, 1998, OPTOMETRY VISION SCI, V75, P879, DOI 10.1097/00006324-199812000-00010; Wiecek E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00472	32	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157825	10.1371/journal.pone.0157825	http://dx.doi.org/10.1371/journal.pone.0157825			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351629	Green Published, Green Submitted, gold			2022-12-27	WOS:000378858900018
J	Ku, KM; Weir, RK; Silverman, JL; Berman, RF; Bauman, MD				Ku, Katherine M.; Weir, Ruth K.; Silverman, Jill L.; Berman, Robert F.; Bauman, Melissa D.			Behavioral Phenotyping of Juvenile Long-Evans and Sprague-Dawley Rats: Implications for Preclinical Models of Autism Spectrum Disorders	PLOS ONE			English	Article							SOCIAL PLAY-BEHAVIOR; ANIMAL-MODELS; ULTRASONIC VOCALIZATIONS; MOUSE MODELS; STRAINS; ANXIETY; COMMUNICATION; DEPRIVATION; ADOLESCENT; EXPERIENCE	The laboratory rat is emerging as an attractive preclinical animal model of autism spectrum disorder (ASD), allowing investigators to explore genetic, environmental and pharmacological manipulations in a species exhibiting complex, reciprocal social behavior. The present study was carried out to compare two commonly used strains of laboratory rats, Sprague-Dawley (SD) and Long-Evans (LE), between the ages of postnatal day (PND) 26-56 using high-throughput behavioral phenotyping tools commonly used in mouse models of ASD that we have adapted for use in rats. We detected few differences between young SD and LE strains on standard assays of exploration, sensorimotor gating, anxiety, repetitive behaviors, and learning. Both SD and LE strains also demonstrated sociability in the 3-chamber social approach test as indexed by spending more time in the social chamber with a constrained age/strain/sex matched novel partner than in an identical chamber without a partner. Pronounced differences between the two strains were, however, detected when the rats were allowed to freely interact with a novel partner in the social dyad paradigm. The SD rats in this particular testing paradigm engaged in play more frequently and for longer durations than the LE rats at both juvenile and young adult developmental time points. Results from this study that are particularly relevant for developing preclinical ASD models in rats are threefold: (i) commonly utilized strains exhibit unique patterns of social interactions, including strain-specific play behaviors, (ii) the testing environment may profoundly influence the expression of strain-specific social behavior and (iii) simple, automated measures of sociability may not capture the complexities of rat social interactions.	[Ku, Katherine M.; Weir, Ruth K.; Silverman, Jill L.; Bauman, Melissa D.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Berman, Robert F.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Silverman, Jill L.; Bauman, Melissa D.] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Bauman, Melissa D.] Calif Natl Primate Res Ctr, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bauman, MD (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA.; Bauman, MD (corresponding author), Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA.; Bauman, MD (corresponding author), Calif Natl Primate Res Ctr, Davis, CA USA.	mdbauman@ucdavis.edu	Bauman, Melissa/O-1256-2017	Bauman, Melissa/0000-0003-0701-3851; Ku, Katherine/0000-0002-1291-2117	NIH [U54 HD079125]; UC Davis Behavioral Health Center of Excellence; UC Davis Rat Phenotyping lab; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079125] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis Behavioral Health Center of Excellence; UC Davis Rat Phenotyping lab; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the NIH-funded MIND Institute Intellectual and Developmental Disabilities Research Center (U54 HD079125) and from the UC Davis Behavioral Health Center of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the UC Davis Rat Phenotyping lab for supporting this research. The authors report no biomedical financial interests or potential conflicts of interest.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ANDREWS JS, 1995, PHYSIOL BEHAV, V57, P785, DOI 10.1016/0031-9384(94)00336-X; ARCHER T, 1987, SCAND J PSYCHOL, V28, P242, DOI 10.1111/j.1467-9450.1987.tb00761.x; Association AP, 2013, DIAGN STAT MAN MENT, V5; Baarendse PJJ, 2013, NEUROPSYCHOPHARMACOL, V38, P1485, DOI 10.1038/npp.2013.47; Bauman MD, 2013, NEUROPSYCHIATRY-LOND, V3, P159, DOI 10.2217/NPY.13.18; BEATTY WW, 1982, PHARMACOL BIOCHEM BE, V16, P417, DOI 10.1016/0091-3057(82)90445-2; Bell HC, 2010, BEHAV BRAIN RES, V207, P7, DOI 10.1016/j.bbr.2009.09.029; Belzung C, 2014, NEUROPSYCHOPHARMACOL, V39, P1041, DOI 10.1038/npp.2013.342; Bishop SL, 2011, AUTISM RES, V4, P317, DOI 10.1002/aur.216; Borsini F, 2002, PSYCHOPHARMACOLOGY, V163, P121, DOI 10.1007/s00213-002-1155-6; Braff L, 2013, JAMA PSYCHIAT, V70, P777, DOI 10.1001/jamapsychiatry.2013.2184; BROEKKAMP CL, 1986, EUR J PHARMACOL, V126, P223, DOI 10.1016/0014-2999(86)90051-8; Burgdorf J, 2013, BEHAV BRAIN RES, V251, P18, DOI 10.1016/j.bbr.2013.04.022; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dufour-Rainfray D, 2010, NEUROSCI LETT, V470, P55, DOI 10.1016/j.neulet.2009.12.054; Faraday MM, 2005, PHARMACOL BIOCHEM BE, V80, P577, DOI 10.1016/j.pbb.2005.01.015; Faraday MM, 2002, PHYSIOL BEHAV, V75, P507, DOI 10.1016/S0031-9384(02)00645-5; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; Galvao MC, 2015, LIFE SCI, V120, P54, DOI 10.1016/j.lfs.2014.10.019; Gokcek-Sarac C, 2015, LEARN BEHAV, V43, P83, DOI 10.3758/s13420-014-0163-9; GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24; Hamilton SM, 2014, BEHAV NEUROSCI, V128, P103, DOI 10.1037/a0035988; Himmler BT, 2013, J COMP PSYCHOL, V127, P453, DOI 10.1037/a0032187; Himmler BT, 2013, JOVE-J VIS EXP, DOI 10.3791/4288; Himmler SM, 2014, INT J COMP PSYCHOL, V27; Himmler SM, 2014, J COMP PSYCHOL, V128, P318, DOI 10.1037/a0036104; Jordan R, 2003, AUTISM, V7, P347, DOI 10.1177/1362361303007004002; Kaffman A, 2012, METHODS MOL BIOL, V829, P3, DOI 10.1007/978-1-61779-458-2_1; Kantor S, 2000, PHYSIOL BEHAV, V71, P551, DOI 10.1016/S0031-9384(00)00374-7; Kas MJ, 2014, PSYCHOPHARMACOLOGY, V231, P1125, DOI 10.1007/s00213-013-3268-5; Keeley RJ, 2015, BEHAV BRAIN RES, V288, P118, DOI 10.1016/j.bbr.2014.10.039; Kennedy BC, 2011, BEHAV PHARMACOL, V22, P147, DOI 10.1097/FBP.0b013e328343d7dd; Kirsten TB, 2015, LIFE SCI, V130, P12, DOI 10.1016/j.lfs.2015.02.027; Kirsten TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134565; Kisko TM, 2015, BEHAV PROCESS, V113, P113, DOI 10.1016/j.beproc.2015.01.016; Kumar G, 2015, PHYSIOL BEHAV, V144, P26, DOI 10.1016/j.physbeh.2015.03.001; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Lewis MH, 2007, BEHAV BRAIN RES, V176, P66, DOI 10.1016/j.bbr.2006.08.023; Llaneza DC, 2009, PHARMACOL BIOCHEM BE, V93, P337, DOI 10.1016/j.pbb.2009.05.003; Manduca A, 2014, EUR NEUROPSYCHOPHARM, V24, P1337, DOI 10.1016/j.euroneuro.2014.05.009; Manduca A, 2014, PSYCHOPHARMACOLOGY, V231, P1661, DOI 10.1007/s00213-013-3337-9; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; NIESINK RJM, 1989, NEUROPHARMACOLOGY, V28, P411, DOI 10.1016/0028-3908(89)90038-5; NIESINK RJM, 1983, PHYSIOL BEHAV, V30, P825, DOI 10.1016/0031-9384(83)90243-3; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Palagi E, 2015, BIOL REV CAMB PHILOS; PANKSEPP J, 1984, NEUROSCI BIOBEHAV R, V8, P465, DOI 10.1016/0149-7634(84)90005-8; PANKSEPP J, 1980, BEHAV NEURAL BIOL, V30, P197, DOI 10.1016/S0163-1047(80)91077-8; PANKSEPP J, 1981, DEV PSYCHOBIOL, V14, P327, DOI 10.1002/dev.420140405; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Panksepp JB, 2011, NEUROSCI BIOBEHAV R, V35, P1864, DOI 10.1016/j.neubiorev.2011.05.013; PELLIS SM, 1990, DEV PSYCHOBIOL, V23, P215, DOI 10.1002/dev.420230303; Pellis SM, 1998, NEUROSCI BIOBEHAV R, V23, P87, DOI 10.1016/S0149-7634(97)00071-7; Pellis SM, 1997, DEV PSYCHOBIOL, V31, P193; PELLIS SM, 1989, AGGRESSIVE BEHAV, V15, P297, DOI 10.1002/ab.2480150405; Peters SM, 2015, EUR J PHARMACOL, V759, P42, DOI 10.1016/j.ejphar.2015.03.043; POOLE TB, 1975, J ZOOL, V175, P61; POTEGAL M, 1989, DEV PSYCHOBIOL, V22, P159, DOI 10.1002/dev.420220206; Raza S, 2015, BEHAV PHARM; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2007, PSYCHONEUROENDOCRINO, V32, P651, DOI 10.1016/j.psyneuen.2007.04.003; Seffer D, 2014, J NEUROSCI METHODS; Servadio M, 2015, BEHAV PHARMACOL, V26, P522, DOI 10.1097/FBP.0000000000000163; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Siviy SM, 2003, PHYSIOL BEHAV, V80, P385, DOI 10.1016/j.physbeh.2003.09.002; Siviy SM, 2011, NEUROSCI BIOBEHAV R, V35, P1821, DOI 10.1016/j.neubiorev.2011.03.006; Smith LK, 1998, DEV PSYCHOBIOL, V33, P147, DOI 10.1002/(SICI)1098-2302(199809)33:2<147::AID-DEV5>3.0.CO;2-J; Spruijt BM, 2014, J NEUROSCI METH, V234, P2, DOI 10.1016/j.jneumeth.2014.03.001; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; THOR DH, 1984, NEUROSCI BIOBEHAV R, V8, P455, DOI 10.1016/0149-7634(84)90004-6; TONKISS J, 1992, DEV PSYCHOBIOL, V25, P567, DOI 10.1002/dev.420250804; Trezza V, 2011, DEV COGN NEUROS-NETH, V1, P444, DOI 10.1016/j.dcn.2011.05.007; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Turner KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093411; Turner KM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00097; Vanderschuren LJMJ, 1997, NEUROSCI BIOBEHAV R, V21, P309, DOI 10.1016/S0149-7634(96)00020-6; VANDERSCHUREN LJMJ, 1995, PHYSIOL BEHAV, V58, P119, DOI 10.1016/0031-9384(94)00385-I; Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6; Varlinskaya EI, 2008, BEHAV BRAIN RES, V188, P398, DOI 10.1016/j.bbr.2007.11.024; VARTY GB, 1994, J PSYCHOPHARMACOL, V8, P148, DOI 10.1177/026988119400800302; Watson DJ, 2009, BEHAV BRAIN RES, V205, P57, DOI 10.1016/j.bbr.2009.07.026; WEBSTER DG, 1981, BEHAV NEURAL BIOL, V31, P32, DOI 10.1016/S0163-1047(81)91034-7; Whishaw IQ, 2003, BEHAV BRAIN RES, V145, P221, DOI 10.1016/S0166-4328(03)00143-8; Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Yang M, 2012, PHYSIOL BEHAV, V107, P649, DOI 10.1016/j.physbeh.2011.12.025; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Young RL, 2003, AUTISM, V7, P125, DOI 10.1177/1362361303007002002; Zhang-James Y, 2014, BEHAV BRAIN RES, V269, P103, DOI 10.1016/j.bbr.2014.04.035	95	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158150	10.1371/journal.pone.0158150	http://dx.doi.org/10.1371/journal.pone.0158150			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351457	gold, Green Submitted, Green Published			2022-12-27	WOS:000378858900039
J	Qin, W; Liang, YZ; Qin, BY; Zhang, JL; Xia, N				Qin, Wen; Liang, Yu-Zhen; Qin, Bao-Yu; Zhang, Jia-Li; Xia, Ning			The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes	PLOS ONE			English	Article							HIGH-ABUNDANCE PROTEINS; LC-MS/MS ANALYSIS; DEPLETION; PLASMA; SERUM; LADA; AUTOANTIBODIES; IDENTIFICATION; MULTICENTER; EXPRESSION	Autoantibodies have been widely used as markers of latent autoimmune diabetes in adults (LADA); however, the specificity and sensitivity of autoantibodies as markers of LADA are weak compared with those found in type 1 diabetes (T1DM). In this study, we aimed to identify other plasma proteins as potential candidates that can be used effectively to determine early stage LADA and type 2 diabetes (T2DM) to facilitate early diagnosis and treatment. These issues were addressed by studying new-onset 'classic' T1DM (n = 156), LADA (n = 174), T2DM (n = 195) and healthy cohorts (n = 166). Plasma samples were obtained from the four cohorts. We employed isobaric tag for relative and absolute quantitation (iTRAQ) together with liquid chromatography tandem mass spectrometry (LC-MS) to identify plasma proteins with significant changes in LADA. The changes were validated by Western blot and ELISA analyses. Among the four cohorts, 311 unique proteins were identified in three iTRAQ runs, with 157 present across the three data sets. Among them, 49/311 (16.0%) proteins had significant changes in LADA compared with normal controls, including glycoprotein phospholipase D (GPLD1), which was upregulated in LADA. Western blot and ELISA analyses showed that GPLD1 levels were higher in both LADA and T1DM cohorts than in both T2DM and healthy cohorts, while there were no significant differences in the plasma concentrations of GPLD1 between the LADA and T1DM cohorts. GPLD1 is implicated as a potential candidate plasma protein for determining early stage LADA and T2DM.	[Qin, Wen] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, Nanning, Guangxi Provinc, Peoples R China; [Liang, Yu-Zhen; Zhang, Jia-Li; Xia, Ning] Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Nanning, Guangxi Provinc, Peoples R China; [Qin, Bao-Yu] Guangxi Med Univ, Affiliated Hosp 1, Dept Elderly Endocrinol, Nanning, Guangxi Provinc, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Xia, N (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Nanning, Guangxi Provinc, Peoples R China.	xianing12@sina.com			National Natural Science Foundation of China [81060070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81060070).	Andersen CD, 2013, DIABETOLOGIA, V56, P252, DOI 10.1007/s00125-012-2759-y; Borriello R, 2015, ANN CLIN LAB SCI, V45, P414; Brooks-Worrell B, 2001, J IMMUNOL, V166, P5265, DOI 10.4049/jimmunol.166.8.5265; Brophy S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006165.pub3; Campos A, 2015, J PROTEOMICS, V127, P264, DOI 10.1016/j.jprot.2015.05.012; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; CHRISTGAU S, 1991, J BIOL CHEM, V266, P21257; Deeg MA, 2001, AM J PHYSIOL-ENDOC M, V281, pE147, DOI 10.1152/ajpendo.2001.281.1.E147; Deeg MA, 2012, BBA-MOL CELL BIOL L, V1821, P381, DOI 10.1016/j.bbalip.2011.12.009; Fourlanos S, 2006, DIABETES CARE, V29, P970, DOI 10.2337/dc05-2101; Fourlanos S, 2005, DIABETOLOGIA, V48, P2206, DOI 10.1007/s00125-005-1960-7; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gray DL, 2008, METABOLISM, V57, P473, DOI 10.1016/j.metabol.2007.11.007; Hyung SW, 2014, ANAL BIOANAL CHEM, V406, P7117, DOI 10.1007/s00216-014-8058-3; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Kucera P, 2003, CLIN EXP IMMUNOL, V133, P139, DOI 10.1046/j.1365-2249.2003.02205.x; Maddaloni E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131837; Mann KJ, 2004, BIOCHEM J, V378, P641, DOI 10.1042/BJ20031326; Massa O, 2013, J PROTEOMICS, V82, P263, DOI 10.1016/j.jprot.2013.02.030; Naghibalhossaini F, 2006, CANCER LETT, V234, P158, DOI 10.1016/j.canlet.2005.03.028; Pakdel A, 2012, MOL BIOL REP, V39, P3695, DOI 10.1007/s11033-011-1144-0; Papadopoulos KP, 1996, DIABETES, V45, P1761, DOI 10.2337/diabetes.45.12.1761; Pham MN, 2011, DIABETOLOGIA, V54, P1630, DOI 10.1007/s00125-011-2088-6; Pietropaolo M, 2007, DIABETES, V56, P1189, DOI 10.2337/db06-0880; Rhode H, 1999, CLIN CHIM ACTA, V281, P127, DOI 10.1016/S0009-8981(98)00218-6; Schofield JN, 2002, MOL GENET METAB, V75, P154, DOI 10.1006/mgme.2001.3287; Schofield JN, 2000, BBA-GENE STRUCT EXPR, V1494, P189, DOI 10.1016/S0167-4781(00)00194-9; Tiberti C, 2011, CLIN EXP IMMUNOL, V166, P317, DOI 10.1111/j.1365-2249.2011.04479.x; Tiberti C, 2008, DIABETES, V57, P1276, DOI 10.2337/db07-0874; Tozzoli R, 2013, IMMUNOL RES, V56, P425, DOI 10.1007/s12026-013-8418-7; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zhou ZG, 2013, DIABETES, V62, P543, DOI 10.2337/db12-0207; Zhu SC, 2012, PROTEOMICS, V12, P3451, DOI 10.1002/pmic.201200036	35	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0156959	10.1371/journal.pone.0156959	http://dx.doi.org/10.1371/journal.pone.0156959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351175	gold, Green Submitted, Green Published			2022-12-27	WOS:000378858900004
J	Schroeder, H; Cronn, R; Yanbaev, Y; Jennings, T; Mader, M; Degen, B; Kersten, B				Schroeder, Hilke; Cronn, Richard; Yanbaev, Yulai; Jennings, Tara; Mader, Malte; Degen, Bernd; Kersten, Birgit			Development of Molecular Markers for Determining Continental Origin of Wood from White Oaks (Quercus L. sect. Quercus)	PLOS ONE			English	Article							CHLOROPLAST DNA VARIATION; POSTGLACIAL COLONIZATION; LAND PLANTS; IDENTIFICATION; DIFFERENTIATION; BARCODE; PHYLOGEOGRAPHY; BIOGEOGRAPHY; INTRON; SET	To detect and avoid illegal logging of valuable tree species, identification methods for the origin of timber are necessary. We used next-generation sequencing to identify chloroplast genome regions that differentiate the origin of white oaks from the three continents; Asia, Europe, and North America. By using the chloroplast genome of Asian Q. mongolica as a reference, we identified 861 variant sites (672 single nucleotide polymorphisms (SNPs); 189 insertion/deletion (indel) polymorphism) from representative species of three continents (Q. mongolica from Asia; Q. petraea and Q. robur from Europe; Q. alba from North America), and we identified additional chloroplast polymorphisms in pools of 20 individuals each from Q. mongolica (789 variant sites) and Q. robur (346 variant sites). Genome sequences were screened for indels to develop markers that identify continental origin of oak species, and that can be easily evaluated using a variety of detection methods. We identified five indels and one SNP that reliably identify continent-of-origin, based on evaluations of up to 1078 individuals representing 13 white oak species and three continents. Due to the size of length polymorphisms revealed, this marker set can be visualized using capillary electrophoresis or high resolution gel (acrylamide or agarose) electrophoresis. With these markers, we provide the wood trading market with an instrument to comply with the U.S. and European laws that require timber companies to avoid the trade of illegally harvested timber.	[Schroeder, Hilke; Mader, Malte; Degen, Bernd; Kersten, Birgit] Thuenen Insitute Forest Genet, Grosshansdorf, Germany; [Cronn, Richard] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Yanbaev, Yulai] Bashkir State Univ, Ufa 450074, Russia; [Jennings, Tara] Oregon State Univ, Bot & Plant Pathol, Corvallis, OR 97331 USA	Johann Heinrich von Thunen Institute; United States Department of Agriculture (USDA); United States Forest Service; Bashkir State University; Oregon State University	Schroeder, H (corresponding author), Thuenen Insitute Forest Genet, Grosshansdorf, Germany.	hilke.schroeder@thuenen.de	Degen, Bernd/S-1730-2016; Yanbaev, Yulay/B-2266-2016	Degen, Bernd/0000-0001-9082-3163; Yanbaev, Yulay/0000-0003-1039-5344; Kersten, Birgit/0000-0001-9900-9133; Cronn, Richard/0000-0001-5342-3494	German Federal Ministry of Food and Agriculture (BMEL); Deutsche Bundesstiftung Umwelt (DBU); USDA Forest Service International Programs Office; US Agency for International Development; US Department of State	German Federal Ministry of Food and Agriculture (BMEL); Deutsche Bundesstiftung Umwelt (DBU); USDA Forest Service International Programs Office; US Agency for International Development(United States Agency for International Development (USAID)); US Department of State	This project has been financially supported by German Federal Ministry of Food and Agriculture (BMEL) (http://www.bmel.de), the Deutsche Bundesstiftung Umwelt (DBU) (http://www.dbu.de), the USDA Forest Service International Programs Office (http://www.fs.fed.us/about-agency/international-programs), the US Agency for International Development, and US Department of State (http://www.state.gov/s/d/rm/rls/dosstrat/). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baker CS, 2010, BIOL LETTERS, V6, P647, DOI 10.1098/rsbl.2010.0239; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bordacs S, 2002, FOREST ECOL MANAG, V156, P197, DOI 10.1016/S0378-1127(01)00643-0; Carvalho DC, 2015, FOOD CONTROL, V50, P784, DOI 10.1016/j.foodcont.2014.10.025; Cassens D., 2007, HARDWOOD LUMBER AND; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Cottrell JE, 2002, FOREST ECOL MANAG, V156, P181, DOI 10.1016/S0378-1127(01)00642-9; Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1; Csaikl UM, 2002, FOREST ECOL MANAG, V156, P131, DOI 10.1016/S0378-1127(01)00639-9; Deguilloux MF, 2003, MOL ECOL, V12, P1629, DOI 10.1046/j.1365-294X.2003.01836.x; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Dormontt EE, 2015, BIOL CONSERV, V191, P790, DOI 10.1016/j.biocon.2015.06.038; Drabkova L, 2004, J MOL EVOL, V59, P1, DOI 10.1007/s00239-004-2598-7; Dumolin S, 1995, THEOR APPL GENET, V91, P1253, DOI 10.1007/BF00220937; Fineschi S, 2002, FOREST ECOL MANAG, V156, P103, DOI 10.1016/S0378-1127(01)00637-5; Goncalves PFM, 2015, J HERED, V106, P560, DOI 10.1093/jhered/esv035; Handy SM, 2011, J AGR FOOD CHEM, V59, P10995, DOI 10.1021/jf203215v; Hartvig I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138231; Holtken AM, 2012, HOLZFORSCHUNG, V66, P97, DOI 10.1515/HF.2011.142; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huang XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129295; Jensen JS, 2002, FOREST ECOL MANAG, V156, P167, DOI 10.1016/S0378-1127(01)00641-7; Kanno M, 2004, J PLANT RES, V117, P311, DOI 10.1007/s10265-004-0160-8; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Konig AO, 2002, FOREST ECOL MANAG, V156, P147, DOI 10.1016/S0378-1127(01)00640-5; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lowe A, 2015, International Patent, Patent No. [WO/2015/070279, 2015070279]; Lu S, 2015, MITOCHONDR DNA, P1; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Martin-Bravo S, 2007, MOL PHYLOGENET EVOL, V44, P1105, DOI 10.1016/j.ympev.2006.12.016; Mitchell A, 2015, MOL ECOL RESOUR, V15, P1102, DOI 10.1111/1755-0998.12380; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Nithaniyal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107669; Olalde M, 2002, FOREST ECOL MANAG, V156, P89, DOI 10.1016/S0378-1127(01)00636-3; Pappalardo AM, 2015, FISH RES, V164, P153, DOI 10.1016/j.fishres.2014.11.004; Parks M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-100; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Petit RJ, 2002, FOREST ECOL MANAG, V156, P115, DOI 10.1016/S0378-1127(01)00638-7; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Pirie MD, 2007, AM J BOT, V94, P1003, DOI 10.3732/ajb.94.6.1003; Rehman A, 2015, J BIORESOUR MANAG, V2, P3, DOI [10.35691/JBM.5102.0017, DOI 10.35691/JBM.5102.0017]; Schroeder H, 2012, PLANT BIOLOGY, V14, P374, DOI 10.1111/j.1438-8677.2011.00502.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Simeone MC, 2013, BOT J LINN SOC, V172, P478, DOI 10.1111/boj.12059; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Yan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055854; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	58	26	26	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158221	10.1371/journal.pone.0158221	http://dx.doi.org/10.1371/journal.pone.0158221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27352242	Green Submitted, Green Published, gold			2022-12-27	WOS:000378858900046
J	Meaney, R; Hasking, P; Reupert, A				Meaney, Rebecca; Hasking, Penelope; Reupert, Andrea			Borderline Personality Disorder Symptoms in College Students: The Complex Interplay between Alexithymia, Emotional Dysregulation and Rumination	PLOS ONE			English	Article							BEHAVIORAL DYSREGULATION; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL DISTRESS; SUICIDAL-BEHAVIOR; RISK-FACTORS; SELF-INJURY; CASCADES; DIFFICULTIES; COMORBIDITY; POPULATION	Both Emotional Cascade Theory and Linehan's Biosocial Theory suggest dysregulated behaviors associated with Borderline Personality Disorder (BPD) emerge, in part, because of cycles of rumination, poor emotional recognition and poor emotion regulation. In this study we examined relationships between rumination, alexithymia, and emotion regulation in predicting dysregulated behaviors associated with BPD (e.g. self-harm, substance use, aggression), and explored both indirect and moderating effects among these variables. The sample comprised 2261 college students who completed self-report measures of the aforementioned constructs. BPD symptoms, stress, family psychological illness, and alexithymia exerted direct effects on behaviors. Symptoms had an indirect effect on behaviors through rumination, alexithymia and emotional dysregulation. In addition, the relationship between symptoms and dysregulated behaviors was conditional on level of rumination and alexithymia. Implications for early identification and treatment of BPD and related behaviors in college settings are discussed.	[Meaney, Rebecca; Reupert, Andrea] Monash Univ, Fac Educ, Melbourne, Vic 3004, Australia; [Hasking, Penelope] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia; [Hasking, Penelope] Monash Univ, Dept Psychiat, Clayton, Vic, Australia	Monash University; Curtin University; Monash University	Hasking, P (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.; Hasking, P (corresponding author), Monash Univ, Dept Psychiat, Clayton, Vic, Australia.	penelope.hasking@curtin.edu.au		Reupert, Andrea/0000-0003-1447-7769; Hasking, Penelope/0000-0002-0172-9288; Reupert, Andrea/0000-0003-2885-2814				Allen A, 2012, CURR PSYCHIAT REP, V14, P62, DOI 10.1007/s11920-011-0244-9; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Australian Bureau of Statistics, 2012, YB AUSTR; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Belsky DW, 2012, DEV PSYCHOPATHOL, V24, P251, DOI 10.1017/S0954579411000812; Berthoz S, 1999, EUR PSYCHIAT, V14, P372, DOI 10.1016/S0924-9338(99)00233-3; Black DW, 2004, J PERS DISORD, V18, P226, DOI 10.1521/pedi.18.3.226.35445; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Bohus M, 2009, PSYCHOPATHOLOGY, V42, P32, DOI 10.1159/000173701; Brinker JK, 2009, J CLIN PSYCHOL, V65, P1, DOI 10.1002/jclp.20542; Deasy C, 2015, HEALTH PROMOT INT, V30, P77, DOI 10.1093/heapro/dau086; Distel M, 2007, PSYCHOL MED, V38, P119, DOI 10.1017/S0033291707002024; Dyer A, 2013, BODY IMAGE, V10, P220, DOI 10.1016/j.bodyim.2012.12.007; Glenn CR, 2009, PSYCHOPATHOLOGY, V42, P394, DOI 10.1159/000241195; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Gratz K, 2009, PERSONAL MENT HEALTH, V46, P96; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Jacob GA, 2013, J BEHAV THER EXP PSY, V44, P61, DOI 10.1016/j.jbtep.2012.07.006; Johnson DM, 2003, COMPR PSYCHIAT, V44, P284, DOI 10.1016/S0010-440X(03)00090-7; Kernberg OF, 2009, AM J PSYCHIAT, V166, P505, DOI 10.1176/appi.ajp.2009.09020263; Klonsky ED, 2008, J PERS DISORD, V22, P418, DOI 10.1521/pedi.2008.22.4.418; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Lovibond S.H., 1993, MANUAL DEPRESSION AN; Meaney-Tavares R, 2013, J AM COLL HEALTH, V61, P303, DOI 10.1080/07448481.2013.791827; Nicolo G, 2011, PSYCHIAT RES, V190, P37, DOI 10.1016/j.psychres.2010.07.046; Paris J, 2005, CAN MED ASSOC J, V172, P1579, DOI 10.1503/cmaj.045281; Pistorello J, 2012, J CONSULT CLIN PSYCH, V80, P982, DOI 10.1037/a0029096; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Presniak MD, 2010, J PERS ASSESS, V92, P137, DOI 10.1080/00223890903510373; Putnam KM, 2005, DEV PSYCHOPATHOL, V17, P899, DOI 10.1017/S0954579405050431; Ridings LE, 2014, PERS INDIV DIFFER, V57, P14, DOI 10.1016/j.paid.2013.09.008; Salsman NL, 2012, J PSYCHOPATHOL BEHAV, V34, P260, DOI 10.1007/s10862-012-9275-8; Sar V, 2014, J TRAUMA DISSOCIATIO, V15, P477, DOI 10.1080/15299732.2014.902415; Sauer SE, 2010, ASSESSMENT, V17, P454, DOI 10.1177/1073191110373226; Schulze L, 2011, BIOL PSYCHIAT, V69, P564, DOI 10.1016/j.biopsych.2010.10.025; Selby EA, 2008, BEHAV RES THER, V46, P593, DOI 10.1016/j.brat.2008.02.002; Selby EA, 2013, J CLIN PSYCHOL, V69, P1213, DOI 10.1002/jclp.21966; Selby EA, 2013, PERSONAL DISORD, V4, P168, DOI 10.1037/a0029933; Selby EA, 2009, REV GEN PSYCHOL, V13, P219, DOI 10.1037/a0015687; Selby EA, 2009, J ABNORM PSYCHOL, V118, P375, DOI 10.1037/a0015711; SOLOFF PH, 1994, AM J PSYCHIAT, V151, P1316; Stallman HM, 2008, AUST FAM PHYSICIAN, V37, P673; Standish AJ, 2014, PSYCHOL REC, V64, P869, DOI 10.1007/s40732-014-0039-6; Steenkamp MM, 2015, J PERS DISORD, V6, P1; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Tanner AK, 2014, PREV SCI, V15, P860, DOI 10.1007/s11121-013-0444-0; Taylor J, 2008, PSYCHOL ASSESSMENT, V20, P351, DOI 10.1037/a0013452; Tuna E, 2014, J GEN PSYCHOL, V141, P1, DOI 10.1080/00221309.2013.834289; van Dijke A, 2013, PSYCHOPATHOLOGY, V46, P153, DOI 10.1159/000338832; Voon D, 2014, BRIT J CLIN PSYCHOL, V53, P95, DOI 10.1111/bjc.12030; Zanarini M., 1989, J PERS DISORD, V3, P10, DOI 10.1521/pedi.1989.3.1.10; Zanarini MC, 2003, AM J PSYCHIAT, V160, P274, DOI 10.1176/appi.ajp.160.2.274; Zanarini MC, 1998, AM J PSYCHIAT, V155, P1733, DOI 10.1176/ajp.155.12.1733; Zivin K, 2009, J AFFECT DISORDERS, V117, P180, DOI 10.1016/j.jad.2009.01.001	59	23	23	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2016	11	6							e0157294	10.1371/journal.pone.0157294	http://dx.doi.org/10.1371/journal.pone.0157294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP9FD	27348858	Green Published, gold, Green Submitted			2022-12-27	WOS:000378801200006
J	Chen, YY; Yu, YN; Zhang, YY; Li, B; Liu, J; Li, DF; Wu, P; Wang, J; Wang, Z; Wang, YY				Chen, Yin-ying; Yu, Ya-nan; Zhang, Ying-ying; Li, Bing; Liu, Jun; Li, Dong-feng; Wu, Ping; Wang, Jie; Wang, Zhong; Wang, Yong-yan			Quantitative Determination of Flexible Pharmacological Mechanisms Based On Topological Variation in Mice Anti-Ischemic Modular Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; DRUG DISCOVERY; CEREBRAL-ISCHEMIA; MOUSE HIPPOCAMPUS; PATHWAYS; ALLOSTERY; EXPRESSION; PREDICTION; COMPLEXES; OCCLUSION	Targeting modules or signalings may open a new path to understanding the complex pharmacological mechanisms of reversing disease processes. However, determining how to quantify the structural alteration of these signalings or modules in pharmacological networks poses a great challenge towards realizing rational drug use in clinical medicine. Here, we explore a novel approach for dynamic comparative and quantitative analysis of the topological structural variation of modules in molecular networks, proposing the concept of allosteric modules (AMs). Based on the ischemic brain of mice, we optimize module distribution in different compound-dependent modular networks by using the minimum entropy criterion and then calculate the variation in similarity values of AMs under various conditions using a novel method of SimiNEF. The diverse pharmacological dynamic stereo-scrolls of AMs with functional gradient alteration, which consist of five types of AMs, may robustly deconstruct modular networks under the same ischemic conditions. The concept of AMs can not only integrate the responsive mechanisms of different compounds based on topological cascading variation but also obtain valuable structural information about disease and pharmacological networks beyond pathway analysis. We thereby provide a new systemic quantitative strategy for rationally determining pharmacological mechanisms of altered modular networks based on topological variation.	[Chen, Yin-ying; Yu, Ya-nan; Zhang, Ying-ying; Li, Bing; Liu, Jun; Wang, Zhong; Wang, Yong-yan] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Chen, Yin-ying; Wu, Ping; Wang, Jie] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Li, Dong-feng] Peking Univ, Sch Math Sci, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Peking University	Wang, Z; Wang, YY (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.; Wang, J (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China.	jie_wang_0107@yeah.net; zhonw@sina.com; wangyongyan2010@sina.cn	Wang, Zhong/AAY-7574-2020; Yu, Yan/GYV-4514-2022		Hi-Tech Research and Development Program of China (863); "Eleventh Five-Year" National Key Technologies RD Program [2006BAI08B04-06]; National Major Scientific and Technological Special Project for "Significant New Drugs Development" [2013ZX09303301]	Hi-Tech Research and Development Program of China (863)(National High Technology Research and Development Program of China); "Eleventh Five-Year" National Key Technologies RD Program; National Major Scientific and Technological Special Project for "Significant New Drugs Development"	Our research was largely supported by the Hi-Tech Research and Development Program of China (863), the "Eleventh Five-Year" National Key Technologies R&D Program (2006BAI08B04-06), and the National Major Scientific and Technological Special Project for "Significant New Drugs Development" (2013ZX09303301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN G, 1993, ANN NEUROL, V33, P457, DOI 10.1002/ana.410330508; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Antal MA, 2009, CURR PROTEIN PEPT SC, V10, P161, DOI 10.2174/138920309787847617; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Blacklock K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071936; Bradley SJ, 2011, MOL PHARMACOL, V79, P874, DOI 10.1124/mol.110.068882; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chen YY, 2012, N-S ARCH PHARMACOL, V385, P797, DOI 10.1007/s00210-012-0743-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Diez D, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-27; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; HIMORI N, 1990, J PHARMACOL METHOD, V23, P311; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Horjales E, 1999, STRUCTURE, V7, P527, DOI 10.1016/S0969-2126(99)80069-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaiser M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/110; King BM, 2009, BIOINFORMATICS, V25, P1165, DOI 10.1093/bioinformatics/btp109; Li GD, 2015, ACTA PHARM SIN B, V5, P93, DOI 10.1016/j.apsb.2015.01.005; Li M, 2009, APPL RES COMPUTERS, V1; Liu J, 2012, CNS NEUROL DISORD-DR, V11, P1070; Lorenz DM, 2011, PHYS LIFE REV, V8, P129, DOI 10.1016/j.plrev.2011.02.003; Martin-Villalba A, 1998, MOL BRAIN RES, V62, P158, DOI 10.1016/S0169-328X(98)00239-3; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mihalik A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002187; Nussinov R, 2013, STRUCTURE, V21, P1509, DOI 10.1016/j.str.2013.06.002; Nussinov R, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045004; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Nussinov R, 2011, TRENDS PHARMACOL SCI, V32, P686, DOI 10.1016/j.tips.2011.08.004; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sidhu PS, 2013, J PHARM PHARMACOL, V1, P1; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Szilagyi A, 2013, CURR TOP MED CHEM, V13, P64, DOI 10.2174/1568026611313010007; [谭跃进 Tan Yuejin], 2004, [系统工程理论与实践, Systems Engineering-Theory & Practice], V24, P1; Thiagalingam S, 2006, CANCER RES, V66, P7379, DOI 10.1158/0008-5472.CAN-06-0993; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Wang Z, 2013, DRUG DISCOV TODAY, V18, P560, DOI 10.1016/j.drudis.2013.01.009; Wang Z, 2012, EXPERT OPIN DRUG DIS, V7, P667, DOI 10.1517/17460441.2012.692673; Wang Z, 2011, EUR J PHARMACOL, V667, P278, DOI 10.1016/j.ejphar.2011.05.046; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu G, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-36; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yellaboina S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-465; Yu Y, 2016, CRIT REV EU IN PRESS; Zhou CX, 2010, CHINESE PHARMACOL B, V4, P547	56	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158379	10.1371/journal.pone.0158379	http://dx.doi.org/10.1371/journal.pone.0158379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383195	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400045
J	Plumer, L; Keis, M; Remm, J; Hindrikson, M; Jogisalu, I; Mannil, P; Kubarsepp, M; Saarma, U				Plumer, Liivi; Keis, Marju; Remm, Jaanus; Hindrikson, Maris; Jogisalu, Inga; Mannil, Peep; Kubarsepp, Marko; Saarma, Urmas			Wolves Recolonizing Islands: Genetic Consequences and Implications for Conservation and Management	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MULTILOCUS GENOTYPE DATA; CANIS-LUPUS; LINKAGE DISEQUILIBRIUM; WOLF POPULATION; DOMESTIC DOGS; MARKERS; HYBRIDIZATION; LOCI; MITOCHONDRIAL	After a long and deliberate persecution, the grey wolf ( Canis lupus) is slowly recolonizing its former areas in Europe, and the genetic consequences of this process are of particular interest. Wolves, though present in mainland Estonia for a long time, have only recently started to recolonize the country's two largest islands, Saaremaa and Hiiumaa. The main objective of this study was to analyse wolf population structure and processes in Estonia, with particular attention to the recolonization of islands. Fifteen microsatellite loci were genotyped for 185 individuals across Estonia. As a methodological novelty, all putative wolf-dog hybrids were identified and removed (n = 17) from the dataset beforehand to avoid interference of dog alleles in wolf population analysis. After the preliminary filtering, our final dataset comprised of 168 "pure" wolves. We recommend using hybrid-removal step as a standard precautionary procedure not only for wolf population studies, but also for other taxa prone to hybridization. STRUCTURE indicated four genetic groups in Estonia. Spatially explicit DResD analysis identified two areas, one of them on Saaremaa island and the other in southwestern Estonia, where neighbouring individuals were genetically more similar than expected from an isolation-by-distance null model. Three blending areas and two contrasting transition zones were identified in central Estonia, where the sampled individuals exhibited strong local differentiation over relatively short distance. Wolves on the largest Estonian islands are part of human-wildlife conflict due to livestock depredation. Negative public attitude, especially on Saaremaa where sheep herding is widespread, poses a significant threat for island wolves. To maintain the long-term viability of the wolf population on Estonian islands, not only wolf hunting quota should be targeted with extreme care, but effective measures should be applied to avoid inbreeding and minimize conflicts with local communities and stakeholders.	[Plumer, Liivi; Keis, Marju; Remm, Jaanus; Hindrikson, Maris; Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia; [Jogisalu, Inga; Mannil, Peep; Kubarsepp, Marko] Estonian Environm Agcy, Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia.	Urmas.Saarma@ut.ee	Remm, Jaanus/G-9347-2012; Saarma, Urmas/AAC-9813-2019; Hindrikson, Maris/G-4573-2017	Remm, Jaanus/0000-0002-8896-0772; Saarma, Urmas/0000-0002-3222-571X; Hindrikson, Maris/0000-0001-8094-1860	Estonian Ministry of Education and Research [IUT20-32]; Estonian Environmental Investment Centre; European Union through the European Regional Development Fund (Centre of Excellence FIBIR); European Union through the European Regional Development Fund [3.2.0802.11-0043]; Estonian Doctoral School of Ecology and Environmental Sciences	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Environmental Investment Centre(Estonian Research Council); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); European Union through the European Regional Development Fund(European Commission); Estonian Doctoral School of Ecology and Environmental Sciences	This work was supported by institutional research funding (IUT20-32) from the Estonian Ministry of Education and Research; the Estonian Environmental Investment Centre; the European Union through the European Regional Development Fund (Centre of Excellence FIBIR); the European Union through the European Regional Development Fund by the program 3.2.0802.11-0043; and the Estonian Doctoral School of Ecology and Environmental Sciences. The authors appreciate the help of Madli Parn with the Structure computings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Andersone Z, 2002, MAMM BIOL, V67, P79, DOI 10.1078/1616-5047-00012; Ausband DE, 2015, ANIM CONSERV, V18, P415, DOI 10.1111/acv.12187; Baltrunaite L, 2013, CENT EUR J BIOL, V8, P440, DOI 10.2478/s11535-013-0154-9; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Boitani L, 2015, KEY ACTIONS LARGE CA; Bryan HM, 2015, FUNCT ECOL, V29, P347, DOI 10.1111/1365-2435.12354; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Chhatre VE, 2016, STRAUTO AUTOMATION P; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2010, MOL ECOL RESOUR, V10, P167, DOI 10.1111/j.1755-0998.2009.02731.x; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabbri E, 2014, MAMM BIOL, V79, P138, DOI 10.1016/j.mambio.2013.10.002; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Falush D, 2003, GENETICS, V164, P1567; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; FREDHOLM M, 1995, MAMM GENOME, V6, P11, DOI 10.1007/BF00350887; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Godinho R, 2015, MOL ECOL RESOUR, V15, P317, DOI 10.1111/1755-0998.12313; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hagen SB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0092; Hindrikson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075765; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; HOLMES NG, 1995, ANIM GENET, V26, P132, DOI 10.1111/j.1365-2052.1995.tb02659.x; Jansson E, 2012, MOL ECOL, V21, P5178, DOI 10.1111/mec.12010; Jedrzejewski W, 2005, ACTA THERIOL, V50, P3, DOI 10.1007/BF03192614; Jedrzejewski W, 2007, ECOGRAPHY, V30, P66, DOI 10.1111/j.2006.0906-7590.04826.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Kubarsepp M, 2013, HUNDI ELUPAIGA KASUT; Kubarsepp Marko, 2003, Acta Zoologica Lituanica, V13, P28; Laikre L, 2013, CONSERV BIOL, V27, P248, DOI 10.1111/j.1523-1739.2012.01965.x; Lam N. S. N., 1983, CARTOGR GEOGR INF SC, V10, P129, DOI [10.1559/152304083783914958, DOI 10.1559/152304083783914958]; Lucchini V, 2002, MOL ECOL, V11, P857, DOI 10.1046/j.1365-294X.2002.01489.x; Mannil P, 2012, STATUS GAME POPULATI; Mannil P, 2013, STATUS GAME POPULATI; Mech D., 2003, WOLVES BEHAV ECOLOGY; Morin PA, 2009, MOL ECOL RESOUR, V9, P1451, DOI 10.1111/j.1755-0998.2009.02672.x; Moura AE, 2014, CONSERV GENET, V15, P405, DOI 10.1007/s10592-013-0547-y; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pebesma E. J., 2005, R NEWS, V5; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2013, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roux JJL, 2015, ECOL EVOL, V5, P288; Saether BE, 2005, J WILDLIFE MANAGE, V69, P1001, DOI 10.2193/0022-541X(2005)069[1001:MSFTWI]2.0.CO;2; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; SHIBUYA H, 1994, ANIM GENET, V25, P122, DOI 10.1111/j.1365-2052.1994.tb00094.x; Sidorovich VE, 2007, CAN J ZOOL, V85, P295, DOI 10.1139/Z07-001; Stahler DR, 2006, J NUTR, V136, p1923S, DOI 10.1093/jn/136.7.1923S; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Valdmann Harri, 2004, Baltic Forestry, V10, P83; Valiere N, 2003, ANIM CONSERV, V6, P83, DOI 10.1017/S1367943003003111; van Oosterhout C, 2004, MOL ECOL NOTES, V2, P377; Veeroja R., 2015, STATUS GAME POPULATI; Verardi A, 2006, MOL ECOL, V15, P2845, DOI 10.1111/j.1365-294X.2006.02995.x; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y	75	8	8	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158911	10.1371/journal.pone.0158911	http://dx.doi.org/10.1371/journal.pone.0158911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384049	Green Published, Green Submitted, gold			2022-12-27	WOS:000379809400091
J	Gao, HJ; Chen, X; Wei, JL; Zhang, YJ; Zhang, LG; Chang, J; Thompson, ML				Gao, Hongjian; Chen, Xi; Wei, Junling; Zhang, Yajie; Zhang, Ligan; Chang, Jiang; Thompson, Michael L.			Decomposition Dynamics and Changes in Chemical Composition of Wheat Straw Residue under Anaerobic and Aerobic Conditions	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; STATE C-13 NMR; LITTER DECOMPOSITION; NITROGEN MINERALIZATION; FIBROUS FEEDS; CROP RESIDUES; PLANT LITTER; CPMAS NMR; CARBON; FRACTIONS	Soil aeration is a crucial factor that regulates crop residue decomposition, and the chemical composition of decomposing crop residues may change the forms and availability of soil nutrients, such as N and P. However, to date, differences in the chemical composition of crop straw residues after incorporation into soil and during its decomposition under anaerobic vs. aerobic conditions have not been well documented. The objective of the present study was to assess changes in the C-containing functional groups of wheat straw residue during its decomposition in anaerobic and aerobic environments. A 12-month incubation experiment was carried out to investigate the temporal variations of mass, carbon, and nitrogen loss, as well as changes in the chemical composition of wheat (Triticum aestivum L) straw residues under anaerobic and aerobic conditions by measuring C-containing functional groups using solid state nuclear magnetic resonance (NMR) spectroscopy. The residual mass, carbon content, and nitrogen content of the straw residue sharply declined during the initial 3 months, and then slowly decreased during the last incubation period from 3 to 12 months. The decomposition rate constant (kappa) for mass loss under aerobic conditions (0.022 d(-1)) was higher than that under anaerobic conditions (0.014 d(-1)). The residual mass percentage of cellulose and hemicellulose in the wheat straw gradually declined, whereas that of lignin gradually increased during the entire 12-month incubation period. The NMR spectra of C-containing functional groups in the decomposing straw under both aerobic and anaerobic conditions were similar at the beginning of the incubation as well as at 1 month, 6 months, and 12 months. The main alterations in C-containing functional groups during the decomposition of wheat straw were a decrease in the relative abundances of O-alkyl C and an increase in the relative abundances of alkyl C, aromatic C and COO/N-C = O functional groups. The NMR signals of alkyl C and aromatic C in decomposing wheat straw residues under anaerobic condition were higher than those under aerobic conditions. The higher mass percentages of lignin and the higher signals of aromatic C and alkyl C functional groups in decomposing wheat residues under anaerobic conditions than under aerobic conditions were due to the slower decomposition rates of aryl C and alkyl C in wheat straw residues under anaerobic conditions.	[Gao, Hongjian; Chen, Xi; Wei, Junling; Zhang, Yajie; Zhang, Ligan; Chang, Jiang] Anhui Agr Univ, Sch Resources & Environm, Hefei 230036, Peoples R China; [Gao, Hongjian] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Peoples R China; [Thompson, Michael L.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Anhui Agricultural University; Anhui Agricultural University; Iowa State University	Gao, HJ (corresponding author), Anhui Agr Univ, Sch Resources & Environm, Hefei 230036, Peoples R China.; Gao, HJ (corresponding author), Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Peoples R China.	hjgao@ahau.edu.cn			National Natural Science Foundation of China [31272254, 31328020]; National Key Technology Support Program of China [2012BAD04B09, 2013BAD07B08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program of China(National Key Technology R&D Program)	This study was jointly funded by the National Natural Science Foundation of China (31272254, 31328020), and the National Key Technology Support Program of China (2012BAD04B09, 2013BAD07B08).	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; ANDREN O, 1987, ECOLOGY, V68, P1190, DOI 10.2307/1939203; Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004; BERG B, 1995, SCAND J FOREST RES, V10, P108, DOI 10.1080/02827589509382874; BERG B, 1993, SCAND J FOREST RES, V8, P457, DOI 10.1080/02827589309382792; BERG B, 1991, CAN J BOT, V69, P1449, DOI 10.1139/b91-187; Bhupinderpal-Singh, 2006, SOIL BIOL BIOCHEM, V38, P32, DOI 10.1016/j.soilbio.2005.03.025; Bierke A, 2008, GEODERMA, V146, P48, DOI 10.1016/j.geoderma.2008.05.004; Cao XY, 2016, GEOCHIM COSMOCHIM AC, V181, P72, DOI 10.1016/j.gca.2016.02.029; Cao XY, 2011, SOIL SCI SOC AM J, V75, P1374, DOI 10.2136/sssaj2010.0382; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Devevre OC, 2000, SOIL BIOL BIOCHEM, V32, P1773, DOI 10.1016/S0038-0717(00)00096-1; DORAN JW, 1987, BIOL FERT SOILS, V5, P68, DOI 10.1007/BF00264349; Dou S, 2008, EUR J SOIL SCI, V59, P532, DOI 10.1111/j.1365-2389.2007.01012.x; Finn D, 2015, SOIL BIOL BIOCHEM, V91, P160, DOI 10.1016/j.soilbio.2015.09.001; Frouz J, 2015, SOIL BIOL BIOCHEM, V91, P23, DOI 10.1016/j.soilbio.2015.08.024; Gong Z.T., 2007, PEDOGENESIS SOIL TAX; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; Jensen LS, 2005, PLANT SOIL, V273, P307, DOI 10.1007/s11104-004-8128-y; Johnson JMF, 2007, SOIL SCI SOC AM J, V71, P155, DOI 10.2136/sssaj2005.0419; Johnson RL, 2014, J MAGN RESON, V239, P44, DOI 10.1016/j.jmr.2013.11.009; Kogel-Knabner I, 2006, GEODERMA, V136, P331; Kruse JS, 2004, NUTR CYCL AGROECOSYS, V69, P247, DOI 10.1023/B:FRES.0000035197.57441.cd; Kumar K, 2000, ADV AGRON, V68, P197; Kumar K, 2003, COMMUN SOIL SCI PLAN, V34, P2441, DOI 10.1081/CSS-120024778; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Leifeld J, 2005, GEODERMA, V124, P143, DOI 10.1016/j.geoderma.2004.04.009; Li Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0101019; Lu R.Q, 1999, METHODS SOIL AGROCHE, P18; Mahieu N, 1999, SOIL SCI SOC AM J, V63, P307, DOI 10.2136/sssaj1999.03615995006300020008x; Mao JD, 2004, SOLID STATE NUCL MAG, V26, P36, DOI 10.1016/j.ssnmr.2003.09.003; Mao JD, 2007, ORG GEOCHEM, V38, P1277, DOI 10.1016/j.orggeochem.2007.04.005; Mathers NJ, 2007, SOIL BIOL BIOCHEM, V39, P993, DOI 10.1016/j.soilbio.2006.11.009; Mathers NJ, 2003, GEODERMA, V114, P19, DOI 10.1016/S0016-7061(02)00339-7; MELILLO JM, 1989, PLANT SOIL, V115, P189, DOI 10.1007/BF02202587; Olk DC, 2007, EUR J SOIL SCI, V58, P270, DOI 10.1111/j.1365-2389.2006.00836.x; Olk DC, 2006, SOIL BIOL BIOCHEM, V38, P3303, DOI 10.1016/j.soilbio.2006.04.009; Olk DC, 1998, EUR J SOIL SCI, V49, P337, DOI 10.1046/j.1365-2389.1998.00163.x; PRESTON CM, 1987, CAN J SOIL SCI, V67, P187, DOI 10.4141/cjss87-016; Preston CM, 1996, SOIL SCI, V161, P144, DOI 10.1097/00010694-199603000-00002; Rengel Z., 2007, NUTR CYCLING TERREST, P183, DOI [DOI 10.1007/978-3-540-68027-7_7, 10.1007/978-3-540-68027-7_7]; Rivas FA, 2014, BIOL FERT SOILS, V50, P527, DOI 10.1007/s00374-013-0870-y; Skene TM, 1996, AUST J SOIL RES, V34, P413, DOI 10.1071/SR9960413; Tulina AS, 2009, EURASIAN SOIL SCI+, V42, P1241, DOI 10.1134/S1064229309110064; VANSOEST PJ, 1967, J ASSOC OFF ANA CHEM, V50, P50; VANSOEST PJ, 1963, J ASSOC OFF AGR CHEM, V46, P829; Wang J, 2015, J CHINA AGR U, V23, P161; Wang XY, 2012, ENVIRON SCI TECHNOL, V46, P7159, DOI 10.1021/es300522x; Witt C, 2000, PLANT SOIL, V225, P263, DOI 10.1023/A:1026594118145; Wu WX, 2009, J SOIL SEDIMENT, V9, P457, DOI 10.1007/s11368-009-0106-9; Yu ZP, 2015, SOIL BIOL BIOCHEM, V90, P188, DOI 10.1016/j.soilbio.2015.07.026; Zhang Y, 2013, J SOIL SEDIMENT, V13, P24, DOI 10.1007/s11368-012-0592-z	52	40	45	5	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158172	10.1371/journal.pone.0158172	http://dx.doi.org/10.1371/journal.pone.0158172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380023	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700020
J	Glavind, E; Aagaard, NK; Gronbaek, H; Moller, HJ; Orntoft, NW; Vilstrup, H; Thomsen, KL				Glavind, Emilie; Aagaard, Niels Kristian; Gronbaek, Henning; Moller, Holger Jon; Orntoft, Nikolaj Worm; Vilstrup, Hendrik; Thomsen, Karen Louise			Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis	PLOS ONE			English	Article							GALACTOSE ELIMINATION CAPACITY; GROWTH-FACTOR-I; SHORT-TERM; NITROGEN CONVERSION; AMINO NITROGEN; LIVER; INCREASES; MORTALITY; CIRRHOSIS; EFFICACY	Background and Aim Data on quantitative metabolic liver functions in the life-threatening disease alcoholic hepatitis are scarce. Urea synthesis is an essential metabolic liver function that plays a key regulatory role in nitrogen homeostasis. The urea synthesis capacity decreases in patients with compromised liver function, whereas it increases in patients with inflammation. Alcoholic hepatitis involves both mechanisms, but how these opposite effects are balanced remains unclear. Our aim was to investigate how alcoholic hepatitis affects the capacity for urea synthesis. We related these findings to another measure of metabolic liver function, the galactose elimination capacity (GEC), as well as to clinical disease severity. Methods We included 20 patients with alcoholic hepatitis and 7 healthy controls. The urea synthesis capacity was quantified by the functional hepatic nitrogen clearance (FHNC), i.e., the slope of the linear relationship between the blood alpha-amino nitrogen concentration and urea nitrogen synthesis rate during alanine infusion. The GEC was determined using blood concentration decay curves after intravenous bolus injection of galactose. Clinical disease severity was assessed by the Glasgow Alcoholic Hepatitis Score and Model for End-Stage Liver Disease (MELD) score. Results The FHNC was markedly decreased in the alcoholic hepatitis patients compared with the healthy controls (7.2 +/- 4.9 L/h vs. 37.4 +/- 6.8 L/h, P<0.01), and the largest decrease was observed in those with severe alcoholic hepatitis (4.9 +/- 3.6 L/h vs. 9.9 +/- 4.9 L/h, P<0.05). The GEC was less markedly reduced than the FHNC. A negative correlation was detected between the FHNC and MELD score (rho = -0.49, P<0.05). Conclusions Alcoholic hepatitis markedly decreases the urea synthesis capacity. This decrease is associated with an increase in clinical disease severity. Thus, the metabolic failure in alcoholic hepatitis prevails such that the liver cannot adequately perform the metabolic up-regulation observed in other stressful states, including extrahepatic inflammation, which may contribute to the patients' poor prognosis.	[Glavind, Emilie; Aagaard, Niels Kristian; Gronbaek, Henning; Orntoft, Nikolaj Worm; Vilstrup, Hendrik; Thomsen, Karen Louise] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark; [Moller, Holger Jon] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark	Aarhus University; Aarhus University	Glavind, E (corresponding author), Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark.	emigla@rm.dk	Gronbaek, Henning/AAJ-3202-2020	Gronbaek, Henning/0000-0001-8998-7910; Moller, Holger Jon/0000-0001-7687-5995; Glavind, Emilie/0000-0003-4933-8064; Thomsen, Karen Louise/0000-0002-8118-4643; Orntoft, Nikolaj/0000-0002-6890-8280	Aase and Ejnar Danielsen's Foundation; Novo Nordisk Foundation; Department of Clinical Medicine, Aarhus University, Denmark; Novo Nordisk Fonden [NNF10OC1013267, NNF14OC0012141] Funding Source: researchfish	Aase and Ejnar Danielsen's Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Department of Clinical Medicine, Aarhus University, Denmark; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Aase and Ejnar Danielsen's Foundation (http://www.danielsensfond.dk) (EG); the Novo Nordisk Foundation (HG); and the Department of Clinical Medicine, Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard NK, 2004, ALCOHOL CLIN EXP RES, V28, P697, DOI 10.1097/01.ALC.0000125355.31808.DC; Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; ALMDAL TP, 1990, EUR J CLIN INVEST, V20, P29, DOI 10.1111/j.1365-2362.1990.tb01787.x; Garcia AB, 2013, REV ESP ENFERM DIG, V105, P513, DOI 10.4321/s1130-01082013000900002; DOSSING M, 1982, CLIN PHARMACOL THER, V32, P392, DOI 10.1038/clpt.1982.177; FABBRI A, 1993, HEPATOLOGY, V18, P28, DOI 10.1002/hep.1840180106; FAWCETT JK, 1960, J CLIN PATHOL, V13, P156, DOI 10.1136/jcp.13.2.156; Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781; Frystyk J, 1995, GROWTH REGULAT, V5, P169; Goodwin JF, 1970, STAND METHODS CLIN C, V6, P89, DOI [10.1016/B978-0-12-609106-9.50014-2, DOI 10.1016/B978-0-12-609106-9.50014-2]; Greisen J, 1999, J HEPATOL, V31, P647, DOI 10.1016/S0168-8278(99)80344-4; Griffin Stephen J., 1997, Biochemical Society Transactions, V25, p97S; HAMBERG O, 1992, J HEPATOL, V14, P237, DOI 10.1016/0168-8278(92)90164-K; HAMBERG O, 1994, SCAND J CLIN LAB INV, V54, P377, DOI 10.3109/00365519409088437; HEINDORFF H, 1988, CLIN SCI, V74, P539, DOI 10.1042/cs0740539; Jepsen P, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-50; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Lundsgaard C, 1996, J HEPATOL, V24, P587, DOI 10.1016/S0168-8278(96)80145-0; MAIER KP, 1974, EUR J CLIN INVEST, V4, P193, DOI 10.1111/j.1365-2362.1974.tb00391.x; Merkel C, 1996, HEPATOLOGY, V24, P820; MEZEY E, 1991, HEPATOLOGY, V14, P1090, DOI 10.1016/0270-9139(91)90134-H; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Nielsen SS, 2005, LIVER INT, V25, P177, DOI 10.1111/j.1478-3231.2005.01039.x; Orntoft NW, 2014, CLIN GASTROENTEROL H, V12, P1739, DOI 10.1016/j.cgh.2014.04.020; RAFOTH RJ, 1975, J CLIN INVEST, V56, P1170, DOI 10.1172/JCI108193; Sandahl TD, 2011, LIVER INT, V31, P132, DOI 10.1111/j.1478-3231.2010.02362.x; Sandahl TD, 2014, AM J GASTROENTEROL, V109, P1749, DOI 10.1038/ajg.2014.262; Sandahl TD, 2011, J HEPATOL, V54, P760, DOI 10.1016/j.jhep.2010.07.016; SIGSGAARD I, 1988, LIVER, V8, P193; Thomsen KL, 2014, INFLAMM BOWEL DIS, V20, P7, DOI 10.1097/01.MIB.0000437496.07181.4c; Thomsen KL, 2010, SCAND J CLIN LAB INV, V70, P151, DOI 10.3109/00365511003599537; Thomsen KL, 2014, AM J PHYSIOL-GASTR L, V307, pG295, DOI 10.1152/ajpgi.00036.2014; TYGSTRUP N, 1966, SCAND J CLIN LAB INV, VS 18, P118; VILSTRUP H, 1980, GUT, V21, P990, DOI 10.1136/gut.21.11.990; VILSTRUP H, 1986, EUR J CLIN INVEST, V16, P193, DOI 10.1111/j.1365-2362.1986.tb01328.x; VILSTRUP H, 1989, DAN MED BULL, V36, P415; VILSTRUP H, 1990, J HEPATOL, V10, P46, DOI 10.1016/0168-8278(90)90072-Y; Wolthers T, 1997, J HEPATOL, V27, P789, DOI 10.1016/S0168-8278(97)80314-5	41	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158388	10.1371/journal.pone.0158388	http://dx.doi.org/10.1371/journal.pone.0158388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379798	Green Published, Green Submitted, gold			2022-12-27	WOS:000379798700028
J	Katuwal, HB; Basnet, K; Khanal, B; Devkota, S; Rai, SK; Gajurel, JP; Scheidegger, C; Nobis, MP				Katuwal, Hem Bahadur; Basnet, Khadga; Khanal, Bhaiya; Devkota, Shiva; Rai, Sanjeev Kumar; Gajurel, Jyoti Prasad; Scheidegger, Christoph; Nobis, Michael P.			Seasonal Changes in Bird Species and Feeding Guilds along Elevational Gradients of the Central Himalayas, Nepal	PLOS ONE			English	Article							LAND-USE; CLIMATE-CHANGE; TEMPORAL VARIATION; COSTA-RICA; RICHNESS; DIVERSITY; ALTITUDE; HABITAT; FOREST; DISTRIBUTIONS	The Himalayas are a global hotspot for bird diversity with a large number of threatened species, but little is known about seasonal changes in bird communities along elevational gradients in this region. We studied the seasonality of bird diversity in six valleys of the Central Himalayas, Nepal. Using 318 plots with a 50 m radius, located from 2200 to 3800 m a.s.l., and repeated sampling during different seasons (mainly pre-monsoon, monsoon, and post-monsoon), we analyzed 3642 occurrences of 178 species. Birds classified in the literature as resident were more species-rich than migratory birds (140 vs. 38 species). In all six valleys and within the studied elevation range, species richness of all birds showed a peak at mid-elevation levels of 2600 or 3000 m a.s.l. Similar patterns were found for the most species-rich feeding guilds of insectivores (96 species) and omnivores (24 species), whereas the species richness of herbivores (37 species including frugivores) increased towards higher elevations. Among these feeding guilds, only species richness of insectivores showed pronounced seasonal changes with higher species numbers during post-monsoon season. Similarly, individual bird species showed distinct spatio-temporal distribution patterns, with transitions from species dominated by elevational differences to those characterized by strong seasonal changes. In an era of climate change, the results demonstrate that individual bird species as well as feeding guilds might greatly differ in their responses to climate warming and changes in the seasonality of the precipitation regime, two aspects of climate change which should not be analyzed independently.	[Katuwal, Hem Bahadur; Basnet, Khadga] Tribhuvan Univ, Cent Dept Zool, Kathmandu, Nepal; [Katuwal, Hem Bahadur] Small Mammals Conservat & Res Fdn, Kathmandu, Nepal; [Khanal, Bhaiya] Tribhuvan Univ, Nat Hist Museum, Kathmandu, Nepal; [Devkota, Shiva; Rai, Sanjeev Kumar; Gajurel, Jyoti Prasad] Tribhuvan Univ, Cent Dept Bot, Kathmandu, Nepal; [Devkota, Shiva; Rai, Sanjeev Kumar; Gajurel, Jyoti Prasad; Scheidegger, Christoph; Nobis, Michael P.] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland	Tribhuvan University; Tribhuvan University; Tribhuvan University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Katuwal, HB (corresponding author), Tribhuvan Univ, Cent Dept Zool, Kathmandu, Nepal.; Katuwal, HB (corresponding author), Small Mammals Conservat & Res Fdn, Kathmandu, Nepal.; Nobis, MP (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	hello2hemu@gmail.com; michael.nobis@wsl.ch	Devkota, Shiva/C-5761-2019; Devkota, Shiva/X-3824-2019; Nobis, Michael P/F-6176-2010; Scheidegger, Christoph/C-6547-2011; Katuwal, Hem Bahadur/R-7895-2019	Devkota, Shiva/0000-0002-5290-1113; Scheidegger, Christoph/0000-0003-3713-5331; Katuwal, Hem Bahadur/0000-0001-6792-1363; Nobis, Michael/0000-0003-3285-1590	Swiss National Science Foundation [JRP IZ70Z0_131338/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (grant JRP IZ70Z0_131338/1 to Christoph Scheidegger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Acharya KP, 2011, J BIOGEOGR, V38, P1821, DOI 10.1111/j.1365-2699.2011.02511.x; [Anonymous], 2004, HOTSPOTS REVISITED E; Basnet TB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150498; Becker A, 2007, MT RES DEV, V27, P58, DOI 10.1659/0276-4741(2007)27[58:EALUSA]2.0.CO;2; Bertuzzo E, 2016, P NATL ACAD SCI USA, V113, P1737, DOI 10.1073/pnas.1518922113; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Blake JG, 2000, AUK, V117, P663, DOI 10.1642/0004-8038(2000)117[0663:DOBAAE]2.0.CO;2; Bonebrake TC, 2010, P NATL ACAD SCI USA, V107, P12581, DOI 10.1073/pnas.0911841107; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Brooks Daniel M., 1997, Hornero, V14, P193; Chamberlain DE, 2013, BIOL CONSERV, V167, P127, DOI 10.1016/j.biocon.2013.07.036; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Colwell RK, 2013, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Ding TS, 2005, GLOBAL ECOL BIOGEOGR, V14, P299, DOI 10.1111/j.1466-822x.2005.00159.x; Ferger SW, 2014, GLOBAL ECOL BIOGEOGR, V23, P541, DOI 10.1111/geb.12151; Fleming RL Sr, 1984, BIRDS OF NEPAL, V3rd; Flousek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139465; Grimmett R, 2000, BIRDS NEPAL HELM FIE; Grimmett R, 2011, BIRDS INDIAN SUBCONT; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Hagen T., 1969, DENCKSCHRIFT DESSCHW, V86, P1; Herzog SK, 2005, ECOGRAPHY, V28, P209, DOI 10.1111/j.0906-7590.2005.03935.x; Herzog SK, 2003, WILSON BULL, V115, P438, DOI 10.1676/03-048; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Howard C, 2015, GLOBAL ECOL BIOGEOGR, V24, P1249, DOI 10.1111/geb.12377; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; INSKIPP C, 1989, INT COUNCIL BIRD PRE, V4; Inskipp C., 2005, IMPORTANT BIRD AREAS; Inskipp Carol, 2013, Journal of Threatened Taxa, V5, P3473; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Katuwal Hem Bahadur, 2013, Asian Journal of Conservation Biology, V2, P21; Kessler Michael, 2001, Diversity and Distributions, V7, P61, DOI 10.1046/j.1472-4642.2001.00097.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Laiolo P, 2004, BIOL CONSERV, V115, P251, DOI 10.1016/S0006-3207(03)00145-9; Lee PF, 2004, J BIOGEOGR, V31, P307, DOI 10.1046/j.0305-0270.2003.00988.x; LEVEY DJ, 1988, ECOL MONOGR, V58, P251, DOI 10.2307/1942539; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; Maggini R, 2011, ECOL MODEL, V222, P21, DOI 10.1016/j.ecolmodel.2010.09.010; Manandhar MS, 1999, NEPAL NATURES PARADI; Manel S, 2000, J APPL ECOL, V37, P756, DOI 10.1046/j.1365-2664.2000.00537.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; Miller-Rushing AJ, 2008, AUK, V125, P565, DOI 10.1525/auk.2008.07005; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Patterson BD, 1998, J BIOGEOGR, V25, P593, DOI 10.1046/j.1365-2699.1998.2530593.x; Paudel PK, 2014, GLOB ECOL CONSERV, V2, P338, DOI 10.1016/j.gecco.2014.10.012; Peh KSH, 2007, CONDOR, V109, P437, DOI 10.1650/0010-5422(2007)109[437:PEOCCO]2.0.CO;2; Petit LJ, 1999, ECOGRAPHY, V22, P292, DOI 10.1111/j.1600-0587.1999.tb00505.x; de Bonilla EPD, 2012, J TROP ECOL, V28, P369, DOI 10.1017/S026646741200034X; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Renner Swen C., 2011, Ornithological Monographs, V70, P1; Renner SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053121; Ruggiero A, 2008, ECOGRAPHY, V31, P306, DOI 10.1111/j.0906-7590.2008.05333.x; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Scheidegger C., 2010, BOT ORIENTALIS, V7, P7; Schulze CH, 2004, ECOL APPL, V14, P1321, DOI 10.1890/02-5409; Shiu Hau-Jie, 2003, Acta Zoologica Taiwanica, V14, P1; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Somveille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070907; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Waltert M, 2005, ECOL APPL, V15, P1351, DOI 10.1890/04-1002; Williams SE, 2010, AUSTRAL ECOL, V35, P650, DOI 10.1111/j.1442-9993.2009.02073.x; Wu YJ, 2013, J BIOGEOGR, V40, P2310, DOI 10.1111/jbi.12177	71	29	34	3	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158362	10.1371/journal.pone.0158362	http://dx.doi.org/10.1371/journal.pone.0158362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0TX	27367903	Green Published, Green Submitted, gold			2022-12-27	WOS:000378914900031
J	Okello, S; Nasasira, B; Muiru, ANW; Muyingo, A				Okello, Samson; Nasasira, Benson; Muiru, Anthony Ndichu Wa; Muyingo, Anthony			Validity and Reliability of a Self-Reported Measure of Antihypertensive Medication Adherence in Uganda	PLOS ONE			English	Article							CARDIOVASCULAR RISK; PREDICTIVE-VALIDITY; HYPERTENSION; POPULATION; HEALTH; SCALE; CARE; SERVICES; VERSION; INCOME	Background The Morisky Medication Adherence scale (MMAS-8) is a widely used self-reported measure of adherence to antihypertensive medications that has not been validated in hypertensive patients in sub-Saharan Africa. Methods We carried out a cross-sectional study to examine psychometric properties of a translated MMAS-8 (MMAS-U) in a tertiary care hypertension clinic in Uganda. We administered the MMAS-U to consecutively selected hypertensive adults and used principal factor analysis and Cronbach's alpha to determine its validity and internal consistency respectively. Then we randomly selected one-sixth of participants for a 2-week test-retest telephone interview. Lastly, we used ordinal logistic regression modeling to explore factors associated with levels of medication adherence. Results Of the 329 participants, 228 (69%) were females, median age of 55 years [Interquartile range (IQR) (46-66)], and median duration of hypertension of 4 years [IQR (2-8)]. The adherence levels were low (MMAS-U score <= 5) in 85%, moderate (MMAS-U score 6-7) in 12% and high (MMAS-U score >= 8) in 3%. The factor analysis of construct validity was good (overall Kaiser's measure of sampling adequacy for residuals of 0.72) and identified unidimensionality of MMAS-U. The internal consistency of MMAS-U was moderate (Cronbach alpha = 0.65), and test-retest reliability was low (weighted kappa = 0.36; 95% CI -0.01, 0.73). Age of 40 years or greater was associated with low medication adherence (p = 0.02) whereas a family member buying medication for participants (p = 0.02) and purchasing medication from a private clinic (p = 0.02) were associated with high adherence. Conclusion The Ugandan version of the MMAS-8 (MMAS-U) is a valid and reliable measure of adherence to antihypertensive medication among Ugandan outpatients receiving care at a public tertiary facility. Though the limited supply of medication affected adherence, this easy to use tool can be adapted to assess medication adherence among adults with hypertension in Uganda.	[Okello, Samson; Nasasira, Benson; Muyingo, Anthony] Mbarara Univ Sci & Technol, Dept Internal Med, Mbarara, Uganda; [Okello, Samson; Muiru, Anthony Ndichu Wa] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Muiru, Anthony Ndichu Wa] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Mbarara University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Okello, S (corresponding author), Mbarara Univ Sci & Technol, Dept Internal Med, Mbarara, Uganda.; Okello, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	okello.samson@must.ac.ug	Okello, Samson/I-1877-2019	Okello, Samson/0000-0001-7377-6094	Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. School of Public Health, Boston, MA, USA	Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. School of Public Health, Boston, MA, USA	Author SO receives support from the Bernard Lown Scholars in Cardiovascular Health Program at Harvard T.H. School of Public Health, Boston, MA, USA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012; [Anonymous], 2011, MAYO CLIN P; [Anonymous], PRACT ASSESS RES EVA; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de Oliveira AD, 2014, RES SOC ADMIN PHARM, V10, P554, DOI 10.1016/j.sapharm.2013.10.006; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Gould E, 2010, GERIATR NURS, V31, P290, DOI 10.1016/j.gerinurse.2010.05.004; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Johnson M J, 1999, Clin Nurs Res, V8, P318, DOI 10.1177/10547739922158331; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Koning A. J., 2003, CONFIDENCE INTERVALS; Korb-Savoldelli V, 2012, J CLIN HYPERTENS, V14, P429, DOI 10.1111/j.1751-7176.2012.00634.x; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Krousel-Wood M, 2005, CURR OPIN CARDIOL, V20, P296, DOI 10.1097/01.hco.0000166597.52335.23; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Lavsa SM, 2011, J AM PHARM ASSOC, V51, P90, DOI 10.1331/JAPhA.2011.09154; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; Moharamzad Y, 2015, GLOBAL J HLTH SCI, V7, pp173; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Norman S, 1984, AM J PREV MED, V1, P10; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Sakthong P, 2009, ANN PHARMACOTHER, V43, P950, DOI 10.1345/aph.1L453; Sankar UV, 2013, ASIA PACIFIC J PUBLI; SHEA S, 1992, AM J PUBLIC HEALTH, V82, P1607, DOI 10.2105/AJPH.82.12.1607; Streiner DL, 2008, REPORTING TEST RESUL, P373, DOI [10.1093/acprof:oso/, DOI 10.1093/ACPROF:OSO/]; Streiner DL, 2014, HLTH MEASUREMENT SCA; Taira DA, 2006, AM J MANAG CARE, V12, P678; Toll BA, 2007, NICOTINE TOB RES, V9, P597, DOI 10.1080/14622200701239662; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d	36	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2016	11	7							e0158499	10.1371/journal.pone.0158499	http://dx.doi.org/10.1371/journal.pone.0158499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0TX	27367542	Green Published, gold			2022-12-27	WOS:000378914900037
J	Chan, K; Coen, M; Hardick, J; Gaydos, CA; Wong, KY; Smith, C; Wilson, SA; Vayugundla, SP; Wong, S				Chan, Kamfai; Coen, Mauricio; Hardick, Justin; Gaydos, Charlotte A.; Wong, Kah-Yat; Smith, Clayton; Wilson, Scott A.; Vayugundla, Siva Praneeth; Wong, Season			Low-Cost 3D Printers Enable High-Quality and Automated Sample Preparation and Molecular Detection	PLOS ONE			English	Article							NUCLEIC-ACID EXTRACTION; DNA EXTRACTION; POINT; PCR; RNA; PURIFICATION; HEALTH; ASSAYS	Most molecular diagnostic assays require upfront sample preparation steps to isolate the target's nucleic acids, followed by its amplification and detection using various nucleic acid amplification techniques. Because molecular diagnostic methods are generally rather difficult to perform manually without highly trained users, automated and integrated systems are highly desirable but too costly for use at point-of-care or low-resource settings. Here, we showcase the development of a low-cost and rapid nucleic acid isolation and amplification platform by modifying entry-level 3D printers that cost between $ 400 and $ 750. Our modifications consisted of replacing the extruder with a tip-comb attachment that houses magnets to conduct magnetic particle-based nucleic acid extraction. We then programmed the 3D printer to conduct motions that can perform high-quality extraction protocols. Up to 12 samples can be processed simultaneously in under 13 minutes and the efficiency of nucleic acid isolation matches well against gold-standard spin-column-based extraction technology. Additionally, we used the 3D printer's heated bed to supply heat to perform water bath-based polymerase chain reactions (PCRs). Using another attachment to hold PCR tubes, the 3D printer was programmed to automate the process of shuttling PCR tubes between water baths. By eliminating the temperature ramping needed in most commercial thermal cyclers, the run time of a 35-cycle PCR protocol was shortened by 33%. This article demonstrates that for applications in resource-limited settings, expensive nucleic acid extraction devices and thermal cyclers that are used in many central laboratories can be potentially replaced by a device modified from inexpensive entry-level 3D printers.	[Chan, Kamfai; Coen, Mauricio; Wong, Kah-Yat; Smith, Clayton; Wilson, Scott A.; Vayugundla, Siva Praneeth; Wong, Season] Al Biosci Inc, College Stn, TX 77845 USA; [Hardick, Justin; Gaydos, Charlotte A.] Johns Hopkins Univ, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University	Wong, S (corresponding author), Al Biosci Inc, College Stn, TX 77845 USA.	season.wong@aibiosciences.com	Gaydos, Charlotte A./E-9937-2010		Small Business Innovative Research (SBIR) grants from the US National Institutes of Health [1R43AI106239, 1R43AI107984]	Small Business Innovative Research (SBIR) grants from the US National Institutes of Health	This work is partly supported by Small Business Innovative Research (SBIR) grants from the US National Institutes of Health, Grant #s 1R43AI106239 and 1R43AI107984. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g; Bordelon H, 2011, ACS APPL MATER INTER, V3, P2161, DOI 10.1021/am2004009; Byrnes S, 2013, ANAL METHODS-UK, V5, P3177, DOI 10.1039/c3ay40162f; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Choi JR, 2015, BIOSENS BIOELECTRON, V74, P427, DOI 10.1016/j.bios.2015.06.065; Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411; Daar AS, 2002, NAT GENET, V32, P229, DOI 10.1038/ng1002-229; Dineva MA, 2007, ANALYST, V132, P1193, DOI 10.1039/b705672a; Dundas N, 2008, J MOL DIAGN, V10, P311, DOI 10.2353/jmoldx.2008.070149; Fu E, 2012, ANAL CHEM, V84, P4574, DOI 10.1021/ac300689s; Fu E, 2011, ANAL CHEM, V83, P7941, DOI 10.1021/ac201950g; HUANG SJ, 2013, PLOS BIOL, V11, DOI DOI 10.1371/JOURNAL.PONE.0060059; Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024; Jangam SR, 2009, J CLIN MICROBIOL, V47, P2363, DOI 10.1128/JCM.r00092-09; Jebrail MJ, 2014, ANAL CHEM, V86, P3856, DOI 10.1021/ac404085p; Jungkind D, 2001, J CLIN VIROL, V20, P1, DOI 10.1016/S1386-6532(00)00148-7; Kim J, 2009, INTEGR BIOL-UK, V1, P574, DOI 10.1039/b905844c; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Linnes JC, 2014, RSC ADV, V4, P42245, DOI 10.1039/c4ra07911f; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Oblath EA, 2013, LAB CHIP, V13, P1325, DOI 10.1039/c3lc40961a; Pan XY, 2011, ELECTROPHORESIS, V32, P3399, DOI 10.1002/elps.201100078; Park TS, 2013, LAB CHIP, V13, P4832, DOI 10.1039/c3lc50976a; Price CW, 2009, LAB CHIP, V9, P2484, DOI 10.1039/b907652m; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Shi X, 2015, LAB CHIP, V15, P1059, DOI 10.1039/c4lc01111b; Strotman L, 2013, ANAL CHEM, V85, P9764, DOI 10.1021/ac402162r; Strotman LN, 2012, ANALYST, V137, P4023, DOI 10.1039/c2an35506j; Sur K, 2010, J MOL DIAGN, V12, P620, DOI 10.2353/jmoldx.2010.090190; Tang YW, 2005, J CLIN MICROBIOL, V43, P4830, DOI 10.1128/JCM.43.9.4830-4833.2005; Vandeventer PE, 2011, J CLIN MICROBIOL, V49, P2533, DOI 10.1128/JCM.02171-10; West SK, 2014, J INFECT DIS, V210, P65, DOI 10.1093/infdis/jiu046; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; You DJ, 2011, BIOSENS BIOELECTRON, V28, P399, DOI 10.1016/j.bios.2011.07.055; Zhang M, 2013, ANAL CHEM, V85, P75, DOI 10.1021/ac301640p	36	47	47	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0158502	10.1371/journal.pone.0158502	http://dx.doi.org/10.1371/journal.pone.0158502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	27362424	Green Published, gold, Green Submitted			2022-12-27	WOS:000378865200084
J	Avila-Rios, S; Sued, O; Rhee, SY; Shafer, RW; Reyes-Teran, G; Ravasi, G				Avila-Rios, Santiago; Sued, Omar; Rhee, Soo-Yon; Shafer, Robert W.; Reyes-Teran, Gustavo; Ravasi, Giovanni			Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRIMARY ANTIRETROVIRAL RESISTANCE; RIO-DE-JANEIRO; NEWLY-DIAGNOSED INDIVIDUALS; REVERSE-TRANSCRIPTASE GENES; TREATMENT-NAIVE INDIVIDUALS; RESOURCE-LIMITED SETTINGS; PREGNANT-WOMEN; MODERATE PREVALENCE; SAO-PAULO	Background HIV transmitted drug resistance (TDR) remains at moderate level in Latin America and the Caribbean (LAC). However, different epidemiologic scenarios could influence national and sub-regional TDR levels and trends. Methods and Findings We performed a systematic review of currently available publications on TDR in antiretroviral treatment-naive adults in LAC. Ninety-eight studies published between January 2000 and June 2015 were included according to critical appraisal criteria and classified by subregion: Brazil (50), Mesoamerica (17), Southern Cone (16), Andean (8) and Caribbean (7). From these, 81 studies encompassing 11,441 individuals with data on DR mutation frequency were included in a meta-analysis. Overall TDR prevalence in LAC was 7.7% (95% CI: 7.2%-8.2%). An increasing trend was observed for overall TDR when comparing 2000-2005 (6.0%) and 2006-2015 (8.2%) (p<0.0001), which was associated with significant NNRTI TDR increase (p<0.0001). NRTI TDR decreased (4.5% vs. 2.3%, p<0.0001). NNRTI TDR increase was associated mainly with K101E, K103N and G190A. NRTI TDR decrease was associated mainly with M184V, K70R and T215Y. All sub-regions reached moderate overall TDR levels. The rapid increase in TDR to all antiretroviral classes in the Caribbean is notable, as well as the significant increase in NNRTI TDR reaching moderate levels in the Southern Cone. NRTI TDR was dominant in 2000-2005, mainly in the Caribbean, Mesoamerica and Brazil. This dominance was lost in 2006-2015 in all sub-regions, with the Southern Cone and the Caribbean switching to NNRTI dominance. PI TDR remained mostly constant with a significant increase only observed in the Caribbean. Conclusions Given the high conceptual and methodological heterogeneity of HIV TDR studies, implementation of surveys with standardized methodology and national representativeness is warranted to generate reliable to inform public health policies. The observed increasing trend in NNRTI TDR supports the need to strengthen TDR surveillance and programme monitoring and evaluation in LAC.	[Avila-Rios, Santiago; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico; [Sued, Omar] Huesped Fdn, Clin Res Sect, Buenos Aires, DF, Argentina; [Rhee, Soo-Yon; Shafer, Robert W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Avila-Rios, Santiago; Ravasi, Giovanni] PAHO, Washington, DC USA	Stanford University; Pan American Health Organization	Avila-Rios, S (corresponding author), Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico.; Ravasi, G (corresponding author), PAHO, Washington, DC USA.	santiago.avila@cieni.org.mx; avasigi@paho.org	Sued, Omar/GRJ-3964-2022; Avila-Rios, Santiago/AAB-4383-2020	Rhee, Soo-Yon/0000-0002-1231-6542; Reyes-Teran, Gustavo/0000-0002-4115-4888	PAHO [ME/CNT/1500013.001]; Mexican Government: Consejo Nacional de Ciencia y Tecnologia (CONACyT) [SALUD-2013-01-202475]; Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068581] Funding Source: NIH RePORTER	PAHO; Mexican Government: Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SAR was supported by grants from the PAHO (ME/CNT/1500013.001) and the Mexican Government: Consejo Nacional de Ciencia y Tecnologia (CONACyT SALUD-2013-01-202475) and Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana.	Acevedo W, 2007, REV MED CHILE, V135, P1406, DOI /S0034-98872007001100006; Afani A, 2005, REV MED CHILE, V133, P295; Afani SA, 2010, REV MED CHILE, V138, P669; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; Alcalde R, 2011, 6TH IAS CONFERENCE O; Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Amarakoon II, 2014, W INDIAN MED J, V63, P596, DOI 10.7727/wimj.2014.016; Ambar RF, 2008, XVII INTERNATIONAL A; Sucupira MCA, 2007, AIDS PATIENT CARE ST, V21, P116, DOI 10.1089/apc.2006.0079; Argel MI, 2008, XVII INTERNATIONAL A; Arreseigor TS, 2010, XVIII INTERNATIONAL; Arruda E, 2011, AIDS RES HUM RETROV, V27, P153, DOI 10.1089/aid.2010.0028; Avila-Rios S, 2015, 24 INT HIV DRUG RES; Avila-Rios S, 2015, AIDS RES HUM RETROV, V31, P401, DOI 10.1089/aid.2014.0057; Avila-Rios S, 2011, REV PANAM SALUD PUBL, V30, P641, DOI 10.1590/S1020-49892011001200024; Avila-Rios S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027812; Bacelar Acioli Lins J, 2010, XVIII INTERNATIONAL; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Barrow GJ, 2013, ANTIVIR THER, V18, P941, DOI 10.3851/IMP2648; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bermudez-Aza EH, 2011, JAIDS-J ACQ IMM DEF, V57, pS186, DOI 10.1097/QAI.0b013e31821e9c36; Bertagnolio S, 2012, CLIN INFECT DIS, V54, pS328, DOI 10.1093/cid/cir938; Boerma JT, 2006, B WORLD HEALTH ORGAN, V84, P145, DOI 10.2471/BLT.05.025189; Bouchard M, 2007, AIDS RES HUM RETROV, V23, P482, DOI 10.1089/aid.2006.0219; Brigido LFM, 2007, AIDS RES HUM RETROV, V23, P1579, DOI 10.1089/aid.2007.0102; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]; Castillo J, 2009, AIDS RES HUM RETROV, V25, P1329, DOI 10.1089/aid.2009.0118; Cecchini D, 2015, MEDICINA-BUENOS AIRE, V75, P163; da Costa ZB, 2013, AIDS PATIENT CARE ST, V27, P439, DOI 10.1089/apc.2012.0448; da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128; de Medeiros LB, 2006, MEM I OSWALDO CRUZ, V101, P845, DOI 10.1590/S0074-02762006000800004; de Medeiros RM, 2011, J MED VIROL, V83, P1682, DOI 10.1002/jmv.22188; Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042; Ferreira JLD, 2008, MEM I OSWALDO CRUZ, V103, P800, DOI 10.1590/S0074-02762008000800010; de Sa DJ, 2009, AIDS RES HUM RETROV, V25, P925, DOI 10.1089/aid.2009.0073; Guimaraes PMD, 2015, AIDS RES HUM RETROV, V31, P1219, DOI [10.1089/aid.2014.0354, 10.1089/AID.2014.0354]; Delgado E, 2001, AIDS RES HUM RETROV, V17, P753, DOI 10.1089/088922201750237022; DiazGranados CA, 2010, INT J INFECT DIS, V14, pE298, DOI 10.1016/j.ijid.2009.05.006; Dilernia DA, 2007, AIDS RES HUM RETROV, V23, P1201, DOI 10.1089/aid.2007.0068; Dumans AT, 2002, ANTIMICROB AGENTS CH, V46, P3075, DOI 10.1128/AAC.46.9.3075-3079.2002; Escoto-Delgadillo M, 2005, HIV MED, V6, P403, DOI 10.1111/j.1468-1293.2005.00326.x; Eyer-Silva WA, 2005, MEM I OSWALDO CRUZ, V100, P869, DOI 10.1590/S0074-02762005000800008; Eyer-Silva WA, 2008, MEM I OSWALDO CRUZ, V103, P143, DOI 10.1590/S0074-02762008000200004; Ferreira AS, 2011, J MED VIROL, V83, P1301, DOI 10.1002/jmv.22128; Frentz D, 2012, AIDS REV, V14, P17; Gagliani LH, 2008, XVII INTERNATIONAL A; Gaspareto KV, 2012, REV INST MED TROP SP, V54, P207, DOI 10.1590/S0036-46652012000400005; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gonsalez CR, 2007, VIRUS RES, V129, P87, DOI 10.1016/j.virusres.2007.06.021; Graf T, 2011, J CLIN VIROL, V51, P186, DOI 10.1016/j.jcv.2011.04.011; Guanira J, 2009, XVIII INTERNATIONAL; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamilton CLC, 2012, AIDS RES HUM RETROV, V28, P923, DOI [10.1089/aid.2011.0312, 10.1089/AID.2011.0312]; Holguin A, 2013, CLIN MICROBIOL INFEC, V19, pE523, DOI 10.1111/1469-0691.12264; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Jack N, 2012, CLIN INFECT DIS, V54, pS290, DOI 10.1093/cid/cir1044; Kijak GH, 2001, ANTIVIR THER, V6, P71; Lama JR, 2006, JAIDS-J ACQ IMM DEF, V42, P501, DOI 10.1097/01.qai.0000221677.29693.dd; Lloyd B, 2008, AIDS RES HUM RETROV, V24, P529, DOI 10.1089/aid.2007.0172; Lourdes de Teixeira M, 2014, INTERNATIONAL JOURNA; Machado LY, 2013, AIDS RES HUM RETROV, V29, P411, DOI [10.1089/AID.2012.0183, 10.1089/aid.2012.0183]; Melo V, 2011, 6TH IAS CONFERENCE O; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Murillo W, 2011, 6TH IAS CONFERENCE O; Murillo W, 2012, J MED VIROL, V84, P1514, DOI 10.1002/jmv.23381; Murillo W, 2010, J CLIN VIROL, V49, P239, DOI 10.1016/j.jcv.2010.03.013; Myers JE, 2012, AIDS RES HUM RETROV, V28, P667, DOI [10.1089/aid.2010.0355, 10.1089/AID.2010.0355]; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; PAHO/WHO, 2014, ANTIRETROVIRAL TREAT; PAHO/WHO, 2013, ANTIRETROVIRAL TREAT; Pando MA, 2011, AIDS RES HUM RETROV, V27, P17, DOI 10.1089/aid.2010.0013; Pando MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-58; Parenti P, 2008, XVII INTERNATIONAL A; Patterson P, 2007, 4TH IAS CONFERENCE O; Ferreira JLP, 2013, ADV VIROL, V2013, DOI 10.1155/2013/878237; Perez F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2565-9; Perez L, 2007, AIDS RES HUM RETROV, V23, P407, DOI 10.1089/aid.2006.0155; Perez L, 2013, INFECT GENET EVOL, V16, P144, DOI 10.1016/j.meegid.2013.02.002; Petroni A, 2006, JAIDS-J ACQ IMM DEF, V42, P506, DOI 10.1097/01.qai.0000222285.44460.e2; Pilotto JH, 2013, AIDS RES HUM RETROV, V29, P681, DOI [10.1089/aid.2011.0333, 10.1089/AID.2011.0333]; Pineda-Pena AC, 2012, AIDS REV, V14, P256; Pires IL, 2004, J CLIN MICROBIOL, V42, P426, DOI 10.1128/JCM.42.1.426-430.2004; Prellwitz IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069033; Rangel HR, 2009, MEM I OSWALDO CRUZ, V104, P522, DOI 10.1590/S0074-02762009000300020; Ravasi G, 2011, REV PANAM SALUD PUBL, V30, P657, DOI 10.1590/S1020-49892011001200026; Reuman EC, 2010, J ANTIMICROB CHEMOTH, V65, P1477, DOI 10.1093/jac/dkq140; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rios M, 2007, J MED VIROL, V79, P647, DOI 10.1002/jmv.20881; Rodrigues R, 2006, VIRUS RES, V116, P201, DOI 10.1016/j.virusres.2005.10.004; Rodrigues R, 2002, XVI INTERNATIONAL AI; Rodrigues R, 2010, XVII INTERNATIONAL A; Rodriguez-Diaz RA, 2007, 4TH IAS CONFERENCE O; Rodriguez-Rodrigues N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18519; Rubio AE, 2009, XVIII INTERNATIONAL; Ruibal-Brunet I J, 2001, Rev Panam Salud Publica, V10, P174, DOI 10.1590/S1020-49892001000900005; Sa-Ferreira JA, 2007, TRANSFUSION, V47, P97, DOI 10.1111/j.1537-2995.2007.01069.x; Cavalcanti AMS, 2012, MEM I OSWALDO CRUZ, V107, P450, DOI 10.1590/S0074-02762012000400002; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Santos AF, 2011, J CLIN VIROL, V52, P373, DOI 10.1016/j.jcv.2011.09.005; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Silva FE, 2008, XVII INTERNATIONAL A; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Moura MES, 2015, J MED VIROL, V87, P798, DOI 10.1002/jmv.24087; Moura MES, 2015, AIDS RES HUM RETROV, V31, P250, DOI 10.1089/aid.2014.0261; Soria J, 2012, AIDS RES HUM RETROV, V28, P333, DOI 10.1089/aid.2011.0131; Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012; Teixeira SLM, 2006, J MED VIROL, V78, P764, DOI 10.1002/jmv.20621; Tupinambas U, 2013, MEM I OSWALDO CRUZ, V108, P470, DOI 10.1590/S0074-0276108042013012; UNAIDS, 2013, UNAIDS REPORT ON THE; UNAIDS, 2015, FAST TRACK ENDING TH; UNAIDS, 2015, AIDS CHANGED EVERYTH; Valle-Bahena OM, 2006, ARCH MED RES, V37, P1022, DOI 10.1016/j.arcmed.2006.05.014; Varella RB, 2009, CURR HIV RES, V7, P601, DOI 10.2174/157016209789973664; Varella RB, 2007, J MED VIROL, V79, P1033, DOI 10.1002/jmv.20845; Vaughan HE, 2003, AIDS RES HUM RETROV, V19, P929, DOI 10.1089/088922203322493120; Cardoso LPV, 2010, J MED VIROL, V82, P351, DOI 10.1002/jmv.21722; Cardoso LPV, 2009, J CLIN VIROL, V46, P134, DOI 10.1016/j.jcv.2009.07.009; Velasco-de-Castro CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087622; Viani RM, 2007, INT J STD AIDS, V18, P235, DOI 10.1258/095646207780658962; WHO, 2015, WHO HIV DRUG RESISTA; WHO, 2015, WHO GLOBAL STRATEGY; WHO, 2015, THE TREATMENT 2 0 FR; WHO, 2015, THE 3 BY 5 INITIATIV; World Health Organization, 2015, GUIDELINE ON WHEN TO; Zapiola I, 2011, 6TH IAS CONFERENCE O	127	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158560	10.1371/journal.pone.0158560	http://dx.doi.org/10.1371/journal.pone.0158560			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355626	gold, Green Published, Green Submitted			2022-12-27	WOS:000378859400077
J	Birules-Muntane, J; Soto-Faraco, S				Birules-Muntane, J.; Soto-Faraco, S.			Watching Subtitled Films Can Help Learning Foreign Languages	PLOS ONE			English	Article							SPEECH-PERCEPTION; MODALITY; INPUT; 1ST	Watching English-spoken films with subtitles is becoming increasingly popular throughout the world. One reason for this trend is the assumption that perceptual learning of the sounds of a foreign language, English, will improve perception skills in non-English speakers. Yet, solid proof for this is scarce. In order to test the potential learning effects derived from watching subtitled media, a group of intermediate Spanish students of English as a foreign language watched a 1h-long episode of a TV drama in its original English version, with English, Spanish or no subtitles overlaid. Before and after the viewing, participants took a listening and vocabulary test to evaluate their speech perception and vocabulary acquisition in English, plus a final plot comprehension test. The results of the listening skills tests revealed that after watching the English subtitled version, participants improved these skills significantly more than after watching the Spanish subtitled or no-subtitles versions. The vocabulary test showed no reliable differences between subtitled conditions. Finally, as one could expect, plot comprehension was best under native, Spanish subtitles. These learning effects with just 1 hour exposure might have major implications with longer exposure times.	[Birules-Muntane, J.; Soto-Faraco, S.] Univ Pompeu Fabra, Cognit & Brain Ctr, Dept Tecnol Informacio & Comunicac, Barcelona, Spain; [Soto-Faraco, S.] ICREA, Barcelona, Spain	Pompeu Fabra University; ICREA	Soto-Faraco, S (corresponding author), Univ Pompeu Fabra, Cognit & Brain Ctr, Dept Tecnol Informacio & Comunicac, Barcelona, Spain.; Soto-Faraco, S (corresponding author), ICREA, Barcelona, Spain.	salvador.soto@icrea.cat	SOTO-FARACO, SALVADOR/B-8400-2011; Birules, Joan/L-4620-2019; Birulés, Joan/AAY-2457-2020; Birulés, Joan/S-2846-2018	SOTO-FARACO, SALVADOR/0000-0002-4799-3762; Birulés, Joan/0000-0001-9708-4922; Birulés, Joan/0000-0001-9708-4922	Ministerio de Economia y Competitividad [PSI2013-42626-P]; AGAUR Generalitat de Catalunya [2014SGR856]; European Research Council [StG-2010 263145]; ICREA Funding Source: Custom	Ministerio de Economia y Competitividad(Spanish Government); AGAUR Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	This research was supported by the Ministerio de Economia y Competitividad (PSI2013-42626-P), AGAUR Generalitat de Catalunya (2014SGR856), and the European Research Council (StG-2010 263145).	Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Bianchi F, 2008, FROM DIDACTAS TO ECO, P69; Bird SA, 2002, APPL PSYCHOLINGUIST, V23, P509, DOI 10.1017/S0142716402004022; Bisson M-J, 2012, APPL PSYCHOLINGUIST, P1; BORRAS I, 1994, MOD LANG J, V78, P61, DOI 10.2307/329253; Brunelliere A, 2013, BRAIN LANG, V125, P82, DOI 10.1016/j.bandl.2013.01.007; Brunken R, 2004, INSTR SCI, V32, P115, DOI 10.1023/B:TRUC.0000021812.96911.c5; Cambridge, 2008, FACE2FACE PLACEMENT, P1; Clarke CM, 2004, J ACOUST SOC AM, V116, P3647, DOI 10.1121/1.1815131; Davis MH, 2007, HEARING RES, V229, P132, DOI 10.1016/j.heares.2007.01.014; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; Keetels M, 2016, ATTEN PERCEPT PSYCHO, V78, P938, DOI 10.3758/s13414-015-1034-y; Kraljic T, 2008, PSYCHOL SCI, V19, P332, DOI 10.1111/j.1467-9280.2008.02090.x; Kruger J., 2014, ATTENTION DISTRIBUTI, V7, P1; Kruger J.-L., 2013, P EYE TRACK S AFR, P62, DOI 10.1145/2509315.2509331; Mitterer H, 2009, PLOS ONE, V4, pA146, DOI 10.1371/journal.pone.0007785; Norris D, 2003, COGNITIVE PSYCHOL, V47, P204, DOI 10.1016/S0010-0285(03)00006-9; Pallier C, 1997, COGNITION, V64, pB9, DOI 10.1016/S0010-0277(97)00030-9; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Perego E, 2010, MEDIA PSYCHOL, V13, P243, DOI 10.1080/15213269.2010.502873; Sebastian-Galles N, 2012, LANG LEARN, V62, P131, DOI 10.1111/j.1467-9922.2012.00709.x; Sydorenko T, 2010, LANG LEARN TECHNOL, V14, P50; Vulchanova M, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01510; Winke P, 2010, LANG LEARN TECHNOL, V14, P65; Zarei A., 2009, PAZHUHESH E ZABANHA, P65; Zarei A.A., 2011, J LANG TEACH RES, V2, P618, DOI [10.4304/jltr.2.3.618-625, DOI 10.4304/JLTR.2.3.618-625]	26	23	24	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158409	10.1371/journal.pone.0158409	http://dx.doi.org/10.1371/journal.pone.0158409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	27355343	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400062
J	Rowley, MI; Coolen, ACC; Vojnovic, B; Barber, PR				Rowley, Mark I.; Coolen, Anthonius C. C.; Vojnovic, Borivoj; Barber, Paul R.			Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; GLOBAL ANALYSIS; MICROSCOPY; FRET; CELLS; ACTIVATION; PARAMETERS; MOLECULES	We present novel Bayesian methods for the analysis of exponential decay data that exploit the evidence carried by every detected decay event and enables robust extension to advanced processing. Our algorithms are presented in the context of fluorescence lifetime imaging microscopy (FLIM) and particular attention has been paid to model the time-domain system (based on time-correlated single photon counting) with unprecedented accuracy. We present estimates of decay parameters for mono- and bi-exponential systems, offering up to a factor of two improvement in accuracy compared to previous popular techniques. Results of the analysis of synthetic and experimental data are presented, and areas where the superior precision of our techniques can be exploited in Forster Resonance Energy Transfer (FRET) experiments are described. Furthermore, we demonstrate two advanced processing methods: decay model selection to choose between differing models such as mono- and bi-exponential, and the simultaneous estimation of instrument and decay parameters.	[Rowley, Mark I.; Coolen, Anthonius C. C.; Barber, Paul R.] Kings Coll London, Inst Math & Mol Biomed, London, England; [Vojnovic, Borivoj; Barber, Paul R.] Univ Oxford, Dept Oncol, Canc Res UK & Med Res Council, Oxford Inst Radiat Oncol, Oxford, England	University of London; King's College London; Cancer Research UK; University of Oxford	Rowley, MI (corresponding author), Kings Coll London, Inst Math & Mol Biomed, London, England.	mark.rowley@kcl.ac.uk	Vojnovic, Borivoj/AAV-4756-2021; LARIJANI, Professor Banafshe/H-3909-2015	Vojnovic, Borivoj/0000-0001-9013-3816; Barber, Paul/0000-0002-8595-1141; LARIJANI, Professor Banafshe/0000-0003-4735-1169	Cancer Research UK [C133/A/1812]; Engineering and Physical Sciences Research Council [EP/C546105/1, EP/C546113/1]; Cancer Research UK [15677] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E032400/1] Funding Source: researchfish; Medical Research Council [MC_PC_15031] Funding Source: researchfish; EPSRC [EP/E032400/1, EP/C546113/1] Funding Source: UKRI; MRC [MC_PC_15031] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK (www.cancerresearchuk.org), Programme grant C133/A/1812: BV, and Engineering and Physical Sciences Research Council (www.epsrc.ac.uk), EP/C546105/1 and EP/C546113/1: BV ACCC.	Ameer-Beg SM, 2005, PROC SPIE, V5700, P152, DOI 10.1117/12.589202; BAJZER Z, 1991, EUR BIOPHYS J BIOPHY, V20, P247, DOI 10.1007/BF00450560; Barber PR, 2013, J MICROSC-OXFORD, V251, P154, DOI 10.1111/jmi.12057; Barber PR, 2010, BIOMED OPT EXPRESS, V1, P1148, DOI 10.1364/BOE.1.001148; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Barber PR, 2015, SLIM CURVE AN OPEN S; Becker W., 2008, THE BH TCSPC HANDBOO; Bhandari A, 2015, OPTICA, V2, P965, DOI 10.1364/OPTICA.2.000965; Bishop CM, 1995, NEURAL NETWORKS PATT; Cheng PC, 2006, THE HANDBOOK OF BIOL, P162; Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dabir AS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103342; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Esposito A, 2012, REMOTE SENS-BASEL, V4, P111, DOI 10.3390/rs4010111; Flannery B. P., 1992, NUMERICAL RECIPES IN; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gerritsen HC, 2002, J MICROSC-OXFORD, V206, P218, DOI 10.1046/j.1365-2818.2002.01031.x; Grecco HE, 2009, OPT EXPRESS, V17, P6493, DOI 10.1364/OE.17.006493; HALL P, 1981, J PHYS CHEM-US, V85, P2941, DOI 10.1021/j150620a019; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Jo JA, 2005, IEEE J SEL TOP QUANT, V11, P835, DOI 10.1109/JSTQE.2005.857685; LAKOWICZ JR, 1992, ANAL BIOCHEM, V202, P316, DOI 10.1016/0003-2697(92)90112-K; Lakowicz JR., 1983, PRINCIPLES OF FLUORE; Laurence TA, 2010, NAT METHODS, V7, P338, DOI 10.1038/nmeth0510-338; Lenz MO, 2011, P SOC PHOTO-OPT INS, V7903; Leung RWK, 2011, BIOMED OPT EXPRESS, V2, P2517, DOI 10.1364/BOE.2.002517; Levine Y., 1997, J FLUORESC, V7, P11, DOI DOI 10.1007/BF02764572; Makrogianneli K, 2009, MOL CELL BIOL, V29, P2997, DOI 10.1128/MCB.01008-08; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Nishimura G, 2005, PHYS MED BIOL, V50, P1327, DOI 10.1088/0031-9155/50/6/019; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pawley J., 2006, HANDBOOK OF BIOLOGIC; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; PLOEM JS, 1987, APPL OPTICS, V26, P3226, DOI 10.1364/AO.26.003226; Rowley MI, 2011, PROC SPIE, V7903, DOI 10.1117/12.873890; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; TELLINGHUISEN J, 1993, ANAL CHEM, V65, P1240, DOI 10.1021/ac00057a022; Turton DA, 2003, ANAL CHEM, V75, P4182, DOI 10.1021/ac034325k; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1	44	27	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158404	10.1371/journal.pone.0158404	http://dx.doi.org/10.1371/journal.pone.0158404			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AM	27355322	Green Published, gold, Green Submitted			2022-12-27	WOS:000378859400061
J	He, XY; Lillemo, M; Shi, JR; Wu, JR; Bjornstad, A; Belova, T; Dreisigacker, S; Duveiller, E; Singh, P				He, Xinyao; Lillemo, Morten; Shi, Jianrong; Wu, Jirong; Bjornstad, Asmund; Belova, Tatiana; Dreisigacker, Susanne; Duveiller, Etienne; Singh, Pawan			QTL Characterization of Fusarium Head Blight Resistance in CIMMYT Bread Wheat Line Soru#1	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; X WANGSHUIBAI POPULATION; DEOXYNIVALENOL ACCUMULATION; ANTHER EXTRUSION; PLANT HEIGHT; IDENTIFICATION; BARLEY; GRAMINEARUM; INFECTION; SELECTION	Fusarium head blight (FHB) resistant line Soru#1 was hybridized with the German cultivar Naxos to generate 131 recombinant inbred lines for QTL mapping. The population was phenotyped for FHB and associated traits in spray inoculated experiments in El Batan (Mexico), spawn inoculated experiments in As (Norway) and point inoculated experiments in Nanjing (China), with two field trials at each location. Genotyping was performed with the Illumina iSelect 90K SNP wheat chip, along with a few SSR and STS markers. A major QTL for FHB after spray and spawn inoculation was detected on 2DLc, explaining 15-22% of the phenotypic variation in different experiments. This QTL remained significant after correction for days to heading (DH) and plant height (PH), while another QTL for FHB detected at the Vrn-A1 locus on 5AL almost disappeared after correction for DH and PH. Minor QTL were detected on chromosomes 2AS, 2DL, 4AL, 4DS and SDL. In point inoculated experiments, QTL on 2DS, 3AS, 4AL and 5AL were identified in single environments. The mechanism of resistance of Soru#1 to FHB was mainly of Type I for resistance to initial infection, conditioned by the major QTL on 2DLc and minor ones that often coincided with QTL for DH, PH and anther extrusion (AE). This indicates that phenological and morphological traits and flowering biology play important roles in resistance/escape of FHB. SNPs tightly linked to resistance QTL, particularly 2DLc, could be utilized in breeding programs to facilitate the transfer and selection of those QTL.	[He, Xinyao; Dreisigacker, Susanne; Duveiller, Etienne; Singh, Pawan] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Edo De Mexico, Mexico; [He, Xinyao; Lillemo, Morten; Bjornstad, Asmund; Belova, Tatiana] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Shi, Jianrong; Wu, Jirong] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Norwegian University of Life Sciences; Jiangsu Academy of Agricultural Sciences	Singh, P (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Edo De Mexico, Mexico.; Lillemo, M (corresponding author), Norwegian Univ Life Sci, Dept Plant Sci, As, Norway.	morten.lillemo@nmbu.no; pk.singh@cgiar.org	SINGH, PAWAN KUMAR/E-3408-2013; Shi, Jianrong/AAQ-3456-2020; Lillemo, Morten/H-9406-2019; Shi, Jianrong/AAQ-1805-2020	SINGH, PAWAN KUMAR/0000-0002-9598-7981; Shi, Jianrong/0000-0003-3818-5074; Lillemo, Morten/0000-0002-8594-8794; shi, jianrong/0000-0001-8650-248X; He, Xinyao/0000-0003-0217-9510; Singh, Pawan/0000-0003-4610-3120	CGIAR Research Program on Wheat; CGIAR scholarship by the Research Council of Norway [208340/H30]	CGIAR Research Program on Wheat(CGIAR); CGIAR scholarship by the Research Council of Norway(CGIAR)	Financial support by the CGIAR Research Program on Wheat is gratefully acknowledged. The first author is grateful for the financial support from a CGIAR scholarship, provided by the Research Council of Norway, through NFR project 208340/H30 - Breeding for Fusarium resistance in wheat.; Financial support by the CGIAR Research Program on Wheat is gratefully acknowledged. The first author is grateful for the financial support from a CGIAR scholarship, provided by the Research Council of Norway, through NFR project 208340/H30-Breeding for Fusarium resistance in wheat. The authors also like to thank Yalew Tarkegne and Anne Guri Maroy at As, and Francisco Lopez, Javier Segura and Nerida Lozano at El Batan for technical help.	Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Belova T, 2014, THEOR APPL GENET, V127, P2029, DOI 10.1007/s00122-014-2358-z; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Buerstmayr H, 2012, CABI PLANT PROT SER, P236, DOI 10.1079/9781845938185.0236; Buerstmayr M, 2015, THEOR APPL GENET, V128, P1519, DOI 10.1007/s00122-015-2527-8; Buerstmayr M, 2011, THEOR APPL GENET, V123, P293, DOI 10.1007/s00122-011-1584-x; Chu CG, 2011, THEOR APPL GENET, V123, P1107, DOI 10.1007/s00122-011-1652-2; Diethelm M, 2014, MOL BREEDING, V34, P31, DOI 10.1007/s11032-013-0010-2; Dreisigacker S, 2011, P 21 INT TRIT MAPP I, P105; Duveiller E, 2014, MYCOTOXIN REDUCTION IN GRAIN CHAINS, P220; [EC] European Commission, 2006, OFF J EUR UNION, V364; Emrich K, 2008, THEOR APPL GENET, V117, P65, DOI 10.1007/s00122-008-0753-z; Faris J.D., 2014, GENOMICS PLANT GENET, P439, DOI 10.1007/978-94-007-7572-5_18/TABLES/1; Gervais L, 2003, THEOR APPL GENET, V106, P961, DOI 10.1007/S00122-002-1160-5; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; He XY, 2013, EUR J PLANT PATHOL, V136, P123, DOI 10.1007/s10658-012-0146-7; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jantasuriyarat C, 2004, THEOR APPL GENET, V108, P261, DOI 10.1007/s00122-003-1432-8; Jiang GL, 2007, THEOR APPL GENET, V115, P1043, DOI 10.1007/s00122-007-0630-1; Jiang GL, 2007, THEOR APPL GENET, V116, P3, DOI 10.1007/s00122-007-0641-y; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Klahr A, 2007, EUPHYTICA, V154, P17, DOI 10.1007/s10681-006-9264-7; Kubo K, 2013, J PHYTOPATHOL, V161, P308, DOI 10.1111/jph.12060; Lewis JM, 2004, P 2 INT S FUS HEAD B, P89; Lin F, 2006, THEOR APPL GENET, V112, P528, DOI 10.1007/s00122-005-0156-3; Lin F, 2004, THEOR APPL GENET, V109, P1504, DOI 10.1007/s00122-004-1772-z; Liu SY, 2012, CROP SCI, V52, P2283, DOI 10.2135/cropsci2012.03.0144; Liu SY, 2009, CROP SCI, V49, P1955, DOI 10.2135/cropsci2009.03.0115; Long XY, 2015, PHYSIOL MOL PLANT P, V90, P1, DOI 10.1016/j.pmpp.2015.02.002; Lu QX, 2014, THEOR APPL GENET, V127, P2635, DOI 10.1007/s00122-014-2404-x; Lu QX, 2013, THEOR APPL GENET, V126, P317, DOI 10.1007/s00122-012-1981-9; Mao SL, 2010, EUPHYTICA, V174, P343, DOI 10.1007/s10681-010-0128-9; Mardi M, 2005, PLANT BREEDING, V124, P329, DOI 10.1111/j.1439-0523.2005.01103.x; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; MILLER JD, 1986, CAN J PLANT PATHOL, V8, P147; Osman M, 2015, EUPHYTICA, V205, P521, DOI 10.1007/s10681-015-1425-0; Paillard S, 2004, THEOR APPL GENET, V109, P323, DOI 10.1007/s00122-004-1628-6; SCHROEDER HW, 1963, PHYTOPATHOLOGY, V53, P831; Shi JR, 2008, GENETICA, V133, P77, DOI 10.1007/s10709-007-9186-x; Singh, 2013, FUSARIUM HEAD BLIGHT, P241; Skinnes H, 2010, PLANT BREEDING, V129, P149, DOI 10.1111/j.1439-0523.2009.01731.x; Somers DJ, 2003, GENOME, V46, P555, DOI 10.1139/G03-033; Srinivasachary, 2009, THEOR APPL GENET, V118, P695, DOI 10.1007/s00122-008-0930-0; Stack R. W., 1994, VISUAL SCALE ESTIMAT, P1095; Van Ginkel M., 2002, P NAT FUS HEAD BLIGH, P268; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xue S, 2010, THEOR APPL GENET, V121, P147, DOI 10.1007/s00122-010-1298-5; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Zhang QJ, 2014, MOL BREEDING, V34, P1677, DOI 10.1007/s11032-014-0180-6; Zhu ZW, 2016, EUPHYTICA, V208, P367, DOI 10.1007/s10681-015-1612-z	56	18	22	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0158052	10.1371/journal.pone.0158052	http://dx.doi.org/10.1371/journal.pone.0158052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351632	Green Published, gold, Green Accepted			2022-12-27	WOS:000378858900029
J	Lee, SG; Huang, MQ; Obholzer, ND; Sun, S; Li, WY; Petrillo, M; Dai, P; Zhou, Y; Cotanche, DA; Megason, SG; Li, HW; Chen, ZY				Lee, Sang Goo; Huang, Mingqian; Obholzer, Nikolaus D.; Sun, Shan; Li, Wenyan; Petrillo, Marco; Dai, Pu; Zhou, Yi; Cotanche, Douglas A.; Megason, Sean G.; Li, Huawei; Chen, Zheng-Yi			Myc and Fgf Are Required for Zebrafish Neuromast Hair Cell Regeneration	PLOS ONE			English	Article							GROWTH-FACTOR FAMILY; INNER-EAR; LATERAL-LINE; C-MYC; GENE-EXPRESSION; DANIO-RERIO; IN-VIVO; DIFFERENTIAL EXPRESSION; EPITHELIAL TRANSITION; RECEPTOR SPECIFICITY	Unlike mammals, the non-mammalian vertebrate inner ear can regenerate the sensory cells, hair cells, either spontaneously or through induction after hair cell loss, leading to hearing recovery. The mechanisms underlying the regeneration are poorly understood. By microarray analysis on a chick model, we show that chick hair cell regeneration involves the activation of proliferation genes and downregulation of differentiation genes. Both MYC and FGF are activated in chick hair cell regeneration. Using a zebrafish lateral line neuromast hair cell regeneration model, we show that the specific inhibition of Myc or Fgf suppresses hair cell regeneration, demonstrating that both pathways are essential to the process. Rapid upregulation of Myc and delayed Fgf activation during regeneration suggest a role of Myc in proliferation and Fgf in differentiation. The dorsal-ventral pattern of fgfr1a in the neuromasts overlaps with the distribution of hair cell precursors. By laser ablation, we show that the fgfr1a-positive supporting cells are likely the hair cell precursors that directly give rise to new hair cells; whereas the anterior-posterior fgfr1a-negative supporting cells have heightened proliferation capacity, likely to serve as more primitive progenitor cells to replenish lost precursors after hair cell loss. Thus fgfr1a is likely to mark compartmentalized supporting cell subtypes with different capacities in renewal proliferation and hair cell regeneration. Manipulation of c-MYC and FGF pathways could be explored for mammalian hair cell regeneration.	[Lee, Sang Goo; Huang, Mingqian; Sun, Shan; Li, Wenyan; Petrillo, Marco; Chen, Zheng-Yi] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA; [Lee, Sang Goo; Huang, Mingqian; Sun, Shan; Li, Wenyan; Petrillo, Marco; Chen, Zheng-Yi] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Obholzer, Nikolaus D.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Sun, Shan; Li, Wenyan; Li, Huawei] Fudan Univ, Shanghai Med Coll, Shanghai Eye & ENT Hosp, Dept Otorhinolaryngol, Shanghai 200433, Peoples R China; [Dai, Pu] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing 100853, Peoples R China; [Zhou, Yi] Childrens Hosp Boston, Stem Cell Program, Boston, MA USA; [Zhou, Yi] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA USA; [Zhou, Yi] Dana Farber Canc Inst, Boston, MA 02115 USA; [Cotanche, Douglas A.] Univ Massachusetts, Sch Med, Cell & Dev Biol, Worcester, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Fudan University; Chinese People's Liberation Army General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Massachusetts System; University of Massachusetts Worcester	Chen, ZY (corresponding author), Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA.; Chen, ZY (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA.; Li, HW (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Eye & ENT Hosp, Dept Otorhinolaryngol, Shanghai 200433, Peoples R China.	hwli@shmu.edu.cn; Zheng-Yi_Chen@meei.harvard.edu	Sun, Shan/GLR-2365-2022	Sun, Shan/0000-0003-2142-4307; Huang, Mingqian/0000-0003-0870-9199; petrillo, marco/0000-0003-2526-6166	National Institutes of Health [R01 DC06908, DC010791]; Frederick & Ines Yeatts Hair Cell Regeneration Grant; Major State Basic Research Development Program of China (973 Program) [2011cb504506]; National Natural Science Foundation of China [81230019, 81470687, 81400463]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick & Ines Yeatts Hair Cell Regeneration Grant; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institutes of Health (R01 DC06908 to ZYC and and DC010791 to SGM), The Frederick & Ines Yeatts Hair Cell Regeneration Grant (ZYC), The Major State Basic Research Development Program of China (973 Program) (2011cb504506) and The National Natural Science Foundation of China (nos. 81230019, 81470687, 81400463) (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bermingham-McDonogh O, 2001, DEV BIOL, V238, P247, DOI 10.1006/dbio.2001.0412; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Brignull HR, 2009, BRAIN RES, V1277, P12, DOI 10.1016/j.brainres.2009.02.028; Burns JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048704; Chen ZY, 2002, JARO-J ASSOC RES OTO, V3, P140, DOI 10.1007/s101620020029; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; CORWIN JT, 1981, J COMP NEUROL, V201, P541, DOI 10.1002/cne.902010406; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dominguez-Frutos E, 2011, J NEUROSCI, V31, P7178, DOI 10.1523/JNEUROSCI.0785-11.2011; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Giorello L, 1998, CANCER RES, V58, P3654; Hargrave Murray, 2006, Methods Mol Biol, V326, P103; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hayashi T, 2010, DEV DYNAM, V239, P1019, DOI 10.1002/dvdy.22236; Hu ZQ, 2007, P NATL ACAD SCI USA, V104, P16675, DOI 10.1073/pnas.0704576104; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang MQ, 2011, CELL CYCLE, V10, P337, DOI 10.4161/cc.10.2.14640; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Jacques BE, 2012, HEARING RES, V289, P27, DOI 10.1016/j.heares.2012.04.018; Jiang LJ, 2014, P NATL ACAD SCI USA, V111, pE1383, DOI 10.1073/pnas.1402898111; Kopecky B, 2011, DEV DYNAM, V240, P1373, DOI 10.1002/dvdy.22620; Kwan KY, 2015, STEM CELL REP, V4, P47, DOI 10.1016/j.stemcr.2014.11.001; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lele Z, 1997, DEV GENET, V21, P123, DOI 10.1002/(SICI)1520-6408(1997)21:2<123::AID-DVG2>3.0.CO;2-9; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li C., 2003, ANAL GENE EXPRESSION, P120; Li H, 1999, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V13, P173; Liang J, 2012, J NEUROSCI, V32, P10662, DOI 10.1523/JNEUROSCI.5785-10.2012; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; Lush ME, 2014, DEV DYNAM, V243, P1187, DOI [10.1002/DVDY.24167, 10.1002/dvdy.24167]; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; Marandel L, 2012, MOL REPROD DEV, V79, P85, DOI 10.1002/mrd.22004; May LA, 2013, J CLIN INVEST, V123, P3577, DOI 10.1172/JCI68480; Menescal LA, 2012, DIS MODEL MECH, V5, P492, DOI 10.1242/dmm.008730; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Murakami SL, 2003, HEARING RES, V186, P47, DOI 10.1016/S0378-5955(03)00259-4; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Roberson DW, 2000, HEARING RES, V141, P155, DOI 10.1016/S0378-5955(99)00218-X; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Romero-Carvajal A, 2015, DEV CELL, V34, P267, DOI 10.1016/j.devcel.2015.05.025; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schimmang T, 2007, INT J DEV BIOL, V51, P473, DOI 10.1387/ijdb.072334ts; SCHREIBERAGUS N, 1993, MOL CELL BIOL, V13, P2765, DOI 10.1128/MCB.13.5.2765; Shi JW, 2013, CELL CYCLE, V12, P1119, DOI 10.4161/cc.24164; Steiner AB, 2014, P NATL ACAD SCI USA, V111, pE1393, DOI 10.1073/pnas.1318692111; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wibowo I, 2011, DEVELOPMENT, V138, P1143, DOI 10.1242/dev.060566; Wright TJ, 2003, CURR TOP DEV BIOL, V57, P225, DOI 10.1016/S0070-2153(03)57008-9; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	74	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2016	11	6							e0157768	10.1371/journal.pone.0157768	http://dx.doi.org/10.1371/journal.pone.0157768			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0AH	27351484	Green Published, gold, Green Submitted			2022-12-27	WOS:000378858900017
